Citrus Sinensis ID: 041080

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------
Protein Sequence
DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPRCGQANC
Secondary Structure (PSIPRED)
cccEEEEEEEEccccccccHHHHHHHHHHHHHHcccccccccEEEEEEEEccEEEEEEEEcccccHHHHHHHccccHHHHHHHHHHHHHHHHHHccccccccccccccEEEcccccEEEEccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHccccccccccHHHHHHHccccccccccccccHHHHHHHHHHHcccccccccHHHHHccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccEEEEEEEcHHHHHHccHHHHHHHHHHHHHHHHHccccEEEEEEEEcccccEEEEEEEEcccHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEcccccEEccccccccccHHHHccccccccccccHHHHHHHHHHHHHcccccccHHHHHHHHHHHccccccccccccHHHHHHHHHHccccccccccHHHHHccccHccccccccccHccc
Coil and Loop (DISEMBL)
DGFFFAVKEvslqdqgaqgKQSILQLEQEISLLSQFEQDNIVqylgtdkdenRLYIFLELVTKgslanlyqkyhlsdsqvsSYTRQILNGLVYLHERNVVHRDIKCANILvdasgsvkladfglakattmndlksckgtpfwmapevvnskndgygltADIWSLGCTVlemltrrppyshlegVQALFRigkgelpsvpsslsrDARDFILKCLqvnpndrptvtelmehpfvkrplqtprcgqanc
Flexible Loop (DISEMBL)
DGFFFAVKevslqdqgaqgKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELmehpfvkrplqtprcgqanc
Low Complexity Region (SEG)
DGFFFAVKEVSLQDQGAQGKqsilqleqeisllsqFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPRCGQANC
Disordered region (IsUnstruct)
***FFAVK**************ILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE***********ARDFILKCLQVN******************************
Disordered Region (DISOPRED)
DGFFFAVKEVS****************QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF***************
Disordered Region (DISEMBL)
DGFFFAVKEVS**********SILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQ*********
Disordered Region (DISPRO)
*GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPRC*****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPRCGQANC
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	247	2.2.26 [Sep-21-2011]
Q39008	608	Mitogen-activated protein	yes	no	0.959	0.389	0.710	4e-95
Q9SZ67	1895	Probable WRKY transcripti	no	no	0.935	0.121	0.626	2e-78
O22040	666	Mitogen-activated protein	no	no	0.931	0.345	0.483	5e-56
Q9FZ36	651	Mitogen-activated protein	no	no	0.931	0.353	0.466	4e-55
O22042	651	Mitogen-activated protein	no	no	0.959	0.364	0.429	5e-52
Q54R82	942	Mitogen-activated protein	yes	no	0.931	0.244	0.418	5e-52
E9Q3S4	1311	Mitogen-activated protein	yes	no	0.935	0.176	0.429	1e-49
P28829	659	Protein kinase byr2 OS=Sc	yes	no	0.931	0.349	0.434	1e-49
Q8T2I8	1167	Serine/threonine-protein	no	no	0.975	0.206	0.404	1e-48
Q56UN5	1328	Mitogen-activated protein	no	no	0.939	0.174	0.406	3e-48

>sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2

 Score =  347 bits (891), Expect = 4e-95,   Method: Compositional matrix adjust.
 Identities = 169/238 (71%), Positives = 194/238 (81%), Gaps = 1/238 (0%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           DG FFAVKEVSL DQG+Q ++ I QLE EI LLSQ +  NIV+Y GT KD + LYIFLEL
Sbjct: 354 DGDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQLQHQNIVRYRGTAKDGSNLYIFLEL 413

Query: 61  VTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
           VT+GSL  LYQ+Y L DS VS YTRQIL+GL YLH++  +HRDIKCANILVDA+G+VKLA
Sbjct: 414 VTQGSLLKLYQRYQLRDSVVSLYTRQILDGLKYLHDKGFIHRDIKCANILVDANGAVKLA 473

Query: 121 DFGLAKATTMNDLKSCKGTPFWMAPEVVNSKN-DGYGLTADIWSLGCTVLEMLTRRPPYS 179
           DFGLAK +  ND+KSCKGTPFWMAPEV+N K+ DGYG  ADIWSLGCTVLEM T + PYS
Sbjct: 474 DFGLAKVSKFNDIKSCKGTPFWMAPEVINRKDSDGYGSPADIWSLGCTVLEMCTGQIPYS 533

Query: 180 HLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL 237
            LE VQALFRIG+G LP VP +LS DAR FILKCL+VNP +RPT  EL+ HPFV+RPL
Sbjct: 534 DLEPVQALFRIGRGTLPEVPDTLSLDARLFILKCLKVNPEERPTAAELLNHPFVRRPL 591

Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5

>sp|Q9SZ67|WRK19_ARATH Probable WRKY transcription factor 19 OS=Arabidopsis thaliana GN=WRKY19 PE=2 SV=1

 Score =  292 bits (747), Expect = 2e-78,   Method: Compositional matrix adjust.
 Identities = 151/241 (62%), Positives = 180/241 (74%), Gaps = 10/241 (4%)

Query: 1    DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
            DG FFA KEVSL DQG+Q  + I Q+E  I+LLSQ +  NIV+Y GT KDE+ LYIFLEL
Sbjct: 1647 DGDFFAFKEVSLLDQGSQAHEWIQQVEGGIALLSQLQHQNIVRYRGTTKDESNLYIFLEL 1706

Query: 61   VTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
            VT+GSL  LYQ+  L DS VS YTRQIL+GL YLH++  +HR+IKCAN+LVDA+G+VKLA
Sbjct: 1707 VTQGSLRKLYQRNQLGDSVVSLYTRQILDGLKYLHDKGFIHRNIKCANVLVDANGTVKLA 1766

Query: 121  DFGLAKATTMNDLKSCKGTPF--WMAPEVV-NSKN-DGYGLTADIWSLGCTVLEMLTRRP 176
            DFGLAK  ++        TP+  WMAPEV+ N K+ DGYG  ADIWSLGCTVLEMLT + 
Sbjct: 1767 DFGLAKVMSLWR------TPYWNWMAPEVILNPKDYDGYGTPADIWSLGCTVLEMLTGQI 1820

Query: 177  PYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP 236
            PYS LE   AL+ IG G+LP +P  LS DARDFIL CL+VNP +RPT  EL+ HPFV  P
Sbjct: 1821 PYSDLEIGTALYNIGTGKLPKIPDILSLDARDFILTCLKVNPEERPTAAELLNHPFVNMP 1880

Query: 237  L 237
            L
Sbjct: 1881 L 1881

Transcription factor. Interacts specifically with the W box (5'-(T)TGAC[CT]-3'), a frequently occurring elicitor-responsive cis-acting element. May act also as a disease resistance protein with a serine/threonine-protein kinase activity.

Arabidopsis thaliana (taxid: 3702)

>sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2

 Score =  217 bits (553), Expect = 5e-56,   Method: Compositional matrix adjust.
 Identities = 117/242 (48%), Positives = 162/242 (66%), Gaps = 12/242 (4%)

Query: 2   GFFFAVKEVSLQDQGAQGKQS---ILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFL 58
           G   AVK+V +    A  +++   I +LE+E+ LL      NIV+YLGT ++++ L I L
Sbjct: 92  GELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLKNLSHPNIVRYLGTVREDDTLNILL 151

Query: 59  ELVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV 117
           E V  GS+++L +K+    +S V +YTRQ+L GL YLH   ++HRDIK ANILVD  G +
Sbjct: 152 EFVPGGSISSLLEKFGPFPESVVRTYTRQLLLGLEYLHNHAIMHRDIKGANILVDNKGCI 211

Query: 118 KLADFG----LAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
           KLADFG    +A+  TM   KS KGTP+WMAPEV+     G+  +ADIWS+GCTV+EM+T
Sbjct: 212 KLADFGASKQVAELATMTGAKSMKGTPYWMAPEVI--LQTGHSFSADIWSVGCTVIEMVT 269

Query: 174 RRPPYS-HLEGVQALFRIGKGEL-PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP 231
            + P+S   + V A+F IG  +  P +P +LS DA+DF+LKCLQ  PN RPT +EL++HP
Sbjct: 270 GKAPWSQQYKEVAAIFFIGTTKSHPPIPDTLSSDAKDFLLKCLQEVPNLRPTASELLKHP 329

Query: 232 FV 233
           FV
Sbjct: 330 FV 331

May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1

 Score =  214 bits (545), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 113/242 (46%), Positives = 160/242 (66%), Gaps = 12/242 (4%)

Query: 2   GFFFAVKEVSLQDQGAQGKQS---ILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFL 58
           G   AVK+V +    A  +++   I +LE+E+ LL      NIV+YLGT +++  L I L
Sbjct: 91  GELLAVKQVLITSNCASKEKTQAHIQELEEEVKLLKNLSHPNIVRYLGTVREDETLNILL 150

Query: 59  ELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV 117
           E V  GS+++L +K+    +S V +YT Q+L GL YLH   ++HRDIK ANILVD  G +
Sbjct: 151 EFVPGGSISSLLEKFGAFPESVVRTYTNQLLLGLEYLHNHAIMHRDIKGANILVDNQGCI 210

Query: 118 KLADFG----LAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
           KLADFG    +A+  T++  KS KGTP+WMAPEV+     G+  +ADIWS+GCTV+EM+T
Sbjct: 211 KLADFGASKQVAELATISGAKSMKGTPYWMAPEVI--LQTGHSFSADIWSVGCTVIEMVT 268

Query: 174 RRPPYS-HLEGVQALFRIGKGEL-PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP 231
            + P+S   + + A+F IG  +  P +P ++S DA DF+LKCLQ  PN RPT +EL++HP
Sbjct: 269 GKAPWSQQYKEIAAIFHIGTTKSHPPIPDNISSDANDFLLKCLQQEPNLRPTASELLKHP 328

Query: 232 FV 233
           FV
Sbjct: 329 FV 330

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1

 Score =  204 bits (519), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 107/249 (42%), Positives = 157/249 (63%), Gaps = 12/249 (4%)

Query: 2   GFFFAVKEVSLQDQGAQGKQS---ILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFL 58
           G   A+K+V +    A  +++   I +LE+E+ LL      NIV+YLGT ++ + L I +
Sbjct: 91  GELLAIKQVLIAPSSASKEKTQGHIRELEEEVQLLKNLSHPNIVRYLGTVRESDSLNILM 150

Query: 59  ELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV 117
           E V  GS+++L +K+    +  +  YT+Q+L GL YLH   ++HRDIK ANILVD  G +
Sbjct: 151 EFVPGGSISSLLEKFGSFPEPVIIMYTKQLLLGLEYLHNNGIMHRDIKGANILVDNKGCI 210

Query: 118 KLADFGLAKA----TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
           +LADFG +K      T+N  KS KGTP+WMAPEV+     G+  +ADIWS+GCTV+EM T
Sbjct: 211 RLADFGASKKVVELATVNGAKSMKGTPYWMAPEVI--LQTGHSFSADIWSVGCTVIEMAT 268

Query: 174 RRPPYS-HLEGVQALFRIGKGEL-PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP 231
            +PP+S   +   A+  IG+ +  P +P  LS +A+DF++KCL   P+ R + TEL++HP
Sbjct: 269 GKPPWSEQYQQFAAVLHIGRTKAHPPIPEDLSPEAKDFLMKCLHKEPSLRLSATELLQHP 328

Query: 232 FVKRPLQTP 240
           FV    Q P
Sbjct: 329 FVTGKRQEP 337

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2

 Score =  204 bits (519), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 100/239 (41%), Positives = 161/239 (67%), Gaps = 9/239 (3%)

Query: 2   GFFFAVKEVSLQDQGA--QGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLE 59
           G  FAVK++ + D  +  + K  IL   +EI ++     DNIV+YLGT  D++ L +FLE
Sbjct: 193 GELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRSLRHDNIVRYLGTSLDQSFLSVFLE 252

Query: 60  LVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
            +  GS+++L  K+   S++ +  YT+QIL GL +LH  +++HRDIK ANIL+D  G VK
Sbjct: 253 YIPGGSISSLLGKFGAFSENVIKVYTKQILQGLSFLHANSIIHRDIKGANILIDTKGIVK 312

Query: 119 LADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP 176
           L+DFG +K+ +  ++  KS +GTP+WMAPEV+  K  G+G ++DIWSLGC ++EM T +P
Sbjct: 313 LSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVI--KQTGHGRSSDIWSLGCVIVEMATAQP 370

Query: 177 PYSHLEGVQA-LFRIGKG-ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           P+S++  + A ++ I     +P++PS +S++A DF+  C + +P +RP   +L++HPF+
Sbjct: 371 PWSNITELAAVMYHIASSNSIPNIPSHMSQEAFDFLNLCFKRDPKERPDANQLLKHPFI 429

Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|E9Q3S4|M3K19_MOUSE Mitogen-activated protein kinase kinase kinase 19 OS=Mus musculus GN=Map3k19 PE=3 SV=1

 Score =  196 bits (498), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 106/247 (42%), Positives = 156/247 (63%), Gaps = 16/247 (6%)

Query: 2    GFFFAVKEVSL--QDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLE 59
            G   AVK+V+L   D+ A  K+   +L++E+ LL   +  NIV YLGT  +EN L IF+E
Sbjct: 1066 GQLIAVKQVALDTSDKLATEKE-YRKLQEEVDLLKALKHVNIVAYLGTCLEENTLSIFME 1124

Query: 60   LVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
             V  GS++++  ++  L +     YTRQIL G+ YLH+  VVHRDIK  N+++  +G +K
Sbjct: 1125 FVPGGSISSIINRFGPLPEMVFCKYTRQILQGVAYLHDNCVVHRDIKGNNVMLMPTGIIK 1184

Query: 119  LADFGLAK--------ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            L DFG AK         T  + LKS +GTP+WMAPEV+N    GYG  +DIWS+GCTV E
Sbjct: 1185 LIDFGCAKRLAWAGLNGTHSDMLKSMRGTPYWMAPEVIN--ESGYGRKSDIWSIGCTVFE 1242

Query: 171  MLTRRPPYSHLEGVQALFRIG--KGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
            M T +PP + ++ + A+F IG  +G +P +P+  S  A DF+  CL  + ++RP+  +L+
Sbjct: 1243 MATGKPPLASMDRMAAMFYIGAHRGLMPPLPARFSEPAADFVRLCLTRDQHERPSALQLL 1302

Query: 229  EHPFVKR 235
            +H F+KR
Sbjct: 1303 KHSFLKR 1309

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P28829|BYR2_SCHPO Protein kinase byr2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=byr2 PE=1 SV=1

 Score =  196 bits (498), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 106/244 (43%), Positives = 150/244 (61%), Gaps = 14/244 (5%)

Query: 2   GFFFAVKEV---SLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFL 58
           G   AVK+V   S+ +   +  + +  L  EI+LL +   ++IVQYLG++ + + L IFL
Sbjct: 417 GELMAVKQVILDSVSESKDRHAKLLDALAGEIALLQELSHEHIVQYLGSNLNSDHLNIFL 476

Query: 59  ELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV 117
           E V  GS+A L   Y    ++ V ++ +Q L GL YLH R +VHRDIK ANILVD  G +
Sbjct: 477 EYVPGGSVAGLLTMYGSFEETLVKNFIKQTLKGLEYLHSRGIVHRDIKGANILVDNKGKI 536

Query: 118 KLADFGLAKATTMNDLK--------SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVL 169
           K++DFG++K   +N           S +G+ FWMAPEVV  K   +    DIWSLGC V+
Sbjct: 537 KISDFGISKKLELNSTSTKTGGARPSFQGSSFWMAPEVV--KQTMHTEKTDIWSLGCLVI 594

Query: 170 EMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
           EMLT + PY + + +QA+FRIG+  LP  PS++S  A DF+ K   ++ N RPT +EL+ 
Sbjct: 595 EMLTSKHPYPNCDQMQAIFRIGENILPEFPSNISSSAIDFLEKTFAIDCNLRPTASELLS 654

Query: 230 HPFV 233
           HPFV
Sbjct: 655 HPFV 658

Serine/threonine protein kinase involved in conjugation and sporulation. It is thought that it phosphorylates the byr1 protein kinase which itself phosphorylate the spk1 kinase.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q8T2I8|SEPA_DICDI Serine/threonine-protein kinase sepA OS=Dictyostelium discoideum GN=sepA PE=2 SV=1

 Score =  193 bits (490), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 102/252 (40%), Positives = 150/252 (59%), Gaps = 11/252 (4%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           DG F A+K+++L        Q I+    EI LL      NIV+Y+   K ++ LYI LE 
Sbjct: 40  DGDFVAIKQINLTKIPKDQLQGIMN---EIDLLKNLNHANIVKYIKYVKTKDNLYIVLEY 96

Query: 61  VTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
           V  GSL+ + +K+    ++ V  Y RQ+L GLVYLHE+ VVHRDIK ANIL    G +KL
Sbjct: 97  VENGSLSGIIKKFGKFPETLVCVYIRQVLEGLVYLHEQGVVHRDIKGANILTTKEGKIKL 156

Query: 120 ADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYS 179
           ADFG+A         +  GTP+WMAPE++    +G    +DIWS+GCTV+E+LT  PPY 
Sbjct: 157 ADFGVATKFDDTSAAAVVGTPYWMAPEIIEL--NGATTKSDIWSVGCTVIELLTGSPPYY 214

Query: 180 HLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV-----K 234
            L  + ALFRI + + P +P  +S   +D++++C Q +PN R +  +L++H ++     K
Sbjct: 215 DLGQMPALFRIVQDDCPPLPEGISPPLKDWLMQCFQKDPNLRISAQKLLKHKWIQASIKK 274

Query: 235 RPLQTPRCGQAN 246
           +P++    G  N
Sbjct: 275 KPVENGAGGVGN 286

Serine/threonine-protein kinase involved in the spatial and temporal control system organizing cortical activities in mitotic and postmitotic cells.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q56UN5|M3K19_HUMAN Mitogen-activated protein kinase kinase kinase 19 OS=Homo sapiens GN=MAP3K19 PE=2 SV=1

 Score =  192 bits (487), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 100/246 (40%), Positives = 151/246 (61%), Gaps = 14/246 (5%)

Query: 2    GFFFAVKEVSLQDQGA-QGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
            G   AVK+V+L        ++   +L++E+ LL   +  NIV YLGT   EN + IF+E 
Sbjct: 1083 GQLIAVKQVALDTSNKLAAEKEYRKLQEEVDLLKALKHVNIVAYLGTCLQENTVSIFMEF 1142

Query: 61   VTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
            V  GS++++  ++  L +     YT+QIL G+ YLHE  VVHRDIK  N+++  +G +KL
Sbjct: 1143 VPGGSISSIINRFGPLPEMVFCKYTKQILQGVAYLHENCVVHRDIKGNNVMLMPTGIIKL 1202

Query: 120  ADFGLAK--------ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
             DFG A+         T  + LKS  GTP+WMAPEV+N    GYG  +DIWS+GCTV EM
Sbjct: 1203 IDFGCARRLAWAGLNGTHSDMLKSMHGTPYWMAPEVINE--SGYGRKSDIWSIGCTVFEM 1260

Query: 172  LTRRPPYSHLEGVQALFRIG--KGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
             T +PP + ++ + A+F IG  +G +P +P   S +A DF+  CL  + ++RP+  +L++
Sbjct: 1261 ATGKPPLASMDRMAAMFYIGAHRGLMPPLPDHFSENAADFVRMCLTRDQHERPSALQLLK 1320

Query: 230  HPFVKR 235
            H F++R
Sbjct: 1321 HSFLER 1326

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	247
255587684	451	Mitogen-activated protein kinase kinase	0.967	0.529	0.820	1e-114
359486016	559	PREDICTED: mitogen-activated protein kin	0.967	0.427	0.820	1e-113
298204644	719	unnamed protein product [Vitis vinifera]	0.967	0.332	0.820	1e-113
356557517	440	PREDICTED: mitogen-activated protein kin	0.971	0.545	0.804	1e-112
255545546	555	Mitogen-activated protein kinase kinase	0.959	0.427	0.805	1e-110
224082218	548	predicted protein [Populus trichocarpa]	0.967	0.436	0.799	1e-109
224066881	558	predicted protein [Populus trichocarpa]	0.967	0.428	0.786	1e-108
225459451	567	PREDICTED: mitogen-activated protein kin	0.967	0.421	0.790	1e-107
302141878	273	unnamed protein product [Vitis vinifera]	0.967	0.875	0.790	1e-107
359486102	418	PREDICTED: mitogen-activated protein kin	0.975	0.576	0.773	1e-107

>gi|255587684|ref|XP_002534356.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis] gi|223525440|gb|EEF28029.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis]

 Score =  416 bits (1069), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 196/239 (82%), Positives = 215/239 (89%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           DGFFFA+KEVSL DQG+QGKQSILQLEQEISLL  FE +NIV+YLGT+KDE +LYIFLEL
Sbjct: 199 DGFFFAIKEVSLLDQGSQGKQSILQLEQEISLLRAFEHENIVRYLGTEKDEAKLYIFLEL 258

Query: 61  VTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
            TKGSLA LYQKYHL DS VS+YTRQILNGL YLH+RNVVHRDIKCANILVDA+GSVKLA
Sbjct: 259 ATKGSLARLYQKYHLRDSHVSAYTRQILNGLKYLHDRNVVHRDIKCANILVDANGSVKLA 318

Query: 121 DFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSH 180
           DFGLAKATTMND+KSCKGT FWMAPEVVN KN GYGL ADIWSLGCTVLE+LT RPPYSH
Sbjct: 319 DFGLAKATTMNDVKSCKGTVFWMAPEVVNLKNRGYGLAADIWSLGCTVLELLTGRPPYSH 378

Query: 181 LEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQT 239
           LEG+QALFRIGKGE P +  SLS DARDFIL+CLQVNP +RPT  +L++HPFVKRP +T
Sbjct: 379 LEGMQALFRIGKGEPPPIADSLSTDARDFILRCLQVNPTNRPTAAQLLDHPFVKRPHET 437

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359486016|ref|XP_002264549.2| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Vitis vinifera]

 Score =  414 bits (1063), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 196/239 (82%), Positives = 217/239 (90%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           DGFFFAVKEVSL DQG+QGKQSI QLEQEISLLSQFE +NIV+Y GTDKD+++LYIFLEL
Sbjct: 307 DGFFFAVKEVSLLDQGSQGKQSIYQLEQEISLLSQFEHENIVRYYGTDKDDSKLYIFLEL 366

Query: 61  VTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
           VTKGSL +LYQKY L +SQ S+YTRQILNGL YLHE+NVVHRDIKCANILVD +GSVKLA
Sbjct: 367 VTKGSLLSLYQKYDLRESQASAYTRQILNGLKYLHEQNVVHRDIKCANILVDVNGSVKLA 426

Query: 121 DFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSH 180
           DFGLAKAT +ND+KSCKGT FWMAPEVVN KN GYGL ADIWSLGCTVLE+LTRRPPYSH
Sbjct: 427 DFGLAKATKLNDVKSCKGTVFWMAPEVVNRKNKGYGLAADIWSLGCTVLEILTRRPPYSH 486

Query: 181 LEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQT 239
           LEG+QALFRIGKGE P V +SLS DAR+FILKCLQVNP+DRPT  +L++HPFVKRPL T
Sbjct: 487 LEGMQALFRIGKGEPPPVSNSLSSDARNFILKCLQVNPSDRPTAGQLLDHPFVKRPLHT 545

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|298204644|emb|CBI23919.3| unnamed protein product [Vitis vinifera]

 Score =  413 bits (1061), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 196/239 (82%), Positives = 217/239 (90%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           DGFFFAVKEVSL DQG+QGKQSI QLEQEISLLSQFE +NIV+Y GTDKD+++LYIFLEL
Sbjct: 467 DGFFFAVKEVSLLDQGSQGKQSIYQLEQEISLLSQFEHENIVRYYGTDKDDSKLYIFLEL 526

Query: 61  VTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
           VTKGSL +LYQKY L +SQ S+YTRQILNGL YLHE+NVVHRDIKCANILVD +GSVKLA
Sbjct: 527 VTKGSLLSLYQKYDLRESQASAYTRQILNGLKYLHEQNVVHRDIKCANILVDVNGSVKLA 586

Query: 121 DFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSH 180
           DFGLAKAT +ND+KSCKGT FWMAPEVVN KN GYGL ADIWSLGCTVLE+LTRRPPYSH
Sbjct: 587 DFGLAKATKLNDVKSCKGTVFWMAPEVVNRKNKGYGLAADIWSLGCTVLEILTRRPPYSH 646

Query: 181 LEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQT 239
           LEG+QALFRIGKGE P V +SLS DAR+FILKCLQVNP+DRPT  +L++HPFVKRPL T
Sbjct: 647 LEGMQALFRIGKGEPPPVSNSLSSDARNFILKCLQVNPSDRPTAGQLLDHPFVKRPLHT 705

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356557517|ref|XP_003547062.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max]

 Score =  411 bits (1056), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 193/240 (80%), Positives = 217/240 (90%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           DG FFAVKEVSL D G+QGKQS+ QL+QEISLLSQF  DNIV+YLGTDKD+++LYIFLEL
Sbjct: 188 DGNFFAVKEVSLLDDGSQGKQSLFQLQQEISLLSQFRHDNIVRYLGTDKDDDKLYIFLEL 247

Query: 61  VTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
           VTKGSLA+LYQKY L DSQVS+YTRQIL+GL YLH+RNVVHRDIKCANILVDA+GSVKLA
Sbjct: 248 VTKGSLASLYQKYRLRDSQVSAYTRQILSGLKYLHDRNVVHRDIKCANILVDANGSVKLA 307

Query: 121 DFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSH 180
           DFGLAKAT +ND+KS KG+P+WMAPEVVN +N GYGL ADIWSLGCTVLEMLTR+PPYSH
Sbjct: 308 DFGLAKATKLNDVKSSKGSPYWMAPEVVNLRNRGYGLAADIWSLGCTVLEMLTRQPPYSH 367

Query: 181 LEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTP 240
           LEG+QALFRIG+G+ P VP SLS DARDFILKCLQVNPN RPT   L++HPFVKRPL +P
Sbjct: 368 LEGMQALFRIGRGQPPPVPESLSTDARDFILKCLQVNPNKRPTAARLLDHPFVKRPLLSP 427

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255545546|ref|XP_002513833.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis] gi|223546919|gb|EEF48416.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis]

 Score =  402 bits (1033), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 191/237 (80%), Positives = 212/237 (89%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           DGFFFA+KEVSL DQG+QGKQSI QLEQEI+LLSQFE +NIV+Y GTDKD++ LYIFLEL
Sbjct: 304 DGFFFAIKEVSLLDQGSQGKQSIYQLEQEIALLSQFEHENIVRYYGTDKDDSNLYIFLEL 363

Query: 61  VTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
           VT+GSL NLYQ+YHL DSQVS+YTRQIL+GL YLH+RNVVHRDIKCANILVDASGSVKLA
Sbjct: 364 VTQGSLMNLYQRYHLRDSQVSAYTRQILHGLKYLHDRNVVHRDIKCANILVDASGSVKLA 423

Query: 121 DFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSH 180
           DFGLAKAT +ND+KSCKGT FWMAPEVVN K  GYGL ADIWSLGCTVLEMLTR+ PYSH
Sbjct: 424 DFGLAKATKLNDVKSCKGTAFWMAPEVVNRKTHGYGLPADIWSLGCTVLEMLTRQVPYSH 483

Query: 181 LEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL 237
           LE +QALFRIGKG  P VP SLS DARDFIL+CLQVNPN RPT  +L+EH FV++PL
Sbjct: 484 LECMQALFRIGKGVPPPVPDSLSNDARDFILQCLQVNPNGRPTAAQLLEHSFVRQPL 540

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224082218|ref|XP_002306607.1| predicted protein [Populus trichocarpa] gi|222856056|gb|EEE93603.1| predicted protein [Populus trichocarpa]

 Score =  400 bits (1029), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 191/239 (79%), Positives = 214/239 (89%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           DGFFFAVKEVSL DQG+QGKQSI QLEQEI+LLS+FE +NIVQY GTDKDE++LYIFLEL
Sbjct: 297 DGFFFAVKEVSLLDQGSQGKQSIYQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL 356

Query: 61  VTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
           VTKGSL  LYQ+Y+L DSQVS+YTRQIL+GL YLH++NVVHRDIKCAN+LVDA+GSVKLA
Sbjct: 357 VTKGSLLKLYQRYNLRDSQVSAYTRQILHGLKYLHDQNVVHRDIKCANLLVDANGSVKLA 416

Query: 121 DFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSH 180
           DFGLAKAT  ND+KSCKGT FWMAPEVVN+KN GYGL ADIWSLGCTVLEMLTR+ PYS 
Sbjct: 417 DFGLAKATKFNDVKSCKGTAFWMAPEVVNNKNQGYGLPADIWSLGCTVLEMLTRQIPYSE 476

Query: 181 LEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQT 239
           LE +QALFRIG+G  P VP SLS DARDFIL+CLQVNPNDRPT   L++HPF+KRPL T
Sbjct: 477 LESMQALFRIGRGVPPLVPDSLSNDARDFILQCLQVNPNDRPTAAVLLDHPFMKRPLPT 535

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224066881|ref|XP_002302260.1| predicted protein [Populus trichocarpa] gi|222843986|gb|EEE81533.1| predicted protein [Populus trichocarpa]

 Score =  395 bits (1016), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 188/239 (78%), Positives = 214/239 (89%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           DGFFFAVKEVSL DQG++GKQSI QLEQEI+LLS+FE +NIVQY GTDKDE++LYIFLEL
Sbjct: 307 DGFFFAVKEVSLLDQGSKGKQSIYQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL 366

Query: 61  VTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
           VTKGSL  LYQ+Y+L DSQVSSYTRQIL+GL YLH++NVVHRDIKCAN+LVDA+GSVKLA
Sbjct: 367 VTKGSLQKLYQRYNLRDSQVSSYTRQILHGLKYLHDQNVVHRDIKCANLLVDANGSVKLA 426

Query: 121 DFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSH 180
           DFGLAKAT +ND+KSCKGT FWMAPEVVN+KN GYGL ADIWSLGCTVLEMLTR+ PYS 
Sbjct: 427 DFGLAKATKLNDVKSCKGTAFWMAPEVVNNKNQGYGLPADIWSLGCTVLEMLTRQIPYSE 486

Query: 181 LEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQT 239
           LE +QALFRIG+G  P VP SLS DAR+FIL+C+QVNPNDRPT   L++HPFVK+ L T
Sbjct: 487 LESMQALFRIGRGVPPLVPDSLSNDAREFILQCIQVNPNDRPTAAVLLDHPFVKKLLPT 545

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225459451|ref|XP_002284356.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Vitis vinifera]

 Score =  394 bits (1013), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 189/239 (79%), Positives = 208/239 (87%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           DG FFAVKEVSL DQG+QGKQS+ QLEQEI LLSQF+ +NIVQY GT KDE++LYIFLEL
Sbjct: 315 DGIFFAVKEVSLLDQGSQGKQSLYQLEQEIDLLSQFQHENIVQYHGTAKDESKLYIFLEL 374

Query: 61  VTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
           VTKGSLA+LYQ+Y+L DSQ S+YTRQIL+GL YLHERNV+HRDIKCANILV A+GSVKL+
Sbjct: 375 VTKGSLASLYQRYNLGDSQASAYTRQILHGLNYLHERNVIHRDIKCANILVGANGSVKLS 434

Query: 121 DFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSH 180
           DFGLAKAT +ND KSCKGTPFWMAPEVVN K  GYGL ADIWSLGCTVLEMLTR  PYSH
Sbjct: 435 DFGLAKATQLNDAKSCKGTPFWMAPEVVNGKGQGYGLAADIWSLGCTVLEMLTREVPYSH 494

Query: 181 LEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQT 239
           LE +QALFRIGKGE P VP SLS DARDFILKCLQV P+DRPT  +L+ H FVKRP  T
Sbjct: 495 LESMQALFRIGKGEPPPVPDSLSPDARDFILKCLQVIPDDRPTAAQLLNHQFVKRPPPT 553

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302141878|emb|CBI19081.3| unnamed protein product [Vitis vinifera]

 Score =  394 bits (1013), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 189/239 (79%), Positives = 208/239 (87%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           DG FFAVKEVSL DQG+QGKQS+ QLEQEI LLSQF+ +NIVQY GT KDE++LYIFLEL
Sbjct: 21  DGIFFAVKEVSLLDQGSQGKQSLYQLEQEIDLLSQFQHENIVQYHGTAKDESKLYIFLEL 80

Query: 61  VTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
           VTKGSLA+LYQ+Y+L DSQ S+YTRQIL+GL YLHERNV+HRDIKCANILV A+GSVKL+
Sbjct: 81  VTKGSLASLYQRYNLGDSQASAYTRQILHGLNYLHERNVIHRDIKCANILVGANGSVKLS 140

Query: 121 DFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSH 180
           DFGLAKAT +ND KSCKGTPFWMAPEVVN K  GYGL ADIWSLGCTVLEMLTR  PYSH
Sbjct: 141 DFGLAKATQLNDAKSCKGTPFWMAPEVVNGKGQGYGLAADIWSLGCTVLEMLTREVPYSH 200

Query: 181 LEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQT 239
           LE +QALFRIGKGE P VP SLS DARDFILKCLQV P+DRPT  +L+ H FVKRP  T
Sbjct: 201 LESMQALFRIGKGEPPPVPDSLSPDARDFILKCLQVIPDDRPTAAQLLNHQFVKRPPPT 259

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359486102|ref|XP_002274605.2| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Vitis vinifera]

 Score =  394 bits (1012), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 188/243 (77%), Positives = 211/243 (86%), Gaps = 2/243 (0%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           DGFFFAVKEVSL DQG +GKQSI QLEQEISLLSQ E +NIV+Y GT+KD+++LYIFLEL
Sbjct: 170 DGFFFAVKEVSLLDQGGKGKQSIYQLEQEISLLSQLEHENIVRYYGTNKDDSKLYIFLEL 229

Query: 61  VTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
           VTKGSL +LYQKYHL +SQ S YT+QILNGL YLHE+NVVHRDIKCANILVD  GSVK+A
Sbjct: 230 VTKGSLLSLYQKYHLQESQASVYTKQILNGLKYLHEQNVVHRDIKCANILVDVHGSVKIA 289

Query: 121 DFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSH 180
           DFGLAKAT +ND+KSC+GTPFWMAPEVVN KN+GYGL  DIWSLGCTVLEMLTRRPPYSH
Sbjct: 290 DFGLAKATKLNDVKSCRGTPFWMAPEVVNWKNEGYGLATDIWSLGCTVLEMLTRRPPYSH 349

Query: 181 LEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL--Q 238
           LEG Q + +I + E P VP S S DARDFILKCLQVNP+DRPT  EL++HPFVKRP   Q
Sbjct: 350 LEGGQVISKIYRSEPPDVPDSFSSDARDFILKCLQVNPSDRPTAGELLDHPFVKRPSGPQ 409

Query: 239 TPR 241
           +PR
Sbjct: 410 SPR 412

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	247
TAIR|locus:2133559	608	MEKK1 "MAPK/ERK kinase kinase	0.983	0.399	0.655	3.2e-81
TAIR|locus:2133539	773	MAPKKK9 "mitogen-activated pro	0.995	0.318	0.611	1.5e-76
TAIR|locus:2133529	560	MEKK3 "MAPK/ERK kinase kinase	0.943	0.416	0.615	1.6e-72
TAIR|locus:2118116	1895	WRKY19 [Arabidopsis thaliana (	0.971	0.126	0.58	9.9e-67
TAIR|locus:2026674	883	YDA "YODA" [Arabidopsis thalia	0.963	0.269	0.471	1.6e-55
TAIR|locus:2024832	609	MAP3KA "mitogen-activated prot	0.939	0.380	0.483	8.9e-54
TAIR|locus:2035989	666	NP1 "NPK1-related protein kina	0.777	0.288	0.522	1.4e-48
TAIR|locus:2174969	716	MAPKKK5 "mitogen-activated pro	0.947	0.326	0.437	2.9e-48
UNIPROTKB|Q40541	690	Q40541 "Protein kinase" [Nicot	0.963	0.344	0.432	5.4e-47
DICTYBASE|DDB_G0283265	1267	mkkA "octicosapeptide/Phox/Bem	0.931	0.181	0.401	2e-45

TAIR|locus:2133559 MEKK1 "MAPK/ERK kinase kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 815 (292.0 bits), Expect = 3.2e-81, P = 3.2e-81
 Identities = 160/244 (65%), Positives = 185/244 (75%)

Query:     1 DGFFFAVKEVSLQDQGAQGKXXXXXXXXXXXXXXXFEQDNIVQYLGTDKDENRLYIFLEL 60
             DG FFAVKEVSL DQG+Q +                +  NIV+Y GT KD + LYIFLEL
Sbjct:   354 DGDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQLQHQNIVRYRGTAKDGSNLYIFLEL 413

Query:    61 VTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
             VT+GSL  LYQ+Y L DS VS YTRQIL+GL YLH++  +HRDIKCANILVDA+G+VKLA
Sbjct:   414 VTQGSLLKLYQRYQLRDSVVSLYTRQILDGLKYLHDKGFIHRDIKCANILVDANGAVKLA 473

Query:   121 DFGLAKATTMNDLKSCKGTPFWMAPEVVNSKN-DGYGLTADIWSLGCTVLEMLTRRPPYS 179
             DFGLAK +  ND+KSCKGTPFWMAPEV+N K+ DGYG  ADIWSLGCTVLEM T + PYS
Sbjct:   474 DFGLAKVSKFNDIKSCKGTPFWMAPEVINRKDSDGYGSPADIWSLGCTVLEMCTGQIPYS 533

Query:   180 HLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQT 239
              LE VQALFRIG+G LP VP +LS DAR FILKCL+VNP +RPT  EL+ HPFV+RPL +
Sbjct:   534 DLEPVQALFRIGRGTLPEVPDTLSLDARLFILKCLKVNPEERPTAAELLNHPFVRRPLPS 593

Query:   240 PRCG 243
                G
Sbjct:   594 VGSG 597

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046686 "response to cadmium ion" evidence=IGI

GO:0006970 "response to osmotic stress" evidence=IGI;IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009611 "response to wounding" evidence=RCA;IDA

GO:0003677 "DNA binding" evidence=IDA

GO:0019900 "kinase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000165 "MAPK cascade" evidence=IMP;RCA;IPI

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0009620 "response to fungus" evidence=RCA

GO:0009695 "jasmonic acid biosynthetic process" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

TAIR|locus:2133539 MAPKKK9 "mitogen-activated protein kinase kinase kinase 9" [Arabidopsis thaliana (taxid:3702)]

 Score = 771 (276.5 bits), Expect = 1.5e-76, P = 1.5e-76
 Identities = 151/247 (61%), Positives = 182/247 (73%)

Query:     1 DGFFFAVKEVSLQDQGAQGKXXXXXXXXXXXXXXXFEQDNIVQYLGTDKDENRLYIFLEL 60
             DG FFAVKEVSL DQG+Q +                E  NI++Y GTDKD + LYIFLEL
Sbjct:   522 DGDFFAVKEVSLLDQGSQAQECIQQLEGEIALLSQLEHQNILRYRGTDKDGSNLYIFLEL 581

Query:    61 VTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
             VT+GSL  LY++Y + DS +S YT+QIL+GL YLH +  +HRDIKCA ILVDA+G+VKLA
Sbjct:   582 VTQGSLLELYRRYQIRDSLISLYTKQILDGLKYLHHKGFIHRDIKCATILVDANGTVKLA 641

Query:   121 DFGLAKATTMNDLKSCKGTPFWMAPEVVNSK-NDGYGLTADIWSLGCTVLEMLTRRPPYS 179
             DFGLAK + +ND+KS K T FWMAPEV+N K NDGY   ADIWSLGCTVLEM T + PYS
Sbjct:   642 DFGLAKVSKLNDIKSRKETLFWMAPEVINRKDNDGYRSPADIWSLGCTVLEMCTGQIPYS 701

Query:   180 HLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQT 239
              LE V+ALFRI +G LP VP +LS DAR FILKCL++NP +RPT TEL+ HPFV+RPL +
Sbjct:   702 DLEPVEALFRIRRGTLPEVPDTLSLDARHFILKCLKLNPEERPTATELLNHPFVRRPLPS 761

Query:   240 PRCGQAN 246
                G  +
Sbjct:   762 SGSGSTS 768

GO:0005737 "cytoplasm" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0031347 "regulation of defense response" evidence=IMP

TAIR|locus:2133529 MEKK3 "MAPK/ERK kinase kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 733 (263.1 bits), Expect = 1.6e-72, P = 1.6e-72
 Identities = 144/234 (61%), Positives = 174/234 (74%)

Query:     1 DGFFFAVKEVSLQDQGAQGKXXXXXXXXXXXXXXXFEQDNIVQYLGTDKDENRLYIFLEL 60
             DG FFAVKEVSL D+G Q +                +  NIV+Y GT KD ++LYIFLEL
Sbjct:   324 DGDFFAVKEVSLLDKGIQAQECIQQLEGEIALLSQLQHQNIVRYRGTAKDVSKLYIFLEL 383

Query:    61 VTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
             VT+GS+  LY++Y LS + VS YTRQIL GL YLH++  VHRDIKCAN+LVDA+G+VKLA
Sbjct:   384 VTQGSVQKLYERYQLSYTVVSLYTRQILAGLNYLHDKGFVHRDIKCANMLVDANGTVKLA 443

Query:   121 DFGLAKATTMNDLKSCKGTPFWMAPEVVNSKN-DGYGLTADIWSLGCTVLEMLTRRPPYS 179
             DFGLA+A+  ND+ SCKGT FWMAPEV+N K+ DG G  ADIWSLGCTVLEM T + PYS
Sbjct:   444 DFGLAEASKFNDIMSCKGTLFWMAPEVINRKDSDGNGSPADIWSLGCTVLEMCTGQIPYS 503

Query:   180 HLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
              L+ +QA F+IG+G LP VP +LS DAR FIL CL+VNP +RPT  EL+ HPFV
Sbjct:   504 DLKPIQAAFKIGRGTLPDVPDTLSLDARHFILTCLKVNPEERPTAAELLHHPFV 557

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

TAIR|locus:2118116 WRKY19 [Arabidopsis thaliana (taxid:3702)]

 Score = 692 (248.7 bits), Expect = 9.9e-67, P = 9.9e-67
 Identities = 145/250 (58%), Positives = 172/250 (68%)

Query:     1 DGFFFAVKEVSLQDQGAQGKXXXXXXXXXXXXXXXFEQDNIVQYLGTDKDENRLYIFLEL 60
             DG FFA KEVSL DQG+Q                  +  NIV+Y GT KDE+ LYIFLEL
Sbjct:  1647 DGDFFAFKEVSLLDQGSQAHEWIQQVEGGIALLSQLQHQNIVRYRGTTKDESNLYIFLEL 1706

Query:    61 VTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
             VT+GSL  LYQ+  L DS VS YTRQIL+GL YLH++  +HR+IKCAN+LVDA+G+VKLA
Sbjct:  1707 VTQGSLRKLYQRNQLGDSVVSLYTRQILDGLKYLHDKGFIHRNIKCANVLVDANGTVKLA 1766

Query:   121 DFGLAKATTMNDLKSCKGTPFW--MAPEVV-NSKN-DGYGLTADIWSLGCTVLEMLTRRP 176
             DFGLAK      + S   TP+W  MAPEV+ N K+ DGYG  ADIWSLGCTVLEMLT + 
Sbjct:  1767 DFGLAK------VMSLWRTPYWNWMAPEVILNPKDYDGYGTPADIWSLGCTVLEMLTGQI 1820

Query:   177 PYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP 236
             PYS LE   AL+ IG G+LP +P  LS DARDFIL CL+VNP +RPT  EL+ HPFV  P
Sbjct:  1821 PYSDLEIGTALYNIGTGKLPKIPDILSLDARDFILTCLKVNPEERPTAAELLNHPFVNMP 1880

Query:   237 LQTPRCGQAN 246
             L +   G  +
Sbjct:  1881 LPSSGSGSVS 1890

GO:0000166 "nucleotide binding" evidence=IEA

GO:0003700 "sequence-specific DNA binding transcription factor activity" evidence=IEA;ISS

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005622 "intracellular" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0006952 "defense response" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0017111 "nucleoside-triphosphatase activity" evidence=IEA

GO:0043531 "ADP binding" evidence=IEA

GO:0043565 "sequence-specific DNA binding" evidence=IEA

GO:0009941 "chloroplast envelope" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

TAIR|locus:2026674 YDA "YODA" [Arabidopsis thaliana (taxid:3702)]

 Score = 577 (208.2 bits), Expect = 1.6e-55, P = 1.6e-55
 Identities = 115/244 (47%), Positives = 157/244 (64%)

Query:     2 GFFFAVKEVSLQDQGAQGKXXXXXXXXXXXXXXXFEQDNIVQYLGTDKDENRLYIFLELV 61
             G   A+KEV+L     + +                   NIVQY G++  +++LYI+LE V
Sbjct:   423 GEMCAMKEVTLCSDDPKSRESAQQLGQEISVLSRLRHQNIVQYYGSETVDDKLYIYLEYV 482

Query:    62 TKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
             + GS+  L Q+Y    ++ + +YT+QIL+GL YLH +N VHRDIK ANILVD  G VK+A
Sbjct:   483 SGGSIYKLLQEYGQFGENAIRNYTQQILSGLAYLHAKNTVHRDIKGANILVDPHGRVKVA 542

Query:   121 DFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYS 179
             DFG+AK  T  +   S KG+P+WMAPEV+ + N G  L  DIWSLGCTVLEM T +PP+S
Sbjct:   543 DFGMAKHITAQSGPLSFKGSPYWMAPEVIKNSN-GSNLAVDIWSLGCTVLEMATTKPPWS 601

Query:   180 HLEGVQALFRIGKG-ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR--P 236
               EGV A+F+IG   ELP +P  LS + +DF+ KCLQ NP +RPT  +L++H FV+   P
Sbjct:   602 QYEGVPAMFKIGNSKELPDIPDHLSEEGKDFVRKCLQRNPANRPTAAQLLDHAFVRNVMP 661

Query:   237 LQTP 240
             ++ P
Sbjct:   662 MERP 665

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0009793 "embryo development ending in seed dormancy" evidence=IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010103 "stomatal complex morphogenesis" evidence=IMP

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2024832 MAP3KA "mitogen-activated protein kinase kinase kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 556 (200.8 bits), Expect = 8.9e-54, P = 8.9e-54
 Identities = 114/236 (48%), Positives = 149/236 (63%)

Query:     2 GFFFAVKEVSLQDQGAQGKXXXXXXXXXXXXXXXFEQDNIVQYLGTDKDENRLYIFLELV 61
             G   A+KEV +       K                   NIVQY G++  E  L ++LE V
Sbjct:   237 GKMCAIKEVKVISDDQTSKECLKQLNQEINLLNQLCHPNIVQYYGSELSEETLSVYLEYV 296

Query:    62 TKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
             + GS+  L + Y   ++  + +YTRQIL GL YLH RN VHRDIK ANILVD +G +KLA
Sbjct:   297 SGGSIHKLLKDYGSFTEPVIQNYTRQILAGLAYLHGRNTVHRDIKGANILVDPNGEIKLA 356

Query:   121 DFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYS 179
             DFG+AK  T  + + S KG+P+WMAPEVV S+N GY    DIWSLGCT+LEM T +PP+S
Sbjct:   357 DFGMAKHVTAFSTMLSFKGSPYWMAPEVVMSQN-GYTHAVDIWSLGCTILEMATSKPPWS 415

Query:   180 HLEGVQALFRIGKG-ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
               EGV A+F+IG   + P +P  LS DA++FI  CLQ NP  RPT ++L+EHPF++
Sbjct:   416 QFEGVAAIFKIGNSKDTPEIPDHLSNDAKNFIRLCLQRNPTVRPTASQLLEHPFLR 471

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

TAIR|locus:2035989 NP1 "NPK1-related protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 507 (183.5 bits), Expect = 1.4e-48, P = 1.4e-48
 Identities = 105/201 (52%), Positives = 142/201 (70%)

Query:    40 NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYLHERN 98
             NIV+YLGT ++++ L I LE V  GS+++L +K+    +S V +YTRQ+L GL YLH   
Sbjct:   133 NIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLLLGLEYLHNHA 192

Query:    99 VVHRDIKCANILVDASGSVKLADFG----LAKATTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             ++HRDIK ANILVD  G +KLADFG    +A+  TM   KS KGTP+WMAPEV+     G
Sbjct:   193 IMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWMAPEVI--LQTG 250

Query:   155 YGLTADIWSLGCTVLEMLTRRPPYSH-LEGVQALFRIGKGEL-PSVPSSLSRDARDFILK 212
             +  +ADIWS+GCTV+EM+T + P+S   + V A+F IG  +  P +P +LS DA+DF+LK
Sbjct:   251 HSFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTLSSDAKDFLLK 310

Query:   213 CLQVNPNDRPTVTELMEHPFV 233
             CLQ  PN RPT +EL++HPFV
Sbjct:   311 CLQEVPNLRPTASELLKHPFV 331

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IDA

GO:0009908 "flower development" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS

TAIR|locus:2174969 MAPKKK5 "mitogen-activated protein kinase kinase kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 504 (182.5 bits), Expect = 2.9e-48, P = 2.9e-48
 Identities = 108/247 (43%), Positives = 150/247 (60%)

Query:     2 GFFFAVKEVSLQDQGAQGKXXXXXXXXXXXXXXXFEQDNIVQYLGTDKDENRLYIFLELV 61
             G   A+KEV L     +                  +  NIVQY G++  E+R +I+LE V
Sbjct:   369 GALCAMKEVELFPDDPKSAECIKQLEQEIKLLSNLQHPNIVQYFGSETVEDRFFIYLEYV 428

Query:    62 TKGSLANLYQKYH---LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
               GS+ N Y + H   +++S V ++TR IL+GL YLH +  VHRDIK AN+LVDASG VK
Sbjct:   429 HPGSI-NKYIRDHCGTMTESVVRNFTRHILSGLAYLHNKKTVHRDIKGANLLVDASGVVK 487

Query:   119 LADFGLAKATTMN--DLKSCKGTPFWMAPEVVNS-----KNDGYGLTADIWSLGCTVLEM 171
             LADFG+AK  T    DL S KG+P+WMAPE++ +      N       DIWSLGCT++EM
Sbjct:   488 LADFGMAKHLTGQRADL-SLKGSPYWMAPELMQAVMQKDSNPDLAFAVDIWSLGCTIIEM 546

Query:   172 LTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP 231
              T +PP+S  EG  A+F++ + + P +P S+S + +DF+  C Q NP +RPT + L+EH 
Sbjct:   547 FTGKPPWSEFEGAAAMFKVMR-DSPPIPESMSPEGKDFLRLCFQRNPAERPTASMLLEHR 605

Query:   232 FVKRPLQ 238
             F+K  LQ
Sbjct:   606 FLKNSLQ 612

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

UNIPROTKB|Q40541 Q40541 "Protein kinase" [Nicotiana tabacum (taxid:4097)]

 Score = 492 (178.3 bits), Expect = 5.4e-47, P = 5.4e-47
 Identities = 108/250 (43%), Positives = 149/250 (59%)

Query:     2 GFFFAVKEVSLQDQGA---QGKXXXXXXXXXXXXXXXFEQDNIVQYLGTDKDENRLYIFL 58
             G   A+KEVS+   GA   + +                   NIV+YLGT ++   L I L
Sbjct:   103 GELLAIKEVSIAMNGASRERAQAHVRELEEEVNLLKNLSHPNIVRYLGTAREAGSLNILL 162

Query:    59 ELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV 117
             E V  GS+++L  K+    +S +  YT+Q+L GL YLH+  ++HRDIK ANILVD  G +
Sbjct:   163 EFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCI 222

Query:   118 KLADFGLAKAT----TMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
             KLADFG +K      TM   KS KGTP+WMAPEV+     G+  +ADIWS+GCT++EM T
Sbjct:   223 KLADFGASKKVVELATMTGAKSMKGTPYWMAPEVI--LQTGHSFSADIWSVGCTIIEMAT 280

Query:   174 RRPPYSH-LEGVQALFRIGKGEL-PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP 231
              +PP+S   + V ALF IG  +  P +P  LS +++DF+LKCLQ  P+ R + + L++HP
Sbjct:   281 GKPPWSQQYQEVAALFHIGTTKSHPPIPEHLSAESKDFLLKCLQKEPHLRHSASNLLQHP 340

Query:   232 FVKRPLQTPR 241
             FV    Q  R
Sbjct:   341 FVTAEHQEAR 350

GO:0005515 "protein binding" evidence=IPI

DICTYBASE|DDB_G0283265 mkkA "octicosapeptide/Phox/Bem1p domain-containing protein" [Dictyostelium discoideum (taxid:44689)]

 Score = 489 (177.2 bits), Expect = 2.0e-45, P = 2.0e-45
 Identities = 96/239 (40%), Positives = 153/239 (64%)

Query:     2 GFFFAVKEVSLQDQGAQGKXXXXXXXXXXXXXX--XFEQDNIVQYLGTDKDENRLYIFLE 59
             G  FAVK++ + D  +  K                    DNIV+YLGT  D++ L +FLE
Sbjct:   518 GELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRSLRHDNIVRYLGTSLDQSFLSVFLE 577

Query:    60 LVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
              +  GS+++L  K+   S++ +  YT+QIL GL +LH  +++HRDIK ANIL+D  G VK
Sbjct:   578 YIPGGSISSLLGKFGAFSENVIKVYTKQILQGLSFLHANSIIHRDIKGANILIDTKGIVK 637

Query:   119 LADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP 176
             L+DFG +K+ +  ++  KS +GTP+WMAPEV+  K  G+G ++DIWSLGC ++EM T +P
Sbjct:   638 LSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVI--KQTGHGRSSDIWSLGCVIVEMATAQP 695

Query:   177 PYSHLEGVQA-LFRIGKGE-LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
             P+S++  + A ++ I     +P++PS +S++A DF+  C + +P +RP   +L++HPF+
Sbjct:   696 PWSNITELAAVMYHIASSNSIPNIPSHMSQEAFDFLNLCFKRDPKERPDANQLLKHPFI 754

GO:0030587 "sorocarp development" evidence=IMP

GO:0009653 "anatomical structure morphogenesis" evidence=IMP

GO:0005938 "cell cortex" evidence=IDA

GO:0004709 "MAP kinase kinase kinase activity" evidence=IEA;ISS

GO:0000186 "activation of MAPKK activity" evidence=IEA;ISS

GO:0000165 "MAPK cascade" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0030435 "sporulation resulting in formation of a cellular spore" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q39008	M3K1_ARATH	2, ., 7, ., 1, 1, ., 2, 5	0.7100	0.9595	0.3898	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input:
	GSVIVG00005840001	SubName- Full=Chromosome chr12 scaffold_159, whole genome shotgun sequence; (552 aa)
		(Vitis vinifera)
Predicted Functional Partners:
	GSVIVG00026919001	SubName- Full=Putative uncharacterized protein (Chromosome chr15 scaffold_40, whole genome shot [...] (375 aa)						•		•	0.800
	GSVIVG00025258001	SubName- Full=Chromosome chr9 scaffold_33, whole genome shotgun sequence; (355 aa)						•		•	0.800
	GSVIVG00016645001	SubName- Full=Putative uncharacterized protein (Chromosome chr11 scaffold_13, whole genome shot [...] (354 aa)						•		•	0.800
	GSVIVG00016514001	SubName- Full=Chromosome chr11 scaffold_13, whole genome shotgun sequence; (354 aa)						•		•	0.800
	GSVIVG00003414001	SubName- Full=Chromosome undetermined scaffold_143, whole genome shotgun sequence; (1088 aa)						•		•	0.800

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	247
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-131
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-107
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-92
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-88
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-81
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-78
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-77
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-76
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-75
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-74
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-74
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	9e-70
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-69
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-68
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-66
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-66
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-64
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-63
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-63
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-63
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-63
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-62
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-60
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-60
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-54
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-54
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-54
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-53
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-52
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-52
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-51
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-51
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-50
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-50
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-50
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-50
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-50
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-49
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-48
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-48
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-48
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	9e-48
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-47
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-47
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-46
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-45
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-45
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-45
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-45
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-45
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-45
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-45
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-45
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-45
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-44
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-44
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-44
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-44
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-44
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-44
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-43
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-43
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-43
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-42
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-40
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-40
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-40
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-39
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-39
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-38
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-38
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-38
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-38
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-38
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-37
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-37
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-37
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-37
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-36
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-36
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-36
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	9e-36
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-35
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-35
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-35
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-34
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-34
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-34
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-34
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-33
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-33
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-33
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	8e-33
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-32
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-32
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-32
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-32
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-31
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-31
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-31
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-31
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-31
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-31
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-30
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-30
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-30
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-30
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-30
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-29
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-29
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-29
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-29
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-29
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	9e-29
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-28
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-28
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-28
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-28
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-28
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-28
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-28
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-28
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-28
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-28
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-28
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-28
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-27
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-27
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-27
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-26
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-26
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-26
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-26
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	7e-26
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	8e-26
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-25
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-25
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-25
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-25
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-25
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-25
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-25
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	6e-25
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-25
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-25
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-24
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-24
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-24
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-24
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-24
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-24
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-24
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-24
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-24
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	8e-24
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-23
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-23
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-23
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-23
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-23
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-23
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-23
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-23
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-23
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-23
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-23
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-23
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-23
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-23
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-23
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-22
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-22
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-22
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-22
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-22
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-22
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-22
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-22
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-22
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-22
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-22
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-22
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-22
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-22
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-22
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	9e-22
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-21
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-21
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-21
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-21
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-21
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-21
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-21
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-21
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	7e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-21
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	9e-21
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-20
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-20
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-20
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-20
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-20
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-20
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-20
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-20
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-20
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-20
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	8e-20
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	8e-20
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-19
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-19
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-19
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-19
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-19
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-19
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-19
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-19
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-19
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	9e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-18
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-18
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-18
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-18
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-18
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-18
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-18
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-18
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-18
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-18
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-18
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	9e-18
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-17
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-17
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-17
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-17
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-17
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-17
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-17
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-17
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	9e-17
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-17
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-16
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-16
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-16
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-16
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-16
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-16
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	7e-16
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	9e-16
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	9e-16
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-15
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-15
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-15
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-15
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-15
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-15
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-15
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-15
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-15
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-15
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-14
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-14
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-14
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-13
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-13
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-13
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-13
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	8e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-12
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-12
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	3e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	9e-12
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-09
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	4e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	7e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-08
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-05
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	5e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	5e-04

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  369 bits (949), Expect = e-131
 Identities = 148/236 (62%), Positives = 180/236 (76%), Gaps = 4/236 (1%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           DG FFAVKEVSL D G  G++++ QLEQEI+LLS+ +  NIVQYLGT+++E+ LYIFLEL
Sbjct: 24  DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL 83

Query: 61  VTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
           V  GSLA L +KY    +  +  YTRQIL GL YLH+RN VHRDIK ANILVD +G VKL
Sbjct: 84  VPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKL 143

Query: 120 ADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY 178
           ADFG+AK        KS KG+P+WMAPEV+  +  GYGL ADIWSLGCTVLEM T +PP+
Sbjct: 144 ADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG-GYGLAADIWSLGCTVLEMATGKPPW 202

Query: 179 SHLEGVQALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           S LEGV A+F+IG+  ELP +P  LS +A+DFILKCLQ +P+ RPT  EL+EHPFV
Sbjct: 203 SQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  311 bits (798), Expect = e-107
 Identities = 120/242 (49%), Positives = 158/242 (65%), Gaps = 14/242 (5%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE--NRLYIFL 58
            G   AVK V L       ++ +  LE+EI +LS  +  NIV+Y G+++DE  N L IFL
Sbjct: 24  TGELMAVKSVELSGDS---EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80

Query: 59  ELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV 117
           E V+ GSL++L +K+  L +  +  YTRQIL GL YLH   +VHRDIK ANILVD+ G V
Sbjct: 81  EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVV 140

Query: 118 KLADFGLAK----ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
           KLADFG AK      T     S +GTP+WMAPEV+    + YG  ADIWSLGCTV+EM T
Sbjct: 141 KLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR--GEEYGRAADIWSLGCTVIEMAT 198

Query: 174 RRPPYSHLEG-VQALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP 231
            +PP+S L   + AL++IG  GE P +P  LS +A+DF+ KCL+ +P  RPT  EL++HP
Sbjct: 199 GKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHP 258

Query: 232 FV 233
           F+
Sbjct: 259 FL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  270 bits (693), Expect = 6e-92
 Identities = 105/238 (44%), Positives = 152/238 (63%), Gaps = 12/238 (5%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
            G F A+K++SL+      ++++  + QEI LL   +  NIV+Y+G+ +  + LYI LE 
Sbjct: 24  TGDFVAIKQISLEKIK---EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80

Query: 61  VTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
              GSL  + +K+    +S V+ Y  Q+L GL YLHE+ V+HRDIK ANIL    G VKL
Sbjct: 81  AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKL 140

Query: 120 ADFGLAKATTMNDL----KSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR 175
           ADFG+A  T +ND+     S  GTP+WMAPEV+     G    +DIWSLGCTV+E+LT  
Sbjct: 141 ADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIE--MSGASTASDIWSLGCTVIELLTGN 196

Query: 176 PPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           PPY  L  + ALFRI + + P +P  +S + +DF+++C Q +PN RPT  +L++HP++
Sbjct: 197 PPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  262 bits (672), Expect = 1e-88
 Identities = 90/238 (37%), Positives = 133/238 (55%), Gaps = 11/238 (4%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
            G   A+K +  +      K+   ++ +EI +L + +  NIV+     +DE++LY+ +E 
Sbjct: 23  TGKLVAIKVIKKKKI----KKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEY 78

Query: 61  VTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
              G L +L +K   LS+ +   Y RQIL+ L YLH + +VHRD+K  NIL+D  G VKL
Sbjct: 79  CEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKL 138

Query: 120 ADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY 178
           ADFGLA+     + L +  GTP +MAPEV+  K  GYG   DIWSLG  + E+LT +PP+
Sbjct: 139 ADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGK--GYGKAVDIWSLGVILYELLTGKPPF 196

Query: 179 SHLEGVQALFRI---GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
              + +  LF+     K   P     +S +A+D I K L  +P  R T  E ++HPF 
Sbjct: 197 PGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  244 bits (624), Expect = 2e-81
 Identities = 95/239 (39%), Positives = 146/239 (61%), Gaps = 16/239 (6%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
            G   A+K + L+ +  +  + I+    EI +L + +  NIV+Y G+   ++ L+I +E 
Sbjct: 24  TGKEVAIKVIKLESKEKK--EKIIN---EIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78

Query: 61  VTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
            + GSL +L +  +  L++SQ++   +++L GL YLH   ++HRDIK ANIL+ + G VK
Sbjct: 79  CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVK 138

Query: 119 LADFGLAKATTMNDLKSCK---GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR 175
           L DFGL  +  ++D K+     GTP+WMAPEV+N K   Y   ADIWSLG T +E+   +
Sbjct: 139 LIDFGL--SAQLSDTKARNTMVGTPYWMAPEVINGK--PYDYKADIWSLGITAIELAEGK 194

Query: 176 PPYSHLEGVQALFRIGKGELPSVPSS--LSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
           PPYS L  ++ALF+I     P + +    S + +DF+ KCLQ NP  RPT  +L++HPF
Sbjct: 195 PPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  237 bits (608), Expect = 1e-78
 Identities = 92/233 (39%), Positives = 135/233 (57%), Gaps = 9/233 (3%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+K + L++     +  I  ++QEI  LSQ     I +Y G+    ++L+I +E    GS
Sbjct: 30  AIKVIDLEE----AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGS 85

Query: 66  LANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA 125
             +L +   L ++ ++   R++L GL YLHE   +HRDIK ANIL+   G VKLADFG++
Sbjct: 86  CLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVS 145

Query: 126 KATTMNDLK--SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG 183
              T    K  +  GTPFWMAPEV+  K  GY   ADIWSLG T +E+    PP S L  
Sbjct: 146 GQLTSTMSKRNTFVGTPFWMAPEVI--KQSGYDEKADIWSLGITAIELAKGEPPLSDLHP 203

Query: 184 VQALFRIGKGELPSVP-SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
           ++ LF I K   PS+  +  S+  +DF+  CL  +P +RP+  EL++H F+K+
Sbjct: 204 MRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  234 bits (598), Expect = 2e-77
 Identities = 101/235 (42%), Positives = 147/235 (62%), Gaps = 9/235 (3%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           AVK+V       + K+ +  LE EI LL   + + IVQY G  +D+  L IF+E +  GS
Sbjct: 31  AVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGS 90

Query: 66  LANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGL 124
           + +  + Y  L+++    YTRQIL G+ YLH   +VHRDIK ANIL D++G+VKL DFG 
Sbjct: 91  VKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGA 150

Query: 125 AK-----ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYS 179
           +K      ++   +KS  GTP+WM+PEV++   +GYG  AD+WS+GCTV+EMLT +PP++
Sbjct: 151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISG--EGYGRKADVWSVGCTVVEMLTEKPPWA 208

Query: 180 HLEGVQALFRIGKGEL-PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
             E + A+F+I      P +PS +S DAR+F+ +    N   RP+  EL+ H FV
Sbjct: 209 EFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  232 bits (593), Expect = 1e-76
 Identities = 112/245 (45%), Positives = 154/245 (62%), Gaps = 15/245 (6%)

Query: 2   GFFFAVKEVSLQDQGAQG---KQSILQ-LEQEISLLSQFEQDNIVQYLGTDKDENRLYIF 57
           G   AVK+V L    A     K+S+L  L +EI+LL + + +NIVQYLG+  D + L IF
Sbjct: 25  GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84

Query: 58  LELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS 116
           LE V  GS+A L   Y    ++ V ++ RQIL GL YLH R ++HRDIK ANILVD  G 
Sbjct: 85  LEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG 144

Query: 117 VKLADFGLAKATTMNDLK--------SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           +K++DFG++K    N L         S +G+ FWMAPEVV  K   Y   ADIWSLGC V
Sbjct: 145 IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV--KQTSYTRKADIWSLGCLV 202

Query: 169 LEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           +EMLT + P+     +QA+F+IG+   P +PS++S +A DF+ K  +++ N RPT  EL+
Sbjct: 203 VEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELL 262

Query: 229 EHPFV 233
           +HPF+
Sbjct: 263 KHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  229 bits (586), Expect = 1e-75
 Identities = 88/242 (36%), Positives = 135/242 (55%), Gaps = 13/242 (5%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
            G   AVK +  + + ++  Q+  +   EI +L +    NIV+ +   +D++ LY+ +E 
Sbjct: 23  TGKIVAVKILKKRSEKSKKDQTARR---EIRILRRLSHPNIVRLIDAFEDKDHLYLVMEY 79

Query: 61  VTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
              G L +   +   LS+ +      QIL GL YLH   ++HRD+K  NIL+D +G VK+
Sbjct: 80  CEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKI 139

Query: 120 ADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPP 177
           ADFGLAK    +   L +  GTP++MAPEV+    +GYG   D+WSLG  + E+LT +PP
Sbjct: 140 ADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL-GGNGYGPKVDVWSLGVILYELLTGKPP 198

Query: 178 YSHLEGV---QALFRIGKGELPS---VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP 231
           +S    +   Q + RI    L       SS S +A+D I KCL  +P+ RPT  E+++HP
Sbjct: 199 FSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHP 258

Query: 232 FV 233
           + 
Sbjct: 259 WF 260

Length = 260

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  227 bits (580), Expect = 2e-74
 Identities = 103/246 (41%), Positives = 146/246 (59%), Gaps = 15/246 (6%)

Query: 2   GFFFAVKEVSL----QDQGAQGKQSILQ-LEQEISLLSQFEQDNIVQYLGTDKDENRLYI 56
           G   AVK+V L      +    ++ +++ L  EI  L   +  NIVQYLG +  E  L I
Sbjct: 26  GEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85

Query: 57  FLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
           FLE V  GS+ +  + Y   + Q V  +T Q+L GL YLH + ++HRD+K  N+LVDA G
Sbjct: 86  FLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG 145

Query: 116 SVKLADFGLAKATT---MNDLK-SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
             K++DFG++K +     ND   S +G+ FWMAPEV++S + GY    DIWSLGC VLEM
Sbjct: 146 ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEM 205

Query: 172 LTRRPPYSHLEGVQALFRIG-KGELPSVP----SSLSRDARDFILKCLQVNPNDRPTVTE 226
              R P+S  E + A+F++G K   P +P     +LS  A DF+  C  +NP++RPT  E
Sbjct: 206 FAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARE 265

Query: 227 LMEHPF 232
           L++HPF
Sbjct: 266 LLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  225 bits (575), Expect = 7e-74
 Identities = 102/244 (41%), Positives = 147/244 (60%), Gaps = 14/244 (5%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
            G   AVKE+ +QD      ++I ++  E+ +L   +  N+V+Y G +    ++YIF+E 
Sbjct: 24  TGELMAVKEIRIQDND---PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80

Query: 61  VTKGSLANLYQKYHLSDSQV-SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
            + G+L  L +   + D  V   YT Q+L GL YLH   +VHRDIK ANI +D +G +KL
Sbjct: 81  CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKL 140

Query: 120 ADFG----LAKATTM--NDLKSCKGTPFWMAPEVV-NSKNDGYGLTADIWSLGCTVLEML 172
            DFG    L   TT    +++S  GTP +MAPEV+   K  G+G  ADIWSLGC VLEM 
Sbjct: 141 GDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMA 200

Query: 173 TRRPPYSHLEGV-QALFRIGKGELPSVPSS--LSRDARDFILKCLQVNPNDRPTVTELME 229
           T + P+S L+   Q +F +G G  P +P S  LS + +DF+ +CL+ +P  RPT +EL++
Sbjct: 201 TGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260

Query: 230 HPFV 233
           HPFV
Sbjct: 261 HPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  214 bits (547), Expect = 9e-70
 Identities = 88/239 (36%), Positives = 135/239 (56%), Gaps = 15/239 (6%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
            G   A+K V +       ++ + ++ +EIS+L Q +   IV+Y G+      L+I +E 
Sbjct: 27  TGQVVAIKVVPV-------EEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79

Query: 61  VTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
              GS++++ +     L++ ++++   Q L GL YLH    +HRDIK  NIL++  G  K
Sbjct: 80  CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAK 139

Query: 119 LADFGLAK--ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP 176
           LADFG++     TM    +  GTPFWMAPEV+     GY   ADIWSLG T +EM   +P
Sbjct: 140 LADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKP 197

Query: 177 PYSHLEGVQALFRIGKGELP--SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           PYS +  ++A+F I     P  S P   S +  DF+ KCL  +P +RP+  +L++HPF+
Sbjct: 198 PYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  213 bits (544), Expect = 2e-69
 Identities = 102/245 (41%), Positives = 150/245 (61%), Gaps = 16/245 (6%)

Query: 2   GFFFAVKEVSLQ--DQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLE 59
           G   AVK+V L   +  A  K+   +L++E+ LL   +  NIVQYLGT  D+N + IF+E
Sbjct: 24  GQLIAVKQVELDTSNVLAAEKE-YEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82

Query: 60  LVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
            V  GS++++  ++  L +     YT+QIL+G+ YLH   VVHRDIK  N+++  +G +K
Sbjct: 83  FVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIK 142

Query: 119 LADFGLAKATTM--------NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
           L DFG A+            N LKS  GTP+WMAPEV+N    GYG  +DIWS+GCTV E
Sbjct: 143 LIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES--GYGRKSDIWSIGCTVFE 200

Query: 171 MLTRRPPYSHLEGVQALFRIG--KGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           M T +PP + ++ + A+F IG  +G +P +P S S  A DF+  CL  + ++RP+  +L+
Sbjct: 201 MATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLL 260

Query: 229 EHPFV 233
            H F+
Sbjct: 261 RHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  211 bits (539), Expect = 2e-68
 Identities = 97/238 (40%), Positives = 132/238 (55%), Gaps = 18/238 (7%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+K + L+            ++QEIS+L +    NIV Y G+    ++L+I +E    GS
Sbjct: 32  AIKVIKLEPG-----DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGS 86

Query: 66  LANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFG 123
           L ++YQ     LS+ Q++   R+ L GL YLHE   +HRDIK ANIL+   G VKLADFG
Sbjct: 87  LQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFG 146

Query: 124 LAK--ATTMNDLKSCKGTPFWMAPEVV-NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSH 180
           ++     T+   KS  GTP+WMAPEV    +  GY    DIW+LG T +E+   +PP   
Sbjct: 147 VSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206

Query: 181 LEGVQALFRIGKGELPSVPSSL------SRDARDFILKCLQVNPNDRPTVTELMEHPF 232
           L  ++ALF I K   P  P  L      S    DFI KCL  +P  RPT T+L++HPF
Sbjct: 207 LHPMRALFLISKSNFP--PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  205 bits (523), Expect = 7e-66
 Identities = 96/253 (37%), Positives = 140/253 (55%), Gaps = 18/253 (7%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQ---------EISLLSQFEQDNIVQYLGTDKDE 51
           DG F  V +   ++ G      I+Q+E          EI +LS+ +  NIV        E
Sbjct: 15  DGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE 74

Query: 52  NRLYIFLELVTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           N+L+I +E    G+L ++  +    L++ Q+    RQ+L  L +LH   V+HRD+K  NI
Sbjct: 75  NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNI 134

Query: 110 LVDASGSVKLADFGL-AK-ATTMNDLKSCKGTPFWMAPEVV---NSKNDGYGLTADIWSL 164
           L+   G VKLADFG+ AK  +T+    +  GTP+WMAPEVV     K++ Y   ADIWSL
Sbjct: 135 LLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSL 194

Query: 165 GCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDARDFILKCLQVNPNDRP 222
           G T++E+    PP+  L  ++ L +I K E P++  PS  S    DF+  CL  +P+DRP
Sbjct: 195 GITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRP 254

Query: 223 TVTELMEHPFVKR 235
           T  EL++HPFV  
Sbjct: 255 TAAELLKHPFVSD 267

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  205 bits (524), Expect = 7e-66
 Identities = 91/238 (38%), Positives = 136/238 (57%), Gaps = 14/238 (5%)

Query: 5   FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKG 64
            A+K++ L+      KQ+   +  EI ++   +  NIV Y  +    + L++ +E +  G
Sbjct: 47  VAIKKMRLR------KQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100

Query: 65  SLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADF 122
           SL ++  +    +++ Q++   R++L GL YLH +NV+HRDIK  NIL+   GSVKLADF
Sbjct: 101 SLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADF 160

Query: 123 GLAKATTMNDLK--SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSH 180
           G A   T    K  S  GTP+WMAPEV+  K+  YG   DIWSLG   +EM    PPY  
Sbjct: 161 GFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKD--YGPKVDIWSLGIMCIEMAEGEPPYLR 218

Query: 181 LEGVQALFRIGKGELPSV--PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP 236
              ++ALF I    +P +  P   S + +DF+ KCL  +P  RP+  EL++HPF+K+ 
Sbjct: 219 EPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  199 bits (509), Expect = 5e-64
 Identities = 75/241 (31%), Positives = 137/241 (56%), Gaps = 14/241 (5%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           DG  + +KE+ L +   + ++  L    E+ +L +    NI++Y  + +++ +L I +E 
Sbjct: 24  DGKLYVLKEIDLSNMSEKEREDALN---EVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80

Query: 61  VTKGSLANLYQKY-----HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
              G L+   +K         + Q+  +  Q+   L YLH R ++HRDIK  NI + ++G
Sbjct: 81  ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG 140

Query: 116 SVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
            VKL DFG++K   +T++  K+  GTP++++PE+   +N  Y   +DIWSLGC + E+ T
Sbjct: 141 LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC--QNKPYNYKSDIWSLGCVLYELCT 198

Query: 174 RRPPYSHLEGVQALF-RIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
            + P+   E +  L  +I KG+ P +PS  S + R+ +   LQ +P +RP++ ++++ PF
Sbjct: 199 LKHPFEG-ENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPF 257

Query: 233 V 233
           +
Sbjct: 258 I 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  199 bits (508), Expect = 1e-63
 Identities = 86/242 (35%), Positives = 136/242 (56%), Gaps = 14/242 (5%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
            G  +A+K++ +       KQ    L +E+  L   E   +V+  G    E  + I LE 
Sbjct: 25  TGKIYALKKIHVDGDEEFRKQ----LLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80

Query: 61  VTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLH-ERNVVHRDIKCANILVDASGSVK 118
           +  GSLA+L +K   + +  ++   RQIL GL YLH +R+++HRDIK +N+L+++ G VK
Sbjct: 81  MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVK 140

Query: 119 LADFGLAK--ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP 176
           +ADFG++K    T++   +  GT  +M+PE +  ++  Y   ADIWSLG T+LE    + 
Sbjct: 141 IADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSY--AADIWSLGLTLLECALGKF 198

Query: 177 PYSHLEG---VQALFRIGKGELPSVPSSL-SRDARDFILKCLQVNPNDRPTVTELMEHPF 232
           P+         + +  I  G  PS+P+   S + RDFI  CLQ +P  RP+  EL++HPF
Sbjct: 199 PFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258

Query: 233 VK 234
           +K
Sbjct: 259 IK 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  198 bits (504), Expect = 4e-63
 Identities = 97/237 (40%), Positives = 148/237 (62%), Gaps = 14/237 (5%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+KE+  +D      + +  L +EI+L S  +  NIVQYLG+D +     IF+E V  GS
Sbjct: 37  AIKEIPERDS-----RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGS 91

Query: 66  LANLYQK----YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA-SGSVKLA 120
           L+ L +        ++  +  YT+QIL GL YLH+  +VHRDIK  N+LV+  SG VK++
Sbjct: 92  LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKIS 151

Query: 121 DFGLAK--ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY 178
           DFG +K  A      ++  GT  +MAPEV++    GYG  ADIWSLGCT++EM T +PP+
Sbjct: 152 DFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211

Query: 179 SHLEGVQ-ALFRIGKGEL-PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
             L   Q A+F++G  ++ P +P SLS +A++FIL+C + +P+ R +  +L++ PF+
Sbjct: 212 IELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  197 bits (503), Expect = 6e-63
 Identities = 85/243 (34%), Positives = 145/243 (59%), Gaps = 15/243 (6%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQ-LEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           G   AVK+V+     +  ++ +++ L +EI L+++    +I++ LG   +++   +F+E 
Sbjct: 25  GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84

Query: 61  VTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS-VK 118
           +  GS+++L  KY    ++ + +YT Q+L GL YLHE  ++HRD+K AN+L+D++G  ++
Sbjct: 85  MAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLR 144

Query: 119 LADFGLA-----KATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEML 172
           +ADFG A     K T   + +    GT  +MAPEV+  +   YG + D+WS+GC ++EM 
Sbjct: 145 IADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ--YGRSCDVWSVGCVIIEMA 202

Query: 173 TRRPPY---SHLEGVQALFRIGKG-ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           T +PP+    H   +  +F+I      PS+P  LS   RD  L+CL++ P DRP   EL+
Sbjct: 203 TAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262

Query: 229 EHP 231
           +HP
Sbjct: 263 KHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  197 bits (502), Expect = 6e-63
 Identities = 103/239 (43%), Positives = 146/239 (61%), Gaps = 12/239 (5%)

Query: 5   FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGT--DKDENRLYIFLELVT 62
            A K+V    +  +  + +  LE EI LL   + + IVQY G   D+ E  L IF+E + 
Sbjct: 30  LAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMP 89

Query: 63  KGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLAD 121
            GS+ +  + Y  L++S    YTRQIL G+ YLH   +VHRDIK ANIL D++G+VKL D
Sbjct: 90  GGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGD 149

Query: 122 FGLAK-----ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP 176
           FG +K       +   ++S  GTP+WM+PEV++   +GYG  AD+WSLGCTV+EMLT +P
Sbjct: 150 FGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKP 207

Query: 177 PYSHLEGVQALFRIGKGEL-PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           P++  E + A+F+I      P +PS +S  ARDF L C+ V    RP+  EL+ HPF +
Sbjct: 208 PWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF-LGCIFVEARHRPSAEELLRHPFAQ 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  192 bits (491), Expect = 8e-62
 Identities = 81/236 (34%), Positives = 119/236 (50%), Gaps = 42/236 (17%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
            G   A+K +  +D        + +L +EI +L +    NIV+  G  +DEN LY+ +E 
Sbjct: 17  TGKKVAIKIIKKEDS----SSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEY 72

Query: 61  VTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA-SGSV 117
              GSL +L ++    LS+ ++     QIL GL YLH   ++HRD+K  NIL+D+ +G V
Sbjct: 73  CEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKV 132

Query: 118 KLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR 175
           KLADFGL+K  T +   LK+  GTP +MAPEV+  K   Y   +DIWSLG  + E+    
Sbjct: 133 KLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKG-YYSEKSDIWSLGVILYEL---- 187

Query: 176 PPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP 231
                                        + +D I K LQ +P  RP+  E++EH 
Sbjct: 188 ----------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  191 bits (487), Expect = 1e-60
 Identities = 102/238 (42%), Positives = 143/238 (60%), Gaps = 12/238 (5%)

Query: 5   FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGT--DKDENRLYIFLELVT 62
            AVK+V       +  + +  LE EI LL     D IVQY G   D +E +L IF+E + 
Sbjct: 30  LAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMP 89

Query: 63  KGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLAD 121
            GS+ +  + Y  L+++    YTRQIL G+ YLH   +VHRDIK ANIL D++G+VKL D
Sbjct: 90  GGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGD 149

Query: 122 FGLAK-----ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP 176
           FG +K       +   +KS  GTP+WM+PEV++   +GYG  AD+WS+ CTV+EMLT +P
Sbjct: 150 FGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG--EGYGRKADVWSVACTVVEMLTEKP 207

Query: 177 PYSHLEGVQALFRIG-KGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           P++  E + A+F+I  +   P +P  +S   RDF LK + V    RPT   L+ HPFV
Sbjct: 208 PWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF-LKQIFVEEKRRPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  190 bits (483), Expect = 4e-60
 Identities = 102/238 (42%), Positives = 142/238 (59%), Gaps = 12/238 (5%)

Query: 5   FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD--ENRLYIFLELVT 62
            AVK+V    +  +  + +  LE EI LL     + IVQY G  +D  E  L IF+E + 
Sbjct: 30  LAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMP 89

Query: 63  KGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLAD 121
            GS+ +  + Y  L+++    YTRQIL G+ YLH   +VHRDIK ANIL D+ G+VKL D
Sbjct: 90  GGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGD 149

Query: 122 FGLAK-----ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP 176
           FG +K       +   +KS  GTP+WM+PEV++   +GYG  ADIWS+GCTV+EMLT +P
Sbjct: 150 FGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG--EGYGRKADIWSVGCTVVEMLTEKP 207

Query: 177 PYSHLEGVQALFRIGKGEL-PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           P++  E + A+F+I      P +P  +S   RDF LK + V    RP+  EL+ H FV
Sbjct: 208 PWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDF-LKRIFVEAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  176 bits (448), Expect = 1e-54
 Identities = 85/222 (38%), Positives = 131/222 (59%), Gaps = 7/222 (3%)

Query: 26  LEQEISLLSQFEQD---NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS 82
           +++E++LLSQ  Q    NI +Y G+     RL+I +E    GS+  L +   +++  +S 
Sbjct: 46  IQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV 105

Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK--SCKGTP 140
             R++L  L Y+H+  V+HRDIK ANILV  +G+VKL DFG+A     N  K  +  GTP
Sbjct: 106 IIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTP 165

Query: 141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVP- 199
           +WMAPEV+ ++   Y   ADIWSLG T+ EM T  PPYS ++  +A+  I K + P +  
Sbjct: 166 YWMAPEVI-TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLED 224

Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPR 241
           +  S+  R+F+  CL   P +R +  EL++  ++K   +TP 
Sbjct: 225 NGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTPV 266

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  175 bits (444), Expect = 4e-54
 Identities = 90/232 (38%), Positives = 135/232 (58%), Gaps = 8/232 (3%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+K + L+    + +  I  ++QEI++LSQ +   I +Y G+     +L+I +E +  GS
Sbjct: 33  AIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGS 88

Query: 66  LANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA 125
             +L +   L ++ +++  R+IL GL YLH    +HRDIK AN+L+   G VKLADFG+A
Sbjct: 89  ALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVA 148

Query: 126 KATTMNDLK--SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG 183
              T   +K  +  GTPFWMAPEV+  K   Y   ADIWSLG T +E+    PP S L  
Sbjct: 149 GQLTDTQIKRNTFVGTPFWMAPEVI--KQSAYDFKADIWSLGITAIELAKGEPPNSDLHP 206

Query: 184 VQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
           ++ LF I K   P++    S+  ++F+  CL  +P  RPT  EL++H F+ R
Sbjct: 207 MRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  174 bits (443), Expect = 5e-54
 Identities = 82/250 (32%), Positives = 128/250 (51%), Gaps = 25/250 (10%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG--TDKDENRLYIFL 58
           DG     KE+   +   + KQ   QL  E+++L + +  NIV+Y     D+    LYI +
Sbjct: 24  DGKILVWKEIDYGNMTEKEKQ---QLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80

Query: 59  ELVTKGSLANLYQKY-----HLSDSQVSSYTRQILNGLVYLHERN-----VVHRDIKCAN 108
           E    G LA L QK      ++ +  +     Q+L  L   H R+     V+HRD+K AN
Sbjct: 81  EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPAN 140

Query: 109 ILVDASGSVKLADFGLAKATTMNDL--KSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           I +DA+ +VKL DFGLAK    +    K+  GTP++M+PE +N  +  Y   +DIWSLGC
Sbjct: 141 IFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLN--HMSYDEKSDIWSLGC 198

Query: 167 TVLEMLTRRPP---YSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
            + E+    PP    + L+      +I +G+   +P   S +  + I   L V+P+ RP+
Sbjct: 199 LIYELCALSPPFTARNQLQLAS---KIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPS 255

Query: 224 VTELMEHPFV 233
             EL++ P +
Sbjct: 256 TEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  173 bits (439), Expect = 2e-53
 Identities = 90/232 (38%), Positives = 138/232 (59%), Gaps = 8/232 (3%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+K + L+    + +  I  ++QEI++LSQ +   + +Y G+   + +L+I +E +  GS
Sbjct: 33  AIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 88

Query: 66  LANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA 125
             +L +   L ++Q+++  R+IL GL YLH    +HRDIK AN+L+   G VKLADFG+A
Sbjct: 89  ALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA 148

Query: 126 KATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG 183
              T   +K     GTPFWMAPEV+  K   Y   ADIWSLG T +E+    PP+S L  
Sbjct: 149 GQLTDTQIKRNTFVGTPFWMAPEVI--KQSAYDSKADIWSLGITAIELAKGEPPHSELHP 206

Query: 184 VQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
           ++ LF I K   P++  + S+  ++F+  CL   P+ RPT  EL++H F+ R
Sbjct: 207 MKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR 258

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  171 bits (435), Expect = 1e-52
 Identities = 82/242 (33%), Positives = 131/242 (54%), Gaps = 20/242 (8%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+K + L+    + + S+ +L +E+  +SQ    N+V+Y  +    + L++ +  ++ GS
Sbjct: 30  AIKRIDLE----KCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS 85

Query: 66  LANL----YQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLAD 121
           L ++    Y +  L ++ +++  +++L GL YLH    +HRDIK  NIL+   GSVK+AD
Sbjct: 86  LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIAD 145

Query: 122 FG----LAKATTMNDL--KSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR 175
           FG    LA          K+  GTP WMAPEV+   + GY   ADIWS G T +E+ T  
Sbjct: 146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH-GYDFKADIWSFGITAIELATGA 204

Query: 176 PPYSHLEGVQALFRIGKGELPSVPSS-----LSRDARDFILKCLQVNPNDRPTVTELMEH 230
            PYS    ++ L    + + PS+ +       S+  R  I  CLQ +P+ RPT  EL++H
Sbjct: 205 APYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264

Query: 231 PF 232
            F
Sbjct: 265 KF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  170 bits (432), Expect = 3e-52
 Identities = 76/227 (33%), Positives = 126/227 (55%), Gaps = 19/227 (8%)

Query: 26  LEQEISLLSQF-EQDNIVQYLGT------DKDENRLYIFLELVTKGSLANLYQKYHLSDS 78
           +++E ++L ++    NI  + G         ++++L++ +EL   GS+ +L +       
Sbjct: 49  IKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK 108

Query: 79  QVS----SYT-RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAK--ATTMN 131
           ++     +Y  R+ L GL YLHE  V+HRDIK  NIL+  +  VKL DFG++    +T+ 
Sbjct: 109 RLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG 168

Query: 132 DLKSCKGTPFWMAPEVVNSKND---GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALF 188
              +  GTP+WMAPEV+         Y   +D+WSLG T +E+   +PP   +  ++ALF
Sbjct: 169 RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF 228

Query: 189 RIGKGELPSV--PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           +I +   P++  P + S+   DFI +CL  N   RP + EL+EHPF+
Sbjct: 229 KIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  168 bits (426), Expect = 1e-51
 Identities = 81/238 (34%), Positives = 124/238 (52%), Gaps = 10/238 (4%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           D  F+A+KEV L     + ++  +    EI +L+     NI+ Y     D N+L I +E 
Sbjct: 24  DNQFYALKEVDLGSMSQKEREDAVN---EIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80

Query: 61  VTKGSLANLYQKYH-----LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
              G L+    K       + + ++     Q+L GL  LHE+ ++HRD+K ANIL+ A+ 
Sbjct: 81  APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND 140

Query: 116 SVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR 175
            VK+ D G++K    N  K+  GTP +MAPEV   K   Y   +DIWSLGC + EM T  
Sbjct: 141 LVKIGDLGISKVLKKNMAKTQIGTPHYMAPEV--WKGRPYSYKSDIWSLGCLLYEMATFA 198

Query: 176 PPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           PP+         +++ +G+ P +P   S+D ++FI   LQV P  RP   +++  P V
Sbjct: 199 PPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  169 bits (429), Expect = 2e-51
 Identities = 84/236 (35%), Positives = 136/236 (57%), Gaps = 11/236 (4%)

Query: 6   AVKEVSLQDQGAQGK-QSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKG 64
           A+K++S   + +  K Q I++   E+  L Q    N ++Y G    E+  ++ +E    G
Sbjct: 44  AIKKMSYSGKQSNEKWQDIIK---EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-G 99

Query: 65  SLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADF 122
           S +++ +  K  L + ++++     L GL YLH    +HRDIK  NIL+   G+VKLADF
Sbjct: 100 SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADF 159

Query: 123 GLAKATTMNDLKSCKGTPFWMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTRRPPYSHL 181
           G   A+ ++   S  GTP+WMAPEV+ + ++G Y    D+WSLG T +E+  R+PP  ++
Sbjct: 160 G--SASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217

Query: 182 EGVQALFRIGKGELPSVPSS-LSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP 236
             + AL+ I + + P++ S+  S   R+F+  CLQ  P DRP+  EL++H FV R 
Sbjct: 218 NAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  166 bits (422), Expect = 1e-50
 Identities = 86/230 (37%), Positives = 134/230 (58%), Gaps = 8/230 (3%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+K + L+    + +  I  ++QEI++LSQ +   + +Y G+     +L+I +E +  GS
Sbjct: 33  AIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS 88

Query: 66  LANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA 125
             +L +     + Q+++  ++IL GL YLH    +HRDIK AN+L+   G VKLADFG+A
Sbjct: 89  ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVA 148

Query: 126 KATTMNDLK--SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG 183
              T   +K  +  GTPFWMAPEV+  +   Y   ADIWSLG T +E+    PP S +  
Sbjct: 149 GQLTDTQIKRNTFVGTPFWMAPEVI--QQSAYDSKADIWSLGITAIELAKGEPPNSDMHP 206

Query: 184 VQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           ++ LF I K   P++    S+  ++FI  CL  +P+ RPT  EL++H F+
Sbjct: 207 MRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  165 bits (421), Expect = 1e-50
 Identities = 80/227 (35%), Positives = 117/227 (51%), Gaps = 19/227 (8%)

Query: 20  KQSILQLEQ------EISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY 73
           K+ I++ ++      E ++LS+     IV+     + E +LY+ LE    G L +   K 
Sbjct: 28  KKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKE 87

Query: 74  H-LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 132
              S+ +   Y  +I+  L YLH   +++RD+K  NIL+DA G +KL DFGLAK    ++
Sbjct: 88  GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAK-ELSSE 146

Query: 133 LKSCK---GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR 189
                   GTP ++APEV+  K  GYG   D WSLG  + EMLT +PP+   E  + ++ 
Sbjct: 147 GSRTNTFCGTPEYLAPEVLLGK--GYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYE 203

Query: 190 -IGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT---VTELMEHPF 232
            I K  L   P  LS +ARD I   LQ +P  R       E+  HPF
Sbjct: 204 KILKDPL-RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  165 bits (420), Expect = 2e-50
 Identities = 81/245 (33%), Positives = 130/245 (53%), Gaps = 17/245 (6%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
            G   AVK + L+   A  KQ +    +E+ +L +     IV + G   +   + I +E 
Sbjct: 25  TGKIMAVKTIRLEINEAIQKQIL----RELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80

Query: 61  VTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHE-RNVVHRDIKCANILVDASGSV 117
           +  GSL  + ++    + +  +      +L GL YLHE   ++HRD+K +NILV++ G +
Sbjct: 81  MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQI 140

Query: 118 KLADFGLAKATTMNDL-KSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP 176
           KL DFG++     N L K+  GT  +MAPE +    + Y + +DIWSLG +++E+ T R 
Sbjct: 141 KLCDFGVSGQLV-NSLAKTFVGTSSYMAPERIQG--NDYSVKSDIWSLGLSLIELATGRF 197

Query: 177 PY-SHLEGVQALF----RIGKGELPSVPSS-LSRDARDFILKCLQVNPNDRPTVTELMEH 230
           PY    +    +F     I     P +PS   S D +DF+  CL  +P +RP+  EL+EH
Sbjct: 198 PYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257

Query: 231 PFVKR 235
           PF+K+
Sbjct: 258 PFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  164 bits (418), Expect = 3e-50
 Identities = 70/230 (30%), Positives = 115/230 (50%), Gaps = 12/230 (5%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           AVK  +L++  A  +Q I +  +E  ++ + +  N+V+ LG   +E  LYI +E +  G 
Sbjct: 32  AVK--TLKE-DASEQQ-IEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGD 87

Query: 66  LANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFG 123
           L +  +K    LS S + S+  QI  G+ YL  +N +HRD+   N LV  +  VK++DFG
Sbjct: 88  LLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFG 147

Query: 124 LAKA---TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYS 179
           L++          +  K    WMAPE +      +   +D+WS G  + E+ T    PY 
Sbjct: 148 LSRDLYDDDYYRKRGGKLPIRWMAPESLKEG--KFTSKSDVWSFGVLLWEIFTLGEQPYP 205

Query: 180 HLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
            +   + L  +  G     P +   +  D +L+C   +P DRPT +EL+E
Sbjct: 206 GMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  165 bits (418), Expect = 3e-50
 Identities = 89/214 (41%), Positives = 127/214 (59%), Gaps = 9/214 (4%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSL--ANLYQKYHLSDSQVSSYTRQ 86
           EI +L+  +  NIV+ L     EN L+I +E    G++    L  +  L++ Q+    +Q
Sbjct: 52  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQ 111

Query: 87  ILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGL-AKAT-TMNDLKSCKGTPFWMA 144
            L  L YLHE  ++HRD+K  NIL    G +KLADFG+ AK T T+    S  GTP+WMA
Sbjct: 112 TLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 171

Query: 145 PEVV---NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV--P 199
           PEVV    SK+  Y   AD+WSLG T++EM    PP+  L  ++ L +I K E P++  P
Sbjct: 172 PEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQP 231

Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           S  S + +DF+ KCL+ N + R T T+L++HPFV
Sbjct: 232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  162 bits (412), Expect = 2e-49
 Identities = 70/231 (30%), Positives = 111/231 (48%), Gaps = 13/231 (5%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           AVK +       Q    I +  +E  ++ + +  NIV+ LG   +E  L I +E +  G 
Sbjct: 32  AVKTLKEDASEQQ----IEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGD 87

Query: 66  LANLYQKYH---LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADF 122
           L +  +K     LS S + S+  QI  G+ YL  +N +HRD+   N LV  +  VK++DF
Sbjct: 88  LLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDF 147

Query: 123 GLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPY 178
           GL++    +D    KG      WMAPE +      +   +D+WS G  + E+ T    PY
Sbjct: 148 GLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG--KFTSKSDVWSFGVLLWEIFTLGEEPY 205

Query: 179 SHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
             +   + L  + KG     P +   +    +L+C   +P DRPT +EL+E
Sbjct: 206 PGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  161 bits (409), Expect = 1e-48
 Identities = 91/253 (35%), Positives = 136/253 (53%), Gaps = 18/253 (7%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSIL------QLEQ---EISLLSQFEQDNIVQYLGTDKDE 51
           DG F  V +   ++ GA     ++      +LE    EI +L+      IV+ LG    +
Sbjct: 22  DGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD 81

Query: 52  NRLYIFLELVTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
            +L+I +E    G++  +  +    L++ Q+    RQ+L  L YLH   ++HRD+K  N+
Sbjct: 82  GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNV 141

Query: 110 LVDASGSVKLADFGL-AKAT-TMNDLKSCKGTPFWMAPEVV---NSKNDGYGLTADIWSL 164
           L+   G +KLADFG+ AK   T+    S  GTP+WMAPEVV     K+  Y   ADIWSL
Sbjct: 142 LLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSL 201

Query: 165 GCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDARDFILKCLQVNPNDRP 222
           G T++EM    PP+  L  ++ L +I K E P++  PS  S + RDF+   L  +P  RP
Sbjct: 202 GITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRP 261

Query: 223 TVTELMEHPFVKR 235
           +  +L+EHPFV  
Sbjct: 262 SAAQLLEHPFVSS 274

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  160 bits (407), Expect = 1e-48
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 13/232 (5%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           AVK  +L++     ++   +  +E S++ +    NIV+ LG       LYI  E +  G 
Sbjct: 32  AVK--TLKEGA--SEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGD 87

Query: 66  LANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFG 123
           L +  +K+   L+   +     QI  G+ YL  +N VHRD+   N LV  +  VK++DFG
Sbjct: 88  LLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFG 147

Query: 124 LAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPY 178
           L++    +D        K    WMAPE +  K+  +   +D+WS G  + E+ T    PY
Sbjct: 148 LSRDIYEDDYYRKRGGGKLPIKWMAPESL--KDGKFTSKSDVWSFGVLLWEIFTLGEQPY 205

Query: 179 SHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
             +   + L  +  G     P +   +  + +L+C   +P DRPT +EL+E 
Sbjct: 206 PGMSNEEVLELLEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVED 257

Length = 258

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  160 bits (406), Expect = 3e-48
 Identities = 91/241 (37%), Positives = 139/241 (57%), Gaps = 15/241 (6%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+K+++LQ Q    K+ I+    EI ++ + +  NIV YL +    + L++ +E +  GS
Sbjct: 48  AIKQMNLQQQ--PKKELIIN---EILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGS 102

Query: 66  LANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA 125
           L ++  +  + + Q+++  R+ L  L +LH   V+HRDIK  NIL+   GSVKL DFG  
Sbjct: 103 LTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 162

Query: 126 KATTMNDLK--SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG 183
              T    K  +  GTP+WMAPEVV  K   YG   DIWSLG   +EM+   PPY +   
Sbjct: 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMVEGEPPYLNENP 220

Query: 184 VQALFRI---GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK--RPLQ 238
           ++AL+ I   G  EL + P  LS   RDF+ +CL+++   R +  EL++HPF+K  +PL 
Sbjct: 221 LRALYLIATNGTPELQN-PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLS 279

Query: 239 T 239
           +
Sbjct: 280 S 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  158 bits (403), Expect = 9e-48
 Identities = 77/240 (32%), Positives = 111/240 (46%), Gaps = 42/240 (17%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQ 86
           EISLL + +  NIV+ L     E +LY+  E      L     K    LS + + S   Q
Sbjct: 48  EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQ 106

Query: 87  ILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKG--TPFWMA 144
           +L GL Y H   ++HRD+K  NIL++  G +KLADFGLA+A  +          T ++ A
Sbjct: 107 LLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRA 166

Query: 145 PEV-VNSKNDGYGLTADIWSLGCTVLEMLTRRPPY---SHLEGVQALFRI---------- 190
           PE+ + SK+  Y    DIWS+GC   EM+T +P +   S ++  Q LF+I          
Sbjct: 167 PEILLGSKH--YSTAVDIWSVGCIFAEMITGKPLFPGDSEID--Q-LFKIFQILGTPTEE 221

Query: 191 ----------GKGELPSVP--------SSLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
                      K   P  P          L  +  D + K LQ NP  R +  E ++HP+
Sbjct: 222 SWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  158 bits (401), Expect = 1e-47
 Identities = 80/250 (32%), Positives = 125/250 (50%), Gaps = 23/250 (9%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
           G  +A+K +   D     K  + Q+  E  +LSQ +   +V+   + + +  LY+ +E +
Sbjct: 18  GDIYAIKVIKKAD--MIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYL 75

Query: 62  TKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
             G LA+L +    L +     Y  +I+  L YLH   ++HRD+K  NIL+D++G +KL 
Sbjct: 76  PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLT 135

Query: 121 DFGLAKATTMNDLKS----------CKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
           DFGL+K   +    +            GTP ++APEV+  +  G+  T D WSLGC + E
Sbjct: 136 DFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ--GHSKTVDWWSLGCILYE 193

Query: 171 MLTRRPPYSHLEGVQALF---RIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP---TV 224
            L   PP+ H E  + +F     GK E P     +S +A D I K L  +P  R    ++
Sbjct: 194 FLVGIPPF-HGETPEEIFQNILNGKIEWPEDV-EVSDEAIDLISKLLVPDPEKRLGAKSI 251

Query: 225 TELMEHPFVK 234
            E+  HPF K
Sbjct: 252 EEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  156 bits (397), Expect = 8e-47
 Identities = 77/234 (32%), Positives = 127/234 (54%), Gaps = 11/234 (4%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           AVK++ L+ Q     Q    L  E+ ++  ++  NIV+   +    + L++ +E +  G+
Sbjct: 48  AVKKMDLRKQ-----QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102

Query: 66  LANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA 125
           L ++     +++ Q+++    +L  L +LH + V+HRDIK  +IL+ + G VKL+DFG  
Sbjct: 103 LTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFC 162

Query: 126 KATT--MNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG 183
              +  +   KS  GTP+WMAPEV++     YG   DIWSLG  V+EM+   PPY +   
Sbjct: 163 AQVSKEVPRRKSLVGTPYWMAPEVISRLP--YGTEVDIWSLGIMVIEMVDGEPPYFNEPP 220

Query: 184 VQALFRIGKGELPSV--PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
           +QA+ RI     P +     +S   R F+ + L  +P  R T  EL+ HPF+ +
Sbjct: 221 LQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  154 bits (390), Expect = 7e-46
 Identities = 87/240 (36%), Positives = 138/240 (57%), Gaps = 13/240 (5%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+K+++LQ Q    K+ I+    EI ++ + +  NIV +L +    + L++ +E +  GS
Sbjct: 48  AIKQINLQKQ--PKKELIIN---EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGS 102

Query: 66  LANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA 125
           L ++  +  + ++Q+++  R+ L  L +LH   V+HRDIK  N+L+   GSVKL DFG  
Sbjct: 103 LTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFC 162

Query: 126 KATTMNDLK--SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG 183
              T    K  +  GTP+WMAPEVV  K   YG   DIWSLG   +EM+   PPY +   
Sbjct: 163 AQITPEQSKRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220

Query: 184 VQALFRIGKGELPSV--PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK--RPLQT 239
           ++AL+ I     P +  P  LS   RDF+ +CL+++   R +  EL++HPF+K  +PL +
Sbjct: 221 LRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  153 bits (390), Expect = 1e-45
 Identities = 77/242 (31%), Positives = 126/242 (52%), Gaps = 26/242 (10%)

Query: 4   FFAVKEVSLQDQGAQGKQSILQLEQ------EISLLSQFEQDNIVQYLGTDKDENRLYIF 57
           ++A+K +S        K  I++L+Q      E  +L       +V   G+ +D++ LY+ 
Sbjct: 28  YYALKILS--------KAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79

Query: 58  LELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNVVHRDIKCANILVDASGS 116
           +E V  G L +  +K       V+  Y  Q++  L YLH  ++V+RD+K  N+L+D+ G 
Sbjct: 80  MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY 139

Query: 117 VKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP 176
           +K+ DFG AK         C GTP ++APE++ SK  GYG   D W+LG  + EML   P
Sbjct: 140 IKITDFGFAKRVKGRTYTLC-GTPEYLAPEIILSK--GYGKAVDWWALGILIYEMLAGYP 196

Query: 177 PYSHLEGVQALF-RIGKGELPSVPSSLSRDARDFILKCLQVNP-----NDRPTVTELMEH 230
           P+   +    ++ +I +G++   PS  S DA+D I   LQV+      N +  V ++  H
Sbjct: 197 PFFD-DNPIQIYEKILEGKV-RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254

Query: 231 PF 232
           P+
Sbjct: 255 PW 256

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  154 bits (392), Expect = 2e-45
 Identities = 81/233 (34%), Positives = 126/233 (54%), Gaps = 17/233 (7%)

Query: 25  QLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDS-QVSSY 83
           Q+ +EI +L      N+V+          + + LE +  GSL       H++D   ++  
Sbjct: 118 QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG----THIADEQFLADV 173

Query: 84  TRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDLKSCKGTPF 141
            RQIL+G+ YLH R++VHRDIK +N+L++++ +VK+ADFG+++  A TM+   S  GT  
Sbjct: 174 ARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIA 233

Query: 142 WMAPEVVNSK-NDGY--GLTADIWSLGCTVLEMLTRRPPYSHLEGVQA-----LFRIGKG 193
           +M+PE +N+  N G   G   DIWSLG ++LE    R P+    G Q      +  I   
Sbjct: 234 YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG--VGRQGDWASLMCAICMS 291

Query: 194 ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPRCGQAN 246
           + P  P++ SR+ R FI  CLQ  P  R +  +L++HPF+ R       G  N
Sbjct: 292 QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQGGPN 344

Length = 353

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  153 bits (388), Expect = 2e-45
 Identities = 89/240 (37%), Positives = 138/240 (57%), Gaps = 13/240 (5%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+K+++LQ Q    K+ I+    EI ++ + +  NIV YL +    + L++ +E +  GS
Sbjct: 48  AIKQMNLQQQ--PKKELIIN---EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 102

Query: 66  LANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA 125
           L ++  +  + + Q+++  R+ L  L +LH   V+HRDIK  NIL+   GSVKL DFG  
Sbjct: 103 LTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 162

Query: 126 KATTMNDLK--SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG 183
              T    K  +  GTP+WMAPEVV  K   YG   DIWSLG   +EM+   PPY +   
Sbjct: 163 AQITPEQSKRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220

Query: 184 VQALFRIGKGELPSV--PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK--RPLQT 239
           ++AL+ I     P +  P  LS   RDF+ +CL+++ + R +  EL++HPF+K  +PL +
Sbjct: 221 LRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  152 bits (387), Expect = 2e-45
 Identities = 78/256 (30%), Positives = 121/256 (47%), Gaps = 33/256 (12%)

Query: 5   FAVKEVSLQDQGAQGKQSILQLEQEI-SLLSQFEQDNIVQYLGTDKDENRLYIFLELVTK 63
           +A+K +  +    + K   +++E+E+ + L+      I++   T +DE  LY  LE    
Sbjct: 29  YAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP--GIIKLYYTFQDEENLYFVLEYAPN 86

Query: 64  GSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADF 122
           G L    +KY  L +     Y  +IL  L YLH + ++HRD+K  NIL+D    +K+ DF
Sbjct: 87  GELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDF 146

Query: 123 GLAKA------TTMNDLKSCK----------------GTPFWMAPEVVNSKNDGYGLTAD 160
           G AK          N   +                  GT  +++PE++N K  G    +D
Sbjct: 147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS--SD 204

Query: 161 IWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPND 220
           +W+LGC + +MLT +PP+          +I K E  S P +   DA+D I K L ++P D
Sbjct: 205 LWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY-SFPPNFPPDAKDLIEKLLVLDPQD 263

Query: 221 RPTV----TELMEHPF 232
           R  V     EL  HPF
Sbjct: 264 RLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  153 bits (388), Expect = 2e-45
 Identities = 87/233 (37%), Positives = 136/233 (58%), Gaps = 10/233 (4%)

Query: 10  VSLQDQGAQGKQSILQLE---QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSL 66
           V+++     GKQS  + +   +E+  L + +  N ++Y G    E+  ++ +E    GS 
Sbjct: 53  VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSA 111

Query: 67  ANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGL 124
           ++L +  K  L + ++++ T   L GL YLH  N++HRDIK  NIL+   G VKLADFG 
Sbjct: 112 SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG- 170

Query: 125 AKATTMNDLKSCKGTPFWMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTRRPPYSHLEG 183
             A+  +   S  GTP+WMAPEV+ + ++G Y    D+WSLG T +E+  R+PP  ++  
Sbjct: 171 -SASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 229

Query: 184 VQALFRIGKGELPSVPSSLSRDA-RDFILKCLQVNPNDRPTVTELMEHPFVKR 235
           + AL+ I + E P++ S+   D  R+F+  CLQ  P DRPT  EL++H FV R
Sbjct: 230 MSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  153 bits (388), Expect = 2e-45
 Identities = 86/234 (36%), Positives = 135/234 (57%), Gaps = 9/234 (3%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           AVK++S    G Q  +    + +E+  L Q +  N ++Y G    E+  ++ +E    GS
Sbjct: 50  AVKKMSYS--GKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GS 106

Query: 66  LANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFG 123
            ++L +  K  L + ++++ T   L GL YLH  N++HRDIK  NIL+   G VKLADFG
Sbjct: 107 ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG 166

Query: 124 LAKATTMNDLKSCKGTPFWMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTRRPPYSHLE 182
              A+  +   S  GTP+WMAPEV+ + ++G Y    D+WSLG T +E+  R+PP  ++ 
Sbjct: 167 --SASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224

Query: 183 GVQALFRIGKGELPSVPSSLSRDA-RDFILKCLQVNPNDRPTVTELMEHPFVKR 235
            + AL+ I + + P++ S+   D+ R F+  CLQ  P +RP   EL+ H FV+R
Sbjct: 225 AMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  152 bits (385), Expect = 5e-45
 Identities = 75/228 (32%), Positives = 120/228 (52%), Gaps = 20/228 (8%)

Query: 25  QLEQEISLLSQFEQDNIVQYLGT--DKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS 82
           Q+ +E+ +    +   IV+Y G   D+  + + I +E    GSL ++Y+K      ++  
Sbjct: 45  QILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGE 104

Query: 83  Y-----TRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK 137
                    +L GL YLH R ++HRDIK +NIL+   G VKL DFG++     +   +  
Sbjct: 105 KVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT 164

Query: 138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR--------PPYSHLEGVQALFR 189
           GT F+MAPE +  K   Y +T+D+WSLG T+LE+   R        PP   +E +  +  
Sbjct: 165 GTSFYMAPERIQGKP--YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN 222

Query: 190 IGKGELPSVPS---SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           +   EL   P      S + +DFI +CL+ +P  RPT  +++EHP++K
Sbjct: 223 MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  154 bits (389), Expect = 6e-45
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 29/263 (11%)

Query: 5   FAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTK 63
            A+K ++ + +     + + +  +EI +L+      NIV+     +DE  LY+ +E V  
Sbjct: 25  VALKVLAKKLESK--SKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82

Query: 64  GSLANLYQKYH----LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS-VK 118
           GSL +L +K      LS+S+      QIL+ L YLH + ++HRDIK  NIL+D  G  VK
Sbjct: 83  GSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVK 142

Query: 119 LADFGLAKATTMND--------LKSCKGTPFWMAPEVVNSKNDGYGLTA-DIWSLGCTVL 169
           L DFGLAK                +  GTP +MAPEV+   +  Y  ++ DIWSLG T+ 
Sbjct: 143 LIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLY 202

Query: 170 EMLTRRPPYSHLEGVQALFRIGK------------GELPSVPSSLSRDARDFILKCLQVN 217
           E+LT  PP+   +   A  +  K               PS P  +S+ A D + K L  +
Sbjct: 203 ELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKD 262

Query: 218 PNDRPTVTELMEHPFVKRPLQTP 240
           P +R + +  + H  +       
Sbjct: 263 PKNRLSSSSDLSHDLLAHLKLKE 285

Length = 384

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  150 bits (382), Expect = 7e-45
 Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 21/237 (8%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           AVK +         ++      +E  ++ +    N+V+ LG   +E  LY+ LE +  G 
Sbjct: 27  AVKTLKEDAS----EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGD 82

Query: 66  L----------ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
           L              +K  LS   + S+  QI  G+ YL  +  VHRD+   N LV    
Sbjct: 83  LLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL 142

Query: 116 SVKLADFGLAKATTMNDL-KSCKGTPF---WMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
            VK++DFGL++    +D  +   G      WMAPE +      +   +D+WS G  + E+
Sbjct: 143 VVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGI--FTSKSDVWSFGVLLWEI 200

Query: 172 LTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
            T    PY  L   + L  + KG     P     +  + +L C Q++P DRPT +EL
Sbjct: 201 FTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSEL 257

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  150 bits (380), Expect = 1e-44
 Identities = 69/237 (29%), Positives = 118/237 (49%), Gaps = 10/237 (4%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           D      KEV+L     + ++  L    EI +LS  +  NI+ Y     D+N L I +E 
Sbjct: 24  DDSLVVWKEVNLTRLSEKERRDALN---EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80

Query: 61  VTKGSLANLY---QKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV 117
              G+L +     +     +  V  Y  QI++ + Y+H+  ++HRDIK  NI +  +G +
Sbjct: 81  ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLI 140

Query: 118 KLADFGLAK--ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR 175
           KL DFG++K   +  +  ++  GTP++M+PE+       Y   +DIW+LGC + E+LT +
Sbjct: 141 KLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK--YNFKSDIWALGCVLYELLTLK 198

Query: 176 PPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
             +     +  + +I +G    V S  S +    +   LQ +P  RPT  E+++ P 
Sbjct: 199 RTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  149 bits (378), Expect = 3e-44
 Identities = 78/241 (32%), Positives = 132/241 (54%), Gaps = 18/241 (7%)

Query: 1   DGFFFAVKEVSLQDQ-GAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLE 59
           DG   A+K+V + +   A+ +Q  L+   EI LL Q +  N+++YL +  + N L I LE
Sbjct: 26  DGRVVALKKVQIFEMMDAKARQDCLK---EIDLLKQLDHPNVIKYLASFIENNELNIVLE 82

Query: 60  LVTKGSLANLY-----QKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS 114
           L   G L+ +      QK  + +  +  Y  Q+ + L ++H + ++HRDIK AN+ + A+
Sbjct: 83  LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITAT 142

Query: 115 GSVKLADFGLAK---ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           G VKL D GL +   + T     S  GTP++M+PE +    +GY   +DIWSLGC + EM
Sbjct: 143 GVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERI--HENGYNFKSDIWSLGCLLYEM 199

Query: 172 LTRRPP-YSHLEGVQALF-RIGKGELPSVPSS-LSRDARDFILKCLQVNPNDRPTVTELM 228
              + P Y     + +L  +I K + P +P+   S + RD + +C+  +P  RP ++ ++
Sbjct: 200 AALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVL 259

Query: 229 E 229
           +
Sbjct: 260 Q 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  148 bits (376), Expect = 3e-44
 Identities = 75/233 (32%), Positives = 131/233 (56%), Gaps = 11/233 (4%)

Query: 7   VKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSL 66
           +KE+ L     + K++    ++E+ LL++ +  NIV +  + ++  RL+I +E    G L
Sbjct: 30  IKEIDLTKMPVKEKEAS---KKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDL 86

Query: 67  ANLYQKYH---LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV-KLADF 122
                +      S+ Q+ S+  QI  GL ++H+R ++HRDIK  NI +  +G V KL DF
Sbjct: 87  MKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDF 146

Query: 123 GLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSH 180
           G+A+    +M    +C GTP++++PE+   +N  Y    DIWSLGC + E+ T + P+  
Sbjct: 147 GIARQLNDSMELAYTCVGTPYYLSPEIC--QNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204

Query: 181 LEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
               Q + +I +G    +  + SRD R  I +  +V+P DRP++T +++ PF+
Sbjct: 205 NNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  149 bits (376), Expect = 5e-44
 Identities = 83/215 (38%), Positives = 123/215 (57%), Gaps = 8/215 (3%)

Query: 26  LEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYT 84
           ++QEI ++   +  NIV Y G+    ++L+I +E    GSL ++Y     LS+SQ++  +
Sbjct: 53  VQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVS 112

Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDLKSCKGTPFW 142
           R+ L GL YLH +  +HRDIK ANIL+  +G VKLADFG++     T+   KS  GTP+W
Sbjct: 113 RETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYW 172

Query: 143 MAPEVVN-SKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL--PSVP 199
           MAPEV    +  GY    DIW++G T +E+   +PP   L  ++ALF + K     P + 
Sbjct: 173 MAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK 232

Query: 200 SSL--SRDARDFILKCLQVNPNDRPTVTELMEHPF 232
             +  S     F+   L  NP  RPT  +L++HPF
Sbjct: 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  148 bits (375), Expect = 7e-44
 Identities = 84/215 (39%), Positives = 119/215 (55%), Gaps = 8/215 (3%)

Query: 26  LEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYT 84
           ++QEI ++ + +  NIV Y G+     +L+I +E    GSL ++Y     LS+ Q++   
Sbjct: 53  IQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVC 112

Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDLKSCKGTPFW 142
           R+ L GL YLH +  +HRDIK ANIL+  +G VKLADFG+A     T+   KS  GTP+W
Sbjct: 113 RETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYW 172

Query: 143 MAPEVVN-SKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL--PSVP 199
           MAPEV    KN GY    DIW++G T +E+   +PP   L  ++ALF + K     P + 
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLK 232

Query: 200 SSL--SRDARDFILKCLQVNPNDRPTVTELMEHPF 232
                S    +F+   L  NP  RPT   L+ H F
Sbjct: 233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  149 bits (377), Expect = 8e-44
 Identities = 87/240 (36%), Positives = 134/240 (55%), Gaps = 13/240 (5%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+++++LQ Q    K+ I+    EI ++ + +  NIV YL +    + L++ +E +  GS
Sbjct: 49  AIRQMNLQQQ--PKKELIIN---EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103

Query: 66  LANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA 125
           L ++  +  + + Q+++  R+ L  L +LH   V+HRDIK  NIL+   GSVKL DFG  
Sbjct: 104 LTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163

Query: 126 KATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG 183
              T    K     GTP+WMAPEVV  K   YG   DIWSLG   +EM+   PPY +   
Sbjct: 164 AQITPEQSKRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221

Query: 184 VQALFRIGKGELPSV--PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK--RPLQT 239
           ++AL+ I     P +  P  LS   RDF+ +CL ++   R +  EL++H F+K  +PL +
Sbjct: 222 LRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSS 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  147 bits (372), Expect = 2e-43
 Identities = 76/243 (31%), Positives = 124/243 (51%), Gaps = 18/243 (7%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
           G +FA+K +   D  A+ + + ++ E+ I ++ Q E   + +   + + ++ LY+ +E +
Sbjct: 21  GDYFAIKVLKKSDMIAKNQVTNVKAERAI-MMIQGESPYVAKLYYSFQSKDYLYLVMEYL 79

Query: 62  TKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
             G  A+L +    L +     Y  +++ G+  LH+R ++HRDIK  N+L+D +G +KL 
Sbjct: 80  NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLT 139

Query: 121 DFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSH 180
           DFGL++    N  K   GTP ++APE +    D     +D WSLGC + E L   PP+ H
Sbjct: 140 DFGLSRNGLEN--KKFVGTPDYLAPETILGVGDDK--MSDWWSLGCVIFEFLFGYPPF-H 194

Query: 181 LEGVQALF------RIGKGELPSVPSSLSRDARDFILKCLQVNPNDR---PTVTELMEHP 231
            E   A+F      RI   E   V    S +A D I + L ++P  R       E+  HP
Sbjct: 195 AETPDAVFDNILSRRINWPE--EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP 252

Query: 232 FVK 234
           F K
Sbjct: 253 FFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  148 bits (375), Expect = 2e-43
 Identities = 84/234 (35%), Positives = 131/234 (55%), Gaps = 9/234 (3%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+K++S    G Q  +    + +E+  L +    N +QY G    E+  ++ +E    GS
Sbjct: 44  AIKKMSYS--GKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GS 100

Query: 66  LANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFG 123
            ++L +  K  L + ++++ T   L GL YLH  N++HRD+K  NIL+   G VKL DFG
Sbjct: 101 ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG 160

Query: 124 LAKATTMNDLKSCKGTPFWMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTRRPPYSHLE 182
              A+ M       GTP+WMAPEV+ + ++G Y    D+WSLG T +E+  R+PP  ++ 
Sbjct: 161 --SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218

Query: 183 GVQALFRIGKGELPSVPSSLSRDA-RDFILKCLQVNPNDRPTVTELMEHPFVKR 235
            + AL+ I + E P++ S    +  R+F+  CLQ  P DRPT   L++H FV R
Sbjct: 219 AMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  146 bits (371), Expect = 2e-43
 Identities = 66/236 (27%), Positives = 118/236 (50%), Gaps = 10/236 (4%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           D   +A+K++ L     + ++  +    E  +L++ +   I++Y  +  D+ +L I +E 
Sbjct: 24  DKRVYAMKQIDLSKMNRREREEAID---EARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80

Query: 61  VTKGSLANLYQKYH---LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV 117
              G L  L +      L + QV  +  QIL GL +LH + ++HRDIK  N+ +DA  +V
Sbjct: 81  AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNV 140

Query: 118 KLADFGLAKATTMNDL--KSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR 175
           K+ D G+AK  + N     +  GTP++++PE+   K   Y   +D+W+LG  + E  T +
Sbjct: 141 KIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP--YNEKSDVWALGVVLYECCTGK 198

Query: 176 PPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP 231
            P+        + +I +G  P V    S+     I +CL  +   RP   +L+ +P
Sbjct: 199 HPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  144 bits (364), Expect = 3e-42
 Identities = 73/241 (30%), Positives = 134/241 (55%), Gaps = 16/241 (6%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           DG  + +KE+++     + ++   +  +E+++LS  +  NIVQY  + ++   LYI ++ 
Sbjct: 24  DGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80

Query: 61  VTKGSLANLYQKYH------LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS 114
              G   +LY+K +        + Q+  +  QI   L ++H+R ++HRDIK  NI +   
Sbjct: 81  CEGG---DLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD 137

Query: 115 GSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEML 172
           G++KL DFG+A+   +T+   ++C GTP++++PE+   +N  Y   +DIW+LGC + EM 
Sbjct: 138 GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEIC--ENRPYNNKSDIWALGCVLYEMC 195

Query: 173 TRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
           T +  +        + +I +G  P V S  S D R+ + +  + NP DRP+V  ++E  F
Sbjct: 196 TLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255

Query: 233 V 233
           +
Sbjct: 256 I 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  140 bits (355), Expect = 1e-40
 Identities = 86/244 (35%), Positives = 133/244 (54%), Gaps = 18/244 (7%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           AVK + L+ Q     Q    L  E+ ++  ++  N+V+   +      L++ +E +  G+
Sbjct: 50  AVKMMDLRKQ-----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104

Query: 66  LANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA 125
           L ++  +  L++ Q+++    +L  L YLH + V+HRDIK  +IL+   G VKL+DFG  
Sbjct: 105 LTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFC 164

Query: 126 KATTMNDL---KSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLE 182
            A    D+   KS  GTP+WMAPEV++     YG   DIWSLG  V+EM+   PPY    
Sbjct: 165 -AQISKDVPKRKSLVGTPYWMAPEVISRTP--YGTEVDIWSLGIMVIEMVDGEPPYFSDS 221

Query: 183 GVQALFRIGKGELPSVPSS--LSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQT- 239
            VQA+ R+     P + ++  +S   RDF+ + L   P +R T  EL++HPF+   LQT 
Sbjct: 222 PVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL---LQTG 278

Query: 240 -PRC 242
            P C
Sbjct: 279 LPEC 282

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  140 bits (354), Expect = 2e-40
 Identities = 82/246 (33%), Positives = 132/246 (53%), Gaps = 16/246 (6%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
           G   A+KE+ L+   ++  Q I++L+    +L +     IV + G    E  +Y+ +E +
Sbjct: 26  GVTMAMKEIRLELDESKFNQIIMELD----ILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81

Query: 62  TKGSLANLY----QKYHLSDSQVSSYTRQILNGLVYLHER-NVVHRDIKCANILVDASGS 116
             GSL  LY        + +  +   T  ++ GL +L E  N++HRD+K  N+LV+ +G 
Sbjct: 82  DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ 141

Query: 117 VKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDG----YGLTADIWSLGCTVLEML 172
           VKL DFG++     +  K+  G   +MAPE + S        Y + +D+WSLG ++LEM 
Sbjct: 142 VKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMA 201

Query: 173 TRR---PPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
             R   PP ++      L  I  G+ P++PS  S DA+DF+ KCL   PN RPT  +L+E
Sbjct: 202 LGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261

Query: 230 HPFVKR 235
           HP++ +
Sbjct: 262 HPWLVK 267

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  139 bits (352), Expect = 2e-40
 Identities = 75/248 (30%), Positives = 124/248 (50%), Gaps = 26/248 (10%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
               FA+K V  +     G+Q  +  E+EI  L +     IV+   T KD+  +Y+ +E 
Sbjct: 17  KNRTFALKCVKKRHIVETGQQEHIFSEKEI--LEECNHPFIVKLYRTFKDKKYIYMLMEY 74

Query: 61  VTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
              G L   L  +    +     Y   ++    YLH R +++RD+K  N+L+D++G VKL
Sbjct: 75  CLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKL 134

Query: 120 ADFGLAKATTMNDLKSCK------GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
            DFG AK      LKS +      GTP ++APE++ +K  GY  + D WSLG  + E+LT
Sbjct: 135 VDFGFAKK-----LKSGQKTWTFCGTPEYVAPEIILNK--GYDFSVDYWSLGILLYELLT 187

Query: 174 RRPPYSHLEGVQ-ALFRI---GKGELPSVPSSLSRDARDFILKCLQVNPNDR-----PTV 224
            RPP+   +     ++     G G+L   P+ + + A+D I + L+ NP +R       +
Sbjct: 188 GRPPFGEDDEDPMEIYNDILKGNGKLEF-PNYIDKAAKDLIKQLLRRNPEERLGNLKGGI 246

Query: 225 TELMEHPF 232
            ++ +H +
Sbjct: 247 KDIKKHKW 254

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  137 bits (346), Expect = 2e-39
 Identities = 75/239 (31%), Positives = 119/239 (49%), Gaps = 20/239 (8%)

Query: 5   FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKG 64
           FA+K ++ Q      K S+  +  E  +L +     +V    + +DE  +Y+ ++L+  G
Sbjct: 28  FAMKYMNKQKCVE--KGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGG 85

Query: 65  SLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFG 123
            L  +L QK   S+ QV  +  +I+  L YLH + ++HRDIK  NIL+D  G V + DF 
Sbjct: 86  DLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFN 145

Query: 124 LA---KATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYS 179
           +A      T+    S  GTP +MAPEV+  +   Y +  D WSLG T  E L  +RP   
Sbjct: 146 IATKVTPDTLTTSTS--GTPGYMAPEVLCRQG--YSVAVDWWSLGVTAYECLRGKRPYRG 201

Query: 180 HL----EGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR--PTVTELMEHPF 232
           H     + ++A     +      P++ S +A D I K L+ +P  R    + +L  HP+
Sbjct: 202 HSRTIRDQIRAKQ---ETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPY 257

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  137 bits (347), Expect = 2e-39
 Identities = 68/244 (27%), Positives = 110/244 (45%), Gaps = 49/244 (20%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-----KYHLSDSQVSSY 83
           EI LL +    NI++ L   + +  LY+  E +      +LY+     +  L +S + SY
Sbjct: 48  EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSY 103

Query: 84  TRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA-----TTMNDLKSCKG 138
             Q+L GL + H   ++HRD+K  N+L++  G +KLADFGLA++                
Sbjct: 104 LYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV--- 160

Query: 139 TPFWMAPEV-VNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------- 190
           T ++ APE+ +  K  GY    DIWS+GC   E+L+RRP +     +  LF+I       
Sbjct: 161 TRWYRAPELLLGDK--GYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTP 218

Query: 191 ----------------------GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
                                     LP +  + S  A D + + L  +P+ R T  + +
Sbjct: 219 DPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQAL 278

Query: 229 EHPF 232
            HP+
Sbjct: 279 AHPY 282

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  135 bits (342), Expect = 1e-38
 Identities = 68/245 (27%), Positives = 111/245 (45%), Gaps = 47/245 (19%)

Query: 29  EISLLSQFEQDNIVQYLG--TDKDENRLYIFLELVT---KGSLANLYQKYHLSDSQVSSY 83
           EI LL +    NIV+     T K +  +Y+  E +     G L +   +   ++SQ+  Y
Sbjct: 48  EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDS--PEVKFTESQIKCY 105

Query: 84  TRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTP--- 140
            +Q+L GL YLH   ++HRDIK +NIL++  G +KLADFGLA+        S   T    
Sbjct: 106 MKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLAR--PYTKRNSADYTNRVI 163

Query: 141 -FWM-APEVV-NSKNDGYGLTADIWSLGCTVLEMLTRRPPY---SHLEGVQALFRI---- 190
             W   PE++  +    YG   D+WS+GC + E+   +P +   + LE ++ +F +    
Sbjct: 164 TLWYRPPELLLGATR--YGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP 221

Query: 191 ------GKGELP---------SVPSSL--------SRDARDFILKCLQVNPNDRPTVTEL 227
                 G  +LP              L           A D + K L ++P  R +  + 
Sbjct: 222 TDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQA 281

Query: 228 MEHPF 232
           ++H +
Sbjct: 282 LQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  135 bits (340), Expect = 2e-38
 Identities = 76/231 (32%), Positives = 127/231 (54%), Gaps = 6/231 (2%)

Query: 8   KEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLA 67
           K+V+++    + +Q    L  E+ ++  +  +N+V    +    + L++ +E +  G+L 
Sbjct: 48  KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107

Query: 68  NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA 127
           ++     +++ Q+++    +L  L YLH + V+HRDIK  +IL+ + G +KL+DFG    
Sbjct: 108 DIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQ 167

Query: 128 TT--MNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQ 185
            +  +   KS  GTP+WMAPEV++     YG   DIWSLG  V+EM+   PPY +   +Q
Sbjct: 168 VSKEVPKRKSLVGTPYWMAPEVISRLP--YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ 225

Query: 186 ALFRIGKGELPSVPSS--LSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           A+ RI     P V  S  +S   R F+   L   P+ R T  EL++HPF+K
Sbjct: 226 AMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  134 bits (337), Expect = 3e-38
 Identities = 77/225 (34%), Positives = 124/225 (55%), Gaps = 16/225 (7%)

Query: 25  QLEQEISLLSQFEQD-NIVQYLGTDKDEN------RLYIFLELVTKGSLANLYQKYH--- 74
           +++QEI++L ++    NI  Y G    +N      +L++ +E    GS+ +L +      
Sbjct: 48  EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT 107

Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMND 132
           L +  ++   R+IL GL +LH+  V+HRDIK  N+L+  +  VKL DFG++     T+  
Sbjct: 108 LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 167

Query: 133 LKSCKGTPFWMAPEVV---NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR 189
             +  GTP+WMAPEV+    + +  Y   +D+WSLG T +EM    PP   +  ++ALF 
Sbjct: 168 RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 227

Query: 190 IGKGELPSVPS-SLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           I +   P + S   S+  + FI  CL  N + RPT  +LM+HPF+
Sbjct: 228 IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  134 bits (338), Expect = 3e-38
 Identities = 76/227 (33%), Positives = 126/227 (55%), Gaps = 18/227 (7%)

Query: 25  QLEQEISLLSQF-EQDNIVQYLGT-----DKDENRLYIFLELVTKGSLANLYQKY----- 73
           ++E E ++L    +  N+V++ G       K+ ++L++ LEL   GS+ +L + +     
Sbjct: 60  EIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE 119

Query: 74  HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL 133
            + +  ++    + L GL +LH    +HRD+K  NIL+   G VKL DFG++   T   L
Sbjct: 120 RMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179

Query: 134 K--SCKGTPFWMAPEVVNSK---NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALF 188
           +  +  GTPFWMAPEV+  +   +  Y    D+WSLG T +E+    PP + L  ++ALF
Sbjct: 180 RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF 239

Query: 189 RIGKGELPSV--PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           +I +   P++  P   S +  DFI KCL  +   RPTV++L++H F+
Sbjct: 240 KIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  133 bits (337), Expect = 7e-38
 Identities = 83/263 (31%), Positives = 121/263 (46%), Gaps = 41/263 (15%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+K+    +     K++ L+   E+ +L Q   +NIV      + + RLY+  E V +  
Sbjct: 30  AIKKFKESEDDEDVKKTALR---EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTL 86

Query: 66  LANL-YQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGL 124
           L  L      L    V SY  Q+L  + Y H  N++HRDIK  NILV  SG +KL DFG 
Sbjct: 87  LELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGF 146

Query: 125 AKATTMN---DLKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSH 180
           A+A        L     T ++ APE+ V   N  YG   D+W++GC + E+L   P +  
Sbjct: 147 ARALRARPASPLTDYVATRWYRAPELLVGDTN--YGKPVDVWAIGCIMAELLDGEPLFPG 204

Query: 181 LEGVQALFRIGK--GEL---------------------PSVPSSL--------SRDARDF 209
              +  L+ I K  G L                     PS P SL        S  A DF
Sbjct: 205 DSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDF 264

Query: 210 ILKCLQVNPNDRPTVTELMEHPF 232
           +  CL+++P +R T  EL++HP+
Sbjct: 265 LKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  132 bits (334), Expect = 2e-37
 Identities = 71/196 (36%), Positives = 110/196 (56%), Gaps = 14/196 (7%)

Query: 51  ENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           + +L++ L+ V  G L  +LYQ+ H ++S+V  Y  +I+  L +LH+  +++RDIK  NI
Sbjct: 77  DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENI 136

Query: 110 LVDASGSVKLADFGLAKATTMNDLK---SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           L+D+ G V L DFGL+K     + +   S  GT  +MAPEV+   + G+    D WSLG 
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGV 196

Query: 167 TVLEMLTRRPPYSHLEGVQ-----ALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
              E+LT   P++ ++G Q        RI K + P  P ++S +ARDFI K L+ +P  R
Sbjct: 197 LTFELLTGASPFT-VDGEQNSQSEISRRILKSK-PPFPKTMSAEARDFIQKLLEKDPKKR 254

Query: 222 ---PTVTELMEHPFVK 234
                  E+  HPF +
Sbjct: 255 LGANGADEIKNHPFFQ 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  132 bits (333), Expect = 2e-37
 Identities = 85/259 (32%), Positives = 130/259 (50%), Gaps = 26/259 (10%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSIL--------QLEQEISLLSQF-EQDNIVQYLG----TD 48
           G +  V +V+ +  G+     IL        ++E E ++L       N+V++ G     D
Sbjct: 33  GTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92

Query: 49  K-DENRLYIFLELVTKGSLANLYQKY-----HLSDSQVSSYTRQILNGLVYLHERNVVHR 102
           K    +L++ LEL   GS+  L +        L ++ +S      L GL +LH   ++HR
Sbjct: 93  KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHR 152

Query: 103 DIKCANILVDASGSVKLADFGLAKATTMNDLK--SCKGTPFWMAPEVVNSKND---GYGL 157
           D+K  NIL+   G VKL DFG++   T   L+  +  GTPFWMAPEV+  +      Y  
Sbjct: 153 DVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDA 212

Query: 158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDARDFILKCLQ 215
             D+WSLG T +E+    PP   +  V+ LF+I +   P++  P    R    FI +CL 
Sbjct: 213 RCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLI 272

Query: 216 VNPNDRPTVTELMEHPFVK 234
            +   RP+VT L+EHPF+K
Sbjct: 273 KDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  131 bits (330), Expect = 3e-37
 Identities = 75/242 (30%), Positives = 133/242 (54%), Gaps = 17/242 (7%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN-RLYIFLE 59
           DG  + +K+++L++   + +++    EQE  LLSQ +  NIV Y  + + E+  LYI + 
Sbjct: 24  DGKQYVIKKLNLRNASRRERKAA---EQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80

Query: 60  LVTKGSLANLYQKYH------LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
               G   +LY K        L ++QV  +  QI   L YLHE++++HRD+K  N+ +  
Sbjct: 81  FCEGG---DLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTR 137

Query: 114 SGSVKLADFGLAKA-TTMNDLKSCK-GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +  +K+ D G+A+      D+ S   GTP++M+PE+ ++K   Y   +D+W+LGC V EM
Sbjct: 138 TNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKP--YNYKSDVWALGCCVYEM 195

Query: 172 LTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP 231
            T +  ++  +    ++RI +G+LP +P   S +  + I   L   P  RP+V  ++  P
Sbjct: 196 ATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQP 255

Query: 232 FV 233
           ++
Sbjct: 256 YI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  132 bits (334), Expect = 6e-37
 Identities = 71/251 (28%), Positives = 115/251 (45%), Gaps = 51/251 (20%)

Query: 29  EISLLSQFEQDNIVQ----YLGTDKDE-NRLYIFLELVTKGSLANLYQ----KYHLSDSQ 79
           EI LL     +NI+           ++ N +YI  EL+      +L++       L+D  
Sbjct: 49  EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELM----ETDLHKVIKSPQPLTDDH 104

Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT 139
           +  +  QIL GL YLH  NV+HRD+K +NILV+++  +K+ DFGLA+    ++ +    T
Sbjct: 105 IQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164

Query: 140 PF----WM-APEVV-NSKNDGYGLTADIWSLGCTVLEMLTRRPPY---SHLEGVQALFR- 189
            +    W  APE++ +S    Y    DIWS+GC   E+LTR+P +    +++ +  +   
Sbjct: 165 EYVVTRWYRAPELLLSSSR--YTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEV 222

Query: 190 IGK------------------GELPSVP--------SSLSRDARDFILKCLQVNPNDRPT 223
           +G                     LP  P           S +A D + K L  +P  R T
Sbjct: 223 LGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT 282

Query: 224 VTELMEHPFVK 234
             E + HP++ 
Sbjct: 283 ADEALAHPYLA 293

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  129 bits (326), Expect = 2e-36
 Identities = 79/250 (31%), Positives = 132/250 (52%), Gaps = 25/250 (10%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           AVK +       + K+ ++ L+  IS+ S  +    V + G    E  ++I +E V   S
Sbjct: 30  AVKRIRATVNSQEQKRLLMDLD--ISMRSV-DCPYTVTFYGALFREGDVWICME-VMDTS 85

Query: 66  LANLYQKYHLSDSQV-----SSYTRQILNGLVYLHER-NVVHRDIKCANILVDASGSVKL 119
           L   Y+K +     +           I+  L YLH + +V+HRD+K +N+L++ +G VKL
Sbjct: 86  LDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKL 145

Query: 120 ADFGLAK------ATTMNDLKSCKGTPFWMAPEVVNSKND--GYGLTADIWSLGCTVLEM 171
            DFG++       A T++    CK  P+ MAPE +N + +  GY + +D+WSLG T++E+
Sbjct: 146 CDFGISGYLVDSVAKTID--AGCK--PY-MAPERINPELNQKGYDVKSDVWSLGITMIEL 200

Query: 172 LTRRPPYSHLEG-VQALFRIGKGELPSVPS-SLSRDARDFILKCLQVNPNDRPTVTELME 229
            T R PY   +   Q L ++ +   P +P+   S + +DF+ KCL+ N  +RP   EL++
Sbjct: 201 ATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260

Query: 230 HPFVKRPLQT 239
           HPF +  L  
Sbjct: 261 HPFFELHLSK 270

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  129 bits (326), Expect = 2e-36
 Identities = 78/239 (32%), Positives = 115/239 (48%), Gaps = 36/239 (15%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--LSDSQVSSYTR 85
           +EI +L Q   +N+V  +   + + RLY+  E V    L +L +KY   L +S+V  Y  
Sbjct: 49  REIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDL-EKYPNGLDESRVRKYLF 107

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDLKSCKGTPFWM 143
           QIL G+ + H  N++HRDIK  NILV  SG VKL DFG A+  A           T ++ 
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYR 167

Query: 144 APEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG---------- 193
           APE++   +  YG   DIW++GC V EMLT  P +     +  L+ I K           
Sbjct: 168 APELL-VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE 226

Query: 194 -----------ELPSVPSSLSRDAR---------DFILKCLQVNPNDRPTVTELMEHPF 232
                       LP V      + R         D   +CL+++P+DRP+ ++L+ H F
Sbjct: 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  128 bits (324), Expect = 4e-36
 Identities = 75/225 (33%), Positives = 121/225 (53%), Gaps = 16/225 (7%)

Query: 25  QLEQEISLLSQFEQD-NIVQYLGT------DKDENRLYIFLELVTKGSLANLYQKYH--- 74
           +++ EI++L ++    NI  Y G          +++L++ +E    GS+ +L +      
Sbjct: 58  EIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA 117

Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMND 132
           L +  ++   R+IL GL +LH   V+HRDIK  N+L+  +  VKL DFG++     T+  
Sbjct: 118 LKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 177

Query: 133 LKSCKGTPFWMAPEVV---NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR 189
             +  GTP+WMAPEV+    + +  Y   +DIWSLG T +EM    PP   +  ++ALF 
Sbjct: 178 RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL 237

Query: 190 IGKGELPSVPS-SLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           I +   P + S   S+   DFI  CL  N   RP+  +L++HPF+
Sbjct: 238 IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  127 bits (320), Expect = 9e-36
 Identities = 76/236 (32%), Positives = 124/236 (52%), Gaps = 16/236 (6%)

Query: 1   DGFFFAVKEVSLQD-QGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLE 59
           DG   A+K+V + D   A+ +   ++   EI LL Q    N+++Y  +  ++N L I LE
Sbjct: 26  DGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82

Query: 60  LVTKGSLANLY-----QKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS 114
           L   G L+ +      QK  + +  V  Y  Q+ + L ++H R V+HRDIK AN+ + A+
Sbjct: 83  LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT 142

Query: 115 GSVKLADFGLAK--ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEML 172
           G VKL D GL +  ++      S  GTP++M+PE ++   +GY   +DIWSLGC + EM 
Sbjct: 143 GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMA 200

Query: 173 TRRPPY--SHLEGVQALFRIGKGELPSVPSS-LSRDARDFILKCLQVNPNDRPTVT 225
             + P+    +       +I + + P +PS   S + R  +  C+  +P  RP +T
Sbjct: 201 ALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDIT 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  126 bits (320), Expect = 2e-35
 Identities = 86/272 (31%), Positives = 123/272 (45%), Gaps = 48/272 (17%)

Query: 1   DGFFFAVKE--VSLQDQGAQGKQSILQLEQEISLLSQ---FEQDNIVQYLG-----TDKD 50
            G F A+K+  V L ++G     S L+   EI+LL Q   FE  NIV+ L          
Sbjct: 23  TGRFVALKKVRVPLSEEGI--PLSTLR---EIALLKQLESFEHPNIVRLLDVCHGPRTDR 77

Query: 51  ENRLYIFLELVTKGSLANLYQKYH---LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           E +L +  E V +  LA    K     L    +    RQ+L G+ +LH   +VHRD+K  
Sbjct: 78  ELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQ 136

Query: 108 NILVDASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           NILV + G VK+ADFGLA+  +    L S   T ++ APEV+      Y    D+WS+GC
Sbjct: 137 NILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL--LQSSYATPVDMWSVGC 194

Query: 167 TVLEMLTRRP---PYSHLEGVQALFRI----GKGELP--------SVPSSLSRD------ 205
              E+  RRP     S  + +  +F +     + E P        S PS   R       
Sbjct: 195 IFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVP 254

Query: 206 -----ARDFILKCLQVNPNDRPTVTELMEHPF 232
                  D + K L  NP+ R +  E ++HP+
Sbjct: 255 EICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  126 bits (318), Expect = 3e-35
 Identities = 75/238 (31%), Positives = 108/238 (45%), Gaps = 35/238 (14%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKG--SLANLYQKYHLSDSQVSSYTR 85
           +EISLL +    NIV+ L     EN+LY+  E + +      +      +    + SY  
Sbjct: 48  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLF 107

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWM 143
           Q+L GL + H   V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ 
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 167

Query: 144 APEV-VNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------ 190
           APE+ +  K   Y    DIWSLGC   EM+TRR  +     +  LFRI            
Sbjct: 168 APEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 225

Query: 191 -GKGELPSVPSS---------------LSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
            G   LP    S               L  D RD + + L  +PN R +    + HPF
Sbjct: 226 PGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  126 bits (318), Expect = 3e-35
 Identities = 77/247 (31%), Positives = 110/247 (44%), Gaps = 55/247 (22%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENRLYI---FLELVTKGSLANLYQKYHLSDSQVSSYTR 85
           EISLL +    NIV+ L     EN+LY+   FL+L  K  + +      L    + SY  
Sbjct: 48  EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLY 106

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTP----- 140
           Q+L G+ Y H   V+HRD+K  N+L+D  G++KLADFGLA+A          G P     
Sbjct: 107 QLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF---------GVPVRTYT 157

Query: 141 -----FWM-APEV-VNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK- 192
                 W  APE+ + S+   Y    DIWS+GC   EM+ RRP +     +  LFRI + 
Sbjct: 158 HEVVTLWYRAPEILLGSRQ--YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRT 215

Query: 193 ---------------------------GELPSVPSSLSRDARDFILKCLQVNPNDRPTVT 225
                                       +L  V  +L  D  D + K L  +P  R +  
Sbjct: 216 LGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAK 275

Query: 226 ELMEHPF 232
             ++HP+
Sbjct: 276 AALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  124 bits (312), Expect = 4e-34
 Identities = 63/161 (39%), Positives = 94/161 (58%), Gaps = 17/161 (10%)

Query: 87  ILNGLVYLHER-NVVHRDIKCANILVDASGSVKLADFGLA------KATTMNDLKSCKGT 139
           I+  L YL E+  V+HRD+K +NIL+DASG+VKL DFG++      KA T    +S  G 
Sbjct: 123 IVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT----RS-AGC 177

Query: 140 PFWMAPEVV--NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG-VQALFRIGKGELP 196
             +MAPE +     N  Y + AD+WSLG +++E+ T + PY + +   + L +I + E P
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP 237

Query: 197 SVPS--SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
           S+P     S D   F+  CL  +   RP   EL++HPF++R
Sbjct: 238 SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  123 bits (310), Expect = 5e-34
 Identities = 73/238 (30%), Positives = 128/238 (53%), Gaps = 11/238 (4%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
           G   AVK++ L+ Q     Q    L  E+ ++  ++ +N+V+   +    + L++ +E +
Sbjct: 45  GKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99

Query: 62  TKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLAD 121
             G+L ++     +++ Q+++    +L  L  LH + V+HRDIK  +IL+   G VKL+D
Sbjct: 100 EGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSD 159

Query: 122 FGLAKATT--MNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYS 179
           FG     +  +   KS  GTP+WMAPE+++     YG   DIWSLG  V+EM+   PPY 
Sbjct: 160 FGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP--YGPEVDIWSLGIMVIEMVDGEPPYF 217

Query: 180 HLEGVQALFRIGKGELPSVPS--SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
           +   ++A+  I     P + +   +S   + F+ + L  +P  R T  EL++HPF+ +
Sbjct: 218 NEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  122 bits (308), Expect = 6e-34
 Identities = 72/230 (31%), Positives = 124/230 (53%), Gaps = 16/230 (6%)

Query: 6   AVKEVSL-QDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKG 64
           A+K+V + +   A+ +Q  ++   EI LL Q    N+++YL +  ++N L I LEL   G
Sbjct: 31  ALKKVQIFEMMDAKARQDCVK---EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAG 87

Query: 65  SLANLY-----QKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
            L+ +      QK  + +  V  Y  Q+ + + ++H R V+HRDIK AN+ + A+G VKL
Sbjct: 88  DLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKL 147

Query: 120 ADFGLAK--ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPP 177
            D GL +  ++      S  GTP++M+PE ++   +GY   +DIWSLGC + EM   + P
Sbjct: 148 GDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSP 205

Query: 178 Y--SHLEGVQALFRIGKGELPSVPSS-LSRDARDFILKCLQVNPNDRPTV 224
           +    +       +I + + P +P+   S   R+ +  C+  +P+ RP +
Sbjct: 206 FYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  122 bits (308), Expect = 7e-34
 Identities = 71/239 (29%), Positives = 121/239 (50%), Gaps = 18/239 (7%)

Query: 4   FFAVKEVSLQDQGAQGK------QSILQLEQEISLL-SQFEQDNIVQYLGTDKDENRLYI 56
             A+KE+++ +  A GK      +SI  +  E++++  Q    NIV+Y  T  + +RLYI
Sbjct: 28  LLALKEINVHNP-AFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYI 86

Query: 57  FLELVTKGSLANLY-----QKYHLSDSQVSSYTRQILNGLVYLH-ERNVVHRDIKCANIL 110
            ++L+    L   +     +K   ++ ++ +   Q++  L YLH E+ +VHRD+   NI+
Sbjct: 87  VMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIM 146

Query: 111 VDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVL 169
           +     V + DFGLAK       L S  GT  +  PE+V  KN+ YG  AD+W+ GC + 
Sbjct: 147 LGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIV--KNEPYGEKADVWAFGCILY 204

Query: 170 EMLTRRPPYSHLEGVQALFRIGKGELPSVPSSL-SRDARDFILKCLQVNPNDRPTVTEL 227
           +M T +PP+     +    +I +     +P  + S D  D I  CL  +   RP + ++
Sbjct: 205 QMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  122 bits (308), Expect = 1e-33
 Identities = 76/247 (30%), Positives = 111/247 (44%), Gaps = 52/247 (21%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVT---KGSLANLYQKYHLSDSQVSSYT 84
           +EISLL + +  NIV        E+RLY+  E ++   K  L +L +  ++    V SY 
Sbjct: 48  REISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYL 107

Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTP---- 140
            QIL G+++ H R V+HRD+K  N+L+D  G +KLADFGLA+A          G P    
Sbjct: 108 YQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF---------GIPVRVY 158

Query: 141 -------FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI--- 190
                  ++ APEV+      Y    DIWS+G    EM T++P +     +  LFRI   
Sbjct: 159 THEVVTLWYRAPEVLLGSPR-YSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRI 217

Query: 191 -------------------------GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT 225
                                     KG L S   +L  D  D + K L  +P  R +  
Sbjct: 218 LGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAK 277

Query: 226 ELMEHPF 232
           + + HP+
Sbjct: 278 KALNHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  121 bits (306), Expect = 2e-33
 Identities = 72/244 (29%), Positives = 111/244 (45%), Gaps = 53/244 (21%)

Query: 31  SLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY------HLSDSQVSSYT 84
           SL    E  NIV+     ++ + LY   E +      NLYQ          S+S + S  
Sbjct: 50  SLRKLNEHPNIVKLKEVFRENDELYFVFEYMEG----NLYQLMKDRKGKPFSESVIRSII 105

Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK------G 138
            QIL GL ++H+    HRD+K  N+LV     VK+ADFGLA+     +++S         
Sbjct: 106 YQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTDYVS 160

Query: 139 TPFWMAPEVV-NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------- 190
           T ++ APE++  S +  Y    DIW+LGC + E+ T RP +     +  L++I       
Sbjct: 161 TRWYRAPEILLRSTS--YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTP 218

Query: 191 GKGELP---------------SVPSSL-------SRDARDFILKCLQVNPNDRPTVTELM 228
            K + P                 P+SL       S +A D I   L+ +P  RPT ++ +
Sbjct: 219 TKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQAL 278

Query: 229 EHPF 232
           +HP+
Sbjct: 279 QHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  121 bits (305), Expect = 3e-33
 Identities = 67/248 (27%), Positives = 115/248 (46%), Gaps = 30/248 (12%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG--TDKDENRLYIFLELVTK 63
           AVK +      +  +Q     E+EI +L   + +NIV+Y G         L + +E +  
Sbjct: 37  AVKSL----NHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPS 92

Query: 64  GSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLAD 121
           GSL +  Q++   ++  ++  ++ QI  G+ YL  +  +HRD+   NILV++   VK++D
Sbjct: 93  GSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISD 152

Query: 122 FGLAKATTMND----LKSCKGTP-FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP 176
           FGLAK    +     +K    +P FW APE +  +   +   +D+WS G T+ E+ T   
Sbjct: 153 FGLAKVLPEDKDYYYVKEPGESPIFWYAPECL--RTSKFSSASDVWSFGVTLYELFTYGD 210

Query: 177 PYSH-----------LEGVQALFR----IGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           P               +G   + R    + +GE    P S   +  D +  C +  P DR
Sbjct: 211 PSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDR 270

Query: 222 PTVTELME 229
           P+  +L+ 
Sbjct: 271 PSFADLIL 278

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  121 bits (305), Expect = 8e-33
 Identities = 69/221 (31%), Positives = 107/221 (48%), Gaps = 15/221 (6%)

Query: 25  QLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSY 83
            +  E  +L+  + + +V+ L   +D+  LY+ +E V  G     L     LS+     Y
Sbjct: 47  HVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFY 106

Query: 84  TRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWM 143
             ++   +  LHE   +HRD+K  N L+DASG +KL DFGL+K   +    S  G+P +M
Sbjct: 107 MAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKG-IVTYANSVVGSPDYM 165

Query: 144 APEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYS---------HLEGVQALFRIGKGE 194
           APEV+  K  GY  T D WSLGC + E L   PP+S         +L+  +   +    +
Sbjct: 166 APEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYD 223

Query: 195 LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
            P    +LS +A D I K +        ++ ++  HPF K 
Sbjct: 224 DPR--FNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  120 bits (304), Expect = 2e-32
 Identities = 73/250 (29%), Positives = 112/250 (44%), Gaps = 48/250 (19%)

Query: 29  EISLLSQFEQ-DNIVQYLGTDKDENR--LYIFLELVTKGSLANLYQKYHLSDSQVSSYTR 85
           EI  L +     NIV+ L   K EN   +Y+  E + +  L  + +   L D        
Sbjct: 56  EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM-ETDLHAVIRANILEDVHKRYIMY 114

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTP----- 140
           Q+L  L Y+H  NV+HRD+K +NIL+++   VKLADFGLA+  ++++L+     P     
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLAR--SLSELEENPENPVLTDY 172

Query: 141 ----FWMAPEV-VNSKNDGYGLTADIWSLGCTVLEML---------------------TR 174
               ++ APE+ + S    Y    D+WS+GC + EML                       
Sbjct: 173 VATRWYRAPEILLGSTR--YTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG 230

Query: 175 RPPYSHLEGVQALF---------RIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT 225
            P    +E +++ F            +  L  +    S DA D + K L  NPN R T  
Sbjct: 231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAE 290

Query: 226 ELMEHPFVKR 235
           E +EHP+V +
Sbjct: 291 EALEHPYVAQ 300

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  118 bits (298), Expect = 6e-32
 Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 13/193 (6%)

Query: 51  ENRLYIFLELVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           ++RL+  +E V  G L    Q+     + +   Y  +I+ GL +LHER +++RD+K  N+
Sbjct: 68  KDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNV 127

Query: 110 LVDASGSVKLADFGLAKATTMNDLKS---CKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           L+D+ G +K+ADFG+ K   +  + +   C GTP ++APE++      YG   D W+LG 
Sbjct: 128 LLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYIAPEIL--SYQPYGPAVDWWALGV 184

Query: 167 TVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT- 225
            + EML  + P+   +    LF+    +    P  LS++A+  +   L  NP  R     
Sbjct: 185 LLYEMLAGQSPF-EGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLP 243

Query: 226 ----ELMEHPFVK 234
               ++  HPF +
Sbjct: 244 TGEQDIKGHPFFR 256

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  119 bits (299), Expect = 6e-32
 Identities = 70/225 (31%), Positives = 112/225 (49%), Gaps = 16/225 (7%)

Query: 20  KQSILQLEQ------EISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY 73
           K+ IL+++Q      E S+L +     IV  + + +DENR+Y  LE V  G L    +K 
Sbjct: 53  KREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA 112

Query: 74  HLSDSQVSS-YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 132
               + V+  Y  +++    YLH +++++RD+K  N+L+D  G VK+ DFG AK      
Sbjct: 113 GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172

Query: 133 LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
              C GTP ++APEV+ SK  G+G   D W++G  + E +   PP+      +   +I  
Sbjct: 173 FTLC-GTPEYLAPEVIQSK--GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA 229

Query: 193 GELPSVPSSLSRDARDFILKCLQVNPNDR-----PTVTELMEHPF 232
           G L   P+     ARD +   LQ +   R       V ++  HP+
Sbjct: 230 GRL-KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY 273

Length = 329

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  117 bits (296), Expect = 6e-32
 Identities = 63/223 (28%), Positives = 113/223 (50%), Gaps = 16/223 (7%)

Query: 25  QLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVSSY 83
           Q+ +E+ ++ +     IV + G   +EN + + +E +  GSL  +Y+K   +    +   
Sbjct: 49  QILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKI 108

Query: 84  TRQILNGLVYLH-ERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFW 142
              ++ GL YL+    ++HRDIK +NILV++ G +KL DFG++     +   +  GT  +
Sbjct: 109 AVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTY 168

Query: 143 MAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG-----------VQALFRIG 191
           M+PE +      Y + +D+WSLG +++E+   + P++               +  L +I 
Sbjct: 169 MSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV 226

Query: 192 KGELPSVPSS-LSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           +   P +PSS    D RDF+  CL  +P +RPT  +L   P  
Sbjct: 227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  117 bits (294), Expect = 2e-31
 Identities = 78/253 (30%), Positives = 127/253 (50%), Gaps = 28/253 (11%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
           G   AVK +       + K+  L ++ ++ + S  +   IV++ G    E   +I +EL+
Sbjct: 29  GTIMAVKRIRSTVDEKEQKR--LLMDLDVVMRSS-DCPYIVKFYGALFREGDCWICMELM 85

Query: 62  TKGSLANLY------QKYHLSDSQVSSYTRQILNGLVYLHER-NVVHRDIKCANILVDAS 114
              SL   Y       K  + +  +       +  L YL E   ++HRD+K +NIL+D +
Sbjct: 86  DI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRN 144

Query: 115 GSVKLADFGLAK------ATTMNDLKSCKGTPFWMAPEVVN-SKNDGYGLTADIWSLGCT 167
           G++KL DFG++       A T +    C+  P+ MAPE ++ S  DGY + +D+WSLG T
Sbjct: 145 GNIKLCDFGISGQLVDSIAKTRD--AGCR--PY-MAPERIDPSARDGYDVRSDVWSLGIT 199

Query: 168 VLEMLTRRPPYSHLEGV-QALFRIGKGELPSVPSSL----SRDARDFILKCLQVNPNDRP 222
           + E+ T + PY     V   L ++ KG+ P + +S     S    +FI  CL  + + RP
Sbjct: 200 LYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRP 259

Query: 223 TVTELMEHPFVKR 235
              EL+EHPF+K 
Sbjct: 260 KYKELLEHPFIKD 272

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  117 bits (295), Expect = 3e-31
 Identities = 87/293 (29%), Positives = 135/293 (46%), Gaps = 63/293 (21%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYL------GTDKDE-------- 51
           AVK++ L D      QS+    +EI ++ + + DNIV+        G+D  E        
Sbjct: 34  AVKKIVLTD-----PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88

Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +YI  E + +  LAN+ ++  LS+     +  Q+L GL Y+H  NV+HRD+K AN+ +
Sbjct: 89  NSVYIVQEYM-ETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFI 147

Query: 112 DASGSV-KLADFGLAKATTMNDLKSCKG-------TPFWMAPEVVNSKNDGYGLTADIWS 163
           +    V K+ DFGLA+   ++   S KG       T ++ +P ++ S N+ Y    D+W+
Sbjct: 148 NTEDLVLKIGDFGLAR--IVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNN-YTKAIDMWA 204

Query: 164 LGCTVLEMLTRRP--PYSH--------LEGVQALFRIGKGELPSV-PSSLSRD------- 205
            GC   EMLT +P    +H        LE V  +    + EL +V PS +  D       
Sbjct: 205 AGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRP 264

Query: 206 -----------ARDFILKCLQVNPNDRPTVTELMEHPFVKR---PLQTPRCGQ 244
                      A DF+ + L  NP DR T  E + HP++     P   P    
Sbjct: 265 LRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLH 317

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  116 bits (291), Expect = 3e-31
 Identities = 68/217 (31%), Positives = 116/217 (53%), Gaps = 13/217 (5%)

Query: 25  QLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYT 84
           Q+  E+ +L + +   I+ + G    ENR+ I  E +  GSL ++Y+K  + +  +    
Sbjct: 45  QIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL-DVYRK--IPEHVLGRIA 101

Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMA 144
             ++ GL YL    ++HRD+K +N+LV+  G VKL DFG++     +  K+  GT  +MA
Sbjct: 102 VAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMA 161

Query: 145 PEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG-------VQALFRIGKGELPS 197
           PE ++   + YG+ +D+WSLG + +E+   R PY  ++        +Q L  I   + P 
Sbjct: 162 PERISG--EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV 219

Query: 198 VPSSL-SRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           +P    S     FI +C++  P +RP    LM+HPF+
Sbjct: 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI 256

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  115 bits (289), Expect = 4e-31
 Identities = 66/232 (28%), Positives = 111/232 (47%), Gaps = 20/232 (8%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           AVK +  Q+  A GK+  L+   E S+++Q +   IV+ +G  K E  L + +EL   G 
Sbjct: 27  AVKTLK-QEHIAAGKKEFLR---EASVMAQLDHPCIVRLIGVCKGEP-LMLVMELAPLGP 81

Query: 66  LANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGL 124
           L    +K   +  S +     Q+  G+ YL  ++ VHRD+   N+L+      K++DFG+
Sbjct: 82  LLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGM 141

Query: 125 AKATTMND--LKSCKGTPF---WMAPEVVNSKNDGYGL---TADIWSLGCTVLEMLTR-R 175
           ++A        ++     +   W APE +N     YG     +D+WS G T+ E  +   
Sbjct: 142 SRALGAGSDYYRATTAGRWPLKWYAPECIN-----YGKFSSKSDVWSYGVTLWEAFSYGA 196

Query: 176 PPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
            PY  ++G + +  +  GE    P    ++    +L C +  P DRPT +EL
Sbjct: 197 KPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSEL 248

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  115 bits (291), Expect = 6e-31
 Identities = 74/246 (30%), Positives = 112/246 (45%), Gaps = 52/246 (21%)

Query: 30  ISLLSQFEQD---NIV-QYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTR 85
           I LL  F      N+V +++ TD         LE V K           L+ + + SY  
Sbjct: 65  IGLLDVFGHKSNINLVFEFMETD---------LEKVIKDK------SIVLTPADIKSYML 109

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDLKSCKGTPFWM 143
             L GL YLH   ++HRD+K  N+L+ + G +KLADFGLA+   +    +     T ++ 
Sbjct: 110 MTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYR 169

Query: 144 APEVV-NSKNDGYGLTADIWSLGCTVLEMLTRRPPY---SHLEGVQALFRI--------- 190
           APE++  +++  YG+  D+WS+GC   E+L R P     S ++ +  +F           
Sbjct: 170 APELLFGARH--YGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW 227

Query: 191 -GKGELPS------VP--------SSLSRDARDFILKCLQVNPNDRPTVTELMEHP-FVK 234
            G   LP        P         + S DA D + + L +NPN R T  + +EHP F  
Sbjct: 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287

Query: 235 RPLQTP 240
            P  TP
Sbjct: 288 DPAPTP 293

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  114 bits (288), Expect = 9e-31
 Identities = 73/229 (31%), Positives = 113/229 (49%), Gaps = 23/229 (10%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQ------EISLLSQFEQDNIVQYLGTDKDENRLY 55
             ++A+K +++ +        +++L+Q      E  +L +     I++   T+ D+  LY
Sbjct: 26  EHYYALKVMAIPE--------VIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLY 77

Query: 56  IFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS 114
           + +E V  G L + L      S+S    Y  +I+  L YLH + +V+RD+K  NIL+D  
Sbjct: 78  MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE 137

Query: 115 GSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR 174
           G +KL DFG AK         C GTP ++APEV+ SK  G+    D W+LG  + EML  
Sbjct: 138 GHIKLTDFGFAKKLRDRTWTLC-GTPEYLAPEVIQSK--GHNKAVDWWALGILIYEMLVG 194

Query: 175 RPPY--SHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
            PP+   +  G+      GK E    P  L   A+D I K L V+   R
Sbjct: 195 YPPFFDDNPFGIYEKILAGKLEF---PRHLDLYAKDLIKKLLVVDRTRR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  115 bits (289), Expect = 2e-30
 Identities = 77/246 (31%), Positives = 122/246 (49%), Gaps = 44/246 (17%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENR-----LYIFLELVTKGSLANLYQKYHLSDSQVSSY 83
           EI +L +F+ +NI+  L   +  +      +YI  EL+ +  L  L +  HLS+  +  +
Sbjct: 53  EIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYF 111

Query: 84  TRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF-- 141
             QIL GL Y+H  NV+HRD+K +N+L++ +  +K+ DFGLA+        +   T +  
Sbjct: 112 LYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171

Query: 142 --WM-APEV-VNSKNDGYGLTADIWSLGCTVLEMLTRRPPY---------SHLEGV---- 184
             W  APE+ +NSK  GY    DIWS+GC + EML+ RP +         + + GV    
Sbjct: 172 TRWYRAPEIMLNSK--GYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP 229

Query: 185 --QALFRI----GKGELPSVP-------SSL----SRDARDFILKCLQVNPNDRPTVTEL 227
             + L  I     +  + S+P       + L       A D + K L  NP+ R TV E 
Sbjct: 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEA 289

Query: 228 MEHPFV 233
           + HP++
Sbjct: 290 LAHPYL 295

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  113 bits (284), Expect = 2e-30
 Identities = 67/208 (32%), Positives = 105/208 (50%), Gaps = 13/208 (6%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTR 85
           QE  ++ QF+  +IV+ +G   + N ++I +EL   G L +  Q  KY L  + +  Y+ 
Sbjct: 56  QEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSY 114

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGT-PF 141
           Q+   L YL  +  VHRDI   N+LV +   VKL DFGL++   + D    K+ KG  P 
Sbjct: 115 QLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGKLPI 172

Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVP 199
            WMAPE +N +   +   +D+W  G  + E+L     P+  ++    + RI  GE   +P
Sbjct: 173 KWMAPESINFRR--FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMP 230

Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTEL 227
            +        + KC   +P+ RP  TEL
Sbjct: 231 PNCPPTLYSLMTKCWAYDPSKRPRFTEL 258

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  113 bits (283), Expect = 3e-30
 Identities = 61/232 (26%), Positives = 114/232 (49%), Gaps = 10/232 (4%)

Query: 7   VKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSL 66
           +K++ ++      + +    + E  +L      NI++Y     ++  L I +E    G+L
Sbjct: 30  IKQIPVEQMTKDERLAA---QNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTL 86

Query: 67  ANLYQKY---HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV-KLADF 122
           A   QK     L +  +  +  QIL  L ++H + ++HRD+K  NIL+D    V K+ DF
Sbjct: 87  AEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDF 146

Query: 123 GLAKA-TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHL 181
           G++K  ++ +   +  GTP +++PE+   K   Y   +DIW+LGC + E+ + +  +   
Sbjct: 147 GISKILSSKSKAYTVVGTPCYISPELCEGKP--YNQKSDIWALGCVLYELASLKRAFEAA 204

Query: 182 EGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
                + +I  G    +    S D R  IL  L ++P+ RP ++++M  P  
Sbjct: 205 NLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  114 bits (288), Expect = 4e-30
 Identities = 70/231 (30%), Positives = 100/231 (43%), Gaps = 41/231 (17%)

Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYLHERNV 99
           IV+   + +DE  LY+ +E +  G L NL  +     +     Y  +++  L  +H+   
Sbjct: 63  IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF 122

Query: 100 VHRDIKCANILVDASGSVKLADFGLAKA-------------------------------T 128
           +HRDIK  NIL+DA G +KLADFGL K                                 
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182

Query: 129 TMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALF 188
                 S  GTP ++APEV+      YGL  D WSLG  + EML   PP+      +   
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240

Query: 189 RIGKGE----LPSVPSSLSRDARDFILKCLQVNPNDR-PTVTELMEHPFVK 234
           +I   +     P  P  +S +A D I + L  +P DR  +  E+  HPF K
Sbjct: 241 KIINWKESLRFPPDP-PVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK 289

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  114 bits (286), Expect = 4e-30
 Identities = 72/198 (36%), Positives = 113/198 (57%), Gaps = 17/198 (8%)

Query: 51  ENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           E +L++ L+ V+ G +  +LYQ+ + S+ +V  Y+ +I+  L +LH+  +V+RDIK  NI
Sbjct: 77  EAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENI 136

Query: 110 LVDASGSVKLADFGLAKATTMNDLK---SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           L+D+ G V L DFGL+K     + +   S  GT  +MAPE++  K  G+G   D WSLG 
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKG-GHGKAVDWWSLGI 195

Query: 167 TVLEMLTRRPPYSHLEG-----VQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
            + E+LT   P++ LEG      +   RI K + P  PS +  +A+D + K L+ +P  R
Sbjct: 196 LIFELLTGASPFT-LEGERNTQSEVSRRILKCD-PPFPSFIGPEAQDLLHKLLRKDPKKR 253

Query: 222 -----PTVTELMEHPFVK 234
                   +E+ EHPF K
Sbjct: 254 LGAGPQGASEIKEHPFFK 271

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  111 bits (278), Expect = 1e-29
 Identities = 70/232 (30%), Positives = 119/232 (51%), Gaps = 17/232 (7%)

Query: 5   FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKG 64
           +A+KE+ L    +  + S     +E  LL++ +  NIV +  + + +  LYI +E    G
Sbjct: 28  YAMKEIRLPKSSSAVEDS----RKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGG 83

Query: 65  SLANLYQKYHL------SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
              +L QK  L       +  +  +  Q+  G+ ++HE+ V+HRDIK  NI +  +G VK
Sbjct: 84  ---DLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVK 140

Query: 119 LADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP 176
           L DFG A+  T     +C   GTP+++ PE+   +N  Y   +DIWSLGC + E+ T + 
Sbjct: 141 LGDFGSARLLTSPGAYACTYVGTPYYVPPEI--WENMPYNNKSDIWSLGCILYELCTLKH 198

Query: 177 PYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           P+        + ++ +G    +PS  S + R  I +  + NP  RP+ T ++
Sbjct: 199 PFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  111 bits (280), Expect = 1e-29
 Identities = 61/238 (25%), Positives = 106/238 (44%), Gaps = 36/238 (15%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--LSDSQVSSYTRQ 86
           EI  L   +   +V+ L      +   + +E +    L+ + +     L ++QV SY R 
Sbjct: 49  EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRM 107

Query: 87  ILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK---GTPFWM 143
           +L G+ Y+H   ++HRD+K AN+L+ A G +K+ADFGLA+  +  + +       T ++ 
Sbjct: 108 LLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYR 167

Query: 144 APEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------- 190
           APE++      Y    D+W++GC   E+L   P +     ++ L  +             
Sbjct: 168 APELLYGARK-YDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWP 226

Query: 191 GKGELP---------SVPSSL-------SRDARDFILKCLQVNPNDRPTVTELMEHPF 232
           G   LP         S P  L       S +A D +   L  +P+ R +  E + HP+
Sbjct: 227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  111 bits (280), Expect = 2e-29
 Identities = 76/242 (31%), Positives = 123/242 (50%), Gaps = 22/242 (9%)

Query: 4   FFAVK----EVSLQDQGAQG---KQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYI 56
           FFA+K    +V L D   +    ++ +L L  E   L+         Y      EN L+ 
Sbjct: 22  FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL-------YCTFQTKEN-LFF 73

Query: 57  FLELVTKGSLANLYQKYHLSD-SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
            +E +  G L    Q  H  D  + + Y  +I+ GL +LH + +V+RD+K  NIL+D  G
Sbjct: 74  VMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG 133

Query: 116 SVKLADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
            +K+ADFG+ K   + D K+C   GTP ++APE++  +   Y  + D WS G  + EML 
Sbjct: 134 HIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK--YNTSVDWWSFGVLLYEMLI 191

Query: 174 RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT-ELMEHPF 232
            + P+ H    + LF+  + + P  P  L+R+A+D ++K     P  R  V  ++ +HPF
Sbjct: 192 GQSPF-HGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPF 250

Query: 233 VK 234
            +
Sbjct: 251 FR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  110 bits (277), Expect = 2e-29
 Identities = 66/212 (31%), Positives = 107/212 (50%), Gaps = 13/212 (6%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS---YT 84
           +E +++   + +N+++  G       + +  EL   GSL +  +K  L    +S+   Y 
Sbjct: 45  KEAAIMHSLDHENLIRLYGVVLTHPLMMVT-ELAPLGSLLDRLRKDALGHFLISTLCDYA 103

Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTP 140
            QI NG+ YL  +  +HRD+   NIL+ +   VK+ DFGL +A   N+    ++     P
Sbjct: 104 VQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP 163

Query: 141 F-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-GELPS 197
           F W APE + ++   +   +D+W  G T+ EM T    P++ L G Q L +I K GE   
Sbjct: 164 FAWCAPESLRTRT--FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE 221

Query: 198 VPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
            P +  +D  + +L+C   NP DRPT   L E
Sbjct: 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 3e-29
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 9/203 (4%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK---YHLSDSQVSSYT 84
           QE  ++ +   D +VQ      +E  +YI  E ++KGSL +  +      L   Q+    
Sbjct: 50  QEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMA 109

Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF--- 141
            QI  G+ YL  RN +HRD+   NILV  +   K+ADFGLA+    ++  + +G  F   
Sbjct: 110 AQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK 169

Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPS 200
           W APE  N     + + +D+WS G  + E++T  R PY  +   + L ++ +G     P 
Sbjct: 170 WTAPEAANYGR--FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPP 227

Query: 201 SLSRDARDFILKCLQVNPNDRPT 223
           +   +  D +L+C   +P +RPT
Sbjct: 228 NCPEELYDLMLQCWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  110 bits (276), Expect = 9e-29
 Identities = 61/193 (31%), Positives = 95/193 (49%), Gaps = 11/193 (5%)

Query: 51  ENRLYIFLELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
            +RLY  +E V  G L    Q+     +     Y  +I  GL +LH + +++RD+K  N+
Sbjct: 73  MDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNV 132

Query: 110 LVDASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           ++DA G +K+ADFG+ K        +    GTP ++APE++      YG + D W+ G  
Sbjct: 133 MLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII--AYQPYGKSVDWWAFGVL 190

Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR----PT 223
           + EML  +PP+   E    LF+       S P SLS++A       L  +P  R    PT
Sbjct: 191 LYEMLAGQPPFDG-EDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPT 249

Query: 224 VT-ELMEHPFVKR 235
              ++ EH F +R
Sbjct: 250 GERDIREHAFFRR 262

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  110 bits (276), Expect = 1e-28
 Identities = 66/191 (34%), Positives = 106/191 (55%), Gaps = 13/191 (6%)

Query: 53  RLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +LY+ LE ++ G L  +L ++    +     Y  +I   L +LH++ +++RD+K  NIL+
Sbjct: 74  KLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL 133

Query: 112 DASGSVKLADFGLAKATTMNDLKS---CKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           DA G VKL DFGL K +      +   C GT  +MAPE++     G+G   D WSLG  +
Sbjct: 134 DAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYMAPEIL--MRSGHGKAVDWWSLGALM 190

Query: 169 LEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR-----PT 223
            +MLT  PP++     + + +I KG+L ++P  L+ +ARD + K L+ NP+ R       
Sbjct: 191 YDMLTGAPPFTAENRKKTIDKILKGKL-NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGD 249

Query: 224 VTELMEHPFVK 234
             E+  HPF +
Sbjct: 250 AAEVQSHPFFR 260

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  110 bits (276), Expect = 1e-28
 Identities = 72/261 (27%), Positives = 121/261 (46%), Gaps = 52/261 (19%)

Query: 29  EISLLSQFEQDNIVQ----YLGTDKDENRLYIFLELVTKGSLANLYQKYH----LSDSQV 80
           E+ +L  F+ DNI+           D   +Y+ ++L+     ++L+   H    L++  +
Sbjct: 54  ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME----SDLHHIIHSDQPLTEEHI 109

Query: 81  SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK--- 137
             +  Q+L GL Y+H  NV+HRD+K +N+LV+    +++ DFG+A+  + +  +      
Sbjct: 110 RYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT 169

Query: 138 ---GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP--P---YSH--------- 180
               T ++ APE++ S  + Y    D+WS+GC   EML RR   P   Y H         
Sbjct: 170 EYVATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVL 228

Query: 181 -LEGVQALFRIGK----------GELPSVPSS-----LSRDARDFILKCLQVNPNDRPTV 224
                + L RIG                VP S      S +A D + + LQ +P +R TV
Sbjct: 229 GSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITV 288

Query: 225 TELMEHPFVKR---PLQTPRC 242
            + ++HPF+ +   P   P C
Sbjct: 289 EQALQHPFLAQYHDPDDEPTC 309

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  109 bits (273), Expect = 2e-28
 Identities = 69/248 (27%), Positives = 113/248 (45%), Gaps = 42/248 (16%)

Query: 28  QEISLLSQFEQDNIVQY--LGTD--------KDENRLYIFLELVTKGSLANLYQKY-HLS 76
           +EI +L Q    NIV    + TD        KD+   Y+  E +    +  L     H S
Sbjct: 55  REIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFS 114

Query: 77  DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK-- 134
           +  + S+ +Q+L GL Y H++N +HRDIKC+NIL++  G +KLADFGLA+     + +  
Sbjct: 115 EDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174

Query: 135 SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYS---HLEGVQALFRIG 191
           + K    W  P  +    + YG   D+WS GC + E+ T++P +     L  ++ + R+ 
Sbjct: 175 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 234

Query: 192 KGELPSV-P-------------------------SSLSRDARDFILKCLQVNPNDRPTVT 225
               P+V P                         S +   A D +   L ++P+ R T  
Sbjct: 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAE 294

Query: 226 ELMEHPFV 233
           E +  P++
Sbjct: 295 EALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  108 bits (273), Expect = 2e-28
 Identities = 70/259 (27%), Positives = 107/259 (41%), Gaps = 60/259 (23%)

Query: 29  EISLLSQFEQDNIVQ-----YLGTDKDENRLYIFLELVT-------KGSLANLYQKYHLS 76
           EI +L + +  N+V          DK + +      +VT        G L N      L+
Sbjct: 57  EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVY-MVTPYMDHDLSGLLEN--PSVKLT 113

Query: 77  DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAK---------- 126
           +SQ+  Y  Q+L G+ YLHE +++HRDIK ANIL+D  G +K+ADFGLA+          
Sbjct: 114 ESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173

Query: 127 ---ATTMNDLKSCKGTPFWMAPEVV-NSKNDGYGLTADIWSLGCTVLEMLTRRP------ 176
                      +   T ++  PE++   +   Y    DIW +GC   EM TRRP      
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERR--YTTAVDIWGIGCVFAEMFTRRPILQGKS 231

Query: 177 --------------P-------YSHLEGVQALFRIG--KGELPSVPSSLSRDARDFILKC 213
                         P       +  L G + +         L      L  +  D + K 
Sbjct: 232 DIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKL 291

Query: 214 LQVNPNDRPTVTELMEHPF 232
           L ++P  R T ++ +EHP+
Sbjct: 292 LSLDPYKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  107 bits (269), Expect = 3e-28
 Identities = 70/240 (29%), Positives = 121/240 (50%), Gaps = 25/240 (10%)

Query: 7   VKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSL 66
           +KE+ +   G       +Q  QE  LLS+ +   IV++  +  + +   I  E      L
Sbjct: 33  LKEIPV---GELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDL 89

Query: 67  ANLYQKYH-----LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLAD 121
               ++       LS++QV  +  Q+L G+ Y+H+R ++HRD+K  NI +  +  +K+ D
Sbjct: 90  DCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFL-KNNLLKIGD 148

Query: 122 FGLAK--------ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
           FG+++        ATT        GTP++M+PE +  K+ GY   +DIWSLGC + EM  
Sbjct: 149 FGVSRLLMGSCDLATTFT------GTPYYMSPEAL--KHQGYDSKSDIWSLGCILYEMCC 200

Query: 174 RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
               +     +  + RI +G  PS+P + SR     +   L  +P+ RP+  E++ +PF+
Sbjct: 201 LAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  108 bits (272), Expect = 4e-28
 Identities = 58/193 (30%), Positives = 104/193 (53%), Gaps = 9/193 (4%)

Query: 47  TDKDENRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIK 105
           T + +  L+  +E +  G L  ++       +++   Y  +I+ GL +LH++ +++RD+K
Sbjct: 64  TFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLK 123

Query: 106 CANILVDASGSVKLADFGLAKATTMNDLKS---CKGTPFWMAPEVVNSKNDGYGLTADIW 162
             N+L+D  G +K+ADFG+ K     + K+   C GTP ++APE++  K   Y  + D W
Sbjct: 124 LDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEIL--KGQKYNESVDWW 180

Query: 163 SLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP 222
           S G  + EML  + P+ H E    LF     + P  P  +S++A+D + K  + +P  R 
Sbjct: 181 SFGVLLYEMLIGQSPF-HGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRL 239

Query: 223 TVT-ELMEHPFVK 234
            V  ++ +HPF +
Sbjct: 240 GVDGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  108 bits (272), Expect = 4e-28
 Identities = 77/263 (29%), Positives = 120/263 (45%), Gaps = 53/263 (20%)

Query: 28  QEISLLSQF-EQDNIVQYLGTD----KDENRLYIFLELVTKGSLANLYQKYH----LSDS 78
           +E+ LL  F    NI      D     + N LY++ EL+     A+L+Q       L+D+
Sbjct: 50  RELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME----ADLHQIIRSGQPLTDA 105

Query: 79  QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND------ 132
              S+  QIL GL Y+H  NV+HRD+K  N+LV+A   +K+ DFGLA+  + N       
Sbjct: 106 HFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF 165

Query: 133 LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
           +     T ++ APE++ S    Y    D+WS+GC + E+L R+P +   + V  L +I +
Sbjct: 166 MTEYVATRWYRAPEIMLS-FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ 224

Query: 193 -------------------------GELPSVP-SSL----SRDARDFILKCLQVNPNDRP 222
                                      +P  P  S+    +  A D + K L  +P  R 
Sbjct: 225 VLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRI 284

Query: 223 TVTELMEHPFVKR---PLQTPRC 242
           +V E +EHP++     P   P C
Sbjct: 285 SVEEALEHPYLAIWHDPDDEPVC 307

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  107 bits (267), Expect = 5e-28
 Identities = 60/212 (28%), Positives = 110/212 (51%), Gaps = 10/212 (4%)

Query: 19  GKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDS 78
           G  S+     E +++   + D +V+ L     +  +YI  E + KGSL +  +    S  
Sbjct: 41  GSMSVEAFLAEANVMKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQ 99

Query: 79  QVSS---YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKS 135
            +     ++ QI  G+ ++ +RN +HRD++ ANILV AS   K+ADFGLA+    N+  +
Sbjct: 100 PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159

Query: 136 CKGTPF---WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIG 191
            +G  F   W APE +N  +  + + +D+WS G  ++E++T  R PY  +   + +  + 
Sbjct: 160 REGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 217

Query: 192 KGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           +G     P +   +  + +++C +  P +RPT
Sbjct: 218 RGYRMPRPENCPEELYNIMMRCWKNRPEERPT 249

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  108 bits (271), Expect = 6e-28
 Identities = 73/243 (30%), Positives = 106/243 (43%), Gaps = 15/243 (6%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
           G  +A+K +      AQ   S    E+E  +LS      I Q     +D++ LY+ +E  
Sbjct: 26  GDIYAMKVMKKSVLLAQETVS--FFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ 83

Query: 62  TKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
             G L +L  +Y     +     Y  +++  +  +H+   VHRDIK  N+L+D +G +KL
Sbjct: 84  PGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKL 143

Query: 120 ADFGLAKATTMNDL---KSCKGTPFWMAPEVVNSKNDG----YGLTADIWSLGCTVLEML 172
           ADFG A   T N +   K   GTP ++APEV+ + N      YG+  D WSLG    EM+
Sbjct: 144 ADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203

Query: 173 TRRPPYSHLEGVQALFRI-GKGELPSVPSSL--SRDARDFILKCLQVNPNDRPTVTELME 229
             R P+      +    I         P     S D  D I   L     +R     L  
Sbjct: 204 YGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLL-CGQKERLGYEGLCC 262

Query: 230 HPF 232
           HPF
Sbjct: 263 HPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  106 bits (267), Expect = 7e-28
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 9/203 (4%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK---YHLSDSQVSSYT 84
            E  ++ +     ++Q       E  +YI  EL+  GSL    Q      L   Q+    
Sbjct: 50  AEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA 109

Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF--- 141
            Q+ +G+ YL  +N +HRD+   N+LV  +   K+ADFGLA+    +  ++ +G  F   
Sbjct: 110 AQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK 169

Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPS 200
           W APE        + + +D+WS G  + E++T  R PY  +   + L ++ +G     P 
Sbjct: 170 WTAPEAALYNR--FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPP 227

Query: 201 SLSRDARDFILKCLQVNPNDRPT 223
              ++  D +L C + +P+DRPT
Sbjct: 228 GCPKELYDIMLDCWKEDPDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  107 bits (268), Expect = 7e-28
 Identities = 65/238 (27%), Positives = 110/238 (46%), Gaps = 34/238 (14%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVSSYTRQ 86
           +EI +L Q +  N+V  +   + + +L++  E      L  L +    + +  +     Q
Sbjct: 49  REIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQ 108

Query: 87  ILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDLKSCKGTPFWMA 144
            L  + + H+ N +HRD+K  NIL+   G +KL DFG A+      +D      T ++ A
Sbjct: 109 TLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRA 168

Query: 145 PEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK--GEL-P----- 196
           PE++      YG   D+W++GC   E+LT +P +     V  L+ I K  G+L P     
Sbjct: 169 PELLVGDTQ-YGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227

Query: 197 ----------SVPS------------SLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
                     S+P             ++S  A  F+  CLQ++P +R +  EL+EHP+
Sbjct: 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  106 bits (267), Expect = 8e-28
 Identities = 61/182 (33%), Positives = 94/182 (51%), Gaps = 23/182 (12%)

Query: 72  KYHL--------SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFG 123
           KYH+         +++   Y  QI+ GL +LH+R +V+RD+K  N+L+D  G+V+++D G
Sbjct: 81  KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLG 140

Query: 124 LAKATTMNDLKSCK---GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY-S 179
           L  A  +   K  K   GTP +MAPEV+  + + Y  + D ++LGCT+ EM+  R P+  
Sbjct: 141 L--AVELKGGKKIKGRAGTPGYMAPEVL--QGEVYDFSVDWFALGCTLYEMIAGRSPFRQ 196

Query: 180 HLEGV--QALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR-----PTVTELMEHPF 232
             E V  + L R         P   S +A+D     LQ +P  R      +  E+ EHP 
Sbjct: 197 RKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPL 256

Query: 233 VK 234
            K
Sbjct: 257 FK 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  106 bits (266), Expect = 2e-27
 Identities = 76/256 (29%), Positives = 124/256 (48%), Gaps = 42/256 (16%)

Query: 20  KQSIL-QLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSD 77
           K +I  Q+ +E+ +L +     IV + G    +  + I +E +  GSL  + +K   + +
Sbjct: 39  KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE 98

Query: 78  SQVSSYTRQILNGLVYLHE-RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSC 136
           + +   +  +L GL YL E   ++HRD+K +NILV++ G +KL DFG++     +   S 
Sbjct: 99  NILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 158

Query: 137 KGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR---PPYSHLE-----GVQ--- 185
            GT  +M+PE +   +  Y + +DIWSLG +++EM   R   PP    E     G     
Sbjct: 159 VGTRSYMSPERLQGTH--YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSE 216

Query: 186 ---------------------ALFR----IGKGELPSVPSS-LSRDARDFILKCLQVNPN 219
                                A+F     I     P +PS   S + +DF+ KCL+ NP 
Sbjct: 217 GEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPK 276

Query: 220 DRPTVTELMEHPFVKR 235
           +R  + EL +HPF+KR
Sbjct: 277 ERADLKELTKHPFIKR 292

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  105 bits (263), Expect = 2e-27
 Identities = 67/228 (29%), Positives = 106/228 (46%), Gaps = 13/228 (5%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           AVK   L+D      Q+ L    E S+++     N+VQ LG     N LYI  E + KGS
Sbjct: 33  AVK--CLKDDST-AAQAFLA---EASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS 86

Query: 66  LANLYQ---KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADF 122
           L +  +   +  ++ +Q   +   +  G+ YL E+N VHRD+   N+LV      K++DF
Sbjct: 87  LVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDF 146

Query: 123 GLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHL 181
           GLAK  +     S K    W APE +  +   +   +D+WS G  + E+ +  R PY  +
Sbjct: 147 GLAKEASQG-QDSGKLPVKWTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203

Query: 182 EGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
                +  + KG     P     +    +  C +++P  RPT  +L E
Sbjct: 204 PLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  104 bits (261), Expect = 6e-27
 Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 24/224 (10%)

Query: 28  QEISLLSQFEQDNIVQYLG--TDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTR 85
           +EI++L     +NIV+Y G  +++    L + +E V  GSL +   K+ L+ +Q+  + +
Sbjct: 55  KEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQ 114

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL-----KSCKGTP 140
           QI  G+ YLH ++ +HRD+   N+L+D    VK+ DFGLAKA           +      
Sbjct: 115 QICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 174

Query: 141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-----RPPYSHLE------GVQALFR 189
           FW A E +  K + +   +D+WS G T+ E+LT       PP    E      G   + R
Sbjct: 175 FWYAVECL--KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR 232

Query: 190 ----IGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
               + +G     P +  ++    +  C +     RPT   L+ 
Sbjct: 233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 2e-26
 Identities = 66/242 (27%), Positives = 106/242 (43%), Gaps = 26/242 (10%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+K V+      +     ++   E S++ +F   ++V+ LG         + +EL+ KG 
Sbjct: 40  AIKTVNENASMRE----RIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGD 95

Query: 66  LANLYQKYHLSDSQ----VSSYTR--------QILNGLVYLHERNVVHRDIKCANILVDA 113
           L + Y +    +++    +   T         +I +G+ YL  +  VHRD+   N +V  
Sbjct: 96  LKS-YLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE 154

Query: 114 SGSVKLADFGLAKATTMNDL--KSCKGT-PF-WMAPEVVNSKNDGYGLTA-DIWSLGCTV 168
             +VK+ DFG+ +     D   K  KG  P  WMAPE   S  DG   T  D+WS G  +
Sbjct: 155 DLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE---SLKDGVFTTKSDVWSFGVVL 211

Query: 169 LEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
            EM T    PY  L   + L  +  G    +P +      + +  C Q NP  RPT  E+
Sbjct: 212 WEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEI 271

Query: 228 ME 229
           + 
Sbjct: 272 VS 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  103 bits (259), Expect = 3e-26
 Identities = 65/194 (33%), Positives = 100/194 (51%), Gaps = 21/194 (10%)

Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSS------YTRQILNGLVYLHERNVVHRDIK 105
           +RL   +E    G L      +HLS  +V S      Y  +I++ L YLH  +VV+RD+K
Sbjct: 68  DRLCFVMEYANGGELF-----FHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLK 122

Query: 106 CANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWS 163
             N+++D  G +K+ DFGL K   +    +K+  GTP ++APEV+   ND YG   D W 
Sbjct: 123 LENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-ND-YGRAVDWWG 180

Query: 164 LGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR-- 221
           LG  + EM+  R P+ + +  + LF +   E    P +LS +A+  +   L+ +P  R  
Sbjct: 181 LGVVMYEMMCGRLPFYNQDH-EKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 239

Query: 222 ---PTVTELMEHPF 232
                  E+MEH F
Sbjct: 240 GGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score =  103 bits (258), Expect = 4e-26
 Identities = 66/276 (23%), Positives = 116/276 (42%), Gaps = 52/276 (18%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           AVK+++L       K+ +  L+QEI    Q +  NI+ Y+ +   ++ LY+   L+  GS
Sbjct: 29  AVKKINLDSCS---KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85

Query: 66  LANL---YQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADF 122
             +L   +    L +  ++   + +LN L Y+H +  +HR +K ++IL+   G V L+  
Sbjct: 86  CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLS-- 143

Query: 123 GLAKATTMNDLKSCKGTPF-----------WMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           GL  + +M      +               W++PEV+     GY   +DI+S+G T  E+
Sbjct: 144 GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACEL 203

Query: 172 LTRRPPYSHLEGVQALFRIGKGELPS-------------------------------VPS 200
                P+  +   Q L    +G +P                                 P 
Sbjct: 204 ANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPY 263

Query: 201 --SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
             + S     F+  CLQ +P  RP+ ++L+ H F K
Sbjct: 264 TRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK 299

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  103 bits (257), Expect = 6e-26
 Identities = 70/199 (35%), Positives = 103/199 (51%), Gaps = 19/199 (9%)

Query: 47  TDKDENRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIK 105
           TD D   LY+  + ++ G L  +L ++   S+ +   Y  +++  L +LH+ ++V+RD+K
Sbjct: 67  TDSD---LYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLK 123

Query: 106 CANILVDASGSVKLADFGLAKAT-TMNDLKS--CKGTPFWMAPEVVNSKNDGYGLTADIW 162
             NIL+DA+G + L DFGL+KA  T N   +  C GT  ++APEV+     GY    D W
Sbjct: 124 PENILLDATGHIALCDFGLSKANLTDNKTTNTFC-GTTEYLAPEVL-LDEKGYTKHVDFW 181

Query: 163 SLGCTVLEMLTRRPPYSHLEGVQALFR---IGKGELPSVPSSLSRDARDFILKCLQVNPN 219
           SLG  V EM     P+ + E  Q ++R    GK   P   + LS + R F+   L  NP 
Sbjct: 182 SLGVLVFEMCCGWSPF-YAEDTQQMYRNIAFGKVRFPK--NVLSDEGRQFVKGLLNRNPQ 238

Query: 220 DR----PTVTELMEHPFVK 234
            R        EL EHPF  
Sbjct: 239 HRLGAHRDAVELKEHPFFA 257

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  102 bits (255), Expect = 7e-26
 Identities = 74/251 (29%), Positives = 117/251 (46%), Gaps = 56/251 (22%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-------- 79
           +EISLL + +  NIV+       E RLY+  E +      +L  K H+  S         
Sbjct: 50  REISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL------DLDLKKHMDSSPDFAKNPRL 103

Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFGLAKA------TTMND 132
           + +Y  QIL G+ Y H   V+HRD+K  N+L+D    ++KLADFGLA+A      T  ++
Sbjct: 104 IKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163

Query: 133 LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI- 190
           +     T ++ APE+ + S++  Y    DIWS+GC   EM+ ++P +     +  LF+I 
Sbjct: 164 VV----TLWYRAPEILLGSRH--YSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIF 217

Query: 191 ------------GKGELP---------------SVPSSLSRDARDFILKCLQVNPNDRPT 223
                       G   LP               +V  +L     D + K L+++P+ R T
Sbjct: 218 RILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT 277

Query: 224 VTELMEHPFVK 234
               +EH + K
Sbjct: 278 ARAALEHEYFK 288

Length = 294

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  102 bits (257), Expect = 8e-26
 Identities = 70/245 (28%), Positives = 114/245 (46%), Gaps = 46/245 (18%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENR-----LYIFLELVTKGSLANLYQ----KYHLSDSQ 79
           EI LL   + +N++         +R     +YI  EL+      +L+Q       LSD  
Sbjct: 54  EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD----TDLHQIIRSSQTLSDDH 109

Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCK 137
              +  Q+L GL Y+H  NV+HRD+K +N+L++A+  +K+ DFGLA+ T+     +    
Sbjct: 110 CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYV 169

Query: 138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK----- 192
            T ++ APE++ + ++ Y    D+WS+GC   E+L R+P +   + V  L  I +     
Sbjct: 170 VTRWYRAPELLLNCSE-YTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP 228

Query: 193 -----------------GELPSVPS-SLSR-------DARDFILKCLQVNPNDRPTVTEL 227
                              LP  P  S +R        A D + K L  +P+ R TV E 
Sbjct: 229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA 288

Query: 228 MEHPF 232
           + HP+
Sbjct: 289 LAHPY 293

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 1e-25
 Identities = 72/211 (34%), Positives = 108/211 (51%), Gaps = 11/211 (5%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD-SQVSSYTRQI 87
           E ++L+Q     IV    + +   +LY+ L  +  G L +  Q+    D S+   YT ++
Sbjct: 43  ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL 102

Query: 88  LNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKS---CKGTPFWMA 144
           L  L  LH+ NV++RD+K  NIL+D  G + L DFGL K    +D K+   C GTP ++A
Sbjct: 103 LCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLA 161

Query: 145 PEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSR 204
           PE++     GY    D W+LG  + EMLT  PP+ + E V  ++R    E    P    R
Sbjct: 162 PELLLGH--GYTKAVDWWTLGVLLYEMLTGLPPF-YDENVNEMYRKILQEPLRFPDGFDR 218

Query: 205 DARDFILKCLQVNPNDRPTVT---ELMEHPF 232
           DA+D ++  L  +P  R       E+  HPF
Sbjct: 219 DAKDLLIGLLSRDPTRRLGYNGAQEIKNHPF 249

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  100 bits (249), Expect = 2e-25
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 9/212 (4%)

Query: 19  GKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDS 78
           G  S+    +E +L+   + D +V+       E  +YI  E + KGSL +  +       
Sbjct: 41  GTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKV 100

Query: 79  QVSS---YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKS 135
            +     ++ QI  G+ Y+  +N +HRD++ AN+LV  S   K+ADFGLA+    N+  +
Sbjct: 101 LLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160

Query: 136 CKGTPF---WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIG 191
            +G  F   W APE +N  +  + + +D+WS G  + E++T  + PY  +     +  + 
Sbjct: 161 REGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ 218

Query: 192 KGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           +G       +   +  D +  C +    +RPT
Sbjct: 219 RGYRMPRMENCPDELYDIMKTCWKEKAEERPT 250

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score =  100 bits (250), Expect = 2e-25
 Identities = 74/256 (28%), Positives = 116/256 (45%), Gaps = 38/256 (14%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG--TDKDENRLYIFLE 59
           G   AVK +  +  G      I  L++EI +L     +NIV+Y G  T+   N + + +E
Sbjct: 33  GEQVAVKSLKPESGGNH----IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88

Query: 60  LVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV 117
            +  GSL       K  ++  Q   Y  QI  G+ YL  R  VHRD+   N+LV++   V
Sbjct: 89  FLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQV 148

Query: 118 KLADFGLAKA--------TTMNDLKSCKGTPFWMAPE-VVNSKNDGYGLTADIWSLGCTV 168
           K+ DFGL KA        T  +DL S     FW APE ++ SK   + + +D+WS G T+
Sbjct: 149 KIGDFGLTKAIETDKEYYTVKDDLDS---PVFWYAPECLIQSK---FYIASDVWSFGVTL 202

Query: 169 LEMLTR---------------RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKC 213
            E+LT                 P +  +   + +  + +G+    P +   +    + KC
Sbjct: 203 YELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKC 262

Query: 214 LQVNPNDRPTVTELME 229
            +  P+ R T   L+E
Sbjct: 263 WEFQPSKRTTFQNLIE 278

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  101 bits (252), Expect = 3e-25
 Identities = 64/190 (33%), Positives = 102/190 (53%), Gaps = 11/190 (5%)

Query: 51  ENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           E +LY+ L+ +  G L   L ++   ++  V  Y  ++   L +LH   +++RD+K  NI
Sbjct: 70  EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENI 129

Query: 110 LVDASGSVKLADFGLAKATTMNDLK--SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           L+D  G +KL DFGL+K +  ++ K  S  GT  +MAPEVVN +  G+  +AD WS G  
Sbjct: 130 LLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVL 187

Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR-----P 222
           + EMLT   P+   +  + +  I K +L  +P  LS +A+  +    + NP +R      
Sbjct: 188 MFEMLTGSLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQSLLRALFKRNPANRLGAGPD 246

Query: 223 TVTELMEHPF 232
            V E+  HPF
Sbjct: 247 GVEEIKRHPF 256

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  100 bits (250), Expect = 3e-25
 Identities = 64/201 (31%), Positives = 109/201 (54%), Gaps = 20/201 (9%)

Query: 51  ENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           + +L++ L+ +  G L  +L Q+    + +V  Y+ +I+  L +LH+  +++RDIK  NI
Sbjct: 77  DTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENI 136

Query: 110 LVDASGSVKLADFGLAKATTMNDLK---SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           L+D++G V L DFGL+K    ++++   S  GT  +MAP++V   + G+    D WS+G 
Sbjct: 137 LLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGV 196

Query: 167 TVLEMLTRRPPY-------SHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPN 219
            + E+LT   P+       S  E  +   RI K E P  P  +S  A+D I + L  +P 
Sbjct: 197 LMYELLTGASPFTVDGEKNSQAEISR---RILKSE-PPYPQEMSALAKDIIQRLLMKDPK 252

Query: 220 DR----PT-VTELMEHPFVKR 235
            R    P+   E+ +HPF ++
Sbjct: 253 KRLGCGPSDADEIKKHPFFQK 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 99.4 bits (247), Expect = 4e-25
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 12/208 (5%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANL----YQKYHLSDSQVSSY 83
           QE  ++ +   + +VQ      +E  +YI  E ++KGSL +       KY L   Q+   
Sbjct: 50  QEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDM 107

Query: 84  TRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF-- 141
             QI +G+ Y+   N VHRD++ ANILV  +   K+ADFGLA+    N+  + +G  F  
Sbjct: 108 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 167

Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVP 199
            W APE   +    + + +D+WS G  + E+ T+ R PY  +   + L ++ +G     P
Sbjct: 168 KWTAPEA--ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP 225

Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTEL 227
                   D + +C +  P +RPT   L
Sbjct: 226 PECPESLHDLMCQCWRKEPEERPTFEYL 253

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 98.8 bits (246), Expect = 6e-25
 Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 16/216 (7%)

Query: 18  QGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK---YH 74
           QG  S      E +L+ Q +   +V+       E  +YI  E +  GSL +  +      
Sbjct: 40  QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIK 98

Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK 134
           L+ +++     QI  G+ ++  +N +HRD++ ANILV  +   K+ADFGLA+    N+  
Sbjct: 99  LTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158

Query: 135 SCKGTPF---WMAPEVVNSKNDGYG---LTADIWSLGCTVLEMLTR-RPPYSHLEGVQAL 187
           + +G  F   W APE +N     YG   + +D+WS G  + E++T  R PY  +   + +
Sbjct: 159 AREGAKFPIKWTAPEAIN-----YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213

Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
             + +G     P +   +  + +  C +  P +RPT
Sbjct: 214 QNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 99.5 bits (248), Expect = 6e-25
 Identities = 78/267 (29%), Positives = 128/267 (47%), Gaps = 44/267 (16%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
           G   A+KE+ L  +      +I    +EISL+ + + +NIV+       EN+L +  E +
Sbjct: 25  GEIVALKEIHLDAEEGTPSTAI----REISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80

Query: 62  TKGSLANLYQKYH-----LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS 116
            K      Y   H     L  + V S+T Q+L G+ + HE  V+HRD+K  N+L++  G 
Sbjct: 81  DKD--LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE 138

Query: 117 VKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVV-NSKNDGYGLTADIWSLGCTVLEMLT 173
           +KLADFGLA+A    +N   +   T ++ AP+V+  S+   Y  + DIWS+GC + EM+T
Sbjct: 139 LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT--YSTSIDIWSVGCIMAEMIT 196

Query: 174 RRPPY---SHLEGVQALFRIG-----------------KGELPSVPS--------SLSRD 205
            RP +   ++ + +  +FRI                  K   P  P              
Sbjct: 197 GRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPL 256

Query: 206 ARDFILKCLQVNPNDRPTVTELMEHPF 232
             D + + LQ+NP  R +  + ++HP+
Sbjct: 257 GIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 99.6 bits (249), Expect = 6e-25
 Identities = 64/249 (25%), Positives = 119/249 (47%), Gaps = 55/249 (22%)

Query: 29  EISLLSQFEQDNIVQY----LGTDKDENRLYIFLELVT---KGSLANLYQKYHLSDSQVS 81
           EI++L + +  NIV      +G++ D  ++Y+ +E V    K  +  +  K     S+V 
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNLD--KIYMVMEYVEHDLKSLMETM--KQPFLQSEVK 109

Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA-------KATTMNDLK 134
               Q+L+G+ +LH+  ++HRD+K +N+L++  G +K+ DFGLA       K  T   + 
Sbjct: 110 CLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV- 168

Query: 135 SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY---SHLEGVQALFRI- 190
               T ++ APE++    + Y    D+WS+GC   E+LT++P +   S ++ +  +F++ 
Sbjct: 169 ----TLWYRAPELLLGAKE-YSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLL 223

Query: 191 ---------GKGELPSV------------------PSSLSRDARDFILKCLQVNPNDRPT 223
                    G  ELP                      SLS +  D + + L  +P  R +
Sbjct: 224 GTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS 283

Query: 224 VTELMEHPF 232
             + ++HP+
Sbjct: 284 AEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 98.3 bits (245), Expect = 8e-25
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 9/209 (4%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTR 85
           QE  +L Q++  NIV+ +G    +  +YI +ELV  GSL    +K    L+  ++   + 
Sbjct: 41  QEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSL 100

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT---PF- 141
               G+ YL  +N +HRD+   N LV  +  +K++DFG+++           G    P  
Sbjct: 101 DAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK 160

Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPS 200
           W APE +N     Y   +D+WS G  + E  +    PY  +   Q   RI  G     P 
Sbjct: 161 WTAPEALNYGR--YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQ 218

Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELME 229
               +    +L+C   +P +RP+ +E+  
Sbjct: 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYN 247

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 99.6 bits (248), Expect = 1e-24
 Identities = 66/246 (26%), Positives = 121/246 (49%), Gaps = 26/246 (10%)

Query: 2   GFFFAVK----EVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIF 57
           G +FAVK    +V L D   +       +E+ +  L+ +E   +     T + +  L+  
Sbjct: 20  GEYFAVKALKKDVVLIDDDVE----CTMVEKRVLALA-WENPFLTHLYCTFQTKEHLFFV 74

Query: 58  LELVTKGSLANLYQKYHLSDS------QVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +E +  G L      +H+ D       + + Y  +I+ GL +LH + +++RD+K  N+++
Sbjct: 75  MEFLNGGDLM-----FHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML 129

Query: 112 DASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVL 169
           D  G +K+ADFG+ K     D ++    GTP ++APE++      Y  + D WS G  + 
Sbjct: 130 DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK--YTFSVDWWSFGVLLY 187

Query: 170 EMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT-ELM 228
           EML  + P+ H +    LF   + + P  P  ++++++D + K  + +P  R  V   + 
Sbjct: 188 EMLIGQSPF-HGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246

Query: 229 EHPFVK 234
            HPF K
Sbjct: 247 GHPFFK 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 98.2 bits (244), Expect = 1e-24
 Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 10/203 (4%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK---YHLSDSQVSSYT 84
           QE  ++ +   D +V       +E  +YI  E + KGSL +  ++    +L   Q+    
Sbjct: 50  QEAQIMKKLRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMA 108

Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF--- 141
            QI +G+ Y+   N +HRD++ ANILV  +   K+ADFGLA+    N+  + +G  F   
Sbjct: 109 AQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK 168

Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPS 200
           W APE   +    + + +D+WS G  + E++T+ R PY  +   + L ++ +G     P 
Sbjct: 169 WTAPEA--ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQ 226

Query: 201 SLSRDARDFILKCLQVNPNDRPT 223
                  + +  C + +P++RPT
Sbjct: 227 GCPESLHELMKLCWKKDPDERPT 249

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 99.4 bits (248), Expect = 1e-24
 Identities = 66/232 (28%), Positives = 104/232 (44%), Gaps = 21/232 (9%)

Query: 20  KQSILQLEQEISLLSQ---FEQDN------IVQYLGTDKDENRLYIFLELVTKGSLANLY 70
           K  I+  ++  SL+ +   FE  N      +V      + E+ +   +E    G L    
Sbjct: 34  KGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI 93

Query: 71  QKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM 130
                S+ +   Y   ++ GL YLHE  +V+RD+K  N+L+D  G VK+ADFGL K    
Sbjct: 94  HTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153

Query: 131 NDLKS---CKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQAL 187
              ++   C GTP ++APEV+   +  Y    D W LG  + EML    P+   +  +  
Sbjct: 154 FGDRTSTFC-GTPEFLAPEVLTETS--YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210

Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR-----PTVTELMEHPFVK 234
             I   E    P  LSR+A   + + L+ NP  R         ++ + PF +
Sbjct: 211 DSIVNDE-VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFR 261

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 97.9 bits (244), Expect = 1e-24
 Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 8/208 (3%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTR 85
           +E  ++ +    N+VQ  G    +  ++I  E +  G L N  +  K  L    +     
Sbjct: 48  EEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCS 107

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---W 142
            +   + YL     +HRD+   N LV     VK++DFGLA+    +   S +GT F   W
Sbjct: 108 DVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKW 167

Query: 143 MAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSS 201
             PEV +     +   +D+WS G  + E+ +  + PY      + +  +  G     P  
Sbjct: 168 APPEVFDYSR--FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKL 225

Query: 202 LSRDARDFILKCLQVNPNDRPTVTELME 229
              +    +  C    P DRP   +L+ 
Sbjct: 226 APTEVYTIMYSCWHEKPEDRPAFKKLLS 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 98.9 bits (246), Expect = 2e-24
 Identities = 64/194 (32%), Positives = 102/194 (52%), Gaps = 21/194 (10%)

Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSS------YTRQILNGLVYLHERNVVHRDIK 105
           +RL   +E    G L      +HLS  +V +      Y  +I++ L YLH R+VV+RDIK
Sbjct: 68  DRLCFVMEYANGGELF-----FHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 122

Query: 106 CANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLTADIWS 163
             N+++D  G +K+ DFGL K    +   +K+  GTP ++APEV+  +++ YG   D W 
Sbjct: 123 LENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL--EDNDYGRAVDWWG 180

Query: 164 LGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR-- 221
           LG  + EM+  R P+ + +  + LF +   E    P +LS +A+  +   L+ +P  R  
Sbjct: 181 LGVVMYEMMCGRLPF-YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 239

Query: 222 ---PTVTELMEHPF 232
                  E+MEH F
Sbjct: 240 GGPSDAKEVMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 98.6 bits (246), Expect = 2e-24
 Identities = 80/277 (28%), Positives = 120/277 (43%), Gaps = 54/277 (19%)

Query: 4   FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYL--------GTDKDENRLY 55
             A+K+V L +   +G   I  L +EI +L   + +N+V  +          ++ +   Y
Sbjct: 39  IVALKKV-LMENEKEGF-PITAL-REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFY 95

Query: 56  IFLELVT---KGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVD 112
           +  E       G L+N   K+ LS  ++    + +LNGL Y+H   ++HRD+K ANIL+ 
Sbjct: 96  LVFEFCEHDLAGLLSNKNVKFTLS--EIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT 153

Query: 113 ASGSVKLADFGLAKATTM--NDLKSCKG----TPFWMAPEVVNSKNDGYGLTADIWSLGC 166
             G +KLADFGLA+A ++  N   +       T ++  PE++  + D YG   D+W  GC
Sbjct: 154 KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERD-YGPPIDMWGAGC 212

Query: 167 TVLEMLTRRPPY------------SHLEG---------VQALFRIGKGELPS-----VPS 200
            + EM TR P              S L G         V  L    K ELP      V  
Sbjct: 213 IMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKE 272

Query: 201 SL-----SRDARDFILKCLQVNPNDRPTVTELMEHPF 232
            L        A D I K L ++P  R      + H F
Sbjct: 273 RLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 97.7 bits (244), Expect = 2e-24
 Identities = 78/287 (27%), Positives = 120/287 (41%), Gaps = 83/287 (28%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQ-----EISLLSQFE-QDNIVQYLGT--DKDEN 52
            G ++A+K +         K+    LEQ     EI  L +     NI++ +    D+   
Sbjct: 23  TGKYYAIKCM---------KKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTG 73

Query: 53  RLYIFLELVTKGSLANLY-----QKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           RL +  EL+      NLY     +K  L + +V SY  Q+L  L ++H   + HRDIK  
Sbjct: 74  RLALVFELMD----MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPE 129

Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGT----PF-------WM-APEVVNSKNDG- 154
           NIL+     +KLADFG           SC+G     P+       W  APE + +  DG 
Sbjct: 130 NILIK-DDILKLADFG-----------SCRGIYSKPPYTEYISTRWYRAPECLLT--DGY 175

Query: 155 YGLTADIWSLGCTVLEMLTRRP--PYSH---------------LEGVQALF--------- 188
           YG   DIW++GC   E+L+  P  P ++                  V   F         
Sbjct: 176 YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYN 235

Query: 189 ---RIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
              + G G    +P + S +  D + K L  +P++R T  + + HP+
Sbjct: 236 FPSKKGTGLRKLLP-NASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 97.1 bits (242), Expect = 3e-24
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 22/223 (9%)

Query: 27  EQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--------------- 71
           E+E  LL+ F+ +NIV++ G   + +   +  E +  G L    +               
Sbjct: 56  EREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSP 115

Query: 72  KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 131
              L+ SQ+     QI +G+VYL  ++ VHRD+   N LV     VK+ DFG+++     
Sbjct: 116 MGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTT 175

Query: 132 DLKSCKGTPF----WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQA 186
           D     G       WM PE +  +   +   +D+WS G  + E+ T  + P+  L   + 
Sbjct: 176 DYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV 233

Query: 187 LFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
           +  I +G L   P +   +  D +L C + +P  R  + ++ E
Sbjct: 234 IECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 97.4 bits (243), Expect = 4e-24
 Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 29/234 (12%)

Query: 27  EQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTR- 85
            +E+ +LS+    NI + LG    +  L + +E +  G L    QK+    S ++  ++ 
Sbjct: 67  LKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126

Query: 86  -----------QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK 134
                      QI +G+ YL   N VHRD+   N LV  + ++K+ADFG+++    +D  
Sbjct: 127 LSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY 186

Query: 135 SCKGTPF----WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT--RRPPYSHL------E 182
             +G       WMA E V      +   +D+W+ G T+ E+LT  R  PY HL      E
Sbjct: 187 RVQGRAPLPIRWMAWESV--LLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIE 244

Query: 183 GVQALFRIGKG-ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
                FR          P +  +D  + +L+C + +  DRPT  E+  H F++R
Sbjct: 245 NAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI--HLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 97.8 bits (243), Expect = 5e-24
 Identities = 65/197 (32%), Positives = 102/197 (51%), Gaps = 21/197 (10%)

Query: 49  KDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS------YTRQILNGLVYLHERNVVHR 102
           + ++RL   +E V  G L      +HLS  +V S      Y  +I++ L YLH   +V+R
Sbjct: 65  QTKDRLCFVMEYVNGGELF-----FHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119

Query: 103 DIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTAD 160
           D+K  N+++D  G +K+ DFGL K   T    +K+  GTP ++APEV+  +++ YG   D
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVL--EDNDYGRAVD 177

Query: 161 IWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPND 220
            W LG  + EM+  R P+ + +  + LF +   E    P +LS DA+  +   L  +PN 
Sbjct: 178 WWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNK 236

Query: 221 R-----PTVTELMEHPF 232
           R         E+M H F
Sbjct: 237 RLGGGPDDAKEIMRHSF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 96.4 bits (240), Expect = 8e-24
 Identities = 71/248 (28%), Positives = 113/248 (45%), Gaps = 34/248 (13%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENR--LYIFLELVTK 63
           AVK+  LQ   A+    +   E+EI +L   + DNIV+Y G      R  L + +E +  
Sbjct: 37  AVKK--LQHSTAE---HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPY 91

Query: 64  GSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLAD 121
           GSL +  QK+   L   ++  Y  QI  G+ YL  +  VHRD+   NILV++   VK+ D
Sbjct: 92  GSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGD 151

Query: 122 FGLAKATTMND----LKSCKGTP-FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT--- 173
           FGL K    +     ++    +P FW APE +      + + +D+WS G  + E+ T   
Sbjct: 152 FGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK--FSVASDVWSFGVVLYELFTYSD 209

Query: 174 --RRPPYSHLE-------GVQALFRI-----GKGELPSVPSSLSRDARDFILKCLQVNPN 219
               PP   +        G   ++ +       G LP  P     +    + +C   +P+
Sbjct: 210 KSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLP-APPGCPAEIYAIMKECWNNDPS 268

Query: 220 DRPTVTEL 227
            RP+ +EL
Sbjct: 269 QRPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 95.3 bits (237), Expect = 1e-23
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 8/208 (3%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKY-HLSDSQVSSYTR 85
           +E  ++ +     +VQ  G    +  LYI  E +  G L N L Q+   LS   + S  +
Sbjct: 48  EEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQ 107

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---W 142
            +  G+ YL   + +HRD+   N LV ++G VK++DFG+ +    ++  S  G  F   W
Sbjct: 108 DVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKW 167

Query: 143 MAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSS 201
             PEV N     Y   +D+WS G  + E+ T  + P+      + +  I +G     P  
Sbjct: 168 SPPEVFNFSK--YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKL 225

Query: 202 LSRDARDFILKCLQVNPNDRPTVTELME 229
            S    + +  C    P  RPT  EL+ 
Sbjct: 226 ASMTVYEVMYSCWHEKPEGRPTFAELLR 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 95.2 bits (237), Expect = 2e-23
 Identities = 65/233 (27%), Positives = 104/233 (44%), Gaps = 19/233 (8%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+K +   D   Q        ++E+  L +    +++           +YI  EL+ KGS
Sbjct: 34  AIKILKSDDLLKQQ-----DFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGS 88

Query: 66  LANLYQKYHLSDSQVSS---YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADF 122
           L    +        V+S      Q+  G+ YL E+N +HRD+   NILV      K+ADF
Sbjct: 89  LLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADF 148

Query: 123 GLAKATTMND---LKSCKGTPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPP 177
           GLA+   + +   L S K  P+ W APE  +     +   +D+WS G  + EM T  + P
Sbjct: 149 GLAR--LIKEDVYLSSDKKIPYKWTAPEAASHGT--FSTKSDVWSFGILLYEMFTYGQVP 204

Query: 178 YSHLEGVQALFRIGKG-ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
           Y  +   +   +I  G  +P  P+   ++    +L+C    P DRP+   L E
Sbjct: 205 YPGMNNHEVYDQITAGYRMPC-PAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 95.1 bits (236), Expect = 2e-23
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 10/203 (4%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK---YHLSDSQVSSYT 84
           +E  ++ +   D +VQ      +E  +YI  E ++KGSL +  +      L    +    
Sbjct: 50  EEAQIMKKLRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA 108

Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF--- 141
            Q+  G+ Y+   N +HRD++ ANILV      K+ADFGLA+    N+  + +G  F   
Sbjct: 109 AQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK 168

Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPS 200
           W APE   +    + + +D+WS G  + E++T+ R PY  +   + L ++ +G     P 
Sbjct: 169 WTAPEA--ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQ 226

Query: 201 SLSRDARDFILKCLQVNPNDRPT 223
                  + +L+C + +P +RPT
Sbjct: 227 DCPISLHELMLQCWKKDPEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 96.2 bits (239), Expect = 2e-23
 Identities = 59/192 (30%), Positives = 101/192 (52%), Gaps = 11/192 (5%)

Query: 52  NRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +RLY  +E V  G L  ++ Q     + Q   Y  +I  GL +LH R +++RD+K  N++
Sbjct: 74  DRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVM 133

Query: 111 VDASGSVKLADFGLAKATTMNDL--KSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           +D+ G +K+ADFG+ K   ++ +  ++  GTP ++APE++  +   YG + D W+ G  +
Sbjct: 134 LDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP--YGKSVDWWAYGVLL 191

Query: 169 LEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR-----PT 223
            EML  +PP+   E    LF+       S P SLS++A       +  +P+ R       
Sbjct: 192 YEMLAGQPPFDG-EDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEG 250

Query: 224 VTELMEHPFVKR 235
             ++ EH F +R
Sbjct: 251 ERDIREHAFFRR 262

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 95.2 bits (237), Expect = 2e-23
 Identities = 70/268 (26%), Positives = 109/268 (40%), Gaps = 44/268 (16%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
                A+K V L D       S L+   EI LL + +  NIV+       + +L +  E 
Sbjct: 24  THEIVALKRVRLDDDDEGVPSSALR---EICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80

Query: 61  VTKGSLANLYQKY------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS 114
             +       +KY       +    V S+  Q+L GL + H  NV+HRD+K  N+L++ +
Sbjct: 81  CDQD-----LKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN 135

Query: 115 GSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
           G +KLADFGLA+A  +     S +    W  P  V      Y  + D+WS GC   E+  
Sbjct: 136 GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 195

Query: 174 RRPP----YSHLEGVQALFRI----------GKGELPSVP---------------SSLSR 204
              P        + ++ +FR+          G  +LP                    L+ 
Sbjct: 196 AGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNS 255

Query: 205 DARDFILKCLQVNPNDRPTVTELMEHPF 232
             RD +   L  NP  R +  E ++HP+
Sbjct: 256 TGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 94.3 bits (234), Expect = 2e-23
 Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 8/206 (3%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTR 85
            E  +L Q++  NIV+ +G       +YI +ELV  G   +  +K    L   Q+  +  
Sbjct: 41  SEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL 100

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSC--KGTPF-W 142
               G+ YL  +N +HRD+   N LV  +  +K++DFG+++        S   K  P  W
Sbjct: 101 DAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW 160

Query: 143 MAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP-PYSHLEGVQALFRIGKGELPSVPSS 201
            APE +N     Y   +D+WS G  + E  +    PY  +   QA  ++ KG   S P  
Sbjct: 161 TAPEALNYGR--YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQK 218

Query: 202 LSRDARDFILKCLQVNPNDRPTVTEL 227
              D    + +C    P +RP  +EL
Sbjct: 219 CPDDVYKVMQRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 95.1 bits (237), Expect = 3e-23
 Identities = 70/245 (28%), Positives = 107/245 (43%), Gaps = 38/245 (15%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENRLYIFLEL-VTKGSLANLYQ--KYHLSDSQVSSYTR 85
           EI+LL      NIV+       ++   IFL +   +  LA+L        S+SQV     
Sbjct: 56  EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLML 115

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDLKSCKGTPFWM 143
           Q+L GL YLHE  ++HRD+K +N+L+   G +K+ADFGLA+   +    +     T ++ 
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYR 175

Query: 144 APEVV-NSKNDGYGLTADIWSLGCTVLEMLTRRP--------------------PYSHL- 181
           APE++       Y    D+W++GC + E+L  +P                    P   + 
Sbjct: 176 APELLLGCTT--YTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233

Query: 182 EGVQALFRIGKGELPSVP--------SSLSRDARDFILKCLQVNPNDRPTVTELMEHP-F 232
            G   L  +GK  LP  P          LS      +   L  +P  R T  E +E   F
Sbjct: 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293

Query: 233 VKRPL 237
            ++PL
Sbjct: 294 KEKPL 298

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 97.2 bits (242), Expect = 3e-23
 Identities = 51/153 (33%), Positives = 91/153 (59%), Gaps = 6/153 (3%)

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAK---ATTMNDL-KSCKGTPF 141
           Q+L  + ++H ++++HRDIK ANIL+ ++G VKL DFG +K   AT  +D+ ++  GTP+
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210

Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSS 201
           ++APE+   K   Y   AD++SLG  + E+LT + P+      + + +   G    +P S
Sbjct: 211 YVAPEIWRRKP--YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPS 268

Query: 202 LSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           +S + ++ +   L  +P  RP+ ++L+  P  K
Sbjct: 269 ISPEMQEIVTALLSSDPKRRPSSSKLLNMPICK 301

Length = 496

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 94.3 bits (234), Expect = 4e-23
 Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 8/206 (3%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYT 84
           +E +++++    N+V+ LG     N LYI +EL++KG+L N  +   +  +S  Q+  ++
Sbjct: 48  EETAVMTKLHHKNLVRLLGVIL-HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFS 106

Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMA 144
             +  G+ YL  + +VHRD+   NILV   G  K++DFGLA+  +M  + + K    W A
Sbjct: 107 LDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-VDNSKLPVKWTA 165

Query: 145 PEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLS 203
           PE +  K+  +   +D+WS G  + E+ +  R PY  +   +    + KG     P    
Sbjct: 166 PEAL--KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCP 223

Query: 204 RDARDFILKCLQVNPNDRPTVTELME 229
            D    +  C +  P  RP+  +L E
Sbjct: 224 ADVYVLMTSCWETEPKKRPSFHKLRE 249

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 95.1 bits (236), Expect = 4e-23
 Identities = 64/195 (32%), Positives = 103/195 (52%), Gaps = 22/195 (11%)

Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSS------YTRQILNGLVYLH-ERNVVHRDI 104
           +RL   +E    G L      +HLS  +V S      Y  +I++ L YLH E+NVV+RD+
Sbjct: 68  DRLCFVMEYANGGELF-----FHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 122

Query: 105 KCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGLTADIW 162
           K  N+++D  G +K+ DFGL K    +   +K+  GTP ++APEV+  +++ YG   D W
Sbjct: 123 KLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL--EDNDYGRAVDWW 180

Query: 163 SLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR- 221
            LG  + EM+  R P+ + +  + LF +   E    P +LS +A+  +   L+ +P  R 
Sbjct: 181 GLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239

Query: 222 ----PTVTELMEHPF 232
                   E+M+H F
Sbjct: 240 GGGPDDAKEIMQHKF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 94.3 bits (234), Expect = 5e-23
 Identities = 78/269 (28%), Positives = 114/269 (42%), Gaps = 44/269 (16%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG------TDKDENRLY 55
           G F A+K V +Q        S ++    +  L  FE  N+V+         TD+ E +L 
Sbjct: 27  GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR-ETKLT 85

Query: 56  IFLELVTKGSLANLYQKY---HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVD 112
           +  E V +  L     K     +    +     Q+L GL +LH   VVHRD+K  NILV 
Sbjct: 86  LVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT 144

Query: 113 ASGSVKLADFGLAKATTMNDLKSCKGTPFWM-APEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +SG +KLADFGLA+  +     +      W  APEV+      Y    D+WS+GC   EM
Sbjct: 145 SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL--LQSSYATPVDLWSVGCIFAEM 202

Query: 172 LTRRPPYSHLEGVQALFRIGKGELPSVPS--------SLSRDA----------------- 206
             R+P +     V  L +I   ++  +P         +L R A                 
Sbjct: 203 FRRKPLFRGSSDVDQLGKI--LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID 260

Query: 207 ---RDFILKCLQVNPNDRPTVTELMEHPF 232
              +D +LKCL  NP  R +    + HP+
Sbjct: 261 ELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 95.6 bits (238), Expect = 5e-23
 Identities = 69/206 (33%), Positives = 100/206 (48%), Gaps = 12/206 (5%)

Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVV 100
           IVQ     +D+  LY+ +E +  G L NL   Y + +     YT +++  L  +H    +
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFI 164

Query: 101 HRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK---GTPFWMAPEVVNSK-NDG-Y 155
           HRD+K  N+L+D SG +KLADFG       N +  C    GTP +++PEV+ S+  DG Y
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYY 224

Query: 156 GLTADIWSLGCTVLEMLTRRPPY--SHLEGVQALFRIGKGELPSVPS--SLSRDARDFIL 211
           G   D WS+G  + EML    P+    L G  +     K  L + P    +S+ A+D I 
Sbjct: 225 GRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL-TFPDDIEISKQAKDLIC 283

Query: 212 KCLQVNPN--DRPTVTELMEHPFVKR 235
             L        R  V E+  HPF K 
Sbjct: 284 AFLTDREVRLGRNGVDEIKSHPFFKN 309

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 96.6 bits (240), Expect = 5e-23
 Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 11/215 (5%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSL-----ANLYQKYHLSDSQVSSY 83
           E+  L+  +   IV++    K +++L + +E  + G L       L +     + +V   
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174

Query: 84  TRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAK----ATTMNDLKSCKGT 139
             QI+  L  +H R ++HRD+K ANI +  +G +KL DFG +K    + +++   S  GT
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGT 234

Query: 140 PFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVP 199
           P+++APE+   K   Y   AD+WSLG  + E+LT   P+      + + ++  G+    P
Sbjct: 235 PYYLAPELWERKR--YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFP 292

Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
             +S   +  +   L  NP  RPT  +L+   F+K
Sbjct: 293 CPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327

Length = 478

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 93.8 bits (233), Expect = 6e-23
 Identities = 73/231 (31%), Positives = 109/231 (47%), Gaps = 21/231 (9%)

Query: 18  QGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD 77
           QG+   L     +SL+S  +   IV         ++L   L+L+  G L      YHLS 
Sbjct: 36  QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL-----HYHLSQ 90

Query: 78  SQVSS------YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 131
             V S      Y  +I+ GL ++H R VV+RD+K ANIL+D  G V+++D GLA   +  
Sbjct: 91  HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 150

Query: 132 DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIG 191
              +  GT  +MAPEV+  K   Y  +AD +SLGC + ++L    P+   +       I 
Sbjct: 151 KPHASVGTHGYMAPEVL-QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EID 208

Query: 192 KGEL---PSVPSSLSRDARDFILKCLQVNPNDR-----PTVTELMEHPFVK 234
           +  L     +P S S + R  +   LQ + N R         E+ EHPF +
Sbjct: 209 RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFR 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 94.9 bits (236), Expect = 6e-23
 Identities = 66/249 (26%), Positives = 104/249 (41%), Gaps = 45/249 (18%)

Query: 28  QEISLLSQFEQDNIVQ----YLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSY 83
           +E+ LL     +NI+     ++   +D   +Y   EL+    L  L     L    +  +
Sbjct: 58  RELKLLKHLRHENIISLSDIFISPLED---IYFVTELLGT-DLHRLLTSRPLEKQFIQYF 113

Query: 84  TRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPF 141
             QIL GL Y+H   VVHRD+K +NIL++ +  +K+ DFGLA+     M    S   T +
Sbjct: 114 LYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS---TRY 170

Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY----------------------- 178
           + APE++ +    Y +  DIWS GC   EML  +P +                       
Sbjct: 171 YRAPEIMLTWQK-YDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229

Query: 179 -------SHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP 231
                  + L  VQ+L +           +    A D + K L  +P  R +  E + HP
Sbjct: 230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289

Query: 232 FVKRPLQTP 240
           ++  P   P
Sbjct: 290 YLA-PYHDP 297

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 94.9 bits (236), Expect = 7e-23
 Identities = 61/203 (30%), Positives = 105/203 (51%), Gaps = 23/203 (11%)

Query: 51  ENRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           E+RL+  +E V+ G L  ++ ++  L +     Y+ +I   L +LHER +++RD+K  N+
Sbjct: 68  ESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNV 127

Query: 110 LVDASGSVKLADFGLAK-ATTMNDLKS--CKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           L+DA G +KL D+G+ K      D  S  C GTP ++APE++  + + YG + D W+LG 
Sbjct: 128 LLDAEGHIKLTDYGMCKEGIRPGDTTSTFC-GTPNYIAPEIL--RGEDYGFSVDWWALGV 184

Query: 167 TVLEMLTRRPPYSHLEGVQA---------LFRIGKGELPSVPSSLSRDARDFILKCLQVN 217
            + EM+  R P+  + G+           LF++   +   +P SLS  A   +   L  +
Sbjct: 185 LMFEMMAGRSPFD-IVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKD 243

Query: 218 PNDR------PTVTELMEHPFVK 234
           P +R          ++  HPF +
Sbjct: 244 PKERLGCHPQTGFRDIKSHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 93.8 bits (233), Expect = 1e-22
 Identities = 60/195 (30%), Positives = 96/195 (49%), Gaps = 13/195 (6%)

Query: 51  ENRLYIFLELVTKGSLANLYQKYHLSD-SQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           ++RL+  +E V  G L    Q+    D  +   Y  ++   L++LH   V++RD+K  NI
Sbjct: 68  KDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNI 127

Query: 110 LVDASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           L+DA G  KLADFG+ K   +N + +    GTP ++APE++      YG + D W+LG  
Sbjct: 128 LLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE--YGPSVDWWALGVL 185

Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT-- 225
           + EM+  +PP+   +    LF     +    P  LS++A   +   +  NPN R      
Sbjct: 186 MYEMMAGQPPF-EADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVAS 244

Query: 226 -----ELMEHPFVKR 235
                 + +HPF K 
Sbjct: 245 QGGEDAIKQHPFFKE 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 93.5 bits (233), Expect = 1e-22
 Identities = 74/277 (26%), Positives = 112/277 (40%), Gaps = 86/277 (31%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKG-SLA------NLYQ--KYH----- 74
           EI+LL + + +N+V  +          +FLE   K   L       +L+Q  K+H     
Sbjct: 52  EIALLRELKHENVVSLVE---------VFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKR 102

Query: 75  --LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV----DASGSVKLADFGLAKAT 128
             +  S V S   QILNG+ YLH   V+HRD+K ANILV       G VK+ D GLA+  
Sbjct: 103 VSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162

Query: 129 TMNDLKS-CKGTP----FWM-APEVV-NSKNDGYGLTADIWSLGCTVLEMLTRRP----- 176
               LK      P     W  APE++  +++  Y    DIW++GC   E+LT  P     
Sbjct: 163 N-APLKPLADLDPVVVTIWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTLEPIFKGR 219

Query: 177 --------PYSHLEGVQALFRI-----------------------GKGELPSVPSSLSR- 204
                   P+   + ++ +F +                                +SL++ 
Sbjct: 220 EAKIKKSNPF-QRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKW 278

Query: 205 ---------DARDFILKCLQVNPNDRPTVTELMEHPF 232
                       D + K L+ +P  R T  E +EHP+
Sbjct: 279 MEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 93.7 bits (233), Expect = 2e-22
 Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 18/200 (9%)

Query: 49  KDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKC 106
           +DEN LY+ ++    G L  L  K+   L +     Y  +++  +  +H+   VHRDIK 
Sbjct: 71  QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKP 130

Query: 107 ANILVDASGSVKLADFG-----LAKATTMNDLKSCKGTPFWMAPEVVNSKNDG---YGLT 158
            N+L+D +G ++LADFG     LA  T  +++    GTP +++PE++ +  DG   YG  
Sbjct: 131 DNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV--GTPDYISPEILQAMEDGKGRYGPE 188

Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE----LPSVPSSLSRDARDFILK-- 212
            D WSLG  + EML    P+     V+   +I   +     P   + +S +A+D I +  
Sbjct: 189 CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLI 248

Query: 213 CLQVNPNDRPTVTELMEHPF 232
           C       R  + +  +HPF
Sbjct: 249 CSPETRLGRNGLQDFKDHPF 268

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 92.6 bits (230), Expect = 2e-22
 Identities = 64/222 (28%), Positives = 96/222 (43%), Gaps = 22/222 (9%)

Query: 21  QSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSL--------ANLYQK 72
           Q   +  +E  L+S F   NIV+ LG        YI +EL+  G L           +  
Sbjct: 41  QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGP 100

Query: 73  YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV-----DASGSVKLADFGLAKA 127
             L+  ++      +  G VYL + + +HRD+   N LV     DA   VK+ DFGLA+ 
Sbjct: 101 PLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160

Query: 128 TTMNDLKSCKGTPF----WMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLT-RRPPYSHL 181
              +D    +G       WMAPE   S  DG +   +D+WS G  + E+LT  + PY  L
Sbjct: 161 IYKSDYYRKEGEGLLPVRWMAPE---SLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217

Query: 182 EGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
              + L  +  G     P +        +  C   +P++RPT
Sbjct: 218 NNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 94.3 bits (234), Expect = 2e-22
 Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 16/207 (7%)

Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVV 100
           +VQ     +D+  LY+ +E +  G L NL   Y + +     YT +++  L  +H    +
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 164

Query: 101 HRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK---GTPFWMAPEVVNSK-NDG-Y 155
           HRD+K  N+L+D SG +KLADFG         +  C    GTP +++PEV+ S+  DG Y
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYY 224

Query: 156 GLTADIWSLGCTVLEMLTRRPPY--SHLEGVQALFRIGKGELPSVP--SSLSRDARDFIL 211
           G   D WS+G  + EML    P+    L G  +     K  L + P  + +S++A++ I 
Sbjct: 225 GRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL-TFPDDNDISKEAKNLI- 282

Query: 212 KCLQVNPND----RPTVTELMEHPFVK 234
            C  +   +    R  V E+  H F K
Sbjct: 283 -CAFLTDREVRLGRNGVEEIKRHLFFK 308

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 93.0 bits (231), Expect = 2e-22
 Identities = 68/248 (27%), Positives = 109/248 (43%), Gaps = 46/248 (18%)

Query: 28  QEISLLSQFEQDN-IVQYLGTDKDENR-----LYIFLELVT---KGSLANLYQKYH--LS 76
           +EISLL    +   IV+ L  +  E +     LY+  E +    K  + +  +     L 
Sbjct: 49  REISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLP 108

Query: 77  DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDLKS 135
              + S+  Q+L G+ + H+  V+HRD+K  N+LVD    + K+AD GL +A ++  +KS
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKS 167

Query: 136 CKG---TPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
                 T ++ APEV+      Y    DIWS+GC   EM  ++P +     +Q L  I K
Sbjct: 168 YTHEIVTLWYRAPEVLLGSTH-YSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK 226

Query: 193 -------------------GELP---------SVPSSLSRDARDFILKCLQVNPNDRPTV 224
                               E P         +VP  LS +  D + K L+ +P  R + 
Sbjct: 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVP-DLSPEGLDLLQKMLRYDPAKRISA 285

Query: 225 TELMEHPF 232
              + HP+
Sbjct: 286 KAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 94.0 bits (234), Expect = 2e-22
 Identities = 73/271 (26%), Positives = 113/271 (41%), Gaps = 60/271 (22%)

Query: 20  KQSILQLEQ------EISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY 73
           K  +L+ EQ      E  +L++ +   +V+   + +DEN LY+ +E +  G +  L  K 
Sbjct: 36  KSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK 95

Query: 74  H-LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAK------ 126
              ++ +   Y  + +  +  +H+   +HRDIK  N+L+DA G +KL+DFGL        
Sbjct: 96  DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155

Query: 127 --------------------ATTMNDLK--------------SCKGTPFWMAPEVVNSKN 152
                               +  M+  +              S  GTP ++APEV     
Sbjct: 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT- 214

Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI--GKGEL---PSVPSSLSRDAR 207
            GY    D WSLG  + EML   PP+      +   +I   K  L     VP  LS +A+
Sbjct: 215 -GYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVP--LSPEAK 271

Query: 208 DFILKCLQVNPNDR---PTVTELMEHPFVKR 235
           D I + L      R     V E+  HPF K 
Sbjct: 272 DLIKR-LCCEAERRLGNNGVNEIKSHPFFKG 301

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 93.5 bits (233), Expect = 2e-22
 Identities = 66/244 (27%), Positives = 111/244 (45%), Gaps = 43/244 (17%)

Query: 29  EISLLSQFEQDNIVQYLG------TDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS 82
           E+ LL   + +N++  L       + +D   +Y+   L+    L N+ +   LSD  +  
Sbjct: 64  ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQKLSDDHIQF 122

Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFW 142
              QIL GL Y+H   ++HRD+K +NI V+    +K+ DFGLA+ T  +++     T ++
Sbjct: 123 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD-DEMTGYVATRWY 181

Query: 143 MAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSS- 201
            APE++ +    Y  T DIWS+GC + E+LT +  +   + +  L RI    L   P   
Sbjct: 182 RAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI--MNLVGTPDEE 238

Query: 202 -----LSRDARDFIL--------------------------KCLQVNPNDRPTVTELMEH 230
                 S  AR++I                           K L ++P+ R T  E + H
Sbjct: 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298

Query: 231 PFVK 234
           P++ 
Sbjct: 299 PYLA 302

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 93.0 bits (231), Expect = 2e-22
 Identities = 75/250 (30%), Positives = 116/250 (46%), Gaps = 27/250 (10%)

Query: 1   DGFFFAVK----EVSLQDQGAQG---KQSILQLEQEISLLSQFEQDNIVQYLGTDKDENR 53
            G  +AVK    +V LQD   +    ++ IL L +    L+Q        +   D    R
Sbjct: 19  SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL----YCCFQTPD----R 70

Query: 54  LYIFLELVTKGSLANLYQKYHLSD-SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVD 112
           L+  +E V  G L    QK    D ++   Y  +I + L++LH++ +++RD+K  N+L+D
Sbjct: 71  LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD 130

Query: 113 ASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
             G  KLADFG+ K    N   +    GTP ++APE++      YG + D W++G  + E
Sbjct: 131 HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML--YGPSVDWWAMGVLLYE 188

Query: 171 MLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL--- 227
           ML    P+   E    LF     +    P+ LS+DA D +   +  NP  R     L   
Sbjct: 189 MLCGHAPF-EAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGE 247

Query: 228 ---MEHPFVK 234
              + HPF K
Sbjct: 248 EAILRHPFFK 257

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 93.7 bits (233), Expect = 3e-22
 Identities = 66/245 (26%), Positives = 112/245 (45%), Gaps = 42/245 (17%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDEN-----RLYIFLELVTKGSLANLYQKYHLSDSQVSS 82
           +E+ +L  F+ DN++  L   +  +      +Y+  EL+       +     LS   V  
Sbjct: 48  RELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKV 107

Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKG---T 139
           +  QIL GL YLH   ++HRDIK  N+LV+++  +K+ DFGLA+    ++ K       T
Sbjct: 108 FLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVT 167

Query: 140 PFWMAPEV-VNSKNDGYGLTADIWSLGCTVLEMLTRR---------------------PP 177
            ++ APE+ + S++  Y    DIWS+GC   E+L RR                     P 
Sbjct: 168 QYYRAPEILMGSRH--YTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPS 225

Query: 178 YSHL----EGVQALFRIGKGELPSVP------SSLSRDARDFILKCLQVNPNDRPTVTEL 227
              +    EG +A    G  + PS+P      S  + +A   + + L  +P+ R +  + 
Sbjct: 226 LEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADA 285

Query: 228 MEHPF 232
           + HP+
Sbjct: 286 LAHPY 290

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 92.1 bits (229), Expect = 3e-22
 Identities = 64/232 (27%), Positives = 111/232 (47%), Gaps = 16/232 (6%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+K +  ++   +  + IL    E  +++  +  ++V+ LG      ++ +  +L+  G 
Sbjct: 40  AIKVL-REETSPKANKEILD---EAYVMASVDHPHVVRLLGICLSS-QVQLITQLMPLGC 94

Query: 66  LANLYQKYH---LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADF 122
           L + Y + H   +    + ++  QI  G+ YL E+ +VHRD+   N+LV     VK+ DF
Sbjct: 95  LLD-YVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDF 153

Query: 123 GLAK--ATTMNDLKSCKG-TPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPP 177
           GLAK       +  +  G  P  WMA E +   +  Y   +D+WS G TV E++T    P
Sbjct: 154 GLAKLLDVDEKEYHAEGGKVPIKWMALESI--LHRIYTHKSDVWSYGVTVWELMTFGAKP 211

Query: 178 YSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
           Y  +  V+    + KGE    P   + D    ++KC  ++   RPT  EL+ 
Sbjct: 212 YEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 93.2 bits (231), Expect = 4e-22
 Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 16/207 (7%)

Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVV 100
           +VQ     +D+  LY+ +E +  G L NL   Y + +     YT +++  L  +H   ++
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLI 164

Query: 101 HRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK---GTPFWMAPEVVNSK-NDG-Y 155
           HRD+K  N+L+D  G +KLADFG         +  C    GTP +++PEV+ S+  DG Y
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYY 224

Query: 156 GLTADIWSLGCTVLEMLTRRPPY--SHLEGVQALFRIGKGELPSVP--SSLSRDARDFIL 211
           G   D WS+G  + EML    P+    L G  +     K  L + P    +S+ A++ I 
Sbjct: 225 GRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL-NFPEDVEISKHAKNLI- 282

Query: 212 KCLQVNPND----RPTVTELMEHPFVK 234
            C  +   +    R  V E+ +HPF K
Sbjct: 283 -CAFLTDREVRLGRNGVEEIKQHPFFK 308

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 91.2 bits (226), Expect = 5e-22
 Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 13/224 (5%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           AVK +   +     K  +L+   E +++ Q +   IV+ +G  + E+   + +EL   G 
Sbjct: 26  AVKILKNDNNDPALKDELLR---EANVMQQLDNPYIVRMIGICEAES-WMLVMELAELGP 81

Query: 66  LANLYQK-YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGL 124
           L    QK  H+++  ++    Q+  G+ YL E N VHRD+   N+L+      K++DFGL
Sbjct: 82  LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGL 141

Query: 125 AKATTMND----LKSCKGTPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPY 178
           +KA   ++     K+    P  W APE +N     +   +D+WS G  + E  +  + PY
Sbjct: 142 SKALGADENYYKAKTHGKWPVKWYAPECMNYYK--FSSKSDVWSFGVLMWEAFSYGQKPY 199

Query: 179 SHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP 222
             ++G +    I  GE    P     +  D +  C     ++RP
Sbjct: 200 KGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERP 243

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 92.0 bits (228), Expect = 6e-22
 Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 18/200 (9%)

Query: 49  KDENRLYIFLELVTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKC 106
           +DEN LY+ ++    G L  L  K+   L +     Y  +++  +  +H+ + VHRDIK 
Sbjct: 71  QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKP 130

Query: 107 ANILVDASGSVKLADFGLAKATTMNDLKSCK-----GTPFWMAPEVVNSKNDG---YGLT 158
            N+L+D +G ++LADFG      MN   + +     GTP +++PE++ +  DG   YG  
Sbjct: 131 DNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPE 188

Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE----LPSVPSSLSRDARDFI--LK 212
            D WSLG  + EML    P+     V+   +I   E     PS  + +S +A+D I  L 
Sbjct: 189 CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLI 248

Query: 213 CLQVNPNDRPTVTELMEHPF 232
           C +     +  + +  +H F
Sbjct: 249 CSRERRLGQNGIEDFKKHAF 268

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 91.7 bits (228), Expect = 8e-22
 Identities = 64/251 (25%), Positives = 118/251 (47%), Gaps = 46/251 (18%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYTRQ 86
           +E+ ++++ + +NI+  +    + + + + ++++    L  +   K  L++SQV     Q
Sbjct: 69  RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQ 127

Query: 87  ILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT-------TMNDLKSCKG- 138
           ILNGL  LH+   +HRD+  ANI +++ G  K+ADFGLA+         T++  ++ +  
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 139 --------TPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI 190
                   T ++ APE++      Y    D+WS+GC   E+LT +P +     +  L RI
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEK-YHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246

Query: 191 GK-------------GELP-------SVPSSL-------SRDARDFILKCLQVNPNDRPT 223
            +              +LP         P  L       S DA D +   L++NP +R +
Sbjct: 247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS 306

Query: 224 VTELMEHPFVK 234
             E ++H + K
Sbjct: 307 AKEALKHEYFK 317

Length = 335

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 91.6 bits (227), Expect = 9e-22
 Identities = 64/222 (28%), Positives = 116/222 (52%), Gaps = 22/222 (9%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQ---EISLLSQFEQDNIVQYLG------TDKDEN 52
           G   AVK++S      +  QSI+  ++   E+ LL   + +N++  L       + ++ N
Sbjct: 42  GLRVAVKKLS------RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95

Query: 53  RLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVD 112
            +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V+
Sbjct: 96  DVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 154

Query: 113 ASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEML 172
               +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+L
Sbjct: 155 EDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELL 212

Query: 173 TRR---PPYSHLEGVQALFRIGKGELPSVPSSL-SRDARDFI 210
           T R   P   H++ ++ + R+       +   + S  AR++I
Sbjct: 213 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 254

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 91.7 bits (227), Expect = 1e-21
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 21/204 (10%)

Query: 49  KDENRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           + E+RL+  +E V  G L  ++ ++  L +     Y+ +I   L YLHER +++RD+K  
Sbjct: 66  QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 125

Query: 108 NILVDASGSVKLADFGLAK-ATTMNDLKS--CKGTPFWMAPEVVNSKNDGYGLTADIWSL 164
           N+L+D+ G +KL D+G+ K      D  S  C GTP ++APE++  + + YG + D W+L
Sbjct: 126 NVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEIL--RGEDYGFSVDWWAL 182

Query: 165 GCTVLEMLTRRPPYSHLEGVQA--------LFRIGKGELPSVPSSLSRDARDFILKCLQV 216
           G  + EM+  R P+  +             LF++   +   +P SLS  A   +   L  
Sbjct: 183 GVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNK 242

Query: 217 NPNDR------PTVTELMEHPFVK 234
           +P +R          ++  HPF +
Sbjct: 243 DPKERLGCHPQTGFADIQGHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 89.9 bits (223), Expect = 2e-21
 Identities = 50/163 (30%), Positives = 84/163 (51%), Gaps = 14/163 (8%)

Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDLKSCKGTP 140
           YT QI++GL +LH+R +++RD+K  N+L+D  G+V+++D GLA       +  K   GTP
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTP 161

Query: 141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY----SHLEGVQALFRIGKGELP 196
            +MAPE++  + + Y  + D ++LG T+ EM+  R P+      +E  +   RI    + 
Sbjct: 162 GFMAPELL--QGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV- 218

Query: 197 SVPSSLSRDARDFILKCLQVNPNDR-----PTVTELMEHPFVK 234
           + P   S  ++ F    L  +P  R          L  HP  +
Sbjct: 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFR 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 90.1 bits (224), Expect = 2e-21
 Identities = 72/265 (27%), Positives = 106/265 (40%), Gaps = 42/265 (15%)

Query: 4   FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTK 63
             A+KE+ L+ +      +I    +E SLL   +  NIV        +  L +  E +  
Sbjct: 32  LVALKEIRLEHEEGAPFTAI----REASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT 87

Query: 64  GSLANLYQKYH---LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
             L   Y       LS   V  +  Q+L GL Y H+R V+HRD+K  N+L+   G +KLA
Sbjct: 88  -DLKQ-YMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLA 145

Query: 121 DFGLAKATTM-NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY- 178
           DFGLA+A ++ +   S +    W  P  V   +  Y  + D+W +GC   EM T RP + 
Sbjct: 146 DFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFP 205

Query: 179 ---------------------------SHLEGVQAL-FRIGKGE-LPSVPSSLSR--DAR 207
                                      S     +   F       L +    L R     
Sbjct: 206 GSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGE 265

Query: 208 DFILKCLQVNPNDRPTVTELMEHPF 232
           +  LK LQ  P  R +  E M+HP+
Sbjct: 266 ELALKFLQYEPKKRISAAEAMKHPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 88.9 bits (220), Expect = 3e-21
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 10/207 (4%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDEN-RLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYT 84
           E S+++Q    N+VQ LG   +E   LYI  E + KGSL +  +   +  L    +  ++
Sbjct: 49  EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 108

Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAK-ATTMNDLKSCKGTPFWM 143
             +   + YL   N VHRD+   N+LV      K++DFGL K A++  D  + K    W 
Sbjct: 109 LDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWT 166

Query: 144 APEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSL 202
           APE +  K   +   +D+WS G  + E+ +  R PY  +     + R+ KG     P   
Sbjct: 167 APEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC 224

Query: 203 SRDARDFILKCLQVNPNDRPTVTELME 229
                D + +C  ++   RP+  +L E
Sbjct: 225 PPVVYDVMKQCWHLDAATRPSFLQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 90.1 bits (223), Expect = 3e-21
 Identities = 73/260 (28%), Positives = 118/260 (45%), Gaps = 39/260 (15%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIV---QYLGTDKDENRLYIFLELVT 62
           A+KE+ L+ +      +I    +E+SLL   +  NIV     + T+K    ++ +L+   
Sbjct: 35  ALKEIRLEHEEGAPCTAI----REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDL 90

Query: 63  KGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADF 122
           K  L +     ++ +  V  +  Q+L GL Y H R V+HRD+K  N+L++  G +KLADF
Sbjct: 91  KQYLDDCGNSINMHN--VKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADF 148

Query: 123 GLAKATTM-NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP--PYS 179
           GLA+A ++     S +    W  P  +   +  Y    D+W +GC   EM T RP  P S
Sbjct: 149 GLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208

Query: 180 HL-EGVQALFRI----GKGELPSVPSS----------------------LSRDARDFILK 212
            + E +  +FRI     +   P + S+                      L  D  + + K
Sbjct: 209 TVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSK 268

Query: 213 CLQVNPNDRPTVTELMEHPF 232
            LQ     R +  E M+HP+
Sbjct: 269 LLQFEGRKRISAEEAMKHPY 288

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 90.1 bits (223), Expect = 3e-21
 Identities = 76/281 (27%), Positives = 125/281 (44%), Gaps = 53/281 (18%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
           G   A K + L+ + A   Q I    +E+ +L +     IV + G    +  + I +E +
Sbjct: 30  GLIMARKLIHLEIKPAIRNQII----RELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85

Query: 62  TKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERN-VVHRDIKCANILVDASGSVKL 119
             GSL  + +K   + +  +   +  ++ GL YL E++ ++HRD+K +NILV++ G +KL
Sbjct: 86  DGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKL 145

Query: 120 ADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR---- 175
            DFG++     +   S  GT  +M+PE +   +  Y + +DIWS+G +++EM   R    
Sbjct: 146 CDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--YSVQSDIWSMGLSLVEMAIGRYPIP 203

Query: 176 -PPYSHLE---GVQALFRIGKGELPSVP-------SSLSRDAR----------------- 207
            P    LE   G        + E    P       SS   D+R                 
Sbjct: 204 PPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPP 263

Query: 208 -------------DFILKCLQVNPNDRPTVTELMEHPFVKR 235
                        DF+ KCL  NP +R  + +LM H F+KR
Sbjct: 264 PKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 89.7 bits (222), Expect = 4e-21
 Identities = 52/182 (28%), Positives = 94/182 (51%), Gaps = 11/182 (6%)

Query: 49  KDENRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           +  +RL++ +E V  G L  ++ ++  L +     Y  +I   L +LHER +++RD+K  
Sbjct: 66  QTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLD 125

Query: 108 NILVDASGSVKLADFGLAKATTM--NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLG 165
           N+L+DA G +KL D+G+ K      +   +  GTP ++APE++  + + YG + D W+LG
Sbjct: 126 NVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL--RGEEYGFSVDWWALG 183

Query: 166 CTVLEMLTRRPPYS------HLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPN 219
             + EM+  R P+        +     LF++   +   +P  LS  A   +   L  +P 
Sbjct: 184 VLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPK 243

Query: 220 DR 221
           +R
Sbjct: 244 ER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 89.5 bits (222), Expect = 4e-21
 Identities = 73/259 (28%), Positives = 119/259 (45%), Gaps = 43/259 (16%)

Query: 5   FAVKEVSLQDQGAQGKQSIL---QLEQ---EISLLSQFEQDNIVQYLGTDKDENRLYIFL 58
           FA+K+++        KQ+++   Q++Q   E  +L+  E   +V    + + +  L + +
Sbjct: 29  FAMKKIN--------KQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80

Query: 59  ELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV 117
           E V  G  A L +    L       Y  + +  L YLH   +VHRD+K  N+L+ + G +
Sbjct: 81  EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHI 140

Query: 118 KLADFGLAKATTMN------------------DLKSCKGTPFWMAPEVVNSKNDGYGLTA 159
           KL DFGL+K   M+                  D + C GTP ++APEV+  +  GYG   
Sbjct: 141 KLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC-GTPEYIAPEVILRQ--GYGKPV 197

Query: 160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFR---IGKGELPSVPSSLSRDARDFILKCLQV 216
           D W++G  + E L    P+   +  + LF        E P    +L  DA+D I + L+ 
Sbjct: 198 DWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQ 256

Query: 217 NPNDR---PTVTELMEHPF 232
           NP +R       E+ +H F
Sbjct: 257 NPLERLGTGGAFEVKQHRF 275

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 89.1 bits (221), Expect = 7e-21
 Identities = 71/240 (29%), Positives = 114/240 (47%), Gaps = 13/240 (5%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           DG F+AVK +  +    + +Q  +  E+ + LL   +   +V    + +  ++LY  L+ 
Sbjct: 19  DGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVGLHYSFQTADKLYFVLDY 77

Query: 61  VTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
           V  G L  +L ++    + +   Y  +I + L YLH  N+++RD+K  NIL+D+ G V L
Sbjct: 78  VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVL 137

Query: 120 ADFGLAK-ATTMNDLKS--CKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP 176
            DFGL K     +   S  C GTP ++APEV+  +   Y  T D W LG  + EML   P
Sbjct: 138 TDFGLCKEGIEHSKTTSTFC-GTPEYLAPEVLRKQP--YDRTVDWWCLGAVLYEMLYGLP 194

Query: 177 PYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR----PTVTELMEHPF 232
           P+   +  +    I    L  +  ++S  AR  +   LQ +   R        E+  H F
Sbjct: 195 PFYSRDTAEMYDNILNKPL-RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 91.0 bits (225), Expect = 7e-21
 Identities = 67/265 (25%), Positives = 124/265 (46%), Gaps = 39/265 (14%)

Query: 4   FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGT--DKDENRLYIFLELV 61
           FF  K +S +    + K    QL  E++++ + +  NIV+Y+    +K   +LYI +E  
Sbjct: 40  FFCWKAISYRGLKEREKS---QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFC 96

Query: 62  TKGSLANLYQKYH-----LSDSQVSSYTRQILNGLVYLHE-------RNVVHRDIKCANI 109
             G L+   QK +     + +  +   TRQ+L+ L Y H          V+HRD+K  NI
Sbjct: 97  DAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNI 156

Query: 110 LVDAS----GSV-------------KLADFGLAKATTMNDL-KSCKGTPFWMAPEVVNSK 151
            +       G +             K+ DFGL+K   +  +  SC GTP++ +PE++  +
Sbjct: 157 FLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHE 216

Query: 152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV-QALFRIGKGELPSVP-SSLSRDARDF 209
              Y   +D+W+LGC + E+ + + P+       Q +  + +G  P +P    S++    
Sbjct: 217 TKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG--PDLPIKGKSKELNIL 274

Query: 210 ILKCLQVNPNDRPTVTELMEHPFVK 234
           I   L ++  +RP+  + + +  +K
Sbjct: 275 IKNLLNLSAKERPSALQCLGYQIIK 299

Length = 1021

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 87.6 bits (217), Expect = 9e-21
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 12/215 (5%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYT 84
           +E +++ + +  N+VQ LG    E   YI  E +T G+L +  +   +  ++   +    
Sbjct: 51  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 110

Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF--- 141
            QI + + YL ++N +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   
Sbjct: 111 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 170

Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPS 200
           W APE +    + + + +D+W+ G  + E+ T    PY  ++  Q    + KG     P 
Sbjct: 171 WTAPESL--AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPE 228

Query: 201 SLSRDARDFILKCLQVNPNDRPTVTEL---MEHPF 232
                  + +  C Q NP+DRP+  E+    E  F
Sbjct: 229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 88.0 bits (218), Expect = 9e-21
 Identities = 52/165 (31%), Positives = 77/165 (46%), Gaps = 19/165 (11%)

Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPF 141
           Y  +I  GL  LH   +V+RD+K  NIL+D  G ++++D GLA      + ++   GT  
Sbjct: 107 YAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVG 166

Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHL------EGVQALFRIGKGEL 195
           +MAPEVV  KN+ Y  + D W LGC + EM+  + P+         E V+   +    E 
Sbjct: 167 YMAPEVV--KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK----ED 220

Query: 196 PSVPSS-LSRDARDFILKCLQVNPNDR-----PTVTELMEHPFVK 234
               S   S  AR    + L  +P  R         E+  HPF +
Sbjct: 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 88.9 bits (220), Expect = 1e-20
 Identities = 53/151 (35%), Positives = 78/151 (51%), Gaps = 4/151 (2%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS-YTRQI 87
           E  +L+       V   G+ KDE+ LY+ LE V  G      ++     + V   Y  QI
Sbjct: 81  ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140

Query: 88  LNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEV 147
           +    YL   N+V+RD+K  N+L+D  G +K+ DFG AK         C GTP ++APE+
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC-GTPEYIAPEI 199

Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTRRPPY 178
           +   N G+G  AD W+LG  + E+L   PP+
Sbjct: 200 L--LNVGHGKAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 88.5 bits (219), Expect = 1e-20
 Identities = 49/158 (31%), Positives = 85/158 (53%), Gaps = 6/158 (3%)

Query: 52  NRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +RLY  +E V  G L   + Q     +     Y  +I  GL +LH + +++RD+K  N++
Sbjct: 74  DRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVM 133

Query: 111 VDASGSVKLADFGLAKATTMNDL--KSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           +D+ G +K+ADFG+ K    + +  K+  GTP ++APE++  +   YG + D W+ G  +
Sbjct: 134 LDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLL 191

Query: 169 LEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDA 206
            EML  + P+   E    LF+       + P S+S++A
Sbjct: 192 YEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEA 228

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 88.2 bits (218), Expect = 2e-20
 Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 18/200 (9%)

Query: 49  KDENRLYIFLELVTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKC 106
           +DEN LY+ ++    G L  L  K+   L +     Y  +++  +  +H+ + VHRDIK 
Sbjct: 71  QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKP 130

Query: 107 ANILVDASGSVKLADFG-----LAKATTMNDLKSCKGTPFWMAPEVVNSKNDG---YGLT 158
            NIL+D +G ++LADFG     +   T  + +    GTP +++PE++ +  DG   YG  
Sbjct: 131 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV--GTPDYISPEILQAMEDGKGKYGPE 188

Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI----GKGELPSVPSSLSRDARDFI--LK 212
            D WSLG  + EML    P+     V+   +I     + + P+  + +S DA+D I  L 
Sbjct: 189 CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLI 248

Query: 213 CLQVNPNDRPTVTELMEHPF 232
           C + +   +  + +  +HPF
Sbjct: 249 CSREHRLGQNGIEDFKQHPF 268

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 87.3 bits (216), Expect = 2e-20
 Identities = 81/272 (29%), Positives = 119/272 (43%), Gaps = 50/272 (18%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLL---SQFEQDNIVQYLG------TDKDEN 52
           G F A+K V +Q     G    L   +E++LL     F+  NIV+ +       TD+ E 
Sbjct: 25  GHFVALKSVRVQT-NEDGLP--LSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR-ET 80

Query: 53  RLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           ++ +  E V +     L +     L    +    RQ L GL +LH   +VHRD+K  NIL
Sbjct: 81  KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENIL 140

Query: 111 VDASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVL 169
           V + G VKLADFGLA+  +    L     T ++ APEV+      Y    D+WS+GC   
Sbjct: 141 VTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQST--YATPVDMWSVGCIFA 198

Query: 170 EMLTRRPPY---SHLEGVQALFR-IGKGELPS-----VPSSLSRDA-------------- 206
           EM  R+P +   S  + +  +F  IG   LP         +L R A              
Sbjct: 199 EMFRRKPLFCGNSEADQLGKIFDLIG---LPPEDDWPRDVTLPRGAFSPRGPRPVQSVVP 255

Query: 207 ------RDFILKCLQVNPNDRPTVTELMEHPF 232
                    +L+ L  NP+ R +    ++HPF
Sbjct: 256 EIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 87.8 bits (217), Expect = 2e-20
 Identities = 67/260 (25%), Positives = 120/260 (46%), Gaps = 51/260 (19%)

Query: 25  QLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSY 83
           Q+ +E+ +L +     IV + G    +  + I +E +  GSL   L +   + +  +   
Sbjct: 49  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKV 108

Query: 84  TRQILNGLVYLHERN-VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFW 142
           +  +L GL YL E++ ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +
Sbjct: 109 SIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 168

Query: 143 MAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR-----PPYSHLEGV--QALFRIGKGE- 194
           M+PE +   +  Y + +DIWS+G +++E+   R     P    LE +  + +    +GE 
Sbjct: 169 MSPERLQGTH--YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEP 226

Query: 195 --------------------------------------LPSVPSSL-SRDARDFILKCLQ 215
                                                  P +P+ + + D ++F+ KCL 
Sbjct: 227 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLI 286

Query: 216 VNPNDRPTVTELMEHPFVKR 235
            NP +R  +  LM H F+KR
Sbjct: 287 KNPAERADLKMLMNHTFIKR 306

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 86.7 bits (215), Expect = 2e-20
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 17/222 (7%)

Query: 21  QSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLE----------LVTKGSLANLY 70
               +  +E+ +  +    N+V+ LG  ++    Y+ LE          L    S     
Sbjct: 50  NLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKL 109

Query: 71  QKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM 130
           +   LS  Q  +   QI  G+ +L     VHRD+   N LV +   VK++   L+K    
Sbjct: 110 KPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYN 169

Query: 131 NDLKSCKGT--PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQA 186
           ++    +    P  W+APE V  + D +   +D+WS G  + E+ T+   P+  L   + 
Sbjct: 170 SEYYKLRNALIPLRWLAPEAV--QEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV 227

Query: 187 LFRIGKGELP-SVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
           L R+  G+L   VP          + +C  VNP DRP+ +EL
Sbjct: 228 LNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSEL 269

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 87.3 bits (217), Expect = 2e-20
 Identities = 74/273 (27%), Positives = 116/273 (42%), Gaps = 45/273 (16%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
           G  FA+K +  ++   + K   +  EQEI  L+  +   +     + + E  L + ++  
Sbjct: 26  GKLFALKVLDKKEMIKRNKVKRVLTEQEI--LATLDHPFLPTLYASFQTETYLCLVMDYC 83

Query: 62  TKGSLANLYQKY---HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
             G L  L Q+     LS+     Y  ++L  L YLH   +V+RD+K  NIL+  SG + 
Sbjct: 84  PGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIM 143

Query: 119 LADFGLAKAT----------------TMNDLK---------------SCKGTPFWMAPEV 147
           L+DF L+K +                  +                  S  GT  ++APEV
Sbjct: 144 LSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEV 203

Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSS--LSRD 205
           +    DG+G   D W+LG  + EML    P+      +    I K E  + P S  +S  
Sbjct: 204 I--SGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKE-VTFPGSPPVSSS 260

Query: 206 ARDFILKCLQVNPNDR----PTVTELMEHPFVK 234
           ARD I K L  +P+ R        E+ +HPF +
Sbjct: 261 ARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 86.5 bits (214), Expect = 3e-20
 Identities = 63/232 (27%), Positives = 115/232 (49%), Gaps = 20/232 (8%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
           G  +A K++  +    +  + +  LE+EI  L +     IV      + +  L + + L+
Sbjct: 18  GKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNLAYAFESKTHLCLVMSLM 75

Query: 62  TKGSLANLYQKYHLSD-----SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS 116
             G L   Y  Y++ +      +V  Y+ QI  G+++LH  ++V+RD+K  N+L+D  G+
Sbjct: 76  NGGDLK--YHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN 133

Query: 117 VKLADFGLAKATTMNDLKSCK---GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
            +L+D GL  A  + D K+     GT  +MAPE++  K + Y    D +++GC++ EM+ 
Sbjct: 134 CRLSDLGL--AVELKDGKTITQRAGTNGYMAPEIL--KEEPYSYPVDWFAMGCSIYEMVA 189

Query: 174 RRPPY-SHLEGV---QALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
            R P+  H E V   +   R  + E+     + + +++D     L   P DR
Sbjct: 190 GRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 86.2 bits (213), Expect = 5e-20
 Identities = 65/250 (26%), Positives = 111/250 (44%), Gaps = 31/250 (12%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           D    AVK  +L+D     ++     ++E  LL+  + ++IV++ G   D + L +  E 
Sbjct: 34  DKMLVAVK--ALKDPTLAARKD---FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEY 88

Query: 61  VTKGSLANLYQKYHLSD------------------SQVSSYTRQILNGLVYLHERNVVHR 102
           +  G L N + + H  D                  SQ+     QI +G+VYL  ++ VHR
Sbjct: 89  MKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHR 147

Query: 103 DIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF----WMAPEVVNSKNDGYGLT 158
           D+   N LV A+  VK+ DFG+++     D     G       WM PE +  +   +   
Sbjct: 148 DLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK--FTTE 205

Query: 159 ADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVN 217
           +D+WS G  + E+ T  + P+  L   + +  I +G +   P    ++  D +L C Q  
Sbjct: 206 SDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQRE 265

Query: 218 PNDRPTVTEL 227
           P  R  + E+
Sbjct: 266 PQQRLNIKEI 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 85.7 bits (212), Expect = 5e-20
 Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 10/218 (4%)

Query: 18  QGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HL 75
           +G  S  +  +E  ++ +   + +VQ  G    +  +YI  E ++ G L N  +++    
Sbjct: 38  EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRF 97

Query: 76  SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKS 135
             SQ+    + +  G+ YL  +  +HRD+   N LVD  G VK++DFGL++    ++  S
Sbjct: 98  QPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157

Query: 136 CKGTPF---WMAPEVVN-SKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRI 190
             G+ F   W  PEV+  SK   +   +D+W+ G  + E+ +  + PY      + + ++
Sbjct: 158 SVGSKFPVRWSPPEVLLYSK---FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV 214

Query: 191 GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
            +G     P   S      +  C      +RPT  +L+
Sbjct: 215 SQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 86.2 bits (213), Expect = 5e-20
 Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 24/202 (11%)

Query: 51  ENRLYIFLELVTKGSLANLYQKYHLSDS-----QVSSYTRQILNGLVYLHERNVVHRDIK 105
           ++ L + L L+  G L   +  YH+ ++     +   Y  +I  GL  LH+  +V+RD+K
Sbjct: 72  KDALCLVLTLMNGGDLK--FHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLK 129

Query: 106 CANILVDASGSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSL 164
             NIL+D  G ++++D GLA        +K   GT  +MAPEVV  KN+ Y  + D W+L
Sbjct: 130 PENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--KNERYTFSPDWWAL 187

Query: 165 GCTVLEMLTRRPPYSH------LEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
           GC + EM+  + P+         E V+ L +  + E        S DAR      L  +P
Sbjct: 188 GCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEY---SEKFSPDARSLCKMLLCKDP 244

Query: 219 NDR-----PTVTELMEHPFVKR 235
            +R         E+ EHP  K+
Sbjct: 245 KERLGCQGGGAREVKEHPLFKQ 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 86.2 bits (213), Expect = 8e-20
 Identities = 72/262 (27%), Positives = 117/262 (44%), Gaps = 39/262 (14%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIV---QYLGTDKDENRLYIFLELVT 62
           A+KE+ L+ +      +I    +E+SLL   +  NIV     + TDK    ++ +L+   
Sbjct: 35  ALKEIRLEHEEGAPCTAI----REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDL 90

Query: 63  KGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADF 122
           K  + +      +S   V  +  QIL GL Y H R V+HRD+K  N+L++  G +KLADF
Sbjct: 91  KQYMDDCGNI--MSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADF 148

Query: 123 GLAKATTM-NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP--PYS 179
           GLA+A ++     S +    W  P  V   +  Y    D+W +GC   EM + RP  P S
Sbjct: 149 GLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208

Query: 180 HLEG-VQALFRI----GKGELPSVPSS----------------------LSRDARDFILK 212
            +E  +  +FR+     +   P + S+                      L  +  + + K
Sbjct: 209 TVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTK 268

Query: 213 CLQVNPNDRPTVTELMEHPFVK 234
            LQ     R +  E M+H + +
Sbjct: 269 FLQYESKKRISAEEAMKHAYFR 290

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 85.5 bits (211), Expect = 8e-20
 Identities = 61/192 (31%), Positives = 99/192 (51%), Gaps = 13/192 (6%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIV---QYLGTDKDENRLYIFLELVT 62
           A+KE+ L+ +      +I    +E+SLL   +  NIV     + T++    ++ +L+   
Sbjct: 34  ALKEIRLEHEEGAPCTAI----REVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDL 89

Query: 63  KGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADF 122
           K  L N      +S   V  +  Q+L GL Y H+R ++HRD+K  N+L++  G +KLADF
Sbjct: 90  KQYLDNCGNL--MSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADF 147

Query: 123 GLAKATTM-NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP--PYS 179
           GLA+A ++     S +    W  P  V   +  Y    D+W +GC + EM T RP  P S
Sbjct: 148 GLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207

Query: 180 HL-EGVQALFRI 190
            + E +  +FR+
Sbjct: 208 TVKEELHLIFRL 219

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 85.8 bits (212), Expect = 1e-19
 Identities = 56/181 (30%), Positives = 95/181 (52%), Gaps = 6/181 (3%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           DG F+AVK +  +    + +Q+ +  E+ + LL   +   +V    + +   +LY  L+ 
Sbjct: 19  DGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVGLHYSFQTAEKLYFVLDY 77

Query: 61  VTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
           V  G L  +L ++    + +   Y  ++ + + YLH  N+++RD+K  NIL+D+ G V L
Sbjct: 78  VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVL 137

Query: 120 ADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPP 177
            DFGL K     +  +    GTP ++APEV+  + + Y  T D W LG  + EML   PP
Sbjct: 138 TDFGLCKEGVEPEETTSTFCGTPEYLAPEVL--RKEPYDRTVDWWCLGAVLYEMLYGLPP 195

Query: 178 Y 178
           +
Sbjct: 196 F 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 85.1 bits (210), Expect = 2e-19
 Identities = 72/240 (30%), Positives = 114/240 (47%), Gaps = 13/240 (5%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           DG  +AVK +  +    + +Q  +  E+ + LL   +   +V    + +   +LY  L+ 
Sbjct: 19  DGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVGLHYSFQTTEKLYFVLDF 77

Query: 61  VTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
           V  G L  +L ++    + +   Y  +I + L YLH  N+V+RD+K  NIL+D+ G V L
Sbjct: 78  VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVL 137

Query: 120 ADFGLAK-ATTMNDLKS--CKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP 176
            DFGL K     +D  +  C GTP ++APEV+  +   Y  T D W LG  + EML   P
Sbjct: 138 TDFGLCKEGIAQSDTTTTFC-GTPEYLAPEVI--RKQPYDNTVDWWCLGAVLYEMLYGLP 194

Query: 177 PYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR----PTVTELMEHPF 232
           P+   +  +    I    L   P + S  A   + + L+ +   R        E+ EHPF
Sbjct: 195 PFYCRDVAEMYDNILHKPLVLRPGA-SLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 85.0 bits (210), Expect = 3e-19
 Identities = 66/240 (27%), Positives = 113/240 (47%), Gaps = 37/240 (15%)

Query: 28  QEISLLSQFEQDNIVQYLGT---DKDENRLYIF-LELVTKGS-LANLYQKYHLSDSQVSS 82
           +E+ LL   + +N++  L     D   +R + F L +   G+ L  L +   LS+ ++  
Sbjct: 63  RELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF 122

Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFW 142
              Q+L GL Y+H   ++HRD+K  N+ V+    +K+ DFGLA+ T  +++     T ++
Sbjct: 123 LVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD-SEMTGYVVTRWY 181

Query: 143 MAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYS---HLEG---------------- 183
            APEV+ +    Y  T DIWS+GC + EMLT +P +    HL+                 
Sbjct: 182 RAPEVILNWMH-YTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240

Query: 184 -----------VQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
                      V+ L R  K +  S+  + +  A + + K L ++   R T  E + HP+
Sbjct: 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 84.0 bits (207), Expect = 3e-19
 Identities = 63/244 (25%), Positives = 111/244 (45%), Gaps = 28/244 (11%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           D    AVK  +L+D     ++      +E  LL+  + ++IV++ G   + + L +  E 
Sbjct: 34  DKILVAVK--TLKDASDNARKD---FHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 88

Query: 61  VTKGSLANLYQKYH---------------LSDSQVSSYTRQILNGLVYLHERNVVHRDIK 105
           +  G L N + + H               L+ SQ+    +QI  G+VYL  ++ VHRD+ 
Sbjct: 89  MKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLA 147

Query: 106 CANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF----WMAPEVVNSKNDGYGLTADI 161
             N LV  +  VK+ DFG+++     D     G       WM PE +  +   +   +D+
Sbjct: 148 TRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDV 205

Query: 162 WSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPND 220
           WSLG  + E+ T  + P+  L   + +  I +G +   P +  ++  D +L C Q  P+ 
Sbjct: 206 WSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHM 265

Query: 221 RPTV 224
           R  +
Sbjct: 266 RLNI 269

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 83.9 bits (207), Expect = 3e-19
 Identities = 52/170 (30%), Positives = 82/170 (48%), Gaps = 13/170 (7%)

Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA-KATTMNDL 133
             + +   Y  +IL GL  LH  N V+RD+K  NIL+D  G ++++D GLA K      +
Sbjct: 99  FEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI 158

Query: 134 KSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY----SHLEGVQALFR 189
           +   GT  +MAPEV+N  N  Y L+ D W LGC + EM+  + P+      ++  +   R
Sbjct: 159 RGRVGTVGYMAPEVLN--NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR 216

Query: 190 IGKGELPSVPSSLSRDARDFILKCLQVNPNDR-----PTVTELMEHPFVK 234
           + + E     +  S +A+      L  +P  R         E+  HPF +
Sbjct: 217 VLETE-EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 83.1 bits (205), Expect = 4e-19
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 11/206 (5%)

Query: 25  QLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSS 82
           ++ +E  ++ Q +   IV+ +G  + E  L + +E+ + G L      +K  ++ S V  
Sbjct: 41  EMMREAEIMHQLDNPYIVRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVE 99

Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKG 138
              Q+  G+ YL  +N VHRD+   N+L+      K++DFGL+KA   +D     +S   
Sbjct: 100 LMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159

Query: 139 TPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELP 196
            P  W APE +N +   +   +D+WS G T+ E  +  + PY  ++G + +  I +G+  
Sbjct: 160 WPLKWYAPECINFRK--FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL 217

Query: 197 SVPSSLSRDARDFILKCLQVNPNDRP 222
             P+    +    +  C      DRP
Sbjct: 218 DCPAECPPEMYALMKDCWIYKWEDRP 243

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 84.4 bits (209), Expect = 4e-19
 Identities = 65/257 (25%), Positives = 103/257 (40%), Gaps = 71/257 (27%)

Query: 30  ISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLS-DSQVSSY-TRQI 87
           I LL+ F     ++      +   +Y+ +EL+     ANL Q   +  D +  SY   Q+
Sbjct: 78  IGLLNVFTPQKSLE------EFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQM 127

Query: 88  LNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEV 147
           L G+ +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P V
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART---------AGTSFMMTPYV 178

Query: 148 VNSK--------NDGYGLTADIWSLGCTVLEMLTRR---------------------PPY 178
           V             GY    DIWS+GC + EM+                        P  
Sbjct: 179 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD 238

Query: 179 SHLEGVQALFRIGKGELPS---------VPSSL------------SRDARDFILKCLQVN 217
             +  +Q   R      P           P  L            +  ARD + K L ++
Sbjct: 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVID 298

Query: 218 PNDRPTVTELMEHPFVK 234
           P  R +V + ++HP++ 
Sbjct: 299 PEKRISVDDALQHPYIN 315

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 83.5 bits (206), Expect = 5e-19
 Identities = 67/261 (25%), Positives = 121/261 (46%), Gaps = 40/261 (15%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+K+    ++  + K++ L+   E+ +L   +Q+NIV+     +   +LY+  E V K  
Sbjct: 30  AIKKFKDSEENEEVKETTLR---ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNM 86

Query: 66  LANLYQKYH-LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGL 124
           L  L +  + +   +V SY  Q++  + + H+ ++VHRDIK  N+L+  +  +KL DFG 
Sbjct: 87  LELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGF 146

Query: 125 AKATTM-NDLKSCK--GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHL 181
           A+  +  ++    +   T ++ +PE++      YG   D+WS+GC + E+   +P +   
Sbjct: 147 ARNLSEGSNANYTEYVATRWYRSPELLLGAP--YGKAVDMWSVGCILGELSDGQPLFPGE 204

Query: 182 EGVQALFRIGK--GELPSV---------------------PSSLSRDAR--------DFI 210
             +  LF I K  G LP+                      P SL R           D +
Sbjct: 205 SEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLM 264

Query: 211 LKCLQVNPNDRPTVTELMEHP 231
              L++NP DR    + + HP
Sbjct: 265 KNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 82.3 bits (203), Expect = 9e-19
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 20/223 (8%)

Query: 18  QGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLY--QKYHL 75
           +G  S     +E  ++ +     +VQ  G   + + + +  E +  G L++    Q+   
Sbjct: 38  EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKF 97

Query: 76  SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKS 135
           S   +      +  G+ YL   NV+HRD+   N LV  +  VK++DFG+ +    +   S
Sbjct: 98  SQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157

Query: 136 CKGTPF---WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSH------LEGVQ 185
             GT F   W +PEV +     Y   +D+WS G  + E+ +  + PY +      +E + 
Sbjct: 158 STGTKFPVKWSSPEVFSFSK--YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN 215

Query: 186 ALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           A FR+ K      P   S+   + +  C +  P DRP+ + L+
Sbjct: 216 AGFRLYK------PRLASQSVYELMQHCWKERPEDRPSFSLLL 252

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 83.4 bits (206), Expect = 9e-19
 Identities = 64/240 (26%), Positives = 111/240 (46%), Gaps = 38/240 (15%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLE--LVTKGSLANLYQK---YHLSDSQVSS 82
           +E++LL   + +N++  L           F +  LV      +L QK   + LS+ +V  
Sbjct: 63  RELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDL-QKIMGHPLSEDKVQY 121

Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFW 142
              Q+L GL Y+H   ++HRD+K  N+ V+    +K+ DFGLA+     ++     T ++
Sbjct: 122 LVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-EMTGYVVTRWY 180

Query: 143 MAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY------------------------ 178
            APEV+ +    Y  T DIWS+GC + EMLT +  +                        
Sbjct: 181 RAPEVILNWMH-YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239

Query: 179 SHLEG------VQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
             LE       +++L +  + +  ++    S  A D + K L+++ + R T TE +EHP+
Sbjct: 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 82.3 bits (203), Expect = 1e-18
 Identities = 69/236 (29%), Positives = 111/236 (47%), Gaps = 15/236 (6%)

Query: 15  QGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH 74
           Q   G+Q+  ++   +  +   +   IV+ LG     + L +  +L   GSL +  +++ 
Sbjct: 45  QDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHR 103

Query: 75  --LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 132
             L   ++ ++  QI  G+ YL E  +VHR++   NIL+ +   V++ADFG+A     +D
Sbjct: 104 DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163

Query: 133 LK---SCKGTPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYS--HLEGVQ 185
            K   S   TP  WMA E +      Y   +D+WS G TV EM++    PY+      V 
Sbjct: 164 KKYFYSEHKTPIKWMALESILFGR--YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP 221

Query: 186 ALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPR 241
            L    KGE  + P   + D    ++KC  ++ N RPT  EL    F +     PR
Sbjct: 222 DLLE--KGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANE-FTRMARDPPR 274

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 81.7 bits (202), Expect = 2e-18
 Identities = 62/227 (27%), Positives = 91/227 (40%), Gaps = 36/227 (15%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYT---- 84
           E  ++S+F   NIV+ +G   +    +I LEL+  G L +  ++      + SS T    
Sbjct: 59  EALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL 118

Query: 85  ----RQILNGLVYLHERNVVHRDIKCANILVDASGS---VKLADFGLAKATTMNDLKSCK 137
               R +  G  YL E + +HRDI   N L+   G     K+ADFG+A+           
Sbjct: 119 LFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178

Query: 138 GTPF----WMAPE-----VVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQAL 187
           G       WM PE     +  SK        D+WS G  + E+ +    PY      + +
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSK-------TDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231

Query: 188 -FRIGKGEL---PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
            F  G G L      P  + R   D    C Q  P DRP    ++E 
Sbjct: 232 EFVTGGGRLDPPKGCPGPVYRIMTD----CWQHTPEDRPNFATILER 274

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 82.5 bits (204), Expect = 2e-18
 Identities = 72/257 (28%), Positives = 106/257 (41%), Gaps = 60/257 (23%)

Query: 28  QEISLLSQFEQDNIVQ----YLGTDKDE-NRLYIFLELVTKGSLANLYQKYHLSDSQVSS 82
           +EI LL      +IV+     L   + E   +Y+  EL+     ++L+Q    +D     
Sbjct: 48  REIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPE 103

Query: 83  YTR----QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKG 138
           + +    Q+L  L Y+H  NV HRD+K  NIL +A   +K+ DFGLA+    ND      
Sbjct: 104 HHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF-ND---TPT 159

Query: 139 TPFWM---------APEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR 189
             FW          APE+  S    Y    DIWS+GC   E+LT +P +     V  L  
Sbjct: 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 219

Query: 190 IGKGELPSVPSSLSRD------ARDFI----------------------LKCLQ----VN 217
           I   +L   PS  +        AR ++                      L+ L+     +
Sbjct: 220 I--TDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFD 277

Query: 218 PNDRPTVTELMEHPFVK 234
           P DRPT  E +  P+ K
Sbjct: 278 PKDRPTAEEALADPYFK 294

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 81.2 bits (201), Expect = 3e-18
 Identities = 66/236 (27%), Positives = 115/236 (48%), Gaps = 21/236 (8%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+K  +L+  G+  KQ +  L  E S++ QF+  NI++  G       + I  E +  GS
Sbjct: 36  AIK--TLKA-GSSDKQRLDFL-TEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGS 91

Query: 66  LANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFG 123
           L    ++     +  Q+    R I +G+ YL E N VHRD+   NILV+++   K++DFG
Sbjct: 92  LDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFG 151

Query: 124 LAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPY 178
           L++    ++     K  K    W APE +  +   +   +D+WS G  + E+++    PY
Sbjct: 152 LSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK--FTSASDVWSFGIVMWEVMSYGERPY 209

Query: 179 SHLEGVQALFRIGKG-ELPS---VPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
             +     +  +  G  LP     PS+L +     +L C Q + N+RPT ++++  
Sbjct: 210 WDMSNQDVIKAVEDGYRLPPPMDCPSALYQ----LMLDCWQKDRNERPTFSQIVST 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 82.0 bits (202), Expect = 3e-18
 Identities = 58/193 (30%), Positives = 97/193 (50%), Gaps = 30/193 (15%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQ-------FEQDNIVQYLGTDKDENR 53
           +  F+AVK +         K++IL+ ++E  ++S+        +   +V    + +  ++
Sbjct: 19  EEKFYAVKVLQ--------KKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 70

Query: 54  LYIFLELVTKGSLANLYQKYHLS------DSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           LY  L+ +  G L      YHL       + +   Y  +I + L YLH  N+V+RD+K  
Sbjct: 71  LYFVLDYINGGELF-----YHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPE 125

Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGLTADIWSLG 165
           NIL+D+ G + L DFGL K    ++  +    GTP ++APEV++ +   Y  T D W LG
Sbjct: 126 NILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQP--YDRTVDWWCLG 183

Query: 166 CTVLEMLTRRPPY 178
             + EML   PP+
Sbjct: 184 AVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 80.8 bits (199), Expect = 3e-18
 Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 9/203 (4%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTR 85
           QE  +L Q+   NIV+ +G    +  +YI +ELV  G      +     L   ++     
Sbjct: 42  QEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVE 101

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKG---TPF- 141
               G+ YL  ++ +HRD+   N LV     +K++DFG+++        S  G    P  
Sbjct: 102 NAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK 161

Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPS 200
           W APE +N     Y   +D+WS G  + E  +    PY++L   Q    I +G     P 
Sbjct: 162 WTAPEALNYGR--YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPE 219

Query: 201 SLSRDARDFILKCLQVNPNDRPT 223
                    + +C + +P  RP+
Sbjct: 220 LCPDAVYRLMERCWEYDPGQRPS 242

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 81.6 bits (201), Expect = 3e-18
 Identities = 74/268 (27%), Positives = 115/268 (42%), Gaps = 42/268 (15%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           +G   A+K +S++ +      +I    +E SLL   +  NIV        +  L    E 
Sbjct: 29  NGQLVALKVISMKTEEGVPFTAI----REASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84

Query: 61  VTKGSLANLYQKYH---LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV 117
           +    LA  Y   H   L    V  +  Q+L GL Y+H ++++HRD+K  N+L+   G +
Sbjct: 85  M-HTDLAQ-YMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGEL 142

Query: 118 KLADFGLAKATTM-NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP 176
           KLADFGLA+A ++ +   S +    W  P  V      Y    DIW  GC  +EML  +P
Sbjct: 143 KLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQP 202

Query: 177 PYSHLEGV-QALFRI-------------GKGELPS----------------VPSSLSR-- 204
            +  +  V + L +I             G  +LP+                V   LSR  
Sbjct: 203 AFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPP 262

Query: 205 DARDFILKCLQVNPNDRPTVTELMEHPF 232
            A D   + L + P DR +  + + HP+
Sbjct: 263 KAEDLASQMLMMFPKDRISAQDALLHPY 290

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 82.0 bits (202), Expect = 3e-18
 Identities = 68/256 (26%), Positives = 115/256 (44%), Gaps = 56/256 (21%)

Query: 28  QEISLLSQFEQDNIVQYLG------TDKDENRLYIFLELVTKGSLANLYQKYH--LSDSQ 79
           +E+ LL      NI+  L       + ++   +Y+ +EL+     ANL Q  H  L   +
Sbjct: 69  RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD----ANLCQVIHMELDHER 124

Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK-G 138
           +S    Q+L G+ +LH   ++HRD+K +NI+V +  ++K+ DFGLA+    N + +    
Sbjct: 125 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV 184

Query: 139 TPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR---------------------PP 177
           T ++ APEV+     GY    DIWS+GC + E++                        P 
Sbjct: 185 TRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242

Query: 178 YSHLEGVQALFR---IGKGELPSV-----------PSSLSRD------ARDFILKCLQVN 217
              +  +Q   R     + + P +           PS   RD      ARD + K L ++
Sbjct: 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVID 302

Query: 218 PNDRPTVTELMEHPFV 233
           P+ R +V E + HP++
Sbjct: 303 PDKRISVDEALRHPYI 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 81.6 bits (201), Expect = 3e-18
 Identities = 69/243 (28%), Positives = 114/243 (46%), Gaps = 31/243 (12%)

Query: 12  LQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANL-- 69
           L+D   +   S L  E E+  +   +  NI+  LG    +  LY+ +E  +KG+L     
Sbjct: 55  LKDDATEKDLSDLVSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR 113

Query: 70  ----------YQKYHLSDSQVS-----SYTRQILNGLVYLHERNVVHRDIKCANILVDAS 114
                     Y    + D Q++     S T Q+  G+ YL  +  +HRD+   N+LV  +
Sbjct: 114 ARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTEN 173

Query: 115 GSVKLADFGLAKATTMNDLKSCKGT-----PF-WMAPEVVNSKNDGYGLTADIWSLGCTV 168
             +K+ADFGLA+   +N++   K T     P  WMAPE +  +   Y   +D+WS G  +
Sbjct: 174 NVMKIADFGLAR--DVNNIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLM 229

Query: 169 LEMLTR-RPPYSHLEGVQALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTE 226
            E+ T    PY  +  V+ LF++ K G     P++ + +    +  C    P+ RPT  +
Sbjct: 230 WEIFTLGGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQ 288

Query: 227 LME 229
           L+E
Sbjct: 289 LVE 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 81.3 bits (201), Expect = 4e-18
 Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 34/234 (14%)

Query: 27  EQEIS-LLSQFEQ-------DNIVQYLGTDKDENRLYIFLELVTKGSL---------ANL 69
           E+++S L+S+ E         NI+  LG    E  LY+ +E    G+L            
Sbjct: 56  EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGE 115

Query: 70  YQKY--------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLAD 121
           Y            L+   + S+  Q+  G+ +L  +  +HRD+   N+LV     +K+AD
Sbjct: 116 YASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIAD 175

Query: 122 FGLAKATTMNDL--KSCKG-TPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP- 176
           FGLA+     D   K+  G  P  WMAPE +  +   Y   +D+WS G  + E+ T    
Sbjct: 176 FGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLLWEIFTLGGS 233

Query: 177 PYSHLEGVQALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
           PY  +  V+ LF++ K G     P + +++    +  C    P+ RPT  +L+E
Sbjct: 234 PYPGIP-VEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 82.0 bits (202), Expect = 4e-18
 Identities = 74/259 (28%), Positives = 109/259 (42%), Gaps = 51/259 (19%)

Query: 20  KQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDS 78
           K+ +  +  E  +L + +   +V+   + +D+  LY+ +E +  G +  L  K   LS+ 
Sbjct: 42  KEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEE 101

Query: 79  QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA----------- 127
               Y  + +  +  +H+   +HRDIK  N+L+DA G VKL+DFGL              
Sbjct: 102 ATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYR 161

Query: 128 ------------TTMNDLK--------------SCKGTPFWMAPEVVNSKNDGYGLTADI 161
                         MN  +              S  GTP ++APEV      GY    D 
Sbjct: 162 NLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVF--MQTGYNKLCDW 219

Query: 162 WSLGCTVLEMLTRRPPYSHLEGVQALFRI---GKGEL---PSVPSSLSRDARDFILK-CL 214
           WSLG  + EML   PP+   E  Q  +R     K  L   P VP  +S  A+D IL+ C 
Sbjct: 220 WSLGVIMYEMLIGYPPFCS-ETPQETYRKVMNWKETLVFPPEVP--ISEKAKDLILRFCT 276

Query: 215 QV-NPNDRPTVTELMEHPF 232
              N      V E+  HPF
Sbjct: 277 DSENRIGSNGVEEIKSHPF 295

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 80.8 bits (199), Expect = 4e-18
 Identities = 58/167 (34%), Positives = 86/167 (51%), Gaps = 12/167 (7%)

Query: 18  QGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD 77
           QG+   L     +SL+S  +   IV         ++L   L+L+  G L      YHLS 
Sbjct: 36  QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDL-----HYHLSQ 90

Query: 78  SQVSS------YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 131
             V S      Y  +I+ GL ++H R VV+RD+K ANIL+D  G V+++D GLA   +  
Sbjct: 91  HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 150

Query: 132 DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY 178
              +  GT  +MAPEV+  K   Y  +AD +SLGC + ++L    P+
Sbjct: 151 KPHASVGTHGYMAPEVLQ-KGTAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 80.8 bits (199), Expect = 6e-18
 Identities = 68/234 (29%), Positives = 109/234 (46%), Gaps = 34/234 (14%)

Query: 27  EQEIS-LLSQFE-------QDNIVQYLGTDKDENRLYIFLELVTKGSLANL--------- 69
           E+++S L+S+ E         NI+  LG    +  LY+ +E  +KG+L            
Sbjct: 64  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 123

Query: 70  ---YQKYHLSDSQVS-----SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLAD 121
              Y    + + Q+S     S   Q+  G+ YL  +  +HRD+   N+LV     +K+AD
Sbjct: 124 EYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 183

Query: 122 FGLAKATTMNDL--KSCKGT-PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RP 176
           FGLA+     D   K+  G  P  WMAPE +  +   Y   +D+WS G  + E+ T    
Sbjct: 184 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGS 241

Query: 177 PYSHLEGVQALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
           PY  +  V+ LF++ K G     PS+ + +    +  C    P+ RPT  +L+E
Sbjct: 242 PYPGVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 80.8 bits (199), Expect = 9e-18
 Identities = 67/241 (27%), Positives = 110/241 (45%), Gaps = 27/241 (11%)

Query: 12  LQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANL-- 69
           L+D       S L  E E+  +   +  NI+  LG    +  LY+ +E  +KG+L     
Sbjct: 52  LKDDATDKDLSDLVSEMEMMKMIG-KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLR 110

Query: 70  ----------YQKYHLSDSQVS-----SYTRQILNGLVYLHERNVVHRDIKCANILVDAS 114
                     +    L + Q++     S   Q+  G+ YL  +  +HRD+   N+LV   
Sbjct: 111 ARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED 170

Query: 115 GSVKLADFGLAKATTMNDL--KSCKGT-PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
             +K+ADFGLA+     D   K+  G  P  WMAPE +  +   Y   +D+WS G  + E
Sbjct: 171 NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLLWE 228

Query: 171 MLTRRP-PYSHLEGVQALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           + T    PY  +  V+ LF++ K G     P++ + +    + +C    P+ RPT  +L+
Sbjct: 229 IFTLGGSPYPGIP-VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLV 287

Query: 229 E 229
           E
Sbjct: 288 E 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 80.0 bits (197), Expect = 1e-17
 Identities = 72/247 (29%), Positives = 111/247 (44%), Gaps = 29/247 (11%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           AVK   L+D       + L  E E+  L   +  NI+  LG    E  LY+ +E   KG+
Sbjct: 48  AVK--MLKDNATDKDLADLISEMELMKLIG-KHKNIINLLGVCTQEGPLYVIVEYAAKGN 104

Query: 66  LANL------------YQKYHLSDSQVS-----SYTRQILNGLVYLHERNVVHRDIKCAN 108
           L               +    + + Q+S     S   Q+  G+ YL  R  +HRD+   N
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164

Query: 109 ILVDASGSVKLADFGLAKATTMNDL--KSCKG-TPF-WMAPEVVNSKNDGYGLTADIWSL 164
           +LV     +K+ADFGLA+     D   K+  G  P  WMAPE +  +   Y   +D+WS 
Sbjct: 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV--YTHQSDVWSF 222

Query: 165 GCTVLEMLTR-RPPYSHLEGVQALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRP 222
           G  + E+ T    PY  +  V+ LF++ + G     PS+ + +    + +C    P  RP
Sbjct: 223 GILMWEIFTLGGSPYPGIP-VEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRP 281

Query: 223 TVTELME 229
           T  +L+E
Sbjct: 282 TFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 79.3 bits (195), Expect = 1e-17
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 22/223 (9%)

Query: 24  LQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS- 82
           ++   E S++ +F   ++V+ LG         + +EL+T+G L + Y +    + + +  
Sbjct: 54  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS-YLRSLRPEMENNPV 112

Query: 83  -----------YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 131
                         +I +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     
Sbjct: 113 QAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 172

Query: 132 DL--KSCKG-TPF-WMAPEVVNSKNDGYGLT-ADIWSLGCTVLEMLT-RRPPYSHLEGVQ 185
           D   K  KG  P  WM+PE   S  DG   T +D+WS G  + E+ T    PY  +   Q
Sbjct: 173 DYYRKGGKGLLPVRWMSPE---SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ 229

Query: 186 ALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
            L  + +G L   P +      + +  C Q NP  RP+  E++
Sbjct: 230 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 79.9 bits (197), Expect = 3e-17
 Identities = 65/253 (25%), Positives = 109/253 (43%), Gaps = 59/253 (23%)

Query: 37  EQDN--IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVY 93
           E DN  +V+   + +D++ LY  ++ +  G + +L  +  + +  ++  Y  ++   +  
Sbjct: 57  EADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIES 116

Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGL------------------AKATTMN---- 131
           +H+   +HRDIK  NIL+D  G +KL DFGL                   +  +M     
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176

Query: 132 --DLKSCK---------------------GTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
             ++  C+                     GTP ++APEV+     GY    D WS+G  +
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVIL 234

Query: 169 LEMLTRRPPYSHLEGVQALFRIGKGE----LPSVPSSLSRDARDFILKCLQVNPNDR--- 221
            EML  +PP+      +   ++   E    +PS  + LSR+A D IL+ L     DR   
Sbjct: 235 YEMLVGQPPFLADTPAETQLKVINWETTLHIPS-QAKLSREASDLILR-LCCGAEDRLGK 292

Query: 222 PTVTELMEHPFVK 234
               E+  HPF K
Sbjct: 293 NGADEIKAHPFFK 305

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 79.2 bits (195), Expect = 3e-17
 Identities = 70/274 (25%), Positives = 109/274 (39%), Gaps = 65/274 (23%)

Query: 22  SILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH---LSDS 78
           + LQ E  +S L  F   NIV Y  T   +N L++    +  GS  +L   +    +S+ 
Sbjct: 44  TFLQGELHVSKL--FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSEL 101

Query: 79  QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM-------- 130
            ++   + +L  L Y+H    VHR +K ++IL+   G V L+  GL    +M        
Sbjct: 102 AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLR 159

Query: 131 --NDLK--SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQA 186
             +D    S K  P W++PEV+     GY   +DI+S+G T  E+     P+  +   Q 
Sbjct: 160 VVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 218

Query: 187 LF-------------------------------------------RIGKGELPSVP--SS 201
           L                                            R   GE  S P   +
Sbjct: 219 LLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRT 278

Query: 202 LSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
            S     F+ +CLQ NP+ RP+ + L+ H F K+
Sbjct: 279 FSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 78.9 bits (194), Expect = 3e-17
 Identities = 49/148 (33%), Positives = 73/148 (49%), Gaps = 7/148 (4%)

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPF 141
           QI  G+ YL ER +VHRD+   N+LV     VK+ DFGLAK    ++     +  K    
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176

Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPS 200
           WMA E +  +   Y   +D+WS G TV E++T    PY  +   +    + KGE    P 
Sbjct: 177 WMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 234

Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELM 228
             + D    ++KC  ++ + RP   EL+
Sbjct: 235 ICTIDVYMIMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 78.4 bits (193), Expect = 4e-17
 Identities = 60/227 (26%), Positives = 103/227 (45%), Gaps = 31/227 (13%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHL------SDSQVS 81
           +EI ++S+ +  NI++ L      + L +  E +  G L     ++        +D    
Sbjct: 68  KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127

Query: 82  SYTR------QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKS 135
           SY+       QI +G+ YL   N VHRD+   N LV  + ++K+ADFG+++     D   
Sbjct: 128 SYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYR 187

Query: 136 CKGTPF----WMAPE-VVNSKNDGYGLTADIWSLGCTVLEMLT--RRPPYSHLEGVQAL- 187
            +G       WM+ E ++  K   +   +D+W+ G T+ E+LT  +  PYS L   Q + 
Sbjct: 188 IQGRAVLPIRWMSWESILLGK---FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIE 244

Query: 188 -----FRIGKGE--LPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
                FR    +  LP  P+         +L C + N  +RP+  E+
Sbjct: 245 NTGEFFRDQGRQVYLPK-PALCPDSLYKLMLSCWRRNAKERPSFQEI 290

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 78.3 bits (193), Expect = 4e-17
 Identities = 55/229 (24%), Positives = 95/229 (41%), Gaps = 30/229 (13%)

Query: 27  EQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANL------YQKYHLSDSQV 80
           ++E +L+++F+  NIV+ LG       + +  E +  G L           +  LS S  
Sbjct: 56  QREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTS 115

Query: 81  S-----------------SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFG 123
           S                    +Q+  G+ YL ER  VHRD+   N LV  +  VK+ADFG
Sbjct: 116 SARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 175

Query: 124 LAKATTMNDLKSCKGTPF----WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPY 178
           L++     D             WM PE +      Y   +D+W+ G  + E+ +    PY
Sbjct: 176 LSRNIYSADYYKASENDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGMQPY 233

Query: 179 SHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
             +   + ++ +  G + S P +   +  + +  C    P+DRP+   +
Sbjct: 234 YGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 78.3 bits (193), Expect = 4e-17
 Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 16/214 (7%)

Query: 26  LEQEISLLSQFEQ-DNIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYH--LSDSQVS 81
           L  E+ ++S     +NIV  LG       + +  E    G L N L +K    L+   + 
Sbjct: 85  LMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLL 144

Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKS-CKGTP 140
           S++ Q+  G+ +L  +N +HRD+   N+L+     VK+ DFGLA+   MND     KG  
Sbjct: 145 SFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-DIMNDSNYVVKGNA 203

Query: 141 F----WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALF--RIGKG 193
                WMAPE +   N  Y   +D+WS G  + E+ +    PY  +  V + F   I +G
Sbjct: 204 RLPVKWMAPESI--FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP-VDSKFYKLIKEG 260

Query: 194 ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
              + P     +  D +  C   +P  RPT  ++
Sbjct: 261 YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 78.1 bits (192), Expect = 4e-17
 Identities = 66/242 (27%), Positives = 108/242 (44%), Gaps = 26/242 (10%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           AVK V   ++ A  ++ I +   E S++  F   ++V+ LG         + +EL+  G 
Sbjct: 40  AVKTV---NESASLRERI-EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 95

Query: 66  LANLYQKYHLSDSQ------------VSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           L + Y +    +++            +     +I +G+ YL+ +  VHRD+   N +V  
Sbjct: 96  LKS-YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH 154

Query: 114 SGSVKLADFGLAKATTMNDL--KSCKG-TPF-WMAPEVVNSKNDG-YGLTADIWSLGCTV 168
             +VK+ DFG+ +     D   K  KG  P  WMAPE   S  DG +  ++D+WS G  +
Sbjct: 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE---SLKDGVFTTSSDMWSFGVVL 211

Query: 169 LEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
            E+ +    PY  L   Q L  +  G     P +      D +  C Q NP  RPT  E+
Sbjct: 212 WEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 271

Query: 228 ME 229
           + 
Sbjct: 272 VN 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 77.4 bits (190), Expect = 6e-17
 Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 29/221 (13%)

Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-----------------LSDSQVSS 82
           NI+  LG  +    LY+ +E    G+L +  +K                   LS  Q+  
Sbjct: 57  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116

Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF- 141
           +   +  G+ YL ++  +HRD+   NILV  +   K+ADFGL++   +   K+    P  
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 176

Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPS 200
           WMA E +N     Y   +D+WS G  + E+++    PY  +   +   ++ +G     P 
Sbjct: 177 WMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234

Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPR 241
           +   +  D + +C +  P +RP         F +  +   R
Sbjct: 235 NCDDEVYDLMRQCWREKPYERP--------SFAQILVSLNR 267

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 77.4 bits (190), Expect = 9e-17
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 7/153 (4%)

Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK----SCK 137
           ++  QI  G+ YL E  +VHRD+   N+LV +   VK+ DFGLA+   +++ +      K
Sbjct: 113 NWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGK 172

Query: 138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELP 196
               WMA E +  +   +   +D+WS G TV E++T    PY  +   +    + KGE  
Sbjct: 173 VPIKWMALESILHRR--FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL 230

Query: 197 SVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
             P   + D    ++KC  ++   RP   EL++
Sbjct: 231 PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 77.4 bits (190), Expect = 9e-17
 Identities = 55/188 (29%), Positives = 91/188 (48%), Gaps = 8/188 (4%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           +G   A+K + LQ++      +I    +E SLL   +  NIV        +  L +  E 
Sbjct: 29  NGKLVALKVIRLQEEEGTPFTAI----REASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84

Query: 61  VTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
           V    L     K+   L    V  +  Q+L GL Y+H+R ++HRD+K  N+L+  +G +K
Sbjct: 85  V-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELK 143

Query: 119 LADFGLAKATTM-NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPP 177
           LADFGLA+A ++ +   S +    W  P  V   +  Y    D+W +GC  +EM+     
Sbjct: 144 LADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203

Query: 178 YSHLEGVQ 185
           +  ++ +Q
Sbjct: 204 FPGMKDIQ 211

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 77.4 bits (190), Expect = 2e-16
 Identities = 52/170 (30%), Positives = 86/170 (50%), Gaps = 11/170 (6%)

Query: 68  NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA 127
           +LY+K  L+   +  Y+ Q+  G+ +L  R  +HRD+   NIL+  +  VK+ DFGLA+ 
Sbjct: 170 DLYKKV-LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARD 228

Query: 128 TTMNDLKSCKGT---PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLE 182
              +     KG    P  WMAPE +  +   Y + +D+WS G  + E+ +    PY  ++
Sbjct: 229 IYKDPDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVK 286

Query: 183 GVQALF--RIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
            +   F  R+ +G     P   + +    +L C    P+ RPT +EL+EH
Sbjct: 287 -IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 76.6 bits (188), Expect = 2e-16
 Identities = 49/161 (30%), Positives = 77/161 (47%), Gaps = 11/161 (6%)

Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPF 141
           Y  ++  GL  L    +V+RD+K  NIL+D  G ++++D GLA      + ++   GT  
Sbjct: 107 YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVG 166

Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY-SHLEGVQ--ALFRIGKGELPSV 198
           +MAPEV+N  N+ Y  + D W LGC + EM+  + P+    E V+   + R  K +    
Sbjct: 167 YMAPEVIN--NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEY 224

Query: 199 PSSLSRDARDFILKCLQVNPNDRPTVT-----ELMEHPFVK 234
               S DA+      L  NP +R          + +HP  K
Sbjct: 225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFK 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 77.6 bits (191), Expect = 2e-16
 Identities = 49/153 (32%), Positives = 65/153 (42%), Gaps = 25/153 (16%)

Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK 134
           L   Q  +  R++L  L YLH R ++HRD+K  NI +D   +  L DFG A     +   
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241

Query: 135 -SCKGTPFWMAPEVVNSKN----DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR 189
             C G   W      NS      D Y    DIWS G  + EM  +      L G Q    
Sbjct: 242 PQCYG---WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT---LFGKQ---- 291

Query: 190 IGKGELPSVPSSLSRDARDFILKCLQVNPNDRP 222
                   V SS S   R  I++C+QV+P + P
Sbjct: 292 --------VKSS-SSQLRS-IIRCMQVHPLEFP 314

Length = 392

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 77.2 bits (190), Expect = 2e-16
 Identities = 67/269 (24%), Positives = 104/269 (38%), Gaps = 59/269 (21%)

Query: 20  KQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ 79
           K  +  ++ E  +L++ +   +V    + +D   LY+ +E +  G L  +  KY      
Sbjct: 42  KDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED 101

Query: 80  VSS-YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA----------- 127
           V+  Y  + +  +  +H+   +HRDIK  NIL+D  G +KL+DFGL+             
Sbjct: 102 VTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161

Query: 128 ------------------------------TTMNDLK--------SCKGTPFWMAPEVVN 149
                                           +   K        S  GTP ++APE+  
Sbjct: 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL 221

Query: 150 SKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR--IGKGELPSVPS--SLSRD 205
            +  GYG   D WSLG  + E L   PP+   E     +R  I   E    P    LS +
Sbjct: 222 QQ--GYGQECDWWSLGAIMFECLIGWPPFCS-ENSHETYRKIINWRETLYFPDDIHLSVE 278

Query: 206 ARDFILKCLQVNPN--DRPTVTELMEHPF 232
           A D I + +    N   R    E+  HPF
Sbjct: 279 AEDLIRRLITNAENRLGRGGAHEIKSHPF 307

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 77.0 bits (189), Expect = 2e-16
 Identities = 60/241 (24%), Positives = 112/241 (46%), Gaps = 39/241 (16%)

Query: 28  QEISLLSQFEQDNIVQYL------GTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVS 81
           +E+ LL   + +N++  L       + ++ N +Y+   L+    L N+ +   LSD  V 
Sbjct: 63  RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQ 121

Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF 141
               Q+L GL Y+H   ++HRD+K +N+ V+    +++ DFGLA+    +++     T +
Sbjct: 122 FLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD-DEMTGYVATRW 180

Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK--------- 192
           + APE++ +    Y  T DIWS+GC + E+L  +  +   + +  L RI +         
Sbjct: 181 YRAPEIMLNWMH-YNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239

Query: 193 -------------GELPSVP----SSLSRDAR----DFILKCLQVNPNDRPTVTELMEHP 231
                          LP +P      + R A     D + K L ++ + R + +E + HP
Sbjct: 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299

Query: 232 F 232
           +
Sbjct: 300 Y 300

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 76.2 bits (187), Expect = 2e-16
 Identities = 57/237 (24%), Positives = 105/237 (44%), Gaps = 30/237 (12%)

Query: 29  EISLLSQFEQD-NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH------------- 74
           E+ +L +     NI+  LG  ++   LYI +E    G+L +  +K               
Sbjct: 52  ELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHG 111

Query: 75  ----LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM 130
               L+  Q+  +   +  G+ YL E+  +HRD+   N+LV  + + K+ADFGL++   +
Sbjct: 112 TASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV 171

Query: 131 NDLKSCKGTPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALF 188
              K+    P  WMA E +N     Y   +D+WS G  + E+++    PY  +   +   
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSV--YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229

Query: 189 RIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPRCGQA 245
           ++ +G     P +   +  + + +C +  P +RP        PF +  +Q  R  +A
Sbjct: 230 KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERP--------PFAQISVQLSRMLEA 278

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 75.9 bits (186), Expect = 3e-16
 Identities = 54/216 (25%), Positives = 107/216 (49%), Gaps = 10/216 (4%)

Query: 19  GKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLS 76
           G ++ ++   E  +++  +  ++V+ LG       + +  +L+  G L +   ++  ++ 
Sbjct: 49  GPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIG 107

Query: 77  DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK-S 135
              + ++  QI  G++YL ER +VHRD+   N+LV +   VK+ DFGLA+    ++ + +
Sbjct: 108 SQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167

Query: 136 CKGTPF---WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIG 191
             G      WMA E ++ +   +   +D+WS G T+ E++T    PY  +   +    + 
Sbjct: 168 ADGGKMPIKWMALECIHYRK--FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE 225

Query: 192 KGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
           KGE    P   + D    ++KC  ++ + RP   EL
Sbjct: 226 KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKEL 261

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 74.9 bits (184), Expect = 5e-16
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 20/213 (9%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQ 86
           E S++ QF+  NI+   G       + I  E +  GSL    +K+    +  Q+    R 
Sbjct: 55  EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRG 114

Query: 87  ILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT-----PF 141
           I +G+ YL +   VHRD+   NILV+++   K++DFGL++    +D ++   T     P 
Sbjct: 115 IASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPI 173

Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKG-ELPS- 197
            W APE +  +   +   +D+WS G  + E+++    PY  +     +  I +G  LP+ 
Sbjct: 174 RWTAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAP 231

Query: 198 --VPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
              P++L +     +L C Q + N+RP   +++
Sbjct: 232 MDCPAALHQ----LMLDCWQKDRNERPKFEQIV 260

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 74.6 bits (183), Expect = 6e-16
 Identities = 61/249 (24%), Positives = 104/249 (41%), Gaps = 30/249 (12%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           D    AVK  +L++     +Q     ++E  LL+  +  +IV++ G   +   L +  E 
Sbjct: 34  DKMLVAVK--ALKEASESARQD---FQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEY 88

Query: 61  VTKGSLANLYQKYHLSD-----------------SQVSSYTRQILNGLVYLHERNVVHRD 103
           +  G L N + + H  D                  Q+ +   QI +G+VYL   + VHRD
Sbjct: 89  MRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRD 147

Query: 104 IKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF----WMAPEVVNSKNDGYGLTA 159
           +   N LV     VK+ DFG+++     D     G       WM PE +  +   +   +
Sbjct: 148 LATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK--FTTES 205

Query: 160 DIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
           DIWS G  + E+ T  + P+  L   +A+  I +G     P +   +    +  C Q  P
Sbjct: 206 DIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREP 265

Query: 219 NDRPTVTEL 227
             R  + ++
Sbjct: 266 QQRMVIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 75.4 bits (185), Expect = 7e-16
 Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 66/283 (23%)

Query: 8   KEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLA 67
           K+V L++Q A  K        E  +L++ + + +V+   + +D++ LY  ++ +  G + 
Sbjct: 37  KDVLLRNQVAHVKA-------ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMM 89

Query: 68  NLYQKYHL-SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA- 125
           +L  +  +  +     Y  ++   +  +H+   +HRDIK  NIL+D  G +KL DFGL  
Sbjct: 90  SLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149

Query: 126 -----------------KATTMN------DLKSCK------------------------- 137
                            +  +M+      D  +C+                         
Sbjct: 150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLV 209

Query: 138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP- 196
           GTP ++APEV+     GY    D WS+G  + EML  +PP+     ++   ++   +   
Sbjct: 210 GTPNYIAPEVL--LRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL 267

Query: 197 SVP--SSLSRDARDFILKCLQVNPNDR---PTVTELMEHPFVK 234
            +P  + LS +A D I+K L   P DR       E+  HPF K
Sbjct: 268 HIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGADEIKAHPFFK 309

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 75.3 bits (185), Expect = 9e-16
 Identities = 47/143 (32%), Positives = 66/143 (46%), Gaps = 21/143 (14%)

Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDLKSCKGTPFW 142
           +QIL GL YLH + ++HRD+K  NI ++    V + D G A+   +    L    GT   
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL-GLAGTVET 222

Query: 143 MAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSL 202
            APEV+    D Y   ADIWS G  + EML     Y        +F     + PS P   
Sbjct: 223 NAPEVL--ARDKYNSKADIWSAGIVLFEMLA----YPS-----TIFE----DPPSTPEEY 267

Query: 203 SRDARDFILK---CLQVNPNDRP 222
            +     +LK    L+V+P + P
Sbjct: 268 VKSCHSHLLKIISTLKVHPEEFP 290

Length = 357

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 74.9 bits (184), Expect = 9e-16
 Identities = 53/158 (33%), Positives = 77/158 (48%), Gaps = 14/158 (8%)

Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT-- 139
           SY+ Q+  G+ +L  R  +HRD+   NIL+  +  VK+ DFGLA+    +     KG   
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236

Query: 140 -PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQA----LFRIGK 192
            P  WMAPE +  K   Y   +D+WS G  + E+ +    PY    GVQ       R+ +
Sbjct: 237 LPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFSLGASPYP---GVQIDEEFCRRLKE 291

Query: 193 GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
           G     P   + +    +L C   NP DRPT +EL+E 
Sbjct: 292 GTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 75.4 bits (185), Expect = 1e-15
 Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 10/162 (6%)

Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK 134
           L+   + S+T Q+  G+ +L  +N VHRD+   N+L+     VK+ DFGLA+    +   
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNY 293

Query: 135 SCKGTPF----WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALF- 188
             KG+ F    WMAPE +   ++ Y   +D+WS G  + E+ +    PY  +  V + F 
Sbjct: 294 VSKGSTFLPVKWMAPESIF--DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI-VDSTFY 350

Query: 189 -RIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
            +I  G   + P   +++  D ++KC    P  RP+   L +
Sbjct: 351 NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 74.7 bits (183), Expect = 1e-15
 Identities = 50/156 (32%), Positives = 77/156 (49%), Gaps = 14/156 (8%)

Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT--- 139
           Y+ Q+  G+ +L  R  +HRD+   NIL+  +  VK+ DFGLA+    +     KG+   
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 140 PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQA----LFRIGKG 193
           P  WMAPE +  K   Y   +D+WS G  + E+ +    PY    GVQ       R+  G
Sbjct: 239 PLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFSLGASPYP---GVQINEEFCQRLKDG 293

Query: 194 ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
                P + + +    +L C Q +P +RPT + L+E
Sbjct: 294 TRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 73.8 bits (181), Expect = 1e-15
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 34/233 (14%)

Query: 26  LEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSL------------------A 67
           L  E +LL Q    ++++  G    +  L + +E    GSL                   
Sbjct: 50  LLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDG 109

Query: 68  NLYQKYHLSDSQ-------VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
           N    Y  +  +       + S+  QI  G+ YL E  +VHRD+   N+LV     +K++
Sbjct: 110 NRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKIS 169

Query: 121 DFGLAKATTMND--LKSCKG-TPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-R 175
           DFGL++     D  +K  KG  P  WMA E +   +  Y   +D+WS G  + E++T   
Sbjct: 170 DFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL--FDHIYTTQSDVWSFGVLLWEIVTLGG 227

Query: 176 PPYSHLEGVQALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
            PY  +   + LF + K G     P + S +  + +L C +  P+ RPT  ++
Sbjct: 228 NPYPGI-APERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 74.3 bits (182), Expect = 1e-15
 Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 21/208 (10%)

Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-----------------LSDSQVSS 82
           NI+  LG  +    LY+ +E    G+L +  +K                   LS  Q+  
Sbjct: 69  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128

Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF- 141
           +   +  G+ YL ++  +HRD+   NILV  +   K+ADFGL++   +   K+    P  
Sbjct: 129 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 188

Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPS 200
           WMA E +N     Y   +D+WS G  + E+++    PY  +   +   ++ +G     P 
Sbjct: 189 WMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 246

Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELM 228
           +   +  D + +C +  P +RP+  +++
Sbjct: 247 NCDDEVYDLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 73.9 bits (181), Expect = 1e-15
 Identities = 57/231 (24%), Positives = 102/231 (44%), Gaps = 38/231 (16%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSL------ANLYQKYHLSDSQVS 81
           +EI ++S+ +  NI++ LG    ++ L +  E +  G L        +   +  +++ + 
Sbjct: 66  KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN-IP 124

Query: 82  SYTR--------QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL 133
           S +         QI +G+ YL   N VHRD+   N LV    ++K+ADFG+++     D 
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184

Query: 134 KSCKGTPF----WMAPEVVNSKNDGYGLTADIWSLGCTVLEM--LTRRPPYSHLEGVQAL 187
              +G       WMA E +      +   +D+W+ G T+ EM  L +  PYS L   Q +
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI 242

Query: 188 FRIGK-----------GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
              G+            + P  PS +       +++C   +  DRPT  ++
Sbjct: 243 ENTGEFFRNQGRQIYLSQTPLCPSPVF----KLMMRCWSRDIKDRPTFNKI 289

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 74.4 bits (182), Expect = 2e-15
 Identities = 67/256 (26%), Positives = 114/256 (44%), Gaps = 56/256 (21%)

Query: 28  QEISLLSQFEQDNIVQYLG------TDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQ 79
           +E+ L+      NI+  L       + ++   +Y+ +EL+     ANL Q  +  L   +
Sbjct: 65  RELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMELDHER 120

Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAK-ATTMNDLKSCKG 138
           +S    Q+L G+ +LH   ++HRD+K +NI+V +  ++K+ DFGLA+ A T   +     
Sbjct: 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 180

Query: 139 TPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR---------------------PP 177
           T ++ APEV+     GY    DIWS+GC + EM+  +                     P 
Sbjct: 181 TRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238

Query: 178 YSHLEGVQALFRIGKGELPS---------VPSSL-----------SRDARDFILKCLQVN 217
              ++ +Q   R      P           P SL           +  ARD + K L ++
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298

Query: 218 PNDRPTVTELMEHPFV 233
           P  R +V E ++HP++
Sbjct: 299 PAKRISVDEALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 74.3 bits (182), Expect = 2e-15
 Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 49/237 (20%)

Query: 20  KQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDS 78
           K+ +  +  E  +L + +   +V+   + +D+  LY+ +E +  G +  L  K   L++ 
Sbjct: 42  KEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEE 101

Query: 79  QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA----------- 127
           +   Y  + +  +  +H+   +HRDIK  N+L+D+ G VKL+DFGL              
Sbjct: 102 ETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYR 161

Query: 128 ------------TTMNDLK--------------SCKGTPFWMAPEVVNSKNDGYGLTADI 161
                         MN  +              S  GTP ++APEV      GY    D 
Sbjct: 162 NLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVF--MQTGYNKLCDW 219

Query: 162 WSLGCTVLEMLTRRPPYSHLEGVQALFR--IGKGEL----PSVPSSLSRDARDFILK 212
           WSLG  + EML   PP+   E  Q  ++  +   E     P VP  +S  A+D IL+
Sbjct: 220 WSLGVIMYEMLIGYPPFCS-ETPQETYKKVMNWKETLIFPPEVP--ISEKAKDLILR 273

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 73.0 bits (179), Expect = 2e-15
 Identities = 68/244 (27%), Positives = 104/244 (42%), Gaps = 26/244 (10%)

Query: 7   VKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSL 66
           VKE  L+      +Q  L   QE+    +    N++Q LG   +     + LE    G L
Sbjct: 27  VKE--LRASATPDEQ--LLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDL 82

Query: 67  ANLYQKYHLSDSQVSSYTRQ------ILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
            N  +      +Q++           + +GL++LH+ + +H D+   N  + A  SVK+ 
Sbjct: 83  KNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIG 142

Query: 121 DFGLAKATTMNDL---KSCKGTPF-WMAPEVVNSKNDGYGLTAD------IWSLGCTVLE 170
           D+GLA      D    K C   P  W+APE+V  +     L  D      IWSLG T+ E
Sbjct: 143 DYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDL-LPKDQTKKSNIWSLGVTMWE 201

Query: 171 MLTRRP-PYSHLEGVQAL---FRIGKGELPSVPSSLSRDARDF-ILKCLQVNPNDRPTVT 225
           + T    PY  L   Q L    R    +LP     L    R + +++   ++P  RPT  
Sbjct: 202 LFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWLDPETRPTAE 261

Query: 226 ELME 229
           E+ E
Sbjct: 262 EVHE 265

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 73.0 bits (180), Expect = 3e-15
 Identities = 58/179 (32%), Positives = 97/179 (54%), Gaps = 14/179 (7%)

Query: 64  GSLANLYQK-YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVD-ASGSVKLAD 121
           G L +L +K   LS+++V    RQ++  L  LH+ N++H DIK  N+L D A   + L D
Sbjct: 94  GDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCD 153

Query: 122 FGLAKATTMNDLKSC-KGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSH 180
           +GL K        SC  GT  + +PE +   N  Y ++ D W++G    E+LT + P+  
Sbjct: 154 YGLCKII---GTPSCYDGTLDYFSPEKIKGHN--YDVSFDWWAVGVLTYELLTGKHPFKE 208

Query: 181 LEG----VQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR-PTVTELMEHPFVK 234
            E     +++L +  + +LP    ++S++A DF+   L+ N N R     E+++HPF+K
Sbjct: 209 DEDEELDLESLLKRQQKKLP-FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266

Length = 267

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 72.8 bits (178), Expect = 3e-15
 Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 20/220 (9%)

Query: 28  QEISLLSQFEQDNIVQYLGT--DKDENRLY----IFLELVTKGSLAN--LYQKY-----H 74
            E   + +F+  N+++ +G      E+  Y    + L  +  G L +  LY +      +
Sbjct: 49  SEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQY 108

Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL- 133
           L    +  +   I +G+ YL  ++ +HRD+   N +++ + +V +ADFGL+K     D  
Sbjct: 109 LPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY 168

Query: 134 ---KSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFR 189
              +  K    W+A E +  +   Y   +D+WS G T+ E+ TR + PY  +E  +    
Sbjct: 169 RQGRIAKMPVKWIAIESLADRV--YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY 226

Query: 190 IGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
           + +G     P          +  C  +NP DRP+   L  
Sbjct: 227 LRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC 266

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 73.0 bits (179), Expect = 4e-15
 Identities = 62/239 (25%), Positives = 106/239 (44%), Gaps = 37/239 (15%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-------- 79
           +E+ +LS+ +  NI++ LG   DE+ L +  E +  G L      +HL D +        
Sbjct: 68  KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127

Query: 80  ------VSSYTR------QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA 127
                   SY+       QI +G+ YL   N VHRD+   N LV  + ++K+ADFG+++ 
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRN 187

Query: 128 TTMNDLKSCKGTPF----WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT--RRPPYSHL 181
               D    +G       WMA E +      +   +D+W+ G T+ E+L   +  PY  L
Sbjct: 188 LYAGDYYRIQGRAVLPIRWMAWECILMGK--FTTASDVWAFGVTLWEILMLCKEQPYGEL 245

Query: 182 ------EGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
                 E     FR  G+      P    +   + +L+C   +  +RP+ +++  H F+
Sbjct: 246 TDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI--HAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 73.1 bits (179), Expect = 6e-15
 Identities = 64/286 (22%), Positives = 121/286 (42%), Gaps = 59/286 (20%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
              +A+K  +L+ +    +  +  ++ E  +L++ + + +V+   + +D++ LY  ++ +
Sbjct: 26  HALYAMK--TLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83

Query: 62  TKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
             G + +L  +  +    ++  Y  ++   +  +H+   +HRDIK  NIL+D  G +KL 
Sbjct: 84  PGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLT 143

Query: 121 DFGLA------------------KATTM------NDLKSCK------------------- 137
           DFGL                   +  +M      +D+ +C+                   
Sbjct: 144 DFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRC 203

Query: 138 ------GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIG 191
                 GTP ++APEV+  K  GY    D WS+G  + EML  +PP+      +   ++ 
Sbjct: 204 LAHSLVGTPNYIAPEVLLRK--GYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVI 261

Query: 192 KGE-LPSVPSS--LSRDARDFILK--CLQVNPNDRPTVTELMEHPF 232
             E    +P    LS +A D I K  C       R    ++  HPF
Sbjct: 262 NWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 71.7 bits (176), Expect = 7e-15
 Identities = 44/149 (29%), Positives = 73/149 (48%), Gaps = 9/149 (6%)

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDLKSCKGT 139
           Q+  G+ YL  +  VHRD+   N ++D S +VK+ADFGLA+        ++++    K  
Sbjct: 106 QVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165

Query: 140 PFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSV 198
             WMA E + ++   +   +D+WS G  + E++TR  PPY  ++       + +G     
Sbjct: 166 VKWMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ 223

Query: 199 PSSLSRDARDFILKCLQVNPNDRPTVTEL 227
           P        + +L C    P  RPT +EL
Sbjct: 224 PEYCPDPLYEVMLSCWHPKPEMRPTFSEL 252

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 72.7 bits (178), Expect = 8e-15
 Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 14/166 (8%)

Query: 75  LSDSQVSSY------TRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT 128
           +++S   SY      + Q+ NG+ +L  +N VHRD+   N+L+     VK+ DFGLA+  
Sbjct: 230 INESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDI 289

Query: 129 TMNDLKSCKGTPF----WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEG 183
             +     KG+ F    WMAPE +   N+ Y   +D+WS G  + E+ T    PY  L  
Sbjct: 290 MRDSNYISKGSTFLPLKWMAPESIF--NNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347

Query: 184 VQALFR-IGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
            +  +  I +G   + P+  S +  + + KC +     RP  ++L+
Sbjct: 348 NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 72.4 bits (177), Expect = 9e-15
 Identities = 67/263 (25%), Positives = 106/263 (40%), Gaps = 70/263 (26%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRL------YIFLELVTKGSLANLYQ--KYHLSDSQ 79
           +E+ L+      NI+  L     +  L      YI +EL+     ANL Q  +  L   +
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHER 127

Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT 139
           +S    Q+L G+ +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GT 178

Query: 140 PFWMAPEVVNSK--------NDGYGLTADIWSLGCTVLEMLTRR---------------- 175
            F M P VV             GY    DIWS+GC + EM+                   
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238

Query: 176 -----PPYSHLEGVQALFRIGKGELPS---------VPSSL-----------SRDARDFI 210
                P    ++ +Q   R      P           P  L           +  ARD +
Sbjct: 239 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298

Query: 211 LKCLQVNPNDRPTVTELMEHPFV 233
            K L ++ + R +V E ++HP++
Sbjct: 299 SKMLVIDASKRISVDEALQHPYI 321

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 71.5 bits (175), Expect = 9e-15
 Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 22/214 (10%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH---LSDSQVSSYTR 85
           E S++ QF   NI++  G         I  E +  G+L + Y + H    S  Q+    R
Sbjct: 56  EASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLR 114

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT-----P 140
            I  G+ YL + N VHRD+   NILV+++   K++DFGL++    +D +    T     P
Sbjct: 115 GIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTTSGGKIP 173

Query: 141 F-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKG-ELPS 197
             W APE +  +   +   +D+WS G  + E+++    PY  +   + +  I  G  LP+
Sbjct: 174 IRWTAPEAIAYRK--FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA 231

Query: 198 ---VPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
               PS++ +     +L+C Q +   RP   +++
Sbjct: 232 PMDCPSAVYQ----LMLQCWQQDRARRPRFVDIV 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 70.5 bits (172), Expect = 3e-14
 Identities = 56/173 (32%), Positives = 84/173 (48%), Gaps = 25/173 (14%)

Query: 28  QEISLLSQFEQDNIVQ-------------YLGTDKDENRLYIFLELVTKGSLANLYQKYH 74
           +EI+LL + +  N++              +L  D  E+ L+  ++   + S AN  +   
Sbjct: 47  REIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKF-HRASKAN-KKPMQ 104

Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS----GSVKLADFGLAK---- 126
           L  S V S   QIL+G+ YLH   V+HRD+K ANILV       G VK+AD G A+    
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Query: 127 -ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY 178
               + DL     T ++ APE++      Y    DIW++GC   E+LT  P +
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARH-YTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 69.8 bits (171), Expect = 4e-14
 Identities = 65/262 (24%), Positives = 112/262 (42%), Gaps = 34/262 (12%)

Query: 1   DGFFFAVKEVSL-QDQGAQGKQSILQLE-------------QEISLLSQFEQDNIVQYLG 46
           +G F +V E  L QD G+Q K ++  ++              E + +  F+  N+++ +G
Sbjct: 9   EGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIG 68

Query: 47  ---TDKDENRL---YIFLELVTKGSLAN--LY-----QKYHLSDSQVSSYTRQILNGLVY 93
                    ++    + L  +  G L +  LY         L    +  +   I  G+ Y
Sbjct: 69  VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEY 128

Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCKGTPFWMAPEVVN 149
           L  RN +HRD+   N ++    +V +ADFGL+K     D     +  K    W+A E + 
Sbjct: 129 LSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL- 187

Query: 150 SKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARD 208
             +  Y   +D+W+ G T+ E+ TR + PY  +E  +    +  G     P     +  D
Sbjct: 188 -ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYD 246

Query: 209 FILKCLQVNPNDRPTVTELMEH 230
            +  C + +P DRPT T+L E 
Sbjct: 247 LMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 69.6 bits (170), Expect = 4e-14
 Identities = 54/223 (24%), Positives = 103/223 (46%), Gaps = 20/223 (8%)

Query: 23  ILQLEQEISLLSQFEQDNIVQYLGTD---KDENRLYI---FLELVTKGSLANLY------ 70
           I +  +E + + +F+  N+++ +G     + + RL I    L  +  G L          
Sbjct: 45  IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIG 104

Query: 71  -QKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT 129
            + + L    +  +   I +G+ YL  +N +HRD+   N +++ + +V +ADFGL+K   
Sbjct: 105 EEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIY 164

Query: 130 MNDL--KSC--KGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGV 184
             D   + C  K    W+A E +   ++ Y   +D+W+ G T+ E++TR + PY+ +E  
Sbjct: 165 SGDYYRQGCASKLPVKWLALESL--ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS 222

Query: 185 QALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
           +    + KG     P     D  + + +C    P  RP+   L
Sbjct: 223 EIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHL 265

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 70.8 bits (173), Expect = 4e-14
 Identities = 59/219 (26%), Positives = 83/219 (37%), Gaps = 18/219 (8%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQIL 88
           E  +L      +I+Q  GT        + L          L  K +++   + +  R +L
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVL 192

Query: 89  NGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA---KATTMNDLKSCKGTPFWMAP 145
             + YLHE  ++HRDIK  NI ++  G V L DFG A        N      GT    AP
Sbjct: 193 RAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAP 252

Query: 146 EVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQA-----------LFRIG--K 192
           E++    D YG   DIWS G  + EM T        +G+             + R G   
Sbjct: 253 ELL--ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP 310

Query: 193 GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP 231
            E P    +   +    + K     P  RP  T L E P
Sbjct: 311 NEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELP 349

Length = 391

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 69.3 bits (169), Expect = 8e-14
 Identities = 55/173 (31%), Positives = 83/173 (47%), Gaps = 25/173 (14%)

Query: 28  QEISLLSQFEQDNIVQ-------------YLGTDKDENRLYIFLELVTKGSLANLYQKYH 74
           +EI+LL + +  N++              +L  D  E+ L+  ++   + S AN  +   
Sbjct: 47  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKF-HRASKAN-KKPVQ 104

Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS----GSVKLADFGLAK---- 126
           L    V S   QIL+G+ YLH   V+HRD+K ANILV       G VK+AD G A+    
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Query: 127 -ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY 178
               + DL     T ++ APE++      Y    DIW++GC   E+LT  P +
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARH-YTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 68.4 bits (167), Expect = 1e-13
 Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 24/216 (11%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQ 86
           E S++ QF+  NI+   G       + I  E +  G+L +  ++     +  Q+    R 
Sbjct: 55  EASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRG 114

Query: 87  ILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAK----ATTMNDLKSCKGTPF- 141
           I  G+ YL E N VHRD+   NILV+++   K++DFGL++     T+     S  G    
Sbjct: 115 IAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIP 174

Query: 142 --WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT--RRPPY--SHLEGVQAL---FRIGK 192
             W APE +  +   +   +D+WS G  + E+++   RP +  S+ + + A+   +R+  
Sbjct: 175 IRWTAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP 232

Query: 193 GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
                 P++L +     +L C Q + N RP   +++
Sbjct: 233 P--MDCPTALHQ----LMLDCWQKDRNARPKFGQIV 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 69.2 bits (169), Expect = 1e-13
 Identities = 61/268 (22%), Positives = 104/268 (38%), Gaps = 60/268 (22%)

Query: 26  LEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH---LSDSQVSS 82
           L+ E+ L   F   NI+         + L++    +  GS  +L + Y    +S++ + +
Sbjct: 46  LQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGN 105

Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF- 141
                L GL YLH+   +HR+IK ++IL+   G V L+      +   N  K+     F 
Sbjct: 106 ILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFP 165

Query: 142 --------WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG 193
                   W++PE++     GY + +DI+S+G T  E+ T R P+  +   Q L +  KG
Sbjct: 166 QFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKG 225

Query: 194 -----------------------------------------------ELPSVPSSLSRDA 206
                                                            PS   + S   
Sbjct: 226 PPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPS-SKTFSPAF 284

Query: 207 RDFILKCLQVNPNDRPTVTELMEHPFVK 234
           ++ +  CLQ +P  RP+ + L+ H F K
Sbjct: 285 QNLVELCLQQDPEKRPSASSLLSHAFFK 312

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 69.3 bits (169), Expect = 1e-13
 Identities = 47/150 (31%), Positives = 75/150 (50%), Gaps = 11/150 (7%)

Query: 51  ENRLYIFLELVTK--GSLANLYQKYHLSDSQ------VSSYTRQILNGLVYLHERNVVHR 102
           +N   IFL +V +      + Y K++  ++       V  Y+ Q+   L Y+H + + HR
Sbjct: 135 KNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHR 194

Query: 103 DIKCANILVDA-SGSVKLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTAD 160
           D+K  N+L+D  + ++KL DFG AK         S   + F+ APE++    + Y    D
Sbjct: 195 DLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATN-YTTHID 253

Query: 161 IWSLGCTVLEMLTRRPPYSHLEGVQALFRI 190
           +WSLGC + EM+   P +S    V  L RI
Sbjct: 254 LWSLGCIIAEMILGYPIFSGQSSVDQLVRI 283

Length = 440

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 66.8 bits (163), Expect = 3e-13
 Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 26/205 (12%)

Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERN 98
           N+V        E+ +++ L+    G L +   K+ ++ +  V  +  +++  L  LH   
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREG 105

Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTP---FWMAPEV--VNSKND 153
           +V RD+   NIL+D  G ++L  F            SC G      + APEV  ++ + +
Sbjct: 106 IVCRDLNPNNILLDDRGHIQLTYFSRWSEVE----DSCDGEAVENMYCAPEVGGISEETE 161

Query: 154 GYGLTADIWSLGCTVLEMLTRRP-PYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
                 D WSLG  + E+LT +     H  G+     +      ++P  +S +AR  + +
Sbjct: 162 A----CDWWSLGAILFELLTGKTLVECHPSGINTHTTL------NIPEWVSEEARSLLQQ 211

Query: 213 CLQVNPNDR-----PTVTELMEHPF 232
            LQ NP +R       V ++  HPF
Sbjct: 212 LLQFNPTERLGAGVAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 66.9 bits (163), Expect = 4e-13
 Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 21/224 (9%)

Query: 16  GAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-- 73
           G   KQ    L  E   L QF+  NIV+  G     N + I  E ++ G+L +  +K+  
Sbjct: 44  GCSDKQRRGFL-AEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG 102

Query: 74  HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA---KATTM 130
            L   Q+      + +G+ YL E   VH+ +    +LV++    K++ F      K+  +
Sbjct: 103 QLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI 162

Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT--RRPPY--SHLEGVQA 186
               S K    W APE +   +  +   +D+WS G  + E+++   RP +  S  + ++A
Sbjct: 163 YTTMSGKSPVLWAAPEAIQYHH--FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA 220

Query: 187 L---FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
           +   FR     LP+ P +        +L C Q    +RP  +++
Sbjct: 221 VEDGFR-----LPA-PRNCPNLLHQLMLDCWQKERGERPRFSQI 258

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 66.8 bits (163), Expect = 8e-13
 Identities = 36/105 (34%), Positives = 52/105 (49%), Gaps = 16/105 (15%)

Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK 134
           L  +QV++  RQ+L+ + Y+H   ++HRDIK  N+LV+    + L DFG A        +
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFA-----R 311

Query: 135 SCKGTPFWM---------APEVVNSKNDGYGLTADIWSLGCTVLE 170
               TPF           APEV+    D Y  + DIWS G  + E
Sbjct: 312 GSWSTPFHYGIAGTVDTNAPEVL--AGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 49/172 (28%), Positives = 75/172 (43%), Gaps = 35/172 (20%)

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDLKSCK------ 137
           +I   + Y+H + V+HRD+K  NIL+   G V + D+G A    +   DL          
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 138 ------------GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQ 185
                       GTP +MAPE           + DI++LG  + +MLT   PY   +G +
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPE--RLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238

Query: 186 ALFRIGKGELPS-------VPSSLSRDARDFILKCLQVNPNDR-PTVTELME 229
             +R      P        +P  LS+ A    +K L V+P +R  +V EL +
Sbjct: 239 ISYR-DVILSPIEVAPYREIPPFLSQIA----MKALAVDPAERYSSVQELKQ 285

Length = 932

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 64.4 bits (157), Expect = 3e-12
 Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 14/181 (7%)

Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           L +FL    +  L        LS  Q+     QI  G+ YLH+R V+H+DI   N ++D 
Sbjct: 96  LKLFL---QQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDE 152

Query: 114 SGSVKLADFGLAKATTMNDLKSCKGT----PF-WMAPE-VVNSKNDGYGLTADIWSLGCT 167
              VK+ D  L++     D   C G     P  WMA E +VN +   Y   +D+WS G  
Sbjct: 153 ELQVKITDNALSRDLFPMDY-HCLGDNENRPVKWMALESLVNKE---YSSASDVWSFGVL 208

Query: 168 VLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTE 226
           + E++T  + PY  ++  +    +  G   + P +   +    +  C  ++P +RP+ ++
Sbjct: 209 LWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQ 268

Query: 227 L 227
           L
Sbjct: 269 L 269

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 65.1 bits (158), Expect = 3e-12
 Identities = 49/170 (28%), Positives = 81/170 (47%), Gaps = 22/170 (12%)

Query: 19  GKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLY-----QKY 73
           G ++ +QLE EI  L +   +NI++     + E   Y    ++T+    +LY     + +
Sbjct: 203 GSRAAIQLENEILALGRLNHENILKIEEILRSEANTY----MITQKYDFDLYSFMYDEAF 258

Query: 74  HLSDSQVSSYTRQILNGLV----YLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT 129
              D  +   TR I+  L+    Y+H++ ++HRDIK  NI ++  G + L DFG   A  
Sbjct: 259 DWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG--TAMP 316

Query: 130 MNDLKSCK-----GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR 174
               +        GT    +PE++    DGY    DIWS G  +L+ML+ 
Sbjct: 317 FEKEREAFDYGWVGTVATNSPEIL--AGDGYCEITDIWSCGLILLDMLSH 364

Length = 501

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 65.6 bits (160), Expect = 3e-12
 Identities = 43/179 (24%), Positives = 76/179 (42%), Gaps = 16/179 (8%)

Query: 12  LQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE-NRLYIFLELVTKGSLANLY 70
           L+    + +    +  +E +L ++    NIV  L + +     L+   E V   +L  + 
Sbjct: 11  LRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL 70

Query: 71  Q-KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG---SVKLADFGL-- 124
                L   +      Q+L+ L   H + +VHRD+K  NI+V  +G     K+ DFG+  
Sbjct: 71  AADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGT 130

Query: 125 -------AKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP 176
                  A   T+       GTP + APE +  + +     +D+++ G   LE LT + 
Sbjct: 131 LLPGVRDADVATLTRTTEVLGTPTYCAPEQL--RGEPVTPNSDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 62.8 bits (153), Expect = 3e-12
 Identities = 44/186 (23%), Positives = 69/186 (37%), Gaps = 28/186 (15%)

Query: 64  GSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLAD 121
            SLA++ +     L++ ++ +   Q L  L  LH +      +   + L+   GSV    
Sbjct: 1   VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKLDGSV---- 56

Query: 122 FGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSH- 180
               K    +        P++MAPEV   +   Y   ADI+SLG T+ E L    PY+  
Sbjct: 57  --AFKTPEQSR-----PDPYFMAPEV--IQGQSYTEKADIYSLGITLYEALDYELPYNEE 107

Query: 181 ----------LEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
                     L G+ A     +  L  V ++ S    DF+  C    P  R      + H
Sbjct: 108 RELSAILEILLNGMPADDPRDRSNLEGVSAARS--FEDFMRLCASRLPQRREAANHYLAH 165

Query: 231 PFVKRP 236
                 
Sbjct: 166 CRALFA 171

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 63.5 bits (154), Expect = 7e-12
 Identities = 55/225 (24%), Positives = 87/225 (38%), Gaps = 25/225 (11%)

Query: 21  QSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQ 79
           Q   + +QE SL+++    NIV  LG    E  + +  E + +G L   L  +   SD  
Sbjct: 49  QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVG 108

Query: 80  VSS-----------------YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADF 122
            SS                    QI  G+ YL     VH+D+   NIL+     VK++D 
Sbjct: 109 CSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDL 168

Query: 123 GLAKATTMNDLKSCKGTPF----WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPP 177
           GL++     D    +        WM PE +      +   +DIWS G  + E+ +    P
Sbjct: 169 GLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK--FSSDSDIWSFGVVLWEIFSFGLQP 226

Query: 178 YSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP 222
           Y      + +  + K +L              + +C Q  P+ RP
Sbjct: 227 YYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 63.2 bits (154), Expect = 9e-12
 Identities = 57/225 (25%), Positives = 86/225 (38%), Gaps = 24/225 (10%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTR- 85
           QE  L+S  +  NIV  LG    E    +  E +  G L   L +    SD    S    
Sbjct: 57  QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116

Query: 86  ---------------QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM 130
                          QI  G+ YL   + VHRD+   N LV    +VK++DFGL++    
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYS 176

Query: 131 ND---LKSCKGTPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQ 185
            D   ++S    P  WM PE +      +   +DIWS G  + E+ +    PY      +
Sbjct: 177 ADYYRVQSKSLLPVRWMPPEAILYGK--FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE 234

Query: 186 ALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
            +  I   +L   P          +++C    P  RP   ++   
Sbjct: 235 VIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 61.4 bits (149), Expect = 5e-11
 Identities = 45/155 (29%), Positives = 76/155 (49%), Gaps = 14/155 (9%)

Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCK 137
            ++ Q+  G+ +L  +N +HRD+   N+L+      K+ DFGLA+   MND    +K   
Sbjct: 216 RFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-DIMNDSNYVVKGNA 274

Query: 138 GTPF-WMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALF--RIGK 192
             P  WMAPE   S  D  Y + +D+WS G  + E+ +  + PY  +  V + F   + +
Sbjct: 275 RLPVKWMAPE---SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI-LVNSKFYKMVKR 330

Query: 193 GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
           G   S P     +    +  C  + P +RPT +++
Sbjct: 331 GYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 60.3 bits (146), Expect = 1e-10
 Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 10/155 (6%)

Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT-- 139
           S++ Q+  G+ +L  +N +HRD+   NIL+      K+ DFGLA+    +     KG   
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNAR 277

Query: 140 -PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALF--RIGKGE 194
            P  WMAPE +   N  Y   +D+WS G  + E+ +    PY  +  V + F   I +G 
Sbjct: 278 LPVKWMAPESIF--NCVYTFESDVWSYGILLWEIFSLGSSPYPGMP-VDSKFYKMIKEGY 334

Query: 195 LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
               P     +  D +  C   +P  RPT  ++++
Sbjct: 335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 59.2 bits (143), Expect = 2e-10
 Identities = 59/242 (24%), Positives = 101/242 (41%), Gaps = 26/242 (10%)

Query: 7   VKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSL 66
           VKE+    + +   Q  ++  +E       +  N++Q LG   +     + +E    G L
Sbjct: 27  VKEL----RVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDL 82

Query: 67  ANLYQKYHLSDSQVSSYTR------QILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
               +    ++      T       +I  GL++LH+ N +H D+   N L+ A  +VK+ 
Sbjct: 83  KGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIG 142

Query: 121 DFGLAKATTMNDL---KSCKGTPF-WMAPEVVNSKNDGYGLTAD------IWSLGCTVLE 170
           D+GL+      D          P  W+APE+V+  + G  L  D      +WSLG T+ E
Sbjct: 143 DYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH-GNLLVVDQTKESNVWSLGVTIWE 201

Query: 171 MLT-RRPPYSHLEGVQAL-FRIGKGELPSVPSSLSRDARDFILKCLQ---VNPNDRPTVT 225
           +      PY HL   Q L + + + +L      L     D   + +Q   + P  RP+  
Sbjct: 202 LFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCWLQPEQRPSAE 261

Query: 226 EL 227
           E+
Sbjct: 262 EV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 59.5 bits (144), Expect = 3e-10
 Identities = 40/132 (30%), Positives = 66/132 (50%), Gaps = 7/132 (5%)

Query: 5   FAVKEVSLQDQGAQGKQSILQLEQEISLLS--QFEQDNIVQYLGTDKDENRLYIFLELVT 62
           +AVK V   D   +     +Q E++   LS   F    IV    + +  N +Y+ +E + 
Sbjct: 32  YAVKVVKKADMINKNMVHQVQAERDALALSKSPF----IVHLYYSLQSANNVYLVMEYLI 87

Query: 63  KGSLANLYQKYHLSDSQVS-SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLAD 121
            G + +L   Y   D +++  Y  ++   L YLH   ++HRD+K  N+L+   G +KL D
Sbjct: 88  GGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTD 147

Query: 122 FGLAKATTMNDL 133
           FGL+K T   +L
Sbjct: 148 FGLSKVTLNREL 159

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 56.8 bits (137), Expect = 1e-09
 Identities = 47/183 (25%), Positives = 86/183 (46%), Gaps = 21/183 (11%)

Query: 63  KGSLANLYQKYHLSDSQVSSYTR---QILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
           K  L+   +++H  +SQ+    R   +I  G+ ++H+ N +H D+   N  + +  +VK+
Sbjct: 83  KSYLSQ--EQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKV 140

Query: 120 ADFGLAKATTMNDL---KSCKGTPF-WMAPEVVNSKNDGYGLTAD------IWSLGCTVL 169
            D+G+  +    D    +  K  P  W+APE+V   + G  +TA+      +W+LG T+ 
Sbjct: 141 GDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGL-ITAEQTKPSNVWALGVTLW 199

Query: 170 EML-TRRPPYSHLEGVQALFRIGKGELPSVPS-SLSRDARDFILKCLQ---VNPNDRPTV 224
           E+      PYSHL   + L  + K +   +    L     +   + LQ   ++P  R T 
Sbjct: 200 ELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWLSPEKRATA 259

Query: 225 TEL 227
            E+
Sbjct: 260 EEV 262

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 56.6 bits (136), Expect = 2e-09
 Identities = 49/220 (22%), Positives = 81/220 (36%), Gaps = 24/220 (10%)

Query: 25  QLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ------------- 71
           + + E  + S+ +  NIV  LG    E  L +     +   L                  
Sbjct: 54  EFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113

Query: 72  ----KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA 127
               K  L  +       QI  G+ +L   +VVH+D+   N+LV    +VK++D GL + 
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFRE 173

Query: 128 TTMNDLKSCKGTPF----WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLE 182
               D     G       WM+PE +      + + +DIWS G  + E+ +    PY    
Sbjct: 174 VYAADYYKLMGNSLLPIRWMSPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYCGYS 231

Query: 183 GVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP 222
               +  I   ++   P          +L+C    P+ RP
Sbjct: 232 NQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 52.2 bits (125), Expect = 4e-08
 Identities = 46/153 (30%), Positives = 71/153 (46%), Gaps = 25/153 (16%)

Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASG-------SVKLADFGLAKATTMNDLKSCK 137
           +Q+ + L YL ++N+VH ++   NIL+   G        +KL+D G++  T ++  +  +
Sbjct: 124 QQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSREERVE 182

Query: 138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM-------LTRRPPYSHLEGVQALFRI 190
             P W+APE V   N      AD WS G T+LE+       L  R P       +  F  
Sbjct: 183 RIP-WIAPECVPGGN-SLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-----KERFYE 235

Query: 191 GKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
            K  LP  PS   ++    I +CL   P  RP+
Sbjct: 236 KKHRLPE-PS--CKELATLISQCLTYEPTQRPS 265

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 51.7 bits (124), Expect = 7e-08
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 24/228 (10%)

Query: 9   EVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG-TDKDENRLYIFLELVTKGSLA 67
            V L+  G+  + S L   +  SL+SQ    ++V+  G   +DEN   +  E V  G L 
Sbjct: 32  SVVLKVLGSDHRDS-LAFFETASLMSQLSHKHLVKLYGVCVRDENI--MVEEYVKFGPLD 88

Query: 68  NLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV-----DASGS--VK 118
                 K ++S        +Q+ + L YL ++ +VH ++   NILV     +      +K
Sbjct: 89  VFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIK 148

Query: 119 LADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT--ADIWSLGCTVLEMLTRRP 176
           L+D G+    T+   +       W+APE +  +N    LT  AD WS G T+LE+ +   
Sbjct: 149 LSDPGI--PITVLSREERVERIPWIAPECI--RNGQASLTIAADKWSFGTTLLEICSNGE 204

Query: 177 -PYSHLEGV-QALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP 222
            P S L    +  F   +  LP +P     +  + I +C   +P  RP
Sbjct: 205 EPLSTLSSSEKERFYQDQHRLP-MPD--CAELANLINQCWTYDPTKRP 249

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 51.3 bits (123), Expect = 9e-08
 Identities = 49/221 (22%), Positives = 94/221 (42%), Gaps = 18/221 (8%)

Query: 20  KQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN----RLYIFLELVTKGSLANLYQKYHL 75
           K  I   E EI  L + + +NI++  G   D      RL + LE  T+G L  +  K   
Sbjct: 59  KVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK--- 115

Query: 76  SDSQVSSYTR-----QILNGLVYLHER-NVVHRDIKCANILVDASGSVKLADFGLAKATT 129
            +  +S  T+         GL  L++  N  ++++   + LV  +  +K+   GL K  +
Sbjct: 116 -EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS 174

Query: 130 MNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHL--EGVQAL 187
               K+      + + +++N     Y +  DI+SLG  + E+ T + P+ +L  + +  L
Sbjct: 175 SPPFKNVN-FMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL 233

Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
                  L  +P     + +  +  C   +   RP + E++
Sbjct: 234 IINKNNSLK-LPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273

Length = 283

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 50.8 bits (121), Expect = 2e-07
 Identities = 23/46 (50%), Positives = 28/46 (60%)

Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA 125
           +    RQ+L GL  LH   +VHRDIK  N+LV   G VK+ DFG A
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 48.3 bits (115), Expect = 1e-06
 Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 6/98 (6%)

Query: 138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR-IGKGEL- 195
           GTP ++APE++  K   +G   D W+LG  + E LT  PP++  E  Q +F+ I   ++ 
Sbjct: 542 GTPDYLAPELLLGK--PHGPAVDWWALGVCLFEFLTGIPPFND-ETPQQVFQNILNRDIP 598

Query: 196 -PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
            P     LS +A++ I   L ++P  R  + EL +HP 
Sbjct: 599 WPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 46.9 bits (111), Expect = 3e-06
 Identities = 45/164 (27%), Positives = 73/164 (44%), Gaps = 31/164 (18%)

Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASG-------SVKLADFGLAKATTMNDLKSCK 137
           +Q+ + L YL ++++VH ++   NIL+   G        +KL+D G+    T+   + C 
Sbjct: 112 KQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI--PITVLSRQECV 169

Query: 138 GTPFWMAPEVV-NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP 196
               W+APE V +SKN    + AD WS G T+ E+                     GE+P
Sbjct: 170 ERIPWIAPECVEDSKN--LSIAADKWSFGTTLWEICY------------------NGEIP 209

Query: 197 SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTP 240
               +L+   R +  +C+ V P     + +LM H     P Q P
Sbjct: 210 LKDKTLAEKERFYEGQCMLVTP-SCKELADLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.4 bits (105), Expect = 3e-05
 Identities = 21/47 (44%), Positives = 27/47 (57%), Gaps = 1/47 (2%)

Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVD-ASGSVKLADFGLA 125
           + +  RQIL  L  LH   +VHRD+K  NI+    SGS K+ D G A
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 41.8 bits (98), Expect = 1e-04
 Identities = 37/150 (24%), Positives = 74/150 (49%), Gaps = 18/150 (12%)

Query: 85  RQILNGLVYLHERNVVHRDIKCANILV-----DASGS---VKLADFGLAKATTMNDLKSC 136
           +Q+   L +L ++ + H ++   N+L+       +G+   +KL+D G++      ++   
Sbjct: 107 KQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLE 166

Query: 137 KGTPFWMAPEVV-NSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQAL-FRIGKG 193
           +  P W+ PE + N +N    L AD WS G T+ E+ +    P S L+  + L F   + 
Sbjct: 167 R-IP-WVPPECIENPQN--LSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRH 222

Query: 194 ELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           +LP+   +   +  + I +C+   P+ RP+
Sbjct: 223 QLPAPKWT---ELANLINQCMDYEPDFRPS 249

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 39.9 bits (93), Expect = 5e-04
 Identities = 26/120 (21%), Positives = 49/120 (40%), Gaps = 7/120 (5%)

Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCK 137
           + +  + +L  L Y+HE  + H DIK  NI+VD +    + D+G+A    ++   ++  K
Sbjct: 128 IKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSK 187

Query: 138 GTPFWMAPEVVNSKNDGYGLT-----ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
                    +  +  D +         D+ SLG  +L+    + P+        L    K
Sbjct: 188 EQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247

Length = 294

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 40.3 bits (94), Expect = 5e-04
 Identities = 52/214 (24%), Positives = 80/214 (37%), Gaps = 65/214 (30%)

Query: 91  LVYLH-ERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-------DLKSC------ 136
           L Y H E +++H D+K  NIL++ S +V   D    +A   +       DL  C      
Sbjct: 244 LDYFHTELHLMHTDLKPENILMETSDTV--VDPVTNRALPPDPCRVRICDLGGCCDERHS 301

Query: 137 ----KGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
                 T  + +PEVV     G+  + D+WS+GC + E+ T +  Y   + ++ L  + K
Sbjct: 302 RTAIVSTRHYRSPEVVLGL--GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359

Query: 193 --GELPSV-------------------------PSSLSRDAR--------------DFIL 211
             G LPS                          P  L+R AR              D I 
Sbjct: 360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIY 419

Query: 212 KCLQVNPNDRPTVTELMEHPFVKRPLQTPRCGQA 245
             L  +   R    ++  HP+V +    P C Q 
Sbjct: 420 GLLHYDRQKRLNARQMTTHPYVLK--YYPECRQH 451

Length = 467

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	247
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
PLN00181	793	protein SPA1-RELATED; Provisional	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.98
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.91
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.9
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.86
PRK09188	365	serine/threonine protein kinase; Provisional	99.86
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.85
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.84
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
PRK10345	210	hypothetical protein; Provisional	99.78
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.75
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.75
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.72
PRK14879	211	serine/threonine protein kinase; Provisional	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.72
smart00090	237	RIO RIO-like kinase.	99.72
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.71
KOG1243	690	consensus Protein kinase [General function predict	99.68
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.68
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.65
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.64
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.56
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.55
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.54
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.53
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.49
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.44
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.37
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.36
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.36
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.34
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.34
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.32
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.29
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.26
KOG3087	229	consensus Serine/threonine protein kinase [General	99.2
COG4248	637	Uncharacterized protein with protein kinase and he	99.16
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.13
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.05
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	99.03
PRK09902	216	hypothetical protein; Provisional	99.02
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.85
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.72
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.52
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.47
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.46
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.35
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.34
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.27
PF01636	239	APH: Phosphotransferase enzyme family This family	98.08
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.96
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.9
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.76
PLN02876	822	acyl-CoA dehydrogenase	97.73
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.61
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.61
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.55
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.52
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.48
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.31
KOG2270	520	consensus Serine/threonine protein kinase involved	97.16
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.16
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.1
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.09
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.06
PRK05231	319	homoserine kinase; Provisional	97.03
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	96.99
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.92
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.81
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.79
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.7
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.66
PRK09550	401	mtnK methylthioribose kinase; Reviewed	96.52
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.44
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.23
PLN02236	344	choline kinase	96.21
PRK11768	325	serine/threonine protein kinase; Provisional	96.09
PRK06148	1013	hypothetical protein; Provisional	96.01
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.93
PLN02756	418	S-methyl-5-thioribose kinase	95.74
PRK10593	297	hypothetical protein; Provisional	95.41
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	95.23
COG4499	434	Predicted membrane protein [Function unknown]	95.19
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.12
PRK10271	188	thiK thiamine kinase; Provisional	94.95
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	94.79
PHA00451	362	protein kinase	94.25

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-55  Score=338.92  Aligned_cols=234  Identities=31%  Similarity=0.585  Sum_probs=213.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC-cEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN-RLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.+|+|++..    .......+++.+|++++++++||+||.++|.|..++ ...++||||++|||+++++.. ++++.
T Consensus       103 t~~i~AlK~I~~----~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~  178 (364)
T KOG0581|consen  103 TGKIYALKVILL----NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEP  178 (364)
T ss_pred             CCeEEEEEeecc----cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHH
Confidence            478899999954    345667788999999999999999999999999998 599999999999999999874 59999


Q ss_pred             HHHHHHHHHHHHHHHhhh-CCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCc
Q 041080           79 QVSSYTRQILNGLVYLHE-RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~-~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      .+..++.+++.||.|||+ ++|+||||||+|++++..|.+||+|||.+............||..|||||.+.+..  |+.
T Consensus       179 ~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~--Ys~  256 (364)
T KOG0581|consen  179 VLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIANTFVGTSAYMSPERISGES--YSV  256 (364)
T ss_pred             HHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhhcccccccccccChhhhcCCc--CCc
Confidence            999999999999999995 89999999999999999999999999999877666778889999999999997765  899


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCC-----hhhHHHHHhhcCCCCCCCCc-CCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHL-----EGVQALFRIGKGELPSVPSS-LSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                      ++||||||..++|+++|+.||...     ...++...+..+..|.+|.. +|++++.||..||++||.+|||+.|+++||
T Consensus       257 ~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp  336 (364)
T KOG0581|consen  257 KSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP  336 (364)
T ss_pred             ccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence            999999999999999999998764     66778888999999999987 999999999999999999999999999999


Q ss_pred             cCCCCCCCC
Q 041080          232 FVKRPLQTP  240 (247)
Q Consensus       232 ~~~~~~~~~  240 (247)
                      |+++.....
T Consensus       337 fi~~~~~~~  345 (364)
T KOG0581|consen  337 FIKKFEDPN  345 (364)
T ss_pred             HHhhccccc
Confidence            999765443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-56  Score=344.91  Aligned_cols=236  Identities=32%  Similarity=0.481  Sum_probs=204.4

Q ss_pred             CCceEEEEEEeecCCCccc--hHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQG--KQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~   77 (247)
                      +|+.||||++.+....-.+  ......+++|+++|++|+|||||+++++|...+..|+||||+.||.|.+.+-.. .+.+
T Consensus       196 tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~e  275 (475)
T KOG0615|consen  196 TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLRE  275 (475)
T ss_pred             cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhcccccc
Confidence            5899999999886532211  222334679999999999999999999999999999999999999998877554 4888


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC---CCeEEcccccccccCccc-cccCCCCCCccCCcccccCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS---GSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~---~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      .....+++|++.|+.|||++||+||||||+||+++.+   ..+||+|||++...+... ....+||+.|.|||++.+...
T Consensus       276 d~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~  355 (475)
T KOG0615|consen  276 DLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGV  355 (475)
T ss_pred             chhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCe
Confidence            8899999999999999999999999999999999876   578999999999887544 557889999999999976654


Q ss_pred             CCC-cchhHHHHHHHHHHHHhCCCCCCCChhhH-HHHHhhcCCCCCCC---CcCCHHHHHHHHHHhcCCCCCCCChhhhh
Q 041080          154 GYG-LTADIWSLGCTVLEMLTRRPPYSHLEGVQ-ALFRIGKGELPSVP---SSLSRDARDFILKCLQVNPNDRPTVTELM  228 (247)
Q Consensus       154 ~~~-~~~Di~slG~ll~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il  228 (247)
                      .+. .+.|+||+||++|-+++|.+||.+..... ...++..+.....|   ..++++..++|.+||..||++|||++++|
T Consensus       356 ~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL  435 (475)
T KOG0615|consen  356 EYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEAL  435 (475)
T ss_pred             ecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHh
Confidence            444 48999999999999999999998887777 77888888776554   57899999999999999999999999999


Q ss_pred             cCccCCCC
Q 041080          229 EHPFVKRP  236 (247)
Q Consensus       229 ~~p~~~~~  236 (247)
                      +||||+.+
T Consensus       436 ~hpW~~~~  443 (475)
T KOG0615|consen  436 NHPWFKDA  443 (475)
T ss_pred             cChhhhcc
Confidence            99999964

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-53  Score=345.08  Aligned_cols=231  Identities=36%  Similarity=0.628  Sum_probs=209.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-CCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~   79 (247)
                      .|+.||+|++.+...  ......+.+.+||++.++|+|||||+++++|++.+..|+|.|.|..++|..++++++ +++.+
T Consensus        42 tge~~A~KvVpk~~l--~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpE  119 (592)
T KOG0575|consen   42 TGEVVAVKVVPKKLL--KKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPE  119 (592)
T ss_pred             CCcEEEEEEeehHHh--cCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHH
Confidence            488999999987653  345567789999999999999999999999999999999999999999999998654 99999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      ++.++.||+.||.|||++||+|||||..|++++.+.++||+|||+|......  .....+||+-|.|||++....  .+.
T Consensus       120 ary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~g--Hsf  197 (592)
T KOG0575|consen  120 ARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSG--HSF  197 (592)
T ss_pred             HHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCC--CCC
Confidence            9999999999999999999999999999999999999999999999876644  344677999999999997444  789


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      .+||||+||+||.|+.|++||+..+-.+.+..+..... ..|..++.+.++||.+||+++|.+|||++++|.|+||+..
T Consensus       198 EvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y-~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g  275 (592)
T KOG0575|consen  198 EVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY-SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG  275 (592)
T ss_pred             chhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc-ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence            99999999999999999999999999999988887665 5677999999999999999999999999999999999553

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-51  Score=316.44  Aligned_cols=232  Identities=33%  Similarity=0.554  Sum_probs=211.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++++......  ...+...+|.++|.+++||.||+++..|++++.+|+|+||++||.|...+++. .+++..
T Consensus        49 t~kiYAmKvl~K~~iv~~--~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~  126 (357)
T KOG0598|consen   49 TGKIYAMKVLKKKKIVEK--KEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDR  126 (357)
T ss_pred             cCceeehhhhhhhHhhhh--hhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchhH
Confidence            478999999988765433  56778889999999999999999999999999999999999999999999854 599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      +..++..|+.||.|||++||+||||||+||+++.+|.++|+|||++...-..  .....+||+.|+|||++.+..  ++.
T Consensus       127 arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~g--y~~  204 (357)
T KOG0598|consen  127 ARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKG--YDK  204 (357)
T ss_pred             HHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCC--CCc
Confidence            9999999999999999999999999999999999999999999999744333  445678999999999997664  899


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC----ChhhhhcCccC
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP----TVTELMEHPFV  233 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----s~~~il~~p~~  233 (247)
                      ++|+||||+++|+|++|..||...+.....+.+...+.+..+..++.+.+++++++|..+|.+|.    ++++|-+||||
T Consensus       205 ~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF  284 (357)
T KOG0598|consen  205 AVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFF  284 (357)
T ss_pred             ccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccc
Confidence            99999999999999999999999999999999999987788888999999999999999999995    78999999999


Q ss_pred             CCC
Q 041080          234 KRP  236 (247)
Q Consensus       234 ~~~  236 (247)
                      +.+
T Consensus       285 ~~i  287 (357)
T KOG0598|consen  285 KGI  287 (357)
T ss_pred             ccC
Confidence            875

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-49  Score=319.70  Aligned_cols=234  Identities=33%  Similarity=0.564  Sum_probs=204.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~   78 (247)
                      +|..||+|++.............+.+.+|+.+++.++ ||||+++++++.....+++||||+.||.|.+.+.+ .++.+.
T Consensus        41 t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~  120 (370)
T KOG0583|consen   41 TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKED  120 (370)
T ss_pred             CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChH
Confidence            3688999977654332122344666779999999998 99999999999999999999999999999998877 569999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC-CCeEEccccccccc--CccccccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFGLAKAT--TMNDLKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~-~~~~l~df~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .+..++.|+++|++|||++||+||||||+|++++.+ +++||+|||++...  .........|++.|+|||++.+.....
T Consensus       121 ~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~  200 (370)
T KOG0583|consen  121 EARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYS  200 (370)
T ss_pred             HHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcC
Confidence            999999999999999999999999999999999999 99999999999876  334566788999999999998765324


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcC-CHHHHHHHHHHhcCCCCCCCChhhhhcCccCC
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSL-SRDARDFILKCLQVNPNDRPTVTELMEHPFVK  234 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~  234 (247)
                      +.++||||+|+++|.|++|..||++.........+..+.. .+|..+ +.+++.++.+||..+|.+|+|+.+|++||||+
T Consensus       201 g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~-~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~  279 (370)
T KOG0583|consen  201 GKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF-KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQ  279 (370)
T ss_pred             CchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc-cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhc
Confidence            7899999999999999999999999777777777666544 566677 99999999999999999999999999999999


Q ss_pred             C
Q 041080          235 R  235 (247)
Q Consensus       235 ~  235 (247)
                      .
T Consensus       280 ~  280 (370)
T KOG0583|consen  280 K  280 (370)
T ss_pred             c
Confidence            7

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-49  Score=296.12  Aligned_cols=230  Identities=32%  Similarity=0.548  Sum_probs=209.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|..||+|++.+....  .-...+...+|..+|+.+.||.++++++.+.+.+.+++||||.+||.|.+++.+. ++++..
T Consensus        68 ~g~yYAmKvL~k~~vV--klKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~  145 (355)
T KOG0616|consen   68 SGNYYAMKVLDKQKVV--KLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPH  145 (355)
T ss_pred             CCceeehhhcCHHHHH--HHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchh
Confidence            4789999999876543  2344667788999999999999999999999999999999999999999999775 599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcch
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTA  159 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~  159 (247)
                      ++.+++|++.|++|||+.+|++||+||+||++|.+|.++|+|||.+...... ....+||+.|+|||.+....  ++.++
T Consensus       146 arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-T~TlCGTPeYLAPEii~sk~--ynkav  222 (355)
T KOG0616|consen  146 ARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-TWTLCGTPEYLAPEIIQSKG--YNKAV  222 (355)
T ss_pred             HHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-EEEecCCccccChHHhhcCC--CCcch
Confidence            9999999999999999999999999999999999999999999999876655 67788999999999997766  89999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCC-----CChhhhhcCccCC
Q 041080          160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR-----PTVTELMEHPFVK  234 (247)
Q Consensus       160 Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R-----ps~~~il~~p~~~  234 (247)
                      |.|+||+++|||+.|.+||.+......+.++..+.. .+|..++.++++|++.+|+.|-.+|     ...++|.+||||+
T Consensus       223 DWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v-~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~  301 (355)
T KOG0616|consen  223 DWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV-KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFK  301 (355)
T ss_pred             hHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc-cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccc
Confidence            999999999999999999999999999999988875 7789999999999999999999999     4578999999998


Q ss_pred             CC
Q 041080          235 RP  236 (247)
Q Consensus       235 ~~  236 (247)
                      ..
T Consensus       302 ~v  303 (355)
T KOG0616|consen  302 GV  303 (355)
T ss_pred             cc
Confidence            63

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-48  Score=306.47  Aligned_cols=231  Identities=32%  Similarity=0.625  Sum_probs=203.1

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSDS   78 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~   78 (247)
                      |..||||++..+.    .....+.+++|+..++.++||||++++..|..+..+++||.||.+||+.++++..   ++++.
T Consensus        51 ~e~VAIK~inLEk----c~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~  126 (516)
T KOG0582|consen   51 NEVVAIKIINLEK----CNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEA  126 (516)
T ss_pred             CCEEEEEEeehhh----hhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHH
Confidence            5789999998753    3445788999999999999999999999999999999999999999999999864   69999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc------cccCCCCCCccCCcccccCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND------LKSCKGTPFWMAPEVVNSKN  152 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~aPE~~~~~~  152 (247)
                      .+..++.+++.||.|||++|.+|||||+.||+++.+|.++|+|||.+.......      .....|+++|+|||.+....
T Consensus       127 ~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~  206 (516)
T KOG0582|consen  127 SIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQL  206 (516)
T ss_pred             HHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcc
Confidence            999999999999999999999999999999999999999999999875332221      14557999999999976666


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCC---------CcCCHHHHHHHHHHhcCCCCCCCC
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVP---------SSLSRDARDFILKCLQVNPNDRPT  223 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps  223 (247)
                      ..|+.++||||||++..||++|..||......+.+.....+..+...         ..++..++.++..||.+||.+|||
T Consensus       207 ~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRpt  286 (516)
T KOG0582|consen  207 HGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPT  286 (516)
T ss_pred             cCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCC
Confidence            66999999999999999999999999999988887766666554211         346778999999999999999999


Q ss_pred             hhhhhcCccCCCC
Q 041080          224 VTELMEHPFVKRP  236 (247)
Q Consensus       224 ~~~il~~p~~~~~  236 (247)
                      ++++++|+||++.
T Consensus       287 AskLlkh~FFk~~  299 (516)
T KOG0582|consen  287 ASKLLKHAFFKKA  299 (516)
T ss_pred             HHHHhccHHHhhc
Confidence            9999999999975

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-49  Score=316.61  Aligned_cols=231  Identities=32%  Similarity=0.556  Sum_probs=204.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-CCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~   78 (247)
                      .++.||||++.+..+..  +...+-+..|-..|.+| .||+|++++..|++...+|+|+||+++|.|.+++++.+ +++.
T Consensus        97 t~keYAiKVl~K~~Iik--e~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~  174 (604)
T KOG0592|consen   97 TGKEYAIKVLDKRYIIK--EKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDET  174 (604)
T ss_pred             CCceeeHhhhhHHHHHh--hcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCcchHH
Confidence            37889999998765432  22344466788889999 79999999999999999999999999999999999876 9999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-------------c--ccCCCCCCcc
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-------------L--KSCKGTPFWM  143 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-------------~--~~~~~~~~~~  143 (247)
                      ..+.++.+|+.||+|||++||+||||||+|||++.++.++|+|||.+.......             .  ...+||..|.
T Consensus       175 caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYV  254 (604)
T KOG0592|consen  175 CARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYV  254 (604)
T ss_pred             HHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeeccc
Confidence            999999999999999999999999999999999999999999999986443221             1  3467999999


Q ss_pred             CCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC
Q 041080          144 APEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT  223 (247)
Q Consensus       144 aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  223 (247)
                      +||++....  .+..+|+|+|||++|+|+.|.+||......-..+++..... .++.++++.+++||+++|..||.+|+|
T Consensus       255 SPElL~~~~--~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y-~fp~~fp~~a~dLv~KLLv~dp~~Rlt  331 (604)
T KOG0592|consen  255 SPELLNDSP--AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY-EFPEGFPEDARDLIKKLLVRDPSDRLT  331 (604)
T ss_pred             CHHHhcCCC--CCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc-cCCCCCCHHHHHHHHHHHccCcccccc
Confidence            999997655  68899999999999999999999999998888888877655 678899999999999999999999999


Q ss_pred             hhhhhcCccCCCC
Q 041080          224 VTELMEHPFVKRP  236 (247)
Q Consensus       224 ~~~il~~p~~~~~  236 (247)
                      +++|-+||||..+
T Consensus       332 ~~qIk~HpFF~~V  344 (604)
T KOG0592|consen  332 SQQIKAHPFFEGV  344 (604)
T ss_pred             HHHHhhCcccccC
Confidence            9999999999874

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-48  Score=310.34  Aligned_cols=225  Identities=34%  Similarity=0.544  Sum_probs=198.3

Q ss_pred             Cce-EEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC-cEEEEEeccccCcHHHHHHh---cCCC
Q 041080            2 GFF-FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN-RLYIFLELVTKGSLANLYQK---YHLS   76 (247)
Q Consensus         2 g~~-~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~---~~~~   76 (247)
                      |+. ||+|++...+.+..   ..+.|.+|+.+|++++|||||+++|++.+.. .+++||||+++|+|.+++..   ..++
T Consensus        64 g~~~vavK~~~~~~~~~~---~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~  140 (362)
T KOG0192|consen   64 GTDVVAVKIISDPDFDDE---SRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLP  140 (362)
T ss_pred             CceeEEEEEecchhcChH---HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCC
Confidence            566 99999987654322   2888999999999999999999999999887 79999999999999999966   4699


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCC-eeecCCCCCcEEEcCCC-CeEEcccccccccCc--cccccCCCCCCccCCcccccCC
Q 041080           77 DSQVSSYTRQILNGLVYLHERN-VVHRDIKCANILVDASG-SVKLADFGLAKATTM--NDLKSCKGTPFWMAPEVVNSKN  152 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~-i~h~dl~~~ni~~~~~~-~~~l~df~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~  152 (247)
                      ...++.++.||+.|+.|||+.+ |+|+|||++|++++.++ ++||+|||+++....  .......||..|+|||.+.+..
T Consensus       141 ~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~  220 (362)
T KOG0192|consen  141 LKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEK  220 (362)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCC
Confidence            9999999999999999999999 99999999999999998 999999999976654  3344467999999999997433


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhh-cCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIG-KGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ..++.++||||||+++||++||+.||...........+. .+..+.++...++.+..++.+||..+|.+||++.+|+.
T Consensus       221 ~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  221 SPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             CcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            348999999999999999999999999998866665554 55667778889999999999999999999999999976

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-49  Score=321.31  Aligned_cols=232  Identities=30%  Similarity=0.556  Sum_probs=209.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHH-hcCCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~   79 (247)
                      +|+..|||++.+..  +........+++|+.+|+-|.||||+.++++++....+|+|.||++||-|.+++- +.++++.+
T Consensus        36 TGqlaaiKii~k~~--~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~e  113 (786)
T KOG0588|consen   36 TGQLAAIKIIPKRS--ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPERE  113 (786)
T ss_pred             ccceeEEEeecccc--ccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHH
Confidence            48999999997753  2334446678899999999999999999999999999999999999999988764 55699999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-ccccCCCCCCccCCcccccCCCCCCcc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ..+++.||+.|+.|||..+|+|+|+||+|++++..+++||+|||++...... -+...+|++.|.+||++.|.+. .+.+
T Consensus       114 aa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pY-dG~~  192 (786)
T KOG0588|consen  114 AAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPY-DGRP  192 (786)
T ss_pred             HHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCC-CCCc
Confidence            9999999999999999999999999999999999999999999998654444 4677889999999999998875 4889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      +||||.|+++|.|++|+.||++.....++.++..+.+ .+|..+|.+.++||++||..||.+|.|.+||++|||+...
T Consensus       193 sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f-~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~  269 (786)
T KOG0588|consen  193 SDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF-EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY  269 (786)
T ss_pred             cccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc-cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence            9999999999999999999999888888888888876 6789999999999999999999999999999999999863

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-49  Score=305.79  Aligned_cols=231  Identities=49%  Similarity=0.825  Sum_probs=196.1

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC--cEEEEEeccccCcHHHHHHhcC--CCH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN--RLYIFLELVTKGSLANLYQKYH--LSD   77 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~--~~~   77 (247)
                      |...|||.+.....    .. .+.+.+|+.+|++++|||||+++|......  .++++|||+++|+|.+++++.+  +++
T Consensus        42 g~~~AvK~v~~~~~----~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E  116 (313)
T KOG0198|consen   42 GELMAVKSVELEDS----PT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPE  116 (313)
T ss_pred             Ccceeeeeeecccc----hh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCH
Confidence            78899999976521    11 667889999999999999999999754444  6999999999999999999875  899


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC-CCCeEEcccccccccCc-----cccccCCCCCCccCCcccccC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA-SGSVKLADFGLAKATTM-----NDLKSCKGTPFWMAPEVVNSK  151 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~-~~~~~l~df~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~  151 (247)
                      ..++.+..|++.||.|||++|++|+||||+||+++. ++.+||+|||++.....     .......|++.|+|||.+...
T Consensus       117 ~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g  196 (313)
T KOG0198|consen  117 PLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNG  196 (313)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCC
Confidence            999999999999999999999999999999999999 79999999999875552     234457799999999999752


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCC-ChhhHHHHHhhc-CCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          152 NDGYGLTADIWSLGCTVLEMLTRRPPYSH-LEGVQALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       152 ~~~~~~~~Di~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      . ....++||||+||++.||+||..||.. .........+.. ...|.+|..+|++.++++.+|+..+|.+|||++++|+
T Consensus       197 ~-~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~  275 (313)
T KOG0198|consen  197 E-VARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE  275 (313)
T ss_pred             C-cCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            1 134589999999999999999999987 344444444443 3467889999999999999999999999999999999


Q ss_pred             CccCCCCCC
Q 041080          230 HPFVKRPLQ  238 (247)
Q Consensus       230 ~p~~~~~~~  238 (247)
                      |||.+....
T Consensus       276 hpf~~~~~~  284 (313)
T KOG0198|consen  276 HPFLKQNSI  284 (313)
T ss_pred             Chhhhcccc
Confidence            999987654

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-48  Score=301.16  Aligned_cols=232  Identities=31%  Similarity=0.606  Sum_probs=206.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|..||||.+.+...   ..+..+.+..|+.+|+.++|||||.+++++.+.+.+++|||||+||+|.+++.++ .+++..
T Consensus        34 ~~~~VAIK~i~~~~l---~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t  110 (429)
T KOG0595|consen   34 SGTEVAIKCIAKKKL---NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEAT  110 (429)
T ss_pred             CCceEEeeeehhhcc---CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHH
Confidence            478899999987643   5667788889999999999999999999999999999999999999999999887 699999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC------CCeEEcccccccccCccc-cccCCCCCCccCCcccccCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS------GSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKN  152 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~------~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~  152 (247)
                      ++.++.|++.|+++||+++|+||||||+||+++.+      -.+||+|||+++...... ....+|++.|||||+++..+
T Consensus       111 ~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~  190 (429)
T KOG0595|consen  111 ARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQ  190 (429)
T ss_pred             HHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhcc
Confidence            99999999999999999999999999999999875      458999999999877554 44667999999999996544


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC--CCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE--LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                        |+-|+|+||+|+++|++++|+.||+..+..+....+..+.  .+..+...+....+++...+..+|..|.++++.+.|
T Consensus       191 --YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~  268 (429)
T KOG0595|consen  191 --YDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH  268 (429)
T ss_pred             --ccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence              8999999999999999999999999999888887766554  355566778888899999999999999999999999


Q ss_pred             ccCCCCC
Q 041080          231 PFVKRPL  237 (247)
Q Consensus       231 p~~~~~~  237 (247)
                      ++....-
T Consensus       269 ~~l~~~p  275 (429)
T KOG0595|consen  269 PFLAANP  275 (429)
T ss_pred             hhcccCc
Confidence            9988753

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.6e-49  Score=293.61  Aligned_cols=230  Identities=29%  Similarity=0.557  Sum_probs=192.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.||||.+..+.   +.....+-..+|+++|++++|+|+|.++++|.....+++|+|||+. ++.+.+++.  +++..
T Consensus        26 TgqIVAIKkF~Ese---dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G~~~~  101 (396)
T KOG0593|consen   26 TGQIVAIKKFVESE---DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNGVPSE  101 (396)
T ss_pred             cccEEEEEeeccCC---ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCCCCHH
Confidence            48999999997542   3344455678999999999999999999999999999999999988 566666654  59999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccC-ccc-cccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT-MND-LKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~-~~~-~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .+..+++|++.|+.|+|+++++||||||+||+++.+|.+||||||+++... +.. ...++.|.||+|||.+.+.. .|+
T Consensus       102 ~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDt-qYG  180 (396)
T KOG0593|consen  102 LVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDT-QYG  180 (396)
T ss_pred             HHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccC-cCC
Confidence            999999999999999999999999999999999999999999999998766 332 44677899999999998744 389


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC--C-------------------CCCC------C---CcCCHHH
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG--E-------------------LPSV------P---SSLSRDA  206 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--~-------------------~~~~------~---~~~~~~~  206 (247)
                      ...|||++||++.||++|.+.|.+.+..++...+...  .                   +|..      .   +..+.-+
T Consensus       181 ~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~  260 (396)
T KOG0593|consen  181 KPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVL  260 (396)
T ss_pred             CcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHH
Confidence            9999999999999999999999887776665433211  0                   0110      0   2356678


Q ss_pred             HHHHHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          207 RDFILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       207 ~~li~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                      .++++.||..||.+|++.++++.||||..
T Consensus       261 ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  261 LDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             HHHHHHHhcCCccccccHHHHhcChHHHH
Confidence            89999999999999999999999999953

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-48  Score=314.39  Aligned_cols=228  Identities=38%  Similarity=0.688  Sum_probs=202.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +++.||||.+......     ..+-+.+|+.+|+..+|+|||++++.|...+.+++||||++||+|.+++....+++.++
T Consensus       297 ~~~~VaiK~m~l~~Q~-----~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~~~E~qI  371 (550)
T KOG0578|consen  297 TKQEVAIKRMDLRKQP-----KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTRMTEGQI  371 (550)
T ss_pred             CCceEEEEEEEeccCC-----chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcccccHHHH
Confidence            4678999999876532     34567899999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCCcc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ..+..+++.||+|||.+||+|+|||.+||+++.+|.+||+|||+.......  .....+||++|+|||.+....  |+.+
T Consensus       372 A~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~--YG~K  449 (550)
T KOG0578|consen  372 AAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKP--YGPK  449 (550)
T ss_pred             HHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcc--cCcc
Confidence            999999999999999999999999999999999999999999998655544  345677999999999996544  8999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCC--CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                      .||||||++++||+.|++||-.......+..+.....+.+  +..+|+++++|+.+||+.|+.+|+++.++|+||||+.
T Consensus       450 VDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  450 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             ccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence            9999999999999999999987666666666655544444  5689999999999999999999999999999999964

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-49  Score=293.46  Aligned_cols=219  Identities=34%  Similarity=0.608  Sum_probs=196.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeece-eeecC-CcEEEEEeccccCcHHHHHHhc-----
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG-TDKDE-NRLYIFLELVTKGSLANLYQKY-----   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~-~~~~lv~e~~~~~~L~~~l~~~-----   73 (247)
                      ||+.+|.|.+...   .......+....|+.+|++|+||||+++++ .|.++ ..+++|||+|.+|+|.+.++..     
T Consensus        43 ~g~l~a~K~i~f~---~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr  119 (375)
T KOG0591|consen   43 DGKLVALKKIQFG---MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKR  119 (375)
T ss_pred             Ccchhhhhhcchh---hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccc
Confidence            6889999999854   456677788889999999999999999999 44444 4589999999999999998653     


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhh--CC--eeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcc
Q 041080           74 HLSDSQVSSYTRQILNGLVYLHE--RN--VVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEV  147 (247)
Q Consensus        74 ~~~~~~~~~~~~~l~~~l~~lh~--~~--i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~  147 (247)
                      .+++..+|+++.|++.||..+|.  .+  ++||||||.||+++.+|.+||+|||+++......  ....+|||+||+||.
T Consensus       120 ~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~  199 (375)
T KOG0591|consen  120 LIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPER  199 (375)
T ss_pred             cCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHH
Confidence            39999999999999999999998  44  9999999999999999999999999998665443  557889999999999


Q ss_pred             cccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCC-CcCCHHHHHHHHHHhcCCCCCCCCh
Q 041080          148 VNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVP-SSLSRDARDFILKCLQVNPNDRPTV  224 (247)
Q Consensus       148 ~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rps~  224 (247)
                      +...+  |+.++||||+||++|||+.-..||....-..+..++..+..+++| ..+|.++..++.-|+..||..||+.
T Consensus       200 i~~~~--Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  200 IHESG--YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HhcCC--CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            97665  999999999999999999999999999888999999999988888 7899999999999999999999985

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-47  Score=302.99  Aligned_cols=233  Identities=26%  Similarity=0.502  Sum_probs=195.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecCC-cEEEEEeccccCcHHHHHHhcC--CC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDEN-RLYIFLELVTKGSLANLYQKYH--LS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~--~~   76 (247)
                      +|+.||||......   ...+...+ .+|++.|++|. ||||+++.+++.+.+ .+++|||||+. +|.++++.++  ++
T Consensus        34 ~~~~VAIK~MK~Kf---~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R~r~fs  108 (538)
T KOG0661|consen   34 TGELVAIKKMKKKF---YSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDRNRLFS  108 (538)
T ss_pred             CCceeeHHHHHhhh---ccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhcCCcCC
Confidence            47789999886543   22333333 48999999998 999999999999887 99999999977 9999998765  99


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-ccccCCCCCCccCCcccccCCCCC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      +..+..|++||++||+++|++|++|||+||+||++..+..+||+|||+++..... ....++.|.||+|||++..... |
T Consensus       109 e~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~-Y  187 (538)
T KOG0661|consen  109 ESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGY-Y  187 (538)
T ss_pred             HHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCcchhhhcccccchHHhhhccc-c
Confidence            9999999999999999999999999999999999999999999999999876654 4567889999999999864443 8


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc---------------------CCCCC--------CCCcCCHHH
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK---------------------GELPS--------VPSSLSRDA  206 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~---------------------~~~~~--------~~~~~~~~~  206 (247)
                      +.+.|+|++||+++|+++-++.|.+.+..+.+.++-.                     -.++.        +-+..+.+.
T Consensus       188 s~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~  267 (538)
T KOG0661|consen  188 SSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEA  267 (538)
T ss_pred             CCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHH
Confidence            9999999999999999999999988777776644321                     11111        123478899


Q ss_pred             HHHHHHHhcCCCCCCCChhhhhcCccCCCCCCC
Q 041080          207 RDFILKCLQVNPNDRPTVTELMEHPFVKRPLQT  239 (247)
Q Consensus       207 ~~li~~~l~~~p~~Rps~~~il~~p~~~~~~~~  239 (247)
                      .++|.+|+..||.+|||+.++++||||+-....
T Consensus       268 ~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  268 ASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             HHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence            999999999999999999999999999975443

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=8.3e-47  Score=278.04  Aligned_cols=230  Identities=29%  Similarity=0.499  Sum_probs=194.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC--CCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--LSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~   78 (247)
                      +|+.||||.+....   ..+.......+||+.|+.++|+||+.++++|...+.+.+|+||++. +|+..++...  ++..
T Consensus        26 t~~~VAIKKIkl~~---~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~i~l~pa  101 (318)
T KOG0659|consen   26 TGKRVAIKKIKLGN---AKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKNIILSPA  101 (318)
T ss_pred             CCcEEEEEEeeccc---cccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhcccccccCHH
Confidence            48999999998753   3333445577999999999999999999999999999999999977 9999998764  8999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc--ccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ++..++.+++.|++|||+++|+||||||.|++++.+|.+||+|||+++..+....  ...+-+.||+|||.+.|... |+
T Consensus       102 ~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~-Yg  180 (318)
T KOG0659|consen  102 DIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQ-YG  180 (318)
T ss_pred             HHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchh-cC
Confidence            9999999999999999999999999999999999999999999999987664432  23367899999999988765 89


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC----------------------CCC-----CCCcCCHHHHHH
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE----------------------LPS-----VPSSLSRDARDF  209 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~----------------------~~~-----~~~~~~~~~~~l  209 (247)
                      ...|+||.||++.||+-|.+.|.+.+..++...+-...                      .|.     +-...+.+..++
T Consensus       181 ~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldL  260 (318)
T KOG0659|consen  181 TGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDL  260 (318)
T ss_pred             CcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHH
Confidence            99999999999999999888887776666654432110                      000     112356778999


Q ss_pred             HHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          210 ILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       210 i~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                      +.+||..||.+|+|+.|+++|+||++
T Consensus       261 l~~m~~ynP~~Rita~qaL~~~yf~~  286 (318)
T KOG0659|consen  261 LSKMLTYNPKKRITASQALKHPYFKS  286 (318)
T ss_pred             HHhhhccCchhcccHHHHhcchhhhc
Confidence            99999999999999999999999996

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.6e-47  Score=294.45  Aligned_cols=238  Identities=27%  Similarity=0.481  Sum_probs=216.7

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-CCHHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQV   80 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~   80 (247)
                      |+.||||.++++.+  ..++..-.+++||.+|+.|+||||+.++++|+..+...+||||..+|.|.+++.+++ +++.+.
T Consensus        78 gR~VAiKsIrKdkI--kdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEa  155 (668)
T KOG0611|consen   78 GREVAIKSIRKDKI--KDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREA  155 (668)
T ss_pred             CcEeehhhhhhhhc--ccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHH
Confidence            88999999988765  456778889999999999999999999999999999999999999999999998765 999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-ccccCCCCCCccCCcccccCCCCCCcch
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYGLTA  159 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~  159 (247)
                      ..++.||++|+.|+|+++++|+|||.+||+++.+++++|+|||++...... ..+.++|++-|.+||++++.+. -++..
T Consensus       156 RhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY-~GPEV  234 (668)
T KOG0611|consen  156 RHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPY-KGPEV  234 (668)
T ss_pred             HHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCC-CCCcc
Confidence            999999999999999999999999999999999999999999999765544 4677889999999999998875 37889


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCCCC
Q 041080          160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQT  239 (247)
Q Consensus       160 Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~~~  239 (247)
                      |.||||+++|.|+.|.+||+..+-..+..++..+...  .+..|.+..-||++||..+|.+|.|+++|-.|=|.+=.+-.
T Consensus       235 DsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr--EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy~~  312 (668)
T KOG0611|consen  235 DSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR--EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVNWGYNM  312 (668)
T ss_pred             chhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc--CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheeeccccc
Confidence            9999999999999999999999999999999887653  34456778999999999999999999999999999988888


Q ss_pred             CCCcC
Q 041080          240 PRCGQ  244 (247)
Q Consensus       240 ~~~~~  244 (247)
                      ++|++
T Consensus       313 ~V~~~  317 (668)
T KOG0611|consen  313 PVIQE  317 (668)
T ss_pred             ccccc
Confidence            88875

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.4e-46  Score=302.29  Aligned_cols=230  Identities=28%  Similarity=0.465  Sum_probs=196.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++.....  ........+.+|+.++++++||||+++++.+..++..++||||+++++|.+++... .+++..
T Consensus        19 ~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   96 (323)
T cd05571          19 TGKYYAMKILKKEVI--IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR   96 (323)
T ss_pred             CCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHH
Confidence            478999999975432  12334556788999999999999999999999999999999999999999888664 489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc--cccccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      +..++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++.....  .......|++.|+|||.+.+..  ++.
T Consensus        97 ~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~  174 (323)
T cd05571          97 ARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND--YGR  174 (323)
T ss_pred             HHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCC--CCc
Confidence            999999999999999999999999999999999999999999999864321  1223345899999999996544  789


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----ChhhhhcCcc
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTELMEHPF  232 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~p~  232 (247)
                      ++|+||+|+++|+|++|..||...+.......+.... ..++..++++++++|.+||..||.+||     ++.++++|||
T Consensus       175 ~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~  253 (323)
T cd05571         175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF  253 (323)
T ss_pred             cccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCC
Confidence            9999999999999999999998877666665555443 356778999999999999999999999     8999999999


Q ss_pred             CCC
Q 041080          233 VKR  235 (247)
Q Consensus       233 ~~~  235 (247)
                      |+.
T Consensus       254 f~~  256 (323)
T cd05571         254 FAS  256 (323)
T ss_pred             cCC
Confidence            986

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-46  Score=297.55  Aligned_cols=229  Identities=30%  Similarity=0.473  Sum_probs=197.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++.....  ......+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++... .+++..
T Consensus        25 ~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  102 (291)
T cd05612          25 SEHYYALKVMAIPEV--IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNST  102 (291)
T ss_pred             CCCEEEEEEEEHHHH--hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHH
Confidence            478999999975422  12234566889999999999999999999999999999999999999999988665 489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcch
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTA  159 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~  159 (247)
                      +..++.|++.||++||++|++|+||||+||+++.++.++|+|||.+...... .....|++.|+|||.+.+..  ++.++
T Consensus       103 ~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~~  179 (291)
T cd05612         103 GLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-TWTLCGTPEYLAPEVIQSKG--HNKAV  179 (291)
T ss_pred             HHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-cccccCChhhcCHHHHcCCC--CCchh
Confidence            9999999999999999999999999999999999999999999998654332 23345889999999986544  78899


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC-----hhhhhcCccCC
Q 041080          160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT-----VTELMEHPFVK  234 (247)
Q Consensus       160 Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~p~~~  234 (247)
                      ||||||+++|+|++|..||...........+.... ..++..++..+++++++||+.||.+|++     ++++++||||+
T Consensus       180 DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~  258 (291)
T cd05612         180 DWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK  258 (291)
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence            99999999999999999998877766666665554 3566778999999999999999999995     99999999997


Q ss_pred             C
Q 041080          235 R  235 (247)
Q Consensus       235 ~  235 (247)
                      .
T Consensus       259 ~  259 (291)
T cd05612         259 S  259 (291)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-46  Score=298.44  Aligned_cols=229  Identities=29%  Similarity=0.537  Sum_probs=196.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC--CcEEEEEeccccCcHHHHHHhc--CCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE--NRLYIFLELVTKGSLANLYQKY--HLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~--~~~   76 (247)
                      +|+.||+|.++.+.   .......-..+||.+|++|+||||+++.+...+.  +.+|+|+|||+. +|.-++...  .|+
T Consensus       141 tgkivALKKvr~d~---~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft  216 (560)
T KOG0600|consen  141 TGKIVALKKVRFDN---EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFT  216 (560)
T ss_pred             cCcEEEEEEeeccc---CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccC
Confidence            58999999998864   3344555677999999999999999999987665  789999999998 888888775  599


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCCC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      +.++..++.||+.||.|||.+|++|||||.+|||||.+|.+||+|||++++.....   ..+.+-|.||+|||.+.|...
T Consensus       217 ~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~  296 (560)
T KOG0600|consen  217 EPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATS  296 (560)
T ss_pred             hHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcc
Confidence            99999999999999999999999999999999999999999999999998655443   556678999999999987654


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC------------CCC---------CCC-------CcCCHH
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG------------ELP---------SVP-------SSLSRD  205 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~------------~~~---------~~~-------~~~~~~  205 (247)
                       |+.+.|+||.||++.||+.|++.|...+..+++..+-+.            +++         .+.       ..++..
T Consensus       297 -Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~  375 (560)
T KOG0600|consen  297 -YGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPAS  375 (560)
T ss_pred             -cccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHH
Confidence             899999999999999999999999988887776554321            111         000       246788


Q ss_pred             HHHHHHHHhcCCCCCCCChhhhhcCccCC
Q 041080          206 ARDFILKCLQVNPNDRPTVTELMEHPFVK  234 (247)
Q Consensus       206 ~~~li~~~l~~~p~~Rps~~~il~~p~~~  234 (247)
                      ..+|+..||..||.+|.|++++|+++||.
T Consensus       376 ~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  376 ALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             HHHHHHHHhccCccccccHHHHhcCcccc
Confidence            88999999999999999999999999994

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.5e-46  Score=300.58  Aligned_cols=229  Identities=29%  Similarity=0.507  Sum_probs=196.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++.....  ......+.+.+|+.++++++||||+++++++..++..++||||+++++|.+++.+. .+++..
T Consensus        42 ~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  119 (329)
T PTZ00263         42 TGEYYAIKCLKKREI--LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDV  119 (329)
T ss_pred             CCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHH
Confidence            478899999975421  12234567889999999999999999999999999999999999999999988765 488999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcch
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTA  159 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~  159 (247)
                      +..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+...... .....|++.|+|||.+.+..  ++.++
T Consensus       120 ~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~~  196 (329)
T PTZ00263        120 AKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-TFTLCGTPEYLAPEVIQSKG--HGKAV  196 (329)
T ss_pred             HHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-cceecCChhhcCHHHHcCCC--CCCcc
Confidence            9999999999999999999999999999999999999999999998755432 22345889999999996554  68899


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC-----hhhhhcCccCC
Q 041080          160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT-----VTELMEHPFVK  234 (247)
Q Consensus       160 Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~p~~~  234 (247)
                      |+||||+++|+|++|..||...........+..+. ..++..++..+++++.+||+.||.+|++     ++++++||||+
T Consensus       197 DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~  275 (329)
T PTZ00263        197 DWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFH  275 (329)
T ss_pred             eeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccC
Confidence            99999999999999999998877666666665543 3566778999999999999999999987     79999999998


Q ss_pred             C
Q 041080          235 R  235 (247)
Q Consensus       235 ~  235 (247)
                      .
T Consensus       276 ~  276 (329)
T PTZ00263        276 G  276 (329)
T ss_pred             C
Confidence            6

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-47  Score=276.29  Aligned_cols=229  Identities=30%  Similarity=0.524  Sum_probs=199.5

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcH-HHHHHhcCCCHHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQV   80 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~~~~   80 (247)
                      |+.+|+|.+........   ..+++.+|+.+.+.|+||||+++.+..++.+..++|+|.+.|+.| .+++++.-+++..+
T Consensus        36 g~~fa~kiin~~k~~~~---~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~a  112 (355)
T KOG0033|consen   36 GLEFAAKIINTKKLSAR---DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA  112 (355)
T ss_pred             hHHHHHHHhhhhhhccc---cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHHH
Confidence            66778888765543322   566788999999999999999999999999999999999999988 55667767899999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC---CCeEEcccccccccCcccc-ccCCCCCCccCCcccccCCCCCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDAS---GSVKLADFGLAKATTMNDL-KSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~---~~~~l~df~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ..++.||+++|.|+|.+||+|||+||.|+++-..   --+||+|||++...+.... ....|++.|++||++...+  ++
T Consensus       113 SH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdp--y~  190 (355)
T KOG0033|consen  113 SHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDP--YS  190 (355)
T ss_pred             HHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCC--CC
Confidence            9999999999999999999999999999999532   3599999999987774433 3567999999999996544  89


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCC---CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV---PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      ..+|||+.|+++|-|+.|.+||.+.+...+...+..+.....   -.+++++.++|+++||..||.+|.|+.|.|+|||+
T Consensus       191 kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi  270 (355)
T KOG0033|consen  191 KPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWI  270 (355)
T ss_pred             CcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchh
Confidence            999999999999999999999999899999999888765333   35789999999999999999999999999999999


Q ss_pred             CC
Q 041080          234 KR  235 (247)
Q Consensus       234 ~~  235 (247)
                      +.
T Consensus       271 ~~  272 (355)
T KOG0033|consen  271 CN  272 (355)
T ss_pred             cc
Confidence            75

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.4e-46  Score=302.41  Aligned_cols=228  Identities=33%  Similarity=0.569  Sum_probs=205.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +++.||+|.+.+.+   ..+..+..+++|+.+++.++||||+.++++|+...++++|.||+.| +|..+++.. .++++.
T Consensus        26 t~~~vAik~i~K~g---r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~lpEe~  101 (808)
T KOG0597|consen   26 TIQVVAIKFIDKSG---RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGKLPEEQ  101 (808)
T ss_pred             ceeEEEEEEehhcC---CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccCCCHHH
Confidence            46789999998764   3456688899999999999999999999999999999999999988 999999765 599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      +..++.++++||.|||+.+|.|+|+||.||++..+|.+|++|||+++......  .....|++.|+|||.+.+.+  ++.
T Consensus       102 v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~p--yd~  179 (808)
T KOG0597|consen  102 VRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQP--YDH  179 (808)
T ss_pred             HHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCC--ccc
Confidence            99999999999999999999999999999999999999999999998665544  44567999999999997555  899


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                      .+|+||+||++||++.|++||...+.......+..... ..|...+..+.+++..+|.+||.+|.|..+++.|||++.
T Consensus       180 ~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v-~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  180 TSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV-KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG  256 (808)
T ss_pred             hhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC-CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence            99999999999999999999999888888888777654 556689999999999999999999999999999999886

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-46  Score=294.93  Aligned_cols=247  Identities=30%  Similarity=0.539  Sum_probs=205.9

Q ss_pred             CCceEEEEEEeecCCC---------ccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC--CcEEEEEeccccCcHHHH
Q 041080            1 DGFFFAVKEVSLQDQG---------AQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE--NRLYIFLELVTKGSLANL   69 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~---------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~   69 (247)
                      +|+.||||++.+....         .....-.++.++||.+|++|.|||||+++++..+.  +.+|+|+|||..|.+.+.
T Consensus       121 ~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~  200 (576)
T KOG0585|consen  121 DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC  200 (576)
T ss_pred             CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccC
Confidence            5889999999764321         11122245899999999999999999999997664  689999999999877665


Q ss_pred             HHhcC-CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc-------cccccCCCCCC
Q 041080           70 YQKYH-LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM-------NDLKSCKGTPF  141 (247)
Q Consensus        70 l~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~-------~~~~~~~~~~~  141 (247)
                      -.... +++.+++.++.+++.||.|||.+||+||||||+|++++.+|.+||+|||.+.....       ..+....||+.
T Consensus       201 p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPA  280 (576)
T KOG0585|consen  201 PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPA  280 (576)
T ss_pred             CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCcc
Confidence            44445 89999999999999999999999999999999999999999999999999874421       12345669999


Q ss_pred             ccCCcccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCC-CCcCCHHHHHHHHHHhcCCC
Q 041080          142 WMAPEVVNSKN--DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV-PSSLSRDARDFILKCLQVNP  218 (247)
Q Consensus       142 ~~aPE~~~~~~--~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p  218 (247)
                      |+|||.+.+..  ...+.+.||||+|+++|.|+.|+.||-+....+...++....+..- ...+.+.++++|.+||++||
T Consensus       281 F~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP  360 (576)
T KOG0585|consen  281 FFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDP  360 (576)
T ss_pred             ccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcCh
Confidence            99999986533  2247789999999999999999999999999999999888765322 13478999999999999999


Q ss_pred             CCCCChhhhhcCccCCCCCCCCCCc-CCCC
Q 041080          219 NDRPTVTELMEHPFVKRPLQTPRCG-QANC  247 (247)
Q Consensus       219 ~~Rps~~~il~~p~~~~~~~~~~~~-~~~~  247 (247)
                      ++|.++.+|..|||.......+.|. +.+|
T Consensus       361 ~~Ri~l~~ik~Hpwvt~~g~~~~~s~~~~c  390 (576)
T KOG0585|consen  361 EQRITLPDIKLHPWVTRDGDSPQSSEPSSC  390 (576)
T ss_pred             hheeehhhheecceeccCCCCCccCCcccc
Confidence            9999999999999999987888777 3444

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-46  Score=278.89  Aligned_cols=237  Identities=30%  Similarity=0.508  Sum_probs=204.3

Q ss_pred             CCceEEEEEEeecCC---CccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CC
Q 041080            1 DGFFFAVKEVSLQDQ---GAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~---~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~   75 (247)
                      .|+.+|+|++.....   ++.....++.-.+|+.+|+++ .||+|+++.++++++...++|+|.++.|.|.+++... .+
T Consensus        41 t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~Vtl  120 (411)
T KOG0599|consen   41 TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTL  120 (411)
T ss_pred             cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheee
Confidence            378899999976543   344455567778899999998 6999999999999999999999999999999999765 59


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCccccc----
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNS----  150 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~----  150 (247)
                      ++....+++.|+++++.|||..+|+|+||||+||+++++.+++|+|||.+......+ ....+|++.|+|||.+..    
T Consensus       121 SEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e  200 (411)
T KOG0599|consen  121 SEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYE  200 (411)
T ss_pred             cHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeeccc
Confidence            999999999999999999999999999999999999999999999999997666554 566779999999999843    


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCC---CCcCCHHHHHHHHHHhcCCCCCCCChhhh
Q 041080          151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV---PSSLSRDARDFILKCLQVNPNDRPTVTEL  227 (247)
Q Consensus       151 ~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~i  227 (247)
                      ....|+...|+|++|++||.|+.|-+||-.....-....+..++...-   -.+++...+++|.+||+.||.+|.|++++
T Consensus       201 ~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~  280 (411)
T KOG0599|consen  201 NHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEA  280 (411)
T ss_pred             CCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHH
Confidence            222378899999999999999999999987777666666766655332   24678899999999999999999999999


Q ss_pred             hcCccCCCCC
Q 041080          228 MEHPFVKRPL  237 (247)
Q Consensus       228 l~~p~~~~~~  237 (247)
                      |.||||.++.
T Consensus       281 LaHpff~q~~  290 (411)
T KOG0599|consen  281 LAHPFFIQIA  290 (411)
T ss_pred             hcChHHHHHH
Confidence            9999996643

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-45  Score=295.57  Aligned_cols=231  Identities=29%  Similarity=0.458  Sum_probs=196.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++.....  ........+.+|+.++.+++||||+++++.+...+..++||||+++++|.+++.+. .+++..
T Consensus        17 ~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~   94 (312)
T cd05585          17 TQRIYALKTIRKAHI--VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSR   94 (312)
T ss_pred             CCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHH
Confidence            477899999975321  22344567789999999999999999999999999999999999999999988654 589999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      +..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......  ......|++.|+|||.+.+..  ++.
T Consensus        95 ~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~  172 (312)
T cd05585          95 ARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG--YTK  172 (312)
T ss_pred             HHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCC--CCC
Confidence            9999999999999999999999999999999999999999999998643222  223345899999999996544  788


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC---ChhhhhcCccCC
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP---TVTELMEHPFVK  234 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~p~~~  234 (247)
                      ++|+||+|+++|+|++|..||...........+.... ..++..+++++++++.+||..+|.+||   ++.++++||||+
T Consensus       173 ~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~  251 (312)
T cd05585         173 AVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP-LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFS  251 (312)
T ss_pred             ccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC-CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcC
Confidence            9999999999999999999998777666666555443 356778999999999999999999997   578999999999


Q ss_pred             CC
Q 041080          235 RP  236 (247)
Q Consensus       235 ~~  236 (247)
                      ..
T Consensus       252 ~~  253 (312)
T cd05585         252 QL  253 (312)
T ss_pred             CC
Confidence            74

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.7e-45  Score=295.90  Aligned_cols=231  Identities=28%  Similarity=0.468  Sum_probs=196.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++.....  ........+.+|+.+++.++||||+++++.+...+..++||||+++++|..++... .+++..
T Consensus        19 ~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~   96 (323)
T cd05595          19 TGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER   96 (323)
T ss_pred             CCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHH
Confidence            478999999976432  12334556778999999999999999999999999999999999999998888665 489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc--cccccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      ++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....  .......|+..|+|||.+.+..  ++.
T Consensus        97 ~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~  174 (323)
T cd05595          97 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND--YGR  174 (323)
T ss_pred             HHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCC--CCc
Confidence            999999999999999999999999999999999999999999998764322  1223455889999999986543  788


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----ChhhhhcCcc
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTELMEHPF  232 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~p~  232 (247)
                      ++|+||||+++|+|++|..||...+.......+.... ..++..++++++++|.+||+.+|.+|+     ++.++++|||
T Consensus       175 ~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~  253 (323)
T cd05595         175 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF  253 (323)
T ss_pred             hhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCC
Confidence            9999999999999999999998777666655554433 346678899999999999999999998     8999999999


Q ss_pred             CCCC
Q 041080          233 VKRP  236 (247)
Q Consensus       233 ~~~~  236 (247)
                      |...
T Consensus       254 ~~~~  257 (323)
T cd05595         254 FLSI  257 (323)
T ss_pred             cCCC
Confidence            9863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.3e-45  Score=295.57  Aligned_cols=231  Identities=28%  Similarity=0.466  Sum_probs=196.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++.....  ........+.+|+.+++.++||||+++++.+...+..++||||+++++|...+... .+++..
T Consensus        19 ~~~~~avK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~   96 (328)
T cd05593          19 SGKYYAMKILKKEVI--IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDR   96 (328)
T ss_pred             CCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHH
Confidence            478999999976432  12334567788999999999999999999999999999999999999998888654 489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc--cccccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      +..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.....  .......|++.|+|||.+.+..  ++.
T Consensus        97 ~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~  174 (328)
T cd05593          97 TRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDND--YGR  174 (328)
T ss_pred             HHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCC--CCc
Confidence            999999999999999999999999999999999999999999999764322  2223445889999999986544  788


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----ChhhhhcCcc
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTELMEHPF  232 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~p~  232 (247)
                      ++|+||||+++|+|++|..||...+.......+.... ..++..+++++.+++.+||..+|.+|+     +++++++|||
T Consensus       175 ~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~  253 (328)
T cd05593         175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED-IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSF  253 (328)
T ss_pred             cCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC-ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCC
Confidence            9999999999999999999998776665555544433 356778999999999999999999997     8999999999


Q ss_pred             CCCC
Q 041080          233 VKRP  236 (247)
Q Consensus       233 ~~~~  236 (247)
                      |...
T Consensus       254 ~~~~  257 (328)
T cd05593         254 FTGV  257 (328)
T ss_pred             cCCC
Confidence            9763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.3e-45  Score=295.19  Aligned_cols=232  Identities=30%  Similarity=0.486  Sum_probs=196.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-CCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~   79 (247)
                      +|+.||+|++...... ........+.+|+.+++.++||||+++++.+..++..++||||+++++|.+++++.+ +++..
T Consensus        23 ~~~~~avK~~~~~~~~-~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  101 (323)
T cd05584          23 TGKIFAMKVLKKATIV-RNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDT  101 (323)
T ss_pred             CCCEEEEEEEEHHHHH-hhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHH
Confidence            3678999999764321 122334567899999999999999999999999999999999999999999987654 78888


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      +..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++......  ......|+..|+|||.+.+..  ++.
T Consensus       102 ~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~  179 (323)
T cd05584         102 ACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSG--HGK  179 (323)
T ss_pred             HHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCC--CCC
Confidence            9999999999999999999999999999999999999999999987543222  223345889999999986544  688


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----ChhhhhcCcc
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTELMEHPF  232 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~p~  232 (247)
                      ++|+||||+++|+|++|..||...........+.... ...+..+++++.+++.+||+.+|.+||     +++++++|||
T Consensus       180 ~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~  258 (323)
T cd05584         180 AVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF  258 (323)
T ss_pred             cceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCC
Confidence            9999999999999999999998877776666665554 356778899999999999999999999     8999999999


Q ss_pred             CCCC
Q 041080          233 VKRP  236 (247)
Q Consensus       233 ~~~~  236 (247)
                      |+..
T Consensus       259 ~~~~  262 (323)
T cd05584         259 FRHV  262 (323)
T ss_pred             cCCC
Confidence            9763

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.6e-46  Score=296.03  Aligned_cols=232  Identities=34%  Similarity=0.605  Sum_probs=211.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCc-EEEEEeccccCcHHHHHHhcC---CC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENR-LYIFLELVTKGSLANLYQKYH---LS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~---~~   76 (247)
                      |++.|++|.+........   ....+.+|+.+++++.||||+.+.+.+..++. .++||+|++||++.+.+++.+   ++
T Consensus        28 ~~~~~vlK~I~l~~~t~~---~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~  104 (426)
T KOG0589|consen   28 DDKLYVLKKINLEKLTEP---ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFP  104 (426)
T ss_pred             CCceEEEEEEeccccCch---hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhcccc
Confidence            467899999988764433   33378899999999999999999999999888 999999999999999886643   99


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      ++.+..|+.|++.|+.|||+++|.|||||+.||+++.++.++|+|||++...+..  ......|++.|++||.+.+.+  
T Consensus       105 E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~p--  182 (426)
T KOG0589|consen  105 EERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIP--  182 (426)
T ss_pred             HHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCC--
Confidence            9999999999999999999999999999999999999999999999999887766  355677999999999997766  


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCC
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK  234 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~  234 (247)
                      |+.++|+|||||++|++++-+.+|...+......++..+...+++..++.+++.+|..||..+|..||++.++|.+|..+
T Consensus       183 Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  183 YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL  262 (426)
T ss_pred             CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence            89999999999999999999999999999999999999988899999999999999999999999999999999999877


Q ss_pred             CCC
Q 041080          235 RPL  237 (247)
Q Consensus       235 ~~~  237 (247)
                      ..+
T Consensus       263 ~~~  265 (426)
T KOG0589|consen  263 RYL  265 (426)
T ss_pred             hHH
Confidence            543

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.8e-45  Score=294.14  Aligned_cols=231  Identities=30%  Similarity=0.509  Sum_probs=199.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-CCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~   79 (247)
                      +|+.+|+|++.++..  ......+.++.|-.+|..-.+|.||+++..|++...+||||||.+||++..++.+.+ +++..
T Consensus       165 Tg~iyAmK~LkKS~M--~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~  242 (550)
T KOG0605|consen  165 TGEIYAMKILKKSEM--LKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDW  242 (550)
T ss_pred             CCcEEeeecccHHHH--HhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHH
Confidence            489999999988653  455667889999999999999999999999999999999999999999999998765 99999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc-----------------------------
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM-----------------------------  130 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~-----------------------------  130 (247)
                      +..++.+++.||..+|+.|++|+||||+|++||..|.+||+|||++.....                             
T Consensus       243 arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (550)
T KOG0605|consen  243 ARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFN  322 (550)
T ss_pred             HHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccc
Confidence            999999999999999999999999999999999999999999999842100                             


Q ss_pred             --cc------------------cccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHh
Q 041080          131 --ND------------------LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI  190 (247)
Q Consensus       131 --~~------------------~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~  190 (247)
                        ..                  ....+|||.|+|||++.+..  |+...|+|||||+|||++.|.+||...+.......+
T Consensus       323 ~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg--Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI  400 (550)
T KOG0605|consen  323 TPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG--YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKI  400 (550)
T ss_pred             cccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC--CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence              00                  12344899999999997665  899999999999999999999999999988888776


Q ss_pred             hcCC--C-CCCCCcCCHHHHHHHHHHhcCCCCCCC---ChhhhhcCccCCCC
Q 041080          191 GKGE--L-PSVPSSLSRDARDFILKCLQVNPNDRP---TVTELMEHPFVKRP  236 (247)
Q Consensus       191 ~~~~--~-~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~p~~~~~  236 (247)
                      ..-.  + -+.....+++.++||.++|. ||.+|.   +++||-.||||+.+
T Consensus       401 ~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v  451 (550)
T KOG0605|consen  401 VNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV  451 (550)
T ss_pred             HHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence            6532  1 12234567999999999999 999996   59999999999974

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.3e-45  Score=296.62  Aligned_cols=228  Identities=27%  Similarity=0.413  Sum_probs=196.0

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHHHH
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQVS   81 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~   81 (247)
                      ..||+|.+.....  ......+.+.+|+.+++.++||||+++++++.+++..++||||+++|+|.+++.+. .+++..+.
T Consensus        57 ~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~  134 (340)
T PTZ00426         57 PPVAIKRFEKSKI--IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGC  134 (340)
T ss_pred             eEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHH
Confidence            5799999875432  12334566889999999999999999999999999999999999999999998764 58999999


Q ss_pred             HHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcchhH
Q 041080           82 SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADI  161 (247)
Q Consensus        82 ~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di  161 (247)
                      .++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... .....|++.|+|||.+.+..  ++.++|+
T Consensus       135 ~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~~Di  211 (340)
T PTZ00426        135 FYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-TYTLCGTPEYIAPEILLNVG--HGKAADW  211 (340)
T ss_pred             HHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-cceecCChhhcCHHHHhCCC--CCccccc
Confidence            99999999999999999999999999999999999999999998654432 23456889999999996544  7889999


Q ss_pred             HHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----ChhhhhcCccCCCC
Q 041080          162 WSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTELMEHPFVKRP  236 (247)
Q Consensus       162 ~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~p~~~~~  236 (247)
                      ||+|+++|+|++|..||...+.......+.... ..++..+++.+++++++||+.+|.+|+     +++++++||||+..
T Consensus       212 wSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        212 WTLGIFIYEILVGCPPFYANEPLLIYQKILEGI-IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             cchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999999999999999998877766666665543 356778899999999999999999995     89999999999863

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-45  Score=294.42  Aligned_cols=217  Identities=28%  Similarity=0.501  Sum_probs=193.6

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh---cCCCHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK---YHLSDSQV   80 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~   80 (247)
                      .||+|.+....      -+.+.|.+|+++|++|+|++||++++++..++.++|||||++.|+|.+++..   ..+...+.
T Consensus       232 ~vavk~ik~~~------m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~L  305 (468)
T KOG0197|consen  232 KVAVKTIKEGS------MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQL  305 (468)
T ss_pred             cccceEEeccc------cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHH
Confidence            78999997532      2334678999999999999999999999998899999999999999999987   34899999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCC---CCCCccCCcccccCCCCCCc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK---GTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~---~~~~~~aPE~~~~~~~~~~~  157 (247)
                      +.++.||++|++||++++++||||...||||+.+..+||+|||+++...........   -...|.|||.+....  ++.
T Consensus       306 l~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~--FS~  383 (468)
T KOG0197|consen  306 LDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGK--FSS  383 (468)
T ss_pred             HHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCC--ccc
Confidence            999999999999999999999999999999999999999999999855544433322   234599999996554  899


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhh
Q 041080          158 TADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM  228 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il  228 (247)
                      ++||||||++|+|++| |+.||...+..+....+..+..-+-|..+|+++.++|..||..+|++|||++.+.
T Consensus       384 kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  384 KSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             ccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence            9999999999999998 9999999999999999999998888999999999999999999999999999775

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-45  Score=301.34  Aligned_cols=231  Identities=27%  Similarity=0.468  Sum_probs=206.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~   79 (247)
                      +++.||||++++...-  .+...+....|..++.-. +||.++.++..|++.+++|+||||..||++..+.+...+++..
T Consensus       392 ~~e~yAIK~LKK~~Il--~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~~~F~e~r  469 (694)
T KOG0694|consen  392 TNEYYAIKVLKKGDIL--QRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHTDVFSEPR  469 (694)
T ss_pred             CCcEEEEEEeecccee--ccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEEecccccHHH
Confidence            4789999999987753  334456667788887777 5999999999999999999999999999987777778899999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccC--ccccccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      +..+++.++.||.|||++||+|||||.+||++|.+|.+||+|||+.....  ........||+.|+|||++.+..  |+.
T Consensus       470 arfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~--Yt~  547 (694)
T KOG0694|consen  470 ARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQS--YTR  547 (694)
T ss_pred             HHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCc--ccc
Confidence            99999999999999999999999999999999999999999999987543  33456788999999999996555  999


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC-----hhhhhcCcc
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT-----VTELMEHPF  232 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~p~  232 (247)
                      +.|+|+||++||+|+.|..||...+..++.+.+.... +.+|..+|.+..++++++|..+|++|..     +++|..|||
T Consensus       548 aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~-~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpF  626 (694)
T KOG0694|consen  548 AVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE-VRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPF  626 (694)
T ss_pred             hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-CCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCc
Confidence            9999999999999999999999999999999988765 4778999999999999999999999975     589999999


Q ss_pred             CCCC
Q 041080          233 VKRP  236 (247)
Q Consensus       233 ~~~~  236 (247)
                      |+.+
T Consensus       627 Fr~i  630 (694)
T KOG0694|consen  627 FRSI  630 (694)
T ss_pred             cccC
Confidence            9985

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7.2e-45  Score=287.51  Aligned_cols=232  Identities=24%  Similarity=0.405  Sum_probs=192.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh---cCCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK---YHLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~   77 (247)
                      +|+.||+|.+......  .......+.+|+.++++++|++|+++++.+.+.+..+++|||+++++|...+..   ..+++
T Consensus        24 ~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~  101 (285)
T cd05631          24 TGKMYACKKLEKKRIK--KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDE  101 (285)
T ss_pred             CCceEEEEEeeHhhhh--hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCH
Confidence            4789999999764321  122344577899999999999999999999999999999999999999887753   24889


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ..+..++.|++.||++||+.|++|+||||+||+++.++.++|+|||.+....... .....|+..|+|||.+.+..  ++
T Consensus       102 ~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~  179 (285)
T cd05631         102 QRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEK--YT  179 (285)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCC--CC
Confidence            9999999999999999999999999999999999999999999999986543222 23456889999999996544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHH---HHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC-----hhhhh
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQA---LFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT-----VTELM  228 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il  228 (247)
                      .++|+||+|+++|+|++|..||........   ............+..+++++.+++++||+.+|.+||+     +++++
T Consensus       180 ~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~  259 (285)
T cd05631         180 FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVK  259 (285)
T ss_pred             cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHh
Confidence            899999999999999999999976543221   2222223334556778999999999999999999997     89999


Q ss_pred             cCccCCCC
Q 041080          229 EHPFVKRP  236 (247)
Q Consensus       229 ~~p~~~~~  236 (247)
                      +||||+..
T Consensus       260 ~h~~~~~~  267 (285)
T cd05631         260 QHPIFKNI  267 (285)
T ss_pred             cCHhhcCC
Confidence            99999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.5e-44  Score=289.25  Aligned_cols=230  Identities=28%  Similarity=0.505  Sum_probs=191.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|..||+|.+....    .....+.+.+|+.++++++||||+++++++..++..++||||+++++|.+++... .+++..
T Consensus        29 ~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  104 (331)
T cd06649          29 SGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEI  104 (331)
T ss_pred             CCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCCCCHHH
Confidence            36789999987532    2345667899999999999999999999999999999999999999999998764 489999


Q ss_pred             HHHHHHHHHHHHHHhhhC-CeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcc
Q 041080           80 VSSYTRQILNGLVYLHER-NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~-~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      +..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++............++..|+|||.+.+..  ++.+
T Consensus       105 ~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~  182 (331)
T cd06649         105 LGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--YSVQ  182 (331)
T ss_pred             HHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccccccCCCCcCcCCHhHhcCCC--CCch
Confidence            999999999999999986 6999999999999999999999999998765544445566899999999996544  7889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHh----------------------------------------------hc
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI----------------------------------------------GK  192 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~----------------------------------------------~~  192 (247)
                      +|+||||+++|++++|+.||......+.....                                              ..
T Consensus       183 ~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (331)
T cd06649         183 SDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVN  262 (331)
T ss_pred             HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHh
Confidence            99999999999999999999755443332111                                              11


Q ss_pred             CCCCCC-CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          193 GELPSV-PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       193 ~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ...+.. ...++++++++|.+||..+|++|||++++++||||+..
T Consensus       263 ~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         263 EPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             CCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence            111111 12478899999999999999999999999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=9e-45  Score=291.28  Aligned_cols=231  Identities=28%  Similarity=0.463  Sum_probs=195.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||||++.....  ......+.+..|..++..+ +||||+++++++...+..++||||+++++|.+++.+. .+++.
T Consensus        19 ~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~   96 (320)
T cd05590          19 SGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA   96 (320)
T ss_pred             CCCEEEEEEEEHHHH--hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHH
Confidence            478899999975432  1223345667888888877 6999999999999999999999999999999888654 58999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc--cccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||++.....  .......|++.|+|||.+.+..  ++
T Consensus        97 ~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  174 (320)
T cd05590          97 RARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML--YG  174 (320)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCC--CC
Confidence            9999999999999999999999999999999999999999999998764321  2223445899999999986544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh------hhhhcC
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV------TELMEH  230 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~~il~~  230 (247)
                      .++|+||+|+++|+|++|..||...+.......+.... ...+..++.++++++.+||+.+|.+||++      +++++|
T Consensus       175 ~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         175 PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            89999999999999999999998887777766665543 35566789999999999999999999998      899999


Q ss_pred             ccCCCC
Q 041080          231 PFVKRP  236 (247)
Q Consensus       231 p~~~~~  236 (247)
                      |||+..
T Consensus       254 ~~f~~~  259 (320)
T cd05590         254 PFFKEL  259 (320)
T ss_pred             CCcCCC
Confidence            999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.3e-44  Score=291.46  Aligned_cols=231  Identities=27%  Similarity=0.500  Sum_probs=190.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~   78 (247)
                      +|+.||+|++.....  ........+..|..++..+ +||||+++++++...+..++||||+++++|.+++.+ ..+++.
T Consensus        19 ~~~~~aiK~i~~~~~--~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~   96 (329)
T cd05588          19 TRRIYAMKVIKKELV--NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEE   96 (329)
T ss_pred             CCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHH
Confidence            478899999976432  2233456678899999998 699999999999999999999999999999888765 469999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccC--ccccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||++....  ........|+..|+|||.+.+..  ++
T Consensus        97 ~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  174 (329)
T cd05588          97 HARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGED--YG  174 (329)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCC--CC
Confidence            999999999999999999999999999999999999999999999876422  12223455889999999996544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChh--------hHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC-----
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEG--------VQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT-----  223 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----  223 (247)
                      .++|+||+|+++|+|++|+.||.....        .+.............+..++.++.+++.+||+.+|.+|++     
T Consensus       175 ~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~  254 (329)
T cd05588         175 FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQT  254 (329)
T ss_pred             CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCC
Confidence            899999999999999999999963221        1112222223334567788999999999999999999987     


Q ss_pred             -hhhhhcCccCCC
Q 041080          224 -VTELMEHPFVKR  235 (247)
Q Consensus       224 -~~~il~~p~~~~  235 (247)
                       ++++++||||+.
T Consensus       255 ~~~~i~~hp~~~~  267 (329)
T cd05588         255 GFRDIKSHPFFRN  267 (329)
T ss_pred             CHHHHhcCCCCCC
Confidence             789999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-44  Score=278.96  Aligned_cols=231  Identities=44%  Similarity=0.778  Sum_probs=195.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|.+...............+.+|+.++++++||||+++++++..++..++++||+++++|.+++... .+++..
T Consensus        26 ~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~  105 (263)
T cd06625          26 TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETV  105 (263)
T ss_pred             CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHHH
Confidence            4788999999765443344445677899999999999999999999999999999999999999999988764 488999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc-----ccCCCCCCccCCcccccCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL-----KSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+........     ....++..|+|||.+.+..  
T Consensus       106 ~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--  183 (263)
T cd06625         106 TRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG--  183 (263)
T ss_pred             HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCC--
Confidence            999999999999999999999999999999999999999999999864332211     2234677899999997654  


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc-CCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      ++.++|+||+|+++|++++|+.||...+.......... ......+..++..+.+++.+||..+|.+|||+.++++||||
T Consensus       184 ~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         184 YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            78999999999999999999999977655544433332 23445677889999999999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=281.91  Aligned_cols=232  Identities=30%  Similarity=0.480  Sum_probs=194.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec-----CCcEEEEEeccccCcHHHHHHhcC-
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD-----ENRLYIFLELVTKGSLANLYQKYH-   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~-   74 (247)
                      +|+.||||.+...-   ......++..+|+++|+.++|+||+.+.+.+..     -+..|+|+|+|.. +|.++++... 
T Consensus        46 t~~~VAIKKi~~~F---~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMet-DL~~iik~~~~  121 (359)
T KOG0660|consen   46 TGEKVAIKKILNPF---ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELMET-DLHQIIKSQQD  121 (359)
T ss_pred             CCCEeehhhhhhhh---hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHhh-HHHHHHHcCcc
Confidence            57899999997432   345567788999999999999999999998755     3578999999954 9999999887 


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccC----ccccccCCCCCCccCCccccc
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT----MNDLKSCKGTPFWMAPEVVNS  150 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~----~~~~~~~~~~~~~~aPE~~~~  150 (247)
                      +++..+..+++|++.||.|+|+.|++||||||+|++++.+..+||+|||+++...    ......++.|.||+|||.+..
T Consensus       122 L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~  201 (359)
T KOG0660|consen  122 LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLN  201 (359)
T ss_pred             ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhc
Confidence            9999999999999999999999999999999999999999999999999998774    344567789999999999854


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC----------------------CCCC--------CCC
Q 041080          151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG----------------------ELPS--------VPS  200 (247)
Q Consensus       151 ~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~----------------------~~~~--------~~~  200 (247)
                      .. .|+.+.||||+||++.||++|+..|.+.+...++..+...                      ..+.        .-+
T Consensus       202 ~~-~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp  280 (359)
T KOG0660|consen  202 SS-EYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP  280 (359)
T ss_pred             cc-cccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC
Confidence            43 4899999999999999999999988766554443222110                      0111        114


Q ss_pred             cCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          201 SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       201 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      +.++...+|+.+||..||.+|+|++|+|+|||+...+
T Consensus       281 ~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h  317 (359)
T KOG0660|consen  281 NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH  317 (359)
T ss_pred             CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence            6788999999999999999999999999999998754

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.9e-44  Score=289.98  Aligned_cols=231  Identities=28%  Similarity=0.453  Sum_probs=193.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHH---hhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLL---SQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~   77 (247)
                      +|+.||||++......  .....+.+.+|+.++   +.++||||+++++++..++..++||||+++++|...+....+++
T Consensus        23 ~~~~~aiK~~~~~~~~--~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~l~~  100 (324)
T cd05589          23 TGELYAIKALKKGDII--ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSE  100 (324)
T ss_pred             CCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhcCCCCH
Confidence            4788999999754321  122344566666554   56689999999999999999999999999999999988878999


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc--cccccCCCCCCccCCcccccCCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDLKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....  .......|++.|+|||.+.+..  +
T Consensus       101 ~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~  178 (324)
T cd05589         101 PRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETS--Y  178 (324)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCC--C
Confidence            99999999999999999999999999999999999999999999998754322  1223455889999999986544  7


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----ChhhhhcC
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTELMEH  230 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~  230 (247)
                      +.++|+||||+++|+|++|..||...+.......+.... ...+..+++++.+++.+||+.+|.+||     ++.++++|
T Consensus       179 ~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         179 TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE-VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            889999999999999999999998877776666655543 346678899999999999999999999     68999999


Q ss_pred             ccCCCC
Q 041080          231 PFVKRP  236 (247)
Q Consensus       231 p~~~~~  236 (247)
                      |||+..
T Consensus       258 ~~f~~~  263 (324)
T cd05589         258 PFFRDI  263 (324)
T ss_pred             CCcCCC
Confidence            999863

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-44  Score=292.11  Aligned_cols=231  Identities=31%  Similarity=0.484  Sum_probs=194.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++.....  ........+.+|+.++..++||||+++++++..++..++||||+++++|.+++... .+++..
T Consensus        25 ~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~  102 (333)
T cd05600          25 TGEIVALKRMKKSLL--FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH  102 (333)
T ss_pred             CCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHH
Confidence            478999999976432  12234566889999999999999999999999999999999999999999999765 489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcch
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTA  159 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~  159 (247)
                      +..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++..... ......|++.|+|||.+.+.  .++.++
T Consensus       103 ~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~  179 (333)
T cd05600         103 ARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-YANSVVGSPDYMAPEVLRGK--GYDFTV  179 (333)
T ss_pred             HHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-ccCCcccCccccChhHhcCC--CCCCcc
Confidence            999999999999999999999999999999999999999999999865443 23345688999999999655  378999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC----CCCCC---CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE----LPSVP---SSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       160 Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      |+||||+++|+|++|..||...+..+....+....    .+...   ..+++++.+++.+||..+|.+||+++++++|||
T Consensus       180 DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~  259 (333)
T cd05600         180 DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF  259 (333)
T ss_pred             ceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence            99999999999999999998777666554433211    11111   256899999999999999999999999999999


Q ss_pred             CCCC
Q 041080          233 VKRP  236 (247)
Q Consensus       233 ~~~~  236 (247)
                      |+..
T Consensus       260 ~~~~  263 (333)
T cd05600         260 FKEV  263 (333)
T ss_pred             cCCC
Confidence            9864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-44  Score=279.53  Aligned_cols=231  Identities=27%  Similarity=0.415  Sum_probs=198.9

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC---CCHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH---LSDS   78 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~   78 (247)
                      +..+|+|++.+...  ..+..+.+++.|-.||+.++||.++.+++.|+.++..|++||||+||+|..++++.+   +++.
T Consensus       102 ~~~fAmKVmdK~~l--~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~  179 (459)
T KOG0610|consen  102 NCLFAMKVMDKESL--ASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSES  179 (459)
T ss_pred             CceEEEEEecHHHH--hhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchh
Confidence            47899999988764  336667788889999999999999999999999999999999999999999988754   9999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccC-----------------------------
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT-----------------------------  129 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~-----------------------------  129 (247)
                      .++.+++.++.||+|||..||++|||||+||+|.++|.+.|+||.++....                             
T Consensus       180 ~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~  259 (459)
T KOG0610|consen  180 AARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFS  259 (459)
T ss_pred             hHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccc
Confidence            999999999999999999999999999999999999999999998873100                             


Q ss_pred             -----c-c-----------------------ccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 041080          130 -----M-N-----------------------DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSH  180 (247)
Q Consensus       130 -----~-~-----------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~  180 (247)
                           . .                       .....+||-.|+|||++.+..  .+.+.|+|+||+++|||+.|.-||..
T Consensus       260 ~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G--HgsAVDWWtfGIflYEmLyG~TPFKG  337 (459)
T KOG0610|consen  260 PRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG--HGSAVDWWTFGIFLYEMLYGTTPFKG  337 (459)
T ss_pred             cchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC--CCchhhHHHHHHHHHHHHhCCCCcCC
Confidence                 0 0                       011234777899999997765  68899999999999999999999999


Q ss_pred             ChhhHHHHHhhcCCCCCC-CCcCCHHHHHHHHHHhcCCCCCCCC----hhhhhcCccCCCC
Q 041080          181 LEGVQALFRIGKGELPSV-PSSLSRDARDFILKCLQVNPNDRPT----VTELMEHPFVKRP  236 (247)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps----~~~il~~p~~~~~  236 (247)
                      .+.......+........ ...++...++||+++|.+||++|..    +.||-+||||+..
T Consensus       338 ~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gV  398 (459)
T KOG0610|consen  338 SNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGV  398 (459)
T ss_pred             CCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCC
Confidence            998888887766543211 1367889999999999999999988    9999999999964

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.1e-45  Score=293.20  Aligned_cols=230  Identities=30%  Similarity=0.453  Sum_probs=195.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++.....   .......+.+|+.++++++||||+++++++..++..++||||+++++|.+++.+. .+++..
T Consensus        23 ~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~   99 (318)
T cd05582          23 AGQLYAMKVLKKATL---KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED   99 (318)
T ss_pred             CCCEEEEEEEEHHHh---hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHH
Confidence            378899999976432   1223445678999999999999999999999999999999999999999988654 489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      ++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+......  ......|+..|+|||.+.+..  ++.
T Consensus       100 ~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~  177 (318)
T cd05582         100 VKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG--HTQ  177 (318)
T ss_pred             HHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCC--CCC
Confidence            9999999999999999999999999999999999999999999998654332  223455889999999986544  688


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC-----hhhhhcCcc
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT-----VTELMEHPF  232 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~p~  232 (247)
                      ++|+||||+++|+|++|+.||...+.......+.... ...+..+++++++++.+||+.+|.+||+     ++++++|||
T Consensus       178 ~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~  256 (318)
T cd05582         178 SADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPF  256 (318)
T ss_pred             ccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCC
Confidence            9999999999999999999998877766666665543 3456778999999999999999999999     677999999


Q ss_pred             CCCC
Q 041080          233 VKRP  236 (247)
Q Consensus       233 ~~~~  236 (247)
                      |+..
T Consensus       257 ~~~~  260 (318)
T cd05582         257 FSTI  260 (318)
T ss_pred             cCCC
Confidence            9753

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2e-44  Score=285.28  Aligned_cols=228  Identities=27%  Similarity=0.469  Sum_probs=184.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-cCCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-YHLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~   79 (247)
                      +|+.||+|++.....   .....+.+.+|+.+++.++||||+++++++...+..++||||++++++..+.+. ..+++..
T Consensus        25 ~~~~~avK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~  101 (287)
T cd07848          25 TKEIVAIKKFKDSEE---NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEK  101 (287)
T ss_pred             CCcEEEEEEEecccc---cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHH
Confidence            467899999976432   233456678999999999999999999999999999999999998777655543 3589999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.......   .....++..|+|||.+.+..  ++
T Consensus       102 ~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~  179 (287)
T cd07848         102 VRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP--YG  179 (287)
T ss_pred             HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCC--CC
Confidence            99999999999999999999999999999999999999999999987543222   22345788999999986544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC---------------------CCC----------CCCCcCCHH
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG---------------------ELP----------SVPSSLSRD  205 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---------------------~~~----------~~~~~~~~~  205 (247)
                      .++|+||+|+++|+|++|+.||......+....+...                     ..+          .....+|.+
T Consensus       180 ~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  259 (287)
T cd07848         180 KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGV  259 (287)
T ss_pred             CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHH
Confidence            8999999999999999999999776543332221110                     000          011236788


Q ss_pred             HHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          206 ARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       206 ~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      +.+++.+||+.+|.+|||++++++||||
T Consensus       260 ~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         260 LLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             HHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.7e-45  Score=292.39  Aligned_cols=231  Identities=27%  Similarity=0.454  Sum_probs=195.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++.....  ........+.+|+.++..++||||+++++.+...+..++||||+++++|..++... .+++..
T Consensus        19 ~~~~~a~K~~~~~~~--~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~   96 (325)
T cd05594          19 TGRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR   96 (325)
T ss_pred             CCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHH
Confidence            478999999976432  12334556778999999999999999999999999999999999999999888654 589999


Q ss_pred             HHHHHHHHHHHHHHhhh-CCeeecCCCCCcEEEcCCCCeEEcccccccccCc--cccccCCCCCCccCCcccccCCCCCC
Q 041080           80 VSSYTRQILNGLVYLHE-RNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~-~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      +..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++.....  .......|+..|+|||.+.+..  ++
T Consensus        97 ~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  174 (325)
T cd05594          97 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND--YG  174 (325)
T ss_pred             HHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCC--CC
Confidence            99999999999999997 7999999999999999999999999998764321  2223445889999999986544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----ChhhhhcCc
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTELMEHP  231 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~p  231 (247)
                      .++|+||||+++|+|++|..||...........+... ...++..+++++.+++.+||+.+|.+|+     ++.++++||
T Consensus       175 ~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~  253 (325)
T cd05594         175 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK  253 (325)
T ss_pred             CccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence            8999999999999999999999877666555554433 3356778899999999999999999996     899999999


Q ss_pred             cCCCC
Q 041080          232 FVKRP  236 (247)
Q Consensus       232 ~~~~~  236 (247)
                      ||+..
T Consensus       254 ~~~~~  258 (325)
T cd05594         254 FFAGI  258 (325)
T ss_pred             CcCCC
Confidence            99864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.5e-44  Score=283.97  Aligned_cols=227  Identities=27%  Similarity=0.457  Sum_probs=183.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC--CCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--LSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~   78 (247)
                      +|+.||+|.+.....    ......+.+|+.++++++||||+++++++..++..++||||+++ +|.+++...+  +++.
T Consensus        29 ~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~  103 (288)
T cd07871          29 TENLVALKEIRLEHE----EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMH  103 (288)
T ss_pred             CCCEEEEEEeccccc----CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHH
Confidence            478899999975432    11234567899999999999999999999999999999999986 8888886543  7889


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .+..++.|++.||++||++|++|+||||+||+++.++.++|+|||.+......  ......++..|+|||.+.+.. .++
T Consensus       104 ~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~  182 (288)
T cd07871         104 NVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST-EYS  182 (288)
T ss_pred             HHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCc-ccC
Confidence            99999999999999999999999999999999999999999999998654322  223445788999999986432 368


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC---------------------CCCC--------CCCcCCHHHH
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG---------------------ELPS--------VPSSLSRDAR  207 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---------------------~~~~--------~~~~~~~~~~  207 (247)
                      .++|+||+|+++|+|++|+.||...+..+....+...                     ..+.        .....+.+.+
T Consensus       183 ~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (288)
T cd07871         183 TPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGI  262 (288)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHH
Confidence            8999999999999999999999776654443322110                     0000        1124678899


Q ss_pred             HHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          208 DFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       208 ~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      +++.+||..||.+|||++|+++||||
T Consensus       263 dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         263 DLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             HHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.5e-44  Score=282.90  Aligned_cols=231  Identities=26%  Similarity=0.430  Sum_probs=189.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-----cCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-----YHL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~   75 (247)
                      +|+.||+|.+.....  ......+.+..|+.+++.++|+||+++.+++..++..++||||+++++|...+..     ..+
T Consensus        17 ~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l   94 (280)
T cd05608          17 TGKLYACKKLNKKRL--KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGF   94 (280)
T ss_pred             CCcEEEEEeeeHHHH--hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCC
Confidence            478999999875432  1223345677899999999999999999999999999999999999999887632     348


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCC
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      ++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+.. 
T Consensus        95 ~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-  173 (280)
T cd05608          95 PEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE-  173 (280)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCC-
Confidence            999999999999999999999999999999999999999999999999986543322  22345788999999997554 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhh----HHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----Ch
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGV----QALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TV  224 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~  224 (247)
                       ++.++|+||+|+++|++++|+.||......    .....+.. .....+..++.++.+++.+||+.+|.+||     ++
T Consensus       174 -~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~  251 (280)
T cd05608         174 -YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN-DSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNC  251 (280)
T ss_pred             -CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcc-cCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCH
Confidence             788999999999999999999999764332    22222222 22345567899999999999999999999     78


Q ss_pred             hhhhcCccCCCC
Q 041080          225 TELMEHPFVKRP  236 (247)
Q Consensus       225 ~~il~~p~~~~~  236 (247)
                      +++++||||+..
T Consensus       252 ~~~l~h~~~~~~  263 (280)
T cd05608         252 DGLRTHPLFRDL  263 (280)
T ss_pred             HHHhcChhhhcC
Confidence            999999999873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-45  Score=267.44  Aligned_cols=230  Identities=33%  Similarity=0.530  Sum_probs=208.0

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSDS   78 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~   78 (247)
                      +-.||||++.++.+.  ......++++|+++-++|+||||++++++|-+....|+++||.+.|++.+.+...   .+++.
T Consensus        47 ~~IvalKVlfKsqi~--~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~  124 (281)
T KOG0580|consen   47 LFIVALKVLFKSQIL--KTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQ  124 (281)
T ss_pred             CcEEEEeeeeHHHHH--HhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhccccccccc
Confidence            567899999876532  2334556889999999999999999999999999999999999999999988743   38999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcc
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ..+.++.|++.|+.|+|..+++||||||+|++++.+|.++++|||-+...........+|+..|++||+..+..  .+..
T Consensus       125 ~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~--hd~~  202 (281)
T KOG0580|consen  125 RAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRG--HDKF  202 (281)
T ss_pred             chhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCCCceeeecccccCCHhhcCCCC--ccch
Confidence            99999999999999999999999999999999999999999999999877777777888999999999997655  7889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      .|+|++|++.|+++.|..||++....+.+.++..... .+|..++.+.+++|.+|+..+|.+|.+..|++.|||..+.
T Consensus       203 Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~-~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  203 VDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL-KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             hhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc-cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence            9999999999999999999999998888888877655 6678999999999999999999999999999999999875

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.9e-44  Score=286.86  Aligned_cols=231  Identities=27%  Similarity=0.473  Sum_probs=195.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||||++.....  ........+..|..++..+ +||||+++++++...+..++||||+++++|...+.+. .+++.
T Consensus        19 ~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~   96 (318)
T cd05570          19 TDELYAVKVLKKDVI--LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP   96 (318)
T ss_pred             CCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHH
Confidence            367899999976432  1223345667888888888 6999999999999999999999999999999888766 59999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc--cccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....  .......++..|+|||.+.+..  ++
T Consensus        97 ~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~  174 (318)
T cd05570          97 RARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQP--YG  174 (318)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCC--CC
Confidence            9999999999999999999999999999999999999999999998754221  1223345788999999996544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh-----hhhhcCc
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV-----TELMEHP  231 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~~p  231 (247)
                      .++|+||+|+++|+|++|..||...+.......+.... ...+..+++++.++|.+||..+|.+|||+     .++++||
T Consensus       175 ~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~  253 (318)
T cd05570         175 PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE-VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHP  253 (318)
T ss_pred             cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCC
Confidence            89999999999999999999998777666665554443 35667889999999999999999999999     9999999


Q ss_pred             cCCCC
Q 041080          232 FVKRP  236 (247)
Q Consensus       232 ~~~~~  236 (247)
                      ||+..
T Consensus       254 ~~~~~  258 (318)
T cd05570         254 FFREI  258 (318)
T ss_pred             CcCCC
Confidence            99874

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.4e-44  Score=288.21  Aligned_cols=230  Identities=27%  Similarity=0.447  Sum_probs=194.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||+|++.....  ......+.+..|..++..+ +||||+++++++..++..++||||+++++|...+.+. .+++.
T Consensus        19 ~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~   96 (321)
T cd05591          19 TDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP   96 (321)
T ss_pred             CCCEEEEEEEeHHHh--hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHH
Confidence            367899999976432  1233445667888888876 7999999999999999999999999999998887654 58999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+......  ......|+..|+|||.+.+..  ++
T Consensus        97 ~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  174 (321)
T cd05591          97 RSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE--YG  174 (321)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCC--CC
Confidence            99999999999999999999999999999999999999999999987643221  223345889999999986544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-------Chhhhhc
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-------TVTELME  229 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-------s~~~il~  229 (247)
                      .++|+||+|+++|+|++|+.||...........+.... ...+..++.++.+++.+||+.+|.+|+       +++++++
T Consensus       175 ~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         175 PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD-VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            89999999999999999999999888777776665544 345667899999999999999999999       8999999


Q ss_pred             CccCCC
Q 041080          230 HPFVKR  235 (247)
Q Consensus       230 ~p~~~~  235 (247)
                      ||||+.
T Consensus       254 hp~~~~  259 (321)
T cd05591         254 HPFFKE  259 (321)
T ss_pred             CCccCC
Confidence            999976

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.7e-44  Score=292.83  Aligned_cols=233  Identities=29%  Similarity=0.452  Sum_probs=195.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.||+|++.....  ........+.+|+.+++.++||||+++++++.+++..++||||+++|+|.+++....+++..+
T Consensus        67 ~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~l~~~~~  144 (370)
T cd05596          67 SKQVYAMKLLSKFEM--IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWA  144 (370)
T ss_pred             CCCEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhcCCCHHHH
Confidence            478899999975322  122334557789999999999999999999999999999999999999999998888999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCC--CCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKN--DGY  155 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~--~~~  155 (247)
                      ..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||.+.......   .....|++.|+|||.+.+..  ..+
T Consensus       145 ~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  224 (370)
T cd05596         145 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYY  224 (370)
T ss_pred             HHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCC
Confidence            9999999999999999999999999999999999999999999986543322   22345899999999986432  236


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC-CCCCC--CcCCHHHHHHHHHHhcCCCCC--CCChhhhhcC
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE-LPSVP--SSLSRDARDFILKCLQVNPND--RPTVTELMEH  230 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~--Rps~~~il~~  230 (247)
                      +.++|+||||+++|+|++|..||...........+.... ...++  ..++.++++++.+||+.+|.+  |+|++++++|
T Consensus       225 ~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         225 GRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            889999999999999999999998877766666654432 12223  357999999999999999987  9999999999


Q ss_pred             ccCCC
Q 041080          231 PFVKR  235 (247)
Q Consensus       231 p~~~~  235 (247)
                      |||+.
T Consensus       305 ~~~~~  309 (370)
T cd05596         305 PFFKN  309 (370)
T ss_pred             cccCC
Confidence            99986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=6.1e-44  Score=284.61  Aligned_cols=230  Identities=29%  Similarity=0.479  Sum_probs=181.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.||||++.....    ......+.+|+.+++.++||||+++++++.+....++||||+.+ +|.+++...  .+++.
T Consensus        29 ~~~~~aiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~  103 (303)
T cd07869          29 NGKLVALKVIRLQEE----EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPE  103 (303)
T ss_pred             CCCEEEEEEeccccc----cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCCc-CHHHHHHhCCCCCCHH
Confidence            478899999975432    11233567899999999999999999999999999999999965 777777553  48899


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .+..++.|++.||++||+.|++|+||||+||+++.++.++|+|||.+......  ......++..|+|||.+.+.. .++
T Consensus       104 ~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~  182 (303)
T cd07869         104 NVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGST-EYS  182 (303)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCC-CCC
Confidence            99999999999999999999999999999999999999999999987643322  223345788999999985433 268


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhh-HHHHHhhc---CC----------CCC---------C---------CCcCCH
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGV-QALFRIGK---GE----------LPS---------V---------PSSLSR  204 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~---~~----------~~~---------~---------~~~~~~  204 (247)
                      .++|+||+|+++|+|++|..||...... .....+..   ..          .+.         .         ....++
T Consensus       183 ~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (303)
T cd07869         183 TCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVN  262 (303)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCCh
Confidence            8999999999999999999999765332 11111100   00          000         0         012457


Q ss_pred             HHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          205 DARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       205 ~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ++++++.+||+.||.+|||++++++||||+..
T Consensus       263 ~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         263 HAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             HHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence            88999999999999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.2e-43  Score=288.45  Aligned_cols=232  Identities=31%  Similarity=0.525  Sum_probs=188.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.||||++...    ........+.+|+.+++.++|+||+++++++..++..++||||+++++|.+.   ...++..+
T Consensus        98 ~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~---~~~~~~~~  170 (353)
T PLN00034         98 TGRLYALKVIYGN----HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT---HIADEQFL  170 (353)
T ss_pred             CCCEEEEEEEecC----CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc---ccCCHHHH
Confidence            4789999998643    2334456788999999999999999999999999999999999999988643   23567788


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCC---CCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKN---DGY  155 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~---~~~  155 (247)
                      ..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......  .....|+..|+|||.+....   ...
T Consensus       171 ~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  250 (353)
T PLN00034        171 ADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYD  250 (353)
T ss_pred             HHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCC
Confidence            8999999999999999999999999999999999999999999986543221  23456889999999874321   123


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhH---HHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQ---ALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      +.++||||||+++|+|++|+.||......+   ....+.....+..+..++.+++++|.+||..+|.+|||++++++|||
T Consensus       251 ~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~  330 (353)
T PLN00034        251 GYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF  330 (353)
T ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence            568999999999999999999997433222   22222333344556788999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 041080          233 VKRPLQT  239 (247)
Q Consensus       233 ~~~~~~~  239 (247)
                      |......
T Consensus       331 ~~~~~~~  337 (353)
T PLN00034        331 ILRAQPG  337 (353)
T ss_pred             cccCCcc
Confidence            9987433

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.3e-44  Score=285.94  Aligned_cols=231  Identities=26%  Similarity=0.456  Sum_probs=192.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||+|.+......  .....+.+..|..++... +||+|+++++.+...+..++||||+++++|..++... .+++.
T Consensus        19 ~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~   96 (316)
T cd05620          19 KGEYFAVKALKKDVVL--IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLY   96 (316)
T ss_pred             CCCEEEEEEEEHHHhh--hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHH
Confidence            4788999999764321  122344566777787765 8999999999999999999999999999999888664 58999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccC--ccccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+....  ........|+..|+|||.+.+..  ++
T Consensus        97 ~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  174 (316)
T cd05620          97 RATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK--YT  174 (316)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCC--CC
Confidence            999999999999999999999999999999999999999999999875422  22233455899999999996544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh-hhhhcCccCCC
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV-TELMEHPFVKR  235 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~il~~p~~~~  235 (247)
                      .++|+||+|+++|+|++|..||...+.......+... .+..+..++.++++++.+||..||.+|+++ +++++||||+.
T Consensus       175 ~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~  253 (316)
T cd05620         175 FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKT  253 (316)
T ss_pred             cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence            8999999999999999999999877766665555433 355677789999999999999999999998 58889999987


Q ss_pred             C
Q 041080          236 P  236 (247)
Q Consensus       236 ~  236 (247)
                      .
T Consensus       254 ~  254 (316)
T cd05620         254 I  254 (316)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.4e-43  Score=279.80  Aligned_cols=226  Identities=21%  Similarity=0.264  Sum_probs=189.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec----CCcEEEEEeccccCcHHHHHHhc-CC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD----ENRLYIFLELVTKGSLANLYQKY-HL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~-~~   75 (247)
                      +|+.||||.+.....  ......+.+.+|+.++++++||||+++++++.+    ....+++|||+++|+|.+++.+. .+
T Consensus        42 ~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~  119 (283)
T PHA02988         42 NNKEVIIRTFKKFHK--GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDL  119 (283)
T ss_pred             CCEEEEEEecccccc--ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCC
Confidence            578999999976432  233445778899999999999999999999866    35789999999999999998764 48


Q ss_pred             CHHHHHHHHHHHHHHHHHhhh-CCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCC
Q 041080           76 SDSQVSSYTRQILNGLVYLHE-RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      ++.....++.+++.|+.+||+ .+++|+||+|+||+++.++.++|+|||++....... ....++..|+|||.+.+....
T Consensus       120 ~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~  198 (283)
T PHA02988        120 SFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-FKNVNFMVYFSYKMLNDIFSE  198 (283)
T ss_pred             ChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-ccccCcccccCHHHhhhcccc
Confidence            889999999999999999998 499999999999999999999999999986543222 234577889999999764445


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc-CCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ++.++||||||+++|+|++|..||...+..+....+.. ......+...++++++++.+||+.+|.+|||++++++
T Consensus       199 ~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        199 YTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             ccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            89999999999999999999999998877666655533 2334556678999999999999999999999999985

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.5e-44  Score=287.69  Aligned_cols=230  Identities=30%  Similarity=0.450  Sum_probs=190.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHH-HHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEIS-LLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||+|++......  .......+..|.. +++.++||||+++++.+...+..++||||+++++|..++.+. .+++.
T Consensus        19 ~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~   96 (323)
T cd05575          19 DGKFYAVKVLQKKAIL--KKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP   96 (323)
T ss_pred             CCCEEEEEEEEHHHHh--hhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHH
Confidence            4789999999754321  1222334445544 567789999999999999999999999999999999888664 58999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc--cccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....  .......|++.|+|||.+.+..  ++
T Consensus        97 ~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  174 (323)
T cd05575          97 RARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP--YD  174 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCC--CC
Confidence            9999999999999999999999999999999999999999999998764322  2223345889999999986544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh----hhhhcCcc
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV----TELMEHPF  232 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~~il~~p~  232 (247)
                      .++|+||||+++|+|++|..||...+.......+..... ..+..++..+.++|.+||+.+|.+||++    +++++|||
T Consensus       175 ~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~  253 (323)
T cd05575         175 RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL-RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVF  253 (323)
T ss_pred             ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCC
Confidence            899999999999999999999988777666666555433 4556789999999999999999999987    69999999


Q ss_pred             CCC
Q 041080          233 VKR  235 (247)
Q Consensus       233 ~~~  235 (247)
                      |+.
T Consensus       254 ~~~  256 (323)
T cd05575         254 FSS  256 (323)
T ss_pred             cCC
Confidence            975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5.8e-44  Score=287.57  Aligned_cols=232  Identities=28%  Similarity=0.506  Sum_probs=189.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||+|++.....  ........+..|+.++.++ +||||+++++++...+..++||||+++++|..++... .+++.
T Consensus        19 ~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~   96 (329)
T cd05618          19 TERIYAMKVVKKELV--NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE   96 (329)
T ss_pred             CCCEEEEEEEEhhHh--cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHH
Confidence            467899999976532  1233455677899988887 7999999999999999999999999999998887654 59999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc--cccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....  .......|+..|+|||.+.+..  ++
T Consensus        97 ~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  174 (329)
T cd05618          97 HARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED--YG  174 (329)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCC--CC
Confidence            9999999999999999999999999999999999999999999998864321  1223455889999999996544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChh--------hHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC-----
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEG--------VQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT-----  223 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----  223 (247)
                      .++|+||||+++|+|++|..||.....        ..............++...+..+++++.+||+.+|.+||+     
T Consensus       175 ~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~  254 (329)
T cd05618         175 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQT  254 (329)
T ss_pred             CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCC
Confidence            899999999999999999999953211        1112222223344567789999999999999999999998     


Q ss_pred             -hhhhhcCccCCCC
Q 041080          224 -VTELMEHPFVKRP  236 (247)
Q Consensus       224 -~~~il~~p~~~~~  236 (247)
                       ++++++||||+..
T Consensus       255 ~~~~i~~hp~f~~~  268 (329)
T cd05618         255 GFADIQGHPFFRNV  268 (329)
T ss_pred             CHHHHhcCCCCCCC
Confidence             5799999999763

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-43  Score=298.60  Aligned_cols=227  Identities=28%  Similarity=0.444  Sum_probs=195.5

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-----cCCC
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-----YHLS   76 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~   76 (247)
                      ++.||+|.+...     .......+.+|+.+++.++||||+++++++..++..++||||+++|+|.+.+..     ..++
T Consensus        93 ~~~vv~K~~~~~-----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~  167 (478)
T PTZ00267         93 KEKVVAKFVMLN-----DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ  167 (478)
T ss_pred             CeEEEEEEcccC-----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCC
Confidence            567888876432     233445678899999999999999999999999999999999999999987753     2488


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCCcccccCC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKN  152 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~  152 (247)
                      +..+..++.|++.||.+||+.||+|+||||+||+++.++.++|+|||++.......    .....|++.|+|||.+.+..
T Consensus       168 ~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  247 (478)
T PTZ00267        168 EYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKR  247 (478)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCC
Confidence            99999999999999999999999999999999999999999999999987543221    23345899999999986543


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                        ++.++|+||||+++|+|++|..||...........+..+.....+..++.+++++|.+||..+|.+||++++++.|||
T Consensus       248 --~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~  325 (478)
T PTZ00267        248 --YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEF  325 (478)
T ss_pred             --CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHH
Confidence              789999999999999999999999887777777776666666677789999999999999999999999999999999


Q ss_pred             CCC
Q 041080          233 VKR  235 (247)
Q Consensus       233 ~~~  235 (247)
                      ++.
T Consensus       326 ~~~  328 (478)
T PTZ00267        326 LKY  328 (478)
T ss_pred             HHH
Confidence            864

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=5.5e-44  Score=288.33  Aligned_cols=233  Identities=31%  Similarity=0.466  Sum_probs=190.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||+|++..... .......+.+.+|+.++..+ +|++|+++++++..++..++||||+++++|.+++.+. .+++.
T Consensus        27 ~~~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~  105 (332)
T cd05614          27 TGKLYAMKVLQKAAL-VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED  105 (332)
T ss_pred             CCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHH
Confidence            368899999975432 12234456688999999999 4899999999999999999999999999999988654 58999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++.......   .....|+..|+|||.+.+.. .+
T Consensus       106 ~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~  184 (332)
T cd05614         106 EVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKG-GH  184 (332)
T ss_pred             HHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCC-CC
Confidence            999999999999999999999999999999999999999999999986533221   22345899999999986432 26


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChh----hHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----Chhh
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEG----VQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTE  226 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~  226 (247)
                      +.++||||||+++|+|++|..||.....    ......+. ...+..+..+++.+++++.+||+.+|.+||     ++++
T Consensus       185 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~  263 (332)
T cd05614         185 GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL-KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASE  263 (332)
T ss_pred             CCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHH
Confidence            7899999999999999999999964322    12222222 233456678899999999999999999999     7889


Q ss_pred             hhcCccCCCC
Q 041080          227 LMEHPFVKRP  236 (247)
Q Consensus       227 il~~p~~~~~  236 (247)
                      +++||||+..
T Consensus       264 ~l~h~~~~~~  273 (332)
T cd05614         264 IKEHPFFKGL  273 (332)
T ss_pred             HHcCCCcCCC
Confidence            9999999863

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.3e-43  Score=289.18  Aligned_cols=232  Identities=28%  Similarity=0.448  Sum_probs=189.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++.....  ........+.+|+.++..++|++|+++++.+.+....++||||+++|+|.+++.+. .+++..
T Consensus        25 ~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~  102 (363)
T cd05628          25 TGHVYAMKILRKADM--LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEE  102 (363)
T ss_pred             CCCEEEEEEEEHHHH--HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHH
Confidence            478999999975432  22334567889999999999999999999999999999999999999999988654 589999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---------------------------
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---------------------------  132 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---------------------------  132 (247)
                      +..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.......                           
T Consensus       103 ~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (363)
T cd05628         103 TQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA  182 (363)
T ss_pred             HHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999999999999999999999875432110                           


Q ss_pred             ----------cccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC-CCCCC--
Q 041080          133 ----------LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE-LPSVP--  199 (247)
Q Consensus       133 ----------~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--  199 (247)
                                .....|++.|+|||.+.+..  ++.++|+||||+++|+|++|..||...........+.... ...++  
T Consensus       183 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  260 (363)
T cd05628         183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTG--YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPE  260 (363)
T ss_pred             chhhhccccccccccCCccccCHHHHcCCC--CCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCc
Confidence                      12345889999999986544  7889999999999999999999998877766666554422 11222  


Q ss_pred             CcCCHHHHHHHHHHhcC--CCCCCCChhhhhcCccCCCC
Q 041080          200 SSLSRDARDFILKCLQV--NPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       200 ~~~~~~~~~li~~~l~~--~p~~Rps~~~il~~p~~~~~  236 (247)
                      ..++++.++++.+|+..  ++..||+++++++||||+..
T Consensus       261 ~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         261 VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCC
Confidence            24688999999997752  23356899999999999863

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2e-43  Score=284.40  Aligned_cols=233  Identities=26%  Similarity=0.474  Sum_probs=186.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh---cCCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK---YHLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~   77 (247)
                      +|+.||+|.+.....   .....+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++..   .++++
T Consensus        24 ~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~  100 (327)
T cd08227          24 TGEYVTVRRINLEAC---TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSE  100 (327)
T ss_pred             cCcEEEEEEechhhc---cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCH
Confidence            578999999865432   233456677899999999999999999999999999999999999999999865   24889


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---------cccCCCCCCccCCccc
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---------LKSCKGTPFWMAPEVV  148 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---------~~~~~~~~~~~aPE~~  148 (247)
                      ..++.++.|++.||.|||++|++|+||||+||+++.++.+++.||+.........         .....++..|+|||.+
T Consensus       101 ~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  180 (327)
T cd08227         101 LAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVL  180 (327)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHh
Confidence            9999999999999999999999999999999999999999999997543221110         1112356679999998


Q ss_pred             ccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCC--------------------------------
Q 041080          149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP--------------------------------  196 (247)
Q Consensus       149 ~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------------------------  196 (247)
                      .+....++.++|+||+|++++++++|..||..............+..+                                
T Consensus       181 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (327)
T cd08227         181 QQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTV  260 (327)
T ss_pred             hcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCccccc
Confidence            654444789999999999999999999999765443332222111110                                


Q ss_pred             -------------CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          197 -------------SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       197 -------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                                   .....+++++.+++.+||+.||.+|||++++++||||++.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         261 STPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             CCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                         1122457789999999999999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-43  Score=287.00  Aligned_cols=232  Identities=28%  Similarity=0.424  Sum_probs=182.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC-----CcEEEEEeccccCcHHHHHHhc-C
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE-----NRLYIFLELVTKGSLANLYQKY-H   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~-~   74 (247)
                      +|+.||||.+.....   .......+.+|+.++++++||||+++++++...     ...++||||+. ++|.+++.+. .
T Consensus        24 ~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~   99 (338)
T cd07859          24 TGEKVAIKKINDVFE---HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD   99 (338)
T ss_pred             CCCEEEEEEechhhc---cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhccc
Confidence            478999999864321   222345678999999999999999999987543     35899999996 5888888664 5


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-----cccCCCCCCccCCcccc
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVN  149 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~aPE~~~  149 (247)
                      +++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+.......     .....++..|+|||.+.
T Consensus       100 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~  179 (338)
T cd07859         100 LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG  179 (338)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHh
Confidence            8999999999999999999999999999999999999999999999999986432211     12345889999999986


Q ss_pred             cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhh---------------------------cCCC---CCCC
Q 041080          150 SKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIG---------------------------KGEL---PSVP  199 (247)
Q Consensus       150 ~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~---------------------------~~~~---~~~~  199 (247)
                      +....++.++||||||+++|+|++|+.||...........+.                           ....   ....
T Consensus       180 ~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  259 (338)
T cd07859         180 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKF  259 (338)
T ss_pred             ccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhc
Confidence            543457889999999999999999999997654332211110                           0000   0111


Q ss_pred             CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          200 SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       200 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ...++.+.+++.+||+.+|.+|||++++++||||+..
T Consensus       260 ~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~  296 (338)
T cd07859         260 PNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL  296 (338)
T ss_pred             CCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence            3467889999999999999999999999999999864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.5e-43  Score=283.81  Aligned_cols=231  Identities=26%  Similarity=0.480  Sum_probs=191.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||+|++......  .....+.+..|..++..+ +||||+++++++..++..++||||+++++|..++... .+++.
T Consensus        19 ~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~   96 (316)
T cd05592          19 TNEFFAIKALKKDVVL--EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA   96 (316)
T ss_pred             CCCEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHH
Confidence            3678999999764321  122334455666677654 7999999999999999999999999999999988654 58999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc--cccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....  .......|+..|+|||.+.+..  ++
T Consensus        97 ~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  174 (316)
T cd05592          97 RARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK--YN  174 (316)
T ss_pred             HHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCC--CC
Confidence            9999999999999999999999999999999999999999999999864322  2223445899999999996544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChh-hhhcCccCCC
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT-ELMEHPFVKR  235 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~il~~p~~~~  235 (247)
                      .++|+||||+++|+|++|..||...+.......+.. ..+.++..++.++.+++.+||..+|.+||++. ++++||||+.
T Consensus       175 ~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~  253 (316)
T cd05592         175 ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG  253 (316)
T ss_pred             CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence            899999999999999999999988777666655544 34566778999999999999999999999874 8889999986


Q ss_pred             C
Q 041080          236 P  236 (247)
Q Consensus       236 ~  236 (247)
                      .
T Consensus       254 ~  254 (316)
T cd05592         254 I  254 (316)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.4e-43  Score=283.90  Aligned_cols=231  Identities=28%  Similarity=0.476  Sum_probs=192.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||+|++......  .....+.+..|..++..+ +||||+++++++.+.+..++||||+++++|.+++... .+++.
T Consensus        19 ~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~   96 (316)
T cd05619          19 TNQFFAIKALKKDVVL--MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLP   96 (316)
T ss_pred             CCCEEEEEEEEHHHhh--hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHH
Confidence            3678999999764311  112234456677777764 8999999999999999999999999999999998764 58999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccC--ccccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....  ........|+..|+|||.+.+..  ++
T Consensus        97 ~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  174 (316)
T cd05619          97 RATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK--YN  174 (316)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCC--CC
Confidence            999999999999999999999999999999999999999999999876422  22233455889999999986544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChh-hhhcCccCCC
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT-ELMEHPFVKR  235 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~il~~p~~~~  235 (247)
                      .++|+||+|+++|+|++|..||...+.......+.... +..+..++.++++++.+||..+|.+||++. ++++||||+.
T Consensus       175 ~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~  253 (316)
T cd05619         175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFRE  253 (316)
T ss_pred             chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCC
Confidence            99999999999999999999998877666665554433 455667899999999999999999999996 8999999987


Q ss_pred             C
Q 041080          236 P  236 (247)
Q Consensus       236 ~  236 (247)
                      .
T Consensus       254 ~  254 (316)
T cd05619         254 I  254 (316)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-46  Score=291.09  Aligned_cols=229  Identities=41%  Similarity=0.702  Sum_probs=208.1

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCC-CHHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHL-SDSQV   80 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~   80 (247)
                      ++.||+|++..+    ......+++.+|+.++.+++++||.++++.+..+..++++|||+.||++.+.++..++ .+..+
T Consensus        38 ~k~vAiKii~Le----~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i  113 (467)
T KOG0201|consen   38 KKVVAIKIIDLE----EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEI  113 (467)
T ss_pred             cceEEEEEechh----hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCCCcccee
Confidence            678999999874    4455678899999999999999999999999999999999999999999999998876 89999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCCcc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ..++.+++.|+.|+|.++.+|+|||+.||++..+|.++++|||.+.......  ....+||+.|||||++.+.  .|+.+
T Consensus       114 ~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~--~Y~~K  191 (467)
T KOG0201|consen  114 AVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQS--GYDTK  191 (467)
T ss_pred             eeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhccc--cccch
Confidence            9999999999999999999999999999999999999999999986544332  3567799999999999743  38999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      +||||||++.++|++|.+|+...........+.+...|.+...+++.+++||..||+++|+.|||+.++|+|+|++..
T Consensus       192 ADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  192 ADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             hhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence            999999999999999999999988877777777888888888999999999999999999999999999999999973

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.1e-43  Score=283.78  Aligned_cols=232  Identities=29%  Similarity=0.524  Sum_probs=189.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|..+|+|.+....    .....+.+.+|++++++++|+||+++++++.+++..++||||+++++|.++++.. .+++..
T Consensus        29 ~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  104 (333)
T cd06650          29 SGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI  104 (333)
T ss_pred             CCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCCCCHHH
Confidence            36788999886532    2344567889999999999999999999999999999999999999999998764 488899


Q ss_pred             HHHHHHHHHHHHHHhhhC-CeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcc
Q 041080           80 VSSYTRQILNGLVYLHER-NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~-~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      +..++.+++.|+.|||+. +++|+||||+||+++.++.++|+|||++............++..|+|||.+.+..  ++.+
T Consensus       105 ~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~  182 (333)
T cd06650         105 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--YSVQ  182 (333)
T ss_pred             HHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccccCCCCccccCHHHhcCCC--CCcH
Confidence            999999999999999975 7999999999999999999999999998655444344456888999999986543  7889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHH--------------------------------------------HhhcCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALF--------------------------------------------RIGKGE  194 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~--------------------------------------------~~~~~~  194 (247)
                      +|+||||+++|++++|+.||..........                                            .+....
T Consensus       183 ~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (333)
T cd06650         183 SDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEP  262 (333)
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCC
Confidence            999999999999999999987544322211                                            111111


Q ss_pred             CCCCC-CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCCC
Q 041080          195 LPSVP-SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQ  238 (247)
Q Consensus       195 ~~~~~-~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~~  238 (247)
                      .+..+ ..++.++++++.+||..||.+|||+++++.||||+....
T Consensus       263 ~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  307 (333)
T cd06650         263 PPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEA  307 (333)
T ss_pred             CccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCcc
Confidence            11222 246789999999999999999999999999999997643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.7e-43  Score=275.20  Aligned_cols=231  Identities=46%  Similarity=0.828  Sum_probs=195.7

Q ss_pred             CCceEEEEEEeecCCCcc----chHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CC
Q 041080            1 DGFFFAVKEVSLQDQGAQ----GKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~   75 (247)
                      +|+.||+|.+........    .....+.+.+|+.++++++||||+++++++...+..++++||+++++|.+++... .+
T Consensus        24 ~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l  103 (267)
T cd06628          24 SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAF  103 (267)
T ss_pred             CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCc
Confidence            367899999876543222    2233467889999999999999999999999999999999999999999999764 48


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--------cccCCCCCCccCCcc
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--------LKSCKGTPFWMAPEV  147 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--------~~~~~~~~~~~aPE~  147 (247)
                      ++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......        .....++..|+|||.
T Consensus       104 ~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~  183 (267)
T cd06628         104 EETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV  183 (267)
T ss_pred             cHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhH
Confidence            889999999999999999999999999999999999999999999999876544211        112336778999999


Q ss_pred             cccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhh
Q 041080          148 VNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL  227 (247)
Q Consensus       148 ~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  227 (247)
                      +.+..  ++.++|+||+|++++++++|..||...........+.....+..+..++..+++++.+||+++|.+||++.++
T Consensus       184 ~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  261 (267)
T cd06628         184 VKQTS--YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAEL  261 (267)
T ss_pred             hccCC--CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHH
Confidence            86543  6889999999999999999999998776655555555555667778899999999999999999999999999


Q ss_pred             hcCccC
Q 041080          228 MEHPFV  233 (247)
Q Consensus       228 l~~p~~  233 (247)
                      ++||||
T Consensus       262 l~~~~~  267 (267)
T cd06628         262 LKHPFL  267 (267)
T ss_pred             hhCCCC
Confidence            999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-44  Score=291.55  Aligned_cols=231  Identities=33%  Similarity=0.501  Sum_probs=194.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++......  .......+.+|+.++..++|+||+++++++.+++..++||||+++++|.+++.+. .+++..
T Consensus        25 ~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~  102 (350)
T cd05573          25 TGQVYAMKVLRKSDMI--KRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET  102 (350)
T ss_pred             CCCEEEEEEEEHHHHh--hccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHH
Confidence            4789999999764321  2234566889999999999999999999999999999999999999999998775 589999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---------------------------
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---------------------------  132 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---------------------------  132 (247)
                      ++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.......                           
T Consensus       103 ~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (350)
T cd05573         103 ARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ  182 (350)
T ss_pred             HHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccccccccccccccccccccc
Confidence            99999999999999999999999999999999999999999999986544322                           


Q ss_pred             ----cccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc--CCC-CCCCCcCCHH
Q 041080          133 ----LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK--GEL-PSVPSSLSRD  205 (247)
Q Consensus       133 ----~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~  205 (247)
                          .....|++.|+|||.+.+.  .++.++||||||+++|+|++|..||...........+..  ... ......++++
T Consensus       183 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~  260 (350)
T cd05573         183 RRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPE  260 (350)
T ss_pred             ccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHH
Confidence                2234588999999999665  378999999999999999999999988776665555443  111 1112336999


Q ss_pred             HHHHHHHHhcCCCCCCCC-hhhhhcCccCCCC
Q 041080          206 ARDFILKCLQVNPNDRPT-VTELMEHPFVKRP  236 (247)
Q Consensus       206 ~~~li~~~l~~~p~~Rps-~~~il~~p~~~~~  236 (247)
                      +.++|.+||. +|.+|++ ++++++||||+..
T Consensus       261 ~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         261 AIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             HHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence            9999999997 9999999 9999999999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-43  Score=284.08  Aligned_cols=232  Identities=33%  Similarity=0.562  Sum_probs=204.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~   79 (247)
                      +|+.+|+|.+.+....  .....+.+.+|+.+|+++. ||||+.+.++|++...+++|||++.||.|.+.+.+..+++..
T Consensus        59 tg~~~A~K~i~k~~~~--~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~~~sE~d  136 (382)
T KOG0032|consen   59 TGKEVACKVIPKRKLR--GKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKKHYSERD  136 (382)
T ss_pred             CCceeEEEEeehhhcc--ccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHccCCHHH
Confidence            4889999999876542  2225678889999999998 999999999999999999999999999999988665699999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC----CCeEEcccccccccCcc-ccccCCCCCCccCCcccccCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS----GSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~----~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +..++.|++.++.|||+.|++|+|+||+|+++...    +.++++|||++...... ......|++.|+|||.+....  
T Consensus       137 a~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~--  214 (382)
T KOG0032|consen  137 AAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRP--  214 (382)
T ss_pred             HHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCC--
Confidence            99999999999999999999999999999999643    47999999999876653 455677999999999996544  


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCC---CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP---SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                      ++...|+||+|+++|.|++|..||...+.......+..+...   ..-..++..++++++.||..||.+|+|+.++|+||
T Consensus       215 y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp  294 (382)
T KOG0032|consen  215 YGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHP  294 (382)
T ss_pred             CCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence            899999999999999999999999999888888777776542   22346799999999999999999999999999999


Q ss_pred             cCCCC
Q 041080          232 FVKRP  236 (247)
Q Consensus       232 ~~~~~  236 (247)
                      |++..
T Consensus       295 Wi~~~  299 (382)
T KOG0032|consen  295 WIKSI  299 (382)
T ss_pred             cccCC
Confidence            99975

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.6e-43  Score=277.58  Aligned_cols=232  Identities=25%  Similarity=0.387  Sum_probs=187.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~   77 (247)
                      +|+.||+|.+.......  ......+..|+.++++++||||+++++.+..+...++||||+++++|.+++...   ++++
T Consensus        17 ~~~~~a~K~~~~~~~~~--~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~   94 (277)
T cd05607          17 TGKMYACKKLDKKRLKK--KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEM   94 (277)
T ss_pred             CCcEEEEEEEcHHHhhc--chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCH
Confidence            47899999996543211  122334567999999999999999999999999999999999999998887543   4888


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ..+..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+....... .....++..|+|||.+.+..  ++
T Consensus        95 ~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~  172 (277)
T cd05607          95 ERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEP--YS  172 (277)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCC--CC
Confidence            8999999999999999999999999999999999999999999999886544322 22345788999999986554  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhh----HHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh----hhhh
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGV----QALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV----TELM  228 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~~il  228 (247)
                      .++|+||+|+++|++++|..||......    .................+++++++++.+||+.+|.+||++    ++++
T Consensus       173 ~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         173 YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             CchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            9999999999999999999999764332    2222222222222335689999999999999999999999    6778


Q ss_pred             cCccCCCC
Q 041080          229 EHPFVKRP  236 (247)
Q Consensus       229 ~~p~~~~~  236 (247)
                      +||||+..
T Consensus       253 ~h~~f~~~  260 (277)
T cd05607         253 KHEFFKTI  260 (277)
T ss_pred             cChhhcCC
Confidence            99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2e-43  Score=284.01  Aligned_cols=231  Identities=27%  Similarity=0.454  Sum_probs=194.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCC-CceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ-DNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||||++.....  ......+.+..|..++..++| ++|+++++.+...+..++||||+++++|.+++... .+++.
T Consensus        24 ~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~  101 (324)
T cd05587          24 TDELYAIKILKKDVI--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP  101 (324)
T ss_pred             CCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHH
Confidence            367899999976432  123345567789999999976 56888999999999999999999999999988664 48999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccC--ccccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....  ........|+..|+|||.+.+..  ++
T Consensus       102 ~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  179 (324)
T cd05587         102 HAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQP--YG  179 (324)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCC--CC
Confidence            999999999999999999999999999999999999999999999875422  22233445889999999996544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh-----hhhhcCc
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV-----TELMEHP  231 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~~p  231 (247)
                      .++|+||+|+++|+|++|+.||...........+.... ..++..++.++.+++.+||..+|.+|++.     +++++||
T Consensus       180 ~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp  258 (324)
T cd05587         180 KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHA  258 (324)
T ss_pred             cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence            89999999999999999999998877777666665543 45677899999999999999999999987     8999999


Q ss_pred             cCCCC
Q 041080          232 FVKRP  236 (247)
Q Consensus       232 ~~~~~  236 (247)
                      ||+..
T Consensus       259 ~~~~~  263 (324)
T cd05587         259 FFRRI  263 (324)
T ss_pred             CcCCC
Confidence            99864

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.5e-43  Score=285.10  Aligned_cols=232  Identities=27%  Similarity=0.482  Sum_probs=191.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~   78 (247)
                      +|+.||+|++.....  ......+.+.+|+.++.++ +||+|+++++.+...+..++||||+++++|...+.. ..+++.
T Consensus        19 ~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~   96 (327)
T cd05617          19 NDQIYAMKVVKKELV--HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEE   96 (327)
T ss_pred             CCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHH
Confidence            467899999976432  2234456788999999998 699999999999999999999999999999988765 469999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccC--ccccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .+..++.|++.||++||++|++|+||||+||+++.++.++|+|||++....  ........|++.|+|||.+.+..  ++
T Consensus        97 ~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  174 (327)
T cd05617          97 HARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE--YG  174 (327)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCC--CC
Confidence            999999999999999999999999999999999999999999999886422  12223455889999999986544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCCh------hhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC------h
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLE------GVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT------V  224 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps------~  224 (247)
                      .++|+||||+++|+|++|..||....      ................+..++..+.+++.+||+.+|.+|++      +
T Consensus       175 ~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~  254 (327)
T cd05617         175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGF  254 (327)
T ss_pred             chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCH
Confidence            89999999999999999999995321      12222222333344567788999999999999999999998      5


Q ss_pred             hhhhcCccCCCC
Q 041080          225 TELMEHPFVKRP  236 (247)
Q Consensus       225 ~~il~~p~~~~~  236 (247)
                      +++++||||+..
T Consensus       255 ~~i~~h~~f~~~  266 (327)
T cd05617         255 SDIKSHTFFRSI  266 (327)
T ss_pred             HHHHcCCCCCCC
Confidence            799999999874

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-43  Score=276.82  Aligned_cols=236  Identities=38%  Similarity=0.671  Sum_probs=203.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.||+|.+....    .......+.+|+.+++.++|+|++++++++..+...++|+||+++++|.+++....+++..+
T Consensus        25 ~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~  100 (274)
T cd06609          25 TNQVVAIKVIDLEE----AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYI  100 (274)
T ss_pred             CCeEEEEEEeeccc----cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhcCCCHHHH
Confidence            47889999987532    23345567899999999999999999999999999999999999999999998888999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCCcc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......  ......++..|+|||.+.+..  ++.+
T Consensus       101 ~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~  178 (274)
T cd06609         101 AFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG--YDEK  178 (274)
T ss_pred             HHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccccCCccccChhhhccCC--CCch
Confidence            999999999999999999999999999999999999999999998665433  223345778899999996655  7899


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCc-CCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSS-LSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      +|+||||+++|++++|..||...........+.....+..+.. ++.++.+++.+||..+|.+|||++++++||||+...
T Consensus       179 sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         179 ADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             hhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence            9999999999999999999987776666666555555555555 899999999999999999999999999999999876


Q ss_pred             CCCCC
Q 041080          238 QTPRC  242 (247)
Q Consensus       238 ~~~~~  242 (247)
                      +...+
T Consensus       259 ~~~~~  263 (274)
T cd06609         259 KTSYL  263 (274)
T ss_pred             cccHH
Confidence            65444

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.1e-44  Score=271.14  Aligned_cols=231  Identities=27%  Similarity=0.454  Sum_probs=191.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeee--cCCcEEEEEeccccCcHHHHHHhc--CCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDK--DENRLYIFLELVTKGSLANLYQKY--HLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~--~~~   76 (247)
                      +++.||+|+++.+..  ....-+. ..+||.+|.+++|||||.+..+..  .-+..|+||||+.. +|..+++..  ++.
T Consensus       100 t~eIVALKr~kmeke--k~GFPIt-sLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~  175 (419)
T KOG0663|consen  100 TDEIVALKRLKMEKE--KEGFPIT-SLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFL  175 (419)
T ss_pred             cceeEEeeecccccc--cCCCcch-hHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccCCCc
Confidence            467899999987642  2222222 458999999999999999988754  44679999999988 999999765  499


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      ..++..++.|++.|++|||.++|+|||||++|++++..|.+||+|||+++..+..  .....+-|.||+|||.+.+... 
T Consensus       176 ~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~t-  254 (419)
T KOG0663|consen  176 PGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKT-  254 (419)
T ss_pred             hHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcc-
Confidence            9999999999999999999999999999999999999999999999999877655  3455667999999999987765 


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC---------------------CCCCC---------CC-cCC
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG---------------------ELPSV---------PS-SLS  203 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---------------------~~~~~---------~~-~~~  203 (247)
                      |+.+.|+||+||++.+++++++.|......+.+..+-..                     .++..         +. ..+
T Consensus       255 yst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~ls  334 (419)
T KOG0663|consen  255 YSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLS  334 (419)
T ss_pred             cCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccc
Confidence            899999999999999999999999888777766554211                     00010         11 155


Q ss_pred             HHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          204 RDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       204 ~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      +.-.+|+..+|..||.+|.|++|.|+|+||++.
T Consensus       335 e~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  335 EQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             hhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence            888899999999999999999999999999983

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=7.3e-43  Score=271.80  Aligned_cols=228  Identities=29%  Similarity=0.535  Sum_probs=197.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~   77 (247)
                      +|+.|++|.+.....   .......+.+|+.++++++|||++++++++...+..+++|||+++++|.+++...   .+++
T Consensus        24 ~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  100 (256)
T cd08529          24 DKRVYAMKQIDLSKM---NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPE  100 (256)
T ss_pred             CCcEEEEEEeehhhC---CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCH
Confidence            478899999875432   2445667889999999999999999999999999999999999999999998764   4889


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ..++.++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+..  +
T Consensus       101 ~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~  178 (256)
T cd08529         101 DQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP--Y  178 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCC--C
Confidence            9999999999999999999999999999999999999999999999876544332  22334778899999986544  7


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      +.++|+||||++++++++|..||...........+.....+..+..++.++.+++.+||+.+|.+||++.++++|||.
T Consensus       179 ~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         179 NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            889999999999999999999998877767677766666667777889999999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.4e-43  Score=289.28  Aligned_cols=234  Identities=27%  Similarity=0.438  Sum_probs=193.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.||+|++.....  ........+.+|+.+++.++||||+++++.+..++..++||||+++|+|.+++....+++..+
T Consensus        67 ~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~~~~~  144 (370)
T cd05621          67 SQKVYAMKLLSKFEM--IKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWA  144 (370)
T ss_pred             CCCEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcCCCHHHH
Confidence            477899999975321  122334557789999999999999999999999999999999999999999998888999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCC--CCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKN--DGY  155 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~--~~~  155 (247)
                      ..++.|++.||++||++||+|+||||+||+++.++.++|+|||.+.......   .....|++.|+|||.+.+..  ..+
T Consensus       145 ~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~  224 (370)
T cd05621         145 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYY  224 (370)
T ss_pred             HHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCC
Confidence            9999999999999999999999999999999999999999999987543322   23455899999999986533  236


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC-CCCCC--CcCCHHHHHHHHHHhcCCCC--CCCChhhhhcC
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE-LPSVP--SSLSRDARDFILKCLQVNPN--DRPTVTELMEH  230 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~--~Rps~~~il~~  230 (247)
                      +.++|+||+|+++|+|++|..||...........+.... ....+  ..++..+++++..||..++.  .|++++++++|
T Consensus       225 ~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         225 GRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            789999999999999999999998877666665554432 12223  35789999999999985554  38999999999


Q ss_pred             ccCCCC
Q 041080          231 PFVKRP  236 (247)
Q Consensus       231 p~~~~~  236 (247)
                      |||+..
T Consensus       305 p~~~~~  310 (370)
T cd05621         305 PFFKND  310 (370)
T ss_pred             cccCCC
Confidence            999863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-43  Score=289.29  Aligned_cols=231  Identities=29%  Similarity=0.480  Sum_probs=191.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++.....  ........+.+|+.++..++||||+++++.+.+++..++||||+++++|.+++... .+++..
T Consensus        25 ~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~  102 (364)
T cd05599          25 TGHIYAMKKLRKSEM--LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE  102 (364)
T ss_pred             CCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHHH
Confidence            478999999975432  12334566889999999999999999999999999999999999999999988664 489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---------------------------
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---------------------------  132 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---------------------------  132 (247)
                      +..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......                           
T Consensus       103 ~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (364)
T cd05599         103 TRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK  182 (364)
T ss_pred             HHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999999999999999999999875432110                           


Q ss_pred             -------------cccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC-CCC
Q 041080          133 -------------LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL-PSV  198 (247)
Q Consensus       133 -------------~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~  198 (247)
                                   .....|++.|+|||.+.+..  ++.++|+|||||++|+|++|..||...........+..... ...
T Consensus       183 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~  260 (364)
T cd05599         183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG--YNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQF  260 (364)
T ss_pred             ccccchhhcccccccccccCccccCHHHHcCCC--CCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCC
Confidence                         01234889999999985443  78999999999999999999999988776666555443221 122


Q ss_pred             C--CcCCHHHHHHHHHHhcCCCCCCCC---hhhhhcCccCCCC
Q 041080          199 P--SSLSRDARDFILKCLQVNPNDRPT---VTELMEHPFVKRP  236 (247)
Q Consensus       199 ~--~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~p~~~~~  236 (247)
                      +  ..++++++++|.+|+. +|.+|++   ++++++||||+..
T Consensus       261 ~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         261 PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            2  2578999999999997 8999997   9999999999763

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.4e-43  Score=288.53  Aligned_cols=232  Identities=25%  Similarity=0.451  Sum_probs=188.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++.....  ......+.+.+|+.+++.++|+||+++++.+.+.+..++||||+++|+|.+++.+. .+++..
T Consensus        25 ~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~  102 (381)
T cd05626          25 THALYAMKTLRKKDV--LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL  102 (381)
T ss_pred             CCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHH
Confidence            478899999976432  22344667889999999999999999999999999999999999999999988764 488999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc----------------------------
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----------------------------  131 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~----------------------------  131 (247)
                      +..++.|++.||.+||+.||+|+||||+||+++.++.++|+|||++......                            
T Consensus       103 ~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (381)
T cd05626         103 ARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN  182 (381)
T ss_pred             HHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccc
Confidence            9999999999999999999999999999999999999999999986421100                            


Q ss_pred             ---------------------ccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHh
Q 041080          132 ---------------------DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI  190 (247)
Q Consensus       132 ---------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~  190 (247)
                                           ......|+..|+|||.+.+..  ++.++|||||||++|+|++|..||...........+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i  260 (381)
T cd05626         183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG--YTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKV  260 (381)
T ss_pred             cccccccchhhccccccccccccccccCCccccCHHHHcCCC--CCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHH
Confidence                                 011245889999999986544  788999999999999999999999877665554444


Q ss_pred             hcC-CCCCCC--CcCCHHHHHHHHHHh--cCCCCCCCChhhhhcCccCCCC
Q 041080          191 GKG-ELPSVP--SSLSRDARDFILKCL--QVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       191 ~~~-~~~~~~--~~~~~~~~~li~~~l--~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ... .....+  ..+++++++++.+|+  ..++..|++++++++||||+..
T Consensus       261 ~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         261 INWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             HccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence            321 112222  357899999999965  4555569999999999999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=5.5e-43  Score=277.43  Aligned_cols=226  Identities=33%  Similarity=0.541  Sum_probs=178.7

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc---CCCceeeeceeee-----cCCcEEEEEeccccCcHHHHHHhc
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF---EQDNIVQYLGTDK-----DENRLYIFLELVTKGSLANLYQKY   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~   73 (247)
                      |+.||+|.+........   ....+.+|+.+++.+   +||||+++++++.     .....++||||+++ +|.+++...
T Consensus        27 ~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~  102 (290)
T cd07862          27 GRFVALKRVRVQTGEEG---MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKV  102 (290)
T ss_pred             CeEEEEEEEecccCCCC---chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCCC-CHHHHHHhC
Confidence            57899999876432221   123344666666655   6999999999875     34578999999975 898888653


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccc
Q 041080           74 ---HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVN  149 (247)
Q Consensus        74 ---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~  149 (247)
                         .+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+....... .....++..|+|||.+.
T Consensus       103 ~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  182 (290)
T cd07862         103 PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL  182 (290)
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCcccccccccccccChHHHh
Confidence               48899999999999999999999999999999999999999999999999986544332 23445789999999986


Q ss_pred             cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC--------------------------CCCCCcCC
Q 041080          150 SKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL--------------------------PSVPSSLS  203 (247)
Q Consensus       150 ~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~  203 (247)
                      +..  ++.++|+||+|+++|+|++|..||......+....+.....                          ......++
T Consensus       183 ~~~--~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (290)
T cd07862         183 QSS--YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID  260 (290)
T ss_pred             CCC--CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCC
Confidence            543  78899999999999999999999987766555444322100                          01113578


Q ss_pred             HHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          204 RDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       204 ~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      +.+++++.+||+.+|++|||+.++++||||
T Consensus       261 ~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         261 ELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             HHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.9e-42  Score=269.62  Aligned_cols=228  Identities=31%  Similarity=0.602  Sum_probs=192.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec-CCcEEEEEeccccCcHHHHHHhc---CCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD-ENRLYIFLELVTKGSLANLYQKY---HLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~---~~~   76 (247)
                      +|+.||+|.+....   ......+.+.+|+.++++++|+|++++++.+.. ....++++||+++++|.+++...   .++
T Consensus        24 ~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~  100 (257)
T cd08223          24 DGKQYVIKKLNLRN---ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLP  100 (257)
T ss_pred             CCcEEEEEEEehhh---cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCC
Confidence            36789999986532   223345568899999999999999999988764 44689999999999999988653   389


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +..++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......  ......+++.|+|||.+.+..  
T Consensus       101 ~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--  178 (257)
T cd08223         101 ENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKP--  178 (257)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCC--
Confidence            9999999999999999999999999999999999999999999999988654322  122344788899999986543  


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      ++.++|+||+|++++++++|..||...+..........+..+..+..+++++.+++.+||+.+|.+|||+.++++||||
T Consensus       179 ~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         179 YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            7889999999999999999999998776666655565666666777899999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.2e-43  Score=283.93  Aligned_cols=231  Identities=29%  Similarity=0.432  Sum_probs=190.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHH-HHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEIS-LLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||+|++......  .......+..|.. +++.++||||+++++.+...+..++||||+++++|...+.+. .+++.
T Consensus        19 ~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~   96 (325)
T cd05604          19 DGKCYAVKVLQKKIVL--NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP   96 (325)
T ss_pred             CCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHH
Confidence            5789999999754221  1223344455554 467789999999999999999999999999999998887654 58999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccC--ccccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....  ........|+..|+|||.+.+..  ++
T Consensus        97 ~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  174 (325)
T cd05604          97 RARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQP--YD  174 (325)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCC--CC
Confidence            999999999999999999999999999999999999999999999976432  22233455889999999996544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh----hhhhcCcc
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV----TELMEHPF  232 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~~il~~p~  232 (247)
                      .++|+||||+++|+|++|..||...+.......+..... ..+...+..+.+++.+||..+|.+||++    .++++|||
T Consensus       175 ~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~  253 (325)
T cd05604         175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL-VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPF  253 (325)
T ss_pred             CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc-cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCC
Confidence            899999999999999999999988777666666555433 4455689999999999999999999987    58999999


Q ss_pred             CCCC
Q 041080          233 VKRP  236 (247)
Q Consensus       233 ~~~~  236 (247)
                      |+..
T Consensus       254 f~~~  257 (325)
T cd05604         254 FESL  257 (325)
T ss_pred             cCCC
Confidence            9863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-43  Score=286.46  Aligned_cols=233  Identities=30%  Similarity=0.443  Sum_probs=190.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc---CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF---EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~   76 (247)
                      +|+.||+|++......  ..........|..++..+   +||+|+++++.+......++||||+++++|.+++.+. .++
T Consensus        17 ~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~   94 (330)
T cd05586          17 TRRIYAMKVLSKKEIV--AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS   94 (330)
T ss_pred             CCCEEEEEEEeHHHHh--hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCC
Confidence            4789999999754321  122233445566666665   6999999999999999999999999999998888654 489


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc--cccccCCCCCCccCCcccccCCCC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDLKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.....  .......|+..|+|||.+.+.. .
T Consensus        95 ~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~  173 (330)
T cd05586          95 EDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK-G  173 (330)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCC-C
Confidence            999999999999999999999999999999999999999999999999864322  2233455889999999986432 2


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC----ChhhhhcC
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP----TVTELMEH  230 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----s~~~il~~  230 (247)
                      ++.++|+||+|+++|+|++|..||...........+..+........+++++++++.+||+.+|.+||    +++++++|
T Consensus       174 ~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         174 YTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             CCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            68899999999999999999999988776666666655544333345799999999999999999998    78999999


Q ss_pred             ccCCCC
Q 041080          231 PFVKRP  236 (247)
Q Consensus       231 p~~~~~  236 (247)
                      |||+..
T Consensus       254 ~~~~~~  259 (330)
T cd05586         254 PFFADI  259 (330)
T ss_pred             ccccCC
Confidence            999863

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-43  Score=289.24  Aligned_cols=230  Identities=28%  Similarity=0.482  Sum_probs=187.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++.....  ......+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++... .+++..
T Consensus        25 ~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~  102 (377)
T cd05629          25 TGKIYAMKTLLKSEM--FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV  102 (377)
T ss_pred             CCCEEEEEEEEHHHH--HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHH
Confidence            478899999875421  12344667889999999999999999999999999999999999999999988664 488999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---------------------------
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---------------------------  132 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---------------------------  132 (247)
                      +..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......                           
T Consensus       103 ~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (377)
T cd05629         103 TRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD  182 (377)
T ss_pred             HHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999999999999999999999875211000                           


Q ss_pred             ----------------------cccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHh
Q 041080          133 ----------------------LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI  190 (247)
Q Consensus       133 ----------------------~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~  190 (247)
                                            .....|++.|+|||.+.+..  ++.++|+|||||++|+|++|..||......+....+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i  260 (377)
T cd05629         183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG--YGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKI  260 (377)
T ss_pred             cccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC--CCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHH
Confidence                                  00235888999999986544  789999999999999999999999876665555544


Q ss_pred             hcCC-CCCCC--CcCCHHHHHHHHHHhcCCCCCC---CChhhhhcCccCCC
Q 041080          191 GKGE-LPSVP--SSLSRDARDFILKCLQVNPNDR---PTVTELMEHPFVKR  235 (247)
Q Consensus       191 ~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~R---ps~~~il~~p~~~~  235 (247)
                      .... ...++  ..++.++++++.+||. +|.+|   +++.+++.||||+.
T Consensus       261 ~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~  310 (377)
T cd05629         261 INWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG  310 (377)
T ss_pred             HccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence            3321 11222  2578999999999998 66665   69999999999985

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-43  Score=276.31  Aligned_cols=231  Identities=25%  Similarity=0.414  Sum_probs=190.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~   77 (247)
                      +|+.||+|.+.....  ........+.+|+.+++.++||||+++++.+..++..++||||+.+++|.+++...   .+++
T Consensus        24 ~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  101 (285)
T cd05605          24 TGKMYACKKLEKKRI--KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE  101 (285)
T ss_pred             CCceEEEEEEehhhh--hhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCH
Confidence            478899999975432  12223455678999999999999999999999999999999999999998877542   4899


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+....... .....++..|+|||.+.+..  ++
T Consensus       102 ~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~  179 (285)
T cd05605         102 ERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNER--YT  179 (285)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCC--CC
Confidence            9999999999999999999999999999999999999999999999986543222 22345788999999986543  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHH---hhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----Chhhhh
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR---IGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTELM  228 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il  228 (247)
                      .++|+||+|+++|++++|..||...........   .........+..++..+++++.+||..||.+||     ++++++
T Consensus       180 ~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~  259 (285)
T cd05605         180 FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVK  259 (285)
T ss_pred             ccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHh
Confidence            899999999999999999999987554332211   122223445667899999999999999999999     899999


Q ss_pred             cCccCCC
Q 041080          229 EHPFVKR  235 (247)
Q Consensus       229 ~~p~~~~  235 (247)
                      +||||+.
T Consensus       260 ~~~~~~~  266 (285)
T cd05605         260 AHPFFRT  266 (285)
T ss_pred             cCcCccC
Confidence            9999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.1e-42  Score=269.45  Aligned_cols=232  Identities=64%  Similarity=1.068  Sum_probs=198.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-CCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~   79 (247)
                      +|+.|++|.+..........+..+.+.+|+.+++.++|+||+++++++..++..++++||+++++|.+++.+.. +++..
T Consensus        24 ~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  103 (258)
T cd06632          24 DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV  103 (258)
T ss_pred             CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHHH
Confidence            47899999998755444455667789999999999999999999999999999999999999999999987765 88999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCCCcc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      +..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+....... .....++..|++||.+.... .++.+
T Consensus       104 ~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~  182 (258)
T cd06632         104 IRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG-GYGLA  182 (258)
T ss_pred             HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCC-CCCch
Confidence            99999999999999999999999999999999999999999999876544333 23445788899999985433 36889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc-CCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      +|+||+|++++++++|..||.............. ...+..+..+++.+++++.+||+.+|.+||++++++.|||+
T Consensus       183 ~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         183 ADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             hhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            9999999999999999999977665444444333 44556677889999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-43  Score=280.23  Aligned_cols=235  Identities=28%  Similarity=0.431  Sum_probs=207.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~   78 (247)
                      .|..||||++.++...   .-+...+.+|+.-|+-.+|||||+++++......+|+|.|.-++|+|.+++.+  .++.+.
T Consensus        42 TGekVAVKviDKTKlD---~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~  118 (864)
T KOG4717|consen   42 TGEKVAVKVIDKTKLD---TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNED  118 (864)
T ss_pred             ccceeEEEEecccccc---hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHH
Confidence            4889999999987654   33455678999999999999999999999999999999999999999999854  479999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEc-CCCCeEEcccccccccCcc-ccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVD-ASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~-~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ...+++.||+.|+.|+|+..++|+||||+|+++. .-|-+||+|||++....+. .....+|+..|.|||++.+... ..
T Consensus       119 La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsY-DA  197 (864)
T KOG4717|consen  119 LAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSY-DA  197 (864)
T ss_pred             HHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCcc-CC
Confidence            9999999999999999999999999999999886 4689999999998765544 4667789999999999977653 36


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ++.||||||+++|.|++|+.||......+.+-.+...+. ..|..++.+.++||..||..||++|.|.++|..++|.+..
T Consensus       198 PAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY-tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~  276 (864)
T KOG4717|consen  198 PAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY-TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG  276 (864)
T ss_pred             cchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc-cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence            789999999999999999999999888888777776655 6788999999999999999999999999999999999986


Q ss_pred             CCCC
Q 041080          237 LQTP  240 (247)
Q Consensus       237 ~~~~  240 (247)
                      -++.
T Consensus       277 D~~~  280 (864)
T KOG4717|consen  277 DRGL  280 (864)
T ss_pred             CCCc
Confidence            5543

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=8e-43  Score=280.45  Aligned_cols=231  Identities=25%  Similarity=0.437  Sum_probs=194.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||+|++.....  ......+.+..|..++..+ .|++|+++++.+...+..++||||+++|+|.+.+... .+++.
T Consensus        24 ~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~  101 (323)
T cd05616          24 TDELYAIKILKKDVV--IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEP  101 (323)
T ss_pred             CCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHH
Confidence            367899999976432  1223345566788888877 5899999999999999999999999999999888654 58999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .+..++.|++.||++||+.|++|+||||+||+++.++.++|+|||++......  ......|++.|+|||.+.+..  ++
T Consensus       102 ~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  179 (323)
T cd05616         102 HAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQP--YG  179 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCC--CC
Confidence            99999999999999999999999999999999999999999999998643321  233455889999999996544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh-----hhhhcCc
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV-----TELMEHP  231 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~~p  231 (247)
                      .++|+||||+++|+|++|..||...........+.... ..++..++.++.+++.+||+.+|.+|++.     .++++||
T Consensus       180 ~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~  258 (323)
T cd05616         180 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA  258 (323)
T ss_pred             CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCC
Confidence            99999999999999999999998887777766665543 35677899999999999999999999985     8999999


Q ss_pred             cCCCC
Q 041080          232 FVKRP  236 (247)
Q Consensus       232 ~~~~~  236 (247)
                      ||+..
T Consensus       259 ~~~~~  263 (323)
T cd05616         259 FFRYI  263 (323)
T ss_pred             CcCCC
Confidence            99853

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.2e-42  Score=276.46  Aligned_cols=233  Identities=36%  Similarity=0.628  Sum_probs=193.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.||+|.+.....     ...+.+.+|+.+++.++|+||+++++++..++..++||||+++++|.+++.+..+++..+
T Consensus        43 ~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  117 (297)
T cd06656          43 TGQEVAIKQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI  117 (297)
T ss_pred             CCCEEEEEEEecCcc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhCCCCHHHH
Confidence            478999999865322     223567899999999999999999999999999999999999999999998888999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCCcc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....+++.|++||.+.+..  ++.+
T Consensus       118 ~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~  195 (297)
T cd06656         118 AAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPK  195 (297)
T ss_pred             HHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCC--CCcH
Confidence            9999999999999999999999999999999999999999999876543322  22345778899999986543  7889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC--CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL--PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      +|+||+|+++|++++|..||...+.............  ...+..++..+++++.+||..+|.+||+++++++||||+..
T Consensus       196 ~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (297)
T cd06656         196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA  275 (297)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence            9999999999999999999976554333222222221  22345688999999999999999999999999999999976


Q ss_pred             CCCC
Q 041080          237 LQTP  240 (247)
Q Consensus       237 ~~~~  240 (247)
                      ...+
T Consensus       276 ~~~~  279 (297)
T cd06656         276 KPLS  279 (297)
T ss_pred             cccc
Confidence            5443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=9.2e-43  Score=276.34  Aligned_cols=234  Identities=34%  Similarity=0.616  Sum_probs=193.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.||||.+...     .....+.+.+|+..++.++|+||+++++.+..++..+++|||+++++|.+++....+++..+
T Consensus        46 ~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~  120 (292)
T cd06658          46 TGKQVAVKKMDLR-----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI  120 (292)
T ss_pred             CCCEEEEEEEecc-----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcCCCCHHHH
Confidence            4788999988542     23345668899999999999999999999999999999999999999999988777999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCCcc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++.......  .....++..|+|||.+.+..  ++.+
T Consensus       121 ~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~  198 (292)
T cd06658         121 ATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP--YGTE  198 (292)
T ss_pred             HHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCC--CCch
Confidence            9999999999999999999999999999999999999999999875432221  22344788899999985443  7889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCC--CCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPS--VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      +|+||+|++++++++|..||...........+.....+.  .....+..+.+++.+||..+|.+|||++++++||||+..
T Consensus       199 ~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~  278 (292)
T cd06658         199 VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA  278 (292)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence            999999999999999999998766555444433322222  223578899999999999999999999999999999975


Q ss_pred             CCCCCC
Q 041080          237 LQTPRC  242 (247)
Q Consensus       237 ~~~~~~  242 (247)
                       ..|.|
T Consensus       279 -~~~~~  283 (292)
T cd06658         279 -GPPSC  283 (292)
T ss_pred             -CCccc
Confidence             33444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.1e-43  Score=280.94  Aligned_cols=230  Identities=29%  Similarity=0.434  Sum_probs=189.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHH-HHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEI-SLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||+|++.....  ........+.+|. .+++.++||||+++++.+.+.+..++||||+++++|...+.+. .+++.
T Consensus        19 ~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~   96 (321)
T cd05603          19 DGSFYAVKVLQKKTI--LKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP   96 (321)
T ss_pred             CCCEEEEEEEEHHHH--HHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHH
Confidence            478899999975432  1122234444554 4678889999999999999999999999999999998887654 58899


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc--cccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....  .......|++.|+|||.+.+..  ++
T Consensus        97 ~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  174 (321)
T cd05603          97 RARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEP--YD  174 (321)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCC--CC
Confidence            9999999999999999999999999999999999999999999998764321  2223345889999999986544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh----hhhhcCcc
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV----TELMEHPF  232 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~~il~~p~  232 (247)
                      .++|+||||+++|+|++|..||...+.......+.... ...+...+..+.+++.+||+.+|.+|+++    .++++|||
T Consensus       175 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~  253 (321)
T cd05603         175 RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP-LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVF  253 (321)
T ss_pred             CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCC
Confidence            89999999999999999999998877666666655443 35567789999999999999999999876    49999999


Q ss_pred             CCC
Q 041080          233 VKR  235 (247)
Q Consensus       233 ~~~  235 (247)
                      |+.
T Consensus       254 ~~~  256 (321)
T cd05603         254 FSP  256 (321)
T ss_pred             cCC
Confidence            975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.7e-42  Score=272.93  Aligned_cols=230  Identities=37%  Similarity=0.668  Sum_probs=198.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.||+|.+...    ........+.+|+.+++++.|+||+++++.+.+++..++||||+++++|.+++....+++..+
T Consensus        28 ~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~l~~~~~  103 (277)
T cd06640          28 TQQVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI  103 (277)
T ss_pred             CCEEEEEEEEecc----ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcCCCCHHHH
Confidence            3678999998753    223456788899999999999999999999999999999999999999999998888999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCCcc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ..++.|++.|+.++|+.|++|+||+|+||+++.++.++++|||.+.......  .....++..|+|||.+.+..  .+.+
T Consensus       104 ~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~  181 (277)
T cd06640         104 ATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA--YDSK  181 (277)
T ss_pred             HHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCC--CccH
Confidence            9999999999999999999999999999999999999999999986543322  12234677899999986544  7889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      +|+||||+++|++++|..||...........+.....+..+..++..+.+++.+||+.+|.+||+++++++||||...
T Consensus       182 ~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06640         182 ADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN  259 (277)
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence            999999999999999999998777666655555555566667788999999999999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.4e-43  Score=288.03  Aligned_cols=231  Identities=26%  Similarity=0.471  Sum_probs=189.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++.....  ........+.+|+.++++++|+||+++++.+.+++..++||||+++|+|.+++.+. .+++..
T Consensus        25 ~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~  102 (382)
T cd05625          25 TKALYAMKTLRKKDV--LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDL  102 (382)
T ss_pred             CCCEEEEEEEeHHHh--hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHH
Confidence            478899999975321  22344667889999999999999999999999999999999999999999988764 488999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc----------------------------
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----------------------------  131 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~----------------------------  131 (247)
                      +..++.|++.||.+||+.||+|+||||+||+++.++.++|+|||++......                            
T Consensus       103 ~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (382)
T cd05625         103 ARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN  182 (382)
T ss_pred             HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccccccccccccccccccccccccc
Confidence            9999999999999999999999999999999999999999999986421100                            


Q ss_pred             ---------------------ccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHh
Q 041080          132 ---------------------DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI  190 (247)
Q Consensus       132 ---------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~  190 (247)
                                           ......|++.|+|||.+.+..  ++.++|+||+||++|+|++|..||...+.......+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i  260 (382)
T cd05625         183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG--YTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKV  260 (382)
T ss_pred             ccccccccchhhhhccccccccccccccCcccCCHHHhcCCC--CCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                                 011235889999999986544  789999999999999999999999877665555444


Q ss_pred             hcCC-CCCC--CCcCCHHHHHHHHHHhcCCCCCCCC---hhhhhcCccCCCC
Q 041080          191 GKGE-LPSV--PSSLSRDARDFILKCLQVNPNDRPT---VTELMEHPFVKRP  236 (247)
Q Consensus       191 ~~~~-~~~~--~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~p~~~~~  236 (247)
                      .... ....  ...++++..++|.+|+ .+|.+|++   ++++++||||+..
T Consensus       261 ~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         261 INWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            3321 1122  2467899999999976 59999987   9999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.9e-43  Score=284.90  Aligned_cols=233  Identities=29%  Similarity=0.449  Sum_probs=193.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.||+|++.....  ......+.+.+|+.+++.++|+||+++++.+...+..++||||+++++|.+++.+.  .+++.
T Consensus        25 ~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~  102 (330)
T cd05601          25 TGDIYAMKVMKKSVL--LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDED  102 (330)
T ss_pred             CCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHH
Confidence            478999999976432  12334567889999999999999999999999999999999999999999999774  58999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc---ccCCCCCCccCCcccccC----
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL---KSCKGTPFWMAPEVVNSK----  151 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~----  151 (247)
                      .+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+........   ....++..|+|||.+...    
T Consensus       103 ~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  182 (330)
T cd05601         103 MAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG  182 (330)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccc
Confidence            9999999999999999999999999999999999999999999999865443221   233578899999998532    


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC-CCCC--CCcCCHHHHHHHHHHhcCCCCCCCChhhhh
Q 041080          152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE-LPSV--PSSLSRDARDFILKCLQVNPNDRPTVTELM  228 (247)
Q Consensus       152 ~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il  228 (247)
                      ...++.++|+||||+++|+|++|..||...........+.... ...+  ...++.++++++..||. +|.+|||+++++
T Consensus       183 ~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~  261 (330)
T cd05601         183 KGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLC  261 (330)
T ss_pred             cCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHh
Confidence            2336789999999999999999999998776655555543322 1122  23578999999999998 999999999999


Q ss_pred             cCccCCCC
Q 041080          229 EHPFVKRP  236 (247)
Q Consensus       229 ~~p~~~~~  236 (247)
                      +||||+..
T Consensus       262 ~h~~~~~~  269 (330)
T cd05601         262 CHPFFSKI  269 (330)
T ss_pred             CCCCcCCC
Confidence            99999863

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.6e-43  Score=275.27  Aligned_cols=230  Identities=38%  Similarity=0.677  Sum_probs=196.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.||+|.+....    .....+.+.+|+.++++++||||+++++.+..++..++|+||+++++|.+++....+++..+
T Consensus        28 ~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  103 (277)
T cd06642          28 TKEVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYI  103 (277)
T ss_pred             CCeEEEEEEecccc----chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcCCCCHHHH
Confidence            36789999886432    23345678899999999999999999999999999999999999999999998878999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCCcc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ..++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+.......  .....++..|+|||.+.+..  ++.+
T Consensus       104 ~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~  181 (277)
T cd06642         104 ATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA--YDFK  181 (277)
T ss_pred             HHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCC--Cchh
Confidence            9999999999999999999999999999999999999999999986544322  12234678899999986543  7889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      +|+||||++++++++|..|+...........+.....+..+...+.++.+++.+||..+|.+||++.++++||||+..
T Consensus       182 ~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06642         182 ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY  259 (277)
T ss_pred             hhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence            999999999999999999997766555555555555555666788999999999999999999999999999999863

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.3e-43  Score=289.16  Aligned_cols=230  Identities=27%  Similarity=0.468  Sum_probs=188.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-CCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~   79 (247)
                      +|+.||||++.....  ........+.+|+.++++++|+||+++++.+.+++.+++||||+++++|.+++.+.+ +++..
T Consensus        25 ~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~  102 (376)
T cd05598          25 TNALYAMKTLRKADV--LMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL  102 (376)
T ss_pred             CCCEEEEEEEcHHHH--HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHH
Confidence            478899999865321  122345668899999999999999999999999999999999999999999987654 78889


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc----------------------------
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----------------------------  131 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~----------------------------  131 (247)
                      +..++.|++.||++||++||+|+||||+||+++.++.++|+|||++......                            
T Consensus       103 ~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (376)
T cd05598         103 ARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR  182 (376)
T ss_pred             HHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccccccccccccccccccccccccc
Confidence            9999999999999999999999999999999999999999999986421100                            


Q ss_pred             -----------------ccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC
Q 041080          132 -----------------DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE  194 (247)
Q Consensus       132 -----------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~  194 (247)
                                       ......|++.|+|||.+.+..  ++.++|||||||++|+|++|+.||......+....+....
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~  260 (376)
T cd05598         183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG--YTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWE  260 (376)
T ss_pred             ccccchhhhhhhhcccccccccCCCccccCHHHHcCCC--CCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccC
Confidence                             011235889999999996544  7889999999999999999999998777655544443221


Q ss_pred             C---CCCCCcCCHHHHHHHHHHhcCCCCCCC---ChhhhhcCccCCC
Q 041080          195 L---PSVPSSLSRDARDFILKCLQVNPNDRP---TVTELMEHPFVKR  235 (247)
Q Consensus       195 ~---~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~p~~~~  235 (247)
                      .   ......+++++.+++.+|+ .+|.+|+   +++++++||||+.
T Consensus       261 ~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~  306 (376)
T cd05598         261 TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG  306 (376)
T ss_pred             ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence            1   1122367899999999976 5999999   9999999999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.4e-42  Score=274.50  Aligned_cols=230  Identities=35%  Similarity=0.639  Sum_probs=193.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.|++|.+....     ....+.+.+|+.+++.++|||++++++.+..++..++|+||+++++|..++....+++..+
T Consensus        43 ~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~  117 (296)
T cd06655          43 TGQEVAIKQINLQK-----QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQI  117 (296)
T ss_pred             CCcEEEEEEEeccc-----CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhcCCCHHHH
Confidence            47889999986532     2234567899999999999999999999999999999999999999999998888999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCCcc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+..  ++.+
T Consensus       118 ~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~  195 (296)
T cd06655         118 AAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPK  195 (296)
T ss_pred             HHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCC--CCch
Confidence            9999999999999999999999999999999999999999999876543322  22345778899999986544  7889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC--CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL--PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      +|+||||+++|++++|..||...+.......+.....  ...+..+++.+.+++.+||..+|.+||++.+++.||||+..
T Consensus       196 ~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence            9999999999999999999987665444333322222  23455788999999999999999999999999999999974


Q ss_pred             C
Q 041080          237 L  237 (247)
Q Consensus       237 ~  237 (247)
                      .
T Consensus       276 ~  276 (296)
T cd06655         276 K  276 (296)
T ss_pred             c
Confidence            4

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-42  Score=273.66  Aligned_cols=232  Identities=34%  Similarity=0.591  Sum_probs=194.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc----CCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY----HLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~   76 (247)
                      +|+.||+|.+...    ........+.+|+.++++++|+||+++++.+...+..++||||+++++|..++...    .++
T Consensus        25 ~~~~~a~k~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~  100 (286)
T cd06622          25 TGVTMAMKEIRLE----LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIP  100 (286)
T ss_pred             CCcEEEEEEeecc----cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCC
Confidence            4788999988643    22334567889999999999999999999999999999999999999999988764    689


Q ss_pred             HHHHHHHHHHHHHHHHHhhh-CCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCC--
Q 041080           77 DSQVSSYTRQILNGLVYLHE-RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKND--  153 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--  153 (247)
                      +..+..++.+++.|+.+||+ .|++|+||+|+||+++.++.++|+|||.+............++..|+|||.+.+...  
T Consensus       101 ~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  180 (286)
T cd06622         101 EDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQ  180 (286)
T ss_pred             HHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccccCCCccCccCcchhcCCCCCc
Confidence            99999999999999999996 599999999999999999999999999986554444444557788999999854322  


Q ss_pred             --CCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHH---HHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhh
Q 041080          154 --GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQAL---FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM  228 (247)
Q Consensus       154 --~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il  228 (247)
                        .++.++|+||+|++++++++|..||.........   ..+.....+..+..++.++++++.+||..+|.+||++++++
T Consensus       181 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~  260 (286)
T cd06622         181 NPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLL  260 (286)
T ss_pred             cCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHh
Confidence              3578999999999999999999999765443332   23344455667777999999999999999999999999999


Q ss_pred             cCccCCCC
Q 041080          229 EHPFVKRP  236 (247)
Q Consensus       229 ~~p~~~~~  236 (247)
                      +||||...
T Consensus       261 ~~~~~~~~  268 (286)
T cd06622         261 EHPWLVKY  268 (286)
T ss_pred             cChhhhhc
Confidence            99999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.3e-44  Score=274.72  Aligned_cols=225  Identities=30%  Similarity=0.489  Sum_probs=186.8

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC-----cEEEEEeccccCcHHHHHHh----
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN-----RLYIFLELVTKGSLANLYQK----   72 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~----   72 (247)
                      ++.||||.+-.+.....         +|+.+|+.++||||+++..+|....     ...+||||++. +|.+.++.    
T Consensus        49 ~~~vAIKKv~~d~r~kn---------rEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~  118 (364)
T KOG0658|consen   49 EEEVAIKKVLQDKRYKN---------RELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRA  118 (364)
T ss_pred             CceeEEEEecCCCCcCc---------HHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhc
Confidence            67899999965433222         8999999999999999999875432     45799999987 99998873    


Q ss_pred             -cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC-CCeEEcccccccccCccc-cccCCCCCCccCCcccc
Q 041080           73 -YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVN  149 (247)
Q Consensus        73 -~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~  149 (247)
                       .+++...++-+..||+.|++|||+.||+||||||+|+++|.+ |.+||+|||.+......+ ...+..+..|+|||.+.
T Consensus       119 ~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELif  198 (364)
T KOG0658|consen  119 NQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIF  198 (364)
T ss_pred             CCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHc
Confidence             468888999999999999999999999999999999999976 899999999998665444 34566788999999998


Q ss_pred             cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC-------------------CCC--------C-CCCc
Q 041080          150 SKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG-------------------ELP--------S-VPSS  201 (247)
Q Consensus       150 ~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~~~--------~-~~~~  201 (247)
                      +... |+.+.||||.||++.||+.|++.|.+.+..+++..+.+-                   ..+        . +...
T Consensus       199 ga~~-Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~  277 (364)
T KOG0658|consen  199 GATE-YTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKR  277 (364)
T ss_pred             Cccc-cCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccC
Confidence            7665 899999999999999999999999887776665443210                   001        1 3346


Q ss_pred             CCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          202 LSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       202 ~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      .+++..+++.++|..+|.+|.++.+++.||||++-.
T Consensus       278 ~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr  313 (364)
T KOG0658|consen  278 LPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR  313 (364)
T ss_pred             CCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence            799999999999999999999999999999999753

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7e-43  Score=281.03  Aligned_cols=230  Identities=28%  Similarity=0.432  Sum_probs=188.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHH-HHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEI-SLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||+|++......  .......+..|. .+++.++||||+++++++...+..++||||+++++|.+++... .+++.
T Consensus        19 ~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~   96 (325)
T cd05602          19 EEKFYAVKVLQKKAIL--KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP   96 (325)
T ss_pred             CCCEEEEEEEEHHHHH--hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHH
Confidence            4678999999754221  112223334444 4567889999999999999999999999999999999988764 48888


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc--cccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||++.....  .......|++.|+|||.+.+..  ++
T Consensus        97 ~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  174 (325)
T cd05602          97 RARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQP--YD  174 (325)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCC--CC
Confidence            9999999999999999999999999999999999999999999999864321  2233455899999999986544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChh----hhhcCcc
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT----ELMEHPF  232 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~----~il~~p~  232 (247)
                      .++|+||+|+++|+|++|..||...........+..... ..+..++..+.+++.+||+.+|.+|+++.    ++++|+|
T Consensus       175 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~  253 (325)
T cd05602         175 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIF  253 (325)
T ss_pred             CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc-CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcc
Confidence            899999999999999999999988777666666554433 45567899999999999999999999876    8999999


Q ss_pred             CCC
Q 041080          233 VKR  235 (247)
Q Consensus       233 ~~~  235 (247)
                      |..
T Consensus       254 ~~~  256 (325)
T cd05602         254 FSP  256 (325)
T ss_pred             cCC
Confidence            965

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=9.5e-43  Score=284.51  Aligned_cols=233  Identities=27%  Similarity=0.414  Sum_probs=192.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.||+|++.....  ........+.+|+.+++.++||||+++++.+..++..++||||+++++|.++++...+++..+
T Consensus        67 ~~~~~aiK~i~~~~~--~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~  144 (371)
T cd05622          67 TRKVYAMKLLSKFEM--IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA  144 (371)
T ss_pred             CCcEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcCCCHHHH
Confidence            467899999865321  122334557789999999999999999999999999999999999999999998888999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCC--CCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKN--DGY  155 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~--~~~  155 (247)
                      ..++.|++.||.+||++||+|+||||+||+++.++.++|+|||.+.......   .....|++.|+|||.+.+..  ..+
T Consensus       145 ~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~  224 (371)
T cd05622         145 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYY  224 (371)
T ss_pred             HHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccC
Confidence            9999999999999999999999999999999999999999999986544322   22455899999999986532  236


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC-CCC--CCcCCHHHHHHHHHHhcCCCCC--CCChhhhhcC
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL-PSV--PSSLSRDARDFILKCLQVNPND--RPTVTELMEH  230 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~li~~~l~~~p~~--Rps~~~il~~  230 (247)
                      +.++|+||||+++|+|++|..||...+.......+..... ..+  ...++..+++++.+||..++.+  |++++++++|
T Consensus       225 ~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         225 GRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            8899999999999999999999988776666555543321 122  3468999999999999844433  7899999999


Q ss_pred             ccCCC
Q 041080          231 PFVKR  235 (247)
Q Consensus       231 p~~~~  235 (247)
                      |||+.
T Consensus       305 ~~~~~  309 (371)
T cd05622         305 LFFKN  309 (371)
T ss_pred             cccCC
Confidence            99976

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.5e-42  Score=292.12  Aligned_cols=230  Identities=27%  Similarity=0.448  Sum_probs=196.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC--------cEEEEEeccccCcHHHHHHh
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN--------RLYIFLELVTKGSLANLYQK   72 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~   72 (247)
                      +|+.||||++.....   .......+.+|+..+..++|+|++++++.+...+        .+++||||+++|+|.++++.
T Consensus        56 ~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~  132 (496)
T PTZ00283         56 DGEPFAVKVVDMEGM---SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKS  132 (496)
T ss_pred             CCCEEEEEEEecccC---CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHH
Confidence            578999999976532   3445667889999999999999999888764332        46899999999999998864


Q ss_pred             c-----CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc----ccccCCCCCCcc
Q 041080           73 Y-----HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTPFWM  143 (247)
Q Consensus        73 ~-----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~~~  143 (247)
                      .     .+++..+..++.|++.||.|+|+.|++|+||||+||+++.++.++|+|||++......    ......|++.|+
T Consensus       133 ~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~  212 (496)
T PTZ00283        133 RAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV  212 (496)
T ss_pred             hhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCccee
Confidence            3     4889999999999999999999999999999999999999999999999998643322    123455889999


Q ss_pred             CCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC
Q 041080          144 APEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT  223 (247)
Q Consensus       144 aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  223 (247)
                      |||.+.+..  ++.++||||||+++|+|++|..||..............+.....+..+++++.+++.+||+.+|.+||+
T Consensus       213 aPE~~~~~~--~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs  290 (496)
T PTZ00283        213 APEIWRRKP--YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPS  290 (496)
T ss_pred             CHHHhCCCC--CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcC
Confidence            999996544  789999999999999999999999888777777777766666778889999999999999999999999


Q ss_pred             hhhhhcCccCCC
Q 041080          224 VTELMEHPFVKR  235 (247)
Q Consensus       224 ~~~il~~p~~~~  235 (247)
                      +.++++|||++.
T Consensus       291 ~~ell~~p~~~~  302 (496)
T PTZ00283        291 SSKLLNMPICKL  302 (496)
T ss_pred             HHHHHhCHHHHH
Confidence            999999999875

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-42  Score=271.45  Aligned_cols=231  Identities=38%  Similarity=0.685  Sum_probs=194.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.+|+|.+...     .....+.+.+|+.++++++||||+++++.+..++..++||||+++++|.+++.+.  .+++.
T Consensus        29 ~~~~~~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~  103 (280)
T cd06611          29 TGLFAAAKIIQIE-----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEP  103 (280)
T ss_pred             CCcEEEEEEEeeC-----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHH
Confidence            4788999998643     3344567889999999999999999999999999999999999999999998763  48999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccC---CC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSK---ND  153 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~---~~  153 (247)
                      .++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|++||.+...   ..
T Consensus       104 ~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~  183 (280)
T cd06611         104 QIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDN  183 (280)
T ss_pred             HHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCC
Confidence            999999999999999999999999999999999999999999999875433221  2233478889999997532   23


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCC--CCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPS--VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                      .++.++|+||+|+++|++++|..||...........+.....+.  .+..++.++.+++.+||..+|.+||+++++++||
T Consensus       184 ~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  263 (280)
T cd06611         184 PYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHP  263 (280)
T ss_pred             CCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcCh
Confidence            36779999999999999999999998877666555555543332  3457889999999999999999999999999999


Q ss_pred             cCCCC
Q 041080          232 FVKRP  236 (247)
Q Consensus       232 ~~~~~  236 (247)
                      ||+..
T Consensus       264 ~~~~~  268 (280)
T cd06611         264 FVSDQ  268 (280)
T ss_pred             hhccc
Confidence            99876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.3e-42  Score=284.24  Aligned_cols=231  Identities=29%  Similarity=0.515  Sum_probs=186.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC-----cEEEEEeccccCcHHHHHHh-cC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN-----RLYIFLELVTKGSLANLYQK-YH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~-~~   74 (247)
                      +|+.||||.+....   ........+.+|+.+++.++|+||+++++++...+     ..++|+||+.+ +|.+.+.. ..
T Consensus        24 ~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~   99 (372)
T cd07853          24 DGKRVALKKMPNVF---QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQP   99 (372)
T ss_pred             CCCEEEEEeccccc---cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeecccc-CHHHHHhcCCC
Confidence            47899999886432   22334567889999999999999999999988776     78999999975 77776654 45


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSK  151 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~  151 (247)
                      +++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......   .....++..|+|||.+.+.
T Consensus       100 l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  179 (372)
T cd07853         100 LSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGS  179 (372)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCC
Confidence            8999999999999999999999999999999999999999999999999986543222   2234568889999998654


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc-----------------------C--CCC------CCCC
Q 041080          152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK-----------------------G--ELP------SVPS  200 (247)
Q Consensus       152 ~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-----------------------~--~~~------~~~~  200 (247)
                      .. ++.++|+||+|+++++|++|+.||...........+..                       .  ..+      ....
T Consensus       180 ~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (372)
T cd07853         180 RH-YTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSS  258 (372)
T ss_pred             CC-CCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCC
Confidence            32 68899999999999999999999977655443332211                       0  000      1224


Q ss_pred             cCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          201 SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       201 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ..++++.++|.+||+.||.+|||++++++||||+..
T Consensus       259 ~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         259 QATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             CCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence            468899999999999999999999999999999984

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.7e-42  Score=274.24  Aligned_cols=229  Identities=36%  Similarity=0.631  Sum_probs=191.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.|++|.+.....     ...+.+.+|+.+++.++|+||+++++.+..+...++||||+++++|.+++....+++..+
T Consensus        44 ~~~~v~ik~~~~~~~-----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  118 (296)
T cd06654          44 TGQEVAIRQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI  118 (296)
T ss_pred             CCcEEEEEEEecCCc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhcCCCHHHH
Confidence            477899999875432     224567899999999999999999999999999999999999999999998877899999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCCcc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....+++.|+|||.+.+..  .+.+
T Consensus       119 ~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~  196 (296)
T cd06654         119 AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPK  196 (296)
T ss_pred             HHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCC--CCcc
Confidence            9999999999999999999999999999999999999999999876543222  22345788899999986543  6889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC--CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL--PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      +|+||||+++|++++|+.||.................  ...+..++..+.+++.+||.++|.+||+++++++||||...
T Consensus       197 ~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence            9999999999999999999976655443332222222  22345688999999999999999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.7e-42  Score=269.60  Aligned_cols=231  Identities=28%  Similarity=0.472  Sum_probs=195.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.+++|++.....  ......+.+.+|+.+++.++||||+++++.+.++...++++||+++++|.+++.+. .+++..
T Consensus        17 ~~~~~~iK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~   94 (262)
T cd05572          17 KNRTFALKCVKKRHI--VETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYT   94 (262)
T ss_pred             CCcEEEEEEEehhcc--hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCHHH
Confidence            378999999976432  22334567889999999999999999999999999999999999999999998765 479999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCCCcc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      +..++.|++.||.++|+.|++|+||+|+||+++.++.++|+|||.+....... .....++..|++||.+.+..  ++.+
T Consensus        95 ~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~  172 (262)
T cd05572          95 ARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG--YDFS  172 (262)
T ss_pred             HHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCC--CCCh
Confidence            99999999999999999999999999999999999999999999987654432 22345788899999985433  7889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCh--hhHHHHHhhc-CCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC-----hhhhhcC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLE--GVQALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRPT-----VTELMEH  230 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~  230 (247)
                      +|+|++|+++|++++|..||....  .......+.. ......+...+++++++|.+||..+|.+||+     ++|+++|
T Consensus       173 ~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         173 VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             hhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            999999999999999999997766  4444444442 2344556667999999999999999999999     9999999


Q ss_pred             ccCCC
Q 041080          231 PFVKR  235 (247)
Q Consensus       231 p~~~~  235 (247)
                      |||+.
T Consensus       253 ~~~~~  257 (262)
T cd05572         253 KWFNG  257 (262)
T ss_pred             hhhhC
Confidence            99985

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.8e-42  Score=278.35  Aligned_cols=231  Identities=27%  Similarity=0.468  Sum_probs=193.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||+|++.....  ......+.+..|..++..+. |++|+++++++...+..++||||+++++|.+++... .+++.
T Consensus        24 ~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~  101 (323)
T cd05615          24 TDELYAIKILKKDVV--IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP  101 (323)
T ss_pred             CCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHH
Confidence            478999999975432  12233456778888888885 578888999999999999999999999999988764 58999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++......  ......|+..|+|||.+.+..  ++
T Consensus       102 ~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  179 (323)
T cd05615         102 QAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP--YG  179 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCC--CC
Confidence            99999999999999999999999999999999999999999999988643322  223345889999999986544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh-----hhhhcCc
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV-----TELMEHP  231 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~~p  231 (247)
                      .++|+||+|+++|+|++|..||...........+.... ...+..++.++.+++.+||+.+|.+|++.     +++++||
T Consensus       180 ~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~  258 (323)
T cd05615         180 KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHA  258 (323)
T ss_pred             CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCc
Confidence            89999999999999999999998877766666665543 35667889999999999999999999974     7899999


Q ss_pred             cCCCC
Q 041080          232 FVKRP  236 (247)
Q Consensus       232 ~~~~~  236 (247)
                      ||+..
T Consensus       259 ~f~~~  263 (323)
T cd05615         259 FFRRI  263 (323)
T ss_pred             ccCCC
Confidence            99974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=5.2e-42  Score=268.45  Aligned_cols=231  Identities=43%  Similarity=0.810  Sum_probs=192.9

Q ss_pred             CCceEEEEEEeecCCC-ccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQG-AQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.+|+|.+...... .........+.+|+.++++++|+||+++++++.+.+..++++||+++++|.+++.+. .+++.
T Consensus        23 ~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~  102 (265)
T cd06631          23 QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEP  102 (265)
T ss_pred             CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHH
Confidence            4678999998754322 222344567889999999999999999999999999999999999999999998764 58899


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc--------cccccCCCCCCccCCccccc
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM--------NDLKSCKGTPFWMAPEVVNS  150 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~  150 (247)
                      .+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.....        .......++..|+|||.+.+
T Consensus       103 ~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~  182 (265)
T cd06631         103 VFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE  182 (265)
T ss_pred             HHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcC
Confidence            9999999999999999999999999999999999999999999998764321        11223447888999999865


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc--CCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhh
Q 041080          151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK--GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM  228 (247)
Q Consensus       151 ~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il  228 (247)
                      ..  ++.++|+||+|++++++++|..||...+.......+..  ...+..+..++.++.+++.+||..+|.+||++.+++
T Consensus       183 ~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l  260 (265)
T cd06631         183 SG--YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLL  260 (265)
T ss_pred             CC--CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence            44  68899999999999999999999987655444333322  234566778999999999999999999999999999


Q ss_pred             cCccC
Q 041080          229 EHPFV  233 (247)
Q Consensus       229 ~~p~~  233 (247)
                      +||||
T Consensus       261 ~~~~~  265 (265)
T cd06631         261 RHDFL  265 (265)
T ss_pred             cCCCC
Confidence            99997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3e-42  Score=268.41  Aligned_cols=228  Identities=30%  Similarity=0.607  Sum_probs=196.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~   77 (247)
                      +|+.||+|.+.....   .......+.+|+.++++++||||+++++.+...+..++|+||+.+++|.+.+...   .+++
T Consensus        24 ~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~  100 (256)
T cd08218          24 DGKQYVIKEINISKM---SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPE  100 (256)
T ss_pred             CCCEEEEEEEEhHhC---ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCH
Confidence            478899999875432   2334457889999999999999999999999999999999999999999988653   3789


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+.......  .....++..|+|||.+.+..  .
T Consensus       101 ~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~  178 (256)
T cd08218         101 DQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRP--Y  178 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCC--C
Confidence            9999999999999999999999999999999999999999999999886543322  12234677899999986544  6


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      +.++|+||+|++++++++|..||...+..+....+..+..+..+..++.++++++.+||+.+|.+||++.++++||||
T Consensus       179 ~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         179 NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            889999999999999999999998877777777776666667778899999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.2e-43  Score=285.50  Aligned_cols=231  Identities=29%  Similarity=0.485  Sum_probs=190.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++.....  ........+.+|+.++.+++|++|+++++.+.+++..++||||+++++|.+++.+. .+++..
T Consensus        25 ~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~  102 (360)
T cd05627          25 TGHIYAMKILRKADM--LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEA  102 (360)
T ss_pred             CCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHHH
Confidence            478899999975321  22334567889999999999999999999999999999999999999999998654 589999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---------------------------
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---------------------------  132 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---------------------------  132 (247)
                      +..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++.......                           
T Consensus       103 ~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (360)
T cd05627         103 TQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA  182 (360)
T ss_pred             HHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCccccccccccccccc
Confidence            99999999999999999999999999999999999999999999875332110                           


Q ss_pred             ----------cccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC-CCCCC--
Q 041080          133 ----------LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE-LPSVP--  199 (247)
Q Consensus       133 ----------~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--  199 (247)
                                .....|++.|+|||.+.+..  ++.++|+|||||++|+|++|..||...........+.... ...++  
T Consensus       183 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  260 (360)
T cd05627         183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTG--YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPE  260 (360)
T ss_pred             ccccccccccccccCCCccccCHHHHcCCC--CCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCC
Confidence                      11235889999999986544  7889999999999999999999998877766655554321 11222  


Q ss_pred             CcCCHHHHHHHHHHhcCCCCCCC---ChhhhhcCccCCCC
Q 041080          200 SSLSRDARDFILKCLQVNPNDRP---TVTELMEHPFVKRP  236 (247)
Q Consensus       200 ~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~p~~~~~  236 (247)
                      ..+++++++++.+|+ .+|.+|+   +++++++||||+..
T Consensus       261 ~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         261 VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence            247899999999977 4999998   47999999999863

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.6e-42  Score=268.45  Aligned_cols=231  Identities=45%  Similarity=0.828  Sum_probs=190.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec--CCcEEEEEeccccCcHHHHHHhc-CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD--ENRLYIFLELVTKGSLANLYQKY-HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~-~~~~   77 (247)
                      +|+.|++|.+.............+.+.+|+.++++++||||+++++.+..  ....++++||+++++|.+++.+. .+++
T Consensus        26 ~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~  105 (266)
T cd06651          26 TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE  105 (266)
T ss_pred             CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCH
Confidence            37889999997665433444556778999999999999999999998765  35788999999999999988764 4889


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-----ccccCCCCCCccCCcccccCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-----DLKSCKGTPFWMAPEVVNSKN  152 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~  152 (247)
                      ..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......     ......++..|+|||.+.+. 
T Consensus       106 ~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-  184 (266)
T cd06651         106 SVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE-  184 (266)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCC-
Confidence            999999999999999999999999999999999999999999999988643321     11223467889999998654 


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc-CCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                       .++.++|+||+|++++++++|+.||.............. ...+..+..+++.+++++ +||..+|.+||+++++++||
T Consensus       185 -~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp  262 (266)
T cd06651         185 -GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHP  262 (266)
T ss_pred             -CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCc
Confidence             378899999999999999999999987665554443332 234556677889999999 68888999999999999999


Q ss_pred             cCC
Q 041080          232 FVK  234 (247)
Q Consensus       232 ~~~  234 (247)
                      ||+
T Consensus       263 ~~~  265 (266)
T cd06651         263 FAQ  265 (266)
T ss_pred             ccc
Confidence            997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.4e-42  Score=273.05  Aligned_cols=232  Identities=27%  Similarity=0.437  Sum_probs=190.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~   77 (247)
                      +|+.||+|.+.....  ........+.+|+.++++++|++++++++.+.+.+..+++|||+++++|.+++...   ++++
T Consensus        24 ~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~  101 (285)
T cd05630          24 TGKMYACKKLEKKRI--KKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEE  101 (285)
T ss_pred             CCceEEEEEEehhhc--cchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCH
Confidence            467899999875432  12333455678999999999999999999999999999999999999999888543   4889


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... .....++..|+|||.+.+..  ++
T Consensus       102 ~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~  179 (285)
T cd05630         102 GRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER--YT  179 (285)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCC--CC
Confidence            9999999999999999999999999999999999999999999999886543222 23345888999999996544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhh---HHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC-----hhhhh
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGV---QALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT-----VTELM  228 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il  228 (247)
                      .++|+||+|+++|++++|..||......   ..............+..+++++++++.+||+.+|.+|||     +++++
T Consensus       180 ~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~  259 (285)
T cd05630         180 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVK  259 (285)
T ss_pred             CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHH
Confidence            8999999999999999999999764321   122222222223455678999999999999999999999     89999


Q ss_pred             cCccCCCC
Q 041080          229 EHPFVKRP  236 (247)
Q Consensus       229 ~~p~~~~~  236 (247)
                      +||||++.
T Consensus       260 ~h~~~~~~  267 (285)
T cd05630         260 EHPLFKQI  267 (285)
T ss_pred             cChhhhcc
Confidence            99999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.5e-42  Score=272.23  Aligned_cols=230  Identities=32%  Similarity=0.526  Sum_probs=196.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.+|+|.+.....  ......+.+.+|++++++++||||+++++.+..++..+++|||+++++|.+++... .+++..
T Consensus        25 ~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~  102 (290)
T cd05580          25 SGKYYALKILSKAKI--VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPV  102 (290)
T ss_pred             CCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHH
Confidence            478899999875432  22334567889999999999999999999999999999999999999999998665 489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcch
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTA  159 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~  159 (247)
                      +..++.|++.||.+||+.|++|+||+|.||+++.++.++|+|||.+...... .....+++.|++||.+.+.  ..+.++
T Consensus       103 ~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~  179 (290)
T cd05580         103 ARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-TYTLCGTPEYLAPEIILSK--GYGKAV  179 (290)
T ss_pred             HHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-CCCCCCCccccChhhhcCC--CCCccc
Confidence            9999999999999999999999999999999999999999999998765443 3344578889999998554  368899


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----ChhhhhcCccCC
Q 041080          160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTELMEHPFVK  234 (247)
Q Consensus       160 Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~p~~~  234 (247)
                      |+||||+++++|++|..||...+.......+..+ ...++..++..+++++.+||..+|.+|+     +++++++||||+
T Consensus       180 Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~  258 (290)
T cd05580         180 DWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFA  258 (290)
T ss_pred             cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccc
Confidence            9999999999999999999877755555555443 3456677899999999999999999999     899999999998


Q ss_pred             CC
Q 041080          235 RP  236 (247)
Q Consensus       235 ~~  236 (247)
                      ..
T Consensus       259 ~~  260 (290)
T cd05580         259 GI  260 (290)
T ss_pred             cC
Confidence            63

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=7.6e-42  Score=269.48  Aligned_cols=227  Identities=30%  Similarity=0.534  Sum_probs=187.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.||+|.+....    .......+.+|++++.+++||||+++++.+...+..++||||+++++|..+   ..+++..+
T Consensus        25 ~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~---~~~~~~~~   97 (279)
T cd06619          25 TRRILAVKVIPLDI----TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY---RKIPEHVL   97 (279)
T ss_pred             CCcEEEEEEEecCC----ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh---hcCCHHHH
Confidence            47889999986532    233456788999999999999999999999999999999999999988654   24788899


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcchh
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTAD  160 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D  160 (247)
                      ..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++............++..|+|||.+.+..  ++.++|
T Consensus        98 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~D  175 (279)
T cd06619          98 GRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQ--YGIHSD  175 (279)
T ss_pred             HHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCCCChhhcCceeecCCC--CCCcch
Confidence            999999999999999999999999999999999999999999998765544445566888999999986543  788999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCChhh-------HHHHHhhcCCCCCC-CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          161 IWSLGCTVLEMLTRRPPYSHLEGV-------QALFRIGKGELPSV-PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       161 i~slG~ll~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      +||+|+++|++++|..||......       .....+.....+.. ....++++++++.+||..+|.+||+++++++|||
T Consensus       176 vwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~  255 (279)
T cd06619         176 VWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF  255 (279)
T ss_pred             HHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence            999999999999999998653321       11122222222222 3457889999999999999999999999999999


Q ss_pred             CCCC
Q 041080          233 VKRP  236 (247)
Q Consensus       233 ~~~~  236 (247)
                      |+..
T Consensus       256 ~~~~  259 (279)
T cd06619         256 IVQY  259 (279)
T ss_pred             cccc
Confidence            9865

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.2e-42  Score=276.33  Aligned_cols=230  Identities=28%  Similarity=0.479  Sum_probs=184.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC--CCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--LSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~   78 (247)
                      +++.||+|.+......    .....+.+|+.++++++||||+++++++..++..++||||+++ +|.+.+...+  ++..
T Consensus        30 ~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~  104 (309)
T cd07872          30 TENLVALKEIRLEHEE----GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMH  104 (309)
T ss_pred             CCCeEEEEEeeccccC----CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHH
Confidence            3678999999754321    1223466899999999999999999999999999999999986 7877776543  7889


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.......  .....++..|+|||.+.+.. .++
T Consensus       105 ~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~  183 (309)
T cd07872         105 NVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSS-EYS  183 (309)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCC-CCC
Confidence            999999999999999999999999999999999999999999999986433222  22345788999999886433 368


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC---------------------CCC--------CCCCcCCHHHH
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG---------------------ELP--------SVPSSLSRDAR  207 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---------------------~~~--------~~~~~~~~~~~  207 (247)
                      .++|+||+|+++++|++|..||...+..+....+...                     ..+        .....++++++
T Consensus       184 ~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (309)
T cd07872         184 TQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGI  263 (309)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHH
Confidence            8999999999999999999999776544332221110                     000        01134688999


Q ss_pred             HHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          208 DFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       208 ~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ++|.+||+.+|.+|||++++++||||+..
T Consensus       264 ~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         264 ELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             HHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence            99999999999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.1e-41  Score=265.20  Aligned_cols=228  Identities=30%  Similarity=0.545  Sum_probs=197.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~   77 (247)
                      +|+.+++|.+.....   .......+.+|+.++++++|+||+++++++.+.+..+++|||+++++|.+++.+.   .+++
T Consensus        24 ~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~  100 (256)
T cd08221          24 DDSLVVWKEVNLTRL---SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE  100 (256)
T ss_pred             CCcEEEEEEEeeccc---chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCH
Confidence            478899999876542   2344556889999999999999999999999999999999999999999999764   4889


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|.|||.+.+..  +
T Consensus       101 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~--~  178 (256)
T cd08221         101 EMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK--Y  178 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCC--C
Confidence            9999999999999999999999999999999999999999999999876543322  23345788999999986544  6


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      +.++|+||+|++++++++|..||......+....+..+.....+..++.++.+++.+||..+|.+||+++++++|||+
T Consensus       179 ~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         179 NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence            789999999999999999999998877777776766666666667789999999999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.8e-42  Score=265.66  Aligned_cols=231  Identities=34%  Similarity=0.590  Sum_probs=190.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCc-eeeeceeeecCC------cEEEEEeccccCcHHHHHHhc
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDN-IVQYLGTDKDEN------RLYIFLELVTKGSLANLYQKY   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~   73 (247)
                      +|+.||||+++.+...   +..-....+|+.++++++|+| |+.+++++.+.+      .+++|+||.+- +|.++++..
T Consensus        35 ~g~~VALKkirl~~~~---EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~  110 (323)
T KOG0594|consen   35 TGKFVALKKIRLEFEE---EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSL  110 (323)
T ss_pred             CCCEEEEEEEeccccc---cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhc
Confidence            5789999999876431   112334579999999999999 999999988776      89999999976 999998764


Q ss_pred             -----CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccC--ccccccCCCCCCccCCc
Q 041080           74 -----HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPE  146 (247)
Q Consensus        74 -----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~--~~~~~~~~~~~~~~aPE  146 (247)
                           +++...+..++.||+.||+|||++||+||||||+|++++.+|.+||+|||+++...  .....+...|.+|+|||
T Consensus       111 ~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPE  190 (323)
T KOG0594|consen  111 PKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPE  190 (323)
T ss_pred             cccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHH
Confidence                 47778899999999999999999999999999999999999999999999997554  23356677899999999


Q ss_pred             ccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC------------------C--CCCC--C-----
Q 041080          147 VVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG------------------E--LPSV--P-----  199 (247)
Q Consensus       147 ~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~------------------~--~~~~--~-----  199 (247)
                      .+.+... |+...||||+||+++||++++..|......+....+-..                  +  .+..  +     
T Consensus       191 vLlGs~~-Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~  269 (323)
T KOG0594|consen  191 VLLGSTS-YSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSS  269 (323)
T ss_pred             HhcCCCc-CCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHH
Confidence            9987765 899999999999999999999988877766665443210                  0  0000  0     


Q ss_pred             --CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          200 --SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       200 --~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                        +..+++..+++.+||+.+|.+|.|++.+|.||||+..
T Consensus       270 ~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  270 ILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             hccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence              1233578899999999999999999999999999986

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.2e-41  Score=268.71  Aligned_cols=232  Identities=38%  Similarity=0.647  Sum_probs=192.0

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~   79 (247)
                      |..+++|.+...     .....+.+.+|+.+++.++|||++++++.+..++..++|+||+++++|..++.+  ..+++..
T Consensus        30 ~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~  104 (282)
T cd06643          30 GVLAAAKVIDTK-----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQ  104 (282)
T ss_pred             CeEEEEEEeCCC-----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHH
Confidence            567888888532     234566788999999999999999999999999999999999999999887754  3589999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCccccc---CCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNS---KNDG  154 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~---~~~~  154 (247)
                      +..++.|++.||.+||+.|++|+||+|+||+++.++.++++|||.+......  ......++..|+|||.+..   ....
T Consensus       105 ~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  184 (282)
T cd06643         105 IRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP  184 (282)
T ss_pred             HHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCC
Confidence            9999999999999999999999999999999999999999999987543322  1233457888999999742   2233


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCC--CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP--SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      ++.++|+||+|+++|++++|..||...........+.....+  ..+..++.++++++.+||+.+|.+||+++++++|||
T Consensus       185 ~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  264 (282)
T cd06643         185 YDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF  264 (282)
T ss_pred             CCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence            678999999999999999999999877665555444433222  335568899999999999999999999999999999


Q ss_pred             CCCCCC
Q 041080          233 VKRPLQ  238 (247)
Q Consensus       233 ~~~~~~  238 (247)
                      |+....
T Consensus       265 ~~~~~~  270 (282)
T cd06643         265 VTVNSN  270 (282)
T ss_pred             EeccCC
Confidence            997543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.4e-42  Score=269.40  Aligned_cols=230  Identities=33%  Similarity=0.595  Sum_probs=193.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.+++|.+....    .......+.+|++++++++||||+++++.+...+..++++||+++++|.+++...  .+++.
T Consensus        25 ~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  100 (265)
T cd06605          25 TGKIMAVKTIRLEI----NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPER  100 (265)
T ss_pred             CCcEEEEEEEeccc----ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHH
Confidence            47889999987642    2245667889999999999999999999999999999999999999999999764  58899


Q ss_pred             HHHHHHHHHHHHHHHhhh-CCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCc
Q 041080           79 QVSSYTRQILNGLVYLHE-RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~-~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      .+..++.|++.++.++|+ .|++|+||+|+||+++.++.++|+|||.+............++..|+|||.+.+.  .++.
T Consensus       101 ~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~  178 (265)
T cd06605         101 ILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGN--DYSV  178 (265)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhcccCChhccCHHHHcCC--CCCc
Confidence            999999999999999999 9999999999999999999999999998865543333335678889999998665  3788


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCCh-----hhHHHHHhhcCCCCCCCCc-CCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLE-----GVQALFRIGKGELPSVPSS-LSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                      ++|+||+|++++++++|..||....     .............+..+.. ++.+++++|.+||..+|.+|||+.+++.||
T Consensus       179 ~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  258 (265)
T cd06605         179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHP  258 (265)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCc
Confidence            9999999999999999999986542     2223333334444445544 899999999999999999999999999999


Q ss_pred             cCCCC
Q 041080          232 FVKRP  236 (247)
Q Consensus       232 ~~~~~  236 (247)
                      ||+..
T Consensus       259 ~~~~~  263 (265)
T cd06605         259 FIKKY  263 (265)
T ss_pred             hhhcc
Confidence            99764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-42  Score=269.53  Aligned_cols=232  Identities=37%  Similarity=0.653  Sum_probs=194.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC---CCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE---QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~   77 (247)
                      +|+.||+|.+..+.    .....+.+.+|+.+++.++   |||++++++++..+...+++|||+++++|.+++....+++
T Consensus        25 ~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~  100 (277)
T cd06917          25 TGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAE  100 (277)
T ss_pred             CCcEEEEEEecCCC----CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHccCCCH
Confidence            47889999986532    2334556788999999996   9999999999999999999999999999999998878999


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+. ..+
T Consensus       101 ~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~  179 (277)
T cd06917         101 KYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG-KYY  179 (277)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccC-Ccc
Confidence            9999999999999999999999999999999999999999999999886544332  2234577889999988543 236


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCC-cCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCC
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPS-SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK  234 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~  234 (247)
                      +.++|+||||+++|+|++|..||...........+.....+.++. .++.++.+++.+||+.+|.+||++.++++||||+
T Consensus       180 ~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~  259 (277)
T cd06917         180 DTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIK  259 (277)
T ss_pred             ccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhh
Confidence            889999999999999999999998776655554444443344444 3889999999999999999999999999999998


Q ss_pred             CCC
Q 041080          235 RPL  237 (247)
Q Consensus       235 ~~~  237 (247)
                      ...
T Consensus       260 ~~~  262 (277)
T cd06917         260 AHS  262 (277)
T ss_pred             ccc
Confidence            754

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2e-41  Score=268.74  Aligned_cols=233  Identities=36%  Similarity=0.642  Sum_probs=192.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~   78 (247)
                      +|+.+++|.+...     .....+.+.+|+.+++.++|+||+++++.+..++..++||||+++++|..++.+  ..+++.
T Consensus        36 ~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~  110 (292)
T cd06644          36 TGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP  110 (292)
T ss_pred             CCceEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHH
Confidence            3778999998642     344567788999999999999999999999999999999999999999887754  358999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCccccc---CCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNS---KND  153 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~---~~~  153 (247)
                      .+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......  ......++..|+|||.+.+   ...
T Consensus       111 ~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  190 (292)
T cd06644         111 QIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT  190 (292)
T ss_pred             HHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCC
Confidence            99999999999999999999999999999999999999999999987543222  1223447788999999853   223


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCC--CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP--SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                      .++.++|+||||+++|+|++|..||.................+  ..+..++.++.+++.+||..+|.+||+++++++||
T Consensus       191 ~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  270 (292)
T cd06644         191 PYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHP  270 (292)
T ss_pred             CCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            3678999999999999999999999776655544444433322  23456788999999999999999999999999999


Q ss_pred             cCCCCCC
Q 041080          232 FVKRPLQ  238 (247)
Q Consensus       232 ~~~~~~~  238 (247)
                      ||+....
T Consensus       271 ~~~~~~~  277 (292)
T cd06644         271 FVSSVTS  277 (292)
T ss_pred             ccccccc
Confidence            9987543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.1e-41  Score=269.24  Aligned_cols=229  Identities=34%  Similarity=0.612  Sum_probs=192.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.+++|++...     .....+.+.+|+.+++.++||||+++++++..++..++++||+++++|.+++....+++..+
T Consensus        43 ~~~~~~iK~~~~~-----~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~  117 (285)
T cd06648          43 TGRQVAVKKMDLR-----KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI  117 (285)
T ss_pred             CCCEEEEEEEecc-----chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHhCCCCHHHH
Confidence            4678999988532     22334567899999999999999999999999999999999999999999998877999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCCcc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ..++.|++.|+++||++|++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+..  ++.+
T Consensus       118 ~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~  195 (285)
T cd06648         118 ATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLP--YGTE  195 (285)
T ss_pred             HHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCC--CCCc
Confidence            9999999999999999999999999999999999999999999875433221  22344788899999986544  7889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCC--CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      +|+||+|++++++++|..||...+.......+.....+..  +..++..+.+++.+||..+|.+||+++++++||||+..
T Consensus       196 ~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  275 (285)
T cd06648         196 VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKA  275 (285)
T ss_pred             ccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccC
Confidence            9999999999999999999977665555555444432222  23478999999999999999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=9.2e-42  Score=268.75  Aligned_cols=232  Identities=38%  Similarity=0.674  Sum_probs=198.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.||||.+...    ........+.+|+..+++++||||+++++++..++..++||||+++++|.+++....+++..+
T Consensus        28 ~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~  103 (277)
T cd06641          28 TQKVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQI  103 (277)
T ss_pred             CCcEEEEEEeccc----cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcCCCCHHHH
Confidence            4678999988643    223445678899999999999999999999999999999999999999999998878999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCCcc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ..++.+++.++.+||+.|++|+||+|+||+++.++.++++|||.+.......  .....++..|+|||.+.+..  .+.+
T Consensus       104 ~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~  181 (277)
T cd06641         104 ATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA--YDSK  181 (277)
T ss_pred             HHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhccCC--CCch
Confidence            9999999999999999999999999999999999999999999876543322  12234678899999986443  6889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQ  238 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~~  238 (247)
                      +|+||+|++++++++|..||...........+.....+..+..++.++.+++.+||..+|.+||+++++++||||+....
T Consensus       182 ~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~  261 (277)
T cd06641         182 ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK  261 (277)
T ss_pred             hhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhh
Confidence            99999999999999999999877666666655555556667788999999999999999999999999999999987543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=7.4e-42  Score=272.38  Aligned_cols=230  Identities=29%  Similarity=0.475  Sum_probs=184.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.||+|.+......    .....+.+|+.++++++||||+++++++...+..++||||+++ +|.+++.+.  .+++.
T Consensus        30 ~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~  104 (301)
T cd07873          30 TDNLVALKEIRLEHEE----GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMH  104 (301)
T ss_pred             CCcEEEEEEEeccccc----CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecccc-CHHHHHHhcCCCCCHH
Confidence            3688999998754321    1233466899999999999999999999999999999999975 888887653  48899


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+.. .++
T Consensus       105 ~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~  183 (301)
T cd07873         105 NVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGST-DYS  183 (301)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCC-CCc
Confidence            999999999999999999999999999999999999999999999986543222  22344678899999986433 368


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC---------------------CCC--------CCCCcCCHHHH
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG---------------------ELP--------SVPSSLSRDAR  207 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---------------------~~~--------~~~~~~~~~~~  207 (247)
                      .++|+||||+++|+|++|+.||...+..+....+...                     ..+        .....+++.++
T Consensus       184 ~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (301)
T cd07873         184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGA  263 (301)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHH
Confidence            8999999999999999999999776554333221100                     001        11235788999


Q ss_pred             HHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          208 DFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       208 ~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ++|.+||+.+|.+|||++++++||||+..
T Consensus       264 ~li~~ml~~dp~~R~t~~eil~h~~f~~~  292 (301)
T cd07873         264 ELLSKLLQFEGRKRISAEEAMKHPYFHCL  292 (301)
T ss_pred             HHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            99999999999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.5e-42  Score=268.43  Aligned_cols=229  Identities=31%  Similarity=0.472  Sum_probs=195.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|.+.....  ......+.+.+|+.++++++||||+++++.+..+...++|+||+.+++|.+.+... .+++..
T Consensus        24 ~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~  101 (258)
T cd05578          24 TKKMFAMKYMNKQKC--VEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQ  101 (258)
T ss_pred             CCcEEEEEEEehhhh--cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHH
Confidence            478899999975432  22245678899999999999999999999999999999999999999999999776 799999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCCCcc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      +..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... .....++..|+|||.+....  ++.+
T Consensus       102 ~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~  179 (258)
T cd05578         102 VKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQG--YSVA  179 (258)
T ss_pred             HHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccC--CCCc
Confidence            99999999999999999999999999999999999999999999987654432 23345778899999986544  7889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChh--hHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh--hhhhcCccC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEG--VQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV--TELMEHPFV  233 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--~~il~~p~~  233 (247)
                      +|+||+|+++|++++|..||.....  ............+..+...+..+.++|.+||..+|.+||++  .++++||||
T Consensus       180 ~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         180 VDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            9999999999999999999987664  22223333324456677889999999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-42  Score=276.33  Aligned_cols=233  Identities=26%  Similarity=0.443  Sum_probs=189.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.||+|++.+...  ......+.+.+|+.++..++|+||+++++.+.+++..++||||+++++|.+++.+.  .+++.
T Consensus        25 ~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~  102 (331)
T cd05597          25 TGQVYAMKILNKWEM--LKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED  102 (331)
T ss_pred             CCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHH
Confidence            478899999975321  22334566889999999999999999999999999999999999999999999763  58999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc---ccCCCCCCccCCcccccC---C
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL---KSCKGTPFWMAPEVVNSK---N  152 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~---~  152 (247)
                      .+..++.|++.||++||++|++|+||||+||+++.++.++|+|||.+........   ....|++.|+|||.+...   .
T Consensus       103 ~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  182 (331)
T cd05597         103 MARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK  182 (331)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccc
Confidence            9999999999999999999999999999999999999999999999765432221   223588999999998632   2


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC----CCCCCCCcCCHHHHHHHHHHhcCCCC--CCCChhh
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG----ELPSVPSSLSRDARDFILKCLQVNPN--DRPTVTE  226 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~--~Rps~~~  226 (247)
                      ..++.++|+||+|+++|+|++|+.||......+....+...    ..+.....+++++++++.+||..++.  .|+++++
T Consensus       183 ~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~  262 (331)
T cd05597         183 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQD  262 (331)
T ss_pred             cCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence            33678999999999999999999999876655555444322    12233345799999999999875444  3789999


Q ss_pred             hhcCccCCC
Q 041080          227 LMEHPFVKR  235 (247)
Q Consensus       227 il~~p~~~~  235 (247)
                      +++||||+.
T Consensus       263 ~l~hp~~~~  271 (331)
T cd05597         263 FKDHPFFEG  271 (331)
T ss_pred             HhcCCCCCC
Confidence            999999975

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=7.8e-42  Score=273.79  Aligned_cols=234  Identities=27%  Similarity=0.491  Sum_probs=188.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~   77 (247)
                      +|+.||||++....   ......+.+.+|+.+++.++|+||+++++++...+..+++|||+++++|.+++...   .+++
T Consensus        24 ~~~~~avK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~  100 (314)
T cd08216          24 TNTLVAVKKINLDS---CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPE  100 (314)
T ss_pred             CCCEEEEEEEeccc---cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCH
Confidence            48899999997642   23445677999999999999999999999999999999999999999999998753   4889


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---------cccCCCCCCccCCccc
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---------LKSCKGTPFWMAPEVV  148 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---------~~~~~~~~~~~aPE~~  148 (247)
                      ..+..++.|++.||+|||++|++|+||+|+||+++.++.++++||+.+.......         .....++..|+|||.+
T Consensus       101 ~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  180 (314)
T cd08216         101 LAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL  180 (314)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHh
Confidence            9999999999999999999999999999999999999999999999875332111         1223356679999998


Q ss_pred             ccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC---------------------------------
Q 041080          149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL---------------------------------  195 (247)
Q Consensus       149 ~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------------------------  195 (247)
                      .+....++.++|+||+|++++++++|..||..............+..                                 
T Consensus       181 ~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (314)
T cd08216         181 QQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVD  260 (314)
T ss_pred             cCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhh
Confidence            66544578899999999999999999999986554333221111000                                 


Q ss_pred             CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          196 PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       196 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      ......++.++.+++.+||+.+|.+|||++++++||||+...
T Consensus       261 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         261 HPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             cchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence            011123456789999999999999999999999999998653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-44  Score=286.66  Aligned_cols=216  Identities=29%  Similarity=0.540  Sum_probs=188.4

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-CCHHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQV   80 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~   80 (247)
                      ++.||||.++.-            =+-+|+-|++|+||||+.|.|+|.+...+|||||||..|.|..+++... +....+
T Consensus       147 netVAVKKV~el------------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~ll  214 (904)
T KOG4721|consen  147 NETVAVKKVREL------------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLL  214 (904)
T ss_pred             CceehhHHHhhh------------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHHH
Confidence            567888877421            1258899999999999999999999999999999999999999998764 899999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc-ccCCCCCCccCCcccccCCCCCCcch
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL-KSCKGTPFWMAPEVVNSKNDGYGLTA  159 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~~~  159 (247)
                      ..|..+|+.|+.|||.+.|+|||||.-||+|+.+..+||+|||-+........ -.+.|+..|||||++...+  .+.+.
T Consensus       215 v~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrneP--csEKV  292 (904)
T KOG4721|consen  215 VDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEP--CSEKV  292 (904)
T ss_pred             HHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCC--ccccc
Confidence            99999999999999999999999999999999999999999999876654432 3566999999999996554  89999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC-CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL-PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       160 Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                      ||||||++||||+||..||.+.+...++.-+....+ -..|..+|+.++-||++||+-.|.+||+|.+|+.|-
T Consensus       293 DIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  293 DIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             ceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence            999999999999999999998887766655444332 456789999999999999999999999999999873

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.1e-41  Score=277.66  Aligned_cols=228  Identities=27%  Similarity=0.464  Sum_probs=180.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC------cEEEEEeccccCcHHHHHHhcC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN------RLYIFLELVTKGSLANLYQKYH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~   74 (247)
                      +|+.||+|++....   ........+.+|+.+++.++||||+++++++...+      ..++||||+.+ +|.+.+. ..
T Consensus        45 ~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-~~  119 (359)
T cd07876          45 LGINVAVKKLSRPF---QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH-ME  119 (359)
T ss_pred             CCceeEEEEecccc---cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh-cc
Confidence            47889999996542   22334566779999999999999999999886443      57999999976 5666554 35


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      +++..+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||++....... .....++..|+|||.+.+.. 
T Consensus       120 ~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-  198 (359)
T cd07876         120 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG-  198 (359)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCC-
Confidence            8889999999999999999999999999999999999999999999999986543222 23455788999999996544 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc---------------------CCCC----------------
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK---------------------GELP----------------  196 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~---------------------~~~~----------------  196 (247)
                       ++.++|+||||+++|+|++|..||...+..+.......                     ...+                
T Consensus       199 -~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (359)
T cd07876         199 -YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIF  277 (359)
T ss_pred             -CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhcccccc
Confidence             78899999999999999999999976554332211100                     0000                


Q ss_pred             ----CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          197 ----SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       197 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                          ......+++++++|.+||..||.+|||+.|+++||||+.
T Consensus       278 ~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         278 PSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             ccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence                011234678999999999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=8.9e-42  Score=269.81  Aligned_cols=228  Identities=33%  Similarity=0.542  Sum_probs=181.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh----cCCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK----YHLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~   76 (247)
                      +|+.||+|.+......   ......+.+|+.++++++||||+++++++..++..++||||+.+ +|.+++..    ..++
T Consensus        24 ~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~~~~~~~~~~~~   99 (285)
T cd07861          24 TGQIVAMKKIRLESEE---EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMD   99 (285)
T ss_pred             CCcEEEEEEecccccc---CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCCC-CHHHHHhcCCCCCcCC
Confidence            4788999998754321   22335577899999999999999999999999999999999975 88887754    3488


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+.. .
T Consensus       100 ~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~  178 (285)
T cd07861         100 AELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSP-R  178 (285)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCC-C
Confidence            99999999999999999999999999999999999999999999999886443221  12334678899999885433 2


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc----------------------------CCCCCCCCcCCHHH
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK----------------------------GELPSVPSSLSRDA  206 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~  206 (247)
                      ++.++|+||||++++++++|..||..............                            .........+++++
T Consensus       179 ~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (285)
T cd07861         179 YSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDG  258 (285)
T ss_pred             cCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHH
Confidence            68899999999999999999999976543222211100                            00011123578899


Q ss_pred             HHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          207 RDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       207 ~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      +++|.+||+.||.+|||++++++||||
T Consensus       259 ~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         259 LDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.9e-41  Score=270.80  Aligned_cols=230  Identities=31%  Similarity=0.558  Sum_probs=187.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|..+|+|.+....    .......+.+|+.++++++||||+++++.+..++..+++|||+++++|.+++++. .+++..
T Consensus        25 ~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~  100 (308)
T cd06615          25 SGLIMARKLIHLEI----KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENI  100 (308)
T ss_pred             CCeEEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCCCCHHH
Confidence            36678888876432    2344567889999999999999999999999999999999999999999998764 488999


Q ss_pred             HHHHHHHHHHHHHHhhh-CCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcc
Q 041080           80 VSSYTRQILNGLVYLHE-RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~-~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      +..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+............++..|+|||.+.+..  ++.+
T Consensus       101 ~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~  178 (308)
T cd06615         101 LGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--YTVQ  178 (308)
T ss_pred             HHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccccCCCCcCccChhHhcCCC--CCcc
Confidence            99999999999999997 69999999999999999999999999988655443344556788999999986543  7889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhh------------------------------------cCCCCCCC-Cc
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIG------------------------------------KGELPSVP-SS  201 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~------------------------------------~~~~~~~~-~~  201 (247)
                      +|+||||++++++++|..||...+.........                                    ....+..+ ..
T Consensus       179 ~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (308)
T cd06615         179 SDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGA  258 (308)
T ss_pred             chHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcc
Confidence            999999999999999999986544322221111                                    11111111 23


Q ss_pred             CCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          202 LSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       202 ~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ++.++++++.+||..+|.+|||++++++||||+..
T Consensus       259 ~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         259 FSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence            67889999999999999999999999999999863

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6e-42  Score=277.64  Aligned_cols=231  Identities=27%  Similarity=0.442  Sum_probs=184.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC------CcEEEEEeccccCcHHHHHHhcC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE------NRLYIFLELVTKGSLANLYQKYH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~   74 (247)
                      +|+.||||.+....   ........+.+|+.++++++||||+++++++...      ...+++++++ +++|.++++...
T Consensus        39 ~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~~  114 (343)
T cd07878          39 LRQKVAVKKLSRPF---QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQK  114 (343)
T ss_pred             CCCEEEEEEeCchh---hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhcCC
Confidence            46789999986532   1223345677899999999999999999987543      3578999998 669999988878


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..... ......++..|+|||.+.+.. .
T Consensus       115 l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~~t~~y~aPE~~~~~~-~  192 (343)
T cd07878         115 LSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD-EMTGYVATRWYRAPEIMLNWM-H  192 (343)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC-CcCCccccccccCchHhcCCc-c
Confidence            99999999999999999999999999999999999999999999999999875443 233456889999999986532 3


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC----------------------CCCC--------CCCcCCH
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG----------------------ELPS--------VPSSLSR  204 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~----------------------~~~~--------~~~~~~~  204 (247)
                      ++.++|+||||+++|+|++|..||...........+...                      ..+.        .....++
T Consensus       193 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (343)
T cd07878         193 YNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANP  272 (343)
T ss_pred             CCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCH
Confidence            788999999999999999999999765543332221110                      0001        1124567


Q ss_pred             HHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          205 DARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       205 ~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      .+.+++.+||..||.+|||++++++||||....
T Consensus       273 ~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         273 LAIDLLEKMLVLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence            789999999999999999999999999998753

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2e-41  Score=263.66  Aligned_cols=228  Identities=28%  Similarity=0.541  Sum_probs=195.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~   77 (247)
                      +++.+|+|.+.....   .......+.+|+.+++.++|||++++++.+..++..++||||+++++|.+++.+.   .+++
T Consensus        24 ~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  100 (256)
T cd08220          24 DQKLVIIKQIPVEQM---TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDE  100 (256)
T ss_pred             CCcEEEEEEEecccc---ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCH
Confidence            367899999976432   2344667889999999999999999999999999999999999999999999764   3889


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC-CeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG-SVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~-~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ..+..++.+++.++.+||++|++|+||+|+||+++.++ .++++|||.+....... .....++..|+|||.+.+..  .
T Consensus       101 ~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~  178 (256)
T cd08220         101 DTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKP--Y  178 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCC--C
Confidence            99999999999999999999999999999999998654 57999999987554332 22345778899999986543  6


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      +.++|+||+|++++++++|..||...+.......+........+..++.++++++.+||..+|.+|||+++++.||||
T Consensus       179 ~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         179 NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            889999999999999999999998877766666666666666677889999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.4e-41  Score=270.38  Aligned_cols=238  Identities=28%  Similarity=0.484  Sum_probs=190.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC--CCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--LSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~   78 (247)
                      +|+.||+|.+...............+..|+.+++.++|+||+++++++...+..++||||+ +++|.+++....  +++.
T Consensus        24 ~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~  102 (298)
T cd07841          24 TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPA  102 (298)
T ss_pred             CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHH
Confidence            4789999999876543333444566778999999999999999999999999999999999 889999997754  8999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+.. .++
T Consensus       103 ~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~  181 (298)
T cd07841         103 DIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGAR-HYG  181 (298)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCC-CCC
Confidence            999999999999999999999999999999999999999999999987654332  22234567899999885432 368


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC----------------------C-----CCCCCcCCHHHHHH
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE----------------------L-----PSVPSSLSRDARDF  209 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~----------------------~-----~~~~~~~~~~~~~l  209 (247)
                      .++|+||||++++++++|..+|......+....+....                      .     .......+..+.++
T Consensus       182 ~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  261 (298)
T cd07841         182 VGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDL  261 (298)
T ss_pred             cHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHH
Confidence            89999999999999999987776555433322221100                      0     00113457889999


Q ss_pred             HHHHhcCCCCCCCChhhhhcCccCCCCCCCC
Q 041080          210 ILKCLQVNPNDRPTVTELMEHPFVKRPLQTP  240 (247)
Q Consensus       210 i~~~l~~~p~~Rps~~~il~~p~~~~~~~~~  240 (247)
                      +.+||+.+|.+|||+.++++||||+......
T Consensus       262 i~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         262 LQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             HHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence            9999999999999999999999999864433

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.1e-41  Score=270.82  Aligned_cols=229  Identities=34%  Similarity=0.616  Sum_probs=192.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.||+|.+....     ....+.+.+|+.+++.++|||++++++.+..++..++++||+++++|.+++....+++..+
T Consensus        45 ~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~  119 (297)
T cd06659          45 SGRQVAVKMMDLRK-----QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQI  119 (297)
T ss_pred             CCCEEEEEEEEecc-----cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhcCCCHHHH
Confidence            47889999986432     2234567899999999999999999999999999999999999999999988878999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCCcc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      +.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+..  ++.+
T Consensus       120 ~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~  197 (297)
T cd06659         120 ATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP--YGTE  197 (297)
T ss_pred             HHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCC--CCch
Confidence            9999999999999999999999999999999999999999999875433221  22345788999999986544  7889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC--CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL--PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      +|+||+|++++++++|+.||...........+.....  ......++..+.+++.+||+.+|.+||+++++++||||...
T Consensus       198 ~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~  277 (297)
T cd06659         198 VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT  277 (297)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence            9999999999999999999977665555544433322  12234678899999999999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.1e-41  Score=266.26  Aligned_cols=231  Identities=33%  Similarity=0.540  Sum_probs=195.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.+++|.+.....  ......+.+.+|+.++++++||||+++++.+..++..++++||+++++|.+++.+. .+++..
T Consensus        17 ~~~~~~~k~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   94 (265)
T cd05579          17 TGDIYAIKVIKKADM--IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV   94 (265)
T ss_pred             CCCEEEEEEecchhh--hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHH
Confidence            378999999865432  22455677889999999999999999999999999999999999999999998764 589999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc----------ccccCCCCCCccCCcccc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----------DLKSCKGTPFWMAPEVVN  149 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~----------~~~~~~~~~~~~aPE~~~  149 (247)
                      ++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......          ......++..|++||...
T Consensus        95 ~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~  174 (265)
T cd05579          95 ARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL  174 (265)
T ss_pred             HHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhc
Confidence            9999999999999999999999999999999999999999999987654332          122334677899999986


Q ss_pred             cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCc--CCHHHHHHHHHHhcCCCCCCCCh---
Q 041080          150 SKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSS--LSRDARDFILKCLQVNPNDRPTV---  224 (247)
Q Consensus       150 ~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~p~~Rps~---  224 (247)
                      ...  .+.++|+||||++++++++|..||...........+..... ..+..  .+..+.+++.+||+.+|.+|||+   
T Consensus       175 ~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~  251 (265)
T cd05579         175 GQG--HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI-EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSI  251 (265)
T ss_pred             CCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc-CCCccccCCHHHHHHHHHHhcCCHhhcCCCccH
Confidence            544  78899999999999999999999988777766666554332 22333  48999999999999999999999   


Q ss_pred             hhhhcCccCCCC
Q 041080          225 TELMEHPFVKRP  236 (247)
Q Consensus       225 ~~il~~p~~~~~  236 (247)
                      .++++||||+++
T Consensus       252 ~~~l~~~~~~~~  263 (265)
T cd05579         252 EEIKNHPFFKGI  263 (265)
T ss_pred             HHHhcCccccCC
Confidence            999999999865

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.3e-42  Score=269.47  Aligned_cols=229  Identities=37%  Similarity=0.597  Sum_probs=186.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHH-hcCCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~   79 (247)
                      +|+.||+|++.....   .........+|+.++++++||||+++++++......+++||++++++|.+++. ...+++..
T Consensus        23 ~~~~~~~K~~~~~~~---~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~   99 (260)
T PF00069_consen   23 NGQKVAVKIIDKSEI---EEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKPLSEEE   99 (260)
T ss_dssp             TTEEEEEEEEESTTH---HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSSBBHHH
T ss_pred             CCeEEEEEEeccccc---cccccchhhhhhhccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            467899999986532   22223334569999999999999999999999999999999999999999997 56799999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccc--cCccccccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~--~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      ++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..  ..........++..|.|||.+.. ....+.
T Consensus       100 ~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  178 (260)
T PF00069_consen  100 ILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQ-GKKYTR  178 (260)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTT-TSSBST
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccc
Confidence            999999999999999999999999999999999999999999999864  22334445668889999999861 223789


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCC---hhhHHHHHhhcCCCC---CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHL---EGVQALFRIGKGELP---SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~---~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                      ++|+||+|+++++|++|..||...   +..............   ......+..+.+++.+||+.+|.+|||++++++||
T Consensus       179 ~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~  258 (260)
T PF00069_consen  179 KSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHP  258 (260)
T ss_dssp             HHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSG
T ss_pred             cccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCC
Confidence            999999999999999999999887   222222222211110   11112238999999999999999999999999999


Q ss_pred             cC
Q 041080          232 FV  233 (247)
Q Consensus       232 ~~  233 (247)
                      ||
T Consensus       259 ~~  260 (260)
T PF00069_consen  259 WF  260 (260)
T ss_dssp             GG
T ss_pred             CC
Confidence            98

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.7e-41  Score=265.21  Aligned_cols=230  Identities=37%  Similarity=0.624  Sum_probs=197.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-cCCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-YHLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~   79 (247)
                      +|+.|++|.+.....    ......+.+|+..+.+++|+|++++++++...+..++++||+++++|.+++.. ..+++..
T Consensus        25 ~~~~~~vk~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~  100 (264)
T cd06623          25 TGKIYALKKIHVDGD----EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPV  100 (264)
T ss_pred             CCcEEEEEEeccCcc----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCCHHH
Confidence            478899999876432    14567788999999999999999999999999999999999999999999976 5689999


Q ss_pred             HHHHHHHHHHHHHHhhh-CCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc--cCCCCCCccCCcccccCCCCCC
Q 041080           80 VSSYTRQILNGLVYLHE-RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK--SCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~-~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ++.++.|++.++.++|+ .|++|+||+|+||+++.++.++|+|||.+.........  ...++..|+|||.+...  .++
T Consensus       101 ~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~  178 (264)
T cd06623         101 LAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGE--SYS  178 (264)
T ss_pred             HHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCC--CCC
Confidence            99999999999999999 99999999999999999999999999998765433332  34477889999998655  378


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCCh---hhHHHHHhhcCCCCCCCCc-CCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLE---GVQALFRIGKGELPSVPSS-LSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      .++|+|+||+++|++++|..||....   .......+.....+..+.. ++..+.+++.+||.++|.+||+++++++|||
T Consensus       179 ~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~  258 (264)
T cd06623         179 YAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF  258 (264)
T ss_pred             chhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHH
Confidence            89999999999999999999997763   3444455555555566666 8999999999999999999999999999999


Q ss_pred             CCCC
Q 041080          233 VKRP  236 (247)
Q Consensus       233 ~~~~  236 (247)
                      |+..
T Consensus       259 ~~~~  262 (264)
T cd06623         259 IKKA  262 (264)
T ss_pred             HHhc
Confidence            9864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4e-41  Score=263.44  Aligned_cols=231  Identities=42%  Similarity=0.763  Sum_probs=190.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC--CcEEEEEeccccCcHHHHHHhc-CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE--NRLYIFLELVTKGSLANLYQKY-HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~   77 (247)
                      +|+.||||.+.............+.+.+|+.++++++||||+++++.+.+.  ...+++|||+++++|.+++.+. .+++
T Consensus        26 ~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~  105 (265)
T cd06652          26 TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE  105 (265)
T ss_pred             CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCH
Confidence            478999999876543344445667889999999999999999999987663  4688999999999999998764 4788


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-----ccccCCCCCCccCCcccccCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-----DLKSCKGTPFWMAPEVVNSKN  152 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~  152 (247)
                      ..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......     ......++..|+|||.+.+..
T Consensus       106 ~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  185 (265)
T cd06652         106 NVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG  185 (265)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCC
Confidence            999999999999999999999999999999999999999999999988643321     122334778899999986533


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC-CCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG-ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                        ++.++|+||||+++|++++|..||............... ..+..+...+..+.+++.+|+. +|.+||+++++++||
T Consensus       186 --~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~  262 (265)
T cd06652         186 --YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT  262 (265)
T ss_pred             --CCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence              788999999999999999999999876554444433322 2344566788899999999995 899999999999999


Q ss_pred             cCC
Q 041080          232 FVK  234 (247)
Q Consensus       232 ~~~  234 (247)
                      |++
T Consensus       263 ~~~  265 (265)
T cd06652         263 FVH  265 (265)
T ss_pred             ccC
Confidence            985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.1e-42  Score=280.06  Aligned_cols=222  Identities=26%  Similarity=0.341  Sum_probs=175.3

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-cCCCHHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-YHLSDSQV   80 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~   80 (247)
                      |+.||+|...           ...+.+|+.++++++||||+++++++..+...++++|++.+ +|..++.. ..+++..+
T Consensus       117 ~~~vaiK~~~-----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~  184 (391)
T PHA03212        117 CEHVVIKAGQ-----------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDI  184 (391)
T ss_pred             CCEEEEechh-----------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCCC-CHHHHHHhcCCCCHHHH
Confidence            6778888543           12456899999999999999999999999999999999964 78777754 45899999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc---cccccCCCCCCccCCcccccCCCCCCc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM---NDLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      +.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.....   .......|++.|+|||.+.+..  ++.
T Consensus       185 ~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~  262 (391)
T PHA03212        185 LAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDP--YGP  262 (391)
T ss_pred             HHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCC--CCc
Confidence            99999999999999999999999999999999999999999999854322   2223456899999999986544  789


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChh-------hHHHHHhh--------------------------c--CCCCCC----
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEG-------VQALFRIG--------------------------K--GELPSV----  198 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~-------~~~~~~~~--------------------------~--~~~~~~----  198 (247)
                      ++|+||+|+++|++++|..|+.....       ......+.                          .  ...+..    
T Consensus       263 ~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (391)
T PHA03212        263 AVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLW  342 (391)
T ss_pred             HHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCH
Confidence            99999999999999999877532210       00000000                          0  000000    


Q ss_pred             --CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          199 --PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       199 --~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                        ....+.++.++|.+||+.||.+|||++++++||||+...
T Consensus       343 ~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        343 TNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             HHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence              013467899999999999999999999999999999853

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.4e-41  Score=264.30  Aligned_cols=228  Identities=41%  Similarity=0.707  Sum_probs=186.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CC--C
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HL--S   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~--~   76 (247)
                      ++..|++|.+...     .....+.+.+|+.+++.++|+||+++++++..++..++++||+++++|.+++...  .+  +
T Consensus        32 ~~~~v~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  106 (268)
T cd06624          32 TQVRIAIKEIPER-----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDN  106 (268)
T ss_pred             CCcEEEEEEecCC-----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCc
Confidence            3567899987643     2334567889999999999999999999999999999999999999999998753  34  7


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC-CCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~-~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      +..+..++.|++.|+++||+.|++|+||+|+||+++. ++.++|+|||.+.......  .....++..|+|||.+.....
T Consensus       107 ~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  186 (268)
T cd06624         107 EQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPR  186 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccc
Confidence            8888999999999999999999999999999999976 6789999999876443221  223347788999999865544


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHH--HHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQAL--FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                      .++.++|+||+|++++++++|..||.........  ........+.++...++++++++.+||..+|.+|||+++++.||
T Consensus       187 ~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  266 (268)
T cd06624         187 GYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP  266 (268)
T ss_pred             cCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCC
Confidence            4788999999999999999999998754432221  11122334556778899999999999999999999999999999


Q ss_pred             cC
Q 041080          232 FV  233 (247)
Q Consensus       232 ~~  233 (247)
                      ||
T Consensus       267 ~~  268 (268)
T cd06624         267 FL  268 (268)
T ss_pred             CC
Confidence            97

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.3e-41  Score=263.31  Aligned_cols=223  Identities=39%  Similarity=0.712  Sum_probs=188.2

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~   79 (247)
                      |+.+++|.+....       ..+.+.+|+.++++++|+||+++++.+...+..++++||+++++|.+++...  .+++..
T Consensus        28 ~~~~~~k~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~  100 (256)
T cd06612          28 GQVVAIKVVPVEE-------DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEE  100 (256)
T ss_pred             CcEEEEEEeecHH-------HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHH
Confidence            6789999986431       1567889999999999999999999999999999999999999999998653  489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      +..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+..  ++.
T Consensus       101 ~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~  178 (256)
T cd06612         101 IAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIG--YNN  178 (256)
T ss_pred             HHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCC--CCc
Confidence            99999999999999999999999999999999999999999999987554332  22334678899999986553  788


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCC--CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP--SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      ++|+||+|++++++++|..||...........+.....+  ..+..++.++.+++.+||+.+|.+|||+++++.||||
T Consensus       179 ~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         179 KADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            999999999999999999999876655444333332222  2234678899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.8e-41  Score=268.53  Aligned_cols=227  Identities=32%  Similarity=0.536  Sum_probs=176.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc---CCCceeeeceeeec-----CCcEEEEEeccccCcHHHHHHh
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF---EQDNIVQYLGTDKD-----ENRLYIFLELVTKGSLANLYQK   72 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~   72 (247)
                      +|+.||+|.+........   ....+.+|+.+++.+   +||||+++++++..     ....+++|||+++ +|.+++..
T Consensus        24 ~~~~~aiK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~   99 (288)
T cd07863          24 SGHFVALKSVRVQTNEDG---LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDK   99 (288)
T ss_pred             CCcEEEEEEeccCcCCCC---CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHh
Confidence            478899999876432211   112334566666554   79999999998754     3468999999986 88888865


Q ss_pred             c---CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCccc
Q 041080           73 Y---HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVV  148 (247)
Q Consensus        73 ~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~  148 (247)
                      .   .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+....... .....++..|+|||.+
T Consensus       100 ~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~  179 (288)
T cd07863         100 VPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVL  179 (288)
T ss_pred             cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCcccCCCccccccccCchHh
Confidence            3   38999999999999999999999999999999999999999999999999987554322 2334578889999998


Q ss_pred             ccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC------------------CC--------CCCCCcC
Q 041080          149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG------------------EL--------PSVPSSL  202 (247)
Q Consensus       149 ~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~------------------~~--------~~~~~~~  202 (247)
                      .+..  ++.++|+||+|+++|+|++|..||......+....+...                  ..        ......+
T Consensus       180 ~~~~--~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (288)
T cd07863         180 LQST--YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEI  257 (288)
T ss_pred             hCCC--CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCc
Confidence            6543  788999999999999999999999766554433322110                  00        0112356


Q ss_pred             CHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          203 SRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       203 ~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      ++.+++++.+||++||.+|||+++++.||||
T Consensus       258 ~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         258 EESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             CHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            8889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.8e-41  Score=268.09  Aligned_cols=229  Identities=28%  Similarity=0.514  Sum_probs=184.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++......   ....+.+.+|+.++++++|+|++++++++......+++|||+++++|..+.... .+++..
T Consensus        25 ~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~  101 (286)
T cd07847          25 TGQIVAIKKFVESEDD---PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHL  101 (286)
T ss_pred             CCcEEEEEEEeecccC---ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHH
Confidence            4789999998754321   122345779999999999999999999999999999999999998888876543 589999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      +..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+.. .++.
T Consensus       102 ~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~  180 (286)
T cd07847         102 IKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT-QYGP  180 (286)
T ss_pred             HHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCC-CcCc
Confidence            99999999999999999999999999999999999999999999987554332  22344678899999986432 2688


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC---------------------CCCC---------CCCcCCHHHH
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG---------------------ELPS---------VPSSLSRDAR  207 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---------------------~~~~---------~~~~~~~~~~  207 (247)
                      ++|+||+|++++++++|..||......+....+...                     ..+.         ....++..+.
T Consensus       181 ~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (286)
T cd07847         181 PVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPAL  260 (286)
T ss_pred             hhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHH
Confidence            999999999999999999999766544333221110                     0000         0134688899


Q ss_pred             HHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          208 DFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       208 ~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      +++.+||+++|.+||++.+++.||||
T Consensus       261 ~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         261 SFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             HHHHHHhcCCccccCCHHHHhcCCCC
Confidence            99999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-41  Score=274.96  Aligned_cols=222  Identities=27%  Similarity=0.467  Sum_probs=179.1

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecC-CcEEEEEeccccCcHHHHHHhc------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDE-NRLYIFLELVTKGSLANLYQKY------   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~------   73 (247)
                      ++.||||.+...    ........+.+|+.++.++ +||||+++++++... +.++++|||+++|+|.+++...      
T Consensus        37 ~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~  112 (338)
T cd05102          37 CNTVAVKMLKEG----ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSP  112 (338)
T ss_pred             chhhheeccccc----cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhccc
Confidence            467999988642    2233456788999999999 899999999987664 4689999999999999988642      


Q ss_pred             ---------------------------------------------------------CCCHHHHHHHHHHHHHHHHHhhh
Q 041080           74 ---------------------------------------------------------HLSDSQVSSYTRQILNGLVYLHE   96 (247)
Q Consensus        74 ---------------------------------------------------------~~~~~~~~~~~~~l~~~l~~lh~   96 (247)
                                                                               .+++..+..++.|++.||.|||+
T Consensus       113 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~  192 (338)
T cd05102         113 YREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS  192 (338)
T ss_pred             ccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence                                                                     26677888999999999999999


Q ss_pred             CCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----ccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHH
Q 041080           97 RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEML  172 (247)
Q Consensus        97 ~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~  172 (247)
                      .|++|+||||+||+++.++.++|+|||++........    ....++..|+|||.+.+..  ++.++||||||+++|+++
T Consensus       193 ~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~il~el~  270 (338)
T cd05102         193 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIF  270 (338)
T ss_pred             CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCC--CCcccCHHHHHHHHHHHH
Confidence            9999999999999999999999999999865432211    1223456799999986544  789999999999999999


Q ss_pred             h-CCCCCCCChhhH-HHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          173 T-RRPPYSHLEGVQ-ALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       173 ~-g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      + |..||....... ....+..+.....+...++++.+++.+||+.+|.+|||+.++++
T Consensus       271 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         271 SLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             hCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            7 999997654333 33334444445556788999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.1e-41  Score=265.30  Aligned_cols=232  Identities=35%  Similarity=0.715  Sum_probs=189.8

Q ss_pred             CCceEEEEEEeecCCCccc-hHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQG-KQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||+|++......... ....+.+.+|+..+++++|+||+++++++.+++..++|+||+++++|.+++.+. .+++.
T Consensus        24 ~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~  103 (268)
T cd06630          24 TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEA  103 (268)
T ss_pred             CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHH
Confidence            4788999999764432222 234678899999999999999999999999999999999999999999998764 48899


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC-CeEEcccccccccCccc------cccCCCCCCccCCcccccC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG-SVKLADFGLAKATTMND------LKSCKGTPFWMAPEVVNSK  151 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~-~~~l~df~~~~~~~~~~------~~~~~~~~~~~aPE~~~~~  151 (247)
                      .++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.......      .....++..|+|||.+.+.
T Consensus       104 ~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~  183 (268)
T cd06630         104 VIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE  183 (268)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccC
Confidence            9999999999999999999999999999999998776 59999999986543321      1123467789999998543


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHH---Hh-hcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhh
Q 041080          152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALF---RI-GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL  227 (247)
Q Consensus       152 ~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  227 (247)
                      .  ++.++|+|++|++++++++|..||..........   .. .....+..+..+++++.+++.+||..+|.+||++.++
T Consensus       184 ~--~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~l  261 (268)
T cd06630         184 Q--YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL  261 (268)
T ss_pred             C--CCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHH
Confidence            3  6889999999999999999999986544322221   11 1223355667789999999999999999999999999


Q ss_pred             hcCccCC
Q 041080          228 MEHPFVK  234 (247)
Q Consensus       228 l~~p~~~  234 (247)
                      ++||||+
T Consensus       262 l~~~~~~  268 (268)
T cd06630         262 LKHPVFR  268 (268)
T ss_pred             hcCcccC
Confidence            9999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.9e-41  Score=263.13  Aligned_cols=228  Identities=35%  Similarity=0.605  Sum_probs=196.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec--CCcEEEEEeccccCcHHHHHHhc-----
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD--ENRLYIFLELVTKGSLANLYQKY-----   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~-----   73 (247)
                      +|+.+|+|.+.....   .....+.+.+|+.++++++|+||+++++.+..  +...+++|||+++++|.+++...     
T Consensus        24 ~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~  100 (265)
T cd08217          24 DGKILVWKEIDYGNM---TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERK  100 (265)
T ss_pred             CCCEEEEEEEecccC---CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhccc
Confidence            467899999875432   34445678899999999999999999997653  45689999999999999998652     


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhh-----hCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCc
Q 041080           74 HLSDSQVSSYTRQILNGLVYLH-----ERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPE  146 (247)
Q Consensus        74 ~~~~~~~~~~~~~l~~~l~~lh-----~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE  146 (247)
                      .+++..++.++.|++.||.+||     +.+++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||
T Consensus       101 ~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE  180 (265)
T cd08217         101 YIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPE  180 (265)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChh
Confidence            4889999999999999999999     8899999999999999999999999999987655433  23445788999999


Q ss_pred             ccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhh
Q 041080          147 VVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTE  226 (247)
Q Consensus       147 ~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  226 (247)
                      .+.+..  ++.++|+||||++++++++|..||...........+.....+..+..++..+.+++.+||+.+|.+||++++
T Consensus       181 ~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~  258 (265)
T cd08217         181 QLNHMS--YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEE  258 (265)
T ss_pred             hhcCCC--CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHH
Confidence            986544  788999999999999999999999888777777777777777788889999999999999999999999999


Q ss_pred             hhcCccC
Q 041080          227 LMEHPFV  233 (247)
Q Consensus       227 il~~p~~  233 (247)
                      +++|||+
T Consensus       259 il~~~~~  265 (265)
T cd08217         259 LLQLPLI  265 (265)
T ss_pred             HhhCCCC
Confidence            9999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-41  Score=271.01  Aligned_cols=232  Identities=28%  Similarity=0.446  Sum_probs=192.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~   77 (247)
                      +|+.||+|.+......  .......+.+|+..++.++|+||+++++.+..++..+++|||+.+++|.++++..   .+++
T Consensus        25 ~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~  102 (316)
T cd05574          25 TGKLFALKVLDKKEMI--KRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSE  102 (316)
T ss_pred             CCcEEEEEEEeccccc--hHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCH
Confidence            4789999999765322  2345667889999999999999999999999999999999999999999998763   4899


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-------------------------
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-------------------------  132 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-------------------------  132 (247)
                      ..+..++.|++.||++||+.|++|+||||+||+++.++.++|+|||.+.......                         
T Consensus       103 ~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (316)
T cd05574         103 EVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS  182 (316)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhc
Confidence            9999999999999999999999999999999999999999999999875432111                         


Q ss_pred             ------cccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCC-CCCcCCHH
Q 041080          133 ------LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPS-VPSSLSRD  205 (247)
Q Consensus       133 ------~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  205 (247)
                            .....|+..|+|||.+.+..  ++.++|+||||+++|++++|..||...+.......+....... .....++.
T Consensus       183 ~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (316)
T cd05574         183 EEPSFRSNSFVGTEEYIAPEVISGDG--HGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSS  260 (316)
T ss_pred             ccccCCCCCCcCccCCcCHHHHcCCC--CCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHH
Confidence                  11234677899999986544  7889999999999999999999998777666555544332211 12237899


Q ss_pred             HHHHHHHHhcCCCCCCCC----hhhhhcCccCCCC
Q 041080          206 ARDFILKCLQVNPNDRPT----VTELMEHPFVKRP  236 (247)
Q Consensus       206 ~~~li~~~l~~~p~~Rps----~~~il~~p~~~~~  236 (247)
                      +++++.+||..+|.+|||    +++++.||||+..
T Consensus       261 ~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~  295 (316)
T cd05574         261 ARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV  295 (316)
T ss_pred             HHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence            999999999999999999    9999999999863

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.5e-42  Score=284.98  Aligned_cols=225  Identities=28%  Similarity=0.428  Sum_probs=176.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC--------CcEEEEEeccccCcHHHHHHh
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE--------NRLYIFLELVTKGSLANLYQK   72 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~   72 (247)
                      +|+.||||++....         ....+|+.+++.++||||+++++++...        ..+++||||+++ +|.+++..
T Consensus        90 ~~~~vAiK~i~~~~---------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~  159 (440)
T PTZ00036         90 TSEKVAIKKVLQDP---------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKH  159 (440)
T ss_pred             CCCEEEEEEEecCc---------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHH
Confidence            37889999885421         1234799999999999999998876321        246799999986 77666642


Q ss_pred             -----cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC-CeEEcccccccccCcc-ccccCCCCCCccCC
Q 041080           73 -----YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG-SVKLADFGLAKATTMN-DLKSCKGTPFWMAP  145 (247)
Q Consensus        73 -----~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~-~~~l~df~~~~~~~~~-~~~~~~~~~~~~aP  145 (247)
                           ..+++..++.++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++...... ......+++.|+||
T Consensus       160 ~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aP  239 (440)
T PTZ00036        160 YARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAP  239 (440)
T ss_pred             HhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCH
Confidence                 3488999999999999999999999999999999999998665 6999999998754332 23345678999999


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC-------------------CCC---------C
Q 041080          146 EVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG-------------------ELP---------S  197 (247)
Q Consensus       146 E~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~~~---------~  197 (247)
                      |.+.+.. .++.++|+||+||++|+|++|..||......+....+...                   ..+         .
T Consensus       240 E~~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  318 (440)
T PTZ00036        240 ELMLGAT-NYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKV  318 (440)
T ss_pred             HHhcCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHH
Confidence            9975432 3788999999999999999999999876544433222110                   000         1


Q ss_pred             CCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          198 VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       198 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ++...++++.+||.+||..+|.+|||+.++++||||+..
T Consensus       319 ~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        319 FPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             hccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence            234568899999999999999999999999999999864

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.6e-41  Score=267.20  Aligned_cols=229  Identities=27%  Similarity=0.470  Sum_probs=186.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.||+|++.....   .....+.+.+|+.++++++|||++++++++..+...++|+||+ +++|.+++...  .+++.
T Consensus        24 ~~~~~~vK~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~   99 (286)
T cd07832          24 TGETVALKKVALRRL---EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEA   99 (286)
T ss_pred             CCceEEEEEEEcccc---cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHH
Confidence            478999999976432   2234567889999999999999999999999999999999999 88999988653  48999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......   .....++..|+|||.+.+.. .+
T Consensus       100 ~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~  178 (286)
T cd07832         100 QVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR-KY  178 (286)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccc-cC
Confidence            999999999999999999999999999999999999999999999887554332   23345788999999985433 25


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC---------------------C--------CCCCCcCCHHH
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE---------------------L--------PSVPSSLSRDA  206 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------~--------~~~~~~~~~~~  206 (247)
                      +.++|+||+|++++++++|..+|...........+....                     .        .......+.++
T Consensus       179 ~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (286)
T cd07832         179 DPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEA  258 (286)
T ss_pred             CchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHH
Confidence            889999999999999999988886654433322211100                     0        01113457899


Q ss_pred             HHHHHHHhcCCCCCCCChhhhhcCccCC
Q 041080          207 RDFILKCLQVNPNDRPTVTELMEHPFVK  234 (247)
Q Consensus       207 ~~li~~~l~~~p~~Rps~~~il~~p~~~  234 (247)
                      .+++.+||+.+|.+|||++++++||||.
T Consensus       259 ~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         259 LDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             HHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            9999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.9e-41  Score=266.99  Aligned_cols=231  Identities=29%  Similarity=0.466  Sum_probs=189.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~   77 (247)
                      +|+.||+|.+.....  ........+.+|+.+++.++||||+++++.+...+..++||||+++++|.+++.+.   .+++
T Consensus        17 ~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   94 (277)
T cd05577          17 TGKMYACKKLDKKRL--KKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPE   94 (277)
T ss_pred             CCcEEEEEEEehhhh--hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCH
Confidence            478999999875432  12233556678999999999999999999999999999999999999999988653   4899


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-ccccCCCCCCccCCcccccCCCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+...... ......++..|++||.+.+..  ++
T Consensus        95 ~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~  172 (277)
T cd05577          95 ARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEV--YD  172 (277)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCC--CC
Confidence            999999999999999999999999999999999999999999999987654322 222345677899999986544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhh---HHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----Chhhhh
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGV---QALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTELM  228 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il  228 (247)
                      .++|+||+|++++++++|+.||......   ..............+..+++.+++++.+||+.+|.+||     ++.+++
T Consensus       173 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll  252 (277)
T cd05577         173 FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVR  252 (277)
T ss_pred             chhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHH
Confidence            8999999999999999999999765431   22222222233455667899999999999999999999     788899


Q ss_pred             cCccCCC
Q 041080          229 EHPFVKR  235 (247)
Q Consensus       229 ~~p~~~~  235 (247)
                      +||||+.
T Consensus       253 ~h~~~~~  259 (277)
T cd05577         253 EHPLFKD  259 (277)
T ss_pred             hChhhhc
Confidence            9999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.2e-41  Score=266.38  Aligned_cols=222  Identities=25%  Similarity=0.422  Sum_probs=189.5

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---------
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---------   73 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------   73 (247)
                      ..|++|.+...    ........+.+|+..+++++||||+++++++...+..+++|||+++++|.+++...         
T Consensus        36 ~~v~~K~~~~~----~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~  111 (283)
T cd05048          36 TSVAIKTLKEN----AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAE  111 (283)
T ss_pred             eeEEEEecccC----CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccc
Confidence            56888988643    23444667889999999999999999999999999999999999999999998653         


Q ss_pred             --------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCC
Q 041080           74 --------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPF  141 (247)
Q Consensus        74 --------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~  141 (247)
                              .+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.......    .....++..
T Consensus       112 ~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~  191 (283)
T cd05048         112 SGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVR  191 (283)
T ss_pred             cccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCccccc
Confidence                    36788899999999999999999999999999999999999999999999986443222    122335678


Q ss_pred             ccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCC
Q 041080          142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPND  220 (247)
Q Consensus       142 ~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  220 (247)
                      |+|||.+.+..  ++.++|+||||+++|++++ |..||......+....+.....+..+..+|.++.+++.+||+.+|.+
T Consensus       192 y~aPE~~~~~~--~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~  269 (283)
T cd05048         192 WMPPEAILYGK--FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPAR  269 (283)
T ss_pred             ccCHHHhccCc--CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhh
Confidence            99999985443  7889999999999999998 99999888877777777776666777889999999999999999999


Q ss_pred             CCChhhhhcC
Q 041080          221 RPTVTELMEH  230 (247)
Q Consensus       221 Rps~~~il~~  230 (247)
                      ||++.+++++
T Consensus       270 Rp~~~~i~~~  279 (283)
T cd05048         270 RPRFKDIHTR  279 (283)
T ss_pred             CcCHHHHHHH
Confidence            9999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.9e-41  Score=266.91  Aligned_cols=232  Identities=25%  Similarity=0.411  Sum_probs=190.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~   77 (247)
                      +|+.||+|.+.....  ........+.+|+.+++.++|++|+++.+.+..++..+++|||+++++|.+++...   ++++
T Consensus        24 ~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  101 (285)
T cd05632          24 TGKMYACKRLEKKRI--KKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEE  101 (285)
T ss_pred             CCcEEEEEEeehhhh--hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCH
Confidence            478899999875432  12233455778999999999999999999999999999999999999998877542   4899


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-ccccCCCCCCccCCcccccCCCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.+..  ++
T Consensus       102 ~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~--~~  179 (285)
T cd05632         102 ERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQR--YT  179 (285)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCC--CC
Confidence            999999999999999999999999999999999999999999999988544322 223456889999999986543  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHh---hcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC-----hhhhh
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI---GKGELPSVPSSLSRDARDFILKCLQVNPNDRPT-----VTELM  228 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il  228 (247)
                      .++|+||+|++++++++|..||...........+   ........+..++.++.+++..||+.+|.+||+     +++++
T Consensus       180 ~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~  259 (285)
T cd05632         180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVK  259 (285)
T ss_pred             cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHH
Confidence            8999999999999999999999765543322221   122223455678899999999999999999999     88999


Q ss_pred             cCccCCCC
Q 041080          229 EHPFVKRP  236 (247)
Q Consensus       229 ~~p~~~~~  236 (247)
                      +||||+..
T Consensus       260 ~~~~~~~~  267 (285)
T cd05632         260 RHPFFRNM  267 (285)
T ss_pred             cChhhhcC
Confidence            99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.1e-41  Score=263.47  Aligned_cols=228  Identities=35%  Similarity=0.628  Sum_probs=189.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc----CCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY----HLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~   76 (247)
                      +|..+++|++.....    ......+.+|+..++.++|+|++++++.+...+..++++|++++++|.+++...    .++
T Consensus        25 ~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~  100 (267)
T cd06610          25 NNEKVAIKRIDLEKC----QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD  100 (267)
T ss_pred             CCcEEEEEEeccCCc----chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCC
Confidence            467899999865322    225677899999999999999999999999999999999999999999998653    478


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc------ccCCCCCCccCCccccc
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL------KSCKGTPFWMAPEVVNS  150 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~------~~~~~~~~~~aPE~~~~  150 (247)
                      +..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+........      ....++..|++||.+..
T Consensus       101 ~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~  180 (267)
T cd06610         101 EAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ  180 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHcc
Confidence            999999999999999999999999999999999999999999999998754433221      22347788999999865


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCC-----CcCCHHHHHHHHHHhcCCCCCCCChh
Q 041080          151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVP-----SSLSRDARDFILKCLQVNPNDRPTVT  225 (247)
Q Consensus       151 ~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~  225 (247)
                      . ...+.++|+||||++++++++|+.||.................+..+     ..+++.+.+++.+||..+|.+|||++
T Consensus       181 ~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~  259 (267)
T cd06610         181 V-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAE  259 (267)
T ss_pred             c-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHH
Confidence            4 23788999999999999999999999876655554444333332222     25788999999999999999999999


Q ss_pred             hhhcCccC
Q 041080          226 ELMEHPFV  233 (247)
Q Consensus       226 ~il~~p~~  233 (247)
                      ++++||||
T Consensus       260 ~ll~~p~~  267 (267)
T cd06610         260 ELLKHKFF  267 (267)
T ss_pred             HHhhCCCC
Confidence            99999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.6e-41  Score=275.93  Aligned_cols=228  Identities=26%  Similarity=0.425  Sum_probs=181.3

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC------CcEEEEEeccccCcHHHHHHhcCC
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE------NRLYIFLELVTKGSLANLYQKYHL   75 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~   75 (247)
                      |+.||||++....   ........+.+|+.+++.++||||+++++++...      ...++||||+++ +|.+.+.. .+
T Consensus        49 ~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~  123 (364)
T cd07875          49 ERNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM-EL  123 (364)
T ss_pred             CcEEEEEEeCccc---cCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHh-cC
Confidence            6789999986542   2233455677899999999999999999987543      357999999976 67776643 58


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCC
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      ++..+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||++....... .....++..|+|||.+.+..  
T Consensus       124 ~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~--  201 (364)
T cd07875         124 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG--  201 (364)
T ss_pred             CHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCC--
Confidence            889999999999999999999999999999999999999999999999987554332 23456889999999996544  


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC---------------------CC-----------------
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE---------------------LP-----------------  196 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------~~-----------------  196 (247)
                      ++.++|+||||+++|+|++|+.||...+..+....+....                     .+                 
T Consensus       202 ~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (364)
T cd07875         202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFP  281 (364)
T ss_pred             CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCcccccc
Confidence            7889999999999999999999997765444332221100                     00                 


Q ss_pred             ---CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          197 ---SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       197 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                         ......+..++++|.+||+.||.+|||++++++||||+..
T Consensus       282 ~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         282 ADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             ccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence               0011235678999999999999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6e-41  Score=265.04  Aligned_cols=232  Identities=29%  Similarity=0.514  Sum_probs=191.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++....    .....+.+.+|+.+++.++||||+++++.+...+.+++||||+++++|.+++.+. .+++..
T Consensus        29 ~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  104 (284)
T cd06620          29 TGTVMAKKVVHIGA----KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEI  104 (284)
T ss_pred             CCcEEEEEEEEecC----cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHH
Confidence            47889999886532    2334567889999999999999999999999999999999999999999988764 488999


Q ss_pred             HHHHHHHHHHHHHHhhh-CCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcc
Q 041080           80 VSSYTRQILNGLVYLHE-RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~-~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      +..++.+++.++.+||+ .|++|+||+|+||+++.++.++|+|||++............++..|+|||.+.+.  .++.+
T Consensus       105 ~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~  182 (284)
T cd06620         105 LGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGG--KYTVK  182 (284)
T ss_pred             HHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccCccccCcccCCHHHHccC--CCCcc
Confidence            99999999999999997 6999999999999999999999999998765433333445688899999998544  37889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhh-----------HHHHHhhcCCCCCCCC-cCCHHHHHHHHHHhcCCCCCCCChhh
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGV-----------QALFRIGKGELPSVPS-SLSRDARDFILKCLQVNPNDRPTVTE  226 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~-----------~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rps~~~  226 (247)
                      +|+||+|++++++++|..||......           +....+.....+.++. .++.++.+++.+||+++|.+|||+++
T Consensus       183 ~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e  262 (284)
T cd06620         183 SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQ  262 (284)
T ss_pred             chHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHH
Confidence            99999999999999999999765432           2223333333333333 37889999999999999999999999


Q ss_pred             hhcCccCCCCCC
Q 041080          227 LMEHPFVKRPLQ  238 (247)
Q Consensus       227 il~~p~~~~~~~  238 (247)
                      +++||||.+..+
T Consensus       263 ~~~~~~~~~~~~  274 (284)
T cd06620         263 LCAMPPFIQALR  274 (284)
T ss_pred             HhcCcccccccc
Confidence            999999977543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=5.1e-41  Score=263.03  Aligned_cols=222  Identities=22%  Similarity=0.405  Sum_probs=187.6

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~   79 (247)
                      +..||+|.+....    .......+.+|+..+++++||||+++++++..++..++||||+++++|.+++...  .+++..
T Consensus        33 ~~~vaik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~  108 (266)
T cd05064          33 ELPVAIHTLRAGC----SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQ  108 (266)
T ss_pred             eeeEEEEecCCCC----CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHH
Confidence            4578999886532    2334567889999999999999999999999999999999999999999998764  489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc---cCCCCCCccCCcccccCCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK---SCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ++.++.|++.||++||+.|++|+||+|+||+++.++.++++|||.+.........   ...++..|+|||.+.+..  ++
T Consensus       109 ~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~  186 (266)
T cd05064         109 LMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH--FS  186 (266)
T ss_pred             HHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCC--cc
Confidence            9999999999999999999999999999999999999999999986543322111   122456799999986543  78


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          157 LTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      .++|+||+|++++++++ |..||...........+........+..++..+.+++.+||+.+|.+||++++|++
T Consensus       187 ~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         187 SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            89999999999999775 99999888777777776666555667789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6.6e-41  Score=262.48  Aligned_cols=227  Identities=38%  Similarity=0.690  Sum_probs=184.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|.+....     ......+.+|+.+++.++||||+++++.+...+..++++||+++++|.+++... .+++..
T Consensus        33 ~~~~~~ik~~~~~~-----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  107 (267)
T cd06645          33 TGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQ  107 (267)
T ss_pred             CCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHH
Confidence            47889999986532     223455778999999999999999999999999999999999999999988655 489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCccccc-CCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNS-KNDGYG  156 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~-~~~~~~  156 (247)
                      ++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......  ......++..|+|||.+.. ....++
T Consensus       108 ~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  187 (267)
T cd06645         108 IAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN  187 (267)
T ss_pred             HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCC
Confidence            9999999999999999999999999999999999999999999987544322  1233457889999998742 233367


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC--CCC--CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL--PSV--PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      .++|+||+|+++|++++|..||.................  +..  ...++..+++++.+||..+|.+|||++++++|||
T Consensus       188 ~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             chhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            899999999999999999999865543333222222111  111  1257889999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.5e-41  Score=260.80  Aligned_cols=228  Identities=31%  Similarity=0.643  Sum_probs=198.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-----cCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-----YHL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~   75 (247)
                      +|+.|++|++.....   .......+.+|++.++.++|+|++++.+.+..++..++++|++++++|.+.+.+     ..+
T Consensus        24 ~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  100 (258)
T cd08215          24 DGKLYVLKEIDLSNM---SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPF  100 (258)
T ss_pred             CCcEEEEEEeecccC---ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCc
Confidence            478899999976432   234566788999999999999999999999999999999999999999998876     348


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCC
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      ++..+..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....+++.|+|||.+.+.. 
T Consensus       101 ~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-  179 (258)
T cd08215         101 PEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP-  179 (258)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccCC-
Confidence            999999999999999999999999999999999999999999999999886544332  22344778899999986544 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                       .+.++|+|++|++++++++|..||...+.............+..+..++..+.+++.+||+.+|.+|||++++++||||
T Consensus       180 -~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         180 -YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             -CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence             7889999999999999999999998887777777777776777788899999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7.7e-41  Score=259.96  Aligned_cols=223  Identities=25%  Similarity=0.439  Sum_probs=185.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.||+|.+...    ...+....+.+|+.++++++||||+++++++...+..++||||+++++|.+++...  .+++.
T Consensus        19 ~~~~~a~k~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   94 (252)
T cd05084          19 DNTPVAVKSCRET----LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVK   94 (252)
T ss_pred             CCceEEEEecCcc----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHH
Confidence            4788999987532    23445667889999999999999999999999999999999999999999998654  37899


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccccc----CCCCCCccCCcccccCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKS----CKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~----~~~~~~~~aPE~~~~~~~~  154 (247)
                      .++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..........    ......|+|||.+.+..  
T Consensus        95 ~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--  172 (252)
T cd05084          95 ELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR--  172 (252)
T ss_pred             HHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCC--
Confidence            999999999999999999999999999999999999999999999986433221111    11234599999986544  


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          155 YGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ++.++|+||||+++|++++ |..||...........+........+...+..+.+++.+||+.+|.+|||+.++++
T Consensus       173 ~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7889999999999999997 88898776665555555554445566778999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=8.8e-41  Score=263.28  Aligned_cols=236  Identities=28%  Similarity=0.401  Sum_probs=187.1

Q ss_pred             CCceEEEEEEeecCCCccchH-HHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQ-SILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||+|.+........... ........+..++...||+|+++.+.+...+..++||||++|++|.+++... .+++.
T Consensus        18 ~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~   97 (278)
T cd05606          18 TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA   97 (278)
T ss_pred             CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCHH
Confidence            378999999976533211111 1111122334455568999999999999999999999999999999888654 48999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcc
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      .+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+............++..|+|||.+.+.. .++.+
T Consensus        98 ~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~  176 (278)
T cd05606          98 EMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGV-AYDSS  176 (278)
T ss_pred             HHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCCcCCcCcHHhcCCC-CCCcc
Confidence            99999999999999999999999999999999999999999999998655444444556889999999986432 26889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhh--HHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----ChhhhhcCc
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGV--QALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTELMEHP  231 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~p  231 (247)
                      +|+||+|++++++++|..||......  ..............+..++.++.+++.+||..+|.+||     +++++++||
T Consensus       177 ~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~  256 (278)
T cd05606         177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP  256 (278)
T ss_pred             cchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence            99999999999999999999765322  11222222333456667899999999999999999999     999999999


Q ss_pred             cCCCCC
Q 041080          232 FVKRPL  237 (247)
Q Consensus       232 ~~~~~~  237 (247)
                      ||+...
T Consensus       257 ~~~~~~  262 (278)
T cd05606         257 FFRSLD  262 (278)
T ss_pred             cccCCC
Confidence            998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.8e-41  Score=267.96  Aligned_cols=228  Identities=29%  Similarity=0.475  Sum_probs=179.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~   78 (247)
                      +|+.||+|.+.....   .......+.+|+.++++++||||+++++++.+.+..++++||+.+ +|.+++..  ..+++.
T Consensus        24 ~g~~~~~k~~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~   99 (284)
T cd07839          24 THEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPE   99 (284)
T ss_pred             CCcEEEEEEeecccc---cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHhcCCCCCHH
Confidence            478999999976432   122234567899999999999999999999999999999999975 78777654  348999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+.. .++
T Consensus       100 ~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~  178 (284)
T cd07839         100 IVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK-LYS  178 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCc-ccC
Confidence            999999999999999999999999999999999999999999999886543322  22344678899999986533 268


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCC-CChhhHHHHHhhc-------------------CCCC---------CCCCcCCHHHH
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYS-HLEGVQALFRIGK-------------------GELP---------SVPSSLSRDAR  207 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~-~~~~~~~~~~~~~-------------------~~~~---------~~~~~~~~~~~  207 (247)
                      .++|+||||+++++|++|..|+. ..+.......+..                   ...+         .....++++++
T Consensus       179 ~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (284)
T cd07839         179 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGR  258 (284)
T ss_pred             cHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHH
Confidence            89999999999999999988853 2222222111100                   0000         11234688999


Q ss_pred             HHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          208 DFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       208 ~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      ++|.+||+.+|.+|||++++++||||
T Consensus       259 ~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         259 DLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             HHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            99999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.2e-40  Score=260.46  Aligned_cols=230  Identities=43%  Similarity=0.801  Sum_probs=190.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-CCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~   79 (247)
                      +|+.|++|.+.....   .....+.+.+|+.+++.++|+||+++++.+...+..++|+||+++++|.+++.... +++..
T Consensus        24 ~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  100 (264)
T cd06626          24 TGELMAVKEIRIQDN---DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV  100 (264)
T ss_pred             CCcEEEEEEEECccc---chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCCChHH
Confidence            478899999876532   24567789999999999999999999999999999999999999999999987753 88899


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc------ccCCCCCCccCCcccccCC-
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL------KSCKGTPFWMAPEVVNSKN-  152 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~------~~~~~~~~~~aPE~~~~~~-  152 (247)
                      +..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+........      ....++..|++||.+.+.. 
T Consensus       101 ~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~  180 (264)
T cd06626         101 IRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG  180 (264)
T ss_pred             HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCC
Confidence            999999999999999999999999999999999999999999998865433221      1234678899999986544 


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhH-HHHHhhcCCCCCCCCc--CCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQ-ALFRIGKGELPSVPSS--LSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ...+.++|+|++|++++++++|..||....... ....+.....+..+..  .+..+.+++.+||+.+|.+|||+++++.
T Consensus       181 ~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         181 KGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            336889999999999999999999997653222 2223333334444444  4899999999999999999999999999


Q ss_pred             CccC
Q 041080          230 HPFV  233 (247)
Q Consensus       230 ~p~~  233 (247)
                      |||+
T Consensus       261 ~~~~  264 (264)
T cd06626         261 HPFV  264 (264)
T ss_pred             CCCC
Confidence            9996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1e-40  Score=264.07  Aligned_cols=232  Identities=33%  Similarity=0.594  Sum_probs=186.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec--CCcEEEEEeccccCcHHHHHHh-----c
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD--ENRLYIFLELVTKGSLANLYQK-----Y   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~-----~   73 (247)
                      +++.+|+|.+....    .......+.+|++++++++||||+++++++..  .+..++||||+++++|.+++..     .
T Consensus        25 ~~~~~~~k~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~  100 (287)
T cd06621          25 TGMIFALKTITTDP----NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGG  100 (287)
T ss_pred             CCeEEEEEEEecCC----chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCC
Confidence            36789999987532    22445678899999999999999999998754  3478999999999999887653     2


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCC
Q 041080           74 HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        74 ~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++............++..|++||.+.+.. 
T Consensus       101 ~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-  179 (287)
T cd06621         101 RIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKP-  179 (287)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccccccccCCccccCHHHhcCCC-
Confidence            3788899999999999999999999999999999999999999999999998655444333445778899999986544 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCCh-----hhHHHHHhhcCCCCCCC------CcCCHHHHHHHHHHhcCCCCCCC
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLE-----GVQALFRIGKGELPSVP------SSLSRDARDFILKCLQVNPNDRP  222 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rp  222 (247)
                       ++.++|+|++|+++|+|++|..||....     ..+....+.....+..+      ..+++.+++++.+||..+|.+||
T Consensus       180 -~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  258 (287)
T cd06621         180 -YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRP  258 (287)
T ss_pred             -CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCC
Confidence             7889999999999999999999987652     22333333322222211      24568899999999999999999


Q ss_pred             ChhhhhcCccCCCCCC
Q 041080          223 TVTELMEHPFVKRPLQ  238 (247)
Q Consensus       223 s~~~il~~p~~~~~~~  238 (247)
                      |+.|+++||||+....
T Consensus       259 t~~eil~~~~~~~~~~  274 (287)
T cd06621         259 TPWDMLEHPWIKAQMK  274 (287)
T ss_pred             CHHHHHhCcccccccc
Confidence            9999999999976543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.1e-41  Score=273.11  Aligned_cols=233  Identities=26%  Similarity=0.422  Sum_probs=189.6

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~   79 (247)
                      ++.+|+|++.....  ........+.+|+.++..++|++|+++++.+.+.+..++||||+++|+|.+++.+  ..+++..
T Consensus        26 ~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~  103 (332)
T cd05623          26 DKVFAMKILNKWEM--LKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM  103 (332)
T ss_pred             CCEEEEEEEeHHHH--HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHH
Confidence            57799999864321  2233345578899999999999999999999999999999999999999999976  3589999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccC---CC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSK---ND  153 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~---~~  153 (247)
                      +..++.|++.|+.+||+.|++|+||||+||+++.++.++|+|||++.......   .....|++.|+|||.+.+.   ..
T Consensus       104 ~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  183 (332)
T cd05623         104 ARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG  183 (332)
T ss_pred             HHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCC
Confidence            99999999999999999999999999999999999999999999876433221   2234589999999998531   23


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC----CCCCCCcCCHHHHHHHHHHhcCCCC--CCCChhhh
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE----LPSVPSSLSRDARDFILKCLQVNPN--DRPTVTEL  227 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~--~Rps~~~i  227 (247)
                      .++.++|+||||+++|+|++|+.||...+.......+....    .+.....+++++++++.+||..++.  .|++++++
T Consensus       184 ~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~  263 (332)
T cd05623         184 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDF  263 (332)
T ss_pred             CCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHH
Confidence            36889999999999999999999998877666666654432    2223346799999999999965444  36899999


Q ss_pred             hcCccCCCC
Q 041080          228 MEHPFVKRP  236 (247)
Q Consensus       228 l~~p~~~~~  236 (247)
                      ++||||+..
T Consensus       264 ~~h~~f~~~  272 (332)
T cd05623         264 KQHPFFTGI  272 (332)
T ss_pred             hCCCCcCCC
Confidence            999999853

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-40  Score=259.25  Aligned_cols=228  Identities=44%  Similarity=0.822  Sum_probs=197.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.|++|.+.....   .....+.+.+|++++++++|+|++++++++...+..++++|++++++|.+++.+. .+++..
T Consensus        24 ~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~  100 (254)
T cd06627          24 TGDFVAIKQISLEKI---KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL  100 (254)
T ss_pred             CCcEEEEEEeccccc---CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCCCHHH
Confidence            367899999976543   2345678999999999999999999999999999999999999999999998764 589999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc--ccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      ++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+........  ....++..|++||.+.+..  .+.
T Consensus       101 ~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~  178 (254)
T cd06627         101 VAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG--AST  178 (254)
T ss_pred             HHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCC--CCc
Confidence            999999999999999999999999999999999999999999999876554433  2345788899999986544  688


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      ++|+|++|++++++++|..||.................+..+...++.+++++.+||..+|++|||++++++||||
T Consensus       179 ~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         179 ASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             chhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999998766655555555555566777889999999999999999999999999999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8.5e-41  Score=263.48  Aligned_cols=233  Identities=27%  Similarity=0.378  Sum_probs=184.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHH---HhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISL---LSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~---l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~   76 (247)
                      +|+.+|+|.+.........  ....+.+|..+   +....||+|+.+++.+..++..++||||+++++|.+++... .++
T Consensus        18 ~~~~~aiK~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~   95 (279)
T cd05633          18 TGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFS   95 (279)
T ss_pred             CCcEEEEEEEEccccccch--HHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCC
Confidence            4789999999765432111  12223344333   33347999999999999999999999999999999888654 489


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      +..+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++............++..|+|||.+... ..++
T Consensus        96 ~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~  174 (279)
T cd05633          96 EKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG-TAYD  174 (279)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCCcCccCHHHhcCC-CCCC
Confidence            999999999999999999999999999999999999999999999999865444333445688999999987532 2368


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhH--HHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----Chhhhhc
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQ--ALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTELME  229 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~  229 (247)
                      .++|+||+|++++++++|..||.......  .............+..++.++++++.+||..+|.+||     |+.++++
T Consensus       175 ~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         175 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             chhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            89999999999999999999996543222  2222222233456677899999999999999999999     6999999


Q ss_pred             CccCCCC
Q 041080          230 HPFVKRP  236 (247)
Q Consensus       230 ~p~~~~~  236 (247)
                      ||||+..
T Consensus       255 h~~~~~~  261 (279)
T cd05633         255 HVFFKGI  261 (279)
T ss_pred             CccccCC
Confidence            9999873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.1e-42  Score=267.19  Aligned_cols=222  Identities=28%  Similarity=0.498  Sum_probs=184.8

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSDS   78 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~   78 (247)
                      +..|+||.+..    ....+..+.+.+|++.+++++||||++++|++...+..++|+||+++|+|.+++...   .+++.
T Consensus        28 ~~~V~vk~~~~----~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~  103 (259)
T PF07714_consen   28 NQPVAVKILKP----SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQ  103 (259)
T ss_dssp             EEEEEEEEEST----TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHH
T ss_pred             CEEEEEEEecc----ccccccceeeeeccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            46789999943    233445788999999999999999999999999888899999999999999999886   59999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCCcccccCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      .++.++.|++.||.|||+.+++|++|+++||+++.++.+||+|||.+.......    .........|+|||.+....  
T Consensus       104 ~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--  181 (259)
T PF07714_consen  104 QRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE--  181 (259)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSE--
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--
Confidence            999999999999999999999999999999999999999999999986652211    12233566799999986655  


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          155 YGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ++.++||||||++++++++ |..||...........+........+..++..+.+++.+||..+|.+|||+.++++
T Consensus       182 ~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  182 YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            7999999999999999999 78999988888877777766666677789999999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-41  Score=261.37  Aligned_cols=227  Identities=42%  Similarity=0.702  Sum_probs=187.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +++.+++|.+....     ....+.+.+|+.++++++||||+++++++..++..+++|||+++++|.+++...  .+++.
T Consensus        27 ~~~~~~ik~~~~~~-----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~  101 (262)
T cd06613          27 TGELVAIKVIKLEP-----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL  101 (262)
T ss_pred             CCCEEEEEEEEcCc-----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHH
Confidence            36789999997542     224567889999999999999999999999999999999999999999988654  58999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccC-CCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSK-NDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~  155 (247)
                      .+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......  ......++..|+|||.+.+. ...+
T Consensus       102 ~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~  181 (262)
T cd06613         102 QIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGY  181 (262)
T ss_pred             HHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCc
Confidence            99999999999999999999999999999999999999999999987654322  12234577889999998654 1136


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC----CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL----PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                      +.++|+||+|+++++|++|..||.................    ......++.++.+++.+||..+|.+|||+++++.||
T Consensus       182 ~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~  261 (262)
T cd06613         182 DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP  261 (262)
T ss_pred             CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence            8899999999999999999999977665544443333211    112335678899999999999999999999999999


Q ss_pred             c
Q 041080          232 F  232 (247)
Q Consensus       232 ~  232 (247)
                      |
T Consensus       262 ~  262 (262)
T cd06613         262 F  262 (262)
T ss_pred             C
Confidence            8

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.4e-40  Score=259.34  Aligned_cols=223  Identities=26%  Similarity=0.435  Sum_probs=187.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +++.+|+|++....   ......+.+.+|+.+++.++||||+++++++. .+..++||||+++++|.+++... .+++..
T Consensus        21 ~~~~~aiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   96 (257)
T cd05116          21 SEKTVAVKILKNDN---NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKNKHVTEKN   96 (257)
T ss_pred             CceEEEEEEccCCC---CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcCCCCHHH
Confidence            36789999886442   23345677889999999999999999999875 45678999999999999988654 589999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc-----ccCCCCCCccCCcccccCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL-----KSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +..++.|++.|+.++|++|++|+||||.||+++.++.++|+|||.+........     ....++..|+|||.+...  .
T Consensus        97 ~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~  174 (257)
T cd05116          97 ITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY--K  174 (257)
T ss_pred             HHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccC--C
Confidence            999999999999999999999999999999999999999999999865443321     111234679999988543  3


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          155 YGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ++.++|+||||+++|++++ |..||......+....+..+..+..+...++++.++|.+||+.+|.+||++++|..
T Consensus       175 ~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence            7889999999999999997 99999888777777777776666777889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.9e-41  Score=262.74  Aligned_cols=227  Identities=39%  Similarity=0.649  Sum_probs=183.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++....     ......+.+|+.++++++||||+++++.+..++..++||||+++++|.+++.+. .+++..
T Consensus        33 ~~~~~aik~~~~~~-----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~  107 (267)
T cd06646          33 TGELAAVKIIKLEP-----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQ  107 (267)
T ss_pred             CCeEEEEEEEecCc-----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHH
Confidence            47889999986432     123346789999999999999999999999999999999999999999988654 589999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccC-CCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSK-NDGYG  156 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~-~~~~~  156 (247)
                      +..++.|++.|+.+||+.|++|+|++|+||+++.++.++|+|||.+.......  .....++..|+|||.+... ...++
T Consensus       108 ~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~  187 (267)
T cd06646         108 IAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN  187 (267)
T ss_pred             HHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCc
Confidence            99999999999999999999999999999999999999999999986543221  2234577889999987432 23367


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC--C--CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL--P--SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      .++|+||+|++++++++|..||...........+.....  +  .....++..+++++.+||..+|.+|||++++++|+|
T Consensus       188 ~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             chhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            899999999999999999999865543333222212111  1  112357899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=7e-41  Score=265.53  Aligned_cols=234  Identities=32%  Similarity=0.595  Sum_probs=194.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.||+|.+...     .......+.+|+.+++.++|+|++++++.+..++..+++|||+++++|.+++....+++..+
T Consensus        44 ~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  118 (292)
T cd06657          44 SGKLVAVKKMDLR-----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI  118 (292)
T ss_pred             CCeEEEEEEeccc-----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcCCCCHHHH
Confidence            4788999987532     22345668899999999999999999999999999999999999999999988778999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCCcc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ..++.|++.++++||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|++||.+.+..  ++.+
T Consensus       119 ~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~  196 (292)
T cd06657         119 AAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP--YGPE  196 (292)
T ss_pred             HHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCccccCHHHhcCCC--CCch
Confidence            9999999999999999999999999999999999999999999875443222  22344778899999885433  6889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCC--CCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPS--VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      +|+||+|++++++++|..||...........+.....+.  ....++..+.+++.+||..+|.+||+++++++||||...
T Consensus       197 ~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~  276 (292)
T cd06657         197 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  276 (292)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhcc
Confidence            999999999999999999997765554444333222222  234578999999999999999999999999999999987


Q ss_pred             CCCCCC
Q 041080          237 LQTPRC  242 (247)
Q Consensus       237 ~~~~~~  242 (247)
                      .. +.|
T Consensus       277 ~~-~~~  281 (292)
T cd06657         277 GP-PSC  281 (292)
T ss_pred             CC-Ccc
Confidence            64 445

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.1e-40  Score=262.96  Aligned_cols=222  Identities=27%  Similarity=0.481  Sum_probs=189.5

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--------   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------   73 (247)
                      ++.||+|.+...    ...+..+.+.+|++++++++|+||+++++++...+..+++|||+++++|.+++...        
T Consensus        35 ~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~  110 (280)
T cd05049          35 KELVAVKTLKET----ASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLK  110 (280)
T ss_pred             cceEEEEeeccc----CCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhc
Confidence            467999988643    22334678899999999999999999999999999999999999999999998653        


Q ss_pred             -------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCc
Q 041080           74 -------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFW  142 (247)
Q Consensus        74 -------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~  142 (247)
                             .+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+.......    .....++..|
T Consensus       111 ~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y  190 (280)
T cd05049         111 SPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRW  190 (280)
T ss_pred             ccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCccccee
Confidence                   26788899999999999999999999999999999999999999999999886433221    1122345679


Q ss_pred             cCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCC
Q 041080          143 MAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR  221 (247)
Q Consensus       143 ~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  221 (247)
                      +|||.+.+..  ++.++|+||||++++++++ |..||......+....+..+.....+..++..+++++.+||+.+|.+|
T Consensus       191 ~aPE~~~~~~--~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  268 (280)
T cd05049         191 MPPESIMYRK--FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQR  268 (280)
T ss_pred             cChhhhccCC--cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccC
Confidence            9999986544  7889999999999999998 999998877777777777666666677899999999999999999999


Q ss_pred             CChhhhhc
Q 041080          222 PTVTELME  229 (247)
Q Consensus       222 ps~~~il~  229 (247)
                      |+++++++
T Consensus       269 p~~~eil~  276 (280)
T cd05049         269 INIKDIHE  276 (280)
T ss_pred             CCHHHHHH
Confidence            99999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.4e-41  Score=274.41  Aligned_cols=230  Identities=26%  Similarity=0.418  Sum_probs=181.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC------CcEEEEEeccccCcHHHHHHhcC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE------NRLYIFLELVTKGSLANLYQKYH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~   74 (247)
                      .|+.||||.+....   ........+.+|+.+++.++||||+++++++...      ...+++|||+++ ++.+.+.. .
T Consensus        41 ~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~  115 (355)
T cd07874          41 LDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM-E  115 (355)
T ss_pred             CCceEEEEEeCCcc---cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh-c
Confidence            36789999886542   2233456677899999999999999999987543      357999999976 67666643 5


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      +++..+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+....... .....++..|+|||.+.+.. 
T Consensus       116 l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-  194 (355)
T cd07874         116 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-  194 (355)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCC-
Confidence            8889999999999999999999999999999999999999999999999987554332 23456889999999986544 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC---------------------C------------------
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG---------------------E------------------  194 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---------------------~------------------  194 (247)
                       ++.++|+||||+++|+|++|+.||...+..+........                     .                  
T Consensus       195 -~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (355)
T cd07874         195 -YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLF  273 (355)
T ss_pred             -CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhcccccc
Confidence             788999999999999999999999765533322111000                     0                  


Q ss_pred             --CCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          195 --LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       195 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                        ....+...+.+++++|.+||..||.+|||++++++||||+...
T Consensus       274 ~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~  318 (355)
T cd07874         274 PADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY  318 (355)
T ss_pred             ccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence              0001123456789999999999999999999999999998543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=6.5e-42  Score=287.17  Aligned_cols=220  Identities=29%  Similarity=0.509  Sum_probs=197.8

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC--------
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--------   74 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------   74 (247)
                      ..||||.++..    ......++|++|+.++..++|||||+++|+|..++-.++|+|||..|+|.+++...+        
T Consensus       517 ~lVAVK~LKd~----a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~  592 (774)
T KOG1026|consen  517 QLVAVKALKDK----AENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLAS  592 (774)
T ss_pred             eehhHhhhccc----ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccC
Confidence            46899998743    345578899999999999999999999999999999999999999999999985431        


Q ss_pred             -------CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCC----CCCCcc
Q 041080           75 -------LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK----GTPFWM  143 (247)
Q Consensus        75 -------~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~----~~~~~~  143 (247)
                             ++..+.+.++.||+.|+.||-++.++||||-..|.+|+++-.|||+|||+++.....+.....    -..+||
T Consensus       593 g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWM  672 (774)
T KOG1026|consen  593 GQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWM  672 (774)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecC
Confidence                   678899999999999999999999999999999999999999999999999876655544333    345799


Q ss_pred             CCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC
Q 041080          144 APEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP  222 (247)
Q Consensus       144 aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  222 (247)
                      |||.+.-..  ++.++||||+|++|||+++ |+.||......+.+..+..+..-+-|..+|.++++||..||+.+|++||
T Consensus       673 ppEsIly~k--FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RP  750 (774)
T KOG1026|consen  673 PPESILYGK--FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRP  750 (774)
T ss_pred             CHHHhhcCc--ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCC
Confidence            999995444  8999999999999999997 9999999999999999999998888999999999999999999999999


Q ss_pred             Chhhhh
Q 041080          223 TVTELM  228 (247)
Q Consensus       223 s~~~il  228 (247)
                      ++.||=
T Consensus       751 sF~eI~  756 (774)
T KOG1026|consen  751 SFKEIH  756 (774)
T ss_pred             CHHHHH
Confidence            999984

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-40  Score=261.95  Aligned_cols=233  Identities=43%  Similarity=0.773  Sum_probs=188.4

Q ss_pred             CCceEEEEEEeecCCCc-----cchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-C
Q 041080            1 DGFFFAVKEVSLQDQGA-----QGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-H   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~   74 (247)
                      +|+.||+|.+.......     ......+.+.+|+.+++.++|||++++++++...+..++|+||+++++|.+++.+. .
T Consensus        25 ~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~  104 (272)
T cd06629          25 TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR  104 (272)
T ss_pred             CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhccC
Confidence            47889999986532211     11223456889999999999999999999999999999999999999999988764 5


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCCccccc
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNS  150 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aPE~~~~  150 (247)
                      +++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+.......    .....++..|+|||.+..
T Consensus       105 l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  184 (272)
T cd06629         105 FEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS  184 (272)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhcc
Confidence            8889999999999999999999999999999999999999999999999886433211    222346788999999865


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC-CCC----CCCCcCCHHHHHHHHHHhcCCCCCCCChh
Q 041080          151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG-ELP----SVPSSLSRDARDFILKCLQVNPNDRPTVT  225 (247)
Q Consensus       151 ~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~  225 (247)
                      ....++.++|+||+|++++++++|..||............... ...    .....++.++++++.+||.++|.+|||++
T Consensus       185 ~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  264 (272)
T cd06629         185 YSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTAR  264 (272)
T ss_pred             ccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHH
Confidence            4434788999999999999999999999765554433332211 111    22245689999999999999999999999


Q ss_pred             hhhcCccC
Q 041080          226 ELMEHPFV  233 (247)
Q Consensus       226 ~il~~p~~  233 (247)
                      ++++||||
T Consensus       265 ~il~~~~~  272 (272)
T cd06629         265 ELLQHPFI  272 (272)
T ss_pred             HHhhCCCC
Confidence            99999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=8.9e-41  Score=262.40  Aligned_cols=227  Identities=33%  Similarity=0.634  Sum_probs=184.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecC------CcEEEEEeccccCcHHHHHHhc
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDE------NRLYIFLELVTKGSLANLYQKY   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~   73 (247)
                      +++.||+|.+....      .....+.+|+.+++++ +|+||+++++++...      ...+++|||+++++|.+++...
T Consensus        30 ~~~~~aik~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~  103 (272)
T cd06637          30 TGQLAAIKVMDVTG------DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT  103 (272)
T ss_pred             CCcEEEEEEEEcCC------ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhc
Confidence            36789999986532      1234677899999998 699999999988642      4689999999999999998763


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCccc
Q 041080           74 ---HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVV  148 (247)
Q Consensus        74 ---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~  148 (247)
                         .+++..+..++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||++......  ......++..|+|||.+
T Consensus       104 ~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~  183 (272)
T cd06637         104 KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI  183 (272)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHh
Confidence               3889999999999999999999999999999999999999999999999998644322  22234578889999998


Q ss_pred             ccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC-CCCCCCcCCHHHHHHHHHHhcCCCCCCCCh
Q 041080          149 NSK---NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE-LPSVPSSLSRDARDFILKCLQVNPNDRPTV  224 (247)
Q Consensus       149 ~~~---~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  224 (247)
                      .+.   ...++.++|+||+|+++|+|++|..||................ .......++.++++++.+||..+|.+|||+
T Consensus       184 ~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  263 (272)
T cd06637         184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTT  263 (272)
T ss_pred             ccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCH
Confidence            532   2347889999999999999999999997665444443333322 222345678999999999999999999999


Q ss_pred             hhhhcCccC
Q 041080          225 TELMEHPFV  233 (247)
Q Consensus       225 ~~il~~p~~  233 (247)
                      +++++||||
T Consensus       264 ~~il~~~~~  272 (272)
T cd06637         264 EQLMKHPFI  272 (272)
T ss_pred             HHHhhCCCC
Confidence            999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=9.2e-41  Score=264.21  Aligned_cols=227  Identities=40%  Similarity=0.725  Sum_probs=191.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +++.|++|++.....      ..+.+.+|+..++.++|+|++++++.+...+..++++||+++++|.+++...  .++..
T Consensus        43 ~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~  116 (286)
T cd06614          43 TGKEVAIKKMRLRKQ------NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEP  116 (286)
T ss_pred             CCcEEEEEEEecCch------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHH
Confidence            478899999975432      4566889999999999999999999999999999999999999999999877  69999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|++||.+.+..  ++
T Consensus       117 ~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~  194 (286)
T cd06614         117 QIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKD--YG  194 (286)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCC--CC
Confidence            999999999999999999999999999999999999999999999875433221  12234677899999986543  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCC--CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCC
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK  234 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~  234 (247)
                      .++|+||||+++|++++|..||...........+.....+..  +..++.++++++.+||+.+|.+|||+.++++||||+
T Consensus       195 ~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  274 (286)
T cd06614         195 PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK  274 (286)
T ss_pred             CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhh
Confidence            899999999999999999999987665554444433333332  234789999999999999999999999999999999


Q ss_pred             C
Q 041080          235 R  235 (247)
Q Consensus       235 ~  235 (247)
                      .
T Consensus       275 ~  275 (286)
T cd06614         275 K  275 (286)
T ss_pred             c
Confidence            6

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.6e-40  Score=258.64  Aligned_cols=228  Identities=52%  Similarity=0.930  Sum_probs=194.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC--CcEEEEEeccccCcHHHHHHhc-CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE--NRLYIFLELVTKGSLANLYQKY-HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~   77 (247)
                      +|+.|++|++......   ....+.+.+|+..+++++|+||+++++.+...  +..++++||+++++|.+++.+. .+++
T Consensus        24 ~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~  100 (260)
T cd06606          24 TGELMAVKSVELSGDS---EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE  100 (260)
T ss_pred             CCcEEEEEEeeccccc---hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCH
Confidence            4788999999765422   45567889999999999999999999999888  8999999999999999998776 6899


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCCcccccCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      ..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......    .....++..|++||.+.+.. 
T Consensus       101 ~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-  179 (260)
T cd06606         101 PVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE-  179 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCC-
Confidence            9999999999999999999999999999999999999999999999987655443    23445788899999986544 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhh-HHHHHhh-cCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGV-QALFRIG-KGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                       .+.++|+||||++++++++|..||...... ....... ....+..+...+..+++++.+||+.+|.+||++.+++.||
T Consensus       180 -~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~  258 (260)
T cd06606         180 -YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHP  258 (260)
T ss_pred             -CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCC
Confidence             788999999999999999999999776522 2222222 1344566778899999999999999999999999999999


Q ss_pred             cC
Q 041080          232 FV  233 (247)
Q Consensus       232 ~~  233 (247)
                      ||
T Consensus       259 ~~  260 (260)
T cd06606         259 FL  260 (260)
T ss_pred             CC
Confidence            97

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.3e-40  Score=258.25  Aligned_cols=225  Identities=41%  Similarity=0.760  Sum_probs=192.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.+++|++.....     .....+.+|+..+++++|++++++++.+......++++||+++++|.+++...  .+++.
T Consensus        24 ~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~   98 (253)
T cd05122          24 TGKEVAIKVIKLESK-----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTES   98 (253)
T ss_pred             CCcEEEEEEecccch-----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHH
Confidence            478899999975432     34567889999999999999999999999999999999999999999998775  68999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCCCc
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      .+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... .....++..|++||.+.+..  .+.
T Consensus        99 ~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~  176 (253)
T cd05122          99 QIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP--YDY  176 (253)
T ss_pred             HHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccceecCCcccCHHHHcCCC--CCc
Confidence            999999999999999999999999999999999999999999999987655443 33445788899999986544  788


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCc--CCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSS--LSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      ++|+||+|++++++++|..||...+.............+..+..  ++..+.+++.+||+.+|.+|||+.++++|||
T Consensus       177 ~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         177 KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            99999999999999999999987755555444444434444433  3899999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.2e-40  Score=263.92  Aligned_cols=220  Identities=26%  Similarity=0.500  Sum_probs=186.3

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---------
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---------   73 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------   73 (247)
                      ..+|+|.+..     ........+.+|+.++++++||||+++++++...+..+++|||+++++|.+++...         
T Consensus        36 ~~~~ik~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~  110 (288)
T cd05093          36 ILVAVKTLKD-----ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAE  110 (288)
T ss_pred             eEEEEEecCC-----cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccc
Confidence            4578887753     23345667889999999999999999999999999999999999999999998643         


Q ss_pred             -----CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----ccCCCCCCccC
Q 041080           74 -----HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCKGTPFWMA  144 (247)
Q Consensus        74 -----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~a  144 (247)
                           .+++..++.++.|++.||++||++|++|+||||+||+++.++.++|+|||.+........    ....++..|+|
T Consensus       111 ~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a  190 (288)
T cd05093         111 GNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP  190 (288)
T ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccC
Confidence                 278999999999999999999999999999999999999999999999999865432221    12224567999


Q ss_pred             CcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC
Q 041080          145 PEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT  223 (247)
Q Consensus       145 PE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  223 (247)
                      ||.+.+..  ++.++|+||||+++++|++ |..||...........+..+.....+...+.++.+++.+||+.+|.+|||
T Consensus       191 PE~~~~~~--~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt  268 (288)
T cd05093         191 PESIMYRK--FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLN  268 (288)
T ss_pred             HHHhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCC
Confidence            99986543  7889999999999999998 89999887777777777666655666778999999999999999999999


Q ss_pred             hhhhhc
Q 041080          224 VTELME  229 (247)
Q Consensus       224 ~~~il~  229 (247)
                      ++++++
T Consensus       269 ~~~v~~  274 (288)
T cd05093         269 IKEIHS  274 (288)
T ss_pred             HHHHHH
Confidence            999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=7.1e-41  Score=260.77  Aligned_cols=228  Identities=32%  Similarity=0.618  Sum_probs=193.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~   77 (247)
                      +|+.+|+|.+......   ....+.+.+|+.+++.++|+||+++++.+...+..++++||+++++|.+++.+.   .+++
T Consensus        24 ~~~~~~ik~~~~~~~~---~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  100 (257)
T cd08225          24 DSEHCVIKEIDLTKMP---VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSE  100 (257)
T ss_pred             CCceEEEEEeeHhhcc---chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCH
Confidence            4788999998764322   223456779999999999999999999999999999999999999999988654   3789


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCC-eEEcccccccccCccc--cccCCCCCCccCCcccccCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS-VKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~-~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      ..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++++|||.+.......  .....++..|+|||.+.+..  
T Consensus       101 ~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~--  178 (257)
T cd08225         101 DQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP--  178 (257)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCC--
Confidence            999999999999999999999999999999999998864 6999999886554332  12234778899999885443  


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      ++.++|+||+|++++++++|..||........................+.++++++.+||..+|.+|||+.++++||||
T Consensus       179 ~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         179 YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            7889999999999999999999998776666666666666666667889999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.5e-40  Score=265.37  Aligned_cols=232  Identities=29%  Similarity=0.424  Sum_probs=190.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +++.|++|.+.....  ........+.+|+.+++.++||||+++++.+..++..+++|||+++++|.++++.. .+++..
T Consensus        25 ~~~~v~ik~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~  102 (305)
T cd05609          25 TRQRFAMKKINKQNL--ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDM  102 (305)
T ss_pred             CCcEEEEEEeehhhh--hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCCCCHHH
Confidence            367899998865421  22344567889999999999999999999999999999999999999999999764 488999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-----------------ccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-----------------DLKSCKGTPFW  142 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-----------------~~~~~~~~~~~  142 (247)
                      +..++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+......                 ......++..|
T Consensus       103 ~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  182 (305)
T cd05609         103 ARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY  182 (305)
T ss_pred             HHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccc
Confidence            9999999999999999999999999999999999999999999987531110                 00112356789


Q ss_pred             cCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC--CCCCCcCCHHHHHHHHHHhcCCCCC
Q 041080          143 MAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL--PSVPSSLSRDARDFILKCLQVNPND  220 (247)
Q Consensus       143 ~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~  220 (247)
                      +|||.+....  ++.++|+||||++++++++|..||.................  +.....++.++++++.+||+.+|.+
T Consensus       183 ~aPE~~~~~~--~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~  260 (305)
T cd05609         183 IAPEVILRQG--YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLE  260 (305)
T ss_pred             cCchhccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhh
Confidence            9999985433  78999999999999999999999987666665555444322  2333468999999999999999999


Q ss_pred             CCC---hhhhhcCccCCCC
Q 041080          221 RPT---VTELMEHPFVKRP  236 (247)
Q Consensus       221 Rps---~~~il~~p~~~~~  236 (247)
                      ||+   +.++++||||...
T Consensus       261 R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         261 RLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             ccCccCHHHHHhCccccCC
Confidence            998   7899999999753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-42  Score=259.21  Aligned_cols=232  Identities=29%  Similarity=0.471  Sum_probs=191.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~   78 (247)
                      +|..||||++.+.     ..-++.++.+|++++.++ .|+||++++++|+++..+|+|||.+.||+|...+.+ ..+++.
T Consensus       102 t~~EYAVKiidKq-----~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~F~E~  176 (463)
T KOG0607|consen  102 TGKEYAVKIIDKQ-----PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKHFNER  176 (463)
T ss_pred             cchhhhhhhhhcC-----CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhhccHH
Confidence            4789999999753     455678899999999999 599999999999999999999999999998776655 569999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC---CeEEcccccccccC---------ccccccCCCCCCccCCc
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG---SVKLADFGLAKATT---------MNDLKSCKGTPFWMAPE  146 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~---~~~l~df~~~~~~~---------~~~~~~~~~~~~~~aPE  146 (247)
                      ++.++..+|+.||.+||.+||.|+|+||+||+-...+   -+||+||.+.....         .......+|+..|||||
T Consensus       177 EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPE  256 (463)
T KOG0607|consen  177 EASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPE  256 (463)
T ss_pred             HHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchh
Confidence            9999999999999999999999999999999997654   47999998864322         22344556888999999


Q ss_pred             cc---ccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChh---------------hHHHHHhhcCCCCCC---CCcCCHH
Q 041080          147 VV---NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG---------------VQALFRIGKGELPSV---PSSLSRD  205 (247)
Q Consensus       147 ~~---~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~---------------~~~~~~~~~~~~~~~---~~~~~~~  205 (247)
                      +.   .+...-|+.+.|.||||+++|-|+.|+.||...-.               ..+...+..+.....   ...+|.+
T Consensus       257 VVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~e  336 (463)
T KOG0607|consen  257 VVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSE  336 (463)
T ss_pred             HHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHH
Confidence            86   33334478999999999999999999999965422               233445555554222   2468999


Q ss_pred             HHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          206 ARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       206 ~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      .++++..+|..++.+|.++.++++|||++...
T Consensus       337 akdlisnLlvrda~~rlsa~~vlnhPw~~~~~  368 (463)
T KOG0607|consen  337 AKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA  368 (463)
T ss_pred             HHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence            99999999999999999999999999998654

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8e-42  Score=274.09  Aligned_cols=228  Identities=28%  Similarity=0.478  Sum_probs=183.9

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC--CCHHH
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--LSDSQ   79 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~   79 (247)
                      +.||+|.+...   .........+.+|+..|.+|+ |.+|+++++|-..++.+|+||||.+. +|.++++++.  ++...
T Consensus       386 ~iyalkkv~~~---~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~  461 (677)
T KOG0596|consen  386 QIYALKKVVLL---EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGDI-DLNKILKKKKSIDPDWF  461 (677)
T ss_pred             cchhhhHHHHh---hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecccc-cHHHHHHhccCCCchHH
Confidence            45666666443   345667888999999999995 99999999999999999999999976 9999998876  33348


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc----cCCCCCCccCCcccccCCCC-
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK----SCKGTPFWMAPEVVNSKNDG-  154 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~aPE~~~~~~~~-  154 (247)
                      +..+..||+.|+.++|++||+|.||||.|+++ ..|.+||+|||++.........    ...||.-||+||.+...... 
T Consensus       462 lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~  540 (677)
T KOG0596|consen  462 LKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSR  540 (677)
T ss_pred             HHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccc
Confidence            89999999999999999999999999999999 7899999999999877766543    45699999999998533222 


Q ss_pred             --------CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC--CCCCCcCC-HHHHHHHHHHhcCCCCCCCC
Q 041080          155 --------YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL--PSVPSSLS-RDARDFILKCLQVNPNDRPT  223 (247)
Q Consensus       155 --------~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~-~~~~~li~~~l~~~p~~Rps  223 (247)
                              .++++|||||||++|+|+.|+.||.................  -+++..-+ .++.++++.||..||.+|||
T Consensus       541 ~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~s  620 (677)
T KOG0596|consen  541 ENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWS  620 (677)
T ss_pred             cCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCC
Confidence                    57889999999999999999999977653333222222221  12232222 23899999999999999999


Q ss_pred             hhhhhcCccCCC
Q 041080          224 VTELMEHPFVKR  235 (247)
Q Consensus       224 ~~~il~~p~~~~  235 (247)
                      +.++|+|||.+-
T Consensus       621 i~eLLqhpFl~~  632 (677)
T KOG0596|consen  621 IPELLQHPFLQI  632 (677)
T ss_pred             cHHHhcCccccc
Confidence            999999999985

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1e-40  Score=259.68  Aligned_cols=228  Identities=35%  Similarity=0.594  Sum_probs=198.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-----cCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-----YHL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~   75 (247)
                      +|+.+++|.+.....   .......+.+|+.++++++|+||+++++.+......++++||+++++|.+++.+     ..+
T Consensus        24 ~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~  100 (256)
T cd08530          24 DNQFYALKEVDLGSM---SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLI  100 (256)
T ss_pred             CCCEEEEEEEehhhc---cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCC
Confidence            477899999876432   233455677899999999999999999999999999999999999999998866     358


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCC
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ++..++.++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+............++..|++||.+.+..  +
T Consensus       101 ~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~  178 (256)
T cd08530         101 PEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRP--Y  178 (256)
T ss_pred             CHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCCcccccCCccccCHHHHCCCC--C
Confidence            89999999999999999999999999999999999999999999999998766554444455788999999986544  6


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      +.++|+||+|++++++++|+.||...+.......+.....+..+..++.++++++.+||..+|.+||++.++++||+.
T Consensus       179 ~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            889999999999999999999998888777666666666777777899999999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=7.4e-41  Score=269.63  Aligned_cols=235  Identities=26%  Similarity=0.457  Sum_probs=187.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~   77 (247)
                      +|+.||+|++....   ......+.+.+|+.+++.++||||+++++++..++..++++||+.+++|.+++.+.   .+++
T Consensus        24 ~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~  100 (328)
T cd08226          24 TGTLVTVRITDLEN---CTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSE  100 (328)
T ss_pred             CCcEEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCH
Confidence            47899999987543   23345678899999999999999999999999999999999999999999988763   4889


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---------cccCCCCCCccCCccc
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---------LKSCKGTPFWMAPEVV  148 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---------~~~~~~~~~~~aPE~~  148 (247)
                      ..+..++.|++.||+|||+.|++|+||||+||+++.++.+++.||+.........         .....++..|++||.+
T Consensus       101 ~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  180 (328)
T cd08226         101 ALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELL  180 (328)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhh
Confidence            9999999999999999999999999999999999999999999997542111100         0111245569999998


Q ss_pred             ccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC---------------------------------
Q 041080          149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL---------------------------------  195 (247)
Q Consensus       149 ~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------------------------  195 (247)
                      .+....++.++|+||+|++++++++|..||.................                                 
T Consensus       181 ~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (328)
T cd08226         181 RQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVA  260 (328)
T ss_pred             cCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhc
Confidence            76544578899999999999999999999976654333322211100                                 


Q ss_pred             -------------CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCCC
Q 041080          196 -------------PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQ  238 (247)
Q Consensus       196 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~~  238 (247)
                                   ...+..+++.+.+++++||+.+|.+|||++++++||||+....
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         261 AGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             cccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence                         0112235678999999999999999999999999999987644

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.1e-41  Score=292.84  Aligned_cols=232  Identities=27%  Similarity=0.507  Sum_probs=187.2

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec--CCcEEEEEeccccCcHHHHHHh-----cC
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD--ENRLYIFLELVTKGSLANLYQK-----YH   74 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~-----~~   74 (247)
                      +..+|+|++.....   .......+..|+.++.+|+||||++++++|..  ...+++||||+++++|.+++..     ..
T Consensus        38 g~~vAlKvIk~~~l---~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~  114 (1021)
T PTZ00266         38 QEFFCWKAISYRGL---KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK  114 (1021)
T ss_pred             CeEEEEEEEecccc---CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCC
Confidence            57889999875432   23345678899999999999999999998754  4578999999999999998865     24


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhC-------CeeecCCCCCcEEEcC-----------------CCCeEEcccccccccCc
Q 041080           75 LSDSQVSSYTRQILNGLVYLHER-------NVVHRDIKCANILVDA-----------------SGSVKLADFGLAKATTM  130 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~-------~i~h~dl~~~ni~~~~-----------------~~~~~l~df~~~~~~~~  130 (247)
                      +++..++.++.||+.||.|||+.       +|+|+||||+||+++.                 .+.++|+|||++.....
T Consensus       115 L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~  194 (1021)
T PTZ00266        115 IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI  194 (1021)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccc
Confidence            89999999999999999999985       4999999999999964                 23489999999875543


Q ss_pred             cc-cccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHH
Q 041080          131 ND-LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDF  209 (247)
Q Consensus       131 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  209 (247)
                      .. .....+++.|+|||.+.+....++.++|||||||++|+|++|..||........................+.++.+|
T Consensus       195 ~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dL  274 (1021)
T PTZ00266        195 ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNIL  274 (1021)
T ss_pred             cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHH
Confidence            32 23446899999999986554457889999999999999999999997655443333322222222234678999999


Q ss_pred             HHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          210 ILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       210 i~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      |..||..+|.+||++.++|.|||++..
T Consensus       275 I~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        275 IKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             HHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            999999999999999999999999864

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1e-40  Score=259.74  Aligned_cols=224  Identities=29%  Similarity=0.530  Sum_probs=191.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~   77 (247)
                      +|+.+|+|.+....    .....+.+.+|+.+++.++|+||+++++.+.+++..+++|||+++++|.+++...   .+++
T Consensus        24 ~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~   99 (255)
T cd08219          24 SDQKYAMKEIRLPK----SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPE   99 (255)
T ss_pred             CCceEEEEEEEcCc----chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCH
Confidence            47889999987542    2334567889999999999999999999999999999999999999999888642   3789


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ..++.++.|++.|+.+||++|++|+||+|+||+++.++.++++|||.+.......  .....++..|+|||.+.+..  +
T Consensus       100 ~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~  177 (255)
T cd08219         100 DTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP--Y  177 (255)
T ss_pred             HHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCC--c
Confidence            9999999999999999999999999999999999999999999999986443222  12345788899999986544  7


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      +.++|+||+|++++++++|..||...+.......+..+.....+..++..+++++.+||+.+|.+|||++++++-
T Consensus       178 ~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         178 NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            889999999999999999999998877766666666666666777889999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.9e-40  Score=259.32  Aligned_cols=220  Identities=27%  Similarity=0.473  Sum_probs=186.7

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSDS   78 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~   78 (247)
                      ++.||+|.+..+      ......+.+|+..++.++|+||+++++++...+..+++|||+++++|.+++...   .+++.
T Consensus        31 ~~~~~~K~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~  104 (263)
T cd05052          31 SLTVAVKTLKED------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV  104 (263)
T ss_pred             CceEEEEEecCC------chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHH
Confidence            678999988532      223456889999999999999999999999999999999999999999998653   38889


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccccc---CCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKS---CKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .++.++.|++.+|++||+.|++|+||+|+||+++.++.++|+|||.+..........   ...+..|+|||.+.+..  +
T Consensus       105 ~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~  182 (263)
T cd05052         105 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK--F  182 (263)
T ss_pred             HHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCC--C
Confidence            999999999999999999999999999999999999999999999986554332211   12345799999886544  7


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +.++|+||||+++|+|++ |..||......+....+........+...|.++.+++.+||+.+|.+|||+.++++
T Consensus       183 ~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         183 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            889999999999999998 89999877776666666665556667789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.8e-40  Score=263.11  Aligned_cols=228  Identities=36%  Similarity=0.624  Sum_probs=184.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecC-----CcEEEEEeccccCcHHHHHHh--
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDE-----NRLYIFLELVTKGSLANLYQK--   72 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~--   72 (247)
                      +|+.+|+|++....      .....+.+|+.+++++ +|||++++++++...     +..++|+||+++++|.++++.  
T Consensus        46 ~~~~~aik~~~~~~------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~  119 (291)
T cd06639          46 DGSLAAVKILDPIS------DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLL  119 (291)
T ss_pred             CCCEEEEEEecccc------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhh
Confidence            47889999886421      1234577899999999 799999999987643     368999999999999998753  


Q ss_pred             ---cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcc
Q 041080           73 ---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEV  147 (247)
Q Consensus        73 ---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~  147 (247)
                         ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.
T Consensus       120 ~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  199 (291)
T cd06639         120 ICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV  199 (291)
T ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhh
Confidence               348899999999999999999999999999999999999999999999999876543322  223457788999999


Q ss_pred             cccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCC--CCCcCCHHHHHHHHHHhcCCCCCCC
Q 041080          148 VNSKN---DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPS--VPSSLSRDARDFILKCLQVNPNDRP  222 (247)
Q Consensus       148 ~~~~~---~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp  222 (247)
                      +....   ..++.++|+||+|+++|++++|+.||...........+.....+.  .+..++..+.+++.+||+.+|.+||
T Consensus       200 ~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  279 (291)
T cd06639         200 IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARP  279 (291)
T ss_pred             hcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCc
Confidence            75432   125789999999999999999999998776555554444333322  2445778899999999999999999


Q ss_pred             ChhhhhcCccCC
Q 041080          223 TVTELMEHPFVK  234 (247)
Q Consensus       223 s~~~il~~p~~~  234 (247)
                      ++.++++||||+
T Consensus       280 s~~~il~~~~~~  291 (291)
T cd06639         280 SVTHLLEHPFIK  291 (291)
T ss_pred             CHHHHhcCcccC
Confidence            999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-40  Score=259.19  Aligned_cols=223  Identities=30%  Similarity=0.503  Sum_probs=194.4

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--------   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------   73 (247)
                      +..|++|.+.....    ....+.+.+|+..++.++|+|++++++++......+++|||+++++|.+++...        
T Consensus        23 ~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~   98 (262)
T cd00192          23 TTEVAVKTLKEDAS----EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPE   98 (262)
T ss_pred             CceEEeEeeccccc----hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccc
Confidence            67899999875432    114677889999999999999999999999999999999999999999999763        


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCCcc
Q 041080           74 --HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEV  147 (247)
Q Consensus        74 --~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aPE~  147 (247)
                        .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.......    .....++..|+|||.
T Consensus        99 ~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  178 (262)
T cd00192          99 KSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES  178 (262)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHH
Confidence              48999999999999999999999999999999999999999999999999987655432    333446778999999


Q ss_pred             cccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhh
Q 041080          148 VNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTE  226 (247)
Q Consensus       148 ~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  226 (247)
                      +...  .++.++|+||+|++++++++ |..||...........+........+..++.++.+++.+||+.+|.+|||+++
T Consensus       179 ~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  256 (262)
T cd00192         179 LKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSE  256 (262)
T ss_pred             hccC--CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHH
Confidence            8654  37899999999999999998 69999988887777777766666677788999999999999999999999999


Q ss_pred             hhcC
Q 041080          227 LMEH  230 (247)
Q Consensus       227 il~~  230 (247)
                      ++++
T Consensus       257 l~~~  260 (262)
T cd00192         257 LVER  260 (262)
T ss_pred             HHHh
Confidence            9864

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7e-41  Score=265.72  Aligned_cols=230  Identities=37%  Similarity=0.650  Sum_probs=190.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.|++|.+....     ....+.+.+|+.++++++||||+++++.+...+..++|+||+++++|.+++.+..+++..+
T Consensus        43 ~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~  117 (293)
T cd06647          43 TGQEVAIKQMNLQQ-----QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI  117 (293)
T ss_pred             CCCEEEEEEecccc-----chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhcCCCHHHH
Confidence            46789999885432     2234567899999999999999999999999999999999999999999998888999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCCcc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|++||.+....  ++.+
T Consensus       118 ~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~  195 (293)
T cd06647         118 AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPK  195 (293)
T ss_pred             HHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhccCC--CCch
Confidence            9999999999999999999999999999999999999999999875433222  22334777899999986543  7889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCC--CCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPS--VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      +|+||+|+++|++++|..||...........+.....+.  .+..++..+++++.+||..+|.+||++++++.||||+..
T Consensus       196 ~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~  275 (293)
T cd06647         196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA  275 (293)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence            999999999999999999997765544333322222222  234568899999999999999999999999999999964


Q ss_pred             C
Q 041080          237 L  237 (247)
Q Consensus       237 ~  237 (247)
                      .
T Consensus       276 ~  276 (293)
T cd06647         276 K  276 (293)
T ss_pred             c
Confidence            3

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.3e-40  Score=257.93  Aligned_cols=220  Identities=26%  Similarity=0.470  Sum_probs=186.1

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~   79 (247)
                      +..+|+|.+....      ...+.+.+|+.+++.++||||+++++++...+..+++|||+++++|.+++...  .+++..
T Consensus        28 ~~~~a~K~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~  101 (256)
T cd05114          28 QIKVAIKAINEGA------MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDM  101 (256)
T ss_pred             CceEEEEecccCC------ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHH
Confidence            4578999875332      12356789999999999999999999999999999999999999999988653  488999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc---cCCCCCCccCCcccccCCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK---SCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ++.++.|++.||.+||+.|++|+||+|+||+++.++.++++|||.+.........   ...+...|+|||.+.+..  ++
T Consensus       102 ~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~  179 (256)
T cd05114         102 LLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK--YS  179 (256)
T ss_pred             HHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCc--cc
Confidence            9999999999999999999999999999999999999999999988654322221   122345799999986543  78


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          157 LTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      .++|+||+|+++|++++ |+.||......+....+........+...+..+.+++.+||+.+|.+|||++++++
T Consensus       180 ~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            89999999999999999 89999888777777777666555566778899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.9e-40  Score=263.87  Aligned_cols=231  Identities=34%  Similarity=0.621  Sum_probs=190.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~   78 (247)
                      +|+.||+|.+....  .......+.+.+|+.+++.++||||+++.+++...+..++|+||+.+ ++.+++..  ..+++.
T Consensus        39 ~~~~v~iK~~~~~~--~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~  115 (307)
T cd06607          39 TNEVVAIKKMSYSG--KQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEV  115 (307)
T ss_pred             CCcEEEEEEEeccc--cCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCC-CHHHHHHHcccCCCHH
Confidence            47889999986543  22344556788999999999999999999999999999999999975 77776643  358999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccC-CCCCCc
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSK-NDGYGL  157 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~  157 (247)
                      .+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......  ....++..|+|||.+.+. ...++.
T Consensus       116 ~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~  193 (307)
T cd06607         116 EIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--NSFVGTPYWMAPEVILAMDEGQYDG  193 (307)
T ss_pred             HHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--CCccCCccccCceeeeccCCCCCCc
Confidence            99999999999999999999999999999999999999999999988654322  234577889999987432 233788


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCC-CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV-PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ++|+||||+++|++++|..||...........+.....+.. +..++..+++++.+||..+|.+||++.+++.||||+..
T Consensus       194 ~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             ccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence            99999999999999999999987666555544444333333 34578899999999999999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=8.8e-41  Score=264.03  Aligned_cols=228  Identities=33%  Similarity=0.564  Sum_probs=181.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh---cCCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK---YHLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~   77 (247)
                      +|+.||||.+.....   .......+.+|+.++++++||||+++++++..++..+++|||+.+ +|.+++..   ..+++
T Consensus        24 ~~~~~~ik~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~~~~~~~~~l~~   99 (284)
T cd07860          24 TGEVVALKKIRLDTE---TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPL   99 (284)
T ss_pred             CCCEEEEEEcccccc---ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecccc-CHHHHHHhCCCCCCCH
Confidence            478899998865432   222335678999999999999999999999999999999999964 88888754   34889


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ..+..++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+.. .+
T Consensus       100 ~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~  178 (284)
T cd07860         100 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK-YY  178 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCC-CC
Confidence            9999999999999999999999999999999999999999999999876443221  22334677899999886533 25


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC----------------------------CCCCCCCcCCHHHH
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG----------------------------ELPSVPSSLSRDAR  207 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~  207 (247)
                      +.++|+||||+++|++++|+.||...+...........                            ........++++++
T Consensus       179 ~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (284)
T cd07860         179 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGR  258 (284)
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHH
Confidence            78899999999999999999998765443322221110                            00011234678899


Q ss_pred             HHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          208 DFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       208 ~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      ++|.+||+.+|.+|||++++++||||
T Consensus       259 ~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         259 DLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=8.3e-41  Score=268.18  Aligned_cols=223  Identities=28%  Similarity=0.436  Sum_probs=170.6

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec--CCcEEEEEeccccCcHHHHHHhc------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD--ENRLYIFLELVTKGSLANLYQKY------   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~------   73 (247)
                      ++.||+|.+.....       ...+.+|+.++++++||||+++++++..  +...+++|||+.+ +|.+++...      
T Consensus        28 ~~~~aiK~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~   99 (317)
T cd07868          28 DRDYALKQIEGTGI-------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKAN   99 (317)
T ss_pred             CceEEEEEECCCCC-------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-CHHHHHHhccccccc
Confidence            56799998864321       2246689999999999999999998854  4578999999965 887776431      


Q ss_pred             ----CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEE----cCCCCeEEcccccccccCcc-----ccccCCCCC
Q 041080           74 ----HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV----DASGSVKLADFGLAKATTMN-----DLKSCKGTP  140 (247)
Q Consensus        74 ----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~----~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~  140 (247)
                          .+++..++.++.|++.||.|||+.|++|+||||+||++    +.++.++|+|||.+......     ......++.
T Consensus       100 ~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~  179 (317)
T cd07868         100 KKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF  179 (317)
T ss_pred             CCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccc
Confidence                38889999999999999999999999999999999999    45678999999998654322     123455788


Q ss_pred             CccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhh---------HHHHHhhcC-------------CC---
Q 041080          141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---------QALFRIGKG-------------EL---  195 (247)
Q Consensus       141 ~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---------~~~~~~~~~-------------~~---  195 (247)
                      .|+|||.+.+.. .++.++|+||+|+++++|++|..||......         +....+...             ..   
T Consensus       180 ~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (317)
T cd07868         180 WYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEH  258 (317)
T ss_pred             cccCCHHHcCCC-CcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccch
Confidence            999999986533 2688999999999999999999998543211         000000000             00   


Q ss_pred             ---------------------CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          196 ---------------------PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       196 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                                           .......+.++.++|.+||..||.+|||++|+++||||
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         259 STLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             hhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                                 00011235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.8e-41  Score=270.90  Aligned_cols=233  Identities=25%  Similarity=0.413  Sum_probs=189.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~   78 (247)
                      +|+.||+|++.....  ........+.+|+.++..++|++|+++++++..++..++||||+++|+|.+++.+  ..+++.
T Consensus        25 ~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~  102 (331)
T cd05624          25 TERIYAMKILNKWEM--LKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPED  102 (331)
T ss_pred             CCCEEEEEEEeHHHH--HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHH
Confidence            467899999865321  2233455678899999999999999999999999999999999999999999976  358999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc---ccCCCCCCccCCcccccCC---
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL---KSCKGTPFWMAPEVVNSKN---  152 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~---  152 (247)
                      .+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||++........   ....|+..|+|||.+.+..   
T Consensus       103 ~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  182 (331)
T cd05624         103 MARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM  182 (331)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCC
Confidence            9999999999999999999999999999999999999999999999865433221   2245889999999986421   


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC----CCCCCCcCCHHHHHHHHHHhcCCCCC--CCChhh
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE----LPSVPSSLSRDARDFILKCLQVNPND--RPTVTE  226 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~~  226 (247)
                      ..++.++|+||+|+++|+|++|+.||......+....+....    .+.....+++++++++.+||...+.+  |+++++
T Consensus       183 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~  262 (331)
T cd05624         183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIED  262 (331)
T ss_pred             CCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHH
Confidence            236789999999999999999999998776666555544322    22223457899999999999876544  578999


Q ss_pred             hhcCccCCC
Q 041080          227 LMEHPFVKR  235 (247)
Q Consensus       227 il~~p~~~~  235 (247)
                      +++||||+.
T Consensus       263 ~~~h~~f~~  271 (331)
T cd05624         263 FKKHAFFEG  271 (331)
T ss_pred             HhcCCCcCC
Confidence            999999985

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.5e-40  Score=265.74  Aligned_cols=231  Identities=29%  Similarity=0.467  Sum_probs=183.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC--CcEEEEEeccccCcHHHHHHh--cCCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE--NRLYIFLELVTKGSLANLYQK--YHLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~--~~~~   76 (247)
                      +|+.||+|.+......   ......+.+|+.++++++|+||+++++++...  +..++||||+.+ +|.+++..  ..++
T Consensus        31 ~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~  106 (309)
T cd07845          31 SGEIVALKKVRMDNER---DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFS  106 (309)
T ss_pred             CCcEEEEEEEEeccCC---CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcccCCC
Confidence            4789999999764321   11222356799999999999999999988654  568999999976 88888765  3489


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+.. .
T Consensus       107 ~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~  185 (309)
T cd07845         107 ESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCT-T  185 (309)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCC-C
Confidence            99999999999999999999999999999999999999999999999986554321  22233567899999986433 2


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC---------------------CCCC--------CCcCCHH
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE---------------------LPSV--------PSSLSRD  205 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------~~~~--------~~~~~~~  205 (247)
                      ++.++|+||+|+++|++++|..||...+.......+....                     .+..        ....+++
T Consensus       186 ~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (309)
T cd07845         186 YTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEA  265 (309)
T ss_pred             cCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHH
Confidence            6889999999999999999999998766655543322210                     0000        0125788


Q ss_pred             HHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          206 ARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       206 ~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      +.++|.+||..||++|||++++++||||+..
T Consensus       266 ~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         266 GLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence            9999999999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-40  Score=260.75  Aligned_cols=227  Identities=34%  Similarity=0.668  Sum_probs=185.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCC------cEEEEEeccccCcHHHHHHh-
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDEN------RLYIFLELVTKGSLANLYQK-   72 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~-   72 (247)
                      +|+.+++|++....      ...+.+.+|+.+++++ .|+||+++++++....      ..+++|||+++++|.+++.. 
T Consensus        30 ~~~~~~~k~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~  103 (275)
T cd06608          30 TGQLVAIKIMDIIE------DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGL  103 (275)
T ss_pred             CCcEEEEEEEecCc------hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHH
Confidence            36789999886432      2345688999999999 6999999999986544      58999999999999998764 


Q ss_pred             ----cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCc
Q 041080           73 ----YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPE  146 (247)
Q Consensus        73 ----~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE  146 (247)
                          ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||
T Consensus       104 ~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE  183 (275)
T cd06608         104 RKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPE  183 (275)
T ss_pred             hhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHh
Confidence                358999999999999999999999999999999999999999999999999876443221  22344788899999


Q ss_pred             ccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCC--CcCCHHHHHHHHHHhcCCCCCC
Q 041080          147 VVNSK---NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVP--SSLSRDARDFILKCLQVNPNDR  221 (247)
Q Consensus       147 ~~~~~---~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R  221 (247)
                      .+...   ...++.++|+||||++++++++|..||...........+.....+...  ..++.++++++.+||..+|++|
T Consensus       184 ~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  263 (275)
T cd06608         184 VIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQR  263 (275)
T ss_pred             HhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhC
Confidence            87532   233678899999999999999999999876655555555444332222  3478899999999999999999


Q ss_pred             CChhhhhcCccC
Q 041080          222 PTVTELMEHPFV  233 (247)
Q Consensus       222 ps~~~il~~p~~  233 (247)
                      ||++++++|||+
T Consensus       264 pt~~~ll~~~~~  275 (275)
T cd06608         264 PFMEELLEHPFI  275 (275)
T ss_pred             cCHHHHhcCCCC
Confidence            999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.7e-40  Score=262.14  Aligned_cols=220  Identities=27%  Similarity=0.492  Sum_probs=185.8

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC--------
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--------   74 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------   74 (247)
                      ..+++|.+..     ......+.+.+|+..+++++|+||+++++++...+..++||||+++++|.+++...+        
T Consensus        36 ~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~  110 (291)
T cd05094          36 MLVAVKALKD-----PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVD  110 (291)
T ss_pred             eeeEEEecCC-----ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccc
Confidence            3467777643     233445678899999999999999999999999999999999999999999986532        


Q ss_pred             ---------CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----ccCCCCCC
Q 041080           75 ---------LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCKGTPF  141 (247)
Q Consensus        75 ---------~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~  141 (247)
                               +++..++.++.|++.|+++||++|++|+||+|+||+++.++.++|+|||.+........    ....++..
T Consensus       111 ~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~  190 (291)
T cd05094         111 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR  190 (291)
T ss_pred             cccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCccee
Confidence                     68889999999999999999999999999999999999999999999999865433221    22335678


Q ss_pred             ccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCC
Q 041080          142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPND  220 (247)
Q Consensus       142 ~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  220 (247)
                      |+|||.+.+..  ++.++|+||||+++|+|++ |..||...........+..+..+..+...|..+.+++.+||+.+|.+
T Consensus       191 y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~  268 (291)
T cd05094         191 WMPPESIMYRK--FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQ  268 (291)
T ss_pred             ecChHHhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhh
Confidence            99999986544  7889999999999999998 99999877777776666666666666778999999999999999999


Q ss_pred             CCChhhhhc
Q 041080          221 RPTVTELME  229 (247)
Q Consensus       221 Rps~~~il~  229 (247)
                      |||++++++
T Consensus       269 Rpt~~~v~~  277 (291)
T cd05094         269 RLNIKEIYK  277 (291)
T ss_pred             CcCHHHHHH
Confidence            999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-40  Score=256.63  Aligned_cols=228  Identities=34%  Similarity=0.531  Sum_probs=195.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.+++|.+.....  ........+..|+.+++.++|+||+++++.+..++..+++|||+++++|.+++... .+++..
T Consensus        17 ~~~~~~~k~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~   94 (250)
T cd05123          17 TGKLYAMKVLKKKKI--IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER   94 (250)
T ss_pred             CCcEEEEEEeehhhh--cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCHHH
Confidence            478999999876532  22335667889999999999999999999999999999999999999999999776 589999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      +..++.|++.|+.++|+.|++|+||+|+||+++.++.++|+|||.+......  ......++..|++||...+..  .+.
T Consensus        95 ~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~  172 (250)
T cd05123          95 ARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKG--YGK  172 (250)
T ss_pred             HHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCC--CCc
Confidence            9999999999999999999999999999999999999999999998655433  233445778899999986544  688


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh---hhhhcCccC
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV---TELMEHPFV  233 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~---~~il~~p~~  233 (247)
                      ++|+|+||++++++++|..||...+.......+.. .....+...+..+.+++.+||..+|.+||++   +++++||||
T Consensus       173 ~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             hhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            99999999999999999999987776555555544 3345677789999999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-42  Score=277.45  Aligned_cols=232  Identities=36%  Similarity=0.627  Sum_probs=205.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHH--hcCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--~~~~~~~   78 (247)
                      +.+.||||....+.  ..+.+.-++|..|+..|++++|||++.+.|.|..+...++|||||-| |-.++++  ++++.+.
T Consensus        50 n~evVAIKKMsySG--KQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG-SAsDlleVhkKplqEv  126 (948)
T KOG0577|consen   50 NSEVVAIKKMSYSG--KQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEV  126 (948)
T ss_pred             ccceeeeeeccccc--cccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-cHHHHHHHHhccchHH
Confidence            35789999887654  56667778899999999999999999999999999999999999966 8888774  5689999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccc-cCCCCCCc
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVN-SKNDGYGL  157 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~  157 (247)
                      .+..|..+.+.||+|||+++.+|+|||..||++++.|.|||+|||.+....  ....++|||+|+|||++. ...+.|+.
T Consensus       127 EIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--PAnsFvGTPywMAPEVILAMDEGqYdg  204 (948)
T KOG0577|consen  127 EIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA--PANSFVGTPYWMAPEVILAMDEGQYDG  204 (948)
T ss_pred             HHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC--chhcccCCccccchhHheeccccccCC
Confidence            999999999999999999999999999999999999999999999986543  456788999999999863 34455899


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCC-CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVP-SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ++||||||++..+|+..++|+-+++....+.-+.....|.++ +.++..+++|+..||++-|.+|||.+++++|+|....
T Consensus       205 kvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~  284 (948)
T KOG0577|consen  205 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE  284 (948)
T ss_pred             ccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence            999999999999999999999888887777777766666665 5799999999999999999999999999999999865


Q ss_pred             C
Q 041080          237 L  237 (247)
Q Consensus       237 ~  237 (247)
                      .
T Consensus       285 R  285 (948)
T KOG0577|consen  285 R  285 (948)
T ss_pred             C
Confidence            3

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-40  Score=257.33  Aligned_cols=220  Identities=27%  Similarity=0.474  Sum_probs=185.3

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSDS   78 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~   78 (247)
                      ++.||+|.+.....      ..+.+.+|+.++++++||||+++++++...+..+++|||+++++|.+++...   .+++.
T Consensus        30 ~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  103 (261)
T cd05068          30 TTPVAVKTLKPGTM------DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLP  103 (261)
T ss_pred             CeEEEEEeeCCCcc------cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHH
Confidence            56799999864321      2456789999999999999999999999999999999999999999998764   38899


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCC---CCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKG---TPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~---~~~~~aPE~~~~~~~~~  155 (247)
                      .+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+............+   ...|+|||...+..  +
T Consensus       104 ~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~  181 (261)
T cd05068         104 QLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNR--F  181 (261)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCC--C
Confidence            999999999999999999999999999999999999999999999987654332222222   34699999986544  7


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +.++|+||||++++++++ |+.||...........+........+...+..+.+++.+||+.+|.+||+++++++
T Consensus       182 ~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         182 SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            889999999999999998 99999887766666666555444556678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.8e-40  Score=260.37  Aligned_cols=229  Identities=25%  Similarity=0.442  Sum_probs=189.3

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-------   74 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------   74 (247)
                      +..||+|.+....    .......+.+|+..++.++||||+++++++...+..+++|||+++++|.+++....       
T Consensus        36 ~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~  111 (288)
T cd05061          36 ETRVAVKTVNESA----SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP  111 (288)
T ss_pred             ceEEEEEECCCcC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCC
Confidence            3478999875322    22334457889999999999999999999999999999999999999999986521       


Q ss_pred             ----CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc----cCCCCCCccCCc
Q 041080           75 ----LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK----SCKGTPFWMAPE  146 (247)
Q Consensus        75 ----~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~aPE  146 (247)
                          .+...+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+.........    ...++..|+|||
T Consensus       112 ~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE  191 (288)
T cd05061         112 GRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE  191 (288)
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHH
Confidence                356678899999999999999999999999999999999999999999988644332211    122356799999


Q ss_pred             ccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChh
Q 041080          147 VVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT  225 (247)
Q Consensus       147 ~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  225 (247)
                      .+.+..  ++.++|+||||++++++++ |..||......+....+........+...++.+++++.+||+.+|.+|||+.
T Consensus       192 ~~~~~~--~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  269 (288)
T cd05061         192 SLKDGV--FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFL  269 (288)
T ss_pred             HhccCC--CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHH
Confidence            986543  7889999999999999998 7889988777776666665555566677889999999999999999999999


Q ss_pred             hhhc------CccCCCC
Q 041080          226 ELME------HPFVKRP  236 (247)
Q Consensus       226 ~il~------~p~~~~~  236 (247)
                      ++++      ||||+.+
T Consensus       270 ~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         270 EIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             HHHHHHHhhcCCCCCCC
Confidence            9987      9999864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.6e-40  Score=263.79  Aligned_cols=221  Identities=26%  Similarity=0.455  Sum_probs=177.9

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---------
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---------   73 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------   73 (247)
                      ..||+|.+....    .......+.+|+.++.+++||||+++++++.+.+..+++|||+++++|.+++...         
T Consensus        47 ~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  122 (304)
T cd05096          47 LLVAVKILRPDA----NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENG  122 (304)
T ss_pred             eEEEEEEecCCC----CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhcccccccccc
Confidence            469999886532    2344667889999999999999999999999999999999999999999988653         


Q ss_pred             -----------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----ccCCC
Q 041080           74 -----------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCKG  138 (247)
Q Consensus        74 -----------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~  138 (247)
                                 .+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+........    ....+
T Consensus       123 ~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~  202 (304)
T cd05096         123 NDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVL  202 (304)
T ss_pred             ccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCC
Confidence                       256678899999999999999999999999999999999999999999999865433221    12234


Q ss_pred             CCCccCCcccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCChhhHHHHHhhc-------CCCCCCCCcCCHHHHHH
Q 041080          139 TPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT--RRPPYSHLEGVQALFRIGK-------GELPSVPSSLSRDARDF  209 (247)
Q Consensus       139 ~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~--g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l  209 (247)
                      +..|+|||.+.+..  ++.++|+||||+++|++++  +..||..............       ......+..++..+.++
T Consensus       203 ~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  280 (304)
T cd05096         203 PIRWMAWECILMGK--FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYEL  280 (304)
T ss_pred             CccccCHHHHhcCC--CCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHH
Confidence            67899999986543  7889999999999999986  5678876655444332211       11123345678999999


Q ss_pred             HHHHhcCCCCCCCChhhhhc
Q 041080          210 ILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       210 i~~~l~~~p~~Rps~~~il~  229 (247)
                      +.+||..+|.+|||++++.+
T Consensus       281 i~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         281 MLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             HHHHccCCchhCcCHHHHHH
Confidence            99999999999999999953

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-40  Score=257.29  Aligned_cols=221  Identities=22%  Similarity=0.425  Sum_probs=185.3

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~   79 (247)
                      +..+|+|.+.....      ....+.+|+.+++.++||||+++++++...+..++||||+++++|.+++...  .+++..
T Consensus        28 ~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  101 (256)
T cd05059          28 KIDVAIKMIREGAM------SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW  101 (256)
T ss_pred             CccEEEEEeccCCC------CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHH
Confidence            35789998854321      2345778999999999999999999999999999999999999999998654  478999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCC---CCCCccCCcccccCCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK---GTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~---~~~~~~aPE~~~~~~~~~~  156 (247)
                      ++.++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+............   ++..|+|||.+.+..  ++
T Consensus       102 ~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~--~~  179 (256)
T cd05059         102 LLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSR--FS  179 (256)
T ss_pred             HHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCC--CC
Confidence            9999999999999999999999999999999999999999999988654433222222   234699999986544  78


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          157 LTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      .++|+||||+++|++++ |..||...+..+....+........+...+.++.+++.+||+.+|.+|||++++++.
T Consensus       180 ~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            89999999999999998 899998777776666666655556667789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3e-40  Score=257.24  Aligned_cols=220  Identities=24%  Similarity=0.476  Sum_probs=185.5

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHH
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQV   80 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~   80 (247)
                      ..+|+|.+.....      ..+.+.+|+.++++++||||+++++++...+..+++|||+.+++|.+++...  .+++..+
T Consensus        29 ~~~aik~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~  102 (256)
T cd05113          29 YDVAIKMIKEGSM------SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL  102 (256)
T ss_pred             CcEEEEEcCCCcc------cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHH
Confidence            4589998864321      2346789999999999999999999999888999999999999999998764  4899999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccccc---CCCCCCccCCcccccCCCCCCc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKS---CKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      +.++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+..........   ..++..|++||.+.+..  ++.
T Consensus       103 ~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~  180 (256)
T cd05113         103 LEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK--FSS  180 (256)
T ss_pred             HHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCc--ccc
Confidence            9999999999999999999999999999999999999999999876543332221   22446799999986543  788


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          158 TADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      ++|+||||+++|++++ |..||...........+........+...+..+++++.+||..+|.+||++.+++++
T Consensus       181 ~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         181 KSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             hhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence            9999999999999998 999998777666666666665555566789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-40  Score=258.38  Aligned_cols=230  Identities=29%  Similarity=0.471  Sum_probs=185.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHH-hhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLL-SQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||+|.+......  .......+..|..++ ...+|+|++++++.+..++..++++||+++++|.++++.. .+++.
T Consensus        20 ~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~   97 (260)
T cd05611          20 TGDYFAIKVLKKSDMI--AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPED   97 (260)
T ss_pred             CCCeEEEEEecchhhh--HHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCHH
Confidence            4789999998654321  122223344554444 4458999999999999999999999999999999999764 58999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcc
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      .+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....  .....++..|++||.+.+..  ++.+
T Consensus        98 ~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~~y~~pe~~~~~~--~~~~  173 (260)
T cd05611          98 WAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--NKKFVGTPDYLAPETILGVG--DDKM  173 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc--cccCCCCcCccChhhhcCCC--Ccch
Confidence            9999999999999999999999999999999999999999999998765432  22344778899999986544  6889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC---CCCCCCcCCHHHHHHHHHHhcCCCCCCCC---hhhhhcCcc
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE---LPSVPSSLSRDARDFILKCLQVNPNDRPT---VTELMEHPF  232 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~p~  232 (247)
                      +|+||+|++++++++|..||...+.......+....   .......+++++.+++.+||+.+|.+||+   ++++++|||
T Consensus       174 ~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~  253 (260)
T cd05611         174 SDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPF  253 (260)
T ss_pred             hhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChH
Confidence            999999999999999999998776665554443322   22334468999999999999999999995   479999999


Q ss_pred             CCCC
Q 041080          233 VKRP  236 (247)
Q Consensus       233 ~~~~  236 (247)
                      |+.+
T Consensus       254 ~~~~  257 (260)
T cd05611         254 FKSI  257 (260)
T ss_pred             hhcC
Confidence            9864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=261.49  Aligned_cols=228  Identities=33%  Similarity=0.571  Sum_probs=183.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC---CCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH---LSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~   77 (247)
                      +|+.||+|++......   ......+.+|+.+++.++|||++++++++.+++..+++|||++ ++|.+++....   +++
T Consensus        23 ~~~~~~ik~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~   98 (283)
T cd07835          23 TGEIVALKKIRLETED---EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDP   98 (283)
T ss_pred             CCCEEEEEEeeccccc---ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCH
Confidence            5889999999764321   2233457789999999999999999999999999999999996 58999887653   899


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+.. .+
T Consensus        99 ~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~  177 (283)
T cd07835          99 PLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSR-QY  177 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCc-cc
Confidence            9999999999999999999999999999999999999999999999986443221  12334578899999875432 25


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc----------------------------CCCCCCCCcCCHHHH
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK----------------------------GELPSVPSSLSRDAR  207 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~  207 (247)
                      +.++|+||+|+++|++++|..||...+.......+..                            .........++..+.
T Consensus       178 ~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (283)
T cd07835         178 STPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGL  257 (283)
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHH
Confidence            7899999999999999999999976544332211110                            001112346778999


Q ss_pred             HHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          208 DFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       208 ~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      +++.+||+++|.+|||+++++.||||
T Consensus       258 ~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         258 DLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             HHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.2e-40  Score=260.64  Aligned_cols=227  Identities=33%  Similarity=0.626  Sum_probs=183.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeec------CCcEEEEEeccccCcHHHHHHhc
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKD------ENRLYIFLELVTKGSLANLYQKY   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~   73 (247)
                      +|+.+|+|++...      ......+..|+.+++++ +|+||+++++++..      ....+++|||+++++|.+++...
T Consensus        40 ~~~~~a~K~~~~~------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~  113 (282)
T cd06636          40 TGQLAAIKVMDVT------EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT  113 (282)
T ss_pred             CCcEEEEEEEecC------hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHc
Confidence            3678999988543      22345677899999998 69999999998742      45789999999999999988653


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCccc
Q 041080           74 ---HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVV  148 (247)
Q Consensus        74 ---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~  148 (247)
                         .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......  ......++..|+|||.+
T Consensus       114 ~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l  193 (282)
T cd06636         114 KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI  193 (282)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhc
Confidence               3788889999999999999999999999999999999999999999999987644321  12234578889999987


Q ss_pred             ccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCC-CCCCcCCHHHHHHHHHHhcCCCCCCCCh
Q 041080          149 NSK---NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP-SVPSSLSRDARDFILKCLQVNPNDRPTV  224 (247)
Q Consensus       149 ~~~---~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~  224 (247)
                      ...   ...++.++|+||||+++|++++|..||...........+.....+ .....++.++.++|.+||..+|.+|||+
T Consensus       194 ~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~  273 (282)
T cd06636         194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPST  273 (282)
T ss_pred             CcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCH
Confidence            532   234678999999999999999999999766544444333333222 2334689999999999999999999999


Q ss_pred             hhhhcCccC
Q 041080          225 TELMEHPFV  233 (247)
Q Consensus       225 ~~il~~p~~  233 (247)
                      .++++||||
T Consensus       274 ~ell~~~~~  282 (282)
T cd06636         274 EQLLKHPFI  282 (282)
T ss_pred             HHHhcCCCC
Confidence            999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.3e-40  Score=271.01  Aligned_cols=223  Identities=25%  Similarity=0.416  Sum_probs=180.3

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-------   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------   73 (247)
                      +..||||++....    .....+.+.+|+.++..+ +||||+++++++..++..++||||+++|+|.+++...       
T Consensus        65 ~~~vavK~l~~~~----~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~  140 (375)
T cd05104          65 AMTVAVKMLKPSA----HLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICP  140 (375)
T ss_pred             ceeEEEEeccCCc----CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccc
Confidence            4579999986432    223456788999999999 7999999999999999999999999999999888542       


Q ss_pred             ---------------------------------------------------------------------CCCHHHHHHHH
Q 041080           74 ---------------------------------------------------------------------HLSDSQVSSYT   84 (247)
Q Consensus        74 ---------------------------------------------------------------------~~~~~~~~~~~   84 (247)
                                                                                           .+++..+..++
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  220 (375)
T cd05104         141 KHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFS  220 (375)
T ss_pred             cccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHH
Confidence                                                                                 25677889999


Q ss_pred             HHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc----cCCCCCCccCCcccccCCCCCCcchh
Q 041080           85 RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK----SCKGTPFWMAPEVVNSKNDGYGLTAD  160 (247)
Q Consensus        85 ~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~aPE~~~~~~~~~~~~~D  160 (247)
                      .|++.||.|||+.|++|+||||+||+++.++.++|+|||++.........    ...++..|+|||.+.+..  ++.++|
T Consensus       221 ~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sD  298 (375)
T cd05104         221 YQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESD  298 (375)
T ss_pred             HHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCC--CCCCCC
Confidence            99999999999999999999999999999999999999998654332211    122345699999986544  789999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCChhhHH-HHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          161 IWSLGCTVLEMLT-RRPPYSHLEGVQA-LFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       161 i~slG~ll~~l~~-g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      +||||+++|++++ |..||........ ...+..+.....+...+.++++++.+||+.+|.+|||+.++++.
T Consensus       299 i~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         299 VWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            9999999999997 8889876544333 33333333344456678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.8e-40  Score=271.37  Aligned_cols=222  Identities=24%  Similarity=0.453  Sum_probs=180.2

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-------   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------   73 (247)
                      ++.||+|.+....    .....+.+.+|+.+++.+ +|+||+++++++...+..++||||+++|+|.+++...       
T Consensus        68 ~~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~  143 (374)
T cd05106          68 VLRVAVKMLKASA----HTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNF  143 (374)
T ss_pred             cceeEEEeccCCC----CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccc
Confidence            3579999996532    233456788999999999 8999999999999999999999999999999987532       


Q ss_pred             ----------------------------------------------------------------CCCHHHHHHHHHHHHH
Q 041080           74 ----------------------------------------------------------------HLSDSQVSSYTRQILN   89 (247)
Q Consensus        74 ----------------------------------------------------------------~~~~~~~~~~~~~l~~   89 (247)
                                                                                      ++++..+++++.|++.
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~  223 (374)
T cd05106         144 VMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQ  223 (374)
T ss_pred             cccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHH
Confidence                                                                            2677888999999999


Q ss_pred             HHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc----cCCCCCCccCCcccccCCCCCCcchhHHHHH
Q 041080           90 GLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK----SCKGTPFWMAPEVVNSKNDGYGLTADIWSLG  165 (247)
Q Consensus        90 ~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG  165 (247)
                      ||.|||++|++|+||||+||+++.++.++|+|||++.........    ...++..|+|||.+.+..  ++.++|+||||
T Consensus       224 aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwSlG  301 (374)
T cd05106         224 GMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCV--YTVQSDVWSYG  301 (374)
T ss_pred             HHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCC--CCccccHHHHH
Confidence            999999999999999999999999999999999998654322211    122345699999985433  78999999999


Q ss_pred             HHHHHHHh-CCCCCCCChhhHHHHHhh-cCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          166 CTVLEMLT-RRPPYSHLEGVQALFRIG-KGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       166 ~ll~~l~~-g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +++|+|++ |..||............. .......+...++++++++.+||+.+|.+|||++++++
T Consensus       302 vil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         302 ILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999997 999997765544333332 22233445567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.4e-40  Score=259.04  Aligned_cols=223  Identities=24%  Similarity=0.413  Sum_probs=186.8

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--------   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------   73 (247)
                      +..+++|.+...    ........+.+|+.++++++||||+++++++..++..+++|||+++++|.+++...        
T Consensus        34 ~~~~~ik~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  109 (283)
T cd05090          34 AQLVAIKTLKDI----NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGC  109 (283)
T ss_pred             cceEEEEeccCC----CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCcccc
Confidence            467888888642    23344567889999999999999999999999999999999999999999988522        


Q ss_pred             ----------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCC
Q 041080           74 ----------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGT  139 (247)
Q Consensus        74 ----------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~  139 (247)
                                .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......    .....++
T Consensus       110 ~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  189 (283)
T cd05090         110 SSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP  189 (283)
T ss_pred             ccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCcc
Confidence                      26788899999999999999999999999999999999999999999999986543322    1222345


Q ss_pred             CCccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCC
Q 041080          140 PFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP  218 (247)
Q Consensus       140 ~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  218 (247)
                      ..|+|||.+.+..  ++.++|+||||++++++++ |..||...........+........+..+++.+++++.+||+.+|
T Consensus       190 ~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  267 (283)
T cd05090         190 IRWMPPEAIMYGK--FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGP  267 (283)
T ss_pred             ceecChHHhccCC--CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCc
Confidence            6799999986543  7889999999999999998 989998776666666666655566677889999999999999999


Q ss_pred             CCCCChhhhhcC
Q 041080          219 NDRPTVTELMEH  230 (247)
Q Consensus       219 ~~Rps~~~il~~  230 (247)
                      .+||++.+++++
T Consensus       268 ~~Rp~~~~i~~~  279 (283)
T cd05090         268 SRRPRFKDIHTR  279 (283)
T ss_pred             ccCcCHHHHHHH
Confidence            999999999764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=6.4e-40  Score=258.26  Aligned_cols=223  Identities=25%  Similarity=0.432  Sum_probs=185.1

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--------   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------   73 (247)
                      +..||+|.+...    ........+.+|+.+++.++||||+++++++..+...++||||+++++|.+++.+.        
T Consensus        36 ~~~~aik~~~~~----~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  111 (277)
T cd05062          36 ETRVAIKTVNEA----ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP  111 (277)
T ss_pred             eeEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccc
Confidence            456899987532    22234556889999999999999999999999999999999999999999998652        


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc----cCCCCCCccCCc
Q 041080           74 ---HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK----SCKGTPFWMAPE  146 (247)
Q Consensus        74 ---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~aPE  146 (247)
                         .++...+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.........    ...++..|+|||
T Consensus       112 ~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  191 (277)
T cd05062         112 VQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE  191 (277)
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChh
Confidence               2466788899999999999999999999999999999999999999999988644322211    122456799999


Q ss_pred             ccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChh
Q 041080          147 VVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT  225 (247)
Q Consensus       147 ~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  225 (247)
                      .+.+..  ++.++|+||||+++|++++ |..||...........+........+...+..+++++.+||+.+|.+|||+.
T Consensus       192 ~~~~~~--~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  269 (277)
T cd05062         192 SLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFL  269 (277)
T ss_pred             HhhcCC--cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence            986544  7889999999999999998 7889987777666666666555666778899999999999999999999999


Q ss_pred             hhhcC
Q 041080          226 ELMEH  230 (247)
Q Consensus       226 ~il~~  230 (247)
                      +++++
T Consensus       270 e~l~~  274 (277)
T cd05062         270 EIISS  274 (277)
T ss_pred             HHHHH
Confidence            99864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.4e-40  Score=268.34  Aligned_cols=236  Identities=26%  Similarity=0.428  Sum_probs=184.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC------CcEEEEEeccccCcHHHHHHhcC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE------NRLYIFLELVTKGSLANLYQKYH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~   74 (247)
                      +|+.||+|.+....   ........+.+|+.++++++|+||+++++++...      ...++||||+.+ +|.+.+... 
T Consensus        40 ~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-  114 (353)
T cd07850          40 TGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD-  114 (353)
T ss_pred             CCCEEEEEecCccc---cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhhc-
Confidence            47889999886432   1233445677899999999999999999987643      357999999975 888877654 


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc-ccCCCCCCccCCcccccCCC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL-KSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~  153 (247)
                      ++...+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+........ ....++..|+|||.+.+.. 
T Consensus       115 l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-  193 (353)
T cd07850         115 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-  193 (353)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCC-
Confidence            89999999999999999999999999999999999999999999999999875543322 2344678899999986544 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC---------------------CC----------------
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE---------------------LP----------------  196 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------~~----------------  196 (247)
                       ++.++|+||+|+++++|++|+.||...+.......+....                     .+                
T Consensus       194 -~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (353)
T cd07850         194 -YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLF  272 (353)
T ss_pred             -CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCccccc
Confidence             7899999999999999999999997654333222111000                     00                


Q ss_pred             -----CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCCCCCCCc
Q 041080          197 -----SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPRCG  243 (247)
Q Consensus       197 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~~~~~~~  243 (247)
                           ..+...++.++++|.+||+.||.+|||+.++|.||||+.......|-
T Consensus       273 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~~  324 (353)
T cd07850         273 PPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEVE  324 (353)
T ss_pred             CcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCccCC
Confidence                 00123466789999999999999999999999999998765555543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=8.2e-40  Score=254.96  Aligned_cols=221  Identities=25%  Similarity=0.454  Sum_probs=185.0

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~   79 (247)
                      |..||+|.+...    ......+.+.+|+.++++++||||+++++++. .+..++||||+++++|.+++..  ..+++..
T Consensus        22 ~~~vavk~~~~~----~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~   96 (257)
T cd05115          22 QIDVAIKVLKNE----NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSN   96 (257)
T ss_pred             ceeEEEEEcccc----cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHH
Confidence            346899988643    22444567889999999999999999999875 4578999999999999998864  3489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc-----ccCCCCCCccCCcccccCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL-----KSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      ++.++.|++.|+.+||++|++|+||||+||+++.++.++|+|||.+........     ....++..|+|||.+....  
T Consensus        97 ~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--  174 (257)
T cd05115          97 VVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK--  174 (257)
T ss_pred             HHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCC--
Confidence            999999999999999999999999999999999999999999999864432221     1111246799999986443  


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          155 YGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ++.++|+||||+++|++++ |..||......+....+..+.....+...++++.+++.+||..+|.+||++.++.+
T Consensus       175 ~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         175 FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7889999999999999996 99999888777777777666666777888999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-41  Score=275.98  Aligned_cols=219  Identities=37%  Similarity=0.697  Sum_probs=195.2

Q ss_pred             ccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHh
Q 041080           17 AQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDSQVSSYTRQILNGLVYL   94 (247)
Q Consensus        17 ~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~l~~~l~~l   94 (247)
                      ..+.+.++++.-||.+|..++||+|+++++.|-.++.++++.|||.||-...++-.  +.+.+.++.-+.+|++.||.||
T Consensus        67 tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~L  146 (1187)
T KOG0579|consen   67 TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWL  146 (1187)
T ss_pred             ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHH
Confidence            35677788899999999999999999999999999999999999999988887654  4599999999999999999999


Q ss_pred             hhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc--cccccCCCCCCccCCccccc---CCCCCCcchhHHHHHHHHH
Q 041080           95 HERNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDLKSCKGTPFWMAPEVVNS---KNDGYGLTADIWSLGCTVL  169 (247)
Q Consensus        95 h~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~aPE~~~~---~~~~~~~~~Di~slG~ll~  169 (247)
                      |+++|+|+|||..||+++-+|.++|+|||.+.....  .....+.|+++|+|||+..+   ...+|+.++||||||+++.
T Consensus       147 Hs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLI  226 (1187)
T KOG0579|consen  147 HSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLI  226 (1187)
T ss_pred             hhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHH
Confidence            999999999999999999999999999999854322  23446779999999999754   3334888999999999999


Q ss_pred             HHHhCCCCCCCChhhHHHHHhhcCCCCCC--CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          170 EMLTRRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       170 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                      +|+.+.+|.........+..+.+...|.+  |..++..+.+++.+||.++|..||++.++++||||+.
T Consensus       227 EMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~  294 (1187)
T KOG0579|consen  227 EMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN  294 (1187)
T ss_pred             HHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence            99999999999999888888888777665  5789999999999999999999999999999999984

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=5.2e-40  Score=260.76  Aligned_cols=228  Identities=26%  Similarity=0.486  Sum_probs=182.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC--CcEEEEEeccccCcHHHHHHhc--CCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE--NRLYIFLELVTKGSLANLYQKY--HLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~--~~~   76 (247)
                      +|+.+++|.+......   ......+.+|+.++++++||||+++++++...  +..++++||+.+ +|.+++...  .++
T Consensus        29 ~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~l~  104 (293)
T cd07843          29 TGEIVALKKLKMEKEK---EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFL  104 (293)
T ss_pred             CCcEEEEEEEeecccc---ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccCCCC
Confidence            4788999999765322   22334567899999999999999999988777  899999999975 898888654  389


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......  ......++..|+|||.+.+... 
T Consensus       105 ~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-  183 (293)
T cd07843         105 QSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKE-  183 (293)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCcc-
Confidence            9999999999999999999999999999999999999999999999988755433  2223446788999999865432 


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC------------------------------CCCCCCCc-CC
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG------------------------------ELPSVPSS-LS  203 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~------------------------------~~~~~~~~-~~  203 (247)
                      .+.++|+||+|++++++++|..||...........+...                              ....++.. ++
T Consensus       184 ~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (293)
T cd07843         184 YSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLS  263 (293)
T ss_pred             ccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCC
Confidence            578999999999999999999999766544333221110                              00112222 58


Q ss_pred             HHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          204 RDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       204 ~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      +.+.++|.+||+.+|.+|||+.|++.||||
T Consensus       264 ~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         264 DNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.6e-39  Score=260.16  Aligned_cols=231  Identities=35%  Similarity=0.642  Sum_probs=189.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.|++|.+.....  ........+.+|+.+++.++|||++++++++.+....+++|||+.+ ++.+++...  .+++.
T Consensus        45 ~~~~v~ik~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~  121 (313)
T cd06633          45 TNEVVAVKKMSYSGK--QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEV  121 (313)
T ss_pred             CCcEEEEEEEecccc--CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCCCCCHH
Confidence            477899999876432  2334456788999999999999999999999999999999999975 777776543  48899


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCccccc-CCCCCCc
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNS-KNDGYGL  157 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~  157 (247)
                      .+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.....  .....++..|+|||.+.. ....++.
T Consensus       122 ~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~  199 (313)
T cd06633         122 EIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--ANSFVGTPYWMAPEVILAMDEGQYDG  199 (313)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC--CCCccccccccChhhccccCCCCCCc
Confidence            9999999999999999999999999999999999999999999998754322  223457888999999743 2233688


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCC-CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV-PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ++|+||||++++++++|..||...+.......+.....+.. ...++..+++++.+||+.+|.+||+++++++||||+..
T Consensus       200 ~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         200 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            99999999999999999999877665555544444333332 34678899999999999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-40  Score=269.36  Aligned_cols=220  Identities=25%  Similarity=0.322  Sum_probs=171.1

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~   79 (247)
                      ++.||+|+....           ....|+.++++++|+||+++++++...+..++|+|++.+ +|.+++...  .+++..
T Consensus        91 ~~~valK~~~~~-----------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~  158 (357)
T PHA03209         91 PDPVVLKIGQKG-----------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQ  158 (357)
T ss_pred             CceEEEEeCCcc-----------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccCC-cHHHHHHhccCCCCHHH
Confidence            567888875322           124689999999999999999999999999999999965 788777543  489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-ccccCCCCCCccCCcccccCCCCCCcc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      +..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||.+...... ......|+..|+|||.+.+..  ++.+
T Consensus       159 ~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~  236 (357)
T PHA03209        159 ALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDK--YNSK  236 (357)
T ss_pred             HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccccccccccccCCeecCCCC--CCch
Confidence            9999999999999999999999999999999999999999999998643322 223455889999999996544  7899


Q ss_pred             hhHHHHHHHHHHHHhCCCC-CCCChhh----------HHHHHhhc--CCCCCC---------------------------
Q 041080          159 ADIWSLGCTVLEMLTRRPP-YSHLEGV----------QALFRIGK--GELPSV---------------------------  198 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p-~~~~~~~----------~~~~~~~~--~~~~~~---------------------------  198 (247)
                      +|+||||+++|+|+++..+ |......          .....+..  .....+                           
T Consensus       237 ~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (357)
T PHA03209        237 ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYP  316 (357)
T ss_pred             hhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccH
Confidence            9999999999999985544 3321111          00000000  000000                           


Q ss_pred             ---CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          199 ---PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       199 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                         ...++.+..++|.+||+.||.+|||++|+++||||+.
T Consensus       317 ~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        317 CFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             HHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence               1245667788999999999999999999999999985

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-42  Score=256.90  Aligned_cols=214  Identities=31%  Similarity=0.512  Sum_probs=178.4

Q ss_pred             HHHHHHHHHhhc-CCCceeeeceeee----cCCcEEEEEeccccCcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHhhh
Q 041080           25 QLEQEISLLSQF-EQDNIVQYLGTDK----DENRLYIFLELVTKGSLANLYQKYH---LSDSQVSSYTRQILNGLVYLHE   96 (247)
Q Consensus        25 ~~~~e~~~l~~l-~h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~l~~~l~~lh~   96 (247)
                      +.++|++.-... .|||||.++++++    ....+.+|||.++||.|.+.++.++   +++.++..|+.||..|+.|||+
T Consensus       100 KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~  179 (400)
T KOG0604|consen  100 KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS  179 (400)
T ss_pred             HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh
Confidence            467899887777 5999999999864    3457889999999999999888765   9999999999999999999999


Q ss_pred             CCeeecCCCCCcEEEcCC---CCeEEcccccccccC-ccccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHH
Q 041080           97 RNVVHRDIKCANILVDAS---GSVKLADFGLAKATT-MNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEML  172 (247)
Q Consensus        97 ~~i~h~dl~~~ni~~~~~---~~~~l~df~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~  172 (247)
                      .+|.||||||+|++.+.+   ..+||+|||++.... ........-|++|.|||++....  |+...|+||+|++||-|+
T Consensus       180 ~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eK--ydkscdmwSlgVimYIlL  257 (400)
T KOG0604|consen  180 MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEK--YDKSCDMWSLGVIMYILL  257 (400)
T ss_pred             cchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchh--cCCCCCccchhHHHHHhh
Confidence            999999999999999754   469999999998766 34455666799999999995544  899999999999999999


Q ss_pred             hCCCCCCCChhhHH----HHHhhcCCCC---CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCCCCC
Q 041080          173 TRRPPYSHLEGVQA----LFRIGKGELP---SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTP  240 (247)
Q Consensus       173 ~g~~p~~~~~~~~~----~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~~~~  240 (247)
                      +|.+||.+.....+    ..++..+...   +.-..+|+..+++|+.+|..+|.+|.|++++++|||..+....+
T Consensus       258 CGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp  332 (400)
T KOG0604|consen  258 CGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVP  332 (400)
T ss_pred             cCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCC
Confidence            99999987654322    2334333321   22246899999999999999999999999999999999865443

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.4e-40  Score=258.07  Aligned_cols=223  Identities=28%  Similarity=0.488  Sum_probs=178.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC--CcEEEEEeccccCcHHHHHHhcCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE--NRLYIFLELVTKGSLANLYQKYHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~   78 (247)
                      +|+.||+|.+....    .......+.+|+.++++++||||+++++++...  ...+++|||+++++|.+++....+++.
T Consensus        32 ~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~l~~~  107 (283)
T cd05080          32 TGEMVAVKTLKREC----GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLA  107 (283)
T ss_pred             CCceEEEEEecccc----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHcCCCHH
Confidence            46789999986432    223456788999999999999999999987653  468999999999999999988889999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc-----ccCCCCCCccCCcccccCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL-----KSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~  153 (247)
                      .++.++.|++.|+.+||+.|++|+||||+||+++.++.++|+|||.+........     ....++..|+|||.+.... 
T Consensus       108 ~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-  186 (283)
T cd05080         108 QLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK-  186 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccC-
Confidence            9999999999999999999999999999999999999999999999865443221     1223456699999985433 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhhH---------------HHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCC
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQ---------------ALFRIGKGELPSVPSSLSRDARDFILKCLQVNP  218 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  218 (247)
                       ++.++|+||||+++++|++|..|+.......               .............+...+.++.+++.+||+.+|
T Consensus       187 -~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  265 (283)
T cd05080         187 -FSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEA  265 (283)
T ss_pred             -CCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccCh
Confidence             7889999999999999999998875432110               011111122223456788999999999999999


Q ss_pred             CCCCChhhhhc
Q 041080          219 NDRPTVTELME  229 (247)
Q Consensus       219 ~~Rps~~~il~  229 (247)
                      .+|||++++++
T Consensus       266 ~~Rps~~~i~~  276 (283)
T cd05080         266 KFRPTFRSLIP  276 (283)
T ss_pred             hhCCCHHHHHH
Confidence            99999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-39  Score=253.52  Aligned_cols=220  Identities=30%  Similarity=0.491  Sum_probs=187.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~   77 (247)
                      .|+.||+|.+....      ...+.+.+|+.++++++|+||+++++++...+..++||||+++++|.++++..   .+++
T Consensus        28 ~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~  101 (256)
T cd05039          28 RGQKVAVKCLKDDS------TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITL  101 (256)
T ss_pred             cCcEEEEEEeccch------hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCH
Confidence            36889999996432      14567889999999999999999999999899999999999999999998765   3899


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCc
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      ..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+........ .......|+|||.+....  ++.
T Consensus       102 ~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~ape~~~~~~--~~~  178 (256)
T cd05039         102 AQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-SGKLPVKWTAPEALREKK--FST  178 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc-cCCCcccccCchhhcCCc--CCc
Confidence            99999999999999999999999999999999999999999999999876533222 233456799999985443  788


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          158 TADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ++|+||||++++++++ |..||...........+........+...++.+.+++.+||+.+|.+|||++++++
T Consensus       179 ~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            9999999999999997 99999887777666665555455566778999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-40  Score=272.21  Aligned_cols=222  Identities=23%  Similarity=0.322  Sum_probs=176.9

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQV   80 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~   80 (247)
                      ++.|++|.+....          ...+|+.++++++||||+++++++......+++||++.+ +|.+++... .+++..+
T Consensus       119 ~~~v~vK~~~~~~----------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~l~~~~~  187 (392)
T PHA03207        119 RKKVIVKAVTGGK----------TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQA  187 (392)
T ss_pred             ceeEEEEeccccc----------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcCC-CHHHHHHhcCCCCHHHH
Confidence            4567888775321          245899999999999999999999999999999999965 788877543 5899999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCCcccccCCCCCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      +.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......    .....|+..|+|||.+.+..  ++
T Consensus       188 ~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  265 (392)
T PHA03207        188 ITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDP--YC  265 (392)
T ss_pred             HHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCC--CC
Confidence            9999999999999999999999999999999999999999999986543322    22345899999999996544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhH---HHHHhh----c----------------------CCCCC--C-----CC
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQ---ALFRIG----K----------------------GELPS--V-----PS  200 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~---~~~~~~----~----------------------~~~~~--~-----~~  200 (247)
                      .++|+||||+++|+|++|..||.......   ....+.    .                      ...+.  .     ..
T Consensus       266 ~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (392)
T PHA03207        266 AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKY  345 (392)
T ss_pred             chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhcc
Confidence            89999999999999999999986543211   110000    0                      00000  0     12


Q ss_pred             cCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          201 SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       201 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      .++.++.++|.+||..+|.+|||+.++++||||++.
T Consensus       346 ~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        346 GMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             CcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence            456788999999999999999999999999999864

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=6.8e-40  Score=259.22  Aligned_cols=227  Identities=34%  Similarity=0.620  Sum_probs=181.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeee-----cCCcEEEEEeccccCcHHHHHHh--
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDK-----DENRLYIFLELVTKGSLANLYQK--   72 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~--   72 (247)
                      +|+.+|+|++....      .....+.+|+.+++++ +||||+++++++.     .++..+++|||+++++|.+++..  
T Consensus        42 ~~~~~~ik~~~~~~------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  115 (286)
T cd06638          42 NGSKAAVKILDPIH------DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFL  115 (286)
T ss_pred             CCceeEEEeecccc------chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhh
Confidence            36789999875321      1234577899999999 6999999999873     44678999999999999988753  


Q ss_pred             ---cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcc
Q 041080           73 ---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEV  147 (247)
Q Consensus        73 ---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~  147 (247)
                         ..+++..++.++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.
T Consensus       116 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  195 (286)
T cd06638         116 KRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV  195 (286)
T ss_pred             ccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhh
Confidence               247888999999999999999999999999999999999999999999999986543322  223457888999999


Q ss_pred             cccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCC--CCCCcCCHHHHHHHHHHhcCCCCCCC
Q 041080          148 VNSK---NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP--SVPSSLSRDARDFILKCLQVNPNDRP  222 (247)
Q Consensus       148 ~~~~---~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp  222 (247)
                      +...   ...++.++|+||+|++++++++|..||.................+  ..+..++..+.+++.+||+.+|.+||
T Consensus       196 ~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  275 (286)
T cd06638         196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRP  275 (286)
T ss_pred             hchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCC
Confidence            8532   233688999999999999999999998776554443333222211  22345688999999999999999999


Q ss_pred             ChhhhhcCccC
Q 041080          223 TVTELMEHPFV  233 (247)
Q Consensus       223 s~~~il~~p~~  233 (247)
                      |+.++++|+||
T Consensus       276 s~~ell~~~~~  286 (286)
T cd06638         276 TVSDLLQHVFI  286 (286)
T ss_pred             CHHHHhhcccC
Confidence            99999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-41  Score=273.88  Aligned_cols=235  Identities=27%  Similarity=0.472  Sum_probs=209.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-CCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~   79 (247)
                      .|..||||.+.++..   ....++.+.+|++++..++||||++++.+......+++||||..+|.+.+++.+.+ +.+..
T Consensus        80 t~~~VaiK~idkt~l---n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~  156 (596)
T KOG0586|consen   80 TGTEVAIKIIDKTQL---NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKE  156 (596)
T ss_pred             CCceEEEEEehhccc---ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhh
Confidence            378999999987653   44555668899999999999999999999999999999999999999999987765 77788


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-ccccCCCCCCccCCcccccCCCCCCcc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      +..++.|+++|++|||+++|+|+|||++|++++.+.+++|+|||++...... ......|++.|.|||+..+... .++.
T Consensus       157 ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y-~gpe  235 (596)
T KOG0586|consen  157 ARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKY-DGPE  235 (596)
T ss_pred             hhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccccccCCCCCccChHhhcCccc-CCcc
Confidence            9999999999999999999999999999999999999999999999876644 3567789999999999988774 5889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQ  238 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~~  238 (247)
                      .|+|++|+++|.|+.|..||+...-.........++. .++..++.+..++|+++|-++|.+|++.+++++|.|...-+.
T Consensus       236 ~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~-rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~  314 (596)
T KOG0586|consen  236 VDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY-RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE  314 (596)
T ss_pred             eehhhhhhhheeeeecccccCCcccccccchheeeee-cccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence            9999999999999999999998888777777776655 567778899999999999999999999999999999987665


Q ss_pred             CC
Q 041080          239 TP  240 (247)
Q Consensus       239 ~~  240 (247)
                      ..
T Consensus       315 ~~  316 (596)
T KOG0586|consen  315 AR  316 (596)
T ss_pred             hh
Confidence            53

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.9e-40  Score=262.35  Aligned_cols=229  Identities=34%  Similarity=0.588  Sum_probs=183.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++.....   .....+.+.+|+.+++.++||||+++++++..++..++|+||+++++|..+.... .+++..
T Consensus        25 ~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~  101 (286)
T cd07846          25 TGQIVAIKKFLESED---DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESR  101 (286)
T ss_pred             CCCEEEEEeHhhccC---cchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHH
Confidence            378899999865432   1234556788999999999999999999999999999999999998888876543 589999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      ++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++.......  .....++..|+|||.+.+.. .++.
T Consensus       102 ~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~  180 (286)
T cd07846         102 VRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT-KYGR  180 (286)
T ss_pred             HHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhcccc-ccCc
Confidence            99999999999999999999999999999999999999999999876543222  22345778899999986432 2578


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc---------------------CCCC---------CCCCcCCHHHH
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK---------------------GELP---------SVPSSLSRDAR  207 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~---------------------~~~~---------~~~~~~~~~~~  207 (247)
                      ++|+||||++++++++|..||......+....+..                     ...+         .....++..+.
T Consensus       181 ~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (286)
T cd07846         181 AVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVL  260 (286)
T ss_pred             hHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHH
Confidence            89999999999999999988865443222111110                     0000         11235688999


Q ss_pred             HHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          208 DFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       208 ~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      +++.+||..+|.+||++.++++||||
T Consensus       261 ~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         261 DLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             HHHHHHhcCCcccchhHHHHhcCCCC
Confidence            99999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5e-40  Score=259.66  Aligned_cols=227  Identities=31%  Similarity=0.541  Sum_probs=182.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc----CCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY----HLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~   76 (247)
                      +|+.||||++.....    ......+.+|+.+++.++|+||+++++++.+.+..++||||+.+ +|.+++...    .++
T Consensus        24 ~~~~~~iK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~   98 (284)
T cd07836          24 TGEIVALKEIHLDAE----EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALD   98 (284)
T ss_pred             CCeEEEEEEeccccc----ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcC
Confidence            478899999976432    12234567899999999999999999999999999999999986 888887653    389


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......  ......++..|++||.+.+.. .
T Consensus        99 ~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~  177 (284)
T cd07836          99 PNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR-T  177 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCC-C
Confidence            9999999999999999999999999999999999999999999999988643322  122334678899999886533 2


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC--------------------CCC--------CCCCcCCHHH
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG--------------------ELP--------SVPSSLSRDA  206 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--------------------~~~--------~~~~~~~~~~  206 (247)
                      ++.++|+|++|++++++++|..||...+..+....+...                    ..+        ......+..+
T Consensus       178 ~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (284)
T cd07836         178 YSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLG  257 (284)
T ss_pred             CCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHH
Confidence            688999999999999999999999766544333221110                    000        0112457889


Q ss_pred             HHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          207 RDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       207 ~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      ++++.+||+.+|.+||+++++++||||
T Consensus       258 ~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         258 IDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1e-39  Score=257.51  Aligned_cols=221  Identities=25%  Similarity=0.460  Sum_probs=184.9

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--------   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------   73 (247)
                      +..+++|.+..     ........+.+|+.+++.++|+||+++++++..++..+++|||+++++|.+++...        
T Consensus        35 ~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~  109 (280)
T cd05092          35 KMLVAVKALKE-----ASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILA  109 (280)
T ss_pred             ceEEEEEecCc-----CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhc
Confidence            44677777653     23445667899999999999999999999999999999999999999999988653        


Q ss_pred             --------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----ccCCCCCC
Q 041080           74 --------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCKGTPF  141 (247)
Q Consensus        74 --------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~  141 (247)
                              .+++..+..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+........    ....++..
T Consensus       110 ~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~  189 (280)
T cd05092         110 GGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR  189 (280)
T ss_pred             ccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCcccccc
Confidence                    378889999999999999999999999999999999999999999999998764332221    11223567


Q ss_pred             ccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCC
Q 041080          142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPND  220 (247)
Q Consensus       142 ~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  220 (247)
                      |+|||.+.+..  ++.++|+||||+++|++++ |..||......+....+........+..+++.+.+++.+||..+|.+
T Consensus       190 y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~  267 (280)
T cd05092         190 WMPPESILYRK--FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQ  267 (280)
T ss_pred             ccCHHHhccCC--cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhh
Confidence            99999986544  7889999999999999998 89999877776666666665555566788999999999999999999


Q ss_pred             CCChhhhhc
Q 041080          221 RPTVTELME  229 (247)
Q Consensus       221 Rps~~~il~  229 (247)
                      ||+++++++
T Consensus       268 Rp~~~~l~~  276 (280)
T cd05092         268 RMVIKDIHS  276 (280)
T ss_pred             CCCHHHHHH
Confidence            999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=8.6e-40  Score=258.28  Aligned_cols=223  Identities=22%  Similarity=0.376  Sum_probs=188.6

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh---------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK---------   72 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---------   72 (247)
                      ++.||||++....    .....+.+.+|+.++..++||||+++++++.+.+..++++||+.+++|.+++..         
T Consensus        35 ~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~  110 (283)
T cd05091          35 TQAVAIKTLKDKA----EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGS  110 (283)
T ss_pred             eeEEEEEEccCCC----CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccc
Confidence            4679999986432    233456788999999999999999999999999999999999999999998752         


Q ss_pred             --------cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCC
Q 041080           73 --------YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTP  140 (247)
Q Consensus        73 --------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~  140 (247)
                              ..+++..+..++.|++.||.++|++|++|+||||+||+++.++.++|+|||++.......    .....++.
T Consensus       111 ~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~  190 (283)
T cd05091         111 TDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI  190 (283)
T ss_pred             cccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCc
Confidence                    137788899999999999999999999999999999999999999999999876443222    12233467


Q ss_pred             CccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCC
Q 041080          141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPN  219 (247)
Q Consensus       141 ~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  219 (247)
                      .|+|||.+.+..  ++.++|+||||++++++++ |..||......+....+........+...+..+.+++.+||+.+|.
T Consensus       191 ~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~  268 (283)
T cd05091         191 RWMSPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPS  268 (283)
T ss_pred             cccCHHHHhcCC--CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcc
Confidence            899999985443  7889999999999999998 8889988777777777777766677788999999999999999999


Q ss_pred             CCCChhhhhcC
Q 041080          220 DRPTVTELMEH  230 (247)
Q Consensus       220 ~Rps~~~il~~  230 (247)
                      +||++.+|+..
T Consensus       269 ~RP~~~~i~~~  279 (283)
T cd05091         269 RRPRFKDIHSR  279 (283)
T ss_pred             cCCCHHHHHHH
Confidence            99999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=5.1e-40  Score=258.96  Aligned_cols=228  Identities=33%  Similarity=0.554  Sum_probs=192.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.|++|++..+..  ........+.+|+.+++++. |+||+++++.+...+..+++||++.+++|.+++.+. .+++.
T Consensus        25 ~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~  102 (280)
T cd05581          25 TNKEYAIKILDKRQL--IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK  102 (280)
T ss_pred             CCCEEEEEEechHhc--cchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHH
Confidence            478999999876432  22334567889999999998 999999999999999999999999999999999776 58999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----------------------ccC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----------------------KSC  136 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----------------------~~~  136 (247)
                      .++.++.|++.||.+||+.|++|+||+|+||+++.++.++++|||.+........                      ...
T Consensus       103 ~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (280)
T cd05581         103 CTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF  182 (280)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccc
Confidence            9999999999999999999999999999999999999999999998865443221                      123


Q ss_pred             CCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcC
Q 041080          137 KGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQV  216 (247)
Q Consensus       137 ~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  216 (247)
                      .++..|++||......  .+.++|+||||++++++++|..||............... ....+..+++.+.+++.+||+.
T Consensus       183 ~~~~~~~~Pe~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~  259 (280)
T cd05581         183 VGTAEYVSPELLNEKP--AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL-EYSFPPNFPPDAKDLIEKLLVL  259 (280)
T ss_pred             cCCccccCHHHhCCCC--CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc-CCCCCCccCHHHHHHHHHHhcC
Confidence            3567899999886543  788999999999999999999999877655544444332 2355677899999999999999


Q ss_pred             CCCCCCCh----hhhhcCccC
Q 041080          217 NPNDRPTV----TELMEHPFV  233 (247)
Q Consensus       217 ~p~~Rps~----~~il~~p~~  233 (247)
                      +|.+|||+    +++++||||
T Consensus       260 ~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         260 DPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CHhhCCCcccCHHHHhcCCCC
Confidence            99999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-39  Score=253.40  Aligned_cols=230  Identities=43%  Similarity=0.771  Sum_probs=190.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC--CcEEEEEeccccCcHHHHHHhc-CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE--NRLYIFLELVTKGSLANLYQKY-HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~   77 (247)
                      +|+.||+|.+...............+.+|+.++++++|+||+++++.+.+.  +.+++++||+++++|.+.+... .+++
T Consensus        26 ~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~  105 (264)
T cd06653          26 TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTE  105 (264)
T ss_pred             CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCH
Confidence            478999999865433333455667889999999999999999999988664  4688999999999999988764 4889


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-----ccccCCCCCCccCCcccccCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-----DLKSCKGTPFWMAPEVVNSKN  152 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~  152 (247)
                      ..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......     ......++..|+|||.+.+..
T Consensus       106 ~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  185 (264)
T cd06653         106 NVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG  185 (264)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCC
Confidence            999999999999999999999999999999999999999999999998654321     112344778899999986543


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc-CCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                        .+.++|+||||++++++++|..||...........+.. ...+..+..+++.+.+++.+||. +|..||++.++++||
T Consensus       186 --~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~  262 (264)
T cd06653         186 --YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP  262 (264)
T ss_pred             --CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence              68899999999999999999999987665555444433 23456678899999999999999 479999999999999


Q ss_pred             cC
Q 041080          232 FV  233 (247)
Q Consensus       232 ~~  233 (247)
                      |.
T Consensus       263 ~~  264 (264)
T cd06653         263 FV  264 (264)
T ss_pred             CC
Confidence            84

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.1e-39  Score=251.62  Aligned_cols=223  Identities=27%  Similarity=0.472  Sum_probs=186.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +++.+|+|.+....    .......+.+|+.++++++||||+++++++...+..++||||+++++|.+++...  .+++.
T Consensus        18 ~~~~~a~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   93 (250)
T cd05085          18 DKTPVAVKTCKEDL----PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTK   93 (250)
T ss_pred             CCcEEEEEecCCcC----CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHH
Confidence            46789999886432    2334456889999999999999999999999999999999999999999988654  37899


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc---cCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK---SCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .+..++.+++.++.++|+.|++|+||+|+||+++.++.++|+|||.+.........   ...+...|+|||.+.+..  +
T Consensus        94 ~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~  171 (250)
T cd05085          94 QLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGR--Y  171 (250)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCC--C
Confidence            99999999999999999999999999999999999999999999988643322111   112345699999986544  7


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +.++|+||||++++++++ |..||...........+........+..++..+.+++.+||+.+|.+||++.++++
T Consensus       172 ~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         172 SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            889999999999999998 99999877666666666555555566778999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-40  Score=260.19  Aligned_cols=229  Identities=32%  Similarity=0.581  Sum_probs=184.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-cCCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-YHLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~   79 (247)
                      +|+.|++|.+.....   .....+.+.+|+.++++++|+||+++++++..++..++++||++++.+..+..+ ..+++..
T Consensus        25 ~~~~v~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~  101 (288)
T cd07833          25 TGEIVAIKKFKESED---DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDA  101 (288)
T ss_pred             CCcEEEEehhhhhcc---cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHH
Confidence            367899998865432   233456788999999999999999999999999999999999998767665544 3489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.......   .....++..|+|||.+.+.. .++
T Consensus       102 ~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~  180 (288)
T cd07833         102 VRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT-NYG  180 (288)
T ss_pred             HHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCC-CcC
Confidence            99999999999999999999999999999999999999999999986544332   22345678899999986542 378


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC---------------------CC----------CCCCCcCCHH
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG---------------------EL----------PSVPSSLSRD  205 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---------------------~~----------~~~~~~~~~~  205 (247)
                      .++|+||+|++++++++|..||......+....+...                     ..          ...+..++.+
T Consensus       181 ~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (288)
T cd07833         181 KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSP  260 (288)
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchH
Confidence            8999999999999999999998765443322211100                     00          0122335889


Q ss_pred             HHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          206 ARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       206 ~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      +++++.+||..+|.+|||++++++||||
T Consensus       261 ~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         261 ALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             HHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            9999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.6e-40  Score=271.85  Aligned_cols=225  Identities=31%  Similarity=0.491  Sum_probs=187.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-C-----CceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-Q-----DNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-   73 (247)
                      +|+.||||+++..      .....+...|+.+|..|+ |     -|+|+++++|...++.|+|+|.+.. +|.++++.+ 
T Consensus       210 T~e~VAIKIiKN~------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~~-NLYellK~n~  282 (586)
T KOG0667|consen  210 TGEIVAIKIIKNK------KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLST-NLYELLKNNK  282 (586)
T ss_pred             CCcEEEEEeeccC------hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhhh-hHHHHHHhcC
Confidence            4789999999743      344556678999999996 4     4999999999999999999999965 999999876 


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC--CeEEcccccccccCccccccCCCCCCccCCcccc
Q 041080           74 --HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG--SVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVN  149 (247)
Q Consensus        74 --~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~--~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~  149 (247)
                        +++...++.++.||+.||.+||+.||+|+||||+|||+...+  .+||+|||.+......-. .+..+..|+|||++.
T Consensus       283 f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy-tYiQSRfYRAPEVIL  361 (586)
T KOG0667|consen  283 FRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY-TYIQSRFYRAPEVIL  361 (586)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcce-eeeeccccccchhhc
Confidence              488999999999999999999999999999999999997544  699999999987665544 777889999999998


Q ss_pred             cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC------------------------------------
Q 041080          150 SKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG------------------------------------  193 (247)
Q Consensus       150 ~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~------------------------------------  193 (247)
                      |.+  |+.+.|||||||+++||++|.+.|.+.+..+++..+...                                    
T Consensus       362 Glp--Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~  439 (586)
T KOG0667|consen  362 GLP--YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPR  439 (586)
T ss_pred             cCC--CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccc
Confidence            777  899999999999999999999888777666665432200                                    


Q ss_pred             ------------------CCC----C----CCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          194 ------------------ELP----S----VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       194 ------------------~~~----~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                                        ..+    .    ........+.++|++||..||.+|+|..++++||||..
T Consensus       440 ~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~  507 (586)
T KOG0667|consen  440 GTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTG  507 (586)
T ss_pred             cccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccc
Confidence                              000    0    00122346789999999999999999999999999994

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.9e-40  Score=272.84  Aligned_cols=220  Identities=25%  Similarity=0.329  Sum_probs=171.8

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~   79 (247)
                      ++.||||....           ..+.+|+.++++++|+||+++++++..++..+++||++. ++|..++...  .+++..
T Consensus       194 ~~~vavK~~~~-----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~  261 (461)
T PHA03211        194 PQRVVVKAGWY-----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQ  261 (461)
T ss_pred             CCEEEEecccc-----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCCHHH
Confidence            56678875321           234689999999999999999999999999999999996 4888877653  489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCCcccccCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.......    .....|+..|+|||.+.+..  +
T Consensus       262 ~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~  339 (461)
T PHA03211        262 VTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDP--Y  339 (461)
T ss_pred             HHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCC--C
Confidence            99999999999999999999999999999999999999999999986543221    12345899999999996544  7


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChh--------hHHHHHhhcCC--CCCCC--------------------------
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEG--------VQALFRIGKGE--LPSVP--------------------------  199 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~--------~~~~~~~~~~~--~~~~~--------------------------  199 (247)
                      +.++||||||+++|++++|..++.....        ......+....  ...++                          
T Consensus       340 ~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  419 (461)
T PHA03211        340 TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRP  419 (461)
T ss_pred             CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCc
Confidence            8899999999999999987754322111        11111111100  00000                          


Q ss_pred             -----CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          200 -----SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       200 -----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                           ...+.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       420 ~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        420 AWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             chhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                 134568899999999999999999999999999975

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.4e-40  Score=264.65  Aligned_cols=223  Identities=27%  Similarity=0.409  Sum_probs=170.0

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeee--cCCcEEEEEeccccCcHHHHHHhc------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDK--DENRLYIFLELVTKGSLANLYQKY------   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~------   73 (247)
                      ++.||+|.+.....       ...+.+|+.++++++||||+++++++.  .+...++++||+.+ +|.+++...      
T Consensus        28 ~~~~a~k~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~   99 (317)
T cd07867          28 EKEYALKQIEGTGI-------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKAN   99 (317)
T ss_pred             cceEEEEEecCCCC-------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccC
Confidence            46789998864321       224678999999999999999999874  35678999999976 777766421      


Q ss_pred             ----CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEE----cCCCCeEEcccccccccCccc-----cccCCCCC
Q 041080           74 ----HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV----DASGSVKLADFGLAKATTMND-----LKSCKGTP  140 (247)
Q Consensus        74 ----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~----~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~  140 (247)
                          .+++..++.++.|++.||.+||+.|++|+||||+||++    +.++.++|+|||++.......     .....++.
T Consensus       100 ~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~  179 (317)
T cd07867         100 KKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF  179 (317)
T ss_pred             CCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecc
Confidence                37888899999999999999999999999999999999    456789999999987543321     22345788


Q ss_pred             CccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhH---------HHHHhhc-------------------
Q 041080          141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQ---------ALFRIGK-------------------  192 (247)
Q Consensus       141 ~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~---------~~~~~~~-------------------  192 (247)
                      .|+|||.+.+.. .++.++|+||+|+++|++++|..||.......         ....+..                   
T Consensus       180 ~y~aPE~~~~~~-~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (317)
T cd07867         180 WYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEY  258 (317)
T ss_pred             cccCcHHhcCCC-ccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence            899999986533 26889999999999999999999986432110         0000000                   


Q ss_pred             ---------C---------CCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          193 ---------G---------ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       193 ---------~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                               .         .........+..+.+++.+||..||.+|||++|+++||||
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         259 PTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                     0         0000112345678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.1e-39  Score=263.71  Aligned_cols=234  Identities=27%  Similarity=0.481  Sum_probs=185.6

Q ss_pred             CCceEEEEEEeecCCCccchHH---------HHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQS---------ILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ   71 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   71 (247)
                      +|+.||||.+............         ...+.+|+.++++++|+||+++++++..++..+++|||+.+ +|.++++
T Consensus        33 ~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~  111 (335)
T PTZ00024         33 TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVD  111 (335)
T ss_pred             CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEecccc-CHHHHHH
Confidence            4788999999765332211111         12467899999999999999999999999999999999975 8888886


Q ss_pred             hc-CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc----------------cccc
Q 041080           72 KY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM----------------NDLK  134 (247)
Q Consensus        72 ~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~----------------~~~~  134 (247)
                      .. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....                ....
T Consensus       112 ~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (335)
T PTZ00024        112 RKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT  191 (335)
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeeccccccccccccccccccccccc
Confidence            64 589999999999999999999999999999999999999999999999998865431                1111


Q ss_pred             cCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC---C-----------------
Q 041080          135 SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG---E-----------------  194 (247)
Q Consensus       135 ~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---~-----------------  194 (247)
                      ...++..|+|||.+.+.. .++.++|+||+|++++++++|..||...+..+....+...   .                 
T Consensus       192 ~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  270 (335)
T PTZ00024        192 SKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEF  270 (335)
T ss_pred             ccccccCCCCChhcccCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhccccccc
Confidence            223567899999986533 2688999999999999999999999876655443322110   0                 


Q ss_pred             -------CCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          195 -------LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       195 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                             ........+.++.+++.+||+.+|.+|||+++++.||||+..
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~  319 (335)
T PTZ00024        271 TPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD  319 (335)
T ss_pred             CcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence                   000113457889999999999999999999999999999975

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.3e-39  Score=254.29  Aligned_cols=220  Identities=26%  Similarity=0.481  Sum_probs=184.3

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSDS   78 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~   78 (247)
                      +..||+|.+...      ....+.+.+|+.+++.++|+||+++++.+...+..+++|||+++++|.+++...   .++..
T Consensus        30 ~~~v~iK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  103 (261)
T cd05072          30 STKVAVKTLKPG------TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP  103 (261)
T ss_pred             CceEEEEEccCC------chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHH
Confidence            567899987542      223567889999999999999999999999999999999999999999988653   47888


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc---ccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL---KSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .+..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+........   ....++..|+|||.+.+..  +
T Consensus       104 ~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~  181 (261)
T cd05072         104 KLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--F  181 (261)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCC--C
Confidence            9999999999999999999999999999999999999999999999865443221   1222456799999986544  7


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +.++|+||||+++|++++ |..||...........+......+....++.++.+++.+||+.+|.+||+++++++
T Consensus       182 ~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         182 TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            889999999999999998 99999877766666666555444455678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1e-39  Score=257.76  Aligned_cols=234  Identities=31%  Similarity=0.561  Sum_probs=183.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHH-HhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-----C
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISL-LSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-----H   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~   74 (247)
                      +|+.||+|++.....    ......+..|+.. ++.++||||+++++++..++..+++|||+++ +|.+++...     .
T Consensus        25 ~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~   99 (283)
T cd06617          25 TGTIMAVKRIRATVN----SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLT   99 (283)
T ss_pred             CCcEEEEEEEecCCC----cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhcc-cHHHHHHHhccCCCC
Confidence            488999999875422    1223345556665 5556899999999999999999999999975 888777542     4


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhC-CeeecCCCCCcEEEcCCCCeEEcccccccccCcccc-ccCCCCCCccCCcccccCC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHER-NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL-KSCKGTPFWMAPEVVNSKN  152 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~  152 (247)
                      +++..++.++.|++.|+++||++ +++|+||+|+||+++.++.++|+|||.+........ ....++..|+|||.+.+..
T Consensus       100 ~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  179 (283)
T cd06617         100 IPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPEL  179 (283)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccCCccccChhhcCCcc
Confidence            88999999999999999999997 999999999999999999999999999865433222 2244778899999885421


Q ss_pred             --CCCCcchhHHHHHHHHHHHHhCCCCCCCCh-hhHHHHHhhcCCCCCCC-CcCCHHHHHHHHHHhcCCCCCCCChhhhh
Q 041080          153 --DGYGLTADIWSLGCTVLEMLTRRPPYSHLE-GVQALFRIGKGELPSVP-SSLSRDARDFILKCLQVNPNDRPTVTELM  228 (247)
Q Consensus       153 --~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rps~~~il  228 (247)
                        ..++.++|+||+|++++++++|..||.... .............+..+ ..+|+++.+++.+||..+|.+||++++++
T Consensus       180 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il  259 (283)
T cd06617         180 NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELL  259 (283)
T ss_pred             cccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence              336789999999999999999999986532 22223333333333333 46789999999999999999999999999


Q ss_pred             cCccCCCCCCC
Q 041080          229 EHPFVKRPLQT  239 (247)
Q Consensus       229 ~~p~~~~~~~~  239 (247)
                      +||||+.....
T Consensus       260 ~~~~~~~~~~~  270 (283)
T cd06617         260 QHPFFELHLSK  270 (283)
T ss_pred             cCchhhhcccc
Confidence            99999986443

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-40  Score=261.49  Aligned_cols=227  Identities=30%  Similarity=0.522  Sum_probs=177.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.||||.+.......    ....+.+|+.++++++|+||+++++++..++..++||||+.+ +|.+++.+.  .+++.
T Consensus        29 ~~~~~~iK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~  103 (291)
T cd07844          29 TGQLVALKEIRLEHEEG----APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMH  103 (291)
T ss_pred             CCcEEEEEEEecccccC----CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCCHH
Confidence            47889999997643211    122356899999999999999999999999999999999986 898888654  47899


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+.. .++
T Consensus       104 ~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~  182 (291)
T cd07844         104 NVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST-EYS  182 (291)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCc-ccC
Confidence            999999999999999999999999999999999999999999999876543221  12223577899999886432 268


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCCh-hhHHHHHhhc---C------------------CCC--------CCCCcCC--H
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLE-GVQALFRIGK---G------------------ELP--------SVPSSLS--R  204 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~~---~------------------~~~--------~~~~~~~--~  204 (247)
                      .++|+||+|++++++++|..||.... ..+....+..   .                  ...        ......+  .
T Consensus       183 ~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (291)
T cd07844         183 TSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIP  262 (291)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCch
Confidence            89999999999999999999996554 1111111100   0                  000        0001233  7


Q ss_pred             HHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          205 DARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       205 ~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      ++.+++.+||+.+|.+|||++++++||||
T Consensus       263 ~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         263 HGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             hHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            88999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-39  Score=252.80  Aligned_cols=220  Identities=26%  Similarity=0.490  Sum_probs=184.8

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-CCHHHHH
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVS   81 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~   81 (247)
                      ..+|+|.+.....    ....+.+.+|+.+++.++|+||+++++++. .+..+++|||+++++|.+++.... +++..+.
T Consensus        24 ~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~   98 (257)
T cd05060          24 VEVAVKTLKQEHI----AAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLK   98 (257)
T ss_pred             ceEEEEecccccc----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCCCCCHHHHH
Confidence            6789998865432    244567889999999999999999999875 456899999999999999997755 9999999


Q ss_pred             HHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc-----cCCCCCCccCCcccccCCCCCC
Q 041080           82 SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK-----SCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        82 ~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .++.|++.|+.+||..|++|+||+|+||+++.++.++|+|||.+.........     ...++..|+|||.+.+..  ++
T Consensus        99 ~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~  176 (257)
T cd05060          99 ELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK--FS  176 (257)
T ss_pred             HHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCC--CC
Confidence            99999999999999999999999999999999999999999998654333211     111235699999986544  78


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          157 LTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      .++|+||||++++++++ |..||......+....+........+..++..+++++.+||+.+|.+||++.++++
T Consensus       177 ~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         177 SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             ccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            89999999999999997 99999887777666666666555667788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-40  Score=264.86  Aligned_cols=231  Identities=32%  Similarity=0.536  Sum_probs=182.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC-----CcEEEEEeccccCcHHHHHHhcCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE-----NRLYIFLELVTKGSLANLYQKYHL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~   75 (247)
                      +|+.||+|.+....    .......+.+|+.++++++|+||+++++++...     ...++++||+.+ +|.+.+....+
T Consensus        29 ~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~l  103 (336)
T cd07849          29 TGVKVAIKKISPFE----HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHL  103 (336)
T ss_pred             CCCeEEEEEecccc----cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHhcCCC
Confidence            47899999986421    223455677899999999999999999876543     357999999975 88888888889


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-----cccCCCCCCccCCccccc
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNS  150 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~  150 (247)
                      ++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......     .....++..|+|||.+.+
T Consensus       104 ~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  183 (336)
T cd07849         104 SNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN  183 (336)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhC
Confidence            999999999999999999999999999999999999999999999999886543221     123457888999998743


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhh---------------c------------CCC---CCCCC
Q 041080          151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIG---------------K------------GEL---PSVPS  200 (247)
Q Consensus       151 ~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~---------------~------------~~~---~~~~~  200 (247)
                      . ..++.++|+||+|++++++++|+.||...+.......+.               .            ...   ....+
T Consensus       184 ~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (336)
T cd07849         184 S-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFP  262 (336)
T ss_pred             C-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhc
Confidence            2 236889999999999999999999996654322211110               0            000   00113


Q ss_pred             cCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          201 SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       201 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      ..+.++.+++.+||+.+|.+|||+.++++||||+...
T Consensus       263 ~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         263 NADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             ccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            4678899999999999999999999999999998764

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6.8e-40  Score=260.24  Aligned_cols=232  Identities=30%  Similarity=0.509  Sum_probs=183.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC---CCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH---LSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~   77 (247)
                      +|+.||+|.+.....   .....+.+.+|+.++++++||||+++++++...+..++||||+++ +|.+.+....   +++
T Consensus        26 ~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~  101 (294)
T PLN00009         26 TNETIALKKIRLEQE---DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNP  101 (294)
T ss_pred             CCcEEEEEehhhccc---cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecccc-cHHHHHHhCCCCCcCH
Confidence            478899999865432   223345677899999999999999999999999999999999965 7877775432   578


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC-CCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~-~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      ..++.++.|++.||++||++|++|+||+|+||+++. ++.++|+|||.+......  ......++..|+|||.+.+.. .
T Consensus       102 ~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~  180 (294)
T PLN00009        102 RLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSR-H  180 (294)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCC-C
Confidence            888899999999999999999999999999999985 457899999998654322  122344678899999885432 3


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC---C-----------------CC--------CCCCcCCHHH
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG---E-----------------LP--------SVPSSLSRDA  206 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---~-----------------~~--------~~~~~~~~~~  206 (247)
                      ++.++|+||+|++++++++|..||...+..+........   .                 .+        ......++++
T Consensus       181 ~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (294)
T PLN00009        181 YSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAG  260 (294)
T ss_pred             CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHH
Confidence            688999999999999999999999766554443322110   0                 00        0123568889


Q ss_pred             HHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          207 RDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       207 ~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      .+++.+||+.+|.+||+++++++||||+..-
T Consensus       261 ~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        261 VDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence            9999999999999999999999999998753

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.2e-39  Score=257.24  Aligned_cols=226  Identities=27%  Similarity=0.467  Sum_probs=177.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecC--CcEEEEEeccccCcHHHHHHhc--CC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDE--NRLYIFLELVTKGSLANLYQKY--HL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~--~~   75 (247)
                      +|+.||+|.+......   . ......+|+..+.++. |+|++++++++.+.  +..++|+||+++ +|.+.+...  .+
T Consensus        23 ~~~~~aik~~~~~~~~---~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~   97 (282)
T cd07831          23 TGKYYAIKCMKKHFKS---L-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPL   97 (282)
T ss_pred             CCcEEEEEEehhccCC---c-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cHHHHHHhccCCC
Confidence            4788999988653221   1 1123347888898885 99999999999887  899999999976 777777653  48


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCC
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      ++..+..++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||.+....... .....++..|+|||.+.... .
T Consensus        98 ~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~  175 (282)
T cd07831          98 PEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDG-Y  175 (282)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCC-C
Confidence            99999999999999999999999999999999999999 999999999986554322 22344778899999864332 2


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC---------------C-----C--------CCCCCcCCHHH
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG---------------E-----L--------PSVPSSLSRDA  206 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---------------~-----~--------~~~~~~~~~~~  206 (247)
                      .+.++|+||+|++++++++|..||...+..+....+...               .     .        ......++.++
T Consensus       176 ~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (282)
T cd07831         176 YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEG  255 (282)
T ss_pred             CCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHH
Confidence            678999999999999999999999766544332222110               0     0        01123568999


Q ss_pred             HHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          207 RDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       207 ~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      ++++.+||+++|.+||+++++++||||
T Consensus       256 ~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         256 LDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             HHHHHHHhccCcccccCHHHHhhCCCC
Confidence            999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.2e-39  Score=255.20  Aligned_cols=223  Identities=25%  Similarity=0.433  Sum_probs=184.1

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--------   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------   73 (247)
                      +..|++|.+...    ........+.+|+.++++++|+||+++++++.+.+..+++|||+++++|.+++...        
T Consensus        36 ~~~v~ik~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~  111 (277)
T cd05036          36 ELQVAVKTLPES----CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPS  111 (277)
T ss_pred             ceeEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCC
Confidence            356788877532    22334456889999999999999999999999989999999999999999998764        


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC---CeEEcccccccccCccccc----cCCCCCCccCCc
Q 041080           74 HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG---SVKLADFGLAKATTMNDLK----SCKGTPFWMAPE  146 (247)
Q Consensus        74 ~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~---~~~l~df~~~~~~~~~~~~----~~~~~~~~~aPE  146 (247)
                      .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++   .++|+|||.+.........    .......|+|||
T Consensus       112 ~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  191 (277)
T cd05036         112 SLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPE  191 (277)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHH
Confidence            378899999999999999999999999999999999998765   5899999998654322211    112245699999


Q ss_pred             ccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChh
Q 041080          147 VVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT  225 (247)
Q Consensus       147 ~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  225 (247)
                      .+.+..  ++.++|+||||+++|++++ |..||...........+........+..++..+.+++.+||+.+|.+|||+.
T Consensus       192 ~~~~~~--~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~  269 (277)
T cd05036         192 AFLDGI--FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFA  269 (277)
T ss_pred             HHhcCC--cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence            986544  7899999999999999996 9999988776666666555555566778899999999999999999999999


Q ss_pred             hhhcC
Q 041080          226 ELMEH  230 (247)
Q Consensus       226 ~il~~  230 (247)
                      ++++|
T Consensus       270 ~vl~~  274 (277)
T cd05036         270 TILER  274 (277)
T ss_pred             HHHHH
Confidence            99875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-39  Score=253.63  Aligned_cols=222  Identities=26%  Similarity=0.475  Sum_probs=186.8

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHH
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQV   80 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~   80 (247)
                      ..||+|.+...    ........+.+|+.++++++||||+++++++..++..+++|||+++++|.+++...  .+++..+
T Consensus        33 ~~vaik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~  108 (266)
T cd05033          33 IDVAIKTLKAG----SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL  108 (266)
T ss_pred             ceEEEEEcCCC----CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHH
Confidence            46888987643    23444567889999999999999999999999999999999999999999998653  4899999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--c--ccCCCCCCccCCcccccCCCCCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--L--KSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~--~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      +.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .  ....++..|+|||.+.+..  ++
T Consensus       109 ~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~--~~  186 (266)
T cd05033         109 VGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK--FT  186 (266)
T ss_pred             HHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCC--Cc
Confidence            9999999999999999999999999999999999999999999987653111  1  1122346799999986543  78


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          157 LTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      .++|+||||++++++++ |..||...........+........+...++.+.+++.+||+.+|.+||++++++++
T Consensus       187 ~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         187 SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             cccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            89999999999999987 999998777777766666655555567789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=246.42  Aligned_cols=231  Identities=30%  Similarity=0.545  Sum_probs=192.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~   77 (247)
                      .|..+|||....+.    ..+..+++...+.++.... .|+||+.+|+|..+...++.||.|.. .+++++++-  ++++
T Consensus       116 ~~~iiAVK~M~rt~----Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkrik~piPE  190 (391)
T KOG0983|consen  116 TGHIIAVKQMRRTG----NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-CAEKLLKRIKGPIPE  190 (391)
T ss_pred             cceEEEEEeecccC----CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHHhcCCchH
Confidence            37889999998653    4566778888888887764 89999999999999999999999955 777777653  5888


Q ss_pred             HHHHHHHHHHHHHHHHhhh-CCeeecCCCCCcEEEcCCCCeEEcccccccccCc-cccccCCCCCCccCCcccccC-CCC
Q 041080           78 SQVSSYTRQILNGLVYLHE-RNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDLKSCKGTPFWMAPEVVNSK-NDG  154 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~-~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~  154 (247)
                      ..+-.+...++.||.||.. +|++|||+||+||++|..|++|+||||++-..-. .......|-+.|+|||.+... ...
T Consensus       191 ~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~k  270 (391)
T KOG0983|consen  191 RILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPK  270 (391)
T ss_pred             HhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCc
Confidence            8888999999999999995 5899999999999999999999999999865443 334455688999999999654 445


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCC-hhhHHHHHhhcCCCCCCCC--cCCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHL-EGVQALFRIGKGELPSVPS--SLSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                      |+.++||||||++++||+||..||... ...+..-.+.....|.++.  .+++.+.+++..||.+|+.+||.+.++|+||
T Consensus       271 YDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~  350 (391)
T KOG0983|consen  271 YDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP  350 (391)
T ss_pred             cchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence            899999999999999999999999873 3444454555544455543  4899999999999999999999999999999


Q ss_pred             cCCCC
Q 041080          232 FVKRP  236 (247)
Q Consensus       232 ~~~~~  236 (247)
                      |++..
T Consensus       351 Fi~~y  355 (391)
T KOG0983|consen  351 FIKRY  355 (391)
T ss_pred             ceeec
Confidence            98753

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.5e-39  Score=257.74  Aligned_cols=234  Identities=28%  Similarity=0.444  Sum_probs=190.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||+|++..... .......+.+.+|+.+++++ +|+||+++++.+..+...++|+||+++++|.+++... .+++.
T Consensus        27 ~g~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~  105 (290)
T cd05613          27 SGKLYAMKVLKKATI-VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ  105 (290)
T ss_pred             CCceEEEEEeehhhh-hhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHH
Confidence            478899999875432 12233455678899999999 5999999999999999999999999999999988654 48899


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......   .....++..|++||.+.+....+
T Consensus       106 ~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  185 (290)
T cd05613         106 EVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGH  185 (290)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCC
Confidence            999999999999999999999999999999999999999999999886543322   12344788899999986544446


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChh----hHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----Chhh
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEG----VQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTE  226 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~  226 (247)
                      +.++|+||+|++++++++|..||.....    ......... ..+..+..++..+.+++.+||+.+|.+||     ++++
T Consensus       186 ~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~  264 (290)
T cd05613         186 DKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADE  264 (290)
T ss_pred             CccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc-cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHH
Confidence            7899999999999999999999864322    222222222 23455667899999999999999999997     8999


Q ss_pred             hhcCccCCCC
Q 041080          227 LMEHPFVKRP  236 (247)
Q Consensus       227 il~~p~~~~~  236 (247)
                      ++.||||+..
T Consensus       265 l~~~~~~~~~  274 (290)
T cd05613         265 IKKHPFFQKI  274 (290)
T ss_pred             HHcCcccccC
Confidence            9999999875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=301.21  Aligned_cols=232  Identities=41%  Similarity=0.737  Sum_probs=204.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-CCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~   79 (247)
                      +|...|+|.+......   ......+.+|++++.-|+|||+|+++|+-.+.+..++.||||.+|+|.++++..+ .++..
T Consensus      1259 tGellAvKEI~iq~~~---~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~v 1335 (1509)
T KOG4645|consen 1259 TGELLAVKEIKIQDSD---HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMV 1335 (1509)
T ss_pred             ccchhhhhhhhcCccc---cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhH
Confidence            4788899999876533   5556778899999999999999999999999999999999999999999998765 66777


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc------ccccCCCCCCccCCcccccCC-
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN------DLKSCKGTPFWMAPEVVNSKN-  152 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~-  152 (247)
                      ...+..|++.|+++||++||+|+||||.||+++.+|.+|++|||.+.....+      +.+...||+.|||||.+.+.. 
T Consensus      1336 t~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~ 1415 (1509)
T KOG4645|consen 1336 TRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKG 1415 (1509)
T ss_pred             HHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhccccc
Confidence            7789999999999999999999999999999999999999999999765433      345677999999999998765 


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHH-hhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                      .....++|||||||++.||+||+.||...+....+.. +..+..|++|..++.+-+++|..||..||++|.++.|+++|-
T Consensus      1416 kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1416 KGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             CCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence            4467899999999999999999999998887776644 556778999999999999999999999999999999999998


Q ss_pred             cCCC
Q 041080          232 FVKR  235 (247)
Q Consensus       232 ~~~~  235 (247)
                      |-+.
T Consensus      1496 f~~~ 1499 (1509)
T KOG4645|consen 1496 FGKS 1499 (1509)
T ss_pred             cccc
Confidence            8664

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8.4e-40  Score=274.84  Aligned_cols=227  Identities=22%  Similarity=0.318  Sum_probs=171.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCC------CceeeeceeeecC-CcEEEEEeccccCcHHHHHHhc
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ------DNIVQYLGTDKDE-NRLYIFLELVTKGSLANLYQKY   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~   73 (247)
                      +|+.||||++....      .....+..|+.++..++|      .+++++++++..+ +.+++||+++ +++|.+++.+.
T Consensus       153 ~~~~vAvK~i~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~  225 (467)
T PTZ00284        153 RKEYCAVKIVRNVP------KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH  225 (467)
T ss_pred             CCeEEEEEEEecch------hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc
Confidence            36789999996421      122334556666666644      4588888888765 5789999998 55788777654


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHhhh-CCeeecCCCCCcEEEcCCC----------------CeEEcccccccccCcccccc
Q 041080           74 -HLSDSQVSSYTRQILNGLVYLHE-RNVVHRDIKCANILVDASG----------------SVKLADFGLAKATTMNDLKS  135 (247)
Q Consensus        74 -~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~~~ni~~~~~~----------------~~~l~df~~~~~~~~~~~~~  135 (247)
                       .+++..+..++.|++.||.|||+ .||+|+||||+||+++.++                .++|+|||.+.... .....
T Consensus       226 ~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-~~~~~  304 (467)
T PTZ00284        226 GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER-HSRTA  304 (467)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc-ccccc
Confidence             58999999999999999999997 5999999999999998765                49999999875432 22334


Q ss_pred             CCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC--C------------------
Q 041080          136 CKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE--L------------------  195 (247)
Q Consensus       136 ~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~------------------  195 (247)
                      ..|+..|+|||.+.+..  ++.++|||||||++|+|++|+.||......+....+....  .                  
T Consensus       305 ~~gt~~Y~APE~~~~~~--~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~  382 (467)
T PTZ00284        305 IVSTRHYRSPEVVLGLG--WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYN  382 (467)
T ss_pred             ccCCccccCcHHhhcCC--CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhh
Confidence            56899999999996554  7899999999999999999999998765544332221100  0                  


Q ss_pred             ------CCC---------------CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          196 ------PSV---------------PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       196 ------~~~---------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                            +..               ....++.+.+||.+||..||.+|||++|+|+||||+...
T Consensus       383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~  445 (467)
T PTZ00284        383 SAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYY  445 (467)
T ss_pred             hcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccC
Confidence                  000               001245678999999999999999999999999999743

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.4e-39  Score=253.56  Aligned_cols=226  Identities=30%  Similarity=0.535  Sum_probs=184.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-----cCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-----YHL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~   75 (247)
                      +|+.||||.+.....  ........+.+|+.++++++||||+++++++...+..++++||+++++|.+++..     ..+
T Consensus        26 ~~~~~~iK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~  103 (267)
T cd08228          26 DRKPVALKKVQIFEM--MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLI  103 (267)
T ss_pred             CCCEEEEEEeecccc--CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCC
Confidence            478899998865332  2344556788999999999999999999999999999999999999999988753     237


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCC
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      ++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+.. 
T Consensus       104 ~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-  182 (267)
T cd08228         104 PERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-  182 (267)
T ss_pred             CHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCC-
Confidence            889999999999999999999999999999999999999999999999876544322  12345778899999986543 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChh--hHHHHHhhcCCCCCC-CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEG--VQALFRIGKGELPSV-PSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                       ++.++|+||+|++++++++|..||.....  ......+.....+.. ....+..+++++.+||..+|.+||+++++++.
T Consensus       183 -~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         183 -YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             -CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence             68899999999999999999999855432  233344433333333 34678899999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=257.21  Aligned_cols=228  Identities=28%  Similarity=0.517  Sum_probs=184.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC--CcEEEEEeccccCcHHHHHHhc--CCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE--NRLYIFLELVTKGSLANLYQKY--HLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~--~~~   76 (247)
                      +|+.+|+|.+....   ........+.+|+.+++.++|+|++++++++...  +..++|+||+++ +|.+++...  .++
T Consensus        23 ~~~~~~~K~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~   98 (287)
T cd07840          23 TGELVALKKIRMEN---EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFT   98 (287)
T ss_pred             CCeEEEEEEEeccc---ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccCCCCC
Confidence            36889999998653   1233345677899999999999999999999888  899999999976 888888665  589


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCCC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      +..++.++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+.......   .....++..|+|||.+.+.. 
T Consensus        99 ~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-  177 (287)
T cd07840          99 ESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT-  177 (287)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccc-
Confidence            99999999999999999999999999999999999999999999999987554432   22334677899999875432 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC-------C-----------------------CCCCcCC
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL-------P-----------------------SVPSSLS  203 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~-----------------------~~~~~~~  203 (247)
                      .++.++|+||||++++++++|..||...........+.....       +                       ......+
T Consensus       178 ~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (287)
T cd07840         178 RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLID  257 (287)
T ss_pred             cCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCC
Confidence            368899999999999999999999977665443332221000       0                       0011138


Q ss_pred             HHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          204 RDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       204 ~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      ..+.+++.+||+.+|.+||+++++++||||
T Consensus       258 ~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         258 PSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.1e-39  Score=253.97  Aligned_cols=219  Identities=27%  Similarity=0.458  Sum_probs=176.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|..+|+|.+.......          .|+.....+ +||||+++++.+..++..++||||+++++|.++++.. .+++.
T Consensus        40 ~~~~~~~k~~~~~~~~~----------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~  109 (267)
T PHA03390         40 TQKLFVQKIIKAKNFNA----------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEA  109 (267)
T ss_pred             CCcEEEEEEEehhhcch----------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCCCHH
Confidence            46788999986532111          122222222 6999999999999999999999999999999999776 68999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC-CeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCc
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG-SVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      .+..++.|++.|+.+||+.|++|+||+|+||+++.++ .++|+|||.+......  ....++..|+|||.+.+..  ++.
T Consensus       110 ~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~--~~~  185 (267)
T PHA03390        110 EVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--SCYDGTLDYFSPEKIKGHN--YDV  185 (267)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--ccCCCCCcccChhhhcCCC--CCc
Confidence            9999999999999999999999999999999999998 9999999987654422  2345788899999996544  788


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHH----HHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC-hhhhhcCcc
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQA----LFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT-VTELMEHPF  232 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~~il~~p~  232 (247)
                      ++|+||+|++++++++|..||........    ..... ......+...++.++++|.+||+.+|.+||+ ++++++|||
T Consensus       186 ~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~  264 (267)
T PHA03390        186 SFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF  264 (267)
T ss_pred             hhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCc
Confidence            99999999999999999999975443321    11111 2223445578999999999999999999996 699999999


Q ss_pred             CC
Q 041080          233 VK  234 (247)
Q Consensus       233 ~~  234 (247)
                      |+
T Consensus       265 ~~  266 (267)
T PHA03390        265 LK  266 (267)
T ss_pred             cc
Confidence            96

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.6e-39  Score=258.37  Aligned_cols=221  Identities=29%  Similarity=0.501  Sum_probs=184.5

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--------
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--------   73 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------   73 (247)
                      ..+|+|.+...    ........+.+|+.+++++ +||||+++++++...+..+++|||+++++|.+++...        
T Consensus        45 ~~~aiK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~  120 (314)
T cd05099          45 VTVAVKMLKDN----ATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYT  120 (314)
T ss_pred             eEEEEEecCCC----CChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCccccc
Confidence            46888887643    2234466788999999999 6999999999999999999999999999999998652        


Q ss_pred             ---------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----ccCCCCC
Q 041080           74 ---------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCKGTP  140 (247)
Q Consensus        74 ---------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~  140 (247)
                               .++...+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+........    ....++.
T Consensus       121 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~  200 (314)
T cd05099         121 FDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPV  200 (314)
T ss_pred             ccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCc
Confidence                     277888999999999999999999999999999999999999999999999865432211    1112345


Q ss_pred             CccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCC
Q 041080          141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPN  219 (247)
Q Consensus       141 ~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  219 (247)
                      .|+|||.+.+..  ++.++|+||||+++|++++ |..||......+....+........+..++.++++++.+||+.+|.
T Consensus       201 ~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~  278 (314)
T cd05099         201 KWMAPEALFDRV--YTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPT  278 (314)
T ss_pred             cccCHHHHccCC--cCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcc
Confidence            699999986543  7889999999999999998 8899988777777766666555556778899999999999999999


Q ss_pred             CCCChhhhhc
Q 041080          220 DRPTVTELME  229 (247)
Q Consensus       220 ~Rps~~~il~  229 (247)
                      +|||+.++++
T Consensus       279 ~Rps~~~ll~  288 (314)
T cd05099         279 QRPTFKQLVE  288 (314)
T ss_pred             cCcCHHHHHH
Confidence            9999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2e-39  Score=253.20  Aligned_cols=221  Identities=26%  Similarity=0.455  Sum_probs=186.6

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSDS   78 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~   78 (247)
                      ++.+++|.+...     .......+.+|+.+++.++|+||+++++++...+..+++|||+++++|.+++.+.   .+++.
T Consensus        30 ~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  104 (261)
T cd05148          30 RVRVAIKILKSD-----DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVA  104 (261)
T ss_pred             CCcEEEEecccc-----chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHH
Confidence            567899988643     2223556889999999999999999999999999999999999999999998753   48899


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc--ccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+........  ....++..|++||.+....  ++
T Consensus       105 ~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~  182 (261)
T cd05148         105 SLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT--FS  182 (261)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCC--CC
Confidence            9999999999999999999999999999999999999999999998865432221  1222455799999985443  78


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          157 LTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      .++|+||||++++++++ |..||...........+........+...++.+.+++.+||+.+|.+|||+.++++
T Consensus       183 ~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         183 TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            89999999999999998 89999887776666666665555667788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=9.3e-40  Score=251.68  Aligned_cols=215  Identities=23%  Similarity=0.341  Sum_probs=174.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|.+....          ...+|...+....||||+++++++...+..+++|||+++++|.+++.+. .+++..
T Consensus        17 ~~~~~~~K~i~~~~----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~   86 (237)
T cd05576          17 TQQTFILKGLRKSS----------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEEC   86 (237)
T ss_pred             CCcEEEEEeecchh----------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHH
Confidence            47899999996532          1223444555567999999999999999999999999999999988654 589999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcch
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTA  159 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~  159 (247)
                      +..++.|++.||.+||+.|++|+||||+||+++.++.++++|||.+...... .....++..|+|||...+..  ++.++
T Consensus        87 ~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~--~~~~~  163 (237)
T cd05576          87 VKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-CDGEAVENMYCAPEVGGISE--ETEAC  163 (237)
T ss_pred             HHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-cccCCcCccccCCcccCCCC--CCchh
Confidence            9999999999999999999999999999999999999999999976544332 22334566799999985433  68899


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh-----hhhhcCccC
Q 041080          160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV-----TELMEHPFV  233 (247)
Q Consensus       160 Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~~p~~  233 (247)
                      |+||+|++++++++|..|+......     .........+..+++.+++++.+||+.||.+||++     +++++||||
T Consensus       164 DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         164 DWWSLGAILFELLTGKTLVECHPSG-----INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             hHHHHHHHHHHHHHCcchhhcCchh-----cccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            9999999999999999876543211     11111123556789999999999999999999986     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-39  Score=254.94  Aligned_cols=222  Identities=25%  Similarity=0.437  Sum_probs=186.2

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--------   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------   73 (247)
                      +..||+|.+...    ........+.+|+.++..++|+||+++++++...+..+++|||+++++|.+++...        
T Consensus        36 ~~~~aik~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~  111 (277)
T cd05032          36 ETRVAIKTVNEN----ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNP  111 (277)
T ss_pred             ceeEEEEecCCc----cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhcc
Confidence            367899987532    22334556889999999999999999999999999999999999999999998643        


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----ccCCCCCCccCCc
Q 041080           74 ---HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCKGTPFWMAPE  146 (247)
Q Consensus        74 ---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~aPE  146 (247)
                         .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........    ....++..|+|||
T Consensus       112 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  191 (277)
T cd05032         112 GLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE  191 (277)
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHH
Confidence               256778999999999999999999999999999999999999999999998865433321    1223466799999


Q ss_pred             ccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChh
Q 041080          147 VVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT  225 (247)
Q Consensus       147 ~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  225 (247)
                      .+....  ++.++|+||||++++++++ |..||...+.......+........+...+.++.+++.+||+.+|.+|||+.
T Consensus       192 ~~~~~~--~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~  269 (277)
T cd05032         192 SLKDGV--FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFL  269 (277)
T ss_pred             HHhcCC--CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHH
Confidence            985443  7889999999999999998 9999987777776666666555666778899999999999999999999999


Q ss_pred             hhhc
Q 041080          226 ELME  229 (247)
Q Consensus       226 ~il~  229 (247)
                      ++++
T Consensus       270 ~l~~  273 (277)
T cd05032         270 EIVS  273 (277)
T ss_pred             HHHH
Confidence            9975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-41  Score=255.89  Aligned_cols=231  Identities=28%  Similarity=0.466  Sum_probs=202.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      .|+.||+|+++++-..  .......-.-|-.+|...+||.+..+...|+..+.+|+||||.+||.|.-.+++. .+++..
T Consensus       192 t~k~YAiKIlkKevii--akdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~R  269 (516)
T KOG0690|consen  192 TGKLYAIKILKKEVII--AKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDR  269 (516)
T ss_pred             cCceeehhhhhhhhee--ehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccchh
Confidence            4789999999887643  3445566677899999999999999999999999999999999999997777654 599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccC--ccccccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      ...+...|++||.|||+.+|+++|+|.+|.+++.+|.+||+|||+....-  .......+|++.|+|||++.  ..+|+.
T Consensus       270 tRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVle--DnDYgr  347 (516)
T KOG0690|consen  270 TRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLE--DNDYGR  347 (516)
T ss_pred             hhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhc--cccccc
Confidence            99999999999999999999999999999999999999999999975322  23456788999999999994  445999


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----ChhhhhcCcc
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTELMEHPF  232 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~p~  232 (247)
                      +.|.|.+|++||+|++|+.||.+.+...+..-+..... .+|..++++.+.|+..+|.+||.+|.     .+.+|.+|+|
T Consensus       348 aVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~-kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~F  426 (516)
T KOG0690|consen  348 AVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL-KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRF  426 (516)
T ss_pred             eeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc-cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhh
Confidence            99999999999999999999999888888777766654 67899999999999999999999995     4789999999


Q ss_pred             CCCC
Q 041080          233 VKRP  236 (247)
Q Consensus       233 ~~~~  236 (247)
                      |..+
T Consensus       427 F~~v  430 (516)
T KOG0690|consen  427 FASV  430 (516)
T ss_pred             hccC
Confidence            9875

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-40  Score=278.09  Aligned_cols=219  Identities=25%  Similarity=0.491  Sum_probs=178.9

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeee----c-C--CcEEEEEeccccCcHHHHHHhc
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDK----D-E--NRLYIFLELVTKGSLANLYQKY   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~-~--~~~~lv~e~~~~~~L~~~l~~~   73 (247)
                      |..||+|+....     .+...+.+.+||.+|+.|+ |+|||.+++...    . +  ..++|+||||.||.|.++++.+
T Consensus        62 ~~~~AlKrm~~~-----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~R  136 (738)
T KOG1989|consen   62 GKKYALKRMYVN-----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTR  136 (738)
T ss_pred             CceeeeeeeecC-----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHH
Confidence            378999999753     5677889999999999996 999999999321    1 1  3678999999999999999754


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHhhhCC--eeecCCCCCcEEEcCCCCeEEcccccccccCccc-----------cccCC
Q 041080           74 ---HLSDSQVSSYTRQILNGLVYLHERN--VVHRDIKCANILVDASGSVKLADFGLAKATTMND-----------LKSCK  137 (247)
Q Consensus        74 ---~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-----------~~~~~  137 (247)
                         ++++.++++|+++++.|+++||...  |+|||||.+|||++.+|..||||||.+.......           .....
T Consensus       137 lq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~  216 (738)
T KOG1989|consen  137 LQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKY  216 (738)
T ss_pred             HhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhh
Confidence               5999999999999999999999987  9999999999999999999999999985322221           01122


Q ss_pred             CCCCccCCccccc-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCC-CcCCHHHHHHHHHHhc
Q 041080          138 GTPFWMAPEVVNS-KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVP-SSLSRDARDFILKCLQ  215 (247)
Q Consensus       138 ~~~~~~aPE~~~~-~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~  215 (247)
                      .|+.|++||++.- .....++|+|||+|||+||.|+....||+.....    .|..+....-+ ..++..+++||+.||+
T Consensus       217 TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIlng~Y~~P~~p~ys~~l~~LI~~mL~  292 (738)
T KOG1989|consen  217 TTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AILNGNYSFPPFPNYSDRLKDLIRTMLQ  292 (738)
T ss_pred             CCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEeccccCCCCccHHHHHHHHHHHHhc
Confidence            7899999999842 2333799999999999999999999999875432    33333332222 5789999999999999


Q ss_pred             CCCCCCCChhhhhc
Q 041080          216 VNPNDRPTVTELME  229 (247)
Q Consensus       216 ~~p~~Rps~~~il~  229 (247)
                      ++|.+||++-+++.
T Consensus       293 ~nP~~RPnI~Qv~~  306 (738)
T KOG1989|consen  293 PNPDERPNIYQVLE  306 (738)
T ss_pred             cCcccCCCHHHHHH
Confidence            99999999998886

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.8e-39  Score=251.03  Aligned_cols=218  Identities=28%  Similarity=0.494  Sum_probs=182.9

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceee-ecCCcEEEEEeccccCcHHHHHHhcC---CCH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTD-KDENRLYIFLELVTKGSLANLYQKYH---LSD   77 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~   77 (247)
                      |+.+++|.+...       ...+.+.+|+.++++++|+|++++++++ ..++..++++||+++++|.+++.+..   +++
T Consensus        29 ~~~~~~k~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  101 (256)
T cd05082          29 GNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG  101 (256)
T ss_pred             CCcEEEEEeCCC-------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCH
Confidence            677899987532       1245688999999999999999999975 45568899999999999999987643   788


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCc
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      ..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+....... .....+..|+|||.+.+..  ++.
T Consensus       102 ~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~y~aPE~~~~~~--~~~  178 (256)
T cd05082         102 DCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWTAPEALREKK--FST  178 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC-CCCccceeecCHHHHccCC--CCc
Confidence            9999999999999999999999999999999999999999999999876543222 2223456799999985443  788


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          158 TADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ++|+||||+++|++++ |+.||...........+.....+..+..+++.+++++.+||+.+|.+|||+.++++
T Consensus       179 ~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             hhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999997 99999877766666666665555667788999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=256.59  Aligned_cols=228  Identities=31%  Similarity=0.563  Sum_probs=185.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.+++|.+.....   .......+.+|+.++++++|+||+++++++..++..++++||+++ +|.+++...  .+++.
T Consensus        23 ~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~   98 (283)
T cd05118          23 TGEIVAIKKIKLRFE---SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPES   98 (283)
T ss_pred             CCcEEEEEEeccccc---cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHH
Confidence            478899999865432   223456788899999999999999999999999999999999976 888877664  68999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+.. .++
T Consensus        99 ~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~  177 (283)
T cd05118          99 LIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDK-GYS  177 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCC-CCC
Confidence            999999999999999999999999999999999999999999999886554332  22345778899999986542 378


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC-----------------------------CCCCCCcCCHHHH
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE-----------------------------LPSVPSSLSRDAR  207 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~  207 (247)
                      .++|+||+|+++|++++|+.||...+..+....+....                             ........+.+++
T Consensus       178 ~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (283)
T cd05118         178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQAL  257 (283)
T ss_pred             chhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHH
Confidence            89999999999999999999997665544332221100                             0011234688999


Q ss_pred             HHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          208 DFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       208 ~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      +++.+||+++|.+||++++++.||||
T Consensus       258 ~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         258 DLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             HHHHHHhccCcccCcCHHHHhhCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-39  Score=253.07  Aligned_cols=223  Identities=26%  Similarity=0.445  Sum_probs=186.3

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC------cEEEEEeccccCcHHHHHHhc---
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN------RLYIFLELVTKGSLANLYQKY---   73 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~---   73 (247)
                      ..||+|.+....   ........+.+|+..++.++||||+++++++...+      ..++++||+++++|..++...   
T Consensus        28 ~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~  104 (273)
T cd05035          28 LKVAVKTMKLDI---HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLG  104 (273)
T ss_pred             ceEEEEEeccCc---CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhcc
Confidence            679999987532   23444667889999999999999999999876544      379999999999999887432   


Q ss_pred             ----CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc----cCCCCCCccCC
Q 041080           74 ----HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK----SCKGTPFWMAP  145 (247)
Q Consensus        74 ----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~aP  145 (247)
                          .+++..+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.........    ....+..|++|
T Consensus       105 ~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p  184 (273)
T cd05035         105 GLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI  184 (273)
T ss_pred             CCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCH
Confidence                4788999999999999999999999999999999999999999999999998654332211    12235679999


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh
Q 041080          146 EVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV  224 (247)
Q Consensus       146 E~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  224 (247)
                      |.+.+..  ++.++|+||||+++|++++ |..||......+....+..+.....+..++.++.+++.+||+.+|.+|||+
T Consensus       185 e~~~~~~--~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  262 (273)
T cd05035         185 ESLADRV--YTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTF  262 (273)
T ss_pred             hhcccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCH
Confidence            9985443  7889999999999999998 889998888777777777766667778899999999999999999999999


Q ss_pred             hhhhcC
Q 041080          225 TELMEH  230 (247)
Q Consensus       225 ~~il~~  230 (247)
                      .+++++
T Consensus       263 ~e~~~~  268 (273)
T cd05035         263 TKLREV  268 (273)
T ss_pred             HHHHHH
Confidence            999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.7e-39  Score=251.37  Aligned_cols=225  Identities=31%  Similarity=0.595  Sum_probs=185.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-----cCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-----YHL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~   75 (247)
                      +|+.||+|.+.....  ......+.+.+|++++++++|+|++++++.+...+..+++|||+++++|.+++..     ..+
T Consensus        26 ~~~~~~ik~~~~~~~--~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  103 (267)
T cd08224          26 DGRVVALKKVQIFEM--MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLI  103 (267)
T ss_pred             CCCEEEEEEeecccc--cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCc
Confidence            478999999875332  2233456788999999999999999999999999999999999999999998854     237


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCC
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      ++..++.++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|.|||.+.+.. 
T Consensus       104 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-  182 (267)
T cd08224         104 PERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-  182 (267)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCC-
Confidence            899999999999999999999999999999999999999999999999876443222  22344778899999986543 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChh--hHHHHHhhcCCCCCCCC-cCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEG--VQALFRIGKGELPSVPS-SLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                       ++.++|+||+|++++++++|..||.....  .........+..+..+. .++..+++++.+||..+|.+|||+.++++
T Consensus       183 -~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         183 -YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             -CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence             78899999999999999999999854432  23334444444445554 78899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.5e-39  Score=257.70  Aligned_cols=222  Identities=27%  Similarity=0.488  Sum_probs=184.9

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--------
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--------   73 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------   73 (247)
                      ..+|+|.+....    .......+.+|+.+++.+ +|+||+++++++...+..++||||+++++|.+++...        
T Consensus        51 ~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~  126 (307)
T cd05098          51 TKVAVKMLKSDA----TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYC  126 (307)
T ss_pred             ceEEEEeccCCC----ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccc
Confidence            468888886431    233456688899999999 7999999999999999999999999999999999753        


Q ss_pred             ---------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----ccCCCCC
Q 041080           74 ---------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCKGTP  140 (247)
Q Consensus        74 ---------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~  140 (247)
                               .++...+..++.|++.||++||+.|++|+||||+||+++.++.++|+|||.+........    ....++.
T Consensus       127 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~  206 (307)
T cd05098         127 YNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV  206 (307)
T ss_pred             cccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCcc
Confidence                     267888999999999999999999999999999999999999999999999865432211    1112345


Q ss_pred             CccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCC
Q 041080          141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPN  219 (247)
Q Consensus       141 ~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  219 (247)
                      .|+|||.+.+..  ++.++|+||||+++|+|++ |..||......+....+........+...+.++.+++.+||..+|.
T Consensus       207 ~y~aPE~~~~~~--~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  284 (307)
T cd05098         207 KWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPS  284 (307)
T ss_pred             ceeChHHhccCC--CCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChh
Confidence            799999986543  7889999999999999998 8899987776666666655555566778899999999999999999


Q ss_pred             CCCChhhhhcC
Q 041080          220 DRPTVTELMEH  230 (247)
Q Consensus       220 ~Rps~~~il~~  230 (247)
                      +|||+.+++++
T Consensus       285 ~Rps~~evl~~  295 (307)
T cd05098         285 QRPTFKQLVED  295 (307)
T ss_pred             hCcCHHHHHHH
Confidence            99999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.8e-39  Score=256.34  Aligned_cols=227  Identities=30%  Similarity=0.484  Sum_probs=175.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~   78 (247)
                      +|+.||+|.+.....    ......+.+|+.+++.++|+||+++++++..++..++|+||+.+ ++.+.+..  ..+++.
T Consensus        29 ~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~  103 (291)
T cd07870          29 NGQLVALKVISMKTE----EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPY  103 (291)
T ss_pred             CCcEEEEEEecccCc----CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecccC-CHHHHHHhCCCCCCHH
Confidence            478899999865432    11223456899999999999999999999999999999999964 67666544  247788


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+.. .++
T Consensus       104 ~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~  182 (291)
T cd07870         104 NVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGAT-DYS  182 (291)
T ss_pred             HHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCC-CCC
Confidence            899999999999999999999999999999999999999999999886433221  22334678899999986432 267


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhh-HHHHHhhc-----------------CCCCC------------C--CCcCCH
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGV-QALFRIGK-----------------GELPS------------V--PSSLSR  204 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~-----------------~~~~~------------~--~~~~~~  204 (247)
                      .++|+||||++++++++|..||...... +.......                 ...+.            .  ....+.
T Consensus       183 ~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (291)
T cd07870         183 SALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPP  262 (291)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCCh
Confidence            8899999999999999999999754432 11111100                 00000            0  012367


Q ss_pred             HHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          205 DARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       205 ~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      ++.+++.+|+..+|.+|||+++++.||||
T Consensus       263 ~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         263 KAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             HHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            89999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.5e-39  Score=256.24  Aligned_cols=232  Identities=31%  Similarity=0.528  Sum_probs=183.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcHHHHHH------hc
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ------KY   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~------~~   73 (247)
                      +|+.+|+|.+.....    ......+.+|+.++.++. |+||+++++++..++..+++|||+.. ++.++..      ..
T Consensus        28 ~~~~~aiK~~~~~~~----~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~  102 (288)
T cd06616          28 SGTIMAVKRIRSTVD----EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKS  102 (288)
T ss_pred             CCCEEEEEEehhccC----hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcC
Confidence            478899999875432    244567889999999996 99999999999999999999999865 6555432      23


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhC-CeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccC
Q 041080           74 HLSDSQVSSYTRQILNGLVYLHER-NVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSK  151 (247)
Q Consensus        74 ~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~  151 (247)
                      .+++..+..++.+++.|+++||+. |++|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+.
T Consensus       103 ~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  182 (288)
T cd06616         103 VIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS  182 (288)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccc
Confidence            589999999999999999999974 99999999999999999999999999986443222 2234577889999998654


Q ss_pred             C-CCCCcchhHHHHHHHHHHHHhCCCCCCCChhh-HHHHHhhcCCCCCC----CCcCCHHHHHHHHHHhcCCCCCCCChh
Q 041080          152 N-DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV-QALFRIGKGELPSV----PSSLSRDARDFILKCLQVNPNDRPTVT  225 (247)
Q Consensus       152 ~-~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~  225 (247)
                      . ..++.++|+||+|++++++++|+.||...... ...........+..    +..++.++.+++.+||+.+|.+|||++
T Consensus       183 ~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  262 (288)
T cd06616         183 ARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYK  262 (288)
T ss_pred             cccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHH
Confidence            2 24788999999999999999999999765421 22222222222222    235789999999999999999999999


Q ss_pred             hhhcCccCCCCC
Q 041080          226 ELMEHPFVKRPL  237 (247)
Q Consensus       226 ~il~~p~~~~~~  237 (247)
                      ++++||||+...
T Consensus       263 ~i~~~~~~~~~~  274 (288)
T cd06616         263 ELLEHPFIKDYE  274 (288)
T ss_pred             HHhcChhhhchh
Confidence            999999998754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=9.5e-39  Score=256.23  Aligned_cols=231  Identities=35%  Similarity=0.627  Sum_probs=190.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~   78 (247)
                      +|..+|+|.+.....  ........+.+|+.++++++|+|++++++++..+...++||||+++ +|.+.+..  ..+++.
T Consensus        49 ~~~~valK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~  125 (317)
T cd06635          49 TNEVVAIKKMSYSGK--QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEV  125 (317)
T ss_pred             CCcEEEEEEEecCCC--CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcCCCCHH
Confidence            477899999875432  2344566788999999999999999999999999999999999976 77776643  348899


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCccccc-CCCCCCc
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNS-KNDGYGL  157 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~  157 (247)
                      .+..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.....  .....++..|+|||.+.. .....+.
T Consensus       126 ~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~  203 (317)
T cd06635         126 EIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--ANSFVGTPYWMAPEVILAMDEGQYDG  203 (317)
T ss_pred             HHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--cccccCCccccChhhhhcCCCCCCCc
Confidence            9999999999999999999999999999999999999999999998764432  223457788999999743 2233688


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCC-CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP-SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ++|+||+|++++++++|..||...........+.....+ .....+++.+++++.+||+.+|.+||++.++++|+|+...
T Consensus       204 ~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         204 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence            999999999999999999998776655555554444333 3345678899999999999999999999999999998764

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.9e-39  Score=253.22  Aligned_cols=226  Identities=28%  Similarity=0.529  Sum_probs=186.3

Q ss_pred             EEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-----cCCCHHH
Q 041080            5 FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-----YHLSDSQ   79 (247)
Q Consensus         5 ~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~   79 (247)
                      +++|.................+..|+.+++.++||||+++++++.+....++++||+++++|.+++..     ..+++..
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~  107 (260)
T cd08222          28 ERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQ  107 (260)
T ss_pred             ceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHH
Confidence            45555543322222233344567899999999999999999999999999999999999999988754     3489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      ++.++.|++.|+.+||+.|++|+||+|+||+++. +.++|+|||.+.......  .....++..|++||.+.+..  ++.
T Consensus       108 ~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~  184 (260)
T cd08222         108 VCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQG--YDS  184 (260)
T ss_pred             HHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCC--CCc
Confidence            9999999999999999999999999999999975 679999999876543222  22344778899999885433  678


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      ++|+||+|++++++++|..||.................+..+..++.++.++|.+||..+|.+||+++++++||||
T Consensus       185 ~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         185 KSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            8999999999999999999998777666666666666667777889999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.1e-39  Score=252.28  Aligned_cols=225  Identities=31%  Similarity=0.566  Sum_probs=183.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-----cCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-----YHL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~   75 (247)
                      +|+.++||.+.....  ........+.+|+.+++.++|+||+++++++..++..+++|||+++++|.+++..     ..+
T Consensus        26 ~~~~~~vK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~  103 (267)
T cd08229          26 DGVPVALKKVQIFDL--MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI  103 (267)
T ss_pred             CCceEEEEeeeehhh--hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCC
Confidence            578999998875432  2334456788999999999999999999999999999999999999999998863     237


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCC
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      ++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+.......  .....++..|+|||.+.+.. 
T Consensus       104 ~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~-  182 (267)
T cd08229         104 PEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-  182 (267)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCC-
Confidence            899999999999999999999999999999999999999999999999876543322  22345788899999986544 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChh--hHHHHHhhcCCCCCC-CCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEG--VQALFRIGKGELPSV-PSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                       .+.++|+||+|++++++++|..||.....  ......+.....+.. +...++.+++++.+||..+|.+|||+.++++
T Consensus       183 -~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         183 -YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             -ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence             78899999999999999999999864432  222233333333333 3468899999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5e-39  Score=256.46  Aligned_cols=223  Identities=26%  Similarity=0.489  Sum_probs=185.6

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-------   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------   73 (247)
                      +..||+|.+...    ........+.+|+.+++.+ +||||+++++++...+..+++|||+++++|.+++.+.       
T Consensus        47 ~~~v~iK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  122 (304)
T cd05101          47 AVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY  122 (304)
T ss_pred             ceeEEeeecccc----cchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCccccc
Confidence            346888887532    2234456788999999999 7999999999999999999999999999999998653       


Q ss_pred             ----------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----ccCCCC
Q 041080           74 ----------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCKGT  139 (247)
Q Consensus        74 ----------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~  139 (247)
                                .++...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+........    ....++
T Consensus       123 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~  202 (304)
T cd05101         123 SYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLP  202 (304)
T ss_pred             ccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCC
Confidence                      266778899999999999999999999999999999999999999999999865443221    122245


Q ss_pred             CCccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCC
Q 041080          140 PFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP  218 (247)
Q Consensus       140 ~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  218 (247)
                      ..|+|||.+.+..  ++.++|+||||+++|++++ |..||...+..+....+........+...+.++++++.+||..+|
T Consensus       203 ~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  280 (304)
T cd05101         203 VKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIP  280 (304)
T ss_pred             ceeeCchhhccCC--CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCh
Confidence            6799999986543  7889999999999999998 788888777777776666555555667889999999999999999


Q ss_pred             CCCCChhhhhcC
Q 041080          219 NDRPTVTELMEH  230 (247)
Q Consensus       219 ~~Rps~~~il~~  230 (247)
                      .+|||+.++++.
T Consensus       281 ~~Rps~~e~l~~  292 (304)
T cd05101         281 SHRPTFKQLVED  292 (304)
T ss_pred             hhCCCHHHHHHH
Confidence            999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.8e-39  Score=258.41  Aligned_cols=228  Identities=29%  Similarity=0.520  Sum_probs=176.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC--------cEEEEEeccccCcHHHHHHh
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN--------RLYIFLELVTKGSLANLYQK   72 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~   72 (247)
                      +|+.||||.+......   ......+.+|+.++++++||||+++++++...+        ..++||||+.+ +|.+.+..
T Consensus        36 ~~~~~aik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~  111 (310)
T cd07865          36 TKQIVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSN  111 (310)
T ss_pred             CCcEEEEEEEeccCCc---CCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHh
Confidence            4789999998754321   122334568999999999999999999876543        45999999975 78887766


Q ss_pred             c--CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc------ccCCCCCCccC
Q 041080           73 Y--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL------KSCKGTPFWMA  144 (247)
Q Consensus        73 ~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~------~~~~~~~~~~a  144 (247)
                      .  .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+........      ....++..|+|
T Consensus       112 ~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~a  191 (310)
T cd07865         112 KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRP  191 (310)
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccC
Confidence            5  589999999999999999999999999999999999999999999999998864432221      22346778999


Q ss_pred             CcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc--CC-------------------CCC------
Q 041080          145 PEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK--GE-------------------LPS------  197 (247)
Q Consensus       145 PE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~--~~-------------------~~~------  197 (247)
                      ||.+.+.. .++.++|+||+|+++|++++|..||...........+..  +.                   .+.      
T Consensus       192 PE~~~~~~-~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (310)
T cd07865         192 PELLLGER-DYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKV  270 (310)
T ss_pred             cHHhcCCc-ccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhh
Confidence            99875432 257899999999999999999999876554333221111  00                   000      


Q ss_pred             ---C-CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          198 ---V-PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       198 ---~-~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                         . +...+..++++|.+||..+|.+|||++++++||||
T Consensus       271 ~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         271 KERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             HHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence               0 01235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.1e-39  Score=256.34  Aligned_cols=222  Identities=26%  Similarity=0.491  Sum_probs=185.8

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--------
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--------   73 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------   73 (247)
                      ..+|+|.+....    .......+.+|+.++..+ +|+||+++++++..++..+++|||+++++|.++++..        
T Consensus        43 ~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~  118 (293)
T cd05053          43 STVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYAS  118 (293)
T ss_pred             eeEEEEEccCCC----CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccc
Confidence            568899886432    233456688999999999 7999999999999999999999999999999998642        


Q ss_pred             ---------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----ccCCCCC
Q 041080           74 ---------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCKGTP  140 (247)
Q Consensus        74 ---------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~  140 (247)
                               .+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+........    ....++.
T Consensus       119 ~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~  198 (293)
T cd05053         119 PDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPV  198 (293)
T ss_pred             cccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCc
Confidence                     378889999999999999999999999999999999999999999999999875443221    1122345


Q ss_pred             CccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCC
Q 041080          141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPN  219 (247)
Q Consensus       141 ~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  219 (247)
                      .|+|||.+.+..  ++.++|+||||+++|++++ |..||......+....+........+...+..+.+++.+||..+|.
T Consensus       199 ~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  276 (293)
T cd05053         199 KWMAPEALFDRV--YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPS  276 (293)
T ss_pred             cccCHHHhccCC--cCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcc
Confidence            699999985544  7889999999999999997 9999988776666666666555566677899999999999999999


Q ss_pred             CCCChhhhhcC
Q 041080          220 DRPTVTELMEH  230 (247)
Q Consensus       220 ~Rps~~~il~~  230 (247)
                      +|||+.+++++
T Consensus       277 ~Rps~~eil~~  287 (293)
T cd05053         277 QRPTFKQLVED  287 (293)
T ss_pred             cCcCHHHHHHH
Confidence            99999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.2e-39  Score=255.51  Aligned_cols=220  Identities=24%  Similarity=0.470  Sum_probs=181.6

Q ss_pred             EEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc----------
Q 041080            5 FAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY----------   73 (247)
Q Consensus         5 ~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------   73 (247)
                      +++|.+...    ......+.+.+|+.++.++ +||||+++++++...+..++++||+++++|.+++...          
T Consensus        32 ~~ik~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  107 (297)
T cd05089          32 AAIKMLKEF----ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFA  107 (297)
T ss_pred             eEEEEcccc----CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccc
Confidence            567766421    2233456788999999999 7999999999999999999999999999999998653          


Q ss_pred             -------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccccc-CCCCCCccCC
Q 041080           74 -------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKS-CKGTPFWMAP  145 (247)
Q Consensus        74 -------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~aP  145 (247)
                             .+++..++.++.|++.||++||+.|++|+||||+||+++.++.++|+|||++.......... ...+..|+||
T Consensus       108 ~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aP  187 (297)
T cd05089         108 KEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAI  187 (297)
T ss_pred             cccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCc
Confidence                   37788999999999999999999999999999999999999999999999975432221111 1224569999


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh
Q 041080          146 EVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV  224 (247)
Q Consensus       146 E~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  224 (247)
                      |.+.+..  ++.++|+||||+++|+|++ |..||...........+........+..++.++++++.+||+.+|.+|||+
T Consensus       188 E~~~~~~--~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  265 (297)
T cd05089         188 ESLNYSV--YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPF  265 (297)
T ss_pred             hhhccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            9985544  7889999999999999997 999998877777666666555555667789999999999999999999999


Q ss_pred             hhhhcC
Q 041080          225 TELMEH  230 (247)
Q Consensus       225 ~~il~~  230 (247)
                      +++++.
T Consensus       266 ~~i~~~  271 (297)
T cd05089         266 AQISVQ  271 (297)
T ss_pred             HHHHHH
Confidence            999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=7.2e-39  Score=249.47  Aligned_cols=222  Identities=31%  Similarity=0.525  Sum_probs=190.4

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC---CCHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH---LSDS   78 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~   78 (247)
                      +..||+|.+....    .....+.+.+|+..+++++|+||+++++++.+.+..+++|||+++++|.+++....   +++.
T Consensus        28 ~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~  103 (258)
T smart00219       28 EVEVAVKTLKEDA----DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLS  103 (258)
T ss_pred             CceEEEEEccCCC----ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHH
Confidence            4789999986432    22256678899999999999999999999999999999999999999999987543   8999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccccc---CCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKS---CKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .+..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+..........   ..++..|++||.+....  +
T Consensus       104 ~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~--~  181 (258)
T smart00219      104 DLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGK--F  181 (258)
T ss_pred             HHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCC--C
Confidence            999999999999999999999999999999999999999999999986554332211   22567899999985433  7


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +.++|+|++|++++++++ |..||...........+........+...+.++.+++.+||+.+|.+|||+.++++
T Consensus       182 ~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      182 TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            889999999999999998 78898887777777777776666777789999999999999999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5.2e-39  Score=254.43  Aligned_cols=222  Identities=25%  Similarity=0.462  Sum_probs=184.9

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--------   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------   73 (247)
                      +..||+|.+....    .......+.+|+.++++++||||+++++++..++..++++||+++++|.+++...        
T Consensus        35 ~~~~aiK~~~~~~----~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  110 (288)
T cd05050          35 FTMVAVKMLKEEA----SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSL  110 (288)
T ss_pred             ceeEEEEecCCCc----CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccc
Confidence            5678999886432    2344567889999999999999999999999999999999999999999998642        


Q ss_pred             ---------------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cc
Q 041080           74 ---------------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LK  134 (247)
Q Consensus        74 ---------------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~  134 (247)
                                     .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......    ..
T Consensus       111 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  190 (288)
T cd05050         111 SHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASE  190 (288)
T ss_pred             cccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccC
Confidence                           26778889999999999999999999999999999999999999999999876443221    11


Q ss_pred             cCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHH
Q 041080          135 SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKC  213 (247)
Q Consensus       135 ~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  213 (247)
                      ....+..|+|||.+.+..  ++.++|+||||+++|+|++ |..||......+....+..+.....+...+.++.+++.+|
T Consensus       191 ~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  268 (288)
T cd05050         191 NDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLC  268 (288)
T ss_pred             CCccChhhcCHHHHhcCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence            222455699999886544  7889999999999999997 8889877776666666666655555667899999999999


Q ss_pred             hcCCCCCCCChhhhhc
Q 041080          214 LQVNPNDRPTVTELME  229 (247)
Q Consensus       214 l~~~p~~Rps~~~il~  229 (247)
                      |+.+|.+|||++|+++
T Consensus       269 l~~~p~~Rpt~~el~~  284 (288)
T cd05050         269 WSKLPSDRPSFASINR  284 (288)
T ss_pred             cccCcccCCCHHHHHH
Confidence            9999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.7e-39  Score=248.26  Aligned_cols=222  Identities=27%  Similarity=0.456  Sum_probs=185.6

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~   79 (247)
                      |+.|++|.+.....    ......+.+|++++++++|+||+++++++......+++|||+++++|.+++...  .++...
T Consensus        19 ~~~v~~K~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~   94 (251)
T cd05041          19 NTEVAVKTCRSTLP----PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKK   94 (251)
T ss_pred             CCcEEEEeccccCC----HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHH
Confidence            67899998875432    245667889999999999999999999999999999999999999999998653  478889


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc----cCCCCCCccCCcccccCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK----SCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      +..++.+++.++.+||++|++|+||+|+||+++.++.++|+|||.+.........    .......|+|||.+.+..  +
T Consensus        95 ~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~  172 (251)
T cd05041          95 LLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR--Y  172 (251)
T ss_pred             HHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCC--C
Confidence            9999999999999999999999999999999999999999999998654322111    111245699999986543  7


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +.++|+||||++++++++ |..||...........+........+...+.++.+++.+||+.+|.+|||++++++
T Consensus       173 ~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         173 TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            889999999999999998 88899877766665555554444556678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=7.2e-39  Score=255.21  Aligned_cols=222  Identities=24%  Similarity=0.460  Sum_probs=181.8

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC---CCH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH---LSD   77 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~   77 (247)
                      +..||+|.+....    .....+.+.+|+.+++++ +|+||+++++++...+..+++|||+++++|.+++....   +++
T Consensus        65 ~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~  140 (302)
T cd05055          65 VMKVAVKMLKPTA----HSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL  140 (302)
T ss_pred             eeEEEEEecCccC----ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCH
Confidence            3468888876432    233456788999999999 79999999999999999999999999999999987542   789


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----ccCCCCCCccCCcccccCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~  153 (247)
                      ..+..++.|++.||.+||+.|++|+||+|+||+++.++.++++|||.+........    ....++..|+|||.+.+.. 
T Consensus       141 ~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-  219 (302)
T cd05055         141 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-  219 (302)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCC-
Confidence            99999999999999999999999999999999999999999999999865433221    1223456799999986544 


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHh-hcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          154 GYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRI-GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                       ++.++|+||+|+++|++++ |..||............ ..+.....+...++++.+++.+||+++|++|||+.++++
T Consensus       220 -~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         220 -YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             -CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence             7889999999999999998 99998766554433332 223333445567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-39  Score=263.20  Aligned_cols=230  Identities=30%  Similarity=0.459  Sum_probs=185.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCc------EEEEEeccccCcHHHHHHhcC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENR------LYIFLELVTKGSLANLYQKYH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~   74 (247)
                      +|+.||+|++....   ........+.+|+.+++.++|+|++++.+++...+.      .++|+||+ +++|.+++....
T Consensus        39 ~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~  114 (343)
T cd07851          39 TGRKVAIKKLSRPF---QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQK  114 (343)
T ss_pred             CCcEEEEEeccccc---chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhcCC
Confidence            46889999886432   122334567789999999999999999998766544      89999999 559999998878


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+...... .....++..|+|||.+.+.. .
T Consensus       115 l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~-~  192 (343)
T cd07851         115 LSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-MTGYVATRWYRAPEIMLNWM-H  192 (343)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc-ccCCcccccccCHHHHhCCC-C
Confidence            999999999999999999999999999999999999999999999999998754432 33445778899999985432 3


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC------------------------------CCCCCcCCH
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL------------------------------PSVPSSLSR  204 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~  204 (247)
                      ++.++|+||+|++++++++|..||...........+.....                              .......++
T Consensus       193 ~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  272 (343)
T cd07851         193 YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANP  272 (343)
T ss_pred             CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCH
Confidence            68899999999999999999999976654433332211100                              011124588


Q ss_pred             HHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          205 DARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       205 ~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      .+.+++.+||+.+|.+|||++++++||||++.
T Consensus       273 ~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~  304 (343)
T cd07851         273 LAIDLLEKMLVLDPDKRITAAEALAHPYLAEY  304 (343)
T ss_pred             HHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence            99999999999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.8e-39  Score=250.08  Aligned_cols=219  Identities=32%  Similarity=0.544  Sum_probs=182.9

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSDSQV   80 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~   80 (247)
                      .||||.+......    ...+.+.+|+..+++++||||+++++.+.. ...++++||+++++|.+++.+.   .+++..+
T Consensus        25 ~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~   99 (257)
T cd05040          25 PVAVKCLKSDKLS----DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTL   99 (257)
T ss_pred             EEEEeecCCcccH----HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHH
Confidence            5899988754321    567788999999999999999999999888 8899999999999999998764   3889999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-----cccCCCCCCccCCcccccCCCCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      +.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......     .....++..|+|||.+.+..  +
T Consensus       100 ~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~  177 (257)
T cd05040         100 CDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT--F  177 (257)
T ss_pred             HHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccC--c
Confidence            9999999999999999999999999999999999999999999986554321     11233567799999986544  7


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhc-CCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +.++|+||||+++++|++ |..||......+....+.. ......+...|..+.+++.+||+.+|.+|||+.++++
T Consensus       178 ~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         178 SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence            889999999999999998 9999977666655544432 2233345577899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.5e-39  Score=251.23  Aligned_cols=220  Identities=25%  Similarity=0.442  Sum_probs=184.1

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVS   81 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~   81 (247)
                      .+|+|.+....    .....+.+.+|+.++++++||||+++++++..++..+++|||+++++|.+++...  .+++..+.
T Consensus        34 ~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  109 (267)
T cd05066          34 PVAIKTLKAGY----TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLV  109 (267)
T ss_pred             EEEEEECCCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHH
Confidence            68888875432    2344667889999999999999999999999999999999999999999998764  37899999


Q ss_pred             HHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc-----cCCCCCCccCCcccccCCCCCC
Q 041080           82 SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK-----SCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        82 ~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+.........     ...++..|++||.+.+..  ++
T Consensus       110 ~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~  187 (267)
T cd05066         110 GMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK--FT  187 (267)
T ss_pred             HHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCc--cC
Confidence            99999999999999999999999999999999999999999998754432211     111245799999986543  78


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          157 LTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      .++|+||||++++++++ |..||......+....+........+...++.+.+++.+||+.+|.+||++.++++
T Consensus       188 ~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         188 SASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             chhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            89999999999999886 99999877766666666655444555678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-39  Score=259.15  Aligned_cols=229  Identities=31%  Similarity=0.467  Sum_probs=177.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC--CcEEEEEeccccCcHHHHHHh------
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE--NRLYIFLELVTKGSLANLYQK------   72 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~------   72 (247)
                      +|+.||||.+.....  ......+.+.+|+.++++++||||+++++++...  +..++||||+++ +|.+++..      
T Consensus        26 ~~~~~alK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~  102 (316)
T cd07842          26 DGKEYAIKKFKGDKE--QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKR  102 (316)
T ss_pred             CCCeEEEEEeccccc--cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCC
Confidence            378999999976431  1222345567899999999999999999999888  889999999976 67666542      


Q ss_pred             cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC----CCCeEEcccccccccCccc-----cccCCCCCCcc
Q 041080           73 YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA----SGSVKLADFGLAKATTMND-----LKSCKGTPFWM  143 (247)
Q Consensus        73 ~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~----~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~  143 (247)
                      ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.    ++.++|+|||.+.......     .....++..|+
T Consensus       103 ~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~  182 (316)
T cd07842         103 VSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYR  182 (316)
T ss_pred             cCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCcccccccc
Confidence            14789999999999999999999999999999999999999    8999999999886543222     12334678899


Q ss_pred             CCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhH---------HHHHh------------------------
Q 041080          144 APEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQ---------ALFRI------------------------  190 (247)
Q Consensus       144 aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~---------~~~~~------------------------  190 (247)
                      |||.+.+.. .++.++|+||||++++++++|..||.......         ....+                        
T Consensus       183 aPE~~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (316)
T cd07842         183 APELLLGAR-HYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTL  261 (316)
T ss_pred             CHHHHhCCC-CCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhh
Confidence            999875433 26889999999999999999999986544322         00000                        


Q ss_pred             -hcCCCCCCC-----------CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          191 -GKGELPSVP-----------SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       191 -~~~~~~~~~-----------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                       ........+           ...+.++.+++.+||..+|.+|||+.++++||||
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         262 MKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             hhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence             000001111           1467789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.4e-39  Score=256.31  Aligned_cols=229  Identities=30%  Similarity=0.491  Sum_probs=178.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecCCc-----EEEEEeccccCcHHHHHHhc-
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENR-----LYIFLELVTKGSLANLYQKY-   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~-   73 (247)
                      +|+.||||.+.....   .......+.+|+.+++.+. |+||+++++++...+.     .+++|||+++ +|.+++... 
T Consensus        25 ~~~~v~lK~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~  100 (295)
T cd07837          25 TGKLVALKKTRLEMD---EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNG  100 (295)
T ss_pred             CCcEEEEEeehhhcc---ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhc
Confidence            478999999865422   1223346778999999995 6999999999877665     8999999986 788877542 


Q ss_pred             -----CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC-CCCeEEcccccccccCcc--ccccCCCCCCccCC
Q 041080           74 -----HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMN--DLKSCKGTPFWMAP  145 (247)
Q Consensus        74 -----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~-~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aP  145 (247)
                           .+++..++.++.|++.||.+||+.|++|+||+|+||+++. ++.++|+|||.+......  ......+++.|+||
T Consensus       101 ~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aP  180 (295)
T cd07837         101 RGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP  180 (295)
T ss_pred             ccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCCh
Confidence                 3789999999999999999999999999999999999998 889999999987643322  12223467789999


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC----C---------------CC--------CC
Q 041080          146 EVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG----E---------------LP--------SV  198 (247)
Q Consensus       146 E~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~----~---------------~~--------~~  198 (247)
                      |.+.+.. .++.++|+||+|+++|+|++|..||...+.......+...    .               .+        ..
T Consensus       181 E~~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (295)
T cd07837         181 EVLLGST-HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRA  259 (295)
T ss_pred             HHhhCCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHh
Confidence            9885433 2688999999999999999999998765443332221110    0               00        01


Q ss_pred             CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCC
Q 041080          199 PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK  234 (247)
Q Consensus       199 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~  234 (247)
                      ...+++++.++|.+||.++|.+||++++++.||||+
T Consensus       260 ~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         260 VPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             ccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            135788999999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=8.4e-39  Score=255.55  Aligned_cols=231  Identities=34%  Similarity=0.617  Sum_probs=188.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~   78 (247)
                      +|+.+++|.+.....  ........+.+|+.+++.++|+|++++.+++......++|+||+.+ ++.+++..  ..+++.
T Consensus        39 ~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~  115 (308)
T cd06634          39 NSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEV  115 (308)
T ss_pred             CCcEEEEEEEecccc--cChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccCC-CHHHHHHHcCCCCCHH
Confidence            467899998865322  2334456688999999999999999999999999999999999975 77776643  348899


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccC-CCCCCc
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSK-NDGYGL  157 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~  157 (247)
                      .+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......  ....++..|+|||.+.+. ....+.
T Consensus       116 ~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~  193 (308)
T cd06634         116 EIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--NXFVGTPYWMAPEVILAMDEGQYDG  193 (308)
T ss_pred             HHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--ccccCCccccCHHHHhhcccCCCCc
Confidence            99999999999999999999999999999999999999999999987654322  234577889999997532 233678


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCC-CCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPS-VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ++|+||||++++++++|..||.................+. ....++..++++|.+||..+|.+||+++++++|||+...
T Consensus       194 ~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             ccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence            9999999999999999999987765554444444333333 345788999999999999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-39  Score=250.34  Aligned_cols=220  Identities=30%  Similarity=0.502  Sum_probs=185.8

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSDS   78 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~   78 (247)
                      ++.+|||.+.....      ..+.+.+|+.++++++|+||+++++++......+++|||+++++|.+++...   .++..
T Consensus        30 ~~~~~vK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~  103 (261)
T cd05034          30 TTKVAVKTLKPGTM------SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP  103 (261)
T ss_pred             CceEEEEEecCCcc------CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHH
Confidence            46789998864321      2356889999999999999999999999989999999999999999998653   48899


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc---cCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK---SCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .+..++.+++.|+.+||++|++|+||+|+||+++.++.++|+|||.+.........   ....+..|+|||.+.+..  .
T Consensus       104 ~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~  181 (261)
T cd05034         104 QLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGR--F  181 (261)
T ss_pred             HHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCC--c
Confidence            99999999999999999999999999999999999999999999988655432211   122345799999986544  7


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +.++|+||+|++++++++ |+.||...........+........+...+.++.+++.+||+.+|.+||+++++++
T Consensus       182 ~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         182 TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            889999999999999998 99999887777777776665555556677999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.8e-39  Score=256.96  Aligned_cols=220  Identities=25%  Similarity=0.474  Sum_probs=180.0

Q ss_pred             EEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc----------
Q 041080            5 FAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY----------   73 (247)
Q Consensus         5 ~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------   73 (247)
                      +++|.+..    .........+.+|+.++.++ +|+||+++++++..++..+++|||+++++|.+++.+.          
T Consensus        37 ~~ik~~~~----~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  112 (303)
T cd05088          37 AAIKRMKE----YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA  112 (303)
T ss_pred             EEEEEecc----cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhccccccccccc
Confidence            45555532    12334556788999999999 8999999999999999999999999999999998643          


Q ss_pred             -------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc-cCCCCCCccCC
Q 041080           74 -------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK-SCKGTPFWMAP  145 (247)
Q Consensus        74 -------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~aP  145 (247)
                             .+++..++.++.|++.|+++||+.|++|+||||+||+++.++.++|+|||++......... ....+..|+||
T Consensus       113 ~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aP  192 (303)
T cd05088         113 IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAI  192 (303)
T ss_pred             ccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchhhhcccCCCcccccCH
Confidence                   3678899999999999999999999999999999999999999999999998533211111 11234569999


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh
Q 041080          146 EVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV  224 (247)
Q Consensus       146 E~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  224 (247)
                      |.+.+..  ++.++|+||||++++++++ |..||......+....+........+...+.++.+++.+||+.+|.+||++
T Consensus       193 E~~~~~~--~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  270 (303)
T cd05088         193 ESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF  270 (303)
T ss_pred             HHHhccC--CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            9885544  7889999999999999998 999998777666666655544444556788999999999999999999999


Q ss_pred             hhhhcC
Q 041080          225 TELMEH  230 (247)
Q Consensus       225 ~~il~~  230 (247)
                      ++++.+
T Consensus       271 ~~il~~  276 (303)
T cd05088         271 AQILVS  276 (303)
T ss_pred             HHHHHH
Confidence            999874

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=274.39  Aligned_cols=233  Identities=41%  Similarity=0.734  Sum_probs=196.1

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CC--CHH
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HL--SDS   78 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~--~~~   78 (247)
                      ..+|||.+..     ......+-+..||.+.++|+|.|||+++|.+.+++.+-++||..+||+|.+++...  ++  .+.
T Consensus       601 vrIaIKEIpe-----kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEs  675 (1226)
T KOG4279|consen  601 VRIAIKEIPE-----KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNES  675 (1226)
T ss_pred             eEEEeeeccc-----ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchh
Confidence            3568888753     23334555789999999999999999999999999999999999999999999764  34  788


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC-CCCeEEcccccccccC--ccccccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA-SGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~-~~~~~l~df~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .+-.+..||++||.|||.+.|+|||||-+|++++. .|-+||.|||-+....  ..-.....|+..|||||++...+-.|
T Consensus       676 tm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGY  755 (1226)
T KOG4279|consen  676 TMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGY  755 (1226)
T ss_pred             HHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCC
Confidence            89999999999999999999999999999999974 6789999999986443  22345667999999999998777779


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHh-h-cCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI-G-KGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      +.++|||||||++.||+||++||.....-...... . -...|++|..++.+.+.+|.+|+.++|.+||++.++|.+||.
T Consensus       756 G~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFl  835 (1226)
T KOG4279|consen  756 GKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFL  835 (1226)
T ss_pred             CchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCccc
Confidence            99999999999999999999999776543332221 1 123478888999999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 041080          234 KRPLQTP  240 (247)
Q Consensus       234 ~~~~~~~  240 (247)
                      +.....+
T Consensus       836 q~~~kk~  842 (1226)
T KOG4279|consen  836 QHNNKKP  842 (1226)
T ss_pred             ccCCCCC
Confidence            9874443

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4e-39  Score=260.97  Aligned_cols=236  Identities=27%  Similarity=0.440  Sum_probs=188.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC------cEEEEEeccccCcHHHHHHhcC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN------RLYIFLELVTKGSLANLYQKYH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~   74 (247)
                      +|+.||||++....   ........+.+|+.+++.++||||+++++++....      .+++||||+ +++|.+++....
T Consensus        39 ~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~  114 (343)
T cd07880          39 TGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK  114 (343)
T ss_pred             CCcEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhcCC
Confidence            47889999986432   22334556789999999999999999999887654      458999999 669999988778


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+...... .....++..|++||.+.+.. .
T Consensus       115 l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~-~  192 (343)
T cd07880         115 LSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-MTGYVVTRWYRAPEVILNWM-H  192 (343)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC-ccccccCCcccCHHHHhCCC-C
Confidence            999999999999999999999999999999999999999999999999998754332 23345688899999985432 3


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC------------------------------CCCCCCCcCCH
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG------------------------------ELPSVPSSLSR  204 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~  204 (247)
                      ++.++|+||+|++++++++|..||...........+...                              .........+.
T Consensus       193 ~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (343)
T cd07880         193 YTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANP  272 (343)
T ss_pred             CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCCh
Confidence            688999999999999999999999765443322221110                              00011245678


Q ss_pred             HHHHHHHHHhcCCCCCCCChhhhhcCccCCCCCCCCCC
Q 041080          205 DARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPRC  242 (247)
Q Consensus       205 ~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~~~~~~  242 (247)
                      .+.+++.+||+.+|.+|||+.+++.||||+........
T Consensus       273 ~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~  310 (343)
T cd07880         273 LAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDE  310 (343)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccc
Confidence            89999999999999999999999999999986554433

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=9e-39  Score=253.33  Aligned_cols=221  Identities=26%  Similarity=0.458  Sum_probs=183.4

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---------
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---------   73 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------   73 (247)
                      ..+++|.+....    .......+.+|+.+++.++||||+++++.+...+..++++||+.+++|.+++...         
T Consensus        31 ~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  106 (290)
T cd05045          31 TTVAVKMLKENA----SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLG  106 (290)
T ss_pred             eeEEEEecCCCC----CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccc
Confidence            457778775432    2334567889999999999999999999999999999999999999999987642         


Q ss_pred             ----------------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----
Q 041080           74 ----------------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----  133 (247)
Q Consensus        74 ----------------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----  133 (247)
                                      .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........    
T Consensus       107 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~  186 (290)
T cd05045         107 SDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKR  186 (290)
T ss_pred             cccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcc
Confidence                            367888999999999999999999999999999999999999999999999864432221    


Q ss_pred             ccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHH
Q 041080          134 KSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK  212 (247)
Q Consensus       134 ~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  212 (247)
                      ....++..|+|||.+.+..  ++.++|+||||+++++|++ |..||....................+..++.++.+++.+
T Consensus       187 ~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  264 (290)
T cd05045         187 SKGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLT  264 (290)
T ss_pred             cCCCCCccccCHHHHccCC--cchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence            1122456799999885443  7889999999999999998 999998777666666655544455567789999999999


Q ss_pred             HhcCCCCCCCChhhhhc
Q 041080          213 CLQVNPNDRPTVTELME  229 (247)
Q Consensus       213 ~l~~~p~~Rps~~~il~  229 (247)
                      ||+.+|.+||++.++++
T Consensus       265 cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         265 CWKQEPDKRPTFADISK  281 (290)
T ss_pred             HccCCcccCCCHHHHHH
Confidence            99999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-39  Score=251.09  Aligned_cols=220  Identities=25%  Similarity=0.468  Sum_probs=180.3

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---------
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---------   73 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------   73 (247)
                      .+++|.+...    ......+.+.+|+.++.++ +||||+++++++...+..+++|||+++++|.+++...         
T Consensus        24 ~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~   99 (270)
T cd05047          24 DAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF   99 (270)
T ss_pred             EEEEEEcccc----CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhcccccccccc
Confidence            3577766532    2234456788999999999 7999999999999999999999999999999998653         


Q ss_pred             --------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc-cCCCCCCccC
Q 041080           74 --------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK-SCKGTPFWMA  144 (247)
Q Consensus        74 --------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~a  144 (247)
                              .+++..+..++.|++.|+++||+.|++|+||+|+||+++.++.++++|||++......... ....+..|+|
T Consensus       100 ~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~a  179 (270)
T cd05047         100 AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA  179 (270)
T ss_pred             ccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchhhhccCCCCccccCC
Confidence                    2678899999999999999999999999999999999999999999999987532211111 1123456999


Q ss_pred             CcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC
Q 041080          145 PEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT  223 (247)
Q Consensus       145 PE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  223 (247)
                      ||.+....  ++.++|+||||++++++++ |..||...+..+....+........+...+.++.+++.+||..+|.+|||
T Consensus       180 pE~~~~~~--~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  257 (270)
T cd05047         180 IESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPS  257 (270)
T ss_pred             hHHHccCC--CCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCC
Confidence            99985443  7889999999999999996 99999877666666666555444556678899999999999999999999


Q ss_pred             hhhhhc
Q 041080          224 VTELME  229 (247)
Q Consensus       224 ~~~il~  229 (247)
                      +.+++.
T Consensus       258 ~~~il~  263 (270)
T cd05047         258 FAQILV  263 (270)
T ss_pred             HHHHHH
Confidence            999975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.5e-39  Score=249.91  Aligned_cols=220  Identities=26%  Similarity=0.477  Sum_probs=183.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~   77 (247)
                      +|+.||+|.+.....      ..+.+.+|+.++++++|+||+++++++. .+..+++|||+.+++|.+++...   .+++
T Consensus        29 ~~~~~a~K~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~  101 (260)
T cd05067          29 GHTKVAIKSLKQGSM------SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTI  101 (260)
T ss_pred             CCceEEEEEecCCCC------cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCH
Confidence            468899999864322      2346889999999999999999999864 45789999999999999988642   4888


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc---ccCCCCCCccCCcccccCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL---KSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      ..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........   ....++..|+|||.+....  
T Consensus       102 ~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~--  179 (260)
T cd05067         102 NKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--  179 (260)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCC--
Confidence            99999999999999999999999999999999999999999999999865442221   1223456799999986544  


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          155 YGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ++.++|+||||++++++++ |..||...+.......+........+...+.++.+++.+||+.+|.+||+++++++
T Consensus       180 ~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         180 FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            7889999999999999998 99999877776666666655555666778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-41  Score=253.50  Aligned_cols=231  Identities=39%  Similarity=0.715  Sum_probs=201.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      .|+.+|||.+..       +..++.+..|+.++++++.|+||+++|.+-.+.-+++|||||..|++.+++..+  .+++.
T Consensus        57 sG~v~AIK~VPV-------~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~  129 (502)
T KOG0574|consen   57 SGHVLAIKKVPV-------DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQ  129 (502)
T ss_pred             cCcEEEEEecCc-------cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHH
Confidence            488999998854       345778899999999999999999999988888999999999999999998654  49999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ++..++..-+.||+|||...-+|||||..||+++.+|..+|+|||.+......  ......|++.|+|||++....  |+
T Consensus       130 EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIG--Y~  207 (502)
T KOG0574|consen  130 EISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIG--YD  207 (502)
T ss_pred             HHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhc--cc
Confidence            99999999999999999999999999999999999999999999998544322  234566999999999996544  88


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCC--CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCC
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK  234 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~  234 (247)
                      .++||||||++..+|+.|++||.+......+-.+.....|.+  |..++.++.++++.||-++|++|.|+-++++|||.+
T Consensus       208 ~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fik  287 (502)
T KOG0574|consen  208 TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIK  287 (502)
T ss_pred             hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhc
Confidence            899999999999999999999998877766666666555554  457899999999999999999999999999999999


Q ss_pred             CCCCCCCCc
Q 041080          235 RPLQTPRCG  243 (247)
Q Consensus       235 ~~~~~~~~~  243 (247)
                      ..   +.|+
T Consensus       288 nA---~g~~  293 (502)
T KOG0574|consen  288 NA---PGCD  293 (502)
T ss_pred             CC---Cccc
Confidence            65   6665

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.9e-39  Score=256.93  Aligned_cols=220  Identities=26%  Similarity=0.449  Sum_probs=182.0

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVS   81 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~   81 (247)
                      .||+|.+...    ......+.+.+|+.+++.++||||+++++++... ..+++++|+++|+|.+++...  .++...++
T Consensus        38 ~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~  112 (316)
T cd05108          38 PVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLL  112 (316)
T ss_pred             eEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHH
Confidence            4888888532    2344556788999999999999999999988764 577999999999999998764  47888999


Q ss_pred             HHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----ccCCCCCCccCCcccccCCCCCCc
Q 041080           82 SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        82 ~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      .++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+........    .....+..|++||.+.+..  ++.
T Consensus       113 ~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~  190 (316)
T cd05108         113 NWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRI--YTH  190 (316)
T ss_pred             HHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCC--CCc
Confidence            9999999999999999999999999999999999999999999875443221    1122345799999985543  789


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          158 TADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      ++|+||||+++|++++ |..||....................+...+.++.+++.+||..+|.+||++.+++.+
T Consensus       191 ~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         191 QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             hhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999987 999998776666555555554445566788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.2e-39  Score=254.46  Aligned_cols=234  Identities=31%  Similarity=0.455  Sum_probs=188.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||||.+..... .......+.+.+|+.++.++ +||||+++++.+..+...++||||+++++|.+++... .+++.
T Consensus        27 ~~~~~avk~~~~~~~-~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~  105 (288)
T cd05583          27 AGKLYAMKVLKKATI-VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES  105 (288)
T ss_pred             CCcEEEEEEEehHHH-HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHH
Confidence            367899999875422 12234456688999999999 5999999999999999999999999999999888654 58899


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......   .....++..|++||.+.+.....
T Consensus       106 ~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  185 (288)
T cd05583         106 EVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH  185 (288)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCC
Confidence            999999999999999999999999999999999999999999999876543322   11234778899999986654446


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChh----hHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC---hhhhh
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEG----VQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT---VTELM  228 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il  228 (247)
                      +.++|+||+|++++++++|..||.....    ........ ...+..+..++..+++++.+||+.+|.+|||   +.+++
T Consensus       186 ~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l  264 (288)
T cd05583         186 DKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL-KSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIK  264 (288)
T ss_pred             cchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH-ccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHh
Confidence            7899999999999999999999854321    12222222 2234556778999999999999999999998   46779


Q ss_pred             cCccCCCC
Q 041080          229 EHPFVKRP  236 (247)
Q Consensus       229 ~~p~~~~~  236 (247)
                      +||||+..
T Consensus       265 ~~~~~~~~  272 (288)
T cd05583         265 NHPFFQGI  272 (288)
T ss_pred             cCcccccC
Confidence            99999875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=5e-39  Score=252.07  Aligned_cols=221  Identities=29%  Similarity=0.477  Sum_probs=183.0

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--------C
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--------H   74 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------~   74 (247)
                      +.+++|.+...    ........+.+|+.+++.++||||+++++++...+..+++|||+++++|.+++.+.        .
T Consensus        27 ~~~~iK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~  102 (269)
T cd05044          27 IRVAVKTLRKG----ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPL  102 (269)
T ss_pred             eeehhhhhhcc----cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCcc
Confidence            56788877542    12234556889999999999999999999999999999999999999999988642        2


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC-----CeEEcccccccccCcccc----ccCCCCCCccCC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG-----SVKLADFGLAKATTMNDL----KSCKGTPFWMAP  145 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~-----~~~l~df~~~~~~~~~~~----~~~~~~~~~~aP  145 (247)
                      +++..+..++.|++.|+.+||+.|++|+||+|+||+++.++     .++++|||.+........    ....++..|+||
T Consensus       103 ~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  182 (269)
T cd05044         103 LTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAP  182 (269)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCH
Confidence            67888999999999999999999999999999999999887     899999998864432221    122345679999


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh
Q 041080          146 EVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV  224 (247)
Q Consensus       146 E~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  224 (247)
                      |.+.+..  ++.++|+||||+++|++++ |..||...........+........+...|..+.+++.+||+.+|.+||++
T Consensus       183 E~~~~~~--~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  260 (269)
T cd05044         183 ESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTF  260 (269)
T ss_pred             HHHccCC--cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCH
Confidence            9986544  7899999999999999998 999998776666666655555556667889999999999999999999999


Q ss_pred             hhhhc
Q 041080          225 TELME  229 (247)
Q Consensus       225 ~~il~  229 (247)
                      +++++
T Consensus       261 ~~i~~  265 (269)
T cd05044         261 DRIQE  265 (269)
T ss_pred             HHHHH
Confidence            99875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.3e-38  Score=248.68  Aligned_cols=219  Identities=27%  Similarity=0.462  Sum_probs=180.8

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSDS   78 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~   78 (247)
                      +..+|+|.+....      ...+.+.+|+.+++.++|+|++++++++. .+..+++|||+.+++|.+++...   .+++.
T Consensus        30 ~~~~~lK~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~  102 (260)
T cd05069          30 TTKVAIKTLKPGT------MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLP  102 (260)
T ss_pred             CceEEEEEcccCC------ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHH
Confidence            3468999875432      12356788999999999999999999875 45688999999999999998753   27888


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc---cCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK---SCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........   ...++..|+|||...+..  .
T Consensus       103 ~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~--~  180 (260)
T cd05069         103 QLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--F  180 (260)
T ss_pred             HHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCC--c
Confidence            99999999999999999999999999999999999999999999998654332211   223456799999885443  7


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +.++|+||||+++|++++ |..||...........+........+...+..+++++.+||..+|.+||+++++++
T Consensus       181 ~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         181 TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            889999999999999999 89999887766666666555445556778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.2e-38  Score=250.25  Aligned_cols=222  Identities=23%  Similarity=0.415  Sum_probs=182.3

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec------CCcEEEEEeccccCcHHHHHHh-----
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD------ENRLYIFLELVTKGSLANLYQK-----   72 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~-----   72 (247)
                      .+|+|.+....   ......+.+.+|+.+++.++|+||+++++++..      ....++++||+.+++|.+++..     
T Consensus        28 ~~a~k~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~  104 (272)
T cd05075          28 KVAVKTMKIAI---CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD  104 (272)
T ss_pred             eEEEEecccCc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccC
Confidence            58888886532   234456778899999999999999999997632      2357899999999999988732     


Q ss_pred             --cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----ccCCCCCCccCCc
Q 041080           73 --YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCKGTPFWMAPE  146 (247)
Q Consensus        73 --~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~aPE  146 (247)
                        ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+........    ....++..|++||
T Consensus       105 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe  184 (272)
T cd05075         105 CPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE  184 (272)
T ss_pred             CcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHH
Confidence              2378899999999999999999999999999999999999999999999999875443221    1223456799999


Q ss_pred             ccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChh
Q 041080          147 VVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT  225 (247)
Q Consensus       147 ~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  225 (247)
                      .+.+..  ++.++|+||||+++|++++ |..||...........+..+.....+..++..+++++.+||+.+|.+|||++
T Consensus       185 ~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  262 (272)
T cd05075         185 SLADRV--YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFE  262 (272)
T ss_pred             HccCCC--cChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence            986543  7889999999999999998 8899987777666666666655566678899999999999999999999999


Q ss_pred             hhhcC
Q 041080          226 ELMEH  230 (247)
Q Consensus       226 ~il~~  230 (247)
                      ++++.
T Consensus       263 ~l~~~  267 (272)
T cd05075         263 TLRCE  267 (272)
T ss_pred             HHHHH
Confidence            99863

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.3e-38  Score=248.70  Aligned_cols=222  Identities=26%  Similarity=0.454  Sum_probs=179.7

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeee-cCCcEEEEEeccccCcHHHHHHhcC--CCHHH
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDK-DENRLYIFLELVTKGSLANLYQKYH--LSDSQ   79 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~   79 (247)
                      ..+|+|.+...    ......+.+.+|+.+++.++||||+++++++. .++..++++||+.+++|.+++.+..  .+...
T Consensus        24 ~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   99 (262)
T cd05058          24 IHCAVKSLNRI----TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKD   99 (262)
T ss_pred             EEEEEEecCcc----CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHH
Confidence            46888887432    22344567889999999999999999999765 4567899999999999999987643  67778


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc------cccCCCCCCccCCcccccCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND------LKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      +..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.......      .....++..|+|||.+.+.. 
T Consensus       100 ~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-  178 (262)
T cd05058         100 LIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK-  178 (262)
T ss_pred             HHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCc-
Confidence            88999999999999999999999999999999999999999999886433211      11223456799999985443 


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          154 GYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                       ++.++|+||||++++++++ |..||...........+........+...++.+.+++.+||..+|.+||++.++++.
T Consensus       179 -~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         179 -FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             -cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence             7889999999999999999 466777666666666655555555566789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.9e-39  Score=260.62  Aligned_cols=232  Identities=32%  Similarity=0.508  Sum_probs=188.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC-----cEEEEEeccccCcHHHHHHhc-C
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN-----RLYIFLELVTKGSLANLYQKY-H   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~-~   74 (247)
                      +|+.||||.+....   ......+.+.+|+.+++.++|+||+++.+++...+     ..+++|||+.+ +|.+++.+. .
T Consensus        24 ~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~   99 (330)
T cd07834          24 TGRKVAIKKISNVF---DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQP   99 (330)
T ss_pred             CCcEEEEEeecccc---ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchhh-hHHHHHhCCCC
Confidence            37889999986532   12334566889999999999999999999987765     78999999975 888888765 5


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-----cccCCCCCCccCCcccc
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVN  149 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~aPE~~~  149 (247)
                      +++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......     .....++..|+|||.+.
T Consensus       100 l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  179 (330)
T cd07834         100 LTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLL  179 (330)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeee
Confidence            8999999999999999999999999999999999999999999999999987654432     23345788899999987


Q ss_pred             cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC------------------------------CCCCC
Q 041080          150 SKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE------------------------------LPSVP  199 (247)
Q Consensus       150 ~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~------------------------------~~~~~  199 (247)
                      +.. ..+.++|+||+|++++++++|..||......+....+....                              .....
T Consensus       180 ~~~-~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (330)
T cd07834         180 SSS-RYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLF  258 (330)
T ss_pred             ccc-CCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhc
Confidence            653 47889999999999999999999997665443332221100                              00112


Q ss_pred             CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          200 SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       200 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      ...+.++.+++.+||+.+|.+||++++++.||||+...
T Consensus       259 ~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         259 PGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence            34688999999999999999999999999999998743

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.4e-39  Score=262.85  Aligned_cols=230  Identities=27%  Similarity=0.486  Sum_probs=181.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec----CCcEEEEEeccccCcHHHHHHhc-CC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD----ENRLYIFLELVTKGSLANLYQKY-HL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~-~~   75 (247)
                      +|+.||+|++.....   .......+.+|+.+++.++||||+++++++..    ....++||||+.+ +|.+++... .+
T Consensus        29 ~~~~valK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~  104 (334)
T cd07855          29 SGKKVAIKKIPHAFD---VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPL  104 (334)
T ss_pred             CCCEEEEEEeccccc---cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhhh-hHHHHhccCCCC
Confidence            478999999875422   22345567789999999999999999998753    3578999999964 898888654 48


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc------cccCCCCCCccCCcccc
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND------LKSCKGTPFWMAPEVVN  149 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~aPE~~~  149 (247)
                      ++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......      .....++..|+|||.+.
T Consensus       105 ~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  184 (334)
T cd07855         105 TEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL  184 (334)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhc
Confidence            999999999999999999999999999999999999999999999999986433221      12335788899999985


Q ss_pred             cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc-------------------------CCCCC-----CC
Q 041080          150 SKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK-------------------------GELPS-----VP  199 (247)
Q Consensus       150 ~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-------------------------~~~~~-----~~  199 (247)
                      +.. .++.++|+||+|+++|++++|..||...+.......+..                         .....     ..
T Consensus       185 ~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (334)
T cd07855         185 SLP-EYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIF  263 (334)
T ss_pred             CCc-ccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHc
Confidence            432 368899999999999999999999976543322211000                         00111     11


Q ss_pred             CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          200 SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       200 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                      ...++++.++|.+||+.+|.+|||+++++.||||+.
T Consensus       264 ~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~  299 (334)
T cd07855         264 PKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ  299 (334)
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence            456899999999999999999999999999999976

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.2e-38  Score=248.16  Aligned_cols=221  Identities=23%  Similarity=0.437  Sum_probs=184.3

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~   79 (247)
                      ++.+|+|.+.....      ....+.+|++++++++|||++++++++......++++||+++++|.+++...  .+++..
T Consensus        28 ~~~~~~k~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~  101 (256)
T cd05112          28 KRKVAIKTIREGAM------SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQET  101 (256)
T ss_pred             CCeEEEEECCCCCC------CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHH
Confidence            57789998864322      1345789999999999999999999999999999999999999999998654  378999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc---cCCCCCCccCCcccccCCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK---SCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ++.++.+++.++++||+.|++|+||+|+||+++.++.++|+|||.+.........   ....+..|+|||.+.+..  ++
T Consensus       102 ~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~--~~  179 (256)
T cd05112         102 LLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSK--YS  179 (256)
T ss_pred             HHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCC--cC
Confidence            9999999999999999999999999999999999999999999987654333222   122345799999986543  78


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          157 LTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      .++|+||+|+++|++++ |..||...........+..+.....+...+..+.+++.+||+.+|.+|||++++++.
T Consensus       180 ~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         180 SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence            89999999999999998 999998777666666665554444456678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4.8e-39  Score=260.42  Aligned_cols=228  Identities=31%  Similarity=0.512  Sum_probs=179.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC--------------CcEEEEEeccccCcH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE--------------NRLYIFLELVTKGSL   66 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------------~~~~lv~e~~~~~~L   66 (247)
                      +|+.||+|.+.....     ...+.+.+|+.++++++||||+++++.+...              ...++++||+++ +|
T Consensus        29 ~~~~v~iK~i~~~~~-----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L  102 (342)
T cd07854          29 CDKRVAVKKIVLTDP-----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DL  102 (342)
T ss_pred             CCcEEEEEEEecCCC-----chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeecccc-cH
Confidence            478999999865432     3445677899999999999999999876543              357899999975 89


Q ss_pred             HHHHHhcCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC-CCCeEEcccccccccCccc-----cccCCCCC
Q 041080           67 ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMND-----LKSCKGTP  140 (247)
Q Consensus        67 ~~~l~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~-~~~~~l~df~~~~~~~~~~-----~~~~~~~~  140 (247)
                      .+++....+++..++.++.|++.|+.+||+.|++|+||+|+||+++. ++.++++|||.+.......     .....++.
T Consensus       103 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~  182 (342)
T cd07854         103 ANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK  182 (342)
T ss_pred             HHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccc
Confidence            98888778999999999999999999999999999999999999974 5578999999986443211     12234677


Q ss_pred             CccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC------------------------CCC
Q 041080          141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG------------------------ELP  196 (247)
Q Consensus       141 ~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~------------------------~~~  196 (247)
                      .|+|||.+.... .++.++|+||||++++++++|..||...............                        ..+
T Consensus       183 ~y~aPE~~~~~~-~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (342)
T cd07854         183 WYRSPRLLLSPN-NYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEP  261 (342)
T ss_pred             cccCHHHHhCcc-ccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhccccc
Confidence            899999875422 3688999999999999999999999765443332221110                        000


Q ss_pred             -----CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          197 -----SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       197 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                           ......+.++.+++.+||+.+|.+|||++++++||||+.
T Consensus       262 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         262 RRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             CCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence                 112357889999999999999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.3e-38  Score=248.67  Aligned_cols=219  Identities=28%  Similarity=0.483  Sum_probs=182.7

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSDS   78 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~   78 (247)
                      +..+|+|.+.....      ..+.+.+|+.++++++|+|++++++++. ....+++|||+++++|.+++...   .+++.
T Consensus        30 ~~~~~~k~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  102 (260)
T cd05070          30 NTKVAVKTLKPGTM------SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLP  102 (260)
T ss_pred             CceeEEEEecCCCC------CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHH
Confidence            56789998865332      1345889999999999999999999875 45688999999999999998653   38899


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc---ccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL---KSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .+..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+........   ....++..|+|||.+.+..  +
T Consensus       103 ~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~  180 (260)
T cd05070         103 NLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--F  180 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCC--C
Confidence            9999999999999999999999999999999999999999999999865433221   1222445799999985443  7


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +.++|+||||++++++++ |..||......+....+........+...+..+.+++.+||..+|.+|||+.++++
T Consensus       181 ~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         181 TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            889999999999999998 89999887777777777665555666788999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.9e-38  Score=248.71  Aligned_cols=220  Identities=25%  Similarity=0.432  Sum_probs=183.5

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVS   81 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~   81 (247)
                      .+++|.+...    ......+.+.+|+.++++++|+|++++.+++...+..+++|||+++++|.+++...  .+++..+.
T Consensus        35 ~~~ik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  110 (268)
T cd05063          35 AVAIKTLKPG----YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLV  110 (268)
T ss_pred             EEEEEecccc----CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHH
Confidence            6888887543    12334567889999999999999999999999999999999999999999998654  48899999


Q ss_pred             HHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccccc-----CCCCCCccCCcccccCCCCCC
Q 041080           82 SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKS-----CKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        82 ~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+..........     ......|+|||.+....  ++
T Consensus       111 ~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~  188 (268)
T cd05063         111 GMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK--FT  188 (268)
T ss_pred             HHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCC--cC
Confidence            999999999999999999999999999999999999999999986443222111     11234699999986543  78


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          157 LTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      .++|+||||+++|++++ |..||......+....+......+.+...+.++.+++.+||+.+|.+||++.++++
T Consensus       189 ~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         189 SASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             hHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            89999999999999987 99999877776776666655444555678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-40  Score=239.82  Aligned_cols=224  Identities=30%  Similarity=0.491  Sum_probs=179.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC-----CcEEEEEeccccCcHHHHHHhc--
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE-----NRLYIFLELVTKGSLANLYQKY--   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~--   73 (247)
                      +++.||+|.+...     ..+..+.+.+|+...++++||||++++++...+     ...|++++|...|||.+.++..  
T Consensus        45 ~~~~YAlKkI~c~-----~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~  119 (302)
T KOG2345|consen   45 TGHLYALKKILCH-----SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKI  119 (302)
T ss_pred             cccchhhheeecc-----chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhh
Confidence            4788999999864     356778899999999999999999999975433     3589999999999999988654  


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHhhhCC--eeecCCCCCcEEEcCCCCeEEcccccccccCcc-----------ccccCC
Q 041080           74 ---HLSDSQVSSYTRQILNGLVYLHERN--VVHRDIKCANILVDASGSVKLADFGLAKATTMN-----------DLKSCK  137 (247)
Q Consensus        74 ---~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-----------~~~~~~  137 (247)
                         .+++.++++|+.+++.||.+||...  ++|+||||.||+++..+.+++.|||........           +.....
T Consensus       120 kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~  199 (302)
T KOG2345|consen  120 KGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEER  199 (302)
T ss_pred             cCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHh
Confidence               2999999999999999999999998  999999999999999999999999987532211           111233


Q ss_pred             CCCCccCCcccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHH--HHHhhcC--CCCCCCCcCCHHHHHHHHH
Q 041080          138 GTPFWMAPEVVNSK-NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQA--LFRIGKG--ELPSVPSSLSRDARDFILK  212 (247)
Q Consensus       138 ~~~~~~aPE~~~~~-~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~--~~~~~~~--~~~~~~~~~~~~~~~li~~  212 (247)
                      .+..|+|||.+... ....+.++|||||||++|.++.|..||+.......  ...+.+.  ..|. ...+|+.+.+++++
T Consensus       200 Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~-~~~yse~l~~lik~  278 (302)
T KOG2345|consen  200 CTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPN-SSRYSEALHQLIKS  278 (302)
T ss_pred             CCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCC-CCCccHHHHHHHHH
Confidence            67889999998643 33468999999999999999999999965432111  1111111  1222 23489999999999


Q ss_pred             HhcCCCCCCCChhhhhcC
Q 041080          213 CLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       213 ~l~~~p~~Rps~~~il~~  230 (247)
                      ||+.||.+||++.+++.+
T Consensus       279 mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  279 MLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             HhcCCcccCCCHHHHHHH
Confidence            999999999999999863

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=9.5e-39  Score=262.50  Aligned_cols=221  Identities=28%  Similarity=0.454  Sum_probs=179.2

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--------
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--------   73 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------   73 (247)
                      ..||||++....    .....+.+.+|+.++.++. ||||+++++++...+..++||||+++|+|.+++.+.        
T Consensus        68 ~~vavK~l~~~~----~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~  143 (400)
T cd05105          68 MKVAVKMLKPTA----RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRH  143 (400)
T ss_pred             eEEEEEecCCCC----ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccc
Confidence            468999886432    2334567889999999996 999999999999999999999999999999887542        


Q ss_pred             --------------------------------------------------------------------------------
Q 041080           74 --------------------------------------------------------------------------------   73 (247)
Q Consensus        74 --------------------------------------------------------------------------------   73 (247)
                                                                                                      
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  223 (400)
T cd05105         144 PEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVK  223 (400)
T ss_pred             cccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHH
Confidence                                                                                            


Q ss_pred             ---------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----ccCCCCC
Q 041080           74 ---------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCKGTP  140 (247)
Q Consensus        74 ---------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~  140 (247)
                               .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........    ....++.
T Consensus       224 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~  303 (400)
T cd05105         224 NLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV  303 (400)
T ss_pred             HHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCc
Confidence                     256777889999999999999999999999999999999999999999999865432221    1223556


Q ss_pred             CccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhH-HHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCC
Q 041080          141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQ-ALFRIGKGELPSVPSSLSRDARDFILKCLQVNP  218 (247)
Q Consensus       141 ~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  218 (247)
                      .|+|||.+.+..  ++.++||||||+++|++++ |..||....... ....+........+..++.++.+++.+||+.+|
T Consensus       304 ~y~aPE~~~~~~--~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  381 (400)
T cd05105         304 KWMAPESIFDNL--YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEP  381 (400)
T ss_pred             ceEChhhhcCCC--CCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCH
Confidence            799999986543  7889999999999999997 889987654332 233333443445567789999999999999999


Q ss_pred             CCCCChhhhhc
Q 041080          219 NDRPTVTELME  229 (247)
Q Consensus       219 ~~Rps~~~il~  229 (247)
                      .+|||+.++.+
T Consensus       382 ~~RPt~~~l~~  392 (400)
T cd05105         382 EKRPSFLHLSD  392 (400)
T ss_pred             hHCcCHHHHHH
Confidence            99999998865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.6e-38  Score=249.29  Aligned_cols=220  Identities=25%  Similarity=0.446  Sum_probs=182.9

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVS   81 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~   81 (247)
                      .||||.+...    ........+..|+.+++.++||||+++++++..++..+++|||+++++|.+++...  .+++..++
T Consensus        34 ~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  109 (269)
T cd05065          34 FVAIKTLKSG----YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLV  109 (269)
T ss_pred             eEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHH
Confidence            5899988642    23445677899999999999999999999999999999999999999999998754  38899999


Q ss_pred             HHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc----cCC---CCCCccCCcccccCCCC
Q 041080           82 SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK----SCK---GTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        82 ~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~----~~~---~~~~~~aPE~~~~~~~~  154 (247)
                      .++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.........    ...   .+..|++||.+.+..  
T Consensus       110 ~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--  187 (269)
T cd05065         110 GMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK--  187 (269)
T ss_pred             HHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCc--
Confidence            99999999999999999999999999999999999999999987644322111    111   134699999986544  


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          155 YGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ++.++|+||+|++++++++ |..||......+....+........+..++..+.+++.+||+.+|.+||++++++.
T Consensus       188 ~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         188 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7889999999999999886 99999877766666665544444445678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=9.4e-39  Score=254.58  Aligned_cols=228  Identities=31%  Similarity=0.550  Sum_probs=180.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC----------cEEEEEeccccCcHHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN----------RLYIFLELVTKGSLANLY   70 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----------~~~lv~e~~~~~~L~~~l   70 (247)
                      +|+.||+|.+.....   .......+.+|+.++++++||||+++++++.+..          ..++++||+++ ++...+
T Consensus        31 ~~~~v~iK~~~~~~~---~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l  106 (302)
T cd07864          31 TGELVALKKVRLDNE---KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLL  106 (302)
T ss_pred             CCcEEEEEEEeeccc---ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHH
Confidence            478899999976532   1223345678999999999999999999886654          78999999987 677766


Q ss_pred             Hhc--CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc---ccCCCCCCccCC
Q 041080           71 QKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL---KSCKGTPFWMAP  145 (247)
Q Consensus        71 ~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~aP  145 (247)
                      ...  .+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+........   ....++..|++|
T Consensus       107 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~P  186 (302)
T cd07864         107 ESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPP  186 (302)
T ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccCh
Confidence            543  589999999999999999999999999999999999999999999999998865433221   122356779999


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC---CCC--------------------------
Q 041080          146 EVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG---ELP--------------------------  196 (247)
Q Consensus       146 E~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---~~~--------------------------  196 (247)
                      |.+.+.. ..+.++|+||+|++++++++|+.||...+.......+...   ..+                          
T Consensus       187 E~~~~~~-~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (302)
T cd07864         187 ELLLGEE-RYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLR  265 (302)
T ss_pred             HHhcCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchh
Confidence            9875432 2578999999999999999999999765544433222111   000                          


Q ss_pred             CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          197 SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       197 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      .....+|..+.+++.+||+.+|.+||+++++++||||
T Consensus       266 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         266 EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            0112468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.4e-38  Score=248.71  Aligned_cols=218  Identities=28%  Similarity=0.466  Sum_probs=179.1

Q ss_pred             EEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHHHH
Q 041080            5 FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSS   82 (247)
Q Consensus         5 ~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~   82 (247)
                      +++|.+..    .........+..|+..+.+++||||+++++++. +...++++||+++++|.+++...  .+++..+..
T Consensus        39 ~~~k~~~~----~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~  113 (279)
T cd05111          39 VAIKTIQD----RSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLN  113 (279)
T ss_pred             EEEeeccc----ccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHH
Confidence            56666532    223444567888999999999999999999875 45678899999999999999653  488999999


Q ss_pred             HHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCCcccccCCCCCCcc
Q 041080           83 YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        83 ~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+.......    .....++..|++||.+.+..  ++.+
T Consensus       114 i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~  191 (279)
T cd05111         114 WCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR--YTHQ  191 (279)
T ss_pred             HHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCC--cCch
Confidence            99999999999999999999999999999999999999999986543221    11233556799999986543  7899


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          159 ADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       159 ~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +|+||||+++|++++ |..||...........+..+.....+...+.++..++.+||..+|.+|||+.++++
T Consensus       192 ~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         192 SDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            999999999999998 99999887666655555555555556677889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.4e-39  Score=259.60  Aligned_cols=231  Identities=28%  Similarity=0.448  Sum_probs=182.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC------CcEEEEEeccccCcHHHHHHhcC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE------NRLYIFLELVTKGSLANLYQKYH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~   74 (247)
                      +|+.||+|++....   ......+.+.+|+.++++++||||+++++++...      ...+++++++ +++|.++++...
T Consensus        41 ~~~~vaiK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~  116 (345)
T cd07877          41 TGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK  116 (345)
T ss_pred             CCeEEEEEEecCcc---hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcCC
Confidence            47889999886532   2223345677899999999999999999987543      3478888887 669999988778


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +++..++.++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+..... ......++..|+|||.+.+.. .
T Consensus       117 l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~  194 (345)
T cd07877         117 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-EMTGYVATRWYRAPEIMLNWM-H  194 (345)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc-cccccccCCCccCHHHHhCcc-C
Confidence            99999999999999999999999999999999999999999999999999865432 223445788899999875422 3


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC-------------------------CC-----CCCCCcCCH
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG-------------------------EL-----PSVPSSLSR  204 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-------------------------~~-----~~~~~~~~~  204 (247)
                      ++.++|+||+|++++++++|..||...........+...                         ..     .......++
T Consensus       195 ~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (345)
T cd07877         195 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP  274 (345)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCH
Confidence            688999999999999999999999765443332221110                         00     011124578


Q ss_pred             HHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          205 DARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       205 ~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      ++.++|.+||+.+|.+||++.++++||||++..
T Consensus       275 ~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~  307 (345)
T cd07877         275 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  307 (345)
T ss_pred             HHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence            899999999999999999999999999999743

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.9e-38  Score=247.96  Aligned_cols=218  Identities=28%  Similarity=0.466  Sum_probs=180.1

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCHHH
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSDSQ   79 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~   79 (247)
                      ..||+|.+.....      ..+.+.+|+.+++.++|+||+++++.+.. +..+++|||+++++|.+++.+.   .+++..
T Consensus        31 ~~valK~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  103 (262)
T cd05071          31 TRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ  103 (262)
T ss_pred             ceEEEEecccCcc------CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHH
Confidence            4689998864321      23467899999999999999999998754 5679999999999999998752   478899


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc---cCCCCCCccCCcccccCCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK---SCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      +..++.|++.||+++|+.|++|+||+|+||+++.++.++|+|||.+.........   ...++..|++||...+..  ++
T Consensus       104 ~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~  181 (262)
T cd05071         104 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FT  181 (262)
T ss_pred             HHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCC--CC
Confidence            9999999999999999999999999999999999999999999998654332221   223456799999885444  78


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          157 LTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      .++|+||||+++|++++ |..||...........+........+...+..+.+++.+||+.+|.+||+++++++
T Consensus       182 ~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         182 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             chhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            89999999999999999 88899877766666665554444556678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.3e-39  Score=259.74  Aligned_cols=231  Identities=29%  Similarity=0.478  Sum_probs=181.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC-----CcEEEEEeccccCcHHHHHHhc-C
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE-----NRLYIFLELVTKGSLANLYQKY-H   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~-~   74 (247)
                      +|+.||||.+.....   .......+.+|+.+++.++|+||+++++++...     ...++++||+. ++|.+++... .
T Consensus        29 ~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~  104 (337)
T cd07858          29 TNEKVAIKKIANAFD---NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQT  104 (337)
T ss_pred             CCCeEEEEEeccccc---ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCCC
Confidence            478899999865321   222344567899999999999999999987644     35799999996 5888888654 5


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKN  152 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~  152 (247)
                      +++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+....
T Consensus       105 l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  184 (337)
T cd07858         105 LSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCS  184 (337)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCC
Confidence            8999999999999999999999999999999999999999999999999986544321  22345778899999875432


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhh---------------------------cCC---CCCCCCcC
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIG---------------------------KGE---LPSVPSSL  202 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~---------------------------~~~---~~~~~~~~  202 (247)
                      . ++.++|+||||++++++++|..||...+.......+.                           ...   .......+
T Consensus       185 ~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (337)
T cd07858         185 E-YTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHA  263 (337)
T ss_pred             C-CCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccC
Confidence            2 7889999999999999999999997654322111110                           000   01112457


Q ss_pred             CHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          203 SRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       203 ~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ++++.+++.+||+.+|.+|||++++++||||+..
T Consensus       264 ~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         264 NPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             CHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            8899999999999999999999999999999874

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.9e-38  Score=256.18  Aligned_cols=221  Identities=26%  Similarity=0.490  Sum_probs=184.9

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---------
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---------   73 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------   73 (247)
                      .||+|.+...    ........+.+|+.+++++ +||||+++++++...+..++++||+++++|.+++.+.         
T Consensus        46 ~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~  121 (334)
T cd05100          46 TVAVKMLKDD----ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSF  121 (334)
T ss_pred             eEEEEEcccc----cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCccccccc
Confidence            5788877532    2334566788999999999 7999999999999999999999999999999998653         


Q ss_pred             --------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCC
Q 041080           74 --------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPF  141 (247)
Q Consensus        74 --------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~  141 (247)
                              .++...+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.......    .....++..
T Consensus       122 ~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~  201 (334)
T cd05100         122 DTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVK  201 (334)
T ss_pred             ccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCce
Confidence                    26678889999999999999999999999999999999999999999999986543222    111223456


Q ss_pred             ccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCC
Q 041080          142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPND  220 (247)
Q Consensus       142 ~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  220 (247)
                      |+|||.+.+..  ++.++|+||||+++|+|++ |..||......+....+........+...+.++.+++.+||..+|.+
T Consensus       202 y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~  279 (334)
T cd05100         202 WMAPEALFDRV--YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQ  279 (334)
T ss_pred             EcCHHHhccCC--cCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhh
Confidence            99999986544  7889999999999999998 88999887777777666665555666778999999999999999999


Q ss_pred             CCChhhhhcC
Q 041080          221 RPTVTELMEH  230 (247)
Q Consensus       221 Rps~~~il~~  230 (247)
                      |||+.+++++
T Consensus       280 Rps~~ell~~  289 (334)
T cd05100         280 RPTFKQLVED  289 (334)
T ss_pred             CcCHHHHHHH
Confidence            9999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-40  Score=266.03  Aligned_cols=222  Identities=26%  Similarity=0.511  Sum_probs=187.9

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDSQVS   81 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~   81 (247)
                      .||||.+..+..   ..+..+.|++|+..+++-+|.||+=|+|++...+. .+|+.+|.|-+|..++.-  -.+.....+
T Consensus       416 dVAVK~Lnv~~p---t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~i  491 (678)
T KOG0193|consen  416 DVAVKLLNVDDP---TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTI  491 (678)
T ss_pred             ceEEEEEecCCC---CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHH
Confidence            699999987653   44588999999999999999999999999988877 999999999999998754  358999999


Q ss_pred             HHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccc----cCccccccCCCCCCccCCccccc-CCCCCC
Q 041080           82 SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA----TTMNDLKSCKGTPFWMAPEVVNS-KNDGYG  156 (247)
Q Consensus        82 ~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~----~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~  156 (247)
                      .|+.|+++|+.|||.++|+|+|||..||++.+++.|+|+|||++..    .+........+...|+|||+++. ....++
T Consensus       492 dIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS  571 (678)
T KOG0193|consen  492 DIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFS  571 (678)
T ss_pred             HHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCC
Confidence            9999999999999999999999999999999999999999999853    22333444457788999999853 344589


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC----CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL----PSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ..+||||||+++|||++|..||.......++-.+..+..    .......++++++|+..||.+++++||.+.+||.
T Consensus       572 ~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  572 FQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             cccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            999999999999999999999995555555555555522    2233578889999999999999999999999987

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7e-39  Score=252.78  Aligned_cols=228  Identities=33%  Similarity=0.551  Sum_probs=184.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.||+|.+....   ......+.+.+|+.+++.++|+|++++++++...+..++|+||+++ +|.+++.+.  .+++.
T Consensus        23 ~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~i~~~~~~~~~~   98 (282)
T cd07829          23 TGEIVALKKIRLDN---EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPN   98 (282)
T ss_pred             CCcEEEEEEecccc---ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCc-CHHHHHHhhccCCCHH
Confidence            47899999997653   1223345567899999999999999999999999999999999985 899999876  69999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+. ..++
T Consensus        99 ~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~  177 (282)
T cd07829          99 LIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGS-KHYS  177 (282)
T ss_pred             HHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCC-cCCC
Confidence            999999999999999999999999999999999999999999999886543322  2233356779999998644 2378


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc--------------------CCCC--------CCCCcCCHHHHH
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK--------------------GELP--------SVPSSLSRDARD  208 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~--------------------~~~~--------~~~~~~~~~~~~  208 (247)
                      .++|+||||++++++++|..||......+....+..                    ...+        ......+..+.+
T Consensus       178 ~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (282)
T cd07829         178 TAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGID  257 (282)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHH
Confidence            899999999999999999999977654433322211                    0000        111234788999


Q ss_pred             HHHHHhcCCCCCCCChhhhhcCccC
Q 041080          209 FILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       209 li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      ++.+||..+|.+||+++++++||||
T Consensus       258 ~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         258 LLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             HHHHhhccCcccCCCHHHHhhCcCC
Confidence            9999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=280.39  Aligned_cols=220  Identities=28%  Similarity=0.498  Sum_probs=193.9

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--------CC
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--------HL   75 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~   75 (247)
                      .||+|.+...    .+.+....|.+|..+|++++|||||+++|++-+.+..++++|||.||+|..++++.        .+
T Consensus       724 ~vaiK~l~~~----~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L  799 (1025)
T KOG1095|consen  724 QVAVKSLKRL----SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNL  799 (1025)
T ss_pred             EEEEEecccc----CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCC
Confidence            4788877653    35667888999999999999999999999999999999999999999999999765        28


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCC----CCCCccCCcccccC
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK----GTPFWMAPEVVNSK  151 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~----~~~~~~aPE~~~~~  151 (247)
                      +..+++.++.+++.|+.||++++++||||...|+|++....+||+|||+++.+.........    ....|||||.+.. 
T Consensus       800 ~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-  878 (1025)
T KOG1095|consen  800 SMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-  878 (1025)
T ss_pred             CHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhh-
Confidence            89999999999999999999999999999999999999999999999999855544433222    2357999999965 


Q ss_pred             CCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          152 NDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       152 ~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                       ..++.++||||||+++||+++ |..||.+....+.......+..-..|..+|+.+.++|.+||+.+|.+||++..|++
T Consensus       879 -~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  879 -GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             -cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence             348999999999999999998 88999999999998865555566778899999999999999999999999999997

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.3e-38  Score=255.00  Aligned_cols=231  Identities=27%  Similarity=0.422  Sum_probs=183.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec-CCcEEEEEeccccCcHHHHHHhcCCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD-ENRLYIFLELVTKGSLANLYQKYHLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~   79 (247)
                      +|+.||+|++.....   .....+.+.+|+.+++.++||||+++.+++.. ....++++||+. ++|.++++...+++..
T Consensus        34 ~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~  109 (328)
T cd07856          34 TGQNVAIKKIMKPFS---TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLG-TDLHRLLTSRPLEKQF  109 (328)
T ss_pred             CCCEEEEEEeccccc---ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehhc-cCHHHHHhcCCCCHHH
Confidence            478899998865422   12334567799999999999999999998865 567899999995 5899998877889999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcch
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTA  159 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~  159 (247)
                      +..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...... .....++..|+|||.+.+.. .++.++
T Consensus       110 ~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~~  187 (328)
T cd07856         110 IQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-MTGYVSTRYYRAPEIMLTWQ-KYDVEV  187 (328)
T ss_pred             HHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC-cCCCcccccccCceeeeccC-CcCcHH
Confidence            9999999999999999999999999999999999999999999998654322 23345677899999875422 378899


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCChhhHHHHHhh------------------------cCC-CC-----CCCCcCCHHHHHH
Q 041080          160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIG------------------------KGE-LP-----SVPSSLSRDARDF  209 (247)
Q Consensus       160 Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~------------------------~~~-~~-----~~~~~~~~~~~~l  209 (247)
                      |+||+|++++++++|..||...........+.                        ... ..     .....+++.++++
T Consensus       188 Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  267 (328)
T cd07856         188 DIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDL  267 (328)
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHH
Confidence            99999999999999999997654322111000                        000 00     1113568899999


Q ss_pred             HHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          210 ILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       210 i~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      |.+||+.+|.+|||+++++.||||+...
T Consensus       268 i~~~l~~~P~~R~t~~ell~~~~~~~~~  295 (328)
T cd07856         268 LEKMLVFDPQKRISAAEALAHPYLAPYH  295 (328)
T ss_pred             HHHHcCCChhhCCCHHHHhcCCcccccc
Confidence            9999999999999999999999998653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.1e-38  Score=245.64  Aligned_cols=218  Identities=29%  Similarity=0.531  Sum_probs=181.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~   77 (247)
                      +|+.||+|.+....       ..+.+.+|+.+++.++|||++++++++..+ ..+++|||+++++|.+++...   .+++
T Consensus        28 ~~~~~~iK~~~~~~-------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~   99 (254)
T cd05083          28 TGQKVAVKNIKCDV-------TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSV   99 (254)
T ss_pred             CCCceEEEeecCcc-------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCH
Confidence            46789999885421       234678999999999999999999988665 479999999999999998754   3788


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCc
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      ..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+...... .........|+|||.+.+.  .++.
T Consensus       100 ~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~y~~pe~~~~~--~~~~  176 (254)
T cd05083         100 IQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-VDNSKLPVKWTAPEALKHK--KFSS  176 (254)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-CCCCCCCceecCHHHhccC--CcCc
Confidence            899999999999999999999999999999999999999999999987643322 1222345679999998543  3788


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          158 TADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ++|+||||++++++++ |..||......+....+........+..++..+.+++.+||+.+|.+||++++++.
T Consensus       177 ~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         177 KSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999997 99999887776666666655555556778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.7e-38  Score=249.37  Aligned_cols=222  Identities=25%  Similarity=0.401  Sum_probs=184.2

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec-CCcEEEEEeccccCcHHHHHHh--------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD-ENRLYIFLELVTKGSLANLYQK--------   72 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~--------   72 (247)
                      +..|++|.+..    .......+.+.+|+.+++.++|+||+++++++.. +...+++++|+++++|.+++..        
T Consensus        35 ~~~v~~k~~~~----~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~  110 (280)
T cd05043          35 EEEVFVKTVKD----HASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANN  110 (280)
T ss_pred             eeEEEEEEccC----CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhcccccccc
Confidence            56788888753    2344556778899999999999999999998665 5788999999999999999865        


Q ss_pred             -cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----ccCCCCCCccCCcc
Q 041080           73 -YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCKGTPFWMAPEV  147 (247)
Q Consensus        73 -~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~aPE~  147 (247)
                       ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++++|||+++.......    ....++..|+|||.
T Consensus       111 ~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~  190 (280)
T cd05043         111 PQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALES  190 (280)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHH
Confidence             2378999999999999999999999999999999999999999999999999865432221    12234567999999


Q ss_pred             cccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhh
Q 041080          148 VNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTE  226 (247)
Q Consensus       148 ~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  226 (247)
                      +.+..  ++.++|+||||++++++++ |+.||......+....+..+.....+..+++++++++.+||..+|.+|||+.+
T Consensus       191 ~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  268 (280)
T cd05043         191 LVNKE--YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQ  268 (280)
T ss_pred             HhcCC--CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHH
Confidence            85443  7899999999999999998 99999877766666655555444455678999999999999999999999999


Q ss_pred             hhc
Q 041080          227 LME  229 (247)
Q Consensus       227 il~  229 (247)
                      +++
T Consensus       269 ~~~  271 (280)
T cd05043         269 LVQ  271 (280)
T ss_pred             HHH
Confidence            975

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.5e-38  Score=248.63  Aligned_cols=219  Identities=25%  Similarity=0.433  Sum_probs=182.3

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVS   81 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~   81 (247)
                      .||+|.+...    ........+.+|+.++..++|+||+++++++.. ...+++++|+++|+|.+++...  .+++..++
T Consensus        38 ~va~K~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~  112 (279)
T cd05109          38 PVAIKVLREN----TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLL  112 (279)
T ss_pred             EEEEEEecCC----CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHH
Confidence            4789988643    233445678899999999999999999998865 4578999999999999998753  48999999


Q ss_pred             HHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----ccCCCCCCccCCcccccCCCCCCc
Q 041080           82 SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        82 ~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      .++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++........    ....++..|++||...+..  ++.
T Consensus       113 ~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~  190 (279)
T cd05109         113 NWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR--FTH  190 (279)
T ss_pred             HHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCC--CCc
Confidence            9999999999999999999999999999999999999999999865442221    1122456799999985443  788


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          158 TADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ++|+||||+++|++++ |..||...........+........+...+.++.+++.+||+.+|.+||++.++++
T Consensus       191 ~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         191 QSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999998 89999877766666666555555566778999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.6e-38  Score=249.96  Aligned_cols=223  Identities=30%  Similarity=0.522  Sum_probs=177.2

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC--CcEEEEEeccccCcHHHHHHhc--CCCH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE--NRLYIFLELVTKGSLANLYQKY--HLSD   77 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~--~~~~   77 (247)
                      |+.||+|.+....    .......+.+|+.+++.++|||++++.+++...  ...+++|||+++++|.+++.+.  .+++
T Consensus        33 ~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~  108 (284)
T cd05079          33 GEQVAVKSLKPES----GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL  108 (284)
T ss_pred             cceEEEEEcCccc----cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCH
Confidence            6789999886432    233456788999999999999999999988765  5789999999999999998654  3789


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-----cccCCCCCCccCCcccccCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSKN  152 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~  152 (247)
                      ..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.......     .....++..|+|||.+.+..
T Consensus       109 ~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~  188 (284)
T cd05079         109 KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK  188 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCC
Confidence            9999999999999999999999999999999999999999999999987544322     12234566799999985443


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCC---------------hhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCC
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHL---------------EGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVN  217 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  217 (247)
                        ++.++|+||||+++++++++..|....               ........+......+.+..++..+.+++.+||+.+
T Consensus       189 --~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  266 (284)
T cd05079         189 --FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQ  266 (284)
T ss_pred             --CCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCC
Confidence              788999999999999999976553211               011112222233333445678999999999999999


Q ss_pred             CCCCCChhhhhcC
Q 041080          218 PNDRPTVTELMEH  230 (247)
Q Consensus       218 p~~Rps~~~il~~  230 (247)
                      |.+|||++++++.
T Consensus       267 p~~Rpt~~~il~~  279 (284)
T cd05079         267 PSKRTTFQNLIEG  279 (284)
T ss_pred             cccCcCHHHHHHH
Confidence            9999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.9e-38  Score=251.13  Aligned_cols=230  Identities=31%  Similarity=0.558  Sum_probs=181.8

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDS   78 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~   78 (247)
                      |+.||||.+.....    ......+..|+.++... .|+||+++++++.+....+++|||+.+ ++.+++..  ..+++.
T Consensus        40 ~~~~avK~~~~~~~----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~  114 (296)
T cd06618          40 GHVMAVKQMRRTGN----KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPED  114 (296)
T ss_pred             CeEEEEEEEeccCC----hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCc-CHHHHHHHhcCCCCHH
Confidence            78999999975421    22344566677767666 499999999999999999999999865 78777755  348899


Q ss_pred             HHHHHHHHHHHHHHHhhh-CCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCC--CC
Q 041080           79 QVSSYTRQILNGLVYLHE-RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKN--DG  154 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~-~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~--~~  154 (247)
                      .+..++.|++.|++|||+ .|++|+||+|+||+++.++.++|+|||.+....... .....++..|+|||.+.+..  ..
T Consensus       115 ~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  194 (296)
T cd06618         115 ILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPK  194 (296)
T ss_pred             HHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccc
Confidence            999999999999999997 599999999999999999999999999976443222 22234667899999986543  34


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChh-hHHHHHhhcCCCCCCC--CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEG-VQALFRIGKGELPSVP--SSLSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                      ++.++|+||||+++|++++|+.||..... .+....+.....+..+  ..++.++++++.+||..+|.+||+++++++||
T Consensus       195 ~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         195 YDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             cccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            68899999999999999999999976433 2233333333322322  34789999999999999999999999999999


Q ss_pred             cCCCC
Q 041080          232 FVKRP  236 (247)
Q Consensus       232 ~~~~~  236 (247)
                      ||+..
T Consensus       275 ~~~~~  279 (296)
T cd06618         275 FIRRY  279 (296)
T ss_pred             hhhcc
Confidence            99864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.1e-38  Score=255.91  Aligned_cols=223  Identities=28%  Similarity=0.464  Sum_probs=179.6

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeec-CCcEEEEEeccccCcHHHHHHh-------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKD-ENRLYIFLELVTKGSLANLYQK-------   72 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~-------   72 (247)
                      |+.||+|.+....    .....+.+.+|+.++.++ +|+||+++++++.. +..+++++||+++++|.+++..       
T Consensus        37 ~~~va~K~~~~~~----~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~  112 (337)
T cd05054          37 CRTVAVKMLKEGA----TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSP  112 (337)
T ss_pred             cceeeeeeccCCC----CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccc
Confidence            4689999886432    233455678899999999 79999999998764 4578899999999999988753       


Q ss_pred             -------------------------------------------------------cCCCHHHHHHHHHHHHHHHHHhhhC
Q 041080           73 -------------------------------------------------------YHLSDSQVSSYTRQILNGLVYLHER   97 (247)
Q Consensus        73 -------------------------------------------------------~~~~~~~~~~~~~~l~~~l~~lh~~   97 (247)
                                                                             ..+++..+..++.|++.||.|||+.
T Consensus       113 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~  192 (337)
T cd05054         113 YRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR  192 (337)
T ss_pred             cccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC
Confidence                                                                   1468888999999999999999999


Q ss_pred             CeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----ccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHh
Q 041080           98 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT  173 (247)
Q Consensus        98 ~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~  173 (247)
                      ||+|+||||+||+++.++.++|+|||++........    ....++..|+|||.+.+..  ++.++|+||||++++++++
T Consensus       193 ~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~SlGv~l~el~t  270 (337)
T cd05054         193 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFS  270 (337)
T ss_pred             CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCC--CCccccHHHHHHHHHHHHH
Confidence            999999999999999999999999999875432221    1223456799999986544  7899999999999999997


Q ss_pred             -CCCCCCCChhhHH-HHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          174 -RRPPYSHLEGVQA-LFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       174 -g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                       |..||......+. ...+........+...++++.+++.+||+.+|.+||++++++++
T Consensus       271 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         271 LGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             cCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             9999876443332 23333334445566788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.9e-38  Score=251.07  Aligned_cols=222  Identities=30%  Similarity=0.463  Sum_probs=181.4

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-------   74 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------   74 (247)
                      +..||+|.+....    .....+.+.+|+.++++++||||+++++++..++..++++|++++++|.+++.+..       
T Consensus        46 ~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  121 (296)
T cd05051          46 PVLVAVKVLRPDA----SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLA  121 (296)
T ss_pred             ceeEEEEEecCcc----CHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhccccccccc
Confidence            3568999887542    23456778899999999999999999999999999999999999999999986643       


Q ss_pred             -----CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCC
Q 041080           75 -----LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAP  145 (247)
Q Consensus        75 -----~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aP  145 (247)
                           +++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.......    .....++..|+||
T Consensus       122 ~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  201 (296)
T cd05051         122 CNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAW  201 (296)
T ss_pred             ccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCH
Confidence                 7899999999999999999999999999999999999999999999999986543322    1122345679999


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCChhhHHHHHhhcC-------CCCCCCCcCCHHHHHHHHHHhcC
Q 041080          146 EVVNSKNDGYGLTADIWSLGCTVLEMLT--RRPPYSHLEGVQALFRIGKG-------ELPSVPSSLSRDARDFILKCLQV  216 (247)
Q Consensus       146 E~~~~~~~~~~~~~Di~slG~ll~~l~~--g~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~  216 (247)
                      |.+.+..  ++.++|+||||+++|++++  +..||...............       .....+...|.++.+++.+||+.
T Consensus       202 E~~~~~~--~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  279 (296)
T cd05051         202 ESVLLGK--FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRR  279 (296)
T ss_pred             HHhhcCC--CCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhcc
Confidence            9986543  7899999999999999987  67888776655554443322       11223456789999999999999


Q ss_pred             CCCCCCChhhhhc
Q 041080          217 NPNDRPTVTELME  229 (247)
Q Consensus       217 ~p~~Rps~~~il~  229 (247)
                      +|.+|||+.++++
T Consensus       280 ~p~~Rpt~~el~~  292 (296)
T cd05051         280 DEEDRPTFREIHL  292 (296)
T ss_pred             ChhcCCCHHHHHH
Confidence            9999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-39  Score=263.38  Aligned_cols=214  Identities=34%  Similarity=0.617  Sum_probs=186.6

Q ss_pred             chHHHHHHHHHHHHHhhcCCCceeeeceeeecCC--cEEEEEeccccCcHHHHHHhcC-CCHHHHHHHHHHHHHHHHHhh
Q 041080           19 GKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN--RLYIFLELVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYLH   95 (247)
Q Consensus        19 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~l~~~l~~lh   95 (247)
                      ....++++..|+.+|+.|+||||++++++..+..  ...+|+|.+..|+|..++++.+ ++...++.|+.||+.||.|||
T Consensus        81 ~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLH  160 (632)
T KOG0584|consen   81 SPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLH  160 (632)
T ss_pred             ChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhh
Confidence            4456788999999999999999999999876654  5889999999999999998864 899999999999999999999


Q ss_pred             hCC--eeecCCCCCcEEEcCC-CCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHH
Q 041080           96 ERN--VVHRDIKCANILVDAS-GSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEML  172 (247)
Q Consensus        96 ~~~--i~h~dl~~~ni~~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~  172 (247)
                      ++.  |+|||||.+||+|+.+ |.|||+|+|++............|||.|||||+.-   ..|+...||||||++|.||+
T Consensus       161 s~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYE---E~YnE~VDVYaFGMCmLEMv  237 (632)
T KOG0584|consen  161 SQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYE---ENYNELVDVYAFGMCMLEMV  237 (632)
T ss_pred             cCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccceeccCccccChHHHh---hhcchhhhhhhhhHHHHHHH
Confidence            985  9999999999999864 89999999999988888888888999999999984   33899999999999999999


Q ss_pred             hCCCCCCCCh-hhHHHHHhhcCCCCC-CCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          173 TRRPPYSHLE-GVQALFRIGKGELPS-VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       173 ~g~~p~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      |+..||..-. ...++.++..+..|. +..--++++++||.+||.. ..+|+|+.|+|.||||...
T Consensus       238 T~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  238 TSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             hccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            9999996554 445555666655443 3444588999999999999 8999999999999999986

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.5e-38  Score=257.23  Aligned_cols=231  Identities=32%  Similarity=0.479  Sum_probs=182.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecC--CcEEEEEeccccCcHHHHHHhcCCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDE--NRLYIFLELVTKGSLANLYQKYHLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~   77 (247)
                      +|+.+|+|++.....   .......+.+|+.+++++ +||||+++++++...  ...++||||+++ +|.+++....+++
T Consensus        31 ~~~~~~vK~~~~~~~---~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~  106 (337)
T cd07852          31 TKEVVALKKIFDAFR---NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANILED  106 (337)
T ss_pred             CCeEEEEEeeccccC---cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccccc-CHHHHHhcCCCCH
Confidence            367899998864321   122344567899999999 999999999987653  468999999975 9999888777889


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-------cccCCCCCCccCCccccc
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-------LKSCKGTPFWMAPEVVNS  150 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-------~~~~~~~~~~~aPE~~~~  150 (247)
                      ..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......       .....++..|+|||.+.+
T Consensus       107 ~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  186 (337)
T cd07852         107 VHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLG  186 (337)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeec
Confidence            9999999999999999999999999999999999999999999999886443221       223447888999998754


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC------------------------------CCCCCCC
Q 041080          151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG------------------------------ELPSVPS  200 (247)
Q Consensus       151 ~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~------------------------------~~~~~~~  200 (247)
                      . ..++.++|+||+|++++++++|+.||...........+...                              .......
T Consensus       187 ~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (337)
T cd07852         187 S-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLP  265 (337)
T ss_pred             c-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhcc
Confidence            3 23678999999999999999999998654433222111000                              0111223


Q ss_pred             cCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          201 SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       201 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      .++.++.+++.+||+.+|.+|||+.++++||||+..
T Consensus       266 ~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         266 KASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             CCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence            478899999999999999999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.3e-39  Score=258.77  Aligned_cols=232  Identities=29%  Similarity=0.465  Sum_probs=181.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC------CcEEEEEeccccCcHHHHHHhcC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE------NRLYIFLELVTKGSLANLYQKYH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~   74 (247)
                      +|+.||||.+.....   .......+.+|+.+++.++||||+++++++...      ..+++++||+.. +|.++.. ..
T Consensus        39 ~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-~~  113 (342)
T cd07879          39 TGEKVAIKKLSRPFQ---SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG-HP  113 (342)
T ss_pred             CCcEEEEEEecCccc---cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHHc-CC
Confidence            478899999865321   222344577899999999999999999987654      346999999965 7776653 36


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +++..+..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+..... ......++..|+|||.+.+.. .
T Consensus       114 ~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~  191 (342)
T cd07879         114 LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-EMTGYVVTRWYRAPEVILNWM-H  191 (342)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-CCCCceeeecccChhhhcCcc-c
Confidence            89999999999999999999999999999999999999999999999999865432 223345678899999986422 2


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC----------------------CCCC--------CCCcCCH
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG----------------------ELPS--------VPSSLSR  204 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~----------------------~~~~--------~~~~~~~  204 (247)
                      ++.++|+||||++++++++|+.||...+.......+...                      ..+.        .....+.
T Consensus       192 ~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (342)
T cd07879         192 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASP  271 (342)
T ss_pred             cCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCH
Confidence            688999999999999999999999765533332221110                      0001        1124678


Q ss_pred             HHHHHHHHHhcCCCCCCCChhhhhcCccCCCCCCC
Q 041080          205 DARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQT  239 (247)
Q Consensus       205 ~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~~~  239 (247)
                      ++.+++.+||+.+|.+||++++++.||||+.....
T Consensus       272 ~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         272 QAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence            89999999999999999999999999999986443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3e-38  Score=243.41  Aligned_cols=227  Identities=39%  Similarity=0.648  Sum_probs=191.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-CCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~   79 (247)
                      +|+.+++|++.......    ..+.+.+|+..+++++|+|++++++.+......++++|++++++|.+++.... ++...
T Consensus        13 ~~~~~~~k~~~~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~   88 (244)
T smart00220       13 TGKLVAIKVIKKEKIKK----KRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDE   88 (244)
T ss_pred             CCcEEEEEEeccccccc----HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHH
Confidence            47899999997543211    15788899999999999999999999999899999999999999999987765 89999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-ccccCCCCCCccCCcccccCCCCCCcc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ++.++.+++.++.+||+.|++|+||+|+||+++.++.++++|||.+...... ......+...|++||...+..  .+.+
T Consensus        89 ~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~--~~~~  166 (244)
T smart00220       89 ARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKG--YGKA  166 (244)
T ss_pred             HHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCC--CCch
Confidence            9999999999999999999999999999999999999999999998765543 334455788899999986443  6789


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCC-ChhhHHHHHhhcCCCCCCCCc--CCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSH-LEGVQALFRIGKGELPSVPSS--LSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      +|+|++|++++++++|..||.. .....................  ++.++.+++.+||..+|.+||++.++++||||
T Consensus       167 ~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      167 VDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            9999999999999999999977 444444444444333322222  88999999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.5e-38  Score=255.36  Aligned_cols=237  Identities=32%  Similarity=0.513  Sum_probs=182.7

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeec----CCcEEEEEeccccCcHHHHHHh-cCC
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKD----ENRLYIFLELVTKGSLANLYQK-YHL   75 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~-~~~   75 (247)
                      |+.||+|.+....   ......+.+.+|+.+++++ +||||+++++.+..    ....+++++++.+ +|.+++.. ..+
T Consensus        27 ~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~~-~L~~~l~~~~~~  102 (332)
T cd07857          27 EETVAIKKITNVF---SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPL  102 (332)
T ss_pred             CceEEEEEecccc---ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecccC-CHHHHHhcCCCC
Confidence            7789999986432   1223355677899999999 59999999986432    2467899999864 88888754 458


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc------cccCCCCCCccCCcccc
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND------LKSCKGTPFWMAPEVVN  149 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~aPE~~~  149 (247)
                      ++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.......      .....++..|+|||.+.
T Consensus       103 ~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~  182 (332)
T cd07857         103 TDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIML  182 (332)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHh
Confidence            999999999999999999999999999999999999999999999999986443221      12345788899999875


Q ss_pred             cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc------------------------------CCCCCCC
Q 041080          150 SKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK------------------------------GELPSVP  199 (247)
Q Consensus       150 ~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~------------------------------~~~~~~~  199 (247)
                      +. ..++.++|+||+|++++++++|..||...........+..                              .......
T Consensus       183 ~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (332)
T cd07857         183 SF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIF  261 (332)
T ss_pred             CC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhC
Confidence            42 2368899999999999999999999976543222211110                              0011122


Q ss_pred             CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCC---CCCCCCCc
Q 041080          200 SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR---PLQTPRCG  243 (247)
Q Consensus       200 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~---~~~~~~~~  243 (247)
                      ...+..+.+++.+||+.+|.+|||+++++.||||++   +...+.|+
T Consensus       262 ~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~  308 (332)
T cd07857         262 PNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQ  308 (332)
T ss_pred             CCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCcccccccc
Confidence            345789999999999999999999999999999985   44556675

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-38  Score=250.07  Aligned_cols=220  Identities=26%  Similarity=0.426  Sum_probs=177.6

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc----------
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY----------   73 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------   73 (247)
                      .||+|.+....    .....+.+.+|++++++++|+|++++++++...+..++||||+++++|.+++...          
T Consensus        46 ~vavK~~~~~~----~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  121 (295)
T cd05097          46 LVAVKMLRADV----TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHAN  121 (295)
T ss_pred             EEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccc
Confidence            48899886432    2344567889999999999999999999999999999999999999999988653          


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----ccCCCCCCccCCc
Q 041080           74 ---HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCKGTPFWMAPE  146 (247)
Q Consensus        74 ---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~aPE  146 (247)
                         .+++..+..++.|++.|+.+||+.|++|+||||+||+++.++.++|+|||++........    ....++..|+|||
T Consensus       122 ~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  201 (295)
T cd05097         122 NIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWE  201 (295)
T ss_pred             cCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChh
Confidence               257788999999999999999999999999999999999999999999999865432221    1222456799999


Q ss_pred             ccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCChhhHHHHHhhc-------CCCCCCCCcCCHHHHHHHHHHhcCC
Q 041080          147 VVNSKNDGYGLTADIWSLGCTVLEMLT--RRPPYSHLEGVQALFRIGK-------GELPSVPSSLSRDARDFILKCLQVN  217 (247)
Q Consensus       147 ~~~~~~~~~~~~~Di~slG~ll~~l~~--g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~  217 (247)
                      .+....  ++.++|+||||++++++++  +..||..............       ......+...|+.+.+++.+||..+
T Consensus       202 ~~~~~~--~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  279 (295)
T cd05097         202 SILLGK--FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRD  279 (295)
T ss_pred             hhccCC--cCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCC
Confidence            986544  7899999999999999988  6678877655554433211       1112334567899999999999999


Q ss_pred             CCCCCChhhhhc
Q 041080          218 PNDRPTVTELME  229 (247)
Q Consensus       218 p~~Rps~~~il~  229 (247)
                      |.+|||++++++
T Consensus       280 p~~RPs~~~i~~  291 (295)
T cd05097         280 IKDRPTFNKIHH  291 (295)
T ss_pred             chhCcCHHHHHH
Confidence            999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.7e-38  Score=249.94  Aligned_cols=221  Identities=26%  Similarity=0.446  Sum_probs=177.1

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC--------
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--------   74 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------   74 (247)
                      ..+|+|.+...    ......+.+.+|+.+++.++|+||+++++++...+..+++|||+++++|.+++....        
T Consensus        47 ~~~a~K~~~~~----~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  122 (296)
T cd05095          47 VLVAVKMLRED----ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA  122 (296)
T ss_pred             eEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccc
Confidence            46888988643    234446678899999999999999999999999999999999999999999986632        


Q ss_pred             ----CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc----cCCCCCCccCCc
Q 041080           75 ----LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK----SCKGTPFWMAPE  146 (247)
Q Consensus        75 ----~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~aPE  146 (247)
                          +++..+..++.|++.|+++||+.|++|+||||+||+++.++.++|+|||.+.........    ...++..|++||
T Consensus       123 ~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe  202 (296)
T cd05095         123 DVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWE  202 (296)
T ss_pred             cccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHH
Confidence                556789999999999999999999999999999999999999999999998654322211    122346799999


Q ss_pred             ccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCChhhHHHHHhh-------cCCCCCCCCcCCHHHHHHHHHHhcCC
Q 041080          147 VVNSKNDGYGLTADIWSLGCTVLEMLT--RRPPYSHLEGVQALFRIG-------KGELPSVPSSLSRDARDFILKCLQVN  217 (247)
Q Consensus       147 ~~~~~~~~~~~~~Di~slG~ll~~l~~--g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~~  217 (247)
                      ...+..  ++.++|+||||+++|++++  |..||...+..+......       .......+..+++.+.+++.+||+.+
T Consensus       203 ~~~~~~--~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  280 (296)
T cd05095         203 SILLGK--FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRN  280 (296)
T ss_pred             HHhcCC--ccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCC
Confidence            875443  7889999999999999998  778887655544433221       11112334567899999999999999


Q ss_pred             CCCCCChhhhhc
Q 041080          218 PNDRPTVTELME  229 (247)
Q Consensus       218 p~~Rps~~~il~  229 (247)
                      |.+||++.++++
T Consensus       281 p~~Rp~~~~i~~  292 (296)
T cd05095         281 AKERPSFQEIHA  292 (296)
T ss_pred             cccCCCHHHHHH
Confidence            999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-39  Score=262.60  Aligned_cols=221  Identities=29%  Similarity=0.519  Sum_probs=194.5

Q ss_pred             EEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC--CCHHHHHH
Q 041080            5 FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--LSDSQVSS   82 (247)
Q Consensus         5 ~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~   82 (247)
                      ||+|.....  ..........+.+|.+++++++||||++++|+.....-+++|||+|+||+|.+++++.+  ++..+..+
T Consensus       189 VAvK~~k~~--~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~  266 (474)
T KOG0194|consen  189 VAVKTTKGS--SELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLR  266 (474)
T ss_pred             eEEEeeccc--ccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHH
Confidence            788887642  23557778889999999999999999999999999999999999999999999998876  99999999


Q ss_pred             HHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc--cCCCCCCccCCcccccCCCCCCcchh
Q 041080           83 YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK--SCKGTPFWMAPEVVNSKNDGYGLTAD  160 (247)
Q Consensus        83 ~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~~~D  160 (247)
                      ++.+.+.||+|||+++++||||-..|++++.++.+||+|||+++........  ...-...|+|||.+...  .++.++|
T Consensus       267 ~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~--~~s~kTD  344 (474)
T KOG0194|consen  267 FCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG--IFSFKTD  344 (474)
T ss_pred             HHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccC--ccccccc
Confidence            9999999999999999999999999999999999999999998765422211  12245679999999655  4899999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCChhhHHHHHh-hcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          161 IWSLGCTVLEMLT-RRPPYSHLEGVQALFRI-GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       161 i~slG~ll~~l~~-g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      |||||+++||+++ |..||......+...++ ..+.....+...|.++..++.+||..+|.+||++.++.+
T Consensus       345 V~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  345 VWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             hhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            9999999999998 78899999999999888 556667778899999999999999999999999988865

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5.5e-38  Score=246.34  Aligned_cols=220  Identities=29%  Similarity=0.482  Sum_probs=183.5

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVS   81 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~   81 (247)
                      .|++|.+....    .....+.+.+|+.++++++||||+++++++.. +..+++|||+++++|.+++.+.  .+++..++
T Consensus        36 ~v~ik~~~~~~----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  110 (270)
T cd05056          36 AVAVKTCKNCT----SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLI  110 (270)
T ss_pred             ceEEEecCCcC----CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHH
Confidence            57888775432    23455678899999999999999999998875 4567999999999999999764  37899999


Q ss_pred             HHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc---cCCCCCCccCCcccccCCCCCCcc
Q 041080           82 SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK---SCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        82 ~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      .++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........   ...+...|+|||.+....  ++.+
T Consensus       111 ~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~  188 (270)
T cd05056         111 LYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR--FTSA  188 (270)
T ss_pred             HHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCC--CCch
Confidence            99999999999999999999999999999999999999999988654333211   112345799999885443  7889


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          159 ADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       159 ~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      +|+||||++++++++ |..||......+....+........+...|..+.+++.+|+..+|.+|||+.+++..
T Consensus       189 ~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         189 SDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999886 999998887777777766666666777889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=5.5e-38  Score=246.20  Aligned_cols=222  Identities=26%  Similarity=0.425  Sum_probs=175.0

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC------CC
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH------LS   76 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~   76 (247)
                      ..+++|.+...    ........+.+|+..++.++|+||+++++.+......++||||+++++|.+++....      .+
T Consensus        23 ~~~~~k~~~~~----~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~   98 (269)
T cd05042          23 ARVVVKELRAS----ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQ   98 (269)
T ss_pred             eEEEEeecCcc----CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhcccccccccc
Confidence            35677766432    233445667899999999999999999999999999999999999999999986642      35


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCCcccccC-
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSK-  151 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~-  151 (247)
                      +..+..++.|++.|++|||+.|++|+||||+||+++.++.++|+|||.+.......    .....++..|+|||.+... 
T Consensus        99 ~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  178 (269)
T cd05042          99 KDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG  178 (269)
T ss_pred             HHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhcc
Confidence            67788999999999999999999999999999999999999999999975432221    1122345669999987432 


Q ss_pred             ----CCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCC-----CCCCCCcCCHHHHHHHHHHhcCCCCCC
Q 041080          152 ----NDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGE-----LPSVPSSLSRDARDFILKCLQVNPNDR  221 (247)
Q Consensus       152 ----~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~R  221 (247)
                          ...++.++|+||+|+++|++++ |..||......+.........     .+..+..++..+..++..|+ .+|.+|
T Consensus       179 ~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~R  257 (269)
T cd05042         179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETR  257 (269)
T ss_pred             ccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccc
Confidence                2336889999999999999998 788887766555444432222     23344578899999999998 599999


Q ss_pred             CChhhhhc
Q 041080          222 PTVTELME  229 (247)
Q Consensus       222 ps~~~il~  229 (247)
                      ||++++++
T Consensus       258 pt~~~v~~  265 (269)
T cd05042         258 PTAEEVHE  265 (269)
T ss_pred             cCHHHHHH
Confidence            99999976

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.8e-38  Score=245.20  Aligned_cols=217  Identities=22%  Similarity=0.376  Sum_probs=172.0

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVS   81 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~   81 (247)
                      .+++|.+...     .......+.+|+.+++.++||||+++++++......+++|||+++++|..++...  .+++..++
T Consensus        34 ~v~~k~~~~~-----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~  108 (262)
T cd05077          34 KVILKVLDPS-----HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKF  108 (262)
T ss_pred             eEEEeecChh-----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHH
Confidence            4777776432     2334556788999999999999999999999999999999999999998888653  48999999


Q ss_pred             HHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCC-------eEEcccccccccCccccccCCCCCCccCCcccccCCCC
Q 041080           82 SYTRQILNGLVYLHERNVVHRDIKCANILVDASGS-------VKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        82 ~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~-------~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      .++.|++.|++|||+.|++|+||+|+||+++.++.       ++++|||.+......  ....++..|+|||.+... ..
T Consensus       109 ~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~y~aPE~~~~~-~~  185 (262)
T cd05077         109 KVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR--QECVERIPWIAPECVEDS-KN  185 (262)
T ss_pred             HHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc--ccccccccccChhhhcCC-CC
Confidence            99999999999999999999999999999987664       899999987544322  234467789999987532 23


Q ss_pred             CCcchhHHHHHHHHHHHH-hCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          155 YGLTADIWSLGCTVLEML-TRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      ++.++||||||+++|+++ .|..|+......+.... ..... ......++++++++.+||+.+|.+||++.+|+++
T Consensus       186 ~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         186 LSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF-YEGQC-MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-HhcCc-cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            788999999999999997 58888866543333221 11111 2233456789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-38  Score=248.27  Aligned_cols=227  Identities=33%  Similarity=0.533  Sum_probs=179.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc---CCCceeeeceeeecCCc-----EEEEEeccccCcHHHHHHh
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF---EQDNIVQYLGTDKDENR-----LYIFLELVTKGSLANLYQK   72 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~   72 (247)
                      +|+.||+|.+......   ......+.+|+.+++++   .|+|++++++.+...+.     .+++|||+++ +|.+++..
T Consensus        23 ~~~~~aiK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~   98 (287)
T cd07838          23 TGRFVALKKVRVPLSE---EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSK   98 (287)
T ss_pred             CCCEEEEEEecccccc---chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHH
Confidence            4789999999754321   12233455677777665   59999999999988776     9999999976 88888765


Q ss_pred             c---CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCccc
Q 041080           73 Y---HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVV  148 (247)
Q Consensus        73 ~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~  148 (247)
                      .   .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... .....++..|+|||.+
T Consensus        99 ~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~  178 (287)
T cd07838          99 CPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL  178 (287)
T ss_pred             ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCcccccccccccccChHHh
Confidence            3   38999999999999999999999999999999999999999999999999886544332 2233467889999998


Q ss_pred             ccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC------------------C--------CCCCCcC
Q 041080          149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE------------------L--------PSVPSSL  202 (247)
Q Consensus       149 ~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~------------------~--------~~~~~~~  202 (247)
                      .+..  ++.++|+||+|+++++|++|..||......+....+....                  .        .......
T Consensus       179 ~~~~--~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (287)
T cd07838         179 LQSS--YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEI  256 (287)
T ss_pred             ccCC--CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhh
Confidence            6544  7889999999999999999999987766544433322100                  0        0011235


Q ss_pred             CHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          203 SRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       203 ~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      ++.+.+++.+||+.+|.+||++++++.||||
T Consensus       257 ~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         257 CEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             hHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            6788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-40  Score=258.15  Aligned_cols=232  Identities=26%  Similarity=0.403  Sum_probs=196.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh---cCCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK---YHLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~   77 (247)
                      +|+-||.|.+.+.++.  .+....-..+|-.+|.+++.+.||.+-.+|++.+.+|+|+..|+||+|.-.+-+   .++++
T Consensus       209 TGKMYAcKkL~KKRiK--kr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e  286 (591)
T KOG0986|consen  209 TGKMYACKKLDKKRIK--KRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDE  286 (591)
T ss_pred             chhhHHHHHHHHHHHH--HhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCch
Confidence            3667777877665542  233445567899999999999999999999999999999999999999665533   36999


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc-ccCCCCCCccCCcccccCCCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL-KSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ..++.++++|+.||.+||+.+|++||+||+||++|+.|+++|+|+|++........ ...+||..|||||+++...  |+
T Consensus       287 ~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~--Y~  364 (591)
T KOG0986|consen  287 QRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV--YD  364 (591)
T ss_pred             HHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCc--cc
Confidence            99999999999999999999999999999999999999999999999987765554 4458999999999997666  89


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHH---HHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----Chhhhh
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQA---LFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTELM  228 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il  228 (247)
                      ...|.|+|||++|+|+.|+.||.....+.-   .++........++..+|++.+++.+.+|.+||.+|.     ++.++-
T Consensus       365 ~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk  444 (591)
T KOG0986|consen  365 FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVK  444 (591)
T ss_pred             CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhh
Confidence            999999999999999999999976543332   334444455677889999999999999999999995     467999


Q ss_pred             cCccCCCC
Q 041080          229 EHPFVKRP  236 (247)
Q Consensus       229 ~~p~~~~~  236 (247)
                      +||||+..
T Consensus       445 ~HpfFk~l  452 (591)
T KOG0986|consen  445 EHPFFKDL  452 (591)
T ss_pred             hCcccccC
Confidence            99999974

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-39  Score=262.84  Aligned_cols=217  Identities=29%  Similarity=0.431  Sum_probs=176.8

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      ++.+++|++.....         +-.+|+.++... +||||+++.+.+.++...++|||.+.|+-+.+.+-..+.....+
T Consensus       347 ~~~~~vkii~~~~~---------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~~e~  417 (612)
T KOG0603|consen  347 DQEPAVKIISKRAD---------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFCSEA  417 (612)
T ss_pred             ccchhheecccccc---------ccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhHHHH
Confidence            45667777765411         122566555555 69999999999999999999999999987766554444334778


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEE-cCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcch
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILV-DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTA  159 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~-~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~  159 (247)
                      ..|+.+|+.|+.+||.+|++||||||+||++ +..++++|+|||.+...... .....-+..|.|||.+.  ...++.++
T Consensus       418 ~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-~~tp~~t~~y~APEvl~--~~~yt~ac  494 (612)
T KOG0603|consen  418 SQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-CDTPALTLQYVAPEVLA--IQEYTEAC  494 (612)
T ss_pred             HHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-hcccchhhcccChhhhc--cCCCCcch
Confidence            8899999999999999999999999999999 68899999999998765544 22334567799999997  34499999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCChhh-HHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          160 DIWSLGCTVLEMLTRRPPYSHLEGV-QALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       160 Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      |+||||+++|+|++|..||...... ++...+..   +.+...+|++.++|+.+||+.+|.+|+++.++..||||
T Consensus       495 D~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~---~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  495 DWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQM---PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             hhHHHHHHHHHHHhCCCccccCCchHHHHHhhcC---CccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            9999999999999999999887777 33333333   34447899999999999999999999999999999999

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=9.9e-38  Score=243.62  Aligned_cols=219  Identities=27%  Similarity=0.511  Sum_probs=181.3

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSDS   78 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~   78 (247)
                      +..+++|.+...      ....+.+.+|+.+++.++|+||+++++.+.. ...+++|||+++++|.+++.+.   .++..
T Consensus        30 ~~~~~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~  102 (260)
T cd05073          30 HTKVAVKTMKPG------SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLP  102 (260)
T ss_pred             CccEEEEecCCC------hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHH
Confidence            456888877532      2235678899999999999999999999877 7889999999999999998653   37788


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc---ccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL---KSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........   ....+...|+|||.+....  +
T Consensus       103 ~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~  180 (260)
T cd05073         103 KLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--F  180 (260)
T ss_pred             HHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCC--c
Confidence            8999999999999999999999999999999999999999999998764432221   1222446699999986543  7


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +.++|+||||++++++++ |..||...+.......+........+...+.++.+++.+||..+|.+||++.++++
T Consensus       181 ~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         181 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            889999999999999998 89999887766666666555555556788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.1e-37  Score=246.34  Aligned_cols=222  Identities=27%  Similarity=0.497  Sum_probs=173.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec--CCcEEEEEeccccCcHHHHHHhc--CCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD--ENRLYIFLELVTKGSLANLYQKY--HLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~--~~~   76 (247)
                      +|+.||+|.+...     .....+.+.+|+.++++++||||+++++++..  ....++|+||+++++|.+++.+.  .++
T Consensus        32 ~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~  106 (284)
T cd05081          32 TGEVVAVKKLQHS-----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLD  106 (284)
T ss_pred             CCcEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCC
Confidence            3678999988642     23445678899999999999999999997643  35789999999999999998754  388


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc-----cCCCCCCccCCcccccC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK-----SCKGTPFWMAPEVVNSK  151 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~aPE~~~~~  151 (247)
                      +..++.++.|++.||++||+.|++|+||||+||+++.++.++|+|||.+.........     ...+...|+|||.+.+.
T Consensus       107 ~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  186 (284)
T cd05081         107 HRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES  186 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccC
Confidence            9999999999999999999999999999999999999999999999998754322211     11133458999998654


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhh----------------HHHHHhhcCCCCCCCCcCCHHHHHHHHHHhc
Q 041080          152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV----------------QALFRIGKGELPSVPSSLSRDARDFILKCLQ  215 (247)
Q Consensus       152 ~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  215 (247)
                      .  ++.++|+||||+++++++++..++......                .....+........+..++.++.+++.+||.
T Consensus       187 ~--~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  264 (284)
T cd05081         187 K--FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWN  264 (284)
T ss_pred             C--cChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcc
Confidence            3  788999999999999999976654322111                0111122222233456788999999999999


Q ss_pred             CCCCCCCChhhhhc
Q 041080          216 VNPNDRPTVTELME  229 (247)
Q Consensus       216 ~~p~~Rps~~~il~  229 (247)
                      .+|.+|||+.++++
T Consensus       265 ~~p~~Rpt~~ei~~  278 (284)
T cd05081         265 NDPSQRPSFSELAL  278 (284)
T ss_pred             CChhhCCCHHHHHH
Confidence            99999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.4e-38  Score=245.80  Aligned_cols=218  Identities=22%  Similarity=0.340  Sum_probs=173.9

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHHHH
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDSQV   80 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~   80 (247)
                      ..|++|.+...     .......+.+|+.+++.++||||+++++++..+...++||||+++++|..++.+  ..+++..+
T Consensus        45 ~~v~~k~~~~~-----~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~  119 (274)
T cd05076          45 LRVVLKVLDPS-----HRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK  119 (274)
T ss_pred             eeEEEEecChH-----HHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHH
Confidence            35788887532     223345678899999999999999999999999999999999999999998865  34889999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC-------CeEEcccccccccCccccccCCCCCCccCCcccccCCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASG-------SVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~-------~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      ..++.|++.||+|||+.|++|+||||+||+++..+       .++++|||.+......  ....++..|+|||.+.+. .
T Consensus       120 ~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~~~-~  196 (274)
T cd05076         120 ITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVPGG-N  196 (274)
T ss_pred             HHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc--cccccCCcccCchhhcCC-C
Confidence            99999999999999999999999999999997654       3799999987543222  223467789999988643 3


Q ss_pred             CCCcchhHHHHHHHHHHHH-hCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          154 GYGLTADIWSLGCTVLEML-TRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      .++.++|+||||+++|+++ +|..||..............  ....+...++.+.+++.+||+.+|.+|||+.+++++
T Consensus       197 ~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         197 SLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEK--KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHh--ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            3789999999999999985 68999876655443332222  123344456789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-38  Score=254.39  Aligned_cols=222  Identities=29%  Similarity=0.470  Sum_probs=173.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC-cEEEEEeccccCcHHHHHHhc---CCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN-RLYIFLELVTKGSLANLYQKY---HLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~---~~~   76 (247)
                      ||+.||||++......    . ..+|.+|+.++.+++|||+++++|+|.+.+ ..+||+||++.|+|.+.+...   .++
T Consensus        98 ~~~~vAVK~~~~~~~~----~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~  172 (361)
T KOG1187|consen   98 DGTVVAVKRLSSNSGQ----G-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLD  172 (361)
T ss_pred             CCCEEEEEEecCCCCc----c-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCC
Confidence            4688999977643211    1 334999999999999999999999999998 599999999999999998654   579


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCC---eeecCCCCCcEEEcCCCCeEEcccccccccCc-ccccc-C-CCCCCccCCccccc
Q 041080           77 DSQVSSYTRQILNGLVYLHERN---VVHRDIKCANILVDASGSVKLADFGLAKATTM-NDLKS-C-KGTPFWMAPEVVNS  150 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~-~~~~~-~-~~~~~~~aPE~~~~  150 (247)
                      |....+|+.+++.||+|||...   |+|||||++||++|.+.+.||+|||++..... ..... . .|+..|++||+...
T Consensus       173 W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~  252 (361)
T KOG1187|consen  173 WETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST  252 (361)
T ss_pred             HHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhcc
Confidence            9999999999999999999854   99999999999999999999999999965543 32222 2 78999999999965


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCh---hhHHHH----HhhcCCC-----CCCC-CcCC--HH---HHHHHHH
Q 041080          151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLE---GVQALF----RIGKGEL-----PSVP-SSLS--RD---ARDFILK  212 (247)
Q Consensus       151 ~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~---~~~~~~----~~~~~~~-----~~~~-~~~~--~~---~~~li~~  212 (247)
                      .  ..+.++||||||+++.|+++|+.+.+...   ......    .+.....     +.+. ..++  ..   +..+..+
T Consensus       253 g--~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~  330 (361)
T KOG1187|consen  253 G--KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALR  330 (361)
T ss_pred             C--CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHH
Confidence            3  37999999999999999999997765432   111111    1111111     1211 2333  23   5567788


Q ss_pred             HhcCCCCCCCChhhhhc
Q 041080          213 CLQVNPNDRPTVTELME  229 (247)
Q Consensus       213 ~l~~~p~~Rps~~~il~  229 (247)
                      |++.+|.+||++.++++
T Consensus       331 C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  331 CLRPDPKERPTMSQVVK  347 (361)
T ss_pred             HcCcCCCcCcCHHHHHH
Confidence            99999999999999764

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.2e-38  Score=246.15  Aligned_cols=217  Identities=20%  Similarity=0.336  Sum_probs=174.6

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC--CCHHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--LSDSQVS   81 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~   81 (247)
                      .+++|.+..     ......+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++...+  +++..+.
T Consensus        29 ~~~~k~~~~-----~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  103 (258)
T cd05078          29 EVLLKVLDK-----SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKL  103 (258)
T ss_pred             hhhHHhhcc-----hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHH
Confidence            366666642     223445678889999999999999999999999899999999999999999997643  7899999


Q ss_pred             HHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCC--------eEEcccccccccCccccccCCCCCCccCCcccccCCC
Q 041080           82 SYTRQILNGLVYLHERNVVHRDIKCANILVDASGS--------VKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        82 ~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~--------~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      .++.|++.|+.+||+.|++|+||||+||+++.++.        ++++|||.+......  ....++..|+|||.+.+.. 
T Consensus       104 ~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~y~aPE~~~~~~-  180 (258)
T cd05078         104 EVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK--EILLERIPWVPPECIENPQ-  180 (258)
T ss_pred             HHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCCc--hhccccCCccCchhccCCC-
Confidence            99999999999999999999999999999987764        699999987654332  2244677899999986432 


Q ss_pred             CCCcchhHHHHHHHHHHHHhC-CCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      .++.++|+||||+++|++++| ..|+...+.........  ....++...+.++.+++.+||+.+|.+|||++++++.
T Consensus       181 ~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         181 NLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE--DRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             CCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH--ccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            268899999999999999998 46666555443332222  2234556677899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.9e-38  Score=273.01  Aligned_cols=224  Identities=23%  Similarity=0.283  Sum_probs=178.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-------
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-------   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------   73 (247)
                      +|+.||||++....  .......+++.+|+.++++++||||+++++++.+++..+++|||++|++|.+++...       
T Consensus        26 tg~~VAIK~I~~~l--~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~  103 (932)
T PRK13184         26 CSRRVALKKIREDL--SENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLS  103 (932)
T ss_pred             CCcEEEEEEECccc--ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccc
Confidence            47899999997543  223344667889999999999999999999999999999999999999999988641       


Q ss_pred             -----CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-----------------
Q 041080           74 -----HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-----------------  131 (247)
Q Consensus        74 -----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-----------------  131 (247)
                           ..+...++.++.|++.||++||+.|++||||||+||+++.++.++|+|||.+......                 
T Consensus       104 e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s  183 (932)
T PRK13184        104 KELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS  183 (932)
T ss_pred             hhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceeccccccccccccccccccccc
Confidence                 2456678899999999999999999999999999999999999999999998654111                 


Q ss_pred             ---ccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCC--CCcCCHHH
Q 041080          132 ---DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDA  206 (247)
Q Consensus       132 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  206 (247)
                         ......|++.|+|||.+.+..  ++.++|+||+|+++++|++|..||....................  ...+|+.+
T Consensus       184 ~~t~~g~~vGT~~YmAPE~l~g~~--~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L  261 (932)
T PRK13184        184 SMTIPGKIVGTPDYMAPERLLGVP--ASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFL  261 (932)
T ss_pred             ccccCCCCCCCCCCCCHHHhcCCC--CCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHH
Confidence               011235889999999986554  78899999999999999999999977554433322211111111  24678999


Q ss_pred             HHHHHHHhcCCCCCCCChhhhh
Q 041080          207 RDFILKCLQVNPNDRPTVTELM  228 (247)
Q Consensus       207 ~~li~~~l~~~p~~Rps~~~il  228 (247)
                      .+++.+||..+|.+|++..+.+
T Consensus       262 ~~LI~rcL~~DP~kR~ss~eeL  283 (932)
T PRK13184        262 SQIAMKALAVDPAERYSSVQEL  283 (932)
T ss_pred             HHHHHHHccCChhhCcCHHHHH
Confidence            9999999999999998755544

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4.1e-38  Score=251.82  Aligned_cols=228  Identities=30%  Similarity=0.532  Sum_probs=175.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC--------CcEEEEEeccccCcHHHHHHh
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE--------NRLYIFLELVTKGSLANLYQK   72 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~   72 (247)
                      +|+.+|||.+.......   .....+.+|+.+++.++||||+++++++...        ...++++||+.+ ++...+..
T Consensus        32 ~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~  107 (311)
T cd07866          32 TGRVVALKKILMHNEKD---GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLEN  107 (311)
T ss_pred             CCcEEEEEEEEeccCCC---CcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhc
Confidence            47889999987643211   1123456899999999999999999976443        356999999976 67766654


Q ss_pred             c--CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc-------------ccCC
Q 041080           73 Y--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL-------------KSCK  137 (247)
Q Consensus        73 ~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~-------------~~~~  137 (247)
                      .  .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........             ....
T Consensus       108 ~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (311)
T cd07866         108 PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV  187 (311)
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccce
Confidence            3  599999999999999999999999999999999999999999999999998864332211             1223


Q ss_pred             CCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC----------------------C
Q 041080          138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE----------------------L  195 (247)
Q Consensus       138 ~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~----------------------~  195 (247)
                      ++..|+|||.+.+.. .++.++|+||+|+++++|++|..||...........+....                      .
T Consensus       188 ~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (311)
T cd07866         188 VTRWYRPPELLLGER-RYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSF  266 (311)
T ss_pred             eccCcCChHHhhCCC-ccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccC
Confidence            567799999875432 26889999999999999999999997655443322211100                      0


Q ss_pred             CCC-------CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          196 PSV-------PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       196 ~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      ...       ....++.+.+++.+||+.+|.+|||+.+++.||||
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         267 TNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            000       02345788999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-38  Score=248.09  Aligned_cols=226  Identities=30%  Similarity=0.511  Sum_probs=179.4

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSD   77 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~   77 (247)
                      |+.|+||.+......    .......+|+..+.+++ |+|++++++++..++..++||||+ +++|.+.+...   .+++
T Consensus        24 ~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~   98 (283)
T cd07830          24 GELVAIKKMKKKFYS----WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSE   98 (283)
T ss_pred             CcEEEEEEehhhccc----hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCH
Confidence            678999988654221    12223457899999998 999999999999999999999999 66888877654   5899


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ..+..++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+....... .....++..|+|||.+.... .++
T Consensus        99 ~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~  177 (283)
T cd07830          99 SVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRST-SYS  177 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCc-CcC
Confidence            9999999999999999999999999999999999999999999999986554332 23345778899999875433 268


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC---------------------C--------CCCCCCcCCHHHH
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG---------------------E--------LPSVPSSLSRDAR  207 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---------------------~--------~~~~~~~~~~~~~  207 (247)
                      .++|+||||++++++++|..||......+....+...                     .        ........+..+.
T Consensus       178 ~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (283)
T cd07830         178 SPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAI  257 (283)
T ss_pred             CccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHH
Confidence            8999999999999999999998665443332221110                     0        0011122368899


Q ss_pred             HHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          208 DFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       208 ~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      +++.+||+.+|.+|||+++++.||||
T Consensus       258 ~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         258 DLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             HHHHHhcccCcccCCCHHHHhhCCCC
Confidence            99999999999999999999999998

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-40  Score=261.68  Aligned_cols=229  Identities=29%  Similarity=0.431  Sum_probs=194.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHH--hcCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--~~~~~~~   78 (247)
                      +|+.||||++.+-+-..+   ....+++|+.+|+++.||+||.+.-.|++.+..++|||.+.|.-|+-++.  +.++++.
T Consensus       588 tGrdVAvKvIdKlrFp~k---qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er  664 (888)
T KOG4236|consen  588 TGRDVAVKVIDKLRFPTK---QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPER  664 (888)
T ss_pred             cCceeeeeeeecccCCCc---hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHH
Confidence            589999999988764333   23678899999999999999999999999999999999998866666664  3469999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC---CCeEEcccccccccCccccc-cCCCCCCccCCcccccCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS---GSVKLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~---~~~~l~df~~~~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~  154 (247)
                      ....++.||+.||.|||-+||+|.||||+||++...   ..+||||||.++.++..... ..+|++.|+|||+++...  
T Consensus       665 ~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkG--  742 (888)
T KOG4236|consen  665 ITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKG--  742 (888)
T ss_pred             HHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhcc--
Confidence            999999999999999999999999999999999754   46999999999998877654 566999999999996554  


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC---CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL---PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                      |+...|+||.|+++|--+.|..||...  .++.+++.+..+   +.....++++..++|..+|+..-.+|.|.++.+.||
T Consensus       743 yNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~  820 (888)
T KOG4236|consen  743 YNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHP  820 (888)
T ss_pred             ccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence            899999999999999999999998643  344444444433   233357899999999999999999999999999999


Q ss_pred             cCCCC
Q 041080          232 FVKRP  236 (247)
Q Consensus       232 ~~~~~  236 (247)
                      |++..
T Consensus       821 Wlq~y  825 (888)
T KOG4236|consen  821 WLQDY  825 (888)
T ss_pred             hhhcc
Confidence            99863

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.1e-37  Score=245.31  Aligned_cols=223  Identities=26%  Similarity=0.477  Sum_probs=182.6

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-------   74 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------   74 (247)
                      .+.+++|.+...    ......+.+.+|+.++++++|+||+++++++...+..++||||+++++|.+++....       
T Consensus        35 ~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~  110 (275)
T cd05046          35 ETLVLVKALQKT----KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLK  110 (275)
T ss_pred             cceEEEEccCCc----cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhccccccccc
Confidence            356888877532    223356678899999999999999999999999899999999999999999986543       


Q ss_pred             ---CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCccc
Q 041080           75 ---LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVV  148 (247)
Q Consensus        75 ---~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~  148 (247)
                         +++..+..++.|++.||++||+.|++|+||+|+||+++.++.++++|||.+.......   .....++..|++||.+
T Consensus       111 ~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~  190 (275)
T cd05046         111 PPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAV  190 (275)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhh
Confidence               8899999999999999999999999999999999999999999999999875432221   1223345679999998


Q ss_pred             ccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCC-CCCCCcCCHHHHHHHHHHhcCCCCCCCChhh
Q 041080          149 NSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGEL-PSVPSSLSRDARDFILKCLQVNPNDRPTVTE  226 (247)
Q Consensus       149 ~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  226 (247)
                      .+..  .+.++|+||||++++++++ |..||................. ...+..++..+.+++.+||+.+|.+|||+.+
T Consensus       191 ~~~~--~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~  268 (275)
T cd05046         191 QEDD--FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSE  268 (275)
T ss_pred             ccCC--CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence            6544  6789999999999999998 7889877666555555543332 2335578899999999999999999999999


Q ss_pred             hhcC
Q 041080          227 LMEH  230 (247)
Q Consensus       227 il~~  230 (247)
                      ++..
T Consensus       269 ~l~~  272 (275)
T cd05046         269 LVSA  272 (275)
T ss_pred             HHHH
Confidence            9864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.1e-37  Score=242.94  Aligned_cols=222  Identities=24%  Similarity=0.408  Sum_probs=174.5

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc------CCC
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY------HLS   76 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~   76 (247)
                      ..+|+|.+....    .......+.+|+.++++++||||+++++.+.+....++||||+++++|.+++...      ..+
T Consensus        23 ~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~   98 (269)
T cd05087          23 AQVVVKELRVSA----SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPD   98 (269)
T ss_pred             eEEEEEecCCCC----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhccccccc
Confidence            467888776432    2334456888999999999999999999999989999999999999999998643      245


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCCcccccCC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKN  152 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~  152 (247)
                      +..+..++.|++.|+.+||+.|++|+||||+||+++.++.++|+|||.+.......    .....++..|+|||.+.+..
T Consensus        99 ~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  178 (269)
T cd05087          99 PTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH  178 (269)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhcccc
Confidence            66788899999999999999999999999999999999999999999885433221    11233567799999985432


Q ss_pred             -----CCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCC-----CCCCCCcCCHHHHHHHHHHhcCCCCCC
Q 041080          153 -----DGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGE-----LPSVPSSLSRDARDFILKCLQVNPNDR  221 (247)
Q Consensus       153 -----~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~R  221 (247)
                           ..++.++|+||||+++|++++ |..||......+.........     .+......++.+.+++..|+ .+|.+|
T Consensus       179 ~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~R  257 (269)
T cd05087         179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQR  257 (269)
T ss_pred             ccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccC
Confidence                 125789999999999999996 999997766555433322211     12333457888999999998 689999


Q ss_pred             CChhhhhc
Q 041080          222 PTVTELME  229 (247)
Q Consensus       222 ps~~~il~  229 (247)
                      ||+++++.
T Consensus       258 pt~~~l~~  265 (269)
T cd05087         258 PSAEEVHL  265 (269)
T ss_pred             CCHHHHHH
Confidence            99999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-37  Score=243.88  Aligned_cols=219  Identities=27%  Similarity=0.468  Sum_probs=183.9

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVS   81 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~   81 (247)
                      .+|+|......    .......+.+|+..+.+++||||+++++++.. ...++++||+++++|.+++...  .+++..+.
T Consensus        38 ~~aik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~  112 (279)
T cd05057          38 PVAIKVLREET----SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLL  112 (279)
T ss_pred             EEEEEeccCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHH
Confidence            57888775432    24456678899999999999999999999877 7899999999999999998764  48899999


Q ss_pred             HHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc----cCCCCCCccCCcccccCCCCCCc
Q 041080           82 SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK----SCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        82 ~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      .++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+.........    ...++..|++||.+...  .++.
T Consensus       113 ~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~  190 (279)
T cd05057         113 NWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR--IYTH  190 (279)
T ss_pred             HHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcC--CcCc
Confidence            99999999999999999999999999999999999999999998754432211    11134579999988543  3788


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          158 TADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ++|+||||++++++++ |..||......+....+........+...+.++.+++.+||..+|.+||++.++++
T Consensus       191 ~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         191 KSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             hhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            9999999999999998 99999888777777666666555666778899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.8e-38  Score=246.75  Aligned_cols=222  Identities=29%  Similarity=0.525  Sum_probs=179.8

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec--CCcEEEEEeccccCcHHHHHHhcC--CCH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD--ENRLYIFLELVTKGSLANLYQKYH--LSD   77 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~--~~~   77 (247)
                      |+.+|||.+......    ...+.+.+|+++++.+.|+||+++++++..  ....+++|||+++++|.+++....  +++
T Consensus        33 ~~~~avK~~~~~~~~----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~  108 (284)
T cd05038          33 GEQVAVKSLNHSGEE----QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINL  108 (284)
T ss_pred             ceEEEEEEeccccch----HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCH
Confidence            678999999754321    456778999999999999999999998877  568899999999999999997755  899


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc-----ccCCCCCCccCCcccccCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL-----KSCKGTPFWMAPEVVNSKN  152 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~  152 (247)
                      ..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+........     ....+...|++||.+....
T Consensus       109 ~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~  188 (284)
T cd05038         109 KRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK  188 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCC
Confidence            99999999999999999999999999999999999999999999999876542211     1122445699999886543


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhH---------------HHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCC
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQ---------------ALFRIGKGELPSVPSSLSRDARDFILKCLQVN  217 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  217 (247)
                        ++.++|+||||++++++++|..|+.......               ....+........+..++.++.+++.+||+.+
T Consensus       189 --~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  266 (284)
T cd05038         189 --FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAE  266 (284)
T ss_pred             --CCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccC
Confidence              7889999999999999999998875432211               12222223333345567899999999999999


Q ss_pred             CCCCCChhhhhc
Q 041080          218 PNDRPTVTELME  229 (247)
Q Consensus       218 p~~Rps~~~il~  229 (247)
                      |.+|||+.++++
T Consensus       267 p~~Rpt~~ei~~  278 (284)
T cd05038         267 PQDRPSFADLIL  278 (284)
T ss_pred             hhhCCCHHHHHH
Confidence            999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.1e-37  Score=254.51  Aligned_cols=223  Identities=27%  Similarity=0.436  Sum_probs=180.7

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-------   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------   73 (247)
                      ++.||||++....    .....+.+.+|+.++.++. ||||+++++++...+..++|+||+++|+|.+++.+.       
T Consensus        67 ~~~vavK~l~~~~----~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~  142 (401)
T cd05107          67 TMKVAVKMLKSTA----RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQY  142 (401)
T ss_pred             ceEEEEEecCCCC----ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhh
Confidence            3579999996532    2233456889999999997 999999999999999999999999999999988542       


Q ss_pred             --------------------------------------------------------------------------------
Q 041080           74 --------------------------------------------------------------------------------   73 (247)
Q Consensus        74 --------------------------------------------------------------------------------   73 (247)
                                                                                                      
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (401)
T cd05107         143 YLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPE  222 (401)
T ss_pred             hcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCC
Confidence                                                                                            


Q ss_pred             ------------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCC
Q 041080           74 ------------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCK  137 (247)
Q Consensus        74 ------------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~  137 (247)
                                  .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+.......    .....
T Consensus       223 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~  302 (401)
T cd05107         223 RTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTF  302 (401)
T ss_pred             CcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcC
Confidence                        14566788899999999999999999999999999999999999999999986533221    11223


Q ss_pred             CCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHH-HHhhcCCCCCCCCcCCHHHHHHHHHHhc
Q 041080          138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQAL-FRIGKGELPSVPSSLSRDARDFILKCLQ  215 (247)
Q Consensus       138 ~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~  215 (247)
                      ++..|+|||.+.+..  ++.++|+||||++++++++ |..||......+.. ..+..+..+..+..++.++.+++.+||.
T Consensus       303 ~~~~y~aPE~~~~~~--~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~  380 (401)
T cd05107         303 LPLKWMAPESIFNNL--YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWE  380 (401)
T ss_pred             CCCceeChHHhcCCC--CCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcC
Confidence            567799999986543  7889999999999999998 88898765544433 3333344445667789999999999999


Q ss_pred             CCCCCCCChhhhhcC
Q 041080          216 VNPNDRPTVTELMEH  230 (247)
Q Consensus       216 ~~p~~Rps~~~il~~  230 (247)
                      .+|.+||+++++++.
T Consensus       381 ~~P~~RPs~~ell~~  395 (401)
T cd05107         381 EKFEIRPDFSQLVHL  395 (401)
T ss_pred             CChhHCcCHHHHHHH
Confidence            999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2e-37  Score=251.08  Aligned_cols=223  Identities=27%  Similarity=0.463  Sum_probs=177.1

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeec-CCcEEEEEeccccCcHHHHHHhc------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKD-ENRLYIFLELVTKGSLANLYQKY------   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~------   73 (247)
                      ++.||||.+....    .......+.+|+.++.++ +|+||+++++++.. +...+++|||+++|+|.+++...      
T Consensus        37 ~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~  112 (343)
T cd05103          37 CRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVP  112 (343)
T ss_pred             ceeEEEEEeccCC----ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCcccc
Confidence            6789999986432    233456688999999999 68999999997754 45689999999999999987542      


Q ss_pred             --------------------------------------------------------------CCCHHHHHHHHHHHHHHH
Q 041080           74 --------------------------------------------------------------HLSDSQVSSYTRQILNGL   91 (247)
Q Consensus        74 --------------------------------------------------------------~~~~~~~~~~~~~l~~~l   91 (247)
                                                                                    .++...+..++.|++.||
T Consensus       113 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al  192 (343)
T cd05103         113 YKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGM  192 (343)
T ss_pred             ccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHH
Confidence                                                                          256777889999999999


Q ss_pred             HHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----ccCCCCCCccCCcccccCCCCCCcchhHHHHHHH
Q 041080           92 VYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT  167 (247)
Q Consensus        92 ~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~l  167 (247)
                      +|||+.|++|+||||+||+++.++.++|+|||++........    ....++..|+|||.+.+..  ++.++|+||||++
T Consensus       193 ~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~  270 (343)
T cd05103         193 EFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVL  270 (343)
T ss_pred             HHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCC--CCchhhHHHHHHH
Confidence            999999999999999999999999999999999865432211    1122456799999986543  7889999999999


Q ss_pred             HHHHHh-CCCCCCCChhhH-HHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          168 VLEMLT-RRPPYSHLEGVQ-ALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       168 l~~l~~-g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      ++++++ |..||....... .......+.....+...++++.+++.+||+.+|.+|||+.++++|
T Consensus       271 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         271 LWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999996 888987654322 233333333444556678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.1e-37  Score=241.25  Aligned_cols=227  Identities=28%  Similarity=0.557  Sum_probs=185.3

Q ss_pred             CceEEEEEEeecCCC-----ccchHHHHHHHHHHHHHhh-cCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh---
Q 041080            2 GFFFAVKEVSLQDQG-----AQGKQSILQLEQEISLLSQ-FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK---   72 (247)
Q Consensus         2 g~~~~lK~~~~~~~~-----~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---   72 (247)
                      ++.+|+|.+......     .........+.+|+.++.+ ++||||+++++++..++..+++|||+++++|.+++..   
T Consensus        26 ~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~  105 (269)
T cd08528          26 QNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKE  105 (269)
T ss_pred             CceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHh
Confidence            578999988654321     1334456667789998876 6899999999999999999999999999999888743   


Q ss_pred             --cCCCHHHHHHHHHHHHHHHHHhhh-CCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-ccccCCCCCCccCCccc
Q 041080           73 --YHLSDSQVSSYTRQILNGLVYLHE-RNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVV  148 (247)
Q Consensus        73 --~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~  148 (247)
                        ..+++..++.++.|++.++.+||+ .|++|+||+|+||+++.++.++|+|||.+...... ......++..|++||.+
T Consensus       106 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~  185 (269)
T cd08528         106 KKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIV  185 (269)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeecccccccccccCcccCcChhhh
Confidence              248899999999999999999996 78999999999999999999999999998654433 22344578889999999


Q ss_pred             ccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCC-CcCCHHHHHHHHHHhcCCCCCCCChhhh
Q 041080          149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVP-SSLSRDARDFILKCLQVNPNDRPTVTEL  227 (247)
Q Consensus       149 ~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rps~~~i  227 (247)
                      .+..  ++.++|+||||+++|++++|..||...........+........+ ..+++.+.+++.+||+.+|.+||++.++
T Consensus       186 ~~~~--~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~  263 (269)
T cd08528         186 KNEP--YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV  263 (269)
T ss_pred             cCCC--CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHH
Confidence            6544  788999999999999999999999776655555554444333333 3678999999999999999999999998


Q ss_pred             hcC
Q 041080          228 MEH  230 (247)
Q Consensus       228 l~~  230 (247)
                      ..+
T Consensus       264 ~~~  266 (269)
T cd08528         264 SAM  266 (269)
T ss_pred             HHH
Confidence            753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.2e-37  Score=240.43  Aligned_cols=202  Identities=24%  Similarity=0.382  Sum_probs=165.5

Q ss_pred             HHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHhhhCCee
Q 041080           23 ILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVV  100 (247)
Q Consensus        23 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~  100 (247)
                      ...+.+|+.+++.++||||+++++++.. +..++||||+++++|.+++...+  ++...+..++.|++.||.+||+.|++
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~  123 (259)
T cd05037          45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLV  123 (259)
T ss_pred             HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence            5678899999999999999999999887 77899999999999999987644  88999999999999999999999999


Q ss_pred             ecCCCCCcEEEcCCC-------CeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHh
Q 041080          101 HRDIKCANILVDASG-------SVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT  173 (247)
Q Consensus       101 h~dl~~~ni~~~~~~-------~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~  173 (247)
                      |+||||+||+++.++       .++|+|||.+.....  .....+...|+|||.+.+....++.++|+||||++++++++
T Consensus       124 H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~  201 (259)
T cd05037         124 HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICS  201 (259)
T ss_pred             cccCccceEEEecCccccCCceeEEeCCCCccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHh
Confidence            999999999999887       799999999875443  22334567799999987653447899999999999999998


Q ss_pred             -CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          174 -RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       174 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                       |..|+...............  ...+......+.+++.+||..+|.+|||+.++++
T Consensus       202 ~~~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         202 NGEEPLSTLSSSEKERFYQDQ--HRLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CCCCCcccCCchhHHHHHhcC--CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence             57777665433322222211  1222223478999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.2e-36  Score=238.65  Aligned_cols=220  Identities=21%  Similarity=0.348  Sum_probs=172.4

Q ss_pred             EEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-----CCCHHH
Q 041080            5 FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-----HLSDSQ   79 (247)
Q Consensus         5 ~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~   79 (247)
                      +++|.+...    ......+.+.+|+..++.++||||+++++.+......++||||+++++|.+++.+.     ..+...
T Consensus        25 ~~~k~~~~~----~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~  100 (268)
T cd05086          25 VVVKELKAN----ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL  100 (268)
T ss_pred             EEEEEecCC----CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHH
Confidence            455555432    22344667889999999999999999999999999999999999999999998753     256667


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc----ccccCCCCCCccCCcccccC----
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTPFWMAPEVVNSK----  151 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~----  151 (247)
                      +..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+......    ......++..|+|||.+...    
T Consensus       101 ~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  180 (268)
T cd05086         101 LQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGL  180 (268)
T ss_pred             HHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCcc
Confidence            8899999999999999999999999999999999999999999987532211    11233467789999987432    


Q ss_pred             -CCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCC-----CCCCCCcCCHHHHHHHHHHhcCCCCCCCCh
Q 041080          152 -NDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGE-----LPSVPSSLSRDARDFILKCLQVNPNDRPTV  224 (247)
Q Consensus       152 -~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  224 (247)
                       ...++.++|+||||+++|+|++ +..||......+.........     .+..+..+++.+.+++..|| .+|.+||++
T Consensus       181 ~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~  259 (268)
T cd05086         181 ITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATA  259 (268)
T ss_pred             ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCH
Confidence             1235778999999999999997 567887666555444432221     23444568899999999999 679999999


Q ss_pred             hhhhc
Q 041080          225 TELME  229 (247)
Q Consensus       225 ~~il~  229 (247)
                      +++++
T Consensus       260 ~~i~~  264 (268)
T cd05086         260 EEVHR  264 (268)
T ss_pred             HHHHH
Confidence            99975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1e-36  Score=239.47  Aligned_cols=223  Identities=23%  Similarity=0.409  Sum_probs=180.0

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC------cEEEEEeccccCcHHHHHHhc--
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN------RLYIFLELVTKGSLANLYQKY--   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~--   73 (247)
                      |+.||||.+....   ......+.+.+|+++++.++||||+++++++...+      ..+++++|+.+++|..++...  
T Consensus        27 ~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  103 (273)
T cd05074          27 FQKVAVKMLKADI---FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRI  103 (273)
T ss_pred             ceEEEEEEecccc---CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcc
Confidence            5789999996542   22334667889999999999999999999875432      347889999999998876421  


Q ss_pred             -----CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccC
Q 041080           74 -----HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMA  144 (247)
Q Consensus        74 -----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~a  144 (247)
                           .++...+..++.|++.|+++||+.|++|+||+|+||+++.++.++++|||.+.......    .....+...|++
T Consensus       104 ~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~  183 (273)
T cd05074         104 GEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA  183 (273)
T ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcC
Confidence                 36888899999999999999999999999999999999999999999999887543222    112224467899


Q ss_pred             CcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC
Q 041080          145 PEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT  223 (247)
Q Consensus       145 PE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  223 (247)
                      ||.+....  ++.++|+||||+++|++++ |..||...........+........+...+..+.+++.+||+.+|.+|||
T Consensus       184 pe~~~~~~--~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps  261 (273)
T cd05074         184 LESLADNV--YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPS  261 (273)
T ss_pred             HhHHhcCc--cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence            99885443  6889999999999999998 88998877766665555555444555678899999999999999999999


Q ss_pred             hhhhhc
Q 041080          224 VTELME  229 (247)
Q Consensus       224 ~~~il~  229 (247)
                      +.+++.
T Consensus       262 ~~~~~~  267 (273)
T cd05074         262 FQHLRD  267 (273)
T ss_pred             HHHHHH
Confidence            999975

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-37  Score=261.17  Aligned_cols=212  Identities=26%  Similarity=0.396  Sum_probs=164.9

Q ss_pred             HHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC------CCHHHHHHHHHHHHHHHHHhh
Q 041080           22 SILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH------LSDSQVSSYTRQILNGLVYLH   95 (247)
Q Consensus        22 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~l~~~l~~lh   95 (247)
                      ....+.+|+.++++++||||+++++++...+..+++++++.+ +|.+++....      .....+..++.|++.||.|||
T Consensus       206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH  284 (501)
T PHA03210        206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH  284 (501)
T ss_pred             HHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            345678999999999999999999999999999999999965 6766654322      345667889999999999999


Q ss_pred             hCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHH
Q 041080           96 ERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEML  172 (247)
Q Consensus        96 ~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~  172 (247)
                      ++||+|+||||+||+++.++.++|+|||++.......   .....|+..|+|||.+.+..  ++.++||||||+++|+|+
T Consensus       285 ~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~ell  362 (501)
T PHA03210        285 DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG--YCEITDIWSCGLILLDML  362 (501)
T ss_pred             hCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC--CCcHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999986544322   22345899999999996544  789999999999999999


Q ss_pred             hCCC-CCCCChhh--HHHHHhhc----------------------CCCCCC---------CCcCCHHHHHHHHHHhcCCC
Q 041080          173 TRRP-PYSHLEGV--QALFRIGK----------------------GELPSV---------PSSLSRDARDFILKCLQVNP  218 (247)
Q Consensus       173 ~g~~-p~~~~~~~--~~~~~~~~----------------------~~~~~~---------~~~~~~~~~~li~~~l~~~p  218 (247)
                      +|.. |+......  .....+..                      ......         ....+.++.+++.+||+.||
T Consensus       363 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP  442 (501)
T PHA03210        363 SHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDW  442 (501)
T ss_pred             HCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCc
Confidence            9875 44322111  11111000                      000000         11356778888999999999


Q ss_pred             CCCCChhhhhcCccCCCC
Q 041080          219 NDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       219 ~~Rps~~~il~~p~~~~~  236 (247)
                      .+|||+.|+|.||||+..
T Consensus       443 ~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        443 HLRPGAAELLALPLFSAE  460 (501)
T ss_pred             ccCcCHHHHhhChhhhcC
Confidence            999999999999999863

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=6e-38  Score=255.33  Aligned_cols=219  Identities=29%  Similarity=0.498  Sum_probs=192.7

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC--CCHHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--LSDSQVS   81 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~   81 (247)
                      .||||..+.++.    ....+.|.+|..++++++||||++++|++.+. -.++|||.++.|-|..+++.+.  ++...+.
T Consensus       420 aVAvKtCK~d~t----~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~  494 (974)
T KOG4257|consen  420 AVAVKTCKTDCT----PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLT  494 (974)
T ss_pred             eeeeehhccCCC----hhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhccccchHHHHH
Confidence            378888776543    22367899999999999999999999998655 6899999999999999998764  8888999


Q ss_pred             HHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccC---CCCCCccCCcccccCCCCCCcc
Q 041080           82 SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSC---KGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        82 ~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~---~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      .+++|+..|++|||+.+++||||...||++.....+||+|||+++..........   .-...|+|||.++-..  ++.+
T Consensus       495 ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRr--FTtA  572 (974)
T KOG4257|consen  495 LYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRR--FTTA  572 (974)
T ss_pred             HHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhc--ccch
Confidence            9999999999999999999999999999999999999999999987665543322   1334599999997655  8999


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          159 ADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       159 ~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +|||.||++|||++. |.-||......+.+..+.++...+.|..+|+.+..++.+||.++|.+||.+.+|..
T Consensus       573 SDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  573 SDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             hhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence            999999999999886 99999999999999999999999999999999999999999999999999987753

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.2e-36  Score=242.54  Aligned_cols=220  Identities=25%  Similarity=0.474  Sum_probs=178.2

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVS   81 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~   81 (247)
                      .+|+|.+...    ........+.+|+.+++.++||||+++++++... ..++++||+++|+|.+++...  .+++..++
T Consensus        38 ~vaiK~~~~~----~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~  112 (303)
T cd05110          38 PVAIKILNET----TGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLL  112 (303)
T ss_pred             eEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHH
Confidence            4677877542    2233344678999999999999999999988654 567999999999999998764  47889999


Q ss_pred             HHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCCcccccCCCCCCc
Q 041080           82 SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        82 ~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      .++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.......    .....++..|++||.+.+..  ++.
T Consensus       113 ~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~  190 (303)
T cd05110         113 NWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK--FTH  190 (303)
T ss_pred             HHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCC--CCh
Confidence            999999999999999999999999999999999999999999986543222    11222456799999985444  788


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          158 TADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      ++|+||||+++|++++ |..||...........+........+...+..+.+++.+||..+|.+||+++++++.
T Consensus       191 ~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         191 QSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999997 889997766555555555444444556678999999999999999999999998773

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-38  Score=269.72  Aligned_cols=232  Identities=30%  Similarity=0.428  Sum_probs=194.8

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-CCHHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQV   80 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~   80 (247)
                      ++.||+|++.+-.  -..+.....|..|-.+|..-+.+=|+.++..|+++.++|+||||++||+|..++.++. +++..+
T Consensus       100 ~~VYAMK~lnK~e--MlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~A  177 (1317)
T KOG0612|consen  100 EKVYAMKILNKWE--MLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWA  177 (1317)
T ss_pred             ccchhHHHhhHHH--HhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHH
Confidence            5678888886521  1123334568889999988889999999999999999999999999999999999987 999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCccccc---CCCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNS---KNDG  154 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~---~~~~  154 (247)
                      +.++..|+.||..+|+.|++||||||+||+++..|.++|+|||..-......   ....+|||.|.+||++..   ..+.
T Consensus       178 rFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~  257 (1317)
T KOG0612|consen  178 RFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGE  257 (1317)
T ss_pred             HHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccc
Confidence            9999999999999999999999999999999999999999999875544333   335669999999999853   2245


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC-CCCCC--CcCCHHHHHHHHHHhcCCCCCCCC---hhhhh
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE-LPSVP--SSLSRDARDFILKCLQVNPNDRPT---VTELM  228 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~~il  228 (247)
                      |++..|+||+|+++|+|+.|.-||....-.+.+..|.... .-.+|  ..+|++.++||.+++.. |..|..   ++++-
T Consensus       258 yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~~-~e~RLgrngiedik  336 (1317)
T KOG0612|consen  258 YGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLCD-REVRLGRNGIEDIK  336 (1317)
T ss_pred             cCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhcC-hhhhcccccHHHHH
Confidence            8999999999999999999999998888777777765542 12333  56999999999999875 667777   99999


Q ss_pred             cCccCCCC
Q 041080          229 EHPFVKRP  236 (247)
Q Consensus       229 ~~p~~~~~  236 (247)
                      .||||..+
T Consensus       337 ~HpFF~g~  344 (1317)
T KOG0612|consen  337 NHPFFEGI  344 (1317)
T ss_pred             hCccccCC
Confidence            99999853

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=5.6e-38  Score=236.54  Aligned_cols=229  Identities=29%  Similarity=0.461  Sum_probs=178.3

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec-CCcEEEEEeccccCcHHHHHHh------cCC
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD-ENRLYIFLELVTKGSLANLYQK------YHL   75 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~------~~~   75 (247)
                      +.+|||.++.+..   ........-+|+.+++.++|||++.+..+|.. +...++++||.+. +|..+++-      +.+
T Consensus        54 k~yAiKkfk~~kd---~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~l  129 (438)
T KOG0666|consen   54 KEYAIKKFKGEKD---GTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQL  129 (438)
T ss_pred             hhhHHHHHhccCC---CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccC
Confidence            3678888765532   22233445689999999999999999999877 7789999999988 89888842      348


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC----CCeEEcccccccccCccc-----cccCCCCCCccCCc
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS----GSVKLADFGLAKATTMND-----LKSCKGTPFWMAPE  146 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~----~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~aPE  146 (247)
                      +...+..++.||+.|++|||++.++||||||.||++..+    |.+||+|+|+++.....-     ....+-|.||+|||
T Consensus       130 p~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPE  209 (438)
T KOG0666|consen  130 PRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPE  209 (438)
T ss_pred             CHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChH
Confidence            899999999999999999999999999999999999988    899999999997654332     23344688999999


Q ss_pred             ccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhh---------HHHHHhh---cC----------CCCCC------
Q 041080          147 VVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---------QALFRIG---KG----------ELPSV------  198 (247)
Q Consensus       147 ~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---------~~~~~~~---~~----------~~~~~------  198 (247)
                      .+.+... |+.+.|+|+.||++.||++..+.|...+.+         +...++-   -.          +.|+.      
T Consensus       210 LLLGa~h-YT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~  288 (438)
T KOG0666|consen  210 LLLGARH-YTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSD  288 (438)
T ss_pred             Hhccccc-ccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHH
Confidence            9987765 899999999999999999987766433211         1111110   00          00000      


Q ss_pred             ------C-----------CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          199 ------P-----------SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       199 ------~-----------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                            .           ..-++...+|+.+||+.||.+|.|++++++|+||.+.
T Consensus       289 f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d  343 (438)
T KOG0666|consen  289 FRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTED  343 (438)
T ss_pred             hHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccC
Confidence                  0           1134557799999999999999999999999999985

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-38  Score=232.37  Aligned_cols=231  Identities=30%  Similarity=0.492  Sum_probs=190.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHH------hc
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ------KY   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~------~~   73 (247)
                      .|+.+|||+++....    ..+.+++..|.....+- +.||||+++|..-.++-.++.||.|+- ||..+.+      +.
T Consensus        88 sg~~mAVKrIr~~n~----~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~  162 (361)
T KOG1006|consen   88 SGKLMAVKRIRSNNI----EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKS  162 (361)
T ss_pred             cCcEEEEEEeeeccc----hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhc
Confidence            378999999986532    45566777787766665 689999999998889999999999965 8877653      44


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhh-CCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccC
Q 041080           74 HLSDSQVSSYTRQILNGLVYLHE-RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSK  151 (247)
Q Consensus        74 ~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~  151 (247)
                      .++++.+-.+..-.+.||.||.. ..|+|||+||+||+++..|.+||||||+.......- .....|-..|+|||.+...
T Consensus       163 ~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~  242 (361)
T KOG1006|consen  163 RIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPS  242 (361)
T ss_pred             cCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCc
Confidence            69999999999999999999996 489999999999999999999999999975443322 2234477889999999877


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCCh-hhHHHHHhhcCCCCCCC-----CcCCHHHHHHHHHHhcCCCCCCCChh
Q 041080          152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLE-GVQALFRIGKGELPSVP-----SSLSRDARDFILKCLQVNPNDRPTVT  225 (247)
Q Consensus       152 ~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~  225 (247)
                      ...++.++|+||||++++|++||..||.... ..+++..+..+..|.+.     .+++..+..++.-||.+|-..||++.
T Consensus       243 ~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~  322 (361)
T KOG1006|consen  243 DKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYD  322 (361)
T ss_pred             cCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchh
Confidence            6679999999999999999999999997654 44555566666665543     24889999999999999999999999


Q ss_pred             hhhcCccCCCC
Q 041080          226 ELMEHPFVKRP  236 (247)
Q Consensus       226 ~il~~p~~~~~  236 (247)
                      +++++||++-.
T Consensus       323 ~Lk~~~fyr~y  333 (361)
T KOG1006|consen  323 DLKKFPFYRMY  333 (361)
T ss_pred             hhhcCchhhhh
Confidence            99999999874

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-37  Score=214.15  Aligned_cols=230  Identities=30%  Similarity=0.492  Sum_probs=188.5

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~   79 (247)
                      ++.||+|+++.++..   +..-....+|+-+++.++|.||++++++.-+++.+-+|+|||.. +|.++....  .++.+.
T Consensus        27 ~eivalkrvrldddd---egvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng~~d~~~  102 (292)
T KOG0662|consen   27 HEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGDLDPEI  102 (292)
T ss_pred             cceEEEEEEeccCCC---CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcCCcCCHHH
Confidence            678999999886532   23344577999999999999999999999999999999999966 888888764  389999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      +..++.|++.|+.++|++++.|+|+||+|.+++.+|.+++.|||+++..+..-  ....+-+.+|++|..+.+..- |+.
T Consensus       103 ~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakl-y~t  181 (292)
T KOG0662|consen  103 VRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL-YST  181 (292)
T ss_pred             HHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeeh-hcc
Confidence            99999999999999999999999999999999999999999999997655432  334557899999999987664 789


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcC-------CC------------CCCC---------CcCCHHHHH
Q 041080          158 TADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKG-------EL------------PSVP---------SSLSRDARD  208 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-------~~------------~~~~---------~~~~~~~~~  208 (247)
                      +.|+||.||++.|+.. |++.|...+..+...++-..       ..            |.++         +.....-++
T Consensus       182 sidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grd  261 (292)
T KOG0662|consen  182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRD  261 (292)
T ss_pred             chHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHH
Confidence            9999999999999986 66667777766665543210       00            1111         123345679


Q ss_pred             HHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          209 FILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       209 li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ++.++|.-+|.+|.++++.++||||...
T Consensus       262 llqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  262 LLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             HHHHHhccCcccccCHHHHhcCcccccc
Confidence            9999999999999999999999999864

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=7.4e-36  Score=259.48  Aligned_cols=124  Identities=29%  Similarity=0.497  Sum_probs=110.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++.....  ........+..|+.++..++|+||+++++.+...+..++||||+.+++|.+++... .+++..
T Consensus        28 ~~~~vAiKvi~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~~~  105 (669)
T cd05610          28 NSKLYAVKVVKKADM--INKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEM  105 (669)
T ss_pred             CCcEEEEEEEehhhc--cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCHHH
Confidence            478999999975432  23445667889999999999999999999999999999999999999999998764 478999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEccccccc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAK  126 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~  126 (247)
                      ++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.
T Consensus       106 ~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610         106 AVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             HHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=248.51  Aligned_cols=217  Identities=26%  Similarity=0.475  Sum_probs=191.4

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC---CCHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH---LSDSQV   80 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~   80 (247)
                      .||||.++      +..-..+.|..|..+|+.++|||+|+++|+|..+.-+|||+|||..|+|.+++.+..   ++...+
T Consensus       294 TvAVKtLK------EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvL  367 (1157)
T KOG4278|consen  294 TVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVL  367 (1157)
T ss_pred             eeehhhhh------hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHH
Confidence            57888774      334457789999999999999999999999999999999999999999999997654   777788


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCC---CCCccCCcccccCCCCCCc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKG---TPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~---~~~~~aPE~~~~~~~~~~~  157 (247)
                      +.++.||.+|+.||..++++|+||...|.++..+..+|+.|||+++.........-.|   ...|.|||.+.  .+.++.
T Consensus       368 lyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLA--yNtFSi  445 (1157)
T KOG4278|consen  368 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA--YNTFSI  445 (1157)
T ss_pred             HHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCccccc--cccccc
Confidence            8999999999999999999999999999999999999999999998655444333222   34599999994  444899


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhh
Q 041080          158 TADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM  228 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il  228 (247)
                      ++|||+||+++||++| |-.||...+....+.-+.++....-|..+|+.++.||+.||+.+|.+||++.+|-
T Consensus       446 KSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  446 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             chhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence            9999999999999998 8889999999999999999988888999999999999999999999999998873

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.7e-36  Score=262.04  Aligned_cols=180  Identities=33%  Similarity=0.554  Sum_probs=146.0

Q ss_pred             cEEEEEeccccCcHHHHHHhcCCC--HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccC-
Q 041080           53 RLYIFLELVTKGSLANLYQKYHLS--DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT-  129 (247)
Q Consensus        53 ~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~-  129 (247)
                      .+|+-||||+..++.+++.++.+.  ....|+++.+|++||+|+|++|++||||||.||+++.++.|||+|||++.... 
T Consensus       670 ~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~  749 (1351)
T KOG1035|consen  670 ILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKE  749 (1351)
T ss_pred             EEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhh
Confidence            368889999998888888887764  88899999999999999999999999999999999999999999999986411 


Q ss_pred             -------------------ccccccCCCCCCccCCcccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHH
Q 041080          130 -------------------MNDLKSCKGTPFWMAPEVVNSKND-GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR  189 (247)
Q Consensus       130 -------------------~~~~~~~~~~~~~~aPE~~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~  189 (247)
                                         ........||.-|.|||.+.+... .|+.++|+||||++++||+.-  .-..+++...+..
T Consensus       750 ~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP--F~TsMERa~iL~~  827 (1351)
T KOG1035|consen  750 NLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP--FGTSMERASILTN  827 (1351)
T ss_pred             hhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc--CCchHHHHHHHHh
Confidence                               112345568899999999976552 589999999999999999853  2245566666666


Q ss_pred             hhcCCCCCC---CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCC
Q 041080          190 IGKGELPSV---PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK  234 (247)
Q Consensus       190 ~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~  234 (247)
                      +.++..|..   ....-+.-+.+|++|++.||.+|||+.|+|++.||-
T Consensus       828 LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  828 LRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             cccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            666655444   222234457899999999999999999999999987

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=258.00  Aligned_cols=221  Identities=24%  Similarity=0.442  Sum_probs=197.6

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHH
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQV   80 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~   80 (247)
                      ..||||.++..    ..+....+|..|..||-+++||||+++.|+.....-..+|+|||++|+|+.++..+  .+...++
T Consensus       658 ~~VAIKTLK~G----ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQL  733 (996)
T KOG0196|consen  658 ITVAIKTLKAG----YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQL  733 (996)
T ss_pred             eeEEEeeeccC----ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehH
Confidence            47999999753    34555777999999999999999999999999999999999999999999999765  4899999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCC-----CCCCccCCcccccCCCCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK-----GTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~-----~~~~~~aPE~~~~~~~~~  155 (247)
                      ..++..|+.|+.||-+.|++||||...||+++.+-.+|++|||+++.........+.     -..+|.|||.+...+  +
T Consensus       734 VgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RK--F  811 (996)
T KOG0196|consen  734 VGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRK--F  811 (996)
T ss_pred             HHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcc--c
Confidence            999999999999999999999999999999999999999999999866544322111     236799999997666  8


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +.++||||+|++|||.++ |..||=+++..+.+..+..+..-+.|.++|..+.+|+..||++|-.+||.+.+|+.
T Consensus       812 TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  812 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             CchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence            999999999999999775 99999999999999999999888888999999999999999999999999999986

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=259.66  Aligned_cols=223  Identities=34%  Similarity=0.487  Sum_probs=177.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-----
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-----   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----   74 (247)
                      +|+.||||++..        +....+.+|+..|+.- +||||+++++.-++.+..|+..|.|.. +|.++++..+     
T Consensus       532 e~R~VAVKrll~--------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~  602 (903)
T KOG1027|consen  532 EGREVAVKRLLE--------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEM  602 (903)
T ss_pred             CCceehHHHHhh--------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhh
Confidence            588999998853        2344677999999998 599999999999999999999999977 9999998731     


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC---CC--CeEEcccccccccCccc-----cccCCCCCCccC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA---SG--SVKLADFGLAKATTMND-----LKSCKGTPFWMA  144 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~---~~--~~~l~df~~~~~~~~~~-----~~~~~~~~~~~a  144 (247)
                      ......+..+.|+++||++||+.+|+||||||+||+|+.   ++  +++|+|||++.......     .....|+..|+|
T Consensus       603 ~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~A  682 (903)
T KOG1027|consen  603 QSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQA  682 (903)
T ss_pred             cccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccC
Confidence            112445788999999999999999999999999999986   34  57999999997655443     334569999999


Q ss_pred             CcccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC
Q 041080          145 PEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT  223 (247)
Q Consensus       145 PE~~~~~~~~~~~~~Di~slG~ll~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  223 (247)
                      ||.+....  -+.++||||+||++|+.++| .+||.+.-..+............+......+..+||.+|++++|..||+
T Consensus       683 PE~L~~~~--~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPs  760 (903)
T KOG1027|consen  683 PEQLREDR--KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPS  760 (903)
T ss_pred             HHHHhccc--cCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCC
Confidence            99997655  46689999999999999885 8999875544333222222222222222238999999999999999999


Q ss_pred             hhhhhcCccCC
Q 041080          224 VTELMEHPFVK  234 (247)
Q Consensus       224 ~~~il~~p~~~  234 (247)
                      +.++|.||+|=
T Consensus       761 a~~VL~HPlFW  771 (903)
T KOG1027|consen  761 ATDVLNHPLFW  771 (903)
T ss_pred             HHHHhCCCccC
Confidence            99999999884

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-37  Score=246.61  Aligned_cols=222  Identities=27%  Similarity=0.439  Sum_probs=186.2

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC---CCHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH---LSDS   78 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~   78 (247)
                      +..||+|.++...    ....+..|.+|+++|.+|+||||++++++|..++-+++++||+..|+|.+++.+..   ...+
T Consensus       562 ~lkVAVK~Lr~~a----~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~  637 (807)
T KOG1094|consen  562 PLKVAVKILRPDA----TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETA  637 (807)
T ss_pred             ceEEEEeecCccc----chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccc
Confidence            3679999997643    34457889999999999999999999999999999999999999999999998763   3556


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccccc----CCCCCCccCCcccccCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKS----CKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~----~~~~~~~~aPE~~~~~~~~  154 (247)
                      ...+++.||++|++||.+.+++|||+.+.|++++.++++||+|||+++.........    .+...+|+|+|.+...+  
T Consensus       638 ~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgk--  715 (807)
T KOG1094|consen  638 PGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGK--  715 (807)
T ss_pred             hhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhcc--
Confidence            778899999999999999999999999999999999999999999998554444332    22457899999985444  


Q ss_pred             CCcchhHHHHHHHHHHHHh--CCCCCCCChhhHHHHHhhcC-------CCCCCCCcCCHHHHHHHHHHhcCCCCCCCChh
Q 041080          155 YGLTADIWSLGCTVLEMLT--RRPPYSHLEGVQALFRIGKG-------ELPSVPSSLSRDARDFILKCLQVNPNDRPTVT  225 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~--g~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  225 (247)
                      ++.++|+|+||+++||+++  ...||..............-       -...-|.-+|..+.++|-+||..+..+|||++
T Consensus       716 FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe  795 (807)
T KOG1094|consen  716 FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFE  795 (807)
T ss_pred             ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHH
Confidence            8999999999999999865  78999888877776553321       11234567899999999999999999999999


Q ss_pred             hhhc
Q 041080          226 ELME  229 (247)
Q Consensus       226 ~il~  229 (247)
                      ++..
T Consensus       796 ~lh~  799 (807)
T KOG1094|consen  796 QLHL  799 (807)
T ss_pred             HHHH
Confidence            9854

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-37  Score=239.13  Aligned_cols=230  Identities=28%  Similarity=0.453  Sum_probs=192.7

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-CCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~   79 (247)
                      .+.||||+++++...+..+-.  --..|-.+|.-. +-|.+++++..|++-+.+|+||||++||+|--.+++.+ +.+..
T Consensus       374 dELyAiKiLkKDViiQdDDve--ctm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~  451 (683)
T KOG0696|consen  374 DELYAIKILKKDVIIQDDDVE--CTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPV  451 (683)
T ss_pred             chhhhhhhhccceeeecCccc--ceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCch
Confidence            356899998876554333222  222444555444 46788899999999999999999999999987777754 99999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEccccccccc--CccccccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT--TMNDLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      +..++..|+.||-+||++||++||||.+||+++.+|.++|.|||+....  .........|++.|+|||++.-  .+|+.
T Consensus       452 AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~Y--qPYgk  529 (683)
T KOG0696|consen  452 AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAY--QPYGK  529 (683)
T ss_pred             hhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEe--ccccc
Confidence            9999999999999999999999999999999999999999999998643  3334567789999999999954  44899


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh-----hhhhcCcc
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV-----TELMEHPF  232 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~~p~  232 (247)
                      +.|+||+|+++|||+.|+.||+..+..++...+.... ..+|.++|.+..++.+..|.+.|.+|...     .+|-.|||
T Consensus       530 svDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn-vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~F  608 (683)
T KOG0696|consen  530 SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN-VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPF  608 (683)
T ss_pred             chhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc-CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcc
Confidence            9999999999999999999999999988888876554 47889999999999999999999999543     67889999


Q ss_pred             CCCC
Q 041080          233 VKRP  236 (247)
Q Consensus       233 ~~~~  236 (247)
                      |+.+
T Consensus       609 FR~i  612 (683)
T KOG0696|consen  609 FRRI  612 (683)
T ss_pred             hhhc
Confidence            9864

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=238.53  Aligned_cols=225  Identities=24%  Similarity=0.381  Sum_probs=178.9

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-C-C----ceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-Q-D----NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-   74 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-~----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-   74 (247)
                      +..||||+++..      ....+...-|++++.+|. + |    -++.+.++|.-.++.|+|+|.+ |-|+.+++.+++ 
T Consensus       114 ~~~vAlKIik~V------~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y  186 (415)
T KOG0671|consen  114 KEHVALKIIKNV------DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNY  186 (415)
T ss_pred             CceehHHHHHHH------HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCc
Confidence            467888888642      344556678999999994 2 2    4677888899999999999999 559999998764 


Q ss_pred             --CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC--------------------CCCeEEcccccccccCccc
Q 041080           75 --LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA--------------------SGSVKLADFGLAKATTMND  132 (247)
Q Consensus        75 --~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~--------------------~~~~~l~df~~~~~~~~~~  132 (247)
                        ++...+..++.|++.++++||+.+++|.||||+||++..                    +..++++|||.+....+..
T Consensus       187 ~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h  266 (415)
T KOG0671|consen  187 IPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH  266 (415)
T ss_pred             cccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc
Confidence              899999999999999999999999999999999999842                    2348999999998766544


Q ss_pred             cccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc--CCCC--------------
Q 041080          133 LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK--GELP--------------  196 (247)
Q Consensus       133 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~--~~~~--------------  196 (247)
                       ...+.|..|+|||++.+..  ++...||||+||+++|+.+|...|...+..+.+.-+..  +..|              
T Consensus       267 -s~iVsTRHYRAPEViLgLG--wS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~  343 (415)
T KOG0671|consen  267 -STIVSTRHYRAPEVILGLG--WSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFR  343 (415)
T ss_pred             -ceeeeccccCCchheeccC--cCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhh
Confidence             4556789999999997766  89999999999999999999998887776554322211  0000              


Q ss_pred             ----CCC-------------------------CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          197 ----SVP-------------------------SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       197 ----~~~-------------------------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                          ..+                         ...-.++.+||++||..||.+|+|+.|+|.||||+..
T Consensus       344 ~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  344 RGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL  412 (415)
T ss_pred             cccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence                000                         0012247799999999999999999999999999864

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-37  Score=230.99  Aligned_cols=226  Identities=27%  Similarity=0.456  Sum_probs=184.6

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC------CcEEEEEeccccCcHHHHHHhcCC
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE------NRLYIFLELVTKGSLANLYQKYHL   75 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~   75 (247)
                      +++||+|....+..   ......+..+|...+..+.|+||++++.+|.-.      ...|+|||++.. +|...+. ..+
T Consensus        41 ~~~v~ikk~~~pf~---n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~-~el  115 (369)
T KOG0665|consen   41 GRPVAIKKLSRPFQ---NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVIL-MEL  115 (369)
T ss_pred             cCceehhhhcCccc---cCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHH-Hhc
Confidence            67899998876633   244556778999999999999999999987533      367999999977 8888776 467


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-ccccCCCCCCccCCcccccCCCC
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +-..+..+++|++.|+.++|+.||+||||||+||++..++.+|+.|||++...+.. ....+..+..|.|||.+.+..  
T Consensus       116 DH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~--  193 (369)
T KOG0665|consen  116 DHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG--  193 (369)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheeccC--
Confidence            88899999999999999999999999999999999999999999999999877666 566777899999999997766  


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc---------------------CCCC-----------------
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK---------------------GELP-----------------  196 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~---------------------~~~~-----------------  196 (247)
                      +...+||||+||++.+|++|...|.+.+..+...++..                     ...+                 
T Consensus       194 ~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~  273 (369)
T KOG0665|consen  194 YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFP  273 (369)
T ss_pred             CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCccccc
Confidence            89999999999999999999988866554444322110                     0000                 


Q ss_pred             ---CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCC
Q 041080          197 ---SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK  234 (247)
Q Consensus       197 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~  234 (247)
                         +.+..-+...++++.+||..+|++|.|++++|+|||++
T Consensus       274 ~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  274 VVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             ccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence               00112344578999999999999999999999999997

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=247.86  Aligned_cols=227  Identities=27%  Similarity=0.461  Sum_probs=201.9

Q ss_pred             EEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-CCHHHHHHH
Q 041080            5 FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVSSY   83 (247)
Q Consensus         5 ~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~   83 (247)
                      +|+|++++.....  ....+.+..|-++|..++.|.||+++..|.+....|++||-|-||.|+.++.+++ +++.....+
T Consensus       448 fAlKilkK~hIVd--tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~  525 (732)
T KOG0614|consen  448 FALKILKKKHIVD--TKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFY  525 (732)
T ss_pred             HHHHHHhHhhccc--hhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhh
Confidence            5777776655432  3345678899999999999999999999999999999999999999999997765 999999999


Q ss_pred             HHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-ccccCCCCCCccCCcccccCCCCCCcchhHH
Q 041080           84 TRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYGLTADIW  162 (247)
Q Consensus        84 ~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~  162 (247)
                      +.-+++|+.|||++||++|||||+|.+++.+|.+||.|||.+...... ..+..+||+.|.|||.+....  .+.++|.|
T Consensus       526 ~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKG--HD~avDyW  603 (732)
T KOG0614|consen  526 VACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKG--HDRAVDYW  603 (732)
T ss_pred             HHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccC--cchhhHHH
Confidence            999999999999999999999999999999999999999999877655 467889999999999985544  68899999


Q ss_pred             HHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC-CCCCCCcCCHHHHHHHHHHhcCCCCCCCC-----hhhhhcCccCCC
Q 041080          163 SLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE-LPSVPSSLSRDARDFILKCLQVNPNDRPT-----VTELMEHPFVKR  235 (247)
Q Consensus       163 slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~p~~~~  235 (247)
                      +||++++||++|.+||...+....+..+.++- .-.+|..++....++|+++...+|.+|..     +.||-+|-||..
T Consensus       604 aLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g  682 (732)
T KOG0614|consen  604 ALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG  682 (732)
T ss_pred             HHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence            99999999999999999999998888877763 34678899999999999999999999975     899999999975

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-36  Score=246.98  Aligned_cols=228  Identities=29%  Similarity=0.452  Sum_probs=197.5

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSDSQV   80 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~   80 (247)
                      .||||.++......    ...+|.+|+.+|.+|+|+|+++++|+..+ ....+|||.+++|+|.+.+.+.   .+....+
T Consensus       140 ~VAVKclr~d~l~~----~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~L  214 (1039)
T KOG0199|consen  140 NVAVKCLRDDSLNA----IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRL  214 (1039)
T ss_pred             eEEEEeccCCccch----hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHH
Confidence            57999998654432    67789999999999999999999999877 7889999999999999988762   2778888


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc-----cCCCCCCccCCcccccCCCCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK-----SCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      -.++.||+.|+.||..++++||||-..|+++-..-.+||+|||+.+..+..+..     ...--..|+|||.++...  +
T Consensus       215 cdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~k--F  292 (1039)
T KOG0199|consen  215 CDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRK--F  292 (1039)
T ss_pred             HHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcccc--c
Confidence            899999999999999999999999999999998889999999998876654421     222345699999997666  8


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCC
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK  234 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~  234 (247)
                      +.++|+|++|+++|||++ |..||.......++..+..+..-.-+..++++++++++.||..+|.+||||.+|.+.-+.+
T Consensus       293 ShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  293 SHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             cccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence            999999999999999998 8899999999999998887777677789999999999999999999999999998766665


Q ss_pred             CCCC
Q 041080          235 RPLQ  238 (247)
Q Consensus       235 ~~~~  238 (247)
                      ....
T Consensus       373 eaqp  376 (1039)
T KOG0199|consen  373 EAQP  376 (1039)
T ss_pred             hcCC
Confidence            5433

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-37  Score=225.16  Aligned_cols=232  Identities=29%  Similarity=0.524  Sum_probs=180.9

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec--------CCcEEEEEeccccCcHHHHHHhc
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD--------ENRLYIFLELVTKGSLANLYQKY   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~   73 (247)
                      |+.||+|.+..+.   +.+..-....+|+++|..|+|+|++.+++.+..        ...+++||++|.. +|.-++...
T Consensus        42 ~kkvalkkvlmen---eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~  117 (376)
T KOG0669|consen   42 GKKVALKKVLMEN---EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNR  117 (376)
T ss_pred             cchhHHHHHHHhc---cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCc
Confidence            5667777665432   122223345689999999999999999998653        2368999999987 888888665


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc------cccCCCCCCccCC
Q 041080           74 --HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND------LKSCKGTPFWMAP  145 (247)
Q Consensus        74 --~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~aP  145 (247)
                        +++...+..++.++..||.|+|+..|+|||+|+.|++|+.+|.++|+|||+++......      ..+.+-+.+|++|
T Consensus       118 ~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrpp  197 (376)
T KOG0669|consen  118 KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPP  197 (376)
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCH
Confidence              48999999999999999999999999999999999999999999999999996544333      2334458999999


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc---------------------CCCCCCC-----
Q 041080          146 EVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK---------------------GELPSVP-----  199 (247)
Q Consensus       146 E~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~---------------------~~~~~~~-----  199 (247)
                      |.+.+... ++++.|+|+.||++.+|.++.+.+...+....+..+..                     ...++++     
T Consensus       198 EllLG~r~-yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~r  276 (376)
T KOG0669|consen  198 ELLLGDRE-YGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKR  276 (376)
T ss_pred             HHhhcccc-cCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhh
Confidence            99987665 89999999999999999999888766655444332211                     0001111     


Q ss_pred             --------CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCC-CCC
Q 041080          200 --------SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR-PLQ  238 (247)
Q Consensus       200 --------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~-~~~  238 (247)
                              -.-+++..+++.++|..||.+|++++++++|.||.+ ++.
T Consensus       277 kv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  277 KVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP  324 (376)
T ss_pred             hhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence                    112557889999999999999999999999998876 444

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.1e-35  Score=215.52  Aligned_cols=226  Identities=26%  Similarity=0.444  Sum_probs=179.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecC--CcEEEEEeccccCcHHHHHHhcCCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDE--NRLYIFLELVTKGSLANLYQKYHLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~   77 (247)
                      |.+.++||++++..        .+.+.+|+++|..|. ||||+++++...+.  ....+++||.+..+...+...  ++.
T Consensus        62 ~~eK~ViKiLKPVk--------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t--l~d  131 (338)
T KOG0668|consen   62 NNEKCVIKILKPVK--------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT--LTD  131 (338)
T ss_pred             CCceEEEeeechHH--------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhh--hch
Confidence            45678899987543        346889999999996 99999999987664  578999999999877776554  778


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC-CeEEcccccccccCcccccc-CCCCCCccCCcccccCCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG-SVKLADFGLAKATTMNDLKS-CKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~-~~~l~df~~~~~~~~~~~~~-~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ..+..++.+++.||.|+|+.||+|+|+||.|++++... .++|+|+|++.+..+....+ .+.+..|..||.+..-+. +
T Consensus       132 ~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~-Y  210 (338)
T KOG0668|consen  132 YDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQM-Y  210 (338)
T ss_pred             hhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechh-c
Confidence            88999999999999999999999999999999999654 59999999998877665444 457788899999875443 7


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCC-CChhhHHHHHhh-------------cCC----------------------CCCCC
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYS-HLEGVQALFRIG-------------KGE----------------------LPSVP  199 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~-~~~~~~~~~~~~-------------~~~----------------------~~~~~  199 (247)
                      +.+.|+|||||++..|+..+.||- +.+..++.-.+.             +..                      .....
T Consensus       211 DYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n  290 (338)
T KOG0668|consen  211 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSEN  290 (338)
T ss_pred             cccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccc
Confidence            889999999999999999888863 223322221110             000                      00111


Q ss_pred             -CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          200 -SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       200 -~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                       .-.+++..+++.++|..|-++|+|+.|++.||||....
T Consensus       291 ~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~  329 (338)
T KOG0668|consen  291 QHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR  329 (338)
T ss_pred             cccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence             12468999999999999999999999999999998643

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-35  Score=250.14  Aligned_cols=221  Identities=30%  Similarity=0.514  Sum_probs=191.6

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-------
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-------   74 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------   74 (247)
                      ..||||......    .....+.+..|+++++.+ +|+||+.++|++...+..++|+||+..|+|.+++...+       
T Consensus       329 ~~VaVK~~k~~~----~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~  404 (609)
T KOG0200|consen  329 VTVAVKMLKENA----SSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDG  404 (609)
T ss_pred             EEEEEEeccccc----CcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccc
Confidence            468999886542    235677889999999999 59999999999999999999999999999999998877       


Q ss_pred             ----------CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCC-----CC
Q 041080           75 ----------LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK-----GT  139 (247)
Q Consensus        75 ----------~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~-----~~  139 (247)
                                ++...++.++.||+.|++||++.+++||||-..||++..+..+||+|||+++...........     -.
T Consensus       405 ~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP  484 (609)
T KOG0200|consen  405 SGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLP  484 (609)
T ss_pred             cCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccc
Confidence                      889999999999999999999999999999999999999999999999999865544433222     12


Q ss_pred             CCccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCh-hhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCC
Q 041080          140 PFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLE-GVQALFRIGKGELPSVPSSLSRDARDFILKCLQVN  217 (247)
Q Consensus       140 ~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  217 (247)
                      ..|+|||.+...  .++.++||||+|+++||+++ |..||.... ..+....+..+.....|...++++.++|+.||+.+
T Consensus       485 ~kWmApEsl~~~--~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~  562 (609)
T KOG0200|consen  485 VKWMAPESLFDR--VFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNAD  562 (609)
T ss_pred             eeecCHHHhccC--cccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCC
Confidence            349999999763  38999999999999999998 889998755 55566678888888889999999999999999999


Q ss_pred             CCCCCChhhhhc
Q 041080          218 PNDRPTVTELME  229 (247)
Q Consensus       218 p~~Rps~~~il~  229 (247)
                      |.+||++.++.+
T Consensus       563 p~~RP~F~~~~~  574 (609)
T KOG0200|consen  563 PEDRPTFSECVE  574 (609)
T ss_pred             cccCCCHHHHHH
Confidence            999999998864

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=243.60  Aligned_cols=228  Identities=32%  Similarity=0.636  Sum_probs=196.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeec-----CCcEEEEEeccccCcHHHHHHhc-
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKD-----ENRLYIFLELVTKGSLANLYQKY-   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~-   73 (247)
                      +|+..|+|+......      ..+.++.|+++++.. .|||++.++++|.-     ++.++||||||.|||.-++++.. 
T Consensus        43 ~~~~aa~kI~~~~~d------~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~  116 (953)
T KOG0587|consen   43 TGQLAAIKIMDPTED------EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK  116 (953)
T ss_pred             cCceeeeEeecCCcc------ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc
Confidence            477788998865432      234567899999998 59999999998743     56899999999999999998763 


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccc
Q 041080           74 --HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVN  149 (247)
Q Consensus        74 --~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~  149 (247)
                        ++.++.+..|+..++.|+.+||+..++|+|+|-.||+++.++.+||+|||.+......  ......|++.|+|||++.
T Consensus       117 g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEVia  196 (953)
T KOG0587|consen  117 GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIA  196 (953)
T ss_pred             ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeee
Confidence              4899999999999999999999999999999999999999999999999998654432  345677999999999986


Q ss_pred             cC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCC--CCcCCHHHHHHHHHHhcCCCCCCCCh
Q 041080          150 SK---NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDARDFILKCLQVNPNDRPTV  224 (247)
Q Consensus       150 ~~---~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~  224 (247)
                      ..   ...++.++|+||||++..||.-|.+|+.++-....+-.+...+.|.+  +..+++++.++|..||.+|..+||+.
T Consensus       197 c~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~  276 (953)
T KOG0587|consen  197 CDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPST  276 (953)
T ss_pred             cccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcch
Confidence            53   33478899999999999999999999999888888888777776665  45789999999999999999999999


Q ss_pred             hhhhcCccCC
Q 041080          225 TELMEHPFVK  234 (247)
Q Consensus       225 ~~il~~p~~~  234 (247)
                      .++|+|||..
T Consensus       277 ~~ll~hpFi~  286 (953)
T KOG0587|consen  277 EELLKHPFIT  286 (953)
T ss_pred             hhhccCCccc
Confidence            9999999998

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.7e-35  Score=236.48  Aligned_cols=225  Identities=29%  Similarity=0.472  Sum_probs=187.2

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC------CCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE------QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-   74 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-   74 (247)
                      |..||||+++..      +...+.=..|+.+|++|.      .-|+++++-.|...+++|+|||-+.- +|.+++++++ 
T Consensus       457 ~~~vAiKIIRnN------E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~  529 (752)
T KOG0670|consen  457 GQEVAIKIIRNN------EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGR  529 (752)
T ss_pred             CCeeEEEEeecc------hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhhc-hHHHHHHHhCc
Confidence            678999999854      344555668999999994      25899999999999999999999865 8999999875 


Q ss_pred             ---CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC-CeEEcccccccccCccccccCCCCCCccCCccccc
Q 041080           75 ---LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG-SVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNS  150 (247)
Q Consensus        75 ---~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~  150 (247)
                         +....+..++.|++.||..|.+.|++|.||||+||+++... .++|||||.+...+..+...+.-+..|.|||++.|
T Consensus       530 nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG  609 (752)
T KOG0670|consen  530 NVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILG  609 (752)
T ss_pred             ccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccccccccHHHHHHhccCcceeec
Confidence               77889999999999999999999999999999999998754 57999999999999898888888889999999987


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhh--cCCCC--------------------------------
Q 041080          151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIG--KGELP--------------------------------  196 (247)
Q Consensus       151 ~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~--~~~~~--------------------------------  196 (247)
                      .+  |+...|+||.||+||||.||+..|.+.+....+....  ++++|                                
T Consensus       610 ~~--yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~  687 (752)
T KOG0670|consen  610 LP--YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTERE  687 (752)
T ss_pred             Cc--ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccce
Confidence            77  7888999999999999999999987776655542211  01110                                


Q ss_pred             ----------------------CCC---CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          197 ----------------------SVP---SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       197 ----------------------~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                                            .++   ...-..+++|+.+||..||.+|.|.+++|.||||..
T Consensus       688 ~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  688 KRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             eEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence                                  000   011235789999999999999999999999999974

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=220.24  Aligned_cols=230  Identities=27%  Similarity=0.494  Sum_probs=187.1

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHH-HhcCCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLY-QKYHLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l-~~~~~~~~~   79 (247)
                      .+.||+|+++++-...  ++.+.-.+-|-.+..+- +||.+|-++..|+++..+++|.||.+||+|--.+ .++.++++.
T Consensus       275 ~qiyamkvvkkel~nd--dedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeh  352 (593)
T KOG0695|consen  275 DQIYAMKVVKKELVND--DEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH  352 (593)
T ss_pred             ceeeehhhHHHHhcCC--cccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHH
Confidence            4678999998764322  23333444566666665 6999999999999999999999999999884433 456799999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccC--ccccccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      +..+...|..||.|||+.||+++|||.+|++++..|.+||+|+|+....-  ........|++-|.|||.+++..  |+.
T Consensus       353 arfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgee--ygf  430 (593)
T KOG0695|consen  353 ARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE--YGF  430 (593)
T ss_pred             hhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccc--cCc
Confidence            99999999999999999999999999999999999999999999975322  22355678999999999997766  899


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCC-------hhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC------Ch
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHL-------EGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP------TV  224 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~  224 (247)
                      +.|.|+||++|++|+.|+.||+-.       ...+.+-++.-.+...+|..++-....+++..|++||.+|.      .+
T Consensus       431 svdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~  510 (593)
T KOG0695|consen  431 SVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGF  510 (593)
T ss_pred             eehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccch
Confidence            999999999999999999999422       22223333444455577888888899999999999999994      47


Q ss_pred             hhhhcCccCCC
Q 041080          225 TELMEHPFVKR  235 (247)
Q Consensus       225 ~~il~~p~~~~  235 (247)
                      .++-.|+||+.
T Consensus       511 ~dik~h~ffr~  521 (593)
T KOG0695|consen  511 SDIKSHAFFRS  521 (593)
T ss_pred             hhhhcchhhhh
Confidence            89999999985

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=7e-33  Score=219.98  Aligned_cols=196  Identities=19%  Similarity=0.336  Sum_probs=152.6

Q ss_pred             HHHHHhhcCCCceeeeceeeecCC----cEEEEEeccccCcHHHHHHhcC-CCHHHHHHHHHHHHHHHHHhhhCCeeecC
Q 041080           29 EISLLSQFEQDNIVQYLGTDKDEN----RLYIFLELVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYLHERNVVHRD  103 (247)
Q Consensus        29 e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~d  103 (247)
                      +...+..+.|++++++++.+....    ..++++++... ++.+.++... .++..+..++.|++.|+.+||+.|++|||
T Consensus        73 ~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrD  151 (294)
T PHA02882         73 LWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGD  151 (294)
T ss_pred             HHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            344556678999999998755433    34678887754 6777766543 67888999999999999999999999999


Q ss_pred             CCCCcEEEcCCCCeEEcccccccccCcc---------ccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhC
Q 041080          104 IKCANILVDASGSVKLADFGLAKATTMN---------DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR  174 (247)
Q Consensus       104 l~~~ni~~~~~~~~~l~df~~~~~~~~~---------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g  174 (247)
                      |||+||+++.++.++|+|||++......         ......|++.|+|||...+..  ++.++||||||+++++|++|
T Consensus       152 iKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~--~~~~~DiwSlG~~l~el~~g  229 (294)
T PHA02882        152 IKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC--VTRRGDLESLGYCMLKWAGI  229 (294)
T ss_pred             CCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC--CCcHHHHHHHHHHHHHHHhC
Confidence            9999999999999999999998643211         112235889999999986544  79999999999999999999


Q ss_pred             CCCCCCChhhHH---------HHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          175 RPPYSHLEGVQA---------LFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       175 ~~p~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ..||........         ...+....  ......++++.+++..|+..+|.+||+++++++
T Consensus       230 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        230 KLPWKGFGHNGNLIHAAKCDFIKRLHEGK--IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             CCCCCccccchHHHHHhHHHHHHHhhhhh--hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            999987632211         12222221  123456899999999999999999999999875

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-34  Score=235.45  Aligned_cols=179  Identities=28%  Similarity=0.475  Sum_probs=151.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec------CCcEEEEEeccccCcHHHHHHh--
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD------ENRLYIFLELVTKGSLANLYQK--   72 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~--   72 (247)
                      .|+.||||.+....    ...-.+..-+|++++++++|+|||+++++-.+      .....+|||||.||+|...+++  
T Consensus        37 tG~~vAvK~~~~~~----~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PE  112 (732)
T KOG4250|consen   37 TGRLVAVKTFNKES----SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPE  112 (732)
T ss_pred             cccchhHHhhhhhc----ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcc
Confidence            48899999998754    22335566789999999999999999997544      3367899999999999999964  


Q ss_pred             --cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC--C--CeEEcccccccccCccc-cccCCCCCCccCC
Q 041080           73 --YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS--G--SVKLADFGLAKATTMND-LKSCKGTPFWMAP  145 (247)
Q Consensus        73 --~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~--~--~~~l~df~~~~~~~~~~-~~~~~~~~~~~aP  145 (247)
                        +++++.+++.++.++..|+.+||++||+||||||.||++-..  |  ..||+|||.++...... .....||..|++|
T Consensus       113 N~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhP  192 (732)
T KOG4250|consen  113 NAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHP  192 (732)
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcCh
Confidence              579999999999999999999999999999999999998543  3  36999999998776554 4567799999999


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhh
Q 041080          146 EVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV  184 (247)
Q Consensus       146 E~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~  184 (247)
                      |.... ...++...|.||||+++|+++||..||......
T Consensus       193 el~E~-q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  193 ELYER-QKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             HHHhh-ccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            99853 234889999999999999999999999766554

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.1e-33  Score=254.99  Aligned_cols=214  Identities=23%  Similarity=0.371  Sum_probs=162.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.||+|.+.....         ....|+..+++++||||+++++++.+.+..++||||+++|+|.++++.  +++..+
T Consensus       714 ~~~~vavK~~~~~~~---------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--l~~~~~  782 (968)
T PLN00113        714 NGMQFVVKEINDVNS---------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--LSWERR  782 (968)
T ss_pred             CCcEEEEEEccCCcc---------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc--CCHHHH
Confidence            478899998864321         112468889999999999999999999999999999999999999964  888999


Q ss_pred             HHHHHHHHHHHHHhh---hCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCc
Q 041080           81 SSYTRQILNGLVYLH---ERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh---~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      ..++.|++.|++|||   +.+++|+|+||+||+++.++..++. ++......  ......++..|+|||.+.+..  ++.
T Consensus       783 ~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~--~~~  857 (968)
T PLN00113        783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC--TDTKCFISSAYVAPETRETKD--ITE  857 (968)
T ss_pred             HHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc--cCCCccccccccCcccccCCC--CCc
Confidence            999999999999999   6699999999999999988887764 44432221  112235778999999986544  789


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhh--HHHH---HhhcC------CCCC------CCCcCCHHHHHHHHHHhcCCCCC
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGV--QALF---RIGKG------ELPS------VPSSLSRDARDFILKCLQVNPND  220 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~--~~~~---~~~~~------~~~~------~~~~~~~~~~~li~~~l~~~p~~  220 (247)
                      ++||||||+++||+++|+.||......  ....   .....      ..+.      .+.....++.+++.+||+.+|.+
T Consensus       858 ~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~  937 (968)
T PLN00113        858 KSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTA  937 (968)
T ss_pred             ccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchh
Confidence            999999999999999999998532111  1110   00000      0011      11122335778999999999999


Q ss_pred             CCChhhhhcC
Q 041080          221 RPTVTELMEH  230 (247)
Q Consensus       221 Rps~~~il~~  230 (247)
                      |||++++++.
T Consensus       938 RPt~~evl~~  947 (968)
T PLN00113        938 RPCANDVLKT  947 (968)
T ss_pred             CcCHHHHHHH
Confidence            9999999874

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-33  Score=230.99  Aligned_cols=228  Identities=25%  Similarity=0.461  Sum_probs=179.6

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-CCHHHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVSS   82 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~   82 (247)
                      .||.|.+++.+  -..+......+.|-.||..-+.+=||+++..|++.+.+|+||+|++||++-.++-+.+ |.+..++.
T Consensus       656 lYAmKTLrKaD--Vl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARF  733 (1034)
T KOG0608|consen  656 LYAMKTLRKAD--VLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARF  733 (1034)
T ss_pred             HHHHhhhHHHH--HHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHH
Confidence            45666665543  1234455667889999999999999999999999999999999999999988776655 88888999


Q ss_pred             HHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccC---------cc----------------------
Q 041080           83 YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT---------MN----------------------  131 (247)
Q Consensus        83 ~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~---------~~----------------------  131 (247)
                      ++..+.+|+++.|+.|++||||||+|||||.+|.+||+|||+.....         ..                      
T Consensus       734 YIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lk  813 (1034)
T KOG0608|consen  734 YIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLK  813 (1034)
T ss_pred             HHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccch
Confidence            99999999999999999999999999999999999999999874110         00                      


Q ss_pred             -------------ccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc-CCC--
Q 041080          132 -------------DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK-GEL--  195 (247)
Q Consensus       132 -------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-~~~--  195 (247)
                                   .....+|++-|+|||++....  ++...|+|+.|++||+|+.|+.||-..+..+...++.+ ...  
T Consensus       814 vL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g--~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~  891 (1034)
T KOG0608|consen  814 VLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG--YTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLH  891 (1034)
T ss_pred             HHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC--ccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccc
Confidence                         012344888999999996544  88899999999999999999999977665554433322 111  


Q ss_pred             CCCCCcCCHHHHHHHHHHhcCCCCCCC---ChhhhhcCccCCCC
Q 041080          196 PSVPSSLSRDARDFILKCLQVNPNDRP---TVTELMEHPFVKRP  236 (247)
Q Consensus       196 ~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~p~~~~~  236 (247)
                      -.....++.+..++|.++.. ++..|.   .++++-.||||+.+
T Consensus       892 ~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgI  934 (1034)
T KOG0608|consen  892 IPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGI  934 (1034)
T ss_pred             cccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCcccccc
Confidence            12235789999999988654 355664   46789999999975

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=8.7e-33  Score=235.20  Aligned_cols=187  Identities=24%  Similarity=0.303  Sum_probs=134.5

Q ss_pred             ecCCcEEEEEeccccCcHHHHHHhcCC---------------------CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCC
Q 041080           49 KDENRLYIFLELVTKGSLANLYQKYHL---------------------SDSQVSSYTRQILNGLVYLHERNVVHRDIKCA  107 (247)
Q Consensus        49 ~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~  107 (247)
                      ..+...++|+||+.+++|.+++.....                     ....+..++.|++.||.|||+.||+|+||||+
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~  284 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ  284 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence            456689999999999999998865432                     13346689999999999999999999999999


Q ss_pred             cEEEcC-CCCeEEcccccccccCcc---ccccCCCCCCccCCcccccCCC--------------------CCCcchhHHH
Q 041080          108 NILVDA-SGSVKLADFGLAKATTMN---DLKSCKGTPFWMAPEVVNSKND--------------------GYGLTADIWS  163 (247)
Q Consensus       108 ni~~~~-~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~--------------------~~~~~~Di~s  163 (247)
                      ||+++. ++.++|+|||++......   ......+++.|+|||.+.....                    .++.++||||
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            999986 578999999998643322   2234557889999996532211                    1344569999


Q ss_pred             HHHHHHHHHhCCCCCCCChhhHHHHHhhcC--------------CCCC------CCCcCCHHHHHHHHHHhcCCCCCCCC
Q 041080          164 LGCTVLEMLTRRPPYSHLEGVQALFRIGKG--------------ELPS------VPSSLSRDARDFILKCLQVNPNDRPT  223 (247)
Q Consensus       164 lG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--------------~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps  223 (247)
                      +||++|+|+++..++..... .....+...              ..+.      .....+....+||.+||+.||.+|||
T Consensus       365 lGviL~el~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t  443 (566)
T PLN03225        365 AGLIFLQMAFPNLRSDSNLI-QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS  443 (566)
T ss_pred             HHHHHHHHHhCcCCCchHHH-HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence            99999999987766433211 111110000              0000      00112334568999999999999999


Q ss_pred             hhhhhcCccCCCC
Q 041080          224 VTELMEHPFVKRP  236 (247)
Q Consensus       224 ~~~il~~p~~~~~  236 (247)
                      +.++++||||+..
T Consensus       444 a~e~L~Hpff~~~  456 (566)
T PLN03225        444 AKAALAHPYFDRE  456 (566)
T ss_pred             HHHHhCCcCcCCC
Confidence            9999999999874

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-33  Score=218.40  Aligned_cols=234  Identities=25%  Similarity=0.392  Sum_probs=187.3

Q ss_pred             CceEEEEEEeecCC--CccchHHHHHHHHHHHHHhhcCCCceeeeceeeec-CCcEEEEEeccccCcHHHHHHhcC-CCH
Q 041080            2 GFFFAVKEVSLQDQ--GAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD-ENRLYIFLELVTKGSLANLYQKYH-LSD   77 (247)
Q Consensus         2 g~~~~lK~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~   77 (247)
                      .++||+|+-.....  .+......+..-+|..+-+.|+||.||+++++|.- .+.+|.|.|||+|.+|.-+++... +++
T Consensus       488 qRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSE  567 (775)
T KOG1151|consen  488 QRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSE  567 (775)
T ss_pred             hheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhH
Confidence            57899998765442  23445556678889999999999999999999865 578899999999999999998765 999


Q ss_pred             HHHHHHHHHHHHHHHHhhhC--CeeecCCCCCcEEEcC---CCCeEEcccccccccCccc---------cccCCCCCCcc
Q 041080           78 SQVSSYTRQILNGLVYLHER--NVVHRDIKCANILVDA---SGSVKLADFGLAKATTMND---------LKSCKGTPFWM  143 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~--~i~h~dl~~~ni~~~~---~~~~~l~df~~~~~~~~~~---------~~~~~~~~~~~  143 (247)
                      .++..|+.||+.||.||...  -|+|.||||.||++-.   -|.++|+|||++.......         .....|+.||+
T Consensus       568 KEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYL  647 (775)
T KOG1151|consen  568 KEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYL  647 (775)
T ss_pred             HHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeec
Confidence            99999999999999999976  5999999999999954   3679999999996433222         23345899999


Q ss_pred             CCcccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCChh-hHHHHH--hhcCCCCCCC--CcCCHHHHHHHHHHhcC
Q 041080          144 APEVVNSK--NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG-VQALFR--IGKGELPSVP--SSLSRDARDFILKCLQV  216 (247)
Q Consensus       144 aPE~~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~--~~~~~~~~~~--~~~~~~~~~li~~~l~~  216 (247)
                      +||.+.-.  +...+.+.||||+|+++|.++.|+-||..... .+++..  +.+.....+|  +-++.+.+++|++||++
T Consensus       648 PPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaY  727 (775)
T KOG1151|consen  648 PPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAY  727 (775)
T ss_pred             CcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHh
Confidence            99997543  33368899999999999999999999976543 333332  2222222233  46789999999999999


Q ss_pred             CCCCCCChhhhhcCccCCC
Q 041080          217 NPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       217 ~p~~Rps~~~il~~p~~~~  235 (247)
                      .-.+|....++-.||||..
T Consensus       728 RKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  728 RKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             hhhhhhhHHHHccCccccc
Confidence            9999999999999999986

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.5e-32  Score=224.65  Aligned_cols=234  Identities=22%  Similarity=0.282  Sum_probs=162.0

Q ss_pred             CceEEEEEEeecCCCccch---------HHHHHHHHHHHHHhhcCCCce-----eeeceeeec--------CCcEEEEEe
Q 041080            2 GFFFAVKEVSLQDQGAQGK---------QSILQLEQEISLLSQFEQDNI-----VQYLGTDKD--------ENRLYIFLE   59 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~e   59 (247)
                      ++.||||.+.........+         ...+....|+.++.+++|.++     +++++++..        .+..++|+|
T Consensus       186 ~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~E  265 (507)
T PLN03224        186 KRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWK  265 (507)
T ss_pred             CceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEE
Confidence            4679999986533211000         011223347777777766544     667776643        356899999


Q ss_pred             ccccCcHHHHHHhc-------------------------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC
Q 041080           60 LVTKGSLANLYQKY-------------------------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS  114 (247)
Q Consensus        60 ~~~~~~L~~~l~~~-------------------------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~  114 (247)
                      |+++++|.++++..                         .+++..++.++.|++.+|.++|+.|++|+||||+||+++.+
T Consensus       266 y~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~  345 (507)
T PLN03224        266 FESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD  345 (507)
T ss_pred             cCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCC
Confidence            99999999887532                         13456788899999999999999999999999999999999


Q ss_pred             CCeEEcccccccccCcccc-c--cCCCCCCccCCcccccCCC--------------------CCCcchhHHHHHHHHHHH
Q 041080          115 GSVKLADFGLAKATTMNDL-K--SCKGTPFWMAPEVVNSKND--------------------GYGLTADIWSLGCTVLEM  171 (247)
Q Consensus       115 ~~~~l~df~~~~~~~~~~~-~--~~~~~~~~~aPE~~~~~~~--------------------~~~~~~Di~slG~ll~~l  171 (247)
                      +.++|+|||++........ .  ...+++.|++||.+.....                    ......|+||+|+++++|
T Consensus       346 ~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em  425 (507)
T PLN03224        346 GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQM  425 (507)
T ss_pred             CcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHH
Confidence            9999999999854332211 1  1224788999998753221                    112347999999999999


Q ss_pred             HhCCC-CCCCChhhHHHH----------Hhhc-CCC-CCCCCcCCHHHHHHHHHHhcCCC---CCCCChhhhhcCccCCC
Q 041080          172 LTRRP-PYSHLEGVQALF----------RIGK-GEL-PSVPSSLSRDARDFILKCLQVNP---NDRPTVTELMEHPFVKR  235 (247)
Q Consensus       172 ~~g~~-p~~~~~~~~~~~----------~~~~-~~~-~~~~~~~~~~~~~li~~~l~~~p---~~Rps~~~il~~p~~~~  235 (247)
                      +++.. |+..........          .... ... -......++..++++.+||..+|   .+|+|++|+|+||||..
T Consensus       426 ~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        426 CVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             HhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            99875 654322111100          0011 111 11224568899999999999766   68999999999999964

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-32  Score=196.80  Aligned_cols=195  Identities=29%  Similarity=0.521  Sum_probs=159.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-----cC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-----YH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~   74 (247)
                      +|..+|+|.+..+-    ..+..++...|+++..+. .+|.+|.|+|.....+..++.||.+.. ||+.+-++     ..
T Consensus        70 sg~imAvKri~~tv----n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~  144 (282)
T KOG0984|consen   70 SGTIMAVKRIRATV----NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGT  144 (282)
T ss_pred             CCeEEEEeeehhhc----ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCc
Confidence            58889999997643    345566777888888776 699999999998899999999999966 88876543     23


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhC-CeeecCCCCCcEEEcCCCCeEEcccccccccCcccccc-CCCCCCccCCcccccC-
Q 041080           75 LSDSQVSSYTRQILNGLVYLHER-NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKS-CKGTPFWMAPEVVNSK-  151 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~aPE~~~~~-  151 (247)
                      +++..+-+++..++.|+.|||++ .++|||+||+||+++.+|++|+||||++-.....-... ..|-..|+|||.+... 
T Consensus       145 ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~  224 (282)
T KOG0984|consen  145 IPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPEL  224 (282)
T ss_pred             CchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCccc
Confidence            89999999999999999999975 89999999999999999999999999986655444444 4577889999998643 


Q ss_pred             -CCCCCcchhHHHHHHHHHHHHhCCCCCCCC-hhhHHHHHhhcCCCCCCCC
Q 041080          152 -NDGYGLTADIWSLGCTVLEMLTRRPPYSHL-EGVQALFRIGKGELPSVPS  200 (247)
Q Consensus       152 -~~~~~~~~Di~slG~ll~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~  200 (247)
                       +..|+.++||||||+++.||++++.||+.. +...++.++.....|.++.
T Consensus       225 n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~  275 (282)
T KOG0984|consen  225 NQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPA  275 (282)
T ss_pred             CcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCcc
Confidence             335899999999999999999999998654 5666666766666666553

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-33  Score=231.53  Aligned_cols=219  Identities=28%  Similarity=0.470  Sum_probs=190.3

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVS   81 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~   81 (247)
                      +||+|++...    .+.+....+..|+..|.+++|||++++++++.... ..||++|+++|+|.++++..  .+.....+
T Consensus       727 pVaiKvl~~~----t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lL  801 (1177)
T KOG1025|consen  727 PVAIKVLIEF----TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLL  801 (1177)
T ss_pred             eeEEEEeecc----CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHH
Confidence            6889988653    44555667889999999999999999999988765 88999999999999998654  48888999


Q ss_pred             HHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc----cCCCCCCccCCcccccCCCCCCc
Q 041080           82 SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK----SCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        82 ~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      .|..||++|+.|||.++++||||-..||++.....+++.|||++.........    ...-...|+|-|.+....  ++.
T Consensus       802 nw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~--~th  879 (1177)
T KOG1025|consen  802 NWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRK--YTH  879 (1177)
T ss_pred             HHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccC--CCc
Confidence            99999999999999999999999999999999999999999999766544322    122334578888875555  899


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          158 TADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ++||||+|+++||++| |..|+......++.+.+..+..-+-|+..+.++..++.+||-.|+..||+++++..
T Consensus       880 qSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  880 QSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             hhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence            9999999999999998 99999999999999988888887888999999999999999999999999988754

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=3.8e-31  Score=199.36  Aligned_cols=193  Identities=42%  Similarity=0.692  Sum_probs=169.8

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~   79 (247)
                      |+.+++|++.......    ..+.+.+|+..++.++|++++++++++......++++|++++++|.+++...  .++...
T Consensus        18 ~~~~~~K~~~~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~   93 (215)
T cd00180          18 GKKVAIKIIKKEDSSS----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDE   93 (215)
T ss_pred             CcEEEEEEeccccchh----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHH
Confidence            7899999997543211    4567889999999999999999999999999999999999989999999876  689999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC-CCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~-~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+||+.+.......  .....+...|.+||..... ...+
T Consensus        94 ~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~  172 (215)
T cd00180          94 ILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGK-GYYS  172 (215)
T ss_pred             HHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhccc-CCCC
Confidence            9999999999999999999999999999999999 8999999999987655443  3445577889999998654 2368


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                      .++|+|++|++++++                                ..+.+++.+|++.+|.+||++.++++++
T Consensus       173 ~~~D~~~lg~~~~~l--------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         173 EKSDIWSLGVILYEL--------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             chhhhHHHHHHHHHH--------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence            899999999999998                                6899999999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-32  Score=213.73  Aligned_cols=217  Identities=26%  Similarity=0.370  Sum_probs=166.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhh--cCCCceeeeceeeecCC----cEEEEEeccccCcHHHHHHhcC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQ--FEQDNIVQYLGTDKDEN----RLYIFLELVTKGSLANLYQKYH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~   74 (247)
                      +++.||||++..        +..+.+.+|-++.+-  ++|+||++|+++.....    .++||++|.+.|+|.++++.+-
T Consensus       232 ~~~~VAVKifp~--------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~nt  303 (534)
T KOG3653|consen  232 DNRLVAVKIFPE--------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANT  303 (534)
T ss_pred             cCceeEEEecCH--------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhcc
Confidence            478999999963        334456666666665  58999999999876665    8999999999999999999999


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhC---------CeeecCCCCCcEEEcCCCCeEEcccccccccCcc----ccccCCCCCC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHER---------NVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTPF  141 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~---------~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~  141 (247)
                      +++....+++..++.||+|||..         .|+|||||++||++..|++..|+|||++....+.    .....+||.+
T Consensus       304 isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~R  383 (534)
T KOG3653|consen  304 ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRR  383 (534)
T ss_pred             ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhh
Confidence            99999999999999999999952         5999999999999999999999999999655433    2445779999


Q ss_pred             ccCCcccccCCCC----CCcchhHHHHHHHHHHHHhCC------------CCCCC-----ChhhHHHHHhh-cCCCCCCC
Q 041080          142 WMAPEVVNSKNDG----YGLTADIWSLGCTVLEMLTRR------------PPYSH-----LEGVQALFRIG-KGELPSVP  199 (247)
Q Consensus       142 ~~aPE~~~~~~~~----~~~~~Di~slG~ll~~l~~g~------------~p~~~-----~~~~~~~~~~~-~~~~~~~~  199 (247)
                      |||||++.+..+-    .-.+.||||+|.++||++++=            .||+.     ....+...... +...|.++
T Consensus       384 YMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p  463 (534)
T KOG3653|consen  384 YMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIP  463 (534)
T ss_pred             hcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCCh
Confidence            9999999654321    124699999999999998731            12220     01112222222 23344554


Q ss_pred             Cc-----CCHHHHHHHHHHhcCCCCCCCChh
Q 041080          200 SS-----LSRDARDFILKCLQVNPNDRPTVT  225 (247)
Q Consensus       200 ~~-----~~~~~~~li~~~l~~~p~~Rps~~  225 (247)
                      ..     ...-+++.+..||..|+..|.|+.
T Consensus       464 ~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  464 DAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             hhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence            32     245688999999999999999974

>PLN00181 protein SPA1-RELATED; Provisional

Probab=100.00  E-value=6e-33  Score=246.41  Aligned_cols=199  Identities=17%  Similarity=0.267  Sum_probs=145.4

Q ss_pred             HhhcCC-Cceeeeceee-------ecCCcEEEEEeccccCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHhhhCCeeec
Q 041080           33 LSQFEQ-DNIVQYLGTD-------KDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHR  102 (247)
Q Consensus        33 l~~l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~  102 (247)
                      .+.++| +||+++++++       .....++.++|++. ++|.++++..  .+++..++.++.||+.||.|||++||+|+
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr  104 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVH  104 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            345566 6888888877       23346778889884 5999999753  48999999999999999999999999999


Q ss_pred             CCCCCcEEEcCC-------------------CCeEEcccccccccCcc------------------ccccCCCCCCccCC
Q 041080          103 DIKCANILVDAS-------------------GSVKLADFGLAKATTMN------------------DLKSCKGTPFWMAP  145 (247)
Q Consensus       103 dl~~~ni~~~~~-------------------~~~~l~df~~~~~~~~~------------------~~~~~~~~~~~~aP  145 (247)
                      ||||+||+++..                   +.++++|||++......                  ......++++|+||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            999999999654                   44566666665421100                  00113468889999


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChh
Q 041080          146 EVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT  225 (247)
Q Consensus       146 E~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  225 (247)
                      |.+.+..  ++.++|||||||++|||+++..|+.....  ....+.....+............++.+||.++|.+||++.
T Consensus       185 E~~~~~~--~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~  260 (793)
T PLN00181        185 EEDNGSS--SNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMS  260 (793)
T ss_pred             hhhccCC--CCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChH
Confidence            9986654  78999999999999999998888653221  1111111111111112245567899999999999999999


Q ss_pred             hhhcCccCCCC
Q 041080          226 ELMEHPFVKRP  236 (247)
Q Consensus       226 ~il~~p~~~~~  236 (247)
                      ++++||||...
T Consensus       261 eil~h~~~~~~  271 (793)
T PLN00181        261 ELLQSEFINEP  271 (793)
T ss_pred             HHhhchhhhhh
Confidence            99999999763

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=8e-32  Score=211.74  Aligned_cols=218  Identities=26%  Similarity=0.416  Sum_probs=164.9

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhh--cCCCceeeeceeeecC----CcEEEEEeccccCcHHHHHHhcCC
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQ--FEQDNIVQYLGTDKDE----NRLYIFLELVTKGSLANLYQKYHL   75 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~   75 (247)
                      |+.||||+|...+        .....+|.++.++  |+|+||+.|++.-..+    .+++||++|.+.|||.+++++..+
T Consensus       234 Ge~VAVKiF~srd--------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~tv  305 (513)
T KOG2052|consen  234 GEDVAVKIFSSRD--------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNTV  305 (513)
T ss_pred             CCceEEEEecccc--------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhccC
Confidence            8899999997543        2235566666665  5999999999986443    268999999999999999999999


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhC--------CeeecCCCCCcEEEcCCCCeEEcccccccccCcc------ccccCCCCCC
Q 041080           76 SDSQVSSYTRQILNGLVYLHER--------NVVHRDIKCANILVDASGSVKLADFGLAKATTMN------DLKSCKGTPF  141 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~--------~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~------~~~~~~~~~~  141 (247)
                      +.+..++++..+++||++||..        .|.|||||+.||++..+|.+.|+|+|++......      .....+||.+
T Consensus       306 ~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKR  385 (513)
T KOG2052|consen  306 TTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKR  385 (513)
T ss_pred             CHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceee
Confidence            9999999999999999999953        4999999999999999999999999998644433      2446779999


Q ss_pred             ccCCcccccCCC----CCCcchhHHHHHHHHHHHHhC----------CCCCCCChhhHH-HHHhh-----cCCCCCCCCc
Q 041080          142 WMAPEVVNSKND----GYGLTADIWSLGCTVLEMLTR----------RPPYSHLEGVQA-LFRIG-----KGELPSVPSS  201 (247)
Q Consensus       142 ~~aPE~~~~~~~----~~~~~~Di~slG~ll~~l~~g----------~~p~~~~~~~~~-~~~~~-----~~~~~~~~~~  201 (247)
                      |||||++...-.    ..-..+||||||.++||++.+          +.||.+....+- ...+.     ..-.|.+|+.
T Consensus       386 YMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnr  465 (513)
T KOG2052|consen  386 YMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNR  465 (513)
T ss_pred             ccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcc
Confidence            999999854321    123469999999999999752          356654433222 11111     1123444443


Q ss_pred             C--C---HHHHHHHHHHhcCCCCCCCChhhh
Q 041080          202 L--S---RDARDFILKCLQVNPNDRPTVTEL  227 (247)
Q Consensus       202 ~--~---~~~~~li~~~l~~~p~~Rps~~~i  227 (247)
                      +  .   ..+.++|+.||..+|..|.|+--|
T Consensus       466 W~s~~~l~~m~klMkeCW~~Np~aRltALri  496 (513)
T KOG2052|consen  466 WKSDPALRVMAKLMKECWYANPAARLTALRI  496 (513)
T ss_pred             cccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence            2  2   246688999999999999987554

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-33  Score=208.39  Aligned_cols=231  Identities=31%  Similarity=0.503  Sum_probs=182.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC-----cEEEEEeccccCcHHHHHHh-cC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN-----RLYIFLELVTKGSLANLYQK-YH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~-~~   74 (247)
                      ||+.||+|.+....   .+-.+.+++.+|+++|..++|.|++..++.-+-..     .+|+++|.+.. +|.+++-. ..
T Consensus        77 dgrrvalkK~pnvf---q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHKIIVSPQ~  152 (449)
T KOG0664|consen   77 SGKRVALKKMPNVF---QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHKIIVSPQA  152 (449)
T ss_pred             CccchhHhhcchHH---HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhheeccCCC
Confidence            68889999886532   33445677889999999999999999888755432     56788888865 77776644 45


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccccc---CCCCCCccCCcccccC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKS---CKGTPFWMAPEVVNSK  151 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~aPE~~~~~  151 (247)
                      ++...+.-+++||+.||.|||+.||.|+||||.|.+++.|..+||||||+++........+   .+-+.+|+|||.+.+.
T Consensus       153 Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGa  232 (449)
T KOG0664|consen  153 LTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGA  232 (449)
T ss_pred             CCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcc
Confidence            8899999999999999999999999999999999999999999999999998766555433   3357889999999887


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhh-----------------------cC--CCCCCC-------
Q 041080          152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIG-----------------------KG--ELPSVP-------  199 (247)
Q Consensus       152 ~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~-----------------------~~--~~~~~~-------  199 (247)
                      .. |+.+.||||.||++.|++.++..|.........+-+.                       ..  +.+..+       
T Consensus       233 Rh-Ys~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS  311 (449)
T KOG0664|consen  233 RR-YTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIAS  311 (449)
T ss_pred             hh-hcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecC
Confidence            65 8999999999999999999888887666554443321                       11  111111       


Q ss_pred             -CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          200 -SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       200 -~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                       ..-..+...++..++.++|.+|.+.++.+.|++..+.
T Consensus       312 ~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  312 PDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             CcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence             1233456788899999999999999999999998874

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-30  Score=201.05  Aligned_cols=210  Identities=22%  Similarity=0.378  Sum_probs=183.0

Q ss_pred             cchHHHHHHHHHHHHHhhcCCCceeeeceeeec-CCcEEEEEeccccCcHHHHHHhc---------CCCHHHHHHHHHHH
Q 041080           18 QGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD-ENRLYIFLELVTKGSLANLYQKY---------HLSDSQVSSYTRQI   87 (247)
Q Consensus        18 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~l   87 (247)
                      .++-....+.+|--++..+.|||++++.+++.+ ....++++.+..-|+|..++...         .++..++..++.|+
T Consensus       326 AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQl  405 (563)
T KOG1024|consen  326 ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQL  405 (563)
T ss_pred             ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHH
Confidence            344556667888888888999999999998654 56889999999999999999732         27778899999999


Q ss_pred             HHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccccc----CCCCCCccCCcccccCCCCCCcchhHHH
Q 041080           88 LNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKS----CKGTPFWMAPEVVNSKNDGYGLTADIWS  163 (247)
Q Consensus        88 ~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~----~~~~~~~~aPE~~~~~~~~~~~~~Di~s  163 (247)
                      +.|+++||++|++|.||...|.+|++.-+++|+|=.+++..-+.....    ......|++||.+....  ++.++|+||
T Consensus       406 a~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~--yssasDvWs  483 (563)
T KOG1024|consen  406 AMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH--YSSASDVWS  483 (563)
T ss_pred             HHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhh--hcchhhhHH
Confidence            999999999999999999999999999999999999988765544322    12345699999996544  899999999


Q ss_pred             HHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          164 LGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       164 lG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ||+++|||++ |+.|+...+..+....+..+..-.-|.++|+++..++.-||...|++||+++|++.
T Consensus       484 fGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  484 FGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             HHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            9999999998 99999999999999999999988889999999999999999999999999999875

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-30  Score=206.78  Aligned_cols=103  Identities=30%  Similarity=0.418  Sum_probs=87.4

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-----C---Cceeeeceeeec----CCcEEEEEeccccCcHHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-----Q---DNIVQYLGTDKD----ENRLYIFLELVTKGSLANL   69 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~   69 (247)
                      .++||+|+.+      ..+...+....||++|++++     |   ..||++++.|..    +.++|+|+|++ |.+|..+
T Consensus       103 ~r~VAlKVvK------SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLkl  175 (590)
T KOG1290|consen  103 KRYVALKVVK------SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKL  175 (590)
T ss_pred             CeEEEEEEEe------hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHH
Confidence            5789999996      33445566778999999983     2   479999999876    45899999999 5588888


Q ss_pred             HHhc---CCCHHHHHHHHHHHHHHHHHhhhC-CeeecCCCCCcEEE
Q 041080           70 YQKY---HLSDSQVSSYTRQILNGLVYLHER-NVVHRDIKCANILV  111 (247)
Q Consensus        70 l~~~---~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~~~ni~~  111 (247)
                      |+..   +++...+..|+.||+.||.|||+. ||+|.||||+||++
T Consensus       176 I~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  176 IKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             HHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence            8764   599999999999999999999965 99999999999998

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=5.3e-31  Score=205.89  Aligned_cols=230  Identities=30%  Similarity=0.459  Sum_probs=178.4

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      ++.||+|.+.....       ..++.+|+++|..+ .+.||+++.+.+..++...+|+||++..+..++...  ++...+
T Consensus        64 ~~~valk~i~~ts~-------p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~--l~~~~i  134 (418)
T KOG1167|consen   64 RRYVALKAIYRTSS-------PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS--LSLAEI  134 (418)
T ss_pred             cceEeeeecccccC-------chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc--CCHHHH
Confidence            56899999976542       33588999999999 599999999999999999999999999988888765  667789


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC-CCeEEccccccccc-----------------Cc-c----------
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFGLAKAT-----------------TM-N----------  131 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~-~~~~l~df~~~~~~-----------------~~-~----------  131 (247)
                      .+++..++.||.++|..||+|+||||+|++.+.. +.-.|+|||++...                 .+ .          
T Consensus       135 ~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~  214 (418)
T KOG1167|consen  135 RWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVA  214 (418)
T ss_pred             HHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccc
Confidence            9999999999999999999999999999999854 67899999998510                 00 0          


Q ss_pred             ------------------ccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChh-hHHHH----
Q 041080          132 ------------------DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG-VQALF----  188 (247)
Q Consensus       132 ------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~----  188 (247)
                                        ...+..|++.|+|||++...+. .+.+.|+||.|+++..++++..||-.... .+.+.    
T Consensus       215 ~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~-QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~t  293 (418)
T KOG1167|consen  215 TASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR-QTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIAT  293 (418)
T ss_pred             cccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC-cCCccceeeccceeehhhccccccccCccccchHHHHHH
Confidence                              0113348899999999976655 58899999999999999999999722110 00000    


Q ss_pred             -----------------------------------------HhhcCC-----CCCCCCcCCHHHHHHHHHHhcCCCCCCC
Q 041080          189 -----------------------------------------RIGKGE-----LPSVPSSLSRDARDFILKCLQVNPNDRP  222 (247)
Q Consensus       189 -----------------------------------------~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp  222 (247)
                                                               .+....     ........+..+.+++++||..+|.+|.
T Consensus       294 ifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRi  373 (418)
T KOG1167|consen  294 IFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRI  373 (418)
T ss_pred             HhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcc
Confidence                                                     000000     0011123456789999999999999999


Q ss_pred             ChhhhhcCccCCCCCCCCC
Q 041080          223 TVTELMEHPFVKRPLQTPR  241 (247)
Q Consensus       223 s~~~il~~p~~~~~~~~~~  241 (247)
                      |++++|+||||.+..+.-+
T Consensus       374 tAEeALkHpFF~~~~~~~~  392 (418)
T KOG1167|consen  374 TAEDALKHPFFDEADRTER  392 (418)
T ss_pred             cHHHHhcCcCCcchhhhhh
Confidence            9999999999997654433

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=3.7e-30  Score=189.39  Aligned_cols=158  Identities=29%  Similarity=0.390  Sum_probs=124.8

Q ss_pred             CcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCC
Q 041080           64 GSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF  141 (247)
Q Consensus        64 ~~L~~~l~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  141 (247)
                      |+|.++++.+  ++++..++.++.|++.||.|||+.+      ||+||+++.++.+++  ||.+.......   ..+++.
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---~~g~~~   69 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---SRVDPY   69 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc---CCCccc
Confidence            5899999753  4999999999999999999999998      999999999999998  99876543322   257899


Q ss_pred             ccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhH-HHHHhhcCCCCC------CCCcCCH--HHHHHHHH
Q 041080          142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQ-ALFRIGKGELPS------VPSSLSR--DARDFILK  212 (247)
Q Consensus       142 ~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~------~~~~~~~--~~~~li~~  212 (247)
                      |+|||.+.+..  ++.++||||+|+++|+|++|..||....... ..........+.      .+..++.  ++++++.+
T Consensus        70 y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  147 (176)
T smart00750       70 FMAPEVIQGQS--YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV  147 (176)
T ss_pred             ccChHHhcCCC--CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence            99999996554  7889999999999999999999986543322 222221111111      1223333  69999999


Q ss_pred             HhcCCCCCCCChhhhhcCccCC
Q 041080          213 CLQVNPNDRPTVTELMEHPFVK  234 (247)
Q Consensus       213 ~l~~~p~~Rps~~~il~~p~~~  234 (247)
                      ||+.+|.+||++.++++|+|+.
T Consensus       148 cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      148 CASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHhcccccccCHHHHHHHHHHH
Confidence            9999999999999999999875

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=7.1e-31  Score=215.39  Aligned_cols=231  Identities=39%  Similarity=0.657  Sum_probs=191.4

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-cCCCHHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-YHLSDSQV   80 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~   80 (247)
                      |+..|+|+++..     ......-+.+|+-+++.++||||+.+++.+...+..+++||||.+|+|.++-.- ..+++.++
T Consensus        40 ~elaavkvVkLe-----p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~Tgplselqi  114 (829)
T KOG0576|consen   40 GELAAVKVVKLE-----PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQI  114 (829)
T ss_pred             Cchhhheeeecc-----CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhHHH
Confidence            678899999763     233455677999999999999999999999999999999999999999997654 35889999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccc-cCCCCCCc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVN-SKNDGYGL  157 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~-~~~~~~~~  157 (247)
                      .......+.+++|||+.|-+|||||-.||++++.|.+++.|||.+..+...  ......|+++|+|||+-. .....|..
T Consensus       115 ayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynq  194 (829)
T KOG0576|consen  115 AYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQ  194 (829)
T ss_pred             HHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccc
Confidence            999999999999999999999999999999999999999999998655433  345677999999999853 34455888


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCC----CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP----SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      ..|+|++|+...++..-+.|.-+.-......-+.+..+.    ..+..+++.+.+|++.+|.++|++||+++.+|.|||.
T Consensus       195 lcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fv  274 (829)
T KOG0576|consen  195 LCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFV  274 (829)
T ss_pred             cccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceee
Confidence            999999999999998877775554444444444433321    2234689999999999999999999999999999999


Q ss_pred             CCCC
Q 041080          234 KRPL  237 (247)
Q Consensus       234 ~~~~  237 (247)
                      ...+
T Consensus       275 s~~l  278 (829)
T KOG0576|consen  275 SQTL  278 (829)
T ss_pred             ccch
Confidence            8763

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=2.2e-28  Score=186.51  Aligned_cols=189  Identities=39%  Similarity=0.573  Sum_probs=157.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC--CCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--LSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~   78 (247)
                      +|+.+++|.+......    ...+.+.+|+..+++++|+|++++++++......++++|++++++|.+++....  +++.
T Consensus        23 ~~~~~~iK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~   98 (225)
T smart00221       23 TGELVAVKVLKKEKTE----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEE   98 (225)
T ss_pred             CCcEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHH
Confidence            3688999999764322    356788899999999999999999999999899999999999999999997754  8999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc---ccccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN---DLKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .+..++.+++.++.+||+.|++|+|+++.||+++.++.++|+|||.+......   ......+...|++||.+. ....+
T Consensus        99 ~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~  177 (225)
T smart00221       99 EARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLL-GGKGY  177 (225)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhc-CCCCC
Confidence            99999999999999999999999999999999999999999999988655433   223345677899999985 33346


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCC-Chhh-HHHHHhhcCC
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSH-LEGV-QALFRIGKGE  194 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~-~~~~-~~~~~~~~~~  194 (247)
                      +.++|+|++|++++++++|+.||.. .+.. ...+.+..+.
T Consensus       178 ~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      178 GEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             CchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence            7799999999999999999999976 3333 4455555443

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-30  Score=210.26  Aligned_cols=178  Identities=26%  Similarity=0.444  Sum_probs=154.7

Q ss_pred             CceEEEEEEeecCCCccc---hHHHHHHHHHHHHHhhcC---CCceeeeceeeecCCcEEEEEecc-ccCcHHHHHHhcC
Q 041080            2 GFFFAVKEVSLQDQGAQG---KQSILQLEQEISLLSQFE---QDNIVQYLGTDKDENRLYIFLELV-TKGSLANLYQKYH   74 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~---~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~   74 (247)
                      ...|+||.+.+++.-...   +..+-.+-.||.+|.+++   |+||++++++|++++.++++||.. +|.+|.++++..+
T Consensus       586 ~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp  665 (772)
T KOG1152|consen  586 NYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP  665 (772)
T ss_pred             ceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccC
Confidence            467899999876542111   111222567999999996   999999999999999999999975 4568999998764


Q ss_pred             -CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCC
Q 041080           75 -LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        75 -~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  153 (247)
                       +++.....++.|++.|+++||+.||+|||||-+|+.++.+|.++|+|||.+...........+||..|.|||.+.+...
T Consensus       666 ~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y  745 (772)
T KOG1152|consen  666 RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKY  745 (772)
T ss_pred             ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhcCCCcceeeeeccccchhhhCCCcc
Confidence             9999999999999999999999999999999999999999999999999999888888899999999999999987664


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSH  180 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~  180 (247)
                       .+..-|||++|+++|.++....||.+
T Consensus       746 -~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  746 -LGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             -CCCcchhhhhhheeeEEEeccCCCcC
Confidence             47789999999999999999998864

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-29  Score=186.80  Aligned_cols=227  Identities=20%  Similarity=0.269  Sum_probs=173.8

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeece-eeecCCcEEEEEeccccCcHHHHHHhcCCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLG-TDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~-~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~   79 (247)
                      ...++||.+..      ......+|.+|...--.|. |.||+.-++ .|++.+.+.+++||++.|+|.+-+...++.+..
T Consensus        49 ~t~ivlKavp~------p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~GigE~~  122 (378)
T KOG1345|consen   49 KTRIVLKAVPR------PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAGIGEAN  122 (378)
T ss_pred             ceEEEeeccCc------chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcccccHHH
Confidence            35688888843      4556778889988877775 899999776 488889999999999999999999999999999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC--CCCeEEcccccccccCccccccCCCCCCccCCcccccCC---CC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDA--SGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKN---DG  154 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~  154 (247)
                      ...++.|+++||.|||+++++|||||.+||+|-.  ..++||||||.+...+..-.. ..-...|.+||.+....   ..
T Consensus       123 ~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~-~~~~~~y~~pe~~~~~~ne~~~  201 (378)
T KOG1345|consen  123 TKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY-LEYVNNYHAPELCDTVVNEKLV  201 (378)
T ss_pred             HHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceehh-hhhhcccCCcHHHhhccccceE
Confidence            9999999999999999999999999999999963  347999999998765533211 11344588888763322   12


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHH-----HHHh--hcCCCCCCCCcCCHHHHHHHHHHhcCCCCCC---CCh
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQA-----LFRI--GKGELPSVPSSLSRDARDFILKCLQVNPNDR---PTV  224 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~-----~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R---ps~  224 (247)
                      ..+.+|+|.||+++|.+++|..||......+.     ..+.  .....|..-..+++.+..+.++-|.++|++|   .++
T Consensus       202 ~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~  281 (378)
T KOG1345|consen  202 VNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTA  281 (378)
T ss_pred             ecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHH
Confidence            46789999999999999999999963322221     1111  1222334445688999999999999999999   566


Q ss_pred             hhhhcCccCCC
Q 041080          225 TELMEHPFVKR  235 (247)
Q Consensus       225 ~~il~~p~~~~  235 (247)
                      .......|..+
T Consensus       282 kk~rk~~w~E~  292 (378)
T KOG1345|consen  282 KKMRKCLWKEK  292 (378)
T ss_pred             HHHHHHHHHHh
Confidence            66566556544

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=2.2e-29  Score=214.14  Aligned_cols=211  Identities=24%  Similarity=0.398  Sum_probs=174.9

Q ss_pred             HHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHhhhCCeeec
Q 041080           24 LQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHR  102 (247)
Q Consensus        24 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~  102 (247)
                      ..+..|+-+-.++.|+|++..+....+.....-.|||+++ +|..++... .+...++-.++.|++.|+.|+|..|+.|+
T Consensus       366 ~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~Giahr  444 (601)
T KOG0590|consen  366 YNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHR  444 (601)
T ss_pred             hhhhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceec
Confidence            3377888888999999999988887777766666999999 999999887 68899999999999999999999999999


Q ss_pred             CCCCCcEEEcCCCCeEEcccccccccCcc------ccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCC
Q 041080          103 DIKCANILVDASGSVKLADFGLAKATTMN------DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP  176 (247)
Q Consensus       103 dl~~~ni~~~~~~~~~l~df~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~  176 (247)
                      |+|++|++++.+|.++|+|||.+......      ......|+..|.|||.+.+... .....||||.|+++..|.+|+.
T Consensus       445 dlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~y-dpr~vDiwS~~ii~~~m~~~~~  523 (601)
T KOG0590|consen  445 DLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEY-DPRAVDVWSCGIIYICMILGRF  523 (601)
T ss_pred             cCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCccccccccc-CcchhhhhhccceEEEEecCCC
Confidence            99999999999999999999998643322      2445669999999999976553 2667999999999999999999


Q ss_pred             CCCCChhhHHH--HHhhc------CCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          177 PYSHLEGVQAL--FRIGK------GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       177 p~~~~~~~~~~--~~~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ||......+..  .....      .....+...++.+.+.+|.+||+.+|.+|.|+++|++++||+++
T Consensus       524 ~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i  591 (601)
T KOG0590|consen  524 PWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI  591 (601)
T ss_pred             ccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence            99766555442  11111      11112334678899999999999999999999999999999986

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.94  E-value=4e-27  Score=202.86  Aligned_cols=221  Identities=21%  Similarity=0.294  Sum_probs=162.0

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-CCHHHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVSS   82 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~   82 (247)
                      .|+||++.+.+..-.-+...++ ..|++ ...+++||++++..+-...+..|+|.+|... +|.+.+..++ +...+.++
T Consensus        48 ~vVvKVFvk~~p~~sL~~~~qr-L~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRPFL~~iEKkW  124 (1431)
T KOG1240|consen   48 LVVVKVFVKQDPTISLRPFKQR-LEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRPFLVLIEKKW  124 (1431)
T ss_pred             eEEEEEEeccCCCCCchHHHHH-HHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccchHHHHHHHHH
Confidence            4999999876532222222222 23334 4455899999999988888889999999987 8999888776 67788999


Q ss_pred             HHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---------cccCCCCCCccCCcccccC--
Q 041080           83 YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---------LKSCKGTPFWMAPEVVNSK--  151 (247)
Q Consensus        83 ~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---------~~~~~~~~~~~aPE~~~~~--  151 (247)
                      |+.|++.|+..+|+.||+|||||.+||+++.-+.+.|+||.......-.+         ........+|.|||.+...  
T Consensus       125 iaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~  204 (1431)
T KOG1240|consen  125 IAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALG  204 (1431)
T ss_pred             HHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhcccc
Confidence            99999999999999999999999999999999999999998765433222         1123345679999987431  


Q ss_pred             ------CCC-CCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcC--CCCCC-CCcCCHHHHHHHHHHhcCCCCC
Q 041080          152 ------NDG-YGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKG--ELPSV-PSSLSRDARDFILKCLQVNPND  220 (247)
Q Consensus       152 ------~~~-~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~li~~~l~~~p~~  220 (247)
                            ... .+++.||||+||+++||++ |.++|....   +..+...+  ..... ..--+..++.++..|++.||.+
T Consensus       205 ~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ---L~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~  281 (1431)
T KOG1240|consen  205 KTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ---LLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSK  281 (1431)
T ss_pred             ccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH---HHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchh
Confidence                  112 5788999999999999998 677774321   11111111  00000 1112457899999999999999


Q ss_pred             CCChhhhhcC
Q 041080          221 RPTVTELMEH  230 (247)
Q Consensus       221 Rps~~~il~~  230 (247)
                      |.|+++.|+.
T Consensus       282 RlSAedyL~~  291 (1431)
T KOG1240|consen  282 RLSAEDYLQK  291 (1431)
T ss_pred             ccCHHHHHHh
Confidence            9999999974

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.2e-26  Score=170.04  Aligned_cols=219  Identities=22%  Similarity=0.419  Sum_probs=174.2

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC---CCHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH---LSDS   78 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~   78 (247)
                      |..++.|++....   -......+|..|.-.|+-+.||||+++++.+.+...+.++..|++.|+|...+....   .+..
T Consensus       213 gndivakil~vr~---~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~s  289 (448)
T KOG0195|consen  213 GNDIVAKILNVRE---VTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHS  289 (448)
T ss_pred             Ccchhhhhhhhhh---cchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecc
Confidence            4455666664432   122233457889999999999999999999999999999999999999999997654   7788


Q ss_pred             HHHHHHHHHHHHHHHhhhCC--eeecCCCCCcEEEcCCCCeEE--cccccccccCccccccCCCCCCccCCcccccCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERN--VVHRDIKCANILVDASGSVKL--ADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~--i~h~dl~~~ni~~~~~~~~~l--~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +..+++.+++.|++|||+..  |.--.+++..++++++-+.+|  .|--++.     ......-++.|++||.++..+.+
T Consensus       290 qav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf-----qe~gr~y~pawmspealqrkped  364 (448)
T KOG0195|consen  290 QAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-----QEVGRAYSPAWMSPEALQRKPED  364 (448)
T ss_pred             hHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee-----eccccccCcccCCHHHHhcCchh
Confidence            89999999999999999875  445568899999998876554  3332221     11223346789999999877665


Q ss_pred             CC-cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhh-cCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhh
Q 041080          155 YG-LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIG-KGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM  228 (247)
Q Consensus       155 ~~-~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il  228 (247)
                      .+ .++|+|||++++||+.|...||.+....+.-.++. .+-...+|++++..+..++.-|++.||.+||.+..|+
T Consensus       365 ~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  365 LNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             cchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            53 46999999999999999999999988877765544 3445778999999999999999999999999998875

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=7e-24  Score=165.74  Aligned_cols=187  Identities=26%  Similarity=0.377  Sum_probs=147.6

Q ss_pred             CCCceeeeceeeec---------------------------CCcEEEEEeccccCcHHHHHHhcCCCHHHHHHHHHHHHH
Q 041080           37 EQDNIVQYLGTDKD---------------------------ENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILN   89 (247)
Q Consensus        37 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~l~~   89 (247)
                      +||||+++.++|.+                           +..+|+||.-++. +|..++-.+..+.....-++.|+++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLE  352 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLE  352 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHH
Confidence            69999999887643                           3478999999977 9999998888888889999999999


Q ss_pred             HHHHhhhCCeeecCCCCCcEEEcCC--C--CeEEcccccccccCcc--------ccccCCCCCCccCCcccccCCCCC--
Q 041080           90 GLVYLHERNVVHRDIKCANILVDAS--G--SVKLADFGLAKATTMN--------DLKSCKGTPFWMAPEVVNSKNDGY--  155 (247)
Q Consensus        90 ~l~~lh~~~i~h~dl~~~ni~~~~~--~--~~~l~df~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~--  155 (247)
                      |+.+||++|+.|+|+|++||++.-+  +  .+.+.|||..-.....        ......|....+|||+....+...  
T Consensus       353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av  432 (598)
T KOG4158|consen  353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV  432 (598)
T ss_pred             HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence            9999999999999999999999533  2  4788999986422221        123344788899999975444321  


Q ss_pred             --CcchhHHHHHHHHHHHHhCCCCCCCChhhHHH-HHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh
Q 041080          156 --GLTADIWSLGCTVLEMLTRRPPYSHLEGVQAL-FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV  224 (247)
Q Consensus       156 --~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  224 (247)
                        -.++|.|+.|.+.||+++...||........- ..-....+|.++..+++.+++++..+|+.||.+|+|.
T Consensus       433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp  504 (598)
T KOG4158|consen  433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP  504 (598)
T ss_pred             eccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence              34799999999999999999999763322111 1122345678889999999999999999999999984

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.4e-25  Score=183.93  Aligned_cols=222  Identities=28%  Similarity=0.435  Sum_probs=184.6

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-CCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~   79 (247)
                      |+-||+|+..+.........   .-..|-.++..++ ||.++++...++.+...+++.++..+|.|...+.... +.+..
T Consensus        22 ~~~yamkvl~k~t~~~~~~~---~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~   98 (612)
T KOG0603|consen   22 GHLYAMKVLKKATLKVRDRT---HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELD   98 (612)
T ss_pred             cchhhhhccccccccccccc---ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHH
Confidence            56788888877654333332   4446778888886 9999999999999999999999999998887766544 77888


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcch
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTA  159 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~  159 (247)
                      ...+...++-++.++|+.|++|+|+|++||+++.+|.+++.|||.++..-..+..  .|+.-|+|||++++    ...++
T Consensus        99 ~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--cgt~eymApEI~~g----h~~a~  172 (612)
T KOG0603|consen   99 VAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--CGTYEYRAPEIING----HLSAA  172 (612)
T ss_pred             HHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc--ccchhhhhhHhhhc----cCCcc
Confidence            8899999999999999999999999999999999999999999998755444333  78999999999972    56789


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC-----hhhhhcCccCC
Q 041080          160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT-----VTELMEHPFVK  234 (247)
Q Consensus       160 Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~p~~~  234 (247)
                      |.||+|++++++++|..||..    +....+.... ...|...+...++++.+++..+|.+|.-     ..++.+|+||+
T Consensus       173 D~ws~gvl~felltg~~pf~~----~~~~~Il~~~-~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~  247 (612)
T KOG0603|consen  173 DWWSFGVLAFELLTGTLPFGG----DTMKRILKAE-LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQ  247 (612)
T ss_pred             cchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchhe
Confidence            999999999999999999987    4444444433 3667888999999999999999999964     57999999998


Q ss_pred             CCC
Q 041080          235 RPL  237 (247)
Q Consensus       235 ~~~  237 (247)
                      .+-
T Consensus       248 ~i~  250 (612)
T KOG0603|consen  248 SID  250 (612)
T ss_pred             eee
Confidence            753

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=7.1e-22  Score=158.70  Aligned_cols=231  Identities=35%  Similarity=0.505  Sum_probs=183.7

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCC-ceeeeceeeecCCcEEEEEeccccCcHHHHHHhc----CCCHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQD-NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY----HLSDS   78 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~   78 (247)
                      .+++|.+......  .......+.+|+.++..+.|+ +++++.+.+......+++++++.++++.+++...    .++..
T Consensus        24 ~~~~k~~~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  101 (384)
T COG0515          24 LVALKVLAKKLES--KSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSES  101 (384)
T ss_pred             EEEEEeechhhcc--chhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHH
Confidence            5788888765322  113567788999999999987 7999999997777789999999999999887765    58899


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC-CeEEcccccccccCcc--------ccccCCCCCCccCCcccc
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG-SVKLADFGLAKATTMN--------DLKSCKGTPFWMAPEVVN  149 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~-~~~l~df~~~~~~~~~--------~~~~~~~~~~~~aPE~~~  149 (247)
                      ....++.|++.++.++|+.|++|+|+||+||+++..+ .++++|||.+......        ......++..|++||.+.
T Consensus       102 ~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~  181 (384)
T COG0515         102 EALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL  181 (384)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhc
Confidence            9999999999999999999999999999999999988 6999999998643322        234566899999999997


Q ss_pred             cCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCChh----hHHHHHhhcCCCC----CCCCcC----CHHHHHHHHHHhcC
Q 041080          150 SKN-DGYGLTADIWSLGCTVLEMLTRRPPYSHLEG----VQALFRIGKGELP----SVPSSL----SRDARDFILKCLQV  216 (247)
Q Consensus       150 ~~~-~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~----~~~~~~~~~~~~~----~~~~~~----~~~~~~li~~~l~~  216 (247)
                      +.. ...+...|+|++|++++++++|..|+.....    ......+.....+    ......    ...+.+++..++..
T Consensus       182 ~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (384)
T COG0515         182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAK  261 (384)
T ss_pred             CCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhc
Confidence            642 3478899999999999999999999776653    3333333333322    111111    25789999999999


Q ss_pred             CCCCCCChhhhhcCccCCCC
Q 041080          217 NPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       217 ~p~~Rps~~~il~~p~~~~~  236 (247)
                      +|..|.+..+...+++....
T Consensus       262 ~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         262 DPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             CchhcCCHHHHhhchHhhCc
Confidence            99999999998888776654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.90  E-value=2.2e-23  Score=160.79  Aligned_cols=212  Identities=24%  Similarity=0.281  Sum_probs=137.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCC----------Cceeeecee---------eecC---C-----c
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ----------DNIVQYLGT---------DKDE---N-----R   53 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h----------~~i~~~~~~---------~~~~---~-----~   53 (247)
                      +|+.+|||++....  .......+++++|.-....+.+          -.++-.++.         +...   .     .
T Consensus        36 t~~~~avkvf~~~~--~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n  113 (288)
T PF14531_consen   36 TGEEFAVKVFLLPA--DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLN  113 (288)
T ss_dssp             TTEEEEEEEEEESS--TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECETTEEEEEES
T ss_pred             CCceEEEEEEeccc--ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCCCccceeeh
Confidence            47899999998876  3455567777777766555322          122222222         1111   1     3


Q ss_pred             EEEEEeccccCcHHHHHHh---cC-----CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccc
Q 041080           54 LYIFLELVTKGSLANLYQK---YH-----LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA  125 (247)
Q Consensus        54 ~~lv~e~~~~~~L~~~l~~---~~-----~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~  125 (247)
                      .+++|+-+.+ +|.++++.   ..     ........+..|++..+++||..|++|+||+|+|++++.+|.+.|+||+..
T Consensus       114 ~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~  192 (288)
T PF14531_consen  114 RFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSL  192 (288)
T ss_dssp             EEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGE
T ss_pred             hhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHH
Confidence            4778888855 88887642   21     334445567789999999999999999999999999999999999999887


Q ss_pred             cccCccccccCCCCCCccCCcccccC------CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCC
Q 041080          126 KATTMNDLKSCKGTPFWMAPEVVNSK------NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVP  199 (247)
Q Consensus       126 ~~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  199 (247)
                      ...+..... ...+..|.+||.....      ...++.+.|.|+||+++|.+.++..||...........    .+....
T Consensus       193 ~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~----~f~~C~  267 (288)
T PF14531_consen  193 VRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW----DFSRCR  267 (288)
T ss_dssp             EETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----GGTTSS
T ss_pred             eecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc----cchhcC
Confidence            655543332 3345678999976432      23368899999999999999999999986654333222    222334


Q ss_pred             CcCCHHHHHHHHHHhcCCCCCC
Q 041080          200 SSLSRDARDFILKCLQVNPNDR  221 (247)
Q Consensus       200 ~~~~~~~~~li~~~l~~~p~~R  221 (247)
                       ++|+.++.||..+|+++|.+|
T Consensus       268 -~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  268 -DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             ----HHHHHHHHHHT-SSGGGS
T ss_pred             -CcCHHHHHHHHHHccCCcccC
Confidence             789999999999999999887

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=1.8e-21  Score=148.92  Aligned_cols=216  Identities=20%  Similarity=0.305  Sum_probs=169.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~   77 (247)
                      ++++||||.=....       ..-+++.|....+.| ..++|+.++.+.+.+.+-.+|+|.+ |.||+++++=.  .++.
T Consensus        52 nne~VAIKfEPrkS-------~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSv  123 (449)
T KOG1165|consen   52 NNEPVAIKFEPRKS-------EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSV  123 (449)
T ss_pred             cCceEEEEeccccC-------CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccH
Confidence            57899999653322       223467788888888 4799999999999998999999999 66999998754  5999


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC-----CeEEcccccccccC---------ccccccCCCCCCcc
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG-----SVKLADFGLAKATT---------MNDLKSCKGTPFWM  143 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~-----~~~l~df~~~~~~~---------~~~~~~~~~~~~~~  143 (247)
                      ..+.-++.|++.-++++|++.+++|||||+|++|...+     .+.++|||++....         ..+.....||.+||
T Consensus       124 KTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYM  203 (449)
T KOG1165|consen  124 KTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYM  203 (449)
T ss_pred             HhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeee
Confidence            99999999999999999999999999999999998544     48999999996432         23345566999999


Q ss_pred             CCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChh---hHHHHHhhcCCCC----CCCCcCCHHHHHHHHHHhcC
Q 041080          144 APEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG---VQALFRIGKGELP----SVPSSLSRDARDFILKCLQV  216 (247)
Q Consensus       144 aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~  216 (247)
                      +.-...+..  .+.+.|+=|||.++++++-|..||.....   +..+.+|...+..    .+-.++|.++..-++..-+.
T Consensus       204 SINTHlGrE--QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L  281 (449)
T KOG1165|consen  204 SINTHLGRE--QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRL  281 (449)
T ss_pred             Eeeccccch--hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhc
Confidence            988876655  68899999999999999999999976543   3334444444332    22256888888888887777


Q ss_pred             CCCCCCChhh
Q 041080          217 NPNDRPTVTE  226 (247)
Q Consensus       217 ~p~~Rps~~~  226 (247)
                      +-.+-|..+-
T Consensus       282 ~F~E~PDYdy  291 (449)
T KOG1165|consen  282 DFFETPDYDY  291 (449)
T ss_pred             CcccCCCHHH
Confidence            7777777543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=2.2e-21  Score=155.66  Aligned_cols=219  Identities=25%  Similarity=0.282  Sum_probs=166.1

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC----CCceeeeceee-ecCCcEEEEEeccccCcHHHHHHhc---C
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE----QDNIVQYLGTD-KDENRLYIFLELVTKGSLANLYQKY---H   74 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~---~   74 (247)
                      ..+|+|.-........     ..+..|..++..+.    .+++..+++.+ ..+...++||+.. |.+|.++.+..   .
T Consensus        45 ~~~a~K~e~~~~~~~~-----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~  118 (322)
T KOG1164|consen   45 KEYAKKLEKKELGSKP-----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGR  118 (322)
T ss_pred             eeEEEEEEEecccCCC-----ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCC
Confidence            3578887765422111     13567888888876    26899999988 5778899999999 66999988654   4


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC-----CeEEcccccccccC-----------ccc-cccCC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG-----SVKLADFGLAKATT-----------MND-LKSCK  137 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~-----~~~l~df~~~~~~~-----------~~~-~~~~~  137 (247)
                      ++...+.+++.|++.+|.++|+.|++||||||+|+++....     .+.+.|||+++...           ... .....
T Consensus       119 fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~r  198 (322)
T KOG1164|consen  119 FSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFR  198 (322)
T ss_pred             cCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCC
Confidence            99999999999999999999999999999999999998653     58999999997211           111 12344


Q ss_pred             CCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC---CCC-CCCcCCHHHHHHHHHH
Q 041080          138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE---LPS-VPSSLSRDARDFILKC  213 (247)
Q Consensus       138 ~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~~~~li~~~  213 (247)
                      ||..|.++....+..  .+.+.|+||++.++.+++.|..||...+............   ... .....+.++..+...+
T Consensus       199 GT~ry~S~~~H~~~e--~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (322)
T KOG1164|consen  199 GTLRYASINVHLGIE--QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYI  276 (322)
T ss_pred             CccccccHHHhCCCc--cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHh
Confidence            899999999886555  7899999999999999999999997766443332222211   111 3345678888888888


Q ss_pred             hcCCCCCCCChhhhhc
Q 041080          214 LQVNPNDRPTVTELME  229 (247)
Q Consensus       214 l~~~p~~Rps~~~il~  229 (247)
                      -..+...+|....+..
T Consensus       277 ~~~~~~~~Pdy~~~~~  292 (322)
T KOG1164|consen  277 DSLDYEDKPDYEKLAE  292 (322)
T ss_pred             hccCCcCCCCHHHHHH
Confidence            8899999999887754

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.86  E-value=1.5e-21  Score=159.86  Aligned_cols=196  Identities=27%  Similarity=0.514  Sum_probs=154.7

Q ss_pred             HhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHhhhCCe-eecCCCCCcE
Q 041080           33 LSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNV-VHRDIKCANI  109 (247)
Q Consensus        33 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i-~h~dl~~~ni  109 (247)
                      |+.+.|.|+.+|+|.+..+...+.|.+||..|+|.+.+...  .+++.....++.+++.|+.|+|...| +|+.+++.|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            35789999999999999999999999999999999999764  47788888999999999999998765 9999999999


Q ss_pred             EEcCCCCeEEcccccccccCc----cccccCCCCCCccCCcccccCCCC-----CCcchhHHHHHHHHHHHHhCCCCCCC
Q 041080          110 LVDASGSVKLADFGLAKATTM----NDLKSCKGTPFWMAPEVVNSKNDG-----YGLTADIWSLGCTVLEMLTRRPPYSH  180 (247)
Q Consensus       110 ~~~~~~~~~l~df~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~-----~~~~~Di~slG~ll~~l~~g~~p~~~  180 (247)
                      +++....+|++|||+......    ..........-|.|||.+......     .+.+.|+||+|++++++++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            999999999999999865532    111122234558999998764211     36679999999999999999999865


Q ss_pred             Ch----hhHHHHHhhcCCC----CCCC--CcCCHHHHHHHHHHhcCCCCCCCChhhhh
Q 041080          181 LE----GVQALFRIGKGEL----PSVP--SSLSRDARDFILKCLQVNPNDRPTVTELM  228 (247)
Q Consensus       181 ~~----~~~~~~~~~~~~~----~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~il  228 (247)
                      ..    ..+....+.....    |...  ...++++..++.+||..+|.+||+++++-
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~  218 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR  218 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence            32    2234444444121    2222  14556799999999999999999999884

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=2.4e-21  Score=155.61  Aligned_cols=138  Identities=19%  Similarity=0.146  Sum_probs=103.6

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceee-eceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQ-YLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      |+.+|||++...............+.+|+.++++++|+|+++ +++    .+..++||||++|++|... .  ...   .
T Consensus        44 ~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~~-~--~~~---~  113 (365)
T PRK09188         44 GTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHLA-R--PHG---D  113 (365)
T ss_pred             CeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHHh-C--ccc---h
Confidence            567899987532111112345667999999999999999985 433    2468999999999999632 1  111   2


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCC-CCCcEEEcCCCCeEEcccccccccCccc----------cccCCCCCCccCCcccc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDI-KCANILVDASGSVKLADFGLAKATTMND----------LKSCKGTPFWMAPEVVN  149 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl-~~~ni~~~~~~~~~l~df~~~~~~~~~~----------~~~~~~~~~~~aPE~~~  149 (247)
                      ..++.+++.+|.+||+.||+|+|| ||+||+++.++.++|+|||++.......          .....+++.|.+||.+.
T Consensus       114 ~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        114 PAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             HHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            467889999999999999999999 9999999999999999999987443222          12334677799999874

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.85  E-value=1.4e-21  Score=146.58  Aligned_cols=150  Identities=16%  Similarity=0.223  Sum_probs=111.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHH------HHHHHHHHhhcCCCceeeeceeeecC--------CcEEEEEeccccCcH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQ------LEQEISLLSQFEQDNIVQYLGTDKDE--------NRLYIFLELVTKGSL   66 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~------~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L   66 (247)
                      ++..+|||.+.......  +...+.      +++|+..+.++.|++|..+.+++...        +..+++|||++|.+|
T Consensus        53 ~~~~~iiKvf~~~~~~~--~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL  130 (232)
T PRK10359         53 DYGKYILKVFAPKVKRT--ERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVEL  130 (232)
T ss_pred             CCCcEEEEEechhcCch--HHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccH
Confidence            35679999997654322  222233      67999999999999999988875533        358999999999999


Q ss_pred             HHHHHhcCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCc
Q 041080           67 ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPE  146 (247)
Q Consensus        67 ~~~l~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE  146 (247)
                      .++..   +++    ....+++.++..+|+.|++|+|++|+||+++++| ++++|||.............          
T Consensus       131 ~~~~~---~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d~----------  192 (232)
T PRK10359        131 NDMPE---ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKDR----------  192 (232)
T ss_pred             HHhhh---ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhhHHH----------
Confidence            88732   333    3456999999999999999999999999999988 99999998754432221111          


Q ss_pred             ccccCCCCCCcchhHHHHHHHHHHHH
Q 041080          147 VVNSKNDGYGLTADIWSLGCTVLEML  172 (247)
Q Consensus       147 ~~~~~~~~~~~~~Di~slG~ll~~l~  172 (247)
                      ... .. .+..++|+|+||+++..+.
T Consensus       193 ~vl-er-~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        193 IDL-ER-HYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             HHH-Hh-HhcccccccceeEeehHHH
Confidence            111 11 1557899999999987654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=2.8e-20  Score=136.68  Aligned_cols=214  Identities=20%  Similarity=0.270  Sum_probs=164.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~   77 (247)
                      +|+.||||.=+.....       ..+..|.++.+.|+ ..+|+.+..++.+...-.+||+.. |.||+++++-  +.++.
T Consensus        39 ~ge~VAiK~Es~~a~h-------pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftm  110 (341)
T KOG1163|consen   39 SGEEVAIKLESSKAKH-------PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTM  110 (341)
T ss_pred             CCceEEEEeecccCCC-------cchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhH
Confidence            5899999987543221       13557888888886 578888888888899999999999 6699998864  46999


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC---CCeEEcccccccccC---------ccccccCCCCCCccCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS---GSVKLADFGLAKATT---------MNDLKSCKGTPFWMAP  145 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~---~~~~l~df~~~~~~~---------~~~~~~~~~~~~~~aP  145 (247)
                      ..++-++-|++.-++|+|.++++|+||||+|+++.-+   ..+.++|||++....         ..+.....||.+|.+-
T Consensus       111 kTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASi  190 (341)
T KOG1163|consen  111 KTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASI  190 (341)
T ss_pred             HhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhh
Confidence            9999999999999999999999999999999999754   468999999996332         2223445588888887


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHH---HHhhcCCC----CCCCCcCCHHHHHHHHHHhcCCC
Q 041080          146 EVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQAL---FRIGKGEL----PSVPSSLSRDARDFILKCLQVNP  218 (247)
Q Consensus       146 E~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~---~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p  218 (247)
                      -...+..  .+.+.|+=|+|.++.++..|..||.......-.   ..+...+.    ..+=..+|.++.-.+..|-..--
T Consensus       191 nAh~g~e--qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F  268 (341)
T KOG1163|consen  191 NAHLGIE--QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGF  268 (341)
T ss_pred             hhhhhhh--hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCC
Confidence            7664433  578899999999999999999999876543332   22222222    12225789999999999887777


Q ss_pred             CCCCCh
Q 041080          219 NDRPTV  224 (247)
Q Consensus       219 ~~Rps~  224 (247)
                      .+-|..
T Consensus       269 ~E~Pdy  274 (341)
T KOG1163|consen  269 EEKPDY  274 (341)
T ss_pred             CCCCcH
Confidence            777764

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.84  E-value=2.3e-20  Score=138.20  Aligned_cols=125  Identities=17%  Similarity=0.131  Sum_probs=94.9

Q ss_pred             CCceEEEEEEeecCCCccch---------------------HHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEe
Q 041080            1 DGFFFAVKEVSLQDQGAQGK---------------------QSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLE   59 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~---------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   59 (247)
                      +|++||||+++.........                     .......+|+..+.++.++++.........  ..++|||
T Consensus        20 ~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~~~~~--~~~iVmE   97 (190)
T cd05147          20 NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEPILLK--SHVLVME   97 (190)
T ss_pred             CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcEEEec--CCEEEEE
Confidence            58999999998753221110                     011234469999999988776443333222  2389999


Q ss_pred             ccccCcHHHH-HHhcCCCHHHHHHHHHHHHHHHHHh-hhCCeeecCCCCCcEEEcCCCCeEEccccccccc
Q 041080           60 LVTKGSLANL-YQKYHLSDSQVSSYTRQILNGLVYL-HERNVVHRDIKCANILVDASGSVKLADFGLAKAT  128 (247)
Q Consensus        60 ~~~~~~L~~~-l~~~~~~~~~~~~~~~~l~~~l~~l-h~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~  128 (247)
                      |++|+++... ++..+++...+..++.|++.+|.++ |+.|++|+||||+||+++ ++.++|+|||++...
T Consensus        98 ~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147          98 FIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             EeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence            9998777544 4556789999999999999999999 799999999999999998 578999999998644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=2.3e-19  Score=133.25  Aligned_cols=125  Identities=18%  Similarity=0.165  Sum_probs=96.5

Q ss_pred             CCceEEEEEEeecCCCccc---------------------hHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEe
Q 041080            1 DGFFFAVKEVSLQDQGAQG---------------------KQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLE   59 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~---------------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   59 (247)
                      +|+.||||++.........                     ......+..|...+.++.++++.....+...  ..++|||
T Consensus        20 ~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~lVmE   97 (190)
T cd05145          20 DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEPILLK--KNVLVME   97 (190)
T ss_pred             CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceEEEec--CCEEEEE
Confidence            5899999999875321111                     1112335689999999999887544443332  2489999


Q ss_pred             ccccCcHH-HHHHhcCCCHHHHHHHHHHHHHHHHHhhh-CCeeecCCCCCcEEEcCCCCeEEccccccccc
Q 041080           60 LVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHE-RNVVHRDIKCANILVDASGSVKLADFGLAKAT  128 (247)
Q Consensus        60 ~~~~~~L~-~~l~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~  128 (247)
                      |++|+++. ..+....++......++.|++.++.++|+ .|++|+||||+||+++ ++.++|+|||++...
T Consensus        98 ~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~  167 (190)
T cd05145          98 FIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVEL  167 (190)
T ss_pred             EecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceec
Confidence            99987543 34566678888999999999999999999 9999999999999998 889999999998644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=2.1e-19  Score=132.25  Aligned_cols=144  Identities=21%  Similarity=0.138  Sum_probs=109.2

Q ss_pred             HHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHhhhCCeeecC
Q 041080           25 QLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRD  103 (247)
Q Consensus        25 ~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~d  103 (247)
                      .+.+|+++|++|. ++++++++++    +..+++|+|+.|.+|.+....      ....++.|++.++.++|++|++|+|
T Consensus        47 l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~------~~~~~~~qi~~~L~~lH~~GIvHrD  116 (218)
T PRK12274         47 LARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR------GDLAYFRAARRLLQQLHRCGVAHND  116 (218)
T ss_pred             HHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh------hhHHHHHHHHHHHHHHHHCcCccCC
Confidence            5789999999995 5889999886    356999999999888654322      1235778999999999999999999


Q ss_pred             C-CCCcEEEcCCCCeEEcccccccccCccccc---------------cCCCCCCccCCcccccCCCCCCcchhHHHHHHH
Q 041080          104 I-KCANILVDASGSVKLADFGLAKATTMNDLK---------------SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT  167 (247)
Q Consensus       104 l-~~~ni~~~~~~~~~l~df~~~~~~~~~~~~---------------~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~l  167 (247)
                      | ||+||+++.++.++|+|||++.........               -...++.+++|+.........-.+.+.++.|.-
T Consensus       117 L~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~  196 (218)
T PRK12274        117 LAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKP  196 (218)
T ss_pred             CCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcch
Confidence            9 799999999999999999999754432210               011355566666543222211256889999999


Q ss_pred             HHHHHhCCCCC
Q 041080          168 VLEMLTRRPPY  178 (247)
Q Consensus       168 l~~l~~g~~p~  178 (247)
                      +|.++|+..+.
T Consensus       197 ~~~~~~~~~~~  207 (218)
T PRK12274        197 VYRFVTRRVLH  207 (218)
T ss_pred             HHHHHhccCCc
Confidence            99999988774

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=1.4e-20  Score=152.10  Aligned_cols=173  Identities=27%  Similarity=0.492  Sum_probs=133.2

Q ss_pred             cEEEEEeccccCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEccccccccc
Q 041080           53 RLYIFLELVTKGSLANLYQKYH----LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT  128 (247)
Q Consensus        53 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~  128 (247)
                      .+++.|++|...+|.+|+..+.    .+......++.|++.++.|   +|.+|+|+||.||+...+..++|.|||+....
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            5789999999999999997543    6777889999999999999   99999999999999999999999999997543


Q ss_pred             Cccc--------cccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCC-CCC
Q 041080          129 TMND--------LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP-SVP  199 (247)
Q Consensus       129 ~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~  199 (247)
                      ....        .....|+.+|++||.+.+..  |+.++|||+||++++|++.--.  ..++.......+..+.+| .+.
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~--y~~kvdIyaLGlil~EL~~~f~--T~~er~~t~~d~r~g~ip~~~~  482 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ--YSEKVDIYALGLILAELLIQFS--TQFERIATLTDIRDGIIPPEFL  482 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhhhh--hhhhcchhhHHHHHHHHHHHhc--cHHHHHHhhhhhhcCCCChHHh
Confidence            3222        33455999999999997655  8999999999999999986211  111222223334444444 233


Q ss_pred             CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          200 SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       200 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      ..+|. -..|+.+|+.+.|.+||++.+.-.|+|.
T Consensus       483 ~d~p~-e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  483 QDYPE-EYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hcCcH-HHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            34444 4789999999999999977777667664

>PRK10345 hypothetical protein; Provisional

Probab=99.78  E-value=3.5e-18  Score=127.81  Aligned_cols=111  Identities=18%  Similarity=0.258  Sum_probs=88.3

Q ss_pred             EEEEEeecCCCccchHHHHHHHHHHHHHhhc-----CCCceeeeceeeecCC---c-EEEEEec--cccCcHHHHHHhcC
Q 041080            6 AVKEVSLQDQGAQGKQSILQLEQEISLLSQF-----EQDNIVQYLGTDKDEN---R-LYIFLEL--VTKGSLANLYQKYH   74 (247)
Q Consensus         6 ~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~-~~lv~e~--~~~~~L~~~l~~~~   74 (247)
                      +||++.....     ...+.+.+|+.+++++     .||||++++++++++.   . +.+|+||  +.+++|.+++++..
T Consensus        28 ~IKv~~~~~~-----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~  102 (210)
T PRK10345         28 CIKIVYHRGD-----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQCR  102 (210)
T ss_pred             EEEEEecccc-----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHccc
Confidence            6888765321     2345688999999999     5799999999998873   3 3478999  55789999998766


Q ss_pred             CCHHHHHHHHHHHHHHH-HHhhhCCeeecCCCCCcEEEcCC----CCeEEcccc
Q 041080           75 LSDSQVSSYTRQILNGL-VYLHERNVVHRDIKCANILVDAS----GSVKLADFG  123 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l-~~lh~~~i~h~dl~~~ni~~~~~----~~~~l~df~  123 (247)
                      +++.  ..++.+++.++ .|||+++|+|+||||+||+++.+    +.++|+|++
T Consensus       103 ~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345        103 YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            6665  35677888777 99999999999999999999743    379999954

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.75  E-value=2.2e-18  Score=149.15  Aligned_cols=146  Identities=32%  Similarity=0.526  Sum_probs=121.9

Q ss_pred             HHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-----------------cccCCCCCCccCCccccc
Q 041080           88 LNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----------------LKSCKGTPFWMAPEVVNS  150 (247)
Q Consensus        88 ~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-----------------~~~~~~~~~~~aPE~~~~  150 (247)
                      +.+++|+|+.||+|+|+||+|.+|+.=|.++++|||++.......                 .....|++.|.|||++..
T Consensus       153 vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr  232 (1205)
T KOG0606|consen  153 VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR  232 (1205)
T ss_pred             hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh
Confidence            778999999999999999999999999999999999986322111                 223458999999999854


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC--CCCCCcCCHHHHHHHHHHhcCCCCCC---CChh
Q 041080          151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL--PSVPSSLSRDARDFILKCLQVNPNDR---PTVT  225 (247)
Q Consensus       151 ~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R---ps~~  225 (247)
                      ..  |+...|+|++|+++|+++.|..||...+..++.........  ++-..-.+++.++++.++|..+|..|   +.+-
T Consensus       233 qg--ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~  310 (1205)
T KOG0606|consen  233 QG--YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGAL  310 (1205)
T ss_pred             hc--cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence            33  89999999999999999999999999888888777665443  33345678999999999999999999   4567


Q ss_pred             hhhcCccCCC
Q 041080          226 ELMEHPFVKR  235 (247)
Q Consensus       226 ~il~~p~~~~  235 (247)
                      ++..|+||+.
T Consensus       311 evk~h~ff~~  320 (1205)
T KOG0606|consen  311 EVKQHGFFQL  320 (1205)
T ss_pred             hhhhccceee
Confidence            7789999985

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=9.5e-18  Score=146.92  Aligned_cols=166  Identities=20%  Similarity=0.252  Sum_probs=130.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC---CCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-CC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE---QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~   76 (247)
                      ||+.||||+=+.....+-  ...      .+++.+|+   -+.|.++.....-.+..++|+||.+.|||.++++..+ ++
T Consensus       721 ~~~~~alK~e~P~~~WEf--YI~------~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~  792 (974)
T KOG1166|consen  721 NGKLVALKVEKPPNPWEF--YIC------LQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMD  792 (974)
T ss_pred             CCcEEEEEeecCCCceee--eeh------HHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhccCCCCC
Confidence            478999998876643211  111      13333343   3456666666667788999999999999999998544 89


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC-------CCCeEEcccccccccC----ccccccCCCCCCccCC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA-------SGSVKLADFGLAKATT----MNDLKSCKGTPFWMAP  145 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~-------~~~~~l~df~~~~~~~----~~~~~~~~~~~~~~aP  145 (247)
                      +..+..+..|++..+.+||..||+||||||+|+++..       .--++|+|||.+....    ........++..+-.+
T Consensus       793 e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~  872 (974)
T KOG1166|consen  793 EYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCI  872 (974)
T ss_pred             chhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhH
Confidence            9999999999999999999999999999999999963       2348999999885432    1234455578889999


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHHhCCC
Q 041080          146 EVVNSKNDGYGLTADIWSLGCTVLEMLTRRP  176 (247)
Q Consensus       146 E~~~~~~~~~~~~~Di~slG~ll~~l~~g~~  176 (247)
                      |+..|..  |+.++|.|.++.+++-|+.|+.
T Consensus       873 EM~~grp--WtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  873 EMREGRP--WTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             HHhcCCC--CchhhhhHHHHHHHHHHHHHHH
Confidence            9998777  8999999999999999999874

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=5.4e-19  Score=150.93  Aligned_cols=227  Identities=31%  Similarity=0.435  Sum_probs=180.0

Q ss_pred             EEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcHHHHH-Hhc--CCCHHHH
Q 041080            5 FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSLANLY-QKY--HLSDSQV   80 (247)
Q Consensus         5 ~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l-~~~--~~~~~~~   80 (247)
                      +|+|.+....   ......+.+..|..+-..+. |+|++.+++.....+..++++++..|+++.+.+ +..  +.+....
T Consensus        49 ~a~~~~s~~~---~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~  125 (601)
T KOG0590|consen   49 SATKPISIPP---KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSA  125 (601)
T ss_pred             eeccCCCCCC---CccchhhhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcch
Confidence            3444444332   33444556667888888886 999999999999999999999999999998877 432  5777888


Q ss_pred             HHHHHHHHHHHHHhh-hCCeeecCCCCCcEEEcCCC-CeEEcccccccccCc-cc----cccCCC-CCCccCCcccccCC
Q 041080           81 SSYTRQILNGLVYLH-ERNVVHRDIKCANILVDASG-SVKLADFGLAKATTM-ND----LKSCKG-TPFWMAPEVVNSKN  152 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh-~~~i~h~dl~~~ni~~~~~~-~~~l~df~~~~~~~~-~~----~~~~~~-~~~~~aPE~~~~~~  152 (247)
                      ..++.|+..++.|+| ..++.|+|++|+|.+++..+ .+++.|||++..... ..    .....| ++.|.|||...+..
T Consensus       126 ~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~  205 (601)
T KOG0590|consen  126 SRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKA  205 (601)
T ss_pred             hhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchh
Confidence            999999999999999 99999999999999999999 999999999875554 22    234447 99999999987643


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHH--HHhhcC-C-CCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhh
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQAL--FRIGKG-E-LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM  228 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~--~~~~~~-~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il  228 (247)
                      . .....|+||.|+++..+++|..|+.........  ..+... . ........+....+++.+++..+|..|.+.+++.
T Consensus       206 ~-~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  206 Y-RGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             h-cCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhcccccccc
Confidence            2 578899999999999999999998665544422  111111 1 1233456788899999999999999999999999


Q ss_pred             cCccCCC
Q 041080          229 EHPFVKR  235 (247)
Q Consensus       229 ~~p~~~~  235 (247)
                      .+||+..
T Consensus       285 ~d~~~~~  291 (601)
T KOG0590|consen  285 LDNWLSS  291 (601)
T ss_pred             ccccccc
Confidence            9999987

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=1.1e-16  Score=121.11  Aligned_cols=123  Identities=19%  Similarity=0.236  Sum_probs=99.5

Q ss_pred             CCceEEEEEEeecCCCc---cchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCH
Q 041080            1 DGFFFAVKEVSLQDQGA---QGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~   77 (247)
                      +|..+++|.........   ........+.+|+.++..+.|++++....++...+..+++|||++|++|.+++.....  
T Consensus        18 ~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~~--   95 (211)
T PRK14879         18 LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGM--   95 (211)
T ss_pred             CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhccH--
Confidence            46788999865432111   1112235678899999999999988777777677788999999999999998865332  


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccc
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA  127 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~  127 (247)
                       ....++.+++.++.++|+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus        96 -~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         96 -EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             -HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence             7889999999999999999999999999999998 78999999998754

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.72  E-value=1.1e-16  Score=122.71  Aligned_cols=122  Identities=22%  Similarity=0.256  Sum_probs=93.4

Q ss_pred             CceEEEEEEeecCC--------CccchHHHHHHHHHHHHHhhcCCCce--eeeceeeecC-C---cEEEEEecccc-CcH
Q 041080            2 GFFFAVKEVSLQDQ--------GAQGKQSILQLEQEISLLSQFEQDNI--VQYLGTDKDE-N---RLYIFLELVTK-GSL   66 (247)
Q Consensus         2 g~~~~lK~~~~~~~--------~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~-~---~~~lv~e~~~~-~~L   66 (247)
                      |..++||.+.....        ..........+.+|+.++..|.|+++  ++.+++.... +   ..++|||+++| .+|
T Consensus        55 ~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L  134 (239)
T PRK01723         55 GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDL  134 (239)
T ss_pred             CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCH
Confidence            66789999964321        01112345678899999999988775  6666654332 2   23599999997 689


Q ss_pred             HHHHHhcCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccc
Q 041080           67 ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA  127 (247)
Q Consensus        67 ~~~l~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~  127 (247)
                      .+++....+++..    +.+++.++.+||+.||+|+||||.||+++.++.++|+|||.+..
T Consensus       135 ~~~l~~~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        135 VALLQEAPLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             HHHHhcCCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            9988776666543    56899999999999999999999999999999999999998754

>smart00090 RIO RIO-like kinase

Probab=99.72  E-value=6.9e-17  Score=123.62  Aligned_cols=122  Identities=20%  Similarity=0.184  Sum_probs=92.4

Q ss_pred             CCceEEEEEEeecCCCcc-------------------chHHHHHHHHHHHHHhhcCC--CceeeeceeeecCCcEEEEEe
Q 041080            1 DGFFFAVKEVSLQDQGAQ-------------------GKQSILQLEQEISLLSQFEQ--DNIVQYLGTDKDENRLYIFLE   59 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~-------------------~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e   59 (247)
                      +|+.||||++........                   .......+..|+..+.++.+  ..++++++.    ...++|||
T Consensus        53 ~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E  128 (237)
T smart00090       53 SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPIAW----RRNVLVME  128 (237)
T ss_pred             CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeEe----cCceEEEE
Confidence            588999999986432110                   01122346789999999975  334454443    23589999


Q ss_pred             ccccCcHHHHH-HhcCCCHHHHHHHHHHHHHHHHHhhhCC-eeecCCCCCcEEEcCCCCeEEcccccccc
Q 041080           60 LVTKGSLANLY-QKYHLSDSQVSSYTRQILNGLVYLHERN-VVHRDIKCANILVDASGSVKLADFGLAKA  127 (247)
Q Consensus        60 ~~~~~~L~~~l-~~~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~dl~~~ni~~~~~~~~~l~df~~~~~  127 (247)
                      |++|.+|.... .........+..++.|++.++.+||+.| ++|+||||+||+++ ++.++|+|||.+..
T Consensus       129 ~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      129 FIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             EecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence            99998886654 3444666677899999999999999999 99999999999998 88999999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.71  E-value=1.3e-16  Score=119.54  Aligned_cols=120  Identities=23%  Similarity=0.271  Sum_probs=94.3

Q ss_pred             CCceEEEEEEeecCCCc---cchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCH
Q 041080            1 DGFFFAVKEVSLQDQGA---QGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~   77 (247)
                      +|..+++|.........   ......+++.+|+.+++.+.|+++.....++...+..+++|||++|++|.+++.....  
T Consensus        16 ~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~--   93 (199)
T TIGR03724        16 LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND--   93 (199)
T ss_pred             CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH--
Confidence            47789999865432111   1122346688999999999888765555555566677899999999999988765321  


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccc
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA  127 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~  127 (247)
                          .++.+++.+|.++|+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus        94 ----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        94 ----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence                7899999999999999999999999999998 88999999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.68  E-value=2.7e-15  Score=125.10  Aligned_cols=162  Identities=25%  Similarity=0.383  Sum_probs=125.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|.++.|.++....    . +..+.+.+.++.|+.++||+|+++++.+...+..|+|+|-+.  .|...+++.+  ...+
T Consensus        36 ~~~~vsVF~~~~~~----~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~--~~~v  106 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSN----G-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG--KEEV  106 (690)
T ss_pred             cCCceEEEEEeCCC----c-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH--HHHH
Confidence            57889999887532    1 456667899999999999999999999999999999999985  4777777643  6677


Q ss_pred             HHHHHHHHHHHHHhh-hCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCCc
Q 041080           81 SSYTRQILNGLVYLH-ERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh-~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      ...+.||+.||.||| +.+++|+++..++|+++..|..+|++|..........  .........|..|+.....    .-
T Consensus       107 ~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s----~~  182 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS----EW  182 (690)
T ss_pred             HHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc----cc
Confidence            888999999999997 6689999999999999999999999997753222111  1122223345666654221    23


Q ss_pred             chhHHHHHHHHHHHHhCC
Q 041080          158 TADIWSLGCTVLEMLTRR  175 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~  175 (247)
                      ..|.|.||+++++++.|.
T Consensus       183 s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  183 SIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             chhhhhHHHHHHHHhCcc
Confidence            579999999999999883

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.68  E-value=1.9e-16  Score=121.64  Aligned_cols=203  Identities=23%  Similarity=0.342  Sum_probs=142.2

Q ss_pred             HHHHHHHHhhcCCCceeeeceeeecC-----CcEEEEEeccccCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHhh
Q 041080           26 LEQEISLLSQFEQDNIVQYLGTDKDE-----NRLYIFLELVTKGSLANLYQKY-----HLSDSQVSSYTRQILNGLVYLH   95 (247)
Q Consensus        26 ~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~l~~~l~~lh   95 (247)
                      .+.-..-+-++-|.|+++++.+..+.     ....++.||+..|++..++++-     .+......+|+.||+.||.|||
T Consensus       114 ~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh  193 (458)
T KOG1266|consen  114 RRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH  193 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh
Confidence            33444555666799999999986543     3578999999999999999753     3778888899999999999999


Q ss_pred             hC--CeeecCCCCCcEEEcCCCCeEEccccccccc------CccccccCCCCCCccCCcccccCCCCCCcchhHHHHHHH
Q 041080           96 ER--NVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT  167 (247)
Q Consensus        96 ~~--~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~l  167 (247)
                      +.  -++|+++..+.+++..+|-+++..-.-....      ...+.....+.+.|.+||.=...  ..+.++|||++|..
T Consensus       194 s~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t--n~~~a~dIy~fgmc  271 (458)
T KOG1266|consen  194 SCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT--NTTGASDIYKFGMC  271 (458)
T ss_pred             ccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccc--ccccchhhhhhhHH
Confidence            87  4999999999999999988887533221110      01112223356788999875333  35778999999999


Q ss_pred             HHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       168 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      ..++..+...-...+...........-..-+.   ..--+.++.+|++..|+.||++.+++.||..
T Consensus       272 AlemailEiq~tnseS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpll  334 (458)
T KOG1266|consen  272 ALEMAILEIQSTNSESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLL  334 (458)
T ss_pred             HHHHHHheeccCCCcceeehhhhhhhheeecc---CccccCcCcccccCCCCCCcchhhhhcCcee
Confidence            99998877653333222222111111110111   1223568899999999999999999999954

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.65  E-value=1.2e-15  Score=114.20  Aligned_cols=118  Identities=20%  Similarity=0.226  Sum_probs=89.4

Q ss_pred             CCceEEEEEEeecCCCccc-----------------hHHHHHHHHHHHHHhhcCCC--ceeeeceeeecCCcEEEEEecc
Q 041080            1 DGFFFAVKEVSLQDQGAQG-----------------KQSILQLEQEISLLSQFEQD--NIVQYLGTDKDENRLYIFLELV   61 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~-----------------~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~   61 (247)
                      +|+.||||++..+..+...                 .........|+..+..+.++  .+++.++    ....+++|||+
T Consensus        38 ~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~  113 (198)
T cd05144          38 DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYI  113 (198)
T ss_pred             CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEe
Confidence            5889999998754311100                 01122467889999999776  4444443    23558999999


Q ss_pred             ccCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccc
Q 041080           62 TKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA  127 (247)
Q Consensus        62 ~~~~L~~~l~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~  127 (247)
                      +|++|.++...     .....++.+++.++.++|+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus       114 ~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~  174 (198)
T cd05144         114 DGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVS  174 (198)
T ss_pred             CCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCcccc
Confidence            99998776431     34567889999999999999999999999999999999999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.64  E-value=2.6e-15  Score=128.43  Aligned_cols=98  Identities=23%  Similarity=0.328  Sum_probs=87.0

Q ss_pred             HHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHhhhCCeee
Q 041080           22 SILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVH  101 (247)
Q Consensus        22 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h  101 (247)
                      ..+.+.+|+.+++.++|++++....+.......++||||+++++|.+++.       ....++.+++.++.+||+.|++|
T Consensus       379 ~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiH  451 (535)
T PRK09605        379 RTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVH  451 (535)
T ss_pred             HHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCcc
Confidence            34678899999999999999887777777777899999999999998875       35678999999999999999999


Q ss_pred             cCCCCCcEEEcCCCCeEEcccccccc
Q 041080          102 RDIKCANILVDASGSVKLADFGLAKA  127 (247)
Q Consensus       102 ~dl~~~ni~~~~~~~~~l~df~~~~~  127 (247)
                      +|+||+||++ .++.++|+|||.+..
T Consensus       452 rDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        452 GDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CCCChHHEEE-ECCcEEEEeCccccc
Confidence            9999999999 678999999998754

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.56  E-value=7.5e-15  Score=121.04  Aligned_cols=231  Identities=24%  Similarity=0.248  Sum_probs=168.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~   77 (247)
                      ++..+|+|.-.....+...   ...=.+|......++ |++.++....+...+..++-+|.+. .+|..+....  .++.
T Consensus       142 s~~~~a~k~s~~p~s~p~~---~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~  217 (524)
T KOG0601|consen  142 SPHKFAVKKSKIPFSPPLD---SKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPD  217 (524)
T ss_pred             CCcccccccccCCCCCccc---cccccchhhcccccCccccccccCcccccCCcceeeecccc-chhHHhhhcccccCCc
Confidence            4567788874433221111   111225666666774 8999998888999999999999996 4777776543  2788


Q ss_pred             HHHHHHHHHHHH----HHHHhhhCCeeecCCCCCcEEEcCC-CCeEEcccccccccCccccc-------cCCCCCCccCC
Q 041080           78 SQVSSYTRQILN----GLVYLHERNVVHRDIKCANILVDAS-GSVKLADFGLAKATTMNDLK-------SCKGTPFWMAP  145 (247)
Q Consensus        78 ~~~~~~~~~l~~----~l~~lh~~~i~h~dl~~~ni~~~~~-~~~~l~df~~~~~~~~~~~~-------~~~~~~~~~aP  145 (247)
                      ..++..+.+...    |+.++|..+++|.|++|.|++...+ ...+++|||.....+.....       ...+...|++|
T Consensus       218 ~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~k  297 (524)
T KOG0601|consen  218 NLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAK  297 (524)
T ss_pred             hhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeCh
Confidence            889999999999    9999999999999999999999999 78999999988766555422       12467789999


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC-CCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh
Q 041080          146 EVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG-ELPSVPSSLSRDARDFILKCLQVNPNDRPTV  224 (247)
Q Consensus       146 E~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  224 (247)
                      |..++.   ++...|+|++|.++.+...+..+......... .++... ...++-...+.++...+..|+..+|..|+++
T Consensus       298 e~~~~l---~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~  373 (524)
T KOG0601|consen  298 ELLNGL---ATFASDIFSLGEVILEAILGSHLPSVGKNSSW-SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTA  373 (524)
T ss_pred             hhhccc---cchHhhhcchhhhhHhhHhhcccccCCCCCCc-cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHH
Confidence            998654   58899999999999998887655432211111 111111 1122334556677789999999999999999


Q ss_pred             hhhhcCccCCCCCCC
Q 041080          225 TELMEHPFVKRPLQT  239 (247)
Q Consensus       225 ~~il~~p~~~~~~~~  239 (247)
                      +.++++++..+....
T Consensus       374 q~~~~l~~i~s~~~~  388 (524)
T KOG0601|consen  374 QILTALNVIHSKLFV  388 (524)
T ss_pred             HHHhccccccchhhh
Confidence            999999998865443

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.55  E-value=4.6e-14  Score=100.76  Aligned_cols=112  Identities=20%  Similarity=0.312  Sum_probs=92.9

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCC--CceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ--DNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~   79 (247)
                      ++.+++|.+.....       ...+.+|+..++.+++  .++++++++....+..++++||++++++..+      +...
T Consensus        21 ~~~~~iK~~~~~~~-------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~------~~~~   87 (155)
T cd05120          21 DEDYVLKINPSREK-------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV------SEEE   87 (155)
T ss_pred             CCeEEEEecCCCCc-------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC------CHHH
Confidence            45788888754321       4567899999999976  5899998888888899999999998777654      4566


Q ss_pred             HHHHHHHHHHHHHHhhhC---CeeecCCCCCcEEEcCCCCeEEccccccc
Q 041080           80 VSSYTRQILNGLVYLHER---NVVHRDIKCANILVDASGSVKLADFGLAK  126 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~---~i~h~dl~~~ni~~~~~~~~~l~df~~~~  126 (247)
                      ...++.+++.+++.+|..   +++|+|++|+||+++..+.++++||+.+.
T Consensus        88 ~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          88 KEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             HHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            778899999999999985   79999999999999998999999998763

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.54  E-value=7.7e-14  Score=103.45  Aligned_cols=121  Identities=24%  Similarity=0.259  Sum_probs=82.4

Q ss_pred             CCceEEEEEEeecCCCccchHHH-------------------HHHHHHHHHHhhcCCC--ceeeeceeeecCCcEEEEEe
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSI-------------------LQLEQEISLLSQFEQD--NIVQYLGTDKDENRLYIFLE   59 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~-------------------~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e   59 (247)
                      +|+.||||++.............                   .....|...+.++.+.  .+++.++.    ...+++||
T Consensus        20 ~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e   95 (187)
T cd05119          20 DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPIDL----NRHVLVME   95 (187)
T ss_pred             CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceEec----CCCEEEEE
Confidence            58899999997643221111100                   1124566666666433  34444443    24589999


Q ss_pred             ccccCcHH-HHHHhcCCCHHHHHHHHHHHHHHHHHhhh-CCeeecCCCCCcEEEcCCCCeEEcccccccc
Q 041080           60 LVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHE-RNVVHRDIKCANILVDASGSVKLADFGLAKA  127 (247)
Q Consensus        60 ~~~~~~L~-~~l~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~  127 (247)
                      |++++++. ..+...... .....++.+++.++.++|. .|++|+||+|+||+++ ++.++++|||.+..
T Consensus        96 ~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~  163 (187)
T cd05119          96 FIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVE  163 (187)
T ss_pred             EeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECccccc
Confidence            99984332 112221111 5678899999999999999 9999999999999999 89999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.53  E-value=1.9e-13  Score=111.26  Aligned_cols=198  Identities=16%  Similarity=0.247  Sum_probs=144.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec----CCcEEEEEecccc-CcHHHHH-----
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD----ENRLYIFLELVTK-GSLANLY-----   70 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~-~~L~~~l-----   70 (247)
                      ||..|++|++...+.-..     .....-+++++++.|+|++++.++|..    +..+++|++|.++ ++|.+..     
T Consensus       300 DG~~YvLkRlhg~r~~~~-----nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~  374 (655)
T KOG3741|consen  300 DGNAYVLKRLHGDRDQST-----NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPP  374 (655)
T ss_pred             CCceeeeeeeccccccCc-----ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCc
Confidence            799999999943322111     122366789999999999999998863    3478999999987 4665543     


Q ss_pred             -----------HhcCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCC
Q 041080           71 -----------QKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT  139 (247)
Q Consensus        71 -----------~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~  139 (247)
                                 +..+.++..+|.++.|+..||.++|+.|+..+-|.+.+|+++.+.+++|...|+.........      
T Consensus       375 ~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~------  448 (655)
T KOG3741|consen  375 FTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT------  448 (655)
T ss_pred             cccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCCC------
Confidence                       112377899999999999999999999999999999999999998999998888765543321      


Q ss_pred             CCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCC--CCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCC
Q 041080          140 PFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY--SHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVN  217 (247)
Q Consensus       140 ~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  217 (247)
                            +.+.     --.+-|.=.||.+++.|.+|..--  .+......        ...+...++.++++++..+...+
T Consensus       449 ------~~le-----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~--------~~~I~~~yS~D~rn~v~yl~s~~  509 (655)
T KOG3741|consen  449 ------EPLE-----SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSH--------LTRITTTYSTDLRNVVEYLESLN  509 (655)
T ss_pred             ------cchh-----HHhhhhHHHHHHHHHHHhhcccccccccchHHHH--------HHHhhhhhhHHHHHHHHHHHhcC
Confidence                  1121     123578999999999999985321  11111111        12334567889999999999988


Q ss_pred             CCCCCChhhhhc
Q 041080          218 PNDRPTVTELME  229 (247)
Q Consensus       218 p~~Rps~~~il~  229 (247)
                      +.+ -++.+++.
T Consensus       510 ~~~-ksI~~llp  520 (655)
T KOG3741|consen  510 FRE-KSIQDLLP  520 (655)
T ss_pred             ccc-ccHHHHHH
Confidence            876 67777764

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.49  E-value=5.6e-13  Score=98.18  Aligned_cols=98  Identities=20%  Similarity=0.277  Sum_probs=76.2

Q ss_pred             HHHHHHHhhcCC--CceeeeceeeecCCcEEEEEeccccCcH-HHHHHhcCCCHHHHHHHHHHHHHHHHHh-hhCCeeec
Q 041080           27 EQEISLLSQFEQ--DNIVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYL-HERNVVHR  102 (247)
Q Consensus        27 ~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~~~~~~~~~~l~~~l~~l-h~~~i~h~  102 (247)
                      ++|+..|+++..  -++++++++    ..-++||||+.+..+ ...++...++......+..+++.++..+ |+.|++|+
T Consensus        74 ~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHG  149 (197)
T cd05146          74 EKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHA  149 (197)
T ss_pred             HHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            389999999953  566777764    467899999976433 2234444455666778889999999988 89999999


Q ss_pred             CCCCCcEEEcCCCCeEEcccccccccC
Q 041080          103 DIKCANILVDASGSVKLADFGLAKATT  129 (247)
Q Consensus       103 dl~~~ni~~~~~~~~~l~df~~~~~~~  129 (247)
                      ||++.||++. ++.+.++|||.+....
T Consensus       150 DLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         150 DLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            9999999996 5789999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.44  E-value=3.7e-13  Score=117.44  Aligned_cols=203  Identities=26%  Similarity=0.352  Sum_probs=162.7

Q ss_pred             CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC
Q 041080           37 EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG  115 (247)
Q Consensus        37 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~  115 (247)
                      .+|-++.....+.......++++|.++++|...+...+ .+.+.....+..++.+.++||...+.|+|++|.|.+...++
T Consensus       862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g  941 (1205)
T KOG0606|consen  862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG  941 (1205)
T ss_pred             CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccC
Confidence            44666655555566778899999999999988887765 66777778888999999999999999999999999999999


Q ss_pred             CeEEcccccccccCcc---------------------------------ccccCCCCCCccCCcccccCCCCCCcchhHH
Q 041080          116 SVKLADFGLAKATTMN---------------------------------DLKSCKGTPFWMAPEVVNSKNDGYGLTADIW  162 (247)
Q Consensus       116 ~~~l~df~~~~~~~~~---------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~  162 (247)
                      ...+.+|+.....+..                                 ......+++.|.+||.+.+..  ....+|+|
T Consensus       942 h~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~--hgs~ad~~ 1019 (1205)
T KOG0606|consen  942 HRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR--HGSAADWW 1019 (1205)
T ss_pred             CcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc--CCCcchhh
Confidence            9999998733211000                                 012234788899999997766  57789999


Q ss_pred             HHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC--CCCCCcCCHHHHHHHHHHhcCCCCCCCChh---hhhcCccCCCCC
Q 041080          163 SLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL--PSVPSSLSRDARDFILKCLQVNPNDRPTVT---ELMEHPFVKRPL  237 (247)
Q Consensus       163 slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~---~il~~p~~~~~~  237 (247)
                      +.|+++++.++|..||...........+.....  +.-+...+.+.++++...+..+|.+|..+.   +.-.||||+..-
T Consensus      1020 ~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1020 SSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred             hhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence            999999999999999999888888877766544  344567899999999999999999998877   888999999865


Q ss_pred             CCCC
Q 041080          238 QTPR  241 (247)
Q Consensus       238 ~~~~  241 (247)
                      -...
T Consensus      1100 ~~~l 1103 (1205)
T KOG0606|consen 1100 WENL 1103 (1205)
T ss_pred             cccc
Confidence            4443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.37  E-value=4.2e-12  Score=90.80  Aligned_cols=99  Identities=19%  Similarity=0.306  Sum_probs=80.1

Q ss_pred             HHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHhhhCCeeec
Q 041080           23 ILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHR  102 (247)
Q Consensus        23 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~  102 (247)
                      ..+-.+|..++.++.--+|.-.+-++.+.+...++|||++|..|.+.+....      ..++..+=.-+.-||..||+||
T Consensus        43 r~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~~------~~~~r~vG~~vg~lH~~givHG  116 (204)
T COG3642          43 RERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEAR------PDLLREVGRLVGKLHKAGIVHG  116 (204)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhcc------hHHHHHHHHHHHHHHhcCeecC
Confidence            4557789999999976666665566667888899999999988888887752      3455566667889999999999


Q ss_pred             CCCCCcEEEcCCCCeEEccccccccc
Q 041080          103 DIKCANILVDASGSVKLADFGLAKAT  128 (247)
Q Consensus       103 dl~~~ni~~~~~~~~~l~df~~~~~~  128 (247)
                      ||+++||.++.+ .+.++|||++...
T Consensus       117 DLTtsNiIl~~~-~i~~IDfGLg~~s  141 (204)
T COG3642         117 DLTTSNIILSGG-RIYFIDFGLGEFS  141 (204)
T ss_pred             CCccceEEEeCC-cEEEEECCccccc
Confidence            999999999665 4999999998643

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.36  E-value=6.1e-12  Score=104.66  Aligned_cols=76  Identities=17%  Similarity=0.228  Sum_probs=59.9

Q ss_pred             CCcEEEEEeccccCcHHHHHHhc--CCCHHHHHHHHHHHHH-HHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccc
Q 041080           51 ENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILN-GLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA  127 (247)
Q Consensus        51 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~l~~-~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~  127 (247)
                      .+..++||||++|++|.++....  +.+   ...++..++. .+..+|..|++|+|++|.||+++.++.++++|||+...
T Consensus       230 ~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~  306 (437)
T TIGR01982       230 TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGR  306 (437)
T ss_pred             cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence            34568999999999998876432  232   3345555555 47889999999999999999999999999999999865


Q ss_pred             cC
Q 041080          128 TT  129 (247)
Q Consensus       128 ~~  129 (247)
                      ..
T Consensus       307 l~  308 (437)
T TIGR01982       307 LS  308 (437)
T ss_pred             CC
Confidence            44

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.36  E-value=2.2e-11  Score=94.58  Aligned_cols=126  Identities=13%  Similarity=0.136  Sum_probs=91.0

Q ss_pred             CCceEEEEEEeecCCCccch------HHHHHHHHHHHHHhhcCC--Cceeeeceeeec-----CCcEEEEEeccccC-cH
Q 041080            1 DGFFFAVKEVSLQDQGAQGK------QSILQLEQEISLLSQFEQ--DNIVQYLGTDKD-----ENRLYIFLELVTKG-SL   66 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~------~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~-----~~~~~lv~e~~~~~-~L   66 (247)
                      +|+.|.||..........-.      .....+.+|...+..|..  -.+++.+++...     ....++|+|++++. +|
T Consensus        44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL  123 (268)
T PRK15123         44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL  123 (268)
T ss_pred             CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence            47889999885432110000      011136788888888853  334455555543     23578999999885 79


Q ss_pred             HHHHHh---cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC-------CCCeEEccccccc
Q 041080           67 ANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA-------SGSVKLADFGLAK  126 (247)
Q Consensus        67 ~~~l~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~-------~~~~~l~df~~~~  126 (247)
                      .+++..   ...+......++.+++..+..||..|++|+|++++||+++.       ++.+.++||+.+.
T Consensus       124 ~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        124 EDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            888863   34566677899999999999999999999999999999975       4578999998763

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.34  E-value=1.1e-11  Score=91.08  Aligned_cols=122  Identities=25%  Similarity=0.284  Sum_probs=79.6

Q ss_pred             CCceEEEEEEeecCCC---------------------ccchHHHHHHHHHHHHHhhcCCC--ceeeeceeeecCCcEEEE
Q 041080            1 DGFFFAVKEVSLQDQG---------------------AQGKQSILQLEQEISLLSQFEQD--NIVQYLGTDKDENRLYIF   57 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~---------------------~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv   57 (247)
                      +|..+|||+++....+                     ..........++|...|.++..-  ++++++++.    .-.+|
T Consensus         9 ~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~iv   84 (188)
T PF01163_consen    9 DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIV   84 (188)
T ss_dssp             TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEE
T ss_pred             CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEE
Confidence            5788999999764221                     12223355678899999999755  566676552    34799


Q ss_pred             Eeccc--cCcHHHHHHhcCCCHHHHHHHHHHHHHHHHH-hhhCCeeecCCCCCcEEEcCCCCeEEccccccccc
Q 041080           58 LELVT--KGSLANLYQKYHLSDSQVSSYTRQILNGLVY-LHERNVVHRDIKCANILVDASGSVKLADFGLAKAT  128 (247)
Q Consensus        58 ~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~l~~~l~~-lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~  128 (247)
                      |||++  |..+..+ ....++......++.+++..+.. +|+.|++|||+++.||+++++ .+.++|||.+...
T Consensus        85 ME~I~~~G~~~~~l-~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen   85 MEYIGEDGVPLPRL-KDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             EE--EETTEEGGCH-HHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred             EEecCCCccchhhH-HhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence            99998  6555443 33333345567778888885444 689999999999999999877 9999999987544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.34  E-value=4.3e-12  Score=92.57  Aligned_cols=109  Identities=18%  Similarity=0.186  Sum_probs=78.6

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCce-eeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNI-VQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      |+.|+||.......      ....+..|+..++.+.+.++ ++++....  ...++||||++|.++...    ..   ..
T Consensus        21 ~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~----~~---~~   85 (170)
T cd05151          21 NKKYVVRIPGNGTE------LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTE----DF---SD   85 (170)
T ss_pred             CeEEEEEeCCCCcc------cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccccc----cc---cC
Confidence            67899998754321      12235688889988865444 44544432  345799999999877643    11   12


Q ss_pred             HHHHHHHHHHHHHhhhCCe-----eecCCCCCcEEEcCCCCeEEccccccc
Q 041080           81 SSYTRQILNGLVYLHERNV-----VHRDIKCANILVDASGSVKLADFGLAK  126 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i-----~h~dl~~~ni~~~~~~~~~l~df~~~~  126 (247)
                      ...+.+++.+++.||+.++     +|+|++|.||+++ ++.++++||+.+.
T Consensus        86 ~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          86 PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            3456789999999999885     9999999999998 6789999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.32  E-value=1e-12  Score=110.39  Aligned_cols=158  Identities=22%  Similarity=0.319  Sum_probs=115.0

Q ss_pred             HHHHHHHHHHHHHHHHHhhhC-CeeecCCCCCcEEEcCCCCeEEcccccccccCccccc-----------cCCCCCCccC
Q 041080           77 DSQVSSYTRQILNGLVYLHER-NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK-----------SCKGTPFWMA  144 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-----------~~~~~~~~~a  144 (247)
                      .+....=+.+++.|+.++|+. +++|++|.|++|+++.++.+||+.|+...........           .......|.|
T Consensus        98 Te~~f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~a  177 (700)
T KOG2137|consen   98 TEDGFANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLA  177 (700)
T ss_pred             ccHhhhhhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCccccc
Confidence            333444456677899999975 8999999999999999999999999887544331111           1114556999


Q ss_pred             CcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHH---hhcCCCCCCCCcCCHHHHHHHHHHhcCCCCC
Q 041080          145 PEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFR---IGKGELPSVPSSLSRDARDFILKCLQVNPND  220 (247)
Q Consensus       145 PE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  220 (247)
                      ||.+.+..  .+.++|+||+|+++|.+.. |+.-+...........   .......-....+|.++++=+.+++..++..
T Consensus       178 pE~~~~~~--~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~  255 (700)
T KOG2137|consen  178 PEYLLGTT--NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAV  255 (700)
T ss_pred             chhhcccc--ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCccc
Confidence            99997633  6889999999999999884 5444433322111111   1111122334678999999999999999999


Q ss_pred             CCChhhhhcCccCCCC
Q 041080          221 RPTVTELMEHPFVKRP  236 (247)
Q Consensus       221 Rps~~~il~~p~~~~~  236 (247)
                      ||++..+...|||...
T Consensus       256 rp~~~~l~~~~ff~D~  271 (700)
T KOG2137|consen  256 RPTLDLLLSIPFFSDP  271 (700)
T ss_pred             CcchhhhhcccccCCc
Confidence            9999999999999875

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.29  E-value=2.4e-12  Score=106.39  Aligned_cols=226  Identities=24%  Similarity=0.208  Sum_probs=156.3

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHH-hcCCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~   79 (247)
                      |..|++|........   .........|+.+...+ .|.+++.........+..++=-||+.++++..... ...+.+..
T Consensus       291 ~~~Y~~ke~~~~l~~---~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~  367 (524)
T KOG0601|consen  291 DCIYAAKELLNGLAT---FASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDP  367 (524)
T ss_pred             CceEeChhhhccccc---hHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcch
Confidence            455666666543221   22222334577777777 48888887777777777779999999988765442 22478889


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC-CCeEEcccccccccCccccccCCCCCCcc-CCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFGLAKATTMNDLKSCKGTPFWM-APEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~-aPE~~~~~~~~~~~  157 (247)
                      .+++..|++.++.++|+..++|+|++|+||++..+ +..++.||+........... .....++. ..|.+. ....+..
T Consensus       368 ~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~-~~~~~r~~p~~~~~~-e~~~~~~  445 (524)
T KOG0601|consen  368 RLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSGV-FHHIDRLYPIAEILL-EDYPHLS  445 (524)
T ss_pred             hhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceeccc-ccccccccccchhhc-ccccccc
Confidence            99999999999999999999999999999999886 67788899887532211111 11233334 244443 2333688


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ++|+|+||..+.+.+++...-..   ......+..+..+..+. .+.++..+.+.++.+++..||.+.++..|+=|...
T Consensus       446 ~~~~~sl~~~~~e~~~~~~ls~~---~~~~~~i~~~~~p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  446 KADIFSLGLSVDEAITGSPLSES---GVQSLTIRSGDTPNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             ccccccccccccccccCcccCcc---cccceeeecccccCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence            99999999999999987654322   12233333343333333 34888999999999999999999999988866543

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.26  E-value=1.7e-11  Score=103.49  Aligned_cols=76  Identities=12%  Similarity=0.134  Sum_probs=53.3

Q ss_pred             CcEEEEEeccccCcHHHH--HHhcCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC----CeEEcccccc
Q 041080           52 NRLYIFLELVTKGSLANL--YQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG----SVKLADFGLA  125 (247)
Q Consensus        52 ~~~~lv~e~~~~~~L~~~--l~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~----~~~l~df~~~  125 (247)
                      ...++||||+.|+.+.++  +++.+.+...+.....+  ..+..+...|++|+|+||.||+++.+|    .++++|||+.
T Consensus       234 t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~--~~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGiv  311 (537)
T PRK04750        234 SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVE--VFFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIV  311 (537)
T ss_pred             CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHH--HHHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceE
Confidence            456799999999999774  34444433332221111  113344568999999999999999888    8999999997


Q ss_pred             cccC
Q 041080          126 KATT  129 (247)
Q Consensus       126 ~~~~  129 (247)
                      ....
T Consensus       312 g~l~  315 (537)
T PRK04750        312 GSLN  315 (537)
T ss_pred             EECC
Confidence            5443

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.20  E-value=4.6e-10  Score=80.31  Aligned_cols=108  Identities=22%  Similarity=0.311  Sum_probs=83.3

Q ss_pred             HHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEecccc-CcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHhhh
Q 041080           21 QSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTK-GSLANLYQKY---HLSDSQVSSYTRQILNGLVYLHE   96 (247)
Q Consensus        21 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~---~~~~~~~~~~~~~l~~~l~~lh~   96 (247)
                      -...+..+|+..+.++.--+|.-..-++.+...-.++|||++| .++.+++...   .........++.++=..+.-||.
T Consensus        52 Ltr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~  131 (229)
T KOG3087|consen   52 LTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD  131 (229)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh
Confidence            3456678899999998765665555566677788899999987 3566666432   23334447888889999999999


Q ss_pred             CCeeecCCCCCcEEEcCCC---CeEEccccccccc
Q 041080           97 RNVVHRDIKCANILVDASG---SVKLADFGLAKAT  128 (247)
Q Consensus        97 ~~i~h~dl~~~ni~~~~~~---~~~l~df~~~~~~  128 (247)
                      .+++||||..+||++..++   .+.++|||++...
T Consensus       132 ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen  132 NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             CCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            9999999999999998765   3589999998654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.16  E-value=5.4e-10  Score=89.58  Aligned_cols=174  Identities=20%  Similarity=0.271  Sum_probs=121.5

Q ss_pred             cEEEEEeccccC-cHHHHHH---hc----CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEccccc
Q 041080           53 RLYIFLELVTKG-SLANLYQ---KY----HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGL  124 (247)
Q Consensus        53 ~~~lv~e~~~~~-~L~~~l~---~~----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~  124 (247)
                      ...++|...+|. .+..+.+   ++    ...+..+++.+.+++.+.+.||..|..-||++++|+++++++.+.|.|-..
T Consensus        84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence            378889888774 2333332   11    178899999999999999999999999999999999999999999987655


Q ss_pred             ccccCcc-ccccCCCCCCccCCcccc-cC--CCCCCcchhHHHHHHHHHHHHhC-CCCCCCChhhH--------HH----
Q 041080          125 AKATTMN-DLKSCKGTPFWMAPEVVN-SK--NDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQ--------AL----  187 (247)
Q Consensus       125 ~~~~~~~-~~~~~~~~~~~~aPE~~~-~~--~~~~~~~~Di~slG~ll~~l~~g-~~p~~~~~~~~--------~~----  187 (247)
                      ....... .....+|.+.|.+||..+ +.  ...-+...|.|.||+++|+++.| .+||.......        .+    
T Consensus       164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~  243 (637)
T COG4248         164 FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR  243 (637)
T ss_pred             eeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence            4332222 233456889999999865 11  12246679999999999999886 89986542111        00    


Q ss_pred             ----HHhhcCCCC---CCC-CcCCHHHHHHHHHHhcCC--CCCCCChhh
Q 041080          188 ----FRIGKGELP---SVP-SSLSRDARDFILKCLQVN--PNDRPTVTE  226 (247)
Q Consensus       188 ----~~~~~~~~~---~~~-~~~~~~~~~li~~~l~~~--p~~Rps~~~  226 (247)
                          .....+..+   ..| .-+++++..++.+|+...  +.-|||++.
T Consensus       244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence                001111111   111 246889999999999753  568999754

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.13  E-value=8.9e-10  Score=82.83  Aligned_cols=104  Identities=22%  Similarity=0.309  Sum_probs=82.8

Q ss_pred             HHHHHHHHHHHhhcCC--CceeeeceeeecC----CcEEEEEecccc-CcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHh
Q 041080           23 ILQLEQEISLLSQFEQ--DNIVQYLGTDKDE----NRLYIFLELVTK-GSLANLYQKY-HLSDSQVSSYTRQILNGLVYL   94 (247)
Q Consensus        23 ~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~----~~~~lv~e~~~~-~~L~~~l~~~-~~~~~~~~~~~~~l~~~l~~l   94 (247)
                      ...+.+|...+..|..  -.+++.+++....    ...++|+|++++ .+|.+++... ..+......++.+++..+..|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            4457788888888743  3456666665542    245899999988 4799988762 366777889999999999999


Q ss_pred             hhCCeeecCCCCCcEEEcCCC---CeEEccccccc
Q 041080           95 HERNVVHRDIKCANILVDASG---SVKLADFGLAK  126 (247)
Q Consensus        95 h~~~i~h~dl~~~ni~~~~~~---~~~l~df~~~~  126 (247)
                      |..|++|+|+++.||+++.++   .+.++||+-..
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~  169 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR  169 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence            999999999999999999887   79999998654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.05  E-value=8.9e-10  Score=83.79  Aligned_cols=121  Identities=20%  Similarity=0.250  Sum_probs=84.0

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCC--CceeeeceeeecC---CcEEEEEeccccCcHHHHHHhcCCC
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ--DNIVQYLGTDKDE---NRLYIFLELVTKGSLANLYQKYHLS   76 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~   76 (247)
                      |+.++||........    .....+.+|+.++..+.+  ..+++++.+....   +..+++|||++|.++.+.+....++
T Consensus        22 g~~~ilK~~~~~~~~----~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~~~~~   97 (223)
T cd05154          22 GRRLVLRRPPPGALL----PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLRPELS   97 (223)
T ss_pred             CcceEEEeCCCcccC----cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCCCCCC
Confidence            578999988653221    123457799999999965  3457777776553   3678999999998776543222345


Q ss_pred             HHHHHHHHHHHHHHHHHhhh--------------------------------------------------------CCee
Q 041080           77 DSQVSSYTRQILNGLVYLHE--------------------------------------------------------RNVV  100 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~--------------------------------------------------------~~i~  100 (247)
                      ......++.+++.++..||+                                                        ..++
T Consensus        98 ~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  177 (223)
T cd05154          98 PEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLV  177 (223)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEE
Confidence            55555556666666666652                                                        2468


Q ss_pred             ecCCCCCcEEEcC--CCCeEEccccccc
Q 041080          101 HRDIKCANILVDA--SGSVKLADFGLAK  126 (247)
Q Consensus       101 h~dl~~~ni~~~~--~~~~~l~df~~~~  126 (247)
                      |+|+++.||+++.  ++.+.++||+.+.
T Consensus       178 HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         178 HGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             ECCCCcccEEEcCCCCcEEEEEeccccc
Confidence            9999999999998  5668899998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=99.03  E-value=2.1e-09  Score=79.92  Aligned_cols=116  Identities=14%  Similarity=0.233  Sum_probs=73.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHH------HHHHHHHHhhcCC---Cceeeeceeee-----cCCcEEEEEeccccCcH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQ------LEQEISLLSQFEQ---DNIVQYLGTDK-----DENRLYIFLELVTKGSL   66 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~------~~~e~~~l~~l~h---~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L   66 (247)
                      ||+.+++|..+....-  .+.....      ..+.+..+.++..   ....+++.+..     -....+++|||++|..|
T Consensus        53 ~~~kyIlK~pr~~~~r--~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l  130 (229)
T PF06176_consen   53 DGKKYILKEPREENRR--PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVEL  130 (229)
T ss_pred             CCcEEEEeccchhhhh--HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeec
Confidence            5788899988754321  1111111      2334444444432   33333333221     22356789999999887


Q ss_pred             HHHHHhcCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEccccccc
Q 041080           67 ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAK  126 (247)
Q Consensus        67 ~~~l~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~  126 (247)
                      .+...   +++    .+...+.+++..+|+.|++|||.+|.|++++.+ .++++|++...
T Consensus       131 ~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~  182 (229)
T PF06176_consen  131 NDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGKR  182 (229)
T ss_pred             ccchh---cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECcccc
Confidence            66532   222    244567778999999999999999999999855 59999997643

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=99.02  E-value=7.3e-09  Score=76.76  Aligned_cols=126  Identities=16%  Similarity=0.157  Sum_probs=90.6

Q ss_pred             CCceEEEEEEeecCCCccc-hHHHHHHHHHHHHHhhcCC--Cceeeeceeeec--C--CcEEEEEecccc-CcHHHHHHh
Q 041080            1 DGFFFAVKEVSLQDQGAQG-KQSILQLEQEISLLSQFEQ--DNIVQYLGTDKD--E--NRLYIFLELVTK-GSLANLYQK   72 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~--~--~~~~lv~e~~~~-~~L~~~l~~   72 (247)
                      +|+.+-||.-...-..... ..-...|.+|...+.+|..  -.+++.......  +  -..+||+|-+.+ .+|.+++.+
T Consensus        40 ~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~  119 (216)
T PRK09902         40 NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQ  119 (216)
T ss_pred             CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhc
Confidence            3566777776532222211 2245568899999999853  335555532211  1  246899997754 589998876


Q ss_pred             cC---CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCC--eEEccccccc
Q 041080           73 YH---LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS--VKLADFGLAK  126 (247)
Q Consensus        73 ~~---~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~--~~l~df~~~~  126 (247)
                      ..   .+......++.+++.++..||+.|+.|+|+.+.||+++.+|.  +.++||..++
T Consensus       120 ~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        120 HAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             CCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            44   467777899999999999999999999999999999987777  8999997654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.85  E-value=3.8e-08  Score=75.00  Aligned_cols=119  Identities=25%  Similarity=0.269  Sum_probs=86.9

Q ss_pred             CCceEEEEEEeecCC-----------------CccchHHHHHHHHHHHHHhhcCCC--ceeeeceeeecCCcEEEEEecc
Q 041080            1 DGFFFAVKEVSLQDQ-----------------GAQGKQSILQLEQEISLLSQFEQD--NIVQYLGTDKDENRLYIFLELV   61 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~-----------------~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~   61 (247)
                      +|.++|||.=+....                 .++-..++..+++|..+|..|...  .|++.+++    +.-.+|||++
T Consensus       114 ~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~i  189 (304)
T COG0478         114 KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYI  189 (304)
T ss_pred             CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehc
Confidence            377888886543221                 112234456688999999999654  77887765    4557999999


Q ss_pred             ccCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccc
Q 041080           62 TKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA  127 (247)
Q Consensus        62 ~~~~L~~~l~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~  127 (247)
                      +|..|...    +++.+....++..|+..+..+-..|++|||+++-||+++.+|.+.++||-.+..
T Consensus       190 eG~eL~~~----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         190 EGVELYRL----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             ccceeecc----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCccccc
Confidence            99666543    223445556677777777777789999999999999999999999999976543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.72  E-value=1.1e-07  Score=85.21  Aligned_cols=205  Identities=23%  Similarity=0.324  Sum_probs=138.1

Q ss_pred             HHHHHHHHHHHHHhhcCCCceeeeceeeecCCc----EEEEEeccccCcHHHHHHhcC-CCHHHHHHHHHHHHHHHHHhh
Q 041080           21 QSILQLEQEISLLSQFEQDNIVQYLGTDKDENR----LYIFLELVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYLH   95 (247)
Q Consensus        21 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~l~~~l~~lh   95 (247)
                      ..+...+-|...+..+.|+|+..+..+......    ..+..++++..++...+...+ .+....+.+..++++|+.++|
T Consensus       224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence            334445567788888899999999888654432    234557888888888776654 888889999999999999999


Q ss_pred             hCCeeecCCCCC---cEEEcCCCCeEEc--ccccccccCccccc-cCCCCCCccCCcccccCCCCCCcchhHHHHHHHHH
Q 041080           96 ERNVVHRDIKCA---NILVDASGSVKLA--DFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVL  169 (247)
Q Consensus        96 ~~~i~h~dl~~~---ni~~~~~~~~~l~--df~~~~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~  169 (247)
                      +....|.-+..+   +.-.+..+.+.+.  ||+.+......... .......+.++|.............|+|.+|.+..
T Consensus       304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence            985555544444   3333444555555  77766544333221 12234446677776555544455689999999999


Q ss_pred             HHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          170 EMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       170 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                      .+..+..+-.....          .....+........+.+.+|+..++++|+++.+++.|||.+.
T Consensus       384 ~~~~~~~i~~~~~~----------~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  384 QLSQGEDISEKSAV----------PVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRF  439 (1351)
T ss_pred             hhhhcCcccccccc----------hhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence            98877644211110          001112222227888999999999999999999999998776

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.52  E-value=5.4e-07  Score=76.10  Aligned_cols=76  Identities=20%  Similarity=0.294  Sum_probs=58.6

Q ss_pred             CcEEEEEeccccCcHHHH--HHhcCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccC
Q 041080           52 NRLYIFLELVTKGSLANL--YQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT  129 (247)
Q Consensus        52 ~~~~lv~e~~~~~~L~~~--l~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~  129 (247)
                      +.-.++|||++|..+.++  ++..+++...+...+.++  .+..+=..|++|.|.+|.||+++.+|.+.+.|||+.....
T Consensus       239 ~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         239 TRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             CCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            466899999999988877  566677755554444433  2344445899999999999999999999999999975444

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.47  E-value=1.7e-06  Score=65.37  Aligned_cols=124  Identities=18%  Similarity=0.175  Sum_probs=83.3

Q ss_pred             CCceEEEEEEeecCCCccch-------------------HHHHHHHHHHHHHhhcC--CCceeeeceeeecCCcEEEEEe
Q 041080            1 DGFFFAVKEVSLQDQGAQGK-------------------QSILQLEQEISLLSQFE--QDNIVQYLGTDKDENRLYIFLE   59 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~-------------------~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e   59 (247)
                      ++..+|+|++......-...                   ....=..+|+.-|+++.  +-.+++.+++.    .-.||||
T Consensus        71 ~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvME  146 (268)
T COG1718          71 DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVME  146 (268)
T ss_pred             CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEE
Confidence            47899999998653321110                   00011345777777773  44555555543    4569999


Q ss_pred             ccccCcH-HHHHHhcCCCHHHHHHHHHHHHHHHHHhhh-CCeeecCCCCCcEEEcCCCCeEEcccccccccC
Q 041080           60 LVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHE-RNVVHRDIKCANILVDASGSVKLADFGLAKATT  129 (247)
Q Consensus        60 ~~~~~~L-~~~l~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~  129 (247)
                      |+..... .=.++..++.......+..+++..+.-|-. .|++|+||+.-||++. ++.+.++|++.+....
T Consensus       147 fIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         147 FIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             eccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            9965311 112333344454677888899888888887 8999999999999998 8899999999886544

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.46  E-value=2.8e-06  Score=64.78  Aligned_cols=117  Identities=11%  Similarity=0.098  Sum_probs=69.1

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCC--ceeeeceeeecCCcEEEEEeccccCc-HHHHH--------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQD--NIVQYLGTDKDENRLYIFLELVTKGS-LANLY--------   70 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~-L~~~l--------   70 (247)
                      |..+++|......       ....+.+|.++++.+..-  .+++.+++....+...++||+++|.+ +...+        
T Consensus        22 ~~~~VlR~~~~~~-------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~   94 (226)
T TIGR02172        22 TGKWMLKLYNPGF-------DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLE   94 (226)
T ss_pred             CCCEEEEeCCCCC-------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHH
Confidence            4467788775321       223467899999998643  35677787777778889999999963 21110        


Q ss_pred             -------------Hhc---CCCHHHHH-HHHHH----------HHHH-HHHhh----hCCeeecCCCCCcEEEcCCCCeE
Q 041080           71 -------------QKY---HLSDSQVS-SYTRQ----------ILNG-LVYLH----ERNVVHRDIKCANILVDASGSVK  118 (247)
Q Consensus        71 -------------~~~---~~~~~~~~-~~~~~----------l~~~-l~~lh----~~~i~h~dl~~~ni~~~~~~~~~  118 (247)
                                   ...   ........ .+..+          +... ..+|.    ...++|+|++|.||++++++ +.
T Consensus        95 ~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~  173 (226)
T TIGR02172        95 EIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TY  173 (226)
T ss_pred             HHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cE
Confidence                         110   01100000 01000          0011 11111    12478999999999999888 99


Q ss_pred             Eccccccc
Q 041080          119 LADFGLAK  126 (247)
Q Consensus       119 l~df~~~~  126 (247)
                      ++||+.+.
T Consensus       174 iIDwe~a~  181 (226)
T TIGR02172       174 WIDLGDFG  181 (226)
T ss_pred             EEechhcC
Confidence            99998653

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.35  E-value=6e-06  Score=63.84  Aligned_cols=59  Identities=15%  Similarity=0.128  Sum_probs=41.1

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSLAN   68 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   68 (247)
                      +..++||+.....        ...+.+|+.+++.+. +--+++++++...++..++||++++|.++..
T Consensus        22 ~~~~~vk~~~~~~--------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150          22 NPGLYLKIAPSGP--------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             CCcEEEEecCCCc--------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            3466777664321        224567888888884 4556778887777777899999999977653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.34  E-value=2.3e-06  Score=63.22  Aligned_cols=95  Identities=25%  Similarity=0.217  Sum_probs=77.7

Q ss_pred             HHHHHHhhcCC-CceeeeceeeecCCcEEEEEeccccCcHHH----HHHhcCCCHHHHHHHHHHHHHHHHHhhh---CCe
Q 041080           28 QEISLLSQFEQ-DNIVQYLGTDKDENRLYIFLELVTKGSLAN----LYQKYHLSDSQVSSYTRQILNGLVYLHE---RNV   99 (247)
Q Consensus        28 ~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~----~l~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i   99 (247)
                      +|.-+++.+.+ +++++++|+|    ..+++.||...+++..    +.+-...++..+.+++.+++..+.+++.   ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            68888999965 7999999998    3367899998765532    1122347899999999999999999997   458


Q ss_pred             eecCCCCCcEEEcCCCCeEEccccccc
Q 041080          100 VHRDIKCANILVDASGSVKLADFGLAK  126 (247)
Q Consensus       100 ~h~dl~~~ni~~~~~~~~~l~df~~~~  126 (247)
                      .-.|++++|+.++.+|+++++|.....
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcc
Confidence            889999999999999999999997654

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.27  E-value=2.7e-05  Score=57.87  Aligned_cols=95  Identities=21%  Similarity=0.301  Sum_probs=71.4

Q ss_pred             HHHHHHHHHHHhhcC------CCceeeeceeeecCCcEEEEEecccc------CcHHHHHHhcCCCHHHHHHHHHHHHHH
Q 041080           23 ILQLEQEISLLSQFE------QDNIVQYLGTDKDENRLYIFLELVTK------GSLANLYQKYHLSDSQVSSYTRQILNG   90 (247)
Q Consensus        23 ~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~l~~~   90 (247)
                      .....+|+.....+.      +.+|.+++|+.+++....+|+|.+..      .||.+++++..++. ...+.+.+   .
T Consensus        55 ~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~~~~L~~---f  130 (199)
T PF10707_consen   55 YRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-ELRQALDE---F  130 (199)
T ss_pred             hHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HHHHHHHH---H
Confidence            445556666666655      78999999999999999999997644      37899998877776 44444444   4


Q ss_pred             HHHhhhCCeeecCCCCCcEEEcCCC----CeEEcc
Q 041080           91 LVYLHERNVVHRDIKCANILVDASG----SVKLAD  121 (247)
Q Consensus        91 l~~lh~~~i~h~dl~~~ni~~~~~~----~~~l~d  121 (247)
                      ..+|-+++|+.+|++|.||++..+.    .+.|+|
T Consensus       131 ~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  131 KRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             HHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence            6677888999999999999997543    355664

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.08  E-value=8.5e-05  Score=56.73  Aligned_cols=60  Identities=17%  Similarity=0.241  Sum_probs=39.7

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCC--ceeeeceee---ecCCcEEEEEeccccCcHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQD--NIVQYLGTD---KDENRLYIFLELVTKGSLAN   68 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~---~~~~~~~lv~e~~~~~~L~~   68 (247)
                      +..+++|.....       .....+.+|..+++.+...  .+++++...   ......+++|++++|.++..
T Consensus        20 ~~~~vlK~~~~~-------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~   84 (239)
T PF01636_consen   20 DGRYVLKFYRPP-------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD   84 (239)
T ss_dssp             TSEEEEEEESSH-------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred             CcEEEEEEeCCC-------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence            357889987431       4456677888888888532  356666643   23345799999999987766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.96  E-value=6.5e-05  Score=57.76  Aligned_cols=29  Identities=28%  Similarity=0.358  Sum_probs=24.2

Q ss_pred             CCeeecCCCCCcEEEcCCCCeEEcccccc
Q 041080           97 RNVVHRDIKCANILVDASGSVKLADFGLA  125 (247)
Q Consensus        97 ~~i~h~dl~~~ni~~~~~~~~~l~df~~~  125 (247)
                      .+++|+|+++.||+++.++..-++||+.+
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a  192 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCL  192 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCccc
Confidence            35899999999999986655579999875

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.90  E-value=0.00012  Score=62.12  Aligned_cols=78  Identities=18%  Similarity=0.201  Sum_probs=58.2

Q ss_pred             CcEEEEEeccccCcHHH--HHHhcCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC----CCCeEEcccccc
Q 041080           52 NRLYIFLELVTKGSLAN--LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA----SGSVKLADFGLA  125 (247)
Q Consensus        52 ~~~~lv~e~~~~~~L~~--~l~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~----~~~~~l~df~~~  125 (247)
                      ....|+|||++|..+.+  .+++.+++...+..-+.+...  ..+=..|++|.|-+|.||+++.    ++.+.+.|||+.
T Consensus       275 t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~  352 (538)
T KOG1235|consen  275 TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLY  352 (538)
T ss_pred             cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccc
Confidence            46789999999986644  567778888766655555433  3333568999999999999994    567999999997


Q ss_pred             cccCcc
Q 041080          126 KATTMN  131 (247)
Q Consensus       126 ~~~~~~  131 (247)
                      ......
T Consensus       353 ~~is~~  358 (538)
T KOG1235|consen  353 AVISHK  358 (538)
T ss_pred             ccccHH
Confidence            654433

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.76  E-value=0.0001  Score=61.68  Aligned_cols=160  Identities=24%  Similarity=0.337  Sum_probs=102.3

Q ss_pred             HHHHHHHHhhcCCCceeeeceeeecC-CcEEEEEeccccCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHhhhCCeeecCC
Q 041080           26 LEQEISLLSQFEQDNIVQYLGTDKDE-NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDI  104 (247)
Q Consensus        26 ~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl  104 (247)
                      +.--..+++++.|+|...++++.... ....+|+|++.. ||++++..+........              .+|+.|.. 
T Consensus        29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~l~~~s~~--------------~~~~~~~~-   92 (725)
T KOG1093|consen   29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGNLKDESLL--------------AHGVLHLN-   92 (725)
T ss_pred             HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcccchhhhc--------------ccccceeh-
Confidence            45567889999999999999986554 347888999954 99998877553222211              22333221 


Q ss_pred             CCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhh
Q 041080          105 KCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV  184 (247)
Q Consensus       105 ~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~  184 (247)
                                 .++.+|.-.              +  +. |       ....+++|||++|.++.++.-|...+......
T Consensus        93 -----------~~~~td~~~--------------t--~~-~-------~~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s  137 (725)
T KOG1093|consen   93 -----------IIYITDHFL--------------T--KY-P-------SPIGPKSDVWSLGFIILELYLGISLEAELTES  137 (725)
T ss_pred             -----------hhhcccccc--------------c--cC-C-------CCCCcchhhhhHHHHHHHHHHhhHHHHHHHHH
Confidence                       222333100              0  00 1       11235899999999999998887665555444


Q ss_pred             HHHHHhhcCCCCC-----------CCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          185 QALFRIGKGELPS-----------VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       185 ~~~~~~~~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      +....+.+-....           +....+....++...|+...|..||...++.+++-|.+.
T Consensus       138 ~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  138 EYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            4443333322111           112356677889999999999999999999999877654

>PLN02876 acyl-CoA dehydrogenase

Probab=97.73  E-value=0.00031  Score=63.82  Aligned_cols=59  Identities=12%  Similarity=0.156  Sum_probs=39.2

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCce--eeeceeeecC---CcEEEEEeccccCc
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNI--VQYLGTDKDE---NRLYIFLELVTKGS   65 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv~e~~~~~~   65 (247)
                      ..+++|+......    ......+.+|+.+++.+. |+++  ++++.++.+.   +..++||||++|..
T Consensus        66 ~~~VLR~~p~~~~----~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~  130 (822)
T PLN02876         66 KRYVLRKKPPGKL----LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI  130 (822)
T ss_pred             eeEEEEeCCCCcc----CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence            3567776533211    112335779999999995 6654  7777776654   46789999998864

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.61  E-value=1.6e-05  Score=67.71  Aligned_cols=202  Identities=29%  Similarity=0.342  Sum_probs=128.4

Q ss_pred             HHHHHHHHHhhcCCCc-eeeeceeeecCCcEEEEEeccccC-cHHHHH--HhcCCCHHHHHHHHHHHHHHHHHhhhCCee
Q 041080           25 QLEQEISLLSQFEQDN-IVQYLGTDKDENRLYIFLELVTKG-SLANLY--QKYHLSDSQVSSYTRQILNGLVYLHERNVV  100 (247)
Q Consensus        25 ~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l--~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~  100 (247)
                      ..+-++++|.+++||| .+..++-++.+....+.++++.++ +-....  ....+..-+...+...-+.+++++|+.--+
T Consensus       279 ~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~  358 (829)
T KOG0576|consen  279 SRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKV  358 (829)
T ss_pred             hhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccccc
Confidence            3557889999999999 677777777788899999999886 221111  111233333444555556778888887667


Q ss_pred             ecCCCCCcEEEcCCCCeEEcccccccccCcc-ccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 041080          101 HRDIKCANILVDASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYS  179 (247)
Q Consensus       101 h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~  179 (247)
                      |+|    ||+. .++..+..+|+........ ......+++.+++||......  +..+.|.|++|.-..++..|..|-.
T Consensus       359 ~~d----~~l~-s~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~--~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  359 HRD----NILG-SEEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENT--IDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             Ccc----cccc-cccccccccccCCcccCcccccccCCCCCCCCCchhhcccc--cccCCCccCCCcchhhcCCCCCCCC
Confidence            777    5555 3467888999886544332 344556889999999875443  7888999999987777766766643


Q ss_pred             CChhhHHHHHhhcCC-CCCCC--CcCCH-HHHHHHHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          180 HLEGVQALFRIGKGE-LPSVP--SSLSR-DARDFILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       180 ~~~~~~~~~~~~~~~-~~~~~--~~~~~-~~~~li~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                      .-.  .....+..+. .+.+.  ..++. .-+++...|+...|..|+.....+-|.+|+.
T Consensus       432 ~P~--~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng  489 (829)
T KOG0576|consen  432 SPP--AVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG  489 (829)
T ss_pred             CCc--cccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence            311  0011111111 00000  01111 1224667789999999999888888888874

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.61  E-value=0.00025  Score=55.28  Aligned_cols=28  Identities=32%  Similarity=0.570  Sum_probs=24.6

Q ss_pred             CeeecCCCCCcEEEcCCCCeEEccccccc
Q 041080           98 NVVHRDIKCANILVDASGSVKLADFGLAK  126 (247)
Q Consensus        98 ~i~h~dl~~~ni~~~~~~~~~l~df~~~~  126 (247)
                      .++|+|+.+.||++++++ +.++||..+.
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence            489999999999999877 7899998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.55  E-value=1.7e-05  Score=73.68  Aligned_cols=206  Identities=16%  Similarity=0.022  Sum_probs=133.6

Q ss_pred             HHHHHHHhhcCCCceeeeceee--ecCCcEEEEEeccccCcHHHHHHhc----C-CCHHHHHHHHHHHHHHHHHhhhC-C
Q 041080           27 EQEISLLSQFEQDNIVQYLGTD--KDENRLYIFLELVTKGSLANLYQKY----H-LSDSQVSSYTRQILNGLVYLHER-N   98 (247)
Q Consensus        27 ~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~~~~~~L~~~l~~~----~-~~~~~~~~~~~~l~~~l~~lh~~-~   98 (247)
                      ..|.+.++...|+++.....-.  .+....+..++++.+|.+.+.+-+.    + ....-+.....+.+....-+|+. |
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            3344455556788877654432  2345678899999999999887543    2 33333333333336666666643 2


Q ss_pred             ----eeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHH
Q 041080           99 ----VVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEML  172 (247)
Q Consensus        99 ----i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~  172 (247)
                          -+|.++++-|.++..+.++++.++|+.+...+.  ......+++.|+.|+..+...  ++.++|+|..|+.+|..-
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik--~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIK--FTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             CCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHh--hhhHHHHHHHHHHHHHHh
Confidence                578999999999999999999999998732222  123344677788888776544  677799999999999887


Q ss_pred             hCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCC
Q 041080          173 TRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK  234 (247)
Q Consensus       173 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~  234 (247)
                      .|..+|...........+.....-..+.-.|.+.......+|...-..||.-...+.-+.|-
T Consensus      1435 ~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1435 DGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             cccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            77666544443333333333333344444455555555555666667888877777776664

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.52  E-value=0.00083  Score=48.49  Aligned_cols=108  Identities=17%  Similarity=0.134  Sum_probs=74.5

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceee-eceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQ-YLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      |..+|+|+-+.++       ....+..|.++|..+.-.++.+ ++.+.    ..++.|||+.|..|.++-...  +.   
T Consensus        45 ~~~~a~Kvrr~ds-------~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~~~~~~~--~r---  108 (201)
T COG2112          45 GGEVALKVRRRDS-------PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLGKLEIGG--DR---  108 (201)
T ss_pred             CceEEEEEecCCc-------chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchhhhhhcc--cH---
Confidence            5678888776432       3456789999999998766655 44443    233559999998887654321  22   


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCC-CCcEEEcCCCCeEEccccccc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIK-CANILVDASGSVKLADFGLAK  126 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~-~~ni~~~~~~~~~l~df~~~~  126 (247)
                       +-+..+++.---|...||-|+.++ |...++..++.+.|+||..++
T Consensus       109 -k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112         109 -KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             -HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence             334456666677888999999987 445555566699999998775

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.48  E-value=0.0015  Score=50.14  Aligned_cols=28  Identities=32%  Similarity=0.522  Sum_probs=25.1

Q ss_pred             CeeecCCCCCcEEEcC-CCCeEEcccccc
Q 041080           98 NVVHRDIKCANILVDA-SGSVKLADFGLA  125 (247)
Q Consensus        98 ~i~h~dl~~~ni~~~~-~~~~~l~df~~~  125 (247)
                      +++|+|+++.||+++. ++.+.++||..+
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a  199 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYA  199 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccC
Confidence            5899999999999998 578999999765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.31  E-value=0.0039  Score=49.63  Aligned_cols=29  Identities=34%  Similarity=0.501  Sum_probs=25.6

Q ss_pred             CCeeecCCCCCcEEEcCCCCeEEcccccc
Q 041080           97 RNVVHRDIKCANILVDASGSVKLADFGLA  125 (247)
Q Consensus        97 ~~i~h~dl~~~ni~~~~~~~~~l~df~~~  125 (247)
                      .+++|+|++|.|++++.++.+.|+||+.+
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a  203 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFA  203 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhh
Confidence            47999999999999998777789999865

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.16  E-value=0.0029  Score=51.17  Aligned_cols=126  Identities=18%  Similarity=0.159  Sum_probs=82.9

Q ss_pred             CCceEEEEEEeecCCCc--------------------cchHHHH-HHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEe
Q 041080            1 DGFFFAVKEVSLQDQGA--------------------QGKQSIL-QLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLE   59 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~--------------------~~~~~~~-~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   59 (247)
                      ||+.+|||+|..+-..-                    .++.... =+..|+.-|.+|...+|+-.--..  -..-.|||+
T Consensus       167 dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~PePIl--Lk~hVLVM~  244 (520)
T KOG2270|consen  167 DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPCPEPIL--LKNHVLVME  244 (520)
T ss_pred             CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCCCCcee--eecceEeee
Confidence            68899999986532211                    1111111 145677777777665543321111  124468999


Q ss_pred             ccccCcH-HHHHHhcCCCHHHHHHHHHHHHHHHHHhh-hCCeeecCCCCCcEEEcCCCCeEEcccccccccC
Q 041080           60 LVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLH-ERNVVHRDIKCANILVDASGSVKLADFGLAKATT  129 (247)
Q Consensus        60 ~~~~~~L-~~~l~~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~  129 (247)
                      ++....- .-.++...++...+..+-.+++.-+.-|- ..+++|.||+--|+++ .+|.+.++|.+.+....
T Consensus       245 FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  245 FLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKLYIIDVSQSVEHD  315 (520)
T ss_pred             eccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEEEEEEccccccCC
Confidence            9854221 22455666888788888888888777665 4589999999999999 77899999999876543

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.16  E-value=0.0019  Score=51.55  Aligned_cols=28  Identities=32%  Similarity=0.430  Sum_probs=25.2

Q ss_pred             CeeecCCCCCcEEEcCC----CCeEEcccccc
Q 041080           98 NVVHRDIKCANILVDAS----GSVKLADFGLA  125 (247)
Q Consensus        98 ~i~h~dl~~~ni~~~~~----~~~~l~df~~~  125 (247)
                      +++|+|+.+.||+++.+    +.+.++||..+
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya  211 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYA  211 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCC
Confidence            58999999999999875    88999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.10  E-value=0.001  Score=52.84  Aligned_cols=97  Identities=19%  Similarity=0.257  Sum_probs=70.0

Q ss_pred             hHHHHHHHHHHHHHhhcC-C-CceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHhhhC
Q 041080           20 KQSILQLEQEISLLSQFE-Q-DNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHER   97 (247)
Q Consensus        20 ~~~~~~~~~e~~~l~~l~-h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~l~~~l~~lh~~   97 (247)
                      .-++-...+|...|+.|. | --|++.+++    +.-++|||.+.|-.|.+.-+-  .   ....+...+...+--|-++
T Consensus       151 yLSRlaa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v--~---d~~~ly~~lm~~Iv~la~~  221 (465)
T KOG2268|consen  151 YLSRLAATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV--E---DPPTLYDDLMGLIVRLANH  221 (465)
T ss_pred             hhHHHHHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec--C---ChHHHHHHHHHHHHHHHHc
Confidence            344445667888888884 3 455555554    466899999998777654321  1   2234455566667788899


Q ss_pred             CeeecCCCCCcEEEcCCCCeEEcccccc
Q 041080           98 NVVHRDIKCANILVDASGSVKLADFGLA  125 (247)
Q Consensus        98 ~i~h~dl~~~ni~~~~~~~~~l~df~~~  125 (247)
                      |++|+|.+--||+++.++.+.++||-.-
T Consensus       222 GlIHgDFNEFNimv~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  222 GLIHGDFNEFNIMVKDDDKIVVIDFPQM  249 (465)
T ss_pred             CceecccchheeEEecCCCEEEeechHh
Confidence            9999999999999999999999999543

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.09  E-value=0.005  Score=48.52  Aligned_cols=29  Identities=38%  Similarity=0.539  Sum_probs=24.1

Q ss_pred             CeeecCCCCCcEEEcCCCCe-EEccccccc
Q 041080           98 NVVHRDIKCANILVDASGSV-KLADFGLAK  126 (247)
Q Consensus        98 ~i~h~dl~~~ni~~~~~~~~-~l~df~~~~  126 (247)
                      .++|+|+++.||++++++.+ -|+||+.+.
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            48999999999999875654 699998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.06  E-value=0.0058  Score=48.83  Aligned_cols=123  Identities=13%  Similarity=0.214  Sum_probs=71.0

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCC--CceeeeceeeecCC--cEEEEEeccccCcHH----------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ--DNIVQYLGTDKDEN--RLYIFLELVTKGSLA----------   67 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~----------   67 (247)
                      ++.++|+  .+..  .....+.....+|+.++..+.-  --+...++.+.++.  ..+.||+|..|..+.          
T Consensus        48 ~~~~vlR--~P~~--~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~  123 (321)
T COG3173          48 GQKYVLR--KPPR--GDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGR  123 (321)
T ss_pred             CceEEEe--cCCc--cccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchH
Confidence            4556666  2211  1233445556688888888743  34445556665554  779999999884221          


Q ss_pred             --------HHHHhc---------------CCCHHHHHHHHHHH--------------HHHHHHhhh--------CCeeec
Q 041080           68 --------NLYQKY---------------HLSDSQVSSYTRQI--------------LNGLVYLHE--------RNVVHR  102 (247)
Q Consensus        68 --------~~l~~~---------------~~~~~~~~~~~~~l--------------~~~l~~lh~--------~~i~h~  102 (247)
                              +++..-               .....++..+..+.              .....+++.        ..++||
T Consensus       124 ~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHG  203 (321)
T COG3173         124 QFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHG  203 (321)
T ss_pred             HHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeC
Confidence                    111100               00111222222222              112333332        248999


Q ss_pred             CCCCCcEEEcCCCCeEEccccccccc
Q 041080          103 DIKCANILVDASGSVKLADFGLAKAT  128 (247)
Q Consensus       103 dl~~~ni~~~~~~~~~l~df~~~~~~  128 (247)
                      |+++.|+++++++.+-++||+.+...
T Consensus       204 D~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         204 DYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             CcccCCEEEeCCCeeEEEeccccccC
Confidence            99999999999988999999987643

>PRK05231 homoserine kinase; Provisional

Probab=97.03  E-value=0.014  Score=46.98  Aligned_cols=30  Identities=30%  Similarity=0.431  Sum_probs=25.1

Q ss_pred             CCeeecCCCCCcEEEcCCCCeEEccccccc
Q 041080           97 RNVVHRDIKCANILVDASGSVKLADFGLAK  126 (247)
Q Consensus        97 ~~i~h~dl~~~ni~~~~~~~~~l~df~~~~  126 (247)
                      .|++|+|+++.||+++.+...-++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            489999999999999866555799998753

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=96.99  E-value=0.0084  Score=44.58  Aligned_cols=108  Identities=22%  Similarity=0.272  Sum_probs=69.1

Q ss_pred             CCceEEEEEEee---cCCC-------ccc------hHHHHHHHHHHHHHhhcC---CCce--eeeceeeecC--------
Q 041080            1 DGFFFAVKEVSL---QDQG-------AQG------KQSILQLEQEISLLSQFE---QDNI--VQYLGTDKDE--------   51 (247)
Q Consensus         1 ~g~~~~lK~~~~---~~~~-------~~~------~~~~~~~~~e~~~l~~l~---h~~i--~~~~~~~~~~--------   51 (247)
                      +|+.||||.+..   ....       ...      .....-|..|.....+|+   +.++  ++.+|+..-.        
T Consensus        60 ~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~  139 (207)
T PF13095_consen   60 DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQL  139 (207)
T ss_pred             CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHh
Confidence            588999999432   1110       000      022345778888888874   4455  8888875211        


Q ss_pred             ----------CcEEEEEeccccCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcc
Q 041080           52 ----------NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLAD  121 (247)
Q Consensus        52 ----------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~d  121 (247)
                                ....||.||.+...        .++...    +.+|.+-+..+|+.||+-+|+++.|..     .-+|+|
T Consensus       140 ~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~~~----~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvD  202 (207)
T PF13095_consen  140 RQRGSDHRPLPIRAIVKDFVPDDP--------PLQIRD----IPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVD  202 (207)
T ss_pred             hcccccCCCCccEEEEEeecCCcc--------ccchhH----HHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEe
Confidence                      13467888776632        233333    445666678999999999999999876     346888


Q ss_pred             cccc
Q 041080          122 FGLA  125 (247)
Q Consensus       122 f~~~  125 (247)
                      ||.+
T Consensus       203 fs~~  206 (207)
T PF13095_consen  203 FSSS  206 (207)
T ss_pred             cccC
Confidence            8753

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.92  E-value=0.003  Score=47.63  Aligned_cols=28  Identities=43%  Similarity=0.679  Sum_probs=20.1

Q ss_pred             CeeecCCCCCcEEE-cCCCCeEEcccccc
Q 041080           98 NVVHRDIKCANILV-DASGSVKLADFGLA  125 (247)
Q Consensus        98 ~i~h~dl~~~ni~~-~~~~~~~l~df~~~  125 (247)
                      .++|+|+.+.||++ +.++.++++||..+
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya  172 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYA  172 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHH
Confidence            48999999999999 88899999999865

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.81  E-value=0.0084  Score=48.60  Aligned_cols=28  Identities=21%  Similarity=0.539  Sum_probs=24.6

Q ss_pred             eeecCCCCCcEEEcC-CCCeEEccccccc
Q 041080           99 VVHRDIKCANILVDA-SGSVKLADFGLAK  126 (247)
Q Consensus        99 i~h~dl~~~ni~~~~-~~~~~l~df~~~~  126 (247)
                      ++|+|+.+.||++++ ++.++++||..+.
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            799999999999975 4689999998764

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.79  E-value=0.012  Score=44.60  Aligned_cols=48  Identities=15%  Similarity=0.304  Sum_probs=38.4

Q ss_pred             hHHHHHHHHHHHHHhhcC---CCceeeeceeeecCCcEEEEEeccccCcHH
Q 041080           20 KQSILQLEQEISLLSQFE---QDNIVQYLGTDKDENRLYIFLELVTKGSLA   67 (247)
Q Consensus        20 ~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   67 (247)
                      ++....|..|+.-|+.|.   --.|++++.+..+.+..++|+||.+.+.+.
T Consensus        49 ~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          49 REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            445667888988888884   356888999999999999999999886553

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.70  E-value=0.035  Score=44.57  Aligned_cols=28  Identities=21%  Similarity=0.313  Sum_probs=26.0

Q ss_pred             CeeecCCCCCcEEEcCCCCeEEcccccc
Q 041080           98 NVVHRDIKCANILVDASGSVKLADFGLA  125 (247)
Q Consensus        98 ~i~h~dl~~~ni~~~~~~~~~l~df~~~  125 (247)
                      +++|+|+.+.|+++++++.+.++||..+
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~  224 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKA  224 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhc
Confidence            7999999999999999999999999765

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.66  E-value=0.012  Score=47.65  Aligned_cols=71  Identities=24%  Similarity=0.362  Sum_probs=53.7

Q ss_pred             CcEEEEEeccccCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHhhhC-CeeecCCCCCcEEEcCCCCeEEcccccccc
Q 041080           52 NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHER-NVVHRDIKCANILVDASGSVKLADFGLAKA  127 (247)
Q Consensus        52 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~~~ni~~~~~~~~~l~df~~~~~  127 (247)
                      ...+++|++. |+++..+ +  ....+++..++.+.+..++-+... .+-|+++...||+++ +|++.|+||.+++.
T Consensus       299 ~y~yl~~kdh-gt~is~i-k--~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         299 LYLYLHFKDH-GTPISII-K--ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             eEEEEEEecC-Cceeeee-e--cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence            3557777776 5455432 1  244667888888888777777654 588999999999998 99999999999873

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=96.52  E-value=0.086  Score=43.81  Aligned_cols=60  Identities=15%  Similarity=0.025  Sum_probs=37.3

Q ss_pred             ceEEEEEEeecCC--CccchHHHHHHHHHHHHHhhcC---CCceeeeceeeecCCcEEEEEeccccC
Q 041080            3 FFFAVKEVSLQDQ--GAQGKQSILQLEQEISLLSQFE---QDNIVQYLGTDKDENRLYIFLELVTKG   64 (247)
Q Consensus         3 ~~~~lK~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~   64 (247)
                      +.++||.-.....  +....-..++...|...|+.+.   ...+++++.+  +.+..++|||++++.
T Consensus        52 ~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lVME~L~~~  116 (401)
T PRK09550         52 KSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTVMEDLSDH  116 (401)
T ss_pred             eEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEEEecCCCc
Confidence            4789998642211  1111234556677888888763   2456777766  446678999998764

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.44  E-value=0.026  Score=44.75  Aligned_cols=56  Identities=20%  Similarity=0.217  Sum_probs=34.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC---CCceeeeceeeecCCcEEEEEeccccC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE---QDNIVQYLGTDKDENRLYIFLELVTKG   64 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~   64 (247)
                      +++.+.||.-....        ...+..|..-|+.|.   --.+++++++....+..++++||++.+
T Consensus        39 ~~~~~FvK~~~~~~--------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   39 DGGSYFVKVNSESG--------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             TS-EEEEEEEEGGG--------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             CCccEEEEecChhh--------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            46788899876221        224678888888883   456788888888777789999998776

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.23  E-value=0.018  Score=43.42  Aligned_cols=87  Identities=18%  Similarity=0.222  Sum_probs=58.8

Q ss_pred             HHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHhhh--CCee
Q 041080           23 ILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHE--RNVV  100 (247)
Q Consensus        23 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~  100 (247)
                      ...++.+..++.++.  +|+++..-  .+-.+.++.|+|.....        ..    ..++..=+.+|.-.|+  .+..
T Consensus       102 ~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i--------~~----~N~i~agi~~L~~fH~~~~~~l  165 (308)
T PF07387_consen  102 DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI--------NF----SNFITAGIKDLMDFHSENQHCL  165 (308)
T ss_pred             hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc--------ch----hHHHHHhHHHHHHhhccCCCee
Confidence            344667778877653  46666531  44577899999865311        00    1111122356777884  4799


Q ss_pred             ecCCCCCcEEEcCCCCeEEcccccc
Q 041080          101 HRDIKCANILVDASGSVKLADFGLA  125 (247)
Q Consensus       101 h~dl~~~ni~~~~~~~~~l~df~~~  125 (247)
                      |||..|+||+-+..|.+||.|.+..
T Consensus       166 HGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  166 HGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             cCCCChhheeecCCCCEEecChhhh
Confidence            9999999999999999999998754

The function of this family is unknown.

>PLN02236 choline kinase

Probab=96.21  E-value=0.048  Score=44.50  Aligned_cols=29  Identities=24%  Similarity=0.604  Sum_probs=25.1

Q ss_pred             CeeecCCCCCcEEEcC-CCCeEEccccccc
Q 041080           98 NVVHRDIKCANILVDA-SGSVKLADFGLAK  126 (247)
Q Consensus        98 ~i~h~dl~~~ni~~~~-~~~~~l~df~~~~  126 (247)
                      .++|+|+++.||++++ ++.+.++||..+.
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            5899999999999986 4679999998764

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.09  E-value=0.17  Score=40.94  Aligned_cols=27  Identities=26%  Similarity=0.213  Sum_probs=22.9

Q ss_pred             CCeeecCCCCCcEEEcCCCCeEEcccccc
Q 041080           97 RNVVHRDIKCANILVDASGSVKLADFGLA  125 (247)
Q Consensus        97 ~~i~h~dl~~~ni~~~~~~~~~l~df~~~  125 (247)
                      .+++|+|+.+.||+++ + .+.++||+.+
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~  222 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDA  222 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCC
Confidence            4689999999999995 4 5788999865

>PRK06148 hypothetical protein; Provisional

Probab=96.01  E-value=0.054  Score=50.64  Aligned_cols=30  Identities=47%  Similarity=0.626  Sum_probs=25.4

Q ss_pred             CCeeecCCCCCcEEEcCCC--CeE-Eccccccc
Q 041080           97 RNVVHRDIKCANILVDASG--SVK-LADFGLAK  126 (247)
Q Consensus        97 ~~i~h~dl~~~ni~~~~~~--~~~-l~df~~~~  126 (247)
                      .+++|+|+++.||+++.++  .+. |+|||.+.
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            4799999999999999875  555 99999764

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.93  E-value=0.072  Score=43.46  Aligned_cols=59  Identities=14%  Similarity=-0.010  Sum_probs=35.7

Q ss_pred             ceEEEEEEeecCC--CccchHHHHHHHHHHHHHhhcC--CC-ceeeeceeeecCCcEEEEEecccc
Q 041080            3 FFFAVKEVSLQDQ--GAQGKQSILQLEQEISLLSQFE--QD-NIVQYLGTDKDENRLYIFLELVTK   63 (247)
Q Consensus         3 ~~~~lK~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv~e~~~~   63 (247)
                      +-++||.-.....  ++...-..++..-|...|+...  -| .+++++.+  +.....+|||+++.
T Consensus        21 ~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vMEdL~~   84 (370)
T TIGR01767        21 RAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVMEDLSH   84 (370)
T ss_pred             eeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehHhhCcc
Confidence            4688887754221  2233444556667777887763  34 45555443  55667799999855

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.74  E-value=0.25  Score=41.16  Aligned_cols=27  Identities=22%  Similarity=0.450  Sum_probs=22.2

Q ss_pred             CeeecCCCCCcEEEcCCCCeEEcccccc
Q 041080           98 NVVHRDIKCANILVDASGSVKLADFGLA  125 (247)
Q Consensus        98 ~i~h~dl~~~ni~~~~~~~~~l~df~~~  125 (247)
                      .++|||+++.||++++++ .+++|...+
T Consensus       231 ~L~HGDl~~g~i~~~~~~-~~~id~ef~  257 (418)
T PLN02756        231 ALVHGDLHTGSVMVTPDS-TQVIDPEFA  257 (418)
T ss_pred             ceeecCCCCCcEEEcCCC-ceEecchhh
Confidence            589999999999998875 777776644

>PRK10593 hypothetical protein; Provisional

Probab=95.41  E-value=0.12  Score=41.20  Aligned_cols=69  Identities=19%  Similarity=0.155  Sum_probs=47.8

Q ss_pred             HHHHHHHHHhhcCC---Cceeeeceeeec---CCcEEEEEeccccCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHhhhC
Q 041080           25 QLEQEISLLSQFEQ---DNIVQYLGTDKD---ENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHER   97 (247)
Q Consensus        25 ~~~~e~~~l~~l~h---~~i~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~l~~~l~~lh~~   97 (247)
                      .+..|...++.|..   -.++++++++..   .+..++|||+++|.++.+.    ..+......+..+++.+++.||+.
T Consensus        53 ~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~~~~----~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         53 VAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSVEAP----ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             HHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEecCCC----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            57789999988853   367888877654   4678999999999877541    123333445566677777777763

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=95.23  E-value=0.036  Score=44.44  Aligned_cols=29  Identities=34%  Similarity=0.509  Sum_probs=26.0

Q ss_pred             CCeeecCCCCCcEEEcCCCCeEEcccccc
Q 041080           97 RNVVHRDIKCANILVDASGSVKLADFGLA  125 (247)
Q Consensus        97 ~~i~h~dl~~~ni~~~~~~~~~l~df~~~  125 (247)
                      .+++|+|+++.|++++.++...++||+.+
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~  215 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFA  215 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeecccc
Confidence            58999999999999998876789999865

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG4499 Predicted membrane protein [Function unknown]

Probab=95.19  E-value=0.16  Score=41.09  Aligned_cols=125  Identities=15%  Similarity=0.132  Sum_probs=77.0

Q ss_pred             HHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCc
Q 041080           29 EISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCAN  108 (247)
Q Consensus        29 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~n  108 (247)
                      ++.++.. ..|+++.-+.  ++++.+.+-++  .......+-..+.+.....++++.+.+..|..+... -.|-=+.|+|
T Consensus        41 ~~~lld~-~~~f~~~eit--~~~Ds~vIsy~--i~~~~~~F~~~k~~~k~~Klr~a~~~I~~l~e~~~t-r~~~~laPeN  114 (434)
T COG4499          41 LAELLDK-SPPFIVAEIT--EDNDSFVISYP--IPEAAKSFASAKRKEKTRKLRLALQNIATLSELNNT-RYTFFLAPEN  114 (434)
T ss_pred             HHHHhcc-CCCccceeec--ccCceeEEEec--CccccchHHHHHHHHHHHHHHHHHHHHHHHHHhhcc-ceeEEecchh
Confidence            4555555 3445444332  23333333333  333444444444577778888888888888776644 3445589999


Q ss_pred             EEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 041080          109 ILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHL  181 (247)
Q Consensus       109 i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~  181 (247)
                      |+++.++.+.+.-+|+-....          |.-+.||.+            .=.+-+++..++.|+.+|.+.
T Consensus       115 ilf~~~l~p~~vH~Glk~~lp----------Pye~tee~f------------~~~ykA~~~~~fn~k~~Fe~l  165 (434)
T COG4499         115 ILFDGGLTPFFVHRGLKNSLP----------PYEMTEERF------------LKEYKALAIYAFNGKFSFESL  165 (434)
T ss_pred             eEEcCCCceEEEecchhccCC----------CCCCCHHHH------------HHHHHHHHHHHHcCCccHHHH
Confidence            999999999999998754322          222334433            224567777888899888643

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.12  E-value=0.055  Score=43.37  Aligned_cols=28  Identities=32%  Similarity=0.525  Sum_probs=24.6

Q ss_pred             CCeeecCCCCCcEEEcCCCCeEEcccccc
Q 041080           97 RNVVHRDIKCANILVDASGSVKLADFGLA  125 (247)
Q Consensus        97 ~~i~h~dl~~~ni~~~~~~~~~l~df~~~  125 (247)
                      .+++|||+++.||+++. +.+.++||+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            57899999999999987 67899999854

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK10271 thiK thiamine kinase; Provisional

Probab=94.95  E-value=0.025  Score=41.63  Aligned_cols=28  Identities=32%  Similarity=0.572  Sum_probs=24.6

Q ss_pred             eeecCCCCCcEEEcCCCCeEEcccccccc
Q 041080           99 VVHRDIKCANILVDASGSVKLADFGLAKA  127 (247)
Q Consensus        99 i~h~dl~~~ni~~~~~~~~~l~df~~~~~  127 (247)
                      .+|+|+.|.|+++++++ ++++||+.+..
T Consensus        79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            68999999999998777 88999998743

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=94.79  E-value=0.074  Score=41.76  Aligned_cols=47  Identities=19%  Similarity=0.305  Sum_probs=35.8

Q ss_pred             HHHHHHHHHHHHHHhhhC--CeeecCCCCCcEEEcCCCCeEEccccccc
Q 041080           80 VSSYTRQILNGLVYLHER--NVVHRDIKCANILVDASGSVKLADFGLAK  126 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~--~i~h~dl~~~ni~~~~~~~~~l~df~~~~  126 (247)
                      +...+..+-.++.-.+..  -++|+|+.|+|++.++.+.+.|+||..+.
T Consensus       134 ~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg  182 (269)
T COG0510         134 LRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG  182 (269)
T ss_pred             HHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence            334555555555555544  48999999999999999999999998764

>PHA00451 protein kinase

Probab=94.25  E-value=0.21  Score=38.58  Aligned_cols=96  Identities=9%  Similarity=0.142  Sum_probs=59.2

Q ss_pred             HHHHHHhhc--CCCceeeeceeeecCCcEEEEEeccccCc------------HHHHHHhcCCCHHHHHHHHHHHHHHHHH
Q 041080           28 QEISLLSQF--EQDNIVQYLGTDKDENRLYIFLELVTKGS------------LANLYQKYHLSDSQVSSYTRQILNGLVY   93 (247)
Q Consensus        28 ~e~~~l~~l--~h~~i~~~~~~~~~~~~~~lv~e~~~~~~------------L~~~l~~~~~~~~~~~~~~~~l~~~l~~   93 (247)
                      ..+....++  ..++|+.++.+-...+.+-+|++++....            +..++.....+.......-...++....
T Consensus       103 AAYtAFCRM~QGR~GIPnVY~VaRHaGCYTVVLD~L~~C~r~~nd~h~~ya~~a~~~~e~~~d~~~~~~~~~~FIETCk~  182 (362)
T PHA00451        103 AAYTAFCRMHQGRAGIPNVYHVARHAGCYTVVLDYLNPCYRESNDVHHHYAAAAYIIIECCSDAAEEYPGSQEFIETCKM  182 (362)
T ss_pred             HHHHHHHHHhcCCCCCccHHHHHHhcCceEEehhhccccccccchHHHHHHHHHHHHHhccCCHHhccCCchhHHHHHHH
Confidence            344555666  47999999999888899999999875521            1112222112222211112222222222


Q ss_pred             hhh--CCeeecCCCCCcEEEcCCCCeEEcccc
Q 041080           94 LHE--RNVVHRDIKCANILVDASGSVKLADFG  123 (247)
Q Consensus        94 lh~--~~i~h~dl~~~ni~~~~~~~~~l~df~  123 (247)
                      +-+  .||.--|.++.||+.+.+|.+.|+|.-
T Consensus       183 IRkFF~GIASFDmHSGNiMf~~~g~p~ITDPV  214 (362)
T PHA00451        183 IRKFFYGIASFDMHSGNIMFDQDGVPYITDPV  214 (362)
T ss_pred             HHHHHhhhhcccccCCceeeCCCCCeEecCCc
Confidence            222  377778999999999999999999864

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	247
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-40
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-40
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-40
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-40
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-39
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-38
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-38
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-38
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-38
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-37
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-37
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-37
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-36
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-36
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		9e-36
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-35
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-35
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-35
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-35
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-34
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-34
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-34
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-32
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-30
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-30
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-29
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-29
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-28
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-28
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-28
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-28
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		9e-28
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-28
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-27
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-27
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-27
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-27
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-27
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-27
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-27
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-27
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-26
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-26
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-26
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-26
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-26
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-26
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-26
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-26
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-26
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-26
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-26
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-26
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-26
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-26
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-26
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-26
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-26
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-26
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-26
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-26
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-26
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-26
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-26
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-26
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-26
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-26
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		9e-26
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		9e-26
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-26
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-26
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-26
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-26
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-25
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-25
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-25
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-25
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-24
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-24
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-24
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-24
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-24
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-24
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-24
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-24
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-24
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-24
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-23
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-23
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-23
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-23
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-23
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-23
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-23
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-23
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-23
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-23
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-23
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		8e-23
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-23
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-23
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-22
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-22
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-22
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-22
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-22
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-22
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-22
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-22
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-22
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-22
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-22
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-22
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-22
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-22
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-22
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-22
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-22
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-22
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-22
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-22
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-22
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-22
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-22
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-22
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-22
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-22
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-22
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-22
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-22
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-22
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-22
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-22
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-22
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-22
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-22
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-22
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-22
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-22
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-22
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-22
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-22
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-22
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-22
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-22
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-22
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-22
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-22
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-22
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-22
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-22
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-22
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-22
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-22
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-22
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-22
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-22
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-22
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-22
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-22
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-22
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-22
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-22
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-22
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-22
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-22
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		7e-22
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		9e-22
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-22
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-22
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-22
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-21
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-21
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-21
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-21
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-21
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-21
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-21
3soa_A	444	Full-Length Human Camkii Length = 444		1e-21
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-21
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-21
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-21
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-21
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-21
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-21
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-21
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-21
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-21
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-21
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-21
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-21
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-21
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-21
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-21
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-21
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-21
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-21
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-21
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-21
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-21
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-21
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-21
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-21
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-21
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-21
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-21
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-21
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-21
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-21
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-21
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-21
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-21
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-21
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-21
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-21
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-21
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-21
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-21
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-21
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-21
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-21
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-21
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-21
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-21
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-21
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-21
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-21
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-21
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-21
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-21
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-21
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-21
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-21
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-21
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-21
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-21
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-21
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-21
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-21
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-21
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-21
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-21
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-21
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		6e-21
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-21
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-21
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-21
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-21
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-21
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-21
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-21
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-21
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-21
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-21
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		9e-21
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-20
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-20
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-20
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-20
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-20
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-20
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-20
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-20
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-20
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-20
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-20
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-20
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-20
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-20
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-20
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-20
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-20
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-20
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-20
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-20
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-20
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-20
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-20
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-20
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-20
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-20
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-20
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-20
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-20
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-20
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-20
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-20
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-20
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-20
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-20
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-20
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-20
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-20
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-20
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-20
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-20
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-20
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-20
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-20
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-20
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-20
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-20
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-20
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-20
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-20
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-20
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-20
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-20
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-20
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-20
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-20
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-20
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-20
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-20
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-20
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-20
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-20
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-20
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-20
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-20
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-20
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-20
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-20
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-20
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-20
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		7e-20
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-20
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-20
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-20
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		7e-20
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-20
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		8e-20
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-20
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		9e-20
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		9e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-20
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-20
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-19
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-19
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-19
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-19
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-19
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-19
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-19
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-19
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-19
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-19
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-19
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-19
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-19
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-19
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-19
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-19
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-19
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-19
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-19
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-19
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-19
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-19
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-19
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-19
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-19
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-19
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-19
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-19
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-19
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-19
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-19
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-19
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-19
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-19
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-19
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-19
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-19
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-19
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-19
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-19
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-19
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-19
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-19
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-19
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-19
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-19
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-19
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-19
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-19
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-19
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-19
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-19
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		6e-19
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-19
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-19
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-19
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-19
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		7e-19
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-19
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		8e-19
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-19
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-19
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		8e-19
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-19
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		8e-19
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		9e-19
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-19
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		9e-19
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-18
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-18
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-18
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-18
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-18
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-18
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-18
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-18
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-18
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-18
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-18
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-18
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-18
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-18
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-18
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-18
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-18
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-18
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-18
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-18
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-18
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		7e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-18
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		8e-18
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-17
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-17
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-17
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-17
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-17
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-17
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-17
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-17
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-17
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-17
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-17
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-17
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-17
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-17
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-17
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-17
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-17
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-17
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-17
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-17
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-17
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-17
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-17
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-17
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-17
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-17
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-17
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-17
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-17
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-17
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-17
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-17
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-17
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-17
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-17
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-17
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-17
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-17
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-17
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-17
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-17
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-17
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-17
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-17
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-17
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-17
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-17
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-17
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-17
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-17
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-17
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-17
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		8e-17
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		8e-17
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		8e-17
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-17
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-17
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-17
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-17
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-17
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-17
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-17
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-17
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		8e-17
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-17
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-17
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-17
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		8e-17
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-17
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-17
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-17
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-17
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-17
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-17
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		9e-17
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		9e-17
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-17
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-17
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-17
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		9e-17
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-16
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-16
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-16
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-16
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-16
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-16
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-16
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-16
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-16
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-16
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-16
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-16
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-16
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-16
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-16
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-16
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-16
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-16
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-16
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-16
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-16
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-16
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-16
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-16
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-16
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-16
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-16
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-16
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-16
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-16
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-16
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-16
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-16
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-16
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-16
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-16
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-16
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-16
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-16
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-16
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-16
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-16
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-16
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-16
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-16
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-16
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-16
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-16
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-16
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-16
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-16
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		6e-16
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-16
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-16
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-16
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-16
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-16
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		7e-16
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-16
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		7e-16
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		8e-16
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		8e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-16
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		8e-16
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-16
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		8e-16
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-16
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		8e-16
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-16
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		9e-16
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-16
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-16
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		9e-16
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-16
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		9e-16
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		9e-16
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		9e-16
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		9e-16
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-16
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		9e-16
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-15
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-15
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-15
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-15
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-15
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-15
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-15
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-15
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-15
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-15
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-15
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-15
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-15
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-15
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-15
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-15
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-15
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-15
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-15
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-15
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-15
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-15
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-15
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-15
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-15
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-15
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-15
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-15
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-15
3gni_B	389	Structure Of Strad And Mo25 Length = 389		3e-15
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		4e-15
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-15
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-15
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-15
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-15
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-15
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-15
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-15
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-15
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-15
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-15
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-15
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-15
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-15
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		8e-15
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-15
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-15
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-14
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-14
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-14
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-14
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-14
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-14
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-14
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-14
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-14
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-14
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-14
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-14
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-14
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-14
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-14
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-14
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-14
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-14
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-14
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-14
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-14
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-14
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-14
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-14
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-14
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-14
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-14
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-14
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-14
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-14
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-14
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-14
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-14
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		6e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-14
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		6e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-14
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		7e-14
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		7e-14
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		7e-14
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		7e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-14
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-14
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		8e-14
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		8e-14
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		9e-14
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		9e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		9e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-13
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-13
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-13
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-13
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-13
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-13
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-13
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-13
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-13
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-13
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-13
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-13
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-13
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-13
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-13
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-13
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-13
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-13
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-13
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-13
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-13
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-13
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-13
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-13
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-13
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-13
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-13
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-13
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-13
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-13
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		3e-13
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		3e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-13
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-13
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-13
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-13
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-13
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-13
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-13
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-13
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-13
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-13
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		5e-13
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		5e-13
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		7e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		7e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		7e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-13
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-13
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-13
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-13
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-13
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-13
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		8e-13
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		9e-13
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-13
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-13
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		9e-13
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		9e-13
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-12
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-12
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-12
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-12
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-12
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-12
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-12
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-12
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-12
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-12
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-12
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-12
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		4e-12
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		4e-12
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-12
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		4e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-12
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-12
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-12
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		5e-12
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		5e-12
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		5e-12
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		5e-12
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-12
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-12
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		5e-12
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-12
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		6e-12
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-12
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-12

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  161 bits (407), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 80/197 (40%), Positives = 119/197 (60%), Gaps = 4/197 (2%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVV 100
           + +Y G+   + +L+I +E +  GS  +L +   L ++Q+++  R+IL GL YLH    +
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI 146
Query: 101 HRDIKCANILVDASGSVKLADFGLAKATTMNDLK--SCKGTPFWMAPEVVNSKNDGYGLT 158
           HRDIK AN+L+   G VKLADFG+A   T   +K  +  GTPFWMAPEV+  K   Y   
Sbjct: 147 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--KQSAYDSK 204
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
           ADIWSLG T +E+    PP+S L  ++ LF I K   P++  + S+  ++F+  CL   P
Sbjct: 205 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 264
Query: 219 NDRPTVTELMEHPFVKR 235
           + RPT  EL++H F+ R
Sbjct: 265 SFRPTAKELLKHKFILR 281

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  161 bits (407), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 80/197 (40%), Positives = 119/197 (60%), Gaps = 4/197 (2%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVV 100
           + +Y G+   + +L+I +E +  GS  +L +   L ++Q+++  R+IL GL YLH    +
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI 126
Query: 101 HRDIKCANILVDASGSVKLADFGLAKATTMNDLK--SCKGTPFWMAPEVVNSKNDGYGLT 158
           HRDIK AN+L+   G VKLADFG+A   T   +K  +  GTPFWMAPEV+  K   Y   
Sbjct: 127 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--KQSAYDSK 184
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
           ADIWSLG T +E+    PP+S L  ++ LF I K   P++  + S+  ++F+  CL   P
Sbjct: 185 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 244
Query: 219 NDRPTVTELMEHPFVKR 235
           + RPT  EL++H F+ R
Sbjct: 245 SFRPTAKELLKHKFILR 261

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  160 bits (406), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 80/197 (40%), Positives = 118/197 (59%), Gaps = 4/197 (2%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVV 100
           + +Y G+   + +L+I +E +  GS  +L +   L ++Q+++  R+IL GL YLH    +
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI 141
Query: 101 HRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGLT 158
           HRDIK AN+L+   G VKLADFG+A   T   +K     GTPFWMAPEV+  K   Y   
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI--KQSAYDSK 199
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
           ADIWSLG T +E+    PP+S L  ++ LF I K   P++  + S+  ++F+  CL   P
Sbjct: 200 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 259
Query: 219 NDRPTVTELMEHPFVKR 235
           + RPT  EL++H F+ R
Sbjct: 260 SFRPTAKELLKHKFILR 276

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  160 bits (406), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 80/197 (40%), Positives = 118/197 (59%), Gaps = 4/197 (2%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVV 100
           + +Y G+   + +L+I +E +  GS  +L +   L ++Q+++  R+IL GL YLH    +
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI 126
Query: 101 HRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGLT 158
           HRDIK AN+L+   G VKLADFG+A   T   +K     GTPFWMAPEV+  K   Y   
Sbjct: 127 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI--KQSAYDSK 184
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
           ADIWSLG T +E+    PP+S L  ++ LF I K   P++  + S+  ++F+  CL   P
Sbjct: 185 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 244
Query: 219 NDRPTVTELMEHPFVKR 235
           + RPT  EL++H F+ R
Sbjct: 245 SFRPTAKELLKHKFILR 261

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  157 bits (396), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 80/197 (40%), Positives = 114/197 (57%), Gaps = 4/197 (2%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVV 100
           I +Y G+     +L+I +E +  GS  +L +   L ++ +++  R+IL GL YLH    +
Sbjct: 79  ITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKI 138
Query: 101 HRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGLT 158
           HRDIK AN+L+   G VKLADFG+A   T   +K     GTPFWMAPEV+  K   Y   
Sbjct: 139 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI--KQSAYDFK 196
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
           ADIWSLG T +E+    PP S L  ++ LF I K   P++    S+  ++F+  CL  +P
Sbjct: 197 ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLNKDP 256
Query: 219 NDRPTVTELMEHPFVKR 235
             RPT  EL++H F+ R
Sbjct: 257 RFRPTAKELLKHKFITR 273

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  155 bits (393), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 86/208 (41%), Positives = 131/208 (62%), Gaps = 9/208 (4%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--LSDSQ--VSSYTRQILNGL 91
            +  NIVQYLG+  +   + IF+E V  GSL+ L +     L D++  +  YT+QIL GL
Sbjct: 76  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 135
Query: 92  VYLHERNVVHRDIKCANILVDA-SGSVKLADFGLAK--ATTMNDLKSCKGTPFWMAPEVV 148
            YLH+  +VHRDIK  N+L++  SG +K++DFG +K  A      ++  GT  +MAPE++
Sbjct: 136 KYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII 195
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHL-EGVQALFRIGKGEL-PSVPSSLSRDA 206
           +    GYG  ADIWSLGCT++EM T +PP+  L E   A+F++G  ++ P +P S+S +A
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA 255
Query: 207 RDFILKCLQVNPNDRPTVTELMEHPFVK 234
           + FILKC + +P+ R    +L+   F+K
Sbjct: 256 KAFILKCFEPDPDKRACANDLLVDEFLK 283

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/208 (41%), Positives = 131/208 (62%), Gaps = 9/208 (4%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--LSDSQ--VSSYTRQILNGL 91
            +  NIVQYLG+  +   + IF+E V  GSL+ L +     L D++  +  YT+QIL GL
Sbjct: 62  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 121
Query: 92  VYLHERNVVHRDIKCANILVDA-SGSVKLADFGLAK--ATTMNDLKSCKGTPFWMAPEVV 148
            YLH+  +VHRDIK  N+L++  SG +K++DFG +K  A      ++  GT  +MAPE++
Sbjct: 122 KYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII 181
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHL-EGVQALFRIGKGEL-PSVPSSLSRDA 206
           +    GYG  ADIWSLGCT++EM T +PP+  L E   A+F++G  ++ P +P S+S +A
Sbjct: 182 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA 241
Query: 207 RDFILKCLQVNPNDRPTVTELMEHPFVK 234
           + FILKC + +P+ R    +L+   F+K
Sbjct: 242 KAFILKCFEPDPDKRACANDLLVDEFLK 269

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  153 bits (387), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 84/203 (41%), Positives = 123/203 (60%), Gaps = 9/203 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHER 97
           NIV+ L     EN L+I +E    G++  +  +    L++SQ+    +Q L+ L YLH+ 
Sbjct: 95  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 98  NVVHRDIKCANILVDASGSVKLADFGL-AKAT-TMNDLKSCKGTPFWMAPEVV---NSKN 152
            ++HRD+K  NIL    G +KLADFG+ AK T T+    S  GTP+WMAPEVV    SK+
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDARDFI 210
             Y   AD+WSLG T++EM    PP+  L  ++ L +I K E P++  PS  S + +DF+
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 274
Query: 211 LKCLQVNPNDRPTVTELMEHPFV 233
            KCL+ N + R T ++L++HPFV
Sbjct: 275 KKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  152 bits (385), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 81/203 (39%), Positives = 121/203 (59%), Gaps = 9/203 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHER 97
           NIV+ L     EN L+I +E    G++  +  +    L++SQ+    +Q L+ L YLH+ 
Sbjct: 95  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 98  NVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVV---NSKN 152
            ++HRD+K  NIL    G +KLADFG++   T  +    S  GTP+WMAPEVV    SK+
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDARDFI 210
             Y   AD+WSLG T++EM    PP+  L  ++ L +I K E P++  PS  S + +DF+
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 274
Query: 211 LKCLQVNPNDRPTVTELMEHPFV 233
            KCL+ N + R T ++L++HPFV
Sbjct: 275 KKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  150 bits (380), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 80/203 (39%), Positives = 120/203 (59%), Gaps = 9/203 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHER 97
           NIV+ L     EN L+I +E    G++  +  +    L++SQ+    +Q L+ L YLH+ 
Sbjct: 95  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 98  NVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVV---NSKN 152
            ++HRD+K  NIL    G +KLADFG++   T  +       GTP+WMAPEVV    SK+
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDARDFI 210
             Y   AD+WSLG T++EM    PP+  L  ++ L +I K E P++  PS  S + +DF+
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 274
Query: 211 LKCLQVNPNDRPTVTELMEHPFV 233
            KCL+ N + R T ++L++HPFV
Sbjct: 275 KKCLEKNVDARWTTSQLLQHPFV 297

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  150 bits (380), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 75/195 (38%), Positives = 115/195 (58%), Gaps = 4/195 (2%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVV 100
           + +Y G+    ++L+I +E +  GS  +L +     + Q+++  ++IL GL YLH    +
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKI 142
Query: 101 HRDIKCANILVDASGSVKLADFGLAKATTMNDLK--SCKGTPFWMAPEVVNSKNDGYGLT 158
           HRDIK AN+L+   G VKLADFG+A   T   +K  +  GTPFWMAPEV+  +   Y   
Sbjct: 143 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--QQSAYDSK 200
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
           ADIWSLG T +E+    PP S +  ++ LF I K   P++    ++  ++FI  CL  +P
Sbjct: 201 ADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKDP 260
Query: 219 NDRPTVTELMEHPFV 233
           + RPT  EL++H F+
Sbjct: 261 SFRPTAKELLKHKFI 275

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  147 bits (371), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 76/202 (37%), Positives = 117/202 (57%), Gaps = 9/202 (4%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERN 98
           IV+ LG    + +L+I +E    G++  +  +    L++ Q+    RQ+L  L +LH + 
Sbjct: 70  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 129
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKAT--TMNDLKSCKGTPFWMAPEVV---NSKND 153
           ++HRD+K  N+L+   G ++LADFG++     T+    S  GTP+WMAPEVV     K+ 
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 189
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDARDFIL 211
            Y   ADIWSLG T++EM    PP+  L  ++ L +I K + P++  PS  S + RDF+ 
Sbjct: 190 PYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLK 249
Query: 212 KCLQVNPNDRPTVTELMEHPFV 233
             L  NP  RP+  +L+EHPFV
Sbjct: 250 IALDKNPETRPSAAQLLEHPFV 271

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  147 bits (371), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 76/202 (37%), Positives = 117/202 (57%), Gaps = 9/202 (4%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERN 98
           IV+ LG    + +L+I +E    G++  +  +    L++ Q+    RQ+L  L +LH + 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKAT--TMNDLKSCKGTPFWMAPEVV---NSKND 153
           ++HRD+K  N+L+   G ++LADFG++     T+    S  GTP+WMAPEVV     K+ 
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 197
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDARDFIL 211
            Y   ADIWSLG T++EM    PP+  L  ++ L +I K + P++  PS  S + RDF+ 
Sbjct: 198 PYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLK 257
Query: 212 KCLQVNPNDRPTVTELMEHPFV 233
             L  NP  RP+  +L+EHPFV
Sbjct: 258 IALDKNPETRPSAAQLLEHPFV 279

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  146 bits (369), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 77/201 (38%), Positives = 118/201 (58%), Gaps = 8/201 (3%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHER 97
           ++V+Y G+      L+I +E    GS++++ +  +  L++ ++++  +  L GL YLH  
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 98  NVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKNDGY 155
             +HRDIK  NIL++  G  KLADFG+A   T  M       GTPFWMAPEV+  +  GY
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVI--QEIGY 202
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDARDFILKC 213
              ADIWSLG T +EM   +PPY+ +  ++A+F I     P+   P   S +  DF+ +C
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQC 262
Query: 214 LQVNPNDRPTVTELMEHPFVK 234
           L  +P  R T T+L++HPFV+
Sbjct: 263 LVKSPEQRATATQLLQHPFVR 283

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  145 bits (365), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 79/206 (38%), Positives = 116/206 (56%), Gaps = 8/206 (3%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           NIV YL +    + L++ +E +  GSL ++  +  + + Q+++  R+ L  L +LH   V
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGL 157
           +HRDIK  NIL+   GSVKL DFG     T    K     GTP+WMAPEVV  K   YG 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRK--AYGP 195
Query: 158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDARDFILKCLQ 215
             DIWSLG   +EM+   PPY +   ++AL+ I     P +  P  LS   RDF+ +CL+
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 255
Query: 216 VNPNDRPTVTELMEHPFVK--RPLQT 239
           ++   R +  EL++H F+K  +PL +
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLSS 281

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 79/206 (38%), Positives = 116/206 (56%), Gaps = 8/206 (3%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           NIV YL +    + L++ +E +  GSL ++  +  + + Q+++  R+ L  L +LH   V
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 138
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGL 157
           +HRDIK  NIL+   GSVKL DFG     T    K     GTP+WMAPEVV  K   YG 
Sbjct: 139 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRK--AYGP 196
Query: 158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDARDFILKCLQ 215
             DIWSLG   +EM+   PPY +   ++AL+ I     P +  P  LS   RDF+ +CL+
Sbjct: 197 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 256
Query: 216 VNPNDRPTVTELMEHPFVK--RPLQT 239
           ++   R +  EL++H F+K  +PL +
Sbjct: 257 MDVEKRGSAKELIQHQFLKIAKPLSS 282

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  144 bits (364), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 79/206 (38%), Positives = 116/206 (56%), Gaps = 8/206 (3%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           NIV YL +    + L++ +E +  GSL ++  +  + + Q+++  R+ L  L +LH   V
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGL 157
           +HRDIK  NIL+   GSVKL DFG     T    K  +  GTP+WMAPEVV  K   YG 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRK--AYGP 195
Query: 158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDARDFILKCLQ 215
             DIWSLG   +EM+   PPY +   ++AL+ I     P +  P  LS   RDF+ +CL 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255
Query: 216 VNPNDRPTVTELMEHPFVK--RPLQT 239
           ++   R +  EL++H F+K  +PL +
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLSS 281

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  144 bits (363), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 79/206 (38%), Positives = 116/206 (56%), Gaps = 8/206 (3%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           NIV YL +    + L++ +E +  GSL ++  +  + + Q+++  R+ L  L +LH   V
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLK--SCKGTPFWMAPEVVNSKNDGYGL 157
           +HRDIK  NIL+   GSVKL DFG     T    K  +  GTP+WMAPEVV  K   YG 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK--AYGP 195
Query: 158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDARDFILKCLQ 215
             DIWSLG   +EM+   PPY +   ++AL+ I     P +  P  LS   RDF+ +CL 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255
Query: 216 VNPNDRPTVTELMEHPFVK--RPLQT 239
           ++   R +  EL++H F+K  +PL +
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLSS 281

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 78/206 (37%), Positives = 117/206 (56%), Gaps = 8/206 (3%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           NIV YL +    + L++ +E +  GSL ++  +  + + Q+++  R+ L  L +LH   V
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 138
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLK--SCKGTPFWMAPEVVNSKNDGYGL 157
           +HR+IK  NIL+   GSVKL DFG     T    K  +  GTP+WMAPEVV  K   YG 
Sbjct: 139 IHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK--AYGP 196
Query: 158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDARDFILKCLQ 215
             DIWSLG   +EM+   PPY +   ++AL+ I     P +  P  LS   RDF+ +CL+
Sbjct: 197 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 256
Query: 216 VNPNDRPTVTELMEHPFVK--RPLQT 239
           ++   R +  EL++H F+K  +PL +
Sbjct: 257 MDVEKRGSAKELIQHQFLKIAKPLSS 282

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  142 bits (358), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 78/200 (39%), Positives = 116/200 (58%), Gaps = 7/200 (3%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHER 97
           N +QY G    E+  ++ +E    GS ++L +  K  L + ++++ T   L GL YLH  
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 98  NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDG-YG 156
           N++HRD+K  NIL+   G VKL DFG   A+ M       GTP+WMAPEV+ + ++G Y 
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFG--SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 231
Query: 157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSS-LSRDARDFILKCLQ 215
              D+WSLG T +E+  R+PP  ++  + AL+ I + E P++ S   S   R+F+  CLQ
Sbjct: 232 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 291
Query: 216 VNPNDRPTVTELMEHPFVKR 235
             P DRPT   L++H FV R
Sbjct: 292 KIPQDRPTSEVLLKHRFVLR 311

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  142 bits (357), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 78/200 (39%), Positives = 116/200 (58%), Gaps = 7/200 (3%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHER 97
           N +QY G    E+  ++ +E    GS ++L +  K  L + ++++ T   L GL YLH  
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 98  NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDG-YG 156
           N++HRD+K  NIL+   G VKL DFG   A+ M       GTP+WMAPEV+ + ++G Y 
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFG--SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSS-LSRDARDFILKCLQ 215
              D+WSLG T +E+  R+PP  ++  + AL+ I + E P++ S   S   R+F+  CLQ
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 252
Query: 216 VNPNDRPTVTELMEHPFVKR 235
             P DRPT   L++H FV R
Sbjct: 253 KIPQDRPTSEVLLKHRFVLR 272

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  135 bits (339), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 75/213 (35%), Positives = 118/213 (55%), Gaps = 11/213 (5%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLH 95
           ++  N+V+   +      L++ +E +  G+L ++  +  L++ Q+++    +L  L YLH
Sbjct: 99  YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLH 158
Query: 96  ERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKND 153
            + V+HRDIK  +IL+   G VKL+DFG     + +    K   GTP+WMAPEV++    
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVIS--RS 216
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSS--LSRDARDFIL 211
            Y    DIWSLG  V+EM+   PPY     VQA+ R+     P + +S  +S   RDF+ 
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLE 276
Query: 212 KCLQVNPNDRPTVTELMEHPFVKRPLQT--PRC 242
           + L  +P +R T  EL++HPF+   LQT  P C
Sbjct: 277 RMLVRDPQERATAQELLDHPFL---LQTGLPEC 306

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  129 bits (323), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 70/203 (34%), Positives = 110/203 (54%), Gaps = 6/203 (2%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLH 95
           +  DN+V    +    + L++ +E +  G+L ++     +++ Q+++    +L  L YLH
Sbjct: 99  YHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLH 158
Query: 96  ERNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKND 153
            + V+HRDIK  +IL+ + G +KL+DFG     +  +   K   GTP+WMAPEV++    
Sbjct: 159 NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLP- 217
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPS--SLSRDARDFIL 211
            YG   DIWSLG  V+EM+   PPY +   +QA+ RI     P V     +S   R F+ 
Sbjct: 218 -YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFLD 276
Query: 212 KCLQVNPNDRPTVTELMEHPFVK 234
             L   P+ R T  EL+ HPF+K
Sbjct: 277 LMLVREPSQRATAQELLGHPFLK 299

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  127 bits (320), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 113/210 (53%), Gaps = 15/210 (7%)
Query: 40  NIVQYLGTDKDEN------RLYIFLELVTKGSLANLYQKYH---LSDSQVSSYTRQILNG 90
           NI  Y G    +N      +L++ +E    GS+ +L +      L +  ++   R+IL G
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 91  LVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVV 148
           L +LH+  V+HRDIK  N+L+  +  VKL DFG++     T+    +  GTP+WMAPEV+
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201
Query: 149 ---NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPS-SLSR 204
               + +  Y   +D+WSLG T +EM    PP   +  ++ALF I +   P + S   S+
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSK 261
Query: 205 DARDFILKCLQVNPNDRPTVTELMEHPFVK 234
             + FI  CL  N + RP   +LM+HPF++
Sbjct: 262 KFQSFIESCLVKNHSQRPATEQLMKHPFIR 291

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  124 bits (312), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 73/221 (33%), Positives = 117/221 (52%), Gaps = 26/221 (11%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANL---------YQKYHLSDSQVSSYTRQILNG 90
           NIV Y  +   ++ L++ ++L++ GS+ ++         ++   L +S +++  R++L G
Sbjct: 74  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 91  LVYLHERNVVHRDIKCANILVDASGSVKLADFGL-AKATTMNDL------KSCKGTPFWM 143
           L YLH+   +HRD+K  NIL+   GSV++ADFG+ A   T  D+      K+  GTP WM
Sbjct: 134 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 144 APEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSL- 202
           APEV+     GY   ADIWS G T +E+ T   PY     ++ L    + + PS+ + + 
Sbjct: 194 APEVMEQVR-GYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ 252
Query: 203 --------SRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
                    +  R  I  CLQ +P  RPT  EL+ H F ++
Sbjct: 253 DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  124 bits (311), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 73/221 (33%), Positives = 117/221 (52%), Gaps = 26/221 (11%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANL---------YQKYHLSDSQVSSYTRQILNG 90
           NIV Y  +   ++ L++ ++L++ GS+ ++         ++   L +S +++  R++L G
Sbjct: 69  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 128
Query: 91  LVYLHERNVVHRDIKCANILVDASGSVKLADFGL-AKATTMNDL------KSCKGTPFWM 143
           L YLH+   +HRD+K  NIL+   GSV++ADFG+ A   T  D+      K+  GTP WM
Sbjct: 129 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 188
Query: 144 APEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSL- 202
           APEV+     GY   ADIWS G T +E+ T   PY     ++ L    + + PS+ + + 
Sbjct: 189 APEVMEQVR-GYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ 247
Query: 203 --------SRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
                    +  R  I  CLQ +P  RPT  EL+ H F ++
Sbjct: 248 DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 288

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  122 bits (306), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 123/243 (50%), Gaps = 10/243 (4%)
Query: 1   DGFFFAVKEVSLQDQGAQGKXXXXXXXXXXXXXXXFEQDNIVQYLGTDKDENRLYIFLEL 60
           DG  + +KE+++    ++ +                +  NIVQY  + ++   LYI ++ 
Sbjct: 48  DGRQYVIKEINISRMSSKEREESRREVAVLAN---MKHPNIVQYRESFEENGSLYIVMDY 104
Query: 61  VTKGSL---ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV 117
              G L    N  +     + Q+  +  QI   L ++H+R ++HRDIK  NI +   G+V
Sbjct: 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTV 164
Query: 118 KLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR 175
           +L DFG+A+   +T+   ++C GTP++++PE+   +N  Y   +DIW+LGC + E+ T +
Sbjct: 165 QLGDFGIARVLNSTVELARACIGTPYYLSPEIC--ENKPYNNKSDIWALGCVLYELCTLK 222
Query: 176 PPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
             +        + +I  G  P V    S D R  + +  + NP DRP+V  ++E  F+ +
Sbjct: 223 HAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282
Query: 236 PLQ 238
            ++
Sbjct: 283 RIE 285

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  120 bits (302), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 109/198 (55%), Gaps = 6/198 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYLHE 96
             ++V + G  +D + +++ LEL  + SL  L+++   L++ +   Y RQI+ G  YLH 
Sbjct: 76  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 135
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+ ++    VK+ DFGLA     +    K+  GTP ++APEV++ K  G
Sbjct: 136 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKK--G 193
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCL 214
           +    D+WS+GC +  +L  +PP+      +   RI K E  S+P  ++  A   I K L
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIPKHINPVAASLIQKML 252
Query: 215 QVNPNDRPTVTELMEHPF 232
           Q +P  RPT+ EL+   F
Sbjct: 253 QTDPTARPTINELLNDEF 270

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  120 bits (302), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 109/198 (55%), Gaps = 6/198 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYLHE 96
             ++V + G  +D + +++ LEL  + SL  L+++   L++ +   Y RQI+ G  YLH 
Sbjct: 80  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 139
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+ ++    VK+ DFGLA     +    K+  GTP ++APEV++ K  G
Sbjct: 140 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKK--G 197
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCL 214
           +    D+WS+GC +  +L  +PP+      +   RI K E  S+P  ++  A   I K L
Sbjct: 198 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIPKHINPVAASLIQKML 256
Query: 215 QVNPNDRPTVTELMEHPF 232
           Q +P  RPT+ EL+   F
Sbjct: 257 QTDPTARPTINELLNDEF 274

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  120 bits (302), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 109/198 (55%), Gaps = 6/198 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYLHE 96
             ++V + G  +D + +++ LEL  + SL  L+++   L++ +   Y RQI+ G  YLH 
Sbjct: 76  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 135
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+ ++    VK+ DFGLA     +    K+  GTP ++APEV++ K  G
Sbjct: 136 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKK--G 193
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCL 214
           +    D+WS+GC +  +L  +PP+      +   RI K E  S+P  ++  A   I K L
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIPKHINPVAASLIQKML 252
Query: 215 QVNPNDRPTVTELMEHPF 232
           Q +P  RPT+ EL+   F
Sbjct: 253 QTDPTARPTINELLNDEF 270

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  120 bits (300), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 118/205 (57%), Gaps = 9/205 (4%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHL---SDSQVSSYTRQILNGLV 92
            +  +I++     +D N +Y+ LE+   G + N Y K  +   S+++   +  QI+ G++
Sbjct: 68  LKHPSILELYNYFEDSNYVYLVLEMCHNGEM-NRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK--SCKGTPFWMAPEVVNS 150
           YLH   ++HRD+  +N+L+  + ++K+ADFGLA    M   K  +  GTP +++PE+  +
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEI--A 184
Query: 151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFI 210
               +GL +D+WSLGC    +L  RPP+        L ++   +   +PS LS +A+D I
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY-EMPSFLSIEAKDLI 243
Query: 211 LKCLQVNPNDRPTVTELMEHPFVKR 235
            + L+ NP DR +++ +++HPF+ R
Sbjct: 244 HQLLRRNPADRLSLSSVLDHPFMSR 268

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  120 bits (300), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 108/198 (54%), Gaps = 6/198 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYLHE 96
             ++V + G  +D + +++ LEL  + SL  L+++   L++ +   Y RQI+ G  YLH 
Sbjct: 74  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+ ++    VK+ DFGLA     +    K   GTP ++APEV++ K  G
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK--G 191
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCL 214
           +    D+WS+GC +  +L  +PP+      +   RI K E  S+P  ++  A   I K L
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIPKHINPVAASLIQKML 250
Query: 215 QVNPNDRPTVTELMEHPF 232
           Q +P  RPT+ EL+   F
Sbjct: 251 QTDPTARPTINELLNDEF 268

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 108/198 (54%), Gaps = 6/198 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYLHE 96
             ++V + G  +D + +++ LEL  + SL  L+++   L++ +   Y RQI+ G  YLH 
Sbjct: 98  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 157
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+ ++    VK+ DFGLA     +    K   GTP ++APEV++ K  G
Sbjct: 158 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK--G 215
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCL 214
           +    D+WS+GC +  +L  +PP+      +   RI K E  S+P  ++  A   I K L
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIPKHINPVAASLIQKML 274
Query: 215 QVNPNDRPTVTELMEHPF 232
           Q +P  RPT+ EL+   F
Sbjct: 275 QTDPTARPTINELLNDEF 292

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  119 bits (299), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 108/198 (54%), Gaps = 6/198 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYLHE 96
             ++V + G  +D + +++ LEL  + SL  L+++   L++ +   Y RQI+ G  YLH 
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+ ++    VK+ DFGLA     +    K   GTP ++APEV++ K  G
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK--G 217
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCL 214
           +    D+WS+GC +  +L  +PP+      +   RI K E  S+P  ++  A   I K L
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIPKHINPVAASLIQKML 276
Query: 215 QVNPNDRPTVTELMEHPF 232
           Q +P  RPT+ EL+   F
Sbjct: 277 QTDPTARPTINELLNDEF 294

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  118 bits (295), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 112/204 (54%), Gaps = 6/204 (2%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLH 95
           ++ +N+V+   +    + L++ +E +  G+L ++     +++ Q+++    +L  L  LH
Sbjct: 128 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH 187
Query: 96  ERNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKND 153
            + V+HRDIK  +IL+   G VKL+DFG     +  +   K   GTP+WMAPE+++    
Sbjct: 188 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP- 246
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPS--SLSRDARDFIL 211
            YG   DIWSLG  V+EM+   PPY +   ++A+  I     P + +   +S   + F+ 
Sbjct: 247 -YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 305
Query: 212 KCLQVNPNDRPTVTELMEHPFVKR 235
           + L  +P  R T  EL++HPF+ +
Sbjct: 306 RLLVRDPAQRATAAELLKHPFLAK 329

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  118 bits (295), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 112/204 (54%), Gaps = 6/204 (2%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLH 95
           ++ +N+V+   +    + L++ +E +  G+L ++     +++ Q+++    +L  L  LH
Sbjct: 85  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH 144
Query: 96  ERNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKND 153
            + V+HRDIK  +IL+   G VKL+DFG     +  +   K   GTP+WMAPE+++    
Sbjct: 145 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP- 203
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPS--SLSRDARDFIL 211
            YG   DIWSLG  V+EM+   PPY +   ++A+  I     P + +   +S   + F+ 
Sbjct: 204 -YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 262
Query: 212 KCLQVNPNDRPTVTELMEHPFVKR 235
           + L  +P  R T  EL++HPF+ +
Sbjct: 263 RLLVRDPAQRATAAELLKHPFLAK 286

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  118 bits (295), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 112/204 (54%), Gaps = 6/204 (2%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLH 95
           ++ +N+V+   +    + L++ +E +  G+L ++     +++ Q+++    +L  L  LH
Sbjct: 78  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH 137
Query: 96  ERNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKND 153
            + V+HRDIK  +IL+   G VKL+DFG     +  +   K   GTP+WMAPE+++    
Sbjct: 138 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP- 196
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPS--SLSRDARDFIL 211
            YG   DIWSLG  V+EM+   PPY +   ++A+  I     P + +   +S   + F+ 
Sbjct: 197 -YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 255
Query: 212 KCLQVNPNDRPTVTELMEHPFVKR 235
           + L  +P  R T  EL++HPF+ +
Sbjct: 256 RLLVRDPAQRATAAELLKHPFLAK 279

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  118 bits (295), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 112/204 (54%), Gaps = 6/204 (2%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLH 95
           ++ +N+V+   +    + L++ +E +  G+L ++     +++ Q+++    +L  L  LH
Sbjct: 74  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH 133
Query: 96  ERNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKND 153
            + V+HRDIK  +IL+   G VKL+DFG     +  +   K   GTP+WMAPE+++    
Sbjct: 134 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP- 192
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPS--SLSRDARDFIL 211
            YG   DIWSLG  V+EM+   PPY +   ++A+  I     P + +   +S   + F+ 
Sbjct: 193 -YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 251
Query: 212 KCLQVNPNDRPTVTELMEHPFVKR 235
           + L  +P  R T  EL++HPF+ +
Sbjct: 252 RLLVRDPAQRATAAELLKHPFLAK 275

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  117 bits (294), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 112/204 (54%), Gaps = 6/204 (2%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLH 95
           ++ +N+V+   +    + L++ +E +  G+L ++     +++ Q+++    +L  L  LH
Sbjct: 83  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH 142
Query: 96  ERNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKND 153
            + V+HRDIK  +IL+   G VKL+DFG     +  +   K   GTP+WMAPE+++    
Sbjct: 143 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP- 201
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPS--SLSRDARDFIL 211
            YG   DIWSLG  V+EM+   PPY +   ++A+  I     P + +   +S   + F+ 
Sbjct: 202 -YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 260
Query: 212 KCLQVNPNDRPTVTELMEHPFVKR 235
           + L  +P  R T  EL++HPF+ +
Sbjct: 261 RLLVRDPAQRATAAELLKHPFLAK 284

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  117 bits (294), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 112/204 (54%), Gaps = 6/204 (2%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLH 95
           ++ +N+V+   +    + L++ +E +  G+L ++     +++ Q+++    +L  L  LH
Sbjct: 205 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH 264
Query: 96  ERNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKND 153
            + V+HRDIK  +IL+   G VKL+DFG     +  +   K   GTP+WMAPE+++    
Sbjct: 265 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP- 323
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPS--SLSRDARDFIL 211
            YG   DIWSLG  V+EM+   PPY +   ++A+  I     P + +   +S   + F+ 
Sbjct: 324 -YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 382
Query: 212 KCLQVNPNDRPTVTELMEHPFVKR 235
           + L  +P  R T  EL++HPF+ +
Sbjct: 383 RLLVRDPAQRATAAELLKHPFLAK 406

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  116 bits (290), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE   +G +    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +      GT  ++ PE++  +   +   
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTLDYLPPEMIEGRM--HDEK 191
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 250
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 251 SQRPMLREVLEHPWI 265

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  115 bits (289), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 109/200 (54%), Gaps = 6/200 (3%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYL 94
            +  ++V + G  +D++ +Y+ LE+  + SL  L+++   +++ +   + RQ + G+ YL
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 95  HERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKN 152
           H   V+HRD+K  N+ ++    VK+ DFGLA     +    K+  GTP ++APEV+  K 
Sbjct: 159 HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKK- 217
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            G+    DIWSLGC +  +L  +PP+      +   RI K E  SVP  ++  A   I +
Sbjct: 218 -GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY-SVPRHINPVASALIRR 275
Query: 213 CLQVNPNDRPTVTELMEHPF 232
            L  +P  RP+V EL+   F
Sbjct: 276 MLHADPTLRPSVAELLTDEF 295

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  115 bits (289), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 105/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE   +G +    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  +   +   
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM--HDEK 191
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 250
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 251 SQRPMLREVLEHPWI 265

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 108/200 (54%), Gaps = 6/200 (3%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYL 94
            +  ++V + G  +D++ +Y+ LE+  + SL  L+++   +++ +   + RQ + G+ YL
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 95  HERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKN 152
           H   V+HRD+K  N+ ++    VK+ DFGLA     +    K   GTP ++APEV+  K 
Sbjct: 159 HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKK- 217
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            G+    DIWSLGC +  +L  +PP+      +   RI K E  SVP  ++  A   I +
Sbjct: 218 -GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY-SVPRHINPVASALIRR 275
Query: 213 CLQVNPNDRPTVTELMEHPF 232
            L  +P  RP+V EL+   F
Sbjct: 276 MLHADPTLRPSVAELLTDEF 295

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 108/200 (54%), Gaps = 6/200 (3%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYL 94
            +  ++V + G  +D++ +Y+ LE+  + SL  L+++   +++ +   + RQ + G+ YL
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 142
Query: 95  HERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKN 152
           H   V+HRD+K  N+ ++    VK+ DFGLA     +    K   GTP ++APEV+  K 
Sbjct: 143 HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKK- 201
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            G+    DIWSLGC +  +L  +PP+      +   RI K E  SVP  ++  A   I +
Sbjct: 202 -GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY-SVPRHINPVASALIRR 259
Query: 213 CLQVNPNDRPTVTELMEHPF 232
            L  +P  RP+V EL+   F
Sbjct: 260 MLHADPTLRPSVAELLTDEF 279

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 108/200 (54%), Gaps = 6/200 (3%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYL 94
            +  ++V + G  +D++ +Y+ LE+  + SL  L+++   +++ +   + RQ + G+ YL
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 95  HERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKN 152
           H   V+HRD+K  N+ ++    VK+ DFGLA     +    K   GTP ++APEV+  K 
Sbjct: 159 HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKK- 217
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            G+    DIWSLGC +  +L  +PP+      +   RI K E  SVP  ++  A   I +
Sbjct: 218 -GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY-SVPRHINPVASALIRR 275
Query: 213 CLQVNPNDRPTVTELMEHPF 232
            L  +P  RP+V EL+   F
Sbjct: 276 MLHADPTLRPSVAELLTDEF 295

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 105/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  +   +   
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTLDYLPPEMIEGRM--HDEK 187
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 246
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 247 SQRPMLREVLEHPWI 261

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 105/196 (53%), Gaps = 12/196 (6%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLY-----QKYHLSDSQVSSYTRQILNGLVYL 94
           N+++Y  +  ++N L I LEL   G L+ +      QK  + +  V  Y  Q+ + L ++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 95  HERNVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDLKSCKGTPFWMAPEVVNSKN 152
           H R V+HRDIK AN+ + A+G VKL D GL +  ++      S  GTP++M+PE ++   
Sbjct: 153 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-- 210
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPY--SHLEGVQALFRIGKGELPSVPSS-LSRDARDF 209
           +GY   +DIWSLGC + EM   + P+    +       +I + + P +PS   S + R  
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 270
Query: 210 ILKCLQVNPNDRPTVT 225
           +  C+  +P  RP VT
Sbjct: 271 VNMCINPDPEKRPDVT 286

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  114 bits (285), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 105/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  +   +   
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRM--HDEK 189
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 248
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 249 SQRPMLREVLEHPWI 263

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  114 bits (285), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 105/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  +   +   
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM--HDEK 189
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 248
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 249 SQRPMLREVLEHPWI 263

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  114 bits (285), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 105/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  +   +   
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM--HDEK 186
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 245
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 246 SQRPMLREVLEHPWI 260

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  114 bits (285), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 105/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  +   +   
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM--HDEK 191
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 250
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 251 SQRPMLREVLEHPWI 265

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  114 bits (285), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 105/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  +   +   
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRM--HDEK 187
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 246
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 247 SQRPMLREVLEHPWI 261

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  114 bits (285), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 105/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 95  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 154
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  +   +   
Sbjct: 155 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM--HDEK 212
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 213 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 271
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 272 SQRPMLREVLEHPWI 286

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  114 bits (285), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 105/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 86  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 145
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  +   +   
Sbjct: 146 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM--HDEK 203
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 204 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 262
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 263 SQRPMLREVLEHPWI 277

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  114 bits (285), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 105/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  +   +   
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRM--HDEK 186
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 245
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 246 SQRPMLREVLEHPWI 260

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  114 bits (284), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 105/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 68  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 127
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  +   +   
Sbjct: 128 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM--HDEK 185
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 186 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 244
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 245 SQRPMLREVLEHPWI 259

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  114 bits (284), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 105/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  +   +   
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM--HDEK 189
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 248
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 249 SQRPMLREVLEHPWI 263

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  114 bits (284), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 105/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 66  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 125
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  +   +   
Sbjct: 126 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM--HDEK 183
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 184 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 242
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 243 SQRPMLREVLEHPWI 257

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  114 bits (284), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE +  +   +   
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEXIEGRX--HDEK 191
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 250
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 251 SQRPXLREVLEHPWI 265

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  114 bits (284), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 105/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 132
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  +   +   
Sbjct: 133 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM--HDEK 190
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 191 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 249
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 250 SQRPMLREVLEHPWI 264

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  114 bits (284), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +      GT  ++ PE++  +   +   
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTLDYLPPEMIEGRM--HDEK 186
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 245
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 246 SQRPMLREVLEHPWI 260

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  114 bits (284), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 109/198 (55%), Gaps = 10/198 (5%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 95  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 154
Query: 99  VVHRDIKCANILVDASGSVKLADFGL---AKATTMNDLKSCKGTPFWMAPEVVNSKNDGY 155
           V+HRDIK  N+L+ ++G +K+ADFG    A ++  +DL  C GT  ++ PE++  +   +
Sbjct: 155 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDL--C-GTLDYLPPEMIEGRM--H 209
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQ 215
               D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLK 268
Query: 216 VNPNDRPTVTELMEHPFV 233
            NP+ RP + E++EHP++
Sbjct: 269 HNPSQRPMLREVLEHPWI 286

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  113 bits (283), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 71  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 130
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +      GT  ++ PE++  +   +   
Sbjct: 131 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRM--HDEK 188
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 189 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 247
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 248 SQRPMLREVLEHPWI 262

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  113 bits (283), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +      GT  ++ PE++  +   +   
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRM--HDEK 191
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 250
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 251 SQRPMLREVLEHPWI 265

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  113 bits (283), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +      GT  ++ PE++  +   +   
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRM--HDEK 187
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 246
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 247 SQRPMLREVLEHPWI 261

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  113 bits (283), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 69  NILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKK 128
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  +   +   
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRM--HDEK 186
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+          RI + E  + P  ++  ARD I + L+ NP
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 245
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 246 SQRPMLREVLEHPWI 260

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  113 bits (283), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +      GT  ++ PE++  +   +   
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRM--HDEK 189
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 248
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 249 SQRPMLREVLEHPWI 263

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  113 bits (283), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +      GT  ++ PE++  +   +   
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRM--HDEK 189
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 248
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 249 SQRPMLREVLEHPWI 263

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  113 bits (283), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +      GT  ++ PE++  +   +   
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRM--HDEK 186
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 245
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 246 SQRPMLREVLEHPWI 260

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  113 bits (283), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +      GT  ++ PE++  +   +   
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRM--HDEK 186
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 245
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 246 SQRPMLREVLEHPWI 260

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  113 bits (283), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +      GT  ++ PE++  +   +   
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRM--HDEK 186
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 245
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 246 SQRPMLREVLEHPWI 260

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +      GT  ++ PE++  +   +   
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTLDYLPPEMIEGRM--HDEK 186
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 245
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 246 SQRPMLREVLEHPWI 260

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 111/205 (54%), Gaps = 9/205 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           +I+  + + +  + +++  +L+ KG L + L +K  LS+ +  S  R +L  + +LH  N
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN 220
Query: 99  VVHRDIKCANILVDASGSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVVNSKND---- 153
           +VHRD+K  NIL+D +  ++L+DFG +        L+   GTP ++APE++    D    
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHP 280
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP-SVPSSLSRDA--RDFI 210
           GYG   D+W+ G  +  +L   PP+ H   +  L  I +G+   S P    R +  +D I
Sbjct: 281 GYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLI 340
Query: 211 LKCLQVNPNDRPTVTELMEHPFVKR 235
            + LQV+P  R T  + ++HPF +R
Sbjct: 341 SRLLQVDPEARLTAEQALQHPFFER 365

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 105/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 71  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 130
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+A+FG +     +   +  GT  ++ PE++  +   +   
Sbjct: 131 VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM--HDEK 188
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 189 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 247
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 248 SQRPMLREVLEHPWI 262

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 105/195 (53%), Gaps = 4/195 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+A+FG +     +   +  GT  ++ PE++  +   +   
Sbjct: 132 VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM--HDEK 189
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L  +PP+      +   RI + E  + P  ++  ARD I + L+ NP
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNP 248
Query: 219 NDRPTVTELMEHPFV 233
           + RP + E++EHP++
Sbjct: 249 SQRPMLREVLEHPWI 263

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 104/196 (53%), Gaps = 4/196 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKR 132
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  +   +   
Sbjct: 133 VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM--HDEK 190
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L   PP+      +   RI + E  + P  ++  ARD I + L+ N 
Sbjct: 191 VDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEF-TFPDFVTEGARDLISRLLKHNA 249
Query: 219 NDRPTVTELMEHPFVK 234
           + R T+ E++EHP++K
Sbjct: 250 SQRLTLAEVLEHPWIK 265

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 104/196 (53%), Gaps = 4/196 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYLHERN 98
           NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L Y H + 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKR 132
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           V+HRDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  +   +   
Sbjct: 133 VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRM--HDEK 190
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WSLG    E L   PP+      +   RI + E  + P  ++  ARD I + L+ N 
Sbjct: 191 VDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEF-TFPDFVTEGARDLISRLLKHNA 249
Query: 219 NDRPTVTELMEHPFVK 234
           + R T+ E++EHP++K
Sbjct: 250 SQRLTLAEVLEHPWIK 265

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 118/247 (47%), Gaps = 19/247 (7%)
Query: 1   DGFFFAVKEVSLQDQGAQGKXXXXXXXXXXXXXXXFEQDNIVQYLG--TDKDENRLYIFL 58
           DG     KE+   D G+  +                +  NIV+Y     D+    LYI +
Sbjct: 30  DGKILVWKEL---DYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86
Query: 59  ELVTKGSLANLY-----QKYHLSDSQVSSYTRQILNGLVYLHERN-----VVHRDIKCAN 108
           E    G LA++      ++ +L +  V     Q+   L   H R+     V+HRD+K AN
Sbjct: 87  EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 146
Query: 109 ILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           + +D   +VKL DFGLA+    ++   K   GTP++M+PE +N  +  Y   +DIWSLGC
Sbjct: 147 VFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRMS--YNEKSDIWSLGC 204
Query: 167 TVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTE 226
            + E+    PP++     +   +I +G+   +P   S +  + I + L +    RP+V E
Sbjct: 205 LLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEE 264
Query: 227 LMEHPFV 233
           ++E+P +
Sbjct: 265 ILENPLI 271

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 111/202 (54%), Gaps = 9/202 (4%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERN- 98
           IV + G    +  + I +E +  GSL  + +K   + +  +   +  ++ GL YL E++ 
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 144
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y + 
Sbjct: 145 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--YSVQ 202
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFR----IGKGELPSVPSSL-SRDARDFILKC 213
           +DIWS+G +++EM   R P     G  A+F     I     P +PS + S + +DF+ KC
Sbjct: 203 SDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 262
Query: 214 LQVNPNDRPTVTELMEHPFVKR 235
           L  NP +R  + +LM H F+KR
Sbjct: 263 LIKNPAERADLKQLMVHAFIKR 284

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 118/247 (47%), Gaps = 19/247 (7%)
Query: 1   DGFFFAVKEVSLQDQGAQGKXXXXXXXXXXXXXXXFEQDNIVQYLG--TDKDENRLYIFL 58
           DG     KE+   D G+  +                +  NIV+Y     D+    LYI +
Sbjct: 30  DGKILVWKEL---DYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86
Query: 59  ELVTKGSLANLY-----QKYHLSDSQVSSYTRQILNGLVYLHERN-----VVHRDIKCAN 108
           E    G LA++      ++ +L +  V     Q+   L   H R+     V+HRD+K AN
Sbjct: 87  EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 146
Query: 109 ILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           + +D   +VKL DFGLA+    +    K+  GTP++M+PE +N  +  Y   +DIWSLGC
Sbjct: 147 VFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMS--YNEKSDIWSLGC 204
Query: 167 TVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTE 226
            + E+    PP++     +   +I +G+   +P   S +  + I + L +    RP+V E
Sbjct: 205 LLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEE 264
Query: 227 LMEHPFV 233
           ++E+P +
Sbjct: 265 ILENPLI 271

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 118/247 (47%), Gaps = 19/247 (7%)
Query: 1   DGFFFAVKEVSLQDQGAQGKXXXXXXXXXXXXXXXFEQDNIVQYLG--TDKDENRLYIFL 58
           DG     KE+   D G+  +                +  NIV+Y     D+    LYI +
Sbjct: 30  DGKILVWKEL---DYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86
Query: 59  ELVTKGSLANLY-----QKYHLSDSQVSSYTRQILNGLVYLHERN-----VVHRDIKCAN 108
           E    G LA++      ++ +L +  V     Q+   L   H R+     V+HRD+K AN
Sbjct: 87  EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 146
Query: 109 ILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           + +D   +VKL DFGLA+    +    K+  GTP++M+PE +N  +  Y   +DIWSLGC
Sbjct: 147 VFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS--YNEKSDIWSLGC 204
Query: 167 TVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTE 226
            + E+    PP++     +   +I +G+   +P   S +  + I + L +    RP+V E
Sbjct: 205 LLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEE 264
Query: 227 LMEHPFV 233
           ++E+P +
Sbjct: 265 ILENPLI 271

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  107 bits (268), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 104/193 (53%), Gaps = 6/193 (3%)
Query: 48  DKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           D +E+ LY+  ELV +G +  +     LS+ Q   Y + ++ G+ YLH + ++HRDIK +
Sbjct: 107 DPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166
Query: 108 NILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGY-GLTADIWSL 164
           N+LV   G +K+ADFG++     +D  L +  GTP +MAPE ++     + G   D+W++
Sbjct: 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAM 226
Query: 165 GCTVLEMLTRRPPY--SHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP 222
           G T+   +  + P+    +  + +  +    E P  P  ++ D +D I + L  NP  R 
Sbjct: 227 GVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQP-DIAEDLKDLITRMLDKNPESRI 285
Query: 223 TVTELMEHPFVKR 235
            V E+  HP+V R
Sbjct: 286 VVPEIKLHPWVTR 298

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  107 bits (267), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 111/204 (54%), Gaps = 11/204 (5%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NI++     +D +  YI  EL T G L + + ++   S+   +   +Q+ +G+ Y+H+ N
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 99  VVHRDIKCANILVDASGS---VKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDG 154
           +VHRD+K  NIL+++      +K+ DFGL+     N  +K   GT +++APEV+      
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--- 198
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP-SVPS--SLSRDARDFIL 211
           Y    D+WS G  +  +L+  PP+        L R+  G+    +P   ++S DA+D I 
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 212 KCLQVNPNDRPTVTELMEHPFVKR 235
           K L  +P+ R T T+ +EHP++++
Sbjct: 259 KMLTFHPSLRITATQCLEHPWIQK 282

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  107 bits (267), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 111/205 (54%), Gaps = 13/205 (6%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NI++     +D +  YI  EL T G L + + ++   S+   +   +Q+ +G+ Y+H+ N
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 99  VVHRDIKCANILVDASGS---VKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDG 154
           +VHRD+K  NIL+++      +K+ DFGL+     N  +K   GT +++APEV+      
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--- 198
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG----ELPSVPSSLSRDARDFI 210
           Y    D+WS G  +  +L+  PP+        L R+  G    +LP    ++S DA+D I
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW-RTISDDAKDLI 257
Query: 211 LKCLQVNPNDRPTVTELMEHPFVKR 235
            K L  +P+ R T T+ +EHP++++
Sbjct: 258 RKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  107 bits (267), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 111/205 (54%), Gaps = 13/205 (6%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NI++     +D +  YI  EL T G L + + ++   S+   +   +Q+ +G+ Y+H+ N
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 99  VVHRDIKCANILVDASGS---VKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDG 154
           +VHRD+K  NIL+++      +K+ DFGL+     N  +K   GT +++APEV+      
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--- 198
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG----ELPSVPSSLSRDARDFI 210
           Y    D+WS G  +  +L+  PP+        L R+  G    +LP    ++S DA+D I
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW-RTISDDAKDLI 257
Query: 211 LKCLQVNPNDRPTVTELMEHPFVKR 235
            K L  +P+ R T T+ +EHP++++
Sbjct: 258 RKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 9/205 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NI+Q   T +     ++  +L+ KG L + L +K  LS+ +     R +L  +  LH+ N
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144
Query: 99  VVHRDIKCANILVDASGSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVV----NSKND 153
           +VHRD+K  NIL+D   ++KL DFG + +      L+S  GTP ++APE++    N  + 
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHP 204
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP-SVPS--SLSRDARDFI 210
           GYG   D+WS G  +  +L   PP+ H + +  L  I  G      P     S   +D +
Sbjct: 205 GYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV 264
Query: 211 LKCLQVNPNDRPTVTELMEHPFVKR 235
            + L V P  R T  E + HPF ++
Sbjct: 265 SRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 107/203 (52%), Gaps = 7/203 (3%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD-SQVSSYTRQILNGLVYL 94
           +E   +     T + +  L+  +E +  G L    Q  H  D S+ + Y  +I+ GL +L
Sbjct: 76  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 135
Query: 95  HERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKN 152
           H + +V+RD+K  NIL+D  G +K+ADFG+ K   + D K+ +  GTP ++APE++  + 
Sbjct: 136 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQK 195
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
             Y  + D WS G  + EML  + P+ H +  + LF   + + P  P  L ++A+D ++K
Sbjct: 196 --YNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 252
Query: 213 CLQVNPNDRPTVT-ELMEHPFVK 234
                P  R  V  ++ +HP  +
Sbjct: 253 LFVREPEKRLGVRGDIRQHPLFR 275

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  105 bits (262), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 109/212 (51%), Gaps = 13/212 (6%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY----HLSDSQVSSYTRQILNGLVYLH 95
           NIV ++G       L I  E +++GSL  L  K      L + +  S    +  G+ YLH
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 96  ERN--VVHRDIKCANILVDASGSVKLADFGLA--KATTMNDLKSCKGTPFWMAPEVVNSK 151
            RN  +VHR++K  N+LVD   +VK+ DFGL+  KA+T    KS  GTP WMAPEV+  +
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL--R 212
Query: 152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIG-KGELPSVPSSLSRDARDFI 210
           ++     +D++S G  + E+ T + P+ +L   Q +  +G K +   +P +L+      I
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAII 272
Query: 211 LKCLQVNPNDRPTVTELME--HPFVKRPLQTP 240
             C    P  RP+   +M+   P +K  +  P
Sbjct: 273 EGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 103/205 (50%), Gaps = 9/205 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NI+Q   T +     ++  +L+ KG L + L +K  LS+ +     R +L  +  LH+ N
Sbjct: 72  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 131
Query: 99  VVHRDIKCANILVDASGSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVV----NSKND 153
           +VHRD+K  NIL+D   ++KL DFG + +      L+   GTP ++APE++    N  + 
Sbjct: 132 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP 191
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP-SVPS--SLSRDARDFI 210
           GYG   D+WS G  +  +L   PP+ H + +  L  I  G      P     S   +D +
Sbjct: 192 GYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV 251
Query: 211 LKCLQVNPNDRPTVTELMEHPFVKR 235
            + L V P  R T  E + HPF ++
Sbjct: 252 SRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  105 bits (261), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 106/203 (52%), Gaps = 7/203 (3%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD-SQVSSYTRQILNGLVYL 94
           +E   +     T + +  L+  +E +  G L    Q  H  D S+ + Y  +I+ GL +L
Sbjct: 75  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 134
Query: 95  HERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKN 152
           H + +V+RD+K  NIL+D  G +K+ADFG+ K   + D K+    GTP ++APE++  + 
Sbjct: 135 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQK 194
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
             Y  + D WS G  + EML  + P+ H +  + LF   + + P  P  L ++A+D ++K
Sbjct: 195 --YNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 251
Query: 213 CLQVNPNDRPTVT-ELMEHPFVK 234
                P  R  V  ++ +HP  +
Sbjct: 252 LFVREPEKRLGVRGDIRQHPLFR 274

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  105 bits (261), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 103/205 (50%), Gaps = 9/205 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NI+Q   T +     ++  +L+ KG L + L +K  LS+ +     R +L  +  LH+ N
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144
Query: 99  VVHRDIKCANILVDASGSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVV----NSKND 153
           +VHRD+K  NIL+D   ++KL DFG + +      L+   GTP ++APE++    N  + 
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP 204
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP-SVPS--SLSRDARDFI 210
           GYG   D+WS G  +  +L   PP+ H + +  L  I  G      P     S   +D +
Sbjct: 205 GYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV 264
Query: 211 LKCLQVNPNDRPTVTELMEHPFVKR 235
            + L V P  R T  E + HPF ++
Sbjct: 265 SRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  105 bits (261), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 100/197 (50%), Gaps = 6/197 (3%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVS-SYTRQILNGLVYLHERN 98
           NI++      D  R+Y+ LE   +G L    QK+   D Q S ++  ++ + L Y HER 
Sbjct: 76  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 135
Query: 99  VVHRDIKCANILVDASGSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVVNSKNDGYGL 157
           V+HRDIK  N+L+   G +K+ADFG +  A ++     C GT  ++ PE++  K   +  
Sbjct: 136 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC-GTLDYLPPEMIEGKT--HDE 192
Query: 158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVN 217
             D+W  G    E L   PP+      +   RI   +L   P  LS  ++D I K L+ +
Sbjct: 193 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL-KFPPFLSDGSKDLISKLLRYH 251
Query: 218 PNDRPTVTELMEHPFVK 234
           P  R  +  +MEHP+VK
Sbjct: 252 PPQRLPLKGVMEHPWVK 268

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 60/174 (34%), Positives = 93/174 (53%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +K+ADFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIKVADFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  104 bits (260), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 100/197 (50%), Gaps = 6/197 (3%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVS-SYTRQILNGLVYLHERN 98
           NI++      D  R+Y+ LE   +G L    QK+   D Q S ++  ++ + L Y HER 
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 134
Query: 99  VVHRDIKCANILVDASGSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVVNSKNDGYGL 157
           V+HRDIK  N+L+   G +K+ADFG +  A ++     C GT  ++ PE++  K   +  
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC-GTLDYLPPEMIEGKT--HDE 191
Query: 158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVN 217
             D+W  G    E L   PP+      +   RI   +L   P  LS  ++D I K L+ +
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL-KFPPFLSDGSKDLISKLLRYH 250
Query: 218 PNDRPTVTELMEHPFVK 234
           P  R  +  +MEHP+VK
Sbjct: 251 PPQRLPLKGVMEHPWVK 267

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  104 bits (260), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 109/198 (55%), Gaps = 5/198 (2%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERN- 98
           IV + G    +  + I +E +  GSL  + +K   + +  +   +  ++ GL YL E++ 
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 128
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           ++HRD+K +NILV++ G +KL DFG++            GT  +M+PE +   +  Y + 
Sbjct: 129 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPERLQGTH--YSVQ 186
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSL-SRDARDFILKCLQVN 217
           +DIWS+G +++EM   R P   +   + L  I     P +PS++ S + +DF+ KCL  N
Sbjct: 187 SDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKN 246
Query: 218 PNDRPTVTELMEHPFVKR 235
           P +R  + +LM H F+KR
Sbjct: 247 PAERADLKQLMVHAFIKR 264

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  103 bits (258), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 60/174 (34%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ LE    G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 112 KDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +K+ADFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 172 NLLIDQQGYIKVADFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 228
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 229 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 59/174 (33%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   E +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADEPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 59/174 (33%), Positives = 93/174 (53%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E +  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +K+ADFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIKVADFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  103 bits (257), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 96/177 (54%), Gaps = 9/177 (5%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDS---QVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +YI  E + KGSL +  +    S     ++  ++ QI  G+ ++ +RN +HRD++ ANIL
Sbjct: 84  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 143
Query: 111 VDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSLGCT 167
           V AS   K+ADFGLA+    N+  + +G  F   W APE +N     + + +D+WS G  
Sbjct: 144 VSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGIL 201
Query: 168 VLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           ++E++T  R PY  +   + +  + +G     P +   +  + +++C +  P +RPT
Sbjct: 202 LMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPT 258

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 59/174 (33%), Positives = 93/174 (53%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E +  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +K+ADFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIKVADFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 97/177 (54%), Gaps = 9/177 (5%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDS---QVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +YI  E + KGSL +  +    S     ++  ++ QI  G+ ++ +RN +HRD++ ANIL
Sbjct: 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 316
Query: 111 VDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSLGCT 167
           V AS   K+ADFGLA+    N+  + +G  F   W APE +N  +  + + +D+WS G  
Sbjct: 317 VSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKSDVWSFGIL 374
Query: 168 VLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           ++E++T  R PY  +   + +  + +G     P +   +  + +++C +  P +RPT
Sbjct: 375 LMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPT 431

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 107/201 (53%), Gaps = 15/201 (7%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           L I +E +  G L +  Q+      ++ + +   R I   + +LH  N+ HRD+K  N+L
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 141
Query: 111 V---DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
               +    +KL DFG AK TT N L++   TP+++APEV+  +   Y  + D+WSLG  
Sbjct: 142 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGVI 199
Query: 168 VLEMLTRRPP-YSHL-----EGVQALFRIGKGELPSVP-SSLSRDARDFILKCLQVNPND 220
           +  +L   PP YS+       G++   R+G+   P+   S +S DA+  I   L+ +P +
Sbjct: 200 MYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTE 259
Query: 221 RPTVTELMEHPFVKRPLQTPR 241
           R T+T+ M HP++ + +  P+
Sbjct: 260 RLTITQFMNHPWINQSMVVPQ 280

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 107/201 (53%), Gaps = 15/201 (7%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           L I +E +  G L +  Q+      ++ + +   R I   + +LH  N+ HRD+K  N+L
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 160
Query: 111 V---DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
               +    +KL DFG AK TT N L++   TP+++APEV+  +   Y  + D+WSLG  
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGVI 218
Query: 168 VLEMLTRRPP-YSHL-----EGVQALFRIGKGELPSVP-SSLSRDARDFILKCLQVNPND 220
           +  +L   PP YS+       G++   R+G+   P+   S +S DA+  I   L+ +P +
Sbjct: 219 MYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTE 278
Query: 221 RPTVTELMEHPFVKRPLQTPR 241
           R T+T+ M HP++ + +  P+
Sbjct: 279 RLTITQFMNHPWINQSMVVPQ 299

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  102 bits (255), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 107/212 (50%), Gaps = 13/212 (6%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY----HLSDSQVSSYTRQILNGLVYLH 95
           NIV ++G       L I  E +++GSL  L  K      L + +  S    +  G+ YLH
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 96  ERN--VVHRDIKCANILVDASGSVKLADFGLA--KATTMNDLKSCKGTPFWMAPEVVNSK 151
            RN  +VHRD+K  N+LVD   +VK+ DFGL+  KA+     K   GTP WMAPEV+  +
Sbjct: 155 NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVL--R 212
Query: 152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIG-KGELPSVPSSLSRDARDFI 210
           ++     +D++S G  + E+ T + P+ +L   Q +  +G K +   +P +L+      I
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAII 272
Query: 211 LKCLQVNPNDRPTVTELME--HPFVKRPLQTP 240
             C    P  RP+   +M+   P +K  +  P
Sbjct: 273 EGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 112 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 228
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 229 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 98  KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 157
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 158 NLLIDEQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 214
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 215 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 267

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score =  102 bits (253), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 110/202 (54%), Gaps = 12/202 (5%)
Query: 42  VQYLGTDKDENRLYIFLELVTKGSLANLYQKY-----HLSDSQVSSYTRQILNGLVYLHE 96
           V + G    E  ++I +EL+   SL   Y++       + +  +      I+  L +LH 
Sbjct: 113 VTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 171
Query: 97  R-NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSC-KGTPFWMAPEVVNSK--N 152
           + +V+HRD+K +N+L++A G VK+ DFG++     +  K+   G   +MAPE +N +   
Sbjct: 172 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQ 231
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPY-SHLEGVQALFRIGKGELPSVPS-SLSRDARDFI 210
            GY + +DIWSLG T++E+   R PY S     Q L ++ +   P +P+   S +  DF 
Sbjct: 232 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 291
Query: 211 LKCLQVNPNDRPTVTELMEHPF 232
            +CL+ N  +RPT  ELM+HPF
Sbjct: 292 SQCLKKNSKERPTYPELMQHPF 313

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E    G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+++D  G +K+ DFGLAK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLMIDQQGYIKVTDFGLAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  102 bits (253), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 106/196 (54%), Gaps = 3/196 (1%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           +I++     K ++ + + +E         + Q+  +S+ +   + +QI++ + Y H   +
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 124
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATT-MNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           VHRD+K  N+L+D   +VK+ADFGL+   T  N LK+  G+P + APEV++ K    G  
Sbjct: 125 VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA-GPE 183
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WS G  +  ML RR P+   E +  LF+     + ++P  LS  A   I + L VNP
Sbjct: 184 VDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNP 242
Query: 219 NDRPTVTELMEHPFVK 234
            +R ++ E+M+  + K
Sbjct: 243 LNRISIHEIMQDDWFK 258

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 106/196 (54%), Gaps = 3/196 (1%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           +I++     K ++ + + +E         + Q+  +S+ +   + +QI++ + Y H   +
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 128
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATT-MNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           VHRD+K  N+L+D   +VK+ADFGL+   T  N LK+  G+P + APEV++ K    G  
Sbjct: 129 VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA-GPE 187
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WS G  +  ML RR P+   E +  LF+     + ++P  LS  A   I + L VNP
Sbjct: 188 VDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNP 246
Query: 219 NDRPTVTELMEHPFVK 234
            +R ++ E+M+  + K
Sbjct: 247 LNRISIHEIMQDDWFK 262

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 112 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 228
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 229 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 111/217 (51%), Gaps = 13/217 (5%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYL 94
            +  NIV+   +  +E   Y+  +LVT G L  ++  + + S++  S   +QIL  +++ 
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 137
Query: 95  HERNVVHRDIKCANILVDAS---GSVKLADFGLAKAT--TMNDLKSCKGTPFWMAPEVVN 149
           H+  VVHRD+K  N+L+ +     +VKLADFGLA              GTP +++PEV+ 
Sbjct: 138 HQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL- 196
Query: 150 SKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPS----SLSRD 205
            + D YG   D+W+ G  +  +L   PP+   E    L++  K      PS    +++ +
Sbjct: 197 -RKDPYGKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTPE 254
Query: 206 ARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPRC 242
           A+D I K L +NP+ R T  E ++HP++        C
Sbjct: 255 AKDLINKMLTINPSKRITAAEALKHPWISHRSTVASC 291

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 106/196 (54%), Gaps = 3/196 (1%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           +I++     K ++ + + +E         + Q+  +S+ +   + +QI++ + Y H   +
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 133
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATT-MNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           VHRD+K  N+L+D   +VK+ADFGL+   T  N LK+  G+P + APEV++ K    G  
Sbjct: 134 VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA-GPE 192
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WS G  +  ML RR P+   E +  LF+     + ++P  LS  A   I + L VNP
Sbjct: 193 VDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNP 251
Query: 219 NDRPTVTELMEHPFVK 234
            +R ++ E+M+  + K
Sbjct: 252 LNRISIHEIMQDDWFK 267

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 112 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 228
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 229 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 112 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 228
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 229 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 132 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 191
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 192 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 248
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 249 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+++D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLIIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIIISK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 106/196 (54%), Gaps = 3/196 (1%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           +I++     K ++ + + +E         + Q+  +S+ +   + +QI++ + Y H   +
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 134
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATT-MNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           VHRD+K  N+L+D   +VK+ADFGL+   T  N LK+  G+P + APEV++ K    G  
Sbjct: 135 VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA-GPE 193
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            D+WS G  +  ML RR P+   E +  LF+     + ++P  LS  A   I + L VNP
Sbjct: 194 VDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNP 252
Query: 219 NDRPTVTELMEHPFVK 234
            +R ++ E+M+  + K
Sbjct: 253 LNRISIHEIMQDDWFK 268

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 112 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 228
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 229 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 132 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 191
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 192 NLLIDQQGYIQVTDFGFAKRVKGATWTLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 248
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 249 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 97  KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 156
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 157 NLLIDQQGYIQVTDFGFAKRVKGRTWTLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 213
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 214 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 266

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 112 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWTLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 228
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 229 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 104 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 163
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 164 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 220
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 221 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 273

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 109/209 (52%), Gaps = 18/209 (8%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-----YHLSDSQVSSYTRQILNGLVYL 94
           +IV+ L T   +  LY+  E +    L     K     +  S++  S Y RQIL  L Y 
Sbjct: 87  HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 95  HERNVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAPEVVN 149
           H+ N++HRD+K  N+L+   + S  VKL DFG+A     + L +    GTP +MAPEVV 
Sbjct: 147 HDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVV- 205
Query: 150 SKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR-IGKGELPSVP---SSLSRD 205
            K + YG   D+W  G  +  +L+   P+   +  + LF  I KG+    P   S +S  
Sbjct: 206 -KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYKMNPRQWSHISES 262
Query: 206 ARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           A+D + + L ++P +R TV E + HP++K
Sbjct: 263 AKDLVRRMLMLDPAERITVYEALNHPWLK 291

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 114/207 (55%), Gaps = 17/207 (8%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+ YLH   
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 99  VVHRDIKCANI-LVDAS---GSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVVNSKND 153
           + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN   +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY--E 192
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVPSSLSRDAR 207
             GL AD+WS+G     +L+   P+        L  V A+    + E  S  S+L   A+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL---AK 249
Query: 208 DFILKCLQVNPNDRPTVTELMEHPFVK 234
           DFI + L  +P  R T+ + ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 91/170 (53%), Gaps = 5/170 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVN 217
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    ++     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score =  101 bits (251), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 109/202 (53%), Gaps = 12/202 (5%)
Query: 42  VQYLGTDKDENRLYIFLELVTKGSLANLYQKY-----HLSDSQVSSYTRQILNGLVYLHE 96
           V + G    E  ++I +EL+   SL   Y++       + +  +      I+  L +LH 
Sbjct: 69  VTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 97  R-NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSC-KGTPFWMAPEVVNSK--N 152
           + +V+HRD+K +N+L++A G VK+ DFG++     +  K    G   +MAPE +N +   
Sbjct: 128 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPY-SHLEGVQALFRIGKGELPSVPS-SLSRDARDFI 210
            GY + +DIWSLG T++E+   R PY S     Q L ++ +   P +P+   S +  DF 
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 247
Query: 211 LKCLQVNPNDRPTVTELMEHPF 232
            +CL+ N  +RPT  ELM+HPF
Sbjct: 248 SQCLKKNSKERPTYPELMQHPF 269

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 114/207 (55%), Gaps = 17/207 (8%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+ YLH   
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 99  VVHRDIKCANI-LVDAS---GSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVVNSKND 153
           + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN   +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNY--E 192
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVPSSLSRDAR 207
             GL AD+WS+G     +L+   P+        L  V A+    + E  S  S+L   A+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL---AK 249
Query: 208 DFILKCLQVNPNDRPTVTELMEHPFVK 234
           DFI + L  +P  R T+ + ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 114/207 (55%), Gaps = 17/207 (8%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+ YLH   
Sbjct: 74  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 133
Query: 99  VVHRDIKCANI-LVDAS---GSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVVNSKND 153
           + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN   +
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY--E 191
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVPSSLSRDAR 207
             GL AD+WS+G     +L+   P+        L  V A+    + E  S  S+L   A+
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL---AK 248
Query: 208 DFILKCLQVNPNDRPTVTELMEHPFVK 234
           DFI + L  +P  R T+ + ++HP++K
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 114/207 (55%), Gaps = 17/207 (8%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+ YLH   
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 99  VVHRDIKCANI-LVDAS---GSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVVNSKND 153
           + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN   +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY--E 192
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVPSSLSRDAR 207
             GL AD+WS+G     +L+   P+        L  V A+    + E  S  S+L   A+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL---AK 249
Query: 208 DFILKCLQVNPNDRPTVTELMEHPFVK 234
           DFI + L  +P  R T+ + ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 114/207 (55%), Gaps = 17/207 (8%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+ YLH   
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 99  VVHRDIKCANI-LVDAS---GSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVVNSKND 153
           + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN   +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY--E 192
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVPSSLSRDAR 207
             GL AD+WS+G     +L+   P+        L  V A+    + E  S  S+L   A+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL---AK 249
Query: 208 DFILKCLQVNPNDRPTVTELMEHPFVK 234
           DFI + L  +P  R T+ + ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 114/207 (55%), Gaps = 17/207 (8%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+ YLH   
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 99  VVHRDIKCANI-LVDAS---GSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVVNSKND 153
           + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN   +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY--E 192
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVPSSLSRDAR 207
             GL AD+WS+G     +L+   P+        L  V A+    + E  S  S+L   A+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL---AK 249
Query: 208 DFILKCLQVNPNDRPTVTELMEHPFVK 234
           DFI + L  +P  R T+ + ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 114/207 (55%), Gaps = 17/207 (8%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+ YLH   
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 99  VVHRDIKCANI-LVDAS---GSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVVNSKND 153
           + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN   +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY--E 192
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVPSSLSRDAR 207
             GL AD+WS+G     +L+   P+        L  V A+    + E  S  S+L   A+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL---AK 249
Query: 208 DFILKCLQVNPNDRPTVTELMEHPFVK 234
           DFI + L  +P  R T+ + ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 108/205 (52%), Gaps = 13/205 (6%)
Query: 40  NIVQYL----GTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV-SSYTRQILNGLVYL 94
           NIV++      T K +  + +  EL T G+L    +++ +   +V  S+ RQIL GL +L
Sbjct: 86  NIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFL 145
Query: 95  HERN--VVHRDIKCANILVDA-SGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSK 151
           H R   ++HRD+KC NI +   +GSVK+ D GLA     +  K+  GTP + APE    K
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFXAPEXYEEK 205
Query: 152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALF-RIGKGELPSVPSSLS-RDARDF 209
              Y  + D+++ G   LE  T   PYS  +    ++ R+  G  P+    ++  + ++ 
Sbjct: 206 ---YDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 262
Query: 210 ILKCLQVNPNDRPTVTELMEHPFVK 234
           I  C++ N ++R ++ +L+ H F +
Sbjct: 263 IEGCIRQNKDERYSIKDLLNHAFFQ 287

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 114/207 (55%), Gaps = 17/207 (8%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+ YLH   
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 99  VVHRDIKCANI-LVDAS---GSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVVNSKND 153
           + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN   +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY--E 192
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVPSSLSRDAR 207
             GL AD+WS+G     +L+   P+        L  V A+    + E  S  S+L   A+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL---AK 249
Query: 208 DFILKCLQVNPNDRPTVTELMEHPFVK 234
           DFI + L  +P  R T+ + ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 114/207 (55%), Gaps = 17/207 (8%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+ YLH   
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 99  VVHRDIKCANI-LVDAS---GSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVVNSKND 153
           + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN   +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY--E 192
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVPSSLSRDAR 207
             GL AD+WS+G     +L+   P+        L  V A+    + E  S  S+L   A+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL---AK 249
Query: 208 DFILKCLQVNPNDRPTVTELMEHPFVK 234
           DFI + L  +P  R T+ + ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 114/207 (55%), Gaps = 17/207 (8%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+ YLH   
Sbjct: 74  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 133
Query: 99  VVHRDIKCANI-LVDAS---GSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVVNSKND 153
           + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN   +
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY--E 191
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVPSSLSRDAR 207
             GL AD+WS+G     +L+   P+        L  V A+    + E  S  S+L   A+
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL---AK 248
Query: 208 DFILKCLQVNPNDRPTVTELMEHPFVK 234
           DFI + L  +P  R T+ + ++HP++K
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 114/207 (55%), Gaps = 17/207 (8%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+ YLH   
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 99  VVHRDIKCANI-LVDAS---GSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVVNSKND 153
           + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN   +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY--E 192
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVPSSLSRDAR 207
             GL AD+WS+G     +L+   P+        L  V A+    + E  S  S+L   A+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL---AK 249
Query: 208 DFILKCLQVNPNDRPTVTELMEHPFVK 234
           DFI + L  +P  R T+ + ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 10/206 (4%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYL 94
            + +NIV      +  N LY+ ++LV+ G L + + +K   ++   S+  RQ+L+ + YL
Sbjct: 77  IKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYL 136
Query: 95  HERNVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNS 150
           H   +VHRD+K  N+L    D    + ++DFGL+K     D+ S   GTP ++APEV+  
Sbjct: 137 HRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQ 196
Query: 151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL---PSVPSSLSRDAR 207
           K   Y    D WS+G     +L   PP+      +   +I K E          +S  A+
Sbjct: 197 K--PYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAK 254
Query: 208 DFILKCLQVNPNDRPTVTELMEHPFV 233
           DFI   ++ +PN R T  +   HP++
Sbjct: 255 DFIRNLMEKDPNKRYTCEQAARHPWI 280

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 114/207 (55%), Gaps = 17/207 (8%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+ YLH   
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 99  VVHRDIKCANI-LVDAS---GSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVVNSKND 153
           + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN   +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY--E 192
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVPSSLSRDAR 207
             GL AD+WS+G     +L+   P+        L  V A+    + E  S  S+L   A+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL---AK 249
Query: 208 DFILKCLQVNPNDRPTVTELMEHPFVK 234
           DFI + L  +P  R T+ + ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + +M    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYQMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 91/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E    G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 112 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+++D  G +K+ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 172 NLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 228
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 229 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 91/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E    G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+++D  G +K+ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 114/207 (55%), Gaps = 17/207 (8%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+ YLH   
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 99  VVHRDIKCANI-LVDAS---GSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVVNSKND 153
           + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN   +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY--E 192
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVPSSLSRDAR 207
             GL AD+WS+G     +L+   P+        L  V A+    + E  S  S+L   A+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL---AK 249
Query: 208 DFILKCLQVNPNDRPTVTELMEHPFVK 234
           DFI + L  +P  R T+ + ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 91/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E    G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 112 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+++D  G +K+ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 172 NLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 228
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 229 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 91/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E    G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 112 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+++D  G +K+ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 172 NLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 228
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 229 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 91/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 106 KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 165
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 166 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 222
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 223 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 275

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E    G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+++D  G +++ DFGLAK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLMIDQQGYIQVTDFGLAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  100 bits (250), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 110/210 (52%), Gaps = 19/210 (9%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERN- 98
           IV + G    +  + I +E +  GSL  + +K   + +  +   +  ++ GL YL E++ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y + 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--YSVQ 183
Query: 159 ADIWSLGCTVLEMLT-------------RRPPYSHLEGVQALFRIGKGELPSVPSSLSRD 205
           +DIWS+G +++EM                RPP +  E +  +      +LPS     S +
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPS--GVFSLE 241
Query: 206 ARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
            +DF+ KCL  NP +R  + +LM H F+KR
Sbjct: 242 FQDFVNKCLIKNPAERADLKQLMVHAFIKR 271

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  100 bits (249), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 91/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  100 bits (249), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 91/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  100 bits (249), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 91/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  100 bits (249), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 91/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 132 KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 191
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 192 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 248
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 249 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  100 bits (249), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 107/204 (52%), Gaps = 4/204 (1%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYL 94
           F   +I++           ++ +E V+ G L +   K+  + + +     +QIL+ + Y 
Sbjct: 68  FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYC 127
Query: 95  HERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKND 153
           H   VVHRD+K  N+L+DA  + K+ADFGL+   +  + L++  G+P + APEV++ +  
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKC 213
             G   DIWS G  +  +L    P+   E V  LF+  +G +  +P  L+R     ++  
Sbjct: 188 A-GPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLNRSVATLLMHM 245
Query: 214 LQVNPNDRPTVTELMEHPFVKRPL 237
           LQV+P  R T+ ++ EH + K+ L
Sbjct: 246 LQVDPLKRATIKDIREHEWFKQDL 269

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  100 bits (249), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 106/199 (53%), Gaps = 16/199 (8%)
Query: 51  ENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           E +L++ L+ +  G L  +L Q+   ++ +V  Y  +I+  L +LH+  +++RDIK  NI
Sbjct: 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENI 190
Query: 110 LVDASGSVKLADFGLAKATTMNDLKSCK---GTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           L+D++G V L DFGL+K    ++ +      GT  +MAP++V   + G+    D WSLG 
Sbjct: 191 LLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGV 250
Query: 167 TVLEMLTRRPPYSHLEG-----VQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
            + E+LT   P++ ++G      +   RI K E P  P  +S  A+D I + L  +P  R
Sbjct: 251 LMYELLTGASPFT-VDGEKNSQAEISRRILKSE-PPYPQEMSALAKDLIQRLLMKDPKKR 308
Query: 222 -----PTVTELMEHPFVKR 235
                    E+ EH F ++
Sbjct: 309 LGCGPRDADEIKEHLFFQK 327

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  100 bits (248), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 91/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP  +APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEALAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  100 bits (248), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 91/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  100 bits (248), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 101/192 (52%), Gaps = 11/192 (5%)
Query: 52  NRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +RLY  +E V  G L  ++ Q     + Q   Y  +I  GL +LH+R +++RD+K  N++
Sbjct: 93  DRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVM 152
Query: 111 VDASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           +D+ G +K+ADFG+ K   M+ + + +  GTP ++APE++  +   YG + D W+ G  +
Sbjct: 153 LDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQP--YGKSVDWWAYGVLL 210
Query: 169 LEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR-----PT 223
            EML  +PP+   E    LF+       S P SLS++A       +  +P  R       
Sbjct: 211 YEMLAGQPPFDG-EDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPAKRLGCGPEG 269
Query: 224 VTELMEHPFVKR 235
             ++ EH F +R
Sbjct: 270 ERDVREHAFFRR 281

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  100 bits (248), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 91/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 112 KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 228
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 229 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 91/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 91/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 104 KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 163
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 164 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 220
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 221 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 273

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 91/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK         C GTP ++AP ++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPAIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 113/207 (54%), Gaps = 15/207 (7%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH---LSDSQVSSYTRQILNGLVYLHER 97
           IVQ  GT      ++I +EL+  G+ A   +K     + +  +   T  I+  L YL E+
Sbjct: 86  IVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 98  N-VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKS-CKGTPFWMAPEVVN----SK 151
           + V+HRD+K +NIL+D  G +KL DFG++     +  K    G   +MAPE ++    +K
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLE-GVQALFRIGKGELPSVPSSL--SRDARD 208
            D Y + AD+WSLG +++E+ T + PY + +   + L ++ + E P +P  +  S D + 
Sbjct: 204 PD-YDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQS 262
Query: 209 FILKCLQVNPNDRPTVTELMEHPFVKR 235
           F+  CL  +   RP   +L+EH F+KR
Sbjct: 263 FVKDCLTKDHRKRPKYNKLLEHSFIKR 289

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 106/204 (51%), Gaps = 4/204 (1%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYL 94
           F   +I++           ++ +E V+ G L +   K+  + + +     +QIL+ + Y 
Sbjct: 68  FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYC 127
Query: 95  HERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKND 153
           H   VVHRD+K  N+L+DA  + K+ADFGL+   +  + L+   G+P + APEV++ +  
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLY 187
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKC 213
             G   DIWS G  +  +L    P+   E V  LF+  +G +  +P  L+R     ++  
Sbjct: 188 A-GPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLNRSVATLLMHM 245
Query: 214 LQVNPNDRPTVTELMEHPFVKRPL 237
           LQV+P  R T+ ++ EH + K+ L
Sbjct: 246 LQVDPLKRATIKDIREHEWFKQDL 269

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 91/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK           GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTW-XLXGTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 99.4 bits (246), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 56/174 (32%), Positives = 91/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E    G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+++D  G +++ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLMIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 99.4 bits (246), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 111/217 (51%), Gaps = 13/217 (5%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYL 94
            +  NIV+   +  +E   Y+  +LVT G L  ++  + + S++  S   +QIL  +++ 
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 95  HERNVVHRDIKCANILVDAS---GSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVN 149
           H+  VVHR++K  N+L+ +     +VKLADFGLA              GTP +++PEV+ 
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL- 185
Query: 150 SKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPS----SLSRD 205
            + D YG   D+W+ G  +  +L   PP+   E    L++  K      PS    +++ +
Sbjct: 186 -RKDPYGKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTPE 243
Query: 206 ARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPRC 242
           A+D I K L +NP+ R T  E ++HP++        C
Sbjct: 244 AKDLINKMLTINPSKRITAAEALKHPWISHRSTVASC 280

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 91/174 (52%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+L+D  G +++ DFG AK           GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTW-XLAGTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/189 (32%), Positives = 104/189 (55%), Gaps = 11/189 (5%)
Query: 52  NRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +RL   +E    G L  +L ++   ++ +   Y  +I++ L YLH R+VV+RDIK  N++
Sbjct: 81  DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 140
Query: 111 VDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           +D  G +K+ DFGL K    +   +K+  GTP ++APEV+  +++ YG   D W LG  +
Sbjct: 141 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL--EDNDYGRAVDWWGLGVVM 198
Query: 169 LEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR----PT- 223
            EM+  R P+ + +  + LF +   E    P +LS +A+  +   L+ +P  R    P+ 
Sbjct: 199 YEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 257
Query: 224 VTELMEHPF 232
             E+MEH F
Sbjct: 258 AKEVMEHRF 266

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/189 (32%), Positives = 104/189 (55%), Gaps = 11/189 (5%)
Query: 52  NRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +RL   +E    G L  +L ++   ++ +   Y  +I++ L YLH R+VV+RDIK  N++
Sbjct: 78  DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137
Query: 111 VDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           +D  G +K+ DFGL K    +   +K+  GTP ++APEV+  +++ YG   D W LG  +
Sbjct: 138 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL--EDNDYGRAVDWWGLGVVM 195
Query: 169 LEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR----PT- 223
            EM+  R P+ + +  + LF +   E    P +LS +A+  +   L+ +P  R    P+ 
Sbjct: 196 YEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 254
Query: 224 VTELMEHPF 232
             E+MEH F
Sbjct: 255 AKEVMEHRF 263

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 56/174 (32%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E    G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+++D  G +K+ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 171 NLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 227
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/189 (32%), Positives = 104/189 (55%), Gaps = 11/189 (5%)
Query: 52  NRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +RL   +E    G L  +L ++   ++ +   Y  +I++ L YLH R+VV+RDIK  N++
Sbjct: 78  DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137
Query: 111 VDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           +D  G +K+ DFGL K    +   +K+  GTP ++APEV+  +++ YG   D W LG  +
Sbjct: 138 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL--EDNDYGRAVDWWGLGVVM 195
Query: 169 LEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR----PT- 223
            EM+  R P+ + +  + LF +   E    P +LS +A+  +   L+ +P  R    P+ 
Sbjct: 196 YEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 254
Query: 224 VTELMEHPF 232
             E+MEH F
Sbjct: 255 AKEVMEHRF 263

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/198 (35%), Positives = 110/198 (55%), Gaps = 19/198 (9%)
Query: 51  ENRLYIFL--ELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           EN+  + L  ELV  G L + L +K  L++ + + + +QILNG+ YLH   + H D+K  
Sbjct: 84  ENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 108 NI-LVDAS---GSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIW 162
           NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN   +  GL AD+W
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY--EPLGLEADMW 201
Query: 163 SLGCTVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQV 216
           S+G     +L+   P+        L  V A+    + E  S  S+L   A+DFI + L  
Sbjct: 202 SIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL---AKDFIRRLLVK 258
Query: 217 NPNDRPTVTELMEHPFVK 234
           +P  R T+ + ++HP++K
Sbjct: 259 DPKKRMTIQDSLQHPWIK 276

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 108/212 (50%), Gaps = 11/212 (5%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NI++     +D+   Y+ +E    G L + +  +   ++   +   +Q+L+G+ YLH+ N
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 99  VVHRDIKCANILVDASGS---VKLADFGLAKA-TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
           +VHRD+K  N+L+++      +K+ DFGL+        +K   GT +++APEV+  K   
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK--- 213
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP-SVPS--SLSRDARDFIL 211
           Y    D+WS+G  +  +L   PP+      + L ++ KG+     P   ++S  A+D I 
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIK 273
Query: 212 KCLQVNPNDRPTVTELMEHPFVKRPLQTPRCG 243
           + LQ +   R +  + +EHP++K        G
Sbjct: 274 QMLQFDSQRRISAQQALEHPWIKEMCSKKESG 305

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 56/174 (32%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 49  KDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           KD + LY+ +E    G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 112 KDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           N+++D  G +K+ DFG AK         C GTP ++APE++ SK  GY    D W+LG  
Sbjct: 172 NLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GTPEYLAPEIILSK--GYNKAVDWWALGVL 228
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EM    PP+   + +Q   +I  G++   PS  S D +D +   LQV+   R
Sbjct: 229 IYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 61/189 (32%), Positives = 101/189 (53%), Gaps = 11/189 (5%)
Query: 52  NRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +RL   +E    G L  +L ++   ++ +   Y  +I++ L YLH R+VV+RDIK  N++
Sbjct: 78  DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137
Query: 111 VDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           +D  G +K+ DFGL K    +   +K   GTP ++APEV+  +++ YG   D W LG  +
Sbjct: 138 LDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL--EDNDYGRAVDWWGLGVVM 195
Query: 169 LEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR-----PT 223
            EM+  R P+ + +  + LF +   E    P +LS +A+  +   L+ +P  R       
Sbjct: 196 YEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 254
Query: 224 VTELMEHPF 232
             E+MEH F
Sbjct: 255 AKEVMEHRF 263

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXK-Y 187
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 247
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 248 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 295

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXK-Y 180
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 61/189 (32%), Positives = 101/189 (53%), Gaps = 11/189 (5%)
Query: 52  NRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +RL   +E    G L  +L ++   ++ +   Y  +I++ L YLH R+VV+RDIK  N++
Sbjct: 83  DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 142
Query: 111 VDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           +D  G +K+ DFGL K    +   +K   GTP ++APEV+  +++ YG   D W LG  +
Sbjct: 143 LDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL--EDNDYGRAVDWWGLGVVM 200
Query: 169 LEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR-----PT 223
            EM+  R P+ + +  + LF +   E    P +LS +A+  +   L+ +P  R       
Sbjct: 201 YEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 259
Query: 224 VTELMEHPF 232
             E+MEH F
Sbjct: 260 AKEVMEHRF 268

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVY 93
           F+  +IV+ +G    EN ++I +EL T G L +  Q  K+ L  + +  Y  Q+   L Y
Sbjct: 68  FDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 126
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGT-PF-WMAPEVV 148
           L  +  VHRDI   N+LV A+  VKL DFGL++   M D    K+ KG  P  WMAPE +
Sbjct: 127 LESKRFVHRDIAARNVLVSATDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESI 184
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDAR 207
           N +   +   +D+W  G  + E+L     P+  ++    + RI  GE   +P +      
Sbjct: 185 NFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 242
Query: 208 DFILKCLQVNPNDRPTVTEL 227
             + KC   +P+ RP  TEL
Sbjct: 243 SLMTKCWAYDPSRRPRFTEL 262

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/189 (32%), Positives = 103/189 (54%), Gaps = 11/189 (5%)
Query: 52  NRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +RL   +E    G L  +L ++   ++ +   Y  +I++ L YLH R+VV+RDIK  N++
Sbjct: 78  DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137
Query: 111 VDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           +D  G +K+ DFGL K    +   +K   GTP ++APEV+  +++ YG   D W LG  +
Sbjct: 138 LDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL--EDNDYGRAVDWWGLGVVM 195
Query: 169 LEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR----PT- 223
            EM+  R P+ + +  + LF +   E    P +LS +A+  +   L+ +P  R    P+ 
Sbjct: 196 YEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 254
Query: 224 VTELMEHPF 232
             E+MEH F
Sbjct: 255 AKEVMEHRF 263

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/189 (32%), Positives = 103/189 (54%), Gaps = 11/189 (5%)
Query: 52  NRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +RL   +E    G L  +L ++   ++ +   Y  +I++ L YLH R+VV+RDIK  N++
Sbjct: 78  DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137
Query: 111 VDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           +D  G +K+ DFGL K    +   +K   GTP ++APEV+  +++ YG   D W LG  +
Sbjct: 138 LDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL--EDNDYGRAVDWWGLGVVM 195
Query: 169 LEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR----PT- 223
            EM+  R P+ + +  + LF +   E    P +LS +A+  +   L+ +P  R    P+ 
Sbjct: 196 YEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 254
Query: 224 VTELMEHPF 232
             E+MEH F
Sbjct: 255 AKEVMEHRF 263

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 113/204 (55%), Gaps = 11/204 (5%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NI+      +++  + + LELV+ G L + L +K  L++ + + + +QIL+G+ YLH + 
Sbjct: 69  NIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR 128
Query: 99  VVHRDIKCANI-LVDA---SGSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVVNSKND 153
           + H D+K  NI L+D    +  +KL DFG+A K    N+ K+  GTP ++APE+VN   +
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY--E 186
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPY---SHLEGVQALFRIGKGELPSVPSSLSRDARDFI 210
             GL AD+WS+G     +L+   P+   +  E +  +  +         S+ S  A+DFI
Sbjct: 187 PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFI 246
Query: 211 LKCLQVNPNDRPTVTELMEHPFVK 234
            + L  +P  R T+ + +EH ++K
Sbjct: 247 RRLLVKDPKRRMTIAQSLEHSWIK 270

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 101/228 (44%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E ++   L +      L+      + SY  Q+L GL + H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 182
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 242
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 107/194 (55%), Gaps = 10/194 (5%)
Query: 49  KDENRLYIFLELVTKGSLAN--LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKC 106
           +D+  + + LE ++ G L +    + Y +S+++V +Y RQ   GL ++HE ++VH DIK 
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKP 177
Query: 107 ANILVDA--SGSVKLADFGLAKATTMNDL-KSCKGTPFWMAPEVVNSKNDGYGLTADIWS 163
            NI+ +   + SVK+ DFGLA     +++ K    T  + APE+V+   +  G   D+W+
Sbjct: 178 ENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD--REPVGFYTDMWA 235
Query: 164 LGCTVLEMLTRRPPYS---HLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPND 220
           +G     +L+   P++    LE +Q + R          SS+S +A+DFI   LQ  P  
Sbjct: 236 IGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRK 295
Query: 221 RPTVTELMEHPFVK 234
           R TV + +EHP++K
Sbjct: 296 RLTVHDALEHPWLK 309

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 99/230 (43%), Gaps = 34/230 (14%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV-SSYTRQILNGLVYLHE 96
            +N+V  L   K + R Y+  E V    L +L    +  D QV   Y  QI+NG+ + H 
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS 142
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDLKSCKGTPFWMAPEVVNSKNDG 154
            N++HRDIK  NILV  SG VKL DFG A+  A           T ++ APE++   +  
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVG-DVK 201
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI---------------------GKG 193
           YG   D+W++GC V EM    P +     +  L+ I                        
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261
Query: 194 ELPSVPS---------SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
            LP +            LS    D   KCL ++P+ RP   EL+ H F +
Sbjct: 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVY 93
           F+  +IV+ +G    EN ++I +EL T G L +  Q  KY L  + +  Y  Q+   L Y
Sbjct: 70  FDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 128
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGT-PF-WMAPEVV 148
           L  +  VHRDI   N+LV ++  VKL DFGL++   M D    K+ KG  P  WMAPE +
Sbjct: 129 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESI 186
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDAR 207
           N +   +   +D+W  G  + E+L     P+  ++    + RI  GE   +P +      
Sbjct: 187 NFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 244
Query: 208 DFILKCLQVNPNDRPTVTEL 227
             + KC   +P+ RP  TEL
Sbjct: 245 SLMTKCWAYDPSRRPRFTEL 264

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 101/228 (44%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E ++   L +      L+      + SY  Q+L GL + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 183
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVY 93
           F+  +IV+ +G    EN ++I +EL T G L +  Q  KY L  + +  Y  Q+   L Y
Sbjct: 68  FDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 126
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGT-PF-WMAPEVV 148
           L  +  VHRDI   N+LV ++  VKL DFGL++   M D    K+ KG  P  WMAPE +
Sbjct: 127 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESI 184
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDAR 207
           N +   +   +D+W  G  + E+L     P+  ++    + RI  GE   +P +      
Sbjct: 185 NFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 242
Query: 208 DFILKCLQVNPNDRPTVTEL 227
             + KC   +P+ RP  TEL
Sbjct: 243 SLMTKCWAYDPSRRPRFTEL 262

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVY 93
           F+  +IV+ +G    EN ++I +EL T G L +  Q  KY L  + +  Y  Q+   L Y
Sbjct: 96  FDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 154
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGT-PF-WMAPEVV 148
           L  +  VHRDI   N+LV ++  VKL DFGL++   M D    K+ KG  P  WMAPE +
Sbjct: 155 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESI 212
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDAR 207
           N +   +   +D+W  G  + E+L     P+  ++    + RI  GE   +P +      
Sbjct: 213 NFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 270
Query: 208 DFILKCLQVNPNDRPTVTEL 227
             + KC   +P+ RP  TEL
Sbjct: 271 SLMTKCWAYDPSRRPRFTEL 290

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 98.2 bits (243), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 101/228 (44%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L +      L+      + SY  Q+L GL + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 122 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 180
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 98.2 bits (243), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVY 93
           F+  +IV+ +G    EN ++I +EL T G L +  Q  KY L  + +  Y  Q+   L Y
Sbjct: 68  FDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 126
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGT-PF-WMAPEVV 148
           L  +  VHRDI   N+LV ++  VKL DFGL++   M D    K+ KG  P  WMAPE +
Sbjct: 127 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESI 184
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDAR 207
           N +   +   +D+W  G  + E+L     P+  ++    + RI  GE   +P +      
Sbjct: 185 NFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 242
Query: 208 DFILKCLQVNPNDRPTVTEL 227
             + KC   +P+ RP  TEL
Sbjct: 243 SLMTKCWAYDPSRRPRFTEL 262

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 98.2 bits (243), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVY 93
           F+  +IV+ +G    EN ++I +EL T G L +  Q  KY L  + +  Y  Q+   L Y
Sbjct: 71  FDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 129
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGT-PF-WMAPEVV 148
           L  +  VHRDI   N+LV ++  VKL DFGL++   M D    K+ KG  P  WMAPE +
Sbjct: 130 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESI 187
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTRR-PPYSHLEGVQALFRIGKGELPSVPSSLSRDAR 207
           N +   +   +D+W  G  + E+L     P+  ++    + RI  GE   +P +      
Sbjct: 188 NFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 245
Query: 208 DFILKCLQVNPNDRPTVTEL 227
             + KC   +P+ RP  TEL
Sbjct: 246 SLMTKCWAYDPSRRPRFTEL 265

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 98.2 bits (243), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVY 93
           F+  +IV+ +G    EN ++I +EL T G L +  Q  KY L  + +  Y  Q+   L Y
Sbjct: 73  FDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 131
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGT-PF-WMAPEVV 148
           L  +  VHRDI   N+LV ++  VKL DFGL++   M D    K+ KG  P  WMAPE +
Sbjct: 132 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESI 189
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTRR-PPYSHLEGVQALFRIGKGELPSVPSSLSRDAR 207
           N +   +   +D+W  G  + E+L     P+  ++    + RI  GE   +P +      
Sbjct: 190 NFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 247
Query: 208 DFILKCLQVNPNDRPTVTEL 227
             + KC   +P+ RP  TEL
Sbjct: 248 SLMTKCWAYDPSRRPRFTEL 267

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 98.2 bits (243), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVY 93
           F+  +IV+ +G    EN ++I +EL T G L +  Q  K+ L  + +  Y  Q+   L Y
Sbjct: 448 FDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGT-PF-WMAPEVV 148
           L  +  VHRDI   N+LV A+  VKL DFGL++   M D    K+ KG  P  WMAPE +
Sbjct: 507 LESKRFVHRDIAARNVLVSATDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESI 564
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDAR 207
           N +   +   +D+W  G  + E+L     P+  ++    + RI  GE   +P +      
Sbjct: 565 NFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 622
Query: 208 DFILKCLQVNPNDRPTVTEL 227
             + KC   +P+ RP  TEL
Sbjct: 623 SLMTKCWAYDPSRRPRFTEL 642

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 98.2 bits (243), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 59/174 (33%), Positives = 96/174 (55%), Gaps = 6/174 (3%)
Query: 51  ENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           E +LY+ L+ +  G L   L ++   ++  V  Y  ++  GL +LH   +++RD+K  NI
Sbjct: 102 EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENI 161
Query: 110 LVDASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           L+D  G +KL DFGL+K    ++ K+    GT  +MAPEVVN +  G+  +AD WS G  
Sbjct: 162 LLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQ--GHSHSADWWSYGVL 219
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
           + EMLT   P+   +  + +  I K +L  +P  LS +A+  +    + NP +R
Sbjct: 220 MFEMLTGSLPFQGKDRKETMTLILKAKL-GMPQFLSTEAQSLLRALFKRNPANR 272

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 98.2 bits (243), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVY 93
           F+  +IV+ +G    EN ++I +EL T G L +  Q  KY L  + +  Y  Q+   L Y
Sbjct: 65  FDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGT-PF-WMAPEVV 148
           L  +  VHRDI   N+LV ++  VKL DFGL++   M D    K+ KG  P  WMAPE +
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESI 181
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDAR 207
           N +   +   +D+W  G  + E+L     P+  ++    + RI  GE   +P +      
Sbjct: 182 NFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 239
Query: 208 DFILKCLQVNPNDRPTVTEL 227
             + KC   +P+ RP  TEL
Sbjct: 240 SLMTKCWAYDPSRRPRFTEL 259

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 98.2 bits (243), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E ++   L        L+      + SY  Q+L GL + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 181
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 98.2 bits (243), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E ++   L        L+      + SY  Q+L GL + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 125 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 183
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 98.2 bits (243), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 107/200 (53%), Gaps = 19/200 (9%)
Query: 48  DKDENR--LYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDI 104
           D  ENR  + + LELV+ G L + L QK  LS+ + +S+ +QIL+G+ YLH + + H D+
Sbjct: 82  DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDL 141
Query: 105 KCANI-LVDAS---GSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYGLTA 159
           K  NI L+D +     +KL DFGLA       + K+  GTP ++APE+VN   +  GL A
Sbjct: 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY--EPLGLEA 199
Query: 160 DIWSLGCTVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVPSSLSRDARDFILKC 213
           D+WS+G     +L+   P+        L  + A+      E  S  S L   A+DFI K 
Sbjct: 200 DMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL---AKDFIRKL 256
Query: 214 LQVNPNDRPTVTELMEHPFV 233
           L      R T+ E + HP++
Sbjct: 257 LVKETRKRLTIQEALRHPWI 276

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 97.8 bits (242), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 107/200 (53%), Gaps = 19/200 (9%)
Query: 48  DKDENR--LYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDI 104
           D  ENR  + + LELV+ G L + L QK  LS+ + +S+ +QIL+G+ YLH + + H D+
Sbjct: 82  DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDL 141
Query: 105 KCANI-LVDAS---GSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYGLTA 159
           K  NI L+D +     +KL DFGLA       + K+  GTP ++APE+VN   +  GL A
Sbjct: 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY--EPLGLEA 199
Query: 160 DIWSLGCTVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVPSSLSRDARDFILKC 213
           D+WS+G     +L+   P+        L  + A+      E  S  S L   A+DFI K 
Sbjct: 200 DMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL---AKDFIRKL 256
Query: 214 LQVNPNDRPTVTELMEHPFV 233
           L      R T+ E + HP++
Sbjct: 257 LVKETRKRLTIQEALRHPWI 276

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 97.8 bits (242), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 180
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 179
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 181
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 179
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 180
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 105/194 (54%), Gaps = 13/194 (6%)
Query: 51  ENR--LYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           ENR  + + LELV+ G L + L QK  LS+ + +S+ +QIL+G+ YLH + + H D+K  
Sbjct: 85  ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPE 144
Query: 108 NI-LVDAS---GSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYGLTADIW 162
           NI L+D +     +KL DFGLA       + K+  GTP ++APE+VN   +  GL AD+W
Sbjct: 145 NIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY--EPLGLEADMW 202
Query: 163 SLGCTVLEMLTRRPPY---SHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPN 219
           S+G     +L+   P+   +  E +  +  +         S  S  A+DFI K L     
Sbjct: 203 SIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETR 262
Query: 220 DRPTVTELMEHPFV 233
            R T+ E + HP++
Sbjct: 263 KRLTIQEALRHPWI 276

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 184
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 185 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 244
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 245 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 292

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 180
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 179
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 183
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 124 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 182
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 242
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 183
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 180
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 180
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 180
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 179
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 181
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 179
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 181
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 182
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 242
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 112/209 (53%), Gaps = 15/209 (7%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYL 94
            +  NIV+   +  +E   Y+  +LVT G L  ++  + + S++  S   +QIL  +++ 
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 119
Query: 95  HERNVVHRDIKCANILVDAS---GSVKLADFGLAKATTMNDLKSC---KGTPFWMAPEVV 148
           H+  VVHRD+K  N+L+ +     +VKLADFGLA      D ++     GTP +++PEV+
Sbjct: 120 HQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPS----SLSR 204
             + + YG   DIW+ G  +  +L   PP+   E    L++  K      PS    +++ 
Sbjct: 179 --RKEAYGKPVDIWACGVILYILLVGYPPFWD-EDQHKLYQQIKAGAYDFPSPEWDTVTP 235
Query: 205 DARDFILKCLQVNPNDRPTVTELMEHPFV 233
           +A++ I + L +NP  R T  E ++HP+V
Sbjct: 236 EAKNLINQMLTINPAKRITAHEALKHPWV 264

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 181
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 180
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E V +  L        L+      + SY  Q+L GL + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 179
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 183
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 182
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 242
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 187
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 247
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 248 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 295

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 184
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 185 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 244
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 245 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 292

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E V +  L        L+      + SY  Q+L GL + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 183
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 97.4 bits (241), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 101/190 (53%), Gaps = 11/190 (5%)
Query: 51  ENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           E +LY+ L+ +  G L   L ++   ++  V  Y  ++   L +LH   +++RD+K  NI
Sbjct: 98  EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENI 157
Query: 110 LVDASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           L+D  G +KL DFGL+K +  ++ K+    GT  +MAPEVVN +  G+  +AD WS G  
Sbjct: 158 LLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVL 215
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR-----P 222
           + EMLT   P+   +  + +  I K +L  +P  LS +A+  +    + NP +R      
Sbjct: 216 MFEMLTGTLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQSLLRMLFKRNPANRLGAGPD 274
Query: 223 TVTELMEHPF 232
            V E+  H F
Sbjct: 275 GVEEIKRHSF 284

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 97.4 bits (241), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 106/197 (53%), Gaps = 19/197 (9%)
Query: 51  ENR--LYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           ENR  + + LELV+ G L + L QK  LS+ + +S+ +QIL+G+ YLH + + H D+K  
Sbjct: 85  ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPE 144
Query: 108 NI-LVDAS---GSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYGLTADIW 162
           NI L+D +     +KL DFGLA       + K+  GTP ++APE+VN   +  GL AD+W
Sbjct: 145 NIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY--EPLGLEADMW 202
Query: 163 SLGCTVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQV 216
           S+G     +L+   P+        L  + A+      E  S  S L   A+DFI K L  
Sbjct: 203 SIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL---AKDFIRKLLVK 259
Query: 217 NPNDRPTVTELMEHPFV 233
               R T+ E + HP++
Sbjct: 260 ETRKRLTIQEALRHPWI 276

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 97.4 bits (241), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 101/190 (53%), Gaps = 11/190 (5%)
Query: 51  ENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           E +LY+ L+ +  G L   L ++   ++  V  Y  ++   L +LH   +++RD+K  NI
Sbjct: 98  EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENI 157
Query: 110 LVDASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           L+D  G +KL DFGL+K +  ++ K+    GT  +MAPEVVN +  G+  +AD WS G  
Sbjct: 158 LLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVL 215
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR-----P 222
           + EMLT   P+   +  + +  I K +L  +P  LS +A+  +    + NP +R      
Sbjct: 216 MFEMLTGTLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQSLLRMLFKRNPANRLGAGPD 274
Query: 223 TVTELMEHPF 232
            V E+  H F
Sbjct: 275 GVEEIKRHSF 284

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 97.4 bits (241), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 69/197 (35%), Positives = 106/197 (53%), Gaps = 13/197 (6%)
Query: 48  DKDENR--LYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDI 104
           D  ENR  + + LELV+ G L + L QK  LS+ + +S+ +QIL+G+ YLH + + H D+
Sbjct: 82  DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDL 141
Query: 105 KCANI-LVDAS---GSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYGLTA 159
           K  NI L+D +     +KL DFGLA       + K+  GTP ++APE+VN   +  GL A
Sbjct: 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY--EPLGLEA 199
Query: 160 DIWSLGCTVLEMLTRRPPY---SHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQV 216
           D+WS+G     +L+   P+   +  E +  +  +         S  S  A+DFI K L  
Sbjct: 200 DMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVK 259
Query: 217 NPNDRPTVTELMEHPFV 233
               R T+ E + HP++
Sbjct: 260 ETRKRLTIQEALRHPWI 276

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 97.4 bits (241), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 111/218 (50%), Gaps = 39/218 (17%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +YI  +L+ +  L  L +   LS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ 
Sbjct: 121 VYIVQDLM-ETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINT 179
Query: 114 SGSVKLADFGLAK-ATTMND----LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCT 167
           +  +K+ DFGLA+ A   +D    L     T ++ APE+ +NSK  GY  + DIWS+GC 
Sbjct: 180 TCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSK--GYTKSIDIWSVGCI 237
Query: 168 VLEMLTRRPPY---------SHLEGVQA----------LFRIGKGELPSVPSSLS----- 203
           + EML+ RP +         +H+ G+            +    +  L S+PS        
Sbjct: 238 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAK 297
Query: 204 ------RDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
                   A D + + L  NPN R TV E + HP++++
Sbjct: 298 LFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQ 335

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 97.4 bits (241), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 101/190 (53%), Gaps = 11/190 (5%)
Query: 51  ENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           E +LY+ L+ +  G L   L ++   ++  V  Y  ++   L +LH   +++RD+K  NI
Sbjct: 99  EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENI 158
Query: 110 LVDASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           L+D  G +KL DFGL+K +  ++ K+    GT  +MAPEVVN +  G+  +AD WS G  
Sbjct: 159 LLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVL 216
Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR-----P 222
           + EMLT   P+   +  + +  I K +L  +P  LS +A+  +    + NP +R      
Sbjct: 217 MFEMLTGTLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQSLLRMLFKRNPANRLGAGPD 275
Query: 223 TVTELMEHPF 232
            V E+  H F
Sbjct: 276 GVEEIKRHSF 285

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 97.4 bits (241), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 69/197 (35%), Positives = 106/197 (53%), Gaps = 13/197 (6%)
Query: 48  DKDENR--LYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDI 104
           D  ENR  + + LELV+ G L + L QK  LS+ + +S+ +QIL+G+ YLH + + H D+
Sbjct: 82  DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDL 141
Query: 105 KCANI-LVDAS---GSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYGLTA 159
           K  NI L+D +     +KL DFGLA       + K+  GTP ++APE+VN   +  GL A
Sbjct: 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY--EPLGLEA 199
Query: 160 DIWSLGCTVLEMLTRRPPY---SHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQV 216
           D+WS+G     +L+   P+   +  E +  +  +         S  S  A+DFI K L  
Sbjct: 200 DMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVK 259
Query: 217 NPNDRPTVTELMEHPFV 233
               R T+ E + HP++
Sbjct: 260 ETRKRLTIQEALRHPWI 276

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 97.1 bits (240), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD---SQVSSYTRQILNGLVYLHE 96
           NIV+ L     EN+LY+  E + +  L        L+      + SY  Q+L GL + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++      
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 180
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------------------------ 190
           Y    DIWSLGC   EM+TRR  +     +  LFRI                        
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 191 ----GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                + +   V   L  D R  + + L  +PN R +    + HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 97.1 bits (240), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 50  DENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCAN 108
           D    YI LEL+  G L + +     L ++    Y  Q+L  + YLHE  ++HRD+K  N
Sbjct: 84  DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 143
Query: 109 ILVDASGS---VKLADFGLAKATTMNDL-KSCKGTPFWMAPEV-VNSKNDGYGLTADIWS 163
           +L+ +      +K+ DFG +K      L ++  GTP ++APEV V+    GY    D WS
Sbjct: 144 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 203
Query: 164 LGCTVLEMLTRRPPYS-HLEGVQALFRIGKGE---LPSVPSSLSRDARDFILKCLQVNPN 219
           LG  +   L+  PP+S H   V    +I  G+   +P V + +S  A D + K L V+P 
Sbjct: 204 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 263
Query: 220 DRPTVTELMEHPFVK 234
            R T  E + HP+++
Sbjct: 264 ARFTTEEALRHPWLQ 278

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 97.1 bits (240), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVY 93
           F+  +IV+ +G    EN ++I +EL T G L +  Q  K+ L  + +  Y  Q+   L Y
Sbjct: 68  FDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 126
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGT-PF-WMAPEVV 148
           L  +  VHRDI   N+LV ++  VKL DFGL++   M D    K+ KG  P  WMAPE +
Sbjct: 127 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTXXKASKGKLPIKWMAPESI 184
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDAR 207
           N +   +   +D+W  G  + E+L     P+  ++    + RI  GE   +P +      
Sbjct: 185 NFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 242
Query: 208 DFILKCLQVNPNDRPTVTEL 227
             + KC   +P+ RP  TEL
Sbjct: 243 SLMTKCWAYDPSRRPRFTEL 262

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 97.1 bits (240), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 50  DENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCAN 108
           D    YI LEL+  G L + +     L ++    Y  Q+L  + YLHE  ++HRD+K  N
Sbjct: 85  DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 144
Query: 109 ILVDASGS---VKLADFGLAKATTMNDL-KSCKGTPFWMAPEV-VNSKNDGYGLTADIWS 163
           +L+ +      +K+ DFG +K      L ++  GTP ++APEV V+    GY    D WS
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 204
Query: 164 LGCTVLEMLTRRPPYS-HLEGVQALFRIGKGE---LPSVPSSLSRDARDFILKCLQVNPN 219
           LG  +   L+  PP+S H   V    +I  G+   +P V + +S  A D + K L V+P 
Sbjct: 205 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 264
Query: 220 DRPTVTELMEHPFVK 234
            R T  E + HP+++
Sbjct: 265 ARFTTEEALRHPWLQ 279

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 97.1 bits (240), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 50  DENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCAN 108
           D    YI LEL+  G L + +     L ++    Y  Q+L  + YLHE  ++HRD+K  N
Sbjct: 85  DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 144
Query: 109 ILVDASGS---VKLADFGLAKATTMNDL-KSCKGTPFWMAPEV-VNSKNDGYGLTADIWS 163
           +L+ +      +K+ DFG +K      L ++  GTP ++APEV V+    GY    D WS
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 204
Query: 164 LGCTVLEMLTRRPPYS-HLEGVQALFRIGKGE---LPSVPSSLSRDARDFILKCLQVNPN 219
           LG  +   L+  PP+S H   V    +I  G+   +P V + +S  A D + K L V+P 
Sbjct: 205 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 264
Query: 220 DRPTVTELMEHPFVK 234
            R T  E + HP+++
Sbjct: 265 ARFTTEEALRHPWLQ 279

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 97.1 bits (240), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 93/174 (53%), Gaps = 13/174 (7%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDS---QVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +YI  E + KGSL +  +    S     ++  ++ QI  G+ ++ +RN +HRD++ ANIL
Sbjct: 251 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 310
Query: 111 VDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
           V AS   K+ADFGLA+      +K       W APE +N  +  + + +D+WS G  ++E
Sbjct: 311 VSASLVCKIADFGLARVGAKFPIK-------WTAPEAINFGS--FTIKSDVWSFGILLME 361
Query: 171 MLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           ++T  R PY  +   + +  + +G     P +   +  + +++C +  P +RPT
Sbjct: 362 IVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPT 415

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 50  DENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCAN 108
           D    YI LEL+  G L + +     L ++    Y  Q+L  + YLHE  ++HRD+K  N
Sbjct: 85  DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 144
Query: 109 ILVDASGS---VKLADFGLAKATTMNDL-KSCKGTPFWMAPEV-VNSKNDGYGLTADIWS 163
           +L+ +      +K+ DFG +K      L ++  GTP ++APEV V+    GY    D WS
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 204
Query: 164 LGCTVLEMLTRRPPYS-HLEGVQALFRIGKGE---LPSVPSSLSRDARDFILKCLQVNPN 219
           LG  +   L+  PP+S H   V    +I  G+   +P V + +S  A D + K L V+P 
Sbjct: 205 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 264
Query: 220 DRPTVTELMEHPFVK 234
            R T  E + HP+++
Sbjct: 265 ARFTTEEALRHPWLQ 279

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 50  DENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCAN 108
           D    YI LEL+  G L + +     L ++    Y  Q+L  + YLHE  ++HRD+K  N
Sbjct: 91  DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 150
Query: 109 ILVDASGS---VKLADFGLAKATTMNDL-KSCKGTPFWMAPEV-VNSKNDGYGLTADIWS 163
           +L+ +      +K+ DFG +K      L ++  GTP ++APEV V+    GY    D WS
Sbjct: 151 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 210
Query: 164 LGCTVLEMLTRRPPYS-HLEGVQALFRIGKGE---LPSVPSSLSRDARDFILKCLQVNPN 219
           LG  +   L+  PP+S H   V    +I  G+   +P V + +S  A D + K L V+P 
Sbjct: 211 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 270
Query: 220 DRPTVTELMEHPFVK 234
            R T  E + HP+++
Sbjct: 271 ARFTTEEALRHPWLQ 285

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 112/204 (54%), Gaps = 11/204 (5%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NI+      +++  + + LELV+ G L + L +K  L++ + + + +QIL+G+ YLH + 
Sbjct: 76  NIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR 135
Query: 99  VVHRDIKCANI-LVDA---SGSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVVNSKND 153
           + H D+K  NI L+D    +  +KL DFG+A K    N+ K+  GTP ++APE+VN   +
Sbjct: 136 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY--E 193
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPY---SHLEGVQALFRIGKGELPSVPSSLSRDARDFI 210
             GL AD+WS+G     +L+   P+   +  E +  +  +         S+ S  A+DFI
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFI 253
Query: 211 LKCLQVNPNDRPTVTELMEHPFVK 234
            + L  +P  R  + + +EH ++K
Sbjct: 254 RRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 50  DENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCAN 108
           D    YI LEL+  G L + +     L ++    Y  Q+L  + YLHE  ++HRD+K  N
Sbjct: 224 DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 283
Query: 109 ILVDASGS---VKLADFGLAKATTMNDL-KSCKGTPFWMAPEV-VNSKNDGYGLTADIWS 163
           +L+ +      +K+ DFG +K      L ++  GTP ++APEV V+    GY    D WS
Sbjct: 284 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 343
Query: 164 LGCTVLEMLTRRPPYS-HLEGVQALFRIGKGE---LPSVPSSLSRDARDFILKCLQVNPN 219
           LG  +   L+  PP+S H   V    +I  G+   +P V + +S  A D + K L V+P 
Sbjct: 344 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 403
Query: 220 DRPTVTELMEHPFVK 234
            R T  E + HP+++
Sbjct: 404 ARFTTEEALRHPWLQ 418

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 50  DENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCAN 108
           D    YI LEL+  G L + +     L ++    Y  Q+L  + YLHE  ++HRD+K  N
Sbjct: 210 DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 269
Query: 109 ILVDASGS---VKLADFGLAKATTMNDL-KSCKGTPFWMAPEV-VNSKNDGYGLTADIWS 163
           +L+ +      +K+ DFG +K      L ++  GTP ++APEV V+    GY    D WS
Sbjct: 270 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 329
Query: 164 LGCTVLEMLTRRPPYS-HLEGVQALFRIGKGE---LPSVPSSLSRDARDFILKCLQVNPN 219
           LG  +   L+  PP+S H   V    +I  G+   +P V + +S  A D + K L V+P 
Sbjct: 330 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 389
Query: 220 DRPTVTELMEHPFVK 234
            R T  E + HP+++
Sbjct: 390 ARFTTEEALRHPWLQ 404

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVY 93
           F+  +IV+ +G    EN ++I +EL T G L +  Q  K+ L  + +  Y  Q+   L Y
Sbjct: 448 FDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGT-PF-WMAPEVV 148
           L  +  VHRDI   N+LV ++  VKL DFGL++   M D    K+ KG  P  WMAPE +
Sbjct: 507 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESI 564
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDAR 207
           N +   +   +D+W  G  + E+L     P+  ++    + RI  GE   +P +      
Sbjct: 565 NFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 622
Query: 208 DFILKCLQVNPNDRPTVTEL 227
             + KC   +P+ RP  TEL
Sbjct: 623 SLMTKCWAYDPSRRPRFTEL 642

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +YI  E +  GSL +  +      L+ +++     QI  G+ ++ ERN +HRD++ ANIL
Sbjct: 88  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 147
Query: 111 VDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSLGCT 167
           V  + S K+ADFGLA+    N+  + +G  F   W APE +N     + + +D+WS G  
Sbjct: 148 VSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGIL 205
Query: 168 VLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           + E++T  R PY  +   + +  + +G     P +   +    +  C +  P DRPT
Sbjct: 206 LTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 262

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/220 (33%), Positives = 112/220 (50%), Gaps = 19/220 (8%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSLAN--LYQKYHLSDSQVSSYTRQILNGLVYL 94
           +  NI+       D   +Y+  EL+  G L +  L QK+  S+ + S+    I   + YL
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF-FSEREASAVLFTITKTVEYL 132
Query: 95  HERNVVHRDIKCANIL-VDASG---SVKLADFGLAKATTMND---LKSCKGTPFWMAPEV 147
           H + VVHRD+K +NIL VD SG   S+++ DFG AK     +   +  C    F +APEV
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANF-VAPEV 191
Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG---VQALFRIGKGELP---SVPSS 201
           +  +  GY    DIWSLG  +  MLT   P+++       + L RIG G+        +S
Sbjct: 192 LERQ--GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249
Query: 202 LSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPR 241
           +S  A+D + K L V+P+ R T   ++ HP++    Q P+
Sbjct: 250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQ 289

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +YI  E +  GSL +  +      L+ +++     QI  G+ ++ ERN +HRD++ ANIL
Sbjct: 92  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 151
Query: 111 VDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSLGCT 167
           V  + S K+ADFGLA+    N+  + +G  F   W APE +N     + + +D+WS G  
Sbjct: 152 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGIL 209
Query: 168 VLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           + E++T  R PY  +   + +  + +G     P +   +    +  C +  P DRPT
Sbjct: 210 LTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 266

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 112/204 (54%), Gaps = 11/204 (5%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NI+      +++  + + LELV+ G L + L +K  L++ + + + +QIL+G+ YLH + 
Sbjct: 90  NIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR 149
Query: 99  VVHRDIKCANI-LVDA---SGSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVVNSKND 153
           + H D+K  NI L+D    +  +KL DFG+A K    N+ K+  GTP ++APE+VN   +
Sbjct: 150 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY--E 207
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPY---SHLEGVQALFRIGKGELPSVPSSLSRDARDFI 210
             GL AD+WS+G     +L+   P+   +  E +  +  +         S+ S  A+DFI
Sbjct: 208 PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFI 267
Query: 211 LKCLQVNPNDRPTVTELMEHPFVK 234
            + L  +P  R  + + +EH ++K
Sbjct: 268 RRLLVKDPKRRMXIAQSLEHSWIK 291

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +YI  E +  GSL +  +      L+ +++     QI  G+ ++ ERN +HRD++ ANIL
Sbjct: 87  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 146
Query: 111 VDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSLGCT 167
           V  + S K+ADFGLA+    N+  + +G  F   W APE +N     + + +D+WS G  
Sbjct: 147 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGIL 204
Query: 168 VLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           + E++T  R PY  +   + +  + +G     P +   +    +  C +  P DRPT
Sbjct: 205 LTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 261

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +YI  E +  GSL +  +      L+ +++     QI  G+ ++ ERN +HRD++ ANIL
Sbjct: 90  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 149
Query: 111 VDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSLGCT 167
           V  + S K+ADFGLA+    N+  + +G  F   W APE +N     + + +D+WS G  
Sbjct: 150 VSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGIL 207
Query: 168 VLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           + E++T  R PY  +   + +  + +G     P +   +    +  C +  P DRPT
Sbjct: 208 LTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 264

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +YI  E +  GSL +  +      L+ +++     QI  G+ ++ ERN +HRD++ ANIL
Sbjct: 91  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 150
Query: 111 VDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSLGCT 167
           V  + S K+ADFGLA+    N+  + +G  F   W APE +N     + + +D+WS G  
Sbjct: 151 VSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGIL 208
Query: 168 VLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           + E++T  R PY  +   + +  + +G     P +   +    +  C +  P DRPT
Sbjct: 209 LTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 265

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +YI  E +  GSL +  +      L+ +++     QI  G+ ++ ERN +HRD++ ANIL
Sbjct: 88  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 147
Query: 111 VDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSLGCT 167
           V  + S K+ADFGLA+    N+  + +G  F   W APE +N     + + +D+WS G  
Sbjct: 148 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGIL 205
Query: 168 VLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           + E++T  R PY  +   + +  + +G     P +   +    +  C +  P DRPT
Sbjct: 206 LTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 262

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +YI  E +  GSL +  +      L+ +++     QI  G+ ++ ERN +HRD++ ANIL
Sbjct: 77  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 136
Query: 111 VDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSLGCT 167
           V  + S K+ADFGLA+    N+  + +G  F   W APE +N     + + +D+WS G  
Sbjct: 137 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGIL 194
Query: 168 VLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           + E++T  R PY  +   + +  + +G     P +   +    +  C +  P DRPT
Sbjct: 195 LTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 251

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +YI  E +  GSL +  +      L+ +++     QI  G+ ++ ERN +HRD++ ANIL
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141
Query: 111 VDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSLGCT 167
           V  + S K+ADFGLA+    N+  + +G  F   W APE +N     + + +D+WS G  
Sbjct: 142 VSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGIL 199
Query: 168 VLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           + E++T  R PY  +   + +  + +G     P +   +    +  C +  P DRPT
Sbjct: 200 LTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 256

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +YI  E +  GSL +  +      L+ +++     QI  G+ ++ ERN +HRD++ ANIL
Sbjct: 83  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 142
Query: 111 VDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSLGCT 167
           V  + S K+ADFGLA+    N+  + +G  F   W APE +N     + + +D+WS G  
Sbjct: 143 VSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGIL 200
Query: 168 VLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           + E++T  R PY  +   + +  + +G     P +   +    +  C +  P DRPT
Sbjct: 201 LTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 257

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +YI  E +  GSL +  +      L+ +++     QI  G+ ++ ERN +HRD++ ANIL
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141
Query: 111 VDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSLGCT 167
           V  + S K+ADFGLA+    N+  + +G  F   W APE +N     + + +D+WS G  
Sbjct: 142 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGIL 199
Query: 168 VLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           + E++T  R PY  +   + +  + +G     P +   +    +  C +  P DRPT
Sbjct: 200 LTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 256

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           L I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HRD+K  N+L
Sbjct: 104 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 163
Query: 111 VDA---SGSVKLADFGLAKATT-MNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
             +   +  +KL DFG AK TT  N L +   TP+++APEV+    + Y  + D+WSLG 
Sbjct: 164 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGV 221
Query: 167 TVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVP-SSLSRDARDFILKCLQVNPN 219
            +  +L   PP+      +   G++   R+G+ E P+   S +S + +  I   L+  P 
Sbjct: 222 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 281
Query: 220 DRPTVTELMEHPFVKRPLQTPR 241
            R T+TE M HP++ +  + P+
Sbjct: 282 QRMTITEFMNHPWIMQSTKVPQ 303

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +YI  E +  GSL +  +      L+ +++     QI  G+ ++ ERN +HRD++ ANIL
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141
Query: 111 VDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSLGCT 167
           V  + S K+ADFGLA+    N+  + +G  F   W APE +N     + + +D+WS G  
Sbjct: 142 VSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGIL 199
Query: 168 VLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           + E++T  R PY  +   + +  + +G     P +   +    +  C +  P DRPT
Sbjct: 200 LTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 256

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 111/209 (53%), Gaps = 15/209 (7%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYL 94
            +  NIV+   +  +E   Y+  +LVT G L  ++  + + S++  S   +QIL  + + 
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 95  HERNVVHRDIKCANILVDAS---GSVKLADFGLAKATTMNDLKSC---KGTPFWMAPEVV 148
           H   +VHRD+K  N+L+ +     +VKLADFGLA      D ++     GTP +++PEV+
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPS----SLSR 204
             + D YG   D+W+ G  +  +L   PP+   E    L++  K      PS    +++ 
Sbjct: 179 --RKDPYGKPVDMWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTP 235
Query: 205 DARDFILKCLQVNPNDRPTVTELMEHPFV 233
           +A+D I K L +NP  R T +E ++HP++
Sbjct: 236 EAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           L I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HRD+K  N+L
Sbjct: 96  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 155
Query: 111 VDA---SGSVKLADFGLAKATT-MNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
             +   +  +KL DFG AK TT  N L +   TP+++APEV+    + Y  + D+WSLG 
Sbjct: 156 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGV 213
Query: 167 TVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVP-SSLSRDARDFILKCLQVNPN 219
            +  +L   PP+      +   G++   R+G+ E P+   S +S + +  I   L+  P 
Sbjct: 214 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 273
Query: 220 DRPTVTELMEHPFVKRPLQTPR 241
            R T+TE M HP++ +  + P+
Sbjct: 274 QRMTITEFMNHPWIMQSTKVPQ 295

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           L I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HRD+K  N+L
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 111 VDA---SGSVKLADFGLAKATT-MNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
             +   +  +KL DFG AK TT  N L +   TP+++APEV+    + Y  + D+WSLG 
Sbjct: 150 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGV 207
Query: 167 TVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVP-SSLSRDARDFILKCLQVNPN 219
            +  +L   PP+      +   G++   R+G+ E P+   S +S + +  I   L+  P 
Sbjct: 208 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 267
Query: 220 DRPTVTELMEHPFVKRPLQTPR 241
            R T+TE M HP++ +  + P+
Sbjct: 268 QRMTITEFMNHPWIMQSTKVPQ 289

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +YI  E +  GSL +  +      L+ +++     QI  G+ ++ ERN +HRD++ ANIL
Sbjct: 84  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 143
Query: 111 VDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSLGCT 167
           V  + S K+ADFGLA+    N+  + +G  F   W APE +N     + + +D+WS G  
Sbjct: 144 VSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGIL 201
Query: 168 VLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           + E++T  R PY  +   + +  + +G     P +   +    +  C +  P DRPT
Sbjct: 202 LTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 258

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           L I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HRD+K  N+L
Sbjct: 95  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 154
Query: 111 VDA---SGSVKLADFGLAKATT-MNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
             +   +  +KL DFG AK TT  N L +   TP+++APEV+    + Y  + D+WSLG 
Sbjct: 155 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGV 212
Query: 167 TVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVP-SSLSRDARDFILKCLQVNPN 219
            +  +L   PP+      +   G++   R+G+ E P+   S +S + +  I   L+  P 
Sbjct: 213 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 272
Query: 220 DRPTVTELMEHPFVKRPLQTPR 241
            R T+TE M HP++ +  + P+
Sbjct: 273 QRMTITEFMNHPWIMQSTKVPQ 294

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 111/209 (53%), Gaps = 15/209 (7%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYL 94
            +  NIV+   +  +E   Y+  +LVT G L  ++  + + S++  S   +QIL  + + 
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 95  HERNVVHRDIKCANILVDAS---GSVKLADFGLAKATTMNDLKSC---KGTPFWMAPEVV 148
           H   +VHRD+K  N+L+ +     +VKLADFGLA      D ++     GTP +++PEV+
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPS----SLSR 204
             + D YG   D+W+ G  +  +L   PP+   E    L++  K      PS    +++ 
Sbjct: 179 --RKDPYGKPVDMWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTP 235
Query: 205 DARDFILKCLQVNPNDRPTVTELMEHPFV 233
           +A+D I K L +NP  R T +E ++HP++
Sbjct: 236 EAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           L I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HRD+K  N+L
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 147
Query: 111 VDA---SGSVKLADFGLAKATT-MNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
             +   +  +KL DFG AK TT  N L +   TP+++APEV+    + Y  + D+WSLG 
Sbjct: 148 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGV 205
Query: 167 TVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVP-SSLSRDARDFILKCLQVNPN 219
            +  +L   PP+      +   G++   R+G+ E P+   S +S + +  I   L+  P 
Sbjct: 206 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 265
Query: 220 DRPTVTELMEHPFVKRPLQTPR 241
            R T+TE M HP++ +  + P+
Sbjct: 266 QRMTITEFMNHPWIMQSTKVPQ 287

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           L I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HRD+K  N+L
Sbjct: 94  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 153
Query: 111 VDA---SGSVKLADFGLAKATT-MNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
             +   +  +KL DFG AK TT  N L +   TP+++APEV+    + Y  + D+WSLG 
Sbjct: 154 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGV 211
Query: 167 TVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVP-SSLSRDARDFILKCLQVNPN 219
            +  +L   PP+      +   G++   R+G+ E P+   S +S + +  I   L+  P 
Sbjct: 212 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 271
Query: 220 DRPTVTELMEHPFVKRPLQTPR 241
            R T+TE M HP++ +  + P+
Sbjct: 272 QRMTITEFMNHPWIMQSTKVPQ 293

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           L I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HRD+K  N+L
Sbjct: 89  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 148
Query: 111 VDA---SGSVKLADFGLAKATT-MNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
             +   +  +KL DFG AK TT  N L +   TP+++APEV+    + Y  + D+WSLG 
Sbjct: 149 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGV 206
Query: 167 TVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVP-SSLSRDARDFILKCLQVNPN 219
            +  +L   PP+      +   G++   R+G+ E P+   S +S + +  I   L+  P 
Sbjct: 207 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 266
Query: 220 DRPTVTELMEHPFVKRPLQTPR 241
            R T+TE M HP++ +  + P+
Sbjct: 267 QRMTITEFMNHPWIMQSTKVPQ 288

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 93/184 (50%), Gaps = 9/184 (4%)
Query: 51  ENRLYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           E  +YI +E ++KGSL +  +     +L   Q+     QI +G+ Y+   N VHRD++ A
Sbjct: 84  EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 143
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSL 164
           NILV  +   K+ADFGLA+    N+  + +G  F   W APE        + + +D+WS 
Sbjct: 144 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSF 201
Query: 165 GCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           G  + E+ T+ R PY  +   + L ++ +G     P        D + +C + +P +RPT
Sbjct: 202 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPT 261
Query: 224 VTEL 227
              L
Sbjct: 262 FEYL 265

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           L I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HRD+K  N+L
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 111 VDA---SGSVKLADFGLAKATT-MNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
             +   +  +KL DFG AK TT  N L +   TP+++APEV+    + Y  + D+WSLG 
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGV 251
Query: 167 TVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVP-SSLSRDARDFILKCLQVNPN 219
            +  +L   PP+      +   G++   R+G+ E P+   S +S + +  I   L+  P 
Sbjct: 252 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 311
Query: 220 DRPTVTELMEHPFVKRPLQTPR 241
            R T+TE M HP++ +  + P+
Sbjct: 312 QRMTITEFMNHPWIMQSTKVPQ 333

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 93/184 (50%), Gaps = 9/184 (4%)
Query: 51  ENRLYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           E  +YI +E ++KGSL +  +     +L   Q+     QI +G+ Y+   N VHRD++ A
Sbjct: 84  EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 143
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSL 164
           NILV  +   K+ADFGLA+    N+  + +G  F   W APE        + + +D+WS 
Sbjct: 144 NILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSF 201
Query: 165 GCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           G  + E+ T+ R PY  +   + L ++ +G     P        D + +C + +P +RPT
Sbjct: 202 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPT 261
Query: 224 VTEL 227
              L
Sbjct: 262 FEYL 265

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           L I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HRD+K  N+L
Sbjct: 140 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 199
Query: 111 VDA---SGSVKLADFGLAKATT-MNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
             +   +  +KL DFG AK TT  N L +   TP+++APEV+    + Y  + D+WSLG 
Sbjct: 200 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGV 257
Query: 167 TVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVP-SSLSRDARDFILKCLQVNPN 219
            +  +L   PP+      +   G++   R+G+ E P+   S +S + +  I   L+  P 
Sbjct: 258 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 317
Query: 220 DRPTVTELMEHPFVKRPLQTPR 241
            R T+TE M HP++ +  + P+
Sbjct: 318 QRMTITEFMNHPWIMQSTKVPQ 339

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           L I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HRD+K  N+L
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 111 VDA---SGSVKLADFGLAKATT-MNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
             +   +  +KL DFG AK TT  N L +   TP+++APEV+    + Y  + D+WSLG 
Sbjct: 150 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGV 207
Query: 167 TVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVP-SSLSRDARDFILKCLQVNPN 219
            +  +L   PP+      +   G++   R+G+ E P+   S +S + +  I   L+  P 
Sbjct: 208 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 267
Query: 220 DRPTVTELMEHPFVKRPLQTPR 241
            R T+TE M HP++ +  + P+
Sbjct: 268 QRMTITEFMNHPWIMQSTKVPQ 289

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 104/192 (54%), Gaps = 4/192 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV+     + E  LY+ +E  + G + + L     + + +  +  RQI++ + Y H++ 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTM-NDLKSCKGTPFWMAPEVVNSKNDGYGL 157
           +VHRD+K  N+L+DA  ++K+ADFG +   T  N L +  G+P + APE+   K    G 
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD-GP 192
Query: 158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVN 217
             D+WSLG  +  +++   P+      +   R+ +G+   +P  +S D  + + K L +N
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKKFLILN 251
Query: 218 PNDRPTVTELME 229
           P+ R T+ ++M+
Sbjct: 252 PSKRGTLEQIMK 263

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 105/204 (51%), Gaps = 15/204 (7%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN---LYQKYHLSDSQVSSYTRQILNGLVYLHE 96
           NI++     +D+   Y+ +E+   G L +   L QK+   D+ V    +Q+L+G  YLH+
Sbjct: 65  NIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV--IMKQVLSGTTYLHK 122
Query: 97  RNVVHRDIKCANILVDASGS---VKLADFGL-AKATTMNDLKSCKGTPFWMAPEVVNSKN 152
            N+VHRD+K  N+L+++      +K+ DFGL A       +K   GT +++APEV+  K 
Sbjct: 123 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKK- 181
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVP---SSLSRDARDF 209
             Y    D+WS G  +  +L   PP+      + L R+ KG+    P   + +S +A+  
Sbjct: 182 --YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQL 239
Query: 210 ILKCLQVNPNDRPTVTELMEHPFV 233
           +   L   P+ R +  E + HP++
Sbjct: 240 VKLMLTYEPSKRISAEEALNHPWI 263

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 104/192 (54%), Gaps = 4/192 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV+     + E  LY+ +E  + G + + L     + + +  +  RQI++ + Y H++ 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTM-NDLKSCKGTPFWMAPEVVNSKNDGYGL 157
           +VHRD+K  N+L+DA  ++K+ADFG +   T  N L +  G+P + APE+   K    G 
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD-GP 192
Query: 158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVN 217
             D+WSLG  +  +++   P+      +   R+ +G+   +P  +S D  + + K L +N
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKKFLILN 251
Query: 218 PNDRPTVTELME 229
           P+ R T+ ++M+
Sbjct: 252 PSKRGTLEQIMK 263

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 108/213 (50%), Gaps = 18/213 (8%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-----YHLSDSQVSSYTRQILNG 90
            +  +IV+ L T   +  LY+  E +    L     K     +  S++  S Y RQIL  
Sbjct: 85  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 144
Query: 91  LVYLHERNVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAP 145
           L Y H+ N++HRD+K   +L+   + S  VKL  FG+A     + L +    GTP +MAP
Sbjct: 145 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 204
Query: 146 EVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR-IGKGELPSVP---SS 201
           EVV  K + YG   D+W  G  +  +L+   P+   +  + LF  I KG+    P   S 
Sbjct: 205 EVV--KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYKMNPRQWSH 260
Query: 202 LSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           +S  A+D + + L ++P +R TV E + HP++K
Sbjct: 261 ISESAKDLVRRMLMLDPAERITVYEALNHPWLK 293

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 95.5 bits (236), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 104/192 (54%), Gaps = 4/192 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV+     + E  LY+ +E  + G + + L     + + +  +  RQI++ + Y H++ 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTM-NDLKSCKGTPFWMAPEVVNSKNDGYGL 157
           +VHRD+K  N+L+DA  ++K+ADFG +   T  N L +  G+P + APE+   K    G 
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD-GP 192
Query: 158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVN 217
             D+WSLG  +  +++   P+      +   R+ +G+   +P  +S D  + + K L +N
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKKFLILN 251
Query: 218 PNDRPTVTELME 229
           P+ R T+ ++M+
Sbjct: 252 PSKRGTLEQIMK 263

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 95.5 bits (236), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 108/213 (50%), Gaps = 18/213 (8%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-----YHLSDSQVSSYTRQILNG 90
            +  +IV+ L T   +  LY+  E +    L     K     +  S++  S Y RQIL  
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 91  LVYLHERNVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAP 145
           L Y H+ N++HRD+K   +L+   + S  VKL  FG+A     + L +    GTP +MAP
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 146 EVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR-IGKGELPSVP---SS 201
           EVV  K + YG   D+W  G  +  +L+   P+   +  + LF  I KG+    P   S 
Sbjct: 203 EVV--KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYKMNPRQWSH 258
Query: 202 LSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           +S  A+D + + L ++P +R TV E + HP++K
Sbjct: 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 95.5 bits (236), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 110/208 (52%), Gaps = 16/208 (7%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH------LSDSQVSSYTRQILNGLVYL 94
           IVQ+ G    E   +I +EL++  S    Y+  +      + +  +   T   +  L +L
Sbjct: 83  IVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 95  HER-NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSC-KGTPFWMAPEVVN--S 150
            E   ++HRDIK +NIL+D SG++KL DFG++     +  K+   G   +MAPE ++  +
Sbjct: 142 KENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA 201
Query: 151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV-QALFRIGKGELPSVPSSLSRDAR-- 207
              GY + +D+WSLG T+ E+ T R PY     V   L ++ KG+ P + +S  R+    
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPS 261
Query: 208 --DFILKCLQVNPNDRPTVTELMEHPFV 233
             +F+  CL  + + RP   EL++HPF+
Sbjct: 262 FINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 95.5 bits (236), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 108/211 (51%), Gaps = 30/211 (14%)
Query: 54  LYIFLELVTKGSLA---------NLYQKYHLSDS-----QVSSYTRQILNGLVYLHERNV 99
           + +F+  +TK +LA         +LY+  H+ ++     Q+    RQ   G+ YLH +N+
Sbjct: 94  ILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNI 153
Query: 100 VHRDIKCANILVDASGSVKLADFGLA----KATTMNDLKSCKGTPFWMAPEVVNSK-NDG 154
           +HRD+K  NI +    +VK+ DFGLA    + +    ++   G+  WMAPEV+  + N+ 
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNP 213
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGV-QALFRIGKG----ELPSVPSSLSRDARDF 209
           +   +D++S G  + E++T   PYSH+    Q +F +G+G    +L  +  +  +  +  
Sbjct: 214 FSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRL 273
Query: 210 ILKCLQVNPNDRP------TVTELMEHPFVK 234
           +  C++    +RP      +  EL++H   K
Sbjct: 274 VADCVKKVKEERPLFPQILSSIELLQHSLPK 304

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 95.5 bits (236), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 108/204 (52%), Gaps = 13/204 (6%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV+   +  +E   Y+  +LVT G L  ++  + + S++  S    QIL  + ++H+ +
Sbjct: 91  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHD 150
Query: 99  VVHRDIKCANILVDAS---GSVKLADFGLAKAT--TMNDLKSCKGTPFWMAPEVVNSKND 153
           +VHRD+K  N+L+ +     +VKLADFGLA              GTP +++PEV+  + D
Sbjct: 151 IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVL--RKD 208
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPS----SLSRDARDF 209
            YG   DIW+ G  +  +L   PP+   E    L++  K      PS    +++ +A++ 
Sbjct: 209 PYGKPVDIWACGVILYILLVGYPPFWD-EDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNL 267
Query: 210 ILKCLQVNPNDRPTVTELMEHPFV 233
           I + L +NP  R T  + ++HP+V
Sbjct: 268 INQMLTINPAKRITADQALKHPWV 291

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 103/192 (53%), Gaps = 4/192 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV+     + E  LY+ +E  + G + + L     + + +  +  RQI++ + Y H++ 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTM-NDLKSCKGTPFWMAPEVVNSKNDGYGL 157
           +VHRD+K  N+L+DA  ++K+ADFG +   T  N L +  G P + APE+   K    G 
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD-GP 192
Query: 158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVN 217
             D+WSLG  +  +++   P+      +   R+ +G+   +P  +S D  + + K L +N
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKKFLILN 251
Query: 218 PNDRPTVTELME 229
           P+ R T+ ++M+
Sbjct: 252 PSKRGTLEQIMK 263

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 16/202 (7%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           L I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HRD+K  N+L
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 147
Query: 111 VDA---SGSVKLADFGLAKATT-MNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
             +   +  +KL DFG AK TT  N L     TP+++APEV+    + Y  + D+WSLG 
Sbjct: 148 YTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGP--EKYDKSCDMWSLGV 205
Query: 167 TVLEMLTRRPPY------SHLEGVQALFRIGKGELPSVP-SSLSRDARDFILKCLQVNPN 219
            +  +L   PP+      +   G++   R+G+ E P+   S +S + +  I   L+  P 
Sbjct: 206 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 265
Query: 220 DRPTVTELMEHPFVKRPLQTPR 241
            R T+TE M HP++ +  + P+
Sbjct: 266 QRMTITEFMNHPWIMQSTKVPQ 287

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 105/204 (51%), Gaps = 15/204 (7%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN---LYQKYHLSDSQVSSYTRQILNGLVYLHE 96
           NI++     +D+   Y+ +E+   G L +   L QK+   D+ V    +Q+L+G  YLH+
Sbjct: 82  NIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV--IMKQVLSGTTYLHK 139
Query: 97  RNVVHRDIKCANILVDASGS---VKLADFGL-AKATTMNDLKSCKGTPFWMAPEVVNSKN 152
            N+VHRD+K  N+L+++      +K+ DFGL A       +K   GT +++APEV+  K 
Sbjct: 140 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKKY 199
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVP---SSLSRDARDF 209
           D      D+WS G  +  +L   PP+      + L R+ KG+    P   + +S +A+  
Sbjct: 200 DE---KCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQL 256
Query: 210 ILKCLQVNPNDRPTVTELMEHPFV 233
           +   L   P+ R +  E + HP++
Sbjct: 257 VKLMLTYEPSKRISAEEALNHPWI 280

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 9/204 (4%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLH 95
           + +NIV      +     Y+ ++LV+ G L + + ++   ++   S   +Q+L+ + YLH
Sbjct: 64  KHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH 123
Query: 96  ERNVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKN 152
           E  +VHRD+K  N+L    + +  + + DFGL+K      + +  GTP ++APEV+  K 
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQK- 182
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG--ELPS-VPSSLSRDARDF 209
             Y    D WS+G     +L   PP+      +   +I +G  E  S     +S  A+DF
Sbjct: 183 -PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241
Query: 210 ILKCLQVNPNDRPTVTELMEHPFV 233
           I   L+ +PN+R T  + + HP++
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWI 265

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 96/190 (50%), Gaps = 7/190 (3%)
Query: 52  NRLYIFLELVTKGSLANLYQK-YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +RL+  +E V  G L    QK     +++   Y  +I++ L++LH++ +++RD+K  N+L
Sbjct: 97  DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVL 156
Query: 111 VDASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           +D  G  KLADFG+ K    N + +    GTP ++APE++      YG   D W++G  +
Sbjct: 157 LDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML--YGPAVDWWAMGVLL 214
Query: 169 LEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR-PTVTEL 227
            EML    P+   E    LF     +    P+ L  DA   +   +  NP  R  ++T+ 
Sbjct: 215 YEMLCGHAPFE-AENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQG 273
Query: 228 MEHPFVKRPL 237
            EH  ++ P 
Sbjct: 274 GEHAILRHPF 283

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 103/192 (53%), Gaps = 4/192 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV+     + E  LY+ +E  + G + + L     + + +  +  RQI++ + Y H++ 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTM-NDLKSCKGTPFWMAPEVVNSKNDGYGL 157
           +VHRD+K  N+L+DA  ++K+ADFG +   T  N L    G+P + APE+   K    G 
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYD-GP 192
Query: 158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVN 217
             D+WSLG  +  +++   P+      +   R+ +G+   +P  +S D  + + K L +N
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKKFLILN 251
Query: 218 PNDRPTVTELME 229
           P+ R T+ ++M+
Sbjct: 252 PSKRGTLEQIMK 263

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 94.7 bits (234), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 95/193 (49%), Gaps = 10/193 (5%)
Query: 49  KDENRLYIFLELVTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKC 106
           +D+N + +  E ++ G L       H  +S+ +   Y RQ+  GL ++HE N VH D+K 
Sbjct: 118 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKP 177
Query: 107 ANIL--VDASGSVKLADFGL-AKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWS 163
            NI+     S  +KL DFGL A       +K   GT  + APEV   K  GY    D+WS
Sbjct: 178 ENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY--YTDMWS 235
Query: 164 LGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL---PSVPSSLSRDARDFILKCLQVNPND 220
           +G     +L+   P+      + L  +   +     S  S +S D +DFI K L  +PN 
Sbjct: 236 VGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNT 295
Query: 221 RPTVTELMEHPFV 233
           R T+ + +EHP++
Sbjct: 296 RMTIHQALEHPWL 308

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 92/184 (50%), Gaps = 9/184 (4%)
Query: 51  ENRLYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           E  +YI  E ++KGSL +  +     +L   Q+     QI +G+ Y+   N VHRD++ A
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 143
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSL 164
           NILV  +   K+ADFGLA+    N+  + +G  F   W APE        + + +D+WS 
Sbjct: 144 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSF 201
Query: 165 GCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           G  + E+ T+ R PY  +   + L ++ +G     P        D + +C + +P +RPT
Sbjct: 202 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPT 261
Query: 224 VTEL 227
              L
Sbjct: 262 FEYL 265

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 94.7 bits (234), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 95/193 (49%), Gaps = 10/193 (5%)
Query: 49  KDENRLYIFLELVTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKC 106
           +D+N + +  E ++ G L       H  +S+ +   Y RQ+  GL ++HE N VH D+K 
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKP 283
Query: 107 ANILVDA--SGSVKLADFGL-AKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWS 163
            NI+     S  +KL DFGL A       +K   GT  + APEV   K  GY    D+WS
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY--YTDMWS 341
Query: 164 LGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL---PSVPSSLSRDARDFILKCLQVNPND 220
           +G     +L+   P+      + L  +   +     S  S +S D +DFI K L  +PN 
Sbjct: 342 VGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNT 401
Query: 221 RPTVTELMEHPFV 233
           R T+ + +EHP++
Sbjct: 402 RMTIHQALEHPWL 414

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 94.7 bits (234), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 105/203 (51%), Gaps = 11/203 (5%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NI++     +    + + LELVT G L + + +K + S+   +   +QIL  + YLHE  
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 99  VVHRDIKCANILVDA---SGSVKLADFGLAKATTMNDL-KSCKGTPFWMAPEVVNSKNDG 154
           +VHRD+K  N+L         +K+ADFGL+K      L K+  GTP + APE++  +   
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEIL--RGCA 226
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALF-RIGKGELPSVP---SSLSRDARDFI 210
           YG   D+WS+G     +L    P+    G Q +F RI   E   +      +S +A+D +
Sbjct: 227 YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLV 286
Query: 211 LKCLQVNPNDRPTVTELMEHPFV 233
            K + ++P  R T  + ++HP+V
Sbjct: 287 RKLIVLDPKKRLTTFQALQHPWV 309

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 93/184 (50%), Gaps = 9/184 (4%)
Query: 51  ENRLYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           E  +YI  E ++KGSL +  +     +L   Q+     QI +G+ Y+   N VHRD++ A
Sbjct: 84  EEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 143
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSL 164
           NILV  +   K+ADFGLA+    N+  + +G  F   W APE   +    + + +D+WS 
Sbjct: 144 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA--ALYGRFTIKSDVWSF 201
Query: 165 GCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           G  + E+ T+ R PY  +   + L ++ +G     P        D + +C + +P +RPT
Sbjct: 202 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPT 261
Query: 224 VTEL 227
              L
Sbjct: 262 FEYL 265

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 94.7 bits (234), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 104/192 (54%), Gaps = 4/192 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV+     + E  LY+ +E  + G + + L     + + +  +  RQI++ + Y H++ 
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKF 126
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTM-NDLKSCKGTPFWMAPEVVNSKNDGYGL 157
           +VHRD+K  N+L+DA  ++K+ADFG +   T  N L +  G+P + APE+   K    G 
Sbjct: 127 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD-GP 185
Query: 158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVN 217
             D+WSLG  +  +++   P+      +   R+ +G+   +P  +S D  + + K L +N
Sbjct: 186 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKKFLILN 244
Query: 218 PNDRPTVTELME 229
           P+ R T+ ++M+
Sbjct: 245 PSKRGTLEQIMK 256

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 94.7 bits (234), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 19/201 (9%)
Query: 51  ENRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           E+RL+  +E V  G L  ++ ++  L +     Y+ +I   L YLHER +++RD+K  N+
Sbjct: 125 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 184
Query: 110 LVDASGSVKLADFGLAKATTM--NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           L+D+ G +KL D+G+ K      +   +  GTP ++APE++  + + YG + D W+LG  
Sbjct: 185 LLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL--RGEDYGFSVDWWALGVL 242
Query: 168 VLEMLTRRPPYSHLEGVQA--------LFRIGKGELPSVPSSLSRDARDFILKCLQVNPN 219
           + EM+  R P+  +             LF++   +   +P SLS  A   +   L  +P 
Sbjct: 243 MFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPK 302
Query: 220 DR------PTVTELMEHPFVK 234
           +R          ++  HPF +
Sbjct: 303 ERLGCHPQTGFADIQGHPFFR 323

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 94.7 bits (234), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNV 99
           I++  GT +D  ++++ ++ +  G L +L +K     + V+  Y  ++   L YLH +++
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 127
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTA 159
           ++RD+K  NIL+D +G +K+ DFG AK         C GTP ++APEVV++K   Y  + 
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC-GTPDYIAPEVVSTK--PYNKSI 184
Query: 160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPN 219
           D WS G  + EML    P+     ++   +I   EL   P   + D +D + + +  + +
Sbjct: 185 DWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFFNEDVKDLLSRLITRDLS 243
Query: 220 DR--------------PTVTELMEHPFVKRPLQTP 240
            R              P   E++    + R ++TP
Sbjct: 244 QRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP 278

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 93/184 (50%), Gaps = 9/184 (4%)
Query: 51  ENRLYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           E  +YI  E ++KGSL +  +     +L   Q+     QI +G+ Y+   N VHRD++ A
Sbjct: 75  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 134
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSL 164
           NILV  +   K+ADFGLA+    N+  + +G  F   W APE   +    + + +D+WS 
Sbjct: 135 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA--ALYGRFTIKSDVWSF 192
Query: 165 GCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           G  + E+ T+ R PY  +   + L ++ +G     P        D + +C + +P +RPT
Sbjct: 193 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPT 252
Query: 224 VTEL 227
              L
Sbjct: 253 FEYL 256

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 92/184 (50%), Gaps = 9/184 (4%)
Query: 51  ENRLYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           E  +YI  E ++KGSL +  +     +L   Q+     QI +G+ Y+   N VHRD++ A
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 143
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSL 164
           NILV  +   K+ADFGLA+    N+  + +G  F   W APE        + + +D+WS 
Sbjct: 144 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSF 201
Query: 165 GCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           G  + E+ T+ R PY  +   + L ++ +G     P        D + +C + +P +RPT
Sbjct: 202 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPT 261
Query: 224 VTEL 227
              L
Sbjct: 262 FEYL 265

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 94.7 bits (234), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 93/184 (50%), Gaps = 9/184 (4%)
Query: 51  ENRLYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           E  +YI  E ++KGSL +  +     +L   Q+     QI +G+ Y+   N VHRD++ A
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 132
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSL 164
           NILV  +   K+ADFGLA+    N+  + +G  F   W APE   +    + + +D+WS 
Sbjct: 133 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA--ALYGRFTIKSDVWSF 190
Query: 165 GCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           G  + E+ T+ R PY  +   + L ++ +G     P        D + +C + +P +RPT
Sbjct: 191 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPT 250
Query: 224 VTEL 227
              L
Sbjct: 251 FEYL 254

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 92/184 (50%), Gaps = 9/184 (4%)
Query: 51  ENRLYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           E  +YI +E ++KG L +  +     +L   Q+     QI +G+ Y+   N VHRD++ A
Sbjct: 84  EEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 143
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSL 164
           NILV  +   K+ADFGLA+    N+  + +G  F   W APE        + + +D+WS 
Sbjct: 144 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSF 201
Query: 165 GCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           G  + E+ T+ R PY  +   + L ++ +G     P        D + +C + +P +RPT
Sbjct: 202 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPT 261
Query: 224 VTEL 227
              L
Sbjct: 262 FEYL 265

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 94.4 bits (233), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 39/218 (17%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +YI  +L+ +  L  L +  HLS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ 
Sbjct: 99  VYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 157
Query: 114 SGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCT 167
           +  +K+ DFGLA+    +      L     T ++ APE+ +NSK  GY  + DIWS+GC 
Sbjct: 158 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCI 215
Query: 168 VLEMLTRRPPY---SHLEGVQALFRI-GKGELPSVPSSLSRDARDFIL------------ 211
           + EML+ RP +    +L+ +  +  I G  E   +   ++  AR+++L            
Sbjct: 216 LAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARNYLLSLPHKNKVPWNR 275
Query: 212 --------------KCLQVNPNDRPTVTELMEHPFVKR 235
                         K L  NP+ R  V + + HP++++
Sbjct: 276 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 313

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +YI  E +  GSL +  +      L+ +++     QI  G+ ++ ERN +HR+++ ANIL
Sbjct: 78  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRNLRAANIL 137
Query: 111 VDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSLGCT 167
           V  + S K+ADFGLA+    N+  + +G  F   W APE +N     + + +D+WS G  
Sbjct: 138 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGIL 195
Query: 168 VLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           + E++T  R PY  +   + +  + +G     P +   +    +  C +  P DRPT
Sbjct: 196 LTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 252

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 92/184 (50%), Gaps = 9/184 (4%)
Query: 51  ENRLYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           E  +YI  E + KGSL +  +     +L   Q+   + QI +G+ Y+   N VHRD++ A
Sbjct: 81  EEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAA 140
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSL 164
           NILV  +   K+ADFGLA+    N+  + +G  F   W APE   +    + + +D+WS 
Sbjct: 141 NILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEA--ALYGRFTIKSDVWSF 198
Query: 165 GCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           G  + E+ T+ R PY  +   + L ++ +G     P        D + +C +  P +RPT
Sbjct: 199 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 258
Query: 224 VTEL 227
              L
Sbjct: 259 FEYL 262

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 92/184 (50%), Gaps = 9/184 (4%)
Query: 51  ENRLYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           E  +YI  E ++KGSL +  +     +L   Q+     QI +G+ Y+   N VHRD++ A
Sbjct: 77  EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 136
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSL 164
           NILV  +   K+ADFGLA+    N+  + +G  F   W APE   +    + + +D+WS 
Sbjct: 137 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA--ALYGRFTIKSDVWSF 194
Query: 165 GCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           G  + E+ T+ R PY  +   + L ++ +G     P        D + +C +  P +RPT
Sbjct: 195 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 254
Query: 224 VTEL 227
              L
Sbjct: 255 FEYL 258

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 111/218 (50%), Gaps = 39/218 (17%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +YI  +L+ +  L  L +  HLS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ 
Sbjct: 101 VYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 159
Query: 114 SGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCT 167
           +  +K+ DFGLA+    +      L     T ++ APE+ +NSK  GY  + DIWS+GC 
Sbjct: 160 TXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCI 217
Query: 168 VLEMLTRRPPY---------SHLEGV------QALFRI----GKGELPSVPS-------- 200
           + EML+ RP +         +H+ G+      + L  I     +  L S+P         
Sbjct: 218 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNR 277
Query: 201 ---SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
              +    A D + K L  NP+ R  V + + HP++++
Sbjct: 278 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 111/218 (50%), Gaps = 39/218 (17%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +YI  +L+ +  L  L +  HLS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ 
Sbjct: 101 VYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 159
Query: 114 SGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCT 167
           +  +K+ DFGLA+    +      L     T ++ APE+ +NSK  GY  + DIWS+GC 
Sbjct: 160 TXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCI 217
Query: 168 VLEMLTRRPPY---------SHLEGV------QALFRI----GKGELPSVPS-------- 200
           + EML+ RP +         +H+ G+      + L  I     +  L S+P         
Sbjct: 218 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNR 277
Query: 201 ---SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
              +    A D + K L  NP+ R  V + + HP++++
Sbjct: 278 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 92/184 (50%), Gaps = 9/184 (4%)
Query: 51  ENRLYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           E  +YI  E + KGSL +  +     +L   Q+   + QI +G+ Y+   N VHRD++ A
Sbjct: 81  EEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAA 140
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSL 164
           NILV  +   K+ADFGLA+    N+  + +G  F   W APE   +    + + +D+WS 
Sbjct: 141 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA--ALYGRFTIKSDVWSF 198
Query: 165 GCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           G  + E+ T+ R PY  +   + L ++ +G     P        D + +C +  P +RPT
Sbjct: 199 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 258
Query: 224 VTEL 227
              L
Sbjct: 259 FEYL 262

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 102/195 (52%), Gaps = 22/195 (11%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSS------YTRQILNGLVYLH-ERNVVHRDI 104
           +RL   +E    G L      +HLS  +V S      Y  +I++ L YLH E+NVV+RD+
Sbjct: 221 DRLCFVMEYANGGELF-----FHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 275
Query: 105 KCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGLTADIW 162
           K  N+++D  G +K+ DFGL K    +   +K+  GTP ++APEV+  +++ YG   D W
Sbjct: 276 KLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL--EDNDYGRAVDWW 333
Query: 163 SLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR- 221
            LG  + EM+  R P+ + +  + LF +   E    P +L  +A+  +   L+ +P  R 
Sbjct: 334 GLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRL 392
Query: 222 ----PTVTELMEHPF 232
                   E+M+H F
Sbjct: 393 GGGSEDAKEIMQHRF 407

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 102/195 (52%), Gaps = 22/195 (11%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSS------YTRQILNGLVYLH-ERNVVHRDI 104
           +RL   +E    G L      +HLS  +V S      Y  +I++ L YLH E+NVV+RD+
Sbjct: 224 DRLCFVMEYANGGELF-----FHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 278
Query: 105 KCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGLTADIW 162
           K  N+++D  G +K+ DFGL K    +   +K+  GTP ++APEV+  +++ YG   D W
Sbjct: 279 KLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL--EDNDYGRAVDWW 336
Query: 163 SLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR- 221
            LG  + EM+  R P+ + +  + LF +   E    P +L  +A+  +   L+ +P  R 
Sbjct: 337 GLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRL 395
Query: 222 ----PTVTELMEHPF 232
                   E+M+H F
Sbjct: 396 GGGSEDAKEIMQHRF 410

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 94.0 bits (232), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 105/196 (53%), Gaps = 4/196 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV+     + E  LY+ +E  + G + + L     + + +  S  RQI++ + Y H++ 
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 131
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTM-NDLKSCKGTPFWMAPEVVNSKNDGYGL 157
           +VHRD+K  N+L+DA  ++K+ADFG +   T+   L +  G+P + APE+   K    G 
Sbjct: 132 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYD-GP 190
Query: 158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVN 217
             D+WSLG  +  +++   P+      +   R+ +G+   +P  +S D  + + + L +N
Sbjct: 191 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKRFLVLN 249
Query: 218 PNDRPTVTELMEHPFV 233
           P  R T+ ++M+  ++
Sbjct: 250 PIKRGTLEQIMKDRWI 265

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 94.0 bits (232), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 116/268 (43%), Gaps = 38/268 (14%)
Query: 2   GFFFAVKEVSLQDQGAQGKXXXXXXXXXXXXXXXFEQDNIVQYLG------TDKDENRLY 55
           G F A+K V +Q                      FE  N+V+         TD+ E +L 
Sbjct: 37  GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR-ETKLT 95
Query: 56  IFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +  E V +     L +  +  +    +     Q+L GL +LH   VVHRD+K  NILV +
Sbjct: 96  LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS 155
Query: 114 SGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEML 172
           SG +KLADFGLA+  +    L S   T ++ APEV+   +  Y    D+WS+GC   EM 
Sbjct: 156 SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMF 213
Query: 173 TRRPPYSHLEGVQALFRI-------GKGELP---SVP----------------SSLSRDA 206
            R+P +     V  L +I       G+ + P   ++P                + +    
Sbjct: 214 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG 273
Query: 207 RDFILKCLQVNPNDRPTVTELMEHPFVK 234
           +D +LKCL  NP  R +    + HP+ +
Sbjct: 274 KDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 94.0 bits (232), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 116/268 (43%), Gaps = 38/268 (14%)
Query: 2   GFFFAVKEVSLQDQGAQGKXXXXXXXXXXXXXXXFEQDNIVQYLG------TDKDENRLY 55
           G F A+K V +Q                      FE  N+V+         TD+ E +L 
Sbjct: 37  GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR-ETKLT 95
Query: 56  IFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +  E V +     L +  +  +    +     Q+L GL +LH   VVHRD+K  NILV +
Sbjct: 96  LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS 155
Query: 114 SGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEML 172
           SG +KLADFGLA+  +    L S   T ++ APEV+   +  Y    D+WS+GC   EM 
Sbjct: 156 SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMF 213
Query: 173 TRRPPYSHLEGVQALFRI-------GKGELP---SVP----------------SSLSRDA 206
            R+P +     V  L +I       G+ + P   ++P                + +    
Sbjct: 214 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG 273
Query: 207 RDFILKCLQVNPNDRPTVTELMEHPFVK 234
           +D +LKCL  NP  R +    + HP+ +
Sbjct: 274 KDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 94.0 bits (232), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 21/202 (10%)
Query: 51  ENRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           E+RL+  +E V  G L  ++ ++  L +     Y+ +I   L YLHER +++RD+K  N+
Sbjct: 78  ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 137
Query: 110 LVDASGSVKLADFGLAK-ATTMNDLKS--CKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           L+D+ G +KL D+G+ K      D  S  C GTP ++APE++  + + YG + D W+LG 
Sbjct: 138 LLDSEGHIKLTDYGMCKEGLRPGDTTSXFC-GTPNYIAPEIL--RGEDYGFSVDWWALGV 194
Query: 167 TVLEMLTRRPPYSHLEGV--------QALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            + EM+  R P+  +             LF++   +   +P SLS  A   +   L  +P
Sbjct: 195 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDP 254
Query: 219 NDR------PTVTELMEHPFVK 234
            +R          ++  HPF +
Sbjct: 255 KERLGCHPQTGFADIQGHPFFR 276

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 116/268 (43%), Gaps = 38/268 (14%)
Query: 2   GFFFAVKEVSLQDQGAQGKXXXXXXXXXXXXXXXFEQDNIVQYLG------TDKDENRLY 55
           G F A+K V +Q                      FE  N+V+         TD+ E +L 
Sbjct: 37  GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR-ETKLT 95
Query: 56  IFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +  E V +     L +  +  +    +     Q+L GL +LH   VVHRD+K  NILV +
Sbjct: 96  LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS 155
Query: 114 SGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEML 172
           SG +KLADFGLA+  +    L S   T ++ APEV+   +  Y    D+WS+GC   EM 
Sbjct: 156 SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMF 213
Query: 173 TRRPPYSHLEGVQALFRI-------GKGELP---SVP----------------SSLSRDA 206
            R+P +     V  L +I       G+ + P   ++P                + +    
Sbjct: 214 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG 273
Query: 207 RDFILKCLQVNPNDRPTVTELMEHPFVK 234
           +D +LKCL  NP  R +    + HP+ +
Sbjct: 274 KDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 94.0 bits (232), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 21/202 (10%)
Query: 51  ENRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           E+RL+  +E V  G L  ++ ++  L +     Y+ +I   L YLHER +++RD+K  N+
Sbjct: 82  ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 141
Query: 110 LVDASGSVKLADFGLAK-ATTMNDLKS--CKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           L+D+ G +KL D+G+ K      D  S  C GTP ++APE++  ++  YG + D W+LG 
Sbjct: 142 LLDSEGHIKLTDYGMCKEGLRPGDTTSXFC-GTPNYIAPEILRGED--YGFSVDWWALGV 198
Query: 167 TVLEMLTRRPPYSHLEGV--------QALFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            + EM+  R P+  +             LF++   +   +P SLS  A   +   L  +P
Sbjct: 199 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDP 258
Query: 219 NDR------PTVTELMEHPFVK 234
            +R          ++  HPF +
Sbjct: 259 KERLGCHPQTGFADIQGHPFFR 280

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 93.6 bits (231), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 109/218 (50%), Gaps = 39/218 (17%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +YI  +L+ +  L  L +  HLS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ 
Sbjct: 103 VYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 161
Query: 114 SGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCT 167
           +  +K+ DFGLA+    +      L     T ++ APE+ +NSK  GY  + DIWS+GC 
Sbjct: 162 TSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCI 219
Query: 168 VLEMLTRRPPY---------SHLEGV-----QALFRIG-----KGELPSVPS-------- 200
           + EML+ RP +         +H+ G+     Q     G     +  L S+P         
Sbjct: 220 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARNYLLSLPHKNKVPWNR 279
Query: 201 ---SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
              +    A D + K L  NP+ R  V + + HP++ +
Sbjct: 280 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQ 317

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 93.6 bits (231), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 59/185 (31%), Positives = 93/185 (50%), Gaps = 11/185 (5%)
Query: 51  ENRLYIFLELVTKGSLANLYQ----KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKC 106
           E  +YI  E ++KGSL +  +    KY L   Q+     QI +G+ Y+   N VHRD++ 
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 308
Query: 107 ANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWS 163
           ANILV  +   K+ADFGLA+    N+  + +G  F   W APE   +    + + +D+WS
Sbjct: 309 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA--ALYGRFTIKSDVWS 366
Query: 164 LGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP 222
            G  + E+ T+ R PY  +   + L ++ +G     P        D + +C +  P +RP
Sbjct: 367 FGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERP 426
Query: 223 TVTEL 227
           T   L
Sbjct: 427 TFEYL 431

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 93.6 bits (231), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 39/218 (17%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +YI  +L+ +  L  L +  HLS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ 
Sbjct: 101 VYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 159
Query: 114 SGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCT 167
           +  +K+ DFGLA+    +      L     T ++ APE+ +NSK  GY  + DIWS+GC 
Sbjct: 160 TXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCI 217
Query: 168 VLEMLTRRPPY---SHLEGVQALFRI----------------GKGELPSVPS-------- 200
           + EML+ RP +    +L+ +  +  I                 +  L S+P         
Sbjct: 218 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 277
Query: 201 ---SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
              +    A D + K L  NP+ R  V + + HP++++
Sbjct: 278 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 93.6 bits (231), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 59/185 (31%), Positives = 93/185 (50%), Gaps = 11/185 (5%)
Query: 51  ENRLYIFLELVTKGSLANLYQ----KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKC 106
           E  +YI  E ++KGSL +  +    KY L   Q+     QI +G+ Y+   N VHRD++ 
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 308
Query: 107 ANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWS 163
           ANILV  +   K+ADFGLA+    N+  + +G  F   W APE   +    + + +D+WS
Sbjct: 309 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA--ALYGRFTIKSDVWS 366
Query: 164 LGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP 222
            G  + E+ T+ R PY  +   + L ++ +G     P        D + +C +  P +RP
Sbjct: 367 FGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERP 426
Query: 223 TVTEL 227
           T   L
Sbjct: 427 TFEYL 431

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 93.6 bits (231), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 104/196 (53%), Gaps = 4/196 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV+     + E  LY+ +E  + G + + L     + + +  S  RQI++ + Y H++ 
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTM-NDLKSCKGTPFWMAPEVVNSKNDGYGL 157
           +VHRD+K  N+L+DA  ++K+ADFG +   T+   L +  G P + APE+   K    G 
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYD-GP 193
Query: 158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVN 217
             D+WSLG  +  +++   P+      +   R+ +G+   +P  +S D  + + + L +N
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKRFLVLN 252
Query: 218 PNDRPTVTELMEHPFV 233
           P  R T+ ++M+  ++
Sbjct: 253 PIKRGTLEQIMKDRWI 268

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 93.6 bits (231), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 39/218 (17%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +YI  +L+ +  L  L +  HLS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ 
Sbjct: 105 VYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 163
Query: 114 SGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCT 167
           +  +K+ DFGLA+    +      L     T ++ APE+ +NSK  GY  + DIWS+GC 
Sbjct: 164 TXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCI 221
Query: 168 VLEMLTRRPPY---SHLEGVQALFRI----------------GKGELPSVPS-------- 200
           + EML+ RP +    +L+ +  +  I                 +  L S+P         
Sbjct: 222 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 281
Query: 201 ---SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
              +    A D + K L  NP+ R  V + + HP++++
Sbjct: 282 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 93.6 bits (231), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 113/220 (51%), Gaps = 19/220 (8%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSLAN--LYQKYHLSDSQVSSYTRQILNGLVYL 94
           +  NI+       D   +Y+  EL+  G L +  L QK+  S+ + S     I   + YL
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF-FSEREASFVLHTIGKTVEYL 137
Query: 95  HERNVVHRDIKCANIL-VDASGS---VKLADFGLAKATTMND---LKSCKGTPFWMAPEV 147
           H + VVHRD+K +NIL VD SG+   +++ DFG AK     +   +  C    F +APEV
Sbjct: 138 HSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANF-VAPEV 196
Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG---VQALFRIGKGELPSVP---SS 201
           +  K  GY    DIWSLG  +  ML    P+++       + L RIG G+        ++
Sbjct: 197 L--KRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNT 254
Query: 202 LSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPR 241
           +S  A+D + K L V+P+ R T  ++++HP+V +  + P+
Sbjct: 255 VSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQ 294

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 91/184 (49%), Gaps = 9/184 (4%)
Query: 51  ENRLYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           E  +YI  E ++KGSL +  +     +L   Q+     QI +G+ Y+   N VHRD+  A
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLAAA 143
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSL 164
           NILV  +   K+ADFGLA+    N+  + +G  F   W APE        + + +D+WS 
Sbjct: 144 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSF 201
Query: 165 GCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           G  + E+ T+ R PY  +   + L ++ +G     P        D + +C + +P +RPT
Sbjct: 202 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPT 261
Query: 224 VTEL 227
              L
Sbjct: 262 FEYL 265

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 93.6 bits (231), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 39/218 (17%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +YI  +L+ +  L  L +  HLS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ 
Sbjct: 105 VYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 163
Query: 114 SGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCT 167
           +  +K+ DFGLA+    +      L     T ++ APE+ +NSK  GY  + DIWS+GC 
Sbjct: 164 TXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCI 221
Query: 168 VLEMLTRRPPY---SHLEGVQALFRI----------------GKGELPSVPS-------- 200
           + EML+ RP +    +L+ +  +  I                 +  L S+P         
Sbjct: 222 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 281
Query: 201 ---SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
              +    A D + K L  NP+ R  V + + HP++++
Sbjct: 282 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 21/202 (10%)
Query: 51  ENRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           E+RL+  +E V  G L  ++ ++  L +     Y+ +I   L YLHER +++RD+K  N+
Sbjct: 93  ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 152
Query: 110 LVDASGSVKLADFGLAK-ATTMNDLKS--CKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           L+D+ G +KL D+G+ K      D  S  C GTP ++APE++  + + YG + D W+LG 
Sbjct: 153 LLDSEGHIKLTDYGMCKEGLRPGDTTSXFC-GTPNYIAPEIL--RGEDYGFSVDWWALGV 209
Query: 167 TVLEMLTRRPPYSHLEGVQA--------LFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
            + EM+  R P+  +             LF++   +   +P S+S  A   +   L  +P
Sbjct: 210 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSMSVKAASVLKSFLNKDP 269
Query: 219 NDR------PTVTELMEHPFVK 234
            +R          ++  HPF +
Sbjct: 270 KERLGCLPQTGFADIQGHPFFR 291

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 101/195 (51%), Gaps = 22/195 (11%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSS------YTRQILNGLVYLH-ERNVVHRDI 104
           +RL   +E    G L      +HLS  +V S      Y  +I++ L YLH E+NVV+RD+
Sbjct: 82  DRLCFVMEYANGGELF-----FHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 136
Query: 105 KCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGLTADIW 162
           K  N+++D  G +K+ DFGL K    +   +K   GTP ++APEV+  +++ YG   D W
Sbjct: 137 KLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL--EDNDYGRAVDWW 194
Query: 163 SLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR- 221
            LG  + EM+  R P+ + +  + LF +   E    P +L  +A+  +   L+ +P  R 
Sbjct: 195 GLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRL 253
Query: 222 ----PTVTELMEHPF 232
                   E+M+H F
Sbjct: 254 GGGSEDAKEIMQHRF 268

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 91/184 (49%), Gaps = 9/184 (4%)
Query: 51  ENRLYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           E  +YI  E ++KGSL +  +     +L   Q+     QI +G+ Y+   N VHRD++ A
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 392
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSL 164
           NILV  +   K+ADFGLA+    N+  + +G  F   W APE        + + +D+WS 
Sbjct: 393 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSF 450
Query: 165 GCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           G  + E+ T+ R PY  +   + L ++ +G     P        D + +C +  P +RPT
Sbjct: 451 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 510
Query: 224 VTEL 227
              L
Sbjct: 511 FEYL 514

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVV 100
           +VQ     +D+  LY+ +E +  G L NL   Y + +     YT +++  L  +H   ++
Sbjct: 137 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLI 196
Query: 101 HRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK---GTPFWMAPEVVNSK-NDG-Y 155
           HRD+K  N+L+D  G +KLADFG         +  C    GTP +++PEV+ S+  DG Y
Sbjct: 197 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYY 256
Query: 156 GLTADIWSLGCTVLEMLTRRPPY--SHLEGVQALFRIGKGEL--PSVPSSLSRDARDFIL 211
           G   D WS+G  + EML    P+    L G  +     K  L  P   + +S+ A++ I 
Sbjct: 257 GRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPE-DAEISKHAKNLIC 315
Query: 212 KCLQVNPN--DRPTVTELMEHPFVK 234
             L        R  V E+ +HPF K
Sbjct: 316 AFLTDREVRLGRNGVEEIKQHPFFK 340

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +YI  E +  GSL +  +      L+ +++     QI  G+ ++ ERN +HRD++ ANIL
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141
Query: 111 VDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSLGCT 167
           V  + S K+ADFGLA+     +  + +G  F   W APE +N     + + +D+WS G  
Sbjct: 142 VSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGIL 199
Query: 168 VLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           + E++T  R PY  +   + +  + +G     P +   +    +  C +  P DRPT
Sbjct: 200 LTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 256

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 101/195 (51%), Gaps = 22/195 (11%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSS------YTRQILNGLVYLH-ERNVVHRDI 104
           +RL   +E    G L      +HLS  +V S      Y  +I++ L YLH E+NVV+RD+
Sbjct: 81  DRLCFVMEYANGGELF-----FHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 135
Query: 105 KCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGLTADIW 162
           K  N+++D  G +K+ DFGL K    +   +K   GTP ++APEV+  +++ YG   D W
Sbjct: 136 KLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL--EDNDYGRAVDWW 193
Query: 163 SLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR- 221
            LG  + EM+  R P+ + +  + LF +   E    P +L  +A+  +   L+ +P  R 
Sbjct: 194 GLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRL 252
Query: 222 ----PTVTELMEHPF 232
                   E+M+H F
Sbjct: 253 GGGSEDAKEIMQHRF 267

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 101/195 (51%), Gaps = 22/195 (11%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSS------YTRQILNGLVYLH-ERNVVHRDI 104
           +RL   +E    G L      +HLS  +V S      Y  +I++ L YLH E+NVV+RD+
Sbjct: 83  DRLCFVMEYANGGELF-----FHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 137
Query: 105 KCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGLTADIW 162
           K  N+++D  G +K+ DFGL K    +   +K   GTP ++APEV+  +++ YG   D W
Sbjct: 138 KLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL--EDNDYGRAVDWW 195
Query: 163 SLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR- 221
            LG  + EM+  R P+ + +  + LF +   E    P +L  +A+  +   L+ +P  R 
Sbjct: 196 GLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRL 254
Query: 222 ----PTVTELMEHPF 232
                   E+M+H F
Sbjct: 255 GGGSEDAKEIMQHRF 269

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 39/218 (17%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +YI  +L+ +  L  L +  HLS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ 
Sbjct: 105 VYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 163
Query: 114 SGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCT 167
           +  +K+ DFGLA+    +      L     T ++ APE+ +NSK  GY  + DIWS+GC 
Sbjct: 164 TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK--GYTKSIDIWSVGCI 221
Query: 168 VLEMLTRRPPY---SHLEGVQALFRI----------------GKGELPSVPS-------- 200
           + EML+ RP +    +L+ +  +  I                 +  L S+P         
Sbjct: 222 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 281
Query: 201 ---SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
              +    A D + K L  NP+ R  V + + HP++++
Sbjct: 282 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 39/218 (17%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +YI  +L+ +  L  L +  HLS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ 
Sbjct: 106 VYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 164
Query: 114 SGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCT 167
           +  +K+ DFGLA+    +      L     T ++ APE+ +NSK  GY  + DIWS+GC 
Sbjct: 165 TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK--GYTKSIDIWSVGCI 222
Query: 168 VLEMLTRRPPY---SHLEGVQALFRI----------------GKGELPSVPS-------- 200
           + EML+ RP +    +L+ +  +  I                 +  L S+P         
Sbjct: 223 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 282
Query: 201 ---SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
              +    A D + K L  NP+ R  V + + HP++++
Sbjct: 283 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 320

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 39/218 (17%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +YI  +L+ +  L  L +  HLS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ 
Sbjct: 101 VYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 159
Query: 114 SGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCT 167
           +  +K+ DFGLA+    +      L     T ++ APE+ +NSK  GY  + DIWS+GC 
Sbjct: 160 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCI 217
Query: 168 VLEMLTRRPPY---SHLEGVQALFRI----------------GKGELPSVPS-------- 200
           + EML+ RP +    +L+ +  +  I                 +  L S+P         
Sbjct: 218 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 277
Query: 201 ---SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
              +    A D + K L  NP+ R  V + + HP++++
Sbjct: 278 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/152 (36%), Positives = 86/152 (56%), Gaps = 6/152 (3%)
Query: 87  ILNGLVYLHER-NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSC-KGTPFWMA 144
           I+  L +LH + +V+HRD+K +N+L++A G VK  DFG++     +  K    G   + A
Sbjct: 145 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXA 204
Query: 145 PEVVNSK--NDGYGLTADIWSLGCTVLEMLTRRPPY-SHLEGVQALFRIGKGELPSVPS- 200
           PE +N +    GY + +DIWSLG T +E+   R PY S     Q L ++ +   P +P+ 
Sbjct: 205 PERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 264
Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
             S +  DF  +CL+ N  +RPT  EL +HPF
Sbjct: 265 KFSAEFVDFTSQCLKKNSKERPTYPELXQHPF 296

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 39/218 (17%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +YI  +L+ +  L  L +  HLS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ 
Sbjct: 109 VYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 167
Query: 114 SGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCT 167
           +  +K+ DFGLA+    +      L     T ++ APE+ +NSK  GY  + DIWS+GC 
Sbjct: 168 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCI 225
Query: 168 VLEMLTRRPPY---SHLEGVQALFRI----------------GKGELPSVPS-------- 200
           + EML+ RP +    +L+ +  +  I                 +  L S+P         
Sbjct: 226 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 285
Query: 201 ---SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
              +    A D + K L  NP+ R  V + + HP++++
Sbjct: 286 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 323

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 39/218 (17%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +YI  +L+ +  L  L +  HLS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ 
Sbjct: 101 VYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 159
Query: 114 SGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCT 167
           +  +K+ DFGLA+    +      L     T ++ APE+ +NSK  GY  + DIWS+GC 
Sbjct: 160 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCI 217
Query: 168 VLEMLTRRPPY---SHLEGVQALFRI----------------GKGELPSVPS-------- 200
           + EML+ RP +    +L+ +  +  I                 +  L S+P         
Sbjct: 218 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 277
Query: 201 ---SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
              +    A D + K L  NP+ R  V + + HP++++
Sbjct: 278 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 39/218 (17%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +YI  +L+ +  L  L +  HLS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ 
Sbjct: 106 VYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 164
Query: 114 SGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCT 167
           +  +K+ DFGLA+    +      L     T ++ APE+ +NSK  GY  + DIWS+GC 
Sbjct: 165 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCI 222
Query: 168 VLEMLTRRPPY---SHLEGVQALFRI----------------GKGELPSVPS-------- 200
           + EML+ RP +    +L+ +  +  I                 +  L S+P         
Sbjct: 223 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 282
Query: 201 ---SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
              +    A D + K L  NP+ R  V + + HP++++
Sbjct: 283 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 320

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 39/218 (17%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +YI  +L+ +  L  L +  HLS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ 
Sbjct: 107 VYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 165
Query: 114 SGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCT 167
           +  +K+ DFGLA+    +      L     T ++ APE+ +NSK  GY  + DIWS+GC 
Sbjct: 166 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCI 223
Query: 168 VLEMLTRRPPY---SHLEGVQALFRI----------------GKGELPSVPS-------- 200
           + EML+ RP +    +L+ +  +  I                 +  L S+P         
Sbjct: 224 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 283
Query: 201 ---SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
              +    A D + K L  NP+ R  V + + HP++++
Sbjct: 284 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 321

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 39/218 (17%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +YI  +L+ +  L  L +  HLS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ 
Sbjct: 98  VYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 156
Query: 114 SGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCT 167
           +  +K+ DFGLA+    +      L     T ++ APE+ +NSK  GY  + DIWS+GC 
Sbjct: 157 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCI 214
Query: 168 VLEMLTRRPPY---SHLEGVQALFRI----------------GKGELPSVPS-------- 200
           + EML+ RP +    +L+ +  +  I                 +  L S+P         
Sbjct: 215 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 274
Query: 201 ---SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
              +    A D + K L  NP+ R  V + + HP++++
Sbjct: 275 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 312

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 39/218 (17%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +YI  +L+ +  L  L +  HLS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ 
Sbjct: 105 VYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 163
Query: 114 SGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCT 167
           +  +K+ DFGLA+    +      L     T ++ APE+ +NSK  GY  + DIWS+GC 
Sbjct: 164 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCI 221
Query: 168 VLEMLTRRPPY---SHLEGVQALFRI----------------GKGELPSVPS-------- 200
           + EML+ RP +    +L+ +  +  I                 +  L S+P         
Sbjct: 222 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 281
Query: 201 ---SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
              +    A D + K L  NP+ R  V + + HP++++
Sbjct: 282 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 39/218 (17%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +YI  +L+ +  L  L +  HLS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ 
Sbjct: 99  VYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 157
Query: 114 SGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCT 167
           +  +K+ DFGLA+    +      L     T ++ APE+ +NSK  GY  + DIWS+GC 
Sbjct: 158 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCI 215
Query: 168 VLEMLTRRPPY---SHLEGVQALFRI----------------GKGELPSVPS-------- 200
           + EML+ RP +    +L+ +  +  I                 +  L S+P         
Sbjct: 216 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 275
Query: 201 ---SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
              +    A D + K L  NP+ R  V + + HP++++
Sbjct: 276 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 313

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 39/218 (17%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +YI  +L+ +  L  L +  HLS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ 
Sbjct: 103 VYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 161
Query: 114 SGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCT 167
           +  +K+ DFGLA+    +      L     T ++ APE+ +NSK  GY  + DIWS+GC 
Sbjct: 162 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCI 219
Query: 168 VLEMLTRRPPY---SHLEGVQALFRI----------------GKGELPSVPS-------- 200
           + EML+ RP +    +L+ +  +  I                 +  L S+P         
Sbjct: 220 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 279
Query: 201 ---SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
              +    A D + K L  NP+ R  V + + HP++++
Sbjct: 280 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 317

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 39/218 (17%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +YI  +L+ +  L  L +  HLS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ 
Sbjct: 105 VYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 163
Query: 114 SGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCT 167
           +  +K+ DFGLA+    +      L     T ++ APE+ +NSK  GY  + DIWS+GC 
Sbjct: 164 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCI 221
Query: 168 VLEMLTRRPPY---SHLEGVQALFRI----------------GKGELPSVPS-------- 200
           + EML+ RP +    +L+ +  +  I                 +  L S+P         
Sbjct: 222 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 281
Query: 201 ---SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
              +    A D + K L  NP+ R  V + + HP++++
Sbjct: 282 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 113/220 (51%), Gaps = 19/220 (8%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSLAN--LYQKYHLSDSQVSSYTRQILNGLVYL 94
           +  NI+       D   +Y+  EL+  G L +  L QK+  S+ + S     I   + YL
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF-FSEREASFVLHTIGKTVEYL 137
Query: 95  HERNVVHRDIKCANIL-VDASGS---VKLADFGLAKATTMND---LKSCKGTPFWMAPEV 147
           H + VVHRD+K +NIL VD SG+   +++ DFG AK     +   +  C    F +APEV
Sbjct: 138 HSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANF-VAPEV 196
Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG---VQALFRIGKGELPSVP---SS 201
           +  K  GY    DIWSLG  +  ML    P+++       + L RIG G+        ++
Sbjct: 197 L--KRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNT 254
Query: 202 LSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPR 241
           +S  A+D + K L V+P+ R T  ++++HP+V +  + P+
Sbjct: 255 VSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQ 294

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 39/218 (17%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +YI  +L+ +  L  L +  HLS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ 
Sbjct: 121 VYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 179
Query: 114 SGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCT 167
           +  +K+ DFGLA+    +      L     T ++ APE+ +NSK  GY  + DIWS+GC 
Sbjct: 180 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCI 237
Query: 168 VLEMLTRRPPY---SHLEGVQALFRI----------------GKGELPSVPS-------- 200
           + EML+ RP +    +L+ +  +  I                 +  L S+P         
Sbjct: 238 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 297
Query: 201 ---SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
              +    A D + K L  NP+ R  V + + HP++++
Sbjct: 298 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 335

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 41/215 (19%)
Query: 60  LVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS 116
           LVT    A+LY+     HLS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ +  
Sbjct: 123 LVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD 182
Query: 117 VKLADFGLAKATTMND-----LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCTVLE 170
           +K+ DFGLA+    +      L     T ++ APE+ +NSK  GY  + DIWS+GC + E
Sbjct: 183 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCILAE 240
Query: 171 MLTRRPPY---SHLEGVQALFRI----------------GKGELPSVPS----------- 200
           ML+ RP +    +L+ +  +  I                 +  L S+P            
Sbjct: 241 MLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP 300
Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
           +    A D + K L  NP+ R  V + + HP++++
Sbjct: 301 NADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 335

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 92/184 (50%), Gaps = 9/184 (4%)
Query: 51  ENRLYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           E  +YI  E ++KG L +  +     +L   Q+     QI +G+ Y+   N VHRD++ A
Sbjct: 84  EEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 143
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSL 164
           NILV  +   K+ADFGLA+    N+  + +G  F   W APE   +    + + +D+WS 
Sbjct: 144 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA--ALYGRFTIKSDVWSF 201
Query: 165 GCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           G  + E+ T+ R PY  +   + L ++ +G     P        D + +C + +P +RPT
Sbjct: 202 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPT 261
Query: 224 VTEL 227
              L
Sbjct: 262 FEYL 265

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 92.8 bits (229), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 95/170 (55%), Gaps = 6/170 (3%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYLHERN 98
           NIV  +  D++++  Y+ +E +   +L+   + +  LS     ++T QIL+G+ + H+  
Sbjct: 72  NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR 131
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKA---TTMNDLKSCKGTPFWMAPEVVNSKNDGY 155
           +VHRDIK  NIL+D++ ++K+ DFG+AKA   T++       GT  + +PE   +K +  
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE--QAKGEAT 189
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRD 205
               DI+S+G  + EML   PP++    V    +  +  +P+V + + +D
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD 239

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 92.8 bits (229), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 17/219 (7%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSLAN--LYQKYHLSDSQVSSYTRQILNGLVYL 94
           +  NI+       D   +Y+  EL   G L +  L QK+  S+ + S+    I   + YL
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKF-FSEREASAVLFTITKTVEYL 132
Query: 95  HERNVVHRDIKCANIL-VDASG---SVKLADFGLAKATTMND--LKSCKGTPFWMAPEVV 148
           H + VVHRD+K +NIL VD SG   S+++ DFG AK     +  L +   T  ++APEV+
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVL 192
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG---VQALFRIGKGELP---SVPSSL 202
             +  GY    DIWSLG  +   LT   P+++       + L RIG G+        +S+
Sbjct: 193 ERQ--GYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250
Query: 203 SRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPR 241
           S  A+D + K L V+P+ R T   ++ HP++    Q P+
Sbjct: 251 SDTAKDLVSKXLHVDPHQRLTAALVLRHPWIVHWDQLPQ 289

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/185 (31%), Positives = 93/185 (50%), Gaps = 11/185 (5%)
Query: 51  ENRLYIFLELVTKGSLANLYQ----KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKC 106
           E  +YI  E ++KGSL +  +    KY L   Q+     QI +G+ Y+   N VHRD++ 
Sbjct: 250 EEPIYIVGEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 308
Query: 107 ANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWS 163
           ANILV  +   K+ADFGLA+    N+  + +G  F   W APE   +    + + +D+WS
Sbjct: 309 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA--ALYGRFTIKSDVWS 366
Query: 164 LGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP 222
            G  + E+ T+ R PY  +   + L ++ +G     P        D + +C +  P +RP
Sbjct: 367 FGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERP 426
Query: 223 TVTEL 227
           T   L
Sbjct: 427 TFEYL 431

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 93/192 (48%), Gaps = 11/192 (5%)
Query: 54  LYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           + +  EL   GSL +  +K+  H     +S Y  Q+  G+ YL  +  +HRD+   N+L+
Sbjct: 89  MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL 148
Query: 112 DASGSVKLADFGLAKATTMND----LKSCKGTPF-WMAPEVVNSKNDGYGLTADIWSLGC 166
                VK+ DFGL +A   ND    ++  +  PF W APE + ++   +   +D W  G 
Sbjct: 149 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGV 206
Query: 167 TVLEMLTR-RPPYSHLEGVQALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRPTV 224
           T+ EM T  + P+  L G Q L +I K GE    P    +D  + +++C    P DRPT 
Sbjct: 207 TLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 266
Query: 225 TELMEHPFVKRP 236
             L +     +P
Sbjct: 267 VALRDFLLEAQP 278

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 91/187 (48%), Gaps = 11/187 (5%)
Query: 59  ELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS 116
           EL   GSL +  +K+  H     +S Y  Q+  G+ YL  +  +HRD+   N+L+     
Sbjct: 100 ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL 159
Query: 117 VKLADFGLAKATTMND----LKSCKGTPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           VK+ DFGL +A   ND    ++  +  PF W APE + ++   +   +D W  G T+ EM
Sbjct: 160 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEM 217
Query: 172 LTR-RPPYSHLEGVQALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
            T  + P+  L G Q L +I K GE    P    +D  + +++C    P DRPT   L +
Sbjct: 218 FTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277
Query: 230 HPFVKRP 236
                +P
Sbjct: 278 FLLEAQP 284

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 93/192 (48%), Gaps = 11/192 (5%)
Query: 54  LYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           + +  EL   GSL +  +K+  H     +S Y  Q+  G+ YL  +  +HRD+   N+L+
Sbjct: 95  MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL 154
Query: 112 DASGSVKLADFGLAKATTMND----LKSCKGTPF-WMAPEVVNSKNDGYGLTADIWSLGC 166
                VK+ DFGL +A   ND    ++  +  PF W APE + ++   +   +D W  G 
Sbjct: 155 ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGV 212
Query: 167 TVLEMLTR-RPPYSHLEGVQALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRPTV 224
           T+ EM T  + P+  L G Q L +I K GE    P    +D  + +++C    P DRPT 
Sbjct: 213 TLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 272
Query: 225 TELMEHPFVKRP 236
             L +     +P
Sbjct: 273 VALRDFLLEAQP 284

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 91/187 (48%), Gaps = 11/187 (5%)
Query: 59  ELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS 116
           EL   GSL +  +K+  H     +S Y  Q+  G+ YL  +  +HRD+   N+L+     
Sbjct: 90  ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL 149
Query: 117 VKLADFGLAKATTMND----LKSCKGTPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           VK+ DFGL +A   ND    ++  +  PF W APE + ++   +   +D W  G T+ EM
Sbjct: 150 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEM 207
Query: 172 LTR-RPPYSHLEGVQALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
            T  + P+  L G Q L +I K GE    P    +D  + +++C    P DRPT   L +
Sbjct: 208 FTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267
Query: 230 HPFVKRP 236
                +P
Sbjct: 268 FLLEAQP 274

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 39/218 (17%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +YI  +L+ +  L  L +  HLS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ 
Sbjct: 103 VYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 161
Query: 114 SGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCT 167
           +  +K+ DFGLA+    +      L     T ++ APE+ +NSK  GY  + DIWS+GC 
Sbjct: 162 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCI 219
Query: 168 VLEMLTRRPPY---SHLEGVQALFRI----------------GKGELPSVPS-------- 200
           + EML+ RP +    +L+ +  +  I                 +  L S+P         
Sbjct: 220 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 279
Query: 201 ---SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
              +    A D + K L  NP+ R  V + + HP++ +
Sbjct: 280 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQ 317

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 91/187 (48%), Gaps = 11/187 (5%)
Query: 59  ELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS 116
           EL   GSL +  +K+  H     +S Y  Q+  G+ YL  +  +HRD+   N+L+     
Sbjct: 90  ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL 149
Query: 117 VKLADFGLAKATTMND----LKSCKGTPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           VK+ DFGL +A   ND    ++  +  PF W APE + ++   +   +D W  G T+ EM
Sbjct: 150 VKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEM 207
Query: 172 LTR-RPPYSHLEGVQALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
            T  + P+  L G Q L +I K GE    P    +D  + +++C    P DRPT   L +
Sbjct: 208 FTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267
Query: 230 HPFVKRP 236
                +P
Sbjct: 268 FLLEAQP 274

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 88/178 (49%), Gaps = 11/178 (6%)
Query: 59  ELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS 116
           EL   GSL +  +K+  H     +S Y  Q+  G+ YL  +  +HRD+   N+L+     
Sbjct: 90  ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL 149
Query: 117 VKLADFGLAKATTMND----LKSCKGTPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           VK+ DFGL +A   ND    ++  +  PF W APE + ++   +   +D W  G T+ EM
Sbjct: 150 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEM 207
Query: 172 LTR-RPPYSHLEGVQALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
            T  + P+  L G Q L +I K GE    P    +D  + +++C    P DRPT   L
Sbjct: 208 FTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 91/184 (49%), Gaps = 9/184 (4%)
Query: 51  ENRLYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           E  +YI  E ++KGSL +  +     +L   Q+     QI +G+ Y+   N VHRD++ A
Sbjct: 251 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 310
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSL 164
           NILV  +   K+ADFGL +    N+  + +G  F   W APE        + + +D+WS 
Sbjct: 311 NILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSF 368
Query: 165 GCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           G  + E+ T+ R PY  +   + L ++ +G     P        D + +C + +P +RPT
Sbjct: 369 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPT 428
Query: 224 VTEL 227
              L
Sbjct: 429 FEYL 432

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 88/178 (49%), Gaps = 11/178 (6%)
Query: 59  ELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS 116
           EL   GSL +  +K+  H     +S Y  Q+  G+ YL  +  +HRD+   N+L+     
Sbjct: 94  ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL 153
Query: 117 VKLADFGLAKATTMND----LKSCKGTPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           VK+ DFGL +A   ND    ++  +  PF W APE + ++   +   +D W  G T+ EM
Sbjct: 154 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEM 211
Query: 172 LTR-RPPYSHLEGVQALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
            T  + P+  L G Q L +I K GE    P    +D  + +++C    P DRPT   L
Sbjct: 212 FTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 269

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 39/218 (17%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +YI  +L+ +  L  L +  HLS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ 
Sbjct: 105 VYIVQDLM-ETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 163
Query: 114 SGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCT 167
           +  +K+ DFGLA+    +      L     T ++ APE+ +NSK  GY  + DIWS+GC 
Sbjct: 164 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCI 221
Query: 168 VLEMLTRRPPY---SHLEGVQALFRI----------------GKGELPSVPS-------- 200
           + EML+ RP +    +L+ +  +  I                 +  L S+P         
Sbjct: 222 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 281
Query: 201 ---SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
              +    A D + K L  NP+ R  V + + HP++++
Sbjct: 282 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NI++     +D+   Y+  E    G L   +  ++   +   ++  +QIL+G+ YLH+ N
Sbjct: 107 NIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN 166
Query: 99  VVHRDIKCANILVDASGS---VKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDG 154
           +VHRDIK  NIL++   S   +K+ DFGL+   + +  L+   GT +++APEV+  K   
Sbjct: 167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKK--- 223
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP---SVPSSLSRDARDFIL 211
           Y    D+WS G  +  +L   PP+        + ++ KG+     +   ++S +A++ I 
Sbjct: 224 YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIK 283
Query: 212 KCLQVNPNDRPTVTELMEHPFVKR 235
             L  + N R T  E +   ++K+
Sbjct: 284 LMLTYDYNKRCTAEEALNSRWIKK 307

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 104/199 (52%), Gaps = 24/199 (12%)
Query: 54  LYIFLELVTKGSLA---------NLYQKYHLSDSQVS-----SYTRQILNGLVYLHERNV 99
           + +F+   TK  LA         +LY   H+ +++          RQ   G+ YLH +++
Sbjct: 66  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 100 VHRDIKCANILVDASGSVKLADFGLA----KATTMNDLKSCKGTPFWMAPEVVNSKN-DG 154
           +HRD+K  NI +    +VK+ DFGLA    + +  +  +   G+  WMAPEV+  ++ + 
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGV-QALFRIGKG----ELPSVPSSLSRDARDF 209
           Y   +D+++ G  + E++T + PYS++    Q +F +G+G    +L  V S+  +  +  
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL 245
Query: 210 ILKCLQVNPNDRPTVTELM 228
           + +CL+   ++RP   +++
Sbjct: 246 MAECLKKKRDERPLFPQIL 264

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 49  KDENRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           +DE  +++ ++L+  G L  +L Q  H  +  V  +  +++  L YL  + ++HRD+K  
Sbjct: 85  QDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPD 144
Query: 108 NILVDASGSVKLADFGLAKATTM-NDLKSCKGTPFWMAPEVVNS-KNDGYGLTADIWSLG 165
           NIL+D  G V + DF +A        + +  GT  +MAPE+ +S K  GY    D WSLG
Sbjct: 145 NILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLG 204
Query: 166 CTVLEMLTRRPPYSHLE---GVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR- 221
            T  E+L  R PY H+      + +    +  + + PS+ S++    + K L+ NP+ R 
Sbjct: 205 VTAYELLRGRRPY-HIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRF 263
Query: 222 PTVTELMEHP----------FVKR--PLQTPRCGQANC 247
             ++++   P          F KR  P   P  G+ NC
Sbjct: 264 SQLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLNC 301

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 103/199 (51%), Gaps = 24/199 (12%)
Query: 54  LYIFLELVTKGSLA---------NLYQKYHLSDSQVS-----SYTRQILNGLVYLHERNV 99
           + +F+   TK  LA         +LY   H+ +++          RQ   G+ YLH +++
Sbjct: 93  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 152
Query: 100 VHRDIKCANILVDASGSVKLADFGLA----KATTMNDLKSCKGTPFWMAPEVVNSKNDG- 154
           +HRD+K  NI +    +VK+ DFGLA    + +  +  +   G+  WMAPEV+  ++   
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 212
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGV-QALFRIGKG----ELPSVPSSLSRDARDF 209
           Y   +D+++ G  + E++T + PYS++    Q +F +G+G    +L  V S+  +  +  
Sbjct: 213 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL 272
Query: 210 ILKCLQVNPNDRPTVTELM 228
           + +CL+   ++RP   +++
Sbjct: 273 MAECLKKKRDERPLFPQIL 291

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 103/199 (51%), Gaps = 24/199 (12%)
Query: 54  LYIFLELVTKGSLA---------NLYQKYHLSDSQVS-----SYTRQILNGLVYLHERNV 99
           + +F+   TK  LA         +LY   H+ +++          RQ   G+ YLH +++
Sbjct: 94  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 153
Query: 100 VHRDIKCANILVDASGSVKLADFGLA----KATTMNDLKSCKGTPFWMAPEVVNSKNDG- 154
           +HRD+K  NI +    +VK+ DFGLA    + +  +  +   G+  WMAPEV+  ++   
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGV-QALFRIGKG----ELPSVPSSLSRDARDF 209
           Y   +D+++ G  + E++T + PYS++    Q +F +G+G    +L  V S+  +  +  
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL 273
Query: 210 ILKCLQVNPNDRPTVTELM 228
           + +CL+   ++RP   +++
Sbjct: 274 MAECLKKKRDERPLFPQIL 292

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 103/199 (51%), Gaps = 24/199 (12%)
Query: 54  LYIFLELVTKGSLA---------NLYQKYHLSDSQVS-----SYTRQILNGLVYLHERNV 99
           + +F+   TK  LA         +LY   H+ +++          RQ   G+ YLH +++
Sbjct: 86  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 145
Query: 100 VHRDIKCANILVDASGSVKLADFGLA----KATTMNDLKSCKGTPFWMAPEVVNSKNDG- 154
           +HRD+K  NI +    +VK+ DFGLA    + +  +  +   G+  WMAPEV+  ++   
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 205
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGV-QALFRIGKG----ELPSVPSSLSRDARDF 209
           Y   +D+++ G  + E++T + PYS++    Q +F +G+G    +L  V S+  +  +  
Sbjct: 206 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL 265
Query: 210 ILKCLQVNPNDRPTVTELM 228
           + +CL+   ++RP   +++
Sbjct: 266 MAECLKKKRDERPLFPQIL 284

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 103/199 (51%), Gaps = 24/199 (12%)
Query: 54  LYIFLELVTKGSLA---------NLYQKYHLSDSQVS-----SYTRQILNGLVYLHERNV 99
           + +F+   TK  LA         +LY   H+ +++          RQ   G+ YLH +++
Sbjct: 94  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 153
Query: 100 VHRDIKCANILVDASGSVKLADFGLA----KATTMNDLKSCKGTPFWMAPEVVNSKNDG- 154
           +HRD+K  NI +    +VK+ DFGLA    + +  +  +   G+  WMAPEV+  ++   
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGV-QALFRIGKG----ELPSVPSSLSRDARDF 209
           Y   +D+++ G  + E++T + PYS++    Q +F +G+G    +L  V S+  +  +  
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL 273
Query: 210 ILKCLQVNPNDRPTVTELM 228
           + +CL+   ++RP   +++
Sbjct: 274 MAECLKKKRDERPLFPQIL 292

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 104/199 (52%), Gaps = 24/199 (12%)
Query: 54  LYIFLELVTKGSLA---------NLYQKYHLSDSQVS-----SYTRQILNGLVYLHERNV 99
           + +F+   TK  LA         +LY   H+ +++          RQ   G+ YLH +++
Sbjct: 71  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 130
Query: 100 VHRDIKCANILVDASGSVKLADFGLA----KATTMNDLKSCKGTPFWMAPEVVNSKN-DG 154
           +HRD+K  NI +    +VK+ DFGLA    + +  +  +   G+  WMAPEV+  ++ + 
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGV-QALFRIGKG----ELPSVPSSLSRDARDF 209
           Y   +D+++ G  + E++T + PYS++    Q +F +G+G    +L  V S+  +  +  
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL 250
Query: 210 ILKCLQVNPNDRPTVTELM 228
           + +CL+   ++RP   +++
Sbjct: 251 MAECLKKKRDERPLFPQIL 269

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 109/208 (52%), Gaps = 14/208 (6%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYL 94
            +  NIV+   + ++E+  Y+  +LVT G L  ++  +   S++  S   +QIL  + Y 
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 95  HERNVVHRDIKCANILVDAS---GSVKLADFGLAKATTMNDLKSCK---GTPFWMAPEVV 148
           H   +VHR++K  N+L+ +     +VKLADFGL  A  +ND ++     GTP +++PEV+
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPY--SHLEGVQALFRIGKGELPSVP-SSLSRD 205
             K D Y    DIW+ G  +  +L   PP+       + A  + G  + PS    +++ +
Sbjct: 180 --KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 237
Query: 206 ARDFILKCLQVNPNDRPTVTELMEHPFV 233
           A+  I   L VNP  R T  + ++ P++
Sbjct: 238 AKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 109/208 (52%), Gaps = 14/208 (6%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYL 94
            +  NIV+   + ++E+  Y+  +LVT G L  ++  +   S++  S   +QIL  + Y 
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 120
Query: 95  HERNVVHRDIKCANILVDAS---GSVKLADFGLAKATTMNDLKSCK---GTPFWMAPEVV 148
           H   +VHR++K  N+L+ +     +VKLADFGL  A  +ND ++     GTP +++PEV+
Sbjct: 121 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFAGTPGYLSPEVL 178
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPY--SHLEGVQALFRIGKGELPSVP-SSLSRD 205
             K D Y    DIW+ G  +  +L   PP+       + A  + G  + PS    +++ +
Sbjct: 179 --KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 236
Query: 206 ARDFILKCLQVNPNDRPTVTELMEHPFV 233
           A+  I   L VNP  R T  + ++ P++
Sbjct: 237 AKSLIDSMLTVNPKKRITADQALKVPWI 264

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 104/199 (52%), Gaps = 24/199 (12%)
Query: 54  LYIFLELVTKGSLA---------NLYQKYHLSDSQVS-----SYTRQILNGLVYLHERNV 99
           + +F+   TK  LA         +LY   H+ +++          RQ   G+ YLH +++
Sbjct: 71  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 130
Query: 100 VHRDIKCANILVDASGSVKLADFGLA----KATTMNDLKSCKGTPFWMAPEVVNSKN-DG 154
           +HRD+K  NI +    +VK+ DFGLA    + +  +  +   G+  WMAPEV+  ++ + 
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGV-QALFRIGKG----ELPSVPSSLSRDARDF 209
           Y   +D+++ G  + E++T + PYS++    Q +F +G+G    +L  V S+  +  +  
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL 250
Query: 210 ILKCLQVNPNDRPTVTELM 228
           + +CL+   ++RP   +++
Sbjct: 251 MAECLKKKRDERPLFPQIL 269

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 97/177 (54%), Gaps = 15/177 (8%)
Query: 67  ANLYQKYHLSDSQVS-----SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLAD 121
           ++LY   H+ +++          RQ   G+ YLH ++++HRD+K  NI +    +VK+ D
Sbjct: 88  SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGD 147
Query: 122 FGLA----KATTMNDLKSCKGTPFWMAPEVVNSKN-DGYGLTADIWSLGCTVLEMLTRRP 176
           FGLA    + +  +  +   G+  WMAPEV+  ++ + Y   +D+++ G  + E++T + 
Sbjct: 148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 207
Query: 177 PYSHLEGV-QALFRIGKG----ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           PYS++    Q +F +G+G    +L  V S+  +  +  + +CL+   ++RP   +++
Sbjct: 208 PYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 97/177 (54%), Gaps = 15/177 (8%)
Query: 67  ANLYQKYHLSDSQVS-----SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLAD 121
           ++LY   H+ +++          RQ   G+ YLH ++++HRD+K  NI +    +VK+ D
Sbjct: 88  SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGD 147
Query: 122 FGLA----KATTMNDLKSCKGTPFWMAPEVVNSKN-DGYGLTADIWSLGCTVLEMLTRRP 176
           FGLA    + +  +  +   G+  WMAPEV+  ++ + Y   +D+++ G  + E++T + 
Sbjct: 148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 207
Query: 177 PYSHLEGV-QALFRIGKG----ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           PYS++    Q +F +G+G    +L  V S+  +  +  + +CL+   ++RP   +++
Sbjct: 208 PYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 109/208 (52%), Gaps = 14/208 (6%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYL 94
            +  NIV+   + ++E+  Y+  +LVT G L  ++  +   S++  S   +QIL  + Y 
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 95  HERNVVHRDIKCANILVDAS---GSVKLADFGLAKATTMNDLKSCK---GTPFWMAPEVV 148
           H   +VHR++K  N+L+ +     +VKLADFGL  A  +ND ++     GTP +++PEV+
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPY--SHLEGVQALFRIGKGELPSVP-SSLSRD 205
             K D Y    DIW+ G  +  +L   PP+       + A  + G  + PS    +++ +
Sbjct: 180 --KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 237
Query: 206 ARDFILKCLQVNPNDRPTVTELMEHPFV 233
           A+  I   L VNP  R T  + ++ P++
Sbjct: 238 AKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 104/199 (52%), Gaps = 24/199 (12%)
Query: 54  LYIFLELVTKGSLA---------NLYQKYHLSDSQVS-----SYTRQILNGLVYLHERNV 99
           + +F+   TK  LA         +LY   H+ +++          RQ   G+ YLH +++
Sbjct: 68  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 127
Query: 100 VHRDIKCANILVDASGSVKLADFGLA----KATTMNDLKSCKGTPFWMAPEVVNSKN-DG 154
           +HRD+K  NI +    +VK+ DFGLA    + +  +  +   G+  WMAPEV+  ++ + 
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 187
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGV-QALFRIGKG----ELPSVPSSLSRDARDF 209
           Y   +D+++ G  + E++T + PYS++    Q +F +G+G    +L  V S+  +  +  
Sbjct: 188 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL 247
Query: 210 ILKCLQVNPNDRPTVTELM 228
           + +CL+   ++RP   +++
Sbjct: 248 MAECLKKKRDERPLFPQIL 266

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 109/208 (52%), Gaps = 14/208 (6%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYL 94
            +  NIV+   + ++E+  Y+  +LVT G L  ++  +   S++  S   +QIL  + Y 
Sbjct: 85  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 95  HERNVVHRDIKCANILVDAS---GSVKLADFGLAKATTMNDLKSCK---GTPFWMAPEVV 148
           H   +VHR++K  N+L+ +     +VKLADFGL  A  +ND ++     GTP +++PEV+
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFAGTPGYLSPEVL 202
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPY--SHLEGVQALFRIGKGELPSVP-SSLSRD 205
             K D Y    DIW+ G  +  +L   PP+       + A  + G  + PS    +++ +
Sbjct: 203 --KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 260
Query: 206 ARDFILKCLQVNPNDRPTVTELMEHPFV 233
           A+  I   L VNP  R T  + ++ P++
Sbjct: 261 AKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV      +    LY+ ++LV+ G L + + +K   ++   S    Q+L+ + YLH+  
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 99  VVHRDIKCANIL---VDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSK 151
           +VHRD+K  N+L   +D    + ++DFGL+K   M D    L +  GTP ++APEV+  K
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL---PSVPSSLSRDARD 208
              Y    D WS+G     +L   PP+      +   +I K E          +S  A+D
Sbjct: 194 P--YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 251
Query: 209 FILKCLQVNPNDRPTVTELMEHPFV 233
           FI   ++ +P  R T  + ++HP++
Sbjct: 252 FIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 91.3 bits (225), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA---SGSVKLADFGLAKATT-M 130
            ++ + S   + I   + YLH  N+ HRD+K  N+L  +   +  +KL DFG AK TT  
Sbjct: 158 FTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV------ 184
           N L +   TP+++APEV+    + Y  + D WSLG     +L   PP+    G+      
Sbjct: 218 NSLTTPCYTPYYVAPEVLGP--EKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGX 275
Query: 185 QALFRIGKGELPSVP-SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPR 241
           +   R G+ E P+   S +S + +  I   L+  P  R T+TE   HP++ +  + P+
Sbjct: 276 KTRIRXGQYEFPNPEWSEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQSTKVPQ 333

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           IV  +   +   +LY+ LE ++ G L   L ++    +     Y  +I   L +LH++ +
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGL 157
           ++RD+K  NI+++  G VKL DFGL K +  +   +    GT  +MAPE++     G+  
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEIL--MRSGHNR 200
Query: 158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVN 217
             D WSLG  + +MLT  PP++     + + +I K +L ++P  L+++ARD + K L+ N
Sbjct: 201 AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-NLPPYLTQEARDLLKKLLKRN 259
Query: 218 PNDR-----PTVTELMEHPFVK 234
              R         E+  HPF +
Sbjct: 260 AASRLGAGPGDAGEVQAHPFFR 281

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV      +    LY+ ++LV+ G L + + +K   ++   S    Q+L+ + YLH+  
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 99  VVHRDIKCANIL---VDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSK 151
           +VHRD+K  N+L   +D    + ++DFGL+K   M D    L +  GTP ++APEV+  K
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL---PSVPSSLSRDARD 208
              Y    D WS+G     +L   PP+      +   +I K E          +S  A+D
Sbjct: 194 P--YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 251
Query: 209 FILKCLQVNPNDRPTVTELMEHPFV 233
           FI   ++ +P  R T  + ++HP++
Sbjct: 252 FIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV      +    LY+ ++LV+ G L + + +K   ++   S    Q+L+ + YLH+  
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 99  VVHRDIKCANIL---VDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSK 151
           +VHRD+K  N+L   +D    + ++DFGL+K   M D    L +  GTP ++APEV+  K
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL---PSVPSSLSRDARD 208
              Y    D WS+G     +L   PP+      +   +I K E          +S  A+D
Sbjct: 194 P--YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 251
Query: 209 FILKCLQVNPNDRPTVTELMEHPFV 233
           FI   ++ +P  R T  + ++HP++
Sbjct: 252 FIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 90.9 bits (224), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV      +    LY+ ++LV+ G L + + +K   ++   S    Q+L+ + YLH+  
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 99  VVHRDIKCANIL---VDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSK 151
           +VHRD+K  N+L   +D    + ++DFGL+K   M D    L +  GTP ++APEV+  K
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL---PSVPSSLSRDARD 208
              Y    D WS+G     +L   PP+      +   +I K E          +S  A+D
Sbjct: 194 P--YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 251
Query: 209 FILKCLQVNPNDRPTVTELMEHPFV 233
           FI   ++ +P  R T  + ++HP++
Sbjct: 252 FIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 90.9 bits (224), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           IV  +   +   +LY+ LE ++ G L   L ++    +     Y  +I   L +LH++ +
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGL 157
           ++RD+K  NI+++  G VKL DFGL K +  +   +    GT  +MAPE++     G+  
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEIL--MRSGHNR 200
Query: 158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVN 217
             D WSLG  + +MLT  PP++     + + +I K +L ++P  L+++ARD + K L+ N
Sbjct: 201 AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-NLPPYLTQEARDLLKKLLKRN 259
Query: 218 PNDR-----PTVTELMEHPFVK 234
              R         E+  HPF +
Sbjct: 260 AASRLGAGPGDAGEVQAHPFFR 281

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 102/199 (51%), Gaps = 24/199 (12%)
Query: 54  LYIFLELVTKGSLA---------NLYQKYHLSDSQVS-----SYTRQILNGLVYLHERNV 99
           + +F+   TK  LA         +LY   H S+++          RQ   G+ YLH +++
Sbjct: 82  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 100 VHRDIKCANILVDASGSVKLADFGLA----KATTMNDLKSCKGTPFWMAPEVVNSKNDG- 154
           +HRD+K  NI +    +VK+ DFGLA    + +  +  +   G+  WMAPEV+  ++   
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGV-QALFRIGKG----ELPSVPSSLSRDARDF 209
           Y   +D+++ G  + E++T + PYS++    Q +  +G+G    +L  V S+  +  +  
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 261
Query: 210 ILKCLQVNPNDRPTVTELM 228
           + +CL+   ++RP+   ++
Sbjct: 262 MAECLKKKRDERPSFPRIL 280

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 18/202 (8%)
Query: 49  KDENRLYIFLELVTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKC 106
           +DEN LY+ ++    G L  L  K+   L +     Y  +++  +  +H+ + VHRDIK 
Sbjct: 160 QDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKP 219
Query: 107 ANILVDASGSVKLADFGLAKATTMNDLKSCK-----GTPFWMAPEVVNSKNDG---YGLT 158
            N+L+D +G ++LADFG      MND  + +     GTP +++PE++ +  DG   YG  
Sbjct: 220 DNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPE 277
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE----LPSVPSSLSRDARDFI--LK 212
            D WSLG  + EML    P+     V+   +I   E     PS  + +S +A+D I  L 
Sbjct: 278 CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLI 337
Query: 213 CLQVNPNDRPTVTELMEHPFVK 234
           C +     +  + +  +H F +
Sbjct: 338 CSRERRLGQNGIEDFKKHAFFE 359

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 89/190 (46%), Gaps = 31/190 (16%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK 134
           L      S+  Q+LNG+ Y H+R V+HRD+K  N+L++  G +K+ADFGLA+A  +   K
Sbjct: 97  LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156
Query: 135 SCKG--TPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
                 T ++ AP+V+   +  Y  T DIWS+GC   EM+   P +  +     L RI +
Sbjct: 157 YTHEVVTLWYRAPDVLMG-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215
Query: 193 -------------GELP---------------SVPSSLSRDARDFILKCLQVNPNDRPTV 224
                         ELP               S    L     D + K L+++PN R T 
Sbjct: 216 ILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275
Query: 225 TELMEHPFVK 234
            + +EH + K
Sbjct: 276 KQALEHAYFK 285

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 90/180 (50%), Gaps = 9/180 (5%)
Query: 51  ENRLYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCA 107
           E  + I  E ++KGSL +  +     +L   Q+     QI +G+ Y+   N VHRD++ A
Sbjct: 74  EEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 133
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSL 164
           NILV  +   K+ADFGLA+    N+  + +G  F   W APE   +    + + +D+WS 
Sbjct: 134 NILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEA--ALYGRFTIKSDVWSF 191
Query: 165 GCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           G  + E+ T+ R PY  +   + L ++ +G     P        D + +C +  P +RPT
Sbjct: 192 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 251

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 89/190 (46%), Gaps = 31/190 (16%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK 134
           L      S+  Q+LNG+ Y H+R V+HRD+K  N+L++  G +K+ADFGLA+A  +   K
Sbjct: 97  LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156
Query: 135 SCKG--TPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
                 T ++ AP+V+   +  Y  T DIWS+GC   EM+   P +  +     L RI +
Sbjct: 157 YTHEIVTLWYRAPDVLMG-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215
Query: 193 -------------GELP---------------SVPSSLSRDARDFILKCLQVNPNDRPTV 224
                         ELP               S    L     D + K L+++PN R T 
Sbjct: 216 ILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275
Query: 225 TELMEHPFVK 234
            + +EH + K
Sbjct: 276 KQALEHAYFK 285

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 102/199 (51%), Gaps = 24/199 (12%)
Query: 54  LYIFLELVTKGSLA---------NLYQKYHLSDSQVS-----SYTRQILNGLVYLHERNV 99
           + +F+   TK  LA         +LY   H S+++          RQ   G+ YLH +++
Sbjct: 70  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 129
Query: 100 VHRDIKCANILVDASGSVKLADFGLA----KATTMNDLKSCKGTPFWMAPEVVNSKNDG- 154
           +HRD+K  NI +    +VK+ DFGLA    + +  +  +   G+  WMAPEV+  ++   
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 189
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGV-QALFRIGKG----ELPSVPSSLSRDARDF 209
           Y   +D+++ G  + E++T + PYS++    Q +  +G+G    +L  V S+  +  +  
Sbjct: 190 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 249
Query: 210 ILKCLQVNPNDRPTVTELM 228
           + +CL+   ++RP+   ++
Sbjct: 250 MAECLKKKRDERPSFPRIL 268

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 23/219 (10%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY----HLSDSQVSSYTRQILNGLVYLH 95
           NIV+  G     N + + +E    GSL N+        + + +   S+  Q   G+ YLH
Sbjct: 63  NIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 120
Query: 96  E---RNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSK 151
               + ++HRD+K  N+L+ A G+V K+ DFG A       + + KG+  WMAPEV    
Sbjct: 121 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-CDIQTHMTNNKGSAAWMAPEVFEGS 179
Query: 152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG--VQALFRIGKGELPSVPSSLSRDARDF 209
           N  Y    D++S G  + E++TRR P+  + G   + ++ +  G  P +  +L +     
Sbjct: 180 N--YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL 237
Query: 210 ILKCLQVNPNDRPTVTE---LMEH-----PFVKRPLQTP 240
           + +C   +P+ RP++ E   +M H     P    PLQ P
Sbjct: 238 MTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 276

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 18/202 (8%)
Query: 49  KDENRLYIFLELVTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKC 106
           +DEN LY+ ++    G L  L  K+   L +     Y  +++  +  +H+ + VHRDIK 
Sbjct: 144 QDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKP 203
Query: 107 ANILVDASGSVKLADFGLAKATTMNDLKSCK-----GTPFWMAPEVVNSKNDG---YGLT 158
            N+L+D +G ++LADFG      MND  + +     GTP +++PE++ +  DG   YG  
Sbjct: 204 DNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPE 261
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE----LPSVPSSLSRDARDFI--LK 212
            D WSLG  + EML    P+     V+   +I   E     PS  + +S +A+D I  L 
Sbjct: 262 CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLI 321
Query: 213 CLQVNPNDRPTVTELMEHPFVK 234
           C +     +  + +  +H F +
Sbjct: 322 CSRERRLGQNGIEDFKKHAFFE 343

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 89/190 (46%), Gaps = 31/190 (16%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK 134
           L      S+  Q+LNG+ Y H+R V+HRD+K  N+L++  G +K+ADFGLA+A  +   K
Sbjct: 97  LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156
Query: 135 SCKG--TPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
                 T ++ AP+V+   +  Y  T DIWS+GC   EM+   P +  +     L RI +
Sbjct: 157 YTHEVVTLWYRAPDVLMG-SKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFR 215
Query: 193 -------------GELP---------------SVPSSLSRDARDFILKCLQVNPNDRPTV 224
                         ELP               S    L     D + K L+++PN R T 
Sbjct: 216 ILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275
Query: 225 TELMEHPFVK 234
            + +EH + K
Sbjct: 276 KQALEHAYFK 285

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 95/177 (53%), Gaps = 15/177 (8%)
Query: 67  ANLYQKYHLSDSQVS-----SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLAD 121
           ++LY   H S+++          RQ   G+ YLH ++++HRD+K  NI +    +VK+ D
Sbjct: 104 SSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGD 163
Query: 122 FGLA----KATTMNDLKSCKGTPFWMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTRRP 176
           FGLA    + +  +  +   G+  WMAPEV+  ++   Y   +D+++ G  + E++T + 
Sbjct: 164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL 223
Query: 177 PYSHLEGV-QALFRIGKG----ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           PYS++    Q +  +G+G    +L  V S+  +  +  + +CL+   ++RP+   ++
Sbjct: 224 PYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRIL 280

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 23/219 (10%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY----HLSDSQVSSYTRQILNGLVYLH 95
           NIV+  G     N + + +E    GSL N+        + + +   S+  Q   G+ YLH
Sbjct: 62  NIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 96  E---RNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSK 151
               + ++HRD+K  N+L+ A G+V K+ DFG A       + + KG+  WMAPEV    
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-CDIQTHMTNNKGSAAWMAPEVFEGS 178
Query: 152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG--VQALFRIGKGELPSVPSSLSRDARDF 209
           N  Y    D++S G  + E++TRR P+  + G   + ++ +  G  P +  +L +     
Sbjct: 179 N--YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL 236
Query: 210 ILKCLQVNPNDRPTVTE---LMEH-----PFVKRPLQTP 240
           + +C   +P+ RP++ E   +M H     P    PLQ P
Sbjct: 237 MTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 275

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 90.5 bits (223), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 90/165 (54%), Gaps = 3/165 (1%)
Query: 69  LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT 128
           + +K  +++ +   + +QI+  + Y H   +VHRD+K  N+L+D + +VK+ADFGL+   
Sbjct: 99  IVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158
Query: 129 T-MNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQAL 187
           T  N LK+  G+P + APEV+N K    G   D+WS G  +  ML  R P+   E +  L
Sbjct: 159 TDGNFLKTSCGSPNYAAPEVINGKLYA-GPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNL 216
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
           F+     +  +P  LS  A+  I + +  +P  R T+ E+   P+
Sbjct: 217 FKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 90.5 bits (223), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 107/204 (52%), Gaps = 13/204 (6%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NI++     +D+   Y+  E+ T G L + +  +   S+   +   RQ+L+G+ Y+H+  
Sbjct: 111 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 170
Query: 99  VVHRDIKCANILVDAS---GSVKLADFGLAKA-TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
           +VHRD+K  N+L+++     ++++ DFGL+        +K   GT +++APEV++     
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--- 227
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG----ELPSVPSSLSRDARDFI 210
           Y    D+WS G  +  +L+  PP++       L ++ KG    ELP     +S  A+D I
Sbjct: 228 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK-KVSESAKDLI 286
Query: 211 LKCLQVNPNDRPTVTELMEHPFVK 234
            K L   P+ R +  + ++H +++
Sbjct: 287 RKMLTYVPSMRISARDALDHEWIQ 310

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 90.5 bits (223), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 107/204 (52%), Gaps = 13/204 (6%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NI++     +D+   Y+  E+ T G L + +  +   S+   +   RQ+L+G+ Y+H+  
Sbjct: 110 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 169
Query: 99  VVHRDIKCANILVDAS---GSVKLADFGLAKA-TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
           +VHRD+K  N+L+++     ++++ DFGL+        +K   GT +++APEV++     
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--- 226
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG----ELPSVPSSLSRDARDFI 210
           Y    D+WS G  +  +L+  PP++       L ++ KG    ELP     +S  A+D I
Sbjct: 227 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK-KVSESAKDLI 285
Query: 211 LKCLQVNPNDRPTVTELMEHPFVK 234
            K L   P+ R +  + ++H +++
Sbjct: 286 RKMLTYVPSMRISARDALDHEWIQ 309

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 90.5 bits (223), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 4/200 (2%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQ-VSSYTRQILNGLVYL 94
               NI++      D  R+Y+ LE   +G L    QK    D Q  ++   ++ + L+Y 
Sbjct: 80  LHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYC 139
Query: 95  HERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDG 154
           H + V+HRDIK  N+L+   G +K+ADFG +        K+  GT  ++ PE++  +   
Sbjct: 140 HGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEMIEGRM-- 197
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCL 214
           +    D+W +G    E+L   PP+      +   RI K +L   P+S+   A+D I K L
Sbjct: 198 HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDL-KFPASVPTGAQDLISKLL 256
Query: 215 QVNPNDRPTVTELMEHPFVK 234
           + NP++R  + ++  HP+V+
Sbjct: 257 RHNPSERLPLAQVSAHPWVR 276

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 90.5 bits (223), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 107/204 (52%), Gaps = 13/204 (6%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NI++     +D+   Y+  E+ T G L + +  +   S+   +   RQ+L+G+ Y+H+  
Sbjct: 93  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 152
Query: 99  VVHRDIKCANILVDAS---GSVKLADFGLAKA-TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
           +VHRD+K  N+L+++     ++++ DFGL+        +K   GT +++APEV++     
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--- 209
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG----ELPSVPSSLSRDARDFI 210
           Y    D+WS G  +  +L+  PP++       L ++ KG    ELP     +S  A+D I
Sbjct: 210 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW-KKVSESAKDLI 268
Query: 211 LKCLQVNPNDRPTVTELMEHPFVK 234
            K L   P+ R +  + ++H +++
Sbjct: 269 RKMLTYVPSMRISARDALDHEWIQ 292

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 90.5 bits (223), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVV 100
           +VQ     +D+  LY+ +E +  G L NL   Y + +     YT +++  L  +H    +
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 190
Query: 101 HRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK---GTPFWMAPEVVNSK-NDG-Y 155
           HRD+K  N+L+D SG +KLADFG         +  C    GTP +++PEV+ S+  DG Y
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYY 250
Query: 156 GLTADIWSLGCTVLEMLTRRPPY--SHLEGVQALFRIGKGELPSVP--SSLSRDARDFIL 211
           G   D WS+G  + EML    P+    L G  +     K  L + P  + +S++A++ I 
Sbjct: 251 GRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL-TFPDDNDISKEAKNLI- 308
Query: 212 KCLQVNPND----RPTVTELMEHPFVK 234
            C  +   +    R  V E+  H F K
Sbjct: 309 -CAFLTDREVRLGRNGVEEIKRHLFFK 334

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 90.5 bits (223), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 107/204 (52%), Gaps = 13/204 (6%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NI++     +D+   Y+  E+ T G L + +  +   S+   +   RQ+L+G+ Y+H+  
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 99  VVHRDIKCANILVDAS---GSVKLADFGLAKA-TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
           +VHRD+K  N+L+++     ++++ DFGL+        +K   GT +++APEV++     
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--- 203
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG----ELPSVPSSLSRDARDFI 210
           Y    D+WS G  +  +L+  PP++       L ++ KG    ELP     +S  A+D I
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK-KVSESAKDLI 262
Query: 211 LKCLQVNPNDRPTVTELMEHPFVK 234
            K L   P+ R +  + ++H +++
Sbjct: 263 RKMLTYVPSMRISARDALDHEWIQ 286

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 90.5 bits (223), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVV 100
           +VQ     +D+  LY+ +E +  G L NL   Y + +     YT +++  L  +H    +
Sbjct: 136 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 195
Query: 101 HRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK---GTPFWMAPEVVNSK-NDG-Y 155
           HRD+K  N+L+D SG +KLADFG         +  C    GTP +++PEV+ S+  DG Y
Sbjct: 196 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYY 255
Query: 156 GLTADIWSLGCTVLEMLTRRPPY--SHLEGVQALFRIGKGELPSVP--SSLSRDARDFIL 211
           G   D WS+G  + EML    P+    L G  +     K  L + P  + +S++A++ I 
Sbjct: 256 GRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL-TFPDDNDISKEAKNLI- 313
Query: 212 KCLQVNPND----RPTVTELMEHPFVK 234
            C  +   +    R  V E+  H F K
Sbjct: 314 -CAFLTDREVRLGRNGVEEIKRHLFFK 339

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVV 100
           +VQ     +D+  LY+ +E +  G L NL   Y + +     YT +++  L  +H    +
Sbjct: 136 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 195
Query: 101 HRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK---GTPFWMAPEVVNSK-NDG-Y 155
           HRD+K  N+L+D SG +KLADFG         +  C    GTP +++PEV+ S+  DG Y
Sbjct: 196 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYY 255
Query: 156 GLTADIWSLGCTVLEMLTRRPPY--SHLEGVQALFRIGKGELPSVP--SSLSRDARDFIL 211
           G   D WS+G  + EML    P+    L G  +     K  L + P  + +S++A++ I 
Sbjct: 256 GRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL-TFPDDNDISKEAKNLI- 313
Query: 212 KCLQVNPND----RPTVTELMEHPFVK 234
            C  +   +    R  V E+  H F K
Sbjct: 314 -CAFLTDREVRLGRNGVEEIKRHLFFK 339

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 26/219 (11%)
Query: 38  QDNIVQYLGT--DKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLH 95
            ++I++Y G   D+ E  L + +E V  GSL +   ++ +  +Q+  + +QI  G+ YLH
Sbjct: 75  HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 96  ERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTP-FWMAPEVVNS 150
            ++ +HR++   N+L+D    VK+ DFGLAKA         ++    +P FW APE +  
Sbjct: 135 SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL-- 192
Query: 151 KNDGYGLTADIWSLGCTVLEMLT-----RRPPYSHLE------GVQALFRIG----KGEL 195
           K   +   +D+WS G T+ E+LT     + PP   LE      G   + R+     +GE 
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 252
Query: 196 PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
              P     +    +  C +   + RPT   L+  P +K
Sbjct: 253 LPRPDKCPCEVYHLMKNCWETEASFRPTFENLI--PILK 289

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 90.1 bits (222), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 26/219 (11%)
Query: 38  QDNIVQYLGT--DKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLH 95
            ++I++Y G   D+ E  L + +E V  GSL +   ++ +  +Q+  + +QI  G+ YLH
Sbjct: 75  HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 96  ERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTP-FWMAPEVVNS 150
            ++ +HR++   N+L+D    VK+ DFGLAKA         ++    +P FW APE +  
Sbjct: 135 AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL-- 192
Query: 151 KNDGYGLTADIWSLGCTVLEMLT-----RRPPYSHLE------GVQALFRIG----KGEL 195
           K   +   +D+WS G T+ E+LT     + PP   LE      G   + R+     +GE 
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 252
Query: 196 PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
              P     +    +  C +   + RPT   L+  P +K
Sbjct: 253 LPRPDKCPCEVYHLMKNCWETEASFRPTFENLI--PILK 289

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 51/242 (21%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV-SSYTRQILNGLVYLHERN- 98
           IV + G    +  + I +E +  GSL  + +K      Q+    +  ++ GL YL E++ 
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 187
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y + 
Sbjct: 188 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--YSVQ 245
Query: 159 ADIWSLGCTVLEM---------------------------------------------LT 173
           +DIWS+G +++EM                                             + 
Sbjct: 246 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 305
Query: 174 RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
            RPP +  E +  +      +LPS   SL  + +DF+ KCL  NP +R  + +LM H F+
Sbjct: 306 SRPPMAIFELLDYIVNEPPPKLPSAVFSL--EFQDFVNKCLIKNPAERADLKQLMVHAFI 363
Query: 234 KR 235
           KR
Sbjct: 364 KR 365

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 92/163 (56%), Gaps = 7/163 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 129 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 187
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y +T DIWS+GC + E+
Sbjct: 188 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWMH-YNMTVDIWSVGCIMAEL 245
Query: 172 LTRR---PPYSHLEGVQALFRIGKGELPSVPSSL-SRDARDFI 210
           LT R   P   H+  +Q + R+      SV S + S +AR++I
Sbjct: 246 LTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYI 288

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH---LSDSQVSSYTRQILNGLV 92
            + D +VQ      +E  +YI  E + KGSL +  +      L    +     Q+  G+ 
Sbjct: 61  LKHDKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 119
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVN 149
           Y+   N +HRD++ ANILV      K+ADFGLA+    N+  + +G  F   W APE   
Sbjct: 120 YIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEA-- 177
Query: 150 SKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARD 208
           +    + + +D+WS G  + E++T+ R PY  +   + L ++ +G     P        +
Sbjct: 178 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHE 237
Query: 209 FILKCLQVNPNDRPTVTEL 227
            ++ C + +P +RPT   L
Sbjct: 238 LMIHCWKKDPEERPTFEYL 256

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 112/238 (47%), Gaps = 36/238 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGS-LANLYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NI++ +   +D+ R Y+  E +  GS LA++ ++ H ++ + S   R +   L +LH + 
Sbjct: 72  NILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKG 131
Query: 99  VVHRDIKCANILVDAS---GSVKLADFGLAKATTMN---------DLKSCKGTPFWMAPE 146
           + HRD+K  NIL ++      VK+ DF L     +N         +L +  G+  +MAPE
Sbjct: 132 IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPE 191
Query: 147 VVNSKNDG---YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQA--------------LF- 188
           VV    D    Y    D+WSLG  +  ML+  PP+    G                 LF 
Sbjct: 192 VVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 251
Query: 189 --RIGKGELPSVP-SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPRCG 243
             + GK E P    + +S +A+D I K L  +   R +  ++++HP+V+   Q P  G
Sbjct: 252 SIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQG--QAPEKG 307

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 89/168 (52%), Gaps = 9/168 (5%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS---GSVKLADFGLA-KATTM 130
           +S++ V    +QIL G+ YLH+ N+VH D+K  NIL+ +    G +K+ DFG++ K    
Sbjct: 128 VSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI 190
            +L+   GTP ++APE++N   D      D+W++G     +LT   P+   +  +    I
Sbjct: 188 CELREIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI 245
Query: 191 GKGEL---PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
            +  +       SS+S+ A DFI   L  NP  RPT    + H ++++
Sbjct: 246 SQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 104/219 (47%), Gaps = 26/219 (11%)
Query: 38  QDNIVQYLGTDKDEN--RLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLH 95
            ++I++Y G  +D     L + +E V  GSL +   ++ +  +Q+  + +QI  G+ YLH
Sbjct: 92  HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 96  ERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTP-FWMAPEVVNS 150
            ++ +HRD+   N+L+D    VK+ DFGLAKA         ++    +P FW APE +  
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKE 211
Query: 151 KNDGYGLTADIWSLGCTVLEMLT-----RRPPYSHLE------GVQALFRIG----KGEL 195
               Y   +D+WS G T+ E+LT     + PP   LE      G   + R+     +GE 
Sbjct: 212 YKFYY--ASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 269
Query: 196 PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
              P     +    +  C +   + RPT   L+  P +K
Sbjct: 270 LPRPDKCPAEVYHLMKNCWETEASFRPTFENLI--PILK 306

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 111/242 (45%), Gaps = 51/242 (21%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERN- 98
           IV + G    +  + I +E +  GSL  + +K   + +  +   +  ++ GL YL E++ 
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y + 
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--YSVQ 210
Query: 159 ADIWSLGCTVLEM---------------------------------------------LT 173
           +DIWS+G +++EM                                             + 
Sbjct: 211 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270
Query: 174 RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
            RPP +  E +  +      +LPS     S + +DF+ KCL  NP +R  + +LM H F+
Sbjct: 271 SRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328
Query: 234 KR 235
           KR
Sbjct: 329 KR 330

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 111/242 (45%), Gaps = 51/242 (21%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERN- 98
           IV + G    +  + I +E +  GSL  + +K   + +  +   +  ++ GL YL E++ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y + 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--YSVQ 183
Query: 159 ADIWSLGCTVLEM---------------------------------------------LT 173
           +DIWS+G +++EM                                             + 
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 174 RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
            RPP +  E +  +      +LPS     S + +DF+ KCL  NP +R  + +LM H F+
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
Query: 234 KR 235
           KR
Sbjct: 302 KR 303

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 111/242 (45%), Gaps = 51/242 (21%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERN- 98
           IV + G    +  + I +E +  GSL  + +K   + +  +   +  ++ GL YL E++ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y + 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--YSVQ 183
Query: 159 ADIWSLGCTVLEM---------------------------------------------LT 173
           +DIWS+G +++EM                                             + 
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 174 RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
            RPP +  E +  +      +LPS     S + +DF+ KCL  NP +R  + +LM H F+
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
Query: 234 KR 235
           KR
Sbjct: 302 KR 303

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 111/242 (45%), Gaps = 51/242 (21%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERN- 98
           IV + G    +  + I +E +  GSL  + +K   + +  +   +  ++ GL YL E++ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y + 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--YSVQ 183
Query: 159 ADIWSLGCTVLEM---------------------------------------------LT 173
           +DIWS+G +++EM                                             + 
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 174 RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
            RPP +  E +  +      +LPS     S + +DF+ KCL  NP +R  + +LM H F+
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
Query: 234 KR 235
           KR
Sbjct: 302 KR 303

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 111/242 (45%), Gaps = 51/242 (21%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERN- 98
           IV + G    +  + I +E +  GSL  + +K   + +  +   +  ++ GL YL E++ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y + 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--YSVQ 183
Query: 159 ADIWSLGCTVLEM---------------------------------------------LT 173
           +DIWS+G +++EM                                             + 
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 174 RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
            RPP +  E +  +      +LPS     S + +DF+ KCL  NP +R  + +LM H F+
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
Query: 234 KR 235
           KR
Sbjct: 302 KR 303

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 9/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE 96
           N+VQ LG    E   YI +E +T G+L +  +   +  +S   +     QI + + YL +
Sbjct: 68  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
           +N +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +    +
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL--AYN 185
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            + + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  
Sbjct: 186 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRA 245
Query: 213 CLQVNPNDRPTVTEL 227
           C Q NP+DRP+  E+
Sbjct: 246 CWQWNPSDRPSFAEI 260

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 99/192 (51%), Gaps = 4/192 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV+     + E  LY+  E  + G + + L       + +  +  RQI++ + Y H++ 
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF 133
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTM-NDLKSCKGTPFWMAPEVVNSKNDGYGL 157
           +VHRD+K  N+L+DA  ++K+ADFG +   T  N L +  G P + APE+   K    G 
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD-GP 192
Query: 158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVN 217
             D+WSLG  +  +++   P+      +   R+ +G+   +P   S D  + + K L +N
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYXSTDCENLLKKFLILN 251
Query: 218 PNDRPTVTELME 229
           P+ R T+ ++ +
Sbjct: 252 PSKRGTLEQIXK 263

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 14/207 (6%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLH 95
            +  NI+   G    E  L + +E    G L  +     +    + ++  QI  G+ YLH
Sbjct: 63  LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLH 122
Query: 96  ERNVV---HRDIKCANILV-------DASGSV-KLADFGLAKATTMNDLKSCKGTPFWMA 144
           +  +V   HRD+K +NIL+       D S  + K+ DFGLA+        S  G   WMA
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMA 182
Query: 145 PEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP-SVPSSLS 203
           PEV+ +     G  +D+WS G  + E+LT   P+  ++G+   + +   +L   +PS+  
Sbjct: 183 PEVIRASMFSKG--SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCP 240
Query: 204 RDARDFILKCLQVNPNDRPTVTELMEH 230
                 +  C   +P+ RP+ T +++ 
Sbjct: 241 EPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 9/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE 96
           N+VQ LG    E   YI +E +T G+L +  +   +  +S   +     QI + + YL +
Sbjct: 70  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
           +N +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +    +
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYN 187
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            + + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 247
Query: 213 CLQVNPNDRPTVTEL 227
           C Q NP+DRP+  E+
Sbjct: 248 CWQWNPSDRPSFAEI 262

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 93/195 (47%), Gaps = 9/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE 96
           N+VQ LG    E   YI  E +T G+L +  +   +  +S   +     QI + + YL +
Sbjct: 68  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
           +N +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +    +
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESL--AYN 185
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            + + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  
Sbjct: 186 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRA 245
Query: 213 CLQVNPNDRPTVTEL 227
           C Q NP+DRP+  E+
Sbjct: 246 CWQWNPSDRPSFAEI 260

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 9/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE 96
           N+VQ LG    E   YI +E +T G+L +  +   +  +S   +     QI + + YL +
Sbjct: 70  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
           +N +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +    +
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYN 187
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            + + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 247
Query: 213 CLQVNPNDRPTVTEL 227
           C Q NP+DRP+  E+
Sbjct: 248 CWQWNPSDRPSFAEI 262

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 19/200 (9%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDS-------QVSSYTRQIL 88
            + D +V+       E  +YI  E + KGSL +  +    SD        ++  ++ QI 
Sbjct: 65  LQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLK----SDEGGKVLLPKLIDFSAQIA 120
Query: 89  NGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAP 145
            G+ Y+  +N +HRD++ AN+LV  S   K+ADFGLA+    N+  + +G  F   W AP
Sbjct: 121 EGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 180
Query: 146 EVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKG-ELPSVPSSLS 203
           E +N     + + +D+WS G  + E++T  + PY        +  + +G  +P V  +  
Sbjct: 181 EAINF--GCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRV-ENCP 237
Query: 204 RDARDFILKCLQVNPNDRPT 223
            +  D +  C +    +RPT
Sbjct: 238 DELYDIMKMCWKEKAEERPT 257

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 33/227 (14%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV  +     E  L +  E + K     L + K  L DSQ+  Y  Q+L G+ + H+  
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR 139
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDGYG 156
           ++HRD+K  N+L+++ G++KLADFGLA+A    +        T ++ AP+V+   +  Y 
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG-SKKYS 198
Query: 157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK-------------GELP------- 196
            + DIWS+GC   EM+T +P +  +     L +I                ELP       
Sbjct: 199 TSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF 258
Query: 197 ---------SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                    S+     ++  D +   L  +PN R +  + M HP+ K
Sbjct: 259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 33/227 (14%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV  +     E  L +  E + K     L + K  L DSQ+  Y  Q+L G+ + H+  
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR 139
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDGYG 156
           ++HRD+K  N+L+++ G++KLADFGLA+A    +        T ++ AP+V+   +  Y 
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG-SKKYS 198
Query: 157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK-------------GELP------- 196
            + DIWS+GC   EM+T +P +  +     L +I                ELP       
Sbjct: 199 TSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF 258
Query: 197 ---------SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                    S+     ++  D +   L  +PN R +  + M HP+ K
Sbjct: 259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 117/224 (52%), Gaps = 25/224 (11%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV+      D+   ++ +EL+  G L   + +K H S+++ S   R++++ + ++H+  
Sbjct: 67  NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG 126
Query: 99  VVHRDIKCANILVDASG---SVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKND 153
           VVHRD+K  N+L         +K+ DFG A+    ++  LK+   T  + APE++N   +
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLN--QN 184
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPY-SH------LEGVQALFRIGKGELP---SVPSSLS 203
           GY  + D+WSLG  +  ML+ + P+ SH         V+ + +I KG+         ++S
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244
Query: 204 RDARDFILKCLQVNPNDRPTVTELMEHPFVK-------RPLQTP 240
           ++A+D I   L V+PN R  ++ L  + +++        PL TP
Sbjct: 245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTP 288

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 4/204 (1%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYL 94
           F   +I++        + +++ +E V+ G L +   K   L + +     +QIL+G+ Y 
Sbjct: 73  FRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYC 132
Query: 95  HERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKND 153
           H   VVHRD+K  N+L+DA  + K+ADFGL+   +  + L+   G+P + APEV++ +  
Sbjct: 133 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLY 192
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKC 213
             G   DIWS G  +  +L    P+   + V  LF+     +   P  L+      +   
Sbjct: 193 A-GPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFYTPQYLNPSVISLLKHM 250
Query: 214 LQVNPNDRPTVTELMEHPFVKRPL 237
           LQV+P  R T+ ++ EH + K+ L
Sbjct: 251 LQVDPMKRATIKDIREHEWFKQDL 274

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 106/214 (49%), Gaps = 21/214 (9%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDSQVSSYTRQILNGLVYL 94
           E  N+++Y  T+KD    YI +EL        + QK   HL    ++   +Q  +GL +L
Sbjct: 76  EHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPIT-LLQQTTSGLAHL 134
Query: 95  HERNVVHRDIKCANILV---DASGSVK--LADFGLAKAT-----TMNDLKSCKGTPFWMA 144
           H  N+VHRD+K  NIL+   +A G +K  ++DFGL K       + +      GT  W+A
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 145 PEVVNS---KNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPS 200
           PE+++    +N  Y  T DI+S GC    +++    P+      QA   +G   L  +  
Sbjct: 195 PEMLSEDCKENPTY--TVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHP 252
Query: 201 SLSRD--ARDFILKCLQVNPNDRPTVTELMEHPF 232
               D  AR+ I K + ++P  RP+   +++HPF
Sbjct: 253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 14/216 (6%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYL 94
            +  NI++   T +D   +Y+ +EL T G L   +  K    +S  +   + +L+ + Y 
Sbjct: 63  LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 122
Query: 95  HERNVVHRDIKCAN--ILVDASGS-VKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNS 150
           H+ NV HRD+K  N   L D+  S +KL DFGLA       +   K GTP++++P+V+  
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG 182
Query: 151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPS----SLSRDA 206
               YG   D WS G  +  +L   PP+S     + + +I +G   + P     ++S  A
Sbjct: 183 L---YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTF-TFPEKDWLNVSPQA 238
Query: 207 RDFILKCLQVNPNDRPTVTELMEHPFVKRPL-QTPR 241
              I + L  +P  R T  + +EH + ++ L  +PR
Sbjct: 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPR 274

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 14/216 (6%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYL 94
            +  NI++   T +D   +Y+ +EL T G L   +  K    +S  +   + +L+ + Y 
Sbjct: 80  LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 139
Query: 95  HERNVVHRDIKCAN--ILVDASGS-VKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNS 150
           H+ NV HRD+K  N   L D+  S +KL DFGLA       +   K GTP++++P+V+  
Sbjct: 140 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG 199
Query: 151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPS----SLSRDA 206
               YG   D WS G  +  +L   PP+S     + + +I +G   + P     ++S  A
Sbjct: 200 L---YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTF-TFPEKDWLNVSPQA 255
Query: 207 RDFILKCLQVNPNDRPTVTELMEHPFVKRPL-QTPR 241
              I + L  +P  R T  + +EH + ++ L  +PR
Sbjct: 256 ESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPR 291

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 93/195 (47%), Gaps = 9/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE 96
           N+VQ LG    E   YI  E +T G+L +  +   +  +S   +     QI + + YL +
Sbjct: 68  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
           +N +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +    +
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL--AYN 185
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            + + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  
Sbjct: 186 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRA 245
Query: 213 CLQVNPNDRPTVTEL 227
           C Q NP+DRP+  E+
Sbjct: 246 CWQWNPSDRPSFAEI 260

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 104/204 (50%), Gaps = 13/204 (6%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NI +     +D+   Y+  E+ T G L + +  +   S+   +   RQ+L+G+ Y H+  
Sbjct: 87  NIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK 146
Query: 99  VVHRDIKCANILVDAS---GSVKLADFGLAKA-TTMNDLKSCKGTPFWMAPEVVNSKNDG 154
           +VHRD+K  N+L+++     ++++ DFGL+         K   GT +++APEV++     
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT--- 203
Query: 155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG----ELPSVPSSLSRDARDFI 210
           Y    D+WS G  +  +L+  PP++       L ++ KG    ELP     +S  A+D I
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK-KVSESAKDLI 262
Query: 211 LKCLQVNPNDRPTVTELMEHPFVK 234
            K L   P+ R +  + ++H +++
Sbjct: 263 RKXLTYVPSXRISARDALDHEWIQ 286

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 87.4 bits (215), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 93/195 (47%), Gaps = 9/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE 96
           N+VQ LG    E   YI  E +T G+L +  +   +  +S   +     QI + + YL +
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
           +N +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +    +
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYN 187
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            + + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 247
Query: 213 CLQVNPNDRPTVTEL 227
           C Q NP+DRP+  E+
Sbjct: 248 CWQWNPSDRPSFAEI 262

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 9/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE 96
           N+VQ LG    E   YI +E +T G+L +  +   +  ++   +     QI + + YL +
Sbjct: 75  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
           +N +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +    +
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYN 192
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            + + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  
Sbjct: 193 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 252
Query: 213 CLQVNPNDRPTVTEL 227
           C Q NP+DRP+  E+
Sbjct: 253 CWQWNPSDRPSFAEI 267

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 93/195 (47%), Gaps = 9/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE 96
           N+VQ LG    E   YI  E +T G+L +  +   +  +S   +     QI + + YL +
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 134
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
           +N +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +    +
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYN 192
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            + + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  
Sbjct: 193 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 252
Query: 213 CLQVNPNDRPTVTEL 227
           C Q NP+DRP+  E+
Sbjct: 253 CWQWNPSDRPSFAEI 267

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 9/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE 96
           N+VQ LG    E   YI +E +T G+L +  +   +  ++   +     QI + + YL +
Sbjct: 71  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 130
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
           +N +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +    +
Sbjct: 131 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL--AYN 188
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            + + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  
Sbjct: 189 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 248
Query: 213 CLQVNPNDRPTVTEL 227
           C Q NP+DRP+  E+
Sbjct: 249 CWQWNPSDRPSFAEI 263

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 93/195 (47%), Gaps = 9/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE 96
           N+VQ LG    E   YI  E +T G+L +  +   +  +S   +     QI + + YL +
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
           +N +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +    +
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYN 187
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            + + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 247
Query: 213 CLQVNPNDRPTVTEL 227
           C Q NP+DRP+  E+
Sbjct: 248 CWQWNPSDRPSFAEI 262

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 87.0 bits (214), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 107/217 (49%), Gaps = 14/217 (6%)
Query: 36  FEQDNIVQYLGT--DKDENRLYIFLELVTKG--SLANLYQKYHLSDSQVSSYTRQILNGL 91
               N++Q +    ++++ ++Y+ +E    G   + +   +      Q   Y  Q+++GL
Sbjct: 63  LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA----TTMNDLKSCKGTPFWMAPEV 147
            YLH + +VH+DIK  N+L+   G++K++  G+A+A       +  ++ +G+P +  PE+
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR-IGKGELPSVPSSLSRDA 206
            N  +   G   DIWS G T+  + T   P+   + +  LF  IGKG   ++P       
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSY-AIPGDCGPPL 240
Query: 207 RDFILKCLQVNPNDRPTVTELMEHPFVKR---PLQTP 240
            D +   L+  P  R ++ ++ +H + ++   P + P
Sbjct: 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAP 277

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDS-------QVSSYTRQIL 88
            + D +V+       E  +YI  E + KGSL +  +    SD        ++  ++ QI 
Sbjct: 64  LQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLK----SDEGGKVLLPKLIDFSAQIA 119
Query: 89  NGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAP 145
            G+ Y+  +N +HRD++ AN+LV  S   K+ADFGLA+    N+  + +G  F   W AP
Sbjct: 120 EGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 179
Query: 146 EVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSR 204
           E +N     + + +++WS G  + E++T  + PY        +  + +G       +   
Sbjct: 180 EAINF--GCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCPD 237
Query: 205 DARDFILKCLQVNPNDRPT 223
           +  D +  C +    +RPT
Sbjct: 238 ELYDIMKMCWKEKAEERPT 256

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 88/173 (50%), Gaps = 6/173 (3%)
Query: 52  NRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +RLY  +E V  G L  ++ Q     +     Y  +I  GL +L  + +++RD+K  N++
Sbjct: 94  DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM 153
Query: 111 VDASGSVKLADFGLAKATTMNDL--KSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           +D+ G +K+ADFG+ K    + +  K   GTP ++APE++  +   YG + D W+ G  +
Sbjct: 154 LDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLL 211
Query: 169 LEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
            EML  + P+   E    LF+       + P S+S++A       +  +P  R
Sbjct: 212 YEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 263

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 9/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE 96
           N+VQ LG    E   YI  E +T G+L +  +   +  ++   +     QI + + YL +
Sbjct: 74  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 133
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
           +N +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +    +
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYN 191
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            + + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 251
Query: 213 CLQVNPNDRPTVTEL 227
           C Q NP+DRP+  E+
Sbjct: 252 CWQWNPSDRPSFAEI 266

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 9/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE 96
           N+VQ LG    E   YI  E +T G+L +  +   +  ++   +     QI + + YL +
Sbjct: 83  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 142
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
           +N +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +    +
Sbjct: 143 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYN 200
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            + + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  
Sbjct: 201 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 260
Query: 213 CLQVNPNDRPTVTEL 227
           C Q NP+DRP+  E+
Sbjct: 261 CWQWNPSDRPSFAEI 275

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 9/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE 96
           N+VQ LG    E   YI  E +T G+L +  +   +  ++   +     QI + + YL +
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
           +N +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +    +
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYN 192
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            + + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  
Sbjct: 193 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 252
Query: 213 CLQVNPNDRPTVTEL 227
           C Q NP+DRP+  E+
Sbjct: 253 CWQWNPSDRPSFAEI 267

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 9/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE 96
           N+VQ LG    E   YI  E +T G+L +  +   +  ++   +     QI + + YL +
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 129
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
           +N +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +    +
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYN 187
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            + + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 247
Query: 213 CLQVNPNDRPTVTEL 227
           C Q NP+DRP+  E+
Sbjct: 248 CWQWNPSDRPSFAEI 262

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 88/173 (50%), Gaps = 6/173 (3%)
Query: 52  NRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +RLY  +E V  G L  ++ Q     +     Y  +I  GL +L  + +++RD+K  N++
Sbjct: 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM 474
Query: 111 VDASGSVKLADFGLAKATTMNDL--KSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           +D+ G +K+ADFG+ K    + +  K   GTP ++APE++  +   YG + D W+ G  +
Sbjct: 475 LDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLL 532
Query: 169 LEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
            EML  + P+   E    LF+       + P S+S++A       +  +P  R
Sbjct: 533 YEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 584

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/164 (34%), Positives = 85/164 (51%), Gaps = 8/164 (4%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFG-LAKATTMNDL 133
           L ++QV  Y R  L  L +LH + +VH D+K ANI +   G  KL DFG L +  T    
Sbjct: 154 LPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG 213
Query: 134 KSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG 193
           +  +G P +MAPE++      YG  AD++SLG T+LE+          EG Q L    +G
Sbjct: 214 EVQEGDPRYMAPELLQGS---YGTAADVFSLGLTILEVACNMELPHGGEGWQQLR---QG 267
Query: 194 EL-PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP 236
            L P   + LS + R  ++  L+ +P  R T   L+  P +++P
Sbjct: 268 YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQP 311

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 9/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE 96
           N+VQ LG    E   YI  E +T G+L +  +   +  ++   +     QI + + YL +
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 129
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
           +N +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +    +
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYN 187
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            + + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 247
Query: 213 CLQVNPNDRPTVTEL 227
           C Q NP+DRP+  E+
Sbjct: 248 CWQWNPSDRPSFAEI 262

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 120/277 (43%), Gaps = 56/277 (20%)
Query: 2   GFFFAVKEVSLQDQGAQGKXXXXXXXXXXXXXXXFEQDNIVQYLGTDKDENRLYIFLELV 61
           G + A+KEV L  +    +                + +NIV+       EN+L +  E  
Sbjct: 30  GVYVALKEVKLDSE----EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF- 84
Query: 62  TKGSLANLYQKYH-----------LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
               + N  +KY            L  + V  +  Q+L GL + HE  ++HRD+K  N+L
Sbjct: 85  ----MDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLL 140
Query: 111 VDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           ++  G +KL DFGLA+A    +N   S   T ++ AP+V+      Y  + DIWS GC +
Sbjct: 141 INKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRT-YSTSIDIWSCGCIL 199
Query: 169 LEMLTRRPPY---SHLEGVQALFRI----GKGELPSV-------PSSLSRDAR------- 207
            EM+T +P +   +  E ++ +F I     +   PSV       P+   R  R       
Sbjct: 200 AEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQ 259
Query: 208 ------------DFILKCLQVNPNDRPTVTELMEHPF 232
                       DF+   LQ+NP+ R +  + + HP+
Sbjct: 260 PHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 9/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE 96
           N+VQ LG    E   YI  E +T G+L +  +   +  ++   +     QI + + YL +
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
           +N +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +    +
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL--AYN 192
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            + + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  
Sbjct: 193 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 252
Query: 213 CLQVNPNDRPTVTEL 227
           C Q NP+DRP+  E+
Sbjct: 253 CWQWNPSDRPSFAEI 267

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 9/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE 96
           N+VQ LG    E   YI  E +T G+L +  +   +  ++   +     QI + + YL +
Sbjct: 71  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 130
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
           +N +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +    +
Sbjct: 131 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESL--AYN 188
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            + + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  
Sbjct: 189 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 248
Query: 213 CLQVNPNDRPTVTEL 227
           C Q NP+DRP+  E+
Sbjct: 249 CWQWNPSDRPSFAEI 263

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 9/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE 96
           N+VQ LG    E   YI  E +T G+L +  +   +  ++   +     QI + + YL +
Sbjct: 72  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
           +N +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +    +
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESL--AYN 189
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            + + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  
Sbjct: 190 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 249
Query: 213 CLQVNPNDRPTVTEL 227
           C Q NP+DRP+  E+
Sbjct: 250 CWQWNPSDRPSFAEI 264

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 9/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE 96
           N+VQ LG    E   YI  E +T G+L +  +   +  ++   +     QI + + YL +
Sbjct: 72  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
           +N +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +    +
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYN 189
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            + + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  
Sbjct: 190 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 249
Query: 213 CLQVNPNDRPTVTEL 227
           C Q NP+DRP+  E+
Sbjct: 250 CWQWNPSDRPSFAEI 264

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 9/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE 96
           N+VQ LG    E   YI  E +T G+L +  +   +  ++   +     QI + + YL +
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
           +N +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +    +
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYN 192
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            + + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  
Sbjct: 193 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 252
Query: 213 CLQVNPNDRPTVTEL 227
           C Q NP+DRP+  E+
Sbjct: 253 CWQWNPSDRPSFAEI 267

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 31/219 (14%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVY 93
            E  N+++++G    + RL    E +  G+L  + +        SQ  S+ + I +G+ Y
Sbjct: 64  LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAY 123
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAK-----ATTMNDLKSCK----------- 137
           LH  N++HRD+   N LV  + +V +ADFGLA+      T    L+S K           
Sbjct: 124 LHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR------RPPYSHLEGVQALFRIG 191
           G P+WMAPE++N ++  Y    D++S G  + E++ R        P +   G+     + 
Sbjct: 184 GNPYWMAPEMINGRS--YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241
Query: 192 KGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
           +   P+ P S         ++C  ++P  RP+  +L EH
Sbjct: 242 RYCPPNCPPSFF----PITVRCCDLDPEKRPSFVKL-EH 275

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 9/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE 96
           N+VQ LG    E   YI  E +T G+L +  +   +  ++   +     QI + + YL +
Sbjct: 72  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
           +N +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +    +
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYN 189
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            + + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  
Sbjct: 190 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 249
Query: 213 CLQVNPNDRPTVTEL 227
           C Q NP+DRP+  E+
Sbjct: 250 CWQWNPSDRPSFAEI 264

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 18/200 (9%)
Query: 49  KDENRLYIFLELVTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKC 106
           +D+N LY+ ++    G L  L  K+   L +     Y  +++  +  +H+ + VHRDIK 
Sbjct: 144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKP 203
Query: 107 ANILVDASGSVKLADFG-----LAKATTMNDLKSCKGTPFWMAPEVVNSKNDG---YGLT 158
            NIL+D +G ++LADFG     +   T  + +    GTP +++PE++ +   G   YG  
Sbjct: 204 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV--GTPDYISPEILQAMEGGKGRYGPE 261
Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI----GKGELPSVPSSLSRDARDFI--LK 212
            D WSLG  + EML    P+     V+   +I     + + P+  + +S +A+D I  L 
Sbjct: 262 CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLI 321
Query: 213 CLQVNPNDRPTVTELMEHPF 232
           C + +   +  + +  +HPF
Sbjct: 322 CSREHRLGQNGIEDFKKHPF 341

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 28/217 (12%)
Query: 38  QDNIVQYLG--TDKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLVY 93
            +NIV+Y G  T+   N + + +E +  GSL       K  ++  Q   Y  QI  G+ Y
Sbjct: 82  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 141
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTP-FWMAPE-V 147
           L  R  VHRD+   N+LV++   VK+ DFGL KA   +     +K  + +P FW APE +
Sbjct: 142 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTR---------------RPPYSHLEGVQALFRIGK 192
           + SK   + + +D+WS G T+ E+LT                 P +  +   + +  + +
Sbjct: 202 MQSK---FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258
Query: 193 GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
           G+    P +   +    + KC +  P++R +   L+E
Sbjct: 259 GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 38  QDNIVQYLGT--DKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLH 95
            ++IV+Y G   D+ E  + + +E V  GSL +   ++ +  +Q+  + +QI  G+ YLH
Sbjct: 69  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLH 128
Query: 96  ERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTP-FWMAPEVVNS 150
            ++ +HR +   N+L+D    VK+ DFGLAKA         ++    +P FW APE +  
Sbjct: 129 AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL-- 186
Query: 151 KNDGYGLTADIWSLGCTVLEMLT----RRPPYS-------HLEGVQALFRIG----KGEL 195
           K   +   +D+WS G T+ E+LT     + P++       H +G   + R+     +GE 
Sbjct: 187 KECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGER 246
Query: 196 PSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
              P     +    +  C +   + RPT   L+
Sbjct: 247 LPRPDRCPCEIYHLMKNCWETEASFRPTFQNLV 279

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 38  QDNIVQYLGT--DKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLH 95
            ++IV+Y G   D+ E  + + +E V  GSL +   ++ +  +Q+  + +QI  G+ YLH
Sbjct: 70  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLH 129
Query: 96  ERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTP-FWMAPEVVNS 150
            ++ +HR +   N+L+D    VK+ DFGLAKA         ++    +P FW APE +  
Sbjct: 130 AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL-- 187
Query: 151 KNDGYGLTADIWSLGCTVLEMLT----RRPPYS-------HLEGVQALFRIG----KGEL 195
           K   +   +D+WS G T+ E+LT     + P++       H +G   + R+     +GE 
Sbjct: 188 KECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGER 247
Query: 196 PSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
              P     +    +  C +   + RPT   L+
Sbjct: 248 LPRPDRCPCEIYHLMKNCWETEASFRPTFQNLV 280

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 52  NRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           ++L   L+L+  G L  +L Q    S++ +  Y  +I+ GL ++H R VV+RD+K ANIL
Sbjct: 264 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 323
Query: 111 VDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
           +D  G V+++D GLA   +     +  GT  +MAPEV+  K   Y  +AD +SLGC + +
Sbjct: 324 LDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGVAYDSSADWFSLGCMLFK 382
Query: 171 MLTRRPPYSH--LEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR-----PT 223
           +L    P+     +    + R+       +P S S + R  +   LQ + N R       
Sbjct: 383 LLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRG 442
Query: 224 VTELMEHPFVK 234
             E+ E PF +
Sbjct: 443 AQEVKESPFFR 453

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 100 NDVYLVTHLM-GADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 159 NEDXELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 216
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 36  FEQDNIVQYLGTDKDENR--LYIFLELVTKGSLANLYQKYH--LSDSQVSSYTRQILNGL 91
              D IV+Y G      R  L + +E +  G L +  Q++   L  S++  Y+ QI  G+
Sbjct: 65  LHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 124
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTP-----FWMAPE 146
            YL  R  VHRD+   NILV++   VK+ADFGLAK   ++        P     FW APE
Sbjct: 125 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPE 184
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLTR-----RPPYSHL------EGVQALFR----IG 191
            ++  ++ +   +D+WS G  + E+ T       P    L        V AL R    + 
Sbjct: 185 SLS--DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLE 242
Query: 192 KGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
           +G+    P +   +  + +  C   +P DRP+ + L
Sbjct: 243 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 278

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 52  NRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           ++L   L+L+  G L  +L Q    S++ +  Y  +I+ GL ++H R VV+RD+K ANIL
Sbjct: 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 324
Query: 111 VDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
           +D  G V+++D GLA   +     +  GT  +MAPEV+  K   Y  +AD +SLGC + +
Sbjct: 325 LDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGVAYDSSADWFSLGCMLFK 383
Query: 171 MLTRRPPYSH--LEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR-----PT 223
           +L    P+     +    + R+       +P S S + R  +   LQ + N R       
Sbjct: 384 LLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRG 443
Query: 224 VTELMEHPFVK 234
             E+ E PF +
Sbjct: 444 AQEVKESPFFR 454

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 28/217 (12%)
Query: 38  QDNIVQYLG--TDKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLVY 93
            +NIV+Y G  T+   N + + +E +  GSL       K  ++  Q   Y  QI  G+ Y
Sbjct: 70  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 129
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTP-FWMAPE-V 147
           L  R  VHRD+   N+LV++   VK+ DFGL KA   +     +K  + +P FW APE +
Sbjct: 130 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTR---------------RPPYSHLEGVQALFRIGK 192
           + SK   + + +D+WS G T+ E+LT                 P +  +   + +  + +
Sbjct: 190 MQSK---FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 246
Query: 193 GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
           G+    P +   +    + KC +  P++R +   L+E
Sbjct: 247 GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 283

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 106/226 (46%), Gaps = 41/226 (18%)
Query: 45  LGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDI 104
           +G+  + N +YI  E + +  LAN+ ++  L +     +  Q+L GL Y+H  NV+HRD+
Sbjct: 88  VGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDL 146
Query: 105 KCANILVDASGSV-KLADFGLAKATTMNDLKSCKG-------TPFWMAPEVVNSKNDGYG 156
           K AN+ ++    V K+ DFGLA+   M+   S KG       T ++ +P ++ S N+ Y 
Sbjct: 147 KPANLFINTEDLVLKIGDFGLAR--IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNN-YT 203
Query: 157 LTADIWSLGCTVLEMLTRRP------------------PYSHLEGVQALFRI-------- 190
              D+W+ GC   EMLT +                   P  H E  Q L  +        
Sbjct: 204 KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRND 263
Query: 191 ---GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
                  L  +   +SR+A DF+ + L  +P DR T  E + HP++
Sbjct: 264 MTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 52  NRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           ++L   L+L+  G L  +L Q    S++ +  Y  +I+ GL ++H R VV+RD+K ANIL
Sbjct: 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 324
Query: 111 VDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
           +D  G V+++D GLA   +     +  GT  +MAPEV+  K   Y  +AD +SLGC + +
Sbjct: 325 LDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGVAYDSSADWFSLGCMLFK 383
Query: 171 MLTRRPPYSH--LEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR-----PT 223
           +L    P+     +    + R+       +P S S + R  +   LQ + N R       
Sbjct: 384 LLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRG 443
Query: 224 VTELMEHPFVK 234
             E+ E PF +
Sbjct: 444 AQEVKESPFFR 454

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 52  NRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           ++L   L+L+  G L  +L Q    S++ +  Y  +I+ GL ++H R VV+RD+K ANIL
Sbjct: 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 324
Query: 111 VDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
           +D  G V+++D GLA   +     +  GT  +MAPEV+  K   Y  +AD +SLGC + +
Sbjct: 325 LDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGVAYDSSADWFSLGCMLFK 383
Query: 171 MLTRRPPYSH--LEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR-----PT 223
           +L    P+     +    + R+       +P S S + R  +   LQ + N R       
Sbjct: 384 LLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRG 443
Query: 224 VTELMEHPFVK 234
             E+ E PF +
Sbjct: 444 AQEVKESPFFR 454

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 83/145 (57%), Gaps = 9/145 (6%)
Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKS--CKGTP 140
           YT QI++GL +LH+RN+++RD+K  N+L+D  G+V+++D GLA        K+    GTP
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY----SHLEGVQALFRIGKGELP 196
            +MAPE++  +   Y  + D ++LG T+ EM+  R P+      +E  +   R+ +  + 
Sbjct: 354 GFMAPELLLGEE--YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV- 410
Query: 197 SVPSSLSRDARDFILKCLQVNPNDR 221
           + P   S  ++DF    LQ +P  R
Sbjct: 411 TYPDKFSPASKDFCEALLQKDPEKR 435

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 83/145 (57%), Gaps = 9/145 (6%)
Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKS--CKGTP 140
           YT QI++GL +LH+RN+++RD+K  N+L+D  G+V+++D GLA        K+    GTP
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY----SHLEGVQALFRIGKGELP 196
            +MAPE++  +   Y  + D ++LG T+ EM+  R P+      +E  +   R+ +  + 
Sbjct: 354 GFMAPELLLGEE--YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV- 410
Query: 197 SVPSSLSRDARDFILKCLQVNPNDR 221
           + P   S  ++DF    LQ +P  R
Sbjct: 411 TYPDKFSPASKDFCEALLQKDPEKR 435

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 83/145 (57%), Gaps = 9/145 (6%)
Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKS--CKGTP 140
           YT QI++GL +LH+RN+++RD+K  N+L+D  G+V+++D GLA        K+    GTP
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY----SHLEGVQALFRIGKGELP 196
            +MAPE++  +   Y  + D ++LG T+ EM+  R P+      +E  +   R+ +  + 
Sbjct: 354 GFMAPELLLGEE--YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV- 410
Query: 197 SVPSSLSRDARDFILKCLQVNPNDR 221
           + P   S  ++DF    LQ +P  R
Sbjct: 411 TYPDKFSPASKDFCEALLQKDPEKR 435

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 83/145 (57%), Gaps = 9/145 (6%)
Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKS--CKGTP 140
           YT QI++GL +LH+RN+++RD+K  N+L+D  G+V+++D GLA        K+    GTP
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY----SHLEGVQALFRIGKGELP 196
            +MAPE++  +   Y  + D ++LG T+ EM+  R P+      +E  +   R+ +  + 
Sbjct: 354 GFMAPELLLGEE--YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV- 410
Query: 197 SVPSSLSRDARDFILKCLQVNPNDR 221
           + P   S  ++DF    LQ +P  R
Sbjct: 411 TYPDKFSPASKDFCEALLQKDPEKR 435

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 36  FEQDNIVQYLGTDKDENR--LYIFLELVTKGSLANLYQKYH--LSDSQVSSYTRQILNGL 91
              D IV+Y G      R  L + +E +  G L +  Q++   L  S++  Y+ QI  G+
Sbjct: 69  LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 128
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTP-FWMAPE 146
            YL  R  VHRD+   NILV++   VK+ADFGLAK   ++     ++    +P FW APE
Sbjct: 129 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 188
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLTR-----RPPYSHL------EGVQALFR----IG 191
            ++  ++ +   +D+WS G  + E+ T       P    L        V AL R    + 
Sbjct: 189 SLS--DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLE 246
Query: 192 KGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
           +G+    P +   +  + +  C   +P DRP+ + L
Sbjct: 247 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 282

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 102 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 160
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 161 NEDSELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 218
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 219 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 267

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 100 NDVYLVTHLM-GADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 159 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 216
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 36  FEQDNIVQYLGTDKDENR--LYIFLELVTKGSLANLYQKYH--LSDSQVSSYTRQILNGL 91
              D IV+Y G      R  L + +E +  G L +  Q++   L  S++  Y+ QI  G+
Sbjct: 81  LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTP-FWMAPE 146
            YL  R  VHRD+   NILV++   VK+ADFGLAK   ++     ++    +P FW APE
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 200
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLTR-----RPPYSHL------EGVQALFR----IG 191
            ++  ++ +   +D+WS G  + E+ T       P    L        V AL R    + 
Sbjct: 201 SLS--DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258
Query: 192 KGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
           +G+    P +   +  + +  C   +P DRP+ + L
Sbjct: 259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 47/129 (36%), Positives = 74/129 (57%), Gaps = 9/129 (6%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           ++ F E    G L+N+  K+ LS  ++    + +LNGL Y+H   ++HRD+K AN+L+  
Sbjct: 103 VFDFCEHDLAGLLSNVLVKFTLS--EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR 160
Query: 114 SGSVKLADFGLAKATTM------NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
            G +KLADFGLA+A ++      N   +   T ++  PE++  + D YG   D+W  GC 
Sbjct: 161 DGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERD-YGPPIDLWGAGCI 219
Query: 168 VLEMLTRRP 176
           + EM TR P
Sbjct: 220 MAEMWTRSP 228

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 36  FEQDNIVQYLGTDKDENR--LYIFLELVTKGSLANLYQKYH--LSDSQVSSYTRQILNGL 91
              D IV+Y G      R  L + +E +  G L +  Q++   L  S++  Y+ QI  G+
Sbjct: 68  LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 127
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTP-FWMAPE 146
            YL  R  VHRD+   NILV++   VK+ADFGLAK   ++     ++    +P FW APE
Sbjct: 128 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 187
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLTR-----RPPYSHL------EGVQALFR----IG 191
            ++  ++ +   +D+WS G  + E+ T       P    L        V AL R    + 
Sbjct: 188 SLS--DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLE 245
Query: 192 KGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
           +G+    P +   +  + +  C   +P DRP+ + L
Sbjct: 246 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 281

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 106 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 164
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 165 NEDSELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 222
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 223 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 271

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 93/170 (54%), Gaps = 9/170 (5%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 100 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEV-VNSKNDGYGLTADIWSLGCTVLE 170
           +    +K+ DFGLA+ T  +++     T ++ APE+ +N+ +  Y  T DIWS+GC + E
Sbjct: 159 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNAMH--YNQTVDIWSVGCIMAE 215
Query: 171 MLTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           +LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 216 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 89/168 (52%), Gaps = 13/168 (7%)
Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS--VKLADFGLAKA-TTMND---- 132
           +S+  RQI + L YLH + + HRDIK  N L   + S  +KL DFGL+K    +N+    
Sbjct: 170 ISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYY 229
Query: 133 -LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIG 191
            + +  GTP+++APEV+N+ N+ YG   D WS G  +  +L    P+  +     + ++ 
Sbjct: 230 GMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVL 289
Query: 192 KGEL----PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
             +L    P+  + LS  ARD +   L  N ++R      ++HP++ +
Sbjct: 290 NKKLCFENPNY-NVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 94/197 (47%), Gaps = 9/197 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE 96
           N+VQ LG    E   YI  E +T G+L +  +   +  +S   +     QI + + YL +
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
           +N +HR++   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +    +
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYN 394
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            + + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 454
Query: 213 CLQVNPNDRPTVTELME 229
           C Q NP+DRP+  E+ +
Sbjct: 455 CWQWNPSDRPSFAEIHQ 471

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 36  FEQDNIVQYLGTDKDENR--LYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGL 91
            + DNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 73  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 132
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTP-FWMAPE 146
            YL  +  +HRD+   NILV+    VK+ DFGL K    +     +K    +P FW APE
Sbjct: 133 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 192
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLT-----RRPPYSHL-------EGVQALFRI---- 190
            +      + + +D+WS G  + E+ T     + PP   +       +G   +F +    
Sbjct: 193 SLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 250
Query: 191 -GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
              G LP  P     +    + +C   N N RP+  +L
Sbjct: 251 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 287

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 36  FEQDNIVQYLGTDKDENR--LYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGL 91
            + DNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 66  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 125
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTP-FWMAPE 146
            YL  +  +HRD+   NILV+    VK+ DFGL K    +     +K    +P FW APE
Sbjct: 126 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 185
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLT-----RRPPYSHL-------EGVQALFRI---- 190
            +      + + +D+WS G  + E+ T     + PP   +       +G   +F +    
Sbjct: 186 SLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 243
Query: 191 -GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
              G LP  P     +    + +C   N N RP+  +L
Sbjct: 244 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 280

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 47/129 (36%), Positives = 74/129 (57%), Gaps = 9/129 (6%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           ++ F E    G L+N+  K+ LS  ++    + +LNGL Y+H   ++HRD+K AN+L+  
Sbjct: 102 VFDFCEHDLAGLLSNVLVKFTLS--EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR 159
Query: 114 SGSVKLADFGLAKATTM------NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
            G +KLADFGLA+A ++      N   +   T ++  PE++  + D YG   D+W  GC 
Sbjct: 160 DGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERD-YGPPIDLWGAGCI 218
Query: 168 VLEMLTRRP 176
           + EM TR P
Sbjct: 219 MAEMWTRSP 227

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 36  FEQDNIVQYLGTDKDENR--LYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGL 91
            + DNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTP-FWMAPE 146
            YL  +  +HRD+   NILV+    VK+ DFGL K    +     +K    +P FW APE
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLT-----RRPPYSHL-------EGVQALFRI---- 190
            +      + + +D+WS G  + E+ T     + PP   +       +G   +F +    
Sbjct: 188 SLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
Query: 191 -GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
              G LP  P     +    + +C   N N RP+  +L
Sbjct: 246 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 47/129 (36%), Positives = 74/129 (57%), Gaps = 9/129 (6%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           ++ F E    G L+N+  K+ LS  ++    + +LNGL Y+H   ++HRD+K AN+L+  
Sbjct: 103 VFDFCEHDLAGLLSNVLVKFTLS--EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR 160
Query: 114 SGSVKLADFGLAKATTM------NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
            G +KLADFGLA+A ++      N   +   T ++  PE++  + D YG   D+W  GC 
Sbjct: 161 DGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERD-YGPPIDLWGAGCI 219
Query: 168 VLEMLTRRP 176
           + EM TR P
Sbjct: 220 MAEMWTRSP 228

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 29/218 (13%)
Query: 36  FEQDNIVQYLGTDKDENR--LYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGL 91
            + DNIV+Y G      R  L + +E +  GSL    QK+   +   ++  YT QI  G+
Sbjct: 71  LQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGM 130
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTP-FWMAPE 146
            YL  +  +HRD+   NILV+    VK+ DFGL K    +     +K    +P FW APE
Sbjct: 131 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLT-----RRPPYSHL-------EGVQALFRI---- 190
            +      + + +D+WS G  + E+ T     + PP   +       +G   +F +    
Sbjct: 191 SLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 248
Query: 191 -GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
              G LP  P     +    + +C   N N RP+  +L
Sbjct: 249 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 285

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 47/129 (36%), Positives = 74/129 (57%), Gaps = 9/129 (6%)
Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           ++ F E    G L+N+  K+ LS  ++    + +LNGL Y+H   ++HRD+K AN+L+  
Sbjct: 103 VFDFCEHDLAGLLSNVLVKFTLS--EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR 160
Query: 114 SGSVKLADFGLAKATTM------NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
            G +KLADFGLA+A ++      N   +   T ++  PE++  + D YG   D+W  GC 
Sbjct: 161 DGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERD-YGPPIDLWGAGCI 219
Query: 168 VLEMLTRRP 176
           + EM TR P
Sbjct: 220 MAEMWTRSP 228

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 36  FEQDNIVQYLGTDKDENR--LYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGL 91
            + DNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 99  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTP-FWMAPE 146
            YL  +  +HRD+   NILV+    VK+ DFGL K    +     +K    +P FW APE
Sbjct: 159 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 218
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLT-----RRPPYSHL-------EGVQALFRI---- 190
            +      + + +D+WS G  + E+ T     + PP   +       +G   +F +    
Sbjct: 219 SLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276
Query: 191 -GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
              G LP  P     +    + +C   N N RP+  +L
Sbjct: 277 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 313

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 36  FEQDNIVQYLGTDKDENR--LYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGL 91
            + DNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 75  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 134
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTP-FWMAPE 146
            YL  +  +HRD+   NILV+    VK+ DFGL K    +     +K    +P FW APE
Sbjct: 135 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 194
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLT-----RRPPYSHL-------EGVQALFRI---- 190
            +      + + +D+WS G  + E+ T     + PP   +       +G   +F +    
Sbjct: 195 SLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 252
Query: 191 -GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
              G LP  P     +    + +C   N N RP+  +L
Sbjct: 253 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 289

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 36  FEQDNIVQYLGTDKDENR--LYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGL 91
            + DNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTP-FWMAPE 146
            YL  +  +HRD+   NILV+    VK+ DFGL K    +     +K    +P FW APE
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLT-----RRPPYSHL-------EGVQALFRI---- 190
            +      + + +D+WS G  + E+ T     + PP   +       +G   +F +    
Sbjct: 188 SLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
Query: 191 -GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
              G LP  P     +    + +C   N N RP+  +L
Sbjct: 246 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 36  FEQDNIVQYLGTDKDENR--LYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGL 91
            + DNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 71  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 130
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTP-FWMAPE 146
            YL  +  +HRD+   NILV+    VK+ DFGL K    +     +K    +P FW APE
Sbjct: 131 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLT-----RRPPYSHL-------EGVQALFRI---- 190
            +      + + +D+WS G  + E+ T     + PP   +       +G   +F +    
Sbjct: 191 SLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 248
Query: 191 -GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
              G LP  P     +    + +C   N N RP+  +L
Sbjct: 249 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 285

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 36  FEQDNIVQYLGTDKDENR--LYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGL 91
            + DNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 86  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 145
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTP-FWMAPE 146
            YL  +  +HRD+   NILV+    VK+ DFGL K    +     +K    +P FW APE
Sbjct: 146 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 205
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLT-----RRPPYSHL-------EGVQALFRI---- 190
            +      + + +D+WS G  + E+ T     + PP   +       +G   +F +    
Sbjct: 206 SLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 263
Query: 191 -GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
              G LP  P     +    + +C   N N RP+  +L
Sbjct: 264 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 300

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 36  FEQDNIVQYLGTDKDENR--LYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGL 91
            + DNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTP-FWMAPE 146
            YL  +  +HRD+   NILV+    VK+ DFGL K    +     +K    +P FW APE
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLT-----RRPPYSHL-------EGVQALFRI---- 190
            +      + + +D+WS G  + E+ T     + PP   +       +G   +F +    
Sbjct: 188 SLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
Query: 191 -GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
              G LP  P     +    + +C   N N RP+  +L
Sbjct: 246 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 36  FEQDNIVQYLGTDKDENR--LYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGL 91
            + DNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 86  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 145
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTP-FWMAPE 146
            YL  +  +HRD+   NILV+    VK+ DFGL K    +     +K    +P FW APE
Sbjct: 146 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 205
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLT-----RRPPYSHL-------EGVQALFRI---- 190
            +      + + +D+WS G  + E+ T     + PP   +       +G   +F +    
Sbjct: 206 SLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 263
Query: 191 -GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
              G LP  P     +    + +C   N N RP+  +L
Sbjct: 264 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 300

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 36  FEQDNIVQYLGTDKDENR--LYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGL 91
            + DNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 74  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 133
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTP-FWMAPE 146
            YL  +  +HRD+   NILV+    VK+ DFGL K    +     +K    +P FW APE
Sbjct: 134 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 193
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLT-----RRPPYSHL-------EGVQALFRI---- 190
            +      + + +D+WS G  + E+ T     + PP   +       +G   +F +    
Sbjct: 194 SLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 251
Query: 191 -GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
              G LP  P     +    + +C   N N RP+  +L
Sbjct: 252 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 288

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 36  FEQDNIVQYLGTDKDENR--LYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGL 91
            + DNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 67  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 126
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTP-FWMAPE 146
            YL  +  +HRD+   NILV+    VK+ DFGL K    +     +K    +P FW APE
Sbjct: 127 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 186
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLT-----RRPPYSHL-------EGVQALFRI---- 190
            +      + + +D+WS G  + E+ T     + PP   +       +G   +F +    
Sbjct: 187 SLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 244
Query: 191 -GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
              G LP  P     +    + +C   N N RP+  +L
Sbjct: 245 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 281

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 36  FEQDNIVQYLGTDKDENR--LYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGL 91
            + DNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 72  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 131
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTP-FWMAPE 146
            YL  +  +HRD+   NILV+    VK+ DFGL K    +     +K    +P FW APE
Sbjct: 132 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 191
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLT-----RRPPYSHL-------EGVQALFRI---- 190
            +      + + +D+WS G  + E+ T     + PP   +       +G   +F +    
Sbjct: 192 SLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 249
Query: 191 -GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
              G LP  P     +    + +C   N N RP+  +L
Sbjct: 250 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 286

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 105 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 163
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 164 NEDXELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 221
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 222 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 270

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 31/216 (14%)
Query: 47  TDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYT---------RQILNGLVYLH-E 96
           T+ DE  +YI  E +   S+    + + + D   + +          + +LN   Y+H E
Sbjct: 113 TNYDE--VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE 170
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYG 156
           +N+ HRD+K +NIL+D +G VKL+DFG ++      +K  +GT  +M PE  ++++   G
Sbjct: 171 KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNG 230
Query: 157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALF---RIGKGELP--------------SVP 199
              DIWSLG  +  M     P+S    +  LF   R    E P              S  
Sbjct: 231 AKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTC 290
Query: 200 SS--LSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           S+  LS +  DF+   L+ NP +R T  + ++H ++
Sbjct: 291 SNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 111 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 169
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 170 NEDXELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 227
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 228 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 276

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 105 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 163
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 164 NEDXELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 221
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 222 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 270

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 107 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 165
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 166 NEDCELKILDFGLARHTA-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 223
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 224 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 272

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 107 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 165
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 166 NEDCELKILDFGLARHTA-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 223
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 224 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 272

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 107 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 165
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 166 NEDCELKILDFGLARHTA-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 223
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 224 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 272

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 90/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 100 NDVYLVTHLM-GADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGL + T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 159 NEDSELKILDFGLCRHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 216
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 9/199 (4%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVY 93
            +  +IV+ +G  ++E   +I +EL   G L +  +  K  L    +  Y+ QI   + Y
Sbjct: 66  LDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 124
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNS 150
           L   N VHRDI   NILV +   VKL DFGL++     D      T     WM+PE +N 
Sbjct: 125 LESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 184
Query: 151 KNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDF 209
           +   +   +D+W     + E+L+  + P+  LE    +  + KG+    P          
Sbjct: 185 RR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTL 242
Query: 210 ILKCLQVNPNDRPTVTELM 228
           + +C   +P+DRP  TEL+
Sbjct: 243 MTRCWDYDPSDRPRFTELV 261

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 84.0 bits (206), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 9/199 (4%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVY 93
            +  +IV+ +G  ++E   +I +EL   G L +  +  K  L    +  Y+ QI   + Y
Sbjct: 70  LDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNS 150
           L   N VHRDI   NILV +   VKL DFGL++     D      T     WM+PE +N 
Sbjct: 129 LESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 188
Query: 151 KNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDF 209
           +   +   +D+W     + E+L+  + P+  LE    +  + KG+    P          
Sbjct: 189 RR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTL 246
Query: 210 ILKCLQVNPNDRPTVTELM 228
           + +C   +P+DRP  TEL+
Sbjct: 247 MTRCWDYDPSDRPRFTELV 265

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 9/199 (4%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVY 93
            +  +IV+ +G  ++E   +I +EL   G L +  +  K  L    +  Y+ QI   + Y
Sbjct: 82  LDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 140
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNS 150
           L   N VHRDI   NILV +   VKL DFGL++     D      T     WM+PE +N 
Sbjct: 141 LESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 200
Query: 151 KNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDF 209
           +   +   +D+W     + E+L+  + P+  LE    +  + KG+    P          
Sbjct: 201 RR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTL 258
Query: 210 ILKCLQVNPNDRPTVTELM 228
           + +C   +P+DRP  TEL+
Sbjct: 259 MTRCWDYDPSDRPRFTELV 277

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 100 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 159 NEDCELKILDFGLARHTD-DEMAGFVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 216
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 84.0 bits (206), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 102 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 160
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 161 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 218
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 219 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 267

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 84.0 bits (206), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 107 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 165
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 166 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 223
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 224 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 272

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 100 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 159 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 216
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 100 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 159 NEDCELKILDFGLARHTD-DEMAGFVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 216
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM 265

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 100 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 159 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 216
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 112 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 170
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 171 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 228
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 229 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 277

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 120 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 178
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 179 NEDCELKILDFGLARHTD-DEMXGXVATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAEL 236
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 237 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM 285

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 112 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 170
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 171 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 228
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 229 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 277

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 111 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 169
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 170 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 227
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 228 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 276

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 112 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 170
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 171 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 228
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 229 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 277

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 106 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 164
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 165 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 222
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 223 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 271

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 100 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 159 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 216
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM 265

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 100 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 159 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 216
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 120 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 178
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 179 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAEL 236
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 237 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 285

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 123 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 181
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 182 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAEL 239
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 240 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 288

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 100 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 159 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 216
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 100 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 159 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 216
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 100 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 159 NEDCELKILDFGLARHTD-DEMTGXVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 216
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 123 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 181
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 182 NEDCELKILDFGLARHTD-DEMXGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 239
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 240 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 288

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 100 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 159 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 216
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 83.6 bits (205), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 105 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 163
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 164 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 221
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 222 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 270

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 83.6 bits (205), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 106 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 164
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 165 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 222
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 223 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 271

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 83.6 bits (205), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 110 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 168
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 169 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 226
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 227 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM 275

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 83.6 bits (205), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 102 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 160
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 161 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 218
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 219 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 267

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 83.6 bits (205), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 99  NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 157
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 158 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 215
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 216 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 264

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 83.6 bits (205), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 102 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 160
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 161 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 218
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 219 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 267

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 83.6 bits (205), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 119 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 177
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 178 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAEL 235
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 236 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 284

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 83.6 bits (205), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 97  NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 155
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 156 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 213
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 214 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 262

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 83.6 bits (205), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 120 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 178
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 179 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAEL 236
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 237 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM 285

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 83.6 bits (205), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 100 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 159 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 216
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 83.6 bits (205), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 119 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 177
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 178 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAEL 235
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 236 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM 284

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 83.6 bits (205), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 105 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 163
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 164 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 221
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 222 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 270

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 83.6 bits (205), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 106 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 164
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 165 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 222
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 223 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM 271

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 83.6 bits (205), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 9/197 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE 96
           N+VQ LG    E   YI  E +T G+L +  +   +  ++   +     QI + + YL +
Sbjct: 316 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 375
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
           +N +HR++   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +    +
Sbjct: 376 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYN 433
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            + + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  
Sbjct: 434 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 493
Query: 213 CLQVNPNDRPTVTELME 229
           C Q NP+DRP+  E+ +
Sbjct: 494 CWQWNPSDRPSFAEIHQ 510

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 55  YIFLELVTKGSLANL-YQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           YI +E V   +L ++ + +  ++  +           L + H+  ++HRD+K ANIL+ A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISA 151
Query: 114 SGSVKLADFGLAKA-----TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           + +VK+ DFG+A+A      ++    +  GT  +++PE   ++ D     +D++SLGC +
Sbjct: 152 TNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVL 209
Query: 169 LEMLTRRPPYSHLEGVQALFRIGKGELPSVPSS----LSRDARDFILKCLQVNPNDRPTV 224
            E+LT  PP++    V   ++  + E P  PS+    LS D    +LK L  NP +R   
Sbjct: 210 YEVLTGEPPFTGDSPVSVAYQHVR-EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT 268
Query: 225 TELMEHPFVK----RPLQTPRC 242
              M    V+     P + P+ 
Sbjct: 269 AAEMRADLVRVHNGEPPEAPKV 290

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 83.6 bits (205), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 96  NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 154
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 155 NEDCELKILDFGLARHTD-DEMAGFVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 212
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 213 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM 261

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 97  NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 155
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 156 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 213
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 214 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 262

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 96  NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 154
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 155 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 212
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 213 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM 261

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 96  NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 154
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 155 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 212
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 213 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 261

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 98  NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 156
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 157 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 214
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 215 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 263

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 87/196 (44%), Gaps = 10/196 (5%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH---LSDSQVSSYTRQILNGLVYLHE 96
            +V++ G    E  +YI  E ++ G L N Y + H   L  SQ+      +  G+ +L  
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLN-YLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
              +HRD+   N LVD    VK++DFG+ +    +   S  GT F   W APEV +    
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFK- 181
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            Y   +D+W+ G  + E+ +  + PY      + + ++ +G     P   S      +  
Sbjct: 182 -YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYS 240
Query: 213 CLQVNPNDRPTVTELM 228
           C    P  RPT  +L+
Sbjct: 241 CWHELPEKRPTFQQLL 256

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 96  NDVYLVTHLM-GADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 154
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DFGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 155 NEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 212
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 213 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM 261

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 12/201 (5%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV++         L I +E  + G L   +      S+ +   + +Q+++G+ Y H   
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQ 135
Query: 99  VVHRDIKCANILVDASGS--VKLADFGLAKATTMNDL-KSCKGTPFWMAPEVVNSKNDGY 155
           V HRD+K  N L+D S +  +K+ADFG +KA+ ++   KS  GTP ++APEV+  K +  
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVL-LKKEYD 194
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGV----QALFRIGKGELPSVPS--SLSRDARDF 209
           G  AD+WS G T+  ML    P+   E      + + RI   +  ++P    +S + R  
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY-AIPDYVHISPECRHL 253
Query: 210 ILKCLQVNPNDRPTVTELMEH 230
           I +    +P  R ++ E+  H
Sbjct: 254 ISRIFVADPAKRISIPEIRNH 274

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD------------------ 77
            + ++IV++ G   D + L +  E +  G L N + + H  D                  
Sbjct: 74  LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 78  SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK 137
           SQ+     QI +G+VYL  ++ VHRD+   N LV A+  VK+ DFG+++     D     
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 192
Query: 138 GTPF----WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK 192
           G       WM PE +  +   +   +D+WS G  + E+ T  + P+  L   + +  I +
Sbjct: 193 GHTMLPIRWMPPESIMYRK--FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 250
Query: 193 GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
           G +   P    ++  D +L C Q  P  R  + E+
Sbjct: 251 GRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEI 285

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 103/192 (53%), Gaps = 4/192 (2%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV+     + E  LY+ +E  + G + + L     + + +  +  RQI++ + Y H++ 
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKY 134
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTM-NDLKSCKGTPFWMAPEVVNSKNDGYGL 157
           +VHRD+K  N+L+D   ++K+ADFG +   T+ N L +  G+P + APE+   K    G 
Sbjct: 135 IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYD-GP 193
Query: 158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVN 217
             D+WSLG  +  +++   P+      +   R+ +G+   +P  +S D  + + K L +N
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKKLLVLN 252
Query: 218 PNDRPTVTELME 229
           P  R ++ ++M+
Sbjct: 253 PIKRGSLEQIMK 264

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 55  YIFLELVTKGSLANL-YQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           YI +E V   +L ++ + +  ++  +           L + H+  ++HRD+K ANI++ A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 114 SGSVKLADFGLAKA-----TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           + +VK+ DFG+A+A      ++    +  GT  +++PE   ++ D     +D++SLGC +
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVL 209
Query: 169 LEMLTRRPPYSHLEGVQALFRIGKGELPSVPSS----LSRDARDFILKCLQVNPNDRPTV 224
            E+LT  PP++    V   ++  + E P  PS+    LS D    +LK L  NP +R   
Sbjct: 210 YEVLTGEPPFTGDSPVSVAYQHVR-EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT 268
Query: 225 TELMEHPFVK----RPLQTPRC 242
              M    V+     P + P+ 
Sbjct: 269 AAEMRADLVRVHNGEPPEAPKV 290

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 97/200 (48%), Gaps = 26/200 (13%)
Query: 54  LYIFLELVTKGSLANLYQKYHLS-----DSQVSSYTRQILNGLVYLHERNVVHRDIKCAN 108
           L + L L+  G L   +  YH+      +++   Y  +I  GL  LH   +V+RD+K  N
Sbjct: 259 LCLVLTLMNGGDLK--FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPEN 316
Query: 109 ILVDASGSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           IL+D  G ++++D GLA        +K   GT  +MAPEVV  KN+ Y  + D W+LGC 
Sbjct: 317 ILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--KNERYTFSPDWWALGCL 374
Query: 168 VLEMLTRRPPYSH------LEGVQALFRIGKGELPSVPSS-LSRDARDFILKCLQVNPND 220
           + EM+  + P+         E V+ L +    E+P   S   S  AR    + L  +P +
Sbjct: 375 LYEMIAGQSPFQQRKKKIKREEVERLVK----EVPEEYSERFSPQARSLCSQLLCKDPAE 430
Query: 221 R-----PTVTELMEHPFVKR 235
           R      +  E+ EHP  K+
Sbjct: 431 RLGCRGGSAREVKEHPLFKK 450

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 14/207 (6%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSL-----ANLYQKYHLSDSQVSSYTRQILNGLVYL 94
           NI++     +D + +YI +E    G L     +   +   LS+  V+   +Q++N L Y 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 95  HERNVVHRDIKCANILV-DAS--GSVKLADFGLAKATTMNDLKS-CKGTPFWMAPEVVNS 150
           H ++VVH+D+K  NIL  D S    +K+ DFGLA+    ++  +   GT  +MAPEV   
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF-- 198
Query: 151 KNDGYGLTADIWSLGCTVLEMLTRRPPY--SHLEGVQALFRIGKGELPSVPSSLSRDARD 208
           K D      DIWS G  +  +LT   P+  + LE VQ      +         L+  A D
Sbjct: 199 KRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVD 257
Query: 209 FILKCLQVNPNDRPTVTELMEHPFVKR 235
            + + L  +P  RP+  +++ H + K+
Sbjct: 258 LLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 26/203 (12%)
Query: 51  ENRLYIFLELVTKGSLANLYQKYHLS-----DSQVSSYTRQILNGLVYLHERNVVHRDIK 105
           ++ L + L L+  G L   +  YH+      +++   Y  +I  GL  LH   +V+RD+K
Sbjct: 256 KDALCLVLTLMNGGDLK--FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLK 313
Query: 106 CANILVDASGSVKLADFGLA-KATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSL 164
             NIL+D  G ++++D GLA        +K   GT  +MAPEVV  KN+ Y  + D W+L
Sbjct: 314 PENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--KNERYTFSPDWWAL 371
Query: 165 GCTVLEMLTRRPPYSH------LEGVQALFRIGKGELPSVPSS-LSRDARDFILKCLQVN 217
           GC + EM+  + P+         E V+ L +    E+P   S   S  AR    + L  +
Sbjct: 372 GCLLYEMIAGQSPFQQRKKKIKREEVERLVK----EVPEEYSERFSPQARSLCSQLLCKD 427
Query: 218 PNDR-----PTVTELMEHPFVKR 235
           P +R      +  E+ EHP  K+
Sbjct: 428 PAERLGCRGGSAREVKEHPLFKK 450

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 55  YIFLELVTKGSLANL-YQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           YI +E V   +L ++ + +  ++  +           L + H+  ++HRD+K ANI++ A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 114 SGSVKLADFGLAKA-----TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           + +VK+ DFG+A+A      ++    +  GT  +++PE   ++ D     +D++SLGC +
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVL 209
Query: 169 LEMLTRRPPYSHLEGVQALFRIGKGELPSVPSS----LSRDARDFILKCLQVNPNDRPTV 224
            E+LT  PP++    V   ++  + E P  PS+    LS D    +LK L  NP +R   
Sbjct: 210 YEVLTGEPPFTGDSPVSVAYQHVR-EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT 268
Query: 225 TELMEHPFVK----RPLQTPRC 242
              M    V+     P + P+ 
Sbjct: 269 AAEMRADLVRVHNGEPPEAPKV 290

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 55  YIFLELVTKGSLANL-YQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           YI +E V   +L ++ + +  ++  +           L + H+  ++HRD+K ANI++ A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 114 SGSVKLADFGLAKA-----TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           + +VK+ DFG+A+A      ++    +  GT  +++PE   ++ D     +D++SLGC +
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVL 209
Query: 169 LEMLTRRPPYSHLEGVQALFRIGKGELPSVPSS----LSRDARDFILKCLQVNPNDRPTV 224
            E+LT  PP++    V   ++  + E P  PS+    LS D    +LK L  NP +R   
Sbjct: 210 YEVLTGEPPFTGDSPVSVAYQHVR-EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT 268
Query: 225 TELMEHPFVK----RPLQTPRC 242
              M    V+     P + P+ 
Sbjct: 269 AAEMRADLVRVHNGEPPEAPKV 290

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 36  FEQDNIVQYLGTDKDENR--LYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGL 91
            + DNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 69  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 128
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTP-FWMAPE 146
            YL  +  +HR++   NILV+    VK+ DFGL K    +     +K    +P FW APE
Sbjct: 129 EYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE 188
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLT-----RRPPYSHL-------EGVQALFRI---- 190
            +      + + +D+WS G  + E+ T     + PP   +       +G   +F +    
Sbjct: 189 SLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 246
Query: 191 -GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
              G LP  P     +    + +C   N N RP+  +L
Sbjct: 247 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 283

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 72/135 (53%), Gaps = 15/135 (11%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLS------DSQVSSYTRQILNGLVYLHERNVVHRDIK 105
           ++LY  L+ +  G L      YHL       + +   Y  +I + L YLH  N+V+RD+K
Sbjct: 112 DKLYFVLDYINGGELF-----YHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLK 166
Query: 106 CANILVDASGSVKLADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGLTADIWS 163
             NIL+D+ G + L DFGL K    ++  +    GTP ++APEV++ +   Y  T D W 
Sbjct: 167 PENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWC 224
Query: 164 LGCTVLEMLTRRPPY 178
           LG  + EML   PP+
Sbjct: 225 LGAVLYEMLYGLPPF 239

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNV 99
            V+   T +D+ +LY  L     G L    +K    D   +  YT +I++ L YLH + +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLK----SCKGTPFWMAPEVVNSKNDGY 155
           +HRD+K  NIL++    +++ DFG AK  +    +    S  GT  +++PE++  K+   
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSASK 213
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQ 215
             ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L 
Sbjct: 214 --SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLVEKLLV 270
Query: 216 VNPNDRPTVTE------LMEHPFVK 234
           ++   R    E      L  HPF +
Sbjct: 271 LDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 29/218 (13%)
Query: 36  FEQDNIVQYLGTDKDENR--LYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGL 91
            + DNIV+Y G      R  L + +E +  GSL +  Q +   +   ++  YT QI  G+
Sbjct: 71  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGM 130
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTP-FWMAPE 146
            YL  +  +HRD+   NILV+    VK+ DFGL K    +     +K    +P FW APE
Sbjct: 131 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLT-----RRPPYSHL-------EGVQALFRI---- 190
            +      + + +D+WS G  + E+ T     + PP   +       +G   +F +    
Sbjct: 191 SLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 248
Query: 191 -GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
              G LP  P     +    + +C   N N RP+  +L
Sbjct: 249 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 285

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 91/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 100 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ D+GLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 159 NEDCELKILDYGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 216
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 93/177 (52%), Gaps = 13/177 (7%)
Query: 55  YIFLELVTKGSLANL-YQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           YI +E V   +L ++ + +  ++  +           L + H+  ++HRD+K ANI++ A
Sbjct: 109 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 168
Query: 114 SGSVKLADFGLAKA-----TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           + +VK+ DFG+A+A      ++    +  GT  +++PE   ++ D     +D++SLGC +
Sbjct: 169 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVL 226
Query: 169 LEMLTRRPPYSHLEGVQALFRIGKGELPSVPSS----LSRDARDFILKCLQVNPNDR 221
            E+LT  PP++    V   ++  + E P  PS+    LS D    +LK L  NP +R
Sbjct: 227 YEVLTGEPPFTGDSPVSVAYQHVR-EDPIPPSARHEGLSADLDAVVLKALAKNPENR 282

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 14/205 (6%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNV 99
            V+   T +D+ +LY  L     G L    +K    D   +  YT +I++ L YLH + +
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 156
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK----GTPFWMAPEVVNSKNDGY 155
           +HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE++  K+   
Sbjct: 157 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 216
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQ 215
             ++D+W+LGC + +++   PP+          +I K E    P++    ARD + K L 
Sbjct: 217 --SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPAAFFPKARDLVEKLLV 273
Query: 216 VNPNDRPTVTE------LMEHPFVK 234
           ++   R    E      L  HPF +
Sbjct: 274 LDATKRLGCEEMEGYGPLKAHPFFE 298

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNV 99
            V+   T +D+ +LY  L     G L    +K    D   +  YT +I++ L YLH + +
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 154
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLK----SCKGTPFWMAPEVVNSKNDGY 155
           +HRD+K  NIL++    +++ DFG AK  +    +    S  GT  +++PE++  K+   
Sbjct: 155 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 214
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQ 215
             ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L 
Sbjct: 215 --SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLVEKLLV 271
Query: 216 VNPNDRPTVTE------LMEHPFVK 234
           ++   R    E      L  HPF +
Sbjct: 272 LDATKRLGCEEMEGYGPLKAHPFFE 296

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 110/244 (45%), Gaps = 51/244 (20%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN- 98
           IV + G    +  + I +E +  GSL   L +   + +  +   +  +L GL YL E++ 
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 135
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +MAPE +   +  Y + 
Sbjct: 136 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPERLQGTH--YSVQ 193
Query: 159 ADIWSLGCTVLEMLTRR-----PPYSHLEGV----------------------------- 184
           +DIWS+G +++E+   R     P    LE +                             
Sbjct: 194 SDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSG 253
Query: 185 --------QALFR----IGKGELPSVPSSL-SRDARDFILKCLQVNPNDRPTVTELMEHP 231
                    A+F     I     P +P+ + + D ++F+ KCL  NP +R  +  L  H 
Sbjct: 254 HGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLTNHT 313
Query: 232 FVKR 235
           F+KR
Sbjct: 314 FIKR 317

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 8/208 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYTRQILNGLVYLHE 96
            +N+V++ G  ++ N  Y+FLE  + G L +  +    + +     +  Q++ G+VYLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKN 152
             + HRDIK  N+L+D   ++K++DFGLA     N+    L    GT  ++APE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL-KRR 181
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL- 211
           + +    D+WS G  +  ML    P+         +   K +   +      D+    L 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 212 -KCLQVNPNDRPTVTELMEHPFVKRPLQ 238
            K L  NP+ R T+ ++ +  +  +PL+
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNV 99
            V+   T +D+ +LY  L     G L    +K    D   +  YT +I++ L YLH + +
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLK----SCKGTPFWMAPEVVNSKNDGY 155
           +HRD+K  NIL++    +++ DFG AK  +    +    S  GT  +++PE++  K+   
Sbjct: 151 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 210
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQ 215
             ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L 
Sbjct: 211 --SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLVEKLLV 267
Query: 216 VNPNDRPTVTE------LMEHPFVK 234
           ++   R    E      L  HPF +
Sbjct: 268 LDATKRLGCEEMEGYGPLKAHPFFE 292

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 10/189 (5%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           IV+ +G  + E+ + + +E+   G L   L Q  H+ D  +     Q+  G+ YL E N 
Sbjct: 68  IVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 126
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSKNDG 154
           VHRD+   N+L+      K++DFGL+KA   ++         K    W APE +N     
Sbjct: 127 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-- 184
Query: 155 YGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKC 213
           +   +D+WS G  + E  +  + PY  ++G +    + KGE    P+   R+  D +  C
Sbjct: 185 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 244
Query: 214 LQVNPNDRP 222
              +  +RP
Sbjct: 245 WTYDVENRP 253

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 10/189 (5%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           IV+ +G  + E+ + + +E+   G L   L Q  H+ D  +     Q+  G+ YL E N 
Sbjct: 80  IVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSKNDG 154
           VHRD+   N+L+      K++DFGL+KA   ++         K    W APE +N     
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-- 196
Query: 155 YGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKC 213
           +   +D+WS G  + E  +  + PY  ++G +    + KGE    P+   R+  D +  C
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 256
Query: 214 LQVNPNDRP 222
              +  +RP
Sbjct: 257 WTYDVENRP 265

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 90/189 (47%), Gaps = 10/189 (5%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           IV+ +G  + E+ + + +E+   G L   L Q  H+ D  +     Q+  G+ YL E N 
Sbjct: 74  IVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 132
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKA--TTMNDLKS---CKGTPFWMAPEVVNSKNDG 154
           VHRD+   N+L+      K++DFGL+KA     N  K+    K    W APE +N     
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYK-- 190
Query: 155 YGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKC 213
           +   +D+WS G  + E  +  + PY  ++G +    + KGE    P+   R+  D +  C
Sbjct: 191 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 250
Query: 214 LQVNPNDRP 222
              +  +RP
Sbjct: 251 WTYDVENRP 259

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-----------------KYHLSDSQ 79
           +  NI+  LG    +  LY+ +E  +KG+L    Q                 +  LS   
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKD 151
Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCK 137
           + S   Q+  G+ YL  +  +HRD+   N+LV     +K+ADFGLA+     D   K+  
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 138 GT-PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-G 193
           G  P  WMAPE +  +   Y   +D+WS G  + E+ T    PY  +  V+ LF++ K G
Sbjct: 212 GRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 268
Query: 194 ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
                PS+ + +    +  C    P+ RPT  +L+E
Sbjct: 269 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-----------------KYHLSDSQ 79
           +  NI+  LG    +  LY+ +E  +KG+L    Q                 +  LS   
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 136
Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCK 137
           + S   Q+  G+ YL  +  +HRD+   N+LV     +K+ADFGLA+     D   K+  
Sbjct: 137 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 138 GT-PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-G 193
           G  P  WMAPE +  +   Y   +D+WS G  + E+ T    PY  +  V+ LF++ K G
Sbjct: 197 GRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 253
Query: 194 ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
                PS+ + +    +  C    P+ RPT  +L+E
Sbjct: 254 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 10/189 (5%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           IV+ +G  + E+ + + +E+   G L   L Q  H+ D  +     Q+  G+ YL E N 
Sbjct: 74  IVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 132
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSKNDG 154
           VHRD+   N+L+      K++DFGL+KA   ++         K    W APE +N     
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-- 190
Query: 155 YGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKC 213
           +   +D+WS G  + E  +  + PY  ++G +    + KGE    P+   R+  D +  C
Sbjct: 191 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 250
Query: 214 LQVNPNDRP 222
              +  +RP
Sbjct: 251 WTYDVENRP 259

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-----------------KYHLSDSQ 79
           +  NI+  LG    +  LY+ +E  +KG+L    Q                 +  LS   
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 151
Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCK 137
           + S   Q+  G+ YL  +  +HRD+   N+LV     +K+ADFGLA+     D   K+  
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 138 GT-PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-G 193
           G  P  WMAPE +  +   Y   +D+WS G  + E+ T    PY  +  V+ LF++ K G
Sbjct: 212 GRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 268
Query: 194 ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
                PS+ + +    +  C    P+ RPT  +L+E
Sbjct: 269 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 10/189 (5%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           IV+ +G  + E+ + + +E+   G L   L Q  H+ D  +     Q+  G+ YL E N 
Sbjct: 88  IVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 146
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSKNDG 154
           VHRD+   N+L+      K++DFGL+KA   ++         K    W APE +N     
Sbjct: 147 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-- 204
Query: 155 YGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKC 213
           +   +D+WS G  + E  +  + PY  ++G +    + KGE    P+   R+  D +  C
Sbjct: 205 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 264
Query: 214 LQVNPNDRP 222
              +  +RP
Sbjct: 265 WTYDVENRP 273

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 10/189 (5%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           IV+ +G  + E+ + + +E+   G L   L Q  H+ D  +     Q+  G+ YL E N 
Sbjct: 90  IVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 148
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSKNDG 154
           VHRD+   N+L+      K++DFGL+KA   ++         K    W APE +N     
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-- 206
Query: 155 YGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKC 213
           +   +D+WS G  + E  +  + PY  ++G +    + KGE    P+   R+  D +  C
Sbjct: 207 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 266
Query: 214 LQVNPNDRP 222
              +  +RP
Sbjct: 267 WTYDVENRP 275

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 10/189 (5%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           IV+ +G  + E+ + + +E+   G L   L Q  H+ D  +     Q+  G+ YL E N 
Sbjct: 90  IVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 148
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSKNDG 154
           VHRD+   N+L+      K++DFGL+KA   ++         K    W APE +N     
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-- 206
Query: 155 YGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKC 213
           +   +D+WS G  + E  +  + PY  ++G +    + KGE    P+   R+  D +  C
Sbjct: 207 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 266
Query: 214 LQVNPNDRP 222
              +  +RP
Sbjct: 267 WTYDVENRP 275

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-----------------KYHLSDSQ 79
           +  NI+  LG    +  LY+ +E  +KG+L    Q                 +  LS   
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCK 137
           + S   Q+  G+ YL  +  +HRD+   N+LV     +K+ADFGLA+     D   K+  
Sbjct: 193 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 138 GT-PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-G 193
           G  P  WMAPE +  +   Y   +D+WS G  + E+ T    PY  +  V+ LF++ K G
Sbjct: 253 GRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 309
Query: 194 ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
                PS+ + +    +  C    P+ RPT  +L+E
Sbjct: 310 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 345

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-----------------KYHLSDSQ 79
           +  NI+  LG    +  LY+ +E  +KG+L    Q                 +  LS   
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 151
Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCK 137
           + S   Q+  G+ YL  +  +HRD+   N+LV     +K+ADFGLA+     D   K+  
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 138 GT-PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-G 193
           G  P  WMAPE +  +   Y   +D+WS G  + E+ T    PY  +  V+ LF++ K G
Sbjct: 212 GRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 268
Query: 194 ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
                PS+ + +    +  C    P+ RPT  +L+E
Sbjct: 269 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-----------------KYHLSDSQ 79
           +  NI+  LG    +  LY+ +E  +KG+L    Q                 +  LS   
Sbjct: 85  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 144
Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCK 137
           + S   Q+  G+ YL  +  +HRD+   N+LV     +K+ADFGLA+     D   K+  
Sbjct: 145 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 204
Query: 138 GT-PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-G 193
           G  P  WMAPE +  +   Y   +D+WS G  + E+ T    PY  +  V+ LF++ K G
Sbjct: 205 GRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 261
Query: 194 ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
                PS+ + +    +  C    P+ RPT  +L+E
Sbjct: 262 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 297

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 10/189 (5%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           IV+ +G  + E+ + + +E+   G L   L Q  H+ D  +     Q+  G+ YL E N 
Sbjct: 70  IVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSKNDG 154
           VHRD+   N+L+      K++DFGL+KA   ++         K    W APE +N     
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-- 186
Query: 155 YGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKC 213
           +   +D+WS G  + E  +  + PY  ++G +    + KGE    P+   R+  D +  C
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 246
Query: 214 LQVNPNDRP 222
              +  +RP
Sbjct: 247 WTYDVENRP 255

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-----------------KYHLSDSQ 79
           +  NI+  LG    +  LY+ +E  +KG+L    Q                 +  LS   
Sbjct: 84  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 143
Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCK 137
           + S   Q+  G+ YL  +  +HRD+   N+LV     +K+ADFGLA+     D   K+  
Sbjct: 144 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 203
Query: 138 GT-PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-G 193
           G  P  WMAPE +  +   Y   +D+WS G  + E+ T    PY  +  V+ LF++ K G
Sbjct: 204 GRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 260
Query: 194 ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
                PS+ + +    +  C    P+ RPT  +L+E
Sbjct: 261 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 296

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-----------------KYHLSDSQ 79
           +  NI+  LG    +  LY+ +E  +KG+L    Q                 +  LS   
Sbjct: 81  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 140
Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCK 137
           + S   Q+  G+ YL  +  +HRD+   N+LV     +K+ADFGLA+     D   K+  
Sbjct: 141 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 200
Query: 138 GT-PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-G 193
           G  P  WMAPE +  +   Y   +D+WS G  + E+ T    PY  +  V+ LF++ K G
Sbjct: 201 GRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 257
Query: 194 ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
                PS+ + +    +  C    P+ RPT  +L+E
Sbjct: 258 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 293

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 10/189 (5%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           IV+ +G  + E+ + + +E+   G L   L Q  H+ D  +     Q+  G+ YL E N 
Sbjct: 432 IVRMIGICEAESWMLV-MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 490
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSKNDG 154
           VHRD+   N+L+      K++DFGL+KA   ++         K    W APE +N     
Sbjct: 491 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-- 548
Query: 155 YGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKC 213
           +   +D+WS G  + E  +  + PY  ++G +    + KGE    P+   R+  D +  C
Sbjct: 549 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 608
Query: 214 LQVNPNDRP 222
              +  +RP
Sbjct: 609 WTYDVENRP 617

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-----------------KYHLSDSQ 79
           +  NI+  LG    +  LY+ +E  +KG+L    Q                 +  LS   
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKD 151
Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCK 137
           + S   Q+  G+ YL  +  +HRD+   N+LV     +K+ADFGLA+     D   K+  
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTN 211
Query: 138 GT-PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-G 193
           G  P  WMAPE +  +   Y   +D+WS G  + E+ T    PY  +  V+ LF++ K G
Sbjct: 212 GRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 268
Query: 194 ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
                PS+ + +    +  C    P+ RPT  +L+E
Sbjct: 269 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 10/189 (5%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           IV+ +G  + E+ + + +E+   G L   L Q  H+ D  +     Q+  G+ YL E N 
Sbjct: 433 IVRMIGICEAESWMLV-MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 491
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSKNDG 154
           VHRD+   N+L+      K++DFGL+KA   ++         K    W APE +N     
Sbjct: 492 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-- 549
Query: 155 YGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKC 213
           +   +D+WS G  + E  +  + PY  ++G +    + KGE    P+   R+  D +  C
Sbjct: 550 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 609
Query: 214 LQVNPNDRP 222
              +  +RP
Sbjct: 610 WTYDVENRP 618

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 107 LQEELARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 166
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---QAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E +   Q  
Sbjct: 167 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 222
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 223 FR----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 107 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 166
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLE---GVQAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E   G Q  
Sbjct: 167 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVF 222
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 223 FR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 98/195 (50%), Gaps = 14/195 (7%)
Query: 58  LELVTK----GSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           L+LVT+    GSL +  +++   L    + ++  QI  G+ YL E  +VHR++   N+L+
Sbjct: 107 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL 166
Query: 112 DASGSVKLADFGLAKATTMND---LKSCKGTPF-WMAPEVVNSKNDGYGLTADIWSLGCT 167
            +   V++ADFG+A     +D   L S   TP  WMA E ++     Y   +D+WS G T
Sbjct: 167 KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK--YTHQSDVWSYGVT 224
Query: 168 VLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTE 226
           V E++T    PY+ L   +    + KGE  + P   + D    ++KC  ++ N RPT  E
Sbjct: 225 VWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKE 284
Query: 227 LMEHPFVKRPLQTPR 241
           L    F +     PR
Sbjct: 285 LANE-FTRMARDPPR 298

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNV 99
            V+   T +D+ +LY  L     G L    +K    D   +  YT +I++ L YLH + +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK----GTPFWMAPEVVNSKNDGY 155
           +HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE++  K+   
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXK 213
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQ 215
             ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L 
Sbjct: 214 --SSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-DFPEKFFPKARDLVEKLLV 270
Query: 216 VNPNDRPTVTE------LMEHPFVK 234
           ++   R    E      L  HPF +
Sbjct: 271 LDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNV 99
            V+   T +D+ +LY  L     G L    +K    D   +  YT +I++ L YLH + +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK----GTPFWMAPEVVNSKNDGY 155
           +HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE++  K+   
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 213
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQ 215
             ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L 
Sbjct: 214 --SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLVEKLLV 270
Query: 216 VNPNDRPTVTE------LMEHPFVK 234
           ++   R    E      L  HPF +
Sbjct: 271 LDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 98/195 (50%), Gaps = 14/195 (7%)
Query: 58  LELVTK----GSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           L+LVT+    GSL +  +++   L    + ++  QI  G+ YL E  +VHR++   N+L+
Sbjct: 89  LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL 148
Query: 112 DASGSVKLADFGLAKATTMND---LKSCKGTPF-WMAPEVVNSKNDGYGLTADIWSLGCT 167
            +   V++ADFG+A     +D   L S   TP  WMA E ++     Y   +D+WS G T
Sbjct: 149 KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK--YTHQSDVWSYGVT 206
Query: 168 VLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTE 226
           V E++T    PY+ L   +    + KGE  + P   + D    ++KC  ++ N RPT  E
Sbjct: 207 VWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKE 266
Query: 227 LMEHPFVKRPLQTPR 241
           L    F +     PR
Sbjct: 267 LANE-FTRMARDPPR 280

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNV 99
            V+   T +D+ +LY  L     G L    +K    D   +  YT +I++ L YLH + +
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK----GTPFWMAPEVVNSKNDGY 155
           +HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE++  K+   
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 189
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQ 215
             ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L 
Sbjct: 190 --SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLVEKLLV 246
Query: 216 VNPNDRPTVTE------LMEHPFVK 234
           ++   R    E      L  HPF +
Sbjct: 247 LDATKRLGCEEMEGYGPLKAHPFFE 271

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNV 99
            V+   T +D+ +LY  L     G L    +K    D   +  YT +I++ L YLH + +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK----GTPFWMAPEVVNSKNDGY 155
           +HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE++  K+   
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 213
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQ 215
             ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L 
Sbjct: 214 --SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLVEKLLV 270
Query: 216 VNPNDRPTVTE------LMEHPFVK 234
           ++   R    E      L  HPF +
Sbjct: 271 LDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNV 99
            V+   T +D+ +LY  L     G L    +K    D   +  YT +I++ L YLH + +
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK----GTPFWMAPEVVNSKNDGY 155
           +HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE++  K+   
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 211
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQ 215
             ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L 
Sbjct: 212 --SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLVEKLLV 268
Query: 216 VNPNDRPTVTE------LMEHPFVK 234
           ++   R    E      L  HPF +
Sbjct: 269 LDATKRLGCEEMEGYGPLKAHPFFE 293

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 83/183 (45%), Gaps = 30/183 (16%)
Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDLKSCKG 138
           V  +  Q+L GL Y H + V+HRD+K  N+L++  G +KLADFGLA+A ++       + 
Sbjct: 102 VKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEV 161
Query: 139 TPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP--PYSHL-EGVQALFRI----G 191
              W  P  +   +  Y    D+W +GC   EM T RP  P S + E +  +FRI     
Sbjct: 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT 221
Query: 192 KGELPSVPSS----------------------LSRDARDFILKCLQVNPNDRPTVTELME 229
           +   P + S+                      L  D  D + K LQ    +R +  + M+
Sbjct: 222 EETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281
Query: 230 HPF 232
           HPF
Sbjct: 282 HPF 284

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNV 99
            V+   T +D+ +LY  L     G L    +K    D   +  YT +I++ L YLH + +
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKS----CKGTPFWMAPEVVNSKNDGY 155
           +HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE++  K+   
Sbjct: 151 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 210
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQ 215
             ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L 
Sbjct: 211 --SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLVEKLLV 267
Query: 216 VNPNDRPTVTE------LMEHPFVK 234
           ++   R    E      L  HPF +
Sbjct: 268 LDATKRLGCEEMEGYGPLKAHPFFE 292

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNV 99
            V+   T +D+ +LY  L     G L    +K    D   +  YT +I++ L YLH + +
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 154
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK----GTPFWMAPEVVNSKNDGY 155
           +HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE++  K+   
Sbjct: 155 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 214
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQ 215
             ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L 
Sbjct: 215 --SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLVEKLLV 271
Query: 216 VNPNDRPTVTE------LMEHPFVK 234
           ++   R    E      L  HPF +
Sbjct: 272 LDATKRLGCEEMEGYGPLKAHPFFE 296

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNV 99
            V+   T +D+ +LY  L     G L    +K    D   +  YT +I++ L YLH + +
Sbjct: 71  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 130
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK----GTPFWMAPEVVNSKNDGY 155
           +HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE++  K+   
Sbjct: 131 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 190
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQ 215
             ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L 
Sbjct: 191 --SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLVEKLLV 247
Query: 216 VNPNDRPTVTE------LMEHPFVK 234
           ++   R    E      L  HPF +
Sbjct: 248 LDATKRLGCEEMEGYGPLKAHPFFE 272

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNV 99
            V+   T +D+ +LY  L     G L    +K    D   +  YT +I++ L YLH + +
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK----GTPFWMAPEVVNSKNDGY 155
           +HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE++  K+   
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 211
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQ 215
             ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L 
Sbjct: 212 --SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLVEKLLV 268
Query: 216 VNPNDRPTVTE------LMEHPFVK 234
           ++   R    E      L  HPF +
Sbjct: 269 LDATKRLGCEEMEGYGPLKAHPFFE 293

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNV 99
            V+   T +D+ +LY  L     G L    +K    D   +  YT +I++ L YLH + +
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK----GTPFWMAPEVVNSKNDGY 155
           +HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE++  K+   
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACK 211
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQ 215
             ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L 
Sbjct: 212 --SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLVEKLLV 268
Query: 216 VNPNDRPTVTE------LMEHPFVK 234
           ++   R    E      L  HPF +
Sbjct: 269 LDATKRLGCEEMEGYGPLKAHPFFE 293

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNV 99
            V+   T +D+ +LY  L     G L    +K    D   +  YT +I++ L YLH + +
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 135
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK----GTPFWMAPEVVNSKNDGY 155
           +HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE++  K+   
Sbjct: 136 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 195
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQ 215
             ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L 
Sbjct: 196 --SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLVEKLLV 252
Query: 216 VNPNDRPTVTE------LMEHPFVK 234
           ++   R    E      L  HPF +
Sbjct: 253 LDATKRLGCEEMEGYGPLKAHPFFE 277

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNV 99
            V+   T +D+ +LY  L     G L    +K    D   +  YT +I++ L YLH + +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK----GTPFWMAPEVVNSKNDGY 155
           +HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE++  K+   
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 213
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQ 215
             ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L 
Sbjct: 214 --SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLVEKLLV 270
Query: 216 VNPNDRPTVTE------LMEHPFVK 234
           ++   R    E      L  HPF +
Sbjct: 271 LDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNV 99
            V+   T +D+ +LY  L     G L    +K    D   +  YT +I++ L YLH + +
Sbjct: 69  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 128
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK----GTPFWMAPEVVNSKNDGY 155
           +HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE++  K+   
Sbjct: 129 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 188
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQ 215
             ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L 
Sbjct: 189 --SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLVEKLLV 245
Query: 216 VNPNDRPTVTE------LMEHPFVK 234
           ++   R    E      L  HPF +
Sbjct: 246 LDATKRLGCEEMEGYGPLKAHPFFE 270

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 8/208 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYTRQILNGLVYLHE 96
            +N+V++ G  ++ N  Y+FLE  + G L +  +    + +     +  Q++ G+VYLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKN 152
             + HRDIK  N+L+D   ++K++DFGLA     N+    L    GT  ++APE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL-KRR 181
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL- 211
           + +    D+WS G  +  ML    P+         +   K +   +      D+    L 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 212 -KCLQVNPNDRPTVTELMEHPFVKRPLQ 238
            K L  NP+ R T+ ++ +  +  +PL+
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNV 99
            V+   T +D+ +LY  L     G L    +K    D   +  YT +I++ L YLH + +
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK----GTPFWMAPEVVNSKNDGY 155
           +HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE++  K+   
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 211
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQ 215
             ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L 
Sbjct: 212 --SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLVEKLLV 268
Query: 216 VNPNDRPTVTE------LMEHPFVK 234
           ++   R    E      L  HPF +
Sbjct: 269 LDATKRLGCEEMEGYGPLKAHPFFE 293

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNV 99
            V+   T +D+ +LY  L     G L    +K    D   +  YT +I++ L YLH + +
Sbjct: 72  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 131
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK----GTPFWMAPEVVNSKNDGY 155
           +HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE++  K+   
Sbjct: 132 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 191
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQ 215
             ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L 
Sbjct: 192 --SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLVEKLLV 248
Query: 216 VNPNDRPTVTE------LMEHPFVK 234
           ++   R    E      L  HPF +
Sbjct: 249 LDATKRLGCEEMEGYGPLKAHPFFE 273

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 8/208 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYTRQILNGLVYLHE 96
            +N+V++ G  ++ N  Y+FLE  + G L +  +    + +     +  Q++ G+VYLH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKN 152
             + HRDIK  N+L+D   ++K++DFGLA     N+    L    GT  ++APE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL-KRR 182
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL- 211
           + +    D+WS G  +  ML    P+         +   K +   +      D+    L 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 212 -KCLQVNPNDRPTVTELMEHPFVKRPLQ 238
            K L  NP+ R T+ ++ +  +  +PL+
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLK 270

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 94/196 (47%), Gaps = 33/196 (16%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK 134
            S+ ++     Q+L GL Y+H   VVHRD+K  N+ V+    +K+ DFGLA+     ++ 
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-EMT 181
Query: 135 SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYS---HLEGVQALFRI- 190
               T ++ APEV+ S    Y  T DIWS+GC + EMLT +  +    +L+ +  + ++ 
Sbjct: 182 GYVVTRWYRAPEVILSWMH-YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 240
Query: 191 ---------------GKGELPSVPSSLSRD-----------ARDFILKCLQVNPNDRPTV 224
                           K  + S+P +  +D           A D + K L+++ + R T 
Sbjct: 241 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA 300
Query: 225 TELMEHPFVKRPLQTP 240
            + + HPF + P + P
Sbjct: 301 AQALTHPFFE-PFRDP 315

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 80.9 bits (198), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 93/205 (45%), Gaps = 33/205 (16%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK 134
           L+ S + +Y    L GL YLH+  ++HRD+K  N+L+D +G +KLADFGLAK+    +  
Sbjct: 109 LTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 168
Query: 135 SCKG--TPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
                 T ++ APE++      YG+  D+W++GC + E+L R P       +  L RI +
Sbjct: 169 YXHQVVTRWYRAPELLFGAR-MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE 227
Query: 193 ----------------------GELPSVP-----SSLSRDARDFILKCLQVNPNDRPTVT 225
                                    P +P     S+   D  D I      NP  R T T
Sbjct: 228 TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT 287
Query: 226 ELMEHP-FVKRPLQTPRCG--QANC 247
           + ++   F  RP  TP C   + NC
Sbjct: 288 QALKMKYFSNRPGPTPGCQLPRPNC 312

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 8/208 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYTRQILNGLVYLHE 96
            +N+V++ G  ++ N  Y+FLE  + G L +  +    + +     +  Q++ G+VYLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKN 152
             + HRDIK  N+L+D   ++K++DFGLA     N+    L    GT  ++APE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL-KRR 181
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL- 211
           + +    D+WS G  +  ML    P+         +   K +   +      D+    L 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 212 -KCLQVNPNDRPTVTELMEHPFVKRPLQ 238
            K L  NP+ R T+ ++ +  +  +PL+
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 8/208 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYTRQILNGLVYLHE 96
            +N+V++ G  ++ N  Y+FLE  + G L +  +    + +     +  Q++ G+VYLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKN 152
             + HRDIK  N+L+D   ++K++DFGLA     N+    L    GT  ++APE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL-KRR 181
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL- 211
           + +    D+WS G  +  ML    P+         +   K +   +      D+    L 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 212 -KCLQVNPNDRPTVTELMEHPFVKRPLQ 238
            K L  NP+ R T+ ++ +  +  +PL+
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 94/196 (47%), Gaps = 33/196 (16%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK 134
            S+ ++     Q+L GL Y+H   VVHRD+K  N+ V+    +K+ DFGLA+     ++ 
Sbjct: 141 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD-AEMT 199
Query: 135 SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYS---HLEGVQALFRI- 190
               T ++ APEV+ S    Y  T DIWS+GC + EMLT +  +    +L+ +  + ++ 
Sbjct: 200 GYVVTRWYRAPEVILSWMH-YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 258
Query: 191 ---------------GKGELPSVPSSLSRD-----------ARDFILKCLQVNPNDRPTV 224
                           K  + S+P +  +D           A D + K L+++ + R T 
Sbjct: 259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA 318
Query: 225 TELMEHPFVKRPLQTP 240
            + + HPF + P + P
Sbjct: 319 AQALTHPFFE-PFRDP 333

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 140 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 199
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLE---GVQAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E   G Q  
Sbjct: 200 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVF 255
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 256 FR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 292

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 140 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 199
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLE---GVQAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E   G Q  
Sbjct: 200 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVF 255
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 256 FR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 292

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNV 99
            V+   T +D+ +LY  L     G L    +K    D   +  YT +I++ L YLH + +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK----GTPFWMAPEVVNSKNDGY 155
           +HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE++  K+   
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 213
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQ 215
             ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L 
Sbjct: 214 --SSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-DFPEKFFPKARDLVEKLLV 270
Query: 216 VNPNDRPTVTE------LMEHPFVK 234
           ++   R    E      L  HPF +
Sbjct: 271 LDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 85/188 (45%), Gaps = 29/188 (15%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DL 133
           L    +    RQ L GL +LH   +VHRD+K  NILV + G+VKLADFGLA+  +    L
Sbjct: 109 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL 168
Query: 134 KSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY---SHLEGVQALF-- 188
                T ++ APEV+      Y    D+WS+GC   EM  R+P +   S  + +  +F  
Sbjct: 169 APVVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 226
Query: 189 -------------RIGKGELP--------SVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
                         + +G  P        SV   +       +L+ L  NP+ R +    
Sbjct: 227 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRA 286
Query: 228 MEHPFVKR 235
           ++H ++ +
Sbjct: 287 LQHSYLHK 294

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 139 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 198
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLE---GVQAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E   G Q  
Sbjct: 199 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVF 254
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 255 FR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 291

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 139 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 198
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLE---GVQAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E   G Q  
Sbjct: 199 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVF 254
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 255 FR----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 291

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 140 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 199
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLE---GVQAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E   G Q  
Sbjct: 200 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVF 255
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 256 FR----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 292

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 139 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 198
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLE---GVQAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E   G Q  
Sbjct: 199 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVF 254
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 255 FR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 291

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 85/188 (45%), Gaps = 29/188 (15%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DL 133
           L    +    RQ L GL +LH   +VHRD+K  NILV + G+VKLADFGLA+  +    L
Sbjct: 109 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL 168
Query: 134 KSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY---SHLEGVQALF-- 188
                T ++ APEV+      Y    D+WS+GC   EM  R+P +   S  + +  +F  
Sbjct: 169 DPVVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 226
Query: 189 -------------RIGKGELP--------SVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
                         + +G  P        SV   +       +L+ L  NP+ R +    
Sbjct: 227 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRA 286
Query: 228 MEHPFVKR 235
           ++H ++ +
Sbjct: 287 LQHSYLHK 294

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 90/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 100 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+  FGLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 159 NEDCELKILGFGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 216
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 140 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 199
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLE---GVQAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E   G Q  
Sbjct: 200 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVF 255
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 256 FR----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 292

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 110 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 169
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---QAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E +   Q  
Sbjct: 170 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 225
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 226 FR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 262

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 80.5 bits (197), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 85/188 (45%), Gaps = 29/188 (15%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DL 133
           L    +    RQ L GL +LH   +VHRD+K  NILV + G+VKLADFGLA+  +    L
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL 176
Query: 134 KSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY---SHLEGVQALF-- 188
                T ++ APEV+      Y    D+WS+GC   EM  R+P +   S  + +  +F  
Sbjct: 177 TPVVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234
Query: 189 -------------RIGKGELP--------SVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
                         + +G  P        SV   +       +L+ L  NP+ R +    
Sbjct: 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRA 294
Query: 228 MEHPFVKR 235
           ++H ++ +
Sbjct: 295 LQHSYLHK 302

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 80.5 bits (197), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 107 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 166
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---QAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E +   Q  
Sbjct: 167 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 222
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 223 FR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 80.5 bits (197), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 134 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 193
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---QAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E +   Q  
Sbjct: 194 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 249
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 250 FR----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 286

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 80.5 bits (197), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 112 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 171
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---QAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E +   Q  
Sbjct: 172 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 227
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 228 FR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 264

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 80.5 bits (197), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 49  KDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNVVHRDIKCA 107
           +D+ +LY  L     G L    +K    D   +  YT +I++ L YLH + ++HRD+K  
Sbjct: 107 QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 166
Query: 108 NILVDASGSVKLADFGLAKATTMNDLKSCK----GTPFWMAPEVVNSKNDGYGLTADIWS 163
           NIL++    +++ DFG AK  +    ++      GT  +++PE++  K+     ++D+W+
Sbjct: 167 NILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK--SSDLWA 224
Query: 164 LGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           LGC + +++   PP+          +I K E    P      ARD + K L ++   R  
Sbjct: 225 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLVEKLLVLDATKRLG 283
Query: 224 VTE------LMEHPFVK 234
             E      L  HPF +
Sbjct: 284 CEEMEGYGPLKAHPFFE 300

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 80.5 bits (197), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 111 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 170
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---QAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E +   Q  
Sbjct: 171 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 226
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 227 FR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 263

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 80.5 bits (197), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 111 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 170
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---QAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E +   Q  
Sbjct: 171 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 226
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 227 FR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 263

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 112 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 171
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---QAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E +   Q  
Sbjct: 172 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 227
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 228 FR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 264

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 80.5 bits (197), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 154 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 213
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---QAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E +   Q  
Sbjct: 214 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 269
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 270 FR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 306

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 90/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 100 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ DF LA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 159 NEDCELKILDFYLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 216
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 80.5 bits (197), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSL-----------------ANLYQKYHLSDSQVSS 82
           NI+  LG    +  LY+ +E  +KG+L                  N   +  ++   + S
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVS 161
Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT--- 139
            T Q+  G+ YL  +  +HRD+   N+LV  +  +K+ADFGLA+   +N++   K T   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDXXKKTTNG 219
Query: 140 --PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-GE 194
             P  WMAPE +  +   Y   +D+WS G  + E+ T    PY  +  V+ LF++ K G 
Sbjct: 220 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEGH 276
Query: 195 LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
               P++ + +    +  C    P+ RPT  +L+E
Sbjct: 277 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 112 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 171
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---QAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E +   Q  
Sbjct: 172 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 227
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 228 FR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 264

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSL-----------------ANLYQKYHLSDSQVSS 82
           NI+  LG    +  LY+ +E  +KG+L                  N   +  ++   + S
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT--- 139
            T Q+  G+ YL  +  +HRD+   N+LV  +  +K+ADFGLA+   +N++   K T   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDXXKKTTNG 219
Query: 140 --PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-GE 194
             P  WMAPE +  +   Y   +D+WS G  + E+ T    PY  +  V+ LF++ K G 
Sbjct: 220 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEGH 276
Query: 195 LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
               P++ + +    +  C    P+ RPT  +L+E
Sbjct: 277 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 154 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 213
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---QAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E +   Q  
Sbjct: 214 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 269
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 270 FR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 306

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 127 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 186
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---QAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E +   Q  
Sbjct: 187 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 242
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 243 FR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 279

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 24/214 (11%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYT--RQILNGLVY 93
            E+ N V+ +   K ++ L+I +E    G+L +L    +L+  +   +   RQIL  L Y
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKAT----------------TMNDLKSCK 137
           +H + ++HRD+K  NI +D S +VK+ DFGLAK                  + ++L S  
Sbjct: 132 IHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL-- 195
           GT  ++A EV++     Y    D++SLG    EM+   P  + +E V  L ++    +  
Sbjct: 192 GTAMYVATEVLDGTGH-YNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKLRSVSIEF 248
Query: 196 -PSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
            P    +  +  +  I   +  +PN RP    L+
Sbjct: 249 PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 8/208 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYTRQILNGLVYLHE 96
            +N+V++ G  ++ N  Y+FLE  + G L +  +    + +     +  Q++ G+VYLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKN 152
             + HRDIK  N+L+D   ++K++DFGLA     N+    L    GT  ++APE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL-KRR 181
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL- 211
           + +    D+WS G  +  ML    P+         +   K +   +      D+    L 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 212 -KCLQVNPNDRPTVTELMEHPFVKRPLQ 238
            K L  NP+ R T+ ++ +  +  +PL+
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 90/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 100 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ D GLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 159 NEDCELKILDAGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 216
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 80.1 bits (196), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 126 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 185
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---QAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E +   Q  
Sbjct: 186 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 241
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 242 FR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 278

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 80.1 bits (196), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 126 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 185
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---QAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E +   Q  
Sbjct: 186 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 241
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 242 FR----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 278

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 8/208 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYTRQILNGLVYLHE 96
            +N+V++ G  ++ N  Y+FLE  + G L +  +    + +     +  Q++ G+VYLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKN 152
             + HRDIK  N+L+D   ++K++DFGLA     N+    L    GT  ++APE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL-KRR 181
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL- 211
           + +    D+WS G  +  ML    P+         +   K +   +      D+    L 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 212 -KCLQVNPNDRPTVTELMEHPFVKRPLQ 238
            K L  NP+ R T+ ++ +  +  +PL+
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 80.1 bits (196), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 154 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 213
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---QAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E +   Q  
Sbjct: 214 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 269
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 270 FR----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 306

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 127 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 186
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---QAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E +   Q  
Sbjct: 187 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 242
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 243 FR----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 279

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 8/208 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYTRQILNGLVYLHE 96
            +N+V++ G  ++ N  Y+FLE  + G L +  +    + +     +  Q++ G+VYLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKN 152
             + HRDIK  N+L+D   ++K++DFGLA     N+    L    GT  ++APE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL-KRR 181
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL- 211
           + +    D+WS G  +  ML    P+         +   K +   +      D+    L 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 212 -KCLQVNPNDRPTVTELMEHPFVKRPLQ 238
            K L  NP+ R T+ ++ +  +  +PL+
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 8/208 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYTRQILNGLVYLHE 96
            +N+V++ G  ++ N  Y+FLE  + G L +  +    + +     +  Q++ G+VYLH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKN 152
             + HRDIK  N+L+D   ++K++DFGLA     N+    L    GT  ++APE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL-KRR 182
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL- 211
           + +    D+WS G  +  ML    P+         +   K +   +      D+    L 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 212 -KCLQVNPNDRPTVTELMEHPFVKRPLQ 238
            K L  NP+ R T+ ++ +  +  +PL+
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLK 270

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 159 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 218
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---QAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E +   Q  
Sbjct: 219 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 274
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 275 FR----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 311

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 8/208 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYTRQILNGLVYLHE 96
            +N+V++ G  ++ N  Y+FLE  + G L +  +    + +     +  Q++ G+VYLH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKN 152
             + HRDIK  N+L+D   ++K++DFGLA     N+    L    GT  ++APE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL-KRR 182
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL- 211
           + +    D+WS G  +  ML    P+         +   K +   +      D+    L 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 212 -KCLQVNPNDRPTVTELMEHPFVKRPLQ 238
            K L  NP+ R T+ ++ +  +  +PL+
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLK 270

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 139 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 198
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---QAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E +   Q  
Sbjct: 199 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 254
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 255 FR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 291

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 146 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 205
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---QAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E +   Q  
Sbjct: 206 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 261
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 262 FR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 8/208 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYTRQILNGLVYLHE 96
            +N+V++ G  ++ N  Y+FLE  + G L +  +    + +     +  Q++ G+VYLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKN 152
             + HRDIK  N+L+D   ++K++DFGLA     N+    L    GT  ++APE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL-KRR 181
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL- 211
           + +    D+WS G  +  ML    P+         +   K +   +      D+    L 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 212 -KCLQVNPNDRPTVTELMEHPFVKRPLQ 238
            K L  NP+ R T+ ++ +  +  +PL+
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 8/208 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYTRQILNGLVYLHE 96
            +N+V++ G  ++ N  Y+FLE  + G L +  +    + +     +  Q++ G+VYLH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKN 152
             + HRDIK  N+L+D   ++K++DFGLA     N+    L    GT  ++APE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL-KRR 182
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL- 211
           + +    D+WS G  +  ML    P+         +   K +   +      D+    L 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 212 -KCLQVNPNDRPTVTELMEHPFVKRPLQ 238
            K L  NP+ R T+ ++ +  +  +PL+
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLK 270

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 8/208 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYTRQILNGLVYLHE 96
            +N+V++ G  ++ N  Y+FLE  + G L +  +    + +     +  Q++ G+VYLH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKN 152
             + HRDIK  N+L+D   ++K++DFGLA     N+    L    GT  ++APE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL-KRR 182
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL- 211
           + +    D+WS G  +  ML    P+         +   K +   +      D+    L 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 212 -KCLQVNPNDRPTVTELMEHPFVKRPLQ 238
            K L  NP+ R T+ ++ +  +  +PL+
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLK 270

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 8/208 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYTRQILNGLVYLHE 96
            +N+V++ G  ++ N  Y+FLE  + G L +  +    + +     +  Q++ G+VYLH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKN 152
             + HRDIK  N+L+D   ++K++DFGLA     N+    L    GT  ++APE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL-KRR 182
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL- 211
           + +    D+WS G  +  ML    P+         +   K +   +      D+    L 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 212 -KCLQVNPNDRPTVTELMEHPFVKRPLQ 238
            K L  NP+ R T+ ++ +  +  +PL+
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLK 270

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 90/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 100 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ D GLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 159 NEDCELKILDRGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 216
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 8/208 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYTRQILNGLVYLHE 96
            +N+V++ G  ++ N  Y+FLE  + G L +  +    + +     +  Q++ G+VYLH 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKN 152
             + HRDIK  N+L+D   ++K++DFGLA     N+    L    GT  ++APE++  + 
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL-KRR 180
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL- 211
           + +    D+WS G  +  ML    P+         +   K +   +      D+    L 
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240
Query: 212 -KCLQVNPNDRPTVTELMEHPFVKRPLQ 238
            K L  NP+ R T+ ++ +  +  +PL+
Sbjct: 241 HKILVENPSARITIPDIKKDRWYNKPLK 268

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSL-----------------ANLYQKYHLSDSQVSS 82
           NI+  LG    +  LY+ +E  +KG+L                  N   +  ++   + S
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT--- 139
            T Q+  G+ YL  +  +HRD+   N+LV  +  +K+ADFGLA+   +N++   K T   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKNTTNG 219
Query: 140 --PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-GE 194
             P  WMAPE +  +   Y   +D+WS G  + E+ T    PY  +  V+ LF++ K G 
Sbjct: 220 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEGH 276
Query: 195 LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
               P++ + +    +  C    P+ RPT  +L+E
Sbjct: 277 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 8/208 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYTRQILNGLVYLHE 96
            +N+V++ G  ++ N  Y+FLE  + G L +  +    + +     +  Q++ G+VYLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKN 152
             + HRDIK  N+L+D   ++K++DFGLA     N+    L    GT  ++APE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL-KRR 181
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL- 211
           + +    D+WS G  +  ML    P+         +   K +   +      D+    L 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 212 -KCLQVNPNDRPTVTELMEHPFVKRPLQ 238
            K L  NP+ R T+ ++ +  +  +PL+
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 8/208 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYTRQILNGLVYLHE 96
            +N+V++ G  ++ N  Y+FLE  + G L +  +    + +     +  Q++ G+VYLH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKN 152
             + HRDIK  N+L+D   ++K++DFGLA     N+    L    GT  ++APE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL-KRR 182
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL- 211
           + +    D+WS G  +  ML    P+         +   K +   +      D+    L 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 212 -KCLQVNPNDRPTVTELMEHPFVKRPLQ 238
            K L  NP+ R T+ ++ +  +  +PL+
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLK 270

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 8/208 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYTRQILNGLVYLHE 96
            +N+V++ G  ++ N  Y+FLE  + G L +  +    + +     +  Q++ G+VYLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKN 152
             + HRDIK  N+L+D   ++K++DFGLA     N+    L    GT  ++APE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL-KRR 181
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL- 211
           + +    D+WS G  +  ML    P+         +   K +   +      D+    L 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 212 -KCLQVNPNDRPTVTELMEHPFVKRPLQ 238
            K L  NP+ R T+ ++ +  +  +PL+
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSL-----------------ANLYQKYHLSDSQVSS 82
           NI+  LG    +  LY+ +E  +KG+L                  N   +  ++   + S
Sbjct: 91  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 150
Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT--- 139
            T Q+  G+ YL  +  +HRD+   N+LV  +  +K+ADFGLA+   +N++   K T   
Sbjct: 151 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNG 208
Query: 140 --PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-GE 194
             P  WMAPE +  +   Y   +D+WS G  + E+ T    PY  +  V+ LF++ K G 
Sbjct: 209 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEGH 265
Query: 195 LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
               P++ + +    +  C    P+ RPT  +L+E
Sbjct: 266 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 300

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 50/224 (22%)
Query: 54  LYIFLELVTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +Y+ +EL+     ANL Q  H  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 104 VYLVMELMD----ANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 112 DASGSVKLADFGLAKATTMNDLKS-CKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+    N + +    T ++ APEV+     GY    DIWS+GC + E
Sbjct: 160 KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGM--GYAANVDIWSVGCIMGE 217
Query: 171 MLT---------------------RRPPYSHLEGVQALFR---IGKGELPSV-------- 198
           ++                        P    +  +Q   R     + + P +        
Sbjct: 218 LVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPKYPGIKFEELFPD 277
Query: 199 ---PSSLSRD------ARDFILKCLQVNPNDRPTVTELMEHPFV 233
              PS   RD      ARD + K L ++P+ R +V E + HP++
Sbjct: 278 WIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 321

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 90/169 (53%), Gaps = 7/169 (4%)
Query: 52  NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V
Sbjct: 100 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +    +K+ D GLA+ T  +++     T ++ APE++ +    Y  T DIWS+GC + E+
Sbjct: 159 NEDCELKILDGGLARHTD-DEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAEL 216
Query: 172 LTRR---PPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           LT R   P   H++ ++ + R +G      +    S  AR++I    Q+
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSL-----------------ANLYQKYHLSDSQVSS 82
           NI+  LG    +  LY+ +E  +KG+L                  N   +  ++   + S
Sbjct: 102 NIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT--- 139
            T Q+  G+ YL  +  +HRD+   N+LV  +  +K+ADFGLA+   +N++   K T   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNG 219
Query: 140 --PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-GE 194
             P  WMAPE +  +   Y   +D+WS G  + E+ T    PY  +  V+ LF++ K G 
Sbjct: 220 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEGH 276
Query: 195 LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
               P++ + +    +  C    P+ RPT  +L+E
Sbjct: 277 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 55  YIFLELVTKGSLANL-YQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           YI +E V   +L ++ + +  ++  +           L + H+  ++HRD+K ANI++ A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 114 SGSVKLADFGLAKA-----TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           + +VK+ DFG+A+A      ++    +  GT  +++PE   ++ D     +D++SLGC +
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVL 209
Query: 169 LEMLTRRPPYSHLEGVQALFRIGKGELPSVPSS----LSRDARDFILKCLQVNPNDRPTV 224
            E+LT  PP++        ++  + E P  PS+    LS D    +LK L  NP +R   
Sbjct: 210 YEVLTGEPPFTGDSPDSVAYQHVR-EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT 268
Query: 225 TELMEHPFVK----RPLQTPRC 242
              M    V+     P + P+ 
Sbjct: 269 AAEMRADLVRVHNGEPPEAPKV 290

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 8/208 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYTRQILNGLVYLHE 96
            +N+V++ G  ++ N  Y+FLE  + G L +  +    + +     +  Q++ G+VYLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKN 152
             + HRDIK  N+L+D   ++K++DFGLA     N+    L    GT  ++APE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL-KRR 181
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL- 211
           + +    D+WS G  +  ML    P+         +   K +   +      D+    L 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 212 -KCLQVNPNDRPTVTELMEHPFVKRPLQ 238
            K L  NP+ R T+ ++ +  +  +PL+
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 85/188 (45%), Gaps = 29/188 (15%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DL 133
           L    +    RQ L GL +LH   +VHRD+K  NILV + G+VKLADFGLA+  +    L
Sbjct: 109 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL 168
Query: 134 KSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY---SHLEGVQALF-- 188
                T ++ APEV+      Y    D+WS+GC   EM  R+P +   S  + +  +F  
Sbjct: 169 FPVVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 226
Query: 189 -------------RIGKGELP--------SVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
                         + +G  P        SV   +       +L+ L  NP+ R +    
Sbjct: 227 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRA 286
Query: 228 MEHPFVKR 235
           ++H ++ +
Sbjct: 287 LQHSYLHK 294

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSL-----------------ANLYQKYHLSDSQVSS 82
           NI+  LG    +  LY+ +E  +KG+L                  N   +  ++   + S
Sbjct: 89  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 148
Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT--- 139
            T Q+  G+ YL  +  +HRD+   N+LV  +  +K+ADFGLA+   +N++   K T   
Sbjct: 149 CTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNG 206
Query: 140 --PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-GE 194
             P  WMAPE +  +   Y   +D+WS G  + E+ T    PY  +  V+ LF++ K G 
Sbjct: 207 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEGH 263
Query: 195 LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
               P++ + +    +  C    P+ RPT  +L+E
Sbjct: 264 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 298

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSL-----------------ANLYQKYHLSDSQVSS 82
           NI+  LG    +  LY+ +E  +KG+L                  N   +  ++   + S
Sbjct: 94  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 153
Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT--- 139
            T Q+  G+ YL  +  +HRD+   N+LV  +  +K+ADFGLA+   +N++   K T   
Sbjct: 154 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNG 211
Query: 140 --PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-GE 194
             P  WMAPE +  +   Y   +D+WS G  + E+ T    PY  +  V+ LF++ K G 
Sbjct: 212 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEGH 268
Query: 195 LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
               P++ + +    +  C    P+ RPT  +L+E
Sbjct: 269 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 303

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSL-----------------ANLYQKYHLSDSQVSS 82
           NI+  LG    +  LY+ +E  +KG+L                  N   +  ++   + S
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT--- 139
            T Q+  G+ YL  +  +HRD+   N+LV  +  +K+ADFGLA+   +N++   K T   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNG 219
Query: 140 --PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-GE 194
             P  WMAPE +  +   Y   +D+WS G  + E+ T    PY  +  V+ LF++ K G 
Sbjct: 220 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEGH 276
Query: 195 LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
               P++ + +    +  C    P+ RPT  +L+E
Sbjct: 277 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 81/167 (48%), Gaps = 21/167 (12%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 130
           L +    S+  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 127 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 186
Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---QAL 187
            D     GT  +  PE +      +G +A +WSLG  + +M+    P+ H E +   Q  
Sbjct: 187 TDF---DGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 242
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           FR            +S + +  I  CL + P DRPT  E+  HP+++
Sbjct: 243 FR----------QRVSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQ 279

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 9/178 (5%)
Query: 59  ELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
           E V   +  +LY+ + L+   +  Y+ Q+  G+ +L  R  +HRD+   NIL+     VK
Sbjct: 130 EFVPYKTPEDLYKDF-LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 188
Query: 119 LADFGLAKATTMNDLKSCKG---TPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR 174
           + DFGLA+    +     KG    P  WMAPE +  +   Y + +D+WS G  + E+ + 
Sbjct: 189 ICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSL 246
Query: 175 -RPPYSHLEGVQALF-RIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
              PY  ++  +    R+ +G     P   + +    +L C    P+ RPT +EL+EH
Sbjct: 247 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--------------HLSDSQVS 81
            + ++IV++ G   + + L +  E +  G L    + +               L+ SQ+ 
Sbjct: 72  LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQML 131
Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF 141
              +QI  G+VYL  ++ VHRD+   N LV  +  VK+ DFG+++     D     G   
Sbjct: 132 HIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 191
Query: 142 ----WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELP 196
               WM PE +  +   +   +D+WSLG  + E+ T  + P+  L   + +  I +G + 
Sbjct: 192 LPIRWMPPESIMYRK--FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 249
Query: 197 SVPSSLSRDARDFILKCLQVNPNDRPTV 224
             P +  ++  + +L C Q  P+ R  +
Sbjct: 250 QRPRTCPQEVYELMLGCWQREPHMRKNI 277

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 10/201 (4%)
Query: 36  FEQDNIVQYLGTDKDENR-LYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGL 91
               N+VQ LG   +E   LYI  E + KGSL +  +   +  L    +  ++  +   +
Sbjct: 243 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 302
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNS 150
            YL   N VHRD+   N+LV      K++DFGL K A++  D  + K    W APE +  
Sbjct: 303 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEALRE 360
Query: 151 KNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDF 209
           K   +   +D+WS G  + E+ +  R PY  +     + R+ KG     P        D 
Sbjct: 361 KK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDV 418
Query: 210 ILKCLQVNPNDRPTVTELMEH 230
           +  C  ++   RPT  +L E 
Sbjct: 419 MKNCWHLDAATRPTFLQLREQ 439

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 100/207 (48%), Gaps = 8/207 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYTRQILNGLVYLHE 96
            +N+V++ G  ++ N  Y+FLE  + G L +  +    + +     +  Q++ G+VYLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKN 152
             + HRDIK  N+L+D   ++K++DFGLA     N+    L    GT  ++APE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL-KRR 181
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL- 211
           + +    D+WS G  +  ML    P+         +   K +   +      D+    L 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 212 -KCLQVNPNDRPTVTELMEHPFVKRPL 237
            K L  NP+ R T+ ++ +  +  +PL
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSL-----------------ANLYQKYHLSDSQ 79
           +  NI+  LG    +  LY+ +E  +KG+L                  N   +  ++   
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT 139
           + S T Q+  G+ YL  +  +HRD+   N+LV  +  +K+ADFGLA+   +N++   K T
Sbjct: 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKT 262
Query: 140 -----PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK 192
                P  WMAPE +  +   Y   +D+WS G  + E+ T    PY  +  V+ LF++ K
Sbjct: 263 TNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLK 319
Query: 193 -GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
            G     P++ + +    +  C    P+ RPT  +L+E
Sbjct: 320 EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 16/197 (8%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           N+  YL + ++E   Y       K +  +LY+ + L+   +  Y+ Q+  G+ +L  R  
Sbjct: 118 NLSTYLRSKRNEFVPY-------KVAPEDLYKDF-LTLEHLICYSFQVAKGMEFLASRKC 169
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKG---TPF-WMAPEVVNSKNDGY 155
           +HRD+   NIL+     VK+ DFGLA+    +     KG    P  WMAPE +  +   Y
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRV--Y 227
Query: 156 GLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALF-RIGKGELPSVPSSLSRDARDFILKC 213
            + +D+WS G  + E+ +    PY  ++  +    R+ +G     P   + +    +L C
Sbjct: 228 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 287
Query: 214 LQVNPNDRPTVTELMEH 230
               P+ RPT +EL+EH
Sbjct: 288 WHGEPSQRPTFSELVEH 304

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 16/197 (8%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           N+  YL + ++E   Y       K +  +LY+ + L+   +  Y+ Q+  G+ +L  R  
Sbjct: 109 NLSTYLRSKRNEFVPY-------KVAPEDLYKDF-LTLEHLICYSFQVAKGMEFLASRKC 160
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKG---TPF-WMAPEVVNSKNDGY 155
           +HRD+   NIL+     VK+ DFGLA+    +     KG    P  WMAPE +  +   Y
Sbjct: 161 IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRV--Y 218
Query: 156 GLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALF-RIGKGELPSVPSSLSRDARDFILKC 213
            + +D+WS G  + E+ +    PY  ++  +    R+ +G     P   + +    +L C
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 278
Query: 214 LQVNPNDRPTVTELMEH 230
               P+ RPT +EL+EH
Sbjct: 279 WHGEPSQRPTFSELVEH 295

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSL-----------------ANLYQKYHLSDSQVSS 82
           NI+  LG    +  LY+ +E  +KG+L                  N   +  ++   + S
Sbjct: 102 NIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT--- 139
            T Q+  G+ YL  +  +HRD+   N+LV  +  +K+ADFGLA+   +N++   K T   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNG 219
Query: 140 --PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-GE 194
             P  WMAPE +  +   Y   +D+WS G  + E+ T    PY  +  V+ LF++ K G 
Sbjct: 220 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEGH 276
Query: 195 LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
               P++ + +    +  C    P+ RPT  +L+E
Sbjct: 277 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 100/207 (48%), Gaps = 8/207 (3%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQVSSYTRQILNGLVYLHE 96
            +N+V++ G  ++ N  Y+FLE  + G L +  +    + +     +  Q++ G+VYLH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKN 152
             + HRDIK  N+L+D   ++K++DFGLA     N+    L    GT  ++APE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL-KRR 182
Query: 153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL- 211
           + +    D+WS G  +  ML    P+         +   K +   +      D+    L 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 212 -KCLQVNPNDRPTVTELMEHPFVKRPL 237
            K L  NP+ R T+ ++ +  +  +PL
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 50/224 (22%)
Query: 54  LYIFLELVTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +Y+ +EL+     ANL Q  H  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 102 VYLVMELMD----ANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 157
Query: 112 DASGSVKLADFGLAKATTMNDLKS-CKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+  + N + +    T ++ APEV+     GY    DIWS+GC + E
Sbjct: 158 KSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGE 215
Query: 171 MLTRR---------------------PPYSHLEGVQALFRIGKGELPS------------ 197
           ++                        P    +  +Q   R      P+            
Sbjct: 216 LVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPAYPGIAFEELFPD 275
Query: 198 --VPSSLSRD------ARDFILKCLQVNPNDRPTVTELMEHPFV 233
              PS   RD      ARD + K L ++P+ R +V E + HP++
Sbjct: 276 WIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 319

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 16/197 (8%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           N+  YL + ++E   Y       K +  +LY+ + L+   +  Y+ Q+  G+ +L  R  
Sbjct: 109 NLSTYLRSKRNEFVPY-------KVAPEDLYKDF-LTLEHLICYSFQVAKGMEFLASRKC 160
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKG---TPF-WMAPEVVNSKNDGY 155
           +HRD+   NIL+     VK+ DFGLA+    +     KG    P  WMAPE +  +   Y
Sbjct: 161 IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRV--Y 218
Query: 156 GLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALF-RIGKGELPSVPSSLSRDARDFILKC 213
            + +D+WS G  + E+ +    PY  ++  +    R+ +G     P   + +    +L C
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 278
Query: 214 LQVNPNDRPTVTELMEH 230
               P+ RPT +EL+EH
Sbjct: 279 WHGEPSQRPTFSELVEH 295

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 91/190 (47%), Gaps = 11/190 (5%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLVYLHERN 98
           IV+ +G  + E  L + +E+   G L      ++  +  S V+    Q+  G+ YL E+N
Sbjct: 72  IVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPF-WMAPEVVNSKND 153
            VHRD+   N+L+      K++DFGL+KA   +D     +S    P  W APE +N +  
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK- 189
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            +   +D+WS G T+ E L+  + PY  ++G + +  I +G+    P     +    +  
Sbjct: 190 -FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSD 248
Query: 213 CLQVNPNDRP 222
           C      DRP
Sbjct: 249 CWIYKWEDRP 258

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 34/217 (15%)
Query: 52  NRLYIFLELVTKGS-LANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +R Y+  E +  GS L++++++ H ++ + S   + + + L +LH + + HRD+K  NIL
Sbjct: 84  DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENIL 143
Query: 111 VDASGS---VKLADFGLAKATTMN---------DLKSCKGTPFWMAPEVVNSKNDG---Y 155
            +       VK+ DFGL     +N         +L +  G+  +MAPEVV + ++    Y
Sbjct: 144 CEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY 203
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQA--------------LF---RIGKGELPSV 198
               D+WSLG  +  +L+  PP+    G                 LF   + GK E P  
Sbjct: 204 DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDK 263
Query: 199 P-SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
             + +S  A+D I K L  +   R +  ++++HP+V+
Sbjct: 264 DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 91/194 (46%), Gaps = 9/194 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE 96
           N+VQ LG    E   YI  E +  G+L +  +   +  ++   +     QI + + YL +
Sbjct: 89  NLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEK 148
Query: 97  RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKND 153
           +N +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +    +
Sbjct: 149 KNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYN 206
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            + + +D+W+ G  + E+ T    PY  ++  Q    + KG     P        + +  
Sbjct: 207 TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQPEGCPPKVYELMRA 266
Query: 213 CLQVNPNDRPTVTE 226
           C + +P DRP+  E
Sbjct: 267 CWKWSPADRPSFAE 280

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 12/217 (5%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV++         L I +E  + G L   +      S+ +   + +Q+L+G+ Y H   
Sbjct: 77  NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ 136
Query: 99  VVHRDIKCANILVDASGS--VKLADFGLAKATTMNDL-KSCKGTPFWMAPEVVNSKNDGY 155
           + HRD+K  N L+D S +  +K+ DFG +K++ ++   KS  GTP ++APEV+  + +  
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL-LRQEYD 195
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDAR------DF 209
           G  AD+WS G T+  ML    P+   E  +  +R     + SV  S+  D R        
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRILSVKYSIPDDIRISPECCHL 254
Query: 210 ILKCLQVNPNDRPTVTELMEHPFVKRPLQTPRCGQAN 246
           I +    +P  R ++ E+  H +  + L      ++N
Sbjct: 255 ISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESN 291

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV++         L I +E  + G L   +      S+ +   + +Q+++G+ Y H   
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 99  VVHRDIKCANILVDASGS--VKLADFGLAKATTMNDL-KSCKGTPFWMAPEVVNSKNDGY 155
           V HRD+K  N L+D S +  +K+ DFG +K++ ++   KS  GTP ++APEV+  K +  
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL-LKKEYD 194
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGV----QALFRIGKGELPSVPS--SLSRDARDF 209
           G  AD+WS G T+  ML    P+   E      + + RI   +  ++P    +S + R  
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY-AIPDYVHISPECRHL 253
Query: 210 ILKCLQVNPNDRPTVTELMEH 230
           I +    +P  R ++ E+  H
Sbjct: 254 ISRIFVADPAKRISIPEIRNH 274

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 16/197 (8%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           N+  YL + ++E   Y       K +  +LY+ + L+   +  Y+ Q+  G+ +L  R  
Sbjct: 120 NLSTYLRSKRNEFVPY-------KEAPEDLYKDF-LTLEHLICYSFQVAKGMEFLASRKC 171
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKG---TPF-WMAPEVVNSKNDGY 155
           +HRD+   NIL+     VK+ DFGLA+    +     KG    P  WMAPE +  +   Y
Sbjct: 172 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV--Y 229
Query: 156 GLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALF-RIGKGELPSVPSSLSRDARDFILKC 213
            + +D+WS G  + E+ +    PY  ++  +    R+ +G     P   + +    +L C
Sbjct: 230 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 289
Query: 214 LQVNPNDRPTVTELMEH 230
               P+ RPT +EL+EH
Sbjct: 290 WHGEPSQRPTFSELVEH 306

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 16/197 (8%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           N+  YL + ++E   Y       K +  +LY+ + L+   +  Y+ Q+  G+ +L  R  
Sbjct: 118 NLSTYLRSKRNEFVPY-------KVAPEDLYKDF-LTLEHLICYSFQVAKGMEFLASRKC 169
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKG---TPF-WMAPEVVNSKNDGY 155
           +HRD+   NIL+     VK+ DFGLA+    +     KG    P  WMAPE +  +   Y
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRV--Y 227
Query: 156 GLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALF-RIGKGELPSVPSSLSRDARDFILKC 213
            + +D+WS G  + E+ +    PY  ++  +    R+ +G     P   + +    +L C
Sbjct: 228 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 287
Query: 214 LQVNPNDRPTVTELMEH 230
               P+ RPT +EL+EH
Sbjct: 288 WHGEPSQRPTFSELVEH 304

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV++         L I +E  + G L   +      S+ +   + +Q+++G+ Y H   
Sbjct: 75  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 134
Query: 99  VVHRDIKCANILVDASGS--VKLADFGLAKATTMNDL-KSCKGTPFWMAPEVVNSKNDGY 155
           V HRD+K  N L+D S +  +K+ DFG +K++ ++   KS  GTP ++APEV+  K +  
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL-LKKEYD 193
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGV----QALFRIGKGELPSVPS--SLSRDARDF 209
           G  AD+WS G T+  ML    P+   E      + + RI   +  ++P    +S + R  
Sbjct: 194 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY-AIPDYVHISPECRHL 252
Query: 210 ILKCLQVNPNDRPTVTELMEH 230
           I +    +P  R ++ E+  H
Sbjct: 253 ISRIFVADPAKRISIPEIRNH 273

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 24/224 (10%)
Query: 39  DNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           D I++    +  +  +Y+ +E       + L +K  +   +  SY + +L  +  +H+  
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 147
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKA----TTMNDLKSCKGTPFWMAPEVV----NS 150
           +VH D+K AN L+   G +KL DFG+A      TT     S  GT  +M PE +    +S
Sbjct: 148 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 151 KNDGYGLTA-----DIWSLGCTVLEMLTRRPPYSHL-EGVQALFRI----GKGELPSVPS 200
           + +G   +      D+WSLGC +  M   + P+  +   +  L  I     + E P +P 
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 266
Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPRCGQ 244
              +D +D +  CL+ +P  R ++ EL+ HP+V+  +QT    Q
Sbjct: 267 ---KDLQDVLKCCLKRDPKQRISIPELLAHPYVQ--IQTHPVNQ 305

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 39  DNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           D I++    +  +  +Y+ +E       + L +K  +   +  SY + +L  +  +H+  
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKA----TTMNDLKSCKGTPFWMAPEVV----NS 150
           +VH D+K AN L+   G +KL DFG+A      TT     S  GT  +M PE +    +S
Sbjct: 176 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 234
Query: 151 KNDGYGLTA-----DIWSLGCTVLEMLTRRPPYSHL-EGVQALFRI----GKGELPSVPS 200
           + +G   +      D+WSLGC +  M   + P+  +   +  L  I     + E P +P 
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 294
Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
              +D +D +  CL+ +P  R ++ EL+ HP+V+
Sbjct: 295 ---KDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 39  DNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           D I++    +  +  +Y+ +E       + L +K  +   +  SY + +L  +  +H+  
Sbjct: 72  DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 131
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKA----TTMNDLKSCKGTPFWMAPEVV----NS 150
           +VH D+K AN L+   G +KL DFG+A      TT     S  GT  +M PE +    +S
Sbjct: 132 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 190
Query: 151 KNDGYGLTA-----DIWSLGCTVLEMLTRRPPYSHL-EGVQALFRI----GKGELPSVPS 200
           + +G   +      D+WSLGC +  M   + P+  +   +  L  I     + E P +P 
Sbjct: 191 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 250
Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
              +D +D +  CL+ +P  R ++ EL+ HP+V+
Sbjct: 251 ---KDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 39  DNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           D I++    +  +  +Y+ +E       + L +K  +   +  SY + +L  +  +H+  
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 147
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK----GTPFWMAPEVV----NS 150
           +VH D+K AN L+   G +KL DFG+A     +     K    GT  +M PE +    +S
Sbjct: 148 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 151 KNDGYGLTA-----DIWSLGCTVLEMLTRRPPYSHL-EGVQALFRI----GKGELPSVPS 200
           + +G   +      D+WSLGC +  M   + P+  +   +  L  I     + E P +P 
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 266
Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
              +D +D +  CL+ +P  R ++ EL+ HP+V+
Sbjct: 267 ---KDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 39  DNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           D I++    +  +  +Y+ +E       + L +K  +   +  SY + +L  +  +H+  
Sbjct: 68  DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 127
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKA----TTMNDLKSCKGTPFWMAPEVV----NS 150
           +VH D+K AN L+   G +KL DFG+A      TT     S  GT  +M PE +    +S
Sbjct: 128 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 186
Query: 151 KNDGYGLTA-----DIWSLGCTVLEMLTRRPPYSHL-EGVQALFRI----GKGELPSVPS 200
           + +G   +      D+WSLGC +  M   + P+  +   +  L  I     + E P +P 
Sbjct: 187 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 246
Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
              +D +D +  CL+ +P  R ++ EL+ HP+V+
Sbjct: 247 ---KDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 277

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 16/197 (8%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           N+  YL + ++E   Y       K +  +LY+ + L+   +  Y+ Q+  G+ +L  R  
Sbjct: 118 NLSTYLRSKRNEFVPY-------KVAPEDLYKDF-LTLEHLICYSFQVAKGMEFLASRKC 169
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKG---TPF-WMAPEVVNSKNDGY 155
           +HRD+   NIL+     VK+ DFGLA+    +     KG    P  WMAPE +  +   Y
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV--Y 227
Query: 156 GLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALF-RIGKGELPSVPSSLSRDARDFILKC 213
            + +D+WS G  + E+ +    PY  ++  +    R+ +G     P   + +    +L C
Sbjct: 228 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 287
Query: 214 LQVNPNDRPTVTELMEH 230
               P+ RPT +EL+EH
Sbjct: 288 WHGEPSQRPTFSELVEH 304

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 39  DNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           D I++    +  +  +Y+ +E       + L +K  +   +  SY + +L  +  +H+  
Sbjct: 69  DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 128
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKA----TTMNDLKSCKGTPFWMAPEVV----NS 150
           +VH D+K AN L+   G +KL DFG+A      TT     S  GT  +M PE +    +S
Sbjct: 129 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 151 KNDGYGLTA-----DIWSLGCTVLEMLTRRPPYSHL-EGVQALFRI----GKGELPSVPS 200
           + +G   +      D+WSLGC +  M   + P+  +   +  L  I     + E P +P 
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 247
Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
              +D +D +  CL+ +P  R ++ EL+ HP+V+
Sbjct: 248 ---KDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 16/197 (8%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           N+  YL + ++E   Y       K +  +LY+ + L+   +  Y+ Q+  G+ +L  R  
Sbjct: 109 NLSTYLRSKRNEFVPY-------KVAPEDLYKDF-LTLEHLICYSFQVAKGMEFLASRKC 160
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKG---TPF-WMAPEVVNSKNDGY 155
           +HRD+   NIL+     VK+ DFGLA+    +     KG    P  WMAPE +  +   Y
Sbjct: 161 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV--Y 218
Query: 156 GLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALF-RIGKGELPSVPSSLSRDARDFILKC 213
            + +D+WS G  + E+ +    PY  ++  +    R+ +G     P   + +    +L C
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 278
Query: 214 LQVNPNDRPTVTELMEH 230
               P+ RPT +EL+EH
Sbjct: 279 WHGEPSQRPTFSELVEH 295

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSL-----------------ANLYQKYHLSDSQVSS 82
           NI+  LG    +  LY+ +E  +KG+L                  N   +  ++   + S
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT--- 139
            T Q+  G+ YL  +  +HRD+   N+LV  +  +++ADFGLA+   +N++   K T   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLAR--DINNIDYYKKTTNG 219
Query: 140 --PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-GE 194
             P  WMAPE +  +   Y   +D+WS G  + E+ T    PY  +  V+ LF++ K G 
Sbjct: 220 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEGH 276
Query: 195 LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
               P++ + +    +  C    P+ RPT  +L+E
Sbjct: 277 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 39  DNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           D I++    +  +  +Y+ +E       + L +K  +   +  SY + +L  +  +H+  
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKA----TTMNDLKSCKGTPFWMAPEVV----NS 150
           +VH D+K AN L+   G +KL DFG+A      TT     S  GT  +M PE +    +S
Sbjct: 176 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 234
Query: 151 KNDGYGLTA-----DIWSLGCTVLEMLTRRPPYSHL-EGVQALFRI----GKGELPSVPS 200
           + +G   +      D+WSLGC +  M   + P+  +   +  L  I     + E P +P 
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 294
Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
              +D +D +  CL+ +P  R ++ EL+ HP+V+
Sbjct: 295 ---KDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 16/197 (8%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           N+  YL + ++E   Y       K +  +LY+ + L+   +  Y+ Q+  G+ +L  R  
Sbjct: 109 NLSTYLRSKRNEFVPY-------KVAPEDLYKDF-LTLEHLICYSFQVAKGMEFLASRKC 160
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKG---TPF-WMAPEVVNSKNDGY 155
           +HRD+   NIL+     VK+ DFGLA+    +     KG    P  WMAPE +  +   Y
Sbjct: 161 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV--Y 218
Query: 156 GLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALF-RIGKGELPSVPSSLSRDARDFILKC 213
            + +D+WS G  + E+ +    PY  ++  +    R+ +G     P   + +    +L C
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 278
Query: 214 LQVNPNDRPTVTELMEH 230
               P+ RPT +EL+EH
Sbjct: 279 WHGEPSQRPTFSELVEH 295

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 40  NIVQYLGT-DKDENRLYIFLELVTKGSLA--------------NLYQKYHLSDSQVSSYT 84
           N+V  LG   K    L + +E    G+L+              +LY+ + L+   +  Y+
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF-LTLEHLIXYS 150
Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKG---TPF 141
            Q+  G+ +L  R  +HRD+   NIL+     VK+ DFGLA+    +     KG    P 
Sbjct: 151 FQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPL 210
Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALF-RIGKGELPSV 198
            WMAPE +  +   Y + +D+WS G  + E+ +    PY  ++  +    R+ +G     
Sbjct: 211 KWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRMRA 268
Query: 199 PSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
           P   + +    +L C    P+ RPT +EL+EH
Sbjct: 269 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 85/170 (50%), Gaps = 11/170 (6%)
Query: 68  NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA 127
           +LY+ + L+   +  Y+ Q+  G+ +L  R  +HRD+   NIL+     VK+ DFGLA+ 
Sbjct: 139 DLYKDF-LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 128 TTMNDLKSCKG---TPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLE 182
              +     KG    P  WMAPE +  +   Y + +D+WS G  + E+ +    PY  ++
Sbjct: 198 IXKDPDXVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVK 255
Query: 183 GVQALF--RIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
            +   F  R+ +G     P   + +    +L C    P+ RPT +EL+EH
Sbjct: 256 -IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 16/197 (8%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNV 99
           N+  YL + ++E   Y       K +  +LY+ + L+   +  Y+ Q+  G+ +L  R  
Sbjct: 155 NLSTYLRSKRNEFVPY-------KVAPEDLYKDF-LTLEHLICYSFQVAKGMEFLASRKC 206
Query: 100 VHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKG---TPF-WMAPEVVNSKNDGY 155
           +HRD+   NIL+     VK+ DFGLA+    +     KG    P  WMAPE +  +   Y
Sbjct: 207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV--Y 264
Query: 156 GLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALF-RIGKGELPSVPSSLSRDARDFILKC 213
            + +D+WS G  + E+ +    PY  ++  +    R+ +G     P   + +    +L C
Sbjct: 265 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 324
Query: 214 LQVNPNDRPTVTELMEH 230
               P+ RPT +EL+EH
Sbjct: 325 WHGEPSQRPTFSELVEH 341

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 103/260 (39%), Gaps = 63/260 (24%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHL---SDSQVSSYTRQILNGLV 92
           F   NIV Y  T   +N L++    +  GS  +L   + +   ++  ++   + +L  L 
Sbjct: 83  FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM----------NDLK--SCKGTP 140
           Y+H    VHR +K ++IL+   G V L+  GL    +M          +D    S K  P
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALF------------ 188
            W++PEV+     GY   +DI+S+G T  E+     P+  +   Q L             
Sbjct: 201 -WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259
Query: 189 -------------------------------RIGKGELPSVP--SSLSRDARDFILKCLQ 215
                                          R   G+ PS P   + S     F+ +CLQ
Sbjct: 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319
Query: 216 VNPNDRPTVTELMEHPFVKR 235
            NP+ RP+ + L+ H F K+
Sbjct: 320 RNPDARPSASTLLNHSFFKQ 339

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 35/201 (17%)
Query: 54  LYIFLELVTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           L I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HRD+K  N+L
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 111 VDA---SGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
             +   +  +KL DFG AK TT                       + Y  + D+WSLG  
Sbjct: 150 YTSKRPNAILKLTDFGFAKETT----------------------GEKYDKSCDMWSLGVI 187
Query: 168 VLEMLTRRPPY------SHLEGVQALFRIGKGELPSVP-SSLSRDARDFILKCLQVNPND 220
           +  +L   PP+      +   G++   R+G+ E P+   S +S + +  I   L+  P  
Sbjct: 188 MYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 247
Query: 221 RPTVTELMEHPFVKRPLQTPR 241
           R T+TE M HP++ +  + P+
Sbjct: 248 RMTITEFMNHPWIMQSTKVPQ 268

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 103/260 (39%), Gaps = 63/260 (24%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHL---SDSQVSSYTRQILNGLV 92
           F   NIV Y  T   +N L++    +  GS  +L   + +   ++  ++   + +L  L 
Sbjct: 67  FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 126
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM----------NDLK--SCKGTP 140
           Y+H    VHR +K ++IL+   G V L+  GL    +M          +D    S K  P
Sbjct: 127 YIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMISHGQRQRVVHDFPKYSVKVLP 184
Query: 141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALF------------ 188
            W++PEV+     GY   +DI+S+G T  E+     P+  +   Q L             
Sbjct: 185 -WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 243
Query: 189 -------------------------------RIGKGELPSVP--SSLSRDARDFILKCLQ 215
                                          R   G+ PS P   + S     F+ +CLQ
Sbjct: 244 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 303
Query: 216 VNPNDRPTVTELMEHPFVKR 235
            NP+ RP+ + L+ H F K+
Sbjct: 304 RNPDARPSASTLLNHSFFKQ 323

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 40  NIVQYLGT-DKDENRLYIFLELVTKGSLA--------------NLYQKYHLSDSQVSSYT 84
           N+V  LG   K    L + +E    G+L+              +LY+ + L+   +  Y+
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF-LTLEHLICYS 150
Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKG---TPF 141
            Q+  G+ +L  R  +HRD+   NIL+     VK+ DFGLA+    +     KG    P 
Sbjct: 151 FQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 210
Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALF-RIGKGELPSV 198
            WMAPE +  +   Y + +D+WS G  + E+ +    PY  ++  +    R+ +G     
Sbjct: 211 KWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 268
Query: 199 PSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
           P   + +    +L C    P+ RPT +EL+EH
Sbjct: 269 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 108/249 (43%), Gaps = 54/249 (21%)
Query: 36  FEQDNIVQYLGTDKDE-----NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNG 90
           F+ +NI+      + +     N +YI  EL+ +  L  +     LSD  +  +  Q L  
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 91  LVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT------------TMNDLKSCKG 138
           +  LH  NV+HRD+K +N+L++++  +K+ DFGLA+                + +     
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVA 184
Query: 139 TPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP-----PYSH------------- 180
           T ++ APEV+ + +  Y    D+WS GC + E+  RRP      Y H             
Sbjct: 185 TRWYRAPEVMLT-SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243
Query: 181 -------LEGVQALFRIGKGELPSVPSS--------LSRDARDFILKCLQVNPNDRPTVT 225
                  +E  +A  R     LP  P++        ++    D + + L  +P  R T  
Sbjct: 244 SDNDLRCIESPRA--REYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301
Query: 226 ELMEHPFVK 234
           E +EHP+++
Sbjct: 302 EALEHPYLQ 310

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 108/249 (43%), Gaps = 54/249 (21%)
Query: 36  FEQDNIVQYLGTDKDE-----NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNG 90
           F+ +NI+      + +     N +YI  EL+ +  L  +     LSD  +  +  Q L  
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 91  LVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT------------TMNDLKSCKG 138
           +  LH  NV+HRD+K +N+L++++  +K+ DFGLA+                + +     
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVA 184
Query: 139 TPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP-----PYSH------------- 180
           T ++ APEV+ + +  Y    D+WS GC + E+  RRP      Y H             
Sbjct: 185 TRWYRAPEVMLT-SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243
Query: 181 -------LEGVQALFRIGKGELPSVPSS--------LSRDARDFILKCLQVNPNDRPTVT 225
                  +E  +A  R     LP  P++        ++    D + + L  +P  R T  
Sbjct: 244 SDNDLRCIESPRA--REYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301
Query: 226 ELMEHPFVK 234
           E +EHP+++
Sbjct: 302 EALEHPYLQ 310

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 91/190 (47%), Gaps = 11/190 (5%)
Query: 41  IVQYLGTDKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLVYLHERN 98
           IV+ +G  + E  L + +E+   G L      ++  +  S V+    Q+  G+ YL E+N
Sbjct: 398 IVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPF-WMAPEVVNSKND 153
            VHR++   N+L+      K++DFGL+KA   +D     +S    P  W APE +N +  
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK- 515
Query: 154 GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
            +   +D+WS G T+ E L+  + PY  ++G + +  I +G+    P     +    +  
Sbjct: 516 -FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSD 574
Query: 213 CLQVNPNDRP 222
           C      DRP
Sbjct: 575 CWIYKWEDRP 584

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 9/169 (5%)
Query: 68  NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA 127
           +LY+ + L+   +  Y+ Q+  G+ +L  R  +HRD+   NIL+     VK+ DFGLA+ 
Sbjct: 184 DLYKDF-LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 242
Query: 128 TTMNDLKSCKG---TPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLE 182
              +     KG    P  WMAPE +  +   Y + +D+WS G  + E+ +    PY  ++
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVK 300
Query: 183 GVQALF-RIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
             +    R+ +G     P   + +    +L C    P+ RPT +EL+EH
Sbjct: 301 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 9/169 (5%)
Query: 68  NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA 127
           +LY+ + L+   +  Y+ Q+  G+ +L  R  +HRD+   NIL+     VK+ DFGLA+ 
Sbjct: 191 DLYKDF-LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 249
Query: 128 TTMNDLKSCKGT---PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLE 182
              +     KG    P  WMAPE +  +   Y + +D+WS G  + E+ +    PY  ++
Sbjct: 250 IYKDPDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVK 307
Query: 183 GVQALF-RIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
             +    R+ +G     P   + +    +L C    P+ RPT +EL+EH
Sbjct: 308 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 356

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 9/169 (5%)
Query: 68  NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA 127
           +LY+ + L+   +  Y+ Q+  G+ +L  R  +HRD+   NIL+     VK+ DFGLA+ 
Sbjct: 189 DLYKDF-LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 247
Query: 128 TTMNDLKSCKGT---PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLE 182
              +     KG    P  WMAPE +  +   Y + +D+WS G  + E+ +    PY  ++
Sbjct: 248 IYKDPDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVK 305
Query: 183 GVQALF-RIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
             +    R+ +G     P   + +    +L C    P+ RPT +EL+EH
Sbjct: 306 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 354

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 9/169 (5%)
Query: 68  NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA 127
           +LY+ + L+   +  Y+ Q+  G+ +L  R  +HRD+   NIL+     VK+ DFGLA+ 
Sbjct: 182 DLYKDF-LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 240
Query: 128 TTMNDLKSCKG---TPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLE 182
              +     KG    P  WMAPE +  +   Y + +D+WS G  + E+ +    PY  ++
Sbjct: 241 IYKDPDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVK 298
Query: 183 GVQALF-RIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
             +    R+ +G     P   + +    +L C    P+ RPT +EL+EH
Sbjct: 299 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 347

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 36/233 (15%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANL--YQKYHLSDSQVSSYTRQILNGLVY 93
            +  N+V  L   + + RL++  E      L  L  YQ+  + +  V S T Q L  + +
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNF 117
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSK 151
            H+ N +HRD+K  NIL+     +KL DFG A+  T   +       T ++ +PE++   
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG- 176
Query: 152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPS----------- 200
           +  YG   D+W++GC   E+L+  P +     V  L+ I K     +P            
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236
Query: 201 -------------------SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                              ++S  A   +  CL ++P +R T  +L+ HP+ +
Sbjct: 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 18/209 (8%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDS-----------QVSSYT 84
           F   ++V+ LG         + +EL+  G L +  +                  ++    
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF--- 141
            +I +G+ YL+ +  VHRD+   N +V    +VK+ DFG+ +     D     G      
Sbjct: 137 AEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 196
Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVP 199
            WMAPE +  K+  +  ++D+WS G  + E+ +    PY  L   Q L  +  G     P
Sbjct: 197 RWMAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 254
Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELM 228
            +      D +  C Q NPN RPT  E++
Sbjct: 255 DNCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 77.4 bits (189), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 109/249 (43%), Gaps = 54/249 (21%)
Query: 36  FEQDNIVQYLGTDKDE-----NRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNG 90
           F+ +NI+      + +     N +YI  EL+ +  L  +     LSD  +  +  Q L  
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 91  LVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK------------G 138
           +  LH  NV+HRD+K +N+L++++  +K+ DFGLA+    +   + +             
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 139 TPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP-----PYSH------------- 180
           T ++ APEV+ + +  Y    D+WS GC + E+  RRP      Y H             
Sbjct: 185 TRWYRAPEVMLT-SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243
Query: 181 -------LEGVQALFRIGKGELPSVPSS--------LSRDARDFILKCLQVNPNDRPTVT 225
                  +E  +A  R     LP  P++        ++    D + + L  +P  R T  
Sbjct: 244 SDNDLRCIESPRA--REYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301
Query: 226 ELMEHPFVK 234
           E +EHP+++
Sbjct: 302 EALEHPYLQ 310

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSL-----------------ANLYQKYHLSDSQVSS 82
           NI+  LG    +  LY+ +   +KG+L                  N   +  ++   + S
Sbjct: 102 NIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT--- 139
            T Q+  G+ YL  +  +HRD+   N+LV  +  +K+ADFGLA+   +N++   K T   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNG 219
Query: 140 --PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-GE 194
             P  WMAPE +  +   Y   +D+WS G  + E+ T    PY  +  V+ LF++ K G 
Sbjct: 220 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEGH 276
Query: 195 LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
               P++ + +    +  C    P+ RPT  +L+E
Sbjct: 277 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 110/253 (43%), Gaps = 46/253 (18%)
Query: 36  FEQDNIVQYLGTDK------DENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILN 89
           F+ DNI+      +      +   +Y+ L+L+       ++    L+   V  +  Q+L 
Sbjct: 110 FKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLR 169
Query: 90  GLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND------LKSCKGTPFWM 143
           GL Y+H   V+HRD+K +N+LV+ +  +K+ DFG+A+    +       +     T ++ 
Sbjct: 170 GLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYR 229
Query: 144 APEVVNSKNDGYGLTADIWSLGCTVLEMLTRR---PPYSHLEGVQALFRIGKGELPSVPS 200
           APE++ S ++ Y    D+WS+GC   EML RR   P  +++  +Q +  +     P+V  
Sbjct: 230 APELMLSLHE-YTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288
Query: 201 SLS---------------------------RDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           ++                            R A   + + L+  P+ R +    + HPF+
Sbjct: 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 348
Query: 234 KR---PLQTPRCG 243
            +   P   P C 
Sbjct: 349 AKYHDPDDEPDCA 361

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 12/203 (5%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN--LYQKYHLSDSQVSSYTRQILNGLVYLHER 97
           N++Q     + +N + + +E V  G L +  + + Y+L++     + +QI  G+ ++H+ 
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206
Query: 98  NVVHRDIKCANILV---DASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKND 153
            ++H D+K  NIL    DA   +K+ DFGLA+     + LK   GTP ++APEVVN   D
Sbjct: 207 YILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNY--D 263
Query: 154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI--GKGELPSVP-SSLSRDARDFI 210
                 D+WS+G     +L+   P+      + L  I   + +L       +S +A++FI
Sbjct: 264 FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI 323
Query: 211 LKCLQVNPNDRPTVTELMEHPFV 233
            K L    + R + +E ++HP++
Sbjct: 324 SKLLIKEKSWRISASEALKHPWL 346

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYT--RQILNGLVY 93
            E+ N V+ +   K ++ L+I +E     +L +L    +L+  +   +   RQIL  L Y
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKAT----------------TMNDLKSCK 137
           +H + ++HRD+K  NI +D S +VK+ DFGLAK                  + ++L S  
Sbjct: 132 IHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL-- 195
           GT  ++A EV++     Y    D++SLG    EM+   P  + +E V  L ++    +  
Sbjct: 192 GTAMYVATEVLDGTGH-YNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKLRSVSIEF 248
Query: 196 -PSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
            P    +  +  +  I   +  +PN RP    L+
Sbjct: 249 PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSL-----------------ANLYQKYHLSDSQVSS 82
           NI+  LG    +  LY+ +   +KG+L                  N   +  ++   + S
Sbjct: 102 NIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT--- 139
            T Q+  G+ YL  +  +HRD+   N+LV  +  +K+ADFGLA+   +N++   K T   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNG 219
Query: 140 --PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-GE 194
             P  WMAPE +  +   Y   +D+WS G  + E+ T    PY  +  V+ LF++ K G 
Sbjct: 220 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEGH 276
Query: 195 LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
               P++ + +    +  C    P+ RPT  +L+E
Sbjct: 277 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 110/253 (43%), Gaps = 46/253 (18%)
Query: 36  FEQDNIVQYLGTDK------DENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILN 89
           F+ DNI+      +      +   +Y+ L+L+       ++    L+   V  +  Q+L 
Sbjct: 111 FKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLR 170
Query: 90  GLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND------LKSCKGTPFWM 143
           GL Y+H   V+HRD+K +N+LV+ +  +K+ DFG+A+    +       +     T ++ 
Sbjct: 171 GLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYR 230
Query: 144 APEVVNSKNDGYGLTADIWSLGCTVLEMLTRR---PPYSHLEGVQALFRIGKGELPSVPS 200
           APE++ S ++ Y    D+WS+GC   EML RR   P  +++  +Q +  +     P+V  
Sbjct: 231 APELMLSLHE-YTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 289
Query: 201 SLS---------------------------RDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           ++                            R A   + + L+  P+ R +    + HPF+
Sbjct: 290 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 349
Query: 234 KR---PLQTPRCG 243
            +   P   P C 
Sbjct: 350 AKYHDPDDEPDCA 362

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 39  DNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           D I++    +  +  +Y+ +E       + L +K  +   +  SY + +L  +  +H+  
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKA----TTMNDLKSCKGTPFWMAPEVV----NS 150
           +VH D+K AN L+   G +KL DFG+A      TT     S  G   +M PE +    +S
Sbjct: 176 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 151 KNDGYGLTA-----DIWSLGCTVLEMLTRRPPYSHL-EGVQALFRI----GKGELPSVPS 200
           + +G   +      D+WSLGC +  M   + P+  +   +  L  I     + E P +P 
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 294
Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
              +D +D +  CL+ +P  R ++ EL+ HP+V+
Sbjct: 295 ---KDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 86/197 (43%), Gaps = 8/197 (4%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLH 95
            + +VQ  G    +  ++I  E +  G L N  +  ++     Q+    + +   + YL 
Sbjct: 63  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 122
Query: 96  ERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKN 152
            +  +HRD+   N LV+  G VK++DFGL++    ++  S +G+ F   W  PEV+    
Sbjct: 123 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSK 182
Query: 153 DGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL 211
             +   +DIW+ G  + E+ +  + PY      +    I +G     P   S      + 
Sbjct: 183 --FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 240
Query: 212 KCLQVNPNDRPTVTELM 228
            C     ++RPT   L+
Sbjct: 241 SCWHEKADERPTFKILL 257

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHL-----------SDSQVSSYT 84
           F   ++V+ LG         + +EL+T+G L +  +               S S++    
Sbjct: 70  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 129
Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF--- 141
            +I +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D     G      
Sbjct: 130 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 189
Query: 142 -WMAPEVVNSKNDGYGLT-ADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSV 198
            WM+PE   S  DG   T +D+WS G  + E+ T    PY  L   Q L  + +G L   
Sbjct: 190 RWMSPE---SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 246
Query: 199 PSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           P +      + +  C Q NP  RP+  E++
Sbjct: 247 PDNCPDMLLELMRMCWQYNPKMRPSFLEII 276

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 95/221 (42%), Gaps = 35/221 (15%)
Query: 46  GTDKDENRLYIFLELVT----KGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVH 101
           G  KDE  L + LE V     + S      K  +    +  Y  Q+L  L Y+H   + H
Sbjct: 105 GDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICH 164
Query: 102 RDIKCANILVD-ASGSVKLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTA 159
           RDIK  N+L+D  SG +KL DFG AK     +   S   + ++ APE++    + Y    
Sbjct: 165 RDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGATN-YTTNI 223
Query: 160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK-------------------GELPSV-P 199
           DIWS GC + E++  +P +    G+  L  I K                    + P + P
Sbjct: 224 DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRP 283
Query: 200 SSLSR--------DARDFILKCLQVNPNDRPTVTELMEHPF 232
              S+        DA D I + L+  P+ R T  E + HPF
Sbjct: 284 HPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 88/166 (53%), Gaps = 7/166 (4%)
Query: 49  KDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCAN 108
           +D + +Y+   L+    L N+ +   LSD  V     Q+L GL Y+H   ++HRD+K +N
Sbjct: 103 EDFSEVYLVTTLMG-ADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSN 161
Query: 109 ILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           + V+    +++ DFGLA+     ++     T ++ APE++ +    Y  T DIWS+GC +
Sbjct: 162 VAVNEDSELRILDFGLARQAD-EEMTGYVATRWYRAPEIMLNWMH-YNQTVDIWSVGCIM 219
Query: 169 LEMLTRR---PPYSHLEGVQALFRIGKGELPSVPSSLSRD-ARDFI 210
            E+L  +   P   +++ ++ +  +     P V + +S + AR +I
Sbjct: 220 AELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYI 265

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DLKSCKG 138
           V S+  Q+L GL + H RNV+HRD+K  N+L++ +G +KLADFGLA+A  +     S + 
Sbjct: 103 VKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEV 162
Query: 139 TPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEML-TRRP--PYSHLEG-VQALFRI---- 190
              W  P  V      Y  + D+WS GC   E+    RP  P + ++  ++ +FR+    
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTP 222
Query: 191 ---------------------GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
                                    L +V   L+   RD +   L+ NP  R +  E ++
Sbjct: 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
Query: 230 HPF 232
           HP+
Sbjct: 283 HPY 285

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHL-----------SDSQVSSYT 84
           F   ++V+ LG         + +EL+T+G L +  +               S S++    
Sbjct: 79  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 138
Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF--- 141
            +I +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D     G      
Sbjct: 139 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 198
Query: 142 -WMAPEVVNSKNDGYGLT-ADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSV 198
            WM+PE   S  DG   T +D+WS G  + E+ T    PY  L   Q L  + +G L   
Sbjct: 199 RWMSPE---SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 255
Query: 199 PSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           P +      + +  C Q NP  RP+  E++
Sbjct: 256 PDNCPDMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 34/217 (15%)
Query: 52  NRLYIFLELVTKGS-LANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           +R Y+  E +  GS L++++++ H ++ + S   + + + L +LH + + HRD+K  NIL
Sbjct: 84  DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENIL 143
Query: 111 VDASGS---VKLADFGLAKATTMN---------DLKSCKGTPFWMAPEVVNSKNDG---Y 155
            +       VK+ DF L     +N         +L +  G+  +MAPEVV + ++    Y
Sbjct: 144 CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY 203
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQA--------------LF---RIGKGELPSV 198
               D+WSLG  +  +L+  PP+    G                 LF   + GK E P  
Sbjct: 204 DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDK 263
Query: 199 P-SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
             + +S  A+D I K L  +   R +  ++++HP+V+
Sbjct: 264 DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-----------------LSDSQVSS 82
           NI+  LG  +    LY+ +E    G+L +  +K                   LS  Q+  
Sbjct: 87  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF- 141
           +   +  G+ YL ++  +HRD+   NILV  +   K+ADFGL++   +   K+    P  
Sbjct: 147 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 206
Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPS 200
           WMA E +N     Y   +D+WS G  + E+++    PY  +   +   ++ +G     P 
Sbjct: 207 WMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 264
Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELM 228
           +   +  D + +C +  P +RP+  +++
Sbjct: 265 NCDDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-----------------LSDSQVSS 82
           NI+  LG  +    LY+ +E    G+L +  +K                   LS  Q+  
Sbjct: 77  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 136
Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF- 141
           +   +  G+ YL ++  +HRD+   NILV  +   K+ADFGL++   +   K+    P  
Sbjct: 137 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 196
Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPS 200
           WMA E +N     Y   +D+WS G  + E+++    PY  +   +   ++ +G     P 
Sbjct: 197 WMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 254
Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELM 228
           +   +  D + +C +  P +RP+  +++
Sbjct: 255 NCDDEVYDLMRQCWREKPYERPSFAQIL 282

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV++         L I +E  + G L   +      S+ +   + +Q+++G+ Y H   
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 99  VVHRDIKCANILVDASGS--VKLADFGLAKATTMNDL-KSCKGTPFWMAPEVVNSKNDGY 155
           V HRD+K  N L+D S +  +K+  FG +K++ ++   KS  GTP ++APEV+  K +  
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVL-LKKEYD 194
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGV----QALFRIGKGELPSVPS--SLSRDARDF 209
           G  AD+WS G T+  ML    P+   E      + + RI   +  ++P    +S + R  
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY-AIPDYVHISPECRHL 253
Query: 210 ILKCLQVNPNDRPTVTELMEH 230
           I +    +P  R ++ E+  H
Sbjct: 254 ISRIFVADPAKRISIPEIRNH 274

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 90/201 (44%), Gaps = 10/201 (4%)
Query: 36  FEQDNIVQYLGTDKDENR-LYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGL 91
               N+VQ LG   +E   LYI  E + KGSL +  +   +  L    +  ++  +   +
Sbjct: 56  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNS 150
            YL   N VHRD+   N+LV      K++DFGL K A++  D  + K    W APE +  
Sbjct: 116 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEALRE 173
Query: 151 KNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDF 209
           K   +   +D+WS G  + E+ +  R PY  +     + R+ KG     P        + 
Sbjct: 174 KK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEV 231
Query: 210 ILKCLQVNPNDRPTVTELMEH 230
           +  C  ++   RP+  +L E 
Sbjct: 232 MKNCWHLDAAMRPSFLQLREQ 252

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHL-----------SDSQVSSYT 84
           F   ++V+ LG         + +EL+T+G L +  +               S S++    
Sbjct: 76  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 135
Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCKG-TPF 141
            +I +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P 
Sbjct: 136 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 195
Query: 142 -WMAPEVVNSKNDGYGLT-ADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSV 198
            WM+PE   S  DG   T +D+WS G  + E+ T    PY  L   Q L  + +G L   
Sbjct: 196 RWMSPE---SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 252
Query: 199 PSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           P +      + +  C Q NP  RP+  E++
Sbjct: 253 PDNCPDMLFELMRMCWQYNPKMRPSFLEII 282

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHL-----------SDSQVSSYT 84
           F   ++V+ LG         + +EL+T+G L +  +               S S++    
Sbjct: 72  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 131
Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCKG-TPF 141
            +I +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P 
Sbjct: 132 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 191
Query: 142 -WMAPEVVNSKNDGYGLT-ADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSV 198
            WM+PE   S  DG   T +D+WS G  + E+ T    PY  L   Q L  + +G L   
Sbjct: 192 RWMSPE---SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 248
Query: 199 PSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           P +      + +  C Q NP  RP+  E++
Sbjct: 249 PDNCPDMLFELMRMCWQYNPKMRPSFLEII 278

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 90/201 (44%), Gaps = 10/201 (4%)
Query: 36  FEQDNIVQYLGTDKDENR-LYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGL 91
               N+VQ LG   +E   LYI  E + KGSL +  +   +  L    +  ++  +   +
Sbjct: 71  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNS 150
            YL   N VHRD+   N+LV      K++DFGL K A++  D  + K    W APE +  
Sbjct: 131 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEALRE 188
Query: 151 KNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDF 209
           K   +   +D+WS G  + E+ +  R PY  +     + R+ KG     P        + 
Sbjct: 189 KK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEV 246
Query: 210 ILKCLQVNPNDRPTVTELMEH 230
           +  C  ++   RP+  +L E 
Sbjct: 247 MKNCWHLDAAMRPSFLQLREQ 267

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHL-----------SDSQVSSYT 84
           F   ++V+ LG         + +EL+T+G L +  +               S S++    
Sbjct: 79  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 138
Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCKG-TPF 141
            +I +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P 
Sbjct: 139 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 198
Query: 142 -WMAPEVVNSKNDGYGLT-ADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSV 198
            WM+PE   S  DG   T +D+WS G  + E+ T    PY  L   Q L  + +G L   
Sbjct: 199 RWMSPE---SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 255
Query: 199 PSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           P +      + +  C Q NP  RP+  E++
Sbjct: 256 PDNCPDMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 107/230 (46%), Gaps = 38/230 (16%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVS--------SYTRQILNGL 91
           N+++Y  ++  +  LYI LEL    +L +L +  ++SD  +         S  RQI +G+
Sbjct: 70  NVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 92  VYLHERNVVHRDIKCANILVDASG-------------SVKLADFGLAK------ATTMND 132
            +LH   ++HRD+K  NILV  S               + ++DFGL K      ++   +
Sbjct: 129 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 133 LKSCKGTPFWMAPEVVNSKND-----GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQA 186
           L +  GT  W APE++   N+         + DI+S+GC    +L++ + P+      ++
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248
Query: 187 LFRIGKGELPSVP----SSLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
               G   L  +      SL  +A D I + +  +P  RPT  +++ HP 
Sbjct: 249 NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHL-----------SDSQVSSYT 84
           F   ++V+ LG         + +EL+T+G L +  +               S S++    
Sbjct: 75  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 134
Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCKG-TPF 141
            +I +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P 
Sbjct: 135 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 194
Query: 142 -WMAPEVVNSKNDGYGLT-ADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSV 198
            WM+PE   S  DG   T +D+WS G  + E+ T    PY  L   Q L  + +G L   
Sbjct: 195 RWMSPE---SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 251
Query: 199 PSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           P +      + +  C Q NP  RP+  E++
Sbjct: 252 PDNCPDMLFELMRMCWQYNPKMRPSFLEII 281

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHL-----------SDSQVSSYT 84
           F   ++V+ LG         + +EL+T+G L +  +               S S++    
Sbjct: 78  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 137
Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCKG-TPF 141
            +I +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P 
Sbjct: 138 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 197
Query: 142 -WMAPEVVNSKNDGYGLT-ADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSV 198
            WM+PE   S  DG   T +D+WS G  + E+ T    PY  L   Q L  + +G L   
Sbjct: 198 RWMSPE---SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 254
Query: 199 PSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           P +      + +  C Q NP  RP+  E++
Sbjct: 255 PDNCPDMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHL-----------SDSQVSSYT 84
           F   ++V+ LG         + +EL+T+G L +  +               S S++    
Sbjct: 78  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 137
Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCKG-TPF 141
            +I +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P 
Sbjct: 138 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 197
Query: 142 -WMAPEVVNSKNDGYGLT-ADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSV 198
            WM+PE   S  DG   T +D+WS G  + E+ T    PY  L   Q L  + +G L   
Sbjct: 198 RWMSPE---SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 254
Query: 199 PSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           P +      + +  C Q NP  RP+  E++
Sbjct: 255 PDNCPDMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 77/151 (50%), Gaps = 7/151 (4%)
Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK----SCK 137
           ++  QI  G++YL ER +VHRD+   N+LV +   VK+ DFGLA+    ++ +      K
Sbjct: 121 NWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGK 180
Query: 138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELP 196
               WMA E ++ +   +   +D+WS G T+ E++T    PY  +   +    + KGE  
Sbjct: 181 MPIKWMALECIHYRK--FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL 238
Query: 197 SVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
             P   + D    ++KC  ++ + RP   EL
Sbjct: 239 PQPPICTIDVYMVMVKCWMIDADSRPKFKEL 269

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHL-----------SDSQVSSYT 84
           F   ++V+ LG         + +EL+T+G L +  +               S S++    
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCKG-TPF 141
            +I +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P 
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 204
Query: 142 -WMAPEVVNSKNDGYGLT-ADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSV 198
            WM+PE   S  DG   T +D+WS G  + E+ T    PY  L   Q L  + +G L   
Sbjct: 205 RWMSPE---SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 261
Query: 199 PSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           P +      + +  C Q NP  RP+  E++
Sbjct: 262 PDNCPDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHL-----------SDSQVSSYT 84
           F   ++V+ LG         + +EL+T+G L +  +               S S++    
Sbjct: 107 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 166
Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCKG-TPF 141
            +I +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P 
Sbjct: 167 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 226
Query: 142 -WMAPEVVNSKNDGYGLT-ADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSV 198
            WM+PE   S  DG   T +D+WS G  + E+ T    PY  L   Q L  + +G L   
Sbjct: 227 RWMSPE---SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 283
Query: 199 PSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           P +      + +  C Q NP  RP+  E++
Sbjct: 284 PDNCPDMLFELMRMCWQYNPKMRPSFLEII 313

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 9/171 (5%)
Query: 69  LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA-SGSVKLADFGLAKA 127
           + +K  L +     +  Q++  + + H R VVHRDIK  NIL+D   G  KL DFG    
Sbjct: 130 ITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL 189
Query: 128 TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQAL 187
                     GT  +  PE + S++  + L A +WSLG  + +M+    P+   +     
Sbjct: 190 LHDEPYTDFDGTRVYSPPEWI-SRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----- 243
Query: 188 FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQ 238
             I + EL   P+ +S D    I +CL   P+ RP++ E++  P+++ P +
Sbjct: 244 -EILEAEL-HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 50/224 (22%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +Y+ +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 104 VYLVMELMD----ANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVV 159
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+GC + E
Sbjct: 160 KSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGE 217
Query: 171 MLTRR---------------------PPYSHLEGVQALFRIGKGELPS---------VPS 200
           M+  +                     P    ++ +Q   R      P           P 
Sbjct: 218 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 277
Query: 201 SL-----------SRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           SL           +  ARD + K L ++P  R +V + ++HP++
Sbjct: 278 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHL-----------SDSQVSSYT 84
           F   ++V+ LG         + +EL+T+G L +  +               S S++    
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 144
Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCKG-TPF 141
            +I +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P 
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 204
Query: 142 -WMAPEVVNSKNDGYGLT-ADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSV 198
            WM+PE   S  DG   T +D+WS G  + E+ T    PY  L   Q L  + +G L   
Sbjct: 205 RWMSPE---SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 261
Query: 199 PSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           P +      + +  C Q NP  RP+  E++
Sbjct: 262 PDNCPDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 88/166 (53%), Gaps = 7/166 (4%)
Query: 49  KDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCAN 108
           +D + +Y+   L+    L N+ +   LSD  V     Q+L GL Y+H   ++HRD+K +N
Sbjct: 103 EDFSEVYLVTTLMG-ADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSN 161
Query: 109 ILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           + V+    +++ DFGLA+     ++     T ++ APE++ +    Y  T DIWS+GC +
Sbjct: 162 VAVNEDSELRILDFGLARQAD-EEMTGYVATRWYRAPEIMLNWMH-YNQTVDIWSVGCIM 219
Query: 169 LEMLTRR---PPYSHLEGVQALFRIGKGELPSVPSSLSRD-ARDFI 210
            E+L  +   P   +++ ++ +  +     P V + +S + AR +I
Sbjct: 220 AELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYI 265

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 32/199 (16%)
Query: 66  LANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA 125
           L  L +   L + ++     Q+L GL Y+H   ++HRD+K  N+ V+    +K+ DFGLA
Sbjct: 116 LGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 175
Query: 126 KATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR---------- 175
           +    +++     T ++ APEV+ +    Y  T DIWS+GC + EM+T +          
Sbjct: 176 RQAD-SEMXGXVVTRWYRAPEVILNWMR-YTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 233
Query: 176 -----------PPYSHLEGVQA---------LFRIGKGELPSVPSSLSRDARDFILKCLQ 215
                      PP   ++ +Q+         L  + K +  S+ ++ S  A + + K L 
Sbjct: 234 QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLV 293
Query: 216 VNPNDRPTVTELMEHPFVK 234
           ++   R T  E + HP+ +
Sbjct: 294 LDAEQRVTAGEALAHPYFE 312

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 9/180 (5%)
Query: 56  IFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           + ++L+  G L +  +++  ++    + ++  QI  G+ YL +R +VHRD+   N+LV  
Sbjct: 96  LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 155
Query: 114 SGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVL 169
              VK+ DFGLAK     +     +  K    WMA E +  +   Y   +D+WS G TV 
Sbjct: 156 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVW 213
Query: 170 EMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           E++T    PY  +   +    + KGE    P   + D    ++KC  ++ + RP   EL+
Sbjct: 214 ELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 9/180 (5%)
Query: 56  IFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           + ++L+  G L +  +++  ++    + ++  QI  G+ YL +R +VHRD+   N+LV  
Sbjct: 94  LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 153
Query: 114 SGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVL 169
              VK+ DFGLAK     +     +  K    WMA E +  +   Y   +D+WS G TV 
Sbjct: 154 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVW 211
Query: 170 EMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           E++T    PY  +   +    + KGE    P   + D    ++KC  ++ + RP   EL+
Sbjct: 212 ELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 9/180 (5%)
Query: 56  IFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           + ++L+  G L +  +++  ++    + ++  QI  G+ YL +R +VHRD+   N+LV  
Sbjct: 97  LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 156
Query: 114 SGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVL 169
              VK+ DFGLAK     +     +  K    WMA E +  +   Y   +D+WS G TV 
Sbjct: 157 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVW 214
Query: 170 EMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           E++T    PY  +   +    + KGE    P   + D    ++KC  ++ + RP   EL+
Sbjct: 215 ELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 49  KDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKC 106
           +DEN LY+ +E    G L  L  K+   +       Y  +I+  +  +H    VHRDIK 
Sbjct: 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKP 190
Query: 107 ANILVDASGSVKLADFG----LAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTA--- 159
            NIL+D  G ++LADFG    L    T+  L +  GTP +++PE++ +   G G  +   
Sbjct: 191 DNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGP 249
Query: 160 --DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE----LPSVPSSLSRDARDFI--L 211
             D W+LG    EM   + P+      +   +I   +    LP V   +  +ARDFI  L
Sbjct: 250 ECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRL 309
Query: 212 KCLQVNPNDRPTVTELMEHPF 232
            C       R    +   HPF
Sbjct: 310 LCPPETRLGRGGAGDFRTHPF 330

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 50/224 (22%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +Y+ +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 104 VYLVMELMD----ANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVV 159
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+GC + E
Sbjct: 160 KSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGE 217
Query: 171 MLTRR---------------------PPYSHLEGVQALFRIGKGELPS---------VPS 200
           M+  +                     P    ++ +Q   R      P           P 
Sbjct: 218 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 277
Query: 201 SL-----------SRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           SL           +  ARD + K L ++P  R +V + ++HP++
Sbjct: 278 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 9/180 (5%)
Query: 56  IFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           + ++L+  G L +  +++  ++    + ++  QI  G+ YL +R +VHRD+   N+LV  
Sbjct: 93  LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 152
Query: 114 SGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVL 169
              VK+ DFGLAK     +     +  K    WMA E +  +   Y   +D+WS G TV 
Sbjct: 153 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVW 210
Query: 170 EMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           E++T    PY  +   +    + KGE    P   + D    ++KC  ++ + RP   EL+
Sbjct: 211 ELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 50/224 (22%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +Y+ +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 97  VYLVMELMD----ANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVV 152
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+GC + E
Sbjct: 153 KSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGE 210
Query: 171 MLTRR---------------------PPYSHLEGVQALFRIGKGELPS---------VPS 200
           M+  +                     P    ++ +Q   R      P           P 
Sbjct: 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 270
Query: 201 SL-----------SRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           SL           +  ARD + K L ++P  R +V + ++HP++
Sbjct: 271 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 9/180 (5%)
Query: 56  IFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           + ++L+  G L +  +++  ++    + ++  QI  G+ YL +R +VHRD+   N+LV  
Sbjct: 95  LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 154
Query: 114 SGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVL 169
              VK+ DFGLAK     +     +  K    WMA E +  +   Y   +D+WS G TV 
Sbjct: 155 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVW 212
Query: 170 EMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           E++T    PY  +   +    + KGE    P   + D    ++KC  ++ + RP   EL+
Sbjct: 213 ELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 9/180 (5%)
Query: 56  IFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           + ++L+  G L +  +++  ++    + ++  QI  G+ YL +R +VHRD+   N+LV  
Sbjct: 94  LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 153
Query: 114 SGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVL 169
              VK+ DFGLAK     +     +  K    WMA E +  +   Y   +D+WS G TV 
Sbjct: 154 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVW 211
Query: 170 EMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           E++T    PY  +   +    + KGE    P   + D    ++KC  ++ + RP   EL+
Sbjct: 212 ELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 18/209 (8%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDS-----------QVSSYT 84
           F   ++V+ LG         + +EL+  G L +  +                  ++    
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF--- 141
            +I +G+ YL+ +  VHRD+   N +V    +VK+ DFG+ +     D     G      
Sbjct: 137 AEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 196
Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVP 199
            WMAPE +  K+  +  ++D+WS G  + E+ +    PY  L   Q L  +  G     P
Sbjct: 197 RWMAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 254
Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELM 228
            +      D +  C Q NP  RPT  E++
Sbjct: 255 DNCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 9/180 (5%)
Query: 56  IFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           + ++L+  G L +  +++  ++    + ++  QI  G+ YL +R +VHRD+   N+LV  
Sbjct: 100 LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 159
Query: 114 SGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVL 169
              VK+ DFGLAK     +     +  K    WMA E +  +   Y   +D+WS G TV 
Sbjct: 160 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVW 217
Query: 170 EMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           E++T    PY  +   +    + KGE    P   + D    ++KC  ++ + RP   EL+
Sbjct: 218 ELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 18/209 (8%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDS-----------QVSSYT 84
           F   ++V+ LG         + +EL+  G L +  +                  ++    
Sbjct: 74  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 133
Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF--- 141
            +I +G+ YL+ +  VHRD+   N +V    +VK+ DFG+ +     D     G      
Sbjct: 134 AEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 193
Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVP 199
            WMAPE +  K+  +  ++D+WS G  + E+ +    PY  L   Q L  +  G     P
Sbjct: 194 RWMAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 251
Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELM 228
            +      D +  C Q NP  RPT  E++
Sbjct: 252 DNCPERVTDLMRMCWQFNPKMRPTFLEIV 280

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 7/162 (4%)
Query: 71  QKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM 130
            K ++    + ++  QI  G++YL ER +VHRD+   N+LV +   VK+ DFGLA+    
Sbjct: 133 HKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 192
Query: 131 NDLK----SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQ 185
           ++ +      K    WMA E ++ +   +   +D+WS G T+ E++T    PY  +   +
Sbjct: 193 DEKEYNADGGKMPIKWMALECIHYRK--FTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 250
Query: 186 ALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
               + KGE    P   + D    ++KC  ++ + RP   EL
Sbjct: 251 IPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKEL 292

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 85/197 (43%), Gaps = 8/197 (4%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLH 95
            + +VQ  G    +  ++I  E +  G L N  +  ++     Q+    + +   + YL 
Sbjct: 58  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 96  ERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKN 152
            +  +HRD+   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV+    
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 153 DGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL 211
             +   +DIW+ G  + E+ +  + PY      +    I +G     P   S      + 
Sbjct: 178 --FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 235
Query: 212 KCLQVNPNDRPTVTELM 228
            C     ++RPT   L+
Sbjct: 236 SCWHEKADERPTFKILL 252

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 85/197 (43%), Gaps = 8/197 (4%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLH 95
            + +VQ  G    +  ++I  E +  G L N  +  ++     Q+    + +   + YL 
Sbjct: 62  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 121
Query: 96  ERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKN 152
            +  +HRD+   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV+    
Sbjct: 122 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 181
Query: 153 DGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL 211
             +   +DIW+ G  + E+ +  + PY      +    I +G     P   S      + 
Sbjct: 182 --FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 239
Query: 212 KCLQVNPNDRPTVTELM 228
            C     ++RPT   L+
Sbjct: 240 SCWHEKADERPTFKILL 256

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 85/197 (43%), Gaps = 8/197 (4%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLH 95
            + +VQ  G    +  ++I  E +  G L N  +  ++     Q+    + +   + YL 
Sbjct: 63  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 122
Query: 96  ERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKN 152
            +  +HRD+   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV+    
Sbjct: 123 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 182
Query: 153 DGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL 211
             +   +DIW+ G  + E+ +  + PY      +    I +G     P   S      + 
Sbjct: 183 --FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 240
Query: 212 KCLQVNPNDRPTVTELM 228
            C     ++RPT   L+
Sbjct: 241 SCWHEKADERPTFKILL 257

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 85/197 (43%), Gaps = 8/197 (4%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLH 95
            + +VQ  G    +  ++I  E +  G L N  +  ++     Q+    + +   + YL 
Sbjct: 69  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 128
Query: 96  ERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKN 152
            +  +HRD+   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV+    
Sbjct: 129 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 188
Query: 153 DGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL 211
             +   +DIW+ G  + E+ +  + PY      +    I +G     P   S      + 
Sbjct: 189 --FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 246
Query: 212 KCLQVNPNDRPTVTELM 228
            C     ++RPT   L+
Sbjct: 247 SCWHEKADERPTFKILL 263

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCKG-TPF- 141
           +I +G+ YL+ +  VHR++   N +V    +VK+ DFG+ +     D   K  KG  P  
Sbjct: 138 EIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPS 200
           WMAPE +  K+  +  ++D+WS G  + E+ +    PY  L   Q L  +  G     P 
Sbjct: 198 WMAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 255
Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELM 228
           +      D +  C Q NPN RPT  E++
Sbjct: 256 NCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCKG-TPF- 141
           +I +G+ YL+ +  VHR++   N +V    +VK+ DFG+ +     D   K  KG  P  
Sbjct: 139 EIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPS 200
           WMAPE +  K+  +  ++D+WS G  + E+ +    PY  L   Q L  +  G     P 
Sbjct: 199 WMAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 256
Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELM 228
           +      D +  C Q NPN RPT  E++
Sbjct: 257 NCPERVTDLMRMCWQFNPNMRPTFLEIV 284

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 85/197 (43%), Gaps = 8/197 (4%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLH 95
            + +VQ  G    +  ++I  E +  G L N  +  ++     Q+    + +   + YL 
Sbjct: 78  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 137
Query: 96  ERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKN 152
            +  +HRD+   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV+    
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 197
Query: 153 DGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL 211
             +   +DIW+ G  + E+ +  + PY      +    I +G     P   S      + 
Sbjct: 198 --FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 255
Query: 212 KCLQVNPNDRPTVTELM 228
            C     ++RPT   L+
Sbjct: 256 SCWHEKADERPTFKILL 272

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 72/148 (48%), Gaps = 7/148 (4%)
Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPF 141
           QI  G+ YL +R +VHRD+   N+LV     VK+ DFGLAK     +     +  K    
Sbjct: 150 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 209
Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPS 200
           WMA E +  +   Y   +D+WS G TV E++T    PY  +   +    + KGE    P 
Sbjct: 210 WMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 267
Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELM 228
             + D    ++KC  ++ + RP   EL+
Sbjct: 268 ICTIDVYMIMVKCWMIDADSRPKFRELI 295

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 10/201 (4%)
Query: 36  FEQDNIVQYLGTDKDENR-LYIFLELVTKGSLANLYQ---KYHLSDSQVSSYTRQILNGL 91
               N+VQ LG   +E   LYI  E + KGSL +  +   +  L    +  ++  +   +
Sbjct: 62  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 121
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNS 150
            YL   N VHRD+   N+LV      K++DFGL K A++  D  + K    W APE +  
Sbjct: 122 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEAL-- 177
Query: 151 KNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDF 209
           +   +   +D+WS G  + E+ +  R PY  +     + R+ KG     P        + 
Sbjct: 178 REAAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEV 237
Query: 210 ILKCLQVNPNDRPTVTELMEH 230
           +  C  ++   RP+  +L E 
Sbjct: 238 MKNCWHLDAAMRPSFLQLREQ 258

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-----------------LSDSQVSS 82
           NI+  LG  +    LY+ +E    G+L +  +K                   LS  Q+  
Sbjct: 84  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 143
Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF- 141
           +   +  G+ YL ++  +HR++   NILV  +   K+ADFGL++   +   K+    P  
Sbjct: 144 FAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 203
Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPS 200
           WMA E +N     Y   +D+WS G  + E+++    PY  +   +   ++ +G     P 
Sbjct: 204 WMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 261
Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELM 228
           +   +  D + +C +  P +RP+  +++
Sbjct: 262 NCDDEVYDLMRQCWREKPYERPSFAQIL 289

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHL-----------SDSQVSSYT 84
           F   ++V+ LG         + +EL+T+G L +  +               S S++    
Sbjct: 72  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 131
Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCKG-TPF 141
            +I +G+ YL+    VHRD+   N  V    +VK+ DFG+ +     D   K  KG  P 
Sbjct: 132 GEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 191
Query: 142 -WMAPEVVNSKNDGYGLT-ADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSV 198
            WM+PE   S  DG   T +D+WS G  + E+ T    PY  L   Q L  + +G L   
Sbjct: 192 RWMSPE---SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 248
Query: 199 PSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           P +      + +  C Q NP  RP+  E++
Sbjct: 249 PDNCPDMLLELMRMCWQYNPKMRPSFLEII 278

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 7/152 (4%)
Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCK 137
           ++  QI  G+ YL +R +VHRD+   N+LV     VK+ DFGLAK     +     +  K
Sbjct: 124 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELP 196
               WMA E +  +   Y   +D+WS G TV E++T    PY  +   +    + KGE  
Sbjct: 184 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 241
Query: 197 SVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
             P   + D    ++KC  ++ + RP   EL+
Sbjct: 242 PQPPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 7/152 (4%)
Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCK 137
           ++  QI  G+ YL +R +VHRD+   N+LV     VK+ DFGLAK     +     +  K
Sbjct: 124 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELP 196
               WMA E +  +   Y   +D+WS G TV E++T    PY  +   +    + KGE  
Sbjct: 184 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 241
Query: 197 SVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
             P   + D    ++KC  ++ + RP   EL+
Sbjct: 242 PQPPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 72/148 (48%), Gaps = 7/148 (4%)
Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPF 141
           QI  G+ YL +R +VHRD+   N+LV     VK+ DFGLAK     +     +  K    
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPS 200
           WMA E +  +   Y   +D+WS G TV E++T    PY  +   +    + KGE    P 
Sbjct: 185 WMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242
Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELM 228
             + D    ++KC  ++ + RP   EL+
Sbjct: 243 ICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 78/163 (47%), Gaps = 7/163 (4%)
Query: 71  QKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM 130
            K ++    + ++  QI  G+ YL +R +VHRD+   N+LV     VK+ DFGLAK    
Sbjct: 117 HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 176
Query: 131 ND----LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQ 185
            +     +  K    WMA E +  +   Y   +D+WS G TV E++T    PY  +   +
Sbjct: 177 EEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234
Query: 186 ALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
               + KGE    P   + D    ++KC  ++ + RP   EL+
Sbjct: 235 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DLKSCKG 138
           V S+  Q+L GL + H RNV+HRD+K  N+L++ +G +KLA+FGLA+A  +     S + 
Sbjct: 103 VKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV 162
Query: 139 TPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RP--PYSHLEG-VQALFRI---- 190
              W  P  V      Y  + D+WS GC   E+    RP  P + ++  ++ +FR+    
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222
Query: 191 ---------------------GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
                                    L +V   L+   RD +   L+ NP  R +  E ++
Sbjct: 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
Query: 230 HPF 232
           HP+
Sbjct: 283 HPY 285

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 7/152 (4%)
Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCK 137
           ++  QI  G+ YL +R +VHRD+   N+LV     VK+ DFGLAK     +     +  K
Sbjct: 121 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELP 196
               WMA E +  +   Y   +D+WS G TV E++T    PY  +   +    + KGE  
Sbjct: 181 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238
Query: 197 SVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
             P   + D    ++KC  ++ + RP   EL+
Sbjct: 239 PQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 7/152 (4%)
Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCK 137
           ++  QI  G+ YL +R +VHRD+   N+LV     VK+ DFGLAK     +     +  K
Sbjct: 127 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 186
Query: 138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELP 196
               WMA E +  +   Y   +D+WS G TV E++T    PY  +   +    + KGE  
Sbjct: 187 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 244
Query: 197 SVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
             P   + D    ++KC  ++ + RP   EL+
Sbjct: 245 PQPPICTIDVYMIMVKCWMIDADSRPKFRELI 276

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 12/201 (5%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV++         L I +E  + G L   +      S+ +   + +Q+++G+ Y H   
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 99  VVHRDIKCANILVDASGS--VKLADFGLAKATTMNDL-KSCKGTPFWMAPEVVNSKNDGY 155
           V HRD+K  N L+D S +  +K+  FG +K++ ++   K   GTP ++APEV+  K +  
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVL-LKKEYD 194
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGV----QALFRIGKGELPSVPS--SLSRDARDF 209
           G  AD+WS G T+  ML    P+   E      + + RI   +  ++P    +S + R  
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY-AIPDYVHISPECRHL 253
Query: 210 ILKCLQVNPNDRPTVTELMEH 230
           I +    +P  R ++ E+  H
Sbjct: 254 ISRIFVADPAKRISIPEIRNH 274

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 18/209 (8%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDS-----------QVSSYT 84
           F   ++V+ LG         + +EL+  G L +  +                  ++    
Sbjct: 76  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 135
Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCKG-TPF 141
            +I +G+ YL+ +  VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P 
Sbjct: 136 AEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 195
Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVP 199
            WMAPE +  K+  +  ++D+WS G  + E+ +    PY  L   Q L  +  G     P
Sbjct: 196 RWMAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 253
Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELM 228
            +      D +  C Q NP  RPT  E++
Sbjct: 254 DNCPERVTDLMRMCWQFNPKMRPTFLEIV 282

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 7/152 (4%)
Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCK 137
           ++  QI  G+ YL +R +VHRD+   N+LV     VK+ DFGLAK     +     +  K
Sbjct: 118 NWCVQIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 177
Query: 138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELP 196
               WMA E +  +   Y   +D+WS G TV E++T    PY  +   +    + KGE  
Sbjct: 178 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 235
Query: 197 SVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
             P   + D    ++KC  ++ + RP   EL+
Sbjct: 236 PQPPICTIDVYMIMVKCWMIDADSRPKFRELI 267

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 7/152 (4%)
Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCK 137
           ++  QI  G+ YL +R +VHRD+   N+LV     VK+ DFGLAK     +     +  K
Sbjct: 115 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELP 196
               WMA E +  +   Y   +D+WS G TV E++T    PY  +   +    + KGE  
Sbjct: 175 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 232
Query: 197 SVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
             P   + D    ++KC  ++ + RP   EL+
Sbjct: 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELI 264

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 7/152 (4%)
Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCK 137
           ++  QI  G+ YL +R +VHRD+   N+LV     VK+ DFGLAK     +     +  K
Sbjct: 121 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELP 196
               WMA E +  +   Y   +D+WS G TV E++T    PY  +   +    + KGE  
Sbjct: 181 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238
Query: 197 SVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
             P   + D    ++KC  ++ + RP   EL+
Sbjct: 239 PQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 7/152 (4%)
Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCK 137
           ++  QI  G+ YL +R +VHRD+   N+LV     VK+ DFGLAK     +     +  K
Sbjct: 123 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 182
Query: 138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELP 196
               WMA E +  +   Y   +D+WS G TV E++T    PY  +   +    + KGE  
Sbjct: 183 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 240
Query: 197 SVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
             P   + D    ++KC  ++ + RP   EL+
Sbjct: 241 PQPPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 7/152 (4%)
Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCK 137
           ++  QI  G+ YL +R +VHRD+   N+LV     VK+ DFGLAK     +     +  K
Sbjct: 128 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELP 196
               WMA E +  +   Y   +D+WS G TV E++T    PY  +   +    + KGE  
Sbjct: 188 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 245
Query: 197 SVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
             P   + D    ++KC  ++ + RP   EL+
Sbjct: 246 PQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 86/195 (44%), Gaps = 8/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLVYLHER 97
            +VQ  G   ++  + +  E +  G L++    Q+   +   +      +  G+ YL E 
Sbjct: 63  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 122
Query: 98  NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDG 154
           +V+HRD+   N LV  +  +K++DFG+ +    +   S  GT F   W +PEV +     
Sbjct: 123 SVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-- 180
Query: 155 YGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKC 213
           Y   +D+WS G  + E+ +  + PY +    + +  I  G     P   S      +  C
Sbjct: 181 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 240
Query: 214 LQVNPNDRPTVTELM 228
            +  P DRP  + L+
Sbjct: 241 WKERPEDRPAFSRLL 255

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 50/224 (22%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +Y+ +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 104 VYLVMELMD----ANLXQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+GC + E
Sbjct: 160 KSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGE 217
Query: 171 MLTRR---------------------PPYSHLEGVQALFRIGKGELPS---------VPS 200
           M+  +                     P    ++ +Q   R      P           P 
Sbjct: 218 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 277
Query: 201 SL-----------SRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           SL           +  ARD + K L ++P  R +V + ++HP++
Sbjct: 278 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 88/166 (53%), Gaps = 7/166 (4%)
Query: 49  KDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCAN 108
           +D + +Y+   L+    L N+ +   LSD  V     Q+L GL Y+H   ++HRD+K +N
Sbjct: 95  EDFSEVYLVTTLMG-ADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSN 153
Query: 109 ILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           + V+    +++ DFGLA+     ++     T ++ APE++ +    Y  T DIWS+GC +
Sbjct: 154 VAVNEDCELRILDFGLARQAD-EEMTGYVATRWYRAPEIMLNWMH-YNQTVDIWSVGCIM 211
Query: 169 LEMLTRR---PPYSHLEGVQALFRIGKGELPSVPSSLSRD-ARDFI 210
            E+L  +   P   +++ ++ +  +     P V + +S + AR +I
Sbjct: 212 AELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYI 257

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 18/209 (8%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDS-----------QVSSYT 84
           F   ++V+ LG         + +EL+  G L +  +                  ++    
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCKG-TPF 141
            +I +G+ YL+ +  VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P 
Sbjct: 137 AEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 196
Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVP 199
            WMAPE +  K+  +  ++D+WS G  + E+ +    PY  L   Q L  +  G     P
Sbjct: 197 RWMAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 254
Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELM 228
            +      D +  C Q NP  RPT  E++
Sbjct: 255 DNCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 75/157 (47%), Gaps = 14/157 (8%)
Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT-- 139
           SY+ Q+  G+ +L  R  +HRD+   NIL+  +  VK+ DFGLA+    N     KG   
Sbjct: 203 SYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTR 262
Query: 140 -PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQA----LFRIGK 192
            P  WMAPE +  K   Y   +D+WS G  + E+ +    PY    GVQ       R+ +
Sbjct: 263 LPLKWMAPESIFDKI--YSTKSDVWSYGVLLWEIFSLGGSPYP---GVQMDEDFCSRLRE 317
Query: 193 GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
           G     P   + +    +L C   +P +RP   EL+E
Sbjct: 318 GMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVE 354

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 104/207 (50%), Gaps = 17/207 (8%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLY---QKYHLSDSQVSSYT-RQILNGLV 92
           E  NI++ L  D  EN+ +  L +   GS  +L+    ++   D  ++SY  RQ+++ + 
Sbjct: 87  EHANIIKVL--DIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL-KSCKGTPFWMAPEVVNSK 151
           YL  ++++HRDIK  NI++    ++KL DFG A       L  +  GT  + APEV+   
Sbjct: 145 YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG- 203
Query: 152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHL-EGVQALFRIGKGELPSVPSSLSRDARDFI 210
           N   G   ++WSLG T+  ++    P+  L E V+A            P  +S++    +
Sbjct: 204 NPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIH--------PPYLVSKELMSLV 255
Query: 211 LKCLQVNPNDRPTVTELMEHPFVKRPL 237
              LQ  P  R T+ +L+  P+V +P+
Sbjct: 256 SGLLQPVPERRTTLEKLVTDPWVTQPV 282

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 72/148 (48%), Gaps = 7/148 (4%)
Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPF 141
           QI  G+ YL +R +VHRD+   N+LV     VK+ DFGLAK     +     +  K    
Sbjct: 159 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 218
Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPS 200
           WMA E +  +   Y   +D+WS G TV E++T    PY  +   +    + KGE    P 
Sbjct: 219 WMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 276
Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELM 228
             + D    ++KC  ++ + RP   EL+
Sbjct: 277 ICTIDVYMIMVKCWMIDADSRPKFRELI 304

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 105/230 (45%), Gaps = 38/230 (16%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVS--------SYTRQILNGL 91
           N+++Y  ++  +  LYI LEL    +L +L +  ++SD  +         S  RQI +G+
Sbjct: 70  NVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 92  VYLHERNVVHRDIKCANILVDASG-------------SVKLADFGLAKATT------MND 132
            +LH   ++HRD+K  NILV  S               + ++DFGL K           +
Sbjct: 129 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXN 188
Query: 133 LKSCKGTPFWMAPEVVNSKND-----GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQA 186
           L +  GT  W APE++   N+         + DI+S+GC    +L++ + P+      ++
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248
Query: 187 LFRIGKGELPSVP----SSLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
               G   L  +      SL  +A D I + +  +P  RPT  +++ HP 
Sbjct: 249 NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 85/197 (43%), Gaps = 8/197 (4%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLH 95
            + +VQ  G    +  ++I  E +  G L N  +  ++     Q+    + +   + YL 
Sbjct: 78  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 137
Query: 96  ERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKN 152
            +  +HRD+   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV+    
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSK 197
Query: 153 DGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL 211
             +   +DIW+ G  + E+ +  + PY      +    I +G     P   S      + 
Sbjct: 198 --FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 255
Query: 212 KCLQVNPNDRPTVTELM 228
            C     ++RPT   L+
Sbjct: 256 SCWHEKADERPTFKILL 272

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 40/219 (18%)
Query: 52  NRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           ++LY+  EL+ +  LA +   Q+  +S   +  +   IL GL  LHE  VVHRD+   NI
Sbjct: 107 HKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNI 165
Query: 110 LVDASGSVKLADFGLAKATTMNDLKSCKGTPFWM-APEVVNSKNDGYGLTADIWSLGCTV 168
           L+  +  + + DF LA+  T +  K+   T  W  APE+V  +  G+    D+WS GC +
Sbjct: 166 LLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELV-MQFKGFTKLVDMWSAGCVM 224
Query: 169 LEMLTRRPP------YSHLEGVQALFRIGKGELPSVPSSLSRDARDF------------- 209
            EM  R+        Y+ L  +  +  +G  ++  V    S  ARD+             
Sbjct: 225 AEMFNRKALFRGSTFYNQLNKIVEV--VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAW 282
Query: 210 --------------ILKCLQVNPNDRPTVTELMEHPFVK 234
                         I K L+ NP  R +  + + HP+ +
Sbjct: 283 TAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFE 321

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 34/226 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVS--------SYTRQILNGL 91
           N+++Y  ++  +  LYI LEL    +L +L +  ++SD  +         S  RQI +G+
Sbjct: 88  NVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 146
Query: 92  VYLHERNVVHRDIKCANILVDASG-------------SVKLADFGLAKATTMN------D 132
            +LH   ++HRD+K  NILV  S               + ++DFGL K           +
Sbjct: 147 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXN 206
Query: 133 LKSCKGTPFWMAPEVV-NSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRI 190
           L +  GT  W APE++  S       + DI+S+GC    +L++ + P+      ++    
Sbjct: 207 LNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIR 266
Query: 191 GKGELPSVP----SSLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
           G   L  +      SL  +A D I + +  +P  RPT  +++ HP 
Sbjct: 267 GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 312

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 34/226 (15%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVS--------SYTRQILNGL 91
           N+++Y  ++  +  LYI LEL    +L +L +  ++SD  +         S  RQI +G+
Sbjct: 88  NVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 146
Query: 92  VYLHERNVVHRDIKCANILVDASG-------------SVKLADFGLAKATTMN------D 132
            +LH   ++HRD+K  NILV  S               + ++DFGL K           +
Sbjct: 147 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXN 206
Query: 133 LKSCKGTPFWMAPEVV-NSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRI 190
           L +  GT  W APE++  S       + DI+S+GC    +L++ + P+      ++    
Sbjct: 207 LNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIR 266
Query: 191 GKGELPSVP----SSLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
           G   L  +      SL  +A D I + +  +P  RPT  +++ HP 
Sbjct: 267 GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 312

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 40/219 (18%)
Query: 52  NRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           ++LY+  EL+ +  LA +   Q+  +S   +  +   IL GL  LHE  VVHRD+   NI
Sbjct: 107 HKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNI 165
Query: 110 LVDASGSVKLADFGLAKATTMNDLKSCKGTPFWM-APEVVNSKNDGYGLTADIWSLGCTV 168
           L+  +  + + DF LA+  T +  K+   T  W  APE+V  +  G+    D+WS GC +
Sbjct: 166 LLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELV-MQFKGFTKLVDMWSAGCVM 224
Query: 169 LEMLTRRPP------YSHLEGVQALFRIGKGELPSVPSSLSRDARDF------------- 209
            EM  R+        Y+ L  +  +  +G  ++  V    S  ARD+             
Sbjct: 225 AEMFNRKALFRGSTFYNQLNKIVEV--VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAW 282
Query: 210 --------------ILKCLQVNPNDRPTVTELMEHPFVK 234
                         I K L+ NP  R +  + + HP+ +
Sbjct: 283 TAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFE 321

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 9/154 (5%)
Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDLKS 135
           S+  Q+  G+ YL E+  VHRD+   N ++D S +VK+ADFGLA+        ++   + 
Sbjct: 128 SFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRH 187
Query: 136 CKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGE 194
            +    W A E + +    +   +D+WS G  + E+LTR  PPY H++       + +G 
Sbjct: 188 ARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR 245
Query: 195 LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
               P          + +C + +P  RPT   L+
Sbjct: 246 RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLV 279

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYLHERN 98
            IV   G  ++   + IF+EL+  GSL  L ++   L + +   Y  Q L GL YLH R 
Sbjct: 127 RIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRR 186
Query: 99  VVHRDIKCANILVDASGS-VKLADFGLAKATTMNDLKS-------CKGTPFWMAPEVVNS 150
           ++H D+K  N+L+ + GS   L DFG A     + L           GT   MAPEVV  
Sbjct: 187 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG 246
Query: 151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP--SVPSSLSRDARD 208
           ++       D+WS  C +L ML    P++         +I     P   +P S +     
Sbjct: 247 RS--CDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQ 304
Query: 209 FILKCLQVNPNDRPTVTEL 227
            I + L+  P  R +  EL
Sbjct: 305 AIQEGLRKEPIHRVSAAEL 323

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 45/122 (36%), Positives = 71/122 (58%), Gaps = 9/122 (7%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 104 VYIVMELMD----ANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVV 159
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+GC + E
Sbjct: 160 KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGE 217
Query: 171 ML 172
           M+
Sbjct: 218 MI 219

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYLHERN 98
            IV   G  ++   + IF+EL+  GSL  L ++   L + +   Y  Q L GL YLH R 
Sbjct: 146 RIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRR 205
Query: 99  VVHRDIKCANILVDASGS-VKLADFGLAKATTMNDLKSC-------KGTPFWMAPEVVNS 150
           ++H D+K  N+L+ + GS   L DFG A     + L           GT   MAPEVV  
Sbjct: 206 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLG 265
Query: 151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP--SVPSSLSRDARD 208
           ++       D+WS  C +L ML    P++         +I     P   +P S +     
Sbjct: 266 RS--CDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQ 323
Query: 209 FILKCLQVNPNDRPTVTEL 227
            I + L+  P  R +  EL
Sbjct: 324 AIQEGLRKEPIHRVSAAEL 342

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 50/224 (22%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +Y+ +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 104 VYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+GC + E
Sbjct: 160 KSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGE 217
Query: 171 MLTRR---------------------PPYSHLEGVQALFRIGKGELPS---------VPS 200
           M+  +                     P    ++ +Q   R      P           P 
Sbjct: 218 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 277
Query: 201 SL-----------SRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           SL           +  ARD + K L ++P  R +V + ++HP++
Sbjct: 278 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 50/224 (22%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +Y+ +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 142 VYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+GC + E
Sbjct: 198 KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGE 255
Query: 171 MLTRR---------------------PPYSHLEGVQALFRIGKGELPS---------VPS 200
           M+  +                     P    ++ +Q   R      P           P 
Sbjct: 256 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 315
Query: 201 SL-----------SRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           SL           +  ARD + K L ++P  R +V + ++HP++
Sbjct: 316 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 85/195 (43%), Gaps = 8/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLVYLHER 97
            +VQ  G   ++  + +  E +  G L++    Q+   +   +      +  G+ YL E 
Sbjct: 63  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 122
Query: 98  NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDG 154
            V+HRD+   N LV  +  +K++DFG+ +    +   S  GT F   W +PEV +     
Sbjct: 123 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-- 180
Query: 155 YGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKC 213
           Y   +D+WS G  + E+ +  + PY +    + +  I  G     P   S      +  C
Sbjct: 181 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 240
Query: 214 LQVNPNDRPTVTELM 228
            +  P DRP  + L+
Sbjct: 241 WKERPEDRPAFSRLL 255

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 85/195 (43%), Gaps = 8/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLVYLHER 97
            +VQ  G   ++  + +  E +  G L++    Q+   +   +      +  G+ YL E 
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 98  NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDG 154
            V+HRD+   N LV  +  +K++DFG+ +    +   S  GT F   W +PEV +     
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-- 178
Query: 155 YGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKC 213
           Y   +D+WS G  + E+ +  + PY +    + +  I  G     P   S      +  C
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238
Query: 214 LQVNPNDRPTVTELM 228
            +  P DRP  + L+
Sbjct: 239 WKERPEDRPAFSRLL 253

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/122 (36%), Positives = 71/122 (58%), Gaps = 9/122 (7%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 104 VYIVMELMD----ANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+GC + E
Sbjct: 160 KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGE 217
Query: 171 ML 172
           M+
Sbjct: 218 MI 219

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 50/224 (22%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +Y+ +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 142 VYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+GC + E
Sbjct: 198 KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGE 255
Query: 171 MLTRR---------------------PPYSHLEGVQALFRIGKGELPS---------VPS 200
           M+  +                     P    ++ +Q   R      P           P 
Sbjct: 256 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 315
Query: 201 SL-----------SRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           SL           +  ARD + K L ++P  R +V + ++HP++
Sbjct: 316 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 50/224 (22%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +Y+ +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 104 VYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+GC + E
Sbjct: 160 KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGE 217
Query: 171 MLTRR---------------------PPYSHLEGVQALFRIGKGELPS---------VPS 200
           M+  +                     P    ++ +Q   R      P           P 
Sbjct: 218 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 277
Query: 201 SL-----------SRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           SL           +  ARD + K L ++P  R +V + ++HP++
Sbjct: 278 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 50/224 (22%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +Y+ +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 103 VYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 158
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+GC + E
Sbjct: 159 KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGE 216
Query: 171 MLTRR---------------------PPYSHLEGVQALFRIGKGELPS---------VPS 200
           M+  +                     P    ++ +Q   R      P           P 
Sbjct: 217 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 276
Query: 201 SL-----------SRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           SL           +  ARD + K L ++P  R +V + ++HP++
Sbjct: 277 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 320

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 50/224 (22%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +Y+ +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 98  VYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 153
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+GC + E
Sbjct: 154 KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGE 211
Query: 171 MLTRR---------------------PPYSHLEGVQALFRIGKGELPS---------VPS 200
           M+  +                     P    ++ +Q   R      P           P 
Sbjct: 212 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 271
Query: 201 SL-----------SRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           SL           +  ARD + K L ++P  R +V + ++HP++
Sbjct: 272 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 50/224 (22%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +Y+ +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 105 VYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 160
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+GC + E
Sbjct: 161 KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGE 218
Query: 171 MLTRR---------------------PPYSHLEGVQALFRIGKGELPS---------VPS 200
           M+  +                     P    ++ +Q   R      P           P 
Sbjct: 219 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 278
Query: 201 SL-----------SRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           SL           +  ARD + K L ++P  R +V + ++HP++
Sbjct: 279 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 85/195 (43%), Gaps = 8/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLVYLHER 97
            +VQ  G   ++  + +  E +  G L++    Q+   +   +      +  G+ YL E 
Sbjct: 83  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 142
Query: 98  NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDG 154
            V+HRD+   N LV  +  +K++DFG+ +    +   S  GT F   W +PEV +     
Sbjct: 143 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-- 200
Query: 155 YGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKC 213
           Y   +D+WS G  + E+ +  + PY +    + +  I  G     P   S      +  C
Sbjct: 201 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 260
Query: 214 LQVNPNDRPTVTELM 228
            +  P DRP  + L+
Sbjct: 261 WKERPEDRPAFSRLL 275

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 50/224 (22%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +Y+ +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 105 VYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 160
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+GC + E
Sbjct: 161 KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGE 218
Query: 171 MLTRR---------------------PPYSHLEGVQALFRIGKGELPS---------VPS 200
           M+  +                     P    ++ +Q   R      P           P 
Sbjct: 219 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 278
Query: 201 SL-----------SRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           SL           +  ARD + K L ++P  R +V + ++HP++
Sbjct: 279 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 85/195 (43%), Gaps = 8/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLVYLHER 97
            +VQ  G   ++  + +  E +  G L++    Q+   +   +      +  G+ YL E 
Sbjct: 66  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 125
Query: 98  NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDG 154
            V+HRD+   N LV  +  +K++DFG+ +    +   S  GT F   W +PEV +     
Sbjct: 126 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-- 183
Query: 155 YGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKC 213
           Y   +D+WS G  + E+ +  + PY +    + +  I  G     P   S      +  C
Sbjct: 184 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 243
Query: 214 LQVNPNDRPTVTELM 228
            +  P DRP  + L+
Sbjct: 244 WRERPEDRPAFSRLL 258

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 50/224 (22%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +Y+ +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 98  VYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 153
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+GC + E
Sbjct: 154 KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGE 211
Query: 171 MLTRR---------------------PPYSHLEGVQALFRIGKGELPS---------VPS 200
           M+  +                     P    ++ +Q   R      P           P 
Sbjct: 212 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 271
Query: 201 SL-----------SRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           SL           +  ARD + K L ++P  R +V + ++HP++
Sbjct: 272 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/122 (36%), Positives = 71/122 (58%), Gaps = 9/122 (7%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 104 VYIVMELMD----ANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+GC + E
Sbjct: 160 KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGE 217
Query: 171 ML 172
           M+
Sbjct: 218 MI 219

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 7/152 (4%)
Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCK 137
           ++  QI  G+ YL +R +VHRD+   N+LV     VK+ DFGLAK     +     +  K
Sbjct: 131 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 190
Query: 138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELP 196
               WMA E +  +   Y   +D+WS G TV E++T    PY  +   +    + KGE  
Sbjct: 191 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 248
Query: 197 SVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
             P   + D    + KC  ++ + RP   EL+
Sbjct: 249 PQPPICTIDVYMIMRKCWMIDADSRPKFRELI 280

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 50/224 (22%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +Y+ +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 104 VYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+GC + E
Sbjct: 160 KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGE 217
Query: 171 MLTRR---------------------PPYSHLEGVQALFRIGKGELPS---------VPS 200
           M+  +                     P    ++ +Q   R      P           P 
Sbjct: 218 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 277
Query: 201 SL-----------SRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           SL           +  ARD + K L ++P  R +V + ++HP++
Sbjct: 278 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 50/224 (22%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +Y+ +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 97  VYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 152
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+GC + E
Sbjct: 153 KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGE 210
Query: 171 MLTRR---------------------PPYSHLEGVQALFRIGKGELPS---------VPS 200
           M+  +                     P    ++ +Q   R      P           P 
Sbjct: 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 270
Query: 201 SL-----------SRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           SL           +  ARD + K L ++P  R +V + ++HP++
Sbjct: 271 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 42/216 (19%)
Query: 56  IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HRD+K  N+L+D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEH 168
Query: 116 -SVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
             ++L D+GLA+        + +  + ++  PE++      Y  + D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIF 227
Query: 174 RRPPYSH-LEGVQALFRIGKG---------------EL-PSVPSSLSRDAR--------- 207
           R+ P+ H  +    L RI K                EL P     L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 208 -----------DFILKCLQVNPNDRPTVTELMEHPF 232
                      DF+ K L+ +   R T  E MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 68/129 (52%), Gaps = 23/129 (17%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSK--------NDGYGLTADIWS 163
            +  ++K+ DFGLA+           GT F M PEVV             GY    DIWS
Sbjct: 160 KSDCTLKILDFGLARTA---------GTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWS 210
Query: 164 LGCTVLEML 172
           +GC + EM+
Sbjct: 211 VGCIMGEMI 219

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 7/152 (4%)
Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCK 137
           ++  QI  G+ YL +R +VHRD+   N+LV     VK+ DFGLAK     +     +  K
Sbjct: 124 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELP 196
               WMA E +  +   Y   +D+WS G TV E++T    PY  +   +    + KGE  
Sbjct: 184 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 241
Query: 197 SVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
             P   + D    + KC  ++ + RP   EL+
Sbjct: 242 PQPPICTIDVYMIMRKCWMIDADSRPKFRELI 273

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 83/172 (48%), Gaps = 8/172 (4%)
Query: 73  YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA--SGSVKLADFGLAKATTM 130
           + L++ ++ SY  Q+   L +LH  N+ H DI+  NI+     S ++K+ +FG A+    
Sbjct: 97  FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156
Query: 131 ND-LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR 189
            D  +     P + APEV   ++D      D+WSLG  V  +L+   P+      Q +  
Sbjct: 157 GDNFRLLFTAPEYYAPEV--HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN 214
Query: 190 IGKGEL---PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQ 238
           I   E          +S +A DF+ + L      R T +E ++HP++K+ ++
Sbjct: 215 IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 7/163 (4%)
Query: 71  QKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM 130
            K ++    + ++  QI  G+ YL +R +VHRD+   N+LV     VK+ DFGLAK    
Sbjct: 110 HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
Query: 131 ND----LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQ 185
            +     +  K    WMA E +  +   Y   +D+WS G TV E++T    PY  +   +
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
Query: 186 ALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
               + KGE    P   + D    + KC  ++ + RP   EL+
Sbjct: 228 ISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 270

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 13/180 (7%)
Query: 54  LYIFLELVTKGSLANLYQKYH---LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           L+I +E   KG+L    +K     L          QI  G+ Y+H + ++HRD+K +NI 
Sbjct: 109 LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIF 168
Query: 111 VDASGSVKLADFGLAKATTMNDLKSC--KGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           +  +  VK+ DFGL   +  ND K    KGT  +M+PE ++S++  YG   D+++LG  +
Sbjct: 169 LVDTKQVKIGDFGLV-TSLKNDGKRTRSKGTLRYMSPEQISSQD--YGKEVDLYALGLIL 225
Query: 169 LEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
            E+L      +  E  +    +  G +  +     +  +  + K L   P DRP  +E++
Sbjct: 226 AELL--HVCDTAFETSKFFTDLRDGIISDI---FDKKEKTLLQKLLSKKPEDRPNTSEIL 280

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 64/231 (27%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKND--------GYGLTADIWS 163
            +  ++K+ DFGLA+           GT F M PEVV             GY    DIWS
Sbjct: 160 KSDCTLKILDFGLARTA---------GTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWS 210
Query: 164 LGCTVLEMLTRR---------------------PPYSHLEGVQALFRIGKGELPS----- 197
           +GC + EM+  +                     P  + ++ +Q   R      P      
Sbjct: 211 VGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNYVENRPKYAGYS 270
Query: 198 ----VPSSL-----------SRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
                P  L           +  ARD + K L ++ + R +V E ++HP++
Sbjct: 271 FEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 87/180 (48%), Gaps = 9/180 (5%)
Query: 56  IFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           + ++L+  G L +  +++  ++    + ++  QI  G+ YL +R +VHRD+   N+LV  
Sbjct: 95  LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 154
Query: 114 SGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVL 169
              VK+ DFG AK     +     +  K    WMA E +  +   Y   +D+WS G TV 
Sbjct: 155 PQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVW 212
Query: 170 EMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           E++T    PY  +   +    + KGE    P   + D    ++KC  ++ + RP   EL+
Sbjct: 213 ELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 36  FEQDNIVQYLGT-DKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLV 92
           F   N++  LG   + E    + L  +  G L N    + ++ +   +  +  Q+  G+ 
Sbjct: 87  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 146
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAK------ATTMNDLKSCKGTPFWMAPE 146
           YL  +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E
Sbjct: 147 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALE 206
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRD 205
            + ++   +   +D+WS G  + E++TR  PPY  +        + +G     P      
Sbjct: 207 SLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 264
Query: 206 ARDFILKCLQVNPNDRPTVTELM 228
             + +LKC       RP+ +EL+
Sbjct: 265 LYEVMLKCWHPKAEMRPSFSELV 287

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 87/180 (48%), Gaps = 9/180 (5%)
Query: 56  IFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           + ++L+  G L +  +++  ++    + ++  QI  G+ YL +R +VHRD+   N+LV  
Sbjct: 97  LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 156
Query: 114 SGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVL 169
              VK+ DFG AK     +     +  K    WMA E +  +   Y   +D+WS G TV 
Sbjct: 157 PQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVW 214
Query: 170 EMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           E++T    PY  +   +    + KGE    P   + D    ++KC  ++ + RP   EL+
Sbjct: 215 ELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 64/231 (27%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 112 DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKND--------GYGLTADIWS 163
            +  ++K+ DFGLA+           GT F M PEVV             GY    D+WS
Sbjct: 160 KSDCTLKILDFGLARTA---------GTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWS 210
Query: 164 LGCTVLEMLTRR---------------------PPYSHLEGVQALFRIGKGELPS----- 197
           +GC + EM+  +                     P    ++ +Q   R      P      
Sbjct: 211 VGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYS 270
Query: 198 ----VPSSL-----------SRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
                P  L           +  ARD + K L ++ + R +V E ++HP++
Sbjct: 271 FEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 42/216 (19%)
Query: 56  IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HRD+K  N+++D   
Sbjct: 109 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 166
Query: 116 -SVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
             ++L D+GLA+        + +  + ++  PE++      Y  + D+WSLGC +  M+ 
Sbjct: 167 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIF 225
Query: 174 RRPPYSH-LEGVQALFRIGKG---------------EL-PSVPSSLSRDAR--------- 207
           R+ P+ H  +    L RI K                EL P     L R +R         
Sbjct: 226 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 285
Query: 208 -----------DFILKCLQVNPNDRPTVTELMEHPF 232
                      DF+ K L+ +   R T  E MEHP+
Sbjct: 286 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 18/209 (8%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDS-----------QVSSYT 84
           F   ++V+ LG         + +EL+  G L +  +                  ++    
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT--TMNDLKSCKG-TPF 141
            +I +G+ YL+ +  VHRD+   N +V    +VK+ DFG+ +    T    K  KG  P 
Sbjct: 137 AEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPV 196
Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVP 199
            WMAPE +  K+  +  ++D+WS G  + E+ +    PY  L   Q L  +  G     P
Sbjct: 197 RWMAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 254
Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELM 228
            +      D +  C Q NP  RPT  E++
Sbjct: 255 DNCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 42/216 (19%)
Query: 56  IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HRD+K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 116 -SVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
             ++L D+GLA+        + +  + ++  PE++      Y  + D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIF 227
Query: 174 RRPPYSH-LEGVQALFRIGKG---------------EL-PSVPSSLSRDAR--------- 207
           R+ P+ H  +    L RI K                EL P     L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 208 -----------DFILKCLQVNPNDRPTVTELMEHPF 232
                      DF+ K L+ +   R T  E MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 42/216 (19%)
Query: 56  IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HRD+K  N+++D   
Sbjct: 110 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 167
Query: 116 -SVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
             ++L D+GLA+        + +  + ++  PE++      Y  + D+WSLGC +  M+ 
Sbjct: 168 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIF 226
Query: 174 RRPPYSH-LEGVQALFRIGKG---------------EL-PSVPSSLSRDAR--------- 207
           R+ P+ H  +    L RI K                EL P     L R +R         
Sbjct: 227 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 286
Query: 208 -----------DFILKCLQVNPNDRPTVTELMEHPF 232
                      DF+ K L+ +   R T  E MEHP+
Sbjct: 287 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 42/216 (19%)
Query: 56  IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HRD+K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 116 -SVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
             ++L D+GLA+        + +  + ++  PE++      Y  + D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIF 227
Query: 174 RRPPYSH-LEGVQALFRIGKG---------------EL-PSVPSSLSRDAR--------- 207
           R+ P+ H  +    L RI K                EL P     L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 208 -----------DFILKCLQVNPNDRPTVTELMEHPF 232
                      DF+ K L+ +   R T  E MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 42/216 (19%)
Query: 56  IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HRD+K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 116 -SVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
             ++L D+GLA+        + +  + ++  PE++      Y  + D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIF 227
Query: 174 RRPPYSH-LEGVQALFRIGKG---------------EL-PSVPSSLSRDAR--------- 207
           R+ P+ H  +    L RI K                EL P     L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 208 -----------DFILKCLQVNPNDRPTVTELMEHPF 232
                      DF+ K L+ +   R T  E MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 42/216 (19%)
Query: 56  IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HRD+K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 116 -SVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
             ++L D+GLA+        + +  + ++  PE++      Y  + D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIF 227
Query: 174 RRPPYSH-LEGVQALFRIGKG---------------EL-PSVPSSLSRDAR--------- 207
           R+ P+ H  +    L RI K                EL P     L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 208 -----------DFILKCLQVNPNDRPTVTELMEHPF 232
                      DF+ K L+ +   R T  E MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 42/216 (19%)
Query: 56  IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HRD+K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 116 -SVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
             ++L D+GLA+        + +  + ++  PE++      Y  + D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIF 227
Query: 174 RRPPYSH-LEGVQALFRIGKG---------------EL-PSVPSSLSRDAR--------- 207
           R+ P+ H  +    L RI K                EL P     L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 208 -----------DFILKCLQVNPNDRPTVTELMEHPF 232
                      DF+ K L+ +   R T  E MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 85/195 (43%), Gaps = 8/195 (4%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLVYLHER 97
            +VQ  G   ++  + +  E +  G L++    Q+   +   +      +  G+ YL E 
Sbjct: 64  KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 123
Query: 98  NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDG 154
            V+HRD+   N LV  +  +K++DFG+ +    +   S  GT F   W +PEV +     
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-- 181
Query: 155 YGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKC 213
           Y   +D+WS G  + E+ +  + PY +    + +  I  G     P   S      +  C
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 241
Query: 214 LQVNPNDRPTVTELM 228
            +  P DRP  + L+
Sbjct: 242 WRERPEDRPAFSRLL 256

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 42/216 (19%)
Query: 56  IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HRD+K  N+++D   
Sbjct: 110 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 167
Query: 116 -SVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
             ++L D+GLA+        + +  + ++  PE++      Y  + D+WSLGC +  M+ 
Sbjct: 168 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIF 226
Query: 174 RRPPYSH-LEGVQALFRIGKG---------------EL-PSVPSSLSRDAR--------- 207
           R+ P+ H  +    L RI K                EL P     L R +R         
Sbjct: 227 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 286
Query: 208 -----------DFILKCLQVNPNDRPTVTELMEHPF 232
                      DF+ K L+ +   R T  E MEHP+
Sbjct: 287 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 42/216 (19%)
Query: 56  IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HRD+K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 116 -SVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
             ++L D+GLA+        + +  + ++  PE++      Y  + D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIF 227
Query: 174 RRPPYSH-LEGVQALFRIGKG---------------EL-PSVPSSLSRDAR--------- 207
           R+ P+ H  +    L RI K                EL P     L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 208 -----------DFILKCLQVNPNDRPTVTELMEHPF 232
                      DF+ K L+ +   R T  E MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 36  FEQDNIVQYLGT-DKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLV 92
           F   N++  LG   + E    + L  +  G L N    + ++ +   +  +  Q+  G+ 
Sbjct: 80  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 139
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDLKSCKGTPFWMAPE 146
           YL  +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E
Sbjct: 140 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 199
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRD 205
            + ++   +   +D+WS G  + E++TR  PPY  +        + +G     P      
Sbjct: 200 SLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 257
Query: 206 ARDFILKCLQVNPNDRPTVTELM 228
             + +LKC       RP+ +EL+
Sbjct: 258 LYEVMLKCWHPKAEMRPSFSELV 280

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 42/216 (19%)
Query: 56  IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HRD+K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 116 -SVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
             ++L D+GLA+        + +  + ++  PE++      Y  + D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIF 227
Query: 174 RRPPYSH-LEGVQALFRIGKG---------------EL-PSVPSSLSRDAR--------- 207
           R+ P+ H  +    L RI K                EL P     L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 208 -----------DFILKCLQVNPNDRPTVTELMEHPF 232
                      DF+ K L+ +   R T  E MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 36  FEQDNIVQYLGT-DKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLV 92
           F   N++  LG   + E    + L  +  G L N    + ++ +   +  +  Q+  G+ 
Sbjct: 86  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 145
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDLKSCKGTPFWMAPE 146
           YL  +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E
Sbjct: 146 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 205
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRD 205
            + ++   +   +D+WS G  + E++TR  PPY  +        + +G     P      
Sbjct: 206 SLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 263
Query: 206 ARDFILKCLQVNPNDRPTVTELM 228
             + +LKC       RP+ +EL+
Sbjct: 264 LYEVMLKCWHPKAEMRPSFSELV 286

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 36  FEQDNIVQYLGT-DKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLV 92
           F   N++  LG   + E    + L  +  G L N    + ++ +   +  +  Q+  G+ 
Sbjct: 83  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 142
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDLKSCKGTPFWMAPE 146
           YL  +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E
Sbjct: 143 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRD 205
            + ++   +   +D+WS G  + E++TR  PPY  +        + +G     P      
Sbjct: 203 SLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 260
Query: 206 ARDFILKCLQVNPNDRPTVTELM 228
             + +LKC       RP+ +EL+
Sbjct: 261 LYEVMLKCWHPKAEMRPSFSELV 283

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 36  FEQDNIVQYLGT-DKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLV 92
           F   N++  LG   + E    + L  +  G L N    + ++ +   +  +  Q+  G+ 
Sbjct: 85  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDLKSCKGTPFWMAPE 146
           YL  +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E
Sbjct: 145 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 204
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRD 205
            + ++   +   +D+WS G  + E++TR  PPY  +        + +G     P      
Sbjct: 205 SLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 262
Query: 206 ARDFILKCLQVNPNDRPTVTELM 228
             + +LKC       RP+ +EL+
Sbjct: 263 LYEVMLKCWHPKAEMRPSFSELV 285

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 42/216 (19%)
Query: 56  IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HRD+K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 116 -SVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
             ++L D+GLA+        + +  + ++  PE++      Y  + D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIF 227
Query: 174 RRPPYSH-LEGVQALFRIGKG---------------EL-PSVPSSLSRDAR--------- 207
           R+ P+ H  +    L RI K                EL P     L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 208 -----------DFILKCLQVNPNDRPTVTELMEHPF 232
                      DF+ K L+ +   R T  E MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/122 (36%), Positives = 71/122 (58%), Gaps = 9/122 (7%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 104 VYIVMELMD----ANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+GC + E
Sbjct: 160 KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGE 217
Query: 171 ML 172
           M+
Sbjct: 218 MI 219

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 36  FEQDNIVQYLGT-DKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLV 92
           F   N++  LG   + E    + L  +  G L N    + ++ +   +  +  Q+  G+ 
Sbjct: 88  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 147
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDLKSCKGTPFWMAPE 146
           YL  +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E
Sbjct: 148 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRD 205
            + ++   +   +D+WS G  + E++TR  PPY  +        + +G     P      
Sbjct: 208 SLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 265
Query: 206 ARDFILKCLQVNPNDRPTVTELM 228
             + +LKC       RP+ +EL+
Sbjct: 266 LYEVMLKCWHPKAEMRPSFSELV 288

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 42/216 (19%)
Query: 56  IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HRD+K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 116 -SVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
             ++L D+GLA+        + +  + ++  PE++      Y  + D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIF 227
Query: 174 RRPPYSH-LEGVQALFRIGKG---------------EL-PSVPSSLSRDAR--------- 207
           R+ P+ H  +    L RI K                EL P     L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 208 -----------DFILKCLQVNPNDRPTVTELMEHPF 232
                      DF+ K L+ +   R T  E MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 42/216 (19%)
Query: 56  IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HRD+K  N+++D   
Sbjct: 116 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 173
Query: 116 -SVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
             ++L D+GLA+        + +  + ++  PE++      Y  + D+WSLGC +  M+ 
Sbjct: 174 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIF 232
Query: 174 RRPPYSH-LEGVQALFRIGKG---------------EL-PSVPSSLSRDAR--------- 207
           R+ P+ H  +    L RI K                EL P     L R +R         
Sbjct: 233 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 292
Query: 208 -----------DFILKCLQVNPNDRPTVTELMEHPF 232
                      DF+ K L+ +   R T  E MEHP+
Sbjct: 293 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 328

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 36  FEQDNIVQYLGT-DKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLV 92
           F   N++  LG   + E    + L  +  G L N    + ++ +   +  +  Q+  G+ 
Sbjct: 106 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 165
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDLKSCKGTPFWMAPE 146
           YL  +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E
Sbjct: 166 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 225
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRD 205
            + ++   +   +D+WS G  + E++TR  PPY  +        + +G     P      
Sbjct: 226 SLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 283
Query: 206 ARDFILKCLQVNPNDRPTVTELM 228
             + +LKC       RP+ +EL+
Sbjct: 284 LYEVMLKCWHPKAEMRPSFSELV 306

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 36  FEQDNIVQYLGT-DKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLV 92
           F   N++  LG   + E    + L  +  G L N    + ++ +   +  +  Q+  G+ 
Sbjct: 88  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 147
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDLKSCKGTPFWMAPE 146
           YL  +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E
Sbjct: 148 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRD 205
            + ++   +   +D+WS G  + E++TR  PPY  +        + +G     P      
Sbjct: 208 SLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 265
Query: 206 ARDFILKCLQVNPNDRPTVTELM 228
             + +LKC       RP+ +EL+
Sbjct: 266 LYEVMLKCWHPKAEMRPSFSELV 288

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 36  FEQDNIVQYLGT-DKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLV 92
           F   N++  LG   + E    + L  +  G L N    + ++ +   +  +  Q+  G+ 
Sbjct: 107 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 166
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDLKSCKGTPFWMAPE 146
           YL  +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E
Sbjct: 167 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 226
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRD 205
            + ++   +   +D+WS G  + E++TR  PPY  +        + +G     P      
Sbjct: 227 SLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 284
Query: 206 ARDFILKCLQVNPNDRPTVTELM 228
             + +LKC       RP+ +EL+
Sbjct: 285 LYEVMLKCWHPKAEMRPSFSELV 307

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 7/152 (4%)
Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCK 137
           ++  QI  G+ YL +R +VHRD+   N+LV     VK+ DFG AK     +     +  K
Sbjct: 121 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 180
Query: 138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELP 196
               WMA E +  +   Y   +D+WS G TV E++T    PY  +   +    + KGE  
Sbjct: 181 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238
Query: 197 SVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
             P   + D    ++KC  ++ + RP   EL+
Sbjct: 239 PQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 36  FEQDNIVQYLGT-DKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLV 92
           F   N++  LG   + E    + L  +  G L N    + ++ +   +  +  Q+  G+ 
Sbjct: 87  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 146
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDLKSCKGTPFWMAPE 146
           YL  +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E
Sbjct: 147 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 206
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRD 205
            + ++   +   +D+WS G  + E++TR  PPY  +        + +G     P      
Sbjct: 207 SLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 264
Query: 206 ARDFILKCLQVNPNDRPTVTELM 228
             + +LKC       RP+ +EL+
Sbjct: 265 LYEVMLKCWHPKAEMRPSFSELV 287

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 7/152 (4%)
Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCK 137
           ++  QI  G+ YL +R +VHRD+   N+LV     VK+ DFG AK     +     +  K
Sbjct: 128 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 187
Query: 138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELP 196
               WMA E +  +   Y   +D+WS G TV E++T    PY  +   +    + KGE  
Sbjct: 188 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 245
Query: 197 SVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
             P   + D    ++KC  ++ + RP   EL+
Sbjct: 246 PQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH------LSDSQVSS------- 82
           F+  NIV+ LG       + +  E +  G L    +         LS S +S+       
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 83  ------------YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM 130
                         RQ+  G+ YL ER  VHRD+   N LV  +  VK+ADFGL++    
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 131 NDLKSCKGT---PF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQ 185
            D     G    P  WM PE +      Y   +D+W+ G  + E+ +    PY  +   +
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284
Query: 186 ALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
            ++ +  G + + P +   +  + +  C    P DRP+   +  H  ++R
Sbjct: 285 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI--HRILQR 332

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/122 (36%), Positives = 71/122 (58%), Gaps = 9/122 (7%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+GC + E
Sbjct: 160 KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGE 217
Query: 171 ML 172
           M+
Sbjct: 218 MI 219

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/122 (36%), Positives = 71/122 (58%), Gaps = 9/122 (7%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 105 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 160
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+GC + E
Sbjct: 161 KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGE 218
Query: 171 ML 172
           M+
Sbjct: 219 MI 220

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/122 (36%), Positives = 71/122 (58%), Gaps = 9/122 (7%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+GC + E
Sbjct: 160 KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGE 217
Query: 171 ML 172
           M+
Sbjct: 218 MI 219

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 86/180 (47%), Gaps = 9/180 (5%)
Query: 56  IFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           + ++L+  G L +  +++  ++    + ++  QI  G+ YL +R +VHRD+   N+LV  
Sbjct: 95  LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 154
Query: 114 SGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVL 169
              VK+ DFG AK     +     +  K    WMA E +  +   Y   +D+WS G TV 
Sbjct: 155 PQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVW 212
Query: 170 EMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           E++T    PY  +   +    + KGE    P   + D    + KC  ++ + RP   EL+
Sbjct: 213 ELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 272

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/152 (34%), Positives = 72/152 (47%), Gaps = 15/152 (9%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYLHERN 98
            IV   G  ++   + IF+EL+  GSL  L ++   L + +   Y  Q L GL YLH R 
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR 170
Query: 99  VVHRDIKCANILVDASGS-VKLADF---------GLAKATTMNDLKSCKGTPFWMAPEVV 148
           ++H D+K  N+L+ + GS   L DF         GL K+    D     GT   MAPEVV
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY--IPGTETHMAPEVV 228
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSH 180
             K        DIWS  C +L ML    P++ 
Sbjct: 229 MGKP--CDAKVDIWSSCCMMLHMLNGCHPWTQ 258

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 72/151 (47%), Gaps = 15/151 (9%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYLHERN 98
            IV   G  ++   + IF+EL+  GSL  L ++   L + +   Y  Q L GL YLH R 
Sbjct: 127 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR 186
Query: 99  VVHRDIKCANILVDASGS-VKLADF---------GLAKATTMNDLKSCKGTPFWMAPEVV 148
           ++H D+K  N+L+ + GS   L DF         GL K+    D     GT   MAPEVV
Sbjct: 187 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY--IPGTETHMAPEVV 244
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPYS 179
             K        DIWS  C +L ML    P++
Sbjct: 245 MGKP--CDAKVDIWSSCCMMLHMLNGCHPWT 273

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 45/122 (36%), Positives = 71/122 (58%), Gaps = 9/122 (7%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 106 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 161
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+GC + E
Sbjct: 162 KSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGE 219
Query: 171 ML 172
           M+
Sbjct: 220 MI 221

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 50/224 (22%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 98  VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 153
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    D+WS+GC + E
Sbjct: 154 KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDLWSVGCIMGE 211
Query: 171 MLTRR---------------------PPYSHLEGVQALFRIGKGELPS---------VPS 200
           M+  +                     P    ++ +Q   R      P           P 
Sbjct: 212 MVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPD 271
Query: 201 SL-----------SRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
            L           +  ARD + K L ++ + R +V E ++HP++
Sbjct: 272 VLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 315

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/152 (34%), Positives = 72/152 (47%), Gaps = 15/152 (9%)
Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYLHERN 98
            IV   G  ++   + IF+EL+  GSL  L ++   L + +   Y  Q L GL YLH R 
Sbjct: 125 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR 184
Query: 99  VVHRDIKCANILVDASGS-VKLADF---------GLAKATTMNDLKSCKGTPFWMAPEVV 148
           ++H D+K  N+L+ + GS   L DF         GL K+    D     GT   MAPEVV
Sbjct: 185 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY--IPGTETHMAPEVV 242
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSH 180
             K        DIWS  C +L ML    P++ 
Sbjct: 243 MGKP--CDAKVDIWSSCCMMLHMLNGCHPWTQ 272

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 50/224 (22%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 109 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 164
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    D+WS+GC + E
Sbjct: 165 KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDLWSVGCIMGE 222
Query: 171 MLTRR---------------------PPYSHLEGVQALFRIGKGELPS---------VPS 200
           M+  +                     P    ++ +Q   R      P           P 
Sbjct: 223 MVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPD 282
Query: 201 SL-----------SRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
            L           +  ARD + K L ++ + R +V E ++HP++
Sbjct: 283 VLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 326

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 27/215 (12%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSLANL------------YQKYHLSDSQVSS-- 82
           + +NIV  LG       + +  E    G L N             Y   H  + Q+SS  
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRD 167
Query: 83  ---YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKS 135
              ++ Q+  G+ +L  +N +HRD+   N+L+      K+ DFGLA+   MND    +K 
Sbjct: 168 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMNDSNYIVKG 226
Query: 136 CKGTPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGK- 192
               P  WMAPE +   +  Y + +D+WS G  + E+ +    PY  +      +++ K 
Sbjct: 227 NARLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 284
Query: 193 GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
           G   + P+   ++    +  C  + P  RPT  ++
Sbjct: 285 GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 319

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 44/234 (18%)
Query: 40  NIVQYLGTDKD--ENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHER 97
           NI++ + T KD       +  E +       LYQ   L+D  +  Y  ++L  L Y H +
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQI--LTDFDIRFYMYELLKALDYCHSK 156
Query: 98  NVVHRDIKCANILVD-ASGSVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGY 155
            ++HRD+K  N+++D     ++L D+GLA+        + +  + ++  PE++      Y
Sbjct: 157 GIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQ-MY 215
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSH-LEGVQALFRIGK--------GELPSVPSSL---- 202
             + D+WSLGC +  M+ RR P+ H  +    L RI K        G L      L    
Sbjct: 216 DYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHF 275
Query: 203 ------------------------SRDARDFILKCLQVNPNDRPTVTELMEHPF 232
                                   S +A D + K L+ +   R T  E MEHP+
Sbjct: 276 NDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPY 329

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 44/234 (18%)
Query: 40  NIVQYLGTDKD--ENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHER 97
           NI++ + T KD       +  E +       LYQ   L+D  +  Y  ++L  L Y H +
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQI--LTDFDIRFYMYELLKALDYCHSK 151
Query: 98  NVVHRDIKCANILVD-ASGSVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGY 155
            ++HRD+K  N+++D     ++L D+GLA+        + +  + ++  PE++      Y
Sbjct: 152 GIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELL-VDYQMY 210
Query: 156 GLTADIWSLGCTVLEMLTRRPPYSH-LEGVQALFRIGK--------GELPSVPSSL---- 202
             + D+WSLGC +  M+ RR P+ H  +    L RI K        G L      L    
Sbjct: 211 DYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHF 270
Query: 203 ------------------------SRDARDFILKCLQVNPNDRPTVTELMEHPF 232
                                   S +A D + K L+ +   R T  E MEHP+
Sbjct: 271 NDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPY 324

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 38  QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLH 95
            +N+V ++G       L I   L    +L ++ +  K  L  ++     ++I+ G+ YLH
Sbjct: 88  HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 96  ERNVVHRDIKCANILVDASGSVKLADFGLAKATTM-------NDLKSCKGTPFWMAPEVV 148
            + ++H+D+K  N+  D +G V + DFGL   + +       + L+   G    +APE++
Sbjct: 148 AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 149 -----NSKNDG--YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPS- 200
                +++ D   +   +D+++LG    E+  R  P+        ++++G G  P++   
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQI 266
Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELME 229
            + ++  D +L C      +RPT T+LM+
Sbjct: 267 GMGKEISDILLFCWAFEQEERPTFTKLMD 295

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 70/148 (47%), Gaps = 7/148 (4%)
Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPF 141
           QI  G+ YL +R +VHRD+   N+LV     VK+ DFG AK     +     +  K    
Sbjct: 127 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPS 200
           WMA E +  +   Y   +D+WS G TV E++T    PY  +   +    + KGE    P 
Sbjct: 187 WMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 244
Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELM 228
             + D    + KC  ++ + RP   EL+
Sbjct: 245 ICTIDVYMIMRKCWMIDADSRPKFRELI 272

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 36  FEQDNIVQYLGT-DKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLV 92
           F   N++  LG   + E    + L  +  G L N    + ++ +   +  +  Q+  G+ 
Sbjct: 88  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 147
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDLKSCKGTPFWMAPE 146
           +L  +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E
Sbjct: 148 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRD 205
            + ++   +   +D+WS G  + E++TR  PPY  +        + +G     P      
Sbjct: 208 SLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 265
Query: 206 ARDFILKCLQVNPNDRPTVTELM 228
             + +LKC       RP+ +EL+
Sbjct: 266 LYEVMLKCWHPKAEMRPSFSELV 288

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 36  FEQDNIVQYLGT-DKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLV 92
           F   N++  LG   + E    + L  +  G L N    + ++ +   +  +  Q+  G+ 
Sbjct: 93  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 152
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDLKSCKGTPFWMAPE 146
           +L  +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E
Sbjct: 153 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 212
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRD 205
            + ++   +   +D+WS G  + E++TR  PPY  +        + +G     P      
Sbjct: 213 SLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 270
Query: 206 ARDFILKCLQVNPNDRPTVTELM 228
             + +LKC       RP+ +EL+
Sbjct: 271 LYEVMLKCWHPKAEMRPSFSELV 293

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVY 93
           F+  NI++  G       + I  E +  GSL +  +K+    +  Q+    R I +G+ Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT-----PF-WMAPEV 147
           L +   VHRD+   NIL++++   K++DFGLA+    +D ++   T     P  W +PE 
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLE-DDPEAAYTTRGGKIPIRWTSPEA 221
Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDA 206
           +  +   +   +D+WS G  + E+++    PY  +     +  + +G     P       
Sbjct: 222 IAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 279
Query: 207 RDFILKCLQVNPNDRPTVTELM 228
              +L C Q + N+RP   +++
Sbjct: 280 YQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 36  FEQDNIVQYLGT-DKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLV 92
           F   N++  LG   + E    + L  +  G L N    + ++ +   +  +  Q+  G+ 
Sbjct: 147 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 206
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDLKSCKGTPFWMAPE 146
           +L  +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E
Sbjct: 207 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRD 205
            + ++   +   +D+WS G  + E++TR  PPY  +        + +G     P      
Sbjct: 267 SLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 324
Query: 206 ARDFILKCLQVNPNDRPTVTELM 228
             + +LKC       RP+ +EL+
Sbjct: 325 LYEVMLKCWHPKAEMRPSFSELV 347

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 36  FEQDNIVQYLGT-DKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLV 92
           F   N++  LG   + E    + L  +  G L N    + ++ +   +  +  Q+  G+ 
Sbjct: 86  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 145
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDLKSCKGTPFWMAPE 146
           +L  +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E
Sbjct: 146 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 205
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRD 205
            + ++   +   +D+WS G  + E++TR  PPY  +        + +G     P      
Sbjct: 206 SLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 263
Query: 206 ARDFILKCLQVNPNDRPTVTELM 228
             + +LKC       RP+ +EL+
Sbjct: 264 LYEVMLKCWHPKAEMRPSFSELV 286

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 46  GTDKDENRLYIFLELV--TKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVH 101
           G  KDE  L + L+ V  T   +A  Y   K  L    V  Y  Q+   L Y+H   + H
Sbjct: 86  GEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 145
Query: 102 RDIKCANILVDASGSV-KLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTA 159
           RDIK  N+L+D   +V KL DFG AK     +   S   + ++ APE++    D Y  + 
Sbjct: 146 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATD-YTSSI 204
Query: 160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPN 219
           D+WS GC + E+L  +P +    GV  L  I K         L    R+ I    ++NPN
Sbjct: 205 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK--------VLGTPTREQI---REMNPN 253
Query: 220 -DRPTVTELMEHPFVK--RPLQTPRCGQANC 247
                  ++  HP+ K  RP +TP    A C
Sbjct: 254 YTEFAFPQIKAHPWTKVFRP-RTPPEAIALC 283

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 70/122 (57%), Gaps = 9/122 (7%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 104 VYIVMELMD----ANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVV 159
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+G  + E
Sbjct: 160 KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGVIMGE 217
Query: 171 ML 172
           M+
Sbjct: 218 MI 219

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 36  FEQDNIVQYLGT-DKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLV 92
           F   N++  LG   + E    + L  +  G L N    + ++ +   +  +  Q+  G+ 
Sbjct: 88  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 147
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDLKSCKGTPFWMAPE 146
           +L  +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E
Sbjct: 148 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRD 205
            + ++   +   +D+WS G  + E++TR  PPY  +        + +G     P      
Sbjct: 208 SLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 265
Query: 206 ARDFILKCLQVNPNDRPTVTELM 228
             + +LKC       RP+ +EL+
Sbjct: 266 LYEVMLKCWHPKAEMRPSFSELV 288

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 36  FEQDNIVQYLGT-DKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLV 92
           F   N++  LG   + E    + L  +  G L N    + ++ +   +  +  Q+  G+ 
Sbjct: 89  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 148
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDLKSCKGTPFWMAPE 146
           +L  +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E
Sbjct: 149 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALE 208
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRD 205
            + ++   +   +D+WS G  + E++TR  PPY  +        + +G     P      
Sbjct: 209 SLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 266
Query: 206 ARDFILKCLQVNPNDRPTVTELM 228
             + +LKC       RP+ +EL+
Sbjct: 267 LYEVMLKCWHPKAEMRPSFSELV 289

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 36  FEQDNIVQYLGT-DKDENRLYIFLELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLV 92
           F   N++  LG   + E    + L  +  G L N    + ++ +   +  +  Q+  G+ 
Sbjct: 89  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 148
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDLKSCKGTPFWMAPE 146
           +L  +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E
Sbjct: 149 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 208
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRD 205
            + ++   +   +D+WS G  + E++TR  PPY  +        + +G     P      
Sbjct: 209 SLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 266
Query: 206 ARDFILKCLQVNPNDRPTVTELM 228
             + +LKC       RP+ +EL+
Sbjct: 267 LYEVMLKCWHPKAEMRPSFSELV 289

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 70/122 (57%), Gaps = 9/122 (7%)
Query: 54  LYIFLELVTKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HRD+K +NI+V
Sbjct: 104 VYIVMELMD----ANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVV 159
Query: 112 DASGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +  ++K+ DFGLA+ A T   +     T ++ APEV+     GY    DIWS+G  + E
Sbjct: 160 KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGVIMGE 217
Query: 171 ML 172
           M+
Sbjct: 218 MI 219

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 74/153 (48%), Gaps = 7/153 (4%)
Query: 46  GTDKDENRLYIFLELV--TKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVH 101
           G  KDE  L + L+ V  T   +A  Y   K  L    V  Y  Q+   L Y+H   + H
Sbjct: 90  GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 149
Query: 102 RDIKCANILVDASGSV-KLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTA 159
           RDIK  N+L+D   +V KL DFG AK     +   S   + ++ APE++    D Y  + 
Sbjct: 150 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATD-YTSSI 208
Query: 160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
           D+WS GC + E+L  +P +    GV  L  I K
Sbjct: 209 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 241

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 46  GTDKDENRLYIFLELV--TKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVH 101
           G  KDE  L + L+ V  T   +A  Y   K  L    V  Y  Q+   L Y+H   + H
Sbjct: 86  GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 145
Query: 102 RDIKCANILVDASGSV-KLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTA 159
           RDIK  N+L+D   +V KL DFG AK     +   S   + ++ APE++    D Y  + 
Sbjct: 146 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD-YTSSI 204
Query: 160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPN 219
           D+WS GC + E+L  +P +    GV  L  I K         L    R+ I    ++NPN
Sbjct: 205 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK--------VLGTPTREQI---REMNPN 253
Query: 220 -DRPTVTELMEHPFVK--RPLQTPRCGQANC 247
                  ++  HP+ K  RP +TP    A C
Sbjct: 254 YTEFAFPQIKAHPWTKVFRP-RTPPEAIALC 283

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 74/153 (48%), Gaps = 7/153 (4%)
Query: 46  GTDKDENRLYIFLELV--TKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVH 101
           G  KDE  L + L+ V  T   +A  Y   K  L    V  Y  Q+   L Y+H   + H
Sbjct: 86  GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 145
Query: 102 RDIKCANILVDASGSV-KLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTA 159
           RDIK  N+L+D   +V KL DFG AK     +   S   + ++ APE++    D Y  + 
Sbjct: 146 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATD-YTSSI 204
Query: 160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
           D+WS GC + E+L  +P +    GV  L  I K
Sbjct: 205 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 74/153 (48%), Gaps = 7/153 (4%)
Query: 46  GTDKDENRLYIFLELV--TKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVH 101
           G  KDE  L + L+ V  T   +A  Y   K  L    V  Y  Q+   L Y+H   + H
Sbjct: 86  GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 145
Query: 102 RDIKCANILVDASGSV-KLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTA 159
           RDIK  N+L+D   +V KL DFG AK     +   S   + ++ APE++    D Y  + 
Sbjct: 146 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATD-YTSSI 204
Query: 160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
           D+WS GC + E+L  +P +    GV  L  I K
Sbjct: 205 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 77/160 (48%), Gaps = 7/160 (4%)
Query: 74  HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL 133
            L    + ++  QI  G+ YL +  +VHRD+   N+LV +   VK+ DFGLA+   +++ 
Sbjct: 115 RLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 174
Query: 134 K----SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALF 188
           +      K    WMA E +  +   +   +D+WS G TV E++T    PY  +   +   
Sbjct: 175 EYHADGGKVPIKWMALESILRRR--FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD 232
Query: 189 RIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
            + KGE    P   + D    ++KC  ++   RP   EL+
Sbjct: 233 LLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELV 272

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 74/153 (48%), Gaps = 7/153 (4%)
Query: 46  GTDKDENRLYIFLELV--TKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVH 101
           G  KDE  L + L+ V  T   +A  Y   K  L    V  Y  Q+   L Y+H   + H
Sbjct: 105 GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 164
Query: 102 RDIKCANILVDASGSV-KLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTA 159
           RDIK  N+L+D   +V KL DFG AK     +   S   + ++ APE++    D Y  + 
Sbjct: 165 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATD-YTSSI 223
Query: 160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
           D+WS GC + E+L  +P +    GV  L  I K
Sbjct: 224 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 256

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 74/153 (48%), Gaps = 7/153 (4%)
Query: 46  GTDKDENRLYIFLELV--TKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVH 101
           G  KDE  L + L+ V  T   +A  Y   K  L    V  Y  Q+   L Y+H   + H
Sbjct: 98  GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 157
Query: 102 RDIKCANILVDASGSV-KLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTA 159
           RDIK  N+L+D   +V KL DFG AK     +   S   + ++ APE++    D Y  + 
Sbjct: 158 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATD-YTSSI 216
Query: 160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
           D+WS GC + E+L  +P +    GV  L  I K
Sbjct: 217 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 249

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 74/153 (48%), Gaps = 7/153 (4%)
Query: 46  GTDKDENRLYIFLELV--TKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVH 101
           G  KDE  L + L+ V  T   +A  Y   K  L    V  Y  Q+   L Y+H   + H
Sbjct: 87  GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 146
Query: 102 RDIKCANILVDASGSV-KLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTA 159
           RDIK  N+L+D   +V KL DFG AK     +   S   + ++ APE++    D Y  + 
Sbjct: 147 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATD-YTSSI 205
Query: 160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
           D+WS GC + E+L  +P +    GV  L  I K
Sbjct: 206 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 238

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 74/153 (48%), Gaps = 7/153 (4%)
Query: 46  GTDKDENRLYIFLELV--TKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVH 101
           G  KDE  L + L+ V  T   +A  Y   K  L    V  Y  Q+   L Y+H   + H
Sbjct: 94  GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 153
Query: 102 RDIKCANILVDASGSV-KLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTA 159
           RDIK  N+L+D   +V KL DFG AK     +   S   + ++ APE++    D Y  + 
Sbjct: 154 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATD-YTSSI 212
Query: 160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
           D+WS GC + E+L  +P +    GV  L  I K
Sbjct: 213 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 245

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 74/153 (48%), Gaps = 7/153 (4%)
Query: 46  GTDKDENRLYIFLELV--TKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVH 101
           G  KDE  L + L+ V  T   +A  Y   K  L    V  Y  Q+   L Y+H   + H
Sbjct: 86  GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 145
Query: 102 RDIKCANILVDASGSV-KLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTA 159
           RDIK  N+L+D   +V KL DFG AK     +   S   + ++ APE++    D Y  + 
Sbjct: 146 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD-YTSSI 204
Query: 160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
           D+WS GC + E+L  +P +    GV  L  I K
Sbjct: 205 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 74/153 (48%), Gaps = 7/153 (4%)
Query: 46  GTDKDENRLYIFLELV--TKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVH 101
           G  KDE  L + L+ V  T   +A  Y   K  L    V  Y  Q+   L Y+H   + H
Sbjct: 86  GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 145
Query: 102 RDIKCANILVDASGSV-KLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTA 159
           RDIK  N+L+D   +V KL DFG AK     +   S   + ++ APE++    D Y  + 
Sbjct: 146 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD-YTSSI 204
Query: 160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
           D+WS GC + E+L  +P +    GV  L  I K
Sbjct: 205 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 74/153 (48%), Gaps = 7/153 (4%)
Query: 46  GTDKDENRLYIFLELV--TKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVH 101
           G  KDE  L + L+ V  T   +A  Y   K  L    V  Y  Q+   L Y+H   + H
Sbjct: 98  GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 157
Query: 102 RDIKCANILVDASGSV-KLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTA 159
           RDIK  N+L+D   +V KL DFG AK     +   S   + ++ APE++    D Y  + 
Sbjct: 158 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATD-YTSSI 216
Query: 160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
           D+WS GC + E+L  +P +    GV  L  I K
Sbjct: 217 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 249

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 80/159 (50%), Gaps = 9/159 (5%)
Query: 73  YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 132
           ++L    +  +   I  G+ YL  RN +HRD+   N ++    +V +ADFGL++     D
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 133 L--KSC--KGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQAL 187
              + C  K    W+A E +   ++ Y + +D+W+ G T+ E++TR + PY+ +E  +  
Sbjct: 192 YYRQGCASKLPVKWLALESL--ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249
Query: 188 -FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT 225
            + IG   L   P  +  +  D + +C   +P  RP+ T
Sbjct: 250 NYLIGGNRLKQPPECME-EVYDLMYQCWSADPKQRPSFT 287

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK----------YHLSDSQVSS---- 82
           + +NIV  LG       + +  E    G L N  ++          + +++S +S+    
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLL 167
Query: 83  -YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCK 137
            ++ Q+  G+ +L  +N +HRD+   N+L+      K+ DFGLA+   MND    +K   
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMNDSNYIVKGNA 226
Query: 138 GTPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-GE 194
             P  WMAPE +   +  Y + +D+WS G  + E+ +    PY  +      +++ K G 
Sbjct: 227 RLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY 284
Query: 195 LPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
             + P+   ++    +  C  + P  RPT  ++
Sbjct: 285 QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 74/153 (48%), Gaps = 7/153 (4%)
Query: 46  GTDKDENRLYIFLELV--TKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVH 101
           G  KDE  L + L+ V  T   +A  Y   K  L    V  Y  Q+   L Y+H   + H
Sbjct: 120 GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 179
Query: 102 RDIKCANILVDASGSV-KLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTA 159
           RDIK  N+L+D   +V KL DFG AK     +   S   + ++ APE++    D Y  + 
Sbjct: 180 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATD-YTSSI 238
Query: 160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
           D+WS GC + E+L  +P +    GV  L  I K
Sbjct: 239 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 271

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 74/153 (48%), Gaps = 7/153 (4%)
Query: 46  GTDKDENRLYIFLELV--TKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVH 101
           G  KDE  L + L+ V  T   +A  Y   K  L    V  Y  Q+   L Y+H   + H
Sbjct: 114 GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 173
Query: 102 RDIKCANILVDASGSV-KLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTA 159
           RDIK  N+L+D   +V KL DFG AK     +   S   + ++ APE++    D Y  + 
Sbjct: 174 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD-YTSSI 232
Query: 160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
           D+WS GC + E+L  +P +    GV  L  I K
Sbjct: 233 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 265

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 74/153 (48%), Gaps = 7/153 (4%)
Query: 46  GTDKDENRLYIFLELV--TKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVH 101
           G  KDE  L + L+ V  T   +A  Y   K  L    V  Y  Q+   L Y+H   + H
Sbjct: 99  GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 158
Query: 102 RDIKCANILVDASGSV-KLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTA 159
           RDIK  N+L+D   +V KL DFG AK     +   S   + ++ APE++    D Y  + 
Sbjct: 159 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD-YTSSI 217
Query: 160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
           D+WS GC + E+L  +P +    GV  L  I K
Sbjct: 218 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 250

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 88/180 (48%), Gaps = 13/180 (7%)
Query: 54  LYIFLELVTKGSLANLYQKYH---LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
           L+I +E   KG+L    +K     L          QI  G+ Y+H + +++RD+K +NI 
Sbjct: 95  LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIF 154
Query: 111 VDASGSVKLADFGLAKATTMNDLK--SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           +  +  VK+ DFGL   +  ND K    KGT  +M+PE ++S++  YG   D+++LG  +
Sbjct: 155 LVDTKQVKIGDFGLV-TSLKNDGKRXRSKGTLRYMSPEQISSQD--YGKEVDLYALGLIL 211
Query: 169 LEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
            E+L      +  E  +    +  G +  +     +  +  + K L   P DRP  +E++
Sbjct: 212 AELL--HVCDTAFETSKFFTDLRDGIISDI---FDKKEKTLLQKLLSKKPEDRPNTSEIL 266

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 74/153 (48%), Gaps = 7/153 (4%)
Query: 46  GTDKDENRLYIFLELV--TKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVH 101
           G  KDE  L + L+ V  T   +A  Y   K  L    V  Y  Q+   L Y+H   + H
Sbjct: 120 GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 179
Query: 102 RDIKCANILVDASGSV-KLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTA 159
           RDIK  N+L+D   +V KL DFG AK     +   S   + ++ APE++    D Y  + 
Sbjct: 180 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD-YTSSI 238
Query: 160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
           D+WS GC + E+L  +P +    GV  L  I K
Sbjct: 239 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 271

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 74/153 (48%), Gaps = 7/153 (4%)
Query: 46  GTDKDENRLYIFLELV--TKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVH 101
           G  KDE  L + L+ V  T   +A  Y   K  L    V  Y  Q+   L Y+H   + H
Sbjct: 122 GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 181
Query: 102 RDIKCANILVDASGSV-KLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTA 159
           RDIK  N+L+D   +V KL DFG AK     +   S   + ++ APE++    D Y  + 
Sbjct: 182 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD-YTSSI 240
Query: 160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
           D+WS GC + E+L  +P +    GV  L  I K
Sbjct: 241 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 273

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 74/153 (48%), Gaps = 7/153 (4%)
Query: 46  GTDKDENRLYIFLELV--TKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVH 101
           G  KDE  L + L+ V  T   +A  Y   K  L    V  Y  Q+   L Y+H   + H
Sbjct: 165 GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 224
Query: 102 RDIKCANILVDASGSV-KLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTA 159
           RDIK  N+L+D   +V KL DFG AK     +   S   + ++ APE++    D Y  + 
Sbjct: 225 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD-YTSSI 283
Query: 160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
           D+WS GC + E+L  +P +    GV  L  I K
Sbjct: 284 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 316

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 74/153 (48%), Gaps = 7/153 (4%)
Query: 46  GTDKDENRLYIFLELV--TKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVH 101
           G  KDE  L + L+ V  T   +A  Y   K  L    V  Y  Q+   L Y+H   + H
Sbjct: 91  GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 150
Query: 102 RDIKCANILVDASGSV-KLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTA 159
           RDIK  N+L+D   +V KL DFG AK     +   S   + ++ APE++    D Y  + 
Sbjct: 151 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD-YTSSI 209
Query: 160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
           D+WS GC + E+L  +P +    GV  L  I K
Sbjct: 210 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 242

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 89/214 (41%), Gaps = 25/214 (11%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDS----------------- 78
            +  +IV++ G   +   L +  E +  G L N + + H  D+                 
Sbjct: 71  LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPLGLG 129
Query: 79  QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKG 138
           Q+ +   Q+  G+VYL   + VHRD+   N LV     VK+ DFG+++     D     G
Sbjct: 130 QLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 189
Query: 139 TPF----WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKG 193
                  WM PE +  +   +   +D+WS G  + E+ T  + P+  L   +A+  I +G
Sbjct: 190 RTMLPIRWMPPESILYRK--FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 247
Query: 194 ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
                P +   +    +  C Q  P  R ++ ++
Sbjct: 248 RELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 281

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVY 93
           F+  NI++  G       + I  E +  GSL +  +K+    +  Q+    R I +G+ Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT-----PF-WMAPEV 147
           L +   VHRD+   NIL++++   K++DFGL++    +D ++   T     P  W +PE 
Sbjct: 163 LSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPEA 221
Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDA 206
           +  +   +   +D+WS G  + E+++    PY  +     +  + +G     P       
Sbjct: 222 IAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 279
Query: 207 RDFILKCLQVNPNDRPTVTELM 228
              +L C Q + N+RP   +++
Sbjct: 280 YQLMLDCWQKDRNNRPKFEQIV 301

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 74/153 (48%), Gaps = 7/153 (4%)
Query: 46  GTDKDENRLYIFLELV--TKGSLANLYQ--KYHLSDSQVSSYTRQILNGLVYLHERNVVH 101
           G  KDE  L + L+ V  T   +A  Y   K  L    V  Y  Q+   L Y+H   + H
Sbjct: 124 GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 183
Query: 102 RDIKCANILVDASGSV-KLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTA 159
           RDIK  N+L+D   +V KL DFG AK     +   S   + ++ APE++    D Y  + 
Sbjct: 184 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD-YTSSI 242
Query: 160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
           D+WS GC + E+L  +P +    GV  L  I K
Sbjct: 243 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 275

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 89/214 (41%), Gaps = 25/214 (11%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDS----------------- 78
            +  +IV++ G   +   L +  E +  G L N + + H  D+                 
Sbjct: 77  LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPLGLG 135
Query: 79  QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKG 138
           Q+ +   Q+  G+VYL   + VHRD+   N LV     VK+ DFG+++     D     G
Sbjct: 136 QLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 195
Query: 139 TPF----WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKG 193
                  WM PE +  +   +   +D+WS G  + E+ T  + P+  L   +A+  I +G
Sbjct: 196 RTMLPIRWMPPESILYRK--FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 253
Query: 194 ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
                P +   +    +  C Q  P  R ++ ++
Sbjct: 254 RELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 287

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK----------YHLSDSQVSS---- 82
           + +NIV  LG       + +  E    G L N  ++          + +++S  S+    
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 83  -YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCK 137
            ++ Q+  G+ +L  +N +HRD+   N+L+      K+ DFGLA+   MND    +K   
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMNDSNYIVKGNA 226
Query: 138 GTPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-GE 194
             P  WMAPE +   +  Y + +D+WS G  + E+ +    PY  +      +++ K G 
Sbjct: 227 RLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY 284
Query: 195 LPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
             + P+   ++    +  C  + P  RPT  ++
Sbjct: 285 QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 89/214 (41%), Gaps = 25/214 (11%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDS----------------- 78
            +  +IV++ G   +   L +  E +  G L N + + H  D+                 
Sbjct: 100 LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPLGLG 158
Query: 79  QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKG 138
           Q+ +   Q+  G+VYL   + VHRD+   N LV     VK+ DFG+++     D     G
Sbjct: 159 QLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 218
Query: 139 TPF----WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKG 193
                  WM PE +  +   +   +D+WS G  + E+ T  + P+  L   +A+  I +G
Sbjct: 219 RTMLPIRWMPPESILYRK--FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276
Query: 194 ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
                P +   +    +  C Q  P  R ++ ++
Sbjct: 277 RELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 310

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVY 93
           F+  NI++  G       + I  E +  GSL +  +K+    +  Q+    R I +G+ Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT-----PF-WMAPEV 147
           L +   VHRD+   NIL++++   K++DFGL++    +D ++   T     P  W +PE 
Sbjct: 163 LSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPEA 221
Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDA 206
           +  +   +   +D+WS G  + E+++    PY  +     +  + +G     P       
Sbjct: 222 IAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 279
Query: 207 RDFILKCLQVNPNDRPTVTELM 228
              +L C Q + N+RP   +++
Sbjct: 280 YQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVY 93
           F+  NI++  G       + I  E +  GSL +  +K+    +  Q+    R I +G+ Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT-----PF-WMAPEV 147
           L +   VHRD+   NIL++++   K++DFGL++    +D ++   T     P  W +PE 
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPEA 221
Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDA 206
           +  +   +   +D+WS G  + E+++    PY  +     +  + +G     P       
Sbjct: 222 IAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 279
Query: 207 RDFILKCLQVNPNDRPTVTELM 228
              +L C Q + N+RP   +++
Sbjct: 280 YQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 77/150 (51%), Gaps = 15/150 (10%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSLAN----LYQKYHLSDSQVSSYTRQILNGLV 92
           + +N+V+ LG   D + L +    +  GSL +    L     LS        +   NG+ 
Sbjct: 88  QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGIN 147
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDLKSCKGTPFWMAPE 146
           +LHE + +HRDIK ANIL+D + + K++DFGLA+A      T M       GT  +MAPE
Sbjct: 148 FLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMX--SRIVGTTAYMAPE 205
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLTRRP 176
            +  +       +DI+S G  +LE++T  P
Sbjct: 206 ALRGE---ITPKSDIYSFGVVLLEIITGLP 232

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 104/237 (43%), Gaps = 44/237 (18%)
Query: 40  NIVQYLGTDKDENRLY--IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHER 97
           NIV+ L   +D++     +  E V       LY    L+D  +  Y  ++L  L Y H +
Sbjct: 108 NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ 165
Query: 98  NVVHRDIKCANILVDAS-GSVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGY 155
            ++HRD+K  N+++D     ++L D+GLA+        + +  + ++  PE++    D Y
Sbjct: 166 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-Y 224
Query: 156 GLTADIWSLGCTVLEMLTRRPP--YSH--------------LEGVQALFRIGKGEL-PSV 198
             + D+WSLGC    M+ R+ P  Y H               +G+ A     + EL P +
Sbjct: 225 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRIELDPQL 284
Query: 199 PSSLSRDAR--------------------DFILKCLQVNPNDRPTVTELMEHPFVKR 235
            + + R +R                    DF+ K L+ +  +R T  E M HP+ ++
Sbjct: 285 EALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 341

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 77/150 (51%), Gaps = 15/150 (10%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSLAN----LYQKYHLSDSQVSSYTRQILNGLV 92
           + +N+V+ LG   D + L +    +  GSL +    L     LS        +   NG+ 
Sbjct: 88  QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGIN 147
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDLKSCKGTPFWMAPE 146
           +LHE + +HRDIK ANIL+D + + K++DFGLA+A      T M       GT  +MAPE
Sbjct: 148 FLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMX--XRIVGTTAYMAPE 205
Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLTRRP 176
            +  +       +DI+S G  +LE++T  P
Sbjct: 206 ALRGE---ITPKSDIYSFGVVLLEIITGLP 232

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVY 93
           F+  NI++  G       + I  E +  GSL +  +K+    +  Q+    R I +G+ Y
Sbjct: 101 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 160
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT-----PF-WMAPEV 147
           L +   VHRD+   NIL++++   K++DFGL++    +D ++   T     P  W +PE 
Sbjct: 161 LSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPEA 219
Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDA 206
           +  +   +   +D+WS G  + E+++    PY  +     +  + +G     P       
Sbjct: 220 IAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 277
Query: 207 RDFILKCLQVNPNDRPTVTELM 228
              +L C Q + N+RP   +++
Sbjct: 278 YQLMLDCWQKDRNNRPKFEQIV 299

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 12/202 (5%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVY 93
           F   NI++  G       + I  E +  G+L    ++     S  Q+    R I  G+ Y
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 162
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT-----PF-WMAPEV 147
           L   N VHRD+   NILV+++   K++DFGL++    +D ++   T     P  W APE 
Sbjct: 163 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGGKIPIRWTAPEA 221
Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDA 206
           ++ +   +   +D+WS G  + E++T    PY  L   + +  I  G     P       
Sbjct: 222 ISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI 279
Query: 207 RDFILKCLQVNPNDRPTVTELM 228
              +++C Q     RP   +++
Sbjct: 280 YQLMMQCWQQERARRPKFADIV 301

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVY 93
           F+  NI++  G       + I  E +  GSL +  +K+    +  Q+    R I +G+ Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT-----PF-WMAPEV 147
           L +   VHRD+   NIL++++   K++DFGL++    +D ++   T     P  W +PE 
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPEA 221
Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDA 206
           +  +   +   +D+WS G  + E+++    PY  +     +  + +G     P       
Sbjct: 222 IAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 279
Query: 207 RDFILKCLQVNPNDRPTVTELM 228
              +L C Q + N+RP   +++
Sbjct: 280 YQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVY 93
           F+  NI++  G       + I  E +  GSL +  +K+    +  Q+    R I +G+ Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT-----PF-WMAPEV 147
           L +   VHRD+   NIL++++   K++DFGL++    +D ++   T     P  W +PE 
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPEA 221
Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDA 206
           +  +   +   +D+WS G  + E+++    PY  +     +  + +G     P       
Sbjct: 222 IAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 279
Query: 207 RDFILKCLQVNPNDRPTVTELM 228
              +L C Q + N+RP   +++
Sbjct: 280 YQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVY 93
           F+  NI++  G       + I  E +  GSL +  +K+    +  Q+    R I +G+ Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT-----PF-WMAPEV 147
           L +   VHRD+   NIL++++   K++DFGL++    +D ++   T     P  W +PE 
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPEA 221
Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDA 206
           +  +   +   +D+WS G  + E+++    PY  +     +  + +G     P       
Sbjct: 222 IAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 279
Query: 207 RDFILKCLQVNPNDRPTVTELM 228
              +L C Q + N+RP   +++
Sbjct: 280 YQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVY 93
           F+  NI++  G       + I  E +  GSL +  +K+    +  Q+    R I +G+ Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT-----PF-WMAPEV 147
           L +   VHRD+   NIL++++   K++DFGL++    +D ++   T     P  W +PE 
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPEA 221
Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDA 206
           +  +   +   +D+WS G  + E+++    PY  +     +  + +G     P       
Sbjct: 222 IAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 279
Query: 207 RDFILKCLQVNPNDRPTVTELM 228
              +L C Q + N+RP   +++
Sbjct: 280 YQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVY 93
           F+  NI++  G       + I  E +  GSL +  +K+    +  Q+    R I +G+ Y
Sbjct: 91  FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 150
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT-----PF-WMAPEV 147
           L +   VHRD+   NIL++++   K++DFGL++    +D ++   T     P  W +PE 
Sbjct: 151 LSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPEA 209
Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDA 206
           +  +   +   +D+WS G  + E+++    PY  +     +  + +G     P       
Sbjct: 210 IAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 267
Query: 207 RDFILKCLQVNPNDRPTVTELM 228
              +L C Q + N+RP   +++
Sbjct: 268 YQLMLDCWQKDRNNRPKFEQIV 289

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 93/202 (46%), Gaps = 12/202 (5%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVY 93
           F+  NI++  G       + I  E +  GSL +  +K+    +  Q+    R I +G+ Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT-----PF-WMAPEV 147
           L +   VHRD+   NIL++++   K++DFGL +    +D ++   T     P  W +PE 
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE-DDPEAAYTTRGGKIPIRWTSPEA 221
Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDA 206
           +  +   +   +D+WS G  + E+++    PY  +     +  + +G     P       
Sbjct: 222 IAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 279
Query: 207 RDFILKCLQVNPNDRPTVTELM 228
              +L C Q + N+RP   +++
Sbjct: 280 YQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVY 93
           F+  NI++  G       + I  E +  GSL +  +K+    +  Q+    R I +G+ Y
Sbjct: 74  FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT-----PF-WMAPEV 147
           L +   VHRD+   NIL++++   K++DFGL++    +D ++   T     P  W +PE 
Sbjct: 134 LSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPEA 192
Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDA 206
           +  +   +   +D+WS G  + E+++    PY  +     +  + +G     P       
Sbjct: 193 IAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 250
Query: 207 RDFILKCLQVNPNDRPTVTELM 228
              +L C Q + N+RP   +++
Sbjct: 251 YQLMLDCWQKDRNNRPKFEQIV 272

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 83/169 (49%), Gaps = 10/169 (5%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 132
           L+   + S+  QI  G+ YL E ++VHRD+   NILV     +K++DFGL++     D  
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 133 LKSCKG-TPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP-PYSHLEGVQALFR 189
           +K  +G  P  WMA E +   +  Y   +D+WS G  + E++T    PY  +   +    
Sbjct: 207 VKRSQGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL 264
Query: 190 IGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL---MEHPFVKR 235
           +  G     P + S +    +L+C +  P+ RP   ++   +E   VKR
Sbjct: 265 LKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 90/216 (41%), Gaps = 42/216 (19%)
Query: 56  IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
           +  E V       L Q   L+D  +  Y  +IL  L Y H   ++HRD+K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLRQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 116 -SVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
             ++L D+GLA+        + +  + ++  PE++      Y  + D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIF 227
Query: 174 RRPPYSH-LEGVQALFRIGKG---------------EL-PSVPSSLSRDAR--------- 207
           R+ P+ H  +    L RI K                EL P     L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 208 -----------DFILKCLQVNPNDRPTVTELMEHPF 232
                      DF+ K L+ +   R T  E MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 82/169 (48%), Gaps = 10/169 (5%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 132
           L+   + S+  QI  G+ YL E  +VHRD+   NILV     +K++DFGL++     D  
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 133 LKSCKG-TPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP-PYSHLEGVQALFR 189
           +K  +G  P  WMA E +   +  Y   +D+WS G  + E++T    PY  +   +    
Sbjct: 207 VKRSQGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL 264
Query: 190 IGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL---MEHPFVKR 235
           +  G     P + S +    +L+C +  P+ RP   ++   +E   VKR
Sbjct: 265 LKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 6/161 (3%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLH 95
            +  NI++        +RL++  E         + +   +S   + S+  Q++NG+ + H
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 96  ERNVVHRDIKCANILVDASGS-----VKLADFGLAKATTMNDLK-SCKGTPFWMAPEVVN 149
            R  +HRD+K  N+L+  S +     +K+ DFGLA+A  +   + + +    W  P  + 
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL 209
Query: 150 SKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI 190
             +  Y  + DIWS+ C   EML + P +     +  LF+I
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI 250

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 82/169 (48%), Gaps = 10/169 (5%)
Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 132
           L+   + S+  QI  G+ YL E  +VHRD+   NILV     +K++DFGL++     D  
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 133 LKSCKG-TPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP-PYSHLEGVQALFR 189
           +K  +G  P  WMA E +   +  Y   +D+WS G  + E++T    PY  +   +    
Sbjct: 207 VKRSQGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL 264
Query: 190 IGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL---MEHPFVKR 235
           +  G     P + S +    +L+C +  P+ RP   ++   +E   VKR
Sbjct: 265 LKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVY 93
           F+  NI++  G       + I  E +  GSL +  +K+    +  Q+    R I +G+ Y
Sbjct: 74  FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT-----PF-WMAPEV 147
           L +   VHRD+   NIL++++   K++DFGL++    +D ++   T     P  W +PE 
Sbjct: 134 LSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPEA 192
Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDA 206
           +  +   +   +D+WS G  + E+++    PY  +     +  + +G     P       
Sbjct: 193 IAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 250
Query: 207 RDFILKCLQVNPNDRPTVTELM 228
              +L C Q + N+RP   +++
Sbjct: 251 YQLMLDCWQKDRNNRPKFEQIV 272

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD-----------SQVSSYTR 85
           + +NIV  LG       + +  E    G L N  ++   +D             +  ++ 
Sbjct: 100 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 159
Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPF 141
           Q+  G+ +L  +N +HRD+   N+L+      K+ DFGLA+   MND    +K     P 
Sbjct: 160 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMNDSNYIVKGNARLPV 218
Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-GELPSV 198
            WMAPE +   +  Y + +D+WS G  + E+ +    PY  +      +++ K G   + 
Sbjct: 219 KWMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ 276
Query: 199 PSSLSRDARDFILKCLQVNPNDRPTVTEL 227
           P+   ++    +  C  + P  RPT  ++
Sbjct: 277 PAFAPKNIYSIMQACWALEPTHRPTFQQI 305

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 81/210 (38%), Gaps = 18/210 (8%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYT--------RQI 87
           F   NIV+ +G        +I LEL+  G L +  ++     SQ SS          R I
Sbjct: 82  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 141
Query: 88  LNGLVYLHERNVVHRDIKCANILVDASGS---VKLADFGLAK---ATTMNDLKSCKGTPF 141
             G  YL E + +HRDI   N L+   G     K+ DFG+A+     +      C   P 
Sbjct: 142 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 201
Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVP 199
            WM PE        +    D WS G  + E+ +    PY      + L  +  G     P
Sbjct: 202 KWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 259
Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELME 229
            +        + +C Q  P DRP    ++E
Sbjct: 260 KNCPGPVYRIMTQCWQHQPEDRPNFAIILE 289

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 76/148 (51%), Gaps = 11/148 (7%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSLAN----LYQKYHLSDSQVSSYTRQILNGLV 92
           + +N+V+ LG   D + L +    +  GSL +    L     LS        +   NG+ 
Sbjct: 82  QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGIN 141
Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVV 148
           +LHE + +HRDIK ANIL+D + + K++DFGLA+A+             GT  +MAPE +
Sbjct: 142 FLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL 201
Query: 149 NSKNDGYGLTADIWSLGCTVLEMLTRRP 176
             +       +DI+S G  +LE++T  P
Sbjct: 202 RGE---ITPKSDIYSFGVVLLEIITGLP 226

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 89/202 (44%), Gaps = 12/202 (5%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVY 93
           F+  N+V   G       + I +E +  G+L    +K+    +  Q+    R I  G+ Y
Sbjct: 101 FDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRY 160
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTP------FWMAPEV 147
           L +   VHRD+   NILV+++   K++DFGL++    +D ++   T        W APE 
Sbjct: 161 LADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIE-DDPEAVYTTTGGKIPVRWTAPEA 219
Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDA 206
           +  +   +   +D+WS G  + E+++    PY  +     +  I +G     P       
Sbjct: 220 IQYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPAPMDCPAGL 277
Query: 207 RDFILKCLQVNPNDRPTVTELM 228
              +L C Q    +RP   +++
Sbjct: 278 HQLMLDCWQKERAERPKFEQIV 299

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 37  EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSD-----------SQVSSYTR 85
           + +NIV  LG       + +  E    G L N  ++   +D             +  ++ 
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 167
Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPF 141
           Q+  G+ +L  +N +HRD+   N+L+      K+ DFGLA+   MND    +K     P 
Sbjct: 168 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMNDSNYIVKGNARLPV 226
Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGK-GELPSV 198
            WMAPE +   +  Y + +D+WS G  + E+ +    PY  +      +++ K G   + 
Sbjct: 227 KWMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ 284
Query: 199 PSSLSRDARDFILKCLQVNPNDRPTVTEL 227
           P+   ++    +  C  + P  RPT  ++
Sbjct: 285 PAFAPKNIYSIMQACWALEPTHRPTFQQI 313

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 81/210 (38%), Gaps = 18/210 (8%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYT--------RQI 87
           F   NIV+ +G        +I LEL+  G L +  ++     SQ SS          R I
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 88  LNGLVYLHERNVVHRDIKCANILVDASGS---VKLADFGLAK---ATTMNDLKSCKGTPF 141
             G  YL E + +HRDI   N L+   G     K+ DFG+A+     +      C   P 
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVP 199
            WM PE        +    D WS G  + E+ +    PY      + L  +  G     P
Sbjct: 210 KWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 267
Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELME 229
            +        + +C Q  P DRP    ++E
Sbjct: 268 KNCPGPVYRIMTQCWQHQPEDRPNFAIILE 297

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 78/165 (47%), Gaps = 13/165 (7%)
Query: 40  NIVQ--YLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQ-------VSSYTRQILN 89
           NIV+  Y      E +  ++L LV       +Y+   H S ++       V  Y  Q+  
Sbjct: 74  NIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 90  GLVYLHERNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDLK-SCKGTPFWMAPEV 147
            L Y+H   + HRDIK  N+L+D   +V KL DFG AK     +   S   + ++ APE+
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 193
Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK 192
           +    D Y  + D+WS GC + E+L  +P +    GV  L  I K
Sbjct: 194 IFGATD-YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 71/142 (50%), Gaps = 12/142 (8%)
Query: 44  YLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRD 103
           +L  D  E+ L+  ++   + S AN  +   L    V S   QIL+G+ YLH   V+HRD
Sbjct: 96  WLLFDYAEHDLWHIIKF-HRASKAN-KKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRD 153
Query: 104 IKCANILV----DASGSVKLADFGLAK-----ATTMNDLKSCKGTPFWMAPEVVNSKNDG 154
           +K ANILV       G VK+AD G A+        + DL     T ++ APE++      
Sbjct: 154 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARH- 212
Query: 155 YGLTADIWSLGCTVLEMLTRRP 176
           Y    DIW++GC   E+LT  P
Sbjct: 213 YTKAIDIWAIGCIFAELLTSEP 234

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 81/210 (38%), Gaps = 18/210 (8%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYT--------RQI 87
           F   NIV+ +G        +I LEL+  G L +  ++     SQ SS          R I
Sbjct: 105 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 88  LNGLVYLHERNVVHRDIKCANILVDASGS---VKLADFGLAK---ATTMNDLKSCKGTPF 141
             G  YL E + +HRDI   N L+   G     K+ DFG+A+     +      C   P 
Sbjct: 165 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 224
Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVP 199
            WM PE        +    D WS G  + E+ +    PY      + L  +  G     P
Sbjct: 225 KWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 282
Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELME 229
            +        + +C Q  P DRP    ++E
Sbjct: 283 KNCPGPVYRIMTQCWQHQPEDRPNFAIILE 312

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 81/210 (38%), Gaps = 18/210 (8%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYT--------RQI 87
           F   NIV+ +G        +I LEL+  G L +  ++     SQ SS          R I
Sbjct: 91  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 88  LNGLVYLHERNVVHRDIKCANILVDASGS---VKLADFGLAK---ATTMNDLKSCKGTPF 141
             G  YL E + +HRDI   N L+   G     K+ DFG+A+     +      C   P 
Sbjct: 151 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 210
Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVP 199
            WM PE        +    D WS G  + E+ +    PY      + L  +  G     P
Sbjct: 211 KWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 268
Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELME 229
            +        + +C Q  P DRP    ++E
Sbjct: 269 KNCPGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 103/237 (43%), Gaps = 44/237 (18%)
Query: 40  NIVQYLGTDKDENRLY--IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHER 97
           NIV+ L   +D++     +  E V       LY    L+D  +  Y  ++L  L Y H +
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ 144
Query: 98  NVVHRDIKCANILVDAS-GSVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGY 155
            ++HRD+K  N+++D     ++L D+GLA+        + +  + ++  PE++    D Y
Sbjct: 145 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-Y 203
Query: 156 GLTADIWSLGCTVLEMLTRRPP--YSH--------------LEGVQALFRIGKGEL-PSV 198
             + D+WSLGC    M+ R+ P  Y H               +G+       + EL P +
Sbjct: 204 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQL 263
Query: 199 PSSLSRDAR--------------------DFILKCLQVNPNDRPTVTELMEHPFVKR 235
            + + R +R                    DF+ K L+ +  +R T  E M HP+ ++
Sbjct: 264 EALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 103/237 (43%), Gaps = 44/237 (18%)
Query: 40  NIVQYLGTDKDENRLY--IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHER 97
           NIV+ L   +D++     +  E V       LY    L+D  +  Y  ++L  L Y H +
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ 144
Query: 98  NVVHRDIKCANILVDAS-GSVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGY 155
            ++HRD+K  N+++D     ++L D+GLA+        + +  + ++  PE++    D Y
Sbjct: 145 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-Y 203
Query: 156 GLTADIWSLGCTVLEMLTRRPP--YSH--------------LEGVQALFRIGKGEL-PSV 198
             + D+WSLGC    M+ R+ P  Y H               +G+       + EL P +
Sbjct: 204 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQL 263
Query: 199 PSSLSRDAR--------------------DFILKCLQVNPNDRPTVTELMEHPFVKR 235
            + + R +R                    DF+ K L+ +  +R T  E M HP+ ++
Sbjct: 264 EALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 103/237 (43%), Gaps = 44/237 (18%)
Query: 40  NIVQYLGTDKDENRLY--IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHER 97
           NIV+ L   +D++     +  E V       LY    L+D  +  Y  ++L  L Y H +
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ 144
Query: 98  NVVHRDIKCANILVDAS-GSVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGY 155
            ++HRD+K  N+++D     ++L D+GLA+        + +  + ++  PE++    D Y
Sbjct: 145 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-Y 203
Query: 156 GLTADIWSLGCTVLEMLTRRPP--YSH--------------LEGVQALFRIGKGEL-PSV 198
             + D+WSLGC    M+ R+ P  Y H               +G+       + EL P +
Sbjct: 204 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQL 263
Query: 199 PSSLSRDAR--------------------DFILKCLQVNPNDRPTVTELMEHPFVKR 235
            + + R +R                    DF+ K L+ +  +R T  E M HP+ ++
Sbjct: 264 EALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 103/237 (43%), Gaps = 44/237 (18%)
Query: 40  NIVQYLGTDKDENRLY--IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHER 97
           NIV+ L   +D++     +  E V       LY    L+D  +  Y  ++L  L Y H +
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ 144
Query: 98  NVVHRDIKCANILVDAS-GSVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGY 155
            ++HRD+K  N+++D     ++L D+GLA+        + +  + ++  PE++    D Y
Sbjct: 145 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-Y 203
Query: 156 GLTADIWSLGCTVLEMLTRRPP--YSH--------------LEGVQALFRIGKGEL-PSV 198
             + D+WSLGC    M+ R+ P  Y H               +G+       + EL P +
Sbjct: 204 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQL 263
Query: 199 PSSLSRDAR--------------------DFILKCLQVNPNDRPTVTELMEHPFVKR 235
            + + R +R                    DF+ K L+ +  +R T  E M HP+ ++
Sbjct: 264 EALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 103/237 (43%), Gaps = 44/237 (18%)
Query: 40  NIVQYLGTDKDENRLY--IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHER 97
           NIV+ L   +D++     +  E V       LY    L+D  +  Y  ++L  L Y H +
Sbjct: 89  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ 146
Query: 98  NVVHRDIKCANILVDAS-GSVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGY 155
            ++HRD+K  N+++D     ++L D+GLA+        + +  + ++  PE++    D Y
Sbjct: 147 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-Y 205
Query: 156 GLTADIWSLGCTVLEMLTRRPP--YSH--------------LEGVQALFRIGKGEL-PSV 198
             + D+WSLGC    M+ R+ P  Y H               +G+       + EL P +
Sbjct: 206 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQL 265
Query: 199 PSSLSRDAR--------------------DFILKCLQVNPNDRPTVTELMEHPFVKR 235
            + + R +R                    DF+ K L+ +  +R T  E M HP+ ++
Sbjct: 266 EALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 322

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 30/212 (14%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVS-----SYTRQILNG 90
           FE  NI++  G   +   + I  E +  G+L +  +   L+D Q +        R I +G
Sbjct: 74  FEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR---LNDGQFTVIQLVGMLRGIASG 130
Query: 91  LVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF-------WM 143
           + YL E + VHRD+   NILV+++   K++DFGL++    N     + +         W 
Sbjct: 131 MRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWT 190
Query: 144 APEVVNSKNDGYGLTADIWSLGCTVLEMLT--RRPPYSH-----LEGVQALFRIGKGELP 196
           APE +  +   +   +D WS G  + E+++   RP +       +  ++  +R+     P
Sbjct: 191 APEAIAFRK--FTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPP--P 246
Query: 197 SVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
             P+SL +     +L C Q + N RP   +++
Sbjct: 247 DCPTSLHQ----LMLDCWQKDRNARPRFPQVV 274

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 81/211 (38%), Gaps = 18/211 (8%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYT--------RQI 87
           F   NIV+ +G        +I LEL+  G L +  ++     SQ SS          R I
Sbjct: 107 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 166
Query: 88  LNGLVYLHERNVVHRDIKCANILVDASGS---VKLADFGLAK---ATTMNDLKSCKGTPF 141
             G  YL E + +HRDI   N L+   G     K+ DFG+A+     +      C   P 
Sbjct: 167 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 226
Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVP 199
            WM PE        +    D WS G  + E+ +    PY      + L  +  G     P
Sbjct: 227 KWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 284
Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
            +        + +C Q  P DRP    ++E 
Sbjct: 285 KNCPGPVYRIMTQCWQHQPEDRPNFAIILER 315

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 81/210 (38%), Gaps = 18/210 (8%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYT--------RQI 87
           F   NIV+ +G        +I LEL+  G L +  ++     SQ SS          R I
Sbjct: 117 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 176
Query: 88  LNGLVYLHERNVVHRDIKCANILVDASGS---VKLADFGLAK---ATTMNDLKSCKGTPF 141
             G  YL E + +HRDI   N L+   G     K+ DFG+A+     +      C   P 
Sbjct: 177 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 236
Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVP 199
            WM PE        +    D WS G  + E+ +    PY      + L  +  G     P
Sbjct: 237 KWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 294
Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELME 229
            +        + +C Q  P DRP    ++E
Sbjct: 295 KNCPGPVYRIMTQCWQHQPEDRPNFAIILE 324

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 103/237 (43%), Gaps = 44/237 (18%)
Query: 40  NIVQYLGTDKDENRLY--IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHER 97
           NIV+ L   +D++     +  E V       LY    L+D  +  Y  ++L  L Y H +
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ 144
Query: 98  NVVHRDIKCANILVDAS-GSVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGY 155
            ++HRD+K  N+++D     ++L D+GLA+        + +  + ++  PE++    D Y
Sbjct: 145 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-Y 203
Query: 156 GLTADIWSLGCTVLEMLTRRPP--YSH--------------LEGVQALFRIGKGEL-PSV 198
             + D+WSLGC    M+ R+ P  Y H               +G+       + EL P +
Sbjct: 204 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQL 263
Query: 199 PSSLSRDAR--------------------DFILKCLQVNPNDRPTVTELMEHPFVKR 235
            + + R +R                    DF+ K L+ +  +R T  E M HP+ ++
Sbjct: 264 EALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 103/237 (43%), Gaps = 44/237 (18%)
Query: 40  NIVQYLGTDKDENRLY--IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHER 97
           NIV+ L   +D++     +  E V       LY    L+D  +  Y  ++L  L Y H +
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ 144
Query: 98  NVVHRDIKCANILVDAS-GSVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGY 155
            ++HRD+K  N+++D     ++L D+GLA+        + +  + ++  PE++    D Y
Sbjct: 145 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-Y 203
Query: 156 GLTADIWSLGCTVLEMLTRRPP--YSH--------------LEGVQALFRIGKGEL-PSV 198
             + D+WSLGC    M+ R+ P  Y H               +G+       + EL P +
Sbjct: 204 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQL 263
Query: 199 PSSLSRDAR--------------------DFILKCLQVNPNDRPTVTELMEHPFVKR 235
            + + R +R                    DF+ K L+ +  +R T  E M HP+ ++
Sbjct: 264 EALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 103/237 (43%), Gaps = 44/237 (18%)
Query: 40  NIVQYLGTDKDENRLY--IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHER 97
           NIV+ L   +D++     +  E V       LY    L+D  +  Y  ++L  L Y H +
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ 145
Query: 98  NVVHRDIKCANILVDAS-GSVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGY 155
            ++HRD+K  N+++D     ++L D+GLA+        + +  + ++  PE++    D Y
Sbjct: 146 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-Y 204
Query: 156 GLTADIWSLGCTVLEMLTRRPP--YSH--------------LEGVQALFRIGKGEL-PSV 198
             + D+WSLGC    M+ R+ P  Y H               +G+       + EL P +
Sbjct: 205 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQL 264
Query: 199 PSSLSRDAR--------------------DFILKCLQVNPNDRPTVTELMEHPFVKR 235
            + + R +R                    DF+ K L+ +  +R T  E M HP+ ++
Sbjct: 265 EALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 321

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 103/237 (43%), Gaps = 44/237 (18%)
Query: 40  NIVQYLGTDKDENRLY--IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHER 97
           NIV+ L   +D++     +  E V       LY    L+D  +  Y  ++L  L Y H +
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ 145
Query: 98  NVVHRDIKCANILVDAS-GSVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGY 155
            ++HRD+K  N+++D     ++L D+GLA+        + +  + ++  PE++    D Y
Sbjct: 146 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-Y 204
Query: 156 GLTADIWSLGCTVLEMLTRRPP--YSH--------------LEGVQALFRIGKGEL-PSV 198
             + D+WSLGC    M+ R+ P  Y H               +G+       + EL P +
Sbjct: 205 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQL 264
Query: 199 PSSLSRDAR--------------------DFILKCLQVNPNDRPTVTELMEHPFVKR 235
            + + R +R                    DF+ K L+ +  +R T  E M HP+ ++
Sbjct: 265 EALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 321

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 81/211 (38%), Gaps = 18/211 (8%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYT--------RQI 87
           F   NIV+ +G        +I LEL+  G L +  ++     SQ SS          R I
Sbjct: 97  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 156
Query: 88  LNGLVYLHERNVVHRDIKCANILVDASGS---VKLADFGLAK---ATTMNDLKSCKGTPF 141
             G  YL E + +HRDI   N L+   G     K+ DFG+A+     +      C   P 
Sbjct: 157 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 216
Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVP 199
            WM PE        +    D WS G  + E+ +    PY      + L  +  G     P
Sbjct: 217 KWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 274
Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
            +        + +C Q  P DRP    ++E 
Sbjct: 275 KNCPGPVYRIMTQCWQHQPEDRPNFAIILER 305

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 81/210 (38%), Gaps = 18/210 (8%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYT--------RQI 87
           F   NIV+ +G        +I +EL+  G L +  ++     SQ SS          R I
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 88  LNGLVYLHERNVVHRDIKCANILVDASGS---VKLADFGLAK---ATTMNDLKSCKGTPF 141
             G  YL E + +HRDI   N L+   G     K+ DFG+A+     +      C   P 
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVP 199
            WM PE        +    D WS G  + E+ +    PY      + L  +  G     P
Sbjct: 210 KWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 267
Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELME 229
            +        + +C Q  P DRP    ++E
Sbjct: 268 KNCPGPVYRIMTQCWQHQPEDRPNFAIILE 297

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 81/210 (38%), Gaps = 18/210 (8%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYT--------RQI 87
           F   NIV+ +G        +I LEL+  G L +  ++     SQ SS          R I
Sbjct: 91  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 88  LNGLVYLHERNVVHRDIKCANILVDASGS---VKLADFGLAK---ATTMNDLKSCKGTPF 141
             G  YL E + +HRDI   N L+   G     K+ DFG+A+     +      C   P 
Sbjct: 151 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPV 210
Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVP 199
            WM PE        +    D WS G  + E+ +    PY      + L  +  G     P
Sbjct: 211 KWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 268
Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELME 229
            +        + +C Q  P DRP    ++E
Sbjct: 269 KNCPGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 81/210 (38%), Gaps = 18/210 (8%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYT--------RQI 87
           F   NIV+ +G        +I +EL+  G L +  ++     SQ SS          R I
Sbjct: 105 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 88  LNGLVYLHERNVVHRDIKCANILVDASGS---VKLADFGLAK---ATTMNDLKSCKGTPF 141
             G  YL E + +HRDI   N L+   G     K+ DFG+A+     +      C   P 
Sbjct: 165 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 224
Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVP 199
            WM PE        +    D WS G  + E+ +    PY      + L  +  G     P
Sbjct: 225 KWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 282
Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELME 229
            +        + +C Q  P DRP    ++E
Sbjct: 283 KNCPGPVYRIMTQCWQHQPEDRPNFAIILE 312

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVY 93
           F+  NI+   G       + I  E +  GSL    +K     +  Q+    R I  G+ Y
Sbjct: 80  FDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKY 139
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT-----PF-WMAPEV 147
           L +   VHRD+   NIL++++   K++DFGL++    +D ++   T     P  W APE 
Sbjct: 140 LSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTAPEA 198
Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKG-ELPSVPSSLSRD 205
           +  +   +   +D+WS G  + E+++    PY  +     +  + +G  LPS P      
Sbjct: 199 IAFRK--FTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGYRLPS-PMDCPAA 255
Query: 206 ARDFILKCLQVNPNDRPTVTELM 228
               +L C Q   N RP   E++
Sbjct: 256 LYQLMLDCWQKERNSRPKFDEIV 278

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 24/214 (11%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYT--RQILNGLVY 93
            E+ N V+     K ++ L+I  E     +L +L    +L+  +   +   RQIL  L Y
Sbjct: 72  LERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 94  LHERNVVHRDIKCANILVDASGSVKLADFGLAKAT----------------TMNDLKSCK 137
           +H + ++HR++K  NI +D S +VK+ DFGLAK                  + ++L S  
Sbjct: 132 IHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL-- 195
           GT  ++A EV++     Y    D +SLG    E +   P  +  E V  L ++    +  
Sbjct: 192 GTAXYVATEVLDGTGH-YNEKIDXYSLGIIFFEXIY--PFSTGXERVNILKKLRSVSIEF 248
Query: 196 -PSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
            P    +  +  +  I   +  +PN RP    L+
Sbjct: 249 PPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/132 (35%), Positives = 68/132 (51%), Gaps = 6/132 (4%)
Query: 51  ENRLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           + +LY+   L+    LA  L ++  L+  +  +  RQI + L   H     HRD+K  NI
Sbjct: 106 DGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENI 165
Query: 110 LVDASGSVKLADFGLAKATT---MNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           LV A     L DFG+A ATT   +  L +  GT ++ APE  +  +  Y   ADI++L C
Sbjct: 166 LVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATY--RADIYALTC 223
Query: 167 TVLEMLTRRPPY 178
            + E LT  PPY
Sbjct: 224 VLYECLTGSPPY 235

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 80/211 (37%), Gaps = 18/211 (8%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYT--------RQI 87
           F   NIV+ +G        +I LEL+  G L +  ++     SQ SS          R I
Sbjct: 108 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 167
Query: 88  LNGLVYLHERNVVHRDIKCANILVDASGS---VKLADFGLAKATTMNDL---KSCKGTPF 141
             G  YL E + +HRDI   N L+   G     K+ DFG+A+            C   P 
Sbjct: 168 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 227
Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVP 199
            WM PE        +    D WS G  + E+ +    PY      + L  +  G     P
Sbjct: 228 KWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 285
Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
            +        + +C Q  P DRP    ++E 
Sbjct: 286 KNCPGPVYRIMTQCWQHQPEDRPNFAIILER 316

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 80/211 (37%), Gaps = 18/211 (8%)
Query: 36  FEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYT--------RQI 87
           F   NIV+ +G        +I LEL+  G L +  ++     SQ SS          R I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 88  LNGLVYLHERNVVHRDIKCANILVDASGS---VKLADFGLAKATTMNDL---KSCKGTPF 141
             G  YL E + +HRDI   N L+   G     K+ DFG+A+            C   P 
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 250
Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVP 199
            WM PE        +    D WS G  + E+ +    PY      + L  +  G     P
Sbjct: 251 KWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 308
Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
            +        + +C Q  P DRP    ++E 
Sbjct: 309 KNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 115/285 (40%), Gaps = 84/285 (29%)
Query: 38  QDNIVQYLGT-----DKDENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGL 91
            +NIV  L       D+D   ++ ++E      + AN+ +  H    Q   Y  Q++  +
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVH---KQYVVY--QLIKVI 122
Query: 92  VYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA------------TTMND------- 132
            YLH   ++HRD+K +NIL++A   VK+ADFGL+++             ++N+       
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 133 ----LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALF 188
               L     T ++ APE++      Y    D+WSLGC + E+L  +P +     +  L 
Sbjct: 183 DQPILTDYVATRWYRAPEILLGST-KYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241
Query: 189 R-IGKGELPS------------------------VPSSLSRD------------------ 205
           R IG  + PS                        +  S  RD                  
Sbjct: 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301
Query: 206 ---ARDFILKCLQVNPNDRPTVTELMEHPFVK---RPLQTPRCGQ 244
              A D + K LQ NPN R +  + ++HPFV     P + P C  
Sbjct: 302 NEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDH 346
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	247
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-131
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-114
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-113
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-97
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-95
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-91
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-90
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-88
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-88
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-87
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-83
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-82
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-81
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-81
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-81
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-80
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-78
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-78
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-77
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-77
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-77
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-76
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-74
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-73
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-71
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-70
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-69
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-69
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-68
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-68
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-68
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-66
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-64
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-64
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	8e-63
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-61
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-61
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-59
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-58
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-57
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-56
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	7e-56
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-56
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-55
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-55
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-54
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-54
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-54
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-54
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-54
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-53
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-53
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-53
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-53
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-53
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-53
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-53
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-52
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-52
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-52
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-52
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-52
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	7e-52
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-52
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-51
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-51
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-51
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-51
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-51
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	9e-51
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-50
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-50
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-50
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-50
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-50
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-50
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-50
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-50
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-49
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-49
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-49
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-48
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-48
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-48
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-48
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-48
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-48
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-48
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-48
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-48
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-48
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-48
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-47
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-47
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-47
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-47
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-47
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	7e-47
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-47
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-46
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-45
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-45
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-45
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-45
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-45
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-45
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	8e-45
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-44
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-44
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-43
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-43
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-43
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-43
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-42
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-42
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-42
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-42
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-41
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-41
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-41
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-41
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-41
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-41
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-41
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-41
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-40
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-40
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-40
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-40
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-40
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-40
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-40
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-40
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-40
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-40
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-40
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-40
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-40
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-40
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-40
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-40
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-39
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-39
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-39
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-39
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-39
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-39
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-39
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-39
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	8e-39
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-39
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-38
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-38
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-38
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-38
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-38
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-38
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-37
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-37
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-37
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-37
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-37
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-37
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-37
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-37
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-37
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-37
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-37
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-37
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-37
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-37
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-36
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-36
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-36
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-36
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-36
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-36
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-36
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-36
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-36
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-36
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-35
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-35
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-35
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-35
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-35
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-34
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-34
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	9e-34
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-33
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-33
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-33
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-33
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-33
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-33
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-33
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-32
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	8e-32
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-31
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-31
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-31
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-30
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-30
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-30
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-30
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-30
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	7e-30
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-29
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-29
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-29
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-29
3uqc_A	286	Probable conserved transmembrane protein; structur	9e-29
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-28
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-27
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-27
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-27
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-25
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-24
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-24
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-21
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-21
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-20
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-19
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-18
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-15
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	7e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	7e-10
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	9e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-05

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  371 bits (955), Expect = e-131
 Identities = 92/250 (36%), Positives = 146/250 (58%), Gaps = 14/250 (5%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           +    A+KE+  +D      +    L +EI+L    +  NIVQYLG+  +   + IF+E 
Sbjct: 46  NQVRIAIKEIPERDS-----RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100

Query: 61  VTKGSLANLYQKYH----LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA-SG 115
           V  GSL+ L +        ++  +  YT+QIL GL YLH+  +VHRDIK  N+L++  SG
Sbjct: 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSG 160

Query: 116 SVKLADFGLAK--ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
            +K++DFG +K  A      ++  GT  +MAPE+++    GYG  ADIWSLGCT++EM T
Sbjct: 161 VLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT 220

Query: 174 RRPPYSHL-EGVQALFRIGKGEL-PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP 231
            +PP+  L E   A+F++G  ++ P +P S+S +A+ FILKC + +P+ R    +L+   
Sbjct: 221 GKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDE 280

Query: 232 FVKRPLQTPR 241
           F+K   +  +
Sbjct: 281 FLKVSSKKKK 290

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  329 bits (844), Expect = e-114
 Identities = 67/251 (26%), Positives = 99/251 (39%), Gaps = 23/251 (9%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
           GF  AVK+V L+              +E+   +      IV   G  ++   + IF+EL+
Sbjct: 83  GFQCAVKKVRLEVF----------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132

Query: 62  TKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS-VKL 119
             GSL  L ++   L + +   Y  Q L GL YLH R ++H D+K  N+L+ + GS   L
Sbjct: 133 EGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAAL 192

Query: 120 ADFGLAK-------ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEML 172
            DFG A          ++       GT   MAPEVV           DIWS  C +L ML
Sbjct: 193 CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV--MGKPCDAKVDIWSSCCMMLHML 250

Query: 173 TRRPPYSHLEGVQALFRIGKGE--LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
               P++         +I      +  +P S +      I + L+  P  R +  EL   
Sbjct: 251 NGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRK 310

Query: 231 PFVKRPLQTPR 241
                      
Sbjct: 311 VGKALQEVGGL 321

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  325 bits (836), Expect = e-113
 Identities = 69/245 (28%), Positives = 121/245 (49%), Gaps = 16/245 (6%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG----TDKDENRLYI 56
                A  E+  +      K    + ++E  +L   +  NIV++      T K +  + +
Sbjct: 50  TTVEVAWCELQDRKLT---KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106

Query: 57  FLELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERN--VVHRDIKCANILVDA 113
             EL+T G+L    +++  +    + S+ RQIL GL +LH R   ++HRD+KC NI +  
Sbjct: 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG 166

Query: 114 -SGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEML 172
            +GSVK+ D GLA     +  K+  GTP +MAPE+     + Y  + D+++ G  +LEM 
Sbjct: 167 PTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE---EKYDESVDVYAFGMCMLEMA 223

Query: 173 TRRPPYSHLEGVQALFRIG-KGELP-SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
           T   PYS  +    ++R    G  P S       + ++ I  C++ N ++R ++ +L+ H
Sbjct: 224 TSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283

Query: 231 PFVKR 235
            F + 
Sbjct: 284 AFFQE 288

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  285 bits (731), Expect = 2e-97
 Identities = 57/260 (21%), Positives = 113/260 (43%), Gaps = 34/260 (13%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ-DNIVQYLGTDKDENRLYIFLE 59
           DG  +A+K       G+  +Q+ L+   E+   +   Q  ++V+Y     +++ + I  E
Sbjct: 35  DGCIYAIKRSKKPLAGSVDEQNALR---EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNE 91

Query: 60  LVTKGSLANLYQKY-----HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS 114
               GSLA+   +      +  ++++     Q+  GL Y+H  ++VH DIK +NI +  +
Sbjct: 92  YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRT 151

Query: 115 GS-------------------VKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGY 155
                                 K+ D G    T ++  +  +G   ++A EV+  +N  +
Sbjct: 152 SIPNAASEEGDEDDWASNKVMFKIGDLGH--VTRISSPQVEEGDSRFLANEVLQ-ENYTH 208

Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQ 215
              ADI++L  TV+      P   + +       I +G LP +P  LS++  + +   + 
Sbjct: 209 LPKADIFALALTVVCAAGAEPLPRNGDQWH---EIRQGRLPRIPQVLSQEFTELLKVMIH 265

Query: 216 VNPNDRPTVTELMEHPFVKR 235
            +P  RP+   L++H  +  
Sbjct: 266 PDPERRPSAMALVKHSVLLS 285

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  281 bits (720), Expect = 2e-95
 Identities = 70/239 (29%), Positives = 109/239 (45%), Gaps = 11/239 (4%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           DG  +AVK      +G + +   L   +  S     +    V+     ++   LY+  EL
Sbjct: 81  DGRLYAVKRSMSPFRGPKDRARKLA--EVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL 138

Query: 61  VTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
               SL    + +   L ++QV  Y R  L  L +LH + +VH D+K ANI +   G  K
Sbjct: 139 CG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCK 197

Query: 119 LADFGLAKA-TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPP 177
           L DFGL     T    +  +G P +MAPE++      YG  AD++SLG T+LE+      
Sbjct: 198 LGDFGLLVELGTAGAGEVQEGDPRYMAPELL---QGSYGTAADVFSLGLTILEVACNMEL 254

Query: 178 YSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP 236
               EG Q L +      P   + LS + R  ++  L+ +P  R T   L+  P +++P
Sbjct: 255 PHGGEGWQQLRQ--GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQP 311

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  273 bits (699), Expect = 4e-91
 Identities = 63/253 (24%), Positives = 115/253 (45%), Gaps = 23/253 (9%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ--DNIVQYLGTDKDENRLYIFL 58
               +A+K V+L++      Q++     EI+ L++ +Q  D I++    +  +  +Y+ +
Sbjct: 79  KKQIYAIKYVNLEEAD---NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135

Query: 59  ELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV 117
           E      L + L +K  +   +  SY + +L  +  +H+  +VH D+K AN L+   G +
Sbjct: 136 ECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGML 193

Query: 118 KLADFGLAKA----TTMNDLKSCKGTPFWMAPEVVNSKN---------DGYGLTADIWSL 164
           KL DFG+A      TT     S  G   +M PE +   +               +D+WSL
Sbjct: 194 KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253

Query: 165 GCTVLEMLTRRPPYSHLEG-VQALFRIGKGELP-SVPSSLSRDARDFILKCLQVNPNDRP 222
           GC +  M   + P+  +   +  L  I         P    +D +D +  CL+ +P  R 
Sbjct: 254 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 313

Query: 223 TVTELMEHPFVKR 235
           ++ EL+ HP+V+ 
Sbjct: 314 SIPELLAHPYVQI 326

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  267 bits (684), Expect = 6e-90
 Identities = 75/251 (29%), Positives = 124/251 (49%), Gaps = 14/251 (5%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           DG   A+K+V + D      ++     +EI LL Q    N+++Y  +  ++N L I LEL
Sbjct: 56  DGVPVALKKVQIFDL--MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 113

Query: 61  VTKGSLANLYQKY-----HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
              G L+ + + +      + +  V  Y  Q+ + L ++H R V+HRDIK AN+ + A+G
Sbjct: 114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG 173

Query: 116 SVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
            VKL D GL +   +      S  GTP++M+PE ++    GY   +DIWSLGC + EM  
Sbjct: 174 VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAA 231

Query: 174 RRPPY-SHLEGVQALF-RIGKGELPSVPSS-LSRDARDFILKCLQVNPNDRPTVTELMEH 230
            + P+      + +L  +I + + P +PS   S + R  +  C+  +P  RP VT + + 
Sbjct: 232 LQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291

Query: 231 PFVKRPLQTPR 241
                      
Sbjct: 292 AKRMHACTASS 302

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  264 bits (677), Expect = 2e-88
 Identities = 68/243 (27%), Positives = 129/243 (53%), Gaps = 10/243 (4%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           DG  + +KE+++    ++ ++   +   E+++L+  +  NIVQY  + ++   LYI ++ 
Sbjct: 48  DGRQYVIKEINISRMSSKEREESRR---EVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104

Query: 61  VTKGSLANLYQKY---HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV 117
              G L             + Q+  +  QI   L ++H+R ++HRDIK  NI +   G+V
Sbjct: 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTV 164

Query: 118 KLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR 175
           +L DFG+A+   +T+   ++C GTP++++PE+  +K   Y   +DIW+LGC + E+ T +
Sbjct: 165 QLGDFGIARVLNSTVELARACIGTPYYLSPEICENK--PYNNKSDIWALGCVLYELCTLK 222

Query: 176 PPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
             +        + +I  G  P V    S D R  + +  + NP DRP+V  ++E  F+ +
Sbjct: 223 HAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282

Query: 236 PLQ 238
            ++
Sbjct: 283 RIE 285

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  264 bits (676), Expect = 3e-88
 Identities = 63/253 (24%), Positives = 115/253 (45%), Gaps = 23/253 (9%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ--DNIVQYLGTDKDENRLYIFL 58
               +A+K V+L++      Q++     EI+ L++ +Q  D I++    +  +  +Y+ +
Sbjct: 32  KKQIYAIKYVNLEEAD---NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88

Query: 59  ELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV 117
           E      L +  +K   +   +  SY + +L  +  +H+  +VH D+K AN L+   G +
Sbjct: 89  ECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGML 146

Query: 118 KLADFGLAKA----TTMNDLKSCKGTPFWMAPEVVNSKN---------DGYGLTADIWSL 164
           KL DFG+A      TT     S  GT  +M PE +   +               +D+WSL
Sbjct: 147 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 206

Query: 165 GCTVLEMLTRRPPYSHLEG-VQALFRIGKGELP-SVPSSLSRDARDFILKCLQVNPNDRP 222
           GC +  M   + P+  +   +  L  I         P    +D +D +  CL+ +P  R 
Sbjct: 207 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 266

Query: 223 TVTELMEHPFVKR 235
           ++ EL+ HP+V+ 
Sbjct: 267 SIPELLAHPYVQI 279

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  261 bits (670), Expect = 1e-87
 Identities = 63/253 (24%), Positives = 115/253 (45%), Gaps = 23/253 (9%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ--DNIVQYLGTDKDENRLYIFL 58
               +A+K V+L++      Q++     EI+ L++ +Q  D I++    +  +  +Y+ +
Sbjct: 51  KKQIYAIKYVNLEEAD---NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 107

Query: 59  ELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV 117
           E      L +  +K   +   +  SY + +L  +  +H+  +VH D+K AN L+   G +
Sbjct: 108 ECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGML 165

Query: 118 KLADFGLAKA----TTMNDLKSCKGTPFWMAPEVVNSKN---------DGYGLTADIWSL 164
           KL DFG+A      TT     S  GT  +M PE +   +               +D+WSL
Sbjct: 166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225

Query: 165 GCTVLEMLTRRPPYSHLEG-VQALFRIGKGELP-SVPSSLSRDARDFILKCLQVNPNDRP 222
           GC +  M   + P+  +   +  L  I         P    +D +D +  CL+ +P  R 
Sbjct: 226 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 285

Query: 223 TVTELMEHPFVKR 235
           ++ EL+ HP+V+ 
Sbjct: 286 SIPELLAHPYVQI 298

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  250 bits (641), Expect = 2e-83
 Identities = 89/232 (38%), Positives = 137/232 (59%), Gaps = 8/232 (3%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+K + L+    + +  I  ++QEI++LSQ +   + +Y G+   + +L+I +E +  GS
Sbjct: 51  AIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 106

Query: 66  LANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA 125
             +L +   L ++Q+++  R+IL GL YLH    +HRDIK AN+L+   G VKLADFG+A
Sbjct: 107 ALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA 166

Query: 126 K--ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG 183
                T     +  GTPFWMAPEV+  K   Y   ADIWSLG T +E+    PP+S L  
Sbjct: 167 GQLTDTQIKRNTFVGTPFWMAPEVI--KQSAYDSKADIWSLGITAIELARGEPPHSELHP 224

Query: 184 VQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
           ++ LF I K   P++  + S+  ++F+  CL   P+ RPT  EL++H F+ R
Sbjct: 225 MKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  246 bits (630), Expect = 7e-82
 Identities = 82/234 (35%), Positives = 130/234 (55%), Gaps = 11/234 (4%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+++++LQ Q    K+ I+    EI ++ + +  NIV YL +    + L++ +E +  GS
Sbjct: 49  AIRQMNLQQQ--PKKELIIN---EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103

Query: 66  LANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA 125
           L ++  +  + + Q+++  R+ L  L +LH   V+HRDIK  NIL+   GSVKL DFG  
Sbjct: 104 LTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163

Query: 126 K--ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG 183
                  +   +  GTP+WMAPEVV      YG   DIWSLG   +EM+   PPY +   
Sbjct: 164 AQITPEQSKRSTMVGTPYWMAPEVV--TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221

Query: 184 VQALFRIGKGELPSV--PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
           ++AL+ I     P +  P  LS   RDF+ +CL+++   R +  EL++H F+K 
Sbjct: 222 LRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  246 bits (630), Expect = 1e-81
 Identities = 85/241 (35%), Positives = 138/241 (57%), Gaps = 15/241 (6%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
           G   A+K+V ++         + ++ +EIS++ Q +  ++V+Y G+      L+I +E  
Sbjct: 54  GQIVAIKQVPVESD-------LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106

Query: 62  TKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
             GS++++ +  +  L++ ++++  +  L GL YLH    +HRDIK  NIL++  G  KL
Sbjct: 107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKL 166

Query: 120 ADFGLAK--ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPP 177
           ADFG+A     TM    +  GTPFWMAPEV+  +  GY   ADIWSLG T +EM   +PP
Sbjct: 167 ADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI--QEIGYNCVADIWSLGITAIEMAEGKPP 224

Query: 178 YSHLEGVQALFRIGKGELPSV--PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
           Y+ +  ++A+F I     P+   P   S +  DF+ +CL  +P  R T T+L++HPFV+ 
Sbjct: 225 YADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284

Query: 236 P 236
            
Sbjct: 285 A 285

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  244 bits (626), Expect = 3e-81
 Identities = 82/251 (32%), Positives = 129/251 (51%), Gaps = 26/251 (10%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
            G   A K +  + +     + +     EI +L+  +   IV+ LG    + +L+I +E 
Sbjct: 43  TGALAAAKVIETKSE-----EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97

Query: 61  VTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
              G++  +  +    L++ Q+    RQ+L  L +LH + ++HRD+K  N+L+   G ++
Sbjct: 98  CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIR 157

Query: 119 LADFG--------LAKATTMNDLKSCKGTPFWMAPEVV---NSKNDGYGLTADIWSLGCT 167
           LADFG        L K  +        GTP+WMAPEVV     K+  Y   ADIWSLG T
Sbjct: 158 LADFGVSAKNLKTLQKRDSF------IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGIT 211

Query: 168 VLEMLTRRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDARDFILKCLQVNPNDRPTVT 225
           ++EM    PP+  L  ++ L +I K + P++  PS  S + RDF+   L  NP  RP+  
Sbjct: 212 LIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAA 271

Query: 226 ELMEHPFVKRP 236
           +L+EHPFV   
Sbjct: 272 QLLEHPFVSSI 282

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  245 bits (628), Expect = 4e-81
 Identities = 81/246 (32%), Positives = 127/246 (51%), Gaps = 17/246 (6%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
               A+K++S   + +  K   +   +E+  L +    N +QY G    E+  ++ +E  
Sbjct: 79  SEVVAIKKMSYSGKQSNEKWQDII--KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 136

Query: 62  TKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
             GS ++L + +   L + ++++ T   L GL YLH  N++HRD+K  NIL+   G VKL
Sbjct: 137 L-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKL 195

Query: 120 ADFG----LAKATTMNDLKSCKGTPFWMAPEVV-NSKNDGYGLTADIWSLGCTVLEMLTR 174
            DFG    +A A +        GTP+WMAPEV+       Y    D+WSLG T +E+  R
Sbjct: 196 GDFGSASIMAPANSF------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249

Query: 175 RPPYSHLEGVQALFRIGKGELPSV-PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           +PP  ++  + AL+ I + E P++     S   R+F+  CLQ  P DRPT   L++H FV
Sbjct: 250 KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309

Query: 234 KRPLQT 239
            R    
Sbjct: 310 LRERPP 315

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  243 bits (623), Expect = 1e-80
 Identities = 77/234 (32%), Positives = 127/234 (54%), Gaps = 11/234 (4%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           AVK + L+ Q  Q ++ +     E+ ++  ++  N+V+   +      L++ +E +  G+
Sbjct: 74  AVKMMDLRKQ--QRRELLFN---EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128

Query: 66  LANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA 125
           L ++  +  L++ Q+++    +L  L YLH + V+HRDIK  +IL+   G VKL+DFG  
Sbjct: 129 LTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFC 188

Query: 126 K--ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG 183
              +  +   KS  GTP+WMAPEV+      Y    DIWSLG  V+EM+   PPY     
Sbjct: 189 AQISKDVPKRKSLVGTPYWMAPEVI--SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP 246

Query: 184 VQALFRIGKGELPSV--PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
           VQA+ R+     P +     +S   RDF+ + L  +P +R T  EL++HPF+ +
Sbjct: 247 VQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  238 bits (610), Expect = 1e-78
 Identities = 77/250 (30%), Positives = 128/250 (51%), Gaps = 22/250 (8%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ-DNIVQYLG------TDKDENRL 54
           G   A+K + +            +++QEI++L ++    NI  Y G          +++L
Sbjct: 49  GQLAAIKVMDVTGD------EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 102

Query: 55  YIFLELVTKGSLANLYQKYH---LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
           ++ +E    GS+ +L +      L +  ++   R+IL GL +LH+  V+HRDIK  N+L+
Sbjct: 103 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL 162

Query: 112 DASGSVKLADFGLAK--ATTMNDLKSCKGTPFWMAPEVVNSKND---GYGLTADIWSLGC 166
             +  VKL DFG++     T+    +  GTP+WMAPEV+    +    Y   +D+WSLG 
Sbjct: 163 TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGI 222

Query: 167 TVLEMLTRRPPYSHLEGVQALFRIGKGELPSV-PSSLSRDARDFILKCLQVNPNDRPTVT 225
           T +EM    PP   +  ++ALF I +   P +     S+  + FI  CL  N + RP   
Sbjct: 223 TAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATE 282

Query: 226 ELMEHPFVKR 235
           +LM+HPF++ 
Sbjct: 283 QLMKHPFIRD 292

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  236 bits (605), Expect = 2e-78
 Identities = 75/252 (29%), Positives = 122/252 (48%), Gaps = 19/252 (7%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGT--DKDENRLYIFL 58
           DG     KE+         KQ ++    E++LL + +  NIV+Y     D+    LYI +
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVS---EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86

Query: 59  ELVTKGSLANLYQKY-----HLSDSQVSSYTRQILNGLVYLHERN-----VVHRDIKCAN 108
           E    G LA++  K      +L +  V     Q+   L   H R+     V+HRD+K AN
Sbjct: 87  EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 146

Query: 109 ILVDASGSVKLADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           + +D   +VKL DFGLA+      +  K+  GTP++M+PE +N     Y   +DIWSLGC
Sbjct: 147 VFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM--SYNEKSDIWSLGC 204

Query: 167 TVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTE 226
            + E+    PP++     +   +I +G+   +P   S +  + I + L +    RP+V E
Sbjct: 205 LLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEE 264

Query: 227 LMEHPFVKRPLQ 238
           ++E+P +     
Sbjct: 265 ILENPLILEHHH 276

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  235 bits (601), Expect = 2e-77
 Identities = 78/255 (30%), Positives = 131/255 (51%), Gaps = 30/255 (11%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+K ++L+    + + S+ +L +EI  +SQ    NIV Y  +   ++ L++ ++L++ GS
Sbjct: 44  AIKRINLE----KCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99

Query: 66  LANLYQKYH---------LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS 116
           + ++ +            L +S +++  R++L GL YLH+   +HRD+K  NIL+   GS
Sbjct: 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS 159

Query: 117 VKLADFGLAK--ATTMNDLKSCK-----GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVL 169
           V++ADFG++   AT  +  ++       GTP WMAPEV+  +  GY   ADIWS G T +
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM-EQVRGYDFKADIWSFGITAI 218

Query: 170 EMLTRRPPYSHLEGVQALFRI---------GKGELPSVPSSLSRDARDFILKCLQVNPND 220
           E+ T   PY     ++ L               +   +     +  R  I  CLQ +P  
Sbjct: 219 ELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEK 278

Query: 221 RPTVTELMEHPFVKR 235
           RPT  EL+ H F ++
Sbjct: 279 RPTAAELLRHKFFQK 293

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  234 bits (598), Expect = 3e-77
 Identities = 60/255 (23%), Positives = 107/255 (41%), Gaps = 36/255 (14%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG-------------- 46
           DG  + +K V   ++         + E+E+  L++ +  NIV Y G              
Sbjct: 35  DGKTYVIKRVKYNNE---------KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85

Query: 47  --TDKDENRLYIFLELVTKGSLANLYQKY---HLSDSQVSSYTRQILNGLVYLHERNVVH 101
             +      L+I +E   KG+L    +K     L          QI  G+ Y+H + +++
Sbjct: 86  NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIN 145

Query: 102 RDIKCANILVDASGSVKLADFGLAKA-TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTAD 160
           RD+K +NI +  +  VK+ DFGL  +          KGT  +M+PE ++S+   YG   D
Sbjct: 146 RDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ--DYGKEVD 203

Query: 161 IWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPND 220
           +++LG  + E+L         E  +    +  G +        +  +  + K L   P D
Sbjct: 204 LYALGLILAELLHVCDTAF--ETSKFFTDLRDGII---SDIFDKKEKTLLQKLLSKKPED 258

Query: 221 RPTVTELMEHPFVKR 235
           RP  +E++    V +
Sbjct: 259 RPNTSEILRTLTVWK 273

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  238 bits (609), Expect = 4e-77
 Identities = 63/253 (24%), Positives = 112/253 (44%), Gaps = 26/253 (10%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ-DNIVQYLGTDKDENRLYIFLE 59
           D    AVK +          +     ++E+ LL + ++  N+++Y  T+KD    YI +E
Sbjct: 47  DNRDVAVKRIL--------PECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98

Query: 60  LVTKGSLANLYQK--YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS- 116
           L    +L    ++  +     +  +  +Q  +GL +LH  N+VHRD+K  NIL+    + 
Sbjct: 99  LCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAH 157

Query: 117 ----VKLADFGLAK-----ATTMNDLKSCKGTPFWMAPEVVNSK-NDGYGLTADIWSLGC 166
                 ++DFGL K       + +      GT  W+APE+++    +    T DI+S GC
Sbjct: 158 GKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGC 217

Query: 167 TVLEMLTR-RPPYSHLEGVQALFRIGKGEL--PSVPSSLSRDARDFILKCLQVNPNDRPT 223
               +++    P+      QA   +G   L            AR+ I K + ++P  RP+
Sbjct: 218 VFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPS 277

Query: 224 VTELMEHPFVKRP 236
              +++HPF    
Sbjct: 278 AKHVLKHPFFWSL 290

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  234 bits (597), Expect = 7e-76
 Identities = 59/287 (20%), Positives = 108/287 (37%), Gaps = 60/287 (20%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
            V+ ++L+       + +  L+ E+ +   F   NIV Y  T   +N L++    +  GS
Sbjct: 56  TVRRINLEACS---NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGS 112

Query: 66  LANLYQKYH---LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADF 122
             +L   +    +++  ++   + +L  L Y+H    VHR +K ++IL+   G V L+  
Sbjct: 113 AKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGL 172

Query: 123 GLA--------KATTMNDLKSCK-GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
                      +   ++D          W++PEV+     GY   +DI+S+G T  E+  
Sbjct: 173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN 232

Query: 174 RRPPYSHLEGVQALFRIGKGELPS------------------------------------ 197
              P+  +   Q L     G +P                                     
Sbjct: 233 GHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRP 292

Query: 198 ---------VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
                       + S     F+ +CLQ NP+ RP+ + L+ H F K+
Sbjct: 293 SNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  227 bits (582), Expect = 1e-74
 Identities = 63/274 (22%), Positives = 115/274 (41%), Gaps = 43/274 (15%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENR------- 53
           D  ++A+K++         ++ +  +  E+ LL+      +V+Y     +          
Sbjct: 30  DSRYYAIKKIRHT------EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83

Query: 54  ------LYIFLELVTKGSLANL--YQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIK 105
                 L+I +E    G+L +L   +  +    +     RQIL  L Y+H + ++HRD+K
Sbjct: 84  VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLK 143

Query: 106 CANILVDASGSVKLADFGLAK----------------ATTMNDLKSCKGTPFWMAPEVVN 149
             NI +D S +VK+ DFGLAK                  + ++L S  GT  ++A EV++
Sbjct: 144 PMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD 203

Query: 150 SKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL---PSVPSSLSRDA 206
                Y    D++SLG    EM+   P  + +E V  L ++    +   P    +  +  
Sbjct: 204 GTGH-YNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVE 260

Query: 207 RDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTP 240
           +  I   +  +PN RP    L+   ++    Q  
Sbjct: 261 KKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDE 294

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  223 bits (571), Expect = 5e-73
 Identities = 60/273 (21%), Positives = 109/273 (39%), Gaps = 41/273 (15%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENR------- 53
           D   +A+K + L ++    ++    + +E+  L++ E   IV+Y     ++N        
Sbjct: 29  DDCNYAIKRIRLPNRELAREK----VMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84

Query: 54  -----LYIFLELVTKGSLANLYQK----YHLSDSQVSSYTRQILNGLVYLHERNVVHRDI 104
                LYI ++L  K +L +             S       QI   + +LH + ++HRD+
Sbjct: 85  SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDL 144

Query: 105 KCANILVDASGSVKLADFGLAKA--------------TTMNDLKSCKGTPFWMAPEVVNS 150
           K +NI       VK+ DFGL  A                        GT  +M+PE ++ 
Sbjct: 145 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG 204

Query: 151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFI 210
               Y    DI+SLG  + E+L   P  + +E V+ L  +   + P + +         +
Sbjct: 205 N--SYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMV 260

Query: 211 LKCLQVNPNDRPTVTELMEHPFVKR---PLQTP 240
              L  +P +RP    ++E+   +    P +T 
Sbjct: 261 QDMLSPSPMERPEAINIIENAVFEDLDFPGKTV 293

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  219 bits (561), Expect = 4e-71
 Identities = 72/257 (28%), Positives = 120/257 (46%), Gaps = 35/257 (13%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEIS-LLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           G   AVK +         ++   QL  ++  ++   +   IVQ+ G    E   +I +EL
Sbjct: 47  GQIMAVKRIRSTVD----EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102

Query: 61  VTKGSLANLYQKYH------LSDSQVSSYTRQILNGLVYLH-ERNVVHRDIKCANILVDA 113
           ++  S    Y+  +      + +  +   T   +  L +L     ++HRDIK +NIL+D 
Sbjct: 103 MS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDR 161

Query: 114 SGSVKLADFG--------LAKATTMNDLKSCKGTPFWMAPEVVN--SKNDGYGLTADIWS 163
           SG++KL DFG        +AK           G   +MAPE ++  +   GY + +D+WS
Sbjct: 162 SGNIKLCDFGISGQLVDSIAKTRDA-------GCRPYMAPERIDPSASRQGYDVRSDVWS 214

Query: 164 LGCTVLEMLTRRPPYSHLEGV-QALFRIGKGELPSVPSSL----SRDARDFILKCLQVNP 218
           LG T+ E+ T R PY     V   L ++ KG+ P + +S     S    +F+  CL  + 
Sbjct: 215 LGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDE 274

Query: 219 NDRPTVTELMEHPFVKR 235
           + RP   EL++HPF+  
Sbjct: 275 SKRPKYKELLKHPFILM 291

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  215 bits (549), Expect = 6e-70
 Identities = 69/243 (28%), Positives = 130/243 (53%), Gaps = 19/243 (7%)

Query: 2   GFFFAVKEVS---LQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFL 58
           G   A+K +    +   G        +++ E+ +  Q +  +I++     +D N +Y+ L
Sbjct: 36  GLEVAIKMIDKKAMYKAGMVQ-----RVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90

Query: 59  ELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS 116
           E+   G +    +      S+++   +  QI+ G++YLH   ++HRD+  +N+L+  + +
Sbjct: 91  EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN 150

Query: 117 VKLADFGLAKATTMNDLK---SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
           +K+ADFGLA    M   K    C GTP +++PE+       +GL +D+WSLGC    +L 
Sbjct: 151 IKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRS--AHGLESDVWSLGCMFYTLLI 207

Query: 174 RRPPYSHLEGVQALF-RIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
            RPP+   + V+    ++   +   +PS LS +A+D I + L+ NP DR +++ +++HPF
Sbjct: 208 GRPPF-DTDTVKNTLNKVVLADY-EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265

Query: 233 VKR 235
           + R
Sbjct: 266 MSR 268

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  214 bits (548), Expect = 1e-69
 Identities = 73/253 (28%), Positives = 118/253 (46%), Gaps = 31/253 (12%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEIS-LLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           G   AVK +          Q   +L  ++   +   +    V + G    E  ++I +EL
Sbjct: 32  GQIMAVKRIRATVN----SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL 87

Query: 61  VTKGSLANLYQKYH-----LSDSQVSSYTRQILNGLVYLH-ERNVVHRDIKCANILVDAS 114
           +   SL   Y++       + +  +      I+  L +LH + +V+HRD+K +N+L++A 
Sbjct: 88  MD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINAL 146

Query: 115 GSVKLADFG--------LAKATTMNDLKSCKGTPFWMAPEVVN--SKNDGYGLTADIWSL 164
           G VK+ DFG        +AK           G   +MAPE +N      GY + +DIWSL
Sbjct: 147 GQVKMCDFGISGYLVDDVAKDIDA-------GCKPYMAPERINPELNQKGYSVKSDIWSL 199

Query: 165 GCTVLEMLTRRPPYSHLEGV-QALFRIGKGELPSVPSSL-SRDARDFILKCLQVNPNDRP 222
           G T++E+   R PY       Q L ++ +   P +P+   S +  DF  +CL+ N  +RP
Sbjct: 200 GITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERP 259

Query: 223 TVTELMEHPFVKR 235
           T  ELM+HPF   
Sbjct: 260 TYPELMQHPFFTL 272

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  212 bits (542), Expect = 1e-68
 Identities = 78/243 (32%), Positives = 123/243 (50%), Gaps = 20/243 (8%)

Query: 2   GFFFAVKEV---SLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFL 58
              FA K V    L     + K     +  EIS+       ++V + G  +D + +++ L
Sbjct: 40  KEVFAGKIVPKSLLLKPHQREK-----MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94

Query: 59  ELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV 117
           EL  + SL  L+++   L++ +   Y RQI+ G  YLH   V+HRD+K  N+ ++    V
Sbjct: 95  ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEV 154

Query: 118 KLADFGLAKATTMND---LK-SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
           K+ DFGLA      D    K  C GTP ++APEV++ K  G+    D+WS+GC +  +L 
Sbjct: 155 KIGDFGLA-TKVEYDGERKKVLC-GTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLV 210

Query: 174 RRPPYSHLEGVQALF-RIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
            +PP+     ++  + RI K E  S+P  ++  A   I K LQ +P  RPT+ EL+   F
Sbjct: 211 GKPPF-ETSCLKETYLRIKKNEY-SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 268

Query: 233 VKR 235
              
Sbjct: 269 FTS 271

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  211 bits (539), Expect = 6e-68
 Identities = 70/252 (27%), Positives = 121/252 (48%), Gaps = 30/252 (11%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEIS-LLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           G   AVK++         K+   ++  ++  +L   +   IVQ  GT      ++I +EL
Sbjct: 50  GHVIAVKQMRRSGN----KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105

Query: 61  VTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLH-ERNVVHRDIKCANILVDASGSV 117
           +   +   L ++    + +  +   T  I+  L YL  +  V+HRD+K +NIL+D  G +
Sbjct: 106 MGTCAEK-LKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQI 164

Query: 118 KLADFG--------LAKATTMNDLKSCKGTPFWMAPEVVN---SKNDGYGLTADIWSLGC 166
           KL DFG         AK  +        G   +MAPE ++        Y + AD+WSLG 
Sbjct: 165 KLCDFGISGRLVDDKAKDRSA-------GCAAYMAPERIDPPDPTKPDYDIRADVWSLGI 217

Query: 167 TVLEMLTRRPPYSHLEGV-QALFRIGKGELPSVPSSL--SRDARDFILKCLQVNPNDRPT 223
           +++E+ T + PY + +   + L ++ + E P +P  +  S D + F+  CL  +   RP 
Sbjct: 218 SLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPK 277

Query: 224 VTELMEHPFVKR 235
             +L+EH F+KR
Sbjct: 278 YNKLLEHSFIKR 289

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  211 bits (540), Expect = 7e-68
 Identities = 78/242 (32%), Positives = 124/242 (51%), Gaps = 18/242 (7%)

Query: 2   GFFFAVKEVS---LQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFL 58
              FA K V    L     + K     +  EIS+       ++V + G  +D + +++ L
Sbjct: 66  KEVFAGKIVPKSLLLKPHQREK-----MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120

Query: 59  ELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV 117
           EL  + SL  L+++   L++ +   Y RQI+ G  YLH   V+HRD+K  N+ ++    V
Sbjct: 121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEV 180

Query: 118 KLADFGLA-KATTMNDLK--SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR 174
           K+ DFGLA K     + K   C GTP ++APEV++ K  G+    D+WS+GC +  +L  
Sbjct: 181 KIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVG 237

Query: 175 RPPYSHLEGVQALF-RIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
           +PP+     ++  + RI K E  S+P  ++  A   I K LQ +P  RPT+ EL+   F 
Sbjct: 238 KPPF-ETSCLKETYLRIKKNEY-SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 295

Query: 234 KR 235
             
Sbjct: 296 TS 297

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  205 bits (523), Expect = 6e-66
 Identities = 72/242 (29%), Positives = 122/242 (50%), Gaps = 10/242 (4%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
            F  A+K V  + Q  +      QL +E+ + S     NI++  G   D  R+Y+ LE  
Sbjct: 34  KFILALK-VLFKAQLEKAGV-EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYA 91

Query: 62  TKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
             G++    QK     + + ++Y  ++ N L Y H + V+HRDIK  N+L+ ++G +K+A
Sbjct: 92  PLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIA 151

Query: 121 DFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYS 179
           DFG +     +     C GT  ++ PE++  +   +    D+WSLG    E L  +PP+ 
Sbjct: 152 DFGWSVHAPSSRRTDLC-GTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFE 208

Query: 180 HLEGVQALF-RIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQ 238
                Q  + RI + E  + P  ++  ARD I + L+ NP+ RP + E++EHP++     
Sbjct: 209 A-NTYQETYKRISRVEF-TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266

Query: 239 TP 240
            P
Sbjct: 267 KP 268

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  200 bits (512), Expect = 3e-64
 Identities = 73/245 (29%), Positives = 115/245 (46%), Gaps = 13/245 (5%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
            F  A+K V  + Q  +      QL +EI + S     NI++      D  R+Y+ LE  
Sbjct: 39  KFIMALK-VLFKSQLEKEGV-EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFA 96

Query: 62  TKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
            +G L    QK+    + + +++  ++ + L Y HER V+HRDIK  N+L+   G +K+A
Sbjct: 97  PRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIA 156

Query: 121 DFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYS 179
           DFG +        +  C GT  ++ PE++  K   +    D+W  G    E L   PP+ 
Sbjct: 157 DFGWSVHAPSLRRRTMC-GTLDYLPPEMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFD 213

Query: 180 HLEGVQALF-RIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK---R 235
                     RI   +L   P  LS  ++D I K L+ +P  R  +  +MEHP+VK   R
Sbjct: 214 S-PSHTETHRRIVNVDL-KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271

Query: 236 PLQTP 240
            +  P
Sbjct: 272 RVLPP 276

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  202 bits (516), Expect = 5e-64
 Identities = 71/279 (25%), Positives = 124/279 (44%), Gaps = 51/279 (18%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
           G   A K + L+ + A   Q    + +E+ +L +     IV + G    +  + I +E +
Sbjct: 58  GLVMARKLIHLEIKPAIRNQ----IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 113

Query: 62  TKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYLH-ERNVVHRDIKCANILVDASGSVKL 119
             GSL  + +K   + +  +   +  ++ GL YL  +  ++HRD+K +NILV++ G +KL
Sbjct: 114 DGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKL 173

Query: 120 ADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYS 179
            DFG++     +   S  GT  +M+PE +  +   Y + +DIWS+G +++EM   R P  
Sbjct: 174 CDFGVSGQLIDSMANSFVGTRSYMSPERL--QGTHYSVQSDIWSMGLSLVEMAVGRYPIP 231

Query: 180 HLEGVQA------------------------------------------LFRIGKGELPS 197
             +  +                                           L  I     P 
Sbjct: 232 PPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK 291

Query: 198 VPSSL-SRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
           +PS + S + +DF+ KCL  NP +R  + +LM H F+KR
Sbjct: 292 LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  198 bits (505), Expect = 8e-63
 Identities = 57/265 (21%), Positives = 106/265 (40%), Gaps = 30/265 (11%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG----TDKDENRLYI 56
           DG F+A+K +   +     +Q   + ++E  +   F   NI++ +         ++  ++
Sbjct: 53  DGHFYALKRILCHE-----QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107

Query: 57  FLELVTKGSLANLYQKY-----HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
            L    +G+L N  ++       L++ Q+      I  GL  +H +   HRD+K  NIL+
Sbjct: 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL 167

Query: 112 DASGSVKLADFGLA-----------KATTMNDLKSCKGTPFWMAPEVVNSK-NDGYGLTA 159
              G   L D G             +A T+ D  + + T  + APE+ + + +       
Sbjct: 168 GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERT 227

Query: 160 DIWSLGCTVLEMLTRRPPY---SHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQV 216
           D+WSLGC +  M+    PY          AL    +  +P      S      +   + V
Sbjct: 228 DVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQ-SPRHSSALWQLLNSMMTV 286

Query: 217 NPNDRPTVTELMEHPFVKRPLQTPR 241
           +P+ RP +  L+      +P    +
Sbjct: 287 DPHQRPHIPLLLSQLEALQPPAPGQ 311

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  194 bits (495), Expect = 3e-61
 Identities = 51/225 (22%), Positives = 93/225 (41%), Gaps = 22/225 (9%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANL--YQKYH--LSDSQVSSY 83
            +I  +  F   N V  L     +  LYI ++L  K +L +    +              
Sbjct: 110 VKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHI 169

Query: 84  TRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAK--------ATTMNDLKS 135
             QI   + +LH + ++HRD+K +NI       VK+ DFGL           T +  + +
Sbjct: 170 FIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229

Query: 136 CK------GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR 189
                   GT  +M+PE ++  N  Y    DI+SLG  + E+L      + +E V+ +  
Sbjct: 230 YATHTGQVGTKLYMSPEQIHGNN--YSHKVDIFSLGLILFELLY--SFSTQMERVRIITD 285

Query: 190 IGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           +   + P + +         +   L  +P +RP  T+++E+   +
Sbjct: 286 VRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  194 bits (496), Expect = 4e-61
 Identities = 61/275 (22%), Positives = 114/275 (41%), Gaps = 41/275 (14%)

Query: 1   DGFFFAVKEVS------------LQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTD 48
           D  F+A+K+                +     K      + E+ +++  + +  +   G  
Sbjct: 53  DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII 112

Query: 49  KDENRLYIFLELVTKGSL---------ANLYQKYHLSDSQVSSYTRQILNGLVYLH-ERN 98
            + + +YI  E +   S+          +      +    +    + +LN   Y+H E+N
Sbjct: 113 TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN 172

Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT 158
           + HRD+K +NIL+D +G VKL+DFG ++      +K  +GT  +M PE  ++++   G  
Sbjct: 173 ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAK 232

Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALF-RIGKGEL------------------PSVP 199
            DIWSLG  +  M     P+S    +  LF  I    +                      
Sbjct: 233 VDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSN 292

Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           + LS +  DF+   L+ NP +R T  + ++H ++ 
Sbjct: 293 NFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA 327

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  193 bits (491), Expect = 1e-59
 Identities = 68/274 (24%), Positives = 118/274 (43%), Gaps = 47/274 (17%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ-DNIVQYLGTDKDENRLYIFLE 59
            G   AVK +                  EI LL++ +   N+++Y  ++  +  LYI LE
Sbjct: 38  QGRPVAVKRML--------IDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89

Query: 60  LVTKGSLANLYQKYHLSDSQVSSYT--------RQILNGLVYLHERNVVHRDIKCANILV 111
           L    +L +L +  ++SD  +            RQI +G+ +LH   ++HRD+K  NILV
Sbjct: 90  LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILV 148

Query: 112 DASGS-------------VKLADFGLAK------ATTMNDLKSCKGTPFWMAPEVVNSKN 152
             S               + ++DFGL K      ++   +L +  GT  W APE++   N
Sbjct: 149 STSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESN 208

Query: 153 D-----GYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPS----SL 202
           +         + DI+S+GC    +L++ + P+      ++    G   L  +      SL
Sbjct: 209 NLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSL 268

Query: 203 SRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP 236
             +A D I + +  +P  RPT  +++ HP     
Sbjct: 269 IAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  185 bits (473), Expect = 4e-58
 Identities = 73/235 (31%), Positives = 119/235 (50%), Gaps = 16/235 (6%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           AVK +  QD  A+      +  +E++++ +    NIV ++G       L I  E +++GS
Sbjct: 64  AVKILMEQDFHAERVN---EFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120

Query: 66  LANL----YQKYHLSDSQVSSYTRQILNGLVYLHERN--VVHRDIKCANILVDASGSVKL 119
           L  L      +  L + +  S    +  G+ YLH RN  +VHR++K  N+LVD   +VK+
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKV 180

Query: 120 ADFGLA--KATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVL-EMLTRRP 176
            DFGL+  KA+T    KS  GTP WMAPEV+  +       +D++S G  +L E+ T + 
Sbjct: 181 CDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP--SNEKSDVYSFG-VILWELATLQQ 237

Query: 177 PYSHLEGVQALFRIG-KGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
           P+ +L   Q +  +G K +   +P +L+      I  C    P  RP+   +M+ 
Sbjct: 238 PWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDL 292

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  183 bits (467), Expect = 1e-57
 Identities = 60/237 (25%), Positives = 105/237 (44%), Gaps = 15/237 (6%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           AVK  +  D      Q+I  + QE  L +  +  NI+   G    E  L + +E    G 
Sbjct: 34  AVK-AARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGP 92

Query: 66  LANLYQKYHLSDSQVSSYTRQILNGLVYLHERN---VVHRDIKCANILVDASGS------ 116
           L  +     +    + ++  QI  G+ YLH+     ++HRD+K +NIL+           
Sbjct: 93  LNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN 152

Query: 117 --VKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR 174
             +K+ DFGLA+        S  G   WMAPEV+ +    +   +D+WS G  + E+LT 
Sbjct: 153 KILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASM--FSKGSDVWSYGVLLWELLTG 210

Query: 175 RPPYSHLEGVQALFRIG-KGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
             P+  ++G+   + +        +PS+        +  C   +P+ RP+ T +++ 
Sbjct: 211 EVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  183 bits (467), Expect = 5e-56
 Identities = 73/246 (29%), Positives = 117/246 (47%), Gaps = 20/246 (8%)

Query: 5   FAVKEVS---LQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
            A++ +S        A+     L +E EI +L +     I++       E+  YI LEL+
Sbjct: 163 VAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELM 221

Query: 62  TKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---DASGSV 117
             G L + +     L ++    Y  Q+L  + YLHE  ++HRD+K  N+L+   +    +
Sbjct: 222 EGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI 281

Query: 118 KLADFGLAK----ATTMNDLKSCKGTPFWMAPEVVNSKND-GYGLTADIWSLGCTVLEML 172
           K+ DFG +K     + M  L  C GTP ++APEV+ S    GY    D WSLG  +   L
Sbjct: 282 KITDFGHSKILGETSLMRTL--C-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338

Query: 173 TRRPPYSHLEGVQALF-RIGKGEL--PSVP-SSLSRDARDFILKCLQVNPNDRPTVTELM 228
           +  PP+S      +L  +I  G+        + +S  A D + K L V+P  R T  E +
Sbjct: 339 SGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 398

Query: 229 EHPFVK 234
            HP+++
Sbjct: 399 RHPWLQ 404

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  181 bits (460), Expect = 7e-56
 Identities = 63/287 (21%), Positives = 111/287 (38%), Gaps = 54/287 (18%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
               A+K ++         + + +++ E+ L+ +    NI +     +DE  + + +EL 
Sbjct: 51  RAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELC 110

Query: 62  TKGSL-----------------------------------------ANLYQKYHLSDSQV 80
             G L                                               +   +  +
Sbjct: 111 HGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLI 170

Query: 81  SSYTRQILNGLVYLHERNVVHRDIKCANILV--DASGSVKLADFGLAKATTMNDLKSCK- 137
           S+  RQI + L YLH + + HRDIK  N L   + S  +KL DFGL+K     +      
Sbjct: 171 SNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYG 230

Query: 138 -----GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR-IG 191
                GTP+++APEV+N+ N+ YG   D WS G  +  +L    P+            + 
Sbjct: 231 MTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPG-VNDADTISQVL 289

Query: 192 KGEL--PSVP-SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
             +L   +   + LS  ARD +   L  N ++R      ++HP++ +
Sbjct: 290 NKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  179 bits (457), Expect = 7e-56
 Identities = 73/233 (31%), Positives = 122/233 (52%), Gaps = 10/233 (4%)

Query: 11  SLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQ-Y-LGTDKDENRLYIFLELVTKGSLAN 68
                  Q +  I Q+ QEI++L + +  N+V+   +  D +E+ LY+  ELV +G +  
Sbjct: 68  PAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME 127

Query: 69  LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT 128
           +     LS+ Q   Y + ++ G+ YLH + ++HRDIK +N+LV   G +K+ADFG++   
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187

Query: 129 TMND--LKSCKGTPFWMAPEVVNSKNDGY-GLTADIWSLGCTVLEMLTRRPPYSHLEGVQ 185
             +D  L +  GTP +MAPE ++     + G   D+W++G T+   +  + P+   E + 
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIM 246

Query: 186 ALFR-IGKGEL--PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
            L   I    L  P  P  ++ D +D I + L  NP  R  V E+  HP+V R
Sbjct: 247 CLHSKIKSQALEFPDQP-DIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  177 bits (452), Expect = 6e-55
 Identities = 52/243 (21%), Positives = 111/243 (45%), Gaps = 23/243 (9%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A++ + ++       +     ++E+    Q   +N+V ++G       L I   L    +
Sbjct: 59  AIRLIDIERDNEDQLK---AFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT 115

Query: 66  LANL--YQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFG 123
           L ++    K  L  ++     ++I+ G+ YLH + ++H+D+K  N+  D +G V + DFG
Sbjct: 116 LYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFG 174

Query: 124 LAKATTM-------NDLKSCKGTPFWMAPEVVNSKNDG-------YGLTADIWSLGCTVL 169
           L   + +       + L+   G    +APE++   +         +   +D+++LG T+ 
Sbjct: 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALG-TIW 233

Query: 170 -EMLTRRPPYSHLEGVQALFRIGKGELPSVP-SSLSRDARDFILKCLQVNPNDRPTVTEL 227
            E+  R  P+        ++++G G  P++    + ++  D +L C      +RPT T+L
Sbjct: 234 YELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKL 293

Query: 228 MEH 230
           M+ 
Sbjct: 294 MDM 296

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  177 bits (450), Expect = 7e-55
 Identities = 60/238 (25%), Positives = 115/238 (48%), Gaps = 18/238 (7%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           AVK +++     Q  Q     + E+ +L +    NI+ ++G       L I  +     S
Sbjct: 50  AVKMLNVTAPTPQQLQ---AFKNEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSS 105

Query: 66  LANL--YQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFG 123
           L +     +      ++    RQ   G+ YLH ++++HRD+K  NI +    +VK+ DFG
Sbjct: 106 LYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFG 165

Query: 124 LAKATTM----NDLKSCKGTPFWMAPEVVNSKNDG-YGLTADIWSLGCTVL-EMLTRRPP 177
           LA   +     +  +   G+  WMAPEV+  ++   Y   +D+++ G  VL E++T + P
Sbjct: 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG-IVLYELMTGQLP 224

Query: 178 YSHLEGV-QALFRIGKG----ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
           YS++    Q +  +G+G    +L  V S+  +  +  + +CL+   ++RP+   ++  
Sbjct: 225 YSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  175 bits (445), Expect = 2e-54
 Identities = 44/235 (18%), Positives = 96/235 (40%), Gaps = 17/235 (7%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG--TDKDENRLYIFLELVTK 63
            VK + ++D   +  +      +E   L  F   N++  LG           +    +  
Sbjct: 37  VVKVLKVRDWSTRKSR---DFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPY 93

Query: 64  GSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERN--VVHRDIKCANILVDASGSVK 118
           GSL N+  +   + +  SQ   +   +  G+ +LH     +    +   ++++D   + +
Sbjct: 94  GSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTAR 153

Query: 119 LADFGLAKATTMNDLKSCKGTPFWMAPEVVNSK-NDGYGLTADIWSLGCTVL-EMLTRRP 176
           ++   +  +            P W+APE +  K  D    +AD+WS    +L E++TR  
Sbjct: 154 ISMADVKFSFQS---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFA-VLLWELVTREV 209

Query: 177 PYSHLEGVQALFRIG-KGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
           P++ L  ++   ++  +G  P++P  +S      +  C+  +P  RP    ++  
Sbjct: 210 PFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  176 bits (448), Expect = 3e-54
 Identities = 71/246 (28%), Positives = 114/246 (46%), Gaps = 14/246 (5%)

Query: 2   GFFFAVKEVS---LQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFL 58
               A+K +S        A+     L +E EI +L +     I++       E+  YI L
Sbjct: 35  CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVL 93

Query: 59  ELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG-- 115
           EL+  G L + +     L ++    Y  Q+L  + YLHE  ++HRD+K  N+L+ +    
Sbjct: 94  ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 153

Query: 116 -SVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKN-DGYGLTADIWSLGCTVLEML 172
             +K+ DFG +K       +++  GTP ++APEV+ S    GY    D WSLG  +   L
Sbjct: 154 CLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 213

Query: 173 TRRPPYSHLEGVQALFR-IGKG--ELPSVP-SSLSRDARDFILKCLQVNPNDRPTVTELM 228
           +  PP+S      +L   I  G         + +S  A D + K L V+P  R T  E +
Sbjct: 214 SGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273

Query: 229 EHPFVK 234
            HP+++
Sbjct: 274 RHPWLQ 279

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  175 bits (445), Expect = 4e-54
 Identities = 54/239 (22%), Positives = 104/239 (43%), Gaps = 17/239 (7%)

Query: 6   AVKEVSLQDQGAQGKQS--ILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTK 63
           A+K + L D   + +      + ++E+ ++S     NIV+  G   +     + +E V  
Sbjct: 48  AIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPC 105

Query: 64  GSLANLY--QKYHLSDSQVSSYTRQILNGLVYLHERN--VVHRDIKCANILVDASG---- 115
           G L +    + + +  S        I  G+ Y+  +N  +VHRD++  NI + +      
Sbjct: 106 GDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAP 165

Query: 116 -SVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR 174
              K+ADFGL++ +  + +    G   WMAPE + ++ + Y   AD +S    +  +LT 
Sbjct: 166 VCAKVADFGLSQQSV-HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

Query: 175 RPPYSHLEGVQALFRIG---KGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
             P+      +  F      +G  P++P       R+ I  C   +P  RP  + +++ 
Sbjct: 225 EGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  174 bits (443), Expect = 6e-54
 Identities = 62/245 (25%), Positives = 111/245 (45%), Gaps = 20/245 (8%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
           G    +K ++      + +  + Q+E EI +L   +  NI++     +D + +YI +E  
Sbjct: 47  GLERVIKTINK----DRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC 102

Query: 62  TKGSL-----ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---DA 113
             G L     +   +   LS+  V+   +Q++N L Y H ++VVH+D+K  NIL      
Sbjct: 103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSP 162

Query: 114 SGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEML 172
              +K+ DFGLA+    ++   +  GT  +MAPEV            DIWS G  +  +L
Sbjct: 163 HSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD---VTFKCDIWSAGVVMYFLL 219

Query: 173 TRRPPYSHLEGVQALFR-IGKGEL--PSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
           T   P+     ++ + +     E         L+  A D + + L  +P  RP+  +++ 
Sbjct: 220 TGCLPF-TGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278

Query: 230 HPFVK 234
           H + K
Sbjct: 279 HEWFK 283

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  174 bits (443), Expect = 1e-53
 Identities = 71/246 (28%), Positives = 119/246 (48%), Gaps = 16/246 (6%)

Query: 5   FAVKEVSLQDQGAQGKQSI----LQLEQEISLLSQ-FEQDNIVQYLGTDKDENRLYIFLE 59
           +AVK + +   G+   + +        +E+ +L +     NI+Q   T +     ++  +
Sbjct: 45  YAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFD 104

Query: 60  LVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
           L+ KG L + L +K  LS+ +     R +L  +  LH+ N+VHRD+K  NIL+D   ++K
Sbjct: 105 LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK 164

Query: 119 LADFGLAKATTMND-LKSCKGTPFWMAPEV----VNSKNDGYGLTADIWSLGCTVLEMLT 173
           L DFG +      + L+   GTP ++APE+    +N  + GYG   D+WS G  +  +L 
Sbjct: 165 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

Query: 174 RRPPYSHLEGVQALFR-IGKG--ELPSVP-SSLSRDARDFILKCLQVNPNDRPTVTELME 229
             PP+ H      + R I  G  +  S      S   +D + + L V P  R T  E + 
Sbjct: 225 GSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283

Query: 230 HPFVKR 235
           HPF ++
Sbjct: 284 HPFFQQ 289

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  175 bits (446), Expect = 2e-53
 Identities = 38/276 (13%), Positives = 79/276 (28%), Gaps = 48/276 (17%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLE-----------------------QEISLLSQFE 37
            G  F V      ++        ++ E                           L+   +
Sbjct: 97  TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 156

Query: 38  QDNIVQYLGTDKDENRLYIFLEL-VTKGSLANLY--------QKYHLSDSQVSSYTRQIL 88
           +  +++    ++D   L  F      + +L                L        T Q++
Sbjct: 157 KKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVI 216

Query: 89  NGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVV 148
             L  LH   +VH  ++  +I++D  G V L  F                +  +  PE+ 
Sbjct: 217 RLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR--DGARVVSSVSRGFEPPELE 274

Query: 149 NSK---------NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVP 199
             +               + D W+LG  +  +     P +    +     I +       
Sbjct: 275 ARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS-----C 329

Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
            ++ +  R  +   L+    DR    + ME P  ++
Sbjct: 330 KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  173 bits (441), Expect = 2e-53
 Identities = 66/217 (30%), Positives = 112/217 (51%), Gaps = 11/217 (5%)

Query: 26  LEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYT 84
           LE EI++L + + +NIV      +     Y+ ++LV+ G L + + ++   ++   S   
Sbjct: 53  LENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVI 112

Query: 85  RQILNGLVYLHERNVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDLKSCKGTPF 141
           +Q+L+ + YLHE  +VHRD+K  N+L    + +  + + DFGL+K      + +  GTP 
Sbjct: 113 QQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPG 172

Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR-IGKGEL--PSV 198
           ++APEV+  K   Y    D WS+G     +L   PP+   E    LF  I +G     S 
Sbjct: 173 YVAPEVLAQK--PYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESP 229

Query: 199 P-SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
               +S  A+DFI   L+ +PN+R T  + + HP++ 
Sbjct: 230 FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  175 bits (445), Expect = 2e-53
 Identities = 71/248 (28%), Positives = 126/248 (50%), Gaps = 21/248 (8%)

Query: 5   FAVKEVS---LQDQGAQGKQSILQLEQEISLLSQ-FEQDNIVQYLGTDKDENRLYIFLEL 60
           FAVK +     +    Q ++      +E  +L Q     +I+  + + +  + +++  +L
Sbjct: 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDL 181

Query: 61  VTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
           + KG L + L +K  LS+ +  S  R +L  + +LH  N+VHRD+K  NIL+D +  ++L
Sbjct: 182 MRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRL 241

Query: 120 ADFGLAK----ATTMNDLKSCKGTPFWMAPEV----VNSKNDGYGLTADIWSLGCTVLEM 171
           +DFG +        + +L  C GTP ++APE+    ++  + GYG   D+W+ G  +  +
Sbjct: 242 SDFGFSCHLEPGEKLREL--C-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTL 298

Query: 172 LTRRPPYSHLEGVQALFR-IGKG--ELPSVP-SSLSRDARDFILKCLQVNPNDRPTVTEL 227
           L   PP+ H      + R I +G  +  S      S   +D I + LQV+P  R T  + 
Sbjct: 299 LAGSPPFWH-RRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQA 357

Query: 228 MEHPFVKR 235
           ++HPF +R
Sbjct: 358 LQHPFFER 365

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  174 bits (442), Expect = 6e-53
 Identities = 34/277 (12%), Positives = 73/277 (26%), Gaps = 48/277 (17%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGT-------------- 47
              FA+K  ++       +  + +L +     ++   ++  +                  
Sbjct: 87  LEDFALKVFTMG--AENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS 144

Query: 48  ------------DKDENRLYIFLELVTKGSLANLY--------QKYHLSDSQVSSYTRQI 87
                       D       + +       L  L+         +       +   T Q+
Sbjct: 145 QPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQL 203

Query: 88  LNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWM-APE 146
           +     L  + +VH      N+ +   G + L D        +         P      E
Sbjct: 204 IRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK--VGTRGPASSVPVTYAPRE 261

Query: 147 VVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQA-------LFRIGKGELP-SV 198
            +N+    +    + W LG ++  +     P+  +            L   G   L    
Sbjct: 262 FLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGS 321

Query: 199 PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
            + L    +  I + L  +   R    E ME P   +
Sbjct: 322 CTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  172 bits (437), Expect = 8e-53
 Identities = 61/235 (25%), Positives = 112/235 (47%), Gaps = 22/235 (9%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+K++  + +             E+  LS+    NIV+  G   +   + + +E    GS
Sbjct: 35  AIKQIESESE-------RKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGS 85

Query: 66  LANLYQK----YHLSDSQVSSYTRQILNGLVYLHERN---VVHRDIKCANILVDASGSV- 117
           L N+        + + +   S+  Q   G+ YLH      ++HRD+K  N+L+ A G+V 
Sbjct: 86  LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVL 145

Query: 118 KLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPP 177
           K+ DFG A       + + KG+  WMAPEV    N  Y    D++S G  + E++TRR P
Sbjct: 146 KICDFGTACDIQ-THMTNNKGSAAWMAPEVFEGSN--YSEKCDVFSWGIILWEVITRRKP 202

Query: 178 YSHLEG--VQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
           +  + G   + ++ +  G  P +  +L +     + +C   +P+ RP++ E+++ 
Sbjct: 203 FDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  172 bits (439), Expect = 8e-53
 Identities = 71/266 (26%), Positives = 131/266 (49%), Gaps = 34/266 (12%)

Query: 5   FAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTK 63
           FAVK +S        K+     ++EI+ L       NIV+      D+   ++ +EL+  
Sbjct: 39  FAVKIIS--------KRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90

Query: 64  GSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---DASGSVKL 119
           G L   + +K H S+++ S   R++++ + ++H+  VVHRD+K  N+L    + +  +K+
Sbjct: 91  GELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKI 150

Query: 120 ADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPP 177
            DFG A+    ++  LK+   T  + APE++    +GY  + D+WSLG  +  ML+ + P
Sbjct: 151 IDFGFARLKPPDNQPLKTPCFTLHYAAPELL--NQNGYDESCDLWSLGVILYTMLSGQVP 208

Query: 178 -YSHLEGV-----QALF-RIGKG--ELPSVP-SSLSRDARDFILKCLQVNPNDRPTVTEL 227
             SH   +       +  +I KG          ++S++A+D I   L V+PN R  ++ L
Sbjct: 209 FQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268

Query: 228 MEHPFVK-------RPLQTPRCGQAN 246
             + +++        PL TP    ++
Sbjct: 269 RYNEWLQDGSQLSSNPLMTPDILGSS 294

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  176 bits (447), Expect = 2e-52
 Identities = 61/243 (25%), Positives = 120/243 (49%), Gaps = 15/243 (6%)

Query: 5   FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKG 64
            AVK   +  +  + K     L +E+ LL Q +  NI++     +D+   Y+  E+ T G
Sbjct: 54  CAVK--VISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGG 111

Query: 65  SLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---DASGSVKLA 120
            L + +  +   S+   +   RQ+L+G+ Y+H+  +VHRD+K  N+L+       ++++ 
Sbjct: 112 ELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRII 171

Query: 121 DFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYS 179
           DFGL+     +  +K   GT +++APEV++     Y    D+WS G  +  +L+  PP+ 
Sbjct: 172 DFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT---YDEKCDVWSTGVILYILLSGCPPF- 227

Query: 180 HLEGVQALFR-IGKGEL--PSVP-SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
           +      + + + KG+          +S  A+D I K L   P+ R +  + ++H +++ 
Sbjct: 228 NGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287

Query: 236 PLQ 238
             +
Sbjct: 288 YTK 290

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  172 bits (438), Expect = 2e-52
 Identities = 74/244 (30%), Positives = 117/244 (47%), Gaps = 18/244 (7%)

Query: 5   FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKG 64
           FAVK V +    +    S   L++E S+    +  +IV+ L T   +  LY+  E +   
Sbjct: 52  FAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGA 111

Query: 65  SL-----ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---DASGS 116
            L           +  S++  S Y RQIL  L Y H+ N++HRD+K   +L+   + S  
Sbjct: 112 DLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAP 171

Query: 117 VKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR 174
           VKL  FG+A     +        GTP +MAPEVV  +   YG   D+W  G  +  +L+ 
Sbjct: 172 VKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSG 229

Query: 175 RPPYSHLEGVQALFR-IGKGEL--PSVP-SSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
             P+   +  + LF  I KG+        S +S  A+D + + L ++P +R TV E + H
Sbjct: 230 CLPFYGTK--ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287

Query: 231 PFVK 234
           P++K
Sbjct: 288 PWLK 291

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  172 bits (438), Expect = 2e-52
 Identities = 74/250 (29%), Positives = 122/250 (48%), Gaps = 25/250 (10%)

Query: 5   FAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTK 63
           FAVK +          +S     +EI +L ++ +  NI+       D   +Y+  EL+  
Sbjct: 50  FAVKIID---------KSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100

Query: 64  GSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV----DASGSVK 118
           G L + + ++   S+ + S+    I   + YLH + VVHRD+K +NIL         S++
Sbjct: 101 GELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIR 160

Query: 119 LADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP 176
           + DFG AK     +  L +   T  ++APEV+  +  GY    DIWSLG  +  MLT   
Sbjct: 161 ICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ--GYDAACDIWSLGVLLYTMLTGYT 218

Query: 177 PYSH--LEGVQALF-RIGKG--ELPSVP-SSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
           P+++   +  + +  RIG G   L     +S+S  A+D + K L V+P+ R T   ++ H
Sbjct: 219 PFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278

Query: 231 PFVKRPLQTP 240
           P++    Q P
Sbjct: 279 PWIVHWDQLP 288

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  176 bits (447), Expect = 2e-52
 Identities = 62/248 (25%), Positives = 118/248 (47%), Gaps = 14/248 (5%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
                A+K +      +    S  +L +E+++L   +  NI++     +D+   Y+ +E 
Sbjct: 61  THVERAIKIIRKT---SVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117

Query: 61  VTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---DASGS 116
              G L + +  +   ++   +   +Q+L+G+ YLH+ N+VHRD+K  N+L+   +    
Sbjct: 118 YKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDAL 177

Query: 117 VKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR 175
           +K+ DFGL+        +K   GT +++APEV+  K   Y    D+WS+G  +  +L   
Sbjct: 178 IKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK---YDEKCDVWSIGVILFILLAGY 234

Query: 176 PPY--SHLEGVQALFRIGKGELPSVP-SSLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
           PP+     + +      GK    S    ++S  A+D I + LQ +   R +  + +EHP+
Sbjct: 235 PPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294

Query: 233 VKRPLQTP 240
           +K      
Sbjct: 295 IKEMCSKK 302

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  169 bits (431), Expect = 4e-52
 Identities = 70/244 (28%), Positives = 127/244 (52%), Gaps = 14/244 (5%)

Query: 2   GFFFAVKEVSLQD-QGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           G  +A K +  +    ++   S  ++E+E+++L +    NI+      +++  + + LEL
Sbjct: 30  GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILEL 89

Query: 61  VTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV----DASG 115
           V+ G L + L +K  L++ + + + +QIL+G+ YLH + + H D+K  NI++      + 
Sbjct: 90  VSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNP 149

Query: 116 SVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR 174
            +KL DFG+A      +  K+  GTP ++APE+VN   +  GL AD+WS+G     +L+ 
Sbjct: 150 RIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSG 207

Query: 175 RPPYSHLEGVQALFR-IGKGEL--PSVP-SSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
             P+   E  Q     I            S+ S  A+DFI + L  +P  R T+ + +EH
Sbjct: 208 ASPFLG-ETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266

Query: 231 PFVK 234
            ++K
Sbjct: 267 SWIK 270

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  170 bits (432), Expect = 7e-52
 Identities = 55/275 (20%), Positives = 98/275 (35%), Gaps = 49/275 (17%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGT--DKDENRLYIFLE 59
           G  FA+K  +         + +    +E  +L +    NIV+      +       + +E
Sbjct: 34  GDLFAIKVFNNI----SFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89

Query: 60  LVTKGSLANLYQK----YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---- 111
               GSL  + ++    Y L +S+     R ++ G+ +L E  +VHR+IK  NI+     
Sbjct: 90  FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE 149

Query: 112 DASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVV------NSKNDGYGLTADIWSL 164
           D     KL DFG A+    ++   S  GT  ++ P++             YG T D+WS+
Sbjct: 150 DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209

Query: 165 GCTVLEMLTRRPPYSHLEG----VQALFRIGKGEL------------------------P 196
           G T     T   P+   EG     + +++I  G+                          
Sbjct: 210 GVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSC 269

Query: 197 SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP 231
           S+   L       +   L+ +        +     
Sbjct: 270 SLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  174 bits (443), Expect = 8e-52
 Identities = 65/253 (25%), Positives = 121/253 (47%), Gaps = 21/253 (8%)

Query: 5   FAVKEVS--------LQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYI 56
            A+K +           D     ++   ++  EISLL   +  NI++     +D+   Y+
Sbjct: 64  KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL 123

Query: 57  FLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---D 112
             E    G L   +  ++   +   ++  +QIL+G+ YLH+ N+VHRDIK  NIL+   +
Sbjct: 124 VTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN 183

Query: 113 ASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +  ++K+ DFGL+   + +  L+   GT +++APEV+  K   Y    D+WS G  +  +
Sbjct: 184 SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKK---YNEKCDVWSCGVIMYIL 240

Query: 172 LTRRPPYSHLEGVQALFR-IGKGEL--PSVP-SSLSRDARDFILKCLQVNPNDRPTVTEL 227
           L   PP+   +  Q + + + KG+         ++S +A++ I   L  + N R T  E 
Sbjct: 241 LCGYPPF-GGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299

Query: 228 MEHPFVKRPLQTP 240
           +   ++K+     
Sbjct: 300 LNSRWIKKYANNI 312

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  174 bits (442), Expect = 1e-51
 Identities = 66/239 (27%), Positives = 125/239 (52%), Gaps = 16/239 (6%)

Query: 5   FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKG 64
           +AVK ++     +   +    + +E+ LL + +  NI++     +D +  YI  EL T G
Sbjct: 50  YAVKVINKA---SAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106

Query: 65  SLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---DASGSVKLA 120
            L + + ++   S+   +   +Q+ +G+ Y+H+ N+VHRD+K  NIL+   +    +K+ 
Sbjct: 107 ELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166

Query: 121 DFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYS 179
           DFGL+     N  +K   GT +++APEV+      Y    D+WS G  +  +L+  PP+ 
Sbjct: 167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT---YDEKCDVWSAGVILYILLSGTPPF- 222

Query: 180 HLEGVQALFR-IGKGEL--PSVP-SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           + +    + + +  G+         ++S DA+D I K L  +P+ R T T+ +EHP+++
Sbjct: 223 YGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  169 bits (431), Expect = 1e-51
 Identities = 60/271 (22%), Positives = 108/271 (39%), Gaps = 41/271 (15%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQ-FEQDNIVQYLG-------TDKDEN 52
            G  +A+K +   +     ++    + QE+  + +     NIVQ+               
Sbjct: 52  SGREYALKRLLSNE-----EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106

Query: 53  RLYIFLELVTKGSLA----NLYQKYHLSDSQVSSYTRQILNGLVYLHERN--VVHRDIKC 106
             ++ L  + KG L      +  +  LS   V     Q    + ++H +   ++HRD+K 
Sbjct: 107 AEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKV 166

Query: 107 ANILVDASGSVKLADFGLA--------------KATTMNDLKSCKGTPFWMAPEVVNS-K 151
            N+L+   G++KL DFG A              +   + +  +   TP +  PE+++   
Sbjct: 167 ENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS 226

Query: 152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI--GKGELPSVPSSLSRDARDF 209
           N   G   DIW+LGC +  +  R+ P+   E   A  RI  GK  +P    +        
Sbjct: 227 NFPIGEKQDIWALGCILYLLCFRQHPF---ED-GAKLRIVNGKYSIPP-HDTQYTVFHSL 281

Query: 210 ILKCLQVNPNDRPTVTELMEHPFVKRPLQTP 240
           I   LQVNP +R ++ E++         +  
Sbjct: 282 IRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  168 bits (427), Expect = 1e-51
 Identities = 72/242 (29%), Positives = 121/242 (50%), Gaps = 15/242 (6%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
           G  FA K ++ +   A+  Q    LE+E  +  + +  NIV+   + ++E+  Y+  +LV
Sbjct: 31  GLEFAAKIINTKKLSARDFQK---LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 87

Query: 62  TKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---DASGSV 117
           T G L   +  +   S++  S   +QIL  + Y H   +VHR++K  N+L+       +V
Sbjct: 88  TGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAV 147

Query: 118 KLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP 176
           KLADFGLA     ++      GTP +++PEV+  K D Y    DIW+ G  +  +L   P
Sbjct: 148 KLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL--KKDPYSKPVDIWACGVILYILLVGYP 205

Query: 177 PYSHLEGVQALFR-IGKG--ELPSVP-SSLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
           P+   E    L+  I  G  + PS    +++ +A+  I   L VNP  R T  + ++ P+
Sbjct: 206 PFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264

Query: 233 VK 234
           + 
Sbjct: 265 IC 266

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  169 bits (431), Expect = 2e-51
 Identities = 67/224 (29%), Positives = 110/224 (49%), Gaps = 11/224 (4%)

Query: 20  KQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDS 78
                 +  EI +L +    NI++     +    + + LELVT G L + + +K + S+ 
Sbjct: 89  TVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSER 148

Query: 79  QVSSYTRQILNGLVYLHERNVVHRDIKCANILV---DASGSVKLADFGLAKATTMND-LK 134
             +   +QIL  + YLHE  +VHRD+K  N+L         +K+ADFGL+K       +K
Sbjct: 149 DAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208

Query: 135 SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR-IGKG 193
           +  GTP + APE++      YG   D+WS+G     +L    P+    G Q +FR I   
Sbjct: 209 TVCGTPGYCAPEILRGC--AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNC 266

Query: 194 EL--PSVP-SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           E    S     +S +A+D + K + ++P  R T  + ++HP+V 
Sbjct: 267 EYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  167 bits (426), Expect = 5e-51
 Identities = 57/244 (23%), Positives = 104/244 (42%), Gaps = 27/244 (11%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
            +KE  L     + +++ L+   E+ ++   E  N+++++G    + RL    E +  G+
Sbjct: 39  VMKE--LIRFDEETQRTFLK---EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGT 93

Query: 66  LANL--YQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFG 123
           L  +          SQ  S+ + I +G+ YLH  N++HRD+   N LV  + +V +ADFG
Sbjct: 94  LRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFG 153

Query: 124 LA----------------KATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT 167
           LA                K        +  G P+WMAPE++N ++  Y    D++S G  
Sbjct: 154 LARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS--YDEKVDVFSFGIV 211

Query: 168 VLEMLTRRPPYSHLEGVQALFRIG--KGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT 225
           + E++ R             F +          P +         ++C  ++P  RP+  
Sbjct: 212 LCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFV 271

Query: 226 ELME 229
           +L  
Sbjct: 272 KLEH 275

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  168 bits (428), Expect = 9e-51
 Identities = 75/244 (30%), Positives = 121/244 (49%), Gaps = 14/244 (5%)

Query: 2   GFFFAVKEVS-LQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           G  +A K +   Q + ++      ++E+E+S+L Q    NI+      ++   + + LEL
Sbjct: 37  GLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILEL 96

Query: 61  VTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV----DASG 115
           V+ G L + L QK  LS+ + +S+ +QIL+G+ YLH + + H D+K  NI++        
Sbjct: 97  VSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIP 156

Query: 116 SVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR 174
            +KL DFGLA         K+  GTP ++APE+VN   +  GL AD+WS+G     +L+ 
Sbjct: 157 HIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSG 214

Query: 175 RPPYSHLEGVQALFR-IGKGEL--PSVP-SSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
             P+   +  Q     I            S  S  A+DFI K L      R T+ E + H
Sbjct: 215 ASPFLG-DTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273

Query: 231 PFVK 234
           P++ 
Sbjct: 274 PWIT 277

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  166 bits (422), Expect = 1e-50
 Identities = 63/218 (28%), Positives = 116/218 (53%), Gaps = 13/218 (5%)

Query: 26  LEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYT 84
           + +E+ LL + +  NI++     +D +  YI  EL T G L + + ++   S+   +   
Sbjct: 68  ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII 127

Query: 85  RQILNGLVYLHERNVVHRDIKCANILV---DASGSVKLADFGLAKATTMND-LKSCKGTP 140
           +Q+ +G+ Y+H+ N+VHRD+K  NIL+   +    +K+ DFGL+     N  +K   GT 
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTA 187

Query: 141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR-IGKGEL--PS 197
           +++APEV+      Y    D+WS G  +  +L+  PP+   +    + + +  G+     
Sbjct: 188 YYIAPEVLRGT---YDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDL 243

Query: 198 VP-SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
               ++S DA+D I K L  +P+ R T T+ +EHP+++
Sbjct: 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  167 bits (425), Expect = 1e-50
 Identities = 71/268 (26%), Positives = 116/268 (43%), Gaps = 39/268 (14%)

Query: 5   FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQ----YLGTDKDENRLYIFLEL 60
            A+K +              + E +          +IV     Y      +  L I +E 
Sbjct: 57  CALKLLY--------DSPKARQEVDH-HWQASGGPHIVCILDVYENMHHGKRCLLIIMEC 107

Query: 61  VTKGSL-----ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---D 112
           +  G L         Q +  ++ + +   R I   + +LH  N+ HRD+K  N+L    +
Sbjct: 108 MEGGELFSRIQERGDQAF--TEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE 165

Query: 113 ASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEML 172
               +KL DFG AK TT N L++   TP+++APEV+  +   Y  + D+WSLG  +  +L
Sbjct: 166 KDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILL 223

Query: 173 TRRPPY---SHLEGVQALF-RIGKG--ELPSVP-SSLSRDARDFILKCLQVNPNDRPTVT 225
              PP+   +       +  RI  G    P+   S +S DA+  I   L+ +P +R T+T
Sbjct: 224 CGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTIT 283

Query: 226 ELMEHPFVK-------RPLQTPRCGQAN 246
           + M HP++         PL T R  Q +
Sbjct: 284 QFMNHPWINQSMVVPQTPLHTARVLQED 311

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  165 bits (420), Expect = 1e-50
 Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 13/224 (5%)

Query: 26  LEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYT 84
            +QEI ++   +  NI++   T +D   +Y+ +EL T G L   +  K    +S  +   
Sbjct: 53  FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIM 112

Query: 85  RQILNGLVYLHERNVVHRDIKCANILV---DASGSVKLADFGLAKATTMND-LKSCKGTP 140
           + +L+ + Y H+ NV HRD+K  N L         +KL DFGLA        +++  GTP
Sbjct: 113 KDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTP 172

Query: 141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR-IGKGEL--PS 197
           ++++P+V+      YG   D WS G  +  +L   PP+        +   I +G    P 
Sbjct: 173 YYVSPQVLEGL---YGPECDEWSAGVMMYVLLCGYPPF-SAPTDSEVMLKIREGTFTFPE 228

Query: 198 VP-SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTP 240
               ++S  A   I + L  +P  R T  + +EH + ++ L + 
Sbjct: 229 KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  166 bits (423), Expect = 2e-50
 Identities = 74/244 (30%), Positives = 122/244 (50%), Gaps = 14/244 (5%)

Query: 2   GFFFAVKEVSLQD-QGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           G  +A K +  +  + ++   S  ++E+E+S+L Q    N++      ++   + + LEL
Sbjct: 37  GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL 96

Query: 61  VTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV----DASG 115
           V+ G L + L QK  LS+ + +S+ +QIL+G+ YLH + + H D+K  NI++        
Sbjct: 97  VSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIP 156

Query: 116 SVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR 174
            +KL DFGLA         K+  GTP ++APE+VN   +  GL AD+WS+G     +L+ 
Sbjct: 157 HIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSG 214

Query: 175 RPPYSHLEGVQALFR-IGKGEL--PSVP-SSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
             P+   +  Q     I            S  S  A+DFI K L      R T+ E + H
Sbjct: 215 ASPFLG-DTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273

Query: 231 PFVK 234
           P++ 
Sbjct: 274 PWIT 277

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  167 bits (426), Expect = 2e-50
 Identities = 72/245 (29%), Positives = 120/245 (48%), Gaps = 21/245 (8%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
           G  FA K ++ +   A+  Q    LE+E  +  + +  NIV+   + ++E+  Y+  +LV
Sbjct: 54  GLEFAAKIINTKKLSARDFQK---LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 110

Query: 62  TKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---DASGSV 117
           T G L   +  +   S++  S   +QIL  + Y H   +VHR++K  N+L+       +V
Sbjct: 111 TGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAV 170

Query: 118 KLADFGLAK----ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
           KLADFGLA     +   +      GTP +++PEV+  K D Y    DIW+ G  +  +L 
Sbjct: 171 KLADFGLAIEVNDSEAWHGF--A-GTPGYLSPEVL--KKDPYSKPVDIWACGVILYILLV 225

Query: 174 RRPPYSHLEGVQALFR-IGKGEL--PSVP-SSLSRDARDFILKCLQVNPNDRPTVTELME 229
             PP+   E    L+  I  G    PS    +++ +A+  I   L VNP  R T  + ++
Sbjct: 226 GYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284

Query: 230 HPFVK 234
            P++ 
Sbjct: 285 VPWIC 289

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  164 bits (417), Expect = 4e-50
 Identities = 56/222 (25%), Positives = 106/222 (47%), Gaps = 10/222 (4%)

Query: 25  QLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSY 83
            +++EI +      +N+V++ G  ++ N  Y+FLE  + G L + +     + +     +
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF 110

Query: 84  TRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGT 139
             Q++ G+VYLH   + HRDIK  N+L+D   ++K++DFGLA     N+    L    GT
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

Query: 140 PFWMAPEVVNSKNDGY-GLTADIWSLGCTVLEMLTRRPPY-SHLEGVQALFRIGKGELPS 197
             ++APE++  +   +     D+WS G  +  ML    P+    +  Q      + +   
Sbjct: 171 LPYVAPELLKRR--EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228

Query: 198 VP-SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQ 238
            P   +       + K L  NP+ R T+ ++ +  +  +PL+
Sbjct: 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  165 bits (420), Expect = 5e-50
 Identities = 69/244 (28%), Positives = 126/244 (51%), Gaps = 14/244 (5%)

Query: 2   GFFFAVKEVSLQD-QGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           G  +A K +  +  + ++   S   +E+E+S+L + +  N++      +++  + + LEL
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95

Query: 61  VTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV----DASG 115
           V  G L + L +K  L++ + + + +QILNG+ YLH   + H D+K  NI++        
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKP 155

Query: 116 SVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR 174
            +K+ DFGLA      +  K+  GTP ++APE+VN   +  GL AD+WS+G     +L+ 
Sbjct: 156 RIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSG 213

Query: 175 RPPYSHLEGVQALFR-IGKGEL--PSVP-SSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
             P+   +  Q     +            S+ S  A+DFI + L  +P  R T+ + ++H
Sbjct: 214 ASPF-LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272

Query: 231 PFVK 234
           P++K
Sbjct: 273 PWIK 276

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  168 bits (427), Expect = 7e-50
 Identities = 72/243 (29%), Positives = 123/243 (50%), Gaps = 16/243 (6%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
           G  +A   ++ +   A+  Q    LE+E  +    +  NIV+   +  +E   Y+  +LV
Sbjct: 36  GQEYAAMIINTKKLSARDHQK---LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLV 92

Query: 62  TKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---DASGSV 117
           T G L   +  + + S++  S   +QIL  +++ H+  VVHR++K  N+L+       +V
Sbjct: 93  TGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAV 152

Query: 118 KLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR 175
           KLADFGLA              GTP +++PEV+  + D YG   D+W+ G  +  +L   
Sbjct: 153 KLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL--RKDPYGKPVDLWACGVILYILLVGY 210

Query: 176 PPYSHLEGVQALFR-IGKGEL--PSVP-SSLSRDARDFILKCLQVNPNDRPTVTELMEHP 231
           PP+   E    L++ I  G    PS    +++ +A+D I K L +NP+ R T  E ++HP
Sbjct: 211 PPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHP 269

Query: 232 FVK 234
           ++ 
Sbjct: 270 WIS 272

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  163 bits (415), Expect = 2e-49
 Identities = 58/248 (23%), Positives = 109/248 (43%), Gaps = 18/248 (7%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
              +  K V ++          + +++EIS+L+     NI+    + +    L +  E +
Sbjct: 30  KKTYMAKFVKVK------GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83

Query: 62  TKGSLAN--LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV--DASGSV 117
           +   +        + L++ ++ SY  Q+   L +LH  N+ H DI+  NI+     S ++
Sbjct: 84  SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTI 143

Query: 118 KLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP 176
           K+ +FG A+     D  +     P + APEV    +D      D+WSLG  V  +L+   
Sbjct: 144 KIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ--HDVVSTATDMWSLGTLVYVLLSGIN 201

Query: 177 PYSHLEGVQALFR-IGKGEL--PSVP-SSLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
           P+   E  Q +   I   E          +S +A DF+ + L      R T +E ++HP+
Sbjct: 202 PF-LAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260

Query: 233 VKRPLQTP 240
           +K+ ++  
Sbjct: 261 LKQKIERV 268

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  163 bits (415), Expect = 3e-49
 Identities = 56/221 (25%), Positives = 105/221 (47%), Gaps = 10/221 (4%)

Query: 25  QLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSY 83
            +++EI +      +N+V++ G  ++ N  Y+FLE  + G L + +     + +     +
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF 110

Query: 84  TRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGT 139
             Q++ G+VYLH   + HRDIK  N+L+D   ++K++DFGLA     N+    L    GT
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

Query: 140 PFWMAPEVVNSKNDGY-GLTADIWSLGCTVLEMLTRRPPY-SHLEGVQALFRIGKGELPS 197
             ++APE++  +   +     D+WS G  +  ML    P+    +  Q      + +   
Sbjct: 171 LPYVAPELLKRR--EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228

Query: 198 VP-SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL 237
            P   +       + K L  NP+ R T+ ++ +  +  +PL
Sbjct: 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  162 bits (413), Expect = 6e-49
 Identities = 59/243 (24%), Positives = 111/243 (45%), Gaps = 16/243 (6%)

Query: 6   AVKEVS---LQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVT 62
            VK +    + +        + ++  EI++LS+ E  NI++ L   +++    + +E   
Sbjct: 53  VVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHG 112

Query: 63  KGS--LANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
            G    A + +   L +   S   RQ+++ + YL  ++++HRDIK  NI++    ++KL 
Sbjct: 113 SGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLI 172

Query: 121 DFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGY-GLTADIWSLGCTVLEMLTRRPPY 178
           DFG A          +  GT  + APEV+      Y G   ++WSLG T+  ++    P+
Sbjct: 173 DFGSAAYLERGKLFYTFCGTIEYCAPEVLMGN--PYRGPELEMWSLGVTLYTLVFEENPF 230

Query: 179 SHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQ 238
             LE         +  +   P  +S++    +   LQ  P  R T+ +L+  P+V +P+ 
Sbjct: 231 CELE------ETVEAAI-HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVN 283

Query: 239 TPR 241
              
Sbjct: 284 LAD 286

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  163 bits (415), Expect = 1e-48
 Identities = 68/248 (27%), Positives = 119/248 (47%), Gaps = 17/248 (6%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
           G  F  K ++              ++ EIS+++Q     ++      +D+  + + LE +
Sbjct: 76  GRVFVAKFIN-----TPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130

Query: 62  TKGSLAN--LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV--DASGSV 117
           + G L +    + Y +S+++V +Y RQ   GL ++HE ++VH DIK  NI+     + SV
Sbjct: 131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSV 190

Query: 118 KLADFGLA-KATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP 176
           K+ DFGLA K      +K    T  + APE+V+   +  G   D+W++G     +L+   
Sbjct: 191 KIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD--REPVGFYTDMWAIGVLGYVLLSGLS 248

Query: 177 PYSHLEGVQALFR-IGKGEL--PSVP-SSLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
           P+   E      + + + +        SS+S +A+DFI   LQ  P  R TV + +EHP+
Sbjct: 249 PF-AGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 307

Query: 233 VKRPLQTP 240
           +K      
Sbjct: 308 LKGDHSNL 315

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  162 bits (411), Expect = 1e-48
 Identities = 68/277 (24%), Positives = 128/277 (46%), Gaps = 45/277 (16%)

Query: 5   FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTK 63
           +AVK   ++ Q    +     + +E+ +L Q +   N+++ +   ++E+R Y+  E +  
Sbjct: 41  YAVK--IIEKQPGHIRSR---VFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRG 95

Query: 64  GSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---DASGSVKL 119
           GS+ + ++++ H ++ + S   + + + L +LH + + HRD+K  NIL    +    VK+
Sbjct: 96  GSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKI 155

Query: 120 ADFGLAKATTMND---------LKSCKGTPFWMAPEVVNSKND---GYGLTADIWSLGCT 167
            DF L     +N          L +  G+  +MAPEVV + ++    Y    D+WSLG  
Sbjct: 156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215

Query: 168 VLEMLTRRPP--------------YSHLEGVQALF-RIGKG--ELPSVP-SSLSRDARDF 209
           +  +L+  PP               +       LF  I +G  E P    + +S  A+D 
Sbjct: 216 LYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDL 275

Query: 210 ILKCLQVNPNDRPTVTELMEHPFVK-----RPLQTPR 241
           I K L  +   R +  ++++HP+V+       L TP 
Sbjct: 276 ISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPM 312

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  162 bits (411), Expect = 1e-48
 Identities = 65/250 (26%), Positives = 118/250 (47%), Gaps = 26/250 (10%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLEL 60
           G  +A K +  + +G   +  I     EI++L   +    ++      ++ + + + LE 
Sbjct: 54  GQEYAAKFLKKRRRGQDCRAEI---LHEIAVLELAKSCPRVINLHEVYENTSEIILILEY 110

Query: 61  VTKGSL-----ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---D 112
              G +       L +   +S++ V    +QIL G+ YLH+ N+VH D+K  NIL+    
Sbjct: 111 AAGGEIFSLCLPELAE--MVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIY 168

Query: 113 ASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE- 170
             G +K+ DFG+++       L+   GTP ++APE++N          D+W++G  ++  
Sbjct: 169 PLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD--PITTATDMWNIG--IIAY 224

Query: 171 -MLTRRPPYSHLEGVQALFR-IGKGEL--PSVP-SSLSRDARDFILKCLQVNPNDRPTVT 225
            +LT   P+   E  Q  +  I +  +       SS+S+ A DFI   L  NP  RPT  
Sbjct: 225 MLLTHTSPFVG-EDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAE 283

Query: 226 ELMEHPFVKR 235
             + H ++++
Sbjct: 284 ICLSHSWLQQ 293

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  160 bits (407), Expect = 1e-48
 Identities = 68/223 (30%), Positives = 119/223 (53%), Gaps = 14/223 (6%)

Query: 25  QLEQEISLLSQFEQDNIVQ-Y--LGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQV 80
           ++++EI  L  F   +I++ Y  + T  D    ++ +E V+ G L + + +   + + + 
Sbjct: 57  KIKREIQNLKLFRHPHIIKLYQVISTPTD---FFMVMEYVSGGELFDYICKHGRVEEMEA 113

Query: 81  SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGT 139
               +QIL+ + Y H   VVHRD+K  N+L+DA  + K+ADFGL+   +  + L++  G+
Sbjct: 114 RRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGS 173

Query: 140 PFWMAPEVVNSKNDGY-GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR-IGKGELPS 197
           P + APEV++ +   Y G   DIWS G  +  +L    P+   E V  LF+ I  G    
Sbjct: 174 PNYAAPEVISGR--LYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVF-Y 229

Query: 198 VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTP 240
           +P  L+R     ++  LQV+P  R T+ ++ EH + K+ L + 
Sbjct: 230 IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSY 272

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  163 bits (414), Expect = 1e-48
 Identities = 55/274 (20%), Positives = 98/274 (35%), Gaps = 49/274 (17%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGT--DKDENRLYIFLE 59
           G  FA+K  +         + +    +E  +L +    NIV+      +       + +E
Sbjct: 34  GDLFAIKVFNNI----SFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89

Query: 60  LVTKGSLANLYQK----YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---- 111
               GSL  + ++    Y L +S+     R ++ G+ +L E  +VHR+IK  NI+     
Sbjct: 90  FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE 149

Query: 112 DASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVV------NSKNDGYGLTADIWSL 164
           D     KL DFG A+    ++   S  GT  ++ P++             YG T D+WS+
Sbjct: 150 DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209

Query: 165 GCTVLEMLTRRPPYSHLEG----VQALFRIGKGELP------------------------ 196
           G T     T   P+   EG     + +++I  G+                          
Sbjct: 210 GVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSC 269

Query: 197 SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
           S+   L       +   L+ +        +    
Sbjct: 270 SLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  160 bits (407), Expect = 3e-48
 Identities = 57/224 (25%), Positives = 108/224 (48%), Gaps = 19/224 (8%)

Query: 25  QLEQEISLLSQFEQDNIVQ-----YLGTDKDENRLYIFLELVTKGS--LANLYQKYHLSD 77
            +++EI LL +    N++Q     Y    +    +Y+ +E    G   + +   +     
Sbjct: 52  NVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK---MYMVMEYCVCGMQEMLDSVPEKRFPV 108

Query: 78  SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----L 133
            Q   Y  Q+++GL YLH + +VH+DIK  N+L+   G++K++  G+A+A          
Sbjct: 109 CQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC 168

Query: 134 KSCKGTPFWMAPEVVNSKNDGY-GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR-IG 191
           ++ +G+P +  PE+ N   D + G   DIWS G T+  + T   P+   + +  LF  IG
Sbjct: 169 RTSQGSPAFQPPEIANGL-DTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIG 226

Query: 192 KGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
           KG   ++P        D +   L+  P  R ++ ++ +H + ++
Sbjct: 227 KGSY-AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  160 bits (406), Expect = 4e-48
 Identities = 62/248 (25%), Positives = 113/248 (45%), Gaps = 32/248 (12%)

Query: 4   FFAVKEVSLQDQGAQGKQSILQLEQ------EISLLSQFEQDNIVQYLGTDKDENRLYIF 57
            +A+K +         K+ I++  +      E  ++S+ +    V+   T +D+ +LY  
Sbjct: 57  EYAIKILE--------KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 108

Query: 58  LELVTKGSLANLYQKYHLSDSQVSS-YTRQILNGLVYLHERNVVHRDIKCANILVDASGS 116
           L     G L    +K    D   +  YT +I++ L YLH + ++HRD+K  NIL++    
Sbjct: 109 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH 168

Query: 117 VKLADFGLAKATTMNDLKS-----CKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           +++ DFG AK  +    ++       GT  +++PE++  K      ++D+W+LGC + ++
Sbjct: 169 IQITDFGTAKVLSPESKQARANSFV-GTAQYVSPELLTEK--SACKSSDLWALGCIIYQL 225

Query: 172 LTRRPPYSHLEGVQALF-RIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT------V 224
           +   PP+        +F +I K E    P      ARD + K L ++   R         
Sbjct: 226 VAGLPPFRA-GNEYLIFQKIIKLEY-DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 283

Query: 225 TELMEHPF 232
             L  HPF
Sbjct: 284 GPLKAHPF 291

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  165 bits (420), Expect = 5e-48
 Identities = 67/242 (27%), Positives = 105/242 (43%), Gaps = 17/242 (7%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
           G  FA K V         +     + +EI  +S      +V      +D+N + +  E +
Sbjct: 182 GNNFAAKFVM-----TPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236

Query: 62  TKGSL--ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV--DASGSV 117
           + G L      +   +S+ +   Y RQ+  GL ++HE N VH D+K  NI+     S  +
Sbjct: 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNEL 296

Query: 118 KLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP 176
           KL DFGL         +K   GT  + APEV        G   D+WS+G     +L+   
Sbjct: 297 KLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE--GKPVGYYTDMWSVGVLSYILLSGLS 354

Query: 177 PYSHLEGVQALFR-IGKG--ELPSVP-SSLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
           P+   E      R +      +     S +S D +DFI K L  +PN R T+ + +EHP+
Sbjct: 355 PF-GGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413

Query: 233 VK 234
           + 
Sbjct: 414 LT 415

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  160 bits (406), Expect = 7e-48
 Identities = 61/229 (26%), Positives = 120/229 (52%), Gaps = 14/229 (6%)

Query: 20  KQSILQLEQEISLLSQFEQDNIV---QYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHL 75
             S+ +L +E+ ++      NIV   + + T+K    LY+ +E  + G + + L     +
Sbjct: 55  PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT---LYLIMEYASGGEVFDYLVAHGRM 111

Query: 76  SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LK 134
            + +  S  RQI++ + Y H++ +VHRD+K  N+L+DA  ++K+ADFG +   T+   L 
Sbjct: 112 KEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD 171

Query: 135 SCKGTPFWMAPEVVNSKNDGY-GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALF-RIGK 192
           +  G P + APE+   K   Y G   D+WSLG  +  +++   P+   + ++ L  R+ +
Sbjct: 172 AFCGAPPYAAPELFQGK--KYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLR 228

Query: 193 GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPR 241
           G+   +P  +S D  + + + L +NP  R T+ ++M+  ++    +   
Sbjct: 229 GKYR-IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDE 276

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  161 bits (410), Expect = 7e-48
 Identities = 73/269 (27%), Positives = 117/269 (43%), Gaps = 40/269 (14%)

Query: 5   FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQ----YLGTDKDENRLYIFLEL 60
           FA+K +              + E E+      +  +IV+    Y         L I +E 
Sbjct: 90  FALKMLQ--------DCPKARREVEL-HWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140

Query: 61  VTKGSL-----ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---D 112
           +  G L         Q +  ++ + S   + I   + YLH  N+ HRD+K  N+L     
Sbjct: 141 LDGGELFSRIQDRGDQAF--TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR 198

Query: 113 ASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
            +  +KL DFG AK TT ++ L +   TP+++APEV+  +   Y  + D+WSLG  +  +
Sbjct: 199 PNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYIL 256

Query: 172 LTRRPPY---SHLEGVQALF-RIGKG--ELPSVP-SSLSRDARDFILKCLQVNPNDRPTV 224
           L   PP+     L     +  RI  G  E P+   S +S + +  I   L+  P  R T+
Sbjct: 257 LCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI 316

Query: 225 TELMEHPFVK-------RPLQTPRCGQAN 246
           TE M HP++         PL T R  + +
Sbjct: 317 TEFMNHPWIMQSTKVPQTPLHTSRVLKED 345

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  161 bits (408), Expect = 8e-48
 Identities = 64/244 (26%), Positives = 122/244 (50%), Gaps = 21/244 (8%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELV 61
           G   A K   ++ +G + K+ +   + EIS+++Q +  N++Q     + +N + + +E V
Sbjct: 114 GLKLAAK--IIKTRGMKDKEEV---KNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168

Query: 62  TKGSLAN--LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV--DASGSV 117
             G L +  + + Y+L++     + +QI  G+ ++H+  ++H D+K  NIL     +  +
Sbjct: 169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQI 228

Query: 118 KLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE--MLTR 174
           K+ DFGLA+     + LK   GTP ++APEVVN   D      D+WS+G  V+   +L+ 
Sbjct: 229 KIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN--YDFVSFPTDMWSVG--VIAYMLLSG 284

Query: 175 RPPYSHLEGVQALFR-IGKGEL--PSVP-SSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
             P+   +        I              +S +A++FI K L    + R + +E ++H
Sbjct: 285 LSPF-LGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343

Query: 231 PFVK 234
           P++ 
Sbjct: 344 PWLS 347

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  160 bits (407), Expect = 2e-47
 Identities = 62/246 (25%), Positives = 113/246 (45%), Gaps = 24/246 (9%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQ------EISLLSQFEQDNIVQYLGTDKDENRL 54
               +A+K ++        KQ  ++  +      E+ ++   E   +V    + +DE  +
Sbjct: 39  TKKMYAMKYMN--------KQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90

Query: 55  YIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           ++ ++L+  G L   L Q  H  +  V  +  +++  L YL  + ++HRD+K  NIL+D 
Sbjct: 91  FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDE 150

Query: 114 SGSVKLADFGLAKATTMNDLKS--CKGTPFWMAPEVVNSKN-DGYGLTADIWSLGCTVLE 170
            G V + DF +A         +    GT  +MAPE+ +S+   GY    D WSLG T  E
Sbjct: 151 HGHVHITDFNIAAMLPRETQITTMA-GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYE 209

Query: 171 MLTRRPPY---SHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR-PTVTE 226
           +L  R PY   S     + +       +   PS+ S++    + K L+ NP+ R   +++
Sbjct: 210 LLRGRRPYHIRSSTSSKEIVHTFETTVVT-YPSAWSQEMVSLLKKLLEPNPDQRFSQLSD 268

Query: 227 LMEHPF 232
           +   P+
Sbjct: 269 VQNFPY 274

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  157 bits (400), Expect = 4e-47
 Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 15/228 (6%)

Query: 25  QLEQEISLLSQFEQD--NIVQYLGTDKDENRLYIFLELVT-KGSLAN-LYQKYHLSDSQV 80
           ++  E+ LL +       +++ L   +  +   + LE       L + + ++  L +   
Sbjct: 92  RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 151

Query: 81  SSYTRQILNGLVYLHERNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMNDLKSCKGT 139
            S+  Q+L  + + H   V+HRDIK  NIL+D   G +KL DFG              GT
Sbjct: 152 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGT 211

Query: 140 PFWMAPEVVNSKNDGY-GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV 198
             +  PE +      Y G +A +WSLG  + +M+    P+ H E       I +G++   
Sbjct: 212 RVYSPPEWIRYH--RYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQV-FF 262

Query: 199 PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPRCGQAN 246
              +S + +  I  CL + P+DRPT  E+  HP+++  L      + +
Sbjct: 263 RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 310

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  157 bits (398), Expect = 4e-47
 Identities = 64/268 (23%), Positives = 102/268 (38%), Gaps = 51/268 (19%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN----RLYIFLELV 61
           AVK  S +D     ++S  + E E+        +NI+ ++ +D        +L++     
Sbjct: 35  AVKIFSSRD-----EKSWFR-ETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH 88

Query: 62  TKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHER--------NVVHRDIKCANILVDA 113
             GSL +  Q   L           I +GL +LH           + HRD+K  NILV  
Sbjct: 89  EMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKK 148

Query: 114 SGSVKLADFGLAK----ATTMNDL--KSCKGTPFWMAPEV----VNSKNDGYGLTADIWS 163
           +G   +AD GLA     +T   D+      GT  +MAPEV    +           DIW+
Sbjct: 149 NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWA 208

Query: 164 LGCTVL-EMLTR----------RPPYSHLEGVQALFR------IGKGELPSVPSSLSRDA 206
            G  VL E+  R          +PP+  +      F           + P++P+    D 
Sbjct: 209 FG-LVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDP 267

Query: 207 -----RDFILKCLQVNPNDRPTVTELME 229
                   + +C   NP+ R T   + +
Sbjct: 268 TLTSLAKLMKECWYQNPSARLTALRIKK 295

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  160 bits (405), Expect = 5e-47
 Identities = 35/275 (12%), Positives = 74/275 (26%), Gaps = 43/275 (15%)

Query: 5   FAVKEVSLQDQGAQGKQSILQLEQEI--------------------SLLSQFEQDNIVQY 44
           F V      ++        ++ E                             +     + 
Sbjct: 106 FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKM 165

Query: 45  LGTDKDENRLYIFLELV----TKGSLANLYQ--------KYHLSDSQVSSYTRQILNGLV 92
           +    DE  +++          + +L    +           L        T Q++  L 
Sbjct: 166 IRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLA 225

Query: 93  YLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK---GTPFWMAPEVVN 149
            LH   +VH  ++  +I++D  G V L  F        + +         P   A  ++ 
Sbjct: 226 SLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLP 285

Query: 150 SKNDG---YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDA 206
                        D W+LG  +  +     P +    +     I +        ++ +  
Sbjct: 286 FGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRS-----CKNIPQPV 340

Query: 207 RDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPR 241
           R  +   L+    DR    + ME P  ++      
Sbjct: 341 RALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELS 375

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  157 bits (398), Expect = 6e-47
 Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 17/224 (7%)

Query: 25  QLEQEISLLSQFEQD----NIVQYLGTDKDENRLYIFLELVTKGS--LANLYQKYHLSDS 78
               E++LL +         +++ L   + +    + LE           + +K  L + 
Sbjct: 80  TCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG 139

Query: 79  QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMNDLKSCK 137
               +  Q++  + + H R VVHRDIK  NIL+D   G  KL DFG              
Sbjct: 140 PSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD 199

Query: 138 GTPFWMAPEVVNSKNDGY-GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP 196
           GT  +  PE ++     Y  L A +WSLG  + +M+    P+   +       I + EL 
Sbjct: 200 GTRVYSPPEWISRH--QYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAEL- 250

Query: 197 SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTP 240
             P+ +S D    I +CL   P+ RP++ E++  P+++ P +  
Sbjct: 251 HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDV 294

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  155 bits (394), Expect = 6e-46
 Identities = 69/245 (28%), Positives = 116/245 (47%), Gaps = 26/245 (10%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQ------EISLLSQFEQDNIVQYLGTDKDENRL 54
            G  +A+K +         KQ +++L+Q      E  +L       +V+   + KD + L
Sbjct: 65  SGNHYAMKILD--------KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116

Query: 55  YIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           Y+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++RD+K  N+L+D 
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ 176

Query: 114 SGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
            G +++ DFG AK         C GTP  +APE++ SK  GY    D W+LG  + EM  
Sbjct: 177 QGYIQVTDFGFAKRVKGRTWTLC-GTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAA 233

Query: 174 RRPPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQVNPNDR-----PTVTEL 227
             PP+   +    ++  I  G++   PS  S D +D +   LQV+   R       V ++
Sbjct: 234 GYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI 291

Query: 228 MEHPF 232
             H +
Sbjct: 292 KNHKW 296

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  154 bits (391), Expect = 1e-45
 Identities = 67/223 (30%), Positives = 115/223 (51%), Gaps = 15/223 (6%)

Query: 25  QLEQEISLLSQFEQDNIVQ-Y--LGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQV 80
           ++E+EIS L      +I++ Y  + T  D   + + +E    G L + + +K  +++ + 
Sbjct: 55  RVEREISYLKLLRHPHIIKLYDVITTPTD---IVMVIEYA-GGELFDYIVEKKRMTEDEG 110

Query: 81  SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGT 139
             + +QI+  + Y H   +VHRD+K  N+L+D + +VK+ADFGL+   T  + LK+  G+
Sbjct: 111 RRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGS 170

Query: 140 PFWMAPEVVNSKNDGY-GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR-IGKGELPS 197
           P + APEV+N K   Y G   D+WS G  +  ML  R P+   E +  LF+ +       
Sbjct: 171 PNYAAPEVINGK--LYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSCVY-V 226

Query: 198 VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTP 240
           +P  LS  A+  I + +  +P  R T+ E+   P+    L   
Sbjct: 227 MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDY 269

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  157 bits (398), Expect = 2e-45
 Identities = 68/223 (30%), Positives = 115/223 (51%), Gaps = 14/223 (6%)

Query: 25  QLEQEISLLSQFEQDNIV---QYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQV 80
           ++ +EI  L  F   +I+   Q + T  D   +++ +E V+ G L + + +   L + + 
Sbjct: 62  KIRREIQNLKLFRHPHIIKLYQVISTPSD---IFMVMEYVSGGELFDYICKNGRLDEKES 118

Query: 81  SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGT 139
               +QIL+G+ Y H   VVHRD+K  N+L+DA  + K+ADFGL+   +  + L++  G+
Sbjct: 119 RRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGS 178

Query: 140 PFWMAPEVVNSKNDGY-GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR-IGKGELPS 197
           P + APEV++ +   Y G   DIWS G  +  +L    P+   + V  LF+ I  G    
Sbjct: 179 PNYAAPEVISGR--LYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIF-Y 234

Query: 198 VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTP 240
            P  L+      +   LQV+P  R T+ ++ EH + K+ L   
Sbjct: 235 TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKY 277

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  153 bits (389), Expect = 2e-45
 Identities = 65/250 (26%), Positives = 121/250 (48%), Gaps = 36/250 (14%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQ------EISLLSQFEQDNIVQYLGTDKDENRL 54
           +G ++A+K +         K+ +++L+Q      E  +LS      I++  GT +D  ++
Sbjct: 30  NGRYYAMKVLK--------KEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 81

Query: 55  YIFLELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           ++ ++ +  G L +L +K     +     Y  ++   L YLH +++++RD+K  NIL+D 
Sbjct: 82  FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK 141

Query: 114 SGSVKLADFGLAK-----ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           +G +K+ DFG AK       T+     C GTP ++APEVV++K   Y  + D WS G  +
Sbjct: 142 NGHIKITDFGFAKYVPDVTYTL-----C-GTPDYIAPEVVSTK--PYNKSIDWWSFGILI 193

Query: 169 LEMLTRRPPYSHLEGVQALF-RIGKGELPSVPSSLSRDARDFILKCLQVNPNDR-----P 222
            EML    P+         + +I   EL   P   + D +D + + +  + + R      
Sbjct: 194 YEMLAGYTPFYD-SNTMKTYEKILNAEL-RFPPFFNEDVKDLLSRLITRDLSQRLGNLQN 251

Query: 223 TVTELMEHPF 232
              ++  HP+
Sbjct: 252 GTEDVKNHPW 261

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  153 bits (388), Expect = 4e-45
 Identities = 73/248 (29%), Positives = 95/248 (38%), Gaps = 56/248 (22%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-----KYHLSDSQVSSY 83
           EI LL Q   +N+V  L   K + R Y+  E V       +          L    V  Y
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH----TILDDLELFPNGLDYQVVQKY 129

Query: 84  TRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF-- 141
             QI+NG+ + H  N++HRDIK  NILV  SG VKL DFG A+        +  G  +  
Sbjct: 130 LFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART------LAAPGEVYDD 183

Query: 142 -----WM-APEV-VNSKNDGYGLTADIWSLGCTVLEMLTRRP------------------ 176
                W  APE+ V      YG   D+W++GC V EM    P                  
Sbjct: 184 EVATRWYRAPELLVGDVK--YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCL 241

Query: 177 ---PYSHLEGVQALFRIGKGELPSVP---------SSLSRDARDFILKCLQVNPNDRPTV 224
                 H E            LP +            LS    D   KCL ++P+ RP  
Sbjct: 242 GNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFC 301

Query: 225 TELMEHPF 232
            EL+ H F
Sbjct: 302 AELLHHDF 309

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  152 bits (387), Expect = 5e-45
 Identities = 65/268 (24%), Positives = 102/268 (38%), Gaps = 51/268 (19%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVT--- 62
           AVK     +     + S  + E EI        +NI+ ++  D      +  L L+T   
Sbjct: 64  AVKVFFTTE-----EASWFR-ETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYH 117

Query: 63  -KGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERN--------VVHRDIKCANILVDA 113
             GSL +  +   L    +       ++GL +LH           + HRD+K  NILV  
Sbjct: 118 ENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177

Query: 114 SGSVKLADFGLAK----ATTMNDL--KSCKGTPFWMAPEV----VNSKNDGYGLTADIWS 163
           +G+  +AD GLA      T   D+   +  GT  +M PEV    +N  +    + AD++S
Sbjct: 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYS 237

Query: 164 LGCTVL-EMLTR----------RPPYSHLEGVQALFRI------GKGELPSVPSSLSRDA 206
            G  +L E+  R          + PY  L      +         K   PS P+  S D 
Sbjct: 238 FGL-ILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDE 296

Query: 207 -----RDFILKCLQVNPNDRPTVTELME 229
                   + +C   NP  R T   + +
Sbjct: 297 CLRQMGKLMTECWAHNPASRLTALRVKK 324

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  151 bits (385), Expect = 7e-45
 Identities = 55/248 (22%), Positives = 94/248 (37%), Gaps = 56/248 (22%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-----KYHLSDSQVSSY 83
           EI +L Q +  N+V  L   + + RL++  E         +       +  + +  V S 
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH----TVLHELDRYQRGVPEHLVKSI 107

Query: 84  TRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF-- 141
           T Q L  + + H+ N +HRD+K  NIL+     +KL DFG A+        +     +  
Sbjct: 108 TWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARL------LTGPSDYYDD 161

Query: 142 -----WM-APEV-VNSKNDGYGLTADIWSLGCTVLEMLTRRPPY---------------- 178
                W  +PE+ V      YG   D+W++GC   E+L+  P +                
Sbjct: 162 EVATRWYRSPELLVGDTQ--YGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL 219

Query: 179 -----SHLEGVQAL---------FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV 224
                 H +                     L     ++S  A   +  CL ++P +R T 
Sbjct: 220 GDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTC 279

Query: 225 TELMEHPF 232
            +L+ HP+
Sbjct: 280 EQLLHHPY 287

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  152 bits (386), Expect = 8e-45
 Identities = 64/267 (23%), Positives = 105/267 (39%), Gaps = 49/267 (18%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVT--- 62
           AVK  S ++     ++S  + E EI        +NI+ ++  D  +N  +  L LV+   
Sbjct: 69  AVKIFSSRE-----ERSWFR-EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 122

Query: 63  -KGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHER--------NVVHRDIKCANILVDA 113
             GSL +   +Y ++   +        +GL +LH           + HRD+K  NILV  
Sbjct: 123 EHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 182

Query: 114 SGSVKLADFGLAK----ATTMNDLKSC--KGTPFWMAPEV----VNSKNDGYGLTADIWS 163
           +G+  +AD GLA     AT   D+      GT  +MAPEV    +N K+      ADI++
Sbjct: 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 242

Query: 164 LGCTVLEMLTR----------RPPYSHLEGVQALFR------IGKGELPSVPSSLSRDA- 206
           +G    E+  R          + PY  L                +   P++P+       
Sbjct: 243 MGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEA 302

Query: 207 ----RDFILKCLQVNPNDRPTVTELME 229
                  + +C   N   R T   + +
Sbjct: 303 LRVMAKIMRECWYANGAARLTALRIKK 329

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  150 bits (380), Expect = 8e-44
 Identities = 64/196 (32%), Positives = 100/196 (51%), Gaps = 14/196 (7%)

Query: 50  DENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCAN 108
            E +L++ L+ +  G L   L Q+   ++ +V  Y  +I+  L +LH+  +++RDIK  N
Sbjct: 130 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLEN 189

Query: 109 ILVDASGSVKLADFGLAKATTMNDLKSCK---GTPFWMAPEVVNSKNDGYGLTADIWSLG 165
           IL+D++G V L DFGL+K    ++ +      GT  +MAP++V   + G+    D WSLG
Sbjct: 190 ILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG 249

Query: 166 CTVLEMLTRRPP-YSHLEG--VQALFR-IGKGELPSVPSSLSRDARDFILKCLQVNPNDR 221
             + E+LT   P     E      + R I K E P  P  +S  A+D I + L  +P  R
Sbjct: 250 VLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP-YPQEMSALAKDLIQRLLMKDPKKR 308

Query: 222 ----PT-VTELMEHPF 232
               P    E+ EH F
Sbjct: 309 LGCGPRDADEIKEHLF 324

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  155 bits (393), Expect = 9e-44
 Identities = 46/248 (18%), Positives = 85/248 (34%), Gaps = 20/248 (8%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQ------YLGTDKDENRLYIFLE 59
           A+K+   +       ++  +   EI ++ +    N+V        L      +   + +E
Sbjct: 43  AIKQCRQE----LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 98

Query: 60  LVTKGSLANLYQK----YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
               G L     +      L +  + +    I + L YLHE  ++HRD+K  NI++    
Sbjct: 99  YCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGP 158

Query: 116 S---VKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
                K+ D G AK     +      GT  ++APE++  K   Y +T D WS G    E 
Sbjct: 159 QRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQK--KYTVTVDYWSFGTLAFEC 216

Query: 172 LTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP 231
           +T   P+             + +                   +   PN    +       
Sbjct: 217 ITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLER 276

Query: 232 FVKRPLQT 239
           +++  L  
Sbjct: 277 WLQCMLMW 284

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  148 bits (376), Expect = 2e-43
 Identities = 64/192 (33%), Positives = 102/192 (53%), Gaps = 15/192 (7%)

Query: 51  ENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           E +LY+ L+ +  G L   L ++   ++  V  Y  ++   L +LH   +++RD+K  NI
Sbjct: 98  EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENI 157

Query: 110 LVDASGSVKLADFGLAKATTMNDLKS---CKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           L+D  G +KL DFGL+K +  ++ K+   C GT  +MAPEVVN +  G+  +AD WS G 
Sbjct: 158 LLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNRR--GHTQSADWWSFGV 214

Query: 167 TVLEMLTRRPPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQVNPNDR---- 221
            + EMLT   P+   +  +     I K +L  +P  LS +A+  +    + NP +R    
Sbjct: 215 LMFEMLTGTLPFQG-KDRKETMTMILKAKL-GMPQFLSPEAQSLLRMLFKRNPANRLGAG 272

Query: 222 PT-VTELMEHPF 232
           P  V E+  H F
Sbjct: 273 PDGVEEIKRHSF 284

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  153 bits (389), Expect = 3e-43
 Identities = 60/192 (31%), Positives = 96/192 (50%), Gaps = 11/192 (5%)

Query: 50  DENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCAN 108
             ++L   L+L+  G L  +L Q    S++ +  Y  +I+ GL ++H R VV+RD+K AN
Sbjct: 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 322

Query: 109 ILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           IL+D  G V+++D GLA   +     +  GT  +MAPEV+  K   Y  +AD +SLGC +
Sbjct: 323 ILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGVAYDSSADWFSLGCML 381

Query: 169 LEMLTRRPPYSHLEG--VQALFR-IGKGELPSVPSSLSRDARDFILKCLQVNPNDR---- 221
            ++L    P+   +      + R      +  +P S S + R  +   LQ + N R    
Sbjct: 382 FKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-ELPDSFSPELRSLLEGLLQRDVNRRLGCL 440

Query: 222 -PTVTELMEHPF 232
                E+ E PF
Sbjct: 441 GRGAQEVKESPF 452

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  147 bits (374), Expect = 3e-43
 Identities = 62/192 (32%), Positives = 100/192 (52%), Gaps = 15/192 (7%)

Query: 51  ENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
             +LY+ LE ++ G L   L ++    +     Y  +I   L +LH++ +++RD+K  NI
Sbjct: 93  GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENI 152

Query: 110 LVDASGSVKLADFGLAKATTMNDLKS---CKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           +++  G VKL DFGL K +  +   +   C GT  +MAPE++     G+    D WSLG 
Sbjct: 153 MLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPEILMRS--GHNRAVDWWSLGA 209

Query: 167 TVLEMLTRRPPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQVNPNDR---- 221
            + +MLT  PP++  E  +     I K +L  +P  L+++ARD + K L+ N   R    
Sbjct: 210 LMYDMLTGAPPFTG-ENRKKTIDKILKCKLN-LPPYLTQEARDLLKKLLKRNAASRLGAG 267

Query: 222 PT-VTELMEHPF 232
           P    E+  HPF
Sbjct: 268 PGDAGEVQAHPF 279

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  148 bits (375), Expect = 5e-43
 Identities = 61/228 (26%), Positives = 106/228 (46%), Gaps = 22/228 (9%)

Query: 25  QLEQEISLLSQFEQDNIVQY---LGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQV 80
            +++EI         NIV++   + T      L I +E  + G L   +      S+ + 
Sbjct: 62  NVQREIINHRSLRHPNIVRFKEVILTPTH---LAIIMEYASGGELYERICNAGRFSEDEA 118

Query: 81  SSYTRQILNGLVYLHERNVVHRDIKCANILVDAS--GSVKLADFGLAKATTMND-LKSCK 137
             + +Q+L+G+ Y H   + HRD+K  N L+D S    +K+ DFG +K++ ++   KS  
Sbjct: 119 RFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 178

Query: 138 GTPFWMAPEVVNSKNDGY-GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR-----IG 191
           GTP ++APEV+  +   Y G  AD+WS G T+  ML    P+         +R     I 
Sbjct: 179 GTPAYIAPEVLLRQ--EYDGKIADVWSCGVTLYVMLVGAYPFED-PEEPRDYRKTIQRIL 235

Query: 192 KGELPSVPSS--LSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL 237
             +  S+P    +S +    I +    +P  R ++ E+  H +  + L
Sbjct: 236 SVKY-SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  144 bits (366), Expect = 5e-42
 Identities = 64/267 (23%), Positives = 111/267 (41%), Gaps = 49/267 (18%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVT--- 62
           AVK   +QD     KQS    E E+  L   + +NI+Q++G +K    + + L L+T   
Sbjct: 51  AVKIFPIQD-----KQSWQN-EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH 104

Query: 63  -KGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHER----------NVVHRDIKCANILV 111
            KGSL++  +   +S +++      +  GL YLHE            + HRDIK  N+L+
Sbjct: 105 EKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL 164

Query: 112 DASGSVKLADFGLAK----ATTMNDLKSCKGTPFWMAPEVVN---SKNDGYGLTADIWSL 164
             + +  +ADFGLA       +  D     GT  +MAPEV+    +      L  D++++
Sbjct: 165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224

Query: 165 GCTVLEMLTRRPPYSH-LEGVQALFR----------------IGKGELPSVPSSLSRDA- 206
           G  + E+ +R       ++     F                 + K + P +     + A 
Sbjct: 225 GLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAG 284

Query: 207 ----RDFILKCLQVNPNDRPTVTELME 229
                + I +C   +   R +   + E
Sbjct: 285 MAMLCETIEECWDHDAEARLSAGCVGE 311

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  149 bits (378), Expect = 5e-42
 Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 24/199 (12%)

Query: 51  ENRLYIFLELVTKGSLANLYQKYHL--------SDSQVSSYTRQILNGLVYLHERNVVHR 102
           ++ L + L L+  G L     K+H+         +++   Y  +I  GL  LH   +V+R
Sbjct: 256 KDALCLVLTLMNGGDL-----KFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR 310

Query: 103 DIKCANILVDASGSVKLADFGLAKATTMNDL-KSCKGTPFWMAPEVVNSKNDGYGLTADI 161
           D+K  NIL+D  G ++++D GLA         K   GT  +MAPEVV  KN+ Y  + D 
Sbjct: 311 DLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--KNERYTFSPDW 368

Query: 162 WSLGCTVLEMLTRRPP-YSHLEGVQA--LFRIGKGELPSVPSSLSRDARDFILKCLQVNP 218
           W+LGC + EM+  + P     + ++   + R+ K          S  AR    + L  +P
Sbjct: 369 WALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDP 428

Query: 219 NDR-----PTVTELMEHPF 232
            +R      +  E+ EHP 
Sbjct: 429 AERLGCRGGSAREVKEHPL 447

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  148 bits (375), Expect = 9e-42
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 29/205 (14%)

Query: 51  ENRLYIFLELVTKGSLANLYQKYHL----------SDSQVSSYTRQILNGLVYLHERNVV 100
           +  L + + ++  G +     +YH+           + +   YT QI++GL +LH+RN++
Sbjct: 257 KTDLCLVMTIMNGGDI-----RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII 311

Query: 101 HRDIKCANILVDASGSVKLADFGLAKATTMNDLKS---CKGTPFWMAPEVVNSKNDGYGL 157
           +RD+K  N+L+D  G+V+++D GLA        K+     GTP +MAPE++    + Y  
Sbjct: 312 YRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELL--LGEEYDF 368

Query: 158 TADIWSLGCTVLEMLTRRPP-YSHLEGVQA--LFRIGKGELPSVPSSLSRDARDFILKCL 214
           + D ++LG T+ EM+  R P  +  E V+   L +    +  + P   S  ++DF    L
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALL 428

Query: 215 QVNPNDR-----PTVTELMEHPFVK 234
           Q +P  R      +   L  HP  +
Sbjct: 429 QKDPEKRLGFRDGSCDGLRTHPLFR 453

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  144 bits (366), Expect = 1e-41
 Identities = 59/196 (30%), Positives = 91/196 (46%), Gaps = 24/196 (12%)

Query: 51  ENRLYIFLELVTKGSLANLYQKYHLSDSQVSS------YTRQILNGLVYLHERNVVHRDI 104
            ++LY  L+ +  G L      YHL   +         Y  +I + L YLH  N+V+RD+
Sbjct: 111 ADKLYFVLDYINGGELF-----YHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 165

Query: 105 KCANILVDASGSVKLADFGLAKATTMNDLKS---CKGTPFWMAPEVVNSKNDGYGLTADI 161
           K  NIL+D+ G + L DFGL K    ++  +   C GTP ++APEV++ +   Y  T D 
Sbjct: 166 KPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAPEVLHKQ--PYDRTVDW 222

Query: 162 WSLGCTVLEMLTRRPPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQVNPND 220
           W LG  + EML   PP+        ++  I    L  +  +++  AR  +   LQ +   
Sbjct: 223 WCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPL-QLKPNITNSARHLLEGLLQKDRTK 280

Query: 221 R----PTVTELMEHPF 232
           R        E+  H F
Sbjct: 281 RLGAKDDFMEIKSHVF 296

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  143 bits (363), Expect = 2e-41
 Identities = 63/192 (32%), Positives = 100/192 (52%), Gaps = 15/192 (7%)

Query: 51  ENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
            +RL   +E    G L  +L ++   ++ +   Y  +I++ L YLH R+VV+RDIK  N+
Sbjct: 77  HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENL 136

Query: 110 LVDASGSVKLADFGLAKATTMNDLKS---CKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           ++D  G +K+ DFGL K    +       C GTP ++APEV+      YG   D W LG 
Sbjct: 137 MLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDN--DYGRAVDWWGLGV 193

Query: 167 TVLEMLTRRPPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQVNPNDR---- 221
            + EM+  R P+ + +  + LF  I   E+   P +LS +A+  +   L+ +P  R    
Sbjct: 194 VMYEMMCGRLPFYN-QDHERLFELILMEEIR-FPRTLSPEAKSLLAGLLKKDPKQRLGGG 251

Query: 222 PT-VTELMEHPF 232
           P+   E+MEH F
Sbjct: 252 PSDAKEVMEHRF 263

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  144 bits (364), Expect = 2e-41
 Identities = 41/234 (17%), Positives = 78/234 (33%), Gaps = 28/234 (11%)

Query: 26  LEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH------LSDSQ 79
             Q +  L    Q   +++      +N   +  EL + G+L N    Y       +    
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL 173

Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILV-----------DASGSVKLADFGLAKAT 128
           V S+  ++L  +  +H+  ++H DIK  N ++           D S  + L D G +   
Sbjct: 174 VISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233

Query: 129 TMND----LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV 184
            +        +   T  +   E++++K   +    D + +  TV  ML         EG 
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291

Query: 185 QALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQ 238
           +         LP +         +F    L +         +L+     K   Q
Sbjct: 292 ECKPEGLFRRLPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  143 bits (363), Expect = 2e-41
 Identities = 57/193 (29%), Positives = 96/193 (49%), Gaps = 16/193 (8%)

Query: 51  ENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
            +RL+  +E V  G L  ++ +     +++   Y  +I++ L++LH++ +++RD+K  N+
Sbjct: 96  PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNV 155

Query: 110 LVDASGSVKLADFGLAKATTMNDLKS---CKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           L+D  G  KLADFG+ K    N + +   C GTP ++APE++      YG   D W++G 
Sbjct: 156 LLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPEILQEM--LYGPAVDWWAMGV 212

Query: 167 TVLEMLTRRPPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQVNPNDR---- 221
            + EML    P+   E    LF  I   E+   P+ L  DA   +   +  NP  R    
Sbjct: 213 LLYEMLCGHAPFEA-ENEDDLFEAILNDEV-VYPTWLHEDATGILKSFMTKNPTMRLGSL 270

Query: 222 --PTVTELMEHPF 232
                  ++ HPF
Sbjct: 271 TQGGEHAILRHPF 283

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  141 bits (357), Expect = 5e-41
 Identities = 70/247 (28%), Positives = 102/247 (41%), Gaps = 56/247 (22%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENRLYI---FLELVTKGSLANLYQKYHLSDSQVSSYTR 85
           EIS+L + +  NIV+       + RL +    L+   K  L     +  L      S+  
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLL 107

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---- 141
           Q+LNG+ Y H+R V+HRD+K  N+L++  G +K+ADFGLA+A          G P     
Sbjct: 108 QLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARA---------FGIPVRKYT 158

Query: 142 ------WM-APEV-VNSKNDGYGLTADIWSLGCTVLEMLTRRP----------------- 176
                 W  AP+V + SK   Y  T DIWS+GC   EM+   P                 
Sbjct: 159 HEIVTLWYRAPDVLMGSKK--YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216

Query: 177 ---P-------YSHLEGVQALF-RIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT 225
              P        + L      F         S    L     D + K L+++PN R T  
Sbjct: 217 LGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276

Query: 226 ELMEHPF 232
           + +EH +
Sbjct: 277 QALEHAY 283

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  144 bits (364), Expect = 6e-41
 Identities = 63/247 (25%), Positives = 110/247 (44%), Gaps = 28/247 (11%)

Query: 4   FFAVKEVSLQDQGAQGKQSILQLEQ------EISLLSQFEQDNIVQYLGTDKDENRLYIF 57
            +A+K +S        K  +++         E  +++      +VQ     +D+  LY+ 
Sbjct: 96  VYAMKLLS--------KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147

Query: 58  LELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV 117
           +E +  G L NL   Y + +     YT +++  L  +H    +HRD+K  N+L+D SG +
Sbjct: 148 MEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL 207

Query: 118 KLADFGLAKATTMNDLKSCK---GTPFWMAPEVVNSK--NDGYGLTADIWSLGCTVLEML 172
           KLADFG         +  C    GTP +++PEV+ S+  +  YG   D WS+G  + EML
Sbjct: 208 KLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267

Query: 173 TRRPPYSHLEGVQALFR---IGKGELPSVPSS-LSRDARDFILKCLQVNPNDR---PTVT 225
               P+   + +   +      K  L     + +S++A++ I      +   R     V 
Sbjct: 268 VGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI-CAFLTDREVRLGRNGVE 325

Query: 226 ELMEHPF 232
           E+  H F
Sbjct: 326 EIKRHLF 332

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  141 bits (358), Expect = 6e-41
 Identities = 65/248 (26%), Positives = 107/248 (43%), Gaps = 32/248 (12%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG--TDKDENRLYIFLELVTK 63
           AVK  +L+     G Q     +QEI +L     ++I++Y G   D     L + +E V  
Sbjct: 64  AVK--ALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPL 119

Query: 64  GSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFG 123
           GSL +   ++ +  +Q+  + +QI  G+ YLH ++ +HRD+   N+L+D    VK+ DFG
Sbjct: 120 GSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG 179

Query: 124 LAKATTMNDLKSCKGTP-----FWMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLT---- 173
           LAKA                  FW APE      +  +   +D+WS G T+ E+LT    
Sbjct: 180 LAKAVPEGHEYYRVREDGDSPVFWYAPE---CLKEYKFYYASDVWSFGVTLYELLTHCDS 236

Query: 174 -----------RRPPYSHLEGVQALFRIGKGE-LPSVPSSLSRDARDFILKCLQVNPNDR 221
                             +  ++    + +GE LP  P     +    +  C +   + R
Sbjct: 237 SQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPR-PDKCPAEVYHLMKNCWETEASFR 295

Query: 222 PTVTELME 229
           PT   L+ 
Sbjct: 296 PTFENLIP 303

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  143 bits (362), Expect = 9e-41
 Identities = 69/256 (26%), Positives = 105/256 (41%), Gaps = 65/256 (25%)

Query: 29  EISLLSQFEQDNIVQYL------GTDKDENRLYIFLELVTKGSLANLYQ--------KYH 74
           E+ ++   +  N+V         G  KDE  L + LE V +     +Y+        K  
Sbjct: 82  ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE----TVYRASRHYAKLKQT 137

Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMNDL 133
           +    +  Y  Q+L  L Y+H   + HRDIK  N+L+D  SG +KL DFG AK       
Sbjct: 138 MPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI---- 193

Query: 134 KSCKGTPF-------WM-APEVV-NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV 184
               G P        +  APE++  + N  Y    DIWS GC + E++  +P +    G+
Sbjct: 194 ---AGEPNVSYICSRYYRAPELIFGATN--YTTNIDIWSTGCVMAELMQGQPLFPGESGI 248

Query: 185 QALFRIGK-------GELPSV-------------PSSLSR--------DARDFILKCLQV 216
             L  I K        ++ ++             P   S+        DA D I + L+ 
Sbjct: 249 DQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEY 308

Query: 217 NPNDRPTVTELMEHPF 232
            P+ R T  E + HPF
Sbjct: 309 TPSARLTAIEALCHPF 324

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  143 bits (363), Expect = 1e-40
 Identities = 61/253 (24%), Positives = 111/253 (43%), Gaps = 30/253 (11%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQ------EISLLSQFEQDNIVQYLGTDKDENRL 54
               FA+K ++        K  +L+  +      E  +L   +   I       +D+N L
Sbjct: 98  ADKVFAMKILN--------KWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149

Query: 55  YIFLELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVD 112
           Y+ ++    G L  L  K+   L +     Y  +++  +  +H+ + VHRDIK  NIL+D
Sbjct: 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 209

Query: 113 ASGSVKLADFGLAKATTMNDLKSCK---GTPFWMAPEVVNSKND---GYGLTADIWSLGC 166
            +G ++LADFG       +         GTP +++PE++ +       YG   D WSLG 
Sbjct: 210 MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGV 269

Query: 167 TVLEMLTRRPPYSHLEGVQALFR---IGKGEL--PSVPSSLSRDARDFILKCLQVNPN-- 219
            + EML    P+ + E +   +      K     P+  + +S +A+D I + +    +  
Sbjct: 270 CMYEMLYGETPF-YAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRL 328

Query: 220 DRPTVTELMEHPF 232
            +  + +  +HPF
Sbjct: 329 GQNGIEDFKKHPF 341

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  140 bits (355), Expect = 1e-40
 Identities = 64/254 (25%), Positives = 97/254 (38%), Gaps = 40/254 (15%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG--TDKDENRLYIFLELVTK 63
           AVK   LQ    +  +   +   EI +L   + DNIV+Y G         L + +E +  
Sbjct: 43  AVK--KLQHSTEEHLRDFER---EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 97

Query: 64  GSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLAD 121
           GSL +  QK+   +   ++  YT QI  G+ YL  +  +HRD+   NILV+    VK+ D
Sbjct: 98  GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGD 157

Query: 122 FGLAKATTMNDLKSCKGTP-----FWMAPEVVNSKNDGYGL--TA-DIWSLGCTVLEMLT 173
           FGL K    +        P     FW APE +            A D+WS G  + E+ T
Sbjct: 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT-----ESKFSVASDVWSFGVVLYELFT 212

Query: 174 R----------------RPPYSHLEGVQALFRIGKGE-LPSVPSSLSRDARDFILKCLQV 216
                                  +     +  +     LP  P     +    + +C   
Sbjct: 213 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNN 271

Query: 217 NPNDRPTVTELMEH 230
           N N RP+  +L   
Sbjct: 272 NVNQRPSFRDLALR 285

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  140 bits (355), Expect = 1e-40
 Identities = 67/250 (26%), Positives = 101/250 (40%), Gaps = 61/250 (24%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENRLYI---FLELVTKGSLANLYQKYHLSDSQVSSYTR 85
           EI LL + +  NIV+       + +L +   F +   K    +      L    V S+  
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLF 108

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---- 141
           Q+L GL + H RNV+HRD+K  N+L++ +G +KLA+FGLA+A          G P     
Sbjct: 109 QLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARA---------FGIPVRCYS 159

Query: 142 ------WM-APEV-VNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG---VQALFRI 190
                 W   P+V   +K   Y  + D+WS GC   E+     P     G      L RI
Sbjct: 160 AEVVTLWYRPPDVLFGAKL--YSTSIDMWSAGCIFAELANAGRPL--FPGNDVDDQLKRI 215

Query: 191 -------------GKGELP---------------SVPSSLSRDARDFILKCLQVNPNDRP 222
                           +LP               +V   L+   RD +   L+ NP  R 
Sbjct: 216 FRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275

Query: 223 TVTELMEHPF 232
           +  E ++HP+
Sbjct: 276 SAEEALQHPY 285

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  140 bits (356), Expect = 1e-40
 Identities = 73/248 (29%), Positives = 111/248 (44%), Gaps = 57/248 (22%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENRLYI---FLELVTKGSLANLYQKYHLSDSQVSSYTR 85
           EISLL +    NIV  +     E  L +   F+E   K  L     K  L DSQ+  Y  
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLY 126

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---- 141
           Q+L G+ + H+  ++HRD+K  N+L+++ G++KLADFGLA+A          G P     
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARA---------FGIPVRSYT 177

Query: 142 ------WM-APEV-VNSKNDGYGLTADIWSLGCTVLEMLTRRPPY---SHLEGVQALFRI 190
                 W  AP+V + SK   Y  + DIWS+GC   EM+T +P +   +  + +  +F I
Sbjct: 178 HEVVTLWYRAPDVLMGSKK--YSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSI 235

Query: 191 ----------GKGELP----------------SVPSSLSRDARDFILKCLQVNPNDRPTV 224
                        ELP                S+     ++  D +   L  +PN R + 
Sbjct: 236 LGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISA 295

Query: 225 TELMEHPF 232
            + M HP+
Sbjct: 296 RDAMNHPY 303

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  141 bits (357), Expect = 2e-40
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 23/201 (11%)

Query: 51  ENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           E+RL+  +E V  G L  ++ ++  L +     Y+ +I   L YLHER +++RD+K  N+
Sbjct: 82  ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 141

Query: 110 LVDASGSVKLADFGLAKATTMNDLKS---CKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           L+D+ G +KL D+G+ K        +   C GTP ++APE++  +   YG + D W+LG 
Sbjct: 142 LLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRGE--DYGFSVDWWALGV 198

Query: 167 TVLEMLTRRPPYSHLEG--------VQALFR-IGKGELPSVPSSLSRDARDFILKCLQVN 217
            + EM+  R P+  +             LF+ I + ++  +P SLS  A   +   L  +
Sbjct: 199 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLSVKAASVLKSFLNKD 257

Query: 218 PNDR------PTVTELMEHPF 232
           P +R          ++  HPF
Sbjct: 258 PKERLGCHPQTGFADIQGHPF 278

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  142 bits (361), Expect = 2e-40
 Identities = 64/251 (25%), Positives = 101/251 (40%), Gaps = 55/251 (21%)

Query: 29  EISLLSQFEQDNIVQYL------GTDKDENRLYIFLELVTKGSLANLYQ--------KYH 74
           E+ ++ + +  NIV+        G  KDE  L + L+ V +     +Y+        K  
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE----TVYRVARHYSRAKQT 152

Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMND- 132
           L    V  Y  Q+   L Y+H   + HRDIK  N+L+D  +  +KL DFG AK     + 
Sbjct: 153 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212

Query: 133 LKS--CKGTPFWMAPEVV-NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR 189
             S  C  + ++ APE++  + +  Y  + D+WS GC + E+L  +P +    GV  L  
Sbjct: 213 NVSYIC--SRYYRAPELIFGATD--YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 268

Query: 190 IGK--G-----------------ELPSVP---------SSLSRDARDFILKCLQVNPNDR 221
           I K  G                 + P +               +A     + L+  P  R
Sbjct: 269 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 328

Query: 222 PTVTELMEHPF 232
            T  E   H F
Sbjct: 329 LTPLEACAHSF 339

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  140 bits (354), Expect = 4e-40
 Identities = 61/251 (24%), Positives = 106/251 (42%), Gaps = 59/251 (23%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQVSSYTRQI 87
           E+SLL + +  NI++        +RL++  E      L     K   +S   + S+  Q+
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL 141

Query: 88  LNGLVYLHERNVVHRDIKCANILVDAS-----GSVKLADFGLAKATTMNDLKSCKGTPF- 141
           +NG+ + H R  +HRD+K  N+L+  S       +K+ DFGLA+A          G P  
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA---------FGIPIR 192

Query: 142 ---------WM-APEV-VNSKNDGYGLTADIWSLGCTVLEMLTRRPPY---SHLEGVQAL 187
                    W   PE+ + S++  Y  + DIWS+ C   EML + P +   S ++ +  +
Sbjct: 193 QFTHEIITLWYRPPEILLGSRH--YSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI 250

Query: 188 FRI----------GKGELP----------------SVPSSLSRDARDFILKCLQVNPNDR 221
           F +          G   LP                 + + L  +  D +   L+++P  R
Sbjct: 251 FEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKR 310

Query: 222 PTVTELMEHPF 232
            +    +EHP+
Sbjct: 311 ISAKNALEHPY 321

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  141 bits (358), Expect = 4e-40
 Identities = 66/253 (26%), Positives = 106/253 (41%), Gaps = 34/253 (13%)

Query: 4   FFAVKEVSLQDQGAQGKQSILQLEQ------EISLLSQFEQDNIVQYLGTDKDENRLYIF 57
            +A+K ++        K  +L+  +      E  +L   ++  I Q     +DEN LY+ 
Sbjct: 88  VYAMKIMN--------KWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139

Query: 58  LELVTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
           +E    G L  L  K+   +       Y  +I+  +  +H    VHRDIK  NIL+D  G
Sbjct: 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG 199

Query: 116 SVKLADFGLAKATTMNDLKSCK---GTPFWMAPEVVNSKNDG-----YGLTADIWSLGCT 167
            ++LADFG       +         GTP +++PE++ +   G     YG   D W+LG  
Sbjct: 200 HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVF 259

Query: 168 VLEMLTRRPPYSHLEGVQALFR-IGKGEL----PSVPSSLSRDARDFILKCLQVNPNDR- 221
             EM   + P+ + +     +  I   +     P V   +  +ARDFI + L   P  R 
Sbjct: 260 AYEMFYGQTPF-YADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRL 317

Query: 222 --PTVTELMEHPF 232
                 +   HPF
Sbjct: 318 GRGGAGDFRTHPF 330

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  139 bits (353), Expect = 4e-40
 Identities = 70/264 (26%), Positives = 112/264 (42%), Gaps = 63/264 (23%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENRLYI---FLELVTKG---SLANLYQKYHLSDSQVSS 82
           EISL+ + + +NIV+       EN+L +   F++   K    S         L  + V  
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY 112

Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF- 141
           +  Q+L GL + HE  ++HRD+K  N+L++  G +KL DFGLA+A          G P  
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA---------FGIPVN 163

Query: 142 ---------WM-APEV-VNSKNDGYGLTADIWSLGCTVLEMLTRRPPY---SHLEGVQAL 187
                    W  AP+V + S+   Y  + DIWS GC + EM+T +P +   +  E ++ +
Sbjct: 164 TFSSEVVTLWYRAPDVLMGSRT--YSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221

Query: 188 FRI----------GKGELP--------------------SVPSSLSRDARDFILKCLQVN 217
           F I             +LP                         L  +  DF+   LQ+N
Sbjct: 222 FDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLN 281

Query: 218 PNDRPTVTELMEHP-FVKRPLQTP 240
           P+ R +  + + HP F +      
Sbjct: 282 PDMRLSAKQALHHPWFAEYYHHAS 305

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  139 bits (353), Expect = 5e-40
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 16/213 (7%)

Query: 28  QEISLLSQFEQDNIVQYLG--TDKDENRLYIFLELVTKGSLAN--LYQKYHLSDSQVSSY 83
            E  +++  +  ++ + LG       + + +  +L+  G L +     K ++    + ++
Sbjct: 66  DEAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122

Query: 84  TRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCKG-TP 140
             QI  G+ YL +R +VHRD+   N+LV     VK+ DFGLAK     +    +  G  P
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182

Query: 141 F-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGE-LPS 197
             WMA E +  +   Y   +D+WS G TV E++T    PY  +   +    + KGE LP 
Sbjct: 183 IKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 240

Query: 198 VPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
            P   + D    + KC  ++ + RP   EL+  
Sbjct: 241 -PPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  140 bits (354), Expect = 5e-40
 Identities = 57/188 (30%), Positives = 98/188 (52%), Gaps = 11/188 (5%)

Query: 51  ENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           +  L+  +E +  G L  ++   +    S+ + Y  +I+ GL +LH + +V+RD+K  NI
Sbjct: 90  KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI 149

Query: 110 LVDASGSVKLADFGLAKATTMNDLKS---CKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           L+D  G +K+ADFG+ K   + D K+   C GTP ++APE++  +   Y  + D WS G 
Sbjct: 150 LLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQ--KYNHSVDWWSFGV 206

Query: 167 TVLEMLTRRPPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQVNPNDR-PTV 224
            + EML  + P+ H +  + LF  I        P  L ++A+D ++K     P  R    
Sbjct: 207 LLYEMLIGQSPF-HGQDEEELFHSIRMDNPF-YPRWLEKEAKDLLVKLFVREPEKRLGVR 264

Query: 225 TELMEHPF 232
            ++ +HP 
Sbjct: 265 GDIRQHPL 272

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  138 bits (351), Expect = 5e-40
 Identities = 57/213 (26%), Positives = 107/213 (50%), Gaps = 17/213 (7%)

Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           NIV  +  D++++  Y+ +E +   +L+  +     LS     ++T QIL+G+ + H+  
Sbjct: 72  NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR 131

Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKA---TTMNDLKSCKGTPFWMAPEVVNSKNDGY 155
           +VHRDIK  NIL+D++ ++K+ DFG+AKA   T++       GT  + +PE       G 
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK----GE 187

Query: 156 GLTA--DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPS----SLSRDARDF 209
                 DI+S+G  + EML   PP++    V    +  +  +P+V +     + +   + 
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNV 247

Query: 210 ILKCLQVNPNDRP-TVTELMEHPFVKRPLQTPR 241
           IL+  + +  +R  T+ E+ +   +   L   R
Sbjct: 248 ILRATEKDKANRYKTIQEMKDD--LSSVLHENR 278

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  139 bits (352), Expect = 6e-40
 Identities = 68/248 (27%), Positives = 101/248 (40%), Gaps = 57/248 (22%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENRLYI---FLELVTKGSLANLYQKYHLSDSQVSSYTR 85
           E+SLL   +  NIV        E  L +   +L+   K  L +      ++   V  +  
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLF 107

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---- 141
           Q+L GL Y H + V+HRD+K  N+L++  G +KLADFGLA+A         K  P     
Sbjct: 108 QLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA---------KSIPTKTYD 158

Query: 142 ------WM-APEV-VNSKNDGYGLTADIWSLGCTVLEMLTRRPPY---SHLEGVQALFRI 190
                 W   P++ + S +  Y    D+W +GC   EM T RP +   +  E +  +FRI
Sbjct: 159 NEVVTLWYRPPDILLGSTD--YSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRI 216

Query: 191 ----------GKGELP----------------SVPSSLSRDARDFILKCLQVNPNDRPTV 224
                     G                     S    L  D  D + K LQ    +R + 
Sbjct: 217 LGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA 276

Query: 225 TELMEHPF 232
            + M+HPF
Sbjct: 277 EDAMKHPF 284

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  140 bits (354), Expect = 6e-40
 Identities = 55/192 (28%), Positives = 98/192 (51%), Gaps = 15/192 (7%)

Query: 51  ENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
            +RLY  +E V  G L  ++ Q     +     Y  +I  GL +L  + +++RD+K  N+
Sbjct: 93  MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV 152

Query: 110 LVDASGSVKLADFGLAKATTMNDLKS---CKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           ++D+ G +K+ADFG+ K    + + +   C GTP ++APE++  +   YG + D W+ G 
Sbjct: 153 MLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIAYQ--PYGKSVDWWAFGV 209

Query: 167 TVLEMLTRRPPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQVNPNDR---- 221
            + EML  + P+   E    LF+ I +  + + P S+S++A       +  +P  R    
Sbjct: 210 LLYEMLAGQAPF-EGEDEDELFQSIMEHNV-AYPKSMSKEAVAICKGLMTKHPGKRLGCG 267

Query: 222 PT-VTELMEHPF 232
           P    ++ EH F
Sbjct: 268 PEGERDIKEHAF 279

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  140 bits (356), Expect = 6e-40
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 23/201 (11%)

Query: 51  ENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           E+RL+  +E V  G L  ++ ++  L +     Y+ +I   L YLHER +++RD+K  N+
Sbjct: 125 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 184

Query: 110 LVDASGSVKLADFGLAKATTMNDLKS---CKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           L+D+ G +KL D+G+ K        +   C GTP ++APE++  +   YG + D W+LG 
Sbjct: 185 LLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRGE--DYGFSVDWWALGV 241

Query: 167 TVLEMLTRRPPYSHL--------EGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQVN 217
            + EM+  R P+  +             LF+ I + ++  +P SLS  A   +   L  +
Sbjct: 242 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLSVKAASVLKSFLNKD 300

Query: 218 PNDR------PTVTELMEHPF 232
           P +R          ++  HPF
Sbjct: 301 PKERLGCHPQTGFADIQGHPF 321

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  139 bits (351), Expect = 7e-40
 Identities = 64/251 (25%), Positives = 100/251 (39%), Gaps = 36/251 (14%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG--TDKDENRLYIFLELVTK 63
           AVK   LQ    +  +   +   EI +L   + DNIV+Y G         L + +E +  
Sbjct: 74  AVK--KLQHSTEEHLRDFER---EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 128

Query: 64  GSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLAD 121
           GSL +  QK+   +   ++  YT QI  G+ YL  +  +HRD+   NILV+    VK+ D
Sbjct: 129 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGD 188

Query: 122 FGLAKATTMNDLKSCKGTP-----FWMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTR- 174
           FGL K    +        P     FW APE   S  +  + + +D+WS G  + E+ T  
Sbjct: 189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPE---SLTESKFSVASDVWSFGVVLYELFTYI 245

Query: 175 ---------------RPPYSHLEGVQALFRIGKGE-LPSVPSSLSRDARDFILKCLQVNP 218
                                +     +  +     LP  P     +    + +C   N 
Sbjct: 246 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNV 304

Query: 219 NDRPTVTELME 229
           N RP+  +L  
Sbjct: 305 NQRPSFRDLAL 315

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  138 bits (349), Expect = 1e-39
 Identities = 62/252 (24%), Positives = 97/252 (38%), Gaps = 61/252 (24%)

Query: 29  EISLL---SQFEQDNIVQYL-----GTDKDENRLYI---FLELVTKGSLANLYQKYHLSD 77
           E++LL     FE  N+V+ +          E ++ +    ++   +  L        L  
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA-PPPGLPA 119

Query: 78  SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK 137
             +    RQ L GL +LH   +VHRD+K  NILV + G+VKLADFGLA+           
Sbjct: 120 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI---------Y 170

Query: 138 GTPFWMAPEVV-----------NSKNDGYGLTADIWSLGCTVLEMLTRRPPY---SHLEG 183
                + P VV            S    Y    D+WS+GC   EM  R+P +   S  + 
Sbjct: 171 SYQMALTPVVVTLWYRAPEVLLQST---YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ 227

Query: 184 VQALFRI----------GKGELP-------------SVPSSLSRDARDFILKCLQVNPND 220
           +  +F +              LP             SV   +       +L+ L  NP+ 
Sbjct: 228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHK 287

Query: 221 RPTVTELMEHPF 232
           R +    ++H +
Sbjct: 288 RISAFRALQHSY 299

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  138 bits (350), Expect = 1e-39
 Identities = 68/249 (27%), Positives = 103/249 (41%), Gaps = 33/249 (13%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG--TDKDENRLYIFLELVTK 63
           AVK   LQ  G   ++   +   EI +L     D IV+Y G         L + +E +  
Sbjct: 56  AVK--QLQHSGPDQQRDFQR---EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPS 110

Query: 64  GSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLAD 121
           G L +  Q++   L  S++  Y+ QI  G+ YL  R  VHRD+   NILV++   VK+AD
Sbjct: 111 GCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIAD 170

Query: 122 FGLAKATTMNDLKSCKGTP-----FWMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTR- 174
           FGLAK   ++        P     FW APE   S +D  +   +D+WS G  + E+ T  
Sbjct: 171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPE---SLSDNIFSRQSDVWSFGVVLYELFTYC 227

Query: 175 RPPYSHLEGVQALFRIGKGELPS--VPSSLSRDAR------------DFILKCLQVNPND 220
               S       +    +       +   L    R            + +  C   +P D
Sbjct: 228 DKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQD 287

Query: 221 RPTVTELME 229
           RP+ + L  
Sbjct: 288 RPSFSALGP 296

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  138 bits (350), Expect = 1e-39
 Identities = 61/252 (24%), Positives = 97/252 (38%), Gaps = 61/252 (24%)

Query: 29  EISLL---SQFEQDNIVQ-----YLGTDKDENRLYI---FLELVTKGSLANLYQKYHLSD 77
           E+++L     FE  N+V+      +     E +L +    ++      L  +  +  +  
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPT 119

Query: 78  SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK 137
             +     Q+L GL +LH   VVHRD+K  NILV +SG +KLADFGLA+           
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI---------Y 170

Query: 138 GTPFWMAPEVV-----------NSKNDGYGLTADIWSLGCTVLEMLTRRP--P-YSHLEG 183
                +   VV            S    Y    D+WS+GC   EM  R+P     S ++ 
Sbjct: 171 SFQMALTSVVVTLWYRAPEVLLQSS---YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 227

Query: 184 VQALFRI----------GKGELP-------------SVPSSLSRDARDFILKCLQVNPND 220
           +  +  +              LP                + +    +D +LKCL  NP  
Sbjct: 228 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 287

Query: 221 RPTVTELMEHPF 232
           R +    + HP+
Sbjct: 288 RISAYSALSHPY 299

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  137 bits (348), Expect = 2e-39
 Identities = 70/251 (27%), Positives = 112/251 (44%), Gaps = 34/251 (13%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG--TDKDENRLYIFLELVTK 63
           AVK  SL+ +   G   I  L++EI +L     +NIV+Y G  T+   N + + +E +  
Sbjct: 54  AVK--SLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 109

Query: 64  GSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLAD 121
           GSL     K    ++  Q   Y  QI  G+ YL  R  VHRD+   N+LV++   VK+ D
Sbjct: 110 GSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGD 169

Query: 122 FGLAKATTMNDLKSCKGTP-----FWMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTR- 174
           FGL KA   +              FW APE         + + +D+WS G T+ E+LT  
Sbjct: 170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPE---CLMQSKFYIASDVWSFGVTLHELLTYC 226

Query: 175 --------------RPPYSHLEGVQALFRIGKGE-LPSVPSSLSRDARDFILKCLQVNPN 219
                          P +  +   + +  + +G+ LP  P +   +    + KC +  P+
Sbjct: 227 DSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPC-PPNCPDEVYQLMRKCWEFQPS 285

Query: 220 DRPTVTELMEH 230
           +R +   L+E 
Sbjct: 286 NRTSFQNLIEG 296

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  138 bits (351), Expect = 2e-39
 Identities = 68/255 (26%), Positives = 105/255 (41%), Gaps = 56/255 (21%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENRLYI---FLELVTKGSLANLYQKYHLSDSQVSSYTR 85
           EI LL +    NI+  L     ++ + +   F+E   +  + +      L+ S + +Y  
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYML 119

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---- 141
             L GL YLH+  ++HRD+K  N+L+D +G +KLADFGLAK+          G+P     
Sbjct: 120 MTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS---------FGSPNRAYT 170

Query: 142 ------WM-APEV-VNSKNDGYGLTADIWSLGCTVLEMLTRRP----------------- 176
                 W  APE+   ++   YG+  D+W++GC + E+L R P                 
Sbjct: 171 HQVVTRWYRAPELLFGARM--YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 228

Query: 177 ---P-------YSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTE 226
              P          L             L  + S+   D  D I      NP  R T T+
Sbjct: 229 LGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 288

Query: 227 LMEHP-FVKRPLQTP 240
            ++   F  RP  TP
Sbjct: 289 ALKMKYFSNRPGPTP 303

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  137 bits (347), Expect = 2e-39
 Identities = 64/268 (23%), Positives = 101/268 (37%), Gaps = 59/268 (22%)

Query: 5   FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQ----YLGTDKDENRLYIFLEL 60
           FA+K +              + E E+      +  +IV+    Y         L I +E 
Sbjct: 46  FALKMLQ--------DCPKARREVEL-HWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 96

Query: 61  VTKGSL-----ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---D 112
           +  G L         Q +  ++ + S   + I   + YLH  N+ HRD+K  N+L     
Sbjct: 97  LDGGELFSRIQDRGDQAF--TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR 154

Query: 113 ASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEML 172
            +  +KL DFG                    A E    K   Y  + D+WSLG  +  +L
Sbjct: 155 PNAILKLTDFGF-------------------AKETTGEK---YDKSCDMWSLGVIMYILL 192

Query: 173 TRRPPY---SHLEGVQALF-RIGKGEL--PSVP-SSLSRDARDFILKCLQVNPNDRPTVT 225
              PP+     L     +  RI  G+   P+   S +S + +  I   L+  P  R T+T
Sbjct: 193 CGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTIT 252

Query: 226 ELMEHPFVK-------RPLQTPRCGQAN 246
           E M HP++         PL T R  + +
Sbjct: 253 EFMNHPWIMQSTKVPQTPLHTSRVLKED 280

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  138 bits (350), Expect = 2e-39
 Identities = 62/258 (24%), Positives = 102/258 (39%), Gaps = 63/258 (24%)

Query: 29  EISLLSQFEQDNIVQ--------YLGTDKDENRLYI---FLELVTKGSLANLYQKYHLSD 77
           EI +L   + +N+V             ++ +  +Y+   F E    G L+N       + 
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTL 123

Query: 78  SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK 137
           S++    + +LNGL Y+H   ++HRD+K AN+L+   G +KLADFGLA+A   +  K+ +
Sbjct: 124 SEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA--FSLAKNSQ 181

Query: 138 GTPF-------WM-APEVV-NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG---VQ 185
              +       W   PE++   ++  YG   D+W  GC + EM TR P    ++G     
Sbjct: 182 PNRYTNRVVTLWYRPPELLLGERD--YGPPIDLWGAGCIMAEMWTRSP---IMQGNTEQH 236

Query: 186 ALFRI-------------GKGELPSV---------PSSL---------SRDARDFILKCL 214
            L  I                                 +            A D I K L
Sbjct: 237 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 296

Query: 215 QVNPNDRPTVTELMEHPF 232
            ++P  R    + + H F
Sbjct: 297 VLDPAQRIDSDDALNHDF 314

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  137 bits (347), Expect = 4e-39
 Identities = 59/278 (21%), Positives = 98/278 (35%), Gaps = 60/278 (21%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDK-----DENRLYIFLEL 60
           AVK  S  +     +Q+ +  E+ I  +   E DNI +++  D+           + +E 
Sbjct: 40  AVKVFSFAN-----RQNFIN-EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93

Query: 61  VTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHE---------RNVVHRDIKCANILV 111
              GSL      +             +  GL YLH            + HRD+   N+LV
Sbjct: 94  YPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV 153

Query: 112 DASGSVKLADFGLAKATTMNDLKSCK----------GTPFWMAPEV----VNSKN-DGYG 156
              G+  ++DFGL+   T N L              GT  +MAPEV    VN ++ +   
Sbjct: 154 KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESAL 213

Query: 157 LTADIWSLGCTVLEMLTR---RPPYSHLEGVQALFR----------------IGKGELPS 197
              D+++LG    E+  R     P   +   Q  F+                  + + P 
Sbjct: 214 KQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPK 273

Query: 198 VPSSLSRDA------RDFILKCLQVNPNDRPTVTELME 229
            P +   ++      ++ I  C   +   R T     E
Sbjct: 274 FPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  136 bits (344), Expect = 8e-39
 Identities = 57/215 (26%), Positives = 90/215 (41%), Gaps = 13/215 (6%)

Query: 40  NIVQYLGTDKDENRLYIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERN 98
           ++V      + + +LY+ + L+    LA  L ++  L+  +  +  RQI + L   H   
Sbjct: 95  HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154

Query: 99  VVHRDIKCANILVDASGSVKLADFGLAKA---TTMNDLKSCKGTPFWMAPEVVNSKNDGY 155
             HRD+K  NILV A     L DFG+A A     +  L +  GT ++MAPE         
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF--SESHA 212

Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPS---SLSRDARDFILK 212
              ADI++L C + E LT  PPY   + +  +       +P   +    +       I +
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIAR 271

Query: 213 CLQVNPNDR-PTVTELMEHPFVKRPLQTPRCGQAN 246
            +  NP DR  T  +L         L T    +A 
Sbjct: 272 GMAKNPEDRYVTCGDLSAA--AHAALATADQDRAT 304

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  135 bits (342), Expect = 9e-39
 Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 25/237 (10%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           AVK   L++  A       +L  E +++ Q +   IV+ +G  + E    + +E+   G 
Sbjct: 48  AVK--ILKN-EANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGP 103

Query: 66  LAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGL 124
           L   L Q  H+ D  +     Q+  G+ YL E N VHRD+   N+L+      K++DFGL
Sbjct: 104 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 163

Query: 125 AKATTMNDL--KSCKGTPF---WMAPEVVN-----SKNDGYGLTADIWSLGCTVLEMLTR 174
           +KA   ++   K+     +   W APE +N     SK       +D+WS G  + E  + 
Sbjct: 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK-------SDVWSFGVLMWEAFSY 216

Query: 175 -RPPYSHLEGVQALFRIGKGE-LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
            + PY  ++G +    + KGE +   P+   R+  D +  C   +  +RP    +  
Sbjct: 217 GQKPYRGMKGSEVTAMLEKGERMGC-PAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  138 bits (349), Expect = 1e-38
 Identities = 70/254 (27%), Positives = 118/254 (46%), Gaps = 40/254 (15%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQ---FEQDN---IVQYLGTDKDENRL 54
            G ++A+K +         K+ I+  ++    L++    +      +     + +  +RL
Sbjct: 172 TGRYYAMKILK--------KEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223

Query: 55  YIFLELVTKGSLANLYQKYHLSDSQVSS------YTRQILNGLVYLH-ERNVVHRDIKCA 107
              +E    G L      +HLS  +V S      Y  +I++ L YLH E+NVV+RD+K  
Sbjct: 224 CFVMEYANGGELF-----FHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLE 278

Query: 108 NILVDASGSVKLADFGLAKATTMNDLKS---CKGTPFWMAPEVVNSKNDGYGLTADIWSL 164
           N+++D  G +K+ DFGL K    +       C GTP ++APEV+      YG   D W L
Sbjct: 279 NLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDN--DYGRAVDWWGL 335

Query: 165 GCTVLEMLTRRPPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQVNPNDR-- 221
           G  + EM+  R P+ + +  + LF  I   E+   P +L  +A+  +   L+ +P  R  
Sbjct: 336 GVVMYEMMCGRLPFYN-QDHEKLFELILMEEI-RFPRTLGPEAKSLLSGLLKKDPKQRLG 393

Query: 222 --PT-VTELMEHPF 232
                  E+M+H F
Sbjct: 394 GGSEDAKEIMQHRF 407

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  133 bits (338), Expect = 3e-38
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 23/216 (10%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTR 85
           +E  ++ Q +   IV+ +G  + E  L + +E+   G L          +  S V+    
Sbjct: 59  REAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 117

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCKGTPF-- 141
           Q+  G+ YL E+N VHRD+   N+L+      K++DFGL+KA   +D    +     +  
Sbjct: 118 QVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 177

Query: 142 -WMAPEVVN-----SKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGE 194
            W APE +N     S+       +D+WS G T+ E L+  + PY  ++G + +  I +G+
Sbjct: 178 KWYAPECINFRKFSSR-------SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 230

Query: 195 -LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
            +   P     +    +  C      DRP    + +
Sbjct: 231 RMEC-PPECPPELYALMSDCWIYKWEDRPDFLTVEQ 265

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  135 bits (342), Expect = 5e-38
 Identities = 58/233 (24%), Positives = 93/233 (39%), Gaps = 17/233 (7%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           AVK    +      K   LQ   E  +L Q+   NIV+ +G    +  +YI +ELV  G 
Sbjct: 143 AVKSCR-ETLPPDLKAKFLQ---EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 198

Query: 66  LANLY---QKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADF 122
               +   +   L    +         G+ YL  +  +HRD+   N LV     +K++DF
Sbjct: 199 FLT-FLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDF 257

Query: 123 GLAKATTMNDLKSCKGTPF----WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPP 177
           G+++        +  G       W APE +N     Y   +D+WS G  + E  +    P
Sbjct: 258 GMSREEADGVYAASGGLRQVPVKWTAPEALNYGR--YSSESDVWSFGILLWETFSLGASP 315

Query: 178 YSHLEGVQALFRIGKGE-LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
           Y +L   Q    + KG  LP  P          + +C    P  RP+ + + +
Sbjct: 316 YPNLSNQQTREFVEKGGRLPC-PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  132 bits (335), Expect = 6e-38
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 20/214 (9%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTR 85
           QE   + +     +V++ G    E  +YI  E ++ G L N  + +   L  SQ+     
Sbjct: 52  QEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCY 111

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---W 142
            +  G+ +L     +HRD+   N LVD    VK++DFG+ +    +   S  GT F   W
Sbjct: 112 DVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKW 171

Query: 143 MAPEVVN-----SKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGE-L 195
            APEV +     SK       +D+W+ G  + E+ +  + PY      + + ++ +G  L
Sbjct: 172 SAPEVFHYFKYSSK-------SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL 224

Query: 196 PSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
              P   S      +  C    P  RPT  +L+ 
Sbjct: 225 YR-PHLASDTIYQIMYSCWHELPEKRPTFQQLLS 257

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  136 bits (345), Expect = 6e-38
 Identities = 66/232 (28%), Positives = 111/232 (47%), Gaps = 18/232 (7%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+K +     G    ++ LQ   E  ++ +   + +VQ      +E  +YI  E ++KGS
Sbjct: 212 AIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGS 264

Query: 66  LANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADF 122
           L +  +     +L   Q+     QI +G+ Y+   N VHRD++ ANILV  +   K+ADF
Sbjct: 265 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF 324

Query: 123 GLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPY 178
           GLA+    N+  + +G  F   W APE        + + +D+WS G  + E+ T+ R PY
Sbjct: 325 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPY 382

Query: 179 SHLEGVQALFRIGKGE-LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
             +   + L ++ +G  +P  P        D + +C +  P +RPT   L  
Sbjct: 383 PGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCWRKEPEERPTFEYLQA 433

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  132 bits (334), Expect = 7e-38
 Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 20/214 (9%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDSQVSSYTR 85
           +E  ++ +     +VQ  G   ++  + +  E +  G L++  +      +   +     
Sbjct: 52  EEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCL 111

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---W 142
            +  G+ YL E  V+HRD+   N LV  +  +K++DFG+ +    +   S  GT F   W
Sbjct: 112 DVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKW 171

Query: 143 MAPEVVN-----SKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGE-L 195
            +PEV +     SK       +D+WS G  + E+ +  + PY +    + +  I  G  L
Sbjct: 172 ASPEVFSFSRYSSK-------SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL 224

Query: 196 PSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
              P   S      +  C +  P DRP  + L+ 
Sbjct: 225 YK-PRLASTHVYQIMNHCWRERPEDRPAFSRLLR 257

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  138 bits (349), Expect = 1e-37
 Identities = 54/192 (28%), Positives = 97/192 (50%), Gaps = 15/192 (7%)

Query: 51  ENRLYIFLELVTKGSL-ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
            +RLY  +E V  G L  ++ Q     +     Y  +I  GL +L  + +++RD+K  N+
Sbjct: 414 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV 473

Query: 110 LVDASGSVKLADFGLAKATTMNDLKS---CKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           ++D+ G +K+ADFG+ K    + + +   C GTP ++APE++  +   YG + D W+ G 
Sbjct: 474 MLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIAYQ--PYGKSVDWWAFGV 530

Query: 167 TVLEMLTRRPPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQVNPNDR---- 221
            + EML  + P+   E    LF+ I +  + + P S+S++A       +  +P  R    
Sbjct: 531 LLYEMLAGQAPF-EGEDEDELFQSIMEHNV-AYPKSMSKEAVAICKGLMTKHPGKRLGCG 588

Query: 222 -PTVTELMEHPF 232
                ++ EH F
Sbjct: 589 PEGERDIKEHAF 600

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  133 bits (338), Expect = 1e-37
 Identities = 57/244 (23%), Positives = 108/244 (44%), Gaps = 44/244 (18%)

Query: 29  EISLLSQFEQDNIVQYL------GTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQV 80
           E+ LL   + +N++  L       + ++    Y+ +  +      +L +      S+ ++
Sbjct: 73  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TDLQKIMGLKFSEEKI 128

Query: 81  SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTP 140
                Q+L GL Y+H   VVHRD+K  N+ V+    +K+ DFGLA+     ++     T 
Sbjct: 129 QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVVTR 187

Query: 141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY---SHLEGVQALFRI----GKG 193
           ++ APEV+ S    Y  T DIWS+GC + EMLT +  +    +L+ +  + ++    G  
Sbjct: 188 WYRAPEVILS-WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246

Query: 194 ELPSVPSSLSR-----------------------DARDFILKCLQVNPNDRPTVTELMEH 230
            +  +    ++                        A D + K L+++ + R T  + + H
Sbjct: 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306

Query: 231 PFVK 234
           PF +
Sbjct: 307 PFFE 310

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  134 bits (339), Expect = 1e-37
 Identities = 62/260 (23%), Positives = 109/260 (41%), Gaps = 64/260 (24%)

Query: 29  EISLLSQFEQDNIVQYL------GTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQV 80
           E+ L+      NI+  L       + ++   +YI +EL+     ANL Q  +  L   ++
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERM 129

Query: 81  SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTP 140
           S    Q+L G+ +LH   ++HRD+K +NI+V +  ++K+ DFGLA+    + +     TP
Sbjct: 130 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM----MTP 185

Query: 141 FWM-----APEVVNSKNDGYGLTADIWSLGCTVLEMLTRR-------------------- 175
           + +     APEV+      Y    DIWS+GC + EM+                       
Sbjct: 186 YVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 243

Query: 176 -PPYSHLEGVQ-------------------ALFR-IGKGELPSVPSSLSRDARDFILKCL 214
            P    ++ +Q                    LF  +            +  ARD + K L
Sbjct: 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 303

Query: 215 QVNPNDRPTVTELMEHPFVK 234
            ++ + R +V E ++HP++ 
Sbjct: 304 VIDASKRISVDEALQHPYIN 323

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  133 bits (336), Expect = 1e-37
 Identities = 61/257 (23%), Positives = 109/257 (42%), Gaps = 53/257 (20%)

Query: 29  EISLLSQFEQDNIV--------------QYLGTDKDENRLYIFLELVTKGSLANLYQKYH 74
           EI ++ + + DNIV                +G+  + N +YI  E + +  LAN+ ++  
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGP 116

Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG-SVKLADFGLAKATTMNDL 133
           L +     +  Q+L GL Y+H  NV+HRD+K AN+ ++     +K+ DFGLA+    +  
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176

Query: 134 KSCKGTPF----WM-APEV-VNSKNDGYGLTADIWSLGCTVLEMLTRR------------ 175
                +      W  +P + ++  N  Y    D+W+ GC   EMLT +            
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNN--YTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234

Query: 176 ---------PPYSHLEGVQALFRIGKGELPSVP--------SSLSRDARDFILKCLQVNP 218
                          + + ++  +      + P          +SR+A DF+ + L  +P
Sbjct: 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP 294

Query: 219 NDRPTVTELMEHPFVKR 235
            DR T  E + HP++  
Sbjct: 295 MDRLTAEEALSHPYMSI 311

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  133 bits (336), Expect = 1e-37
 Identities = 65/233 (27%), Positives = 109/233 (46%), Gaps = 16/233 (6%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
            +K   ++D    G+QS   +   +  +   +  +IV+ LG       L +  + +  GS
Sbjct: 46  CIK--VIED--KSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGS 100

Query: 66  LAN--LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFG 123
           L +     +  L    + ++  QI  G+ YL E  +VHR++   N+L+ +   V++ADFG
Sbjct: 101 LLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFG 160

Query: 124 LAKATTMND--LKSCKG-TPF-WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPY 178
           +A     +D  L   +  TP  WMA E ++     Y   +D+WS G TV E++T    PY
Sbjct: 161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGK--YTHQSDVWSYGVTVWELMTFGAEPY 218

Query: 179 SHLEGVQALFRIGKGE-LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
           + L   +    + KGE L   P   + D    ++KC  ++ N RPT  EL   
Sbjct: 219 AGLRLAEVPDLLEKGERLAQ-PQICTIDVYMVMVKCWMIDENIRPTFKELANE 270

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  133 bits (336), Expect = 2e-37
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 12/211 (5%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLAN--LYQKYHLSDSQVSSYTR 85
            E  +++  +  ++ + LG       + +  +L+  G L +     K ++    + ++  
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCKG-TPF- 141
           QI  G+ YL +R +VHRD+   N+LV     VK+ DFGLAK     +    +  G  P  
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184

Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGE-LPSVP 199
           WMA E +  +   Y   +D+WS G TV E++T    PY  +   +    + KGE LP  P
Sbjct: 185 WMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ-P 241

Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
              + D    ++KC  ++ + RP   EL+  
Sbjct: 242 PICTIDVYMIMVKCWMIDADSRPKFRELIIE 272

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  133 bits (337), Expect = 2e-37
 Identities = 70/247 (28%), Positives = 116/247 (46%), Gaps = 44/247 (17%)

Query: 29  EISLLSQFEQDNIVQYL-----GTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSY 83
           EI +L +F  +NI+         T +    +YI  +L+    L  L +  HLS+  +  +
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYF 133

Query: 84  TRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF-- 141
             QIL GL Y+H  NV+HRD+K +N+L++ +  +K+ DFGLA+    +   +   T +  
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193

Query: 142 --WM-APEVV-NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI------- 190
             W  APE++ NSK   Y  + DIWS+GC + EML+ RP +     +  L  I       
Sbjct: 194 TRWYRAPEIMLNSKG--YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251

Query: 191 GKGELPSVPSSLSR-----------------------DARDFILKCLQVNPNDRPTVTEL 227
            + +L  + +  +R                        A D + K L  NP+ R  V + 
Sbjct: 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 311

Query: 228 MEHPFVK 234
           + HP+++
Sbjct: 312 LAHPYLE 318

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  136 bits (344), Expect = 2e-37
 Identities = 66/232 (28%), Positives = 111/232 (47%), Gaps = 18/232 (7%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+K +     G    ++ LQ   E  ++ +   + +VQ      +E  +YI  E ++KGS
Sbjct: 295 AIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGS 347

Query: 66  LANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADF 122
           L +  +     +L   Q+     QI +G+ Y+   N VHRD++ ANILV  +   K+ADF
Sbjct: 348 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF 407

Query: 123 GLAKATTMNDLKSCKGTPF---WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPY 178
           GLA+    N+  + +G  F   W APE        + + +D+WS G  + E+ T+ R PY
Sbjct: 408 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPY 465

Query: 179 SHLEGVQALFRIGKGE-LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
             +   + L ++ +G  +P  P        D + +C +  P +RPT   L  
Sbjct: 466 PGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCWRKEPEERPTFEYLQA 516

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  132 bits (335), Expect = 4e-37
 Identities = 64/253 (25%), Positives = 99/253 (39%), Gaps = 57/253 (22%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENR-----LYIFLELVTKGSLANLYQ-----KYHLSDS 78
           EI LL+ F   NI+                LY+  EL+      +L Q     +  +S  
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQVIHDQRIVISPQ 134

Query: 79  QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKG 138
            +  +   IL GL  LHE  VVHRD+   NIL+  +  + + DF LA+  T +  K    
Sbjct: 135 HIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK---- 190

Query: 139 TPFWM-----APEVV-NSKNDGYGLTADIWSLGCTVLEMLTRRP------PYSHLEGV-- 184
           T +       APE+V   K   +    D+WS GC + EM  R+        Y+ L  +  
Sbjct: 191 THYVTHRWYRAPELVMQFKG--FTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248

Query: 185 -------QALFRIG--------KGELPSVP--------SSLSRDARDFILKCLQVNPNDR 221
                  + +            +  L +VP         +    A D I K L+ NP  R
Sbjct: 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR 308

Query: 222 PTVTELMEHPFVK 234
            +  + + HP+ +
Sbjct: 309 ISTEQALRHPYFE 321

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  130 bits (330), Expect = 5e-37
 Identities = 64/241 (26%), Positives = 103/241 (42%), Gaps = 30/241 (12%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG--TDKDENRLYIFLELVTK 63
           AVK   L+       +++    +E++ +   +  N+++  G         + +  EL   
Sbjct: 50  AVK--CLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL---TPPMKMVTELAPL 104

Query: 64  GSLAN--LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLAD 121
           GSL +     + H     +S Y  Q+  G+ YL  +  +HRD+   N+L+     VK+ D
Sbjct: 105 GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGD 164

Query: 122 FGLAKATTMNDL--KSCKGTPF---WMAPEVVN-----SKNDGYGLTADIWSLGCTVLEM 171
           FGL +A   ND      +       W APE +               +D W  G T+ EM
Sbjct: 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-------SDTWMFGVTLWEM 217

Query: 172 LTR-RPPYSHLEGVQALFRIGK-GE-LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
            T  + P+  L G Q L +I K GE LP  P    +D  + +++C    P DRPT   L 
Sbjct: 218 FTYGQEPWIGLNGSQILHKIDKEGERLPR-PEDCPQDIYNVMVQCWAHKPEDRPTFVALR 276

Query: 229 E 229
           +
Sbjct: 277 D 277

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  132 bits (334), Expect = 5e-37
 Identities = 58/260 (22%), Positives = 98/260 (37%), Gaps = 61/260 (23%)

Query: 28  QEISLLSQFEQDNIVQ-------YLGTDKDENRLYIFLELVTKGSLANLYQ--------K 72
           Q +  L+     NIVQ           D+ +  L + +E V       L++        +
Sbjct: 68  QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQ 123

Query: 73  YHLSDSQVSSYTRQILNGLVYLHER--NVVHRDIKCANILVD-ASGSVKLADFGLAKATT 129
                  +  +  Q++  +  LH    NV HRDIK  N+LV+ A G++KL DFG AK  +
Sbjct: 124 VAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183

Query: 130 MNDLKS---CKGTPFWMAPEVV-NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQ 185
            ++      C  + ++ APE++  +++  Y    DIWS+GC   EM+   P +       
Sbjct: 184 PSEPNVAYIC--SRYYRAPELIFGNQH--YTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG 239

Query: 186 ALFRIGK-------------------------------GELPSVPSSLSRDARDFILKCL 214
            L  I +                                         +++A D +   L
Sbjct: 240 QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALL 299

Query: 215 QVNPNDRPTVTELMEHPFVK 234
           Q  P +R    E + HP+  
Sbjct: 300 QYLPEERMKPYEALCHPYFD 319

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  132 bits (334), Expect = 7e-37
 Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 41/243 (16%)

Query: 29  EISLLSQFEQDNIVQYL------GTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS 82
           E+ LL   + +N++  L       + ++ N +Y+   L+    L N+ +   L+D  V  
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQF 136

Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFW 142
              QIL GL Y+H  +++HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++
Sbjct: 137 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA-DEMTGYVATRWY 195

Query: 143 MAPEVV-NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI-------GKGE 194
            APE++ N  +  Y  T DIWS+GC + E+LT R  +   + +  L  I       G   
Sbjct: 196 RAPEIMLNWMH--YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253

Query: 195 LPSVPSSLSR-----------------------DARDFILKCLQVNPNDRPTVTELMEHP 231
           L  + S  +R                        A D + K L ++ + R T  + + H 
Sbjct: 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313

Query: 232 FVK 234
           +  
Sbjct: 314 YFA 316

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  130 bits (329), Expect = 7e-37
 Identities = 51/215 (23%), Positives = 92/215 (42%), Gaps = 20/215 (9%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDSQVSSYTR 85
           +E  ++     + +VQ  G    +  ++I  E +  G L N  ++  +     Q+    +
Sbjct: 68  EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK 127

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---W 142
            +   + YL  +  +HRD+   N LV+  G VK++DFGL++    ++  S  G+ F   W
Sbjct: 128 DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 187

Query: 143 MAPEVVN-----SKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGE-L 195
             PEV+      SK       +DIW+ G  + E+ +  + PY      +    I +G  L
Sbjct: 188 SPPEVLMYSKFSSK-------SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 240

Query: 196 PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
              P   S      +  C     ++RPT   L+ +
Sbjct: 241 YR-PHLASEKVYTIMYSCWHEKADERPTFKILLSN 274

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  132 bits (335), Expect = 7e-37
 Identities = 66/280 (23%), Positives = 105/280 (37%), Gaps = 70/280 (25%)

Query: 29  EISLLSQFEQDNIVQYLG--TDKDENRLYI---FLE------LVTKGSLANLYQKYHLSD 77
           EI+LL + +  N++          + ++++   + E      +    +     +   L  
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127

Query: 78  SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS----GSVKLADFGLAKATTMNDL 133
             V S   QIL+G+ YLH   V+HRD+K ANILV       G VK+AD G A+       
Sbjct: 128 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187

Query: 134 KSCKGTP----FWM-APEV-VNSKNDGYGLTADIWSLGCTVLEMLTRRP---------PY 178
                 P    FW  APE+ + +++  Y    DIW++GC   E+LT  P           
Sbjct: 188 PLADLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 245

Query: 179 SHLEGVQALFRI-------------GKGELPSVPS------------------------S 201
           S+      L RI                ++P   +                         
Sbjct: 246 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVK 305

Query: 202 LSRDARDFILKCLQVNPNDRPTVTELMEHP-FVKRPLQTP 240
               A   + K L ++P  R T  + M+ P F++ PL T 
Sbjct: 306 PDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTS 345

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  132 bits (333), Expect = 9e-37
 Identities = 56/242 (23%), Positives = 102/242 (42%), Gaps = 39/242 (16%)

Query: 29  EISLLSQFEQDNIVQYL------GTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSS 82
           E+ LL     +N++  L       T  D    Y+ +  +    L  L +   L + ++  
Sbjct: 74  ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQF 132

Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFW 142
              Q+L GL Y+H   ++HRD+K  N+ V+    +K+ DFGLA+    +++     T ++
Sbjct: 133 LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QADSEMTGYVVTRWY 191

Query: 143 MAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI-------GKGEL 195
            APEV+ +    Y  T DIWS+GC + EM+T +  +   + +  L  I           +
Sbjct: 192 RAPEVILN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250

Query: 196 PSVPSSLSR-----------------------DARDFILKCLQVNPNDRPTVTELMEHPF 232
             + S  ++                        A + + K L ++   R T  E + HP+
Sbjct: 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310

Query: 233 VK 234
            +
Sbjct: 311 FE 312

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  131 bits (332), Expect = 1e-36
 Identities = 64/259 (24%), Positives = 106/259 (40%), Gaps = 60/259 (23%)

Query: 29  EISLLSQFEQDNIVQYL-----GTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSY 83
           EI +L  F+ +NI+         + ++ N +YI  EL+    L  +     LSD  +  +
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYF 117

Query: 84  TRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK---GTP 140
             Q L  +  LH  NV+HRD+K +N+L++++  +K+ DFGLA+    +   + +      
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177

Query: 141 FWM---------APEVV-NSKNDGYGLTADIWSLGCTVLEMLTRRP-------------- 176
             +         APEV+  S    Y    D+WS GC + E+  RRP              
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAK--YSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235

Query: 177 ------PYSHLEGVQALFRIGKGE-------LPSVP--------SSLSRDARDFILKCLQ 215
                 P+S       L  I           LP  P          ++    D + + L 
Sbjct: 236 FGIIGTPHSD----NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLV 291

Query: 216 VNPNDRPTVTELMEHPFVK 234
            +P  R T  E +EHP+++
Sbjct: 292 FDPAKRITAKEALEHPYLQ 310

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  129 bits (327), Expect = 1e-36
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 17/212 (8%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTR 85
            E  ++   +  +IV+ +G  ++E   +I +EL   G L +  ++    L    +  Y+ 
Sbjct: 62  SEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---W 142
           QI   + YL   N VHRDI   NILV +   VKL DFGL++     D      T     W
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 180

Query: 143 MAPEVVNSKNDGYGL--TA-DIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGE-LPS 197
           M+PE +N     +    TA D+W     + E+L+  + P+  LE    +  + KG+ LP 
Sbjct: 181 MSPESIN-----FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK 235

Query: 198 VPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
            P          + +C   +P+DRP  TEL+ 
Sbjct: 236 -PDLCPPVLYTLMTRCWDYDPSDRPRFTELVC 266

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  130 bits (329), Expect = 1e-36
 Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 18/214 (8%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTR 85
            E S++ QF+  NI++  G         I  E +  GSL    + +    +  Q+    R
Sbjct: 99  SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCKGTPF-- 141
            +  G+ YL +   VHRD+   N+LVD++   K++DFGL++    +     +  G     
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI 218

Query: 142 -WMAPEVVNSKNDGYGL--TA-DIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGE-L 195
            W APE +      +    +A D+WS G  + E+L     PY ++     +  + +G  L
Sbjct: 219 RWTAPEAIA-----FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL 273

Query: 196 PSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
           P+ P          +L C   +   RP  ++++ 
Sbjct: 274 PA-PMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  134 bits (339), Expect = 2e-36
 Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 13/211 (6%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLAN--LYQKYHLSDSQVSSYTR 85
           +E  ++ Q +   IV+ +G  + E  L + +E+   G L    + ++  +  S V+    
Sbjct: 385 REAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 443

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL--KSCKGTPF-- 141
           Q+  G+ YL E+N VHR++   N+L+      K++DFGL+KA   +D    +     +  
Sbjct: 444 QVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 503

Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGE-LPSV 198
            W APE +N +   +   +D+WS G T+ E L+  + PY  ++G + +  I +G+ +   
Sbjct: 504 KWYAPECINFRK--FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC- 560

Query: 199 PSSLSRDARDFILKCLQVNPNDRPTVTELME 229
           P     +    +  C      DRP    + +
Sbjct: 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  132 bits (334), Expect = 3e-36
 Identities = 62/260 (23%), Positives = 109/260 (41%), Gaps = 64/260 (24%)

Query: 29  EISLLSQFEQDNIVQYL------GTDKDENRLYIFLELVTKGSLANLYQ--KYHLSDSQV 80
           E+ L+      NI+  L       T ++   +Y+ +EL+     ANL Q  +  L   ++
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELDHERM 166

Query: 81  SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTP 140
           S    Q+L G+ +LH   ++HRD+K +NI+V +  ++K+ DFGLA+    + +     TP
Sbjct: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----TP 222

Query: 141 FWM-----APEVVNSKNDGYGLTADIWSLGCTVLEMLTRR-------------------- 175
           + +     APEV+      Y    DIWS+GC + EM+  +                    
Sbjct: 223 YVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 280

Query: 176 -PPYSHLEGVQ-------------------ALF-RIGKGELPSVPSSLSRDARDFILKCL 214
            P    ++ +Q                    LF               +  ARD + K L
Sbjct: 281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 340

Query: 215 QVNPNDRPTVTELMEHPFVK 234
            ++P  R +V + ++HP++ 
Sbjct: 341 VIDPAKRISVDDALQHPYIN 360

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  130 bits (328), Expect = 3e-36
 Identities = 63/249 (25%), Positives = 99/249 (39%), Gaps = 51/249 (20%)

Query: 29  EISLLSQFEQ-DNIVQYLGT--DKDENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTR 85
           EI +L       NI+       D       +  E V       LYQ   L+D  +  Y  
Sbjct: 80  EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--LTDYDIRFYMY 137

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFGLAKATTMNDLKSCK-GTPFWM 143
           +IL  L Y H   ++HRD+K  N+++D     ++L D+GLA+        + +  + ++ 
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 197

Query: 144 APEV-VNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG---VQALFRIGK------- 192
            PE+ V+ +   Y  + D+WSLGC +  M+ R+ P+ H  G      L RI K       
Sbjct: 198 GPELLVDYQM--YDYSLDMWSLGCMLASMIFRKEPFFH--GHDNYDQLVRIAKVLGTEDL 253

Query: 193 ----------------GELPSVP-------------SSLSRDARDFILKCLQVNPNDRPT 223
                             L                   +S +A DF+ K L+ +   R T
Sbjct: 254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 313

Query: 224 VTELMEHPF 232
             E MEHP+
Sbjct: 314 AREAMEHPY 322

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  128 bits (324), Expect = 3e-36
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 11/211 (5%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANL---YQKYHLSDSQVSSYT 84
           +E +++ + +  N+VQ LG    E   YI  E +T G+L +      +  +S   +    
Sbjct: 58  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117

Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF--- 141
            QI + + YL ++N +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177

Query: 142 WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGE-LPSVP 199
           W APE +      + + +D+W+ G  + E+ T    PY  ++  Q    + K   +   P
Sbjct: 178 WTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-P 234

Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
                   + +  C Q NP+DRP+  E+ + 
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQA 265

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  128 bits (324), Expect = 3e-36
 Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 21/214 (9%)

Query: 28  QEISLLSQFEQDNIVQYLG--TDKDENRLYIFLELVTKGSLAN--LYQKYHLSDSQVSSY 83
           QE   + QF+  +IV+ +G  T   EN ++I +EL T G L +    +KY L  + +  Y
Sbjct: 65  QEALTMRQFDHPHIVKLIGVIT---ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY 121

Query: 84  TRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF-- 141
             Q+   L YL  +  VHRDI   N+LV ++  VKL DFGL++    +            
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 181

Query: 142 -WMAPEVVNSKNDGYGL--TA-DIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGE-L 195
            WMAPE +N     +    +A D+W  G  + E+L     P+  ++    + RI  GE L
Sbjct: 182 KWMAPESIN-----FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 236

Query: 196 PSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
           P  P +        + KC   +P+ RP  TEL  
Sbjct: 237 PM-PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  132 bits (333), Expect = 5e-36
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 11/211 (5%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLY----QKYHLSDSQVSSY 83
           +E +++ + +  N+VQ LG    E   YI  E +T G+L + Y     +  +S   +   
Sbjct: 265 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYM 323

Query: 84  TRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF-- 141
             QI + + YL ++N +HR++   N LV  +  VK+ADFGL++  T +   +  G  F  
Sbjct: 324 ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 383

Query: 142 -WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVP 199
            W APE +      + + +D+W+ G  + E+ T    PY  ++  Q    + K      P
Sbjct: 384 KWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP 441

Query: 200 SSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
                   + +  C Q NP+DRP+  E+ + 
Sbjct: 442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQA 472

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  129 bits (327), Expect = 8e-36
 Identities = 52/238 (21%), Positives = 93/238 (39%), Gaps = 52/238 (21%)

Query: 49  KDENRLYIFLELVTKGSLANLYQ--------KYHLSDSQVSSYTRQILNGLVYLHERNVV 100
                L + +E V       L++           +  + +S Y  Q+   + ++H   + 
Sbjct: 108 SQNKYLNVIMEYVP----DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGIC 163

Query: 101 HRDIKCANILVDA-SGSVKLADFGLAKATTMNDLKS---CKGTPFWMAPEVV-NSKNDGY 155
           HRDIK  N+LV++   ++KL DFG AK    ++      C  + F+ APE++  +    Y
Sbjct: 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATE--Y 219

Query: 156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI-------------------GKGELP 196
             + D+WS+GC   E++  +P +S    +  L RI                    +   P
Sbjct: 220 TPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFP 279

Query: 197 S---------VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR---PLQTPRC 242
           +         +P      A D + + L+  P+ R    E M HPF        ++   
Sbjct: 280 TLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVK 337

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  128 bits (324), Expect = 8e-36
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 18/214 (8%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTR 85
            E  ++ QF   NI++  G       + I  E +  G+L    ++     S  Q+    R
Sbjct: 95  GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 154

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPF-- 141
            I  G+ YL   N VHRD+   NILV+++   K++DFGL++    +     +  G     
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 214

Query: 142 -WMAPEVVNSKNDGYGL--TA-DIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGE-L 195
            W APE ++     Y    +A D+WS G  + E++T    PY  L   + +  I  G  L
Sbjct: 215 RWTAPEAIS-----YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 269

Query: 196 PSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
           P+ P          +++C Q     RP   +++ 
Sbjct: 270 PT-PMDCPSAIYQLMMQCWQQERARRPKFADIVS 302

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  127 bits (322), Expect = 1e-35
 Identities = 55/244 (22%), Positives = 100/244 (40%), Gaps = 25/244 (10%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG--TDKD----ENRLYIFLE 59
           AVK +            I +  +E + + +F+  ++ + +G               + L 
Sbjct: 55  AVKMLK---ADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILP 111

Query: 60  LVTKGSLAN-------LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVD 112
            +  G L             ++L    +  +   I  G+ YL  RN +HRD+   N ++ 
Sbjct: 112 FMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA 171

Query: 113 ASGSVKLADFGLAKATTMND--LKSCKGT-PF-WMAPEVVNSKNDG-YGLTADIWSLGCT 167
              +V +ADFGL++     D   + C    P  W+A E   S  D  Y + +D+W+ G T
Sbjct: 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALE---SLADNLYTVHSDVWAFGVT 228

Query: 168 VLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTE 226
           + E++TR + PY+ +E  +    +  G     P     +  D + +C   +P  RP+ T 
Sbjct: 229 MWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTC 288

Query: 227 LMEH 230
           L   
Sbjct: 289 LRME 292

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  127 bits (322), Expect = 1e-35
 Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 36/214 (16%)

Query: 40  NIVQ-Y-LGTDKDENRL--YIFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYL 94
            IV  Y  G  +       YI +E V   +L + ++ +  ++  +           L + 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132

Query: 95  HERNVVHRDIKCANILVDASGSVKLADFGLAKA-----TTMNDLKSCKGTPFWMAPEVVN 149
           H+  ++HRD+K ANI++ A+ +VK+ DFG+A+A      ++    +  GT  +++PE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 150 SKNDGYGLTA--DIWSLGCTVLEMLTRRPPYS----------HL-EGVQALFRIGKGELP 196
               G  + A  D++SLGC + E+LT  PP++          H+ E              
Sbjct: 193 ----GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP----SARHE 244

Query: 197 SVPSSLSRDARDFILKCLQVNPNDRP-TVTELME 229
            + + L       +LK L  NP +R  T  E+  
Sbjct: 245 GLSADL----DAVVLKALAKNPENRYQTAAEMRA 274

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  126 bits (319), Expect = 2e-35
 Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 26/217 (11%)

Query: 28  QEISLLSQFEQDNIVQYLGT-DKDENRLYIFLELVTKGSLANLYQ---KYHLSDSQVSSY 83
            E S+++Q    N+VQ LG   +++  LYI  E + KGSL +  +   +  L    +  +
Sbjct: 63  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 122

Query: 84  TRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF-- 141
           +  +   + YL   N VHRD+   N+LV      K++DFGL K        +        
Sbjct: 123 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPV 178

Query: 142 -WMAPEVVN-----SKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGE 194
            W APE +      +K       +D+WS G  + E+ +  R PY  +     + R+ KG 
Sbjct: 179 KWTAPEALREKKFSTK-------SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY 231

Query: 195 -LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
            + + P        + +  C  ++   RP+  +L E 
Sbjct: 232 KMDA-PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 267

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  126 bits (318), Expect = 2e-35
 Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 26/218 (11%)

Query: 28  QEISLLSQFEQDNIVQYLG--TDKDENRLYIFLELVTKGSLANLYQK---YHLSDSQVSS 82
            E +L+ Q +   +V+     T   +  +YI  E +  GSL +  +      L+ +++  
Sbjct: 57  AEANLMKQLQHQRLVRLYAVVT---QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113

Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF- 141
              QI  G+ ++ ERN +HRD++ ANILV  + S K+ADFGLA+    N+  + +G  F 
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173

Query: 142 --WMAPEVVN-----SKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKG 193
             W APE +N      K       +D+WS G  + E++T  R PY  +   + +  + +G
Sbjct: 174 IKWTAPEAINYGTFTIK-------SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226

Query: 194 E-LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
             +   P +   +    +  C +  P DRPT   L   
Sbjct: 227 YRMVR-PDNCPEELYQLMRLCWKERPEDRPTFDYLRSV 263

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  127 bits (321), Expect = 5e-35
 Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 18/214 (8%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTR 85
            E S++ QF+  NI++  G       + I  E +  GSL +  +K+    +  Q+    R
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPF-- 141
            I +G+ YL +   VHRD+   NIL++++   K++DFGL +    +     + +G     
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI 214

Query: 142 -WMAPEVVNSKNDGYGL--TA-DIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGE-L 195
            W +PE +      Y    +A D+WS G  + E+++    PY  +     +  + +G  L
Sbjct: 215 RWTSPEAIA-----YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL 269

Query: 196 PSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
           P  P          +L C Q + N+RP   +++ 
Sbjct: 270 PP-PMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  125 bits (316), Expect = 8e-35
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 14/221 (6%)

Query: 21  QSILQLEQEISLLSQFEQDNIVQYLGT-DKDENRLYIFLELVTKGSLAN--LYQKYHLSD 77
           Q +    +E  L+      N++  +G     E   ++ L  +  G L       + + + 
Sbjct: 64  QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV 123

Query: 78  SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LK 134
             + S+  Q+  G+ YL E+  VHRD+   N ++D S +VK+ADFGLA+     +   ++
Sbjct: 124 KDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQ 183

Query: 135 SCKGTPF---WMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFR 189
             +       W A E   S     +   +D+WS G  + E+LTR  PPY H++       
Sbjct: 184 QHRHARLPVKWTALE---SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF 240

Query: 190 IGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
           + +G     P          + +C + +P  RPT   L+  
Sbjct: 241 LAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  129 bits (327), Expect = 1e-34
 Identities = 46/198 (23%), Positives = 80/198 (40%), Gaps = 24/198 (12%)

Query: 40  NIVQ-Y-LGTDKDEN---RLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYL 94
           +IVQ +      D +     YI +E V   SL     +  L  ++  +Y  +IL  L YL
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYL 198

Query: 95  HERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDG 154
           H   +V+ D+K  NI++     +KL D G              GTP + APE+V +    
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFG--YLYGTPGFQAPEIVRTGPTV 255

Query: 155 YGLTADIWSLGCTVLEMLTRRPPYS--HLEGVQALFRIGKGELPSVPSSLSRDARDFILK 212
                DI+++G T+  +    P  +  +++G+          +     S  R     + +
Sbjct: 256 A---TDIYTVGRTLAALTLDLPTRNGRYVDGLPE-----DDPVLKTYDSYGR----LLRR 303

Query: 213 CLQVNPNDRP-TVTELME 229
            +  +P  R  T  E+  
Sbjct: 304 AIDPDPRQRFTTAEEMSA 321

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  123 bits (310), Expect = 7e-34
 Identities = 56/243 (23%), Positives = 100/243 (41%), Gaps = 24/243 (9%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG--TDKD---ENRLYIFLEL 60
           AVK  +++   +  ++ I +   E + +  F   N+++ LG   +       +  + L  
Sbjct: 66  AVK--TMKLDNSSQRE-IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPF 122

Query: 61  VTKGSLAN-------LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +  G L              H+    +  +   I  G+ YL  RN +HRD+   N ++  
Sbjct: 123 MKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRD 182

Query: 114 SGSVKLADFGLAKATTMND--LKSCKGT-PF-WMAPEVVNSKNDG-YGLTADIWSLGCTV 168
             +V +ADFGL+K     D   +      P  W+A E   S  D  Y   +D+W+ G T+
Sbjct: 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE---SLADRVYTSKSDVWAFGVTM 239

Query: 169 LEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
            E+ TR   PY  ++  +    +  G     P     +  + +  C + +P DRPT + L
Sbjct: 240 WEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVL 299

Query: 228 MEH 230
              
Sbjct: 300 RLQ 302

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  127 bits (320), Expect = 9e-34
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 9/208 (4%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTR 85
           QE   + QF+  +IV+ +G   +   ++I +EL T G L +  Q     L  + +  Y  
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 498

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF---W 142
           Q+   L YL  +  VHRDI   N+LV ++  VKL DFGL++    +             W
Sbjct: 499 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558

Query: 143 MAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSS 201
           MAPE +N +   +   +D+W  G  + E+L     P+  ++    + RI  GE   +P +
Sbjct: 559 MAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 616

Query: 202 LSRDARDFILKCLQVNPNDRPTVTELME 229
                   + KC   +P+ RP  TEL  
Sbjct: 617 CPPTLYSLMTKCWAYDPSRRPRFTELKA 644

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  122 bits (308), Expect = 1e-33
 Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 14/214 (6%)

Query: 28  QEISLLSQFEQDNIVQYLGT-DKDENRLYIFLELVTKGSLANLYQK--YHLSDSQVSSYT 84
            E  ++  F   N++  LG   + E    + L  +  G L N  +   ++ +   +  + 
Sbjct: 75  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 134

Query: 85  RQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF--- 141
            Q+  G+ YL  +  VHRD+   N ++D   +VK+ADFGLA+     +  S         
Sbjct: 135 LQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 194

Query: 142 ---WMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELP 196
              WMA E   S     +   +D+WS G  + E++TR  PPY  +        + +G   
Sbjct: 195 PVKWMALE---SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL 251

Query: 197 SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
             P        + +LKC       RP+ +EL+  
Sbjct: 252 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  125 bits (315), Expect = 1e-33
 Identities = 59/213 (27%), Positives = 111/213 (52%), Gaps = 18/213 (8%)

Query: 28  QEISLLSQFEQDNIVQYLG--TDKDENRLYIFLELVTKGSLANLYQKYH----LSDSQVS 81
            E +++   + D +V+     T   +  +YI  E + KGSL + + K          ++ 
Sbjct: 232 AEANVMKTLQHDKLVKLHAVVT---KEPIYIITEFMAKGSLLD-FLKSDEGSKQPLPKLI 287

Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF 141
            ++ QI  G+ ++ +RN +HRD++ ANILV AS   K+ADFGLA+    N+  + +G  F
Sbjct: 288 DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF 347

Query: 142 ---WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGE-LP 196
              W APE +N  +  + + +D+WS G  ++E++T  R PY  +   + +  + +G  +P
Sbjct: 348 PIKWTAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP 405

Query: 197 SVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
             P +   +  + +++C +  P +RPT   +  
Sbjct: 406 R-PENCPEELYNIMMRCWKNRPEERPTFEYIQS 437

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  123 bits (312), Expect = 3e-33
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 20/213 (9%)

Query: 28  QEISLLSQFEQDNIVQYLG--TDKDENRLYIFLELVTKGSLANLY----QKYHLSDSQVS 81
            E S+++Q    N+VQ LG    +++  LYI  E + KGSL + Y     +  L    + 
Sbjct: 235 AEASVMTQLRHSNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLL 292

Query: 82  SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPF 141
            ++  +   + YL   N VHRD+   N+LV      K++DFGL K        +      
Sbjct: 293 KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKL 348

Query: 142 ---WMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGE-LP 196
              W APE +  K   +   +D+WS G  + E+ +  R PY  +     + R+ KG  + 
Sbjct: 349 PVKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD 406

Query: 197 SVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
           + P        D +  C  ++   RPT  +L E
Sbjct: 407 A-PDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  123 bits (311), Expect = 4e-33
 Identities = 60/307 (19%), Positives = 109/307 (35%), Gaps = 106/307 (34%)

Query: 29  EISLLSQFEQDNIVQYL-----GTDKDENRLYIFLELVTKGSLANLYQ----KYHLSDSQ 79
           EI++L++   D++V+ L        +  + LY+ LE+      ++  +      +L++  
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD----SDFKKLFRTPVYLTELH 157

Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT 139
           + +    +L G+ Y+H   ++HRD+K AN LV+   SVK+ DFGLA+     +  + +  
Sbjct: 158 IKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLP 217

Query: 140 PFWM-----------------------------APEV-VNSKNDGYGLTADIWSLGCTVL 169
                                            APE+ +  +N  Y    D+WS+GC   
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN--YTEAIDVWSIGCIFA 275

Query: 170 EMLT-----------RRP--------------------PYSHLEGVQALFRI-------G 191
           E+L            R P                     +        L  I        
Sbjct: 276 ELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPS 335

Query: 192 KGELPSVPSSLSR-----------------------DARDFILKCLQVNPNDRPTVTELM 228
           + ++ ++    ++                       DA   + + L  NPN R T+ E +
Sbjct: 336 EEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECL 395

Query: 229 EHPFVKR 235
            HPF K 
Sbjct: 396 AHPFFKE 402

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  122 bits (307), Expect = 5e-33
 Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 14/221 (6%)

Query: 21  QSILQLEQEISLLSQFEQDNIVQYLGT-DKDENRLYIFLELVTKGSLANLYQK--YHLSD 77
             + Q   E  ++  F   N++  LG   + E    + L  +  G L N  +   ++ + 
Sbjct: 132 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 191

Query: 78  SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCK 137
             +  +  Q+  G+ +L  +  VHRD+   N ++D   +VK+ADFGLA+     +  S  
Sbjct: 192 KDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 251

Query: 138 GT-----PF-WMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFR 189
                  P  WMA E   S     +   +D+WS G  + E++TR  PPY  +        
Sbjct: 252 NKTGAKLPVKWMALE---SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 308

Query: 190 IGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
           + +G     P        + +LKC       RP+ +EL+  
Sbjct: 309 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  120 bits (304), Expect = 6e-33
 Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 20/222 (9%)

Query: 26  LEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSL-----------ANLYQKYH 74
              E S++ +F   ++V+ LG         + +EL+T+G L           AN      
Sbjct: 75  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134

Query: 75  LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 132
            S S++     +I +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D  
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194

Query: 133 LKSCKGT-PF-WMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALF 188
            K  KG  P  WM+PE   S  DG +   +D+WS G  + E+ T    PY  L   Q L 
Sbjct: 195 RKGGKGLLPVRWMSPE---SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251

Query: 189 RIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
            + +G L   P +      + +  C Q NP  RP+  E++  
Sbjct: 252 FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  120 bits (302), Expect = 7e-33
 Identities = 44/218 (20%), Positives = 85/218 (38%), Gaps = 26/218 (11%)

Query: 28  QEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSSYTR 85
           +  S++S+    ++V   G     +   +  E V  GSL    +K    ++        +
Sbjct: 61  EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120

Query: 86  QILNGLVYLHERNVVHRDIKCANILVDASGS--------VKLADFGLAKATTMNDLKSCK 137
           Q+   + +L E  ++H ++   NIL+             +KL+D G++      D+    
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ-- 178

Query: 138 GTPF-WMAPEVVNSKNDGYGLT--ADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKG 193
                W+ PE +    +   L    D WS G T+ E+ +    P S L+  + L      
Sbjct: 179 -ERIPWVPPECI---ENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234

Query: 194 E-LPS-VPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
             LP+   + L     + I  C+   P+ RP+   ++ 
Sbjct: 235 HQLPAPKAAEL----ANLINNCMDYEPDHRPSFRAIIR 268

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  121 bits (306), Expect = 1e-32
 Identities = 60/283 (21%), Positives = 103/283 (36%), Gaps = 84/283 (29%)

Query: 29  EISLLSQFEQ-DNIVQYLGTDKDENR--LYIFLELVTKGSLANLYQKYH---LSDSQVSS 82
           EI +L++    +NIV  L   + +N   +Y+  + +      +L+       L       
Sbjct: 58  EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME----TDLHAVIRANILEPVHKQY 113

Query: 83  YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA--------------KAT 128
              Q++  + YLH   ++HRD+K +NIL++A   VK+ADFGL+               + 
Sbjct: 114 VVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173

Query: 129 TMNDLKSCKGTPFWM---------APEV-VNSKNDGYGLTADIWSLGCTVLEMLTRRP-- 176
             N        P            APE+ + S    Y    D+WSLGC + E+L  +P  
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTK--YTKGIDMWSLGCILGEILCGKPIF 231

Query: 177 ---------------------------------------------PYSHLEGVQALFRIG 191
                                                          S+   +   ++  
Sbjct: 232 PGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNL 291

Query: 192 KGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
             ++       + +A D + K LQ NPN R +  + ++HPFV 
Sbjct: 292 LLKINPKADC-NEEALDLLDKLLQFNPNKRISANDALKHPFVS 333

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  117 bits (295), Expect = 8e-32
 Identities = 61/246 (24%), Positives = 105/246 (42%), Gaps = 34/246 (13%)

Query: 7   VKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSL 66
           +K+ +L  +           ++E  LL+  + ++IV++ G   D + L +  E +  G L
Sbjct: 53  LKDPTLAAR--------KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL 104

Query: 67  -----------------ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
                                 K  L  SQ+     QI +G+VYL  ++ VHRD+   N 
Sbjct: 105 NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNC 164

Query: 110 LVDASGSVKLADFGLAKATTMNDL-KSCKGTPF---WMAPEVVNSKNDG-YGLTADIWSL 164
           LV A+  VK+ DFG+++     D  +    T     WM PE   S     +   +D+WS 
Sbjct: 165 LVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE---SIMYRKFTTESDVWSF 221

Query: 165 GCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT 223
           G  + E+ T  + P+  L   + +  I +G +   P    ++  D +L C Q  P  R  
Sbjct: 222 GVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLN 281

Query: 224 VTELME 229
           + E+ +
Sbjct: 282 IKEIYK 287

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  117 bits (295), Expect = 2e-31
 Identities = 60/242 (24%), Positives = 93/242 (38%), Gaps = 24/242 (9%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           AVK +    +    +   L    E  ++S+F   NIV+ +G        +I +EL+  G 
Sbjct: 64  AVKTLP---EVCSEQD-ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGD 119

Query: 66  LAN--------LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS- 116
           L +          Q   L+   +    R I  G  YL E + +HRDI   N L+   G  
Sbjct: 120 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 179

Query: 117 --VKLADFGLAKATTMND--LKSCKGT-PF-WMAPEVVNSKNDG-YGLTADIWSLGCTVL 169
              K+ DFG+A+         K      P  WM PE   +  +G +    D WS G  + 
Sbjct: 180 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE---AFMEGIFTSKTDTWSFGVLLW 236

Query: 170 EMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           E+ +    PY      + L  +  G     P +        + +C Q  P DRP    ++
Sbjct: 237 EIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 296

Query: 229 EH 230
           E 
Sbjct: 297 ER 298

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  118 bits (298), Expect = 2e-31
 Identities = 59/300 (19%), Positives = 103/300 (34%), Gaps = 100/300 (33%)

Query: 29  EISLLSQFEQDNIVQYLGTDKDENR-----LYIFLELVTKGSLANLYQ----KYHLSDSQ 79
           EI++L++ + D I++       ++      LYI LE+      ++L +       L++  
Sbjct: 75  EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD----SDLKKLFKTPIFLTEEH 130

Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGT 139
           + +    +L G  ++HE  ++HRD+K AN L++   SVK+ DFGLA+        +    
Sbjct: 131 IKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190

Query: 140 PFWM------------------------APEV-VNSKNDGYGLTADIWSLGCTVLEMLT- 173
                                       APE+ +  +N  Y  + DIWS GC   E+L  
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQEN--YTKSIDIWSTGCIFAELLNM 248

Query: 174 RRPPYSHLEGVQALFRIGKGELPSVPSSL------------------------------- 202
            +   +       LF  G    P  P                                  
Sbjct: 249 LQSHINDPTNRFPLFP-GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNI 307

Query: 203 -SRDARDFIL--------------------------KCLQVNPNDRPTVTELMEHPFVKR 235
              +   +I                             L+ NPN R T+ + ++HP++K 
Sbjct: 308 NKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  116 bits (292), Expect = 6e-31
 Identities = 61/242 (25%), Positives = 92/242 (38%), Gaps = 24/242 (9%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           AVK +    +    +   L    E  ++S+F   NIV+ +G        +I LEL+  G 
Sbjct: 105 AVKTLP---EVCSEQD-ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 160

Query: 66  L--------ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS- 116
           L            Q   L+   +    R I  G  YL E + +HRDI   N L+   G  
Sbjct: 161 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 220

Query: 117 --VKLADFGLAKATTMND--LKSCKGT-PF-WMAPEVVNSKNDG-YGLTADIWSLGCTVL 169
              K+ DFG+A+         K      P  WM PE   +  +G +    D WS G  + 
Sbjct: 221 RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE---AFMEGIFTSKTDTWSFGVLLW 277

Query: 170 EMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM 228
           E+ +    PY      + L  +  G     P +        + +C Q  P DRP    ++
Sbjct: 278 EIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 337

Query: 229 EH 230
           E 
Sbjct: 338 ER 339

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  113 bits (286), Expect = 1e-30
 Identities = 50/228 (21%), Positives = 84/228 (36%), Gaps = 26/228 (11%)

Query: 26  LEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSL-----------------AN 68
              E  L ++ +  N+V  LG    +  L +     + G L                  +
Sbjct: 59  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118

Query: 69  LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKAT 128
              K  L          QI  G+ YL   +VVH+D+   N+LV    +VK++D GL +  
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV 178

Query: 129 TMNDL-KSCKGTPF---WMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTR-RPPYSHLE 182
              D  K    +     WMAPE   +   G + + +DIWS G  + E+ +    PY    
Sbjct: 179 YAADYYKLLGNSLLPIRWMAPE---AIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 235

Query: 183 GVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
               +  I   ++   P          +++C    P+ RP   ++   
Sbjct: 236 NQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 283

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  113 bits (286), Expect = 3e-30
 Identities = 55/246 (22%), Positives = 95/246 (38%), Gaps = 33/246 (13%)

Query: 7   VKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSL 66
           +KE S   +           ++E  LL+  +  +IV++ G   +   L +  E +  G L
Sbjct: 79  LKEASESAR--------QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL 130

Query: 67  ----------------ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
                                   L   Q+ +   Q+  G+VYL   + VHRD+   N L
Sbjct: 131 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCL 190

Query: 111 VDASGSVKLADFGLAKATTMNDL-KSCKGTPF---WMAPEVVNSKNDG-YGLTADIWSLG 165
           V     VK+ DFG+++     D  +    T     WM PE   S     +   +D+WS G
Sbjct: 191 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE---SILYRKFTTESDVWSFG 247

Query: 166 CTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV 224
             + E+ T  + P+  L   +A+  I +G     P +   +    +  C Q  P  R ++
Sbjct: 248 VVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSI 307

Query: 225 TELMEH 230
            ++   
Sbjct: 308 KDVHAR 313

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  113 bits (286), Expect = 3e-30
 Identities = 60/229 (26%), Positives = 102/229 (44%), Gaps = 27/229 (11%)

Query: 26  LEQEISLLSQFEQ-DNIVQYLGTDKDENRLYIFLELVTKGSL-----------------A 67
           L  E+ ++    +  NI+  LG    +  LY+ +E  +KG+L                  
Sbjct: 87  LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146

Query: 68  NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA 127
           N   +  ++   + S T Q+  G+ YL  +  +HRD+   N+LV  +  +K+ADFGLA+ 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206

Query: 128 TTMND--LKSCKGT-PF-WMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTR-RPPYSHL 181
               D   K+  G  P  WMAPE   +  D  Y   +D+WS G  + E+ T    PY  +
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPE---ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263

Query: 182 EGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
              +    + +G     P++ + +    +  C    P+ RPT  +L+E 
Sbjct: 264 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  113 bits (286), Expect = 5e-30
 Identities = 60/229 (26%), Positives = 102/229 (44%), Gaps = 27/229 (11%)

Query: 26  LEQEISLLSQFEQ-DNIVQYLGTDKDENRLYIFLELVTKGSL-----------------A 67
           L  E+ ++    +  NI+  LG    +  LY+ +E  +KG+L                  
Sbjct: 133 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192

Query: 68  NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA 127
           N   +  ++   + S T Q+  G+ YL  +  +HRD+   N+LV  +  +K+ADFGLA+ 
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 252

Query: 128 TTMND--LKSCKGT-PF-WMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTR-RPPYSHL 181
               D   K+  G  P  WMAPE   +  D  Y   +D+WS G  + E+ T    PY  +
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPE---ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309

Query: 182 EGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
              +    + +G     P++ + +    +  C    P+ RPT  +L+E 
Sbjct: 310 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  112 bits (283), Expect = 6e-30
 Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 34/236 (14%)

Query: 26  LEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSL------------------- 66
           L  E ++L Q    ++++  G    +  L + +E    GSL                   
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132

Query: 67  ------ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
                  +   +  L+   + S+  QI  G+ YL E  +VHRD+   NILV     +K++
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKIS 192

Query: 121 DFGLAKATTMND--LKSCKGT-PF-WMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTR- 174
           DFGL++     D  +K  +G  P  WMA E   S  D  Y   +D+WS G  + E++T  
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIE---SLFDHIYTTQSDVWSFGVLLWEIVTLG 249

Query: 175 RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
             PY  +   +    +  G     P + S +    +L+C +  P+ RP   ++ + 
Sbjct: 250 GNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  112 bits (283), Expect = 7e-30
 Identities = 70/261 (26%), Positives = 115/261 (44%), Gaps = 52/261 (19%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG-TDKDENRLYIFLE 59
           DG   A+K      + +QG +   + E EI  LS     ++V  +G  D+    + I+ +
Sbjct: 62  DGAKVALK--RRTPESSQGIE---EFETEIETLSFCRHPHLVSLIGFCDERNEMILIY-K 115

Query: 60  LVTKGSLANLYQKYHLSDSQVSSY-----TR-QIL----NGLVYLHERNVVHRDIKCANI 109
            +  G+L       HL  S + +       R +I      GL YLH R ++HRD+K  NI
Sbjct: 116 YMENGNLKR-----HLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINI 170

Query: 110 LVDASGSVKLADFGLAKATTMNDLKS-----CKGTPFWMAPEVVNSKNDGYGLT--ADIW 162
           L+D +   K+ DFG++K  T  D ++      KGT  ++ PE       G  LT  +D++
Sbjct: 171 LLDENFVPKITDFGISKKGTELD-QTHLSTVVKGTLGYIDPEYFIK---GR-LTEKSDVY 225

Query: 163 SLGCTVLEMLTRRPPYSHLEGVQ-------ALFRIGKGELPSV----------PSSLSRD 205
           S G  + E+L  R         +       A+     G+L  +          P SL + 
Sbjct: 226 SFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRK- 284

Query: 206 ARDFILKCLQVNPNDRPTVTE 226
             D  +KCL ++  DRP++ +
Sbjct: 285 FGDTAVKCLALSSEDRPSMGD 305

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  111 bits (281), Expect = 1e-29
 Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 31/232 (13%)

Query: 26  LEQEISLLSQFEQ-DNIVQYLG--TDKDENRLYIFLELVTKGSL---------------- 66
           L  E+ +L       N+V  LG  T      L + +E    G+L                
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGG-PLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135

Query: 67  -ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA 125
                 K  L+   +  Y+ Q+  G+ +L  R  +HRD+   NIL+     VK+ DFGLA
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195

Query: 126 KATTMND--LKSCKGT-PF-WMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTR-RPPYS 179
           +    +   ++      P  WMAPE   +  D  Y + +D+WS G  + E+ +    PY 
Sbjct: 196 RDIYKDPDYVRKGDARLPLKWMAPE---TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252

Query: 180 HLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
            ++  +   R + +G     P   + +    +L C    P+ RPT +EL+EH
Sbjct: 253 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  111 bits (279), Expect = 2e-29
 Identities = 66/260 (25%), Positives = 119/260 (45%), Gaps = 50/260 (19%)

Query: 1   DGFFFAVKEVSLQD--QGAQGKQSILQLEQEISLLSQFEQDNIVQYLG--TDKDENRLYI 56
           +    AVK+++        + KQ   Q +QEI ++++ + +N+V+ LG  +D  ++   +
Sbjct: 53  NNTTVAVKKLAAMVDITTEELKQ---QFDQEIKVMAKCQHENLVELLGFSSD-GDDLCLV 108

Query: 57  FLELVTKGSLANLYQKYHLSDSQVSS----YTRQ-----ILNGLVYLHERNVVHRDIKCA 107
           +   +  GSL +      LS    +     + R        NG+ +LHE + +HRDIK A
Sbjct: 109 Y-VYMPNGSLLD-----RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSA 162

Query: 108 NILVDASGSVKLADFGLAKATTMNDLKS-----CKGTPFWMAPEVVNSKNDGYGLT--AD 160
           NIL+D + + K++DFGLA+A+     ++       GT  +MAPE +  +     +T  +D
Sbjct: 163 NILLDEAFTAKISDFGLARASEKFA-QTVMTSRIVGTTAYMAPEALRGE-----ITPKSD 216

Query: 161 IWSLGCTVLEMLT-------RRPPYSHLEGVQALFRIGKGELPSVPSSL----SRDARDF 209
           I+S G  +LE++T        R P   L+  + +    K     +   +    S      
Sbjct: 217 IYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAM 276

Query: 210 I---LKCLQVNPNDRPTVTE 226
                +CL    N RP + +
Sbjct: 277 YSVASQCLHEKKNKRPDIKK 296

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  112 bits (281), Expect = 3e-29
 Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 27/229 (11%)

Query: 26  LEQEISLLSQFEQ-DNIVQYLGTDKDENRLYIFLELVTKGSL-----------------A 67
           L  E+ ++    +  NI+  LG    +  LY+ +E  +KG+L                  
Sbjct: 121 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 180

Query: 68  NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA 127
           +   +  LS   + S   Q+  G+ YL  +  +HRD+   N+LV     +K+ADFGLA+ 
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 240

Query: 128 TTMNDL-KSCKGTPF---WMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTR-RPPYSHL 181
               D  K          WMAPE   +  D  Y   +D+WS G  + E+ T    PY  +
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPE---ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297

Query: 182 EGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
              +    + +G     PS+ + +    +  C    P+ RPT  +L+E 
Sbjct: 298 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  110 bits (278), Expect = 4e-29
 Identities = 53/232 (22%), Positives = 87/232 (37%), Gaps = 30/232 (12%)

Query: 26  LEQEISLLSQFEQ-DNIVQYLGTDKDENRLYIFLELVTKGSL------------------ 66
           L  E+ +LS      NIV  LG         +  E    G L                  
Sbjct: 73  LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132

Query: 67  -ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA 125
                 +  L    + S++ Q+  G+ +L  +N +HRD+   NIL+      K+ DFGLA
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192

Query: 126 KATTMNDL-KSCKGTPF---WMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTR-RPPYS 179
           +    +              WMAPE   S  +  Y   +D+WS G  + E+ +    PY 
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPE---SIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249

Query: 180 HLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
            +      ++ I +G     P     +  D +  C   +P  RPT  ++++ 
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  109 bits (273), Expect = 9e-29
 Identities = 32/230 (13%), Positives = 58/230 (25%), Gaps = 36/230 (15%)

Query: 6   AVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGS 65
           A+  V  Q           +       LS+ ++  + + L          +  E +  GS
Sbjct: 60  ALTFVDPQGVLPDDVLQ--ETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGS 117

Query: 66  LANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA 125
           L  +      S        + +       H   V       + + V   G V LA     
Sbjct: 118 LQEVADT-SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATM 176

Query: 126 KATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY---SHLE 182
                              P+             DI  +G ++  +L  R P        
Sbjct: 177 PDAN---------------PQ------------DDIRGIGASLYALLVNRWPLPEAGVRS 209

Query: 183 GVQALFRIGKGELP---SVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
           G+    R   G+      +   +         + +Q +   R   T L  
Sbjct: 210 GLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNL 259

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  108 bits (273), Expect = 3e-28
 Identities = 55/236 (23%), Positives = 95/236 (40%), Gaps = 34/236 (14%)

Query: 26  LEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSL------------------- 66
            ++E +L+++F+  NIV+ LG       + +  E +  G L                   
Sbjct: 97  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156

Query: 67  ------ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
                  +      LS ++     RQ+  G+ YL ER  VHRD+   N LV  +  VK+A
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 216

Query: 121 DFGLAKATTMND--LKSCKGT-PF-WMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTR- 174
           DFGL++     D          P  WM PE   S     Y   +D+W+ G  + E+ +  
Sbjct: 217 DFGLSRNIYSADYYKADGNDAIPIRWMPPE---SIFYNRYTTESDVWAYGVVLWEIFSYG 273

Query: 175 RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
             PY  +   + ++ +  G + + P +   +  + +  C    P DRP+   +   
Sbjct: 274 LQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  105 bits (265), Expect = 3e-27
 Identities = 53/226 (23%), Positives = 96/226 (42%), Gaps = 24/226 (10%)

Query: 26  LEQEISLLSQFEQ-DNIVQYLGTDKDENRLYIFLELVTKGSL-----------------A 67
              E+ +L +     NI+  LG  +    LY+ +E    G+L                  
Sbjct: 72  FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 131

Query: 68  NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKA 127
                  LS  Q+  +   +  G+ YL ++  +HRD+   NILV  +   K+ADFGL++ 
Sbjct: 132 ANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG 191

Query: 128 TTMNDLKSCKGTPF-WMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTR-RPPYSHLEGV 184
             +   K+    P  WMA E   S N   Y   +D+WS G  + E+++    PY  +   
Sbjct: 192 QEVYVKKTMGRLPVRWMAIE---SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 248

Query: 185 QALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
           +   ++ +G     P +   +  D + +C +  P +RP+  +++  
Sbjct: 249 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  105 bits (265), Expect = 3e-27
 Identities = 53/230 (23%), Positives = 89/230 (38%), Gaps = 30/230 (13%)

Query: 26  LEQEISLLSQFEQ-DNIVQYLGTDKDENRLYIFLELVTKGSL---------------ANL 69
           L  E+ ++S   Q +NIV  LG       + +  E    G L               A  
Sbjct: 96  LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155

Query: 70  YQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT 129
                 S   +  ++ Q+  G+ +L  +N +HRD+   N+L+      K+ DFGLA+   
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 215

Query: 130 MNDL-KSCKGTPF---WMAPEVVNSKNDG-YGLTADIWSLGCTVL--EMLTR-RPPY-SH 180
            +              WMAPE   S  D  Y + +D+WS G  +L  E+ +    PY   
Sbjct: 216 NDSNYIVKGNARLPVKWMAPE---SIFDCVYTVQSDVWSYG--ILLWEIFSLGLNPYPGI 270

Query: 181 LEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
           L   +    +  G   + P+   ++    +  C  + P  RPT  ++   
Sbjct: 271 LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  105 bits (264), Expect = 5e-27
 Identities = 52/237 (21%), Positives = 87/237 (36%), Gaps = 35/237 (14%)

Query: 26  LEQEISLLSQFEQ-DNIVQYLGTDKDENRLYIFLELVTKGSL------------------ 66
           L  E+ +++Q    +NIV  LG       +Y+  E    G L                  
Sbjct: 95  LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 154

Query: 67  ------ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
                         L+   +  +  Q+  G+ +L  ++ VHRD+   N+LV     VK+ 
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKIC 214

Query: 121 DFGLAKATTMNDL-KSCKGTPF---WMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTR- 174
           DFGLA+    +              WMAPE   S  +G Y + +D+WS G  + E+ +  
Sbjct: 215 DFGLARDIMSDSNYVVRGNARLPVKWMAPE---SLFEGIYTIKSDVWSYGILLWEIFSLG 271

Query: 175 RPPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
             PY  +      ++ I  G     P   + +    +  C   +   RP+   L   
Sbjct: 272 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  100 bits (251), Expect = 9e-25
 Identities = 65/292 (22%), Positives = 108/292 (36%), Gaps = 79/292 (27%)

Query: 25  QLEQEISLLSQF-EQD-----NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-----KY 73
           Q  +EI +L    +QD     N++  L      N + +  EL++     NLY+     K+
Sbjct: 139 QAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM----NLYELIKKNKF 194

Query: 74  H-LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV--DASGSVKLADFGLAKATTM 130
              S   V  +   IL  L  LH+  ++H D+K  NIL+       +K+ DFG +     
Sbjct: 195 QGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH- 253

Query: 131 NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV---------------LEMLTR- 174
             + +   + F+ APEV+      YG+  D+WSLGC +                + L   
Sbjct: 254 QRVYTYIQSRFYRAPEVILGA--RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACM 311

Query: 175 -----RPP------------YSHLEGVQALFRIGKGELPSVPSSLSRDAR---------- 207
                 P             +   +G      +      SV  +  R  R          
Sbjct: 312 IELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESR 371

Query: 208 ---------------DFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPRCGQ 244
                          DF+ +CL+ +P  R T  + + HP+++R L  P  G+
Sbjct: 372 EWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGE 423

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 99.0 bits (247), Expect = 2e-24
 Identities = 48/238 (20%), Positives = 82/238 (34%), Gaps = 66/238 (27%)

Query: 54  LYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLH-ERNVVHRDIKCANILVD 112
           L   ++          ++   L    V   ++Q+L GL Y+H    ++H DIK  N+L++
Sbjct: 116 LLALIK-------KYEHRGIPLI--YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 166

Query: 113 AS------GSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
                     +K+AD G A         +   T  + +PEV+      +G  ADIWS  C
Sbjct: 167 IVDSPENLIQIKIADLGNA-CWYDEHYTNSIQTREYRSPEVL--LGAPWGCGADIWSTAC 223

Query: 167 TVLEMLTRRP------------PYSHLEGVQALF-------------------------- 188
            + E++T                  H+  +  L                           
Sbjct: 224 LIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRN 283

Query: 189 ------RIGKGELPSVPSSLSRDAR---DFILKCLQVNPNDRPTVTELMEHPFVKRPL 237
                    +  L         +A+   DF+   LQ++P  R     L+ HP++K  L
Sbjct: 284 ISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 341

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 98.1 bits (244), Expect = 4e-24
 Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 10/166 (6%)

Query: 72  KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 131
           K  L+   +  Y+ Q+  G+ +L  R  +HRD+   NIL+     VK+ DFGLA+    +
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246

Query: 132 DL-KSCKGTPF---WMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQ 185
                         WMAPE   +  D  Y + +D+WS G  + E+ +    PY  ++  +
Sbjct: 247 PDYVRKGDARLPLKWMAPE---TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303

Query: 186 ALFR-IGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
              R + +G     P   + +    +L C    P+ RPT +EL+EH
Sbjct: 304 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 90.0 bits (224), Expect = 3e-21
 Identities = 57/283 (20%), Positives = 90/283 (31%), Gaps = 83/283 (29%)

Query: 29  EISLLSQF-EQD-----NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-----KYH-LS 76
           EI +L      D       VQ L   +    + I  EL+      + Y       +    
Sbjct: 61  EIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGL----STYDFIKENGFLPFR 116

Query: 77  DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG-------------------SV 117
              +     QI   + +LH   + H D+K  NIL   S                     +
Sbjct: 117 LDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176

Query: 118 KLADFGLAKATTMNDLKSC-KGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV-------- 168
           K+ DFG   AT  ++  S    T  + APEV+     G+    D+WS+GC +        
Sbjct: 177 KVVDFG--SATYDDEHHSTLVSTRHYRAPEVI--LALGWSQPCDVWSIGCILIEYYLGFT 232

Query: 169 -------LEMLTR------RPPYSHLEGVQA--LFRIGKGELPSVPSSLSRDAR------ 207
                   E L          P   ++  +    F   + +     S+    +R      
Sbjct: 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK 292

Query: 208 --------------DFILKCLQVNPNDRPTVTELMEHPFVKRP 236
                         D I K L+ +P  R T+ E ++HPF    
Sbjct: 293 EFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 89.6 bits (223), Expect = 3e-21
 Identities = 69/270 (25%), Positives = 111/270 (41%), Gaps = 65/270 (24%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG--TDKDENRLYIFL 58
           DG   AVK   L+++  QG +   Q + E+ ++S     N+++  G      E RL ++ 
Sbjct: 53  DGTLVAVK--RLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTE-RLLVY- 106

Query: 59  ELVTKGSLANLYQKYHLSDSQVSSY-----TRQ-----ILNGLVYLHER---NVVHRDIK 105
             +  GS+A       L +   S        RQ        GL YLH+     ++HRD+K
Sbjct: 107 PYMANGSVA-----SCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVK 161

Query: 106 CANILVDASGSVKLADFGLAKATTMNDLKS-----CKGTPFWMAPEVVNSKNDGYGLT-- 158
            ANIL+D      + DFGLAK   M+   +      +GT   +APE        Y  T  
Sbjct: 162 AANILLDEEFEAVVGDFGLAK--LMDYKDTHVTTAVRGTIGHIAPE--------YLSTGK 211

Query: 159 ----ADIWSLGCTVLEMLTRRPP--YSHLEG---------VQALFRIGK-GEL--PSVPS 200
                D++  G  +LE++T +     + L           V+ L +  K   L    +  
Sbjct: 212 SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQG 271

Query: 201 SLSRD-ARDFI---LKCLQVNPNDRPTVTE 226
           +   +     I   L C Q +P +RP ++E
Sbjct: 272 NYKDEEVEQLIQVALLCTQSSPMERPKMSE 301

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 87.8 bits (218), Expect = 2e-20
 Identities = 57/292 (19%), Positives = 90/292 (30%), Gaps = 91/292 (31%)

Query: 29  EISLLSQF-EQD-----NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-----KYH-LS 76
           EI++L +  E+D       V           + I  EL+ K    N ++      +    
Sbjct: 66  EINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGK----NTFEFLKENNFQPYP 121

Query: 77  DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG-------------------SV 117
              V     Q+ + L +LHE  + H D+K  NIL   S                    S+
Sbjct: 122 LPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181

Query: 118 KLADFGLAKATTMNDLKSCKGTP-----FWMAPEVVNSKNDGYGLTADIWSLGCTV---- 168
           ++ADFG   AT  ++      T       +  PEV+     G+    D+WS+GC +    
Sbjct: 182 RVADFG--SATFDHE----HHTTIVATRHYRPPEVI--LELGWAQPCDVWSIGCILFEYY 233

Query: 169 -----------LEMLTR------RPPYSHLEGVQA--LFRIGKGELPSVPSSLSR----- 204
                       E L          P   +   +    F  G        S         
Sbjct: 234 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 293

Query: 205 ---------------DARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTPR 241
                             D + + L+ +P  R T+ E + HPF        R
Sbjct: 294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEER 345

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 85.1 bits (211), Expect = 2e-19
 Identities = 62/288 (21%), Positives = 107/288 (37%), Gaps = 90/288 (31%)

Query: 29  EISLLSQFEQD-----NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-----KYH-LSD 77
           E  +L + + D     NIV+Y G     + + +  E +      +LY+      Y+    
Sbjct: 81  EADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGP----SLYEIITRNNYNGFHI 136

Query: 78  SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG---------------------- 115
             +  Y  +IL  L YL + ++ H D+K  NIL+D                         
Sbjct: 137 EDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196

Query: 116 ---SVKLADFGLAKATTMNDLKSC-KGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
               +KL DFG   AT  +D       T  + APEV+   N G+ +++D+WS GC + E+
Sbjct: 197 KSTGIKLIDFG--CATFKSDYHGSIINTRQYRAPEVI--LNLGWDVSSDMWSFGCVLAEL 252

Query: 172 LT---------------------RRPPYSHLEGVQAL-----FRIGKGELPSVPSSLSRD 205
            T                     +  P + L               + +L    ++ S +
Sbjct: 253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSIN 312

Query: 206 AR-------------------DFILKCLQVNPNDRPTVTELMEHPFVK 234
           +                    DF+   LQ++P  RP+  EL++H F++
Sbjct: 313 SIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 80.9 bits (200), Expect = 6e-18
 Identities = 54/290 (18%), Positives = 99/290 (34%), Gaps = 86/290 (29%)

Query: 25  QLEQEISLLSQF-EQD-----NIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-----KY 73
           Q + E+ LL    + D      IV         N L +  E+++     NLY       +
Sbjct: 96  QAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY----NLYDLLRNTNF 151

Query: 74  H-LSDSQVSSYTRQILNGLVYLHER--NVVHRDIKCANILV--DASGSVKLADFGLAKAT 128
             +S +    + +Q+   L++L     +++H D+K  NIL+      ++K+ DFG +   
Sbjct: 152 RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQ 210

Query: 129 TMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSL---------------GCTVLEMLT 173
               +     + F+ +PEV+      Y L  D+WSL               G   ++ + 
Sbjct: 211 LGQRIYQYIQSRFYRSPEVL--LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN 268

Query: 174 R------RPPYSHLE--------------------------------GVQALFRIGKGEL 195
           +       PP   L+                                G + L  I   E 
Sbjct: 269 KIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVET 328

Query: 196 PSVPSSLSRDA----------RDFILKCLQVNPNDRPTVTELMEHPFVKR 235
                  + ++          +D IL+ L  +P  R      ++H F K+
Sbjct: 329 GGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 74.2 bits (182), Expect = 2e-15
 Identities = 52/252 (20%), Positives = 73/252 (28%), Gaps = 100/252 (39%)

Query: 78  SQVSSYTRQILNGLVYLH-ERNVVHRDIKCANILVDAS---------------------- 114
             V    +Q+L GL YLH +  ++H DIK  NIL+  +                      
Sbjct: 146 PCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP 205

Query: 115 ---------------------------GSVKLADFGLAKATTMNDLKSCKGTPFWMAPEV 147
                                        VK+AD G A             T  + + EV
Sbjct: 206 SGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH-KHFTEDIQTRQYRSLEV 264

Query: 148 VNSKNDGYGLTADIWSLGCTVLEMLTRRPPYS------------HLEGVQAL-------- 187
           +     GY   ADIWS  C   E+ T    +             H+  +  L        
Sbjct: 265 L--IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322

Query: 188 ---------FRIGKGEL----PSVPSSLSRDAR--------------DFILKCLQVNPND 220
                    F   KG+L       P  L                   DF+L  L++ P  
Sbjct: 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEK 382

Query: 221 RPTVTELMEHPF 232
           R T  E + HP+
Sbjct: 383 RATAAECLRHPW 394

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 60.1 bits (146), Expect = 6e-11
 Identities = 49/211 (23%), Positives = 84/211 (39%), Gaps = 37/211 (17%)

Query: 8   KEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNI--VQYLGTDKDENRLYIFLELVTKG 64
           ++V+++ +  +      QL  E            I  V Y G +   N   + ++L+   
Sbjct: 36  QQVAIKFEPRRSDAP--QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN--VLVIDLLGP- 90

Query: 65  SLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS-----V 117
           SL +L        S   V+   +Q+L  +  +HE+++V+RDIK  N L+    S     +
Sbjct: 91  SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMI 150

Query: 118 KLADFGLAK----ATT-----MNDLKSCKGTPFWMAPEVVNSKNDGYGLTA----DIWSL 164
            + DFG+ K      T       + K+  GT  +M      S N   G       D+ +L
Sbjct: 151 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM------SINTHLGREQSRRDDLEAL 204

Query: 165 GCTVLEMLTRRPPYSHLEGV---QALFRIGK 192
           G   +  L    P+  L+     Q   RIG+
Sbjct: 205 GHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 59.5 bits (143), Expect = 1e-10
 Identities = 17/79 (21%), Positives = 29/79 (36%), Gaps = 1/79 (1%)

Query: 50  DENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHER-NVVHRDIKCAN 108
            +++L+I LE    G      +    S +   S   Q+   L          HRD+   N
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGN 192

Query: 109 ILVDASGSVKLADFGLAKA 127
           +L+  +   KL      K+
Sbjct: 193 VLLKKTSLKKLHYTLNGKS 211

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 58.5 bits (142), Expect = 2e-10
 Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 35/209 (16%)

Query: 8   KEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNI--VQYLGTDKDENRLYIFLELVTKG 64
           +EV+++ +  + K    QL  E  +    +    I  +++ G + D N   + +EL+   
Sbjct: 35  EEVAIKLECVKTKHP--QLHIESKIYKMMQGGVGIPTIRWCGAEGDYN--VMVMELLGP- 89

Query: 65  SLANLYQK--YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---DASGSVKL 119
           SL +L+       S   V     Q+++ + Y+H +N +HRD+K  N L+        V +
Sbjct: 90  SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYI 149

Query: 120 ADFGLAKATTMN---------DLKSCKGTPFWMAPEVVNSKNDGYGLTA----DIWSLGC 166
            DFGLAK              + K+  GT  +       S N   G+      D+ SLG 
Sbjct: 150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYA------SINTHLGIEQSRRDDLESLGY 203

Query: 167 TVLEMLTRRPPYSHLEGV---QALFRIGK 192
            ++       P+  L+     Q   RI +
Sbjct: 204 VLMYFNLGSLPWQGLKAATKRQKYERISE 232

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 57.8 bits (140), Expect = 4e-10
 Identities = 50/194 (25%), Positives = 76/194 (39%), Gaps = 35/194 (18%)

Query: 25  QLEQEISLLSQFE-QDNI--VQYLGTDKDENRLYIFLELVTKGSLANL--YQKYHLSDSQ 79
           QL  E     Q    D I  V Y G     N   + LEL+   SL +L        S   
Sbjct: 50  QLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN--AMVLELLGP-SLEDLFDLCDRTFSLKT 106

Query: 80  VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS-----VKLADFGLAK----ATT- 129
           V     Q+++ + Y+H +N+++RD+K  N L+   G+     + + DF LAK      T 
Sbjct: 107 VLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166

Query: 130 ----MNDLKSCKGTPFWMAPEVVNSKNDGYGLTA----DIWSLGCTVLEMLTRRPPYSHL 181
                 + KS  GT  +M      S N   G       D+ +LG   +  L    P+  L
Sbjct: 167 KHIPYREHKSLTGTARYM------SINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220

Query: 182 EGV---QALFRIGK 192
           +     +   +IG 
Sbjct: 221 KADTLKERYQKIGD 234

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 57.5 bits (139), Expect = 7e-10
 Identities = 26/91 (28%), Positives = 40/91 (43%), Gaps = 7/91 (7%)

Query: 42  VQYLGTDKDENRLYIFL--ELVTKGSLANLYQK--YHLSDSQVSSYTRQILNGLVYLHER 97
               G      + Y F+  +      L  +Y+      S   V   + +IL+ L Y+HE 
Sbjct: 113 YWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH 171

Query: 98  NVVHRDIKCANILVDASGS--VKLADFGLAK 126
             VH DIK +N+L++      V L D+GLA 
Sbjct: 172 EYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 57.4 bits (139), Expect = 7e-10
 Identities = 27/90 (30%), Positives = 41/90 (45%), Gaps = 6/90 (6%)

Query: 42  VQYLGTDKDENRLYIFL--ELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERN 98
               G  + + R Y F+  E +    L  +  +      S V     ++L+ L Y+HE  
Sbjct: 113 FYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE 171

Query: 99  VVHRDIKCANILVDASGS--VKLADFGLAK 126
            VH DIK AN+L+       V LAD+GL+ 
Sbjct: 172 YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 57.3 bits (138), Expect = 9e-10
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 35/209 (16%)

Query: 8   KEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNI--VQYLGTDKDENRLYIFLELVTKG 64
           +EV+++ +  + K    QL  E  +    +    I  V++ G + D N   + ++L+   
Sbjct: 33  EEVAIKLENVKTKHP--QLLYESKIYRILQGGTGIPNVRWFGVEGDYN--VLVMDLLGP- 87

Query: 65  SLANL--YQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS---VKL 119
           SL +L  +    LS   V     Q++N + ++H ++ +HRDIK  N L+        V +
Sbjct: 88  SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 147

Query: 120 ADFGLAKATTMN---------DLKSCKGTPFWMAPEVVNSKNDGYGLTA----DIWSLGC 166
            DFGLAK              + K+  GT  +       S N   G+      D+ SLG 
Sbjct: 148 IDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA------SVNTHLGIEQSRRDDLESLGY 201

Query: 167 TVLEMLTRRPPYSHLEGV---QALFRIGK 192
            ++  L    P+  L+     Q   +I +
Sbjct: 202 VLMYFLRGSLPWQGLKAGTKKQKYEKISE 230

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 56.3 bits (136), Expect = 2e-09
 Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 7/90 (7%)

Query: 42  VQYLGTDKDENRLYIFLELVTKGSLANLYQKYH---LSDSQVSSYTRQILNGLVYLHERN 98
               G  +D+ R ++ L  + + SL +         LS+  V     ++L+ L +LHE  
Sbjct: 122 CMGFGVHQDKYR-FLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE 179

Query: 99  VVHRDIKCANILVDASGS--VKLADFGLAK 126
            VH ++   NI VD      V LA +G A 
Sbjct: 180 YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.5 bits (104), Expect = 2e-05
 Identities = 51/312 (16%), Positives = 93/312 (29%), Gaps = 117/312 (37%)

Query: 21  QSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLY-IFLELVTKGSLANLYQK------- 72
           + +  + + I  LS+ E D+I+    +    +    +F  L++K     + QK       
Sbjct: 36  KDVQDMPKSI--LSKEEIDHIIM---SKDAVSGTLRLFWTLLSKQE--EMVQKFVEEVLR 88

Query: 73  --YHLSDSQVSSYTRQ-ILNGLVYLHERNV------------VHR-----DIKCA----- 107
             Y    S + +  RQ  +   +Y+ +R+             V R      ++ A     
Sbjct: 89  INYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELR 148

Query: 108 ---NILVDASGSVKLADFG---LAKATTMNDLKSCKGTP---FWM------APEVV---- 148
              N+L+D  G   +   G   +A        K         FW+      +PE V    
Sbjct: 149 PAKNVLID--G---VLGSGKTWVA-LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEML 202

Query: 149 ----------------NSKNDGYGLTA----------------------DIWS------- 163
                           +S N    + +                      ++ +       
Sbjct: 203 QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAF 262

Query: 164 -LGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRD-ARDFILKCLQVNPNDR 221
            L C +L + TR    +          I    L     +L+ D  +  +LK L   P D 
Sbjct: 263 NLSCKIL-LTTRFKQVTDFLSAATTTHI---SLDHHSMTLTPDEVKSLLLKYLDCRPQDL 318

Query: 222 PTVTELMEHPFV 233
           P    L  +P  
Sbjct: 319 PREV-LTTNPRR 329

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	247
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.82
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.73
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.58
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.33
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.2
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.06
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.0
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.74
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.72
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.62
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.53
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.39
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.17
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.87
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.83
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.74
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.68
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.59
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.4
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.35
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.33
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.23
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.08
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.93
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.91
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.46
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	95.39
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	94.86
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	93.78
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	92.25
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	91.8
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	87.28
3mes_A	424	Choline kinase; malaria, structural genomics, stru	83.83

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8e-61  Score=382.59  Aligned_cols=233  Identities=29%  Similarity=0.583  Sum_probs=210.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~   77 (247)
                      +|+.||||++.....   .....+.+.+|+.++++|+||||+++++++.+++.+|+||||++||+|.+++...   .+++
T Consensus        48 ~~~~vAiK~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e  124 (350)
T 4b9d_A           48 DGRQYVIKEINISRM---SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE  124 (350)
T ss_dssp             TCCEEEEEEEECTTS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCH
T ss_pred             CCCEEEEEEEehHHC---CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCH
Confidence            589999999987543   3445778999999999999999999999999999999999999999999999654   3789


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.......  .....||+.|+|||.+.+..  +
T Consensus       125 ~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~--y  202 (350)
T 4b9d_A          125 DQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP--Y  202 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCC--C
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCC--C
Confidence            9999999999999999999999999999999999999999999999998665432  23456999999999997654  8


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                      +.++|||||||++|+|++|+.||...+.......+..+..+..+..+|+++++||.+||+.||.+|||++|+++||||++
T Consensus       203 ~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          203 NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence            99999999999999999999999998888888888888888888899999999999999999999999999999999987


Q ss_pred             CCC
Q 041080          236 PLQ  238 (247)
Q Consensus       236 ~~~  238 (247)
                      .++
T Consensus       283 ~~~  285 (350)
T 4b9d_A          283 RIE  285 (350)
T ss_dssp             TGG
T ss_pred             CCC
Confidence            543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.2e-60  Score=377.89  Aligned_cols=229  Identities=31%  Similarity=0.595  Sum_probs=203.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.||||++......     ..+.+.+|+.+|++++||||+++++++.+++.+|+||||++||+|.+++++.++++..+
T Consensus        98 tg~~vAiK~i~~~~~~-----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~l~e~~~  172 (346)
T 4fih_A           98 SGKLVAVKKMDLRKQQ-----RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI  172 (346)
T ss_dssp             TCCEEEEEEEEGGGCS-----SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHSCCCHHHH
T ss_pred             CCCEEEEEEEecCchh-----HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcCCCCHHHH
Confidence            5899999999765322     23457799999999999999999999999999999999999999999999989999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCCcc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++......  ......||+.|+|||.+.+..  ++.+
T Consensus       173 ~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~--y~~~  250 (346)
T 4fih_A          173 AAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP--YGPE  250 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCC--BCTH
T ss_pred             HHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCC--CCcH
Confidence            999999999999999999999999999999999999999999998765433  345677999999999996554  8999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCC--CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      +|||||||++|+|++|..||...+..+....+.....+..  +..+|+++++||.+||+.||.+|||++|+++||||++.
T Consensus       251 ~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          251 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence            9999999999999999999998887777777665543333  35789999999999999999999999999999999874

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.6e-60  Score=371.99  Aligned_cols=231  Identities=26%  Similarity=0.452  Sum_probs=204.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++.+....  .....+.+.+|+.++++++||||+++++++++++.+|+||||++||+|.+++++. .+++..
T Consensus        56 ~~~~~AiK~i~k~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~  133 (311)
T 4aw0_A           56 TSREYAIKILEKRHII--KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC  133 (311)
T ss_dssp             TCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHH
T ss_pred             CCCEEEEEEEEHHHCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHH
Confidence            5889999999764321  2234567899999999999999999999999999999999999999999999765 599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc----ccccCCCCCCccCCcccccCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      +..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++......    ......||+.|+|||.+.+..  +
T Consensus       134 ~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~--y  211 (311)
T 4aw0_A          134 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS--A  211 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSC--B
T ss_pred             HHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCC--C
Confidence            9999999999999999999999999999999999999999999999765322    234567999999999997655  8


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhh------hhc
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTE------LME  229 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~------il~  229 (247)
                      +.++|+||+||++|+|++|..||...+.......+..... .++..+++++++||.+||+.||.+|||++|      |++
T Consensus       212 ~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~  290 (311)
T 4aw0_A          212 CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA  290 (311)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHT
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHC
Confidence            9999999999999999999999998888888877777654 567889999999999999999999999998      589


Q ss_pred             CccCCCC
Q 041080          230 HPFVKRP  236 (247)
Q Consensus       230 ~p~~~~~  236 (247)
                      ||||+.+
T Consensus       291 Hp~F~~i  297 (311)
T 4aw0_A          291 HPFFESV  297 (311)
T ss_dssp             SGGGTTC
T ss_pred             CCCcCCC
Confidence            9999874

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.3e-59  Score=363.74  Aligned_cols=233  Identities=29%  Similarity=0.458  Sum_probs=192.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++.+....  .....+.+.+|+.++++++||||+++++++.+++.+++||||+ +|+|.+.+.+. .+++..
T Consensus        37 ~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~  113 (275)
T 3hyh_A           37 TGQKVALKIINKKVLA--KSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQE  113 (275)
T ss_dssp             TCCEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCSCCHHH
T ss_pred             CCCEEEEEEEeHHHcC--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCCCHHH
Confidence            5899999999765432  2334567899999999999999999999999999999999999 56888887654 599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCCCcc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      +..++.|++.||+|||++||+||||||+||+++.++.++|+|||++....... .....||+.|+|||.+.+... ++.+
T Consensus       114 ~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y-~~~~  192 (275)
T 3hyh_A          114 ARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY-AGPE  192 (275)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------------CTTSCHHHHSSSSC-CCTH
T ss_pred             HHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCC-CCCh
Confidence            99999999999999999999999999999999999999999999997654333 345679999999999976542 3679


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQ  238 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~~  238 (247)
                      +||||+||++|+|++|+.||...+.......+.... ..++..+|++++++|.+||+.||.+|||++|+++||||+..+.
T Consensus       193 ~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~~p  271 (275)
T 3hyh_A          193 VDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV-YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLP  271 (275)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTTCC
T ss_pred             hhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccCCC
Confidence            999999999999999999999887777777766654 4567889999999999999999999999999999999987653

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-58  Score=362.61  Aligned_cols=229  Identities=29%  Similarity=0.523  Sum_probs=195.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec----CCcEEEEEeccccCcHHHHHHhc-CC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD----ENRLYIFLELVTKGSLANLYQKY-HL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~-~~   75 (247)
                      +|..||+|++.....   .....+.+.+|+.++++++|||||++++++.+    ++.+++||||++||+|.+++++. .+
T Consensus        50 ~~~~vAiK~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l  126 (290)
T 3fpq_A           50 TTVEVAWCELQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM  126 (290)
T ss_dssp             TCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSC
T ss_pred             CCeEEEEEEEchhhC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCC
Confidence            478999999976532   34456789999999999999999999999865    35689999999999999999765 59


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCC--eeecCCCCCcEEEcC-CCCeEEcccccccccCccccccCCCCCCccCCcccccCC
Q 041080           76 SDSQVSSYTRQILNGLVYLHERN--VVHRDIKCANILVDA-SGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKN  152 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~~~ni~~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  152 (247)
                      ++..+..++.|++.||+|||++|  |+||||||+||+++. +|.+||+|||++............||+.|+|||.+.+  
T Consensus       127 ~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~--  204 (290)
T 3fpq_A          127 KIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE--  204 (290)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT--
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCccCCcccCccccCHHHcCC--
Confidence            99999999999999999999998  999999999999984 7899999999998666555667789999999999864  


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhH-HHHHhhcCCC-CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQ-ALFRIGKGEL-PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                       .++.++|||||||++|+|++|..||....... ....+..+.. +..+...+++++++|.+||..||.+|||++|+++|
T Consensus       205 -~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          205 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             38999999999999999999999997655443 3444444433 23456788999999999999999999999999999


Q ss_pred             ccCCC
Q 041080          231 PFVKR  235 (247)
Q Consensus       231 p~~~~  235 (247)
                      |||++
T Consensus       284 p~~~~  288 (290)
T 3fpq_A          284 AFFQE  288 (290)
T ss_dssp             GGGC-
T ss_pred             ccccC
Confidence            99985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.2e-58  Score=378.07  Aligned_cols=229  Identities=31%  Similarity=0.589  Sum_probs=203.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.||||++......     ..+.+.+|+.+|++++||||+++++++.+++.+|+||||++||+|.++++..++++..+
T Consensus       175 tg~~vAiK~i~~~~~~-----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~~l~e~~~  249 (423)
T 4fie_A          175 SGKLVAVKKMDLRKQQ-----RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI  249 (423)
T ss_dssp             TCCEEEEEEEESTTCS-----SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHSCCCHHHH
T ss_pred             CCCEEEEEEEeccchh-----HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhccCCCHHHH
Confidence            5899999999765322     23457899999999999999999999999999999999999999999999989999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCCcc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......  ......||+.|+|||++.+..  |+.+
T Consensus       250 ~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~--y~~~  327 (423)
T 4fie_A          250 AAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP--YGPE  327 (423)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCC--BCTH
T ss_pred             HHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCC--CCcH
Confidence            999999999999999999999999999999999999999999998765433  344567999999999996554  8999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCC--CCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPS--VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      +|||||||++|+|++|..||...+.......+.....+.  .+..+|+++++||.+||..||.+|||++|+|+||||++.
T Consensus       328 ~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          328 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence            999999999999999999999888777777766554333  345789999999999999999999999999999999874

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.3e-59  Score=365.88  Aligned_cols=229  Identities=29%  Similarity=0.436  Sum_probs=195.5

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQV   80 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~   80 (247)
                      |+.||||++.+......   ....+.+|+.++++++||||+++++++.+++.+++||||++||+|.+++++. .+++..+
T Consensus        52 ~~~vAiK~i~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~  128 (304)
T 3ubd_A           52 RQLYAMKVLKKATLKVR---DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV  128 (304)
T ss_dssp             TCEEEEEEEESEEEEEE---ECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHH
T ss_pred             CEEEEEEEEehHHcChH---HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHH
Confidence            67899999976543222   1235778999999999999999999999999999999999999999999765 5999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc--cccccCCCCCCccCCcccccCCCCCCcc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDLKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ..++.|++.||+|||++||+||||||+||+++.+|.+||+|||++.....  .......||+.|+|||.+.+..  ++.+
T Consensus       129 ~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~--y~~~  206 (304)
T 3ubd_A          129 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG--HTQS  206 (304)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSC--CCTH
T ss_pred             HHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCC--CCCC
Confidence            99999999999999999999999999999999999999999999975432  2344567999999999997655  8899


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh-----hhhhcCccC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV-----TELMEHPFV  233 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~~p~~  233 (247)
                      +||||+||++|+|++|..||...+..+....+..... .++..+|+++++||.+||+.||.+|||+     +|+++||||
T Consensus       207 ~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f  285 (304)
T 3ubd_A          207 ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF  285 (304)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGG
T ss_pred             CcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccc
Confidence            9999999999999999999999888888877776654 5678899999999999999999999984     799999999


Q ss_pred             CCC
Q 041080          234 KRP  236 (247)
Q Consensus       234 ~~~  236 (247)
                      +.+
T Consensus       286 ~~i  288 (304)
T 3ubd_A          286 STI  288 (304)
T ss_dssp             TTC
T ss_pred             cCC
Confidence            864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7.7e-57  Score=358.07  Aligned_cols=225  Identities=30%  Similarity=0.452  Sum_probs=194.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++..+..          ..+|+.++++++|||||++++++.+++.+++||||++||+|.+++++. .+++..
T Consensus        82 ~g~~vAiK~i~~~~~----------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~  151 (336)
T 4g3f_A           82 TGFQCAVKKVRLEVF----------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR  151 (336)
T ss_dssp             TCCEEEEEEEETTTC----------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHH
T ss_pred             CCCEEEEEEECHHHh----------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCCCCHHH
Confidence            488999999975432          137999999999999999999999999999999999999999999765 599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC-CeEEcccccccccCccc-------cccCCCCCCccCCcccccC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG-SVKLADFGLAKATTMND-------LKSCKGTPFWMAPEVVNSK  151 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~-~~~l~df~~~~~~~~~~-------~~~~~~~~~~~aPE~~~~~  151 (247)
                      +..++.|++.||+|||++||+||||||+||+++.+| .+||+|||++.......       .....||+.|+|||.+.+.
T Consensus       152 ~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~  231 (336)
T 4g3f_A          152 ALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK  231 (336)
T ss_dssp             HHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCC
Confidence            999999999999999999999999999999999987 59999999997554322       1234699999999999765


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC--CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhh--
Q 041080          152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL--PSVPSSLSRDARDFILKCLQVNPNDRPTVTEL--  227 (247)
Q Consensus       152 ~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i--  227 (247)
                      .  ++.++|||||||++|+|++|..||...........+.....  ..++..+|++++++|.+||+.||.+|||+.|+  
T Consensus       232 ~--y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~  309 (336)
T 4g3f_A          232 P--CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRR  309 (336)
T ss_dssp             C--CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C--CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            4  89999999999999999999999988777777666665543  24677899999999999999999999999997  


Q ss_pred             -----------hcCccCCCCC
Q 041080          228 -----------MEHPFVKRPL  237 (247)
Q Consensus       228 -----------l~~p~~~~~~  237 (247)
                                 ++|||+++..
T Consensus       310 ~l~~~l~~~~~l~hPw~~~~~  330 (336)
T 4g3f_A          310 KVGKALQEVGGLKSPWKGEYK  330 (336)
T ss_dssp             HHHHHHHHTTSSCSCSSSSCC
T ss_pred             HHHHHHhhhhhccCCCcCCCC
Confidence                       6799998763

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.8e-56  Score=349.61  Aligned_cols=221  Identities=26%  Similarity=0.494  Sum_probs=197.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-------
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-------   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------   73 (247)
                      +|..||||++..     ......+.|.+|+.++++++|||||++++++.+++..++||||+++|+|.+++.+.       
T Consensus        42 ~~~~vAvK~l~~-----~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~  116 (299)
T 4asz_A           42 DKILVAVKTLKD-----ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLM  116 (299)
T ss_dssp             -CEEEEEEEECS-----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC
T ss_pred             CCEEEEEEEeCC-----CChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccc
Confidence            367899999863     23455678999999999999999999999999999999999999999999999753       


Q ss_pred             -------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----ccCCCCCCc
Q 041080           74 -------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCKGTPFW  142 (247)
Q Consensus        74 -------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~  142 (247)
                             .+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++.......    ....|++.|
T Consensus       117 ~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~y  196 (299)
T 4asz_A          117 AEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW  196 (299)
T ss_dssp             ----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGG
T ss_pred             cccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhh
Confidence                   489999999999999999999999999999999999999999999999999975433321    223478999


Q ss_pred             cCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCC
Q 041080          143 MAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR  221 (247)
Q Consensus       143 ~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  221 (247)
                      +|||.+.+..  ++.++||||||+++|||+| |+.||...+..+....+..+..+..|..+|+++.+++.+||+.||.+|
T Consensus       197 mAPE~~~~~~--~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~R  274 (299)
T 4asz_A          197 MPPESIMYRK--FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMR  274 (299)
T ss_dssp             CCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred             cCHHHHcCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHC
Confidence            9999997655  8999999999999999998 899999999888888888888888889999999999999999999999


Q ss_pred             CChhhhh
Q 041080          222 PTVTELM  228 (247)
Q Consensus       222 ps~~~il  228 (247)
                      ||+++++
T Consensus       275 Ps~~~i~  281 (299)
T 4asz_A          275 KNIKGIH  281 (299)
T ss_dssp             CCHHHHH
T ss_pred             cCHHHHH
Confidence            9999994

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.4e-55  Score=349.64  Aligned_cols=223  Identities=24%  Similarity=0.450  Sum_probs=192.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-------
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-------   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------   73 (247)
                      +|+.||||++..     ......+.|.+|+.++++++|||||++++++.+++..++||||+++|+|.+++.+.       
T Consensus        70 ~~~~vAvK~l~~-----~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~  144 (329)
T 4aoj_A           70 DKMLVAVKALKE-----ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLL  144 (329)
T ss_dssp             -CEEEEEEEESC-----CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC----
T ss_pred             CCeEEEEEEECc-----CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccc
Confidence            367899999963     23455678999999999999999999999999999999999999999999998653       


Q ss_pred             ---------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCC
Q 041080           74 ---------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTP  140 (247)
Q Consensus        74 ---------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~  140 (247)
                               .+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||+++......    .....|++
T Consensus       145 ~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~  224 (329)
T 4aoj_A          145 AGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI  224 (329)
T ss_dssp             -------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCG
T ss_pred             cccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccc
Confidence                     38899999999999999999999999999999999999999999999999997543332    22345889


Q ss_pred             CccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCC
Q 041080          141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPN  219 (247)
Q Consensus       141 ~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  219 (247)
                      .|+|||.+.+..  ++.++||||||+++|||+| |+.||...+..+....+..+..+..|..+|+++.+++.+||+.||.
T Consensus       225 ~ymAPE~~~~~~--~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~  302 (329)
T 4aoj_A          225 RWMPPESILYRK--FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQ  302 (329)
T ss_dssp             GGCCHHHHTTCC--CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTT
T ss_pred             cccChhhhcCCC--CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChh
Confidence            999999996554  8999999999999999998 8999999888888888888777788889999999999999999999


Q ss_pred             CCCChhhhhcC
Q 041080          220 DRPTVTELMEH  230 (247)
Q Consensus       220 ~Rps~~~il~~  230 (247)
                      +|||++|++++
T Consensus       303 ~RPs~~ei~~~  313 (329)
T 4aoj_A          303 QRHSIKDVHAR  313 (329)
T ss_dssp             TSCCHHHHHHH
T ss_pred             HCcCHHHHHHH
Confidence            99999999763

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.3e-55  Score=346.02  Aligned_cols=223  Identities=22%  Similarity=0.387  Sum_probs=197.3

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--------   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------   73 (247)
                      |+.||||++....    .....+.|.+|+.++++++||||++++|++.+++..++||||+++|+|.+++...        
T Consensus        56 ~~~VAvK~l~~~~----~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~  131 (308)
T 4gt4_A           56 TQAVAIKTLKDKA----EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGS  131 (308)
T ss_dssp             CEEEEEEECCC-C----CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-
T ss_pred             CeEEEEEEECccc----ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccc
Confidence            5789999996432    2334567999999999999999999999999999999999999999999999542        


Q ss_pred             ---------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCC
Q 041080           74 ---------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTP  140 (247)
Q Consensus        74 ---------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~  140 (247)
                               .+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++......    .....|++
T Consensus       132 ~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~  211 (308)
T 4gt4_A          132 TDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPI  211 (308)
T ss_dssp             ----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCG
T ss_pred             cccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCC
Confidence                     38899999999999999999999999999999999999999999999999987544332    23455889


Q ss_pred             CccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCC
Q 041080          141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPN  219 (247)
Q Consensus       141 ~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  219 (247)
                      .|+|||.+.+..  ++.++||||||+++|||+| |..||...+..+....+..+..++.|..+|+++.+++.+||+.||.
T Consensus       212 ~ymAPE~l~~~~--~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~  289 (308)
T 4gt4_A          212 RWMAPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPS  289 (308)
T ss_dssp             GGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             cccCHHHHhCCC--CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChh
Confidence            999999997655  8999999999999999998 8999999998888888888877788889999999999999999999


Q ss_pred             CCCChhhhhcC
Q 041080          220 DRPTVTELMEH  230 (247)
Q Consensus       220 ~Rps~~~il~~  230 (247)
                      +|||+++|+++
T Consensus       290 ~RPs~~ei~~~  300 (308)
T 4gt4_A          290 RRPRFKDIHSR  300 (308)
T ss_dssp             GSCCHHHHHHH
T ss_pred             HCcCHHHHHHH
Confidence            99999999874

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.4e-55  Score=344.53  Aligned_cols=227  Identities=26%  Similarity=0.429  Sum_probs=182.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC------------cEEEEEeccccCcHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN------------RLYIFLELVTKGSLAN   68 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------------~~~lv~e~~~~~~L~~   68 (247)
                      +|+.||||++....    .....+.+.+|+.++++++||||+++++++.+.+            .+++||||+++|+|.+
T Consensus        29 ~~~~vAiK~i~~~~----~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~  104 (299)
T 4g31_A           29 DDCNYAIKRIRLPN----RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKD  104 (299)
T ss_dssp             TCCEEEEEEEEECS----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHH
T ss_pred             CCCEEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHH
Confidence            58899999997643    3445677899999999999999999999886543            3799999999999999


Q ss_pred             HHHhcC----CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc------------
Q 041080           69 LYQKYH----LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND------------  132 (247)
Q Consensus        69 ~l~~~~----~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~------------  132 (247)
                      +++...    .++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......            
T Consensus       105 ~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~  184 (299)
T 4g31_A          105 WMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY  184 (299)
T ss_dssp             HHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC-------------------
T ss_pred             HHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccc
Confidence            998754    4456688999999999999999999999999999999999999999999987544322            


Q ss_pred             --cccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChh-hHHHHHhhcCCCCCCCCcCCHHHHHH
Q 041080          133 --LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG-VQALFRIGKGELPSVPSSLSRDARDF  209 (247)
Q Consensus       133 --~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l  209 (247)
                        .....||+.|+|||.+.+..  ++.++|||||||++|+|++   ||..... ......+.....+......++...++
T Consensus       185 ~~~~~~~GT~~YmAPE~~~~~~--y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l  259 (299)
T 4g31_A          185 ARHTGQVGTKLYMSPEQIHGNS--YSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVM  259 (299)
T ss_dssp             -------CCCTTSCHHHHTTCC--CCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHH
T ss_pred             cccCCcccCccccCHHHHcCCC--CCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHH
Confidence              12346999999999997654  8999999999999999996   7754332 22333444444444445567788999


Q ss_pred             HHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          210 ILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       210 i~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      |.+||++||.+|||++|+++||||+..
T Consensus       260 i~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          260 VQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             HHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999864

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-53  Score=347.26  Aligned_cols=232  Identities=27%  Similarity=0.449  Sum_probs=192.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec------CCcEEEEEeccccCcHHHHHHhc-
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD------ENRLYIFLELVTKGSLANLYQKY-   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~-   73 (247)
                      +|+.||||++....   ......+.+.+|+.+|++++||||+++++++..      .+.+|+||||+.| +|.+++.+. 
T Consensus        78 t~~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g-~L~~~i~~~~  153 (398)
T 4b99_A           78 TGQQVAIKKIPNAF---DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQ  153 (398)
T ss_dssp             TCCEEEEEEETTTT---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCSE-EHHHHHTSSS
T ss_pred             CCCEEEEEEECccc---cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCCC-CHHHHHHhcC
Confidence            58999999996543   334456678899999999999999999998653      4688999999975 788888654 


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc------ccccCCCCCCccCCcc
Q 041080           74 HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN------DLKSCKGTPFWMAPEV  147 (247)
Q Consensus        74 ~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~------~~~~~~~~~~~~aPE~  147 (247)
                      .+++..+..++.||+.||.|||++||+||||||+||+++.+|.++|+|||++......      ......||+.|+|||.
T Consensus       154 ~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv  233 (398)
T 4b99_A          154 PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL  233 (398)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHH
Confidence            5999999999999999999999999999999999999999999999999999754322      2345679999999999


Q ss_pred             cccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC----------------------CC--------
Q 041080          148 VNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL----------------------PS--------  197 (247)
Q Consensus       148 ~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------------~~--------  197 (247)
                      +.+... ++.++||||+||++|+|++|+.||...+..+....+.....                      +.        
T Consensus       234 ~~~~~~-~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (398)
T 4b99_A          234 MLSLHE-YTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWET  312 (398)
T ss_dssp             HTTCSC-CCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHH
T ss_pred             hcCCCC-CCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHH
Confidence            865432 68999999999999999999999988777666554432100                      00        


Q ss_pred             CCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          198 VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       198 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      .....++++++||.+||..||.+|||++|+|+||||++..
T Consensus       313 ~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          313 VYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             HSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             hCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence            1135689999999999999999999999999999999753

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-53  Score=334.92  Aligned_cols=223  Identities=25%  Similarity=0.475  Sum_probs=183.9

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHH
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQV   80 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~   80 (247)
                      ..||||+++...   ...+..+.|.+|+.++++++||||+++++++.. +.+++||||+++|+|.+++...  .+++..+
T Consensus        59 ~~vAvK~~~~~~---~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~  134 (307)
T 3omv_A           59 GDVAVKILKVVD---PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQL  134 (307)
T ss_dssp             SEEEEEECCCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHH
T ss_pred             CcEEEEEEEecC---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHH
Confidence            468999986543   345567789999999999999999999998754 5689999999999999999653  5999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc----ccccCCCCCCccCCcccccC-CCCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTPFWMAPEVVNSK-NDGY  155 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~-~~~~  155 (247)
                      ..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......    ......||+.|+|||.+.+. ...+
T Consensus       135 ~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y  214 (307)
T 3omv_A          135 IDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPF  214 (307)
T ss_dssp             HHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCC
T ss_pred             HHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCC
Confidence            999999999999999999999999999999999999999999999754322    23445699999999998654 3348


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhh-cCC----CCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIG-KGE----LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +.++||||||+++|||++|+.||...+......... .+.    .+..+..+|+++.+++.+||+.+|.+|||+.++++
T Consensus       215 ~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          215 SFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             CcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            999999999999999999999998766554443332 221    23455688999999999999999999999998754

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.3e-53  Score=360.82  Aligned_cols=234  Identities=29%  Similarity=0.390  Sum_probs=197.8

Q ss_pred             CCceEEEEEEeecCCC-ccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQG-AQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||||++.+.... ..........+.++.+++.++||||++++++|++.+.+|+||||++||+|.+++.+. .+++.
T Consensus       213 tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~  292 (689)
T 3v5w_A          213 TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA  292 (689)
T ss_dssp             TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHH
T ss_pred             CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHH
Confidence            5899999999865432 222233333445677888889999999999999999999999999999999999765 59999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcc
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      .+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++............||+.|+|||++.... .++.+
T Consensus       293 ~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~~~-~y~~~  371 (689)
T 3v5w_A          293 DMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGV-AYDSS  371 (689)
T ss_dssp             HHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCCCCSCCSCGGGCCHHHHSTTC-CCCTH
T ss_pred             HHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCCCCCccCCcCccCHHHHhCCC-CCCcH
Confidence            99999999999999999999999999999999999999999999999877766677788999999999985322 37999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhh---HHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC-----hhhhhcC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGV---QALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT-----VTELMEH  230 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~  230 (247)
                      +|+|||||++|+|++|..||......   .....+... ...++..+|+++++||.+||+.||.+|++     ++||++|
T Consensus       372 vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~-~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC-CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            99999999999999999999764332   223333333 34677889999999999999999999998     7999999


Q ss_pred             ccCCCC
Q 041080          231 PFVKRP  236 (247)
Q Consensus       231 p~~~~~  236 (247)
                      |||+.+
T Consensus       451 pfF~~i  456 (689)
T 3v5w_A          451 PFFRSL  456 (689)
T ss_dssp             GGGTTC
T ss_pred             ccccCC
Confidence            999864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.4e-52  Score=336.71  Aligned_cols=225  Identities=27%  Similarity=0.377  Sum_probs=181.6

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      |+.||||.+....       ...++.+|+++++.+ +||||+++++++.+.+.+++||||+++++|.++++  .+++..+
T Consensus        49 ~~~vAiK~i~~~~-------~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~--~l~~~~~  119 (361)
T 4f9c_A           49 EEKIALKHLIPTS-------HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN--SLSFQEV  119 (361)
T ss_dssp             EEEEEEEEECTTS-------CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT--TCCHHHH
T ss_pred             CCEEEEEEEcccc-------CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc--CCCHHHH
Confidence            5689999986432       134577999999998 69999999999999999999999999999999985  5999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC-CCeEEcccccccccCcc----------------------------
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFGLAKATTMN----------------------------  131 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~-~~~~l~df~~~~~~~~~----------------------------  131 (247)
                      ..++.|++.||+|||++||+||||||+||+++.+ +.++|+|||++......                            
T Consensus       120 ~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (361)
T 4f9c_A          120 REYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSR  199 (361)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------
T ss_pred             HHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccc
Confidence            9999999999999999999999999999999876 79999999998643221                            


Q ss_pred             --ccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCh-hhHHHHHhhc----------------
Q 041080          132 --DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLE-GVQALFRIGK----------------  192 (247)
Q Consensus       132 --~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~~----------------  192 (247)
                        ......||+.|+|||.+.+... ++.++||||+||++|+|++|+.||.... ..+....+..                
T Consensus       200 ~~~~~~~~GT~~Y~APE~l~~~~~-y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~  278 (361)
T 4f9c_A          200 RQQVAPRAGTPGFRAPEVLTKCPN-QTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGK  278 (361)
T ss_dssp             ------CCCCGGGCCHHHHTTCSC-CCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTE
T ss_pred             cccccccccCccccCHHHHcCCCC-CCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccc
Confidence              1233569999999999865433 7899999999999999999999985432 2221111100                


Q ss_pred             ----------------------C---------------CCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          193 ----------------------G---------------ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       193 ----------------------~---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                                            .               ........+|+++++||.+||..||.+|+|++|+|+||||+.
T Consensus       279 ~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          279 SILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             EEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             cccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence                                  0               000112457899999999999999999999999999999997


Q ss_pred             C
Q 041080          236 P  236 (247)
Q Consensus       236 ~  236 (247)
                      .
T Consensus       359 i  359 (361)
T 4f9c_A          359 M  359 (361)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.5e-51  Score=351.19  Aligned_cols=232  Identities=29%  Similarity=0.453  Sum_probs=202.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~   78 (247)
                      +|+.||+|++...     .....+.+.+|+.+|+.++||||+++++++.+.+.+++||||++||+|.+++.+  ..+++.
T Consensus       181 tg~~~AiK~i~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~  255 (573)
T 3uto_A          181 TGNNFAAKFVMTP-----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED  255 (573)
T ss_dssp             TCCEEEEEEEECC-----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHH
T ss_pred             CCCEEEEEEEecc-----chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHH
Confidence            5889999999753     234456788999999999999999999999999999999999999999998854  359999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC--CCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS--GSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~--~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .+..++.||+.||.|||++||+||||||+||+++.+  +.+||+|||++....... .....||+.|+|||.+.+..  +
T Consensus       256 ~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~--y  333 (573)
T 3uto_A          256 EAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP--V  333 (573)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCC--B
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCC--C
Confidence            999999999999999999999999999999999854  899999999997655433 34567999999999997654  8


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCC---CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP---SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      +.++||||+||++|+|++|..||...........+......   .....+|+++++||.+||..||.+|||++|+|+|||
T Consensus       334 ~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw  413 (573)
T 3uto_A          334 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW  413 (573)
T ss_dssp             CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence            99999999999999999999999998888887777665432   223578999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 041080          233 VKRPLQT  239 (247)
Q Consensus       233 ~~~~~~~  239 (247)
                      |+.....
T Consensus       414 ~~~~~~~  420 (573)
T 3uto_A          414 LTPGNAP  420 (573)
T ss_dssp             TSCCCCT
T ss_pred             cCCCCCC
Confidence            9976443

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.6e-52  Score=333.63  Aligned_cols=223  Identities=26%  Similarity=0.461  Sum_probs=190.1

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCC-Cceeeeceeeec-CCcEEEEEeccccCcHHHHHHhc------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ-DNIVQYLGTDKD-ENRLYIFLELVTKGSLANLYQKY------   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~------   73 (247)
                      ++.||||.+...    ......+.+.+|+.++.+++| ||||++++++.+ ++.+++|||||++|+|.+++++.      
T Consensus        94 ~k~VAvK~l~~~----~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~  169 (353)
T 4ase_A           94 CRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP  169 (353)
T ss_dssp             EEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCC
T ss_pred             CeEEEEEEEccc----cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhccccccc
Confidence            467999998643    234456779999999999975 899999999865 45789999999999999999642      


Q ss_pred             -----------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCC
Q 041080           74 -----------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKG  138 (247)
Q Consensus        74 -----------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~  138 (247)
                                 .+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++......    .....|
T Consensus       170 ~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~g  249 (353)
T 4ase_A          170 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL  249 (353)
T ss_dssp             C-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEE
T ss_pred             ccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccc
Confidence                       27899999999999999999999999999999999999999999999999997654332    223457


Q ss_pred             CCCccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhH-HHHHhhcCCCCCCCCcCCHHHHHHHHHHhcC
Q 041080          139 TPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQ-ALFRIGKGELPSVPSSLSRDARDFILKCLQV  216 (247)
Q Consensus       139 ~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  216 (247)
                      ++.|+|||.+.+..  ++.++|||||||++|||++ |..||....... ....+..+..+..|..+++++.+++.+||+.
T Consensus       250 t~~ymAPE~l~~~~--y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~  327 (353)
T 4ase_A          250 PLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG  327 (353)
T ss_dssp             CGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             cccccCHHHHhcCC--CCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCc
Confidence            88999999997655  8999999999999999998 899998765443 4455556666778889999999999999999


Q ss_pred             CCCCCCChhhhhcC
Q 041080          217 NPNDRPTVTELMEH  230 (247)
Q Consensus       217 ~p~~Rps~~~il~~  230 (247)
                      ||.+|||+++|++|
T Consensus       328 dP~~RPt~~eil~~  341 (353)
T 4ase_A          328 EPSQRPTFSELVEH  341 (353)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             ChhHCcCHHHHHHH
Confidence            99999999999987

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=8.4e-50  Score=320.13  Aligned_cols=232  Identities=26%  Similarity=0.477  Sum_probs=203.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-cCCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-YHLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~   79 (247)
                      +|+.||||++.....   .....+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++.. ..+++..
T Consensus        39 ~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~  115 (328)
T 3fe3_A           39 TGREVAIKIIDKTQL---NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE  115 (328)
T ss_dssp             TCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHH
T ss_pred             CCCEEEEEEEEhhcC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHH
Confidence            588999999976532   345567788999999999999999999999999999999999999999998865 4699999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-ccccCCCCCCccCCcccccCCCCCCcc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...... ......|++.|+|||.+.+... .+.+
T Consensus       116 ~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~  194 (328)
T 3fe3_A          116 ARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY-DGPE  194 (328)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCC-CSHH
T ss_pred             HHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCc-CCch
Confidence            9999999999999999999999999999999999999999999998654432 3445669999999999976542 3579


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      +||||+|+++|+|++|..||...........+..+.. ..+...++++.+++.+||..||.+|||++++++||||+...
T Consensus       195 ~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          195 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             hhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            9999999999999999999999888777777766544 56678899999999999999999999999999999998754

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.1e-49  Score=314.04  Aligned_cols=230  Identities=36%  Similarity=0.625  Sum_probs=199.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.||||++......     ..+.+.+|+.++++++||||+++++++..++..++||||+++++|.+++.+..+++..+
T Consensus        44 ~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  118 (297)
T 3fxz_A           44 TGQEVAIRQMNLQQQP-----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI  118 (297)
T ss_dssp             TCCEEEEEEEEGGGCS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSCCCHHHH
T ss_pred             CCcEEEEEEeeccccc-----HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhcCCCHHHH
Confidence            4789999999764321     24567899999999999999999999999999999999999999999999989999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCCcc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      +.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.......  .....|++.|+|||.+.+..  ++.+
T Consensus       119 ~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~  196 (297)
T 3fxz_A          119 AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPK  196 (297)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSC--BCTH
T ss_pred             HHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCC--CCcH
Confidence            9999999999999999999999999999999999999999999986544332  33456899999999996654  7899


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC--CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL--PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      +||||||+++|+|++|..||...........+.....  ...+..+++.+++++.+||+.||.+|||++++++||||+..
T Consensus       197 ~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence            9999999999999999999988776655544433322  23456789999999999999999999999999999999975


Q ss_pred             C
Q 041080          237 L  237 (247)
Q Consensus       237 ~  237 (247)
                      .
T Consensus       277 ~  277 (297)
T 3fxz_A          277 K  277 (297)
T ss_dssp             C
T ss_pred             C
Confidence            3

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=8.1e-49  Score=315.32  Aligned_cols=231  Identities=28%  Similarity=0.468  Sum_probs=199.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++.....  ......+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|..++.+. .+++..
T Consensus        29 ~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~  106 (337)
T 1o6l_A           29 TGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER  106 (337)
T ss_dssp             TCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHH
T ss_pred             CCCEEEEEEEeHHHh--hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHH
Confidence            488999999976421  12223556789999999999999999999999999999999999999999988764 589999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc--cccccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      ++.++.|++.||.|||++||+|+||||+||+++.+|.++|+|||++.....  .......|++.|+|||.+.+..  ++.
T Consensus       107 ~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~  184 (337)
T 1o6l_A          107 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND--YGR  184 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSC--BCT
T ss_pred             HHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCC--CCc
Confidence            999999999999999999999999999999999999999999999875322  2334556899999999996544  789


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----ChhhhhcCcc
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTELMEHPF  232 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~p~  232 (247)
                      ++|+||||+++|+|++|..||...+.......+.... ..++..++++++++|.+||..+|.+||     +++++++|||
T Consensus       185 ~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~  263 (337)
T 1o6l_A          185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF  263 (337)
T ss_dssp             THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred             hhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence            9999999999999999999998887777766665543 356778999999999999999999999     8999999999


Q ss_pred             CCCC
Q 041080          233 VKRP  236 (247)
Q Consensus       233 ~~~~  236 (247)
                      |+..
T Consensus       264 f~~~  267 (337)
T 1o6l_A          264 FLSI  267 (337)
T ss_dssp             GTTC
T ss_pred             cCCC
Confidence            9753

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2e-48  Score=315.65  Aligned_cols=234  Identities=31%  Similarity=0.481  Sum_probs=201.0

Q ss_pred             CCceEEEEEEeecCCCc-cchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGA-QGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||+|++....... ......+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++... .+++.
T Consensus        36 ~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~  115 (361)
T 2yab_A           36 TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE  115 (361)
T ss_dssp             TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHH
T ss_pred             CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHH
Confidence            48899999998754322 12224567889999999999999999999999999999999999999999999764 49999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC----CeEEcccccccccCcc-ccccCCCCCCccCCcccccCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG----SVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~----~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      .++.++.|++.||.|||+.|++|+||||+||+++.++    .++|+|||++...... ......|++.|+|||.+.+.. 
T Consensus       116 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-  194 (361)
T 2yab_A          116 EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP-  194 (361)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCC-
T ss_pred             HHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCC-
Confidence            9999999999999999999999999999999998877    7999999998765433 234556899999999996544 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCC---CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV---PSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                       ++.++|+||+|+++|+|++|..||...........+........   ...++++++++|.+||..||.+|||++++++|
T Consensus       195 -~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          195 -LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             -CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             78999999999999999999999998887777777666543222   25689999999999999999999999999999


Q ss_pred             ccCCCC
Q 041080          231 PFVKRP  236 (247)
Q Consensus       231 p~~~~~  236 (247)
                      |||+..
T Consensus       274 p~~~~~  279 (361)
T 2yab_A          274 PWITPV  279 (361)
T ss_dssp             TTTSCS
T ss_pred             cCcCCC
Confidence            999853

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-48  Score=310.96  Aligned_cols=230  Identities=26%  Similarity=0.473  Sum_probs=200.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++......  .....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++.+. .+++..
T Consensus        30 ~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~  107 (318)
T 1fot_A           30 NGRYYAMKVLKKEIVV--RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV  107 (318)
T ss_dssp             TCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHH
T ss_pred             CCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHH
Confidence            5889999999764211  1223556789999999999999999999999999999999999999999999764 599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcch
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTA  159 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~  159 (247)
                      ++.++.|++.||.+||++|++|+||||+||+++.+|.++|+|||++..... ......|++.|+|||.+.+..  ++.++
T Consensus       108 ~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~  184 (318)
T 1fot_A          108 AKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-VTYTLCGTPDYIAPEVVSTKP--YNKSI  184 (318)
T ss_dssp             HHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-CBCCCCSCTTTCCHHHHTTCC--BCTTH
T ss_pred             HHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC-ccccccCCccccCHhHhcCCC--CCccc
Confidence            999999999999999999999999999999999999999999999875443 234456899999999996544  78999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----ChhhhhcCccCC
Q 041080          160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTELMEHPFVK  234 (247)
Q Consensus       160 Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~p~~~  234 (247)
                      |+||||+++|+|++|..||...+.......+.... ..++..+++++++++.+||..+|.+||     +++++++||||+
T Consensus       185 DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~  263 (318)
T 1fot_A          185 DWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK  263 (318)
T ss_dssp             HHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred             chhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcccc
Confidence            99999999999999999998887777777666654 356778999999999999999999999     999999999998


Q ss_pred             CC
Q 041080          235 RP  236 (247)
Q Consensus       235 ~~  236 (247)
                      ..
T Consensus       264 ~~  265 (318)
T 1fot_A          264 EV  265 (318)
T ss_dssp             SC
T ss_pred             CC
Confidence            53

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=7.4e-49  Score=317.44  Aligned_cols=231  Identities=27%  Similarity=0.455  Sum_probs=198.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||||++.....  ......+.+.+|..++..+ +||||+++++++.+.+..++||||+++++|.+++.+. .+++.
T Consensus        47 ~~~~~AvK~~~~~~~--~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~  124 (353)
T 3txo_A           47 TGDLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA  124 (353)
T ss_dssp             TCCEEEEEEEEHHHH--HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHH
T ss_pred             CCCEEEEEEEEHHHh--cchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHH
Confidence            478999999976421  1233456678999999998 6999999999999999999999999999999988664 59999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc--cccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.....  .......|++.|+|||.+.+..  ++
T Consensus       125 ~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  202 (353)
T 3txo_A          125 RARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML--YG  202 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHH--CT
T ss_pred             HHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCC--cC
Confidence            9999999999999999999999999999999999999999999999875332  2234556899999999996654  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh------hhhhcC
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV------TELMEH  230 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~~il~~  230 (247)
                      .++|+||||+++|+|++|..||...+..+....+..... .++..++++++++|.+||..+|.+||++      +++++|
T Consensus       203 ~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          203 PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             CccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence            899999999999999999999999888888877776543 5677899999999999999999999999      899999


Q ss_pred             ccCCCC
Q 041080          231 PFVKRP  236 (247)
Q Consensus       231 p~~~~~  236 (247)
                      |||+..
T Consensus       282 p~f~~~  287 (353)
T 3txo_A          282 PFFKEI  287 (353)
T ss_dssp             GGGTTC
T ss_pred             CcccCC
Confidence            999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.7e-48  Score=309.47  Aligned_cols=229  Identities=34%  Similarity=0.620  Sum_probs=199.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.||||++....     ....+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++++..+++..+
T Consensus        69 ~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~  143 (321)
T 2c30_A           69 SGRQVAVKMMDLRK-----QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQI  143 (321)
T ss_dssp             TCCEEEEEEEETTT-----CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHH
T ss_pred             CCcEEEEEEEeccc-----hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHH
Confidence            58899999997543     2234567899999999999999999999999999999999999999999999888999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCCcc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++......  ......|++.|+|||.+.+..  ++.+
T Consensus       144 ~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~  221 (321)
T 2c30_A          144 ATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSL--YATE  221 (321)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCC--BCTH
T ss_pred             HHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCC--CCch
Confidence            999999999999999999999999999999999999999999998654432  233456899999999996543  7889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCC--CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      +|+||||+++|+|++|..||...........+.....+..  ...+++.+++++.+||..+|.+|||++++++||||+..
T Consensus       222 ~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          222 VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence            9999999999999999999988777666666655544333  34689999999999999999999999999999999875

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.7e-49  Score=311.88  Aligned_cols=223  Identities=25%  Similarity=0.335  Sum_probs=172.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC----cEEEEEeccccCcHHHHHHhcCCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN----RLYIFLELVTKGSLANLYQKYHLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~   76 (247)
                      +|+.||||++...      .......+.|+..+.+++||||+++++++.+++    .+++||||+++|+|.+++++.+++
T Consensus        25 ~g~~VAvK~l~~~------~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~l~   98 (303)
T 3hmm_A           25 RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT   98 (303)
T ss_dssp             TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCCBC
T ss_pred             CCEEEEEEEECcc------chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhCCCC
Confidence            4789999998542      122223456777778899999999999987653    579999999999999999999999


Q ss_pred             HHHHHHHHHHHHHHHHHhhhC--------CeeecCCCCCcEEEcCCCCeEEcccccccccCccc------cccCCCCCCc
Q 041080           77 DSQVSSYTRQILNGLVYLHER--------NVVHRDIKCANILVDASGSVKLADFGLAKATTMND------LKSCKGTPFW  142 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~--------~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~  142 (247)
                      ++.+.+++.|++.||+|||++        ||+||||||+||+++.++.+||+|||++.......      .....||+.|
T Consensus        99 ~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~y  178 (303)
T 3hmm_A           99 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY  178 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGG
T ss_pred             HHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccc
Confidence            999999999999999999987        99999999999999999999999999986543222      2234699999


Q ss_pred             cCCcccccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCh---------------hhHHHHHhhc-CCCCCCCCc-
Q 041080          143 MAPEVVNSKND----GYGLTADIWSLGCTVLEMLTRRPPYSHLE---------------GVQALFRIGK-GELPSVPSS-  201 (247)
Q Consensus       143 ~aPE~~~~~~~----~~~~~~Di~slG~ll~~l~~g~~p~~~~~---------------~~~~~~~~~~-~~~~~~~~~-  201 (247)
                      +|||.+.+...    .++.++||||||+++|||++|..|+....               .......+.. ...+.++.. 
T Consensus       179 mAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~  258 (303)
T 3hmm_A          179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW  258 (303)
T ss_dssp             CCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG
T ss_pred             cCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccc
Confidence            99999865421    25678999999999999999976542211               1112222222 222344432 


Q ss_pred             ----CCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          202 ----LSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       202 ----~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                          .++.+.+++.+||+.||.+|||+.++++
T Consensus       259 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  290 (303)
T 3hmm_A          259 QSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             cchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence                3357899999999999999999999976

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.9e-48  Score=308.78  Aligned_cols=234  Identities=29%  Similarity=0.503  Sum_probs=199.1

Q ss_pred             CCceEEEEEEeecCCCc-cchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGA-QGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||+|++....... ......+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++... .+++.
T Consensus        35 ~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~  114 (326)
T 2y0a_A           35 TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE  114 (326)
T ss_dssp             TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHH
T ss_pred             CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHH
Confidence            47899999998754322 12224667889999999999999999999999999999999999999999999654 48999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC----CeEEcccccccccCcc-ccccCCCCCCccCCcccccCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG----SVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~----~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      .++.++.|++.||.|||+.|++|+||||+||+++.++    .++|+|||.+...... ......|++.|+|||.+.+.. 
T Consensus       115 ~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-  193 (326)
T 2y0a_A          115 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP-  193 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCC-
T ss_pred             HHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCC-
Confidence            9999999999999999999999999999999999887    7999999998765432 334456899999999996544 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCC---CCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPS---VPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                       ++.++|+||||+++|+|++|..||...........+.......   ....+++.++++|.+||..+|.+|||++++++|
T Consensus       194 -~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          194 -LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             -CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             7899999999999999999999998877766666555443322   125689999999999999999999999999999


Q ss_pred             ccCCCC
Q 041080          231 PFVKRP  236 (247)
Q Consensus       231 p~~~~~  236 (247)
                      |||+..
T Consensus       273 p~~~~~  278 (326)
T 2y0a_A          273 PWIKPK  278 (326)
T ss_dssp             TTTSCC
T ss_pred             CCccCC
Confidence            999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=318.91  Aligned_cols=230  Identities=28%  Similarity=0.462  Sum_probs=199.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++.....   .....+.+.+|+.+++.++||||+++++++.+.+..++||||+.+++|.+.+... .+++..
T Consensus        35 ~~~~~a~K~i~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~  111 (444)
T 3soa_A           35 AGQEYAAMIINTKKL---SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD  111 (444)
T ss_dssp             TTEEEEEEEEESCSC---HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHH
T ss_pred             CCcEEEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHH
Confidence            478999999976532   3445667889999999999999999999999999999999999999998888664 599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEc---CCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVD---ASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~---~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +..++.|++.||.|||++||+|+||||+||+++   .++.++|+|||++.......  .....|++.|+|||.+.+..  
T Consensus       112 ~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~--  189 (444)
T 3soa_A          112 ASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP--  189 (444)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCC--
T ss_pred             HHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCC--
Confidence            999999999999999999999999999999998   45789999999996554332  23456899999999996544  


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCC---CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV---PSSLSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                      ++.++||||+|+++|+|++|..||...+.......+..+.....   ...++++++++|.+||+.||.+|||++++|+||
T Consensus       190 ~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp  269 (444)
T 3soa_A          190 YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHP  269 (444)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred             CCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence            78999999999999999999999998888777777766544222   247899999999999999999999999999999


Q ss_pred             cCCC
Q 041080          232 FVKR  235 (247)
Q Consensus       232 ~~~~  235 (247)
                      ||+.
T Consensus       270 ~~~~  273 (444)
T 3soa_A          270 WISH  273 (444)
T ss_dssp             TTHH
T ss_pred             cccC
Confidence            9974

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.1e-48  Score=312.78  Aligned_cols=231  Identities=27%  Similarity=0.472  Sum_probs=200.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~   78 (247)
                      +|+.||||++......  .....+.+..|..++..+ +||||+++++++.+.+..++||||+++|+|.+++.+ ..+++.
T Consensus        41 ~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~  118 (345)
T 1xjd_A           41 TNQFFAIKALKKDVVL--MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS  118 (345)
T ss_dssp             TTEEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHH
T ss_pred             CCCEEEEEEEEhHHhh--hhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHH
Confidence            4789999999764211  122345677899999887 899999999999999999999999999999999876 469999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccC--ccccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .++.++.|++.||.|||++|++|+||||+||+++.+|.++|+|||++....  ........|++.|+|||.+.+..  ++
T Consensus       119 ~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  196 (345)
T 1xjd_A          119 RATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK--YN  196 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC--BC
T ss_pred             HHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCC--CC
Confidence            999999999999999999999999999999999999999999999987532  22344566899999999996544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChh-hhhcCccCCC
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT-ELMEHPFVKR  235 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~il~~p~~~~  235 (247)
                      .++|+||||+++|+|++|..||...+.......+.... +.++..++++++++|.+||..+|.+||++. ++++||||+.
T Consensus       197 ~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~  275 (345)
T 1xjd_A          197 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  275 (345)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             ChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccC
Confidence            99999999999999999999999888777777766554 456778999999999999999999999998 9999999986


Q ss_pred             C
Q 041080          236 P  236 (247)
Q Consensus       236 ~  236 (247)
                      .
T Consensus       276 ~  276 (345)
T 1xjd_A          276 I  276 (345)
T ss_dssp             C
T ss_pred             C
Confidence            4

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.7e-48  Score=312.51  Aligned_cols=229  Identities=28%  Similarity=0.445  Sum_probs=200.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++.....  ......+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++.+. .+++..
T Consensus        65 ~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~  142 (350)
T 1rdq_E           65 SGNHYAMKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH  142 (350)
T ss_dssp             TCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHH
T ss_pred             CCCEEEEEEEEhHHh--ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHH
Confidence            488999999976432  11223567889999999999999999999999999999999999999999998764 599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcch
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTA  159 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~  159 (247)
                      ++.++.|++.||.+||++||+|+||||+||+++.+|.++|+|||.+...... .....|++.|+|||.+.+..  ++.++
T Consensus       143 ~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~~  219 (350)
T 1rdq_E          143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-TWTLCGTPEALAPEIILSKG--YNKAV  219 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-BCCCEECGGGCCHHHHTTCC--BCTHH
T ss_pred             HHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-cccccCCccccCHHHhcCCC--CCCcC
Confidence            9999999999999999999999999999999999999999999998765433 33456899999999996544  78999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC-----hhhhhcCccCC
Q 041080          160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT-----VTELMEHPFVK  234 (247)
Q Consensus       160 Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~p~~~  234 (247)
                      |+||||+++|+|++|..||...........+..+. ..++..++++++++|.+||+.||.+||+     ++++++||||+
T Consensus       220 DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~  298 (350)
T 1rdq_E          220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA  298 (350)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred             CEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcC
Confidence            99999999999999999999888777777776654 3567789999999999999999999998     99999999998


Q ss_pred             C
Q 041080          235 R  235 (247)
Q Consensus       235 ~  235 (247)
                      .
T Consensus       299 ~  299 (350)
T 1rdq_E          299 T  299 (350)
T ss_dssp             T
T ss_pred             C
Confidence            5

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.2e-47  Score=314.82  Aligned_cols=234  Identities=26%  Similarity=0.464  Sum_probs=192.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh---cCCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK---YHLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~   77 (247)
                      +|+.||||++....   ......+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++..   ..+++
T Consensus        51 ~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  127 (389)
T 3gni_B           51 TGEYVTVRRINLEA---CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE  127 (389)
T ss_dssp             TCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCH
T ss_pred             CCCEEEEEEecccc---cChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCH
Confidence            48899999998653   2345677888999999999999999999999999999999999999999999976   35999


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc---------ccccCCCCCCccCCccc
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN---------DLKSCKGTPFWMAPEVV  148 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~---------~~~~~~~~~~~~aPE~~  148 (247)
                      ..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||.+......         ......++..|+|||.+
T Consensus       128 ~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  207 (389)
T 3gni_B          128 LAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL  207 (389)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHH
Confidence            999999999999999999999999999999999999999999999987432211         12223578889999999


Q ss_pred             ccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCC--------------------------------
Q 041080          149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP--------------------------------  196 (247)
Q Consensus       149 ~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------------------------  196 (247)
                      .+....++.++||||||+++|+|++|..||...........+.....+                                
T Consensus       208 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (389)
T 3gni_B          208 QQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTT  287 (389)
T ss_dssp             STTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------------------------------
T ss_pred             hccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccccccccccccccccccccc
Confidence            764445899999999999999999999999876655544333221111                                


Q ss_pred             -------------CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          197 -------------SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       197 -------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                                   ..+..+++++++||.+||+.||.+|||++++++||||+...
T Consensus       288 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~  341 (389)
T 3gni_B          288 STPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  341 (389)
T ss_dssp             ------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred             CccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence                         23456789999999999999999999999999999999754

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.1e-48  Score=316.13  Aligned_cols=231  Identities=27%  Similarity=0.486  Sum_probs=192.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||||++.+....  .....+.+.+|..++.++ +||||+++++++.+.+..++||||+++|+|..++.+. .+++.
T Consensus        76 ~~~~~AvK~~~k~~~~--~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~  153 (396)
T 4dc2_A           76 TDRIYAMRVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE  153 (396)
T ss_dssp             TTEEEEEEEEEGGGTC------CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHH
T ss_pred             CCCEEEEEEEEhhhcc--CHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHH
Confidence            4788999999875432  233345677899999887 8999999999999999999999999999999988764 59999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccC--ccccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .++.++.|++.||.|||++||+||||||+||+++.+|.++|+|||++....  ........|++.|+|||.+.+..  ++
T Consensus       154 ~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~--~~  231 (396)
T 4dc2_A          154 HARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED--YG  231 (396)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCC--BC
T ss_pred             HHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCC--CC
Confidence            999999999999999999999999999999999999999999999987422  23344566899999999996654  79


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCCh---------hhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh---
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLE---------GVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV---  224 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~---  224 (247)
                      .++|+||||+++|+|++|..||....         .......+.. ....++..++++++++|.+||+.||.+||++   
T Consensus       232 ~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~  310 (396)
T 4dc2_A          232 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQ  310 (396)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH-CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTT
T ss_pred             hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc-cccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCC
Confidence            99999999999999999999996432         1122233333 3446778899999999999999999999985   


Q ss_pred             ---hhhhcCccCCCC
Q 041080          225 ---TELMEHPFVKRP  236 (247)
Q Consensus       225 ---~~il~~p~~~~~  236 (247)
                         +++++||||+..
T Consensus       311 ~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          311 TGFADIQGHPFFRNV  325 (396)
T ss_dssp             THHHHHHHSTTTTTC
T ss_pred             CCHHHHhcCccccCC
Confidence               799999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.1e-47  Score=305.95  Aligned_cols=233  Identities=30%  Similarity=0.510  Sum_probs=189.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.||+|++....   ........+.+|+.++++++||||+++++++.+++..++||||+++ +|.+.+...  .+++.
T Consensus        44 ~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~  119 (311)
T 3niz_A           44 QGRIVALKRIRLDA---EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS  119 (311)
T ss_dssp             TSCEEEEEEEC---------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHH
T ss_pred             CCCEEEEEEEeccc---ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHH
Confidence            47899999997543   2233456788999999999999999999999999999999999986 888877654  38999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+......  ......+++.|+|||.+.+.. .++
T Consensus       120 ~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~  198 (311)
T 3niz_A          120 QIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK-KYS  198 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCC-SCC
T ss_pred             HHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCC-CCC
Confidence            99999999999999999999999999999999999999999999998754422  233456899999999986533 378


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc---CCCC--------------------------CCCCcCCHHHH
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK---GELP--------------------------SVPSSLSRDAR  207 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~---~~~~--------------------------~~~~~~~~~~~  207 (247)
                      .++|+||+|+++|+|++|..||......+....+..   ...+                          .....+++++.
T Consensus       199 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (311)
T 3niz_A          199 TSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGI  278 (311)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHH
T ss_pred             chHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHH
Confidence            999999999999999999999987766655444321   0000                          01234688999


Q ss_pred             HHHHHHhcCCCCCCCChhhhhcCccCCCCCC
Q 041080          208 DFILKCLQVNPNDRPTVTELMEHPFVKRPLQ  238 (247)
Q Consensus       208 ~li~~~l~~~p~~Rps~~~il~~p~~~~~~~  238 (247)
                      ++|.+||+.||.+|||++|+++||||+..-.
T Consensus       279 ~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          279 DLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             HHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             HHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence            9999999999999999999999999997643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.6e-47  Score=308.93  Aligned_cols=231  Identities=28%  Similarity=0.485  Sum_probs=195.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||||++.....  ......+.+.+|..++.++ +||||+++++++.+.+..++||||+++++|.+++.+. .+++.
T Consensus        33 ~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~  110 (345)
T 3a8x_A           33 TDRIYAMKVVKKELV--NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE  110 (345)
T ss_dssp             TTEEEEEEEEEGGGS--CSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHH
T ss_pred             CCCEEEEEEEEhHHh--cchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHH
Confidence            478999999986542  2345567788999999998 8999999999999999999999999999999988764 59999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccC--ccccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .++.++.|++.||.+||++||+|+||||+||+++.++.++|+|||++....  ........|++.|+|||.+.+..  ++
T Consensus       111 ~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  188 (345)
T 3a8x_A          111 HARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED--YG  188 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCC--BC
T ss_pred             HHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCC--CC
Confidence            999999999999999999999999999999999999999999999987532  22344566899999999996544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCC---------hhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh---
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHL---------EGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV---  224 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~---  224 (247)
                      .++|+||||+++|+|++|..||...         ........+... ...++..++.+++++|.+||+.+|.+||++   
T Consensus       189 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~  267 (345)
T 3a8x_A          189 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQ  267 (345)
T ss_dssp             THHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTT
T ss_pred             hHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCc
Confidence            9999999999999999999999652         122223333333 345677899999999999999999999996   


Q ss_pred             ---hhhhcCccCCCC
Q 041080          225 ---TELMEHPFVKRP  236 (247)
Q Consensus       225 ---~~il~~p~~~~~  236 (247)
                         +++++||||+..
T Consensus       268 ~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          268 TGFADIQGHPFFRNV  282 (345)
T ss_dssp             THHHHHHTSGGGTTC
T ss_pred             CCHHHHhcCCccCCC
Confidence               799999999853

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.9e-48  Score=303.57  Aligned_cols=238  Identities=29%  Similarity=0.521  Sum_probs=199.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-cCCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-YHLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~   79 (247)
                      +|+.||||++.....  ........+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.. ..+++..
T Consensus        33 ~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~  110 (279)
T 3fdn_A           33 SKFILALKVLFKAQL--EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR  110 (279)
T ss_dssp             TCCEEEEEEEEHHHH--HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHH
T ss_pred             CCcEEEEEEEecccc--chhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHH
Confidence            467899999975321  1222356688999999999999999999999999999999999999999998876 4589999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcch
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTA  159 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~  159 (247)
                      ++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+............++..|+|||.+.+..  ++.++
T Consensus       111 ~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~  188 (279)
T 3fdn_A          111 TATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRM--HDEKV  188 (279)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--------CCCCTTCCHHHHTTCC--CCTTH
T ss_pred             HHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcccccccCCCCCccCHhHhccCC--CCccc
Confidence            9999999999999999999999999999999999999999999998766555555667899999999986544  78899


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCCC-
Q 041080          160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQ-  238 (247)
Q Consensus       160 Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~~-  238 (247)
                      |+||||+++++|++|..||...........+.... ...+..+++.+++++.+||+.+|.+|||++++++||||+.... 
T Consensus       189 Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~  267 (279)
T 3fdn_A          189 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSK  267 (279)
T ss_dssp             HHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred             hhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccC
Confidence            99999999999999999999888777766665543 3556778999999999999999999999999999999998443 


Q ss_pred             CCCCc
Q 041080          239 TPRCG  243 (247)
Q Consensus       239 ~~~~~  243 (247)
                      ...|.
T Consensus       268 ~~~~~  272 (279)
T 3fdn_A          268 PSNCQ  272 (279)
T ss_dssp             CCCC-
T ss_pred             ccccc
Confidence            33554

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.6e-48  Score=313.73  Aligned_cols=232  Identities=32%  Similarity=0.501  Sum_probs=192.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-----CC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-----HL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~   75 (247)
                      +|+.||||++.............+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+.+.+.     .+
T Consensus        48 ~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~  127 (351)
T 3c0i_A           48 TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY  127 (351)
T ss_dssp             TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCC
T ss_pred             CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCC
Confidence            4889999999754322222223567889999999999999999999999999999999999999998877543     38


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCC---eEEcccccccccCccc--cccCCCCCCccCCccccc
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS---VKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNS  150 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~---~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~  150 (247)
                      ++..++.++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||.+.......  .....|++.|+|||.+.+
T Consensus       128 ~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  207 (351)
T 3c0i_A          128 SEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR  207 (351)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTT
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcC
Confidence            99999999999999999999999999999999999987655   9999999987654432  234568999999999965


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCC---CcCCHHHHHHHHHHhcCCCCCCCChhhh
Q 041080          151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVP---SSLSRDARDFILKCLQVNPNDRPTVTEL  227 (247)
Q Consensus       151 ~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~i  227 (247)
                      ..  ++.++||||||+++|+|++|..||..... .....+........+   ..++++++++|.+||..||.+|||+.++
T Consensus       208 ~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~  284 (351)
T 3c0i_A          208 EP--YGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEA  284 (351)
T ss_dssp             CC--BCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CC--CCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            44  78999999999999999999999987543 334444443332222   4689999999999999999999999999


Q ss_pred             hcCccCCC
Q 041080          228 MEHPFVKR  235 (247)
Q Consensus       228 l~~p~~~~  235 (247)
                      ++||||+.
T Consensus       285 l~hp~~~~  292 (351)
T 3c0i_A          285 LNHPWLKE  292 (351)
T ss_dssp             HTSHHHHT
T ss_pred             hcChhhcC
Confidence            99999985

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.8e-48  Score=306.96  Aligned_cols=235  Identities=31%  Similarity=0.533  Sum_probs=193.2

Q ss_pred             CCceEEEEEEeecCCCcc---------------------chHHHHHHHHHHHHHhhcCCCceeeeceeeec--CCcEEEE
Q 041080            1 DGFFFAVKEVSLQDQGAQ---------------------GKQSILQLEQEISLLSQFEQDNIVQYLGTDKD--ENRLYIF   57 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~---------------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv   57 (247)
                      +|+.||||++........                     .....+.+.+|+.++++++||||+++++++.+  .+..++|
T Consensus        37 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  116 (298)
T 2zv2_A           37 DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMV  116 (298)
T ss_dssp             TTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEE
T ss_pred             CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEE
Confidence            478999999976532111                     12234668899999999999999999999886  5689999


Q ss_pred             EeccccCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--ccc
Q 041080           58 LELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKS  135 (247)
Q Consensus        58 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~  135 (247)
                      |||+++++|.+++....+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||++.......  ...
T Consensus       117 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  196 (298)
T 2zv2_A          117 FELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN  196 (298)
T ss_dssp             EECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECC
T ss_pred             EecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCccccccccccccC
Confidence            999999999888777789999999999999999999999999999999999999999999999999986544332  234


Q ss_pred             CCCCCCccCCcccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCC-CCCCcCCHHHHHHHHHH
Q 041080          136 CKGTPFWMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP-SVPSSLSRDARDFILKC  213 (247)
Q Consensus       136 ~~~~~~~~aPE~~~~~~~~-~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~  213 (247)
                      ..+++.|+|||.+.+.... .+.++|+||||+++|+|++|..||...........+...... .....++++++++|.+|
T Consensus       197 ~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  276 (298)
T 2zv2_A          197 TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRM  276 (298)
T ss_dssp             CCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHH
T ss_pred             CcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHH
Confidence            5689999999998654422 367899999999999999999999887766665555444332 22357899999999999


Q ss_pred             hcCCCCCCCChhhhhcCccCCC
Q 041080          214 LQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       214 l~~~p~~Rps~~~il~~p~~~~  235 (247)
                      |+.||.+|||++++++||||++
T Consensus       277 l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          277 LDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             TCSCTTTSCCHHHHTTCHHHHC
T ss_pred             hhcChhhCCCHHHHhcCccccC
Confidence            9999999999999999999963

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.5e-47  Score=307.27  Aligned_cols=232  Identities=28%  Similarity=0.447  Sum_probs=190.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++...... ........+.+|+.++++++||||+++++++...+..++||||+++++|.+++.+. .+++..
T Consensus        44 ~~~~~aiK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  122 (327)
T 3a62_A           44 TGKIFAMKVLKKAMIV-RNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT  122 (327)
T ss_dssp             TTCEEEEEEECCC---------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHH
T ss_pred             CCcEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHH
Confidence            4789999999764321 12234556789999999999999999999999999999999999999999998764 489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      ++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||++......  ......|++.|+|||.+.+..  ++.
T Consensus       123 ~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~  200 (327)
T 3a62_A          123 ACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSG--HNR  200 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSC--CCT
T ss_pred             HHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCC--CCC
Confidence            9999999999999999999999999999999999999999999998643322  233456899999999996544  789


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----ChhhhhcCcc
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTELMEHPF  232 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~p~  232 (247)
                      ++|+||||+++|+|++|..||...........+..... .++..++++++++|.+||..+|.+||     +++++++|||
T Consensus       201 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~  279 (327)
T 3a62_A          201 AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF  279 (327)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred             cccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence            99999999999999999999998887777766665543 56678999999999999999999999     7889999999


Q ss_pred             CCCC
Q 041080          233 VKRP  236 (247)
Q Consensus       233 ~~~~  236 (247)
                      |+..
T Consensus       280 f~~~  283 (327)
T 3a62_A          280 FRHI  283 (327)
T ss_dssp             GSSC
T ss_pred             ccCC
Confidence            9864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.6e-47  Score=310.96  Aligned_cols=230  Identities=28%  Similarity=0.484  Sum_probs=198.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++.....   .....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+.+... .+++..
T Consensus        53 ~~~~~avK~~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~  129 (362)
T 2bdw_A           53 TGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD  129 (362)
T ss_dssp             TCCEEEEEEEETTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHH
T ss_pred             CCCEEEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHH
Confidence            478999999976532   3445677899999999999999999999999999999999999999998888654 489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC---CeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG---SVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~---~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ++.++.|++.||.|||++||+|+||||+||+++.++   .++|+|||++....... .....|++.|+|||.+.+..  +
T Consensus       130 ~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~  207 (362)
T 2bdw_A          130 ASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP--Y  207 (362)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCC--C
T ss_pred             HHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCC--C
Confidence            999999999999999999999999999999998654   59999999987655333 33456899999999996544  7


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCC---CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVP---SSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      +.++||||||+++|+|++|..||...+.......+..+......   ..++++++++|.+||..||.+|||++++++|||
T Consensus       208 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  287 (362)
T 2bdw_A          208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW  287 (362)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred             CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence            89999999999999999999999888777777766655432222   467999999999999999999999999999999


Q ss_pred             CCC
Q 041080          233 VKR  235 (247)
Q Consensus       233 ~~~  235 (247)
                      |+.
T Consensus       288 ~~~  290 (362)
T 2bdw_A          288 ICN  290 (362)
T ss_dssp             HHT
T ss_pred             cCC
Confidence            974

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-48  Score=309.39  Aligned_cols=228  Identities=25%  Similarity=0.380  Sum_probs=197.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.||+|.+...      ......+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++...  .+++.
T Consensus        29 ~~~~~a~K~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~  102 (321)
T 1tki_A           29 SKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNER  102 (321)
T ss_dssp             TTEEEEEEEECCC------THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHH
T ss_pred             CCcEEEEEEEecC------cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHH
Confidence            4788999998642      234556889999999999999999999999999999999999999999999764  48999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC--CCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA--SGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~--~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .++.++.|++.||.|||++|++|+||||+||+++.  ++.++|+|||.+....... .....+++.|+|||.+.+..  +
T Consensus       103 ~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~  180 (321)
T 1tki_A          103 EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV--V  180 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCE--E
T ss_pred             HHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCC--C
Confidence            99999999999999999999999999999999987  7899999999987654332 23345889999999996544  6


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCC---CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV---PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      +.++|+||+|+++|+|++|..||...........+........   ...+++++++++.+||..||.+|||++++++|||
T Consensus       181 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  260 (321)
T 1tki_A          181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW  260 (321)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence            8899999999999999999999988887777776665544322   1468999999999999999999999999999999


Q ss_pred             CCCC
Q 041080          233 VKRP  236 (247)
Q Consensus       233 ~~~~  236 (247)
                      |+..
T Consensus       261 ~~~~  264 (321)
T 1tki_A          261 LKQK  264 (321)
T ss_dssp             HHSC
T ss_pred             hccC
Confidence            9875

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.2e-48  Score=318.16  Aligned_cols=234  Identities=27%  Similarity=0.408  Sum_probs=198.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.||+|++.+....  .....+.+.+|+.+++.++||||+++++++.+.+..++||||++||+|.++++...+++..+
T Consensus        93 ~~~~~AiK~~~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~e~~~  170 (410)
T 3v8s_A           93 TRKVYAMKLLSKFEMI--KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA  170 (410)
T ss_dssp             TCCEEEEEEEEHHHHH--HTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHCCCCHHHH
T ss_pred             CCcEEEEEEEehhhhh--hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcCCCCHHHH
Confidence            4789999999753211  11112347789999999999999999999999999999999999999999999889999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCCCC--C
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKNDG--Y  155 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~--~  155 (247)
                      +.++.|++.||.|||++||+||||||+||+++.+|.++|+|||++.......   .....|++.|+|||.+.+....  +
T Consensus       171 ~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~  250 (410)
T 3v8s_A          171 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYY  250 (410)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEE
T ss_pred             HHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCC
Confidence            9999999999999999999999999999999999999999999986554332   3356699999999998654322  6


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC---CCCCCCcCCHHHHHHHHHHhcCCCCC--CCChhhhhcC
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE---LPSVPSSLSRDARDFILKCLQVNPND--RPTVTELMEH  230 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~~il~~  230 (247)
                      +.++|+||||+++|+|++|..||...+.......+....   ..+....++++++++|.+||..+|.+  ||++++|++|
T Consensus       251 ~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          251 GRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             ETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             CCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            789999999999999999999999888777776665431   11223478999999999999998988  9999999999


Q ss_pred             ccCCCC
Q 041080          231 PFVKRP  236 (247)
Q Consensus       231 p~~~~~  236 (247)
                      |||+..
T Consensus       331 p~f~~~  336 (410)
T 3v8s_A          331 LFFKND  336 (410)
T ss_dssp             GGGCCS
T ss_pred             ccccCC
Confidence            999874

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.4e-48  Score=312.31  Aligned_cols=233  Identities=27%  Similarity=0.424  Sum_probs=193.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHH-hcCCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ-KYHLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~   79 (247)
                      +|+.||||++......  .......+.+|+.+++.++||||+++++++...+..++||||+ +|+|.+++. ...+++..
T Consensus        33 ~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~  109 (336)
T 3h4j_B           33 TQQKVALKFISRQLLK--KSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDE  109 (336)
T ss_dssp             TCCEEEEEEEEHHHHH--HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCSCCHHH
T ss_pred             CCCEEEEEEEehHHcc--chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCCCCHHH
Confidence            4789999999753211  1122346889999999999999999999999999999999999 557877664 45699999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCCCcc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....... .....|++.|+|||.+.+... .+.+
T Consensus       110 ~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~  188 (336)
T 3h4j_B          110 GRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY-AGPE  188 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGG-GCHH
T ss_pred             HHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCC-CCCc
Confidence            99999999999999999999999999999999999999999999987554332 345568999999999965442 3789


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQ  238 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~~  238 (247)
                      +||||+|+++|+|++|..||...........+... ....+..+++++.+++.+||..||.+|||++++++||||+..+.
T Consensus       189 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  267 (336)
T 3h4j_B          189 VDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLP  267 (336)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred             cchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCCc
Confidence            99999999999999999999775544433333222 23556778999999999999999999999999999999987544

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.8e-47  Score=309.16  Aligned_cols=229  Identities=25%  Similarity=0.415  Sum_probs=198.5

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-cCCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-YHLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~   79 (247)
                      |+.||||++......  .....+.+..|..++..+ +||+|+++++++++.+..++||||++||+|.+++.+ ..+++..
T Consensus        45 ~~~~AiK~~~~~~~~--~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~  122 (353)
T 2i0e_A           45 DELYAVKILKKDVVI--QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH  122 (353)
T ss_dssp             EEEEEEEEEEHHHHH--HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHH
T ss_pred             CCEEEEEEEEHHHhh--cchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHH
Confidence            678999999764321  122355678899999988 799999999999999999999999999999999876 4699999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccC--ccccccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      ++.++.|++.||.|||++||+|+||||+||+++.+|.++|+|||++....  ........|++.|+|||.+.+..  ++.
T Consensus       123 ~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~  200 (353)
T 2i0e_A          123 AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP--YGK  200 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC--BST
T ss_pred             HHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCC--cCC
Confidence            99999999999999999999999999999999999999999999987532  22344566899999999996544  789


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC-----hhhhhcCcc
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT-----VTELMEHPF  232 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~p~  232 (247)
                      ++|+||||+++|+|++|..||...+.......+.... ..++..+++++++++.+||..+|.+||+     ++++++|||
T Consensus       201 ~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~  279 (353)
T 2i0e_A          201 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF  279 (353)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGG
T ss_pred             cccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcc
Confidence            9999999999999999999999888777777776654 3567789999999999999999999995     699999999


Q ss_pred             CCC
Q 041080          233 VKR  235 (247)
Q Consensus       233 ~~~  235 (247)
                      |+.
T Consensus       280 f~~  282 (353)
T 2i0e_A          280 FRY  282 (353)
T ss_dssp             GTT
T ss_pred             ccC
Confidence            975

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.7e-47  Score=310.88  Aligned_cols=233  Identities=25%  Similarity=0.490  Sum_probs=196.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++.....  ........+.+|+.+++.++||||+++++++.+.+..++||||+.+++|..++... .+++..
T Consensus        39 ~~~~~AiK~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~  116 (384)
T 4fr4_A           39 TKKMYAMKYMNKQKC--VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET  116 (384)
T ss_dssp             TCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHH
T ss_pred             CCCEEEEEEEehhhc--ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHH
Confidence            478899999976431  12233567889999999999999999999999999999999999999999999775 599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-ccccCCCCCCccCCcccccC-CCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSK-NDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~  157 (247)
                      ++.++.|++.||.|||+.||+|+||||+||+++.+|.++|+|||++...... ......|++.|+|||.+... ...++.
T Consensus       117 ~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~  196 (384)
T 4fr4_A          117 VKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSF  196 (384)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCT
T ss_pred             HHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCc
Confidence            9999999999999999999999999999999999999999999998755433 34456699999999998643 234788


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChh---hHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC-hhhhhcCccC
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEG---VQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT-VTELMEHPFV  233 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~~il~~p~~  233 (247)
                      ++|+||||+++|+|++|..||.....   ......+.. .....+..+++++.++|.+||+.+|.+||+ ++++++||||
T Consensus       197 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f  275 (384)
T 4fr4_A          197 AVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET-TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM  275 (384)
T ss_dssp             THHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH-CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGG
T ss_pred             cceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh-cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhh
Confidence            99999999999999999999974332   222333332 344667789999999999999999999998 8999999999


Q ss_pred             CCC
Q 041080          234 KRP  236 (247)
Q Consensus       234 ~~~  236 (247)
                      +..
T Consensus       276 ~~~  278 (384)
T 4fr4_A          276 NDI  278 (384)
T ss_dssp             TTC
T ss_pred             hcC
Confidence            863

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.3e-48  Score=311.62  Aligned_cols=237  Identities=26%  Similarity=0.449  Sum_probs=195.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--------
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--------   72 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------   72 (247)
                      +|+.||+|++.............+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++..        
T Consensus        50 ~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~  129 (345)
T 3hko_A           50 TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGK  129 (345)
T ss_dssp             TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTE
T ss_pred             CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccc
Confidence            477899999976543233345567899999999999999999999999999999999999999999998852        


Q ss_pred             ---------------------------------cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC--Ce
Q 041080           73 ---------------------------------YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG--SV  117 (247)
Q Consensus        73 ---------------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~--~~  117 (247)
                                                       ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++  .+
T Consensus       130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~  209 (345)
T 3hko_A          130 CAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEI  209 (345)
T ss_dssp             EEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCE
T ss_pred             cccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceE
Confidence                                             1135778889999999999999999999999999999998776  89


Q ss_pred             EEcccccccccCcc------ccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhh
Q 041080          118 KLADFGLAKATTMN------DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIG  191 (247)
Q Consensus       118 ~l~df~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~  191 (247)
                      +|+|||.+......      ......+++.|+|||.+.+....++.++||||||+++|+|++|..||......+....+.
T Consensus       210 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (345)
T 3hko_A          210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVL  289 (345)
T ss_dssp             EECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             EEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence            99999998643221      123455899999999997655558999999999999999999999998888777776665


Q ss_pred             cCCCCCCC---CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          192 KGELPSVP---SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       192 ~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      ........   ..+++++.++|.+||+.+|.+|||+.++++||||+...
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          290 NKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             HCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             hcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence            55432222   34799999999999999999999999999999999753

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.7e-47  Score=306.43  Aligned_cols=235  Identities=25%  Similarity=0.429  Sum_probs=191.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++.....    ....+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.++++.. .+++..
T Consensus        31 ~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  106 (323)
T 3tki_A           31 TEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD  106 (323)
T ss_dssp             TCCEEEEEEEECC-----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCHHH
T ss_pred             CCcEEEEEEEEcccc----cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHH
Confidence            478999999975432    223456789999999999999999999999999999999999999999988765 599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc----ccccCCCCCCccCCcccccCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+......    ......|++.|+|||.+.+... .
T Consensus       107 ~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~  185 (323)
T 3tki_A          107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF-H  185 (323)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSB-C
T ss_pred             HHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCC-C
Confidence            9999999999999999999999999999999999999999999998644322    2234568999999999865442 3


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHH--hhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR--IGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      +.++||||||+++|+|++|..||...........  ............+++.+.+++.+||..||.+|||++|+++||||
T Consensus       186 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~  265 (323)
T 3tki_A          186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY  265 (323)
T ss_dssp             HHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred             CCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence            7789999999999999999999976554322222  22222222235789999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 041080          234 KRPLQTP  240 (247)
Q Consensus       234 ~~~~~~~  240 (247)
                      +......
T Consensus       266 ~~~~~~~  272 (323)
T 3tki_A          266 NKPLKKG  272 (323)
T ss_dssp             TCCCCCC
T ss_pred             ccccccc
Confidence            9765443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2e-47  Score=319.28  Aligned_cols=234  Identities=29%  Similarity=0.469  Sum_probs=202.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++.....  ......+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++.+. .+++..
T Consensus        40 ~g~~vAvK~i~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~  117 (476)
T 2y94_A           40 TGHKVAVKILNRQKI--RSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKE  117 (476)
T ss_dssp             TCCEEEEEEEEHHHH--HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHH
T ss_pred             CCCEEEEEEEEhhhc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHH
Confidence            488999999975421  11223567889999999999999999999999999999999999999999998754 599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCCCcc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....... .....|++.|+|||.+.+... .+.+
T Consensus       118 ~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~  196 (476)
T 2y94_A          118 SRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY-AGPE  196 (476)
T ss_dssp             HHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCB-CSHH
T ss_pred             HHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCC-CCCc
Confidence            99999999999999999999999999999999999999999999987654332 345568999999999975432 3789


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQ  238 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~~  238 (247)
                      +|+||+|+++|+|++|..||...........+..+.. ..+..+++++.+++.+||..||.+|||++++++||||+....
T Consensus       197 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  275 (476)
T 2y94_A          197 VDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLP  275 (476)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred             ceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence            9999999999999999999998877777776665543 456778999999999999999999999999999999987544

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=9.3e-47  Score=298.19  Aligned_cols=231  Identities=29%  Similarity=0.465  Sum_probs=187.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~   78 (247)
                      +|+.||||++.....   .......+.+|+.++++++||||+++++++.+++..++||||+++ ++.+.+..  ..+++.
T Consensus        26 ~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~  101 (292)
T 3o0g_A           26 THEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPE  101 (292)
T ss_dssp             TCCEEEEEEEESSCS---STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHH
T ss_pred             CCceEEEEeeeccCC---cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHH
Confidence            478999999986542   334456788999999999999999999999999999999999987 55555543  459999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+......  ......+++.|+|||.+.+.. .++
T Consensus       102 ~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~  180 (292)
T 3o0g_A          102 IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK-LYS  180 (292)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCS-CCC
T ss_pred             HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCC-CcC
Confidence            99999999999999999999999999999999999999999999998754422  233455789999999986543 268


Q ss_pred             cchhHHHHHHHHHHHHhCCCC-CCCChhhHHHHHhhcC----------------------------CCCCCCCcCCHHHH
Q 041080          157 LTADIWSLGCTVLEMLTRRPP-YSHLEGVQALFRIGKG----------------------------ELPSVPSSLSRDAR  207 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p-~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~  207 (247)
                      .++|+||+|+++++|++|..| |...+.......+...                            ........++++++
T Consensus       181 ~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (292)
T 3o0g_A          181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGR  260 (292)
T ss_dssp             THHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHH
T ss_pred             chHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHH
Confidence            999999999999999988777 4444444443332110                            01112235789999


Q ss_pred             HHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          208 DFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       208 ~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      +++.+||+.||.+|||++|+++||||+..
T Consensus       261 ~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          261 DLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHhccChhhCCCHHHHhcCcccccC
Confidence            99999999999999999999999999964

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.9e-47  Score=300.54  Aligned_cols=231  Identities=31%  Similarity=0.518  Sum_probs=188.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~   78 (247)
                      +|+.||+|++......   ....+.+.+|+.++++++||||+++++++...+..++||||+++ +|.+++..  .++++.
T Consensus        25 ~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~  100 (288)
T 1ob3_A           25 YGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESV  100 (288)
T ss_dssp             TSCEEEEEEECCSSGG---GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHH
T ss_pred             CCCEEEEEEEeccccc---cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHH
Confidence            4789999999764322   22235677999999999999999999999999999999999987 99998875  358999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+......  ......+++.|+|||.+.+.. .++
T Consensus       101 ~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~  179 (288)
T 1ob3_A          101 TAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK-KYS  179 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCC-SCC
T ss_pred             HHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeCCC-CCC
Confidence            99999999999999999999999999999999999999999999998654322  223445799999999986433 378


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC---C-------------------------CCCCCCcCCHHHHH
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG---E-------------------------LPSVPSSLSRDARD  208 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---~-------------------------~~~~~~~~~~~~~~  208 (247)
                      .++|+||||+++|+|++|..||......+....+...   .                         .......+++++.+
T Consensus       180 ~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (288)
T 1ob3_A          180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGID  259 (288)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHH
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHH
Confidence            9999999999999999999999887665554433210   0                         00112457899999


Q ss_pred             HHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          209 FILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       209 li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ++.+||..||.+|||++++++||||+..
T Consensus       260 li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          260 LLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             HHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            9999999999999999999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.6e-47  Score=300.19  Aligned_cols=233  Identities=29%  Similarity=0.487  Sum_probs=201.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++......  .......+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++... .+++..
T Consensus        38 ~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  115 (284)
T 2vgo_A           38 NKFIMALKVLFKSQLE--KEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQR  115 (284)
T ss_dssp             TTEEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHH
T ss_pred             CCcEEEEEEEcccccc--hHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHH
Confidence            4678999999754211  1223456889999999999999999999999999999999999999999988764 589999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcch
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTA  159 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~  159 (247)
                      ++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+............++..|+|||.+.+..  ++.++
T Consensus       116 ~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~  193 (284)
T 2vgo_A          116 SATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKT--HDEKV  193 (284)
T ss_dssp             HHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCBCCCCSCGGGCCHHHHTTCC--BCTTH
T ss_pred             HHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccccccccCCCCcCCHHHhccCC--CCccc
Confidence            9999999999999999999999999999999999999999999998665554455566899999999996544  78899


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCCC
Q 041080          160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQ  238 (247)
Q Consensus       160 Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~~  238 (247)
                      |+||||++++++++|..||...........+.... ...+..++.++++++.+||..+|.+|||++++++||||+....
T Consensus       194 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          194 DLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD-LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             HHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             chhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc-cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            99999999999999999998877776666655543 3566789999999999999999999999999999999987543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.2e-47  Score=309.51  Aligned_cols=228  Identities=26%  Similarity=0.427  Sum_probs=196.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.||+|++....     ....+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++...  .+++.
T Consensus       113 ~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~  187 (373)
T 2x4f_A          113 TGLKLAAKIIKTRG-----MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL  187 (373)
T ss_dssp             TCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHH
T ss_pred             CCcEEEEEEEcccc-----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHH
Confidence            47899999997532     344567889999999999999999999999999999999999999999888654  49999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEE--cCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILV--DASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~--~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .++.++.|++.||.|||+.||+|+||||+||++  +.++.++|+|||++....... .....|++.|+|||.+.+..  +
T Consensus       188 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~  265 (373)
T 2x4f_A          188 DTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDF--V  265 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCB--C
T ss_pred             HHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCC--C
Confidence            999999999999999999999999999999999  566789999999987654333 33445899999999986544  7


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCC---CCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPS---VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      +.++||||||+++|+|++|..||...........+.......   ....++++++++|.+||+.+|.+|||++++++|||
T Consensus       266 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~  345 (373)
T 2x4f_A          266 SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPW  345 (373)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence            889999999999999999999998887777766665543322   22568999999999999999999999999999999


Q ss_pred             CCC
Q 041080          233 VKR  235 (247)
Q Consensus       233 ~~~  235 (247)
                      |+.
T Consensus       346 ~~~  348 (373)
T 2x4f_A          346 LSD  348 (373)
T ss_dssp             HHC
T ss_pred             cCC
Confidence            985

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2e-46  Score=295.07  Aligned_cols=231  Identities=28%  Similarity=0.474  Sum_probs=198.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++....   ......+.+.+|+.++++++||||+++++++...+..++||||+++++|.+.+... .+++..
T Consensus        30 ~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~  106 (284)
T 3kk8_A           30 TGLEFAAKIINTKK---LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD  106 (284)
T ss_dssp             TCCEEEEEEEEGGG---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHH
T ss_pred             CCceEEEEEeeccc---CCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHHH
Confidence            47899999997653   23455677889999999999999999999999999999999999999998877554 589999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCC---eEEcccccccccCccc-cccCCCCCCccCCcccccCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS---VKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~---~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ++.++.|++.||.+||+.|++|+||||+||+++.++.   ++|+|||.+....... .....+++.|+|||.+.+..  +
T Consensus       107 ~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~  184 (284)
T 3kk8_A          107 ASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP--Y  184 (284)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCC--B
T ss_pred             HHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCC--C
Confidence            9999999999999999999999999999999987665   9999999986554333 23456899999999996544  7


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCC---CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP---SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      +.++|+||||+++++|++|..||...........+......   .....+++++.+++.+||+.+|.+|||++++++|||
T Consensus       185 ~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  264 (284)
T 3kk8_A          185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW  264 (284)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred             CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence            89999999999999999999999888777777666554432   222578999999999999999999999999999999


Q ss_pred             CCCC
Q 041080          233 VKRP  236 (247)
Q Consensus       233 ~~~~  236 (247)
                      |+..
T Consensus       265 ~~~~  268 (284)
T 3kk8_A          265 ICNR  268 (284)
T ss_dssp             HHSC
T ss_pred             ccCC
Confidence            9874

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.6e-47  Score=317.94  Aligned_cols=231  Identities=27%  Similarity=0.468  Sum_probs=191.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++.....  ........+.+|+.+++.++||||+++++++...+..++||||+++++|.+++.+. .+++..
T Consensus       172 ~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  249 (446)
T 4ejn_A          172 TGRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR  249 (446)
T ss_dssp             TCCEEEEEEEEHHHH--C-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHH
T ss_pred             CCCEEEEEEEEhhhh--hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHH
Confidence            478999999975421  12334556778999999999999999999999999999999999999999988654 589999


Q ss_pred             HHHHHHHHHHHHHHhhh-CCeeecCCCCCcEEEcCCCCeEEcccccccccCc--cccccCCCCCCccCCcccccCCCCCC
Q 041080           80 VSSYTRQILNGLVYLHE-RNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~-~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      +..++.|++.||.|||+ .||+|+||||+||+++.++.++|+|||++.....  .......|++.|+|||.+.+..  ++
T Consensus       250 ~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  327 (446)
T 4ejn_A          250 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND--YG  327 (446)
T ss_dssp             HHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSC--CC
T ss_pred             HHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCC--CC
Confidence            99999999999999998 9999999999999999999999999999865322  2234566899999999996554  79


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----ChhhhhcCc
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTELMEHP  231 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~p  231 (247)
                      .++||||||+++|+|++|..||...........+..... .++..+++++.++|.+||..||.+||     +++++++||
T Consensus       328 ~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp  406 (446)
T 4ejn_A          328 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR  406 (446)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence            999999999999999999999988887777766665543 56778999999999999999999999     999999999


Q ss_pred             cCCCC
Q 041080          232 FVKRP  236 (247)
Q Consensus       232 ~~~~~  236 (247)
                      ||+..
T Consensus       407 ~f~~~  411 (446)
T 4ejn_A          407 FFAGI  411 (446)
T ss_dssp             GGTTC
T ss_pred             cccCC
Confidence            99864

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.3e-47  Score=302.93  Aligned_cols=231  Identities=31%  Similarity=0.523  Sum_probs=191.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-------
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-------   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------   73 (247)
                      +|+.||||++.....    ....+.+.+|+.++++++||||+++++++..++..++||||+++ +|.+++...       
T Consensus        29 ~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~  103 (317)
T 2pmi_A           29 TGVYVALKEVKLDSE----EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPR  103 (317)
T ss_dssp             SCCEEEEEEEECCST----TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCCC-BHHHHHHHHHSSSCCC
T ss_pred             CCcEEEEEEeecccc----cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecCC-CHHHHHHhcccccccc
Confidence            478999999976432    12234577999999999999999999999999999999999985 999988653       


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccC
Q 041080           74 HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSK  151 (247)
Q Consensus        74 ~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~  151 (247)
                      .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+......  ......+++.|+|||.+.+.
T Consensus       104 ~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~  183 (317)
T 2pmi_A          104 GLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGS  183 (317)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCC
Confidence            4899999999999999999999999999999999999999999999999998754422  23345689999999998653


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC---C----------C--------------------CCC
Q 041080          152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG---E----------L--------------------PSV  198 (247)
Q Consensus       152 ~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---~----------~--------------------~~~  198 (247)
                      . .++.++||||||+++|+|++|..||...........+...   .          .                    +..
T Consensus       184 ~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (317)
T 2pmi_A          184 R-TYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT  262 (317)
T ss_dssp             C-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGC
T ss_pred             C-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccc
Confidence            2 3789999999999999999999999887766555443210   0          0                    011


Q ss_pred             CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          199 PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       199 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      +..+++++.++|.+||+.||.+|||++++++||||+...
T Consensus       263 ~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  301 (317)
T 2pmi_A          263 KEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY  301 (317)
T ss_dssp             SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             cccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence            235788999999999999999999999999999999753

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.4e-46  Score=301.03  Aligned_cols=234  Identities=31%  Similarity=0.481  Sum_probs=199.6

Q ss_pred             CCceEEEEEEeecCCCc-cchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGA-QGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||+|++....... ......+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++... .+++.
T Consensus        36 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~  115 (321)
T 2a2a_A           36 TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE  115 (321)
T ss_dssp             TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHH
T ss_pred             CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHH
Confidence            47899999998754322 22224667889999999999999999999999999999999999999999999765 48999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC----CeEEcccccccccCccc-cccCCCCCCccCCcccccCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG----SVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~----~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      .++.++.|++.||.+||+.|++|+||||+||+++.++    .++|+|||.+....... .....+++.|+|||.+.+.. 
T Consensus       116 ~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-  194 (321)
T 2a2a_A          116 EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP-  194 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCC-
T ss_pred             HHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCC-
Confidence            9999999999999999999999999999999999888    79999999987554332 33455899999999996544 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCC---CCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPS---VPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                       ++.++|+||||+++|+|++|..||......+....+.......   ....+++.+.+++.+||..+|.+|||++++++|
T Consensus       195 -~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          195 -LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             -CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             -CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             7899999999999999999999998877777766665543322   125689999999999999999999999999999


Q ss_pred             ccCCCC
Q 041080          231 PFVKRP  236 (247)
Q Consensus       231 p~~~~~  236 (247)
                      |||+..
T Consensus       274 p~~~~~  279 (321)
T 2a2a_A          274 PWITPV  279 (321)
T ss_dssp             TTTSCS
T ss_pred             ccccCC
Confidence            999864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.6e-46  Score=298.49  Aligned_cols=231  Identities=29%  Similarity=0.493  Sum_probs=196.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++....     ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++... .+++..
T Consensus        33 ~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  107 (304)
T 2jam_A           33 TGKLFALKCIKKSP-----AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKD  107 (304)
T ss_dssp             TCCEEEEEEEECC-----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCCCHHH
T ss_pred             CCCEEEEEEEeccc-----ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCCCHHH
Confidence            48899999997532     122346789999999999999999999999999999999999999999988654 589999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEE---cCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ++.++.|++.||.+||+.|++|+||+|+||++   +.++.++|+|||.+............+++.|+|||.+.+..  ++
T Consensus       108 ~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~  185 (304)
T 2jam_A          108 ASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKP--YS  185 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTBSSCS--CC
T ss_pred             HHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccccccCCCCccChHHhccCC--CC
Confidence            99999999999999999999999999999999   77889999999998765544444445899999999996544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC---CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL---PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      .++|+||||+++|+|++|..||...........+.....   ......+++++.+++.+||..+|.+|||++++++||||
T Consensus       186 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~  265 (304)
T 2jam_A          186 KAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI  265 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred             chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence            999999999999999999999988777776666655433   23345789999999999999999999999999999999


Q ss_pred             CCCCC
Q 041080          234 KRPLQ  238 (247)
Q Consensus       234 ~~~~~  238 (247)
                      +....
T Consensus       266 ~~~~~  270 (304)
T 2jam_A          266 DGNTA  270 (304)
T ss_dssp             HSSCS
T ss_pred             cCCCc
Confidence            87543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.9e-46  Score=295.46  Aligned_cols=228  Identities=27%  Similarity=0.471  Sum_probs=188.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-----cCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-----YHL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~   75 (247)
                      +|+.+|+|++.....    ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+.+..     ..+
T Consensus        46 ~~~~~aiK~~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  121 (285)
T 3is5_A           46 SGLERVIKTINKDRS----QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKAL  121 (285)
T ss_dssp             TCCEEEEEEEEGGGC----CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCC
T ss_pred             CCceEEEEEeecccc----chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCC
Confidence            478899999976432    22356788999999999999999999999999999999999999999988743     359


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEE---cCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccC
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---DASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSK  151 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~---~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~  151 (247)
                      ++..++.++.|++.||.+||+.|++|+||||+||++   +.++.++|+|||.+....... .....+++.|+|||.+.+ 
T Consensus       122 ~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-  200 (285)
T 3is5_A          122 SEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-  200 (285)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHTT-
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhcc-
Confidence            999999999999999999999999999999999999   456789999999987544332 334558899999999853 


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC--CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL--PSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       152 ~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                        .++.++|+||||+++++|++|..||.................  ......+++++.+++.+||+.||.+|||++|+++
T Consensus       201 --~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          201 --DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             --CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             --CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              378899999999999999999999988777666655444332  2223457999999999999999999999999999


Q ss_pred             CccCCC
Q 041080          230 HPFVKR  235 (247)
Q Consensus       230 ~p~~~~  235 (247)
                      ||||++
T Consensus       279 hp~f~~  284 (285)
T 3is5_A          279 HEWFKQ  284 (285)
T ss_dssp             SGGGGC
T ss_pred             CHHhhc
Confidence            999986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.3e-47  Score=295.97  Aligned_cols=230  Identities=27%  Similarity=0.476  Sum_probs=197.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      ++..+|+|.+.....     ...+.+.+|+.++++++||||+++++++.+++..++||||+++++|.+++... .+++..
T Consensus        33 ~~~~~a~k~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  107 (277)
T 3f3z_A           33 TRIRRAAKKIPKYFV-----EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESD  107 (277)
T ss_dssp             TCCEEEEEEEEGGGC-----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHH
T ss_pred             CCcEEEEEeehhhcc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCCHHH
Confidence            367899999975432     22456889999999999999999999999999999999999999998887654 589999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEE---cCCCCeEEcccccccccCcc-ccccCCCCCCccCCcccccCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILV---DASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~---~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ++.++.|++.||.+||++|++|+||||+||++   +.++.++|+|||.+...... ......+++.|+|||.+.+.   +
T Consensus       108 ~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~  184 (277)
T 3f3z_A          108 AARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL---Y  184 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC---B
T ss_pred             HHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhccc---C
Confidence            99999999999999999999999999999999   78889999999998654433 23445689999999998543   7


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCC---CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVP---SSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      +.++|+||||+++++|++|..||...........+.........   ..+++.+.+++.+||+.+|.+|||+.++++|||
T Consensus       185 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~  264 (277)
T 3f3z_A          185 GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEW  264 (277)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred             CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence            88999999999999999999999988877777776665443222   268999999999999999999999999999999


Q ss_pred             CCCCCC
Q 041080          233 VKRPLQ  238 (247)
Q Consensus       233 ~~~~~~  238 (247)
                      |+..+.
T Consensus       265 ~~~~~~  270 (277)
T 3f3z_A          265 FEKQLS  270 (277)
T ss_dssp             HHHHHC
T ss_pred             Hhcccc
Confidence            987543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=300.04  Aligned_cols=233  Identities=27%  Similarity=0.469  Sum_probs=189.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++....   ......+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++... .+++..
T Consensus        27 ~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~  103 (311)
T 4agu_A           27 TGQIVAIKKFLESE---DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHL  103 (311)
T ss_dssp             TCCEEEEEEECCCC---C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHH
T ss_pred             CCcEEEEEEeeccc---cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHH
Confidence            48899999986542   33445677889999999999999999999999999999999999999999888754 599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      ++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.......  .....++..|+|||.+.+.. .++.
T Consensus       104 ~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~  182 (311)
T 4agu_A          104 VKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT-QYGP  182 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCS-CCCT
T ss_pred             HHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCC-CCCc
Confidence            99999999999999999999999999999999999999999999986544222  23455888999999986533 3789


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC---------------------CCCCC---------CCcCCHHHH
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG---------------------ELPSV---------PSSLSRDAR  207 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---------------------~~~~~---------~~~~~~~~~  207 (247)
                      ++|+||+|++++++++|..||......+....+...                     ..+..         ...+++++.
T Consensus       183 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (311)
T 4agu_A          183 PVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPAL  262 (311)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHH
T ss_pred             chhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHH
Confidence            999999999999999999999887665554332210                     00000         135788999


Q ss_pred             HHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          208 DFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       208 ~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      +++.+||..||.+|||++++++||||+...
T Consensus       263 ~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  292 (311)
T 4agu_A          263 GLLKGCLHMDPTERLTCEQLLHHPYFENIR  292 (311)
T ss_dssp             HHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             HHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence            999999999999999999999999999764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=9.7e-47  Score=306.92  Aligned_cols=231  Identities=28%  Similarity=0.428  Sum_probs=190.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHH-HhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISL-LSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||||++.+....  .......+.+|..+ ++.++||||+++++++.+.+..++||||++||+|.+++.+. .+++.
T Consensus        62 ~~~~~AiK~~~~~~~~--~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~  139 (373)
T 2r5t_A           62 EEVFYAVKVLQKKAIL--KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP  139 (373)
T ss_dssp             TCCEEEEEEEEGGGBC---------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHH
T ss_pred             CCCEEEEEEEEHHHhh--hhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHH
Confidence            4788999999875432  22334456667766 46689999999999999999999999999999999988764 59999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccC--ccccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .++.++.|++.||.|||++||+|+||||+||+++.+|.++|+|||++....  ........|++.|+|||.+.+..  ++
T Consensus       140 ~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  217 (373)
T 2r5t_A          140 RARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQP--YD  217 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCC--CC
T ss_pred             HHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCC--CC
Confidence            999999999999999999999999999999999999999999999986532  22344566999999999996544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh----hhhhcCcc
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV----TELMEHPF  232 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~~il~~p~  232 (247)
                      .++|+||||+++|+|++|..||...+.......+..... .++..++.+++++|.+||+.||.+||++    +++++|||
T Consensus       218 ~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~  296 (373)
T 2r5t_A          218 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF  296 (373)
T ss_dssp             THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC-CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGG
T ss_pred             chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcc
Confidence            999999999999999999999998888777777766543 5667899999999999999999999987    68999999


Q ss_pred             CCCC
Q 041080          233 VKRP  236 (247)
Q Consensus       233 ~~~~  236 (247)
                      |+.+
T Consensus       297 f~~~  300 (373)
T 2r5t_A          297 FSLI  300 (373)
T ss_dssp             GTTC
T ss_pred             ccCC
Confidence            9863

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-46  Score=304.91  Aligned_cols=231  Identities=26%  Similarity=0.449  Sum_probs=194.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC------cEEEEEeccccCcHHHHHHhcC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN------RLYIFLELVTKGSLANLYQKYH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~   74 (247)
                      +|+.||||++....   ......+.+.+|+.++++++||||+++++++...+      .+++||||+ +++|.++++...
T Consensus        49 ~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~  124 (367)
T 1cm8_A           49 TGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK  124 (367)
T ss_dssp             TCCEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHCC
T ss_pred             CCCEEEEEEeCccc---cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhcCC
Confidence            48899999986542   33455677889999999999999999999987653      469999999 779999999888


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..... ......++.+|+|||.+.+.. .
T Consensus       125 l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~-~~~~~~~t~~y~aPE~~~~~~-~  202 (367)
T 1cm8_A          125 LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-EMTGYVVTRWYRAPEVILNWM-R  202 (367)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-SCCSSCSCGGGCCTHHHHTTT-C
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc-ccCcCcCCCCcCCHHHHhCCC-C
Confidence            99999999999999999999999999999999999999999999999999876543 234556899999999986532 3


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc------------------------------CCCCCCCCcCCH
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK------------------------------GELPSVPSSLSR  204 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~  204 (247)
                      ++.++|+||+|+++++|++|+.||...+.......+..                              ..........++
T Consensus       203 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (367)
T 1cm8_A          203 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP  282 (367)
T ss_dssp             CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCH
T ss_pred             CChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence            78999999999999999999999987765554433221                              011123356789


Q ss_pred             HHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          205 DARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       205 ~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      .+.+++.+||..||.+|||++++++||||+...
T Consensus       283 ~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          283 LAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence            999999999999999999999999999999754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=299.55  Aligned_cols=233  Identities=30%  Similarity=0.513  Sum_probs=187.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc---CCCceeeeceeeecCC-----cEEEEEeccccCcHHHHHHh
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF---EQDNIVQYLGTDKDEN-----RLYIFLELVTKGSLANLYQK   72 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~   72 (247)
                      +|+.||||++...............+.+|+.+++.+   +||||+++++++....     ..+++|||+.+ +|.+++..
T Consensus        33 ~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~  111 (308)
T 3g33_A           33 SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK  111 (308)
T ss_dssp             TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCCC-BHHHHHHT
T ss_pred             CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhhc-CHHHHHhh
Confidence            478999999986543322222233455777777666   4999999999987765     58999999975 99999877


Q ss_pred             cC---CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCccc
Q 041080           73 YH---LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVV  148 (247)
Q Consensus        73 ~~---~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~  148 (247)
                      ..   +++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+....... .....+++.|+|||.+
T Consensus       112 ~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~  191 (308)
T 3g33_A          112 APPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVL  191 (308)
T ss_dssp             CCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHH
T ss_pred             ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcccCCccccccccCchHH
Confidence            54   8999999999999999999999999999999999999999999999999987554332 3345689999999999


Q ss_pred             ccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC----CC----------------------CCCCcC
Q 041080          149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE----LP----------------------SVPSSL  202 (247)
Q Consensus       149 ~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~----~~----------------------~~~~~~  202 (247)
                      .+..  ++.++||||||+++|+|++|..||...........+....    ..                      .....+
T Consensus       192 ~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (308)
T 3g33_A          192 LQST--YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEM  269 (308)
T ss_dssp             HTSC--CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSC
T ss_pred             cCCC--CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccc
Confidence            6554  7899999999999999999999998877766655443210    00                      011357


Q ss_pred             CHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          203 SRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       203 ~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ++++.++|.+||+.||.+|||++++++||||+..
T Consensus       270 ~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          270 EESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             cHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            8999999999999999999999999999999975

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.4e-46  Score=298.57  Aligned_cols=231  Identities=38%  Similarity=0.678  Sum_probs=204.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.||||++.....    ....+.+.+|+.++++++||||+++++++...+..++||||+++++|.++++...+++..+
T Consensus        46 ~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  121 (303)
T 3a7i_A           46 TQKVVAIKIIDLEEA----EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQI  121 (303)
T ss_dssp             TCCEEEEEEEETTTC----STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTTSCCCHHHH
T ss_pred             CCcEEEEEEeccccc----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhcCCCCHHHH
Confidence            478999999976432    2345678899999999999999999999999999999999999999999998888999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCCcc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      +.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....+++.|+|||.+.+..  ++.+
T Consensus       122 ~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~  199 (303)
T 3a7i_A          122 ATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA--YDSK  199 (303)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCC--BCTH
T ss_pred             HHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCC--CCch
Confidence            9999999999999999999999999999999999999999999986544332  23455889999999996544  7889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      +|+||||+++++|++|..||...........+.....+..+..++..+.+++.+||..+|.+|||++++++||||....
T Consensus       200 ~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          200 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred             hhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence            9999999999999999999988877777766666666777888999999999999999999999999999999997653

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.7e-46  Score=304.13  Aligned_cols=235  Identities=29%  Similarity=0.524  Sum_probs=198.3

Q ss_pred             CCceEEEEEEeecCCC---ccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CC
Q 041080            1 DGFFFAVKEVSLQDQG---AQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~---~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~   75 (247)
                      +|+.||||++......   .......+.+.+|+.+++++ +||||+++++++...+..++||||+++++|.+++... .+
T Consensus       118 ~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l  197 (365)
T 2y7j_A          118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVAL  197 (365)
T ss_dssp             TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSC
T ss_pred             CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCC
Confidence            5889999999765321   11233356788999999999 7999999999999999999999999999999998764 59


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-ccccCCCCCCccCCcccccC---
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSK---  151 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~---  151 (247)
                      ++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++...... ......|++.|+|||.+.+.   
T Consensus       198 ~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  277 (365)
T 2y7j_A          198 SEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDE  277 (365)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCT
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccc
Confidence            99999999999999999999999999999999999999999999999988654433 23445689999999998543   


Q ss_pred             -CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCC---CCcCCHHHHHHHHHHhcCCCCCCCChhhh
Q 041080          152 -NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV---PSSLSRDARDFILKCLQVNPNDRPTVTEL  227 (247)
Q Consensus       152 -~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~i  227 (247)
                       ...++.++|+||||+++|+|++|..||...........+........   ....+..+.+++.+||..+|.+|||++++
T Consensus       278 ~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~el  357 (365)
T 2y7j_A          278 THPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQA  357 (365)
T ss_dssp             TSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             cCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence             22368899999999999999999999988777666666555443222   14678999999999999999999999999


Q ss_pred             hcCccCCC
Q 041080          228 MEHPFVKR  235 (247)
Q Consensus       228 l~~p~~~~  235 (247)
                      ++||||++
T Consensus       358 l~hp~f~r  365 (365)
T 2y7j_A          358 LQHPFFER  365 (365)
T ss_dssp             HHSGGGCC
T ss_pred             hcCcccCC
Confidence            99999974

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=7.8e-46  Score=293.13  Aligned_cols=235  Identities=31%  Similarity=0.522  Sum_probs=202.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++.....  ......+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.++++.. .+++..
T Consensus        39 ~~~~~a~K~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  116 (294)
T 2rku_A           39 TKEVFAGKIVPKSLL--LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE  116 (294)
T ss_dssp             TCCEEEEEEEEGGGC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHH
T ss_pred             CCceEEEEEechhhc--cCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHH
Confidence            377899999976432  23455677889999999999999999999999999999999999999999988764 589999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      ++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......  ......++..|+|||.+.+..  ++.
T Consensus       117 ~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~  194 (294)
T 2rku_A          117 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG--HSF  194 (294)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSC--BCT
T ss_pred             HHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCC--CCc
Confidence            9999999999999999999999999999999999999999999998654322  233455889999999986544  788


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      ++|+||||+++++|++|..||......+....+.... ...+..+++.+.+++.+||+.+|.+|||++++++||||+...
T Consensus       195 ~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  273 (294)
T 2rku_A          195 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  273 (294)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc-CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence            9999999999999999999998877766666555443 356678899999999999999999999999999999999865


Q ss_pred             CCC
Q 041080          238 QTP  240 (247)
Q Consensus       238 ~~~  240 (247)
                      ...
T Consensus       274 ~~~  276 (294)
T 2rku_A          274 IPA  276 (294)
T ss_dssp             CCS
T ss_pred             cCC
Confidence            443

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-46  Score=308.82  Aligned_cols=231  Identities=29%  Similarity=0.455  Sum_probs=189.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecCC--cEEEEEeccccCcHHHHHHhcCCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDEN--RLYIFLELVTKGSLANLYQKYHLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~   77 (247)
                      +|+.||||++....   ........+.+|+.+++++. ||||+++++++...+  ..++||||+.+ +|.+++....+++
T Consensus        33 ~~~~vaiK~i~~~~---~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~  108 (388)
T 3oz6_A           33 TGEVVAVKKIFDAF---QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEP  108 (388)
T ss_dssp             TCCEEEEEEECC-----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCSE-EHHHHHHHTCCCH
T ss_pred             CCCEEEEEEecccc---cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccCc-CHHHHHHcCCCCH
Confidence            47899999986432   33455677889999999997 999999999987544  78999999985 9999998888999


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc-----------------------cccc
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM-----------------------NDLK  134 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~-----------------------~~~~  134 (247)
                      ..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.....                       ....
T Consensus       109 ~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (388)
T 3oz6_A          109 VHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT  188 (388)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC--------------
T ss_pred             HHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999999999999999999999999864321                       1123


Q ss_pred             cCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC-CC-----------------
Q 041080          135 SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE-LP-----------------  196 (247)
Q Consensus       135 ~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~-----------------  196 (247)
                      ...|+++|+|||.+.+.. .++.++||||+||++++|++|..||...+.......+.... .+                 
T Consensus       189 ~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~  267 (388)
T 3oz6_A          189 DYVATRWYRAPEILLGST-KYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMI  267 (388)
T ss_dssp             -CCCGGGGCCHHHHTTCC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHH
T ss_pred             CCcccCCcCCHHHhcCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHH
Confidence            356899999999986532 37999999999999999999999998877665554432100 00                 


Q ss_pred             ----------------------------CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          197 ----------------------------SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       197 ----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                                                  ......++++.+||.+||..||.+|||++++++||||+..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~  335 (388)
T 3oz6_A          268 ESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF  335 (388)
T ss_dssp             HHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred             HhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHh
Confidence                                        0112678999999999999999999999999999998764

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.1e-47  Score=296.77  Aligned_cols=232  Identities=28%  Similarity=0.566  Sum_probs=174.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.||||++.....  ......+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++...  .+++.
T Consensus        35 ~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  112 (278)
T 3cok_A           35 TGLEVAIKMIDKKAM--YKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSEN  112 (278)
T ss_dssp             TCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHH
T ss_pred             CCceEEEEEeehhhh--hhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHH
Confidence            478999999975321  11223567889999999999999999999999999999999999999999999864  48999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......  ......+++.|+|||.+.+..  ++
T Consensus       113 ~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~  190 (278)
T 3cok_A          113 EARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA--HG  190 (278)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----------------------------
T ss_pred             HHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCC--CC
Confidence            99999999999999999999999999999999999999999999998654422  223345889999999986544  68


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      .++|+||||++++++++|..||...........+.... ...+..++.++.+++.+||..+|.+|||++++++||||+..
T Consensus       191 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          191 LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD-YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             -CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcc-cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence            89999999999999999999998766555544443332 24566789999999999999999999999999999999875


Q ss_pred             C
Q 041080          237 L  237 (247)
Q Consensus       237 ~  237 (247)
                      -
T Consensus       270 ~  270 (278)
T 3cok_A          270 S  270 (278)
T ss_dssp             -
T ss_pred             C
Confidence            4

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.4e-46  Score=299.11  Aligned_cols=227  Identities=29%  Similarity=0.474  Sum_probs=173.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||||++...        ....+.+|+.+++.+. ||||+++++++.+.+..++||||+++++|.+++.+. .+++.
T Consensus        35 ~~~~vavK~~~~~--------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~  106 (325)
T 3kn6_A           35 SNQAFAVKIISKR--------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSET  106 (325)
T ss_dssp             TCCEEEEEEEEGG--------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSCCCHH
T ss_pred             CCCEEEEEEEChh--------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCCCCHH
Confidence            4789999999642        2345678999999997 999999999999999999999999999999998775 49999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC---CeEEcccccccccCcc--ccccCCCCCCccCCcccccCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG---SVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~---~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      .++.++.|++.||.|||++|++|+||||+||+++.++   .++|+|||.+......  ......+++.|+|||.+.+.. 
T Consensus       107 ~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-  185 (325)
T 3kn6_A          107 EASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG-  185 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------CC-
T ss_pred             HHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCC-
Confidence            9999999999999999999999999999999998766   7999999998654332  233455789999999996544 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChh-------hHHHHHhhcCCCCCCC---CcCCHHHHHHHHHHhcCCCCCCCC
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEG-------VQALFRIGKGELPSVP---SSLSRDARDFILKCLQVNPNDRPT  223 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps  223 (247)
                       ++.++|+||||+++|+|++|..||.....       ......+..+......   ..++++++++|.+||..||.+|||
T Consensus       186 -~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt  264 (325)
T 3kn6_A          186 -YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLK  264 (325)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCC
T ss_pred             -CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCC
Confidence             78999999999999999999999976443       3344444444332221   357999999999999999999999


Q ss_pred             hhhhhcCccCCCCC
Q 041080          224 VTELMEHPFVKRPL  237 (247)
Q Consensus       224 ~~~il~~p~~~~~~  237 (247)
                      ++++++||||+...
T Consensus       265 ~~ell~h~w~~~~~  278 (325)
T 3kn6_A          265 MSGLRYNEWLQDGS  278 (325)
T ss_dssp             TTTSTTCGGGCTTC
T ss_pred             HHHHhcChhhccCc
Confidence            99999999998753

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.7e-46  Score=293.82  Aligned_cols=230  Identities=29%  Similarity=0.514  Sum_probs=193.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec----CCcEEEEEeccccCcHHHHHHh-cCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD----ENRLYIFLELVTKGSLANLYQK-YHL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~-~~~   75 (247)
                      +|..||+|.+.....   .....+.+.+|+.++++++||||+++++++..    ....++||||+++++|.+++.. ..+
T Consensus        50 ~~~~va~k~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~  126 (290)
T 1t4h_A           50 TTVEVAWCELQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM  126 (290)
T ss_dssp             TCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSC
T ss_pred             CceEEEEEEecchhh---CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCC
Confidence            467899999976432   34557788999999999999999999998764    4568999999999999999977 459


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCC--eeecCCCCCcEEEc-CCCCeEEcccccccccCccccccCCCCCCccCCcccccCC
Q 041080           76 SDSQVSSYTRQILNGLVYLHERN--VVHRDIKCANILVD-ASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKN  152 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~~~ni~~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  152 (247)
                      ++..++.++.|++.||.+||+.|  ++|+||||+||+++ .++.++|+|||.+............+++.|+|||.+.+  
T Consensus       127 ~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~--  204 (290)
T 1t4h_A          127 KIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE--  204 (290)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT--
T ss_pred             CHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccccccccCCcCcCCHHHHhc--
Confidence            99999999999999999999999  99999999999998 78899999999997666555566678999999998853  


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHH-HHhhcCC-CCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQAL-FRIGKGE-LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                       .++.++|+||||+++++|++|..||......... ..+.... ....+...++++.+++.+||..+|.+|||++++++|
T Consensus       205 -~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          205 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence             2788999999999999999999999875544443 3333332 223455678999999999999999999999999999


Q ss_pred             ccCCCC
Q 041080          231 PFVKRP  236 (247)
Q Consensus       231 p~~~~~  236 (247)
                      |||++.
T Consensus       284 ~~f~~~  289 (290)
T 1t4h_A          284 AFFQEE  289 (290)
T ss_dssp             GGGC--
T ss_pred             cccccC
Confidence            999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-46  Score=306.62  Aligned_cols=230  Identities=29%  Similarity=0.496  Sum_probs=196.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.||+|++....     ......+.+|+.++++++||||+++++++.+.+..++||||+.+++|.+++...  .+++.
T Consensus        75 ~~~~~a~K~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~  149 (387)
T 1kob_A           75 TGRVFVAKFINTPY-----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEA  149 (387)
T ss_dssp             TCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHH
T ss_pred             CCCEEEEEEecccc-----hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHH
Confidence            47889999997532     334557889999999999999999999999999999999999999999988654  58999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC--CCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA--SGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~--~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .++.++.|++.||.|||+.|++|+||||+||+++.  ++.++|+|||++....... .....+++.|+|||.+.+..  +
T Consensus       150 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~  227 (387)
T 1kob_A          150 EVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP--V  227 (387)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCC--B
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCC--C
Confidence            99999999999999999999999999999999974  4679999999987654332 23345899999999996544  7


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC---CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL---PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      +.++||||||+++|+|++|..||...........+.....   +.....++++++++|.+||..||.+|||++++++|||
T Consensus       228 ~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~  307 (387)
T 1kob_A          228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW  307 (387)
T ss_dssp             CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred             CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcc
Confidence            8999999999999999999999988777666666555432   2233578999999999999999999999999999999


Q ss_pred             CCCCC
Q 041080          233 VKRPL  237 (247)
Q Consensus       233 ~~~~~  237 (247)
                      |+...
T Consensus       308 ~~~~~  312 (387)
T 1kob_A          308 LKGDH  312 (387)
T ss_dssp             TSSCC
T ss_pred             ccCCc
Confidence            98753

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.8e-46  Score=302.80  Aligned_cols=231  Identities=26%  Similarity=0.401  Sum_probs=180.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-cCCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-YHLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~   79 (247)
                      +|+.||||++.....      ..+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.. ..+++..
T Consensus        44 ~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  117 (361)
T 3uc3_A           44 TKELVAVKYIERGAA------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDE  117 (361)
T ss_dssp             TCCEEEEEEEESSTT------SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHH
T ss_pred             CCcEEEEEEEecCcc------ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHH
Confidence            478999999975432      124577999999999999999999999999999999999999999998865 4599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCC--eEEcccccccccCcc-ccccCCCCCCccCCcccccCCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS--VKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~--~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ++.++.|++.||.|||++|++|+||||+||+++.++.  ++|+|||.+...... ......|++.|+|||.+.+... .+
T Consensus       118 ~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~  196 (361)
T 3uc3_A          118 ARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEY-DG  196 (361)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSC-CH
T ss_pred             HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCC-CC
Confidence            9999999999999999999999999999999987765  999999998643322 2344568999999999865542 24


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhh----HHHHHhhcCCC-CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGV----QALFRIGKGEL-PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~----~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                      .++||||||+++|+|++|..||......    .....+..... ......++++++++|.+||..+|.+|||++++++||
T Consensus       197 ~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp  276 (361)
T 3uc3_A          197 KIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHS  276 (361)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred             CeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence            4599999999999999999999765432    22233332222 122336899999999999999999999999999999


Q ss_pred             cCCCCCC
Q 041080          232 FVKRPLQ  238 (247)
Q Consensus       232 ~~~~~~~  238 (247)
                      ||...+.
T Consensus       277 ~f~~~~~  283 (361)
T 3uc3_A          277 WFLKNLP  283 (361)
T ss_dssp             HHHTTCC
T ss_pred             chhcCCc
Confidence            9976543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.6e-46  Score=301.47  Aligned_cols=232  Identities=34%  Similarity=0.615  Sum_probs=197.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~   78 (247)
                      +|+.||||++.....  ......+.+.+|+.++++++||||+++++++..++..++||||+.| +|.+++..  ..+++.
T Consensus        78 ~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~l~~~  154 (348)
T 1u5q_A           78 NSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEV  154 (348)
T ss_dssp             TTEEEEEEEEESCSS--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHHTSCCCHH
T ss_pred             CCeEEEEEEEccccc--cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCCC-CHHHHHHHhcCCCCHH
Confidence            478999999976432  3345567789999999999999999999999999999999999985 78777753  459999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCccccc-CCCCCCc
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNS-KNDGYGL  157 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~  157 (247)
                      .++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.....  .....|++.|+|||.+.+ ....++.
T Consensus       155 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~  232 (348)
T 1u5q_A          155 EIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDG  232 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--BCCCCSCGGGCCHHHHHTTSSCCBCT
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--CCcccCCcceeCHhhhccccCCCCCc
Confidence            9999999999999999999999999999999999999999999999876543  234568999999999853 2334788


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCC-CCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPS-VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ++||||||+++++|++|..||...........+.....+. .+..+++.++++|.+||+.+|.+|||++++++||||...
T Consensus       233 ~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          233 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence            9999999999999999999998877666655554444333 356789999999999999999999999999999999865


Q ss_pred             C
Q 041080          237 L  237 (247)
Q Consensus       237 ~  237 (247)
                      .
T Consensus       313 ~  313 (348)
T 1u5q_A          313 R  313 (348)
T ss_dssp             C
T ss_pred             C
Confidence            3

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6.1e-46  Score=292.56  Aligned_cols=228  Identities=23%  Similarity=0.371  Sum_probs=190.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-----cC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-----YH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~   74 (247)
                      +|+.||||++.....   .......+.+|+..+..+ +||||+++++++.+.+..++||||+++++|.+++..     ..
T Consensus        35 ~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~  111 (289)
T 1x8b_A           35 DGCIYAIKRSKKPLA---GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSY  111 (289)
T ss_dssp             TCCEEEEEEEECCCT---TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCC
T ss_pred             CCceEEEEEeccccc---ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccC
Confidence            488999999986532   233456778999999999 899999999999999999999999999999999876     34


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC-------------------CCeEEcccccccccCcccccc
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-------------------GSVKLADFGLAKATTMNDLKS  135 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~-------------------~~~~l~df~~~~~~~~~~~~~  135 (247)
                      +++..++.++.|++.||.+||++|++|+||||+||+++.+                   ..++|+|||.+.......  .
T Consensus       112 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~  189 (289)
T 1x8b_A          112 FKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ--V  189 (289)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC--C
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc--c
Confidence            8999999999999999999999999999999999999844                   479999999987654332  3


Q ss_pred             CCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhc
Q 041080          136 CKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQ  215 (247)
Q Consensus       136 ~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  215 (247)
                      ..++..|+|||.+.+.. .++.++||||||++++++++|..++....   ....+.....+..+..+++++.+++.+||.
T Consensus       190 ~~gt~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  265 (289)
T 1x8b_A          190 EEGDSRFLANEVLQENY-THLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQGRLPRIPQVLSQEFTELLKVMIH  265 (289)
T ss_dssp             CCCCGGGCCHHHHTTCC-TTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTTCCCCCSSCCCHHHHHHHHHHTC
T ss_pred             cCCCccccChhHhcCCC-CCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHcCCCCCCCcccCHHHHHHHHHHhC
Confidence            45889999999986542 25679999999999999999987765443   334445556677788899999999999999


Q ss_pred             CCCCCCCChhhhhcCccCCCCC
Q 041080          216 VNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       216 ~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      .||.+|||++++++||||+...
T Consensus       266 ~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          266 PDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             SSGGGSCCHHHHHTCTTC----
T ss_pred             CCcccCCCHHHHhhChHhhhhc
Confidence            9999999999999999999754

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.2e-47  Score=311.38  Aligned_cols=233  Identities=28%  Similarity=0.438  Sum_probs=194.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.||||++.+...  ......+.+.+|..++..++||||+++++++++.+..++||||+++|+|.+++.+.  .+++.
T Consensus        85 ~~~~vAiK~l~k~~~--~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~  162 (412)
T 2vd5_A           85 TGQVYAMKIMNKWDM--LKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAE  162 (412)
T ss_dssp             TCCEEEEEEEEHHHH--HHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHH
T ss_pred             CCCEEEEEEEeHHHh--hhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHH
Confidence            488999999975321  11223445789999999999999999999999999999999999999999999774  59999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccC----
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSK----  151 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~----  151 (247)
                      .++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.......   .....|++.|+|||.+...    
T Consensus       163 ~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~  242 (412)
T 2vd5_A          163 MARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGP  242 (412)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCT
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCc
Confidence            999999999999999999999999999999999999999999999986554332   2345689999999998631    


Q ss_pred             -CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc----CCCCCCCCcCCHHHHHHHHHHhcCCCCCC---CC
Q 041080          152 -NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK----GELPSVPSSLSRDARDFILKCLQVNPNDR---PT  223 (247)
Q Consensus       152 -~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~R---ps  223 (247)
                       ...++.++|+||||+++|+|++|..||...+.......+..    ...+..+..+|++++++|.+||. +|.+|   |+
T Consensus       243 ~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~  321 (412)
T 2vd5_A          243 GTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGG  321 (412)
T ss_dssp             TCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTT
T ss_pred             CCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCC
Confidence             22378899999999999999999999988877776655543    22344456899999999999999 99998   59


Q ss_pred             hhhhhcCccCCCC
Q 041080          224 VTELMEHPFVKRP  236 (247)
Q Consensus       224 ~~~il~~p~~~~~  236 (247)
                      ++++++||||+..
T Consensus       322 ~~ei~~Hpff~~i  334 (412)
T 2vd5_A          322 AGDFRTHPFFFGL  334 (412)
T ss_dssp             HHHHHTSGGGTTC
T ss_pred             HHHHhcCCCcCCC
Confidence            9999999999864

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.1e-46  Score=295.88  Aligned_cols=234  Identities=31%  Similarity=0.539  Sum_probs=201.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeee--cCCcEEEEEeccccCcHHHHHHhc-----
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDK--DENRLYIFLELVTKGSLANLYQKY-----   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~-----   73 (247)
                      +|+.||+|++.....   .....+.+.+|+.++++++||||+++++++.  ..+..++||||+++++|.+++...     
T Consensus        30 ~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~  106 (279)
T 2w5a_A           30 DGKILVWKELDYGSM---TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ  106 (279)
T ss_dssp             TCCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTC
T ss_pred             CCcEEEEEEEEcccC---CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCC
Confidence            478999999976532   3455678899999999999999999999774  467899999999999999998653     


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCC-----eeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCc
Q 041080           74 HLSDSQVSSYTRQILNGLVYLHERN-----VVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPE  146 (247)
Q Consensus        74 ~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE  146 (247)
                      .+++..++.++.|++.||.+||+.|     ++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||
T Consensus       107 ~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE  186 (279)
T 2w5a_A          107 YLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPE  186 (279)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChH
Confidence            2899999999999999999999999     9999999999999999999999999986544322  12334788999999


Q ss_pred             ccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhh
Q 041080          147 VVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTE  226 (247)
Q Consensus       147 ~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  226 (247)
                      .+.+..  ++.++|+||||+++|+|++|..||...........+..+..+..+..+++++.+++.+||+.+|.+|||+++
T Consensus       187 ~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  264 (279)
T 2w5a_A          187 QMNRMS--YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEE  264 (279)
T ss_dssp             HHHCC---CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HhccCC--CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHH
Confidence            996554  789999999999999999999999988887777777777777788899999999999999999999999999


Q ss_pred             hhcCccCCCCCCC
Q 041080          227 LMEHPFVKRPLQT  239 (247)
Q Consensus       227 il~~p~~~~~~~~  239 (247)
                      +++|+|+.++...
T Consensus       265 ll~~~~~~~~~~~  277 (279)
T 2w5a_A          265 ILENPLILEHHHH  277 (279)
T ss_dssp             HHTSTTCCGGGSC
T ss_pred             HHhChhhhhhccc
Confidence            9999999987554

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.3e-47  Score=313.82  Aligned_cols=234  Identities=25%  Similarity=0.404  Sum_probs=196.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~   78 (247)
                      +|+.||+|++.+....  .......+.+|+.++..++||||+++++++.+.+..++||||+++|+|.+++.+  ..+++.
T Consensus        98 ~~~~vAvK~~~~~~~~--~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~  175 (437)
T 4aw2_A           98 ADKVFAMKILNKWEML--KRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEE  175 (437)
T ss_dssp             TTEEEEEEEEEHHHHH--HTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHH
T ss_pred             CCcEEEEEEEEHHHhh--hHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHH
Confidence            4788999999753211  111223477899999999999999999999999999999999999999999976  459999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCccccc---CC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNS---KN  152 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~---~~  152 (247)
                      .++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......   .....|++.|+|||.+..   ..
T Consensus       176 ~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~  255 (437)
T 4aw2_A          176 MARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK  255 (437)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSC
T ss_pred             HHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCC
Confidence            999999999999999999999999999999999999999999999986543322   233569999999999862   13


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc----CCCCCCCCcCCHHHHHHHHHHhcCCCCC--CCChhh
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK----GELPSVPSSLSRDARDFILKCLQVNPND--RPTVTE  226 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~~  226 (247)
                      ..++.++|+||||+++|+|++|..||...+..+....+..    ...+.....++++++++|++||..+|.+  |+++++
T Consensus       256 ~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~e  335 (437)
T 4aw2_A          256 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIED  335 (437)
T ss_dssp             CEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHH
T ss_pred             CCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHH
Confidence            3378999999999999999999999998877777666543    2334444568999999999999888887  999999


Q ss_pred             hhcCccCCCC
Q 041080          227 LMEHPFVKRP  236 (247)
Q Consensus       227 il~~p~~~~~  236 (247)
                      +++||||+..
T Consensus       336 il~Hpff~~i  345 (437)
T 4aw2_A          336 FKKHPFFSGI  345 (437)
T ss_dssp             HHTSGGGTTC
T ss_pred             HhCCCccCCC
Confidence            9999999853

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=9.4e-46  Score=297.83  Aligned_cols=234  Identities=31%  Similarity=0.524  Sum_probs=201.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++.....  ......+.+.+|+.+++.++||||+++++++.+.+..++||||+.+++|.+++... .+++..
T Consensus        65 ~~~~~a~K~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~  142 (335)
T 2owb_A           65 TKEVFAGKIVPKSLL--LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE  142 (335)
T ss_dssp             TCCEEEEEEEEGGGC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHH
T ss_pred             CCCEEEEEEechhhh--cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHH
Confidence            377899999976432  23455677889999999999999999999999999999999999999999988764 599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      ++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+......  ......++..|+|||.+.+..  ++.
T Consensus       143 ~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~  220 (335)
T 2owb_A          143 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG--HSF  220 (335)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSC--BCT
T ss_pred             HHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCC--CCc
Confidence            9999999999999999999999999999999999999999999998654322  233455889999999996544  788


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      ++|+||||+++|+|++|..||...........+.... ...+..+++.+.+++.+||..||.+|||++++++||||+...
T Consensus       221 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          221 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             hhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence            9999999999999999999998877666665555443 345678899999999999999999999999999999999865


Q ss_pred             CC
Q 041080          238 QT  239 (247)
Q Consensus       238 ~~  239 (247)
                      ..
T Consensus       300 ~~  301 (335)
T 2owb_A          300 IP  301 (335)
T ss_dssp             CC
T ss_pred             cc
Confidence            43

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.4e-46  Score=294.77  Aligned_cols=234  Identities=28%  Similarity=0.469  Sum_probs=192.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++.....  ......+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++... .+++..
T Consensus        35 ~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  112 (276)
T 2h6d_A           35 TGHKVAVKILNRQKI--RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEME  112 (276)
T ss_dssp             TCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHH
T ss_pred             CCceEEEEEeccccc--cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCHHH
Confidence            478999999975321  12233567889999999999999999999999999999999999999999998654 589999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCCCcc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+....... .....+++.|+|||.+.+... .+.+
T Consensus       113 ~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~  191 (276)
T 2h6d_A          113 ARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY-AGPE  191 (276)
T ss_dssp             HHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCC-CHHH
T ss_pred             HHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCC-CCcc
Confidence            99999999999999999999999999999999999999999999987654332 234457889999999865432 3679


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQ  238 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~~  238 (247)
                      +|+||||+++++|++|..||...........+.... ...+..++..+.+++.+||+.+|.+|||++++++||||+....
T Consensus       192 ~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  270 (276)
T 2h6d_A          192 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLP  270 (276)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             chHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCch
Confidence            999999999999999999998877666666555443 3456778999999999999999999999999999999998654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.2e-46  Score=302.44  Aligned_cols=227  Identities=24%  Similarity=0.422  Sum_probs=185.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC----------------------------
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN----------------------------   52 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----------------------------   52 (247)
                      +|+.||||++....    .....+.+.+|+.++++++||||+++++++.+.+                            
T Consensus        30 ~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  105 (332)
T 3qd2_B           30 DDCNYAIKRIRLPN----RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPM  105 (332)
T ss_dssp             TCCEEEEEEEECCS----TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC------------------
T ss_pred             CCcEEEEEEeecCC----chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcc
Confidence            58899999997643    2335667899999999999999999999875443                            


Q ss_pred             -----------------------------cEEEEEeccccCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHhhhCCe
Q 041080           53 -----------------------------RLYIFLELVTKGSLANLYQKYH----LSDSQVSSYTRQILNGLVYLHERNV   99 (247)
Q Consensus        53 -----------------------------~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~l~~~l~~lh~~~i   99 (247)
                                                   ..++||||+++++|.+++++..    .++..++.++.|++.||.+||++|+
T Consensus       106 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i  185 (332)
T 3qd2_B          106 DAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL  185 (332)
T ss_dssp             --------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             cccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCe
Confidence                                         3899999999999999998754    5566789999999999999999999


Q ss_pred             eecCCCCCcEEEcCCCCeEEcccccccccCccc--------------cccCCCCCCccCCcccccCCCCCCcchhHHHHH
Q 041080          100 VHRDIKCANILVDASGSVKLADFGLAKATTMND--------------LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLG  165 (247)
Q Consensus       100 ~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--------------~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG  165 (247)
                      +|+||||+||+++.++.++|+|||.+.......              .....|++.|+|||.+.+..  ++.++|+||||
T Consensus       186 vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG  263 (332)
T 3qd2_B          186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN--YSHKVDIFSLG  263 (332)
T ss_dssp             ECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCC--CCTHHHHHHHH
T ss_pred             eecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCC--CcchhhHHHHH
Confidence            999999999999999999999999987554331              23345899999999997654  79999999999


Q ss_pred             HHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          166 CTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       166 ~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                      +++|+|++|..|+..  .............+......++++.+++.+||+.+|.+|||++++++||||+.
T Consensus       264 ~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          264 LILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             HHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred             HHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence            999999998766422  22233333344444444567788999999999999999999999999999985

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.9e-46  Score=292.16  Aligned_cols=235  Identities=25%  Similarity=0.419  Sum_probs=193.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++.....    ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++... .+++..
T Consensus        31 ~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  106 (276)
T 2yex_A           31 TEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD  106 (276)
T ss_dssp             TCCEEEEEEEEGGGC----TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHH
T ss_pred             CCcEEEEEEeeeccc----hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCCCHHH
Confidence            478999999975432    234567889999999999999999999999999999999999999999988654 599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc----ccccCCCCCCccCCcccccCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......    ......++..|+|||.+.+... .
T Consensus       107 ~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~  185 (276)
T 2yex_A          107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF-H  185 (276)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSB-C
T ss_pred             HHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCC-C
Confidence            9999999999999999999999999999999999999999999998644322    1234558889999999865431 3


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHH-HHHhhcC-CCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQA-LFRIGKG-ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      +.++|+||||+++++|++|..||........ ....... ........+++.+.+++.+||..+|.+|||++++++||||
T Consensus       186 ~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  265 (276)
T 2yex_A          186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY  265 (276)
T ss_dssp             HHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccc
Confidence            6789999999999999999999976554322 2222221 1122235689999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 041080          234 KRPLQTP  240 (247)
Q Consensus       234 ~~~~~~~  240 (247)
                      +......
T Consensus       266 ~~~~~~~  272 (276)
T 2yex_A          266 NKPLKKG  272 (276)
T ss_dssp             TCCCC--
T ss_pred             cChhhcc
Confidence            9876543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-46  Score=319.30  Aligned_cols=230  Identities=26%  Similarity=0.428  Sum_probs=195.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC---CCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH---LSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~   77 (247)
                      +|+.||||++......  .......+.+|+.++++++||||+++++++.+.+..++||||++||+|.+++...+   +++
T Consensus       208 tg~~vAvK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e  285 (576)
T 2acx_A          208 TGKMYACKKLEKKRIK--KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE  285 (576)
T ss_dssp             TCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCH
T ss_pred             CCCEEEEEEEEhHhhh--hhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCH
Confidence            5889999999764321  12234567899999999999999999999999999999999999999999987643   999


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ..++.++.|++.||.|||++||+|+||||+||+++.+|.++|+|||++....... .....|++.|+|||.+.+..  ++
T Consensus       286 ~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~--~~  363 (576)
T 2acx_A          286 ARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER--YT  363 (576)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCE--ES
T ss_pred             HHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCC--CC
Confidence            9999999999999999999999999999999999999999999999987654332 34457999999999996544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChh----hHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----Chhhh
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEG----VQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTEL  227 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~i  227 (247)
                      .++|+||||+++|+|++|..||.....    ......+.. ....++..++++++++|.+||+.||.+||     +++++
T Consensus       364 ~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~ei  442 (576)
T 2acx_A          364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREV  442 (576)
T ss_dssp             SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHH
T ss_pred             ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHH
Confidence            999999999999999999999976532    222333332 33456778999999999999999999999     78999


Q ss_pred             hcCccCCC
Q 041080          228 MEHPFVKR  235 (247)
Q Consensus       228 l~~p~~~~  235 (247)
                      ++||||+.
T Consensus       443 l~HpfF~~  450 (576)
T 2acx_A          443 KEHPLFKK  450 (576)
T ss_dssp             HTSGGGTT
T ss_pred             HhChhhcc
Confidence            99999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.5e-46  Score=301.79  Aligned_cols=232  Identities=26%  Similarity=0.459  Sum_probs=182.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++....   ......+.+.+|+.++++++||||+++++++.+++..++||||+.+ +|.+++... .+++..
T Consensus        58 ~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~  133 (329)
T 3gbz_A           58 TNETVAIKRIRLEH---EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRV  133 (329)
T ss_dssp             TTEEEEEEECCCCC-----------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHCTTCCHHH
T ss_pred             CCceEEEEEEcccc---cccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHhhcCCCCHHH
Confidence            47899999997543   2233455677999999999999999999999999999999999986 999988765 599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEc-----CCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVD-----ASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKN  152 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~-----~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~  152 (247)
                      ++.++.|++.||.+||++|++|+||||+||+++     .++.++|+|||.+......  ......++..|+|||.+.+..
T Consensus       134 ~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  213 (329)
T 3gbz_A          134 IKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSR  213 (329)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCC
Confidence            999999999999999999999999999999995     4445999999998654322  233445789999999986533


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC-CC----------------CC------------CCcCC
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE-LP----------------SV------------PSSLS  203 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~----------------~~------------~~~~~  203 (247)
                       .++.++||||||+++|+|++|..||......+....+.... .+                ..            +..++
T Consensus       214 -~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (329)
T 3gbz_A          214 -HYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLD  292 (329)
T ss_dssp             -CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSC
T ss_pred             -CCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccC
Confidence             27899999999999999999999998877666554432210 00                00            01268


Q ss_pred             HHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          204 RDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       204 ~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      +++.++|.+||+.||.+|||++++++||||+...
T Consensus       293 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          293 DEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence            9999999999999999999999999999999763

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-46  Score=301.19  Aligned_cols=234  Identities=27%  Similarity=0.437  Sum_probs=188.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.||||++...............+.+|+.++++++||||+++++++...+..++||||+.+ +|.+++...  .+++.
T Consensus        34 ~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~  112 (346)
T 1ua2_A           34 TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPS  112 (346)
T ss_dssp             CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSS
T ss_pred             CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHH
Confidence            478999999976543333333345678999999999999999999999999999999999987 898888765  38899


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+......  ......+++.|+|||.+.+.. .++
T Consensus       113 ~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~  191 (346)
T 1ua2_A          113 HIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR-MYG  191 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCS-CCC
T ss_pred             HHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCC-CCC
Confidence            99999999999999999999999999999999999999999999998765432  233456899999999986433 268


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC--C--C------------------CCC-----CCcCCHHHHHH
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG--E--L------------------PSV-----PSSLSRDARDF  209 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--~--~------------------~~~-----~~~~~~~~~~l  209 (247)
                      .++|+||||+++|+|++|..||...........+...  .  .                  +..     ....+++++++
T Consensus       192 ~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  271 (346)
T 1ua2_A          192 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL  271 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHH
T ss_pred             chhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHH
Confidence            8999999999999999999999887766555443221  0  0                  000     14567899999


Q ss_pred             HHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          210 ILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       210 i~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      |.+||..||.+|||++|+++||||+..
T Consensus       272 i~~~L~~dP~~Rpt~~ell~h~~f~~~  298 (346)
T 1ua2_A          272 IQGLFLFNPCARITATQALKMKYFSNR  298 (346)
T ss_dssp             HHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             HHHHhccChhhCCCHHHHhcChhhhcC
Confidence            999999999999999999999999874

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.7e-46  Score=301.03  Aligned_cols=229  Identities=29%  Similarity=0.436  Sum_probs=179.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++....       ..+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++... .+++..
T Consensus        77 ~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  149 (349)
T 2w4o_A           77 TQKPYALKVLKKTV-------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERD  149 (349)
T ss_dssp             TCCEEEEEEEEC-----------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSCCHHH
T ss_pred             CCcEEEEEEeccch-------hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHH
Confidence            46789999997532       2345779999999999999999999999999999999999999999988765 489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC---CCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDA---SGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~---~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ++.++.|++.||.+||+.|++|+||||+||+++.   ++.++|+|||.+....... .....|++.|+|||.+.+..  +
T Consensus       150 ~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~  227 (349)
T 2w4o_A          150 AADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA--Y  227 (349)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTCC--C
T ss_pred             HHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCC--C
Confidence            9999999999999999999999999999999975   8899999999987554332 23455899999999996544  7


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhH-HHHHhhcCCCC---CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQ-ALFRIGKGELP---SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                      +.++||||||+++|+|++|..||....... ....+......   .....++.+++++|.+||..||.+|||++++++||
T Consensus       228 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  307 (349)
T 2w4o_A          228 GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHP  307 (349)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred             CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence            899999999999999999999997665544 33344333322   23357899999999999999999999999999999


Q ss_pred             cCCCCCC
Q 041080          232 FVKRPLQ  238 (247)
Q Consensus       232 ~~~~~~~  238 (247)
                      ||+....
T Consensus       308 ~~~~~~~  314 (349)
T 2w4o_A          308 WVTGKAA  314 (349)
T ss_dssp             TTTSTTC
T ss_pred             ccCCCcc
Confidence            9997543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.9e-46  Score=313.51  Aligned_cols=229  Identities=26%  Similarity=0.430  Sum_probs=182.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC------CcEEEEEeccccCcHHHHHHhcC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE------NRLYIFLELVTKGSLANLYQKYH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~   74 (247)
                      +|+.||||++....   ......+.+.+|+.+++.++||||+++++++...      ...++||||+++ +|.+.+.. .
T Consensus        86 ~~~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~-~  160 (464)
T 3ttj_A           86 LDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM-E  160 (464)
T ss_dssp             TTEEEEEEEEESGG---GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS-C
T ss_pred             CCCEEEEEEECccc---cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh-c
Confidence            47899999997542   3455667788999999999999999999998654      457999999987 56666643 5


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      +++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++....... .....+++.|+|||.+.+.. 
T Consensus       161 l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-  239 (464)
T 3ttj_A          161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-  239 (464)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCC-
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCC-
Confidence            9999999999999999999999999999999999999999999999999997655432 34466899999999997654 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC---------------------CCCCC---------C---
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE---------------------LPSVP---------S---  200 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------~~~~~---------~---  200 (247)
                       ++.++||||+|+++|+|++|+.||...+..+....+....                     .+...         .   
T Consensus       240 -~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (464)
T 3ttj_A          240 -YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLF  318 (464)
T ss_dssp             -CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGS
T ss_pred             -CCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCccccc
Confidence             8899999999999999999999998876655544332110                     00000         0   


Q ss_pred             --------cCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          201 --------SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       201 --------~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                              ..++++++||.+||..||.+|||++|+++||||+..
T Consensus       319 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~  362 (464)
T 3ttj_A          319 PADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  362 (464)
T ss_dssp             CCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             ccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence                    015679999999999999999999999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.4e-45  Score=292.21  Aligned_cols=237  Identities=28%  Similarity=0.480  Sum_probs=199.3

Q ss_pred             CCceEEEEEEeecCCCcc----chHHHHHHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-C
Q 041080            1 DGFFFAVKEVSLQDQGAQ----GKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-H   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~----~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~   74 (247)
                      +|+.||||++.....+..    .....+.+.+|+.+++++. ||||+++++++...+..++||||+++++|.+++... .
T Consensus        41 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~  120 (298)
T 1phk_A           41 TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT  120 (298)
T ss_dssp             TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS
T ss_pred             cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCC
Confidence            478999999976543222    2334567889999999995 999999999999999999999999999999998765 5


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-ccccCCCCCCccCCccccc---
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNS---  150 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~---  150 (247)
                      +++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.+   
T Consensus       121 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  200 (298)
T 1phk_A          121 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMN  200 (298)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccc
Confidence            999999999999999999999999999999999999999999999999998654433 2334558899999999852   


Q ss_pred             -CCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCC---CCcCCHHHHHHHHHHhcCCCCCCCChhh
Q 041080          151 -KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV---PSSLSRDARDFILKCLQVNPNDRPTVTE  226 (247)
Q Consensus       151 -~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~  226 (247)
                       ....++.++|+||||+++++|++|..||...........+........   ...++..+.+++.+||+.+|.+|||+++
T Consensus       201 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  280 (298)
T 1phk_A          201 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE  280 (298)
T ss_dssp             TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             cccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHH
Confidence             123368899999999999999999999988777666665555433221   2468999999999999999999999999


Q ss_pred             hhcCccCCCCC
Q 041080          227 LMEHPFVKRPL  237 (247)
Q Consensus       227 il~~p~~~~~~  237 (247)
                      +++||||+...
T Consensus       281 ll~h~~~~~~~  291 (298)
T 1phk_A          281 ALAHPFFQQYV  291 (298)
T ss_dssp             HTTSGGGCTTC
T ss_pred             HHhChHhhhcc
Confidence            99999999754

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.6e-46  Score=314.62  Aligned_cols=230  Identities=26%  Similarity=0.438  Sum_probs=195.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-----CC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-----HL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~   75 (247)
                      +|+.||||++.+....  .....+.+.+|+.++++++||||+++++++.+.+..++||||++||+|.+++...     .+
T Consensus       209 tg~~vAiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l  286 (543)
T 3c4z_A          209 TGKLYACKKLNKKRLK--KRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF  286 (543)
T ss_dssp             TCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSC
T ss_pred             CCcEEEEEEEEhHHhh--hhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccc
Confidence            4889999999764321  1223567889999999999999999999999999999999999999999998753     49


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCC
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      ++..++.++.|++.||.|||++||+|+||||+||+++.+|.++|+|||++.......  .....|++.|+|||.+.+.. 
T Consensus       287 ~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-  365 (543)
T 3c4z_A          287 QEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE-  365 (543)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCC-
T ss_pred             cHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCC-
Confidence            999999999999999999999999999999999999999999999999987654332  23457999999999996543 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCCh----hhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC-----h
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLE----GVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT-----V  224 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~  224 (247)
                       ++.++|+||||+++|+|++|..||....    .......+... ...++..++++++++|.+||+.+|.+||+     +
T Consensus       366 -~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a  443 (543)
T 3c4z_A          366 -YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSC  443 (543)
T ss_dssp             -BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBS
T ss_pred             -CChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCH
Confidence             8899999999999999999999997653    23333443333 34567789999999999999999999996     4


Q ss_pred             hhhhcCccCCC
Q 041080          225 TELMEHPFVKR  235 (247)
Q Consensus       225 ~~il~~p~~~~  235 (247)
                      +++++||||+.
T Consensus       444 ~ei~~Hpff~~  454 (543)
T 3c4z_A          444 DGLRTHPLFRD  454 (543)
T ss_dssp             HHHHTSGGGTT
T ss_pred             HHHHcCccccC
Confidence            88999999996

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=8.9e-46  Score=294.70  Aligned_cols=235  Identities=31%  Similarity=0.544  Sum_probs=191.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC----CC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH----LS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~   76 (247)
                      +|+.||||++....   ......+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++.+.+    ++
T Consensus        59 ~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  135 (309)
T 3p86_A           59 HGSDVAVKILMEQD---FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLD  135 (309)
T ss_dssp             TTEEEEEEEECCCC---CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSC
T ss_pred             CCCcEEEEEecCCC---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCC
Confidence            47889999997543   234556778999999999999999999999999999999999999999999997654    89


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCC--eeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCC
Q 041080           77 DSQVSSYTRQILNGLVYLHERN--VVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKN  152 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~  152 (247)
                      +..++.++.|++.||.+||+.|  ++|+||||+||+++.++.++|+|||.+.......  .....|++.|+|||.+.+..
T Consensus       136 ~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  215 (309)
T 3p86_A          136 ERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP  215 (309)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCC
Confidence            9999999999999999999999  9999999999999999999999999986543332  23456899999999996554


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhh-cCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc--
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIG-KGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME--  229 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--  229 (247)
                        ++.++||||||+++|+|++|..||...........+. .......+..+++++.+++.+||+.+|.+|||++++++  
T Consensus       216 --~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L  293 (309)
T 3p86_A          216 --SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL  293 (309)
T ss_dssp             --CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             --CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence              7889999999999999999999999887777665553 34445677889999999999999999999999999987  


Q ss_pred             CccCCCCCCCC
Q 041080          230 HPFVKRPLQTP  240 (247)
Q Consensus       230 ~p~~~~~~~~~  240 (247)
                      .++++.....+
T Consensus       294 ~~~~~~~~p~~  304 (309)
T 3p86_A          294 RPLIKSAVPPP  304 (309)
T ss_dssp             HHHHC------
T ss_pred             HHHHHhCCCCC
Confidence            66776654443

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.2e-46  Score=302.65  Aligned_cols=230  Identities=30%  Similarity=0.516  Sum_probs=193.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++...    ......+.+.+|+.++++++||||+++++++..++..++||||+++++|.++++.. .+++..
T Consensus        57 ~~~~va~K~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  132 (360)
T 3eqc_A           57 SGLVMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI  132 (360)
T ss_dssp             TCCEEEEEEEECC----CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHH
T ss_pred             CCcEEEEEEeccc----cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHH
Confidence            4789999999754    23455677899999999999999999999999999999999999999999999765 599999


Q ss_pred             HHHHHHHHHHHHHHhhhC-CeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcc
Q 041080           80 VSSYTRQILNGLVYLHER-NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~-~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      +..++.|++.||.+||+. |++|+||||+||+++.++.++|+|||.+............+++.|+|||.+.+..  ++.+
T Consensus       133 ~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~  210 (360)
T 3eqc_A          133 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--YSVQ  210 (360)
T ss_dssp             HHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----CCCCTTCCHHHHTTCC--CSHH
T ss_pred             HHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccccccCCCCCCCeECHHHHcCCC--CCch
Confidence            999999999999999986 9999999999999999999999999998655444455567899999999996544  7899


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHH------------------------------------------HHhhcCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQAL------------------------------------------FRIGKGELP  196 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~------------------------------------------~~~~~~~~~  196 (247)
                      +|+||||+++|+|++|..||.........                                          ..+.....+
T Consensus       211 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (360)
T 3eqc_A          211 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP  290 (360)
T ss_dssp             HHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCC
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCC
Confidence            99999999999999999999765543322                                          112222222


Q ss_pred             CC-CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          197 SV-PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       197 ~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      .. ...++.++.++|.+||..+|.+|||++++++||||+..
T Consensus       291 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          291 KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence            22 23579999999999999999999999999999999863

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.4e-46  Score=296.88  Aligned_cols=230  Identities=28%  Similarity=0.482  Sum_probs=184.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||||++....     ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++++|.+++... .+++.
T Consensus        37 ~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~  111 (316)
T 2ac3_A           37 TSQEYAVKIIEKQP-----GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL  111 (316)
T ss_dssp             SCCEEEEEEEECCS-----SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCHH
T ss_pred             CCcEEEEEEEeeCc-----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHH
Confidence            47899999997542     22345678999999995 7999999999999999999999999999999998764 58999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCC---eEEcccccccccCcc---------ccccCCCCCCccCCc
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS---VKLADFGLAKATTMN---------DLKSCKGTPFWMAPE  146 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~---~~l~df~~~~~~~~~---------~~~~~~~~~~~~aPE  146 (247)
                      .++.++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+......         ......|+..|+|||
T Consensus       112 ~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  191 (316)
T 2ac3_A          112 EASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE  191 (316)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHH
T ss_pred             HHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChH
Confidence            99999999999999999999999999999999998776   999999998644321         122344889999999


Q ss_pred             ccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCChh---------------hHHHHHhhcCCCCCCC----CcCCH
Q 041080          147 VVNSKN---DGYGLTADIWSLGCTVLEMLTRRPPYSHLEG---------------VQALFRIGKGELPSVP----SSLSR  204 (247)
Q Consensus       147 ~~~~~~---~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~---------------~~~~~~~~~~~~~~~~----~~~~~  204 (247)
                      .+.+..   ..++.++||||||+++|+|++|..||.....               ......+..... ..+    ..+++
T Consensus       192 ~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~  270 (316)
T 2ac3_A          192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY-EFPDKDWAHISC  270 (316)
T ss_dssp             HHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCC-CCCHHHHTTSCH
T ss_pred             HhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCc-ccCchhcccCCH
Confidence            986411   2267899999999999999999999976532               222333333332 222    46899


Q ss_pred             HHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          205 DARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       205 ~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ++++++.+||..||.+|||++++++||||+..
T Consensus       271 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          271 AAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             HHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence            99999999999999999999999999999964

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=294.27  Aligned_cols=226  Identities=30%  Similarity=0.440  Sum_probs=181.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~   77 (247)
                      +|+.||||++.....   ..........|+..+.++ +||||+++++++.+++..++||||+ +++|.+++...  .+++
T Consensus        81 ~~~~vavK~~~~~~~---~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~  156 (311)
T 3p1a_A           81 DGRLYAVKRSMSPFR---GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPE  156 (311)
T ss_dssp             TSCEEEEEEESSSCC---SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCH
T ss_pred             CCeEEEEEEeccccc---ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCH
Confidence            588999999865432   233344455666666665 8999999999999999999999999 55888887664  4999


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||.+....... .....|++.|+|||.+.+   .++
T Consensus       157 ~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~  233 (311)
T 3p1a_A          157 AQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG---SYG  233 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT---CCS
T ss_pred             HHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC---CCC
Confidence            9999999999999999999999999999999999999999999999986554333 234458999999999865   378


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC-CCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE-LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                      .++||||||+++++|++|..++.....   ...+.... .+..+..+++++.+++.+||+.+|.+|||++++++||||++
T Consensus       234 ~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          234 TAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             THHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            999999999999999999766544332   22222222 22344678999999999999999999999999999999986


Q ss_pred             C
Q 041080          236 P  236 (247)
Q Consensus       236 ~  236 (247)
                      +
T Consensus       311 p  311 (311)
T 3p1a_A          311 P  311 (311)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=301.66  Aligned_cols=229  Identities=25%  Similarity=0.391  Sum_probs=191.6

Q ss_pred             CCceEEEEEEeecCCCcc---chHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccC-cHHHHHHhc-CC
Q 041080            1 DGFFFAVKEVSLQDQGAQ---GKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKG-SLANLYQKY-HL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~-~~   75 (247)
                      +|+.||||++........   .....+.+.+|+.++++++||||+++++++...+..++||||+.+| +|.+++... .+
T Consensus        48 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l  127 (335)
T 3dls_A           48 KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRL  127 (335)
T ss_dssp             TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCC
T ss_pred             CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCC
Confidence            478999999987543221   1123345678999999999999999999999999999999998766 999999776 59


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCC
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      ++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+....... .....|++.|+|||.+.+... 
T Consensus       128 ~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-  206 (335)
T 3dls_A          128 DEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPY-  206 (335)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCB-
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCC-
Confidence            999999999999999999999999999999999999999999999999987554332 334558999999999865442 


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCC
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK  234 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~  234 (247)
                      .+.++||||||+++|+|++|..||......       .......+..+++++.+++.+||+++|.+|||++++++||||+
T Consensus       207 ~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~  279 (335)
T 3dls_A          207 RGPELEMWSLGVTLYTLVFEENPFCELEET-------VEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVT  279 (335)
T ss_dssp             CSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------TTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTT
T ss_pred             CCCcccchhHHHHHHHHHhCCCchhhHHHH-------HhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcccc
Confidence            378899999999999999999999764321       1122344566899999999999999999999999999999998


Q ss_pred             CCC
Q 041080          235 RPL  237 (247)
Q Consensus       235 ~~~  237 (247)
                      ...
T Consensus       280 ~~~  282 (335)
T 3dls_A          280 QPV  282 (335)
T ss_dssp             CCC
T ss_pred             CCc
Confidence            754

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=9.2e-46  Score=321.52  Aligned_cols=231  Identities=25%  Similarity=0.410  Sum_probs=201.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~   78 (247)
                      +|+.||||++.+....  .....+.+..|..++..+ +||+|+++++++++.+.+++||||+++|+|.+++.+ ..+++.
T Consensus       365 ~~~~vAvK~l~~~~~~--~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~  442 (674)
T 3pfq_A          365 TDELYAVKILKKDVVI--QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP  442 (674)
T ss_dssp             SCCEEEEEEEEHHHHH--HTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHH
T ss_pred             CCcEEEEEEEeccccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHH
Confidence            4788999999764221  122345677899999988 699999999999999999999999999999999876 459999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccC--ccccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++....  ........|++.|+|||.+.+..  ++
T Consensus       443 ~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~~  520 (674)
T 3pfq_A          443 HAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP--YG  520 (674)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCC--BS
T ss_pred             HHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCC--CC
Confidence            999999999999999999999999999999999999999999999986432  22344566999999999996544  89


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh-----hhhhcCc
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV-----TELMEHP  231 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~~p  231 (247)
                      .++|+||||+++|+|++|..||...+..+....+.... ..++..+++++++||.+||+.||.+||++     ++|++||
T Consensus       521 ~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~  599 (674)
T 3pfq_A          521 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA  599 (674)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC-CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSG
T ss_pred             ccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCc
Confidence            99999999999999999999999988888888777654 46678899999999999999999999998     9999999


Q ss_pred             cCCCC
Q 041080          232 FVKRP  236 (247)
Q Consensus       232 ~~~~~  236 (247)
                      ||+.+
T Consensus       600 ff~~i  604 (674)
T 3pfq_A          600 FFRYI  604 (674)
T ss_dssp             GGSSC
T ss_pred             cccCC
Confidence            99864

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=6.7e-46  Score=312.49  Aligned_cols=231  Identities=30%  Similarity=0.525  Sum_probs=196.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-cCCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-YHLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~   79 (247)
                      +|+.||||++......   ......+.+|+.++++++||||+++++++.+.+..++||||+.+++|.+.+.. ..+++..
T Consensus        46 ~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  122 (486)
T 3mwu_A           46 TQQEYAVKVINKASAK---NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD  122 (486)
T ss_dssp             TCCEEEEEEEEHHHHB---CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHH
T ss_pred             CCCEEEEEEEeccccc---chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHH
Confidence            4789999999764322   22345688999999999999999999999999999999999999999887754 5699999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEc---CCCCeEEcccccccccCcc-ccccCCCCCCccCCcccccCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVD---ASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~---~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ++.++.|++.||.|||++||+|+||||+||+++   .++.++|+|||++...... ......|++.|+|||.+.+.   +
T Consensus       123 ~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---~  199 (486)
T 3mwu_A          123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT---Y  199 (486)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGSC---C
T ss_pred             HHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCCC---C
Confidence            999999999999999999999999999999995   4567999999998754433 23455689999999998652   7


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCC---CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV---PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      +.++||||+|+++|+|++|..||......+....+..+.....   ...++++++++|.+||..+|.+|||+.++++|||
T Consensus       200 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~  279 (486)
T 3mwu_A          200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW  279 (486)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence            8999999999999999999999998888887777766544322   2468999999999999999999999999999999


Q ss_pred             CCCCC
Q 041080          233 VKRPL  237 (247)
Q Consensus       233 ~~~~~  237 (247)
                      |+...
T Consensus       280 ~~~~~  284 (486)
T 3mwu_A          280 IQKYS  284 (486)
T ss_dssp             HHHTC
T ss_pred             hccCc
Confidence            98753

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.6e-45  Score=299.71  Aligned_cols=231  Identities=29%  Similarity=0.506  Sum_probs=192.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC-----CcEEEEEeccccCcHHHHHHhcCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE-----NRLYIFLELVTKGSLANLYQKYHL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~   75 (247)
                      +|+.||||++...    ......+.+.+|+.++++++||||+++++++...     ...++||||+.+ +|.++++...+
T Consensus        51 ~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~~  125 (364)
T 3qyz_A           51 NKVRVAIKKISPF----EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHL  125 (364)
T ss_dssp             TTEEEEEEEECCT----TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSE-EHHHHHHHCCC
T ss_pred             CCeEEEEEEeccc----cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCc-CHHHHHHhCCC
Confidence            4788999999642    3345567788999999999999999999998654     478999999976 99999998889


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-----cccCCCCCCccCCccccc
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNS  150 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~  150 (247)
                      ++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.......     .....|++.|+|||.+.+
T Consensus       126 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  205 (364)
T 3qyz_A          126 SNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN  205 (364)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHT
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcC
Confidence            999999999999999999999999999999999999999999999999987554332     234468999999998754


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC------------------------C-C-----CCCCC
Q 041080          151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG------------------------E-L-----PSVPS  200 (247)
Q Consensus       151 ~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~------------------------~-~-----~~~~~  200 (247)
                      .. .++.++||||||+++|+|++|..||......+....+...                        . .     .....
T Consensus       206 ~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (364)
T 3qyz_A          206 SK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP  284 (364)
T ss_dssp             BC-SCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCT
T ss_pred             CC-CCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCC
Confidence            33 2788999999999999999999999877665554443210                        0 0     01124


Q ss_pred             cCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          201 SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       201 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      .+++++.++|.+||+.||.+|||++++++||||+...
T Consensus       285 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  321 (364)
T 3qyz_A          285 NADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  321 (364)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             CCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence            5789999999999999999999999999999999763

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=291.55  Aligned_cols=233  Identities=38%  Similarity=0.661  Sum_probs=191.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc----CCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY----HLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~   76 (247)
                      +|+.||||.+....     ....+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++...    .++
T Consensus        46 ~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  120 (295)
T 2clq_A           46 NQVRIAIKEIPERD-----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN  120 (295)
T ss_dssp             TCCEEEEEEEECCC-----C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTC
T ss_pred             CCeEEEEEEccCCc-----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCcc
Confidence            47889999997532     234567889999999999999999999999999999999999999999999765    366


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC-CCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~-~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      +..++.++.|++.||.+||+.|++|+||+|+||+++. ++.++|+|||.+.......  .....++..|+|||.+.+...
T Consensus       121 ~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  200 (295)
T 2clq_A          121 EQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR  200 (295)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGG
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCC
Confidence            8889999999999999999999999999999999987 8999999999986544222  234558899999999865444


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhhHH--HHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQA--LFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                      .++.++|+||||+++|+|++|..||........  .........+..+..+++++.+++.+||..+|.+|||++++++||
T Consensus       201 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~  280 (295)
T 2clq_A          201 GYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDE  280 (295)
T ss_dssp             GCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSG
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            478899999999999999999999965433222  222223445567788999999999999999999999999999999


Q ss_pred             cCCCCCC
Q 041080          232 FVKRPLQ  238 (247)
Q Consensus       232 ~~~~~~~  238 (247)
                      ||+....
T Consensus       281 ~~~~~~~  287 (295)
T 2clq_A          281 FLKVSSK  287 (295)
T ss_dssp             GGCC---
T ss_pred             hhhhccc
Confidence            9997643

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.5e-45  Score=310.96  Aligned_cols=229  Identities=27%  Similarity=0.504  Sum_probs=194.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-cCCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-YHLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~   79 (247)
                      +|..||||++........   ....+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+.+.. ..+++..
T Consensus        61 ~~~~~aiK~~~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~  137 (494)
T 3lij_A           61 THVERAIKIIRKTSVSTS---SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVD  137 (494)
T ss_dssp             TCCEEEEEEEEC-----C---TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHH
T ss_pred             CCcEEEEEEEeccccCch---HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHH
Confidence            478899999986543222   245678999999999999999999999999999999999999999887754 4699999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC---CCeEEcccccccccCcc-ccccCCCCCCccCCcccccCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS---GSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~---~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ++.++.|++.||.|||+.|++|+||||+||+++..   +.++|+|||++...... ......|++.|+|||.+.+   .+
T Consensus       138 ~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~---~~  214 (494)
T 3lij_A          138 AAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK---KY  214 (494)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT---CB
T ss_pred             HHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc---cC
Confidence            99999999999999999999999999999999764   45999999998655433 3345668999999999853   37


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCC---CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVP---SSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      +.++||||+|+++|+|++|..||...........+..+......   ..++++++++|.+||+.+|.+|||++++++|||
T Consensus       215 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~  294 (494)
T 3lij_A          215 DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW  294 (494)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred             CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcc
Confidence            88999999999999999999999998888887777665543222   468999999999999999999999999999999


Q ss_pred             CCC
Q 041080          233 VKR  235 (247)
Q Consensus       233 ~~~  235 (247)
                      |+.
T Consensus       295 ~~~  297 (494)
T 3lij_A          295 IKE  297 (494)
T ss_dssp             HHH
T ss_pred             ccc
Confidence            975

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1e-45  Score=290.87  Aligned_cols=235  Identities=29%  Similarity=0.476  Sum_probs=196.4

Q ss_pred             CCceEEEEEEeecCCCcc-chHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQ-GKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||+|++........ .....+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++... .+++.
T Consensus        29 ~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~  108 (283)
T 3bhy_A           29 TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED  108 (283)
T ss_dssp             TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHH
T ss_pred             CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCHH
Confidence            478999999987643322 2224667889999999999999999999999999999999999999999998654 59999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC----CeEEcccccccccCcc-ccccCCCCCCccCCcccccCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG----SVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~----~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      .++.++.|++.||.+||+.|++|+||+|+||+++.++    .++|+|||.+...... ......+++.|+|||.+.+.. 
T Consensus       109 ~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-  187 (283)
T 3bhy_A          109 EATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEP-  187 (283)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCC-
T ss_pred             HHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCC-
Confidence            9999999999999999999999999999999998877    7999999998654432 233445889999999986544 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCC---CCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPS---VPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                       ++.++|+||||++++++++|..||...........+.......   .....++.+.+++.+||..+|.+|||++++++|
T Consensus       188 -~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          188 -LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             -CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             -CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence             7899999999999999999999998877776666655443321   125678999999999999999999999999999


Q ss_pred             ccCCCCC
Q 041080          231 PFVKRPL  237 (247)
Q Consensus       231 p~~~~~~  237 (247)
                      |||+...
T Consensus       267 ~~~~~~~  273 (283)
T 3bhy_A          267 SWIKAIR  273 (283)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9998753

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6e-46  Score=298.52  Aligned_cols=232  Identities=34%  Similarity=0.546  Sum_probs=189.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-cCCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-YHLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~   79 (247)
                      +|+.||||++....   ......+.+.+|+.++++++||||+++++++...+..++||||+++++|.++... .++++..
T Consensus        49 ~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~  125 (331)
T 4aaa_A           49 TGRIVAIKKFLESD---DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQV  125 (331)
T ss_dssp             TCCEEEEEEEESCS---SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHH
T ss_pred             CCceEEEEEEecCC---CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHH
Confidence            47899999997543   3344566788999999999999999999999999999999999999988887654 4599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      ++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+......  ......++..|+|||.+.+.. .++.
T Consensus       126 ~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~  204 (331)
T 4aaa_A          126 VQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV-KYGK  204 (331)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCT-TCCT
T ss_pred             HHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCC-Ccch
Confidence            9999999999999999999999999999999999999999999998654332  233456899999999986542 3788


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc---------------------CCCCCC---------CCcCCHHHH
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK---------------------GELPSV---------PSSLSRDAR  207 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~---------------------~~~~~~---------~~~~~~~~~  207 (247)
                      ++|+||||+++|+|++|..||...........+..                     ...+..         ...+++.+.
T Consensus       205 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  284 (331)
T 4aaa_A          205 AVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVI  284 (331)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHH
Confidence            99999999999999999999987765554433211                     001111         135789999


Q ss_pred             HHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          208 DFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       208 ~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      +++.+||..||.+|||++++++||||+..
T Consensus       285 ~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          285 DLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             HHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             HHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            99999999999999999999999999853

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.4e-45  Score=311.73  Aligned_cols=235  Identities=26%  Similarity=0.446  Sum_probs=198.5

Q ss_pred             CCceEEEEEEeecCCCcc--------chHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh
Q 041080            1 DGFFFAVKEVSLQDQGAQ--------GKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK   72 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   72 (247)
                      +|+.||||++........        .....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+.+..
T Consensus        60 ~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~  139 (504)
T 3q5i_A           60 GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN  139 (504)
T ss_dssp             TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred             CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHH
Confidence            478899999976542211        113456788999999999999999999999999999999999999999887755


Q ss_pred             -cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC---CeEEcccccccccCcc-ccccCCCCCCccCCcc
Q 041080           73 -YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG---SVKLADFGLAKATTMN-DLKSCKGTPFWMAPEV  147 (247)
Q Consensus        73 -~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~---~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~  147 (247)
                       ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++   .++|+|||++...... ......|++.|+|||.
T Consensus       140 ~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~  219 (504)
T 3q5i_A          140 RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEV  219 (504)
T ss_dssp             HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHH
Confidence             4699999999999999999999999999999999999998876   6999999998755433 3345668999999999


Q ss_pred             cccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCC---CCcCCHHHHHHHHHHhcCCCCCCCCh
Q 041080          148 VNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV---PSSLSRDARDFILKCLQVNPNDRPTV  224 (247)
Q Consensus       148 ~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~  224 (247)
                      +.+   .++.++||||+|+++|+|++|..||...........+..+.....   ...++++++++|.+||..+|.+|||+
T Consensus       220 ~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~  296 (504)
T 3q5i_A          220 LKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTA  296 (504)
T ss_dssp             HTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             hcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCH
Confidence            863   378899999999999999999999999888888877776654322   15689999999999999999999999


Q ss_pred             hhhhcCccCCCCCC
Q 041080          225 TELMEHPFVKRPLQ  238 (247)
Q Consensus       225 ~~il~~p~~~~~~~  238 (247)
                      +++++||||+....
T Consensus       297 ~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          297 EEALNSRWIKKYAN  310 (504)
T ss_dssp             HHHHTSHHHHHTCC
T ss_pred             HHHhcCHhhhhchh
Confidence            99999999987543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=300.84  Aligned_cols=232  Identities=28%  Similarity=0.458  Sum_probs=184.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.||||++......    .....+.+|+.++++++||||+++++++...+..++||||+++ +|.+++...  .+++.
T Consensus        26 ~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~  100 (324)
T 3mtl_A           26 TDNLVALKEIRLEHEE----GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMH  100 (324)
T ss_dssp             TCCEEEEEEECC----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHHTTTCCCHH
T ss_pred             CCcEEEEEEEeccccc----ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccccc-CHHHHHHhcCCCCCHH
Confidence            4789999999654321    1112345799999999999999999999999999999999986 888888764  38999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+......  ......++..|+|||.+.+.. .++
T Consensus       101 ~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~  179 (324)
T 3mtl_A          101 NVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGST-DYS  179 (324)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCC-CCC
T ss_pred             HHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCC-CCC
Confidence            99999999999999999999999999999999999999999999998654422  223445789999999986533 378


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC---CC-C-------------------------CCCCcCCHHHH
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG---EL-P-------------------------SVPSSLSRDAR  207 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---~~-~-------------------------~~~~~~~~~~~  207 (247)
                      .++||||+|+++|+|++|..||......+....+...   .. .                         .....+++++.
T Consensus       180 ~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (324)
T 3mtl_A          180 TQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGA  259 (324)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHH
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHH
Confidence            9999999999999999999999887766655443221   00 0                         01135788999


Q ss_pred             HHHHHHhcCCCCCCCChhhhhcCccCCCCCC
Q 041080          208 DFILKCLQVNPNDRPTVTELMEHPFVKRPLQ  238 (247)
Q Consensus       208 ~li~~~l~~~p~~Rps~~~il~~p~~~~~~~  238 (247)
                      ++|.+||+.||.+|||++|+++||||+....
T Consensus       260 ~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          260 DLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             HHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence            9999999999999999999999999987644

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.8e-45  Score=299.79  Aligned_cols=223  Identities=26%  Similarity=0.486  Sum_probs=194.7

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH------   74 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------   74 (247)
                      |..||||++...    ......+.+.+|+.+++.+ +||||+++++++.+.+..++||||+++|+|.+++...+      
T Consensus       113 ~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~  188 (370)
T 2psq_A          113 AVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY  188 (370)
T ss_dssp             EEEEEEEECCTT----CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC----
T ss_pred             ceeEEEEEecCC----cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccc
Confidence            456999998643    2345677899999999999 89999999999999999999999999999999997642      


Q ss_pred             -----------CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCC
Q 041080           75 -----------LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGT  139 (247)
Q Consensus        75 -----------~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~  139 (247)
                                 +++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......    .....++
T Consensus       189 ~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t  268 (370)
T 2psq_A          189 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP  268 (370)
T ss_dssp             -------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSC
T ss_pred             cccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcc
Confidence                       7889999999999999999999999999999999999999999999999987544322    2233456


Q ss_pred             CCccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCC
Q 041080          140 PFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP  218 (247)
Q Consensus       140 ~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  218 (247)
                      +.|+|||.+.+..  ++.++||||||+++|+|++ |..||...........+..+..+..+..+++++.+++.+||..+|
T Consensus       269 ~~y~aPE~~~~~~--~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP  346 (370)
T 2psq_A          269 VKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVP  346 (370)
T ss_dssp             GGGCCHHHHHTCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred             cceECHhHhcCCC--CCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCh
Confidence            7899999996544  8999999999999999999 999999888888877777777777888999999999999999999


Q ss_pred             CCCCChhhhhcC
Q 041080          219 NDRPTVTELMEH  230 (247)
Q Consensus       219 ~~Rps~~~il~~  230 (247)
                      .+|||+++++++
T Consensus       347 ~~Rpt~~ell~~  358 (370)
T 2psq_A          347 SQRPTFKQLVED  358 (370)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             hhCcCHHHHHHH
Confidence            999999999863

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7.9e-46  Score=298.70  Aligned_cols=224  Identities=31%  Similarity=0.503  Sum_probs=186.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||||++......         ..+|+.++.++ +||||+++++++.+++..++||||+++++|.+.+.+. .+++.
T Consensus        46 ~~~~~avK~~~~~~~~---------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~  116 (342)
T 2qr7_A           46 TNMEFAVKIIDKSKRD---------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER  116 (342)
T ss_dssp             TTEEEEEEEEETTTCC---------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTCCHH
T ss_pred             CCCEEEEEEEEcccCC---------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHH
Confidence            4789999999764321         24688888888 7999999999999999999999999999999988665 48999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC----CCeEEcccccccccCcc--ccccCCCCCCccCCcccccCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS----GSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKN  152 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~----~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~  152 (247)
                      .+..++.|++.||.|||++|++|+||||+||++..+    +.++|+|||.+......  ......+++.|+|||.+.+..
T Consensus       117 ~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  196 (342)
T 2qr7_A          117 EASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQG  196 (342)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCC
Confidence            999999999999999999999999999999998543    24999999998754332  234456899999999986544


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCC---hhhHHHHHhhcCCCC---CCCCcCCHHHHHHHHHHhcCCCCCCCChhh
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHL---EGVQALFRIGKGELP---SVPSSLSRDARDFILKCLQVNPNDRPTVTE  226 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~---~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  226 (247)
                        ++.++|+||||+++|+|++|..||...   ........+..+...   .....++++++++|.+||..||.+|||+++
T Consensus       197 --~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~  274 (342)
T 2qr7_A          197 --YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAAL  274 (342)
T ss_dssp             --HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             --CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence              688999999999999999999999753   334444555444432   223578999999999999999999999999


Q ss_pred             hhcCccCCC
Q 041080          227 LMEHPFVKR  235 (247)
Q Consensus       227 il~~p~~~~  235 (247)
                      +++||||..
T Consensus       275 il~hp~~~~  283 (342)
T 2qr7_A          275 VLRHPWIVH  283 (342)
T ss_dssp             HTTSHHHHT
T ss_pred             HhcCCeecC
Confidence            999999965

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-45  Score=296.13  Aligned_cols=231  Identities=26%  Similarity=0.494  Sum_probs=187.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCC--CceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ--DNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~   77 (247)
                      +|+.||||++....   ......+.+.+|+.++++++|  +||+++++++..++..++|||+. +++|.+++... .+++
T Consensus        32 ~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~  107 (343)
T 3dbq_A           32 KKQIYAIKYVNLEE---ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDP  107 (343)
T ss_dssp             TSCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHSCCCCH
T ss_pred             CCCEEEEEEeeccc---cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeCC-CCCHHHHHHhcCCCCH
Confidence            47889999997653   345566788999999999976  99999999999999999999955 66999998775 4899


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCCccccc---
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNS---  150 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aPE~~~~---  150 (247)
                      ..++.++.|++.||.|||+.||+|+||||+||+++ ++.++|+|||++.......    .....|++.|+|||.+.+   
T Consensus       108 ~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  186 (343)
T 3dbq_A          108 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS  186 (343)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccc
Confidence            99999999999999999999999999999999996 6789999999987654332    224568999999999854   


Q ss_pred             ------CCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhh-HHHHH-hhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC
Q 041080          151 ------KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV-QALFR-IGKGELPSVPSSLSRDARDFILKCLQVNPNDRP  222 (247)
Q Consensus       151 ------~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  222 (247)
                            ....++.++||||||+++|+|++|..||...... ..... +........+...+.++.+++.+||..+|.+||
T Consensus       187 ~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp  266 (343)
T 3dbq_A          187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI  266 (343)
T ss_dssp             ----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSC
T ss_pred             cccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCC
Confidence                  1234788999999999999999999999764332 22222 222334456677889999999999999999999


Q ss_pred             ChhhhhcCccCCCC
Q 041080          223 TVTELMEHPFVKRP  236 (247)
Q Consensus       223 s~~~il~~p~~~~~  236 (247)
                      |++++++||||+..
T Consensus       267 t~~e~l~hp~~~~~  280 (343)
T 3dbq_A          267 SIPELLAHPYVQIQ  280 (343)
T ss_dssp             CHHHHHTSHHHHSC
T ss_pred             CHHHHHhCcccccc
Confidence            99999999999853

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.5e-45  Score=292.49  Aligned_cols=232  Identities=35%  Similarity=0.654  Sum_probs=191.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~   78 (247)
                      +|+.||+|++....     ....+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++..  ..+++.
T Consensus        43 ~~~~~aiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~  117 (302)
T 2j7t_A           43 TGALAAAKVIETKS-----EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP  117 (302)
T ss_dssp             TCCEEEEEEEC---------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHH
T ss_pred             CCcEEEEEEecCCC-----HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHH
Confidence            47889999986532     22356788999999999999999999999999999999999999999998865  459999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc--cccccCCCCCCccCCccccc---CCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDLKSCKGTPFWMAPEVVNS---KND  153 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~aPE~~~~---~~~  153 (247)
                      .++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....  .......++..|+|||.+..   ...
T Consensus       118 ~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  197 (302)
T 2j7t_A          118 QIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT  197 (302)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTST
T ss_pred             HHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCC
Confidence            9999999999999999999999999999999999999999999998643221  12233458899999999841   223


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCC--CCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPS--VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                      .++.++|+||||+++++|++|..||...........+.....+.  .+..++..+.+++.+||..+|.+|||++++++||
T Consensus       198 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~  277 (302)
T 2j7t_A          198 PYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP  277 (302)
T ss_dssp             TTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred             CCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence            37889999999999999999999998877766665555544332  3467899999999999999999999999999999


Q ss_pred             cCCCCC
Q 041080          232 FVKRPL  237 (247)
Q Consensus       232 ~~~~~~  237 (247)
                      ||+...
T Consensus       278 ~~~~~~  283 (302)
T 2j7t_A          278 FVSSIT  283 (302)
T ss_dssp             TTTTCC
T ss_pred             HHhhhc
Confidence            999754

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.1e-46  Score=313.76  Aligned_cols=231  Identities=28%  Similarity=0.480  Sum_probs=198.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++......  .....+.+.+|+.++++++||||+++++++.+.+..++||||+.+++|.+.+... .+++..
T Consensus        50 ~~~~~avK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  127 (484)
T 3nyv_A           50 TGQECAVKVISKRQVK--QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD  127 (484)
T ss_dssp             TCCEEEEEEEETTTCC--BSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHHH
T ss_pred             CCCEEEEEEEEhhhcc--cchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHH
Confidence            4789999999765432  2234567889999999999999999999999999999999999999998887654 599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEE---cCCCCeEEcccccccccCcc-ccccCCCCCCccCCcccccCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILV---DASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~---~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ++.++.|++.||.|||++|++|+||||+||++   +.++.++|+|||++...... ......|++.|+|||.+.+   .+
T Consensus       128 ~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~  204 (484)
T 3nyv_A          128 AARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG---TY  204 (484)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT---CC
T ss_pred             HHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC---CC
Confidence            99999999999999999999999999999999   56789999999998654432 2334568999999999865   27


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCC---CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV---PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      +.++||||+|+++|+|++|..||...........+..+.....   ...++++++++|.+||..+|.+|||++++++|||
T Consensus       205 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~  284 (484)
T 3nyv_A          205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW  284 (484)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred             CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence            8899999999999999999999999888888777766654322   2468999999999999999999999999999999


Q ss_pred             CCCC
Q 041080          233 VKRP  236 (247)
Q Consensus       233 ~~~~  236 (247)
                      |+..
T Consensus       285 ~~~~  288 (484)
T 3nyv_A          285 IQTY  288 (484)
T ss_dssp             HHHH
T ss_pred             hccc
Confidence            9864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.6e-45  Score=297.98  Aligned_cols=224  Identities=28%  Similarity=0.415  Sum_probs=186.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-----CCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-----QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-   74 (247)
                      +|+.||||++..      .......+..|+.+++.+.     ||||+++++++...+..++||||+ +++|.+++.... 
T Consensus        59 ~~~~vavK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~  131 (360)
T 3llt_A           59 NKKYYAVKVVRN------IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY  131 (360)
T ss_dssp             TCCEEEEEEECS------CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT
T ss_pred             CCeEEEEEEecc------chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCC
Confidence            478899999963      2344556778999999996     999999999999999999999999 889999998754 


Q ss_pred             --CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC-------------------------CCCeEEcccccccc
Q 041080           75 --LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA-------------------------SGSVKLADFGLAKA  127 (247)
Q Consensus        75 --~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~-------------------------~~~~~l~df~~~~~  127 (247)
                        +++..++.++.|++.||.|||+.||+|+||||+||+++.                         ++.++|+|||.+..
T Consensus       132 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~  211 (360)
T 3llt_A          132 NGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF  211 (360)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEE
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCcee
Confidence              899999999999999999999999999999999999975                         78899999999875


Q ss_pred             cCccccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCC-----------
Q 041080          128 TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP-----------  196 (247)
Q Consensus       128 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------  196 (247)
                      ... ......+++.|+|||.+.+..  ++.++||||||+++|+|++|..||......+....+.....+           
T Consensus       212 ~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  288 (360)
T 3llt_A          212 KSD-YHGSIINTRQYRAPEVILNLG--WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATK  288 (360)
T ss_dssp             TTS-CCCSCCSCGGGCCHHHHTTCC--CCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTT
T ss_pred             cCC-CCcCccCcccccCcHHHcCCC--CCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhh
Confidence            433 234456899999999997554  889999999999999999999999877665554433221110           


Q ss_pred             ----------------------------------CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCC
Q 041080          197 ----------------------------------SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK  234 (247)
Q Consensus       197 ----------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~  234 (247)
                                                        ..+...++.+.++|.+||+.||.+|||++++|+||||+
T Consensus       289 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          289 TNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             SGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             ccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence                                              00011247788999999999999999999999999996

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.4e-45  Score=295.88  Aligned_cols=231  Identities=27%  Similarity=0.463  Sum_probs=193.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcHHHHHHh---cCCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK---YHLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~   76 (247)
                      +|+.||||++......   ......+.+|+.++..+. ||||+++++++...+..++||||+.+++|.+++..   ..++
T Consensus        53 ~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~  129 (327)
T 3lm5_A           53 TGQEYAAKFLKKRRRG---QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVS  129 (327)
T ss_dssp             TCCEEEEEEEESEETT---EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCC
T ss_pred             CCCEEEEEEEehhhcc---hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCC
Confidence            4889999999765432   223456889999999995 69999999999999999999999999999998754   3589


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC---CCCeEEcccccccccCccc-cccCCCCCCccCCcccccCC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA---SGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKN  152 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~---~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~  152 (247)
                      +..++.++.|++.||.+||+.|++|+||||+||+++.   ++.++|+|||.+....... .....+++.|+|||.+.+..
T Consensus       130 ~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~  209 (327)
T 3lm5_A          130 ENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDP  209 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCC
Confidence            9999999999999999999999999999999999987   7899999999987654332 33456899999999996544


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC---CCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE---LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                        ++.++|+||||+++|+|++|..||...........+....   .......+++.+.+++.+||+.+|.+|||++++++
T Consensus       210 --~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          210 --ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             --CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             --CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence              7899999999999999999999998887776665544432   23334578999999999999999999999999999


Q ss_pred             CccCCCC
Q 041080          230 HPFVKRP  236 (247)
Q Consensus       230 ~p~~~~~  236 (247)
                      ||||+..
T Consensus       288 h~~~~~~  294 (327)
T 3lm5_A          288 HSWLQQW  294 (327)
T ss_dssp             CGGGCCC
T ss_pred             CHhhccc
Confidence            9999874

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.4e-46  Score=301.57  Aligned_cols=231  Identities=29%  Similarity=0.444  Sum_probs=178.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC------CcEEEEEeccccCcHHHHHHhcC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE------NRLYIFLELVTKGSLANLYQKYH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~   74 (247)
                      +|+.||||++....   ......+.+.+|+.+++.++||||+++++++...      ...++++|++ +++|.++++...
T Consensus        53 ~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~  128 (367)
T 2fst_X           53 TGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK  128 (367)
T ss_dssp             TTEEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-----CC
T ss_pred             CCCEEEEEEeCccc---cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhcCC
Confidence            47899999986542   2345567788999999999999999999998654      5689999999 569999998888


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... .....++.+|+|||.+.+.. .
T Consensus       129 l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-~~~~~~t~~y~aPE~~~~~~-~  206 (367)
T 2fst_X          129 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-MTGYVATRWYRAPEIMLNWM-H  206 (367)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------------CCCTTCCHHHHTTCC-S
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc-CCCcCcCcCccChHHHcCCc-C
Confidence            999999999999999999999999999999999999999999999999998764432 34456899999999986532 3


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC----------------------CCCC--------CCCcCCH
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG----------------------ELPS--------VPSSLSR  204 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~----------------------~~~~--------~~~~~~~  204 (247)
                      ++.++||||+|+++++|++|..||...+.......+...                      ..+.        .....++
T Consensus       207 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (367)
T 2fst_X          207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP  286 (367)
T ss_dssp             CCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCH
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCH
Confidence            789999999999999999999999877665544332210                      0000        1135688


Q ss_pred             HHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          205 DARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       205 ~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      ++.+||.+||..||.+|||++++++||||+...
T Consensus       287 ~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~  319 (367)
T 2fst_X          287 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  319 (367)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence            999999999999999999999999999999753

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.6e-45  Score=291.27  Aligned_cols=227  Identities=37%  Similarity=0.694  Sum_probs=194.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~   78 (247)
                      +|+.||||.+....       ..+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++..  ..+++.
T Consensus        53 ~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  125 (314)
T 3com_A           53 TGQIVAIKQVPVES-------DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED  125 (314)
T ss_dssp             TCCEEEEEEEETTS-------CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHH
T ss_pred             CCCEEEEEecCchH-------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHH
Confidence            48899999997532       234578999999999999999999999999999999999999999999863  459999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......  ......++..|+|||.+.+..  ++
T Consensus       126 ~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~  203 (314)
T 3com_A          126 EIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG--YN  203 (314)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSC--BC
T ss_pred             HHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCC--CC
Confidence            99999999999999999999999999999999999999999999998654432  223445888999999986544  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCC--CCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCC
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPS--VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK  234 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~  234 (247)
                      .++|+||||+++|+|++|..||...........+.....+.  .+..++..+.+++.+||..+|.+|||++++++||||+
T Consensus       204 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~  283 (314)
T 3com_A          204 CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR  283 (314)
T ss_dssp             TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence            89999999999999999999998876665554444433322  3456899999999999999999999999999999999


Q ss_pred             CC
Q 041080          235 RP  236 (247)
Q Consensus       235 ~~  236 (247)
                      ..
T Consensus       284 ~~  285 (314)
T 3com_A          284 SA  285 (314)
T ss_dssp             TC
T ss_pred             cC
Confidence            75

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1e-44  Score=301.00  Aligned_cols=232  Identities=28%  Similarity=0.429  Sum_probs=181.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC-----CcEEEEEeccccCcHHHHHHhcC-
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE-----NRLYIFLELVTKGSLANLYQKYH-   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~-   74 (247)
                      +|+.||||++....   ......+.+.+|+.++++++||||+++++++...     +..++||||+.+ +|.++++... 
T Consensus        50 ~~~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~  125 (432)
T 3n9x_A           50 TEKNVAIKKVNRMF---EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIF  125 (432)
T ss_dssp             TTEEEEEEEECSTT---TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSE-EHHHHHHSSCC
T ss_pred             CCcEEEEEEeCchh---cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCc-CHHHHHhccCC
Confidence            47889999997532   3445567889999999999999999999998766     579999999975 9999987754 


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----------------------
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----------------------  132 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----------------------  132 (247)
                      +++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......                      
T Consensus       126 l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  205 (432)
T 3n9x_A          126 LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK  205 (432)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--------------------------
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchh
Confidence            9999999999999999999999999999999999999999999999999987544321                      


Q ss_pred             --cccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCC-----------CCChh----------------
Q 041080          133 --LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY-----------SHLEG----------------  183 (247)
Q Consensus       133 --~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~-----------~~~~~----------------  183 (247)
                        .....++++|+|||.+.... .++.++||||+||++|+|++|..||           .....                
T Consensus       206 ~~~~~~~gt~~Y~APE~~~~~~-~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~  284 (432)
T 3n9x_A          206 KQLTSHVVTRWYRAPELILLQE-NYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKS  284 (432)
T ss_dssp             -----CCCCCTTCCHHHHTTCS-CCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHH
T ss_pred             ccccCCCCCccccCHHHHhcCC-CCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccc
Confidence              24566899999999864332 3799999999999999999854443           22210                


Q ss_pred             -hHHH------------------------HHhhcCCC-CC-----CCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          184 -VQAL------------------------FRIGKGEL-PS-----VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       184 -~~~~------------------------~~~~~~~~-~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                       ....                        ..+..... ..     ....+++++.+||.+||..||.+|||++|+|+|||
T Consensus       285 ~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~  364 (432)
T 3n9x_A          285 NRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPY  364 (432)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGG
T ss_pred             hHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChh
Confidence             0000                        00100000 00     11457999999999999999999999999999999


Q ss_pred             CCCCC
Q 041080          233 VKRPL  237 (247)
Q Consensus       233 ~~~~~  237 (247)
                      |+...
T Consensus       365 f~~~~  369 (432)
T 3n9x_A          365 LKDVR  369 (432)
T ss_dssp             GTTTC
T ss_pred             hhhcc
Confidence            99864

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-45  Score=307.38  Aligned_cols=232  Identities=28%  Similarity=0.474  Sum_probs=178.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec-----CCcEEEEEeccccCcHHHHHHhcC-
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD-----ENRLYIFLELVTKGSLANLYQKYH-   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~-   74 (247)
                      +|+.||||++....   ......+.+.+|+.++++++||||+++++++..     ....++||||+. ++|.+++.... 
T Consensus        77 ~~~~vaiK~i~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~  152 (458)
T 3rp9_A           77 EKRVVAIKKILRVF---EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVY  152 (458)
T ss_dssp             --CEEEEEEECSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHSSCC
T ss_pred             CCcEEEEEEechhh---cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcccCCC
Confidence            47899999996532   344556788999999999999999999999843     357999999985 58999887654 


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-----------------------
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-----------------------  131 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-----------------------  131 (247)
                      +++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++......                       
T Consensus       153 l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (458)
T 3rp9_A          153 LTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH  232 (458)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccc
Confidence            999999999999999999999999999999999999999999999999998754321                       


Q ss_pred             ------ccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHh-----------CCCCCCCChh-----------
Q 041080          132 ------DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-----------RRPPYSHLEG-----------  183 (247)
Q Consensus       132 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-----------g~~p~~~~~~-----------  183 (247)
                            ......|+++|+|||.+... ..++.++|||||||++|+|++           |..+|.....           
T Consensus       233 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~  311 (458)
T 3rp9_A          233 TKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGN  311 (458)
T ss_dssp             ------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC---------------
T ss_pred             cccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccc
Confidence                  12344579999999986432 237999999999999999998           5555544321           


Q ss_pred             ---------hHHHHHhh-----------------------c-------CCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh
Q 041080          184 ---------VQALFRIG-----------------------K-------GELPSVPSSLSRDARDFILKCLQVNPNDRPTV  224 (247)
Q Consensus       184 ---------~~~~~~~~-----------------------~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  224 (247)
                               .+....+.                       .       ..........++++.+||.+||..||.+|||+
T Consensus       312 ~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~  391 (458)
T 3rp9_A          312 DFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITI  391 (458)
T ss_dssp             -----CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             cccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCH
Confidence                     01110000                       0       00011123568999999999999999999999


Q ss_pred             hhhhcCccCCCCC
Q 041080          225 TELMEHPFVKRPL  237 (247)
Q Consensus       225 ~~il~~p~~~~~~  237 (247)
                      +|+|+||||+...
T Consensus       392 ~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          392 NECLAHPFFKEVR  404 (458)
T ss_dssp             HHHHHSGGGTTTC
T ss_pred             HHHhcCHhhhhcC
Confidence            9999999999863

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.9e-45  Score=289.16  Aligned_cols=231  Identities=29%  Similarity=0.488  Sum_probs=176.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-----cCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-----YHL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~   75 (247)
                      +|+.||||++....   ......+.+.++...++.++||||+++++++.+++..++||||+++ +|.+++..     ..+
T Consensus        31 ~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~  106 (290)
T 3fme_A           31 SGQIMAVKRIRATV---NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTI  106 (290)
T ss_dssp             TTEEEEEEEEC------CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCC
T ss_pred             CCeEEEEEEeeccc---CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCC
Confidence            47899999997542   2233344455566668888999999999999999999999999986 88777654     359


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhC-CeeecCCCCCcEEEcCCCCeEEcccccccccCcccc-ccCCCCCCccCCccccc--C
Q 041080           76 SDSQVSSYTRQILNGLVYLHER-NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL-KSCKGTPFWMAPEVVNS--K  151 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~aPE~~~~--~  151 (247)
                      ++..++.++.|++.||.+||++ |++|+||||+||+++.++.++|+|||.+........ ....+++.|+|||.+..  .
T Consensus       107 ~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  186 (290)
T 3fme_A          107 PEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELN  186 (290)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTT
T ss_pred             CHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhc
Confidence            9999999999999999999998 999999999999999999999999999865543332 23458899999999732  2


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCCh-hhHHHHH-hhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLE-GVQALFR-IGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       152 ~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ...++.++|+||+|++++++++|..||.... ....... ............+++++.+++.+||+.+|.+|||++++++
T Consensus       187 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          187 QKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             C--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            2337889999999999999999999997532 2222333 3333333334578999999999999999999999999999


Q ss_pred             CccCCC
Q 041080          230 HPFVKR  235 (247)
Q Consensus       230 ~p~~~~  235 (247)
                      ||||+.
T Consensus       267 hp~f~~  272 (290)
T 3fme_A          267 HPFFTL  272 (290)
T ss_dssp             SHHHHH
T ss_pred             Cccccc
Confidence            999985

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-46  Score=300.81  Aligned_cols=234  Identities=28%  Similarity=0.427  Sum_probs=191.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||||++...... ......+.+.+|+.+++++ +||||+++++++...+..++||||+++++|.+++... .+++.
T Consensus        81 ~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~  159 (355)
T 1vzo_A           81 TGKLYAMKVLKKATIV-QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH  159 (355)
T ss_dssp             TTCEEEEEEESEEEEE-EEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHH
T ss_pred             CCeEEEEEEEeHHHhh-hhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHH
Confidence            4789999999754321 1112233466899999999 6999999999999999999999999999999998764 59999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc---ccccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN---DLKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......   ......|++.|+|||.+.+....+
T Consensus       160 ~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  239 (355)
T 1vzo_A          160 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH  239 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---
T ss_pred             HHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCC
Confidence            99999999999999999999999999999999999999999999998654322   223346899999999997655557


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChh----hHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----Chhh
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEG----VQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTE  226 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~  226 (247)
                      +.++||||||+++|+|++|..||.....    ......+.. ..+..+..++..++++|.+||..||.+||     |+++
T Consensus       240 ~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~e  318 (355)
T 1vzo_A          240 DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADE  318 (355)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH-CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHH
T ss_pred             CchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc-cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHH
Confidence            8899999999999999999999964332    222222222 34566778999999999999999999999     9999


Q ss_pred             hhcCccCCCC
Q 041080          227 LMEHPFVKRP  236 (247)
Q Consensus       227 il~~p~~~~~  236 (247)
                      +++||||+..
T Consensus       319 ll~h~~f~~~  328 (355)
T 1vzo_A          319 IKEHLFFQKI  328 (355)
T ss_dssp             HHTSGGGTTC
T ss_pred             HHcCcchhcC
Confidence            9999999864

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.4e-45  Score=301.78  Aligned_cols=225  Identities=29%  Similarity=0.472  Sum_probs=179.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeec----CCcEEEEEeccccCcHHHHHHhc--
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKD----ENRLYIFLELVTKGSLANLYQKY--   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~--   73 (247)
                      +|+.||||++...          ..+.+|+.++.++ +||||+++++++..    .+.+++||||+++|+|.+++...  
T Consensus        86 ~~~~vAiK~~~~~----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~  155 (400)
T 1nxk_A           86 TQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD  155 (400)
T ss_dssp             TCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC--
T ss_pred             CCCEEEEEEeCcc----------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCC
Confidence            4789999998631          2456788887554 79999999998765    56789999999999999999764  


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC---CCCeEEcccccccccCcc-ccccCCCCCCccCCccc
Q 041080           74 -HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA---SGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVV  148 (247)
Q Consensus        74 -~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~---~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~  148 (247)
                       .+++..++.++.|++.||.|||+.||+|+||||+||+++.   ++.++|+|||++...... ......+++.|+|||.+
T Consensus       156 ~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~  235 (400)
T 1nxk_A          156 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL  235 (400)
T ss_dssp             -CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhc
Confidence             3899999999999999999999999999999999999997   788999999998755432 23445689999999999


Q ss_pred             ccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhH----HHHHhhcCCCC---CCCCcCCHHHHHHHHHHhcCCCCCC
Q 041080          149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQ----ALFRIGKGELP---SVPSSLSRDARDFILKCLQVNPNDR  221 (247)
Q Consensus       149 ~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~----~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R  221 (247)
                      .+..  ++.++||||||+++|+|++|..||.......    ....+..+...   .....++++++++|.+||..||.+|
T Consensus       236 ~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  313 (400)
T 1nxk_A          236 GPEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQR  313 (400)
T ss_dssp             CCCC--SSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGS
T ss_pred             CCCC--CCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHC
Confidence            6544  8899999999999999999999997654322    22222222221   1225689999999999999999999


Q ss_pred             CChhhhhcCccCCCCC
Q 041080          222 PTVTELMEHPFVKRPL  237 (247)
Q Consensus       222 ps~~~il~~p~~~~~~  237 (247)
                      ||++++++||||....
T Consensus       314 pt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          314 MTITEFMNHPWIMQST  329 (400)
T ss_dssp             CCHHHHHHSHHHHTTT
T ss_pred             cCHHHHhcCccccCCC
Confidence            9999999999998653

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4e-45  Score=295.94  Aligned_cols=231  Identities=28%  Similarity=0.478  Sum_probs=186.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec--------CCcEEEEEeccccCcHHHHHHh
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD--------ENRLYIFLELVTKGSLANLYQK   72 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~   72 (247)
                      +|+.||||++.......   .....+.+|+.+++.++||||+++++++..        .+..++||||+.+ +|.+.+..
T Consensus        41 ~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~  116 (351)
T 3mi9_A           41 TGQKVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN  116 (351)
T ss_dssp             TCCEEEEEECCCSSCSS---SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHC
T ss_pred             CCCEEEEEEEecccccc---cchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhh
Confidence            47899999997654322   223456789999999999999999999876        4568999999987 77777655


Q ss_pred             c--CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc------cccccCCCCCCccC
Q 041080           73 Y--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM------NDLKSCKGTPFWMA  144 (247)
Q Consensus        73 ~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~------~~~~~~~~~~~~~a  144 (247)
                      .  .+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.....      .......+++.|+|
T Consensus       117 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~a  196 (351)
T 3mi9_A          117 VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP  196 (351)
T ss_dssp             TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCC
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccC
Confidence            3  599999999999999999999999999999999999999999999999999865431      12234557899999


Q ss_pred             CcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC---CCCCCCCc--------------------
Q 041080          145 PEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG---ELPSVPSS--------------------  201 (247)
Q Consensus       145 PE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~--------------------  201 (247)
                      ||.+.+.. .++.++||||||+++|+|++|..||...........+...   ..+.....                    
T Consensus       197 PE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (351)
T 3mi9_A          197 PELLLGER-DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKV  275 (351)
T ss_dssp             HHHHTTCC-SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCH
T ss_pred             chhhcCCC-CCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCH
Confidence            99986533 2689999999999999999999999887766655443321   11111111                    


Q ss_pred             --------CCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          202 --------LSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       202 --------~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                              .++++.++|.+||..||.+|||++|+++||||+..
T Consensus       276 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  318 (351)
T 3mi9_A          276 KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  318 (351)
T ss_dssp             HHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred             HHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence                    27789999999999999999999999999999874

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=290.92  Aligned_cols=235  Identities=24%  Similarity=0.451  Sum_probs=194.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceee--ecCCcEEEEEeccccCcHHHHHHh---cCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTD--KDENRLYIFLELVTKGSLANLYQK---YHL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~~~~~~L~~~l~~---~~~   75 (247)
                      +|+.||+|++...... ......+.+.+|+.++++++||||+++++++  ...+..++||||+.++ |.+++..   ..+
T Consensus        29 ~~~~~avK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~  106 (305)
T 2wtk_C           29 TLCRRAVKILKKKKLR-RIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRF  106 (305)
T ss_dssp             TCCEEEEEEECHHHHH-HSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSC
T ss_pred             CCcEEEEEEecccccc-ccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCccccc
Confidence            4788999999754321 1123456789999999999999999999988  4556899999999885 7776654   358


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc----ccccCCCCCCccCCcccccC
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTPFWMAPEVVNSK  151 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~  151 (247)
                      ++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+......    ......++..|+|||.+.+.
T Consensus       107 ~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  186 (305)
T 2wtk_C          107 PVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL  186 (305)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCC
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCc
Confidence            99999999999999999999999999999999999999999999999998654321    22344588999999998764


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       152 ~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                      ....+.++|+||||+++|+|++|..||...........+..... ..+..+++.+.+++.+||..||.+|||++++++||
T Consensus       187 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  265 (305)
T 2wtk_C          187 DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY-AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS  265 (305)
T ss_dssp             SCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred             ccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC-CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence            43357899999999999999999999998777776666655543 55678899999999999999999999999999999


Q ss_pred             cCCCCCC
Q 041080          232 FVKRPLQ  238 (247)
Q Consensus       232 ~~~~~~~  238 (247)
                      ||+....
T Consensus       266 ~~~~~~~  272 (305)
T 2wtk_C          266 WFRKKHP  272 (305)
T ss_dssp             HHHSCCC
T ss_pred             ccccCCC
Confidence            9987644

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=7.9e-45  Score=297.85  Aligned_cols=230  Identities=26%  Similarity=0.485  Sum_probs=187.8

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC--CCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE--QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      |+.||||++....   ......+.+.+|+.+++++.  ||||+++++++...+..++|||+ .+++|.+++... .+++.
T Consensus        80 ~~~vaiK~~~~~~---~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~-~~~~L~~~l~~~~~~~~~  155 (390)
T 2zmd_A           80 KQIYAIKYVNLEE---ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPW  155 (390)
T ss_dssp             CCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEEC-CSEEHHHHHHHCSSCCHH
T ss_pred             CCEEEEEEEeccc---ccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEec-CCCCHHHHHHhcCCCCHH
Confidence            7789999997653   23556778999999999996  59999999999999999999995 567999998765 48899


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCCcccccC---
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSK---  151 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~---  151 (247)
                      .++.++.|++.||.|||+.||+|+||||+||+++ ++.++|+|||++.......    .....|++.|+|||.+.+.   
T Consensus       156 ~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  234 (390)
T 2zmd_A          156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS  234 (390)
T ss_dssp             HHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC---
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhcccc
Confidence            9999999999999999999999999999999995 6899999999987654332    2345689999999998642   


Q ss_pred             ------CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhh-HHHHHhhc-CCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC
Q 041080          152 ------NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV-QALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRPT  223 (247)
Q Consensus       152 ------~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  223 (247)
                            ...++.++||||||+++|+|++|..||...... .....+.. ......+...+.++.++|.+||+.+|.+|||
T Consensus       235 ~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps  314 (390)
T 2zmd_A          235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS  314 (390)
T ss_dssp             ---------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCC
T ss_pred             ccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCC
Confidence                  124788999999999999999999999765332 23333332 2233456667899999999999999999999


Q ss_pred             hhhhhcCccCCCC
Q 041080          224 VTELMEHPFVKRP  236 (247)
Q Consensus       224 ~~~il~~p~~~~~  236 (247)
                      ++++++||||+..
T Consensus       315 ~~ell~hp~~~~~  327 (390)
T 2zmd_A          315 IPELLAHPYVQIQ  327 (390)
T ss_dssp             HHHHHTSHHHHSC
T ss_pred             HHHHhhCcCcccc
Confidence            9999999999854

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.5e-46  Score=300.61  Aligned_cols=234  Identities=26%  Similarity=0.471  Sum_probs=196.7

Q ss_pred             CCceEEEEEEeecCCCccc------------hHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQG------------KQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLAN   68 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   68 (247)
                      +|+.||||++.........            ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+
T Consensus        53 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  132 (348)
T 2pml_X           53 DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILK  132 (348)
T ss_dssp             TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSE
T ss_pred             CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHH
Confidence            5789999999764322111            1122678899999999999999999999999999999999999999998


Q ss_pred             H------HHh---cCCCHHHHHHHHHHHHHHHHHhhh-CCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCC
Q 041080           69 L------YQK---YHLSDSQVSSYTRQILNGLVYLHE-RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKG  138 (247)
Q Consensus        69 ~------l~~---~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~  138 (247)
                      +      +..   ..+++..++.++.|++.||.+||+ .|++|+||+|+||+++.++.++|+|||.+............+
T Consensus       133 ~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  212 (348)
T 2pml_X          133 FDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRG  212 (348)
T ss_dssp             ESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTTEECSSCS
T ss_pred             HHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEeccccccccccccccCCCC
Confidence            8      554   459999999999999999999999 999999999999999999999999999987665555556678


Q ss_pred             CCCccCCcccccCCCCCCc-chhHHHHHHHHHHHHhCCCCCCCChh-hHHHHHhhcCCCCCCC-----------------
Q 041080          139 TPFWMAPEVVNSKNDGYGL-TADIWSLGCTVLEMLTRRPPYSHLEG-VQALFRIGKGELPSVP-----------------  199 (247)
Q Consensus       139 ~~~~~aPE~~~~~~~~~~~-~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~-----------------  199 (247)
                      +..|+|||.+.+... ++. ++|+||||+++++|++|..||..... ......+..... ..+                 
T Consensus       213 ~~~y~aPE~~~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~  290 (348)
T 2pml_X          213 TYEFMPPEFFSNESS-YNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNI-EYPLDRNHFLYPLTNKKSTC  290 (348)
T ss_dssp             CGGGCCGGGGSSCCC-EEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCC-CCCCSSSSSTTTTCC-----
T ss_pred             CcCccCchhhcCCCC-CCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCc-CCccchhhhhcccccccccc
Confidence            999999999965422 444 89999999999999999999987766 555555544432 223                 


Q ss_pred             --CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          200 --SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       200 --~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                        ..++.++.+++.+||+.+|.+|||++++++||||+..
T Consensus       291 ~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          291 SNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             ---CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             chhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence              5689999999999999999999999999999999874

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.7e-45  Score=304.49  Aligned_cols=234  Identities=29%  Similarity=0.461  Sum_probs=180.8

Q ss_pred             CCceEEEEEEeecCCCc---cchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCC
Q 041080            1 DGFFFAVKEVSLQDQGA---QGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~   76 (247)
                      +|+.||||++.......   ........+.+|+.++++++||||+++++++.. +..++||||+++++|.+++... .++
T Consensus       159 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~  237 (419)
T 3i6u_A          159 TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLK  237 (419)
T ss_dssp             TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSSCCCC
T ss_pred             CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhccCCCC
Confidence            47899999998653221   122233457899999999999999999999865 4589999999999998877554 599


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC---CeEEcccccccccCccc-cccCCCCCCccCCccccc-C
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG---SVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNS-K  151 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~---~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~-~  151 (247)
                      +..++.++.|++.||.|||++|++|+||||+||+++.++   .++|+|||++....... .....|++.|+|||.+.+ .
T Consensus       238 ~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~  317 (419)
T 3i6u_A          238 EATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVG  317 (419)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC---
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCC
Confidence            999999999999999999999999999999999997654   59999999997655433 334568999999999854 2


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhH-HHHHhhcCCCCCC---CCcCCHHHHHHHHHHhcCCCCCCCChhhh
Q 041080          152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQ-ALFRIGKGELPSV---PSSLSRDARDFILKCLQVNPNDRPTVTEL  227 (247)
Q Consensus       152 ~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~i  227 (247)
                      ...++.++|+||||+++|+|++|..||....... ....+........   ...+++.+.+++.+||..+|.+|||++++
T Consensus       318 ~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~  397 (419)
T 3i6u_A          318 TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA  397 (419)
T ss_dssp             -CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             CCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHH
Confidence            3347889999999999999999999997654332 2333333333222   24689999999999999999999999999


Q ss_pred             hcCccCCC
Q 041080          228 MEHPFVKR  235 (247)
Q Consensus       228 l~~p~~~~  235 (247)
                      ++||||+.
T Consensus       398 l~hp~~~~  405 (419)
T 3i6u_A          398 LRHPWLQD  405 (419)
T ss_dssp             HHSGGGCC
T ss_pred             hCCcccCC
Confidence            99999985

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.8e-46  Score=306.65  Aligned_cols=225  Identities=18%  Similarity=0.232  Sum_probs=177.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHH---HHHhhcCCCceeeec-------eeeecCC-----------------c
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEI---SLLSQFEQDNIVQYL-------GTDKDEN-----------------R   53 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~i~~~~-------~~~~~~~-----------------~   53 (247)
                      +|+.||||++.....  ......+.+.+|+   ..+++++||||++++       +++...+                 .
T Consensus        97 ~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  174 (377)
T 3byv_A           97 TGESFEVHVPYFTER--PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLS  174 (377)
T ss_dssp             CCCEEEEEEEEECC---CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEES
T ss_pred             CCcEEEEEEEeeccc--cchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEE
Confidence            488999999986532  2233566788999   555556899999998       5555543                 3


Q ss_pred             EEEEEeccccCcHHHHHHhc-CCCH-------HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccc
Q 041080           54 LYIFLELVTKGSLANLYQKY-HLSD-------SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA  125 (247)
Q Consensus        54 ~~lv~e~~~~~~L~~~l~~~-~~~~-------~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~  125 (247)
                      .+++|||+ +|+|.++++.. .+++       ..++.++.|++.||+|||++||+|+||||+||+++.++.++|+|||++
T Consensus       175 ~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a  253 (377)
T 3byv_A          175 RFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL  253 (377)
T ss_dssp             EEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGC
T ss_pred             EEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhh
Confidence            89999999 56999999763 2444       778889999999999999999999999999999999999999999998


Q ss_pred             cccCccccccCCCCCCccCCcccccC---------CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCC
Q 041080          126 KATTMNDLKSCKGTPFWMAPEVVNSK---------NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP  196 (247)
Q Consensus       126 ~~~~~~~~~~~~~~~~~~aPE~~~~~---------~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~  196 (247)
                      ..... ......| +.|+|||.+.+.         ...++.++||||||+++|+|++|..||...........+..    
T Consensus       254 ~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~----  327 (377)
T 3byv_A          254 VRDGA-RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR----  327 (377)
T ss_dssp             EETTC-EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGS----
T ss_pred             eecCC-cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhh----
Confidence            75443 2334456 999999998765         01378999999999999999999999976554433333222    


Q ss_pred             CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          197 SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       197 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                       ....+++++.++|.+||+.||.+|||++++++||||+.
T Consensus       328 -~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          328 -SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             -SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             -hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence             23578999999999999999999999999999999985

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.7e-46  Score=294.16  Aligned_cols=231  Identities=34%  Similarity=0.612  Sum_probs=177.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--------
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--------   72 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------   72 (247)
                      +|+.||||++....    .....+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++..        
T Consensus        39 ~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  114 (303)
T 2vwi_A           39 KKEKVAIKRINLEK----CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK  114 (303)
T ss_dssp             --CEEEEECCC--------------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTT
T ss_pred             CCcEEEEEEEEhhh----cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccc
Confidence            47889999986532    223456688999999999999999999999999999999999999999999864        


Q ss_pred             -cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-------ccccCCCCCCccC
Q 041080           73 -YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-------DLKSCKGTPFWMA  144 (247)
Q Consensus        73 -~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-------~~~~~~~~~~~~a  144 (247)
                       ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......       ......+++.|+|
T Consensus       115 ~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~a  194 (303)
T 2vwi_A          115 SGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA  194 (303)
T ss_dssp             TCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccC
Confidence             23899999999999999999999999999999999999999999999999987544322       1223458899999


Q ss_pred             CcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCC---------CCCCcCCHHHHHHHHHHhc
Q 041080          145 PEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP---------SVPSSLSRDARDFILKCLQ  215 (247)
Q Consensus       145 PE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~  215 (247)
                      ||.+.+.. .++.++|+||||+++++|++|..||.................+         .....+++++.+++.+||+
T Consensus       195 PE~~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  273 (303)
T 2vwi_A          195 PEVMEQVR-GYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQ  273 (303)
T ss_dssp             HHHHHHHH-CCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCC
T ss_pred             HHHhcccc-CCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHcc
Confidence            99986422 2688999999999999999999999887665555443332222         2235688999999999999


Q ss_pred             CCCCCCCChhhhhcCccCCCC
Q 041080          216 VNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       216 ~~p~~Rps~~~il~~p~~~~~  236 (247)
                      .+|.+|||++++++||||+..
T Consensus       274 ~dp~~Rps~~~ll~h~~~~~~  294 (303)
T 2vwi_A          274 KDPEKRPTAAELLRHKFFQKA  294 (303)
T ss_dssp             SSGGGSCCHHHHHTSTTC---
T ss_pred             CChhhCcCHHHHhhChhhhcC
Confidence            999999999999999999874

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.9e-45  Score=298.76  Aligned_cols=229  Identities=26%  Similarity=0.409  Sum_probs=180.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC------cEEEEEeccccCcHHHHHHhcC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN------RLYIFLELVTKGSLANLYQKYH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~   74 (247)
                      +|+.||||++....   ......+.+.+|+.+++.++||||+++++++...+      ..++||||+++ +|.+.+. ..
T Consensus        49 ~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-~~  123 (371)
T 2xrw_A           49 LERNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ-ME  123 (371)
T ss_dssp             TTEEEEEEEEECTT---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH-SC
T ss_pred             CCceEEEEEecccc---CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh-hc
Confidence            47889999997543   23455677889999999999999999999987654      78999999986 7888775 46


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      +++..+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+....... .....+++.|+|||.+.+.. 
T Consensus       124 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-  202 (371)
T 2xrw_A          124 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-  202 (371)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----------------CTTCCHHHHTTCC-
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCC-
Confidence            8999999999999999999999999999999999999999999999999987654332 33456899999999996644 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCC---------------------CCC-------------
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP---------------------SVP-------------  199 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------------~~~-------------  199 (247)
                       ++.++||||||+++|+|++|..||...+.......+......                     ...             
T Consensus       203 -~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (371)
T 2xrw_A          203 -YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLF  281 (371)
T ss_dssp             -CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGS
T ss_pred             -CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccC
Confidence             789999999999999999999999887766555444322110                     000             


Q ss_pred             -------CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          200 -------SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       200 -------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                             ...+.+++++|.+||..||.+|||++++++||||+..
T Consensus       282 ~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          282 PADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             CCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             cccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence                   0125689999999999999999999999999999864

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=5.9e-45  Score=291.94  Aligned_cols=222  Identities=23%  Similarity=0.420  Sum_probs=192.7

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~   79 (247)
                      +..||||++...    ......+.+.+|+.++++++||||+++++++.+++..++||||+++++|.++++..  .+++..
T Consensus        77 ~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  152 (325)
T 3kul_A           77 DVPVAIKALKAG----YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQ  152 (325)
T ss_dssp             CEEEEEEEECTT----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHH
T ss_pred             CceEEEEecCCC----CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHH
Confidence            345999999643    23455677899999999999999999999999999999999999999999999654  599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-----cccCCCCCCccCCcccccCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      ++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.......     .....++..|+|||.+.+..  
T Consensus       153 ~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--  230 (325)
T 3kul_A          153 LVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT--  230 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCE--
T ss_pred             HHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCC--
Confidence            99999999999999999999999999999999999999999999987554332     12223466799999996554  


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          155 YGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ++.++||||||+++|++++ |..||...........+........+..+++.+.+++.+||..+|.+|||++++++
T Consensus       231 ~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          231 FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            7889999999999999998 99999998888888888777777778899999999999999999999999999986

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.4e-44  Score=286.03  Aligned_cols=231  Identities=25%  Similarity=0.437  Sum_probs=191.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++....  .......+.+.+|+.++++++||||+++++++..++..++||||+++++|.++++.. .+++..
T Consensus        35 ~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~  112 (294)
T 4eqm_A           35 LNIKVAIKAIFIPP--REKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDT  112 (294)
T ss_dssp             TCSEEEEEEEECCS--SCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHH
T ss_pred             CCCeEEEEEeccCc--cccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHH
Confidence            47899999997643  234566778999999999999999999999999999999999999999999999765 489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+.......   .....|++.|+|||.+.+..  ++
T Consensus       113 ~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  190 (294)
T 4eqm_A          113 AINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA--TD  190 (294)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCC--CC
T ss_pred             HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCC--CC
Confidence            99999999999999999999999999999999999999999999987554332   22345899999999997654  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCC----CCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPS----VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      .++|+||||+++|+|++|..||.................+.    .+..+|+.+.+++.+||+.+|.+||+..+.+.++|
T Consensus       191 ~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l  270 (294)
T 4eqm_A          191 ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDL  270 (294)
T ss_dssp             TTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred             chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence            89999999999999999999998877666655544443332    34678999999999999999999997666666665


Q ss_pred             CCC
Q 041080          233 VKR  235 (247)
Q Consensus       233 ~~~  235 (247)
                      .+-
T Consensus       271 ~~~  273 (294)
T 4eqm_A          271 SSV  273 (294)
T ss_dssp             HTS
T ss_pred             HHH
Confidence            543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-45  Score=298.46  Aligned_cols=226  Identities=26%  Similarity=0.410  Sum_probs=195.8

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--------   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------   73 (247)
                      |+.||||++...    ........+.+|+.++++++||||+++++++...+..++||||+++++|.+++...        
T Consensus       101 ~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~  176 (367)
T 3l9p_A          101 PLQVAVKTLPEV----CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS  176 (367)
T ss_dssp             CEEEEEEECCSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCC
T ss_pred             ceeEEEEecccc----cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccc
Confidence            568999998642    23445567889999999999999999999999999999999999999999999764        


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC---CeEEcccccccccCcc----ccccCCCCCCccCCc
Q 041080           74 HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG---SVKLADFGLAKATTMN----DLKSCKGTPFWMAPE  146 (247)
Q Consensus        74 ~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~---~~~l~df~~~~~~~~~----~~~~~~~~~~~~aPE  146 (247)
                      .+++..++.++.|++.||.|||++||+|+||||+||+++.++   .++|+|||.+......    ......+++.|+|||
T Consensus       177 ~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE  256 (367)
T 3l9p_A          177 SLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE  256 (367)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHH
T ss_pred             cccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHH
Confidence            388999999999999999999999999999999999999555   4999999998643221    222344678899999


Q ss_pred             ccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChh
Q 041080          147 VVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT  225 (247)
Q Consensus       147 ~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  225 (247)
                      .+.+..  ++.++||||||+++|+|++ |..||...........+........+..+++.+.+++.+||+.+|.+|||++
T Consensus       257 ~~~~~~--~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~  334 (367)
T 3l9p_A          257 AFMEGI--FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA  334 (367)
T ss_dssp             HHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HhcCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHH
Confidence            986554  7999999999999999998 9999999888888888887777777888999999999999999999999999


Q ss_pred             hhhcCccC
Q 041080          226 ELMEHPFV  233 (247)
Q Consensus       226 ~il~~p~~  233 (247)
                      +++++.++
T Consensus       335 eil~~l~~  342 (367)
T 3l9p_A          335 IILERIEY  342 (367)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99998754

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.4e-45  Score=284.38  Aligned_cols=222  Identities=22%  Similarity=0.414  Sum_probs=194.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC--CCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--LSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~   78 (247)
                      +++.||+|++.....      ..+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++....  +++.
T Consensus        33 ~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  106 (269)
T 4hcu_A           33 NKDKVAIKTIREGAM------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE  106 (269)
T ss_dssp             TTEEEEEEEECTTSB------CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHH
T ss_pred             CCCeEEEEEeccccc------CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHH
Confidence            467899999975432      12468899999999999999999999999999999999999999999997643  8999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.......   .....++..|+|||.+.+..  +
T Consensus       107 ~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~  184 (269)
T 4hcu_A          107 TLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--Y  184 (269)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCC--C
T ss_pred             HHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCC--C
Confidence            999999999999999999999999999999999999999999999987554332   22333566799999996554  7


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      +.++|+||+|++++++++ |..||...........+........+...++++.+++.+||+.+|.+|||+++++++
T Consensus       185 ~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          185 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            899999999999999999 999999988888888887776777788899999999999999999999999999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=296.58  Aligned_cols=222  Identities=27%  Similarity=0.495  Sum_probs=196.0

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-------
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-------   74 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------   74 (247)
                      ..||||++...    ......+.+.+|+.+++++ +||||+++++++.+.+..++||||+++++|.+++....       
T Consensus       102 ~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~  177 (382)
T 3tt0_A          102 TKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS  177 (382)
T ss_dssp             EEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSC
T ss_pred             eEEEEEeeccc----cCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccc
Confidence            57999998643    3445567889999999999 89999999999999999999999999999999998753       


Q ss_pred             ----------CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCC
Q 041080           75 ----------LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTP  140 (247)
Q Consensus        75 ----------~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~  140 (247)
                                +++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.......    .....++.
T Consensus       178 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~  257 (382)
T 3tt0_A          178 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV  257 (382)
T ss_dssp             CCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGG
T ss_pred             cccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCc
Confidence                      8999999999999999999999999999999999999999999999999987554332    22334567


Q ss_pred             CccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCC
Q 041080          141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPN  219 (247)
Q Consensus       141 ~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  219 (247)
                      .|+|||.+.+..  ++.++||||||+++++|++ |..||...........+........+..+++++.+++.+||+.+|.
T Consensus       258 ~y~aPE~~~~~~--~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~  335 (382)
T 3tt0_A          258 KWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPS  335 (382)
T ss_dssp             GGSCHHHHHSCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGG
T ss_pred             ceeCHHHhcCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChh
Confidence            899999996544  7899999999999999999 9999998888888888877777777889999999999999999999


Q ss_pred             CCCChhhhhcC
Q 041080          220 DRPTVTELMEH  230 (247)
Q Consensus       220 ~Rps~~~il~~  230 (247)
                      +|||+++++++
T Consensus       336 ~Rps~~ell~~  346 (382)
T 3tt0_A          336 QRPTFKQLVED  346 (382)
T ss_dssp             GSCCHHHHHHH
T ss_pred             hCcCHHHHHHH
Confidence            99999999873

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6.5e-45  Score=291.51  Aligned_cols=232  Identities=23%  Similarity=0.433  Sum_probs=182.9

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcE------EEEEeccccCcHHHHHHhc----
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRL------YIFLELVTKGSLANLYQKY----   73 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~----   73 (247)
                      .||||++.....   .....+.+.+|+.++++++||||+++++++...+..      ++||||+.+++|.+++...    
T Consensus        53 ~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~  129 (323)
T 3qup_A           53 KVAVKMLKADII---ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE  129 (323)
T ss_dssp             EEEEEEC---------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC--
T ss_pred             eEEEEEeccccc---CHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccc
Confidence            799999975432   234467789999999999999999999998877655      9999999999999988643    


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----ccCCCCCCccCCc
Q 041080           74 ---HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCKGTPFWMAPE  146 (247)
Q Consensus        74 ---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~aPE  146 (247)
                         .+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+........    ....++..|+|||
T Consensus       130 ~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE  209 (323)
T 3qup_A          130 NPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALE  209 (323)
T ss_dssp             -CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHH
T ss_pred             cccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCch
Confidence               489999999999999999999999999999999999999999999999999865443321    1233566899999


Q ss_pred             ccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC--
Q 041080          147 VVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT--  223 (247)
Q Consensus       147 ~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps--  223 (247)
                      .+.+..  ++.++||||||+++|+|++ |..||...........+........+..+++++.+++.+||..+|.+|||  
T Consensus       210 ~~~~~~--~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  287 (323)
T 3qup_A          210 SLADNL--YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFT  287 (323)
T ss_dssp             HHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred             hhcCCC--CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHH
Confidence            986654  7899999999999999999 99999998888888887777777778889999999999999999999999  


Q ss_pred             -----hhhhhcCccCCCCCCCC
Q 041080          224 -----VTELMEHPFVKRPLQTP  240 (247)
Q Consensus       224 -----~~~il~~p~~~~~~~~~  240 (247)
                           ++++++|||+....+.|
T Consensus       288 ~l~~~l~~~l~~~~~~~~~~~p  309 (323)
T 3qup_A          288 CLRMELENILGHLSVLSTSQDP  309 (323)
T ss_dssp             HHHHHHHHHHHC----------
T ss_pred             HHHHHHHHHHHHhhhcCCCCCC
Confidence                 88888999998865554

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=7.8e-45  Score=296.26  Aligned_cols=229  Identities=28%  Similarity=0.454  Sum_probs=186.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcE------EEEEeccccCcHHHHHHhcC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRL------YIFLELVTKGSLANLYQKYH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~   74 (247)
                      +|+.||||++....   ......+.+.+|+.+++.++||||+++++++...+..      ++||||+.+ +|.+.+.. .
T Consensus        66 ~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~  140 (371)
T 4exu_A           66 SGEKVAIKKLSRPF---QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGM-E  140 (371)
T ss_dssp             TTEEEEEEEECSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCE-EHHHHTTS-C
T ss_pred             CCCEEEEEEecccc---cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEccccc-cHHHHhhc-C
Confidence            47899999997543   3345567888999999999999999999999877654      999999985 88887743 5


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+...... .....+++.|+|||.+.+.. .
T Consensus       141 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~-~  218 (371)
T 4exu_A          141 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-MTGYVVTRWYRAPEVILSWM-H  218 (371)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---------CTTCCCTTSCHHHHSCCS-C
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC-cCCcccCccccCHHHhcCCC-C
Confidence            999999999999999999999999999999999999999999999999998754432 34456899999999986532 3


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC---------------------------C---CCCCCCcCCH
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG---------------------------E---LPSVPSSLSR  204 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---------------------------~---~~~~~~~~~~  204 (247)
                      ++.++|+||||+++++|++|..||...+..+....+...                           .   .......+++
T Consensus       219 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
T 4exu_A          219 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASP  298 (371)
T ss_dssp             CCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCH
T ss_pred             CCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccCh
Confidence            789999999999999999999999887655554433210                           0   0011245789


Q ss_pred             HHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          205 DARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       205 ~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ++.++|.+||+.||.+|||++++++||||+..
T Consensus       299 ~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  330 (371)
T 4exu_A          299 QAADLLEKMLELDVDKRLTAAQALTHPFFEPF  330 (371)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence            99999999999999999999999999999864

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-44  Score=296.44  Aligned_cols=224  Identities=26%  Similarity=0.448  Sum_probs=183.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec------------------------------
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD------------------------------   50 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------------------------------   50 (247)
                      +|+.||||++......         ..+|+.+++.++||||+++++++..                              
T Consensus        31 ~~~~vAiK~~~~~~~~---------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  101 (383)
T 3eb0_A           31 SGKRFALKKVLQDPRY---------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHK  101 (383)
T ss_dssp             TCCEEEEEEEECCTTS---------CCHHHHHHTTCCCTTBCCEEEEEEEC-----------------------------
T ss_pred             CCCEEEEEEEecCcch---------HHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccc
Confidence            5889999999754321         1279999999999999999998843                              


Q ss_pred             --------CCcEEEEEeccccCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEc-CCCC
Q 041080           51 --------ENRLYIFLELVTKGSLANLYQK-----YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVD-ASGS  116 (247)
Q Consensus        51 --------~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~-~~~~  116 (247)
                              ....++||||+++ +|.+.+..     ..+++..++.++.|++.||.|||+.|++|+||||+||+++ .++.
T Consensus       102 ~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~  180 (383)
T 3eb0_A          102 SVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT  180 (383)
T ss_dssp             --------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTE
T ss_pred             cccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCc
Confidence                    3458999999986 88777653     3599999999999999999999999999999999999997 6889


Q ss_pred             eEEcccccccccCcc-ccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC--
Q 041080          117 VKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG--  193 (247)
Q Consensus       117 ~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--  193 (247)
                      ++|+|||.+...... ......++..|+|||.+.+.. .++.++||||+|+++|+|++|..||......+....+...  
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g  259 (383)
T 3eb0_A          181 LKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGAT-EYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMG  259 (383)
T ss_dssp             EEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             EEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCC-CCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            999999998754333 334556899999999986533 2789999999999999999999999887766655443210  


Q ss_pred             -----------------CCC---------CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          194 -----------------ELP---------SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       194 -----------------~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                                       ..+         .++...++++.++|.+||..+|.+|||+.|+++||||+.
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  327 (383)
T 3eb0_A          260 TPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH  327 (383)
T ss_dssp             CCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred             CCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence                             001         134568899999999999999999999999999999975

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.8e-45  Score=291.35  Aligned_cols=230  Identities=33%  Similarity=0.646  Sum_probs=188.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeec------CCcEEEEEeccccCcHHHHHHh-
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKD------ENRLYIFLELVTKGSLANLYQK-   72 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~-   72 (247)
                      +|+.||||++.....      ..+.+.+|+.+++++ +||||+++++++..      .+..++||||+++++|.+++.. 
T Consensus        48 ~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  121 (326)
T 2x7f_A           48 TGQLAAIKVMDVTGD------EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT  121 (326)
T ss_dssp             TCCEEEEEEEECCSS------TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHS
T ss_pred             CCCeEEEEEEecCcc------cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhc
Confidence            478999999975432      234678999999999 79999999999876      5688999999999999999976 


Q ss_pred             --cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCccc
Q 041080           73 --YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVV  148 (247)
Q Consensus        73 --~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~  148 (247)
                        ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......  ......++..|+|||.+
T Consensus       122 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  201 (326)
T 2x7f_A          122 KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI  201 (326)
T ss_dssp             GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHH
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhh
Confidence              35999999999999999999999999999999999999999999999999998654332  22344588999999998


Q ss_pred             ccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCC-CCCcCCHHHHHHHHHHhcCCCCCCCCh
Q 041080          149 NSK---NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPS-VPSSLSRDARDFILKCLQVNPNDRPTV  224 (247)
Q Consensus       149 ~~~---~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~  224 (247)
                      ...   ...++.++|+||||+++|+|++|..||...........+.....+. .+..+++.++++|.+||..+|.+|||+
T Consensus       202 ~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  281 (326)
T 2x7f_A          202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPAT  281 (326)
T ss_dssp             C--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             ccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCH
Confidence            532   2347889999999999999999999998877666655554443333 356789999999999999999999999


Q ss_pred             hhhhcCccCCCC
Q 041080          225 TELMEHPFVKRP  236 (247)
Q Consensus       225 ~~il~~p~~~~~  236 (247)
                      +++++||||+..
T Consensus       282 ~~ll~hp~~~~~  293 (326)
T 2x7f_A          282 EQLMKHPFIRDQ  293 (326)
T ss_dssp             HHHHTSHHHHCC
T ss_pred             HHHhhChHHhhC
Confidence            999999999864

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.8e-44  Score=292.18  Aligned_cols=231  Identities=29%  Similarity=0.512  Sum_probs=188.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC-----CcEEEEEeccccCcHHHHHHhcCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE-----NRLYIFLELVTKGSLANLYQKYHL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~   75 (247)
                      +|+.||||++...    ........+.+|+.++++++||||+++++++...     ...++||||+.+ +|.+++....+
T Consensus        35 ~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~  109 (353)
T 2b9h_A           35 TGEIVAIKKIEPF----DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQML  109 (353)
T ss_dssp             TTEEEEEEEECCC----SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCSE-EHHHHHHHCCC
T ss_pred             CCcEEEEEeeccc----ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccCc-cHHHHHhhcCC
Confidence            4789999999642    2344566788999999999999999999987653     688999999975 99999998889


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc------------cccCCCCCCcc
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND------------LKSCKGTPFWM  143 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~------------~~~~~~~~~~~  143 (247)
                      ++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+.......            .....|++.|+
T Consensus       110 ~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  189 (353)
T 2b9h_A          110 SDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR  189 (353)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGC
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhcccccccc
Confidence            999999999999999999999999999999999999999999999999986543221            12345788999


Q ss_pred             CCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc--C---------------------CCC----
Q 041080          144 APEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK--G---------------------ELP----  196 (247)
Q Consensus       144 aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~--~---------------------~~~----  196 (247)
                      |||.+.+.. .++.++|+||||+++++|++|..||...+.......+..  +                     ..+    
T Consensus       190 aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (353)
T 2b9h_A          190 APEVMLTSA-KYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPA  268 (353)
T ss_dssp             CHHHHHSCC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCC
T ss_pred             CCeeeccCC-CccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCC
Confidence            999875422 378999999999999999999999987765444332211  0                     000    


Q ss_pred             ----CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          197 ----SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       197 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                          .....+++++.+++.+||..||.+|||++++++||||+...
T Consensus       269 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          269 APLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             CCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             cchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence                11246889999999999999999999999999999998753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.9e-45  Score=284.41  Aligned_cols=226  Identities=27%  Similarity=0.508  Sum_probs=181.9

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQVS   81 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~   81 (247)
                      |+.||||++..... .......+.+.+|+.+++.++||||+++++++..++..++||||+++++|.++++...+++..++
T Consensus        30 ~~~vavK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  108 (271)
T 3dtc_A           30 GDEVAVKAARHDPD-EDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILV  108 (271)
T ss_dssp             TEEEEEEEC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTSSCCCHHHHH
T ss_pred             CCeEEEEEEecCCc-ccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhcCCCCHHHHH
Confidence            67899999876432 22234456788999999999999999999999999999999999999999999988889999999


Q ss_pred             HHHHHHHHHHHHhhhCC---eeecCCCCCcEEEcC--------CCCeEEcccccccccCccccccCCCCCCccCCccccc
Q 041080           82 SYTRQILNGLVYLHERN---VVHRDIKCANILVDA--------SGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNS  150 (247)
Q Consensus        82 ~~~~~l~~~l~~lh~~~---i~h~dl~~~ni~~~~--------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~  150 (247)
                      .++.|++.||.+||++|   ++|+||||+||+++.        ++.++|+|||.+............+++.|+|||.+.+
T Consensus       109 ~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~  188 (271)
T 3dtc_A          109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRA  188 (271)
T ss_dssp             HHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-------------CCGGGSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccccccCCCCccceeCHHHhcc
Confidence            99999999999999999   899999999999986        6789999999997666555556678999999999865


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC-CCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE-LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       151 ~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ..  ++.++|+||||++++++++|..||................ ....+..+++.+.+++.+||+.+|.+|||++++++
T Consensus       189 ~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  266 (271)
T 3dtc_A          189 SM--FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILD  266 (271)
T ss_dssp             CC--CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            54  7899999999999999999999998877766665554433 34566789999999999999999999999999986


Q ss_pred             C
Q 041080          230 H  230 (247)
Q Consensus       230 ~  230 (247)
                      +
T Consensus       267 ~  267 (271)
T 3dtc_A          267 Q  267 (271)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.2e-44  Score=282.62  Aligned_cols=221  Identities=24%  Similarity=0.440  Sum_probs=193.3

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~   79 (247)
                      +..||+|++.....      ..+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++...  .+++..
T Consensus        32 ~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  105 (268)
T 3sxs_A           32 QYDVAVKMIKEGSM------SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQ  105 (268)
T ss_dssp             TEEEEEEEECBTTB------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHH
T ss_pred             ceeEEEEEeccCCC------cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHH
Confidence            56799999975432      2345889999999999999999999999999999999999999999998764  499999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc---cCCCCCCccCCcccccCCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK---SCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.........   ...++..|+|||.+.+..  ++
T Consensus       106 ~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~  183 (268)
T 3sxs_A          106 LLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFK--YS  183 (268)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSE--EE
T ss_pred             HHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccC--Cc
Confidence            9999999999999999999999999999999999999999999998755443322   233456799999986554  78


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          157 LTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      .++|+||+|++++++++ |..||...........+........+...++.+.+++.+||+.+|.+|||+.+++++
T Consensus       184 ~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          184 SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            89999999999999998 999999888888887777777767778889999999999999999999999999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-45  Score=293.36  Aligned_cols=222  Identities=25%  Similarity=0.451  Sum_probs=194.6

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh---------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK---------   72 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---------   72 (247)
                      |+.||||++...    ......+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++..         
T Consensus        77 ~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  152 (343)
T 1luf_A           77 FTMVAVKMLKEE----ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL  152 (343)
T ss_dssp             EEEEEEEECCTT----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC------
T ss_pred             ceeEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCccccccc
Confidence            478999999643    2345567889999999999999999999999999999999999999999999976         


Q ss_pred             ----------------cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----
Q 041080           73 ----------------YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----  132 (247)
Q Consensus        73 ----------------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----  132 (247)
                                      ..+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+.......    
T Consensus       153 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  232 (343)
T 1luf_A          153 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA  232 (343)
T ss_dssp             ----------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC-
T ss_pred             ccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccc
Confidence                            458899999999999999999999999999999999999999999999999986443222    


Q ss_pred             cccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHH
Q 041080          133 LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL  211 (247)
Q Consensus       133 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  211 (247)
                      .....++..|+|||.+.+..  ++.++|+||||+++|+|++ |..||...........+..+.....+..+++++.+++.
T Consensus       233 ~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  310 (343)
T 1luf_A          233 DGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMR  310 (343)
T ss_dssp             ---CCBCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             cCCCcccceecChhhhccCC--cCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHH
Confidence            22344677899999986554  7899999999999999998 99999988888888877777777788899999999999


Q ss_pred             HHhcCCCCCCCChhhhhc
Q 041080          212 KCLQVNPNDRPTVTELME  229 (247)
Q Consensus       212 ~~l~~~p~~Rps~~~il~  229 (247)
                      +||+.+|.+|||++++++
T Consensus       311 ~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          311 LCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHcccCcccCCCHHHHHH
Confidence            999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=8.3e-45  Score=289.65  Aligned_cols=223  Identities=25%  Similarity=0.446  Sum_probs=194.6

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-------   74 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------   74 (247)
                      |+.||||++...    ......+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++....       
T Consensus        53 ~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  128 (314)
T 2ivs_A           53 YTTVAVKMLKEN----ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYL  128 (314)
T ss_dssp             EEEEEEEECCTT----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC
T ss_pred             cceEEEEeccCC----CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcc
Confidence            478999998643    235556788999999999999999999999999999999999999999999997632       


Q ss_pred             ------------------CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----
Q 041080           75 ------------------LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----  132 (247)
Q Consensus        75 ------------------~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----  132 (247)
                                        +++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+.......    
T Consensus       129 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  208 (314)
T 2ivs_A          129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVK  208 (314)
T ss_dssp             ----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEEC
T ss_pred             cccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEcccccccccccccccee
Confidence                              7899999999999999999999999999999999999999999999999986543322    


Q ss_pred             cccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHH
Q 041080          133 LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL  211 (247)
Q Consensus       133 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  211 (247)
                      .....++..|+|||.+.+..  ++.++|+||||+++|+|++ |..||...........+........+..+++++.+++.
T Consensus       209 ~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  286 (314)
T 2ivs_A          209 RSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLML  286 (314)
T ss_dssp             SSCCCSCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             ccCCCCcccccChhhhcCCC--cCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHH
Confidence            22333567799999986544  7899999999999999999 99999988887777777777777778899999999999


Q ss_pred             HHhcCCCCCCCChhhhhcC
Q 041080          212 KCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       212 ~~l~~~p~~Rps~~~il~~  230 (247)
                      +||..+|.+|||+++++++
T Consensus       287 ~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          287 QCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHccCChhhCcCHHHHHHH
Confidence            9999999999999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.5e-45  Score=293.76  Aligned_cols=231  Identities=25%  Similarity=0.392  Sum_probs=189.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC----cEEEEEeccccCcHHHHHHhc-CC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN----RLYIFLELVTKGSLANLYQKY-HL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~-~~   75 (247)
                      +|+.||||++.....  ........+.+|+.++++++||||+++++++....    ..++||||+++++|.++++.. .+
T Consensus        36 ~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~  113 (311)
T 3ork_A           36 DHRDVAVKVLRADLA--RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM  113 (311)
T ss_dssp             TTEEEEEEEECTTTT--TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSC
T ss_pred             CCceEEEEEeCcccc--CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCC
Confidence            478999999976432  34455678899999999999999999999887654    349999999999999999764 59


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-----cccCCCCCCccCCccccc
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNS  150 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~  150 (247)
                      ++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.......     .....|++.|+|||.+.+
T Consensus       114 ~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  193 (311)
T 3ork_A          114 TPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG  193 (311)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHT
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcC
Confidence            999999999999999999999999999999999999999999999999986543321     223458999999999966


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCC---CCCcCCHHHHHHHHHHhcCCCCCCCChhhh
Q 041080          151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPS---VPSSLSRDARDFILKCLQVNPNDRPTVTEL  227 (247)
Q Consensus       151 ~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  227 (247)
                      ..  ++.++||||||+++|+|++|..||...................   ....+++++.+++.+||+.||.+||++.++
T Consensus       194 ~~--~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~  271 (311)
T 3ork_A          194 DS--VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAE  271 (311)
T ss_dssp             CC--CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred             CC--CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHH
Confidence            54  7899999999999999999999998877766655544433221   134689999999999999999999999999


Q ss_pred             hcCccCCC
Q 041080          228 MEHPFVKR  235 (247)
Q Consensus       228 l~~p~~~~  235 (247)
                      +.|+|++.
T Consensus       272 l~~~l~~~  279 (311)
T 3ork_A          272 MRADLVRV  279 (311)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8.5e-45  Score=290.75  Aligned_cols=234  Identities=30%  Similarity=0.480  Sum_probs=184.3

Q ss_pred             CCceEEEEEEeecCCC---ccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCC
Q 041080            1 DGFFFAVKEVSLQDQG---AQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~   76 (247)
                      +|+.||||++......   .........+.+|+.++++++||||+++++++..++ .++||||+++++|.+++... .++
T Consensus        34 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~  112 (322)
T 2ycf_A           34 TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLK  112 (322)
T ss_dssp             TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCCC
T ss_pred             CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCCC
Confidence            4789999999764321   112233445889999999999999999999987665 89999999999999988654 599


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCC---eEEcccccccccCccc-cccCCCCCCccCCccccc-C
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS---VKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNS-K  151 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~---~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~-~  151 (247)
                      +..++.++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+....... .....+++.|+|||.+.+ .
T Consensus       113 ~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  192 (322)
T 2ycf_A          113 EATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVG  192 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCC
Confidence            9999999999999999999999999999999999987664   9999999987654332 223448899999999742 2


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhh-HHHHHhhcCCCCC---CCCcCCHHHHHHHHHHhcCCCCCCCChhhh
Q 041080          152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV-QALFRIGKGELPS---VPSSLSRDARDFILKCLQVNPNDRPTVTEL  227 (247)
Q Consensus       152 ~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  227 (247)
                      ...++.++|+||||+++|+|++|..||...... .....+..+....   ....+++.+.+++.+||..||.+|||++++
T Consensus       193 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~  272 (322)
T 2ycf_A          193 TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA  272 (322)
T ss_dssp             TTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             CCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHH
Confidence            334788999999999999999999999765433 2223333333222   225689999999999999999999999999


Q ss_pred             hcCccCCC
Q 041080          228 MEHPFVKR  235 (247)
Q Consensus       228 l~~p~~~~  235 (247)
                      ++||||+.
T Consensus       273 l~h~~~~~  280 (322)
T 2ycf_A          273 LRHPWLQD  280 (322)
T ss_dssp             HTSGGGCC
T ss_pred             hhCcCcCC
Confidence            99999985

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.3e-45  Score=300.97  Aligned_cols=232  Identities=13%  Similarity=0.118  Sum_probs=171.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc--CCCceeeec-------eeeecC-----------------CcE
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF--EQDNIVQYL-------GTDKDE-----------------NRL   54 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~-------~~~~~~-----------------~~~   54 (247)
                      +|+.||||++.....  ......+.+.+|+.+++.+  +||||++++       +++...                 ...
T Consensus        86 ~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~  163 (371)
T 3q60_A           86 RLEDFALKVFTMGAE--NSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANY  163 (371)
T ss_dssp             TTEEEEEEEEECCST--THHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEE
T ss_pred             CCceeEEEEEEeccc--ccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeE
Confidence            478999999987542  2345566778885555554  699988755       344332                 338


Q ss_pred             EEEEeccccCcHHHHHHhc--CCCHHHH------HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEccccccc
Q 041080           55 YIFLELVTKGSLANLYQKY--HLSDSQV------SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAK  126 (247)
Q Consensus        55 ~lv~e~~~~~~L~~~l~~~--~~~~~~~------~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~  126 (247)
                      ++||||++ ++|.++++..  .++...+      ..++.|++.||+|||++||+|+||||+||+++.++.++|+|||++.
T Consensus       164 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~  242 (371)
T 3q60_A          164 LLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW  242 (371)
T ss_dssp             EEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEE
T ss_pred             EEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceee
Confidence            99999998 6999999764  3555555      6778999999999999999999999999999999999999999997


Q ss_pred             ccCccccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHH-----hh--c-CCCCCC
Q 041080          127 ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR-----IG--K-GELPSV  198 (247)
Q Consensus       127 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~-----~~--~-~~~~~~  198 (247)
                      ....... ...+++.|+|||.+.+....++.++||||||+++|+|++|..||...........     ..  . ......
T Consensus       243 ~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (371)
T 3q60_A          243 KVGTRGP-ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGS  321 (371)
T ss_dssp             ETTCEEE-GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTT
T ss_pred             ecCCCcc-CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhh
Confidence            6654332 3345699999999966334489999999999999999999999976533211100     00  0 111122


Q ss_pred             CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          199 PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       199 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ...+++.+.++|.+||..||.+|||++++++||||+..
T Consensus       322 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          322 CTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            24789999999999999999999999999999999853

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.8e-44  Score=299.08  Aligned_cols=230  Identities=28%  Similarity=0.437  Sum_probs=185.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc------CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF------EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   74 (247)
                      +|+.||||++...      ......+.+|+.+++.+      .|+||+++++++...+..++||||+.+ +|.+++....
T Consensus       121 ~~~~vAvK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~  193 (429)
T 3kvw_A          121 VHQHVALKMVRNE------KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNK  193 (429)
T ss_dssp             TTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCCC-BHHHHHHHTT
T ss_pred             CCcEEEEEEECCc------cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccCC-CHHHHHHhcc
Confidence            4789999999642      33455677888888877      567999999999999999999999965 8988887653


Q ss_pred             ---CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCC--eEEcccccccccCccccccCCCCCCccCCcccc
Q 041080           75 ---LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS--VKLADFGLAKATTMNDLKSCKGTPFWMAPEVVN  149 (247)
Q Consensus        75 ---~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~  149 (247)
                         +++..++.++.|++.||.|||+.||+|+||||+||+++.++.  ++|+|||++..... ......+++.|+|||.+.
T Consensus       194 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~  272 (429)
T 3kvw_A          194 FQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ-RVYTYIQSRFYRAPEVIL  272 (429)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC-CCCSSCSCGGGCCHHHHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC-cccccCCCCCccChHHHh
Confidence               899999999999999999999999999999999999999887  99999999865443 233456899999999997


Q ss_pred             cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC----------------------CCC-----------
Q 041080          150 SKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG----------------------ELP-----------  196 (247)
Q Consensus       150 ~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~----------------------~~~-----------  196 (247)
                      +..  ++.++||||||+++|+|++|..||...+..+....+...                      ..+           
T Consensus       273 ~~~--~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
T 3kvw_A          273 GAR--YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDG  350 (429)
T ss_dssp             TBC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC-
T ss_pred             CCC--CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccc
Confidence            655  799999999999999999999999887665554332210                      000           


Q ss_pred             -------------------------CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCCCCC
Q 041080          197 -------------------------SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTP  240 (247)
Q Consensus       197 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~~~~  240 (247)
                                               .++...++++.+||.+||+.||.+|||++|+|+||||+.....+
T Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~~~~  419 (429)
T 3kvw_A          351 SVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKP  419 (429)
T ss_dssp             -CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC------
T ss_pred             cccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCCCCC
Confidence                                     01123478899999999999999999999999999999876544

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.4e-44  Score=285.04  Aligned_cols=230  Identities=30%  Similarity=0.531  Sum_probs=194.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-cCCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-YHLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~   79 (247)
                      +|+.||||++......   ....+.+.+|+.++++++||||+++++++...+..++||||+++++|.+.+.. ..+++..
T Consensus        46 ~~~~valK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  122 (287)
T 2wei_A           46 TQQEYAVKVINKASAK---NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD  122 (287)
T ss_dssp             TCCEEEEEEEEGGGBS---SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHH
T ss_pred             CCcEEEEEEecccccc---hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCHHH
Confidence            4789999999765432   22356788999999999999999999999999999999999999999887754 4699999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC---CCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS---GSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~---~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ++.++.|++.||.+||+.|++|+||+|+||+++.+   +.++|+|||.+....... .....+++.|+|||.+.+.   +
T Consensus       123 ~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~  199 (287)
T 2wei_A          123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT---Y  199 (287)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTC---C
T ss_pred             HHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcCC---C
Confidence            99999999999999999999999999999999764   469999999986544332 2223367889999998643   7


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCC---CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV---PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      +.++|+||||+++++|++|..||...........+..+.....   ...+++++.+++.+||..+|.+|||++++++|||
T Consensus       200 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~  279 (287)
T 2wei_A          200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW  279 (287)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred             CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHH
Confidence            8899999999999999999999998887777666655543221   2468999999999999999999999999999999


Q ss_pred             CCCC
Q 041080          233 VKRP  236 (247)
Q Consensus       233 ~~~~  236 (247)
                      |++.
T Consensus       280 ~~~~  283 (287)
T 2wei_A          280 IQKY  283 (287)
T ss_dssp             HHHH
T ss_pred             Hhcc
Confidence            9864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=298.50  Aligned_cols=227  Identities=28%  Similarity=0.436  Sum_probs=174.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeee--cCCcEEEEEeccccCcHHHHHHhc-----
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDK--DENRLYIFLELVTKGSLANLYQKY-----   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~-----   73 (247)
                      +|+.||||++.....       ...+.+|+.++++++||||+++++++.  .....++||||+.+ +|.+++...     
T Consensus        47 ~~~~vaiK~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~  118 (405)
T 3rgf_A           47 DDKDYALKQIEGTGI-------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKA  118 (405)
T ss_dssp             CCCCEEEEECSSSSC-------CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-
T ss_pred             CCeEEEEEEECCCCC-------CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccc
Confidence            367899999964322       124679999999999999999999984  46789999999976 787776532     


Q ss_pred             -----CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEE----cCCCCeEEcccccccccCcc-----ccccCCCC
Q 041080           74 -----HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV----DASGSVKLADFGLAKATTMN-----DLKSCKGT  139 (247)
Q Consensus        74 -----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~----~~~~~~~l~df~~~~~~~~~-----~~~~~~~~  139 (247)
                           .+++..++.++.|++.||.|||+.||+|+||||+||++    +.++.++|+|||++......     ......|+
T Consensus       119 ~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  198 (405)
T 3rgf_A          119 NKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT  198 (405)
T ss_dssp             ------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CC
T ss_pred             cccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceec
Confidence                 38999999999999999999999999999999999999    67789999999999754432     23345689


Q ss_pred             CCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhh---------HHHHHhhc--C-CCC-----------
Q 041080          140 PFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---------QALFRIGK--G-ELP-----------  196 (247)
Q Consensus       140 ~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---------~~~~~~~~--~-~~~-----------  196 (247)
                      +.|+|||.+.+.. .++.++||||||+++|+|++|..||......         +....+..  + ...           
T Consensus       199 ~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  277 (405)
T 3rgf_A          199 FWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPE  277 (405)
T ss_dssp             CTTCCHHHHTTCC-SCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTT
T ss_pred             CcccCchhhcCCC-cccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcc
Confidence            9999999986533 2789999999999999999999999654331         11111110  0 000           


Q ss_pred             -----------------------CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          197 -----------------------SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       197 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                                             ......++.+.+||.+||..||.+|||++|+|+||||+..
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~  340 (405)
T 3rgf_A          278 HSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLED  340 (405)
T ss_dssp             HHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSS
T ss_pred             hhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccC
Confidence                                   0011226788999999999999999999999999999874

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.9e-44  Score=285.45  Aligned_cols=230  Identities=32%  Similarity=0.548  Sum_probs=186.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc---CCCceeeeceeee-----cCCcEEEEEeccccCcHHHHHHh
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF---EQDNIVQYLGTDK-----DENRLYIFLELVTKGSLANLYQK   72 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~   72 (247)
                      +|+.||||++..........   ..+.+|+.+++.+   +||||+++++++.     .....++||||+.+ +|.+++..
T Consensus        36 ~~~~vavK~~~~~~~~~~~~---~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~  111 (326)
T 1blx_A           36 GGRFVALKRVRVQTGEEGMP---LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDK  111 (326)
T ss_dssp             TTEEEEEEEEEEEBCTTSCB---CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSC-BHHHHHHH
T ss_pred             CCEEEEEEEeccCcccccCC---chhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCCC-CHHHHHHh
Confidence            47889999997654322111   2344666666655   8999999999986     55688999999985 99999876


Q ss_pred             cC---CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-ccccCCCCCCccCCccc
Q 041080           73 YH---LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVV  148 (247)
Q Consensus        73 ~~---~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~  148 (247)
                      ..   +++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+...... ......++..|+|||.+
T Consensus       112 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~  191 (326)
T 1blx_A          112 VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL  191 (326)
T ss_dssp             SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHH
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCCCCccccccccceeCHHHH
Confidence            43   899999999999999999999999999999999999999999999999998765433 23445689999999999


Q ss_pred             ccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC--------------------------CCCCCCCcC
Q 041080          149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG--------------------------ELPSVPSSL  202 (247)
Q Consensus       149 ~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~  202 (247)
                      .+..  ++.++|+||||+++|+|++|..||...........+...                          ........+
T Consensus       192 ~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (326)
T 1blx_A          192 LQSS--YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI  269 (326)
T ss_dssp             TTCC--CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSC
T ss_pred             hcCC--CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccC
Confidence            6544  789999999999999999999999887766554443210                          011233568


Q ss_pred             CHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          203 SRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       203 ~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ++.+++++.+||..+|.+|||++++++||||+..
T Consensus       270 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  303 (326)
T 1blx_A          270 DELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  303 (326)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence            9999999999999999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7e-45  Score=297.08  Aligned_cols=223  Identities=24%  Similarity=0.439  Sum_probs=192.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.||||++...    ......+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++...  .+++.
T Consensus       138 ~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~  213 (377)
T 3cbl_A          138 DNTLVAVKSCRET----LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK  213 (377)
T ss_dssp             TCCEEEEEECCTT----SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHH
T ss_pred             CCeEEEEEEcccc----CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHH
Confidence            4789999998643    23444567889999999999999999999999999999999999999999998764  48999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccC----CCCCCccCCcccccCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSC----KGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~----~~~~~~~aPE~~~~~~~~  154 (247)
                      .++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++...........    .++..|+|||.+.+..  
T Consensus       214 ~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--  291 (377)
T 3cbl_A          214 TLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR--  291 (377)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCE--
T ss_pred             HHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCC--
Confidence            9999999999999999999999999999999999999999999999865433222111    1345699999986544  


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          155 YGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ++.++||||||+++|++++ |..||...........+..+.....+..+|+++.+++.+||+.+|.+|||++++++
T Consensus       292 ~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            7889999999999999998 99999988887777777777666778889999999999999999999999999975

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.7e-44  Score=291.28  Aligned_cols=229  Identities=28%  Similarity=0.458  Sum_probs=186.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCc------EEEEEeccccCcHHHHHHhcC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENR------LYIFLELVTKGSLANLYQKYH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~   74 (247)
                      +|+.||||++....   ......+.+.+|+.++++++||||+++++++...+.      .++||||+.+ +|.+++.. .
T Consensus        48 ~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~  122 (353)
T 3coi_A           48 SGEKVAIKKLSRPF---QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGL-K  122 (353)
T ss_dssp             TTEEEEEEEESSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSE-EGGGTTTS-C
T ss_pred             CCCEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEeccccC-CHHHHhcC-C
Confidence            48899999997543   334556778899999999999999999999887654      4999999975 88887753 5


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+...... .....+++.|+|||.+.+.. .
T Consensus       123 ~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-~~~~~~t~~y~aPE~~~~~~-~  200 (353)
T 3coi_A          123 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-MTGYVVTRWYRAPEVILSWM-H  200 (353)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---------CCSBCCSCHHHHSCCS-C
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC-ccccccCcCcCCHHHHhCcC-C
Confidence            999999999999999999999999999999999999999999999999998764432 33456889999999986522 3


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc------------------------------CCCCCCCCcCCH
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK------------------------------GELPSVPSSLSR  204 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~  204 (247)
                      ++.++|+||||+++++|++|..||...+..+....+..                              .........+++
T Consensus       201 ~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (353)
T 3coi_A          201 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASP  280 (353)
T ss_dssp             CCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCH
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCH
Confidence            78899999999999999999999987665444332211                              112233457899


Q ss_pred             HHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          205 DARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       205 ~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ++.++|.+||+.||.+|||++++++||||+..
T Consensus       281 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  312 (353)
T 3coi_A          281 QAADLLEKMLELDVDKRLTAAQALTHPFFEPF  312 (353)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            99999999999999999999999999999864

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.6e-44  Score=292.29  Aligned_cols=235  Identities=28%  Similarity=0.437  Sum_probs=183.5

Q ss_pred             CCceEEEEEEeecCCCc------cchHHHHHHHHHHHHHhhcCCCceeeeceeee-----cCCcEEEEEeccccCcHHHH
Q 041080            1 DGFFFAVKEVSLQDQGA------QGKQSILQLEQEISLLSQFEQDNIVQYLGTDK-----DENRLYIFLELVTKGSLANL   69 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~   69 (247)
                      +|+.||||++.......      ......+.+.+|+.++++++||||+++++++.     .....++||||+.+ +|.+.
T Consensus        45 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~  123 (362)
T 3pg1_A           45 EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQV  123 (362)
T ss_dssp             TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCSE-EHHHH
T ss_pred             CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCCC-CHHHH
Confidence            47899999997643321      22334578899999999999999999999984     33478999999985 88887


Q ss_pred             HHhc--CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCc
Q 041080           70 YQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPE  146 (247)
Q Consensus        70 l~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE  146 (247)
                      +...  .+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+....... .....+++.|+|||
T Consensus       124 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE  203 (362)
T 3pg1_A          124 IHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPE  203 (362)
T ss_dssp             HHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC---------------CGGGCCHH
T ss_pred             HHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcH
Confidence            7654  48999999999999999999999999999999999999999999999999986443332 33455888999999


Q ss_pred             ccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc-----------------------CCCC-------
Q 041080          147 VVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK-----------------------GELP-------  196 (247)
Q Consensus       147 ~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-----------------------~~~~-------  196 (247)
                      .+.+.. .++.++|+||||+++|++++|..||...........+..                       ....       
T Consensus       204 ~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (362)
T 3pg1_A          204 LVMQFK-GFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAW  282 (362)
T ss_dssp             HHTTCT-TCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCH
T ss_pred             HhcCCC-CCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhH
Confidence            986533 378999999999999999999999988765554433321                       0011       


Q ss_pred             -CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          197 -SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       197 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                       ......++.+.++|.+||..+|.+|||++++++||||+...
T Consensus       283 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          283 TAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             HHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence             11245688999999999999999999999999999999863

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=288.13  Aligned_cols=229  Identities=29%  Similarity=0.482  Sum_probs=188.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeee--------------cCCcEEEEEeccccCcH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDK--------------DENRLYIFLELVTKGSL   66 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--------------~~~~~~lv~e~~~~~~L   66 (247)
                      +|+.||||++...     .....+.+.+|+.++++++||||+++++++.              ..+..++||||+.+ +|
T Consensus        35 ~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L  108 (320)
T 2i6l_A           35 CDKRVAIKKIVLT-----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DL  108 (320)
T ss_dssp             TTEEEEEEEEECC-----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSE-EH
T ss_pred             CCeEEEEEEEecC-----ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccCC-CH
Confidence            4789999999743     3455677889999999999999999998863              44688999999985 99


Q ss_pred             HHHHHhcCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEc-CCCCeEEcccccccccCcc-----ccccCCCCC
Q 041080           67 ANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVD-ASGSVKLADFGLAKATTMN-----DLKSCKGTP  140 (247)
Q Consensus        67 ~~~l~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~-~~~~~~l~df~~~~~~~~~-----~~~~~~~~~  140 (247)
                      .++++...+++..++.++.|++.||.+||++|++|+||||+||+++ .++.++|+|||.+......     ......++.
T Consensus       109 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~  188 (320)
T 2i6l_A          109 ANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK  188 (320)
T ss_dssp             HHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCC
T ss_pred             HHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccc
Confidence            9999888899999999999999999999999999999999999997 5678999999998754322     122334688


Q ss_pred             CccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC-------------------------
Q 041080          141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL-------------------------  195 (247)
Q Consensus       141 ~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------------  195 (247)
                      .|+|||.+.+.. .++.++|+||||+++|+|++|..||...........+.....                         
T Consensus       189 ~y~aPE~~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (320)
T 2i6l_A          189 WYRSPRLLLSPN-NYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEP  267 (320)
T ss_dssp             TTCCHHHHHCTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSC
T ss_pred             cccCcHHhcCcc-cCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCC
Confidence            899999886432 378999999999999999999999987766554433321110                         


Q ss_pred             ----CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          196 ----PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       196 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                          ......++.++++++.+||+.||.+|||++++++||||+..
T Consensus       268 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (320)
T 2i6l_A          268 HKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY  312 (320)
T ss_dssp             CCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             CCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence                01224689999999999999999999999999999999864

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.8e-44  Score=283.64  Aligned_cols=227  Identities=27%  Similarity=0.478  Sum_probs=180.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec-------------CCcEEEEEeccccCcHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD-------------ENRLYIFLELVTKGSLA   67 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------------~~~~~lv~e~~~~~~L~   67 (247)
                      +|+.||||++..      .....+.+.+|+.++++++||||+++++++.+             .+..++||||+++++|.
T Consensus        30 ~~~~vaiK~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~  103 (303)
T 1zy4_A           30 DSRYYAIKKIRH------TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLY  103 (303)
T ss_dssp             TCCEEEEEEEEE------EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHH
T ss_pred             CCeEEEEEEEec------cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHH
Confidence            588999999964      23456778899999999999999999998754             45789999999999999


Q ss_pred             HHHHhcC--CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--------------
Q 041080           68 NLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--------------  131 (247)
Q Consensus        68 ~~l~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--------------  131 (247)
                      +++...+  +++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+......              
T Consensus       104 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~  183 (303)
T 1zy4_A          104 DLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS  183 (303)
T ss_dssp             HHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC---------------
T ss_pred             HhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhcccccccccc
Confidence            9997654  778899999999999999999999999999999999999999999999998654321              


Q ss_pred             --ccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCh-hhHHHHHhhcC---CCCCCCCcCCHH
Q 041080          132 --DLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLE-GVQALFRIGKG---ELPSVPSSLSRD  205 (247)
Q Consensus       132 --~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~~~---~~~~~~~~~~~~  205 (247)
                        ......++..|+|||.+.+.. .++.++|+||||+++|+|++   ||.... .......+...   ..+..+...++.
T Consensus       184 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (303)
T 1zy4_A          184 SDNLTSAIGTAMYVATEVLDGTG-HYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKV  259 (303)
T ss_dssp             ----------CTTSCHHHHTSCS-CCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHH
T ss_pred             ccccccCCCcccccCcccccCCC-CCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHH
Confidence              123345888999999986432 37899999999999999998   554322 22233333222   223445667888


Q ss_pred             HHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          206 ARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       206 ~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      +++++.+||+.||.+|||++++++||||+...
T Consensus       260 ~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (303)
T 1zy4_A          260 EKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH  291 (303)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred             HHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence            99999999999999999999999999998653

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.9e-44  Score=282.59  Aligned_cols=221  Identities=22%  Similarity=0.434  Sum_probs=193.9

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~   79 (247)
                      +..||+|++.....      ..+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++..  ..+++..
T Consensus        48 ~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  121 (283)
T 3gen_A           48 QYDVAIKMIKEGSM------SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ  121 (283)
T ss_dssp             TEEEEEEEECTTSB------CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHH
T ss_pred             CCeEEEEEecCCCC------CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHH
Confidence            56899999975432      134578999999999999999999999999999999999999999999976  4699999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc---ccCCCCCCccCCcccccCCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL---KSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+........   ....++..|+|||.+.+..  ++
T Consensus       122 ~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~  199 (283)
T 3gen_A          122 LLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK--FS  199 (283)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCC--CS
T ss_pred             HHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCC--CC
Confidence            999999999999999999999999999999999999999999999875543322   2333566799999997554  78


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          157 LTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      .++|+||+|+++|++++ |..||...........+........+...++.+.+++.+||+.+|.+|||+++++++
T Consensus       200 ~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          200 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             chhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            99999999999999998 999999988888888877776667778889999999999999999999999999875

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.3e-44  Score=289.04  Aligned_cols=227  Identities=27%  Similarity=0.449  Sum_probs=183.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeec--CCcEEEEEeccccCcHHHHHHhcCCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKD--ENRLYIFLELVTKGSLANLYQKYHLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~   77 (247)
                      +|+.||||++....        .+.+.+|+.++++++ ||||+++++++..  ....++||||+++++|.++++.  +++
T Consensus        60 ~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~  129 (330)
T 3nsz_A           60 NNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--LTD  129 (330)
T ss_dssp             TCCEEEEEEECSCC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG--CCH
T ss_pred             CCcEEEEEEecccc--------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh--CCH
Confidence            47899999986321        346789999999997 9999999999987  6788999999999999998864  899


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC-CeEEcccccccccCcc-ccccCCCCCCccCCcccccCCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG-SVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~-~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ..++.++.|++.||.+||++|++|+||||+||+++.++ .++|+|||.+...... ......++..|+|||.+.+.. .+
T Consensus       130 ~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~  208 (330)
T 3nsz_A          130 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ-MY  208 (330)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCC-CC
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCC-cC
Confidence            99999999999999999999999999999999999777 8999999998754433 234456888999999986532 37


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhh-HHHH-------------HhhcCC-----------------------CCCC
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGV-QALF-------------RIGKGE-----------------------LPSV  198 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~-------------~~~~~~-----------------------~~~~  198 (247)
                      +.++||||||+++++|++|..||...... +...             .+....                       ....
T Consensus       209 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (330)
T 3nsz_A          209 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSEN  288 (330)
T ss_dssp             CTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTT
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccc
Confidence            89999999999999999999998433211 1111             111100                       0111


Q ss_pred             CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCCC
Q 041080          199 PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQ  238 (247)
Q Consensus       199 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~~  238 (247)
                      +..+++++.++|.+||+.||.+|||++++++||||+....
T Consensus       289 ~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          289 QHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             GGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             cccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence            2237999999999999999999999999999999998643

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.1e-44  Score=280.99  Aligned_cols=222  Identities=29%  Similarity=0.487  Sum_probs=182.4

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~   79 (247)
                      +..||+|.+...    ......+.+.+|+.++++++||||+++++++. ++..++||||+++++|.+++...  .+++..
T Consensus        43 ~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  117 (281)
T 1mp8_A           43 ALAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLAS  117 (281)
T ss_dssp             CEEEEEEECTTT----TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHH
T ss_pred             ceEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHH
Confidence            446889887542    33456678899999999999999999999974 56789999999999999999765  489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc---ccCCCCCCccCCcccccCCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL---KSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+........   ....+++.|+|||.+.+..  ++
T Consensus       118 ~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~  195 (281)
T 1mp8_A          118 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR--FT  195 (281)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCC--CS
T ss_pred             HHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCC--CC
Confidence            999999999999999999999999999999999999999999999875543321   2233567899999986544  78


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          157 LTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      .++|+||||+++|++++ |..||......+....+........+..+++.+.+++.+||..+|.+|||+++++++
T Consensus       196 ~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          196 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            89999999999999996 999999888888887777777677788999999999999999999999999999863

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.4e-44  Score=296.84  Aligned_cols=219  Identities=29%  Similarity=0.494  Sum_probs=189.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC-cEEEEEeccccCcHHHHHHhcC---CC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN-RLYIFLELVTKGSLANLYQKYH---LS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~---~~   76 (247)
                      +|+.||||++....       ..+.+.+|+.++++++||||+++++++...+ ..++||||+++|+|.+++...+   ++
T Consensus       215 ~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~  287 (450)
T 1k9a_A          215 RGNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG  287 (450)
T ss_dssp             TTEEEEEEEESSCT-------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCC
T ss_pred             cCCeEEEEEeCCch-------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCC
Confidence            36789999996432       3456889999999999999999999976654 7999999999999999997654   68


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      +..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....... ....++..|+|||.+.+..  ++
T Consensus       288 ~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~y~aPE~~~~~~--~~  364 (450)
T 1k9a_A          288 GDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWTAPEALREKK--FS  364 (450)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-------CCCTTTSCHHHHHSSC--CC
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-cCCCCCcceeCHHHhcCCC--CC
Confidence            99999999999999999999999999999999999999999999999987544322 2235678899999996554  89


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          157 LTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      .++||||||+++|+|++ |..||......+....+..+.....+..+|+++.++|.+||..+|.+|||+.++++
T Consensus       365 ~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          365 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999999999998 99999988888887777777667778899999999999999999999999999875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-44  Score=282.33  Aligned_cols=223  Identities=26%  Similarity=0.445  Sum_probs=193.7

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~   79 (247)
                      |..||||++...    ......+.+.+|+.++++++||||+++++++ ..+..++||||+++++|.+++...  .+++..
T Consensus        37 ~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  111 (287)
T 1u59_A           37 QIDVAIKVLKQG----TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSN  111 (287)
T ss_dssp             CEEEEEEEECSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHH
T ss_pred             cceEEEEecCCc----cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHH
Confidence            667999999753    2345677899999999999999999999998 456799999999999999998543  489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-----cccCCCCCCccCCcccccCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      ++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......     .....++..|+|||.+.+..  
T Consensus       112 ~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--  189 (287)
T 1u59_A          112 VAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--  189 (287)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE--
T ss_pred             HHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCC--
Confidence            99999999999999999999999999999999999999999999987554322     12233567899999986544  


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          155 YGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                      ++.++|+||||+++++|++ |..||...........+.....+..+..+++++.+++.+||..+|.+|||+++++++.
T Consensus       190 ~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          190 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            7889999999999999998 9999998888877777777777778889999999999999999999999999999854

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4e-44  Score=292.06  Aligned_cols=222  Identities=23%  Similarity=0.441  Sum_probs=183.0

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~   79 (247)
                      |..||||++...    ......+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++.+.  .+++..
T Consensus        73 ~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~  148 (373)
T 2qol_A           73 EISVAIKTLKVG----YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ  148 (373)
T ss_dssp             BCCEEEEECCTT----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHH
T ss_pred             ceeEEEEEecCc----cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHH
Confidence            567999998643    23455677999999999999999999999999999999999999999999999765  489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc-----ccCCCCCCccCCcccccCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL-----KSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      ++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........     ....++..|+|||.+.+..  
T Consensus       149 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--  226 (373)
T 2qol_A          149 LVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK--  226 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCC--
T ss_pred             HHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCC--
Confidence            999999999999999999999999999999999999999999999875543221     1122456799999996554  


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          155 YGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ++.++||||||+++|++++ |..||...........+........+..++..+.+++.+||+.+|.+||+++++++
T Consensus       227 ~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            7899999999999999997 99999888877777776666555566788999999999999999999999999876

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.7e-44  Score=278.58  Aligned_cols=222  Identities=22%  Similarity=0.406  Sum_probs=193.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +++.||+|++.....      ..+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++...  .+++.
T Consensus        31 ~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  104 (267)
T 3t9t_A           31 NKDKVAIKTIREGAM------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAE  104 (267)
T ss_dssp             TTEEEEEEEECTTTB------CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHH
T ss_pred             CCCeEEEEEccccCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHH
Confidence            367899999975432      2356889999999999999999999999999999999999999999999765  38999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......   .....++..|+|||.+.+..  +
T Consensus       105 ~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~  182 (267)
T 3t9t_A          105 TLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--Y  182 (267)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCC--C
T ss_pred             HHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCC--c
Confidence            999999999999999999999999999999999999999999999987544322   22334567899999996544  7


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      +.++|+||||+++|+|++ |..||...........+........+...++.+.+++.+||+.+|.+|||+++++++
T Consensus       183 ~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          183 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            899999999999999999 899999888877777777776666778899999999999999999999999999864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=286.43  Aligned_cols=219  Identities=25%  Similarity=0.466  Sum_probs=182.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~   78 (247)
                      +|+.||+|++..     ......+.+.+|+.++++++||||+++++++.+++..++||||+++++|.++++.  ..+++.
T Consensus        34 ~~~~va~K~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  108 (310)
T 3s95_A           34 TGEVMVMKELIR-----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWS  108 (310)
T ss_dssp             TCCEEEEEEESC-----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHH
T ss_pred             CCcEEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHH
Confidence            478899998853     3455677899999999999999999999999999999999999999999999987  358999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----------------ccCCCCCCc
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----------------KSCKGTPFW  142 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----------------~~~~~~~~~  142 (247)
                      .++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+........                ....|++.|
T Consensus       109 ~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  188 (310)
T 3s95_A          109 QRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW  188 (310)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGG
T ss_pred             HHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcce
Confidence            9999999999999999999999999999999999999999999999865432221                134588999


Q ss_pred             cCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHH-----HHHhhcCCCCCCCCcCCHHHHHHHHHHhcCC
Q 041080          143 MAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQA-----LFRIGKGELPSVPSSLSRDARDFILKCLQVN  217 (247)
Q Consensus       143 ~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  217 (247)
                      +|||.+.+..  ++.++||||||+++|++++|..|+........     .....   ....+..+++.+.+++.+||+.+
T Consensus       189 ~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~d  263 (310)
T 3s95_A          189 MAPEMINGRS--YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL---DRYCPPNCPPSFFPITVRCCDLD  263 (310)
T ss_dssp             CCHHHHTTCC--CCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH---HHTCCTTCCTTHHHHHHHHTCSS
T ss_pred             eCHHHhcCCC--CCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc---cccCCCCCCHHHHHHHHHHccCC
Confidence            9999996544  78999999999999999999988754322111     00000   01235677889999999999999


Q ss_pred             CCCCCChhhhhc
Q 041080          218 PNDRPTVTELME  229 (247)
Q Consensus       218 p~~Rps~~~il~  229 (247)
                      |.+|||++++++
T Consensus       264 P~~Rps~~~l~~  275 (310)
T 3s95_A          264 PEKRPSFVKLEH  275 (310)
T ss_dssp             GGGSCCHHHHHH
T ss_pred             hhhCcCHHHHHH
Confidence            999999999986

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-44  Score=288.17  Aligned_cols=228  Identities=24%  Similarity=0.402  Sum_probs=182.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC--cEEEEEeccccCcHHHHHHhcC----
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN--RLYIFLELVTKGSLANLYQKYH----   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~----   74 (247)
                      +|+.||||++.....    ....+.+.+|+.++++++||||+++++++...+  ..++||||+++++|.++++...    
T Consensus        33 ~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~  108 (319)
T 4euu_A           33 TGDLFAIKVFNNISF----LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG  108 (319)
T ss_dssp             TCCEEEEEEECGGGG----GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTC
T ss_pred             CCcEEEEEEeccccc----cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccC
Confidence            478999999975322    223556779999999999999999999987655  7899999999999999997643    


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEE----cCCCCeEEcccccccccCccc-cccCCCCCCccCCcccc
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV----DASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVN  149 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~----~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~  149 (247)
                      +++..++.++.|++.||.+||+.|++|+||||+||++    +.++.++|+|||.+....... .....++..|+|||.+.
T Consensus       109 ~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~  188 (319)
T 4euu_A          109 LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE  188 (319)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhh
Confidence            8999999999999999999999999999999999999    777789999999987654333 33456899999999975


Q ss_pred             cC------CCCCCcchhHHHHHHHHHHHHhCCCCCCCChh----hHHHHHhhcCCC------------------------
Q 041080          150 SK------NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG----VQALFRIGKGEL------------------------  195 (247)
Q Consensus       150 ~~------~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~----~~~~~~~~~~~~------------------------  195 (247)
                      ..      ...++.++||||||+++|+|++|..||.....    ......+.....                        
T Consensus       189 ~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (319)
T 4euu_A          189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVS  268 (319)
T ss_dssp             HHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTT
T ss_pred             hccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcc
Confidence            21      23478899999999999999999999964332    222222222111                        


Q ss_pred             CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          196 PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       196 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      ..++..+++.+.+++.+||+.||.+|||++|+++||-
T Consensus       269 ~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          269 CSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             cccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            0122345678999999999999999999999999884

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=8.5e-44  Score=292.16  Aligned_cols=225  Identities=28%  Similarity=0.426  Sum_probs=179.7

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC------cEEEEEeccccCcHHHHHH----
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN------RLYIFLELVTKGSLANLYQ----   71 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~----   71 (247)
                      +..+|+|++......         ..+|+.+++.++||||+++++++...+      ..++||||++++.+.....    
T Consensus        64 ~~~~aikk~~~~~~~---------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~  134 (394)
T 4e7w_A           64 SDEVAIKKVLQDKRF---------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKL  134 (394)
T ss_dssp             TEEEEEEEEECCTTS---------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCcch---------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhh
Confidence            445889988654321         127999999999999999999985433      3889999998854433332    


Q ss_pred             hcCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEc-CCCCeEEcccccccccCcc-ccccCCCCCCccCCcccc
Q 041080           72 KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVD-ASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVN  149 (247)
Q Consensus        72 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~-~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~  149 (247)
                      ...+++..++.++.|++.||.|||++||+|+||||+||+++ .++.++|+|||.+...... ......+++.|+|||.+.
T Consensus       135 ~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~  214 (394)
T 4e7w_A          135 KQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIF  214 (394)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHc
Confidence            34599999999999999999999999999999999999999 7899999999998754332 334556899999999986


Q ss_pred             cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC-------------------CCC---------CCCCc
Q 041080          150 SKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG-------------------ELP---------SVPSS  201 (247)
Q Consensus       150 ~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~~~---------~~~~~  201 (247)
                      +.. .++.++||||+|+++|+|++|..||......+....+...                   ..+         .++..
T Consensus       215 ~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (394)
T 4e7w_A          215 GAT-NYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPR  293 (394)
T ss_dssp             TCS-SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTT
T ss_pred             CCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhcccc
Confidence            533 2789999999999999999999999887765554433210                   111         12235


Q ss_pred             CCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          202 LSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       202 ~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      .++++.++|.+||..||.+|||+.++++||||+..
T Consensus       294 ~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          294 TPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred             CCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence            78999999999999999999999999999999975

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.4e-44  Score=286.66  Aligned_cols=223  Identities=26%  Similarity=0.486  Sum_probs=193.6

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH------   74 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------   74 (247)
                      |..||||++...    ......+.+.+|+.+++++ +||||+++++++...+..++||||+++++|.+++....      
T Consensus        67 ~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  142 (334)
T 2pvf_A           67 AVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY  142 (334)
T ss_dssp             -CEEEEEECCTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCS
T ss_pred             ceEEEEeeeccC----CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccc
Confidence            567999998643    2345567889999999999 89999999999999999999999999999999997643      


Q ss_pred             -----------CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCC
Q 041080           75 -----------LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGT  139 (247)
Q Consensus        75 -----------~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~  139 (247)
                                 +++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.......    .....++
T Consensus       143 ~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~  222 (334)
T 2pvf_A          143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP  222 (334)
T ss_dssp             CC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCC
T ss_pred             cccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcc
Confidence                       7899999999999999999999999999999999999999999999999986544322    2233456


Q ss_pred             CCccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCC
Q 041080          140 PFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP  218 (247)
Q Consensus       140 ~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  218 (247)
                      ..|+|||.+.+..  ++.++||||||+++|+|++ |..||...........+........+..++.++.+++.+||..+|
T Consensus       223 ~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp  300 (334)
T 2pvf_A          223 VKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVP  300 (334)
T ss_dssp             GGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred             cceeChHHhcCCC--cChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCCh
Confidence            7899999986544  7899999999999999999 999999888777777777766667788899999999999999999


Q ss_pred             CCCCChhhhhcC
Q 041080          219 NDRPTVTELMEH  230 (247)
Q Consensus       219 ~~Rps~~~il~~  230 (247)
                      .+|||+++++++
T Consensus       301 ~~Rps~~ell~~  312 (334)
T 2pvf_A          301 SQRPTFKQLVED  312 (334)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             hhCcCHHHHHHH
Confidence            999999999863

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.2e-44  Score=291.45  Aligned_cols=223  Identities=26%  Similarity=0.468  Sum_probs=187.2

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCC-cEEEEEeccccCcHHHHHHhcC-----
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDEN-RLYIFLELVTKGSLANLYQKYH-----   74 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~-----   74 (247)
                      |+.||||++...    ......+.+.+|+.++.++ +||||+++++++.+.+ ..++||||+++|+|.+++....     
T Consensus        52 ~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~  127 (359)
T 3vhe_A           52 CRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP  127 (359)
T ss_dssp             EEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCS
T ss_pred             ceEEEEEEecCc----CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccc
Confidence            578999999643    3344567789999999999 7899999999988755 4899999999999999987542     


Q ss_pred             --------------------------------------------------------------CCHHHHHHHHHHHHHHHH
Q 041080           75 --------------------------------------------------------------LSDSQVSSYTRQILNGLV   92 (247)
Q Consensus        75 --------------------------------------------------------------~~~~~~~~~~~~l~~~l~   92 (247)
                                                                                    +++..++.++.|++.||.
T Consensus       128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~  207 (359)
T 3vhe_A          128 YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME  207 (359)
T ss_dssp             CC------------------------------------------------------CTTTTCBCHHHHHHHHHHHHHHHH
T ss_pred             cccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHH
Confidence                                                                          889999999999999999


Q ss_pred             HhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCCcccccCCCCCCcchhHHHHHHHH
Q 041080           93 YLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV  168 (247)
Q Consensus        93 ~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll  168 (247)
                      |||++|++|+||||+||+++.++.++|+|||.+.......    .....++..|+|||.+.+..  ++.++||||||+++
T Consensus       208 ~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il  285 (359)
T 3vhe_A          208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLL  285 (359)
T ss_dssp             HHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCC--CCHHHHHHHHHHHH
T ss_pred             HHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCC--CCchhhhhhHHHHH
Confidence            9999999999999999999999999999999987543322    22344677899999987544  78999999999999


Q ss_pred             HHHHh-CCCCCCCChhhHH-HHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          169 LEMLT-RRPPYSHLEGVQA-LFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       169 ~~l~~-g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      |+|++ |..||........ ...+........+..+++++.+++.+||..+|.+|||++++++|
T Consensus       286 ~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          286 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            99998 9999977654433 34444455566778899999999999999999999999999875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6.4e-44  Score=285.58  Aligned_cols=223  Identities=26%  Similarity=0.428  Sum_probs=193.9

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh---------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK---------   72 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---------   72 (247)
                      |+.||||.+...    ........+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++..         
T Consensus        55 ~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  130 (322)
T 1p4o_A           55 ETRVAIKTVNEA----ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP  130 (322)
T ss_dssp             EEEEEEEECCTT----SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCT
T ss_pred             ceEEEEEecccc----cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCC
Confidence            567999998643    2344566788999999999999999999999999999999999999999999865         


Q ss_pred             --cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCCc
Q 041080           73 --YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPE  146 (247)
Q Consensus        73 --~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aPE  146 (247)
                        ..+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+.......    .....+++.|+|||
T Consensus       131 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  210 (322)
T 1p4o_A          131 VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE  210 (322)
T ss_dssp             TCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred             CCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChh
Confidence              246899999999999999999999999999999999999999999999999987544332    12233577899999


Q ss_pred             ccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChh
Q 041080          147 VVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT  225 (247)
Q Consensus       147 ~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  225 (247)
                      .+.+..  ++.++|+||||+++|+|++ |..||...........+........+..+++.+.+++.+||..+|.+|||++
T Consensus       211 ~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  288 (322)
T 1p4o_A          211 SLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFL  288 (322)
T ss_dssp             HHHHCC--CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hhccCC--CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence            986544  7899999999999999999 8999998888888777777777777889999999999999999999999999


Q ss_pred             hhhcC
Q 041080          226 ELMEH  230 (247)
Q Consensus       226 ~il~~  230 (247)
                      +++++
T Consensus       289 e~l~~  293 (322)
T 1p4o_A          289 EIISS  293 (322)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99985

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=9.8e-44  Score=286.08  Aligned_cols=226  Identities=24%  Similarity=0.335  Sum_probs=185.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCC------ceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQD------NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   74 (247)
                      +|+.||||++..      .....+.+.+|+.+++.++|+      +++++++++...+..++||||+ +++|.+++...+
T Consensus        39 ~~~~vavK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~  111 (339)
T 1z57_A           39 GGRHVAVKIVKN------VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENG  111 (339)
T ss_dssp             TTEEEEEEEECS------SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT
T ss_pred             CCcEEEEEEEec------CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcC
Confidence            478899999853      234456788999999988765      4999999999999999999999 779999887653


Q ss_pred             ---CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC-------------------CCCeEEcccccccccCccc
Q 041080           75 ---LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA-------------------SGSVKLADFGLAKATTMND  132 (247)
Q Consensus        75 ---~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~-------------------~~~~~l~df~~~~~~~~~~  132 (247)
                         +++..++.++.|++.||.+||++|++|+||||+||+++.                   ++.++|+|||.+...... 
T Consensus       112 ~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-  190 (339)
T 1z57_A          112 FLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-  190 (339)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-
T ss_pred             CCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-
Confidence               889999999999999999999999999999999999987                   668999999998754432 


Q ss_pred             cccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC--CC---------------
Q 041080          133 LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG--EL---------------  195 (247)
Q Consensus       133 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--~~---------------  195 (247)
                      .....+++.|+|||.+.+..  ++.++|+||||+++|++++|..||...+..+....+...  ..               
T Consensus       191 ~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  268 (339)
T 1z57_A          191 HSTLVSTRHYRAPEVILALG--WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFH  268 (339)
T ss_dssp             CCSSCSCGGGCCHHHHTTSC--CCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEE
T ss_pred             cccccCCccccChHHhhCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHh
Confidence            33456899999999996544  789999999999999999999999877655543322110  00               


Q ss_pred             --------------------------CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          196 --------------------------PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       196 --------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                                                ...+...++++.+++.+||..||.+|||++++++||||+..
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  335 (339)
T 1z57_A          269 HDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL  335 (339)
T ss_dssp             TTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred             hccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHH
Confidence                                      01122346789999999999999999999999999999875

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-43  Score=293.69  Aligned_cols=225  Identities=27%  Similarity=0.409  Sum_probs=179.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC------CcEEEEEeccccCcHHHHHHh--
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE------NRLYIFLELVTKGSLANLYQK--   72 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~--   72 (247)
                      +|+.||||++.....         ...+|+.+++.++||||+++++++...      ..+++||||+++ +|.+.+..  
T Consensus        78 ~~~~vaiK~~~~~~~---------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~  147 (420)
T 1j1b_A           78 SGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYS  147 (420)
T ss_dssp             TCCEEEEEEEECCTT---------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHH
T ss_pred             CCcEEEEEEecccch---------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHh
Confidence            488999999965321         123799999999999999999987432      246799999987 66665542  


Q ss_pred             ---cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC-CCeEEcccccccccCcc-ccccCCCCCCccCCcc
Q 041080           73 ---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEV  147 (247)
Q Consensus        73 ---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~-~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~  147 (247)
                         ..+++..++.++.|++.||.|||++||+|+||||+||+++.+ +.++|+|||++...... ......+++.|+|||.
T Consensus       148 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~  227 (420)
T 1j1b_A          148 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL  227 (420)
T ss_dssp             HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHH
T ss_pred             hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHH
Confidence               359999999999999999999999999999999999999965 56899999999754332 2344568999999999


Q ss_pred             cccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC-------------------CCCC---------CC
Q 041080          148 VNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG-------------------ELPS---------VP  199 (247)
Q Consensus       148 ~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~~~~---------~~  199 (247)
                      +.+.. .++.++|||||||++|+|++|+.||......+....+...                   ..+.         ++
T Consensus       228 ~~~~~-~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  306 (420)
T 1j1b_A          228 IFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR  306 (420)
T ss_dssp             HTTCS-SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSC
T ss_pred             HcCCC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcC
Confidence            86532 3789999999999999999999999887655544332210                   1111         23


Q ss_pred             CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          200 SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       200 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ...++++.+||.+||..||.+|||++++++||||+..
T Consensus       307 ~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          307 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             CCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence            4578999999999999999999999999999999864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.1e-43  Score=280.51  Aligned_cols=222  Identities=25%  Similarity=0.433  Sum_probs=189.9

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-CCHHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-LSDSQV   80 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~   80 (247)
                      |+.||||++....   ......+.+.+|+.+++.++||||+++++++ ..+..++||||+++++|.+++...+ +++..+
T Consensus        44 ~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  119 (291)
T 1xbb_A           44 VKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI  119 (291)
T ss_dssp             EEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHH
T ss_pred             eeeEEEEeecccc---cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHH
Confidence            5789999997542   2234466789999999999999999999998 5668899999999999999998754 999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc-----ccCCCCCCccCCcccccCCCCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL-----KSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      +.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+........     ....++..|+|||.+.+..  +
T Consensus       120 ~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~  197 (291)
T 1xbb_A          120 IELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--F  197 (291)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE--E
T ss_pred             HHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCC--C
Confidence            99999999999999999999999999999999999999999999865443321     1223567799999986544  7


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +.++|+||||+++|+|++ |..||...........+.....+..+..+++.+.+++.+||+.+|.+|||+.++++
T Consensus       198 ~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          198 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            889999999999999999 99999988888877777777777778899999999999999999999999999975

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-43  Score=279.82  Aligned_cols=220  Identities=27%  Similarity=0.465  Sum_probs=192.8

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSDS   78 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~   78 (247)
                      |+.||+|.+...      ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++...   .+++.
T Consensus        38 ~~~vaiK~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~  111 (288)
T 3kfa_A           38 SLTVAVKTLKED------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV  111 (288)
T ss_dssp             TEEEEEEEECSC------STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHH
T ss_pred             CEEEEEEecCcC------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHh
Confidence            678999999642      224567889999999999999999999999999999999999999999999763   38999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc---ccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL---KSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+........   ....++..|+|||.+.+..  +
T Consensus       112 ~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~  189 (288)
T 3kfa_A          112 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK--F  189 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCC--C
T ss_pred             HHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCC--C
Confidence            9999999999999999999999999999999999999999999999876543332   2223567799999996554  7


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +.++|+||||+++++|++ |..||...........+........+..+++.+.+++.+||..+|.+|||++++++
T Consensus       190 ~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            899999999999999999 99999988887777777777667778889999999999999999999999999976

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5.2e-44  Score=286.78  Aligned_cols=227  Identities=25%  Similarity=0.392  Sum_probs=194.4

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-------   74 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------   74 (247)
                      |+.||||++...    ........+.+|+.++++++||||+++++++...+..++||||+++++|.+++....       
T Consensus        60 ~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  135 (327)
T 2yfx_A           60 PLQVAVKTLPEV----CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS  135 (327)
T ss_dssp             CCEEEEEECCSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTT
T ss_pred             cceEEEEEeccc----cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccc
Confidence            668999999642    234456678899999999999999999999999999999999999999999997643       


Q ss_pred             -CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC---CCeEEcccccccccCccc----cccCCCCCCccCCc
Q 041080           75 -LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS---GSVKLADFGLAKATTMND----LKSCKGTPFWMAPE  146 (247)
Q Consensus        75 -~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~---~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aPE  146 (247)
                       +++..++.++.|++.||.+||+.|++|+||||+||+++.+   ..++|+|||.+.......    .....++..|+|||
T Consensus       136 ~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  215 (327)
T 2yfx_A          136 SLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE  215 (327)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHH
T ss_pred             cccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHh
Confidence             8899999999999999999999999999999999999844   469999999885432221    22234678899999


Q ss_pred             ccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChh
Q 041080          147 VVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT  225 (247)
Q Consensus       147 ~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  225 (247)
                      .+.+..  ++.++|+||||+++|+|++ |..||...........+........+..+++.+.+++.+||+.+|.+|||++
T Consensus       216 ~~~~~~--~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  293 (327)
T 2yfx_A          216 AFMEGI--FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA  293 (327)
T ss_dssp             HHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HhcCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHH
Confidence            986544  7899999999999999998 9999988887777777777766777888999999999999999999999999


Q ss_pred             hhhcCccCC
Q 041080          226 ELMEHPFVK  234 (247)
Q Consensus       226 ~il~~p~~~  234 (247)
                      +++++.|+-
T Consensus       294 ~ll~~l~~~  302 (327)
T 2yfx_A          294 IILERIEYC  302 (327)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            999987653

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.7e-44  Score=288.77  Aligned_cols=230  Identities=27%  Similarity=0.428  Sum_probs=191.4

Q ss_pred             CCceEEEEEEeecCCCccch-HHHHHHHHHHHHHhhcC--CCceeeeceeeecCCcEEEEEecccc-CcHHHHHHhc-CC
Q 041080            1 DGFFFAVKEVSLQDQGAQGK-QSILQLEQEISLLSQFE--QDNIVQYLGTDKDENRLYIFLELVTK-GSLANLYQKY-HL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~-~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~-~~   75 (247)
                      +|+.||||++.......... ...+.+.+|+.++++++  |+||+++++++...+..++|+|++.+ ++|.+++... .+
T Consensus        67 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l  146 (320)
T 3a99_A           67 DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL  146 (320)
T ss_dssp             TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSC
T ss_pred             CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCC
Confidence            47899999998754322111 12234568999999996  59999999999999999999999975 7999988764 58


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEc-CCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCC
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVD-ASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      ++..++.++.|++.||.+||+.|++|+||||+||+++ .++.++|+|||.+............+++.|+|||.+.+... 
T Consensus       147 ~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-  225 (320)
T 3a99_A          147 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRY-  225 (320)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCB-
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccccccCCCCCccCCChHHhccCCC-
Confidence            9999999999999999999999999999999999999 77899999999987766555556678999999999865442 


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCC
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK  234 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~  234 (247)
                      .+.++|+||||+++|+|++|..||.....      .... ....+..+++++.+++.+||+.+|.+|||++++++||||+
T Consensus       226 ~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~  298 (320)
T 3a99_A          226 HGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ  298 (320)
T ss_dssp             CHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             CCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc-cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhc
Confidence            36789999999999999999999976432      1111 2345667899999999999999999999999999999999


Q ss_pred             CCCC
Q 041080          235 RPLQ  238 (247)
Q Consensus       235 ~~~~  238 (247)
                      ..+.
T Consensus       299 ~~~~  302 (320)
T 3a99_A          299 DVLL  302 (320)
T ss_dssp             SCCC
T ss_pred             CccC
Confidence            8653

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.3e-43  Score=280.50  Aligned_cols=222  Identities=27%  Similarity=0.486  Sum_probs=182.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec--CCcEEEEEeccccCcHHHHHHhcC--CC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD--ENRLYIFLELVTKGSLANLYQKYH--LS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~--~~   76 (247)
                      +|+.||||++..     ......+.+.+|+.++++++||||+++++++..  ....++||||+++++|.+++....  ++
T Consensus        38 ~~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~  112 (295)
T 3ugc_A           38 TGEVVAVKKLQH-----STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID  112 (295)
T ss_dssp             CCEEEEEEEESC-----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCC
T ss_pred             CCcEEEEEEccc-----CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccC
Confidence            478899999864     234556778999999999999999999998754  356899999999999999997654  99


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-----cccCCCCCCccCCcccccC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSK  151 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~  151 (247)
                      +..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.......     .....++..|+|||.+.+.
T Consensus       113 ~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  192 (295)
T 3ugc_A          113 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES  192 (295)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCC
Confidence            99999999999999999999999999999999999999999999999987554332     1223355679999999765


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhh----------------HHHHHhhcCCCCCCCCcCCHHHHHHHHHHhc
Q 041080          152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV----------------QALFRIGKGELPSVPSSLSRDARDFILKCLQ  215 (247)
Q Consensus       152 ~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  215 (247)
                      .  ++.++||||||++++++++|..|+......                .....+........+..+++++.+++.+||.
T Consensus       193 ~--~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  270 (295)
T 3ugc_A          193 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWN  270 (295)
T ss_dssp             C--CCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSC
T ss_pred             C--CChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcC
Confidence            4  799999999999999999999887654322                2223334444556677899999999999999


Q ss_pred             CCCCCCCChhhhhc
Q 041080          216 VNPNDRPTVTELME  229 (247)
Q Consensus       216 ~~p~~Rps~~~il~  229 (247)
                      .+|.+|||++++++
T Consensus       271 ~dp~~Rps~~el~~  284 (295)
T 3ugc_A          271 NNVNQRPSFRDLAL  284 (295)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CChhhCCCHHHHHH
Confidence            99999999999975

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.6e-43  Score=280.26  Aligned_cols=233  Identities=26%  Similarity=0.487  Sum_probs=186.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC--CCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE--QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~   77 (247)
                      +|+.||||++....   ......+.+.+|+.++.+++  |+||+++++++...+..++|||+ .+++|.+++... .+++
T Consensus        51 ~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~  126 (313)
T 3cek_A           51 KKQIYAIKYVNLEE---ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP  126 (313)
T ss_dssp             TCCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHCSSCCH
T ss_pred             CCcEEEEEEecccc---ccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEec-CCCcHHHHHHhcCCCCH
Confidence            47889999997643   23456678899999999997  59999999999999999999995 467999998764 5899


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCCcccccC--
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSK--  151 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~--  151 (247)
                      ..++.++.|++.||.+||+.|++|+||||+||+++ ++.++|+|||.+.......    .....+++.|+|||.+.+.  
T Consensus       127 ~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  205 (313)
T 3cek_A          127 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS  205 (313)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC-
T ss_pred             HHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhccc
Confidence            99999999999999999999999999999999996 5899999999987554332    1234588999999998642  


Q ss_pred             -------CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhh-HHHHH-hhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC
Q 041080          152 -------NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV-QALFR-IGKGELPSVPSSLSRDARDFILKCLQVNPNDRP  222 (247)
Q Consensus       152 -------~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  222 (247)
                             ...++.++|+||||+++++|++|..||...... ..... .........+...+.++.+++.+||..+|.+||
T Consensus       206 ~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  285 (313)
T 3cek_A          206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI  285 (313)
T ss_dssp             ---------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSC
T ss_pred             ccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCc
Confidence                   124788999999999999999999999765332 22222 222333455667799999999999999999999


Q ss_pred             ChhhhhcCccCCCCCC
Q 041080          223 TVTELMEHPFVKRPLQ  238 (247)
Q Consensus       223 s~~~il~~p~~~~~~~  238 (247)
                      |++++++||||+....
T Consensus       286 s~~ell~h~~~~~~~~  301 (313)
T 3cek_A          286 SIPELLAHPYVQIQTH  301 (313)
T ss_dssp             CHHHHHTSHHHHCC--
T ss_pred             CHHHHhcCccccCCCC
Confidence            9999999999997543

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-43  Score=282.11  Aligned_cols=221  Identities=24%  Similarity=0.430  Sum_probs=186.6

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHH
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQV   80 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~   80 (247)
                      ..||||++...    ........+.+|+.++++++||||+++++++...+..++||||+++++|.+++...  .+++..+
T Consensus        74 ~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  149 (333)
T 1mqb_A           74 VPVAIKTLKAG----YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL  149 (333)
T ss_dssp             EEEEEEEECTT----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHH
T ss_pred             ccEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHH
Confidence            45999998643    23445667889999999999999999999999999999999999999999999764  4899999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc-----ccCCCCCCccCCcccccCCCCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL-----KSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      +.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+........     ....++..|+|||.+.+..  +
T Consensus       150 ~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~  227 (333)
T 1mqb_A          150 VGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK--F  227 (333)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCC--C
T ss_pred             HHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCC--C
Confidence            99999999999999999999999999999999999999999999875543221     1223466799999986544  7


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +.++|+||||+++|++++ |..||...........+..+.....+..+++.+.+++.+||+.+|.+||++.++++
T Consensus       228 ~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  302 (333)
T 1mqb_A          228 TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  302 (333)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            899999999999999998 99999888877777777766666667789999999999999999999999999876

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.5e-43  Score=283.00  Aligned_cols=223  Identities=28%  Similarity=0.491  Sum_probs=188.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC--CcEEEEEeccccCcHHHHHHhcCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE--NRLYIFLELVTKGSLANLYQKYHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~   78 (247)
                      +|+.||||++...    ......+.+.+|+.++++++||||+++++++.+.  ...++||||+++++|.+++...++++.
T Consensus        59 ~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~  134 (318)
T 3lxp_A           59 TGEMVAVKALKAD----AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLA  134 (318)
T ss_dssp             CCEEEEEEEECTT----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSCCCHH
T ss_pred             CCcEEEEEEeccc----cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCCCCHH
Confidence            4788999999753    3345577789999999999999999999998874  678999999999999999999899999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-----cccCCCCCCccCCcccccCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      .++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.......     .....++..|+|||.+.+.. 
T Consensus       135 ~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-  213 (318)
T 3lxp_A          135 QLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK-  213 (318)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE-
T ss_pred             HHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCC-
Confidence            999999999999999999999999999999999999999999999987654332     22344677799999996554 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhh---------------HHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCC
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---------------QALFRIGKGELPSVPSSLSRDARDFILKCLQVNP  218 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  218 (247)
                       ++.++|+||||+++++|++|..||......               .....+........+..+++++.+++.+||+.+|
T Consensus       214 -~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP  292 (318)
T 3lxp_A          214 -FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEA  292 (318)
T ss_dssp             -EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred             -CCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCc
Confidence             788999999999999999999998654322               1223334444556678899999999999999999


Q ss_pred             CCCCChhhhhc
Q 041080          219 NDRPTVTELME  229 (247)
Q Consensus       219 ~~Rps~~~il~  229 (247)
                      .+|||++++++
T Consensus       293 ~~Rps~~ell~  303 (318)
T 3lxp_A          293 SFRPTFENLIP  303 (318)
T ss_dssp             GGSCCHHHHHH
T ss_pred             ccCcCHHHHHH
Confidence            99999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.5e-44  Score=288.09  Aligned_cols=226  Identities=29%  Similarity=0.453  Sum_probs=159.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec----CCcEEEEEeccccCcHHHHHHhc---
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD----ENRLYIFLELVTKGSLANLYQKY---   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~---   73 (247)
                      +|+.||||++...      ....   .+....++.++||||+++++++..    +...++||||+++++|.+++...   
T Consensus        53 ~~~~vavK~~~~~------~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~  123 (336)
T 3fhr_A           53 TGQKCALKLLYDS------PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQ  123 (336)
T ss_dssp             TCCEEEEEEEESS------HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CC
T ss_pred             CCCEEEEEEecCc------HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCC
Confidence            4889999999642      1111   122334566689999999999876    45689999999999999999775   


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC---CCeEEcccccccccCccccccCCCCCCccCCccccc
Q 041080           74 HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS---GSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNS  150 (247)
Q Consensus        74 ~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~  150 (247)
                      .+++..++.++.|++.||.+||+.|++|+||||+||+++.+   +.++|+|||.+............+++.|+|||.+.+
T Consensus       124 ~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~  203 (336)
T 3fhr_A          124 AFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGP  203 (336)
T ss_dssp             CCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----------------------
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccccccccCCCCcCccChhhhCC
Confidence            48999999999999999999999999999999999999864   459999999997666555556678999999999854


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHH----HhhcC---CCCCCCCcCCHHHHHHHHHHhcCCCCCCCC
Q 041080          151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALF----RIGKG---ELPSVPSSLSRDARDFILKCLQVNPNDRPT  223 (247)
Q Consensus       151 ~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~----~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  223 (247)
                      ..  ++.++|+||||+++|+|++|..||..........    .+...   ........+++++++++.+||..+|.+|||
T Consensus       204 ~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  281 (336)
T 3fhr_A          204 EK--YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLT  281 (336)
T ss_dssp             CH--HHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred             CC--CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcC
Confidence            44  7889999999999999999999997655443321    11111   111222578999999999999999999999


Q ss_pred             hhhhhcCccCCCCC
Q 041080          224 VTELMEHPFVKRPL  237 (247)
Q Consensus       224 ~~~il~~p~~~~~~  237 (247)
                      ++++++||||+...
T Consensus       282 ~~ell~hp~~~~~~  295 (336)
T 3fhr_A          282 ITQFMNHPWINQSM  295 (336)
T ss_dssp             HHHHHHSHHHHTGG
T ss_pred             HHHHhcCccccccc
Confidence            99999999998754

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.6e-43  Score=283.97  Aligned_cols=220  Identities=25%  Similarity=0.470  Sum_probs=187.1

Q ss_pred             EEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc----------
Q 041080            5 FAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY----------   73 (247)
Q Consensus         5 ~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------   73 (247)
                      +|+|.+....    .....+.+.+|+.+++++ +||||+++++++.+.+..++||||+++++|.+++...          
T Consensus        55 v~iK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  130 (327)
T 1fvr_A           55 AAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA  130 (327)
T ss_dssp             EEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHH
T ss_pred             eeeeeecccc----chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhccccccccccc
Confidence            4889886432    233455688999999999 8999999999999999999999999999999999764          


Q ss_pred             -------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCC
Q 041080           74 -------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAP  145 (247)
Q Consensus        74 -------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aP  145 (247)
                             .+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+....... .....++..|+||
T Consensus       131 ~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aP  210 (327)
T 1fvr_A          131 IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAI  210 (327)
T ss_dssp             HHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCH
T ss_pred             ccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccCh
Confidence                   48999999999999999999999999999999999999999999999999986433222 2233467789999


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh
Q 041080          146 EVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV  224 (247)
Q Consensus       146 E~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  224 (247)
                      |.+.+..  ++.++|+||||+++|+|++ |..||...........+........+..+++++.+++.+||..+|.+|||+
T Consensus       211 E~~~~~~--~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  288 (327)
T 1fvr_A          211 ESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF  288 (327)
T ss_dssp             HHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hhhcccc--CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence            9986544  7889999999999999998 999999888888877777776667778899999999999999999999999


Q ss_pred             hhhhcC
Q 041080          225 TELMEH  230 (247)
Q Consensus       225 ~~il~~  230 (247)
                      ++++++
T Consensus       289 ~ell~~  294 (327)
T 1fvr_A          289 AQILVS  294 (327)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999873

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.5e-44  Score=284.79  Aligned_cols=230  Identities=24%  Similarity=0.399  Sum_probs=184.5

Q ss_pred             CCceEEEEEEeecCCCcc-chHHHHHHHHHHHHHhhc----CCCceeeeceeeecCCcEEEEEec-cccCcHHHHHHhc-
Q 041080            1 DGFFFAVKEVSLQDQGAQ-GKQSILQLEQEISLLSQF----EQDNIVQYLGTDKDENRLYIFLEL-VTKGSLANLYQKY-   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~-~~~~~~~~~~e~~~l~~l----~h~~i~~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~-   73 (247)
                      +|+.||||++........ .......+.+|+.++.++    +|+||+++++++...+..++|+|+ +.+++|.+++.+. 
T Consensus        55 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~  134 (312)
T 2iwi_A           55 DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG  134 (312)
T ss_dssp             TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC
T ss_pred             CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC
Confidence            478999999976543211 112334466799999998    899999999999999999999999 7889999998765 


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEc-CCCCeEEcccccccccCccccccCCCCCCccCCcccccCC
Q 041080           74 HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVD-ASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKN  152 (247)
Q Consensus        74 ~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  152 (247)
                      .+++..++.++.|++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+............++..|+|||.+.+..
T Consensus       135 ~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  214 (312)
T 2iwi_A          135 PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQ  214 (312)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCcccccCCcccccCceeeecCC
Confidence            499999999999999999999999999999999999999 7899999999998776666666667899999999986543


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      . .+.++|+||||+++|++++|..||.....  .    .. .....+..++..+.+++.+||..+|.+|||++++++|||
T Consensus       215 ~-~~~~~Di~slG~il~~l~~g~~pf~~~~~--~----~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~  286 (312)
T 2iwi_A          215 Y-HALPATVWSLGILLYDMVCGDIPFERDQE--I----LE-AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW  286 (312)
T ss_dssp             B-CHHHHHHHHHHHHHHHHHHSSCSCCSHHH--H----HH-TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred             C-CCccchHHHHHHHHHHHHHCCCCCCChHH--H----hh-hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence            2 35589999999999999999999975432  1    11 123456788999999999999999999999999999999


Q ss_pred             CCCCCC
Q 041080          233 VKRPLQ  238 (247)
Q Consensus       233 ~~~~~~  238 (247)
                      |+...+
T Consensus       287 ~~~~~~  292 (312)
T 2iwi_A          287 MQTPAE  292 (312)
T ss_dssp             TCC---
T ss_pred             hcCchh
Confidence            997543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=6.4e-43  Score=275.45  Aligned_cols=226  Identities=24%  Similarity=0.435  Sum_probs=185.9

Q ss_pred             CCceEEEEEEeecCCCccch--HHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGK--QSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~   76 (247)
                      +|+.||||++..........  ...+.+.+|+.++++++||||+++++++.+..  ++||||+++++|.+.+...  .++
T Consensus        43 ~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~  120 (287)
T 4f0f_A           43 DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIK  120 (287)
T ss_dssp             TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCC
T ss_pred             CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCcc
Confidence            47899999997654322111  11267889999999999999999999987665  6999999999998888543  589


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCC--eeecCCCCCcEEEcCCCC-----eEEcccccccccCccccccCCCCCCccCCcccc
Q 041080           77 DSQVSSYTRQILNGLVYLHERN--VVHRDIKCANILVDASGS-----VKLADFGLAKATTMNDLKSCKGTPFWMAPEVVN  149 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~~~ni~~~~~~~-----~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~  149 (247)
                      +..++.++.|++.||.+||+.|  ++|+||||+||+++.++.     ++|+|||.+..... ......+++.|+|||.+.
T Consensus       121 ~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~g~~~y~aPE~~~  199 (287)
T 4f0f_A          121 WSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-SVSGLLGNFQWMAPETIG  199 (287)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-CEECCCCCCTTSCGGGSS
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc-cccccCCCccccCchhhc
Confidence            9999999999999999999999  999999999999988776     99999999875443 334456899999999986


Q ss_pred             cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHH--HHH-hhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhh
Q 041080          150 SKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQA--LFR-IGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTE  226 (247)
Q Consensus       150 ~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  226 (247)
                      .....++.++|+||||+++|+|++|..||........  ... ......+..+..+++++.+++.+||+.+|.+|||+++
T Consensus       200 ~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  279 (287)
T 4f0f_A          200 AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSY  279 (287)
T ss_dssp             CSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHH
Confidence            5555578899999999999999999999976554333  222 2334455677889999999999999999999999999


Q ss_pred             hhc
Q 041080          227 LME  229 (247)
Q Consensus       227 il~  229 (247)
                      +++
T Consensus       280 ll~  282 (287)
T 4f0f_A          280 IVK  282 (287)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            985

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=9.9e-44  Score=285.13  Aligned_cols=219  Identities=26%  Similarity=0.456  Sum_probs=183.7

Q ss_pred             EEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHHHH
Q 041080            5 FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSS   82 (247)
Q Consensus         5 ~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~   82 (247)
                      ||+|.+...    ......+.+.+|+.++++++||||+++++++..+. .+++++|+.+++|.+++...  .+++..++.
T Consensus        47 vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~  121 (327)
T 3poz_A           47 VAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLN  121 (327)
T ss_dssp             EEEEEC-----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHH
T ss_pred             EEEeecccc----cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHH
Confidence            466666432    23344567889999999999999999999998764 78999999999999998764  489999999


Q ss_pred             HHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCCcccccCCCCCCcc
Q 041080           83 YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        83 ~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......    .....++..|+|||.+.+..  ++.+
T Consensus       122 ~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~  199 (327)
T 3poz_A          122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQ  199 (327)
T ss_dssp             HHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCC--CCHH
T ss_pred             HHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCC--CCch
Confidence            99999999999999999999999999999999999999999986543222    12233567899999997654  7899


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          159 ADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       159 ~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      +||||||+++|++++ |..||...........+........+...+.++.+++.+||+.+|.+|||+.+++++
T Consensus       200 ~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          200 SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             hhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            999999999999999 999999888877777777776667788899999999999999999999999999864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2e-43  Score=277.59  Aligned_cols=221  Identities=27%  Similarity=0.463  Sum_probs=187.6

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHH
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQV   80 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~   80 (247)
                      ..||+|.+...    ......+.+.+|+.++++++||||+++++++..+ ..++||||+++++|.+++.+.  .+++..+
T Consensus        41 ~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~  115 (281)
T 3cc6_A           41 INVAVKTCKKD----CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTL  115 (281)
T ss_dssp             EEEEEEECCTT----SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHH
T ss_pred             ceEEEEecccc----cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHH
Confidence            45899988653    2344567789999999999999999999998654 568999999999999999764  3899999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCCCCCCc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      +.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+.......   .....++..|+|||.+.+..  ++.
T Consensus       116 ~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~  193 (281)
T 3cc6_A          116 VLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR--FTT  193 (281)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCC--CCH
T ss_pred             HHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCC--CCc
Confidence            9999999999999999999999999999999999999999999987554332   12333567899999986544  789


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          158 TADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      ++|+||||+++|++++ |..||...........+........+..+++.+.+++.+||..+|.+|||+++++++
T Consensus       194 ~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          194 ASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            9999999999999998 999998877777777776666666778899999999999999999999999999864

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.1e-43  Score=279.77  Aligned_cols=231  Identities=30%  Similarity=0.529  Sum_probs=178.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~   78 (247)
                      +|+.||||++.....   .....+.+.++..+++.++||||+++++++...+..++||||+ ++.+..+...  ..+++.
T Consensus        49 ~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~  124 (318)
T 2dyl_A           49 TGHVIAVKQMRRSGN---KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPER  124 (318)
T ss_dssp             TCCEEEEEEEETTSC---HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHH
T ss_pred             CCeEEEEEEeccccc---chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHH
Confidence            488999999976432   2233344555566788889999999999999999999999999 5567666654  459999


Q ss_pred             HHHHHHHHHHHHHHHhhhC-CeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCccccc---CCC
Q 041080           79 QVSSYTRQILNGLVYLHER-NVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNS---KND  153 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~-~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~---~~~  153 (247)
                      .++.++.|++.||.+||+. |++|+||+|+||+++.++.++|+|||.+....... .....+++.|+|||.+..   ...
T Consensus       125 ~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  204 (318)
T 2dyl_A          125 ILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKP  204 (318)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------------CCTTCCHHHHC-------
T ss_pred             HHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccccccCCCccccChhhccccccccc
Confidence            9999999999999999995 99999999999999999999999999986543322 233458899999999853   223


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCCh-hhHHHHHhhcCCCCCCC--CcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLE-GVQALFRIGKGELPSVP--SSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      .++.++||||||+++|+|++|..||.... .......+.....+..+  ..+++++.+++.+||+.+|.+|||++++++|
T Consensus       205 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          205 DYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             -CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            37889999999999999999999997643 33344444444433333  4689999999999999999999999999999


Q ss_pred             ccCCC
Q 041080          231 PFVKR  235 (247)
Q Consensus       231 p~~~~  235 (247)
                      |||+.
T Consensus       285 ~~~~~  289 (318)
T 2dyl_A          285 SFIKR  289 (318)
T ss_dssp             HHHHH
T ss_pred             HHHHh
Confidence            99975

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-43  Score=286.72  Aligned_cols=224  Identities=24%  Similarity=0.427  Sum_probs=186.1

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH------   74 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------   74 (247)
                      |..||||++....    .....+.+.+|+.+++++ +||||+++++++...+..++||||+++++|.+++....      
T Consensus        75 ~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~  150 (344)
T 1rjb_A           75 SIQVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSED  150 (344)
T ss_dssp             EEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---
T ss_pred             ceEEEEEeccccc----CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhcccccccc
Confidence            4579999997432    233456788999999999 89999999999999999999999999999999997642      


Q ss_pred             ------------------CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc---
Q 041080           75 ------------------LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL---  133 (247)
Q Consensus        75 ------------------~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~---  133 (247)
                                        +++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+........   
T Consensus       151 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  230 (344)
T 1rjb_A          151 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVV  230 (344)
T ss_dssp             ------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEE
T ss_pred             ccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCcccee
Confidence                              68899999999999999999999999999999999999999999999999875543321   


Q ss_pred             -ccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHH-hhcCCCCCCCCcCCHHHHHHH
Q 041080          134 -KSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFI  210 (247)
Q Consensus       134 -~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li  210 (247)
                       ....+++.|+|||.+.+..  ++.++||||||+++|+|++ |..||........... +........+...++++.+++
T Consensus       231 ~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  308 (344)
T 1rjb_A          231 RGNARLPVKWMAPESLFEGI--YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIM  308 (344)
T ss_dssp             ETTEEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             ccCccCccCccCHHHhccCC--CChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence             2233567899999986544  7899999999999999998 9999987665444333 334444556778899999999


Q ss_pred             HHHhcCCCCCCCChhhhhcCc
Q 041080          211 LKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       211 ~~~l~~~p~~Rps~~~il~~p  231 (247)
                      .+||..+|.+|||+++++++-
T Consensus       309 ~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          309 QSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHcCCCchhCcCHHHHHHHH
Confidence            999999999999999998764

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.2e-43  Score=285.66  Aligned_cols=229  Identities=26%  Similarity=0.358  Sum_probs=182.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCc-------EEEEEeccccCcHHHHHH--
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENR-------LYIFLELVTKGSLANLYQ--   71 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-------~~lv~e~~~~~~L~~~l~--   71 (247)
                      +|+.||||++......      .....+++..+..++||||+++++++...+.       .++||||+++ +|...+.  
T Consensus        47 ~~~~vavK~~~~~~~~------~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~  119 (360)
T 3e3p_A           47 TGMSVAIKKVIQDPRF------RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNY  119 (360)
T ss_dssp             TCCEEEEEEEECCTTC------CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHH
T ss_pred             CCCEEEEEEEecCccc------cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHH
Confidence            4789999998654321      1235578888889999999999999865333       8899999987 5544433  


Q ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHhh--hCCeeecCCCCCcEEEcC-CCCeEEcccccccccCccc-cccCCCCCCccC
Q 041080           72 ---KYHLSDSQVSSYTRQILNGLVYLH--ERNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMND-LKSCKGTPFWMA  144 (247)
Q Consensus        72 ---~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~~~ni~~~~-~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~a  144 (247)
                         ...+++..++.++.|++.||.+||  +.|++|+||||+||+++. ++.++|+|||.+....... .....+++.|+|
T Consensus       120 ~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~a  199 (360)
T 3e3p_A          120 YRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRA  199 (360)
T ss_dssp             HTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCC
T ss_pred             hhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeC
Confidence               234889999999999999999999  999999999999999996 8999999999987654333 334568899999


Q ss_pred             CcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC------------------------------
Q 041080          145 PEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE------------------------------  194 (247)
Q Consensus       145 PE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~------------------------------  194 (247)
                      ||.+.+.. .++.++||||||+++|+|++|..||...........+....                              
T Consensus       200 PE~~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (360)
T 3e3p_A          200 PELIFGNQ-HYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSN  278 (360)
T ss_dssp             HHHHTTCS-SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHH
T ss_pred             HHHHcCCC-CCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCccc
Confidence            99985433 26899999999999999999999998877665554432210                              


Q ss_pred             -CCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          195 -LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       195 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                       .+......++++.++|.+||+.||.+|||++++++||||+...
T Consensus       279 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          279 VFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             HTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             ccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence             1112233578999999999999999999999999999999753

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.8e-43  Score=283.68  Aligned_cols=230  Identities=30%  Similarity=0.529  Sum_probs=167.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHH-HHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHH------hc
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEIS-LLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQ------KY   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~------~~   73 (247)
                      +|+.||||++....    .......+..|+. +++.++||||+++++++...+..++||||+.+ +|.+++.      ..
T Consensus        46 ~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~  120 (327)
T 3aln_A           46 SGQIMAVKRIRSTV----DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDD  120 (327)
T ss_dssp             TTEEEEEEEEECCC----CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCC
T ss_pred             CCCEEEEEEeeccc----CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcc
Confidence            47899999997542    2233444555555 67778999999999999999999999999986 8888776      34


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhC-CeeecCCCCCcEEEcCCCCeEEcccccccccCcccc-ccCCCCCCccCCccccc-
Q 041080           74 HLSDSQVSSYTRQILNGLVYLHER-NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL-KSCKGTPFWMAPEVVNS-  150 (247)
Q Consensus        74 ~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~aPE~~~~-  150 (247)
                      .+++..+..++.|++.||.+||+. |++|+||||+||+++.++.++|+|||.+........ ....++..|+|||.+.. 
T Consensus       121 ~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  200 (327)
T 3aln_A          121 VIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS  200 (327)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-------------------------
T ss_pred             cCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeeccc
Confidence            589999999999999999999998 999999999999999999999999999875543322 23358899999999842 


Q ss_pred             -CCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhh-HHHHHhhcCCCCCCC----CcCCHHHHHHHHHHhcCCCCCCCCh
Q 041080          151 -KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV-QALFRIGKGELPSVP----SSLSRDARDFILKCLQVNPNDRPTV  224 (247)
Q Consensus       151 -~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~  224 (247)
                       ....++.++|+||||+++|+|++|..||...... .....+..+..+.++    ..+++.+.+++.+||..+|.+|||+
T Consensus       201 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  280 (327)
T 3aln_A          201 ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKY  280 (327)
T ss_dssp             -----CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCH
Confidence             1223788999999999999999999999764432 222222222222222    4689999999999999999999999


Q ss_pred             hhhhcCccCCC
Q 041080          225 TELMEHPFVKR  235 (247)
Q Consensus       225 ~~il~~p~~~~  235 (247)
                      +++++||||..
T Consensus       281 ~ell~hp~~~~  291 (327)
T 3aln_A          281 KELLKHPFILM  291 (327)
T ss_dssp             HHHTTSHHHHH
T ss_pred             HHHHhChHHHH
Confidence            99999999975

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=282.90  Aligned_cols=218  Identities=26%  Similarity=0.451  Sum_probs=181.6

Q ss_pred             EEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHHHH
Q 041080            5 FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSS   82 (247)
Q Consensus         5 ~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~   82 (247)
                      |++|.+...    ......+.+.+|+.++++++||||+++++++..+. .+++++++.+++|.+++...  .+++..++.
T Consensus        47 v~iK~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~  121 (327)
T 3lzb_A           47 VAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLN  121 (327)
T ss_dssp             EEEEEECCC----SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHH
T ss_pred             EEEEeeccc----cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHH
Confidence            355555432    23334567889999999999999999999988764 88999999999999998764  489999999


Q ss_pred             HHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCCcccccCCCCCCcc
Q 041080           83 YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        83 ~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+.......    .....++..|+|||.+.+..  ++.+
T Consensus       122 i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~  199 (327)
T 3lzb_A          122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQ  199 (327)
T ss_dssp             HHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCC--CCHH
T ss_pred             HHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCC--CChH
Confidence            99999999999999999999999999999999999999999987543322    22233566899999997654  7899


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          159 ADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       159 ~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +||||||+++|+|++ |..||...........+........+..++.++.+++.+||..+|.+|||++++++
T Consensus       200 ~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          200 SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999 99999998888888777777777778889999999999999999999999999986

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2e-43  Score=294.98  Aligned_cols=219  Identities=27%  Similarity=0.509  Sum_probs=190.2

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSDS   78 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~   78 (247)
                      +..||||++....      ...+.+.+|+.++++++||||+++++++. .+..++||||+++|+|.+++...   .++..
T Consensus       212 ~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~  284 (454)
T 1qcf_A          212 HTKVAVKTMKPGS------MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLP  284 (454)
T ss_dssp             TEEEEEEEECTTS------BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHH
T ss_pred             ccEEEEEEecCCC------ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHH
Confidence            5789999997532      23567889999999999999999999886 56789999999999999999743   58999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......   .....++..|+|||.+....  +
T Consensus       285 ~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~  362 (454)
T 1qcf_A          285 KLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--F  362 (454)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCC--C
T ss_pred             HHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCC--C
Confidence            999999999999999999999999999999999999999999999997654332   22333566899999996544  7


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +.++||||||+++|+|++ |..||......+....+..+.....+..+|+++.++|.+||..+|.+|||++++++
T Consensus       363 ~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          363 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            899999999999999999 99999988888887777776666677889999999999999999999999999975

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.7e-43  Score=273.79  Aligned_cols=223  Identities=19%  Similarity=0.406  Sum_probs=189.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC--CcEEEEEeccccCcHHHHHHhcC---C
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE--NRLYIFLELVTKGSLANLYQKYH---L   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~---~   75 (247)
                      +|+.||||++....   ......+.+.+|+.++++++||||+++++++.+.  +..++||||+++++|.+++....   +
T Consensus        32 ~~~~~avK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~  108 (271)
T 3kmu_A           32 QGNDIVVKVLKVRD---WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV  108 (271)
T ss_dssp             TTEEEEEEEECCTT---CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCC
T ss_pred             CCeeEEEEEecccc---cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCC
Confidence            37889999997653   3345567799999999999999999999999877  78899999999999999998754   8


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCC--eeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCC
Q 041080           76 SDSQVSSYTRQILNGLVYLHERN--VVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      ++..++.++.|++.||.+||+.|  ++|+||||+||+++.++.++++|||.+....   .....+++.|+|||.+.+...
T Consensus       109 ~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~  185 (271)
T 3kmu_A          109 DQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ---SPGRMYAPAWVAPEALQKKPE  185 (271)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS---CTTCBSCGGGSCHHHHHSCGG
T ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec---ccCccCCccccChhhhccCCC
Confidence            99999999999999999999999  9999999999999999999999888764422   233457899999999865432


Q ss_pred             -CCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhh-cCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          154 -GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIG-KGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       154 -~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                       .++.++||||||+++|++++|..||............. ....+..+..+++++.+++.+||+.+|.+|||++++++
T Consensus       186 ~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          186 DTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             GSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             23447999999999999999999998877766655544 34456677889999999999999999999999999985

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.6e-43  Score=280.04  Aligned_cols=223  Identities=25%  Similarity=0.434  Sum_probs=188.0

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH------   74 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------   74 (247)
                      |+.||||++...    ......+.+.+|+.+++++ +||||+++++++..++..++||||+++++|.+++....      
T Consensus        53 ~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  128 (313)
T 1t46_A           53 AMTVAVKMLKPS----AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS  128 (313)
T ss_dssp             EEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC---
T ss_pred             hhhhHHHhcCcc----hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccc
Confidence            578999999643    2334567789999999999 89999999999999999999999999999999997643      


Q ss_pred             -------------CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----ccCC
Q 041080           75 -------------LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCK  137 (247)
Q Consensus        75 -------------~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~  137 (247)
                                   +++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+........    ....
T Consensus       129 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  208 (313)
T 1t46_A          129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR  208 (313)
T ss_dssp             -----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSE
T ss_pred             cccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCC
Confidence                         89999999999999999999999999999999999999999999999999876544332    1233


Q ss_pred             CCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHH-hhcCCCCCCCCcCCHHHHHHHHHHhc
Q 041080          138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQ  215 (247)
Q Consensus       138 ~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~  215 (247)
                      ++..|+|||.+.+..  ++.++|+||||+++++|++ |..||........... +........+..+++++.+++.+||.
T Consensus       209 ~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  286 (313)
T 1t46_A          209 LPVKWMAPESIFNCV--YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWD  286 (313)
T ss_dssp             ECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             CcceeeChHHhcCCC--CChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcC
Confidence            567899999986544  7899999999999999998 9999977664443333 33333445567889999999999999


Q ss_pred             CCCCCCCChhhhhcC
Q 041080          216 VNPNDRPTVTELMEH  230 (247)
Q Consensus       216 ~~p~~Rps~~~il~~  230 (247)
                      .+|.+|||+++++++
T Consensus       287 ~dp~~Rps~~ell~~  301 (313)
T 1t46_A          287 ADPLKRPTFKQIVQL  301 (313)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CCchhCcCHHHHHHH
Confidence            999999999999864

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.2e-43  Score=279.82  Aligned_cols=224  Identities=24%  Similarity=0.422  Sum_probs=184.8

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC-----cEEEEEeccccCcHHHHHHh----
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN-----RLYIFLELVTKGSLANLYQK----   72 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~----   72 (247)
                      |..||+|++....   ......+.+.+|+.++++++||||+++++++...+     ..++||||+.+++|.+++..    
T Consensus        62 ~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~  138 (313)
T 3brb_A           62 SLKVAVKTMKLDN---SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE  138 (313)
T ss_dssp             EEEEEEEEC---C---CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBT
T ss_pred             eeEEEEEEEeccc---cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhh
Confidence            3479999987543   33455677899999999999999999999987654     45999999999999999843    


Q ss_pred             ---cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCC
Q 041080           73 ---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAP  145 (247)
Q Consensus        73 ---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aP  145 (247)
                         ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.......    .....+++.|+||
T Consensus       139 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  218 (313)
T 3brb_A          139 TGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI  218 (313)
T ss_dssp             TSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCH
T ss_pred             cCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCc
Confidence               248999999999999999999999999999999999999999999999999986544322    1223366789999


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCCh
Q 041080          146 EVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV  224 (247)
Q Consensus       146 E~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  224 (247)
                      |.+.+..  ++.++|+||||+++|+|++ |..||...........+........+..+++++.+++.+||..+|.+|||+
T Consensus       219 E~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  296 (313)
T 3brb_A          219 ESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTF  296 (313)
T ss_dssp             HHHHSSC--CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred             hhhcCCC--ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCH
Confidence            9996544  7899999999999999999 889998888888877777777777788899999999999999999999999


Q ss_pred             hhhhcC
Q 041080          225 TELMEH  230 (247)
Q Consensus       225 ~~il~~  230 (247)
                      ++++++
T Consensus       297 ~~l~~~  302 (313)
T 3brb_A          297 SVLRLQ  302 (313)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999864

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.5e-43  Score=291.83  Aligned_cols=226  Identities=29%  Similarity=0.457  Sum_probs=174.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCC----
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHL----   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----   75 (247)
                      +|+.||||++...        ..+.+.+|+.+++++ +||||+++++++.+++..++||||+++ +|.++++....    
T Consensus        38 ~g~~vAvK~~~~~--------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~~~~  108 (434)
T 2rio_A           38 QGRPVAVKRMLID--------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDEN  108 (434)
T ss_dssp             SSSEEEEEEEEGG--------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHTC------
T ss_pred             CCeEEEEEEEcHH--------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCCC-CHHHHHhccCCCchh
Confidence            5889999998642        123567899999987 899999999999999999999999965 99999976542    


Q ss_pred             ----CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC-------------CCeEEcccccccccCccc------
Q 041080           76 ----SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-------------GSVKLADFGLAKATTMND------  132 (247)
Q Consensus        76 ----~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~-------------~~~~l~df~~~~~~~~~~------  132 (247)
                          ++..++.++.|++.||.|||++||+|+||||+||+++.+             +.++|+|||.+.......      
T Consensus       109 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~  188 (434)
T 2rio_A          109 LKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN  188 (434)
T ss_dssp             ------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------
T ss_pred             hhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceee
Confidence                223457799999999999999999999999999999754             479999999987554332      


Q ss_pred             cccCCCCCCccCCcccccC-----CCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCC----CCcC
Q 041080          133 LKSCKGTPFWMAPEVVNSK-----NDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSV----PSSL  202 (247)
Q Consensus       133 ~~~~~~~~~~~aPE~~~~~-----~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~  202 (247)
                      .....|++.|+|||.+.+.     ...++.++||||||+++|+|++ |..||.................+..    +..+
T Consensus       189 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~i~~~~~~~~~~~~~~~~~~  268 (434)
T 2rio_A          189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSL  268 (434)
T ss_dssp             ------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHHHHHTCCCCCCCTTCCCHHH
T ss_pred             ecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHHHhcCCCCcccccccccccc
Confidence            2234689999999998652     2347899999999999999998 9999976543332111111111111    1245


Q ss_pred             CHHHHHHHHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          203 SRDARDFILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       203 ~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                      ++++.+++.+||+.+|.+|||+.++++||||..
T Consensus       269 ~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          269 IAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             hHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            688999999999999999999999999999974

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=8.2e-44  Score=292.51  Aligned_cols=225  Identities=28%  Similarity=0.394  Sum_probs=178.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC--------CCceeeeceeee----cCCcEEEEEeccccCcHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE--------QDNIVQYLGTDK----DENRLYIFLELVTKGSLAN   68 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~   68 (247)
                      +|+.||||++..      .....+.+.+|+.+++.++        |+||+++++++.    .....++||||+.+ +|.+
T Consensus        61 ~~~~vavK~~~~------~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~  133 (397)
T 1wak_A           61 GKKFVAMKVVKS------AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLK  133 (397)
T ss_dssp             TTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCCC-BHHH
T ss_pred             CCeEEEEEEEec------CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccCc-cHHH
Confidence            478999999953      2345667889999999995        788999999987    55689999999955 5655


Q ss_pred             HHHhc---CCCHHHHHHHHHHHHHHHHHhhhC-CeeecCCCCCcEEEcCCC-----------------------------
Q 041080           69 LYQKY---HLSDSQVSSYTRQILNGLVYLHER-NVVHRDIKCANILVDASG-----------------------------  115 (247)
Q Consensus        69 ~l~~~---~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~~~ni~~~~~~-----------------------------  115 (247)
                      .+.+.   .+++..++.++.|++.||.|||++ ||+|+||||+||+++.++                             
T Consensus       134 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  213 (397)
T 1wak_A          134 WIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA  213 (397)
T ss_dssp             HHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC------------------
T ss_pred             HHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccC
Confidence            55433   499999999999999999999998 999999999999998775                             


Q ss_pred             --------------------CeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCC
Q 041080          116 --------------------SVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR  175 (247)
Q Consensus       116 --------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~  175 (247)
                                          .++|+|||.+...... .....++..|+|||.+.+..  ++.++||||||+++|+|++|.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~  290 (397)
T 1wak_A          214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQYRSLEVLIGSG--YNTPADIWSTACMAFELATGD  290 (397)
T ss_dssp             ---CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-SCSCCSCGGGCCHHHHHTSC--CCTHHHHHHHHHHHHHHHHSS
T ss_pred             CcccccccccccccccccccceEecccccccccccc-CccCCCCCcccCChhhcCCC--CCcHHHHHHHHHHHHHHhhCC
Confidence                                7999999998765433 34456899999999997654  789999999999999999999


Q ss_pred             CCCCCChhh------HHHHHhhc--CCC---------------------------------------CCCCCcCCHHHHH
Q 041080          176 PPYSHLEGV------QALFRIGK--GEL---------------------------------------PSVPSSLSRDARD  208 (247)
Q Consensus       176 ~p~~~~~~~------~~~~~~~~--~~~---------------------------------------~~~~~~~~~~~~~  208 (247)
                      .||......      .....+..  +..                                       ...+...++.+.+
T Consensus       291 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (397)
T 1wak_A          291 YLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTD  370 (397)
T ss_dssp             CSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHH
T ss_pred             CCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHH
Confidence            999754321      11111100  000                                       0112334567899


Q ss_pred             HHHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          209 FILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       209 li~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                      ||.+||+.||.+|||++++++||||+.
T Consensus       371 li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          371 FLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             HHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             HHHHHhccChhhcCCHHHHhhCccccC
Confidence            999999999999999999999999974

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.9e-43  Score=296.71  Aligned_cols=220  Identities=26%  Similarity=0.462  Sum_probs=192.1

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSDS   78 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~   78 (247)
                      |..||||.+....      ...+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++...   .+++.
T Consensus       245 ~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~  318 (495)
T 1opk_A          245 SLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV  318 (495)
T ss_dssp             TEEEEEEECCSSS------SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHH
T ss_pred             CeEEEEEEecCcc------cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHH
Confidence            6789999986432      12457889999999999999999999999999999999999999999999763   48899


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc---ccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL---KSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++........   ....++..|+|||.+....  +
T Consensus       319 ~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~  396 (495)
T 1opk_A          319 VLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK--F  396 (495)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCE--E
T ss_pred             HHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCC--C
Confidence            9999999999999999999999999999999999999999999999876543322   2233456899999986544  7


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +.++||||||+++|+|++ |..||...........+........+..+++++.++|.+||+.+|.+|||++++++
T Consensus       397 ~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          397 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            899999999999999999 99999988877777777776666778889999999999999999999999999976

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.2e-43  Score=275.33  Aligned_cols=219  Identities=28%  Similarity=0.485  Sum_probs=183.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC-CcEEEEEeccccCcHHHHHHhcC---CC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE-NRLYIFLELVTKGSLANLYQKYH---LS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~---~~   76 (247)
                      +|+.||||++....       ..+.+.+|+.++++++||||+++++++... +..++||||+++++|.+++...+   ++
T Consensus        43 ~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~  115 (278)
T 1byg_A           43 RGNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG  115 (278)
T ss_dssp             TTEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCC
T ss_pred             cCCEEEEEEecchh-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCC
Confidence            37889999986432       345688999999999999999999986544 57899999999999999987643   89


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      +..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+....... ....++..|+|||.+.+..  ++
T Consensus       116 ~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~y~aPE~~~~~~--~~  192 (278)
T 1byg_A          116 GDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWTAPEALREKK--FS  192 (278)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------------CCTTTSCHHHHHHCC--CC
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc-cCCCccccccCHHHhCCCC--CC
Confidence            99999999999999999999999999999999999999999999999986544332 2334678899999986544  78


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          157 LTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      .++|+||||++++++++ |..||...........+........+..+++.+.+++.+||..+|.+|||+.++++
T Consensus       193 ~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          193 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            99999999999999998 99999988877777777776666777889999999999999999999999999975

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=6.5e-44  Score=285.99  Aligned_cols=219  Identities=28%  Similarity=0.467  Sum_probs=184.5

Q ss_pred             EEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHHHH
Q 041080            5 FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVSS   82 (247)
Q Consensus         5 ~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~   82 (247)
                      ||+|.+....    .......+.+|+.++++++||||+++++++. ++..++||||+.+++|.+++...  .+++..++.
T Consensus        45 v~~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~  119 (325)
T 3kex_A           45 VCIKVIEDKS----GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLN  119 (325)
T ss_dssp             EEEEEECCTT----SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHH
T ss_pred             EEEEeccccc----cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHH
Confidence            6666664322    1222334678999999999999999999886 55789999999999999998764  589999999


Q ss_pred             HHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCCcccccCCCCCCcc
Q 041080           83 YTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        83 ~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+.......    .....++..|+|||.+.+..  ++.+
T Consensus       120 ~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~  197 (325)
T 3kex_A          120 WGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK--YTHQ  197 (325)
T ss_dssp             HHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCC--CCHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCC--CChh
Confidence            99999999999999999999999999999999999999999997654332    22344677899999996554  7899


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          159 ADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       159 ~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      +|+||||+++|++++ |..||...........+........+..++.++.+++.+||..+|.+|||+.+++++
T Consensus       198 ~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          198 SDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             HHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             hHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999 999999888777777777776667778889999999999999999999999999874

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-42  Score=274.47  Aligned_cols=220  Identities=25%  Similarity=0.433  Sum_probs=188.0

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcE-EEEEeccccCcHHHHHHh--cCCCHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRL-YIFLELVTKGSLANLYQK--YHLSDSQV   80 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~lv~e~~~~~~L~~~l~~--~~~~~~~~   80 (247)
                      .+|+|.+..    .......+.+.+|+.++++++||||+++++++.+.+.. +++|||+.+++|.+++..  ..+++..+
T Consensus        51 ~~aiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~  126 (298)
T 3pls_A           51 QCAIKSLSR----ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL  126 (298)
T ss_dssp             EEEEEEETT----CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHH
T ss_pred             eeeeeeccc----cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHH
Confidence            689998864    23445677889999999999999999999999776655 999999999999999976  35889999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc------cccCCCCCCccCCcccccCCCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND------LKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.......      .....++..|+|||.+.+..  
T Consensus       127 ~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--  204 (298)
T 3pls_A          127 ISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR--  204 (298)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCC--
T ss_pred             HHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCC--
Confidence            9999999999999999999999999999999999999999999986543322      22344677899999996544  


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          155 YGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ++.++|+||||+++|+|++ +.+||...........+........+..+++.+.+++.+||..+|.+|||++++++
T Consensus       205 ~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          205 FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            7899999999999999999 55667777777777777776666777889999999999999999999999999876

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.4e-43  Score=273.73  Aligned_cols=219  Identities=28%  Similarity=0.487  Sum_probs=188.5

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSDS   78 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~   78 (247)
                      ++.||||.+.....      ..+.+.+|+.++++++||||+++++++.. +..++||||+++++|.+++...   .+++.
T Consensus        37 ~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~  109 (279)
T 1qpc_A           37 HTKVAVKSLKQGSM------SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN  109 (279)
T ss_dssp             TEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHH
T ss_pred             CcEEEEEEecCCcc------cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHH
Confidence            56899999864321      24568899999999999999999998764 5689999999999999998653   59999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc---ccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL---KSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+........   ....++..|+|||.+.+..  +
T Consensus       110 ~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~  187 (279)
T 1qpc_A          110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--F  187 (279)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCE--E
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCC--C
Confidence            9999999999999999999999999999999999999999999999876543322   2333567899999986544  7


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +.++|+||||+++++|++ |..||...........+........+..+++++.+++.+||..+|.+|||++++++
T Consensus       188 ~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            889999999999999999 99999888877777777766666677889999999999999999999999999976

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.5e-43  Score=278.24  Aligned_cols=223  Identities=30%  Similarity=0.528  Sum_probs=182.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC--CcEEEEEeccccCcHHHHHHhc--CCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE--NRLYIFLELVTKGSLANLYQKY--HLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~--~~~   76 (247)
                      +|+.||||++....    .....+.+.+|+.++++++||||+++++++...  ...++||||+++++|.+++...  .++
T Consensus        49 ~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~  124 (302)
T 4e5w_A           49 TGEQVAVKSLKPES----GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKIN  124 (302)
T ss_dssp             CSEEEEEEEEC---------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCC
T ss_pred             cCeEEEEEEecccc----cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCC
Confidence            47899999997543    223456788999999999999999999998876  6789999999999999999553  499


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-----cccCCCCCCccCCcccccC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSK  151 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~  151 (247)
                      +..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.......     .....++..|+|||.+.+.
T Consensus       125 ~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  204 (302)
T 4e5w_A          125 LKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS  204 (302)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCC
Confidence            99999999999999999999999999999999999999999999999986554332     2234467779999998655


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCC---------------hhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcC
Q 041080          152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHL---------------EGVQALFRIGKGELPSVPSSLSRDARDFILKCLQV  216 (247)
Q Consensus       152 ~~~~~~~~Di~slG~ll~~l~~g~~p~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  216 (247)
                      .  ++.++|+||||+++++|++|..|+...               .................+..+++++.+++.+||+.
T Consensus       205 ~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  282 (302)
T 4e5w_A          205 K--FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEF  282 (302)
T ss_dssp             E--EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCS
T ss_pred             C--CCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCC
Confidence            4  788999999999999999998875322               12222334444555566788999999999999999


Q ss_pred             CCCCCCChhhhhc
Q 041080          217 NPNDRPTVTELME  229 (247)
Q Consensus       217 ~p~~Rps~~~il~  229 (247)
                      +|.+|||++++++
T Consensus       283 dp~~Rps~~~ll~  295 (302)
T 4e5w_A          283 QPSNRTSFQNLIE  295 (302)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             CCCCCCCHHHHHH
Confidence            9999999999985

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.4e-43  Score=301.87  Aligned_cols=222  Identities=26%  Similarity=0.441  Sum_probs=190.9

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQV   80 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~   80 (247)
                      |+.||||++....   ......+.+.+|+.++++++||||+++++++.. +..++||||+++++|.+++... .+++..+
T Consensus       396 ~~~vAvK~~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~  471 (635)
T 4fl3_A          396 VKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNI  471 (635)
T ss_dssp             EEEEEEEEECGGG---GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHH
T ss_pred             ceEEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCCCCCHHHH
Confidence            5689999997542   233446778999999999999999999999865 4688999999999999999765 4999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-----cccCCCCCCccCCcccccCCCCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      +.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.......     .....++..|+|||.+.+..  +
T Consensus       472 ~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~--~  549 (635)
T 4fl3_A          472 IELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--F  549 (635)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCC--C
T ss_pred             HHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCC--C
Confidence            9999999999999999999999999999999999999999999986544322     12223567799999996544  8


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +.++||||||+++|+|++ |..||......+....+..+.....+..+++++.++|.+||..+|.+|||++++++
T Consensus       550 ~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          550 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            999999999999999998 99999999888888888888777888899999999999999999999999999975

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=6.9e-43  Score=285.85  Aligned_cols=226  Identities=27%  Similarity=0.417  Sum_probs=181.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CC-----ceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QD-----NIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-   73 (247)
                      +|+.||||++..      .......+..|+.+++.++ |+     +|+++++++...+..++||||+.+ +|.+++... 
T Consensus        78 ~~~~vaiK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~  150 (382)
T 2vx3_A           78 EQEWVAIKIIKN------KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTN  150 (382)
T ss_dssp             TTEEEEEEEECS------SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTT
T ss_pred             CCcEEEEEEEec------cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCC-CHHHHHhhcC
Confidence            478899999963      2334566778888888885 55     499999999999999999999975 999988764 


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHhh--hCCeeecCCCCCcEEEc--CCCCeEEcccccccccCccccccCCCCCCccCCcc
Q 041080           74 --HLSDSQVSSYTRQILNGLVYLH--ERNVVHRDIKCANILVD--ASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEV  147 (247)
Q Consensus        74 --~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~~~ni~~~--~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~  147 (247)
                        ++++..++.++.|++.||.+||  +.||+|+||||+||+++  .++.++|+|||.+...... .....+++.|+|||.
T Consensus       151 ~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-~~~~~~t~~y~aPE~  229 (382)
T 2vx3_A          151 FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-IYQYIQSRFYRSPEV  229 (382)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-CCSSCSCGGGCCHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc-cccccCCccccChHH
Confidence              4899999999999999999999  57999999999999995  4678999999998765432 345568999999999


Q ss_pred             cccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC--------------------CC----------
Q 041080          148 VNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL--------------------PS----------  197 (247)
Q Consensus       148 ~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------------~~----------  197 (247)
                      +.+..  ++.++||||||+++|+|++|..||......+....+.....                    +.          
T Consensus       230 ~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (382)
T 2vx3_A          230 LLGMP--YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKD  307 (382)
T ss_dssp             HTTCC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCT
T ss_pred             HcCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccc
Confidence            97654  78999999999999999999999988766555443321100                    00          


Q ss_pred             -----CCC----------------------------cCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          198 -----VPS----------------------------SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       198 -----~~~----------------------------~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                           .+.                            ..++++++||.+||+.||.+|||++|+|+||||+..
T Consensus       308 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          308 GKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             TCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred             cccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence                 000                            001478999999999999999999999999999875

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.1e-43  Score=289.44  Aligned_cols=226  Identities=29%  Similarity=0.460  Sum_probs=177.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC--CCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--LSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~   77 (247)
                      +|+.||||++......        .+.+|+.+++++ +||||+++++++.+.+..++||||+.+ +|.+++....  ..+
T Consensus        47 ~~~~vAvK~~~~~~~~--------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g-~L~~~l~~~~~~~~~  117 (432)
T 3p23_A           47 DNRDVAVKRILPECFS--------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQKDFAHLG  117 (432)
T ss_dssp             SSSEEEEEEECTTTEE--------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHSSSCCCCS
T ss_pred             CCeEEEEEEECHHHHH--------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCC-CHHHHHHhcCCCccc
Confidence            5889999999653221        245899999999 799999999999999999999999975 9999997654  555


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC---CC--CeEEcccccccccCcc-----ccccCCCCCCccCCcc
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA---SG--SVKLADFGLAKATTMN-----DLKSCKGTPFWMAPEV  147 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~---~~--~~~l~df~~~~~~~~~-----~~~~~~~~~~~~aPE~  147 (247)
                      ..++.++.|++.||.|||++||+|+||||+||+++.   ++  .++|+|||++......     ......|++.|+|||.
T Consensus       118 ~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~  197 (432)
T 3p23_A          118 LEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM  197 (432)
T ss_dssp             SCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGG
T ss_pred             hhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhh
Confidence            567899999999999999999999999999999953   23  5789999998655432     2234568999999999


Q ss_pred             cccC-CCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCC--CCCcCCHHHHHHHHHHhcCCCCCCCC
Q 041080          148 VNSK-NDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPS--VPSSLSRDARDFILKCLQVNPNDRPT  223 (247)
Q Consensus       148 ~~~~-~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps  223 (247)
                      +.+. ...++.++||||||+++|++++ |..||...................  .....+..++++|.+||+.||.+|||
T Consensus       198 l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps  277 (432)
T 3p23_A          198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPS  277 (432)
T ss_dssp             TSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred             hhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCC
Confidence            8642 2336789999999999999999 899986655444333333222222  12345667899999999999999999


Q ss_pred             hhhhhcCccCCC
Q 041080          224 VTELMEHPFVKR  235 (247)
Q Consensus       224 ~~~il~~p~~~~  235 (247)
                      ++++++||||..
T Consensus       278 ~~evl~hp~f~~  289 (432)
T 3p23_A          278 AKHVLKHPFFWS  289 (432)
T ss_dssp             HHHHHTSTTTCC
T ss_pred             HHHHHhCccccC
Confidence            999999999975

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.4e-42  Score=274.86  Aligned_cols=220  Identities=25%  Similarity=0.444  Sum_probs=187.5

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceee-ecCCcEEEEEeccccCcHHHHHHhc--CCCHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTD-KDENRLYIFLELVTKGSLANLYQKY--HLSDSQV   80 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~   80 (247)
                      .+|+|.+...    ......+.+.+|+.++++++||||+++++++ ..++..++||||+++++|.+++...  .+++..+
T Consensus        55 ~~avk~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~  130 (298)
T 3f66_A           55 HCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL  130 (298)
T ss_dssp             EEEEEEETTC----CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHH
T ss_pred             EEEEEecccC----CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHH
Confidence            5788888642    3445567789999999999999999999985 5567889999999999999999753  4889999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc------cccCCCCCCccCCcccccCCCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND------LKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+.......      .....+++.|+|||.+.+..  
T Consensus       131 ~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--  208 (298)
T 3f66_A          131 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK--  208 (298)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCC--
T ss_pred             HHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCC--
Confidence            9999999999999999999999999999999999999999999987554332      22333567899999996654  


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          155 YGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ++.++|+||||++++++++ +.+||......+....+........+..+++.+.+++.+||..+|.+|||++++++
T Consensus       209 ~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          209 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7899999999999999999 67788877777777777777766777889999999999999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.9e-42  Score=275.57  Aligned_cols=225  Identities=27%  Similarity=0.349  Sum_probs=181.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++....  .......+.+.+|+.++++++||||+++++++...+..+++|||+++++|.++++.. .+++..
T Consensus        58 ~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  135 (309)
T 2h34_A           58 RERIVALKLMSETL--SSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPR  135 (309)
T ss_dssp             TTEEEEEEECGGGG--GGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHH
T ss_pred             CCeEEEEEecCccc--ccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHH
Confidence            47889999986543  233455678899999999999999999999999999999999999999999998765 499999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......   .....++..|+|||.+.+..  ++
T Consensus       136 ~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~  213 (309)
T 2h34_A          136 AVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH--AT  213 (309)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC------
T ss_pred             HHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCC--CC
Confidence            99999999999999999999999999999999999999999999986544332   22445888999999986543  78


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC--CCCCCcCCHHHHHHHHHHhcCCCCCCC-Chhhhhc
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL--PSVPSSLSRDARDFILKCLQVNPNDRP-TVTELME  229 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~~il~  229 (247)
                      .++|+||||+++|++++|..||...........+.....  ...+..+|+++.+++.+||+.+|.+|| |++++++
T Consensus       214 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          214 YRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             chHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            899999999999999999999988776544444333221  234567899999999999999999999 7887765

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1e-42  Score=281.88  Aligned_cols=224  Identities=23%  Similarity=0.320  Sum_probs=181.2

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCc------eeeeceeeecCCcEEEEEeccccCcHHHHHHhc---
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDN------IVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---   73 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---   73 (247)
                      +.||||++..      .....+.+.+|+.+++.++|++      ++.+.+++...+..++||||+.+ ++.+.+...   
T Consensus        46 ~~vavK~~~~------~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~  118 (355)
T 2eu9_A           46 SQVALKIIRN------VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQ  118 (355)
T ss_dssp             EEEEEEEECS------CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTTTC
T ss_pred             eEEEEEEEcc------cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEeccCC-ChHHHHHhccCC
Confidence            6899999953      2344567888999999997655      89999999999999999999955 666666544   


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEE-------------------cCCCCeEEcccccccccCccccc
Q 041080           74 HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV-------------------DASGSVKLADFGLAKATTMNDLK  134 (247)
Q Consensus        74 ~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~-------------------~~~~~~~l~df~~~~~~~~~~~~  134 (247)
                      .+++..++.++.|++.||.+||++|++|+||||+||++                   +.++.++|+|||.+...... ..
T Consensus       119 ~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~  197 (355)
T 2eu9_A          119 PYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-HT  197 (355)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-CC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-cc
Confidence            48999999999999999999999999999999999999                   56789999999998754332 33


Q ss_pred             cCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC--CCC----------------
Q 041080          135 SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG--ELP----------------  196 (247)
Q Consensus       135 ~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--~~~----------------  196 (247)
                      ...+++.|+|||.+.+..  ++.++|+||||+++|+|++|..||...........+...  ..+                
T Consensus       198 ~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  275 (355)
T 2eu9_A          198 TIVATRHYRPPEVILELG--WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKG  275 (355)
T ss_dssp             SSCSCGGGCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETT
T ss_pred             CCcCCCcccCCeeeecCC--CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhccc
Confidence            456899999999996544  789999999999999999999999877665543332211  000                


Q ss_pred             -------------------------CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          197 -------------------------SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       197 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                                               ......+.++.++|.+||..||.+|||++++++||||+..
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  340 (355)
T 2eu9_A          276 GLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL  340 (355)
T ss_dssp             EECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred             ccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCC
Confidence                                     0111235688999999999999999999999999999964

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.8e-43  Score=299.92  Aligned_cols=221  Identities=25%  Similarity=0.449  Sum_probs=188.7

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~   79 (247)
                      |..||||++....    .....+.+.+|+.++++++||||+++++++.. +..++||||+.+++|.+++...  .+++..
T Consensus       363 ~~~vAvK~~~~~~----~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~  437 (613)
T 2ozo_A          363 QIDVAIKVLKQGT----EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSN  437 (613)
T ss_dssp             EEEEEEEECCCCC----SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHH
T ss_pred             cEEEEEEEcCCCC----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHH
Confidence            4569999997542    22345678899999999999999999999876 5699999999999999998643  489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc-----ccCCCCCCccCCcccccCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL-----KSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      ++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++........     ....++..|+|||.+.+..  
T Consensus       438 ~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~--  515 (613)
T 2ozo_A          438 VAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--  515 (613)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCC--
T ss_pred             HHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCC--
Confidence            999999999999999999999999999999999999999999999976543221     1222457899999996544  


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          155 YGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ++.++||||||+++|+|++ |..||......+....+..+.....+..+++++.++|.+||..+|.+||+++++++
T Consensus       516 ~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          516 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8999999999999999998 99999998888888888887777788899999999999999999999999999853

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.5e-43  Score=279.86  Aligned_cols=223  Identities=26%  Similarity=0.462  Sum_probs=186.6

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCC-cEEEEEeccccCcHHHHHHhcC-----
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDEN-RLYIFLELVTKGSLANLYQKYH-----   74 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~-----   74 (247)
                      |+.||||++...    ......+.+.+|+.++.++ +||||+++++++...+ ..++||||+++++|.+++....     
T Consensus        57 ~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~  132 (316)
T 2xir_A           57 CRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP  132 (316)
T ss_dssp             EEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEEC
T ss_pred             ceEEEEEecccC----CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhccccccc
Confidence            578999999643    2344566788999999999 6999999999987654 5899999999999999997653     


Q ss_pred             ------------CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----ccCCC
Q 041080           75 ------------LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCKG  138 (247)
Q Consensus        75 ------------~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~  138 (247)
                                  +++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+........    ....+
T Consensus       133 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  212 (316)
T 2xir_A          133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL  212 (316)
T ss_dssp             C-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEE
T ss_pred             ccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCc
Confidence                        78999999999999999999999999999999999999999999999999875443221    22336


Q ss_pred             CCCccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhH-HHHHhhcCCCCCCCCcCCHHHHHHHHHHhcC
Q 041080          139 TPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQ-ALFRIGKGELPSVPSSLSRDARDFILKCLQV  216 (247)
Q Consensus       139 ~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  216 (247)
                      +..|+|||.+.+..  ++.++|+||||+++|+|++ |..||....... ....+........+..+++.+.+++.+||..
T Consensus       213 t~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  290 (316)
T 2xir_A          213 PLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG  290 (316)
T ss_dssp             CGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             ceeecCchhhcccc--ccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCC
Confidence            77899999986544  7899999999999999998 999997765433 3344444445566778899999999999999


Q ss_pred             CCCCCCChhhhhcC
Q 041080          217 NPNDRPTVTELMEH  230 (247)
Q Consensus       217 ~p~~Rps~~~il~~  230 (247)
                      +|.+|||++++++|
T Consensus       291 dp~~Rps~~ell~~  304 (316)
T 2xir_A          291 EPSQRPTFSELVEH  304 (316)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.2e-42  Score=273.15  Aligned_cols=225  Identities=32%  Similarity=0.566  Sum_probs=179.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-----cCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-----YHL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~   75 (247)
                      +|+.||||++.....  ......+.+.+|+.++++++||||+++++++...+..++||||+++++|.++++.     ..+
T Consensus        56 ~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  133 (310)
T 2wqm_A           56 DGVPVALKKVQIFDL--MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI  133 (310)
T ss_dssp             TCCEEEEEEECTTSS--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCC
T ss_pred             CCceEEEEeeehhhc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCC
Confidence            588999999975432  3345667788999999999999999999999999999999999999999998864     348


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCC
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      ++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+.. 
T Consensus       134 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-  212 (310)
T 2wqm_A          134 PERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-  212 (310)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------------------CCSSCCHHHHTTCC-
T ss_pred             CHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCC-
Confidence            999999999999999999999999999999999999999999999999986544322  23345889999999986543 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChh--hHHHHHhhcCCCCCC-CCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEG--VQALFRIGKGELPSV-PSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                       ++.++|+||||+++++|++|..||.....  ......+.....+.. ...+++++.+++.+||..||.+|||++++++
T Consensus       213 -~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          213 -YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence             78999999999999999999999865432  233344444444333 3678999999999999999999999999986

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=7.7e-43  Score=291.21  Aligned_cols=226  Identities=27%  Similarity=0.458  Sum_probs=189.6

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh---cCCCHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK---YHLSDS   78 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~   78 (247)
                      +..||||++.....      ..+.+.+|+.++++++||||+++++++.. +..++||||+++|+|.+++..   ..+++.
T Consensus       208 ~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~  280 (452)
T 1fmk_A          208 TTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLP  280 (452)
T ss_dssp             TEEEEEEECCTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHH
T ss_pred             CceEEEEEeccCCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHH
Confidence            45799999875321      23568899999999999999999999876 678999999999999999964   348999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc---ccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL---KSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........   ....++..|+|||.+.+..  +
T Consensus       281 ~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~  358 (452)
T 1fmk_A          281 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--F  358 (452)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCC--C
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCC--C
Confidence            9999999999999999999999999999999999999999999999876543321   2233567899999986544  7


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc--Ccc
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME--HPF  232 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--~p~  232 (247)
                      +.++||||||+++|+|++ |..||......+....+..+.....+..+|+.+.++|.+||..+|.+|||++++++  ..+
T Consensus       359 ~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~  438 (452)
T 1fmk_A          359 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  438 (452)
T ss_dssp             CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999 99999988888888777777666778889999999999999999999999999987  356


Q ss_pred             CCCC
Q 041080          233 VKRP  236 (247)
Q Consensus       233 ~~~~  236 (247)
                      +...
T Consensus       439 ~~~~  442 (452)
T 1fmk_A          439 FTST  442 (452)
T ss_dssp             TSCS
T ss_pred             hccC
Confidence            6543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.5e-43  Score=276.06  Aligned_cols=218  Identities=20%  Similarity=0.343  Sum_probs=181.1

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC--CCHHHH
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--LSDSQV   80 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~   80 (247)
                      ..||+|++...     .....+.+.+|+.++++++||||+++++++.+++..++||||+++++|.+++...+  +++..+
T Consensus        41 ~~va~K~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  115 (289)
T 4fvq_A           41 TEVLLKVLDKA-----HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK  115 (289)
T ss_dssp             EEEEEEEECGG-----GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHH
T ss_pred             hhhhhhhcccc-----cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHH
Confidence            46999998642     23445678899999999999999999999999999999999999999999997754  999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCC--------eEEcccccccccCccccccCCCCCCccCCcccccCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS--------VKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKN  152 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~--------~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  152 (247)
                      +.++.|++.||.+||++|++|+||||+||+++.++.        ++|+|||.+.......  ...++..|+|||.+.+..
T Consensus       116 ~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~y~aPE~~~~~~  193 (289)
T 4fvq_A          116 LEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD--ILQERIPWVPPECIENPK  193 (289)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCHH--HHHHTTTTSCHHHHHCGG
T ss_pred             HHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCcc--ccCCcCcccCHHHhCCCC
Confidence            999999999999999999999999999999998887        9999999986543322  233677899999987522


Q ss_pred             CCCCcchhHHHHHHHHHHHHhC-CCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          153 DGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                       .++.++||||||+++|+|++| ..|+..............  ....+...++++.+++.+||+.+|.+|||+++++++
T Consensus       194 -~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          194 -NLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             -GCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             -CCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             278999999999999999995 555655554444333322  334566678899999999999999999999999874

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.3e-43  Score=283.77  Aligned_cols=224  Identities=26%  Similarity=0.379  Sum_probs=181.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-----CC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-----HL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~   75 (247)
                      +|+.||||++....     ....+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++...     .+
T Consensus        62 ~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  136 (321)
T 2qkw_B           62 DGAKVALKRRTPES-----SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSM  136 (321)
T ss_dssp             TCCEEEEEECCSCC-----SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCC
T ss_pred             CCCEEEEEEecccC-----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCcccc
Confidence            47899999886532     234567889999999999999999999999999999999999999999988654     38


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCCcccccC
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSK  151 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~  151 (247)
                      ++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+.......    .....|++.|+|||.+.+.
T Consensus       137 ~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  216 (321)
T 2qkw_B          137 SWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG  216 (321)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHC
T ss_pred             CHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCC
Confidence            899999999999999999999999999999999999999999999999986533221    2233478899999998655


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHH---H----HHhhcCC---------CCCCCCcCCHHHHHHHHHHhc
Q 041080          152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQA---L----FRIGKGE---------LPSVPSSLSRDARDFILKCLQ  215 (247)
Q Consensus       152 ~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~---~----~~~~~~~---------~~~~~~~~~~~~~~li~~~l~  215 (247)
                      .  ++.++|+||||+++|+|++|..||........   .    .......         ....+...+..+.+++.+||+
T Consensus       217 ~--~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  294 (321)
T 2qkw_B          217 R--LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLA  294 (321)
T ss_dssp             B--CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTC
T ss_pred             C--CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcC
Confidence            4  78999999999999999999999865432211   0    0111111         112233456789999999999


Q ss_pred             CCCCCCCChhhhhcCc
Q 041080          216 VNPNDRPTVTELMEHP  231 (247)
Q Consensus       216 ~~p~~Rps~~~il~~p  231 (247)
                      .+|.+|||+++++++.
T Consensus       295 ~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          295 LSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             SSGGGSCCHHHHHHHH
T ss_pred             CCcccCcCHHHHHHHH
Confidence            9999999999999764

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.8e-43  Score=285.82  Aligned_cols=230  Identities=28%  Similarity=0.430  Sum_probs=181.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-----------CCceeeeceeeecCC----cEEEEEeccccCc
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-----------QDNIVQYLGTDKDEN----RLYIFLELVTKGS   65 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~~~----~~~lv~e~~~~~~   65 (247)
                      +|+.||||++..      .....+.+.+|+.+++++.           |+||+++++++...+    ..+++||++ +++
T Consensus        43 ~~~~vaiK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~  115 (373)
T 1q8y_A           43 NNTHVAMKIVRG------DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GEN  115 (373)
T ss_dssp             TTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEE
T ss_pred             CCcEEEEEEecC------CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCC
Confidence            478999999963      2334566788999999886           789999999987654    789999999 779


Q ss_pred             HHHHHHhc---CCCHHHHHHHHHHHHHHHHHhhhC-CeeecCCCCCcEEEcC------CCCeEEcccccccccCcccccc
Q 041080           66 LANLYQKY---HLSDSQVSSYTRQILNGLVYLHER-NVVHRDIKCANILVDA------SGSVKLADFGLAKATTMNDLKS  135 (247)
Q Consensus        66 L~~~l~~~---~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~~~ni~~~~------~~~~~l~df~~~~~~~~~~~~~  135 (247)
                      |.+++...   ++++..++.++.|++.||.+||++ |++|+||||+||+++.      .+.++|+|||.+...... ...
T Consensus       116 L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~  194 (373)
T 1q8y_A          116 LLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-YTN  194 (373)
T ss_dssp             HHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-CCS
T ss_pred             HHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-CCC
Confidence            99998763   499999999999999999999998 9999999999999953      347999999998655432 334


Q ss_pred             CCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhh------HHHHHhhc--CC-------------
Q 041080          136 CKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV------QALFRIGK--GE-------------  194 (247)
Q Consensus       136 ~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~------~~~~~~~~--~~-------------  194 (247)
                      ..+++.|+|||.+.+..  ++.++||||||+++|+|++|..||......      .....+..  +.             
T Consensus       195 ~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  272 (373)
T 1q8y_A          195 SIQTREYRSPEVLLGAP--WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTR  272 (373)
T ss_dssp             CCSCGGGCCHHHHHTCC--CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHH
T ss_pred             CCCCccccCcHHHhCCC--CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhh
Confidence            56899999999997654  789999999999999999999999754421      11111100  00             


Q ss_pred             --------------------------CCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCCCCC
Q 041080          195 --------------------------LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQTP  240 (247)
Q Consensus       195 --------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~~~~  240 (247)
                                                ...++...++++.++|.+||+.||.+|||++++++||||+......
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  344 (373)
T 1q8y_A          273 TFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME  344 (373)
T ss_dssp             HHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCT
T ss_pred             hhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccCcc
Confidence                                      0123345677899999999999999999999999999999875543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.5e-42  Score=278.35  Aligned_cols=222  Identities=29%  Similarity=0.530  Sum_probs=185.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeee--cCCcEEEEEeccccCcHHHHHHhc--CCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDK--DENRLYIFLELVTKGSLANLYQKY--HLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~--~~~   76 (247)
                      +|+.||||++...     .....+.+.+|+.++++++||||+++++++.  ..+..++||||+++++|.++++..  .++
T Consensus        51 ~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~  125 (327)
T 3lxl_A           51 TGALVAVKQLQHS-----GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLD  125 (327)
T ss_dssp             CSEEEEEEEESSC-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCC
T ss_pred             cceEEEEEEeccC-----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCC
Confidence            4778999998643     3455677899999999999999999999876  456789999999999999999763  499


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-----cccCCCCCCccCCcccccC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSK  151 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~  151 (247)
                      +..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.......     .....++..|+|||.+.+.
T Consensus       126 ~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  205 (327)
T 3lxl_A          126 ASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN  205 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccC
Confidence            99999999999999999999999999999999999999999999999987544322     2233467779999998655


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhh---------------HHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcC
Q 041080          152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---------------QALFRIGKGELPSVPSSLSRDARDFILKCLQV  216 (247)
Q Consensus       152 ~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  216 (247)
                      .  ++.++||||||+++++|++|..||......               .....+........+..+++++.+++.+||+.
T Consensus       206 ~--~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  283 (327)
T 3lxl_A          206 I--FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAP  283 (327)
T ss_dssp             E--EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             C--CChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCC
Confidence            4  788999999999999999999998654332               22333444455566788999999999999999


Q ss_pred             CCCCCCChhhhhc
Q 041080          217 NPNDRPTVTELME  229 (247)
Q Consensus       217 ~p~~Rps~~~il~  229 (247)
                      +|.+|||++++++
T Consensus       284 dP~~Rps~~ell~  296 (327)
T 3lxl_A          284 SPQDRPSFSALGP  296 (327)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999965

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-43  Score=284.43  Aligned_cols=220  Identities=25%  Similarity=0.433  Sum_probs=180.0

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeee-cCCcEEEEEeccccCcHHHHHHhc--CCCHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDK-DENRLYIFLELVTKGSLANLYQKY--HLSDSQV   80 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~   80 (247)
                      .||+|.+...    ......+.+.+|+.++++++||||+++++++. .++..++||||+++++|.++++..  .+++..+
T Consensus       119 ~vavK~~~~~----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~  194 (373)
T 3c1x_A          119 HCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL  194 (373)
T ss_dssp             EEEEEECCSC----SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHH
T ss_pred             EEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHH
Confidence            5788887542    23445678899999999999999999999864 456889999999999999999764  3889999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc------cccCCCCCCccCCcccccCCCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND------LKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......      .....++..|+|||.+.+..  
T Consensus       195 ~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--  272 (373)
T 3c1x_A          195 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK--  272 (373)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCC--
T ss_pred             HHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCC--
Confidence            9999999999999999999999999999999999999999999986543222      12233567899999986554  


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          155 YGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ++.++||||||+++|+|++ |..||......+....+..+.....+..+++.+.+++.+||..+|.+|||++++++
T Consensus       273 ~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~  348 (373)
T 3c1x_A          273 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  348 (373)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7899999999999999999 77888877777777666666666677889999999999999999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5e-42  Score=271.65  Aligned_cols=219  Identities=21%  Similarity=0.247  Sum_probs=180.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~   77 (247)
                      +|+.||||++.....       .+.+.+|+.+++.+ +|+|++++++++......++||||+ +++|.++++..  .+++
T Consensus        34 ~~~~vavK~~~~~~~-------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~  105 (298)
T 1csn_A           34 NNQQVAIKFEPRRSD-------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSV  105 (298)
T ss_dssp             TTEEEEEEEEECCTT-------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCH
T ss_pred             CCcEEEEEEeccCCc-------cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCH
Confidence            478999999865432       12367899999999 7999999999999999999999999 88999999864  4899


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCC-----eEEcccccccccCccc---------cccCCCCCCcc
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS-----VKLADFGLAKATTMND---------LKSCKGTPFWM  143 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~-----~~l~df~~~~~~~~~~---------~~~~~~~~~~~  143 (247)
                      ..++.++.|++.||.+||++|++|+||||+||+++.++.     ++|+|||.+.......         .....|++.|+
T Consensus       106 ~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  185 (298)
T 1csn_A          106 KTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM  185 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTC
T ss_pred             HHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccC
Confidence            999999999999999999999999999999999987776     9999999986544322         23445899999


Q ss_pred             CCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChh---hHHHHHhh----cCCCCCCCCcCCHHHHHHHHHHhcC
Q 041080          144 APEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG---VQALFRIG----KGELPSVPSSLSRDARDFILKCLQV  216 (247)
Q Consensus       144 aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~---~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~  216 (247)
                      |||.+.+..  ++.++||||||+++|+|++|..||.....   ......+.    ....+.....+|+++.+++.+||+.
T Consensus       186 aPE~~~~~~--~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  263 (298)
T 1csn_A          186 SINTHLGRE--QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNL  263 (298)
T ss_dssp             CHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHC
T ss_pred             CchhhcCCC--CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcC
Confidence            999986544  79999999999999999999999977432   22222211    1222233457899999999999999


Q ss_pred             CCCCCCChhhhhc
Q 041080          217 NPNDRPTVTELME  229 (247)
Q Consensus       217 ~p~~Rps~~~il~  229 (247)
                      +|.+|||++++++
T Consensus       264 dp~~RP~~~~l~~  276 (298)
T 1csn_A          264 AFDATPDYDYLQG  276 (298)
T ss_dssp             CTTCCCCHHHHHH
T ss_pred             CcccCCCHHHHHH
Confidence            9999999999875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.4e-42  Score=277.96  Aligned_cols=222  Identities=25%  Similarity=0.354  Sum_probs=176.3

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC----cEEEEEeccccCcHHHHHHhcCCCH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN----RLYIFLELVTKGSLANLYQKYHLSD   77 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~   77 (247)
                      |+.||||++...      ........+|+.++++++||||+++++++....    .+++||||+++++|.++++...+++
T Consensus        47 ~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~  120 (322)
T 3soc_A           47 NEYVAVKIFPIQ------DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSW  120 (322)
T ss_dssp             TEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCCBCH
T ss_pred             CCEEEEEEeecC------chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcCCCH
Confidence            678999999542      233445567999999999999999999987754    4799999999999999999989999


Q ss_pred             HHHHHHHHHHHHHHHHhhhC----------CeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCcc
Q 041080           78 SQVSSYTRQILNGLVYLHER----------NVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWM  143 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~----------~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~  143 (247)
                      ..++.++.|++.||.|||+.          |++|+||||+||+++.++.++|+|||.+.......    .....+++.|+
T Consensus       121 ~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~  200 (322)
T 3soc_A          121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYM  200 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGC
T ss_pred             HHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCcccc
Confidence            99999999999999999999          99999999999999999999999999986543222    23356899999


Q ss_pred             CCcccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCChh----------------hHHHHHhhcC-CCCCCCC---
Q 041080          144 APEVVNSKND---GYGLTADIWSLGCTVLEMLTRRPPYSHLEG----------------VQALFRIGKG-ELPSVPS---  200 (247)
Q Consensus       144 aPE~~~~~~~---~~~~~~Di~slG~ll~~l~~g~~p~~~~~~----------------~~~~~~~~~~-~~~~~~~---  200 (247)
                      |||.+.+...   .++.++||||||+++|+|++|..||.....                .......... ..+..+.   
T Consensus       201 aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (322)
T 3soc_A          201 APEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQ  280 (322)
T ss_dssp             CHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGG
T ss_pred             CHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCcccccc
Confidence            9999865321   245678999999999999999999864321                1111222222 1222222   


Q ss_pred             --cCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          201 --SLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       201 --~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                        ..++++.+++.+||+.||.+|||++++++
T Consensus       281 ~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          281 KHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence              23456999999999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.4e-42  Score=270.10  Aligned_cols=224  Identities=25%  Similarity=0.529  Sum_probs=175.8

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~   79 (247)
                      ...||+|++....   ......+.+.+|+.++++++||||++++++. ..+..++||||+.+++|.+++...  .+++..
T Consensus        46 ~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  121 (289)
T 3og7_A           46 HGDVAVKMLNVTA---PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKK  121 (289)
T ss_dssp             SSEEEEEEESCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHH
T ss_pred             cCceEEEEEeccC---CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHH
Confidence            3468999997543   3455677899999999999999999999965 556789999999999999998543  489999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc----cccccCCCCCCccCCcccccC-CCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM----NDLKSCKGTPFWMAPEVVNSK-NDG  154 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~-~~~  154 (247)
                      ++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.....    .......+++.|+|||.+... ...
T Consensus       122 ~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  201 (289)
T 3og7_A          122 LIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP  201 (289)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CC
T ss_pred             HHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCC
Confidence            999999999999999999999999999999999999999999999864432    222344589999999998522 233


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHh-hcCC----CCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI-GKGE----LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ++.++||||||++++++++|..||............ ....    .......+|+.+.+++.+||+.+|.+|||++++++
T Consensus       202 ~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             SCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            688999999999999999999999876554443332 2222    22344578999999999999999999999999985

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.1e-42  Score=276.76  Aligned_cols=218  Identities=22%  Similarity=0.307  Sum_probs=178.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~   77 (247)
                      +|+.||||++......       +.+.+|+.+++++ +||||+++++++..++..++||||+ +++|.+++..  ..+++
T Consensus        33 ~~~~vavK~~~~~~~~-------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~  104 (330)
T 2izr_A           33 TNEYVAIKLEPMKSRA-------PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSL  104 (330)
T ss_dssp             TTEEEEEEEEETTCSS-------CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCH
T ss_pred             CCcEEEEEEeccccch-------HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCH
Confidence            4789999998754321       2477999999999 8999999999999999999999999 8899999985  46999


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCC-----eEEcccccccccCccc---------cccCCCCCCcc
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS-----VKLADFGLAKATTMND---------LKSCKGTPFWM  143 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~-----~~l~df~~~~~~~~~~---------~~~~~~~~~~~  143 (247)
                      ..++.++.|++.||.+||+.|++|+||||+||+++.++.     ++|+|||.+.......         .....|++.|+
T Consensus       105 ~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~  184 (330)
T 2izr_A          105 KTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM  184 (330)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTC
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCcccc
Confidence            999999999999999999999999999999999998887     9999999987543322         23456899999


Q ss_pred             CCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHH---HHHhhcCC----CCCCCCcCCHHHHHHHHHHhcC
Q 041080          144 APEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQA---LFRIGKGE----LPSVPSSLSRDARDFILKCLQV  216 (247)
Q Consensus       144 aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~---~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~  216 (247)
                      |||.+.+..  ++.++|+||||+++|+|++|..||........   ...+....    ........| ++.+++.+||+.
T Consensus       185 aPE~~~~~~--~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~  261 (330)
T 2izr_A          185 SINTHLGKE--QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRL  261 (330)
T ss_dssp             CHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHC
T ss_pred             ChHHHcCCC--CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhC
Confidence            999997644  79999999999999999999999987543222   22221111    111122345 999999999999


Q ss_pred             CCCCCCChhhhhc
Q 041080          217 NPNDRPTVTELME  229 (247)
Q Consensus       217 ~p~~Rps~~~il~  229 (247)
                      +|.+||+++++++
T Consensus       262 ~p~~RP~~~~l~~  274 (330)
T 2izr_A          262 DFFEKPDYDYLRK  274 (330)
T ss_dssp             CTTCCCCHHHHHH
T ss_pred             CCCCCCCHHHHHH
Confidence            9999999998876

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.3e-42  Score=271.66  Aligned_cols=216  Identities=28%  Similarity=0.547  Sum_probs=176.4

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC----CCH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH----LSD   77 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~   77 (247)
                      |+.||||.+..       ....+.+.+|+.++++++||||+++++++.  +..++||||+++++|.+++....    ++.
T Consensus        31 ~~~vavK~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  101 (307)
T 2eva_A           31 AKDVAIKQIES-------ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTA  101 (307)
T ss_dssp             TEEEEEEECSS-------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHHHHCSSSEECCCH
T ss_pred             CeeEEEEEecC-------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHHHhccCCCCccCH
Confidence            67899998853       223567889999999999999999999876  34799999999999999997653    788


Q ss_pred             HHHHHHHHHHHHHHHHhhh---CCeeecCCCCCcEEEcCCCC-eEEcccccccccCccccccCCCCCCccCCcccccCCC
Q 041080           78 SQVSSYTRQILNGLVYLHE---RNVVHRDIKCANILVDASGS-VKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~---~~i~h~dl~~~ni~~~~~~~-~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      ..++.++.|++.||.+||+   +|++|+||||+||+++.++. ++|+|||.+...... .....|+..|+|||.+.+.. 
T Consensus       102 ~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-  179 (307)
T 2eva_A          102 AHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-MTNNKGSAAWMAPEVFEGSN-  179 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------CCTTSSCHHHHTCCC-
T ss_pred             HHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-cccCCCCCceEChhhhCCCC-
Confidence            9999999999999999999   89999999999999998887 799999998654432 23345899999999996544 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhh--HHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGV--QALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                       ++.++||||||+++|+|++|..||......  ...........+..+..+++.+.+++.+||+.+|.+|||++++++
T Consensus       180 -~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          180 -YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             -CCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -CCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence             789999999999999999999999754332  233344455556677789999999999999999999999999987

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.5e-42  Score=273.74  Aligned_cols=226  Identities=28%  Similarity=0.416  Sum_probs=184.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc----CCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY----HLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~   76 (247)
                      +|+.||||++..... .......+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++...    .++
T Consensus        53 ~~~~vavK~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  131 (307)
T 2nru_A           53 NNTTVAVKKLAAMVD-ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS  131 (307)
T ss_dssp             SSCEEEEEEECCCTT-SCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCC
T ss_pred             CCceEEEEEEecccC-cchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCC
Confidence            478899999975432 223445677899999999999999999999999999999999999999999998642    489


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCCcccccCC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKN  152 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~  152 (247)
                      +..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......    .....+++.|+|||.+.+. 
T Consensus       132 ~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-  210 (307)
T 2nru_A          132 WHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-  210 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE-
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC-
Confidence            99999999999999999999999999999999999999999999999986543221    2234588999999998643 


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHH----HHh----------hcCCCCCCCCcCCHHHHHHHHHHhcCCC
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQAL----FRI----------GKGELPSVPSSLSRDARDFILKCLQVNP  218 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~----~~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p  218 (247)
                        ++.++|+||||+++|+|++|..||.........    ...          ........+...++.+.+++.+||..+|
T Consensus       211 --~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p  288 (307)
T 2nru_A          211 --ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKK  288 (307)
T ss_dssp             --ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSST
T ss_pred             --CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCc
Confidence              688999999999999999999999765432211    111          1112223344567789999999999999


Q ss_pred             CCCCChhhhhcC
Q 041080          219 NDRPTVTELMEH  230 (247)
Q Consensus       219 ~~Rps~~~il~~  230 (247)
                      .+|||+++++++
T Consensus       289 ~~Rps~~~l~~~  300 (307)
T 2nru_A          289 NKRPDIKKVQQL  300 (307)
T ss_dssp             TTSCCHHHHHHH
T ss_pred             ccCcCHHHHHHH
Confidence            999999999863

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.8e-43  Score=281.01  Aligned_cols=226  Identities=24%  Similarity=0.364  Sum_probs=179.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-----C
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-----L   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~   75 (247)
                      +|+.||||++.......    ....+.+|+.+++.++||||+++++++...+..++||||+.+++|.+++....     +
T Consensus        53 ~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  128 (326)
T 3uim_A           53 DGTLVAVKRLKEERTQG----GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL  128 (326)
T ss_dssp             SSCCEEEEECCC---------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCC
T ss_pred             CCCEEEEEEeccccCch----HHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCC
Confidence            47899999997643211    12257899999999999999999999999999999999999999999997643     8


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhC---CeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccc
Q 041080           76 SDSQVSSYTRQILNGLVYLHER---NVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVN  149 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~  149 (247)
                      ++..++.++.|++.||.+||+.   |++|+||||+||+++.++.++|+|||.+.......   .....|++.|+|||.+.
T Consensus       129 ~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  208 (326)
T 3uim_A          129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS  208 (326)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhc
Confidence            9999999999999999999999   99999999999999999999999999987543222   23344899999999986


Q ss_pred             cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChh-----hHHHHHhhc---C-C---------CCCCCCcCCHHHHHHHH
Q 041080          150 SKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG-----VQALFRIGK---G-E---------LPSVPSSLSRDARDFIL  211 (247)
Q Consensus       150 ~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-----~~~~~~~~~---~-~---------~~~~~~~~~~~~~~li~  211 (247)
                      +..  ++.++||||||+++|+|++|..||.....     .........   . .         ....+...++.+.+++.
T Consensus       209 ~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  286 (326)
T 3uim_A          209 TGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVAL  286 (326)
T ss_dssp             HSE--ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHH
T ss_pred             cCC--CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHH
Confidence            555  78999999999999999999999952211     111111110   0 0         01122234578999999


Q ss_pred             HHhcCCCCCCCChhhhhcCcc
Q 041080          212 KCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       212 ~~l~~~p~~Rps~~~il~~p~  232 (247)
                      +||+.+|.+|||+++++++-.
T Consensus       287 ~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          287 LCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             HHTCSCGGGSCCHHHHHHHHH
T ss_pred             HHhCcCCccCCCHHHHHHHhc
Confidence            999999999999999998654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.4e-42  Score=275.01  Aligned_cols=225  Identities=22%  Similarity=0.381  Sum_probs=180.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeee----cCCcEEEEEeccccCcHHHHHHh----
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDK----DENRLYIFLELVTKGSLANLYQK----   72 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~----   72 (247)
                      +|+.||||++...     .....+.+.+|+.+++.++||||+++++++.    .....++||||+.+++|.+++..    
T Consensus        53 ~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~  127 (317)
T 2buj_A           53 DGHFYALKRILCH-----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDK  127 (317)
T ss_dssp             TCCEEEEEEEEES-----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTT
T ss_pred             CCcEEEEEEEecC-----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhc
Confidence            4789999999653     3455677889999999999999999999986    34578999999999999998875    


Q ss_pred             -cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-----------cccCCCCC
Q 041080           73 -YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----------LKSCKGTP  140 (247)
Q Consensus        73 -~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-----------~~~~~~~~  140 (247)
                       ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.......           .....+++
T Consensus       128 ~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~  207 (317)
T 2buj_A          128 GNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI  207 (317)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCG
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCc
Confidence             348999999999999999999999999999999999999999999999999875433211           11233688


Q ss_pred             CccCCcccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCChhh--HHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCC
Q 041080          141 FWMAPEVVNSKN-DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV--QALFRIGKGELPSVPSSLSRDARDFILKCLQVN  217 (247)
Q Consensus       141 ~~~aPE~~~~~~-~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  217 (247)
                      .|+|||.+.+.. ..++.++||||||+++|+|++|..||......  ..............+..+++++.+++.+||+.+
T Consensus       208 ~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  287 (317)
T 2buj_A          208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVD  287 (317)
T ss_dssp             GGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSS
T ss_pred             ccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcC
Confidence            999999985432 12578999999999999999999998542111  112222222223344678999999999999999


Q ss_pred             CCCCCChhhhhcC
Q 041080          218 PNDRPTVTELMEH  230 (247)
Q Consensus       218 p~~Rps~~~il~~  230 (247)
                      |.+|||+++++++
T Consensus       288 p~~Rps~~~ll~~  300 (317)
T 2buj_A          288 PHQRPHIPLLLSQ  300 (317)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             hhhCCCHHHHHHH
Confidence            9999999999975

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.9e-42  Score=274.30  Aligned_cols=222  Identities=27%  Similarity=0.486  Sum_probs=182.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC--cEEEEEeccccCcHHHHHHhcC--CC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN--RLYIFLELVTKGSLANLYQKYH--LS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~--~~   76 (247)
                      +|+.||||++...     .....+.+.+|+.++++++||||+++++++...+  ..++||||+++++|.+++....  ++
T Consensus        69 ~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~  143 (326)
T 2w1i_A           69 TGEVVAVKKLQHS-----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID  143 (326)
T ss_dssp             CCEEEEEEEESSC-----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSC
T ss_pred             CceEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCC
Confidence            4788999998642     3445677899999999999999999999876644  7899999999999999998753  89


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-----cccCCCCCCccCCcccccC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSK  151 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~  151 (247)
                      +..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.......     .....++..|+|||.+.+.
T Consensus       144 ~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  223 (326)
T 2w1i_A          144 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES  223 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCC
Confidence            99999999999999999999999999999999999999999999999987554332     1223356679999998655


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhh----------------HHHHHhhcCCCCCCCCcCCHHHHHHHHHHhc
Q 041080          152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV----------------QALFRIGKGELPSVPSSLSRDARDFILKCLQ  215 (247)
Q Consensus       152 ~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  215 (247)
                      .  ++.++|+||||+++++|++|..|+......                .....+........+..+++++.+++.+||+
T Consensus       224 ~--~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  301 (326)
T 2w1i_A          224 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWN  301 (326)
T ss_dssp             E--EEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSC
T ss_pred             C--CCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcC
Confidence            4  788999999999999999999887543211                1122233334445677899999999999999


Q ss_pred             CCCCCCCChhhhhc
Q 041080          216 VNPNDRPTVTELME  229 (247)
Q Consensus       216 ~~p~~Rps~~~il~  229 (247)
                      .+|.+|||++++++
T Consensus       302 ~dP~~Rps~~el~~  315 (326)
T 2w1i_A          302 NNVNQRPSFRDLAL  315 (326)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999975

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.3e-42  Score=276.20  Aligned_cols=221  Identities=23%  Similarity=0.455  Sum_probs=185.1

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--------
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--------   73 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------   73 (247)
                      +.||+|.+...    ......+.+.+|+.+++++ +||||+++++++...+..++||||+++++|.+++...        
T Consensus        77 ~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~  152 (333)
T 2i1m_A           77 LKVAVKMLKST----AHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP  152 (333)
T ss_dssp             CEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-
T ss_pred             hHHHHHhcccc----cChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccc
Confidence            47999998643    2344567789999999999 8999999999999999999999999999999998643        


Q ss_pred             -------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----ccCCCCCCc
Q 041080           74 -------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----KSCKGTPFW  142 (247)
Q Consensus        74 -------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~  142 (247)
                             .+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+........    ....++..|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y  232 (333)
T 2i1m_A          153 AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW  232 (333)
T ss_dssp             ------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGG
T ss_pred             cccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccc
Confidence                   378999999999999999999999999999999999999999999999999875433321    223356689


Q ss_pred             cCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHH-hhcCCCCCCCCcCCHHHHHHHHHHhcCCCCC
Q 041080          143 MAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQVNPND  220 (247)
Q Consensus       143 ~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  220 (247)
                      +|||.+.+..  ++.++||||||+++|+|++ |..||........... .........+...++.+.+++.+||+.+|.+
T Consensus       233 ~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  310 (333)
T 2i1m_A          233 MAPESIFDCV--YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTH  310 (333)
T ss_dssp             SCHHHHHHCC--CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred             cCHHHhccCC--CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhh
Confidence            9999986544  7899999999999999998 8999977654444333 3333344556778999999999999999999


Q ss_pred             CCChhhhhc
Q 041080          221 RPTVTELME  229 (247)
Q Consensus       221 Rps~~~il~  229 (247)
                      |||++++++
T Consensus       311 Rps~~~l~~  319 (333)
T 2i1m_A          311 RPTFQQICS  319 (333)
T ss_dssp             SCCHHHHHH
T ss_pred             CcCHHHHHH
Confidence            999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.9e-42  Score=292.27  Aligned_cols=225  Identities=28%  Similarity=0.456  Sum_probs=192.7

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh---cCCCHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK---YHLSDS   78 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~   78 (247)
                      +..||||++.....      ..+.+.+|+.++++++||||+++++++.. +..++||||+.+++|.+++..   ..+++.
T Consensus       291 ~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~  363 (535)
T 2h8h_A          291 TTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLP  363 (535)
T ss_dssp             TEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHH
T ss_pred             CceEEEEEeCCCCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHH
Confidence            45799999975331      23568899999999999999999999876 678999999999999999964   348999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.......   .....++..|+|||.+....  +
T Consensus       364 ~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~  441 (535)
T 2h8h_A          364 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--F  441 (535)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCC--C
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCC--C
Confidence            999999999999999999999999999999999999999999999997654332   22333567899999986544  7


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC--cc
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH--PF  232 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~--p~  232 (247)
                      +.++||||||+++|+|++ |..||......+....+..+.....+..+++++.++|.+||..+|.+|||++++++.  .+
T Consensus       442 ~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  521 (535)
T 2h8h_A          442 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  521 (535)
T ss_dssp             CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            999999999999999999 999999888888887777776666778899999999999999999999999999873  55


Q ss_pred             CCC
Q 041080          233 VKR  235 (247)
Q Consensus       233 ~~~  235 (247)
                      |..
T Consensus       522 ~~~  524 (535)
T 2h8h_A          522 FTS  524 (535)
T ss_dssp             SCC
T ss_pred             hhc
Confidence            554

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5.4e-42  Score=269.61  Aligned_cols=219  Identities=27%  Similarity=0.478  Sum_probs=182.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec----------------CCcEEEEEeccccC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD----------------ENRLYIFLELVTKG   64 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~   64 (247)
                      +|+.||+|++....         +.+.+|+.++++++||||+++++++..                ....++||||++++
T Consensus        35 ~~~~vavK~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~  105 (284)
T 2a19_B           35 DGKTYVIKRVKYNN---------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKG  105 (284)
T ss_dssp             TCCEEEEEEEECCS---------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSC
T ss_pred             CCeEEEEEEecccc---------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCC
Confidence            58899999997542         135689999999999999999998754                44689999999999


Q ss_pred             cHHHHHHhc---CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCC
Q 041080           65 SLANLYQKY---HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTP  140 (247)
Q Consensus        65 ~L~~~l~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~  140 (247)
                      +|.++++..   .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... .....+++
T Consensus       106 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  185 (284)
T 2a19_B          106 TLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTL  185 (284)
T ss_dssp             BHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCC
T ss_pred             CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcc
Confidence            999999754   58999999999999999999999999999999999999999999999999986554332 33455899


Q ss_pred             CccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCC
Q 041080          141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPND  220 (247)
Q Consensus       141 ~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  220 (247)
                      .|+|||.+.+..  ++.++|+||||+++++|++|..|+...  ..........   ..+..++..+++++.+||..+|.+
T Consensus       186 ~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~  258 (284)
T 2a19_B          186 RYMSPEQISSQD--YGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG---IISDIFDKKEKTLLQKLLSKKPED  258 (284)
T ss_dssp             TTSCHHHHHCSC--CCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT---CCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred             cccChhhhccCC--CcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc---cccccCCHHHHHHHHHHccCChhh
Confidence            999999996544  789999999999999999998886432  2222222222   345678999999999999999999


Q ss_pred             CCChhhhhcCccCCC
Q 041080          221 RPTVTELMEHPFVKR  235 (247)
Q Consensus       221 Rps~~~il~~p~~~~  235 (247)
                      |||+.+++++.+.-.
T Consensus       259 Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          259 RPNTSEILRTLTVWK  273 (284)
T ss_dssp             SCCHHHHHHHHHHHT
T ss_pred             CcCHHHHHHHHHHHh
Confidence            999999999986543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.4e-42  Score=294.98  Aligned_cols=229  Identities=21%  Similarity=0.320  Sum_probs=183.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec------CCcEEEEEeccccCcHHHHHHhc-
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD------ENRLYIFLELVTKGSLANLYQKY-   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~-   73 (247)
                      +|+.||||++...    ......+.+.+|+.++++++||||+++++++..      ++..++||||+++++|.+++... 
T Consensus        38 tg~~VAVKvi~~~----~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~  113 (676)
T 3qa8_A           38 TGEQVAIKQCRQE----LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE  113 (676)
T ss_dssp             TTCCEEECCCCSC----CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSS
T ss_pred             CCcEEEEEEeccc----CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcc
Confidence            4789999998643    234556778999999999999999999998765      67889999999999999999764 


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCC---eEEcccccccccCccc-cccCCCCCCccCCc
Q 041080           74 ---HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS---VKLADFGLAKATTMND-LKSCKGTPFWMAPE  146 (247)
Q Consensus        74 ---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~---~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE  146 (247)
                         ++++..++.++.|++.||.|||+.|++|+||+|+||+++.++.   ++|+|||.+....... .....++..|+|||
T Consensus       114 ~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE  193 (676)
T 3qa8_A          114 NCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE  193 (676)
T ss_dssp             CTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSC
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChH
Confidence               4899999999999999999999999999999999999997765   8999999987655433 33456899999999


Q ss_pred             ccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHH---------HHh-----hcC-----C----CCCCCCcCC
Q 041080          147 VVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQAL---------FRI-----GKG-----E----LPSVPSSLS  203 (247)
Q Consensus       147 ~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~---------~~~-----~~~-----~----~~~~~~~~~  203 (247)
                      .+.+..  ++.++|+||+|+++|++++|..||.........         ...     ..+     .    .......++
T Consensus       194 ~l~~~~--~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls  271 (676)
T 3qa8_A          194 LLEQKK--YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILA  271 (676)
T ss_dssp             SSCCSC--CSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGH
T ss_pred             HhccCC--CCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhh
Confidence            996544  789999999999999999999999654221110         000     000     0    011223467


Q ss_pred             HHHHHHHHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          204 RDARDFILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       204 ~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                      +.+.+++.+||..||.+|||++++++||||+.
T Consensus       272 ~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          272 GKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             HHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             HHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence            89999999999999999999999999999975

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.3e-41  Score=268.39  Aligned_cols=221  Identities=28%  Similarity=0.494  Sum_probs=181.5

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVS   81 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~   81 (247)
                      .||||++.....  ......+.+.+|+.++++++||||+++++++.... .++|+||+++++|.+++...  .+++..++
T Consensus        48 ~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~  124 (291)
T 1u46_A           48 SVAVKCLKPDVL--SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLS  124 (291)
T ss_dssp             EEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHH
T ss_pred             EEEEEEEccCcc--CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHH
Confidence            589999875432  23345678899999999999999999999988765 88999999999999998764  49999999


Q ss_pred             HHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-----cccCCCCCCccCCcccccCCCCCC
Q 041080           82 SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        82 ~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+.......     .....++..|+|||.+.+..  ++
T Consensus       125 ~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~  202 (291)
T 1u46_A          125 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT--FS  202 (291)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE--EE
T ss_pred             HHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCC--CC
Confidence            999999999999999999999999999999999999999999986554332     12234667899999986544  68


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcC-CCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          157 LTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKG-ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      .++|+||||+++++|++ |..||...........+... .....+..+++++.+++.+||..+|.+|||++++++
T Consensus       203 ~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          203 HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            89999999999999999 99999888777776665443 234456788999999999999999999999999986

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.7e-41  Score=268.87  Aligned_cols=205  Identities=28%  Similarity=0.448  Sum_probs=165.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHH-hhcCCCceeeeceeeec----CCcEEEEEeccccCcHHHHHHhc--
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLL-SQFEQDNIVQYLGTDKD----ENRLYIFLELVTKGSLANLYQKY--   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~--   73 (247)
                      +|+.||||++...          ..+.+|+.++ +.++||||+++++++..    .+..++||||+++++|.+++...  
T Consensus        42 ~~~~vaiK~~~~~----------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~  111 (299)
T 3m2w_A           42 TQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD  111 (299)
T ss_dssp             TCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTT
T ss_pred             CCcEEEEEEeccc----------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccC
Confidence            4789999999631          2456888888 44589999999999876    67889999999999999999875  


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC---CCCeEEcccccccccCccccccCCCCCCccCCcccc
Q 041080           74 -HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA---SGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVN  149 (247)
Q Consensus        74 -~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~  149 (247)
                       .+++..++.++.|++.||.+||+.|++|+||||+||+++.   ++.++|+|||.+....                    
T Consensus       112 ~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--------------------  171 (299)
T 3m2w_A          112 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--------------------  171 (299)
T ss_dssp             CCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--------------------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc--------------------
Confidence             3999999999999999999999999999999999999998   7889999999875322                    


Q ss_pred             cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC---CCCCCC----CcCCHHHHHHHHHHhcCCCCCCC
Q 041080          150 SKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG---ELPSVP----SSLSRDARDFILKCLQVNPNDRP  222 (247)
Q Consensus       150 ~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp  222 (247)
                        ...++.++|+||||+++|+|++|..||...............   .....+    ..+++++.+++.+||+.+|.+||
T Consensus       172 --~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp  249 (299)
T 3m2w_A          172 --GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM  249 (299)
T ss_dssp             --TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred             --cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCC
Confidence              122678999999999999999999999765544332221111   111122    46899999999999999999999


Q ss_pred             ChhhhhcCccCCCCC
Q 041080          223 TVTELMEHPFVKRPL  237 (247)
Q Consensus       223 s~~~il~~p~~~~~~  237 (247)
                      |++++++||||+...
T Consensus       250 s~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          250 TITEFMNHPWIMQST  264 (299)
T ss_dssp             CHHHHHTSHHHHTGG
T ss_pred             CHHHHhcChhhcccc
Confidence            999999999998754

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=8.4e-42  Score=275.83  Aligned_cols=225  Identities=19%  Similarity=0.220  Sum_probs=176.2

Q ss_pred             CceEEEEEEeecCCCccch------HHHHHHHHHHHHHhhcCCCceeeeceeeec----CCcEEEEEeccccCcHHHHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGK------QSILQLEQEISLLSQFEQDNIVQYLGTDKD----ENRLYIFLELVTKGSLANLYQ   71 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~   71 (247)
                      +..+|||++.........+      .....+.+|+..++.++||||+++++++..    ....++||||+ +++|.+++.
T Consensus        65 ~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~  143 (345)
T 2v62_A           65 DARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISG  143 (345)
T ss_dssp             GCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCB
T ss_pred             cceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHH
Confidence            5689999997643211100      112236678899999999999999999877    77899999999 889999987


Q ss_pred             hc-CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC--CeEEcccccccccCccc---------cccCCCC
Q 041080           72 KY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG--SVKLADFGLAKATTMND---------LKSCKGT  139 (247)
Q Consensus        72 ~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~--~~~l~df~~~~~~~~~~---------~~~~~~~  139 (247)
                      .. .+++..++.++.|++.||.|||+.|++|+||||+||+++.++  .++|+|||.+.......         .....++
T Consensus       144 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt  223 (345)
T 2v62_A          144 QNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGT  223 (345)
T ss_dssp             GGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSC
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCC
Confidence            65 599999999999999999999999999999999999999887  99999999986543221         1344689


Q ss_pred             CCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHH-HHHhhcCCCCCC---------CCcCCHHHHHH
Q 041080          140 PFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQA-LFRIGKGELPSV---------PSSLSRDARDF  209 (247)
Q Consensus       140 ~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~---------~~~~~~~~~~l  209 (247)
                      ..|+|||.+.+..  ++.++||||||+++|+|++|..||........ ............         ...+++++.++
T Consensus       224 ~~y~aPE~~~~~~--~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  301 (345)
T 2v62_A          224 IEFTSLDAHKGVA--LSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQF  301 (345)
T ss_dssp             TTTCCHHHHHTCC--CCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHH
T ss_pred             ccccCHHHhcCCC--CCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHH
Confidence            9999999997554  79999999999999999999999954221111 111111101111         12688999999


Q ss_pred             HHHHhcCCCCCCCChhhhhc
Q 041080          210 ILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       210 i~~~l~~~p~~Rps~~~il~  229 (247)
                      +.+||..+|.+|||++++++
T Consensus       302 i~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          302 LVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHhhcCcccCCCHHHHHH
Confidence            99999999999999999976

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.7e-41  Score=291.87  Aligned_cols=221  Identities=29%  Similarity=0.487  Sum_probs=188.9

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~   79 (247)
                      +..||||.+...    ......+.+.+|+.++++++||||+++++++. ++..++||||+++++|.+++...  .+++..
T Consensus       418 ~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~  492 (656)
T 2j0j_A          418 AMAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLAS  492 (656)
T ss_dssp             CEEEEEEECSST----TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHH
T ss_pred             cEEEEEEEeccc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHH
Confidence            346888887542    33455678999999999999999999999985 45689999999999999999765  488999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc---ccCCCCCCccCCcccccCCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL---KSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      ++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........   ....++..|+|||.+.+..  ++
T Consensus       493 ~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~  570 (656)
T 2j0j_A          493 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR--FT  570 (656)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCC--CC
T ss_pred             HHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCC--CC
Confidence            999999999999999999999999999999999999999999999876543321   1233567899999996554  78


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          157 LTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      .++||||||+++|+|++ |..||......+....+........+..+++.+.+++.+||..+|.+|||+.++++
T Consensus       571 ~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          571 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999999999997 99999988888888777777777788899999999999999999999999999975

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.2e-41  Score=265.12  Aligned_cols=219  Identities=21%  Similarity=0.267  Sum_probs=175.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeecee-eecCCcEEEEEeccccCcHHHHHHh--cCCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGT-DKDENRLYIFLELVTKGSLANLYQK--YHLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~   77 (247)
                      +|+.||||++......       +.+.+|+.+++.++|+++++.+.. ...++..++||||+ +++|.+++..  ..+++
T Consensus        33 ~~~~vavK~~~~~~~~-------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~  104 (296)
T 3uzp_A           33 AGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSL  104 (296)
T ss_dssp             TTEEEEEEEEESCSSC-------CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCH
T ss_pred             CCcEEEEEEecCCcch-------hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCH
Confidence            4789999998754321       247799999999998776665555 46677889999999 8899999974  45999


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEE---cCCCCeEEcccccccccCccc---------cccCCCCCCccCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---DASGSVKLADFGLAKATTMND---------LKSCKGTPFWMAP  145 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~---~~~~~~~l~df~~~~~~~~~~---------~~~~~~~~~~~aP  145 (247)
                      ..++.++.|++.||.+||++|++|+||||+||++   +.++.++|+|||.+.......         .....+++.|+||
T Consensus       105 ~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  184 (296)
T 3uzp_A          105 KTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI  184 (296)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCH
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCCh
Confidence            9999999999999999999999999999999999   488899999999986544332         2345689999999


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChh---hHHHHHh----hcCCCCCCCCcCCHHHHHHHHHHhcCCC
Q 041080          146 EVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEG---VQALFRI----GKGELPSVPSSLSRDARDFILKCLQVNP  218 (247)
Q Consensus       146 E~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~---~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p  218 (247)
                      |.+.+..  ++.++||||||+++|+|++|..||.....   ......+    .....+.....+|+++.+++.+||+.+|
T Consensus       185 E~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp  262 (296)
T 3uzp_A          185 NTHLGIE--QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRF  262 (296)
T ss_dssp             HHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCT
T ss_pred             hhhcCCC--CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCc
Confidence            9996554  78999999999999999999999976432   1112111    1111222336789999999999999999


Q ss_pred             CCCCChhhhhc
Q 041080          219 NDRPTVTELME  229 (247)
Q Consensus       219 ~~Rps~~~il~  229 (247)
                      .+|||++++++
T Consensus       263 ~~Rps~~~l~~  273 (296)
T 3uzp_A          263 DDKPDYSYLRQ  273 (296)
T ss_dssp             TCCCCHHHHHH
T ss_pred             CcCCCHHHHHH
Confidence            99999999876

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.2e-41  Score=268.33  Aligned_cols=221  Identities=26%  Similarity=0.417  Sum_probs=171.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhh--cCCCceeeeceeeec----CCcEEEEEeccccCcHHHHHHhcC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQ--FEQDNIVQYLGTDKD----ENRLYIFLELVTKGSLANLYQKYH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~   74 (247)
                      +|+.||||++...        ....+..|..++..  ++||||+++++++..    ....++||||+++++|.++++...
T Consensus        30 ~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~  101 (301)
T 3q4u_A           30 QGENVAVKIFSSR--------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT  101 (301)
T ss_dssp             TTEEEEEEEECGG--------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTCC
T ss_pred             CCEEEEEEEeccc--------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhcc
Confidence            4789999998542        12334456666655  799999999998543    356899999999999999998888


Q ss_pred             CCHHHHHHHHHHHHHHHHHhh--------hCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc------cccCCCCC
Q 041080           75 LSDSQVSSYTRQILNGLVYLH--------ERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND------LKSCKGTP  140 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh--------~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~  140 (247)
                      +++..++.++.|++.||.|||        +.|++|+||||+||+++.++.++|+|||.+.......      .....|++
T Consensus       102 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~  181 (301)
T 3q4u_A          102 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK  181 (301)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCG
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeeccccccccccccccccccc
Confidence            999999999999999999999        9999999999999999999999999999985433222      22346899


Q ss_pred             CccCCcccccCCC----CCCcchhHHHHHHHHHHHHhC----------CCCCCCChh----hHHHHH-h-hcCCCCCCC-
Q 041080          141 FWMAPEVVNSKND----GYGLTADIWSLGCTVLEMLTR----------RPPYSHLEG----VQALFR-I-GKGELPSVP-  199 (247)
Q Consensus       141 ~~~aPE~~~~~~~----~~~~~~Di~slG~ll~~l~~g----------~~p~~~~~~----~~~~~~-~-~~~~~~~~~-  199 (247)
                      .|+|||.+.+...    .++.++||||||+++|+|++|          ..||.....    ...... . .....+..+ 
T Consensus       182 ~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (301)
T 3q4u_A          182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPN  261 (301)
T ss_dssp             GGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG
T ss_pred             ceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCCh
Confidence            9999999865432    234689999999999999999          788754321    111211 1 112222333 


Q ss_pred             ----CcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          200 ----SSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       200 ----~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                          ...++++.+++.+||+.+|.+|||++++++
T Consensus       262 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          262 RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence                235678999999999999999999999985

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.2e-41  Score=276.84  Aligned_cols=225  Identities=18%  Similarity=0.244  Sum_probs=172.9

Q ss_pred             CceEEEEEEeecCCCccc------hHHHHHHHHHHHHHhhcCCCceeeeceeeecC----CcEEEEEeccccCcHHHHHH
Q 041080            2 GFFFAVKEVSLQDQGAQG------KQSILQLEQEISLLSQFEQDNIVQYLGTDKDE----NRLYIFLELVTKGSLANLYQ   71 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~   71 (247)
                      |+.||||++.........      ......+..|+..++.++||||+++++++...    ...++||||+ +++|.++++
T Consensus        65 ~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~  143 (364)
T 3op5_A           65 DAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYE  143 (364)
T ss_dssp             TCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHH
T ss_pred             ccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHH
Confidence            578999998754311000      00011233466677788999999999998764    4589999999 889999997


Q ss_pred             hc--CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEc--CCCCeEEcccccccccCccc---------cccCCC
Q 041080           72 KY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVD--ASGSVKLADFGLAKATTMND---------LKSCKG  138 (247)
Q Consensus        72 ~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~--~~~~~~l~df~~~~~~~~~~---------~~~~~~  138 (247)
                      ..  .+++..++.++.|++.||.|||+.||+|+||||+||+++  .++.++|+|||++.......         .....|
T Consensus       144 ~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~g  223 (364)
T 3op5_A          144 ANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDG  223 (364)
T ss_dssp             HTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCC
T ss_pred             hccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCC
Confidence            74  499999999999999999999999999999999999999  88999999999986543221         123348


Q ss_pred             CCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHH-hhc---CCCC------CCCCcCCHHHHH
Q 041080          139 TPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR-IGK---GELP------SVPSSLSRDARD  208 (247)
Q Consensus       139 ~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~-~~~---~~~~------~~~~~~~~~~~~  208 (247)
                      ++.|+|||.+.+..  ++.++||||||+++|+|++|..||........... ...   ...+      .....+|+++.+
T Consensus       224 t~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (364)
T 3op5_A          224 TIEFTSIDAHNGVA--PSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAK  301 (364)
T ss_dssp             CTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHH
T ss_pred             CCCccCHHHhCCCC--CCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHH
Confidence            99999999996554  79999999999999999999999975322221111 000   0000      012467899999


Q ss_pred             HHHHHhcCCCCCCCChhhhhc
Q 041080          209 FILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       209 li~~~l~~~p~~Rps~~~il~  229 (247)
                      ++..||..+|.+||+++++++
T Consensus       302 li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          302 YMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHhcCCCCCCCCHHHHHH
Confidence            999999999999999999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.5e-42  Score=280.29  Aligned_cols=225  Identities=24%  Similarity=0.402  Sum_probs=179.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC--cEEEEEeccccCcHHHHHHhcC----
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN--RLYIFLELVTKGSLANLYQKYH----   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~----   74 (247)
                      +|+.||||++.....    ....+.+.+|+.++++++||||+++++++...+  ..++||||+++++|.++++...    
T Consensus        33 ~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~  108 (396)
T 4eut_A           33 TGDLFAIKVFNNISF----LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG  108 (396)
T ss_dssp             TCCEEEEEEECGGGG----GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTC
T ss_pred             CCcEEEEEEeccccc----cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccC
Confidence            488999999975322    223556779999999999999999999987655  7899999999999999987542    


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEE----cCCCCeEEcccccccccCccc-cccCCCCCCccCCcccc
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV----DASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVN  149 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~----~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~  149 (247)
                      +++..++.++.|++.||.|||+.|++|+||||+||++    +.++.++|+|||.+....... .....|+..|+|||.+.
T Consensus       109 l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~  188 (396)
T 4eut_A          109 LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE  188 (396)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhh
Confidence            8999999999999999999999999999999999999    777789999999987654333 33456899999999985


Q ss_pred             cCC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCh----hhHHHHHhhcCCCC-----------------------
Q 041080          150 SKN------DGYGLTADIWSLGCTVLEMLTRRPPYSHLE----GVQALFRIGKGELP-----------------------  196 (247)
Q Consensus       150 ~~~------~~~~~~~Di~slG~ll~~l~~g~~p~~~~~----~~~~~~~~~~~~~~-----------------------  196 (247)
                      +..      ..++.++|+||||+++|+|++|..||....    .......+..+..+                       
T Consensus       189 ~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (396)
T 4eut_A          189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVS  268 (396)
T ss_dssp             HHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTT
T ss_pred             ccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcc
Confidence            421      225778999999999999999999986432    22333333322211                       


Q ss_pred             -CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          197 -SVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       197 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                       .+...++..+.+++.+||+.||.+|||++++++
T Consensus       269 ~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          269 CSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             CSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             cccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence             112345678899999999999999999999865

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.1e-40  Score=263.68  Aligned_cols=219  Identities=21%  Similarity=0.261  Sum_probs=174.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeecee-eecCCcEEEEEeccccCcHHHHHHh--cCCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGT-DKDENRLYIFLELVTKGSLANLYQK--YHLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~   77 (247)
                      +|+.||||++......       ..+.+|+.+++.++|++++..+.. +...+..++||||+ +++|.+++..  ..+++
T Consensus        33 ~~~~vavK~~~~~~~~-------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~  104 (296)
T 4hgt_A           33 AGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSL  104 (296)
T ss_dssp             TTEEEEEEEEEC---C-------CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCH
T ss_pred             CCceEEEEeecccccc-------hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCH
Confidence            4789999987654321       236789999999998777666655 46778889999999 8899999974  45999


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEE---cCCCCeEEcccccccccCccc---------cccCCCCCCccCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---DASGSVKLADFGLAKATTMND---------LKSCKGTPFWMAP  145 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~---~~~~~~~l~df~~~~~~~~~~---------~~~~~~~~~~~aP  145 (247)
                      ..++.++.|++.||.+||++|++|+||||+||++   +.++.++|+|||.+.......         .....+++.|+||
T Consensus       105 ~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  184 (296)
T 4hgt_A          105 KTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI  184 (296)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCH
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccch
Confidence            9999999999999999999999999999999999   788999999999986544322         2244588999999


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhh---HHHHH----hhcCCCCCCCCcCCHHHHHHHHHHhcCCC
Q 041080          146 EVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGV---QALFR----IGKGELPSVPSSLSRDARDFILKCLQVNP  218 (247)
Q Consensus       146 E~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p  218 (247)
                      |.+.+..  ++.++||||||+++|++++|..||......   .....    ......+.....+|+++.+++.+||+.+|
T Consensus       185 E~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  262 (296)
T 4hgt_A          185 NTHLGIE--QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRF  262 (296)
T ss_dssp             HHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCT
T ss_pred             HHhcCCC--CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCC
Confidence            9996554  789999999999999999999999764322   11111    11111122335679999999999999999


Q ss_pred             CCCCChhhhhc
Q 041080          219 NDRPTVTELME  229 (247)
Q Consensus       219 ~~Rps~~~il~  229 (247)
                      .+|||++++++
T Consensus       263 ~~Rpt~~~l~~  273 (296)
T 4hgt_A          263 DDKPDYSYLRQ  273 (296)
T ss_dssp             TCCCCHHHHHH
T ss_pred             CCCCCHHHHHH
Confidence            99999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-41  Score=273.19  Aligned_cols=215  Identities=18%  Similarity=0.238  Sum_probs=173.1

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceee---------------eceeeec-CCcEEEEEeccccCc
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQ---------------YLGTDKD-ENRLYIFLELVTKGS   65 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~---------------~~~~~~~-~~~~~lv~e~~~~~~   65 (247)
                      |+.||||++...          +.+.+|+.++++++||||++               +++++.. ++..++||||+ +++
T Consensus        75 ~~~vavK~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~  143 (352)
T 2jii_A           75 KQKFSLKLDAKD----------GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRS  143 (352)
T ss_dssp             --CEEEEEEETT----------STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEE
T ss_pred             CceEEEEEeccc----------chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcC
Confidence            789999998743          24779999999999999988               5566655 67889999999 889


Q ss_pred             HHHHHHh---cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC--CeEEcccccccccCccc--------
Q 041080           66 LANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG--SVKLADFGLAKATTMND--------  132 (247)
Q Consensus        66 L~~~l~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~--~~~l~df~~~~~~~~~~--------  132 (247)
                      |.+++..   ..+++..++.++.|++.||.|||++|++|+||||+||+++.++  .++|+|||.+.......        
T Consensus       144 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  223 (352)
T 2jii_A          144 LQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEG  223 (352)
T ss_dssp             HHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTT
T ss_pred             HHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCcccccccc
Confidence            9999986   4599999999999999999999999999999999999999998  89999999996544322        


Q ss_pred             -cccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCh-hhHHH-HHhh--cCCCCCCC------Cc
Q 041080          133 -LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLE-GVQAL-FRIG--KGELPSVP------SS  201 (247)
Q Consensus       133 -~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~-~~~~--~~~~~~~~------~~  201 (247)
                       .....+++.|+|||.+.+..  ++.++||||||+++|+|++|..||.... ..... ....  ......+.      ..
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (352)
T 2jii_A          224 SRSPHEGDLEFISMDLHKGCG--PSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIR  301 (352)
T ss_dssp             SSCTTCSCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEEC
T ss_pred             ccccccCCccccCHHHHccCC--CCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCC
Confidence             12346889999999996544  7899999999999999999999997653 11111 1111  11111111      25


Q ss_pred             CCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          202 LSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       202 ~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +++++.+++.+||..+|.+|||++++++
T Consensus       302 ~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          302 PSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             CCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            6899999999999999999999999976

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-40  Score=267.97  Aligned_cols=221  Identities=26%  Similarity=0.393  Sum_probs=170.2

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhh--cCCCceeeeceeeecC----CcEEEEEeccccCcHHHHHHhcCC
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQ--FEQDNIVQYLGTDKDE----NRLYIFLELVTKGSLANLYQKYHL   75 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~   75 (247)
                      |+.||||++....        ......|..++..  ++||||+++++++...    ...++||||+++++|.++++...+
T Consensus        60 ~~~vavK~~~~~~--------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~  131 (337)
T 3mdy_A           60 GEKVAVKVFFTTE--------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTL  131 (337)
T ss_dssp             TEEEEEEEEEGGG--------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHCCB
T ss_pred             CceEEEEEEeccc--------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhccCC
Confidence            7889999986421        1223344555544  4899999999998877    789999999999999999999899


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhC--------CeeecCCCCCcEEEcCCCCeEEcccccccccCcccc------ccCCCCCC
Q 041080           76 SDSQVSSYTRQILNGLVYLHER--------NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL------KSCKGTPF  141 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~--------~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~------~~~~~~~~  141 (247)
                      ++..++.++.|++.||.+||+.        |++|+||||+||+++.++.++|+|||.+........      ....|++.
T Consensus       132 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~  211 (337)
T 3mdy_A          132 DAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR  211 (337)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGG
T ss_pred             CHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcc
Confidence            9999999999999999999998        999999999999999999999999999864433221      24468999


Q ss_pred             ccCCcccccCCCCCC----cchhHHHHHHHHHHHHhC----------CCCCCCChh-----hHHHHHhh-cCCCCCCCC-
Q 041080          142 WMAPEVVNSKNDGYG----LTADIWSLGCTVLEMLTR----------RPPYSHLEG-----VQALFRIG-KGELPSVPS-  200 (247)
Q Consensus       142 ~~aPE~~~~~~~~~~----~~~Di~slG~ll~~l~~g----------~~p~~~~~~-----~~~~~~~~-~~~~~~~~~-  200 (247)
                      |+|||.+.+......    .++||||||+++|+|++|          ..||.....     ........ ....+..+. 
T Consensus       212 y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (337)
T 3mdy_A          212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNR  291 (337)
T ss_dssp             GCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG
T ss_pred             eeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCcccccc
Confidence            999999865442211    249999999999999999          667654321     11111111 122233332 


Q ss_pred             ----cCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          201 ----SLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       201 ----~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                          .+++++.+++.+||+.+|.+|||+++++++
T Consensus       292 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          292 WSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence                566789999999999999999999999874

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=271.61  Aligned_cols=223  Identities=22%  Similarity=0.467  Sum_probs=183.4

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC--CCHHHH
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH--LSDSQV   80 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~   80 (247)
                      ..+|+|++.......   ...+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|.+++...+  +++..+
T Consensus        56 ~~~avk~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~  132 (319)
T 2y4i_B           56 GEVAIRLIDIERDNE---DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKT  132 (319)
T ss_dssp             SSEEEEECCCCSCCC---CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHH
T ss_pred             CeEEEEEeecCCCCH---HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHH
Confidence            468999987653222   223346789999999999999999999999999999999999999999997654  899999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCc-------cccccCCCCCCccCCcccccC--
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTM-------NDLKSCKGTPFWMAPEVVNSK--  151 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~--  151 (247)
                      +.++.|++.||.+||+.|++|+||||+||+++ ++.++|+|||.+.....       .......++..|+|||.+.+.  
T Consensus       133 ~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~  211 (319)
T 2y4i_B          133 RQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP  211 (319)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSC
T ss_pred             HHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccc
Confidence            99999999999999999999999999999997 78999999998754321       112233477889999998642  


Q ss_pred             -----CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCC-CcCCHHHHHHHHHHhcCCCCCCCChh
Q 041080          152 -----NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVP-SSLSRDARDFILKCLQVNPNDRPTVT  225 (247)
Q Consensus       152 -----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rps~~  225 (247)
                           ...++.++||||||+++|+|++|..||...........+.....+... ..++.++.+++.+||..+|.+|||++
T Consensus       212 ~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  291 (319)
T 2y4i_B          212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFT  291 (319)
T ss_dssp             C--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHH
T ss_pred             cccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHH
Confidence                 233688999999999999999999999988877777666665554443 46889999999999999999999999


Q ss_pred             hhhc
Q 041080          226 ELME  229 (247)
Q Consensus       226 ~il~  229 (247)
                      ++++
T Consensus       292 ~l~~  295 (319)
T 2y4i_B          292 KLMD  295 (319)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=268.09  Aligned_cols=222  Identities=24%  Similarity=0.391  Sum_probs=162.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeee--------cCCcEEEEEeccccCcHHHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDK--------DENRLYIFLELVTKGSLANLYQ   71 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--------~~~~~~lv~e~~~~~~L~~~l~   71 (247)
                      +|+.||||++...     .....+.+.+|+.++.++. ||||+++++++.        .....+++|||+.| +|.+++.
T Consensus        52 ~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~  125 (337)
T 3ll6_A           52 SGREYALKRLLSN-----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKG-QLVEFLK  125 (337)
T ss_dssp             TCCEEEEEEEEES-----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCSE-EHHHHHH
T ss_pred             CCcEEEEEEecCC-----chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecCC-CHHHHHH
Confidence            4789999998643     3455667889999999996 999999999883        34468999999975 8988875


Q ss_pred             h----cCCCHHHHHHHHHHHHHHHHHhhhCC--eeecCCCCCcEEEcCCCCeEEcccccccccCcccc------------
Q 041080           72 K----YHLSDSQVSSYTRQILNGLVYLHERN--VVHRDIKCANILVDASGSVKLADFGLAKATTMNDL------------  133 (247)
Q Consensus        72 ~----~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~------------  133 (247)
                      .    ..+++..++.++.|++.||.+||+.|  ++|+||||+||+++.++.++|+|||.+........            
T Consensus       126 ~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~  205 (337)
T 3ll6_A          126 KMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE  205 (337)
T ss_dssp             HHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------
T ss_pred             HhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccch
Confidence            4    34999999999999999999999999  99999999999999999999999999875543221            


Q ss_pred             --ccCCCCCCccCCccccc-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 041080          134 --KSCKGTPFWMAPEVVNS-KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFI  210 (247)
Q Consensus       134 --~~~~~~~~~~aPE~~~~-~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  210 (247)
                        ....+++.|+|||.+.. ....++.++||||||+++|+|++|..||............   .....+...+..+.+++
T Consensus       206 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li  282 (337)
T 3ll6_A          206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK---YSIPPHDTQYTVFHSLI  282 (337)
T ss_dssp             ------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------------CCCCTTCCSSGGGHHHH
T ss_pred             hhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc---ccCCcccccchHHHHHH
Confidence              13347889999999832 2333788999999999999999999999765443332221   12233456778899999


Q ss_pred             HHHhcCCCCCCCChhhhhcCc
Q 041080          211 LKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       211 ~~~l~~~p~~Rps~~~il~~p  231 (247)
                      .+||+.+|.+|||+++++++-
T Consensus       283 ~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          283 RAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             HHHSCSSGGGSCCHHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHHH
Confidence            999999999999999999864

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.5e-40  Score=268.05  Aligned_cols=222  Identities=25%  Similarity=0.372  Sum_probs=177.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhh--cCCCceeeeceeeecCC----cEEEEEeccccCcHHHHHHhcC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQ--FEQDNIVQYLGTDKDEN----RLYIFLELVTKGSLANLYQKYH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~   74 (247)
                      +|+.||||++...        ....+.+|+.++..  ++||||+++++++....    ..++||||+++++|.+++++..
T Consensus        64 ~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~  135 (342)
T 1b6c_B           64 RGEEVAVKIFSSR--------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT  135 (342)
T ss_dssp             TTEEEEEEEECGG--------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHCC
T ss_pred             cCccEEEEEeCch--------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhccC
Confidence            4789999998532        23456688888887  68999999999988776    8999999999999999999989


Q ss_pred             CCHHHHHHHHHHHHHHHHHhh--------hCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc------cccCCCCC
Q 041080           75 LSDSQVSSYTRQILNGLVYLH--------ERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND------LKSCKGTP  140 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh--------~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~  140 (247)
                      +++..++.++.|++.||.+||        +.|++|+||||+||+++.++.++|+|||.+.......      .....++.
T Consensus       136 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~  215 (342)
T 1b6c_B          136 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK  215 (342)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCG
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCc
Confidence            999999999999999999999        8999999999999999999999999999986543322      23446899


Q ss_pred             CccCCcccccCCCC----CCcchhHHHHHHHHHHHHhC----------CCCCCCChh-----hHHHHHhhcC-CCCCCCC
Q 041080          141 FWMAPEVVNSKNDG----YGLTADIWSLGCTVLEMLTR----------RPPYSHLEG-----VQALFRIGKG-ELPSVPS  200 (247)
Q Consensus       141 ~~~aPE~~~~~~~~----~~~~~Di~slG~ll~~l~~g----------~~p~~~~~~-----~~~~~~~~~~-~~~~~~~  200 (247)
                      .|+|||.+.+....    ++.++||||||+++|+|++|          ..||.....     ......+... ..+..+.
T Consensus       216 ~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (342)
T 1b6c_B          216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN  295 (342)
T ss_dssp             GGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG
T ss_pred             ccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcc
Confidence            99999998654321    23689999999999999999          778865422     2222222222 2233332


Q ss_pred             -----cCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          201 -----SLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       201 -----~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                           ..++.+.+++.+||+.+|.+|||+++++++
T Consensus       296 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          296 RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                 345689999999999999999999999874

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=8.4e-41  Score=268.97  Aligned_cols=234  Identities=24%  Similarity=0.325  Sum_probs=170.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeee-----cCCcEEEEEeccccCcHHHHHHhcCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDK-----DENRLYIFLELVTKGSLANLYQKYHL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~   75 (247)
                      +|+.||||++....      ........++..+..++||||+++++.+.     ....+++||||+++++|.++++....
T Consensus        35 ~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~  108 (336)
T 3g2f_A           35 DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS  108 (336)
T ss_dssp             TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCCB
T ss_pred             CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhccc
Confidence            47899999996432      11112234555555689999999997543     23467899999999999999999889


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhC---------CeeecCCCCCcEEEcCCCCeEEcccccccccCcc----------ccccC
Q 041080           76 SDSQVSSYTRQILNGLVYLHER---------NVVHRDIKCANILVDASGSVKLADFGLAKATTMN----------DLKSC  136 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~---------~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~----------~~~~~  136 (247)
                      ++..++.++.|++.||.|||+.         |++|+||||+||+++.++.++|+|||.+......          .....
T Consensus       109 ~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~  188 (336)
T 3g2f_A          109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE  188 (336)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCT
T ss_pred             chhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccC
Confidence            9999999999999999999999         9999999999999999999999999998654322          12234


Q ss_pred             CCCCCccCCcccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCChh------------------hHHHHH-hhc
Q 041080          137 KGTPFWMAPEVVNSKN-----DGYGLTADIWSLGCTVLEMLTRRPPYSHLEG------------------VQALFR-IGK  192 (247)
Q Consensus       137 ~~~~~~~aPE~~~~~~-----~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~------------------~~~~~~-~~~  192 (247)
                      .|+..|+|||.+.+..     ..++.++||||||+++|+|++|..|+.....                  ...... ...
T Consensus       189 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (336)
T 3g2f_A          189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSRE  268 (336)
T ss_dssp             TSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTS
T ss_pred             CCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhccc
Confidence            5899999999986521     1245789999999999999999766422111                  001111 111


Q ss_pred             CCCCCCCCc------CCHHHHHHHHHHhcCCCCCCCChhhhh------cCccCCCCCCCC
Q 041080          193 GELPSVPSS------LSRDARDFILKCLQVNPNDRPTVTELM------EHPFVKRPLQTP  240 (247)
Q Consensus       193 ~~~~~~~~~------~~~~~~~li~~~l~~~p~~Rps~~~il------~~p~~~~~~~~~  240 (247)
                      ...+.++..      .++++.++|.+||+.+|.+|||+++++      -++|-+...+.+
T Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~~~~  328 (336)
T 3g2f_A          269 KQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSP  328 (336)
T ss_dssp             CCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC------
T ss_pred             ccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcccCCC
Confidence            122333332      445899999999999999999999995      477877665544

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.5e-39  Score=272.32  Aligned_cols=219  Identities=21%  Similarity=0.262  Sum_probs=176.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCC-CceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ-DNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~   77 (247)
                      +|+.||||++......       ..+.+|+.+++.+.| +++..+..++...+..++||||+ +++|.++++.  ..+++
T Consensus        31 ~~~~vAvK~~~~~~~~-------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~  102 (483)
T 3sv0_A           31 TNEEVAIKLENVKTKH-------PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL  102 (483)
T ss_dssp             TCCEEEEEEEETTCSS-------CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCH
T ss_pred             CCcEEEEEEecccccc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCH
Confidence            4789999988654321       136789999999976 56666666777888999999999 8899999974  46999


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEE---cCCCCeEEcccccccccCccc---------cccCCCCCCccCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---DASGSVKLADFGLAKATTMND---------LKSCKGTPFWMAP  145 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~---~~~~~~~l~df~~~~~~~~~~---------~~~~~~~~~~~aP  145 (247)
                      ..++.++.||+.||.|||++||+|+||||+||++   +.++.++|+|||++.......         .....|+..|+||
T Consensus       103 ~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP  182 (483)
T 3sv0_A          103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASV  182 (483)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred             HHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCH
Confidence            9999999999999999999999999999999999   588999999999986544322         1245689999999


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhH---HHHHh----hcCCCCCCCCcCCHHHHHHHHHHhcCCC
Q 041080          146 EVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQ---ALFRI----GKGELPSVPSSLSRDARDFILKCLQVNP  218 (247)
Q Consensus       146 E~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~---~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p  218 (247)
                      |.+.+..  ++.++||||||+++|+|++|..||.......   ....+    .......+...+++++.+++.+||..+|
T Consensus       183 E~~~~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP  260 (483)
T 3sv0_A          183 NTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRF  260 (483)
T ss_dssp             HHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCT
T ss_pred             HHhcCCC--CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCh
Confidence            9996554  7999999999999999999999997654321   11111    1112222335779999999999999999


Q ss_pred             CCCCChhhhhc
Q 041080          219 NDRPTVTELME  229 (247)
Q Consensus       219 ~~Rps~~~il~  229 (247)
                      .+||+++++++
T Consensus       261 ~~RPs~~el~~  271 (483)
T 3sv0_A          261 DDKPDYSYLKR  271 (483)
T ss_dssp             TCCCCHHHHHH
T ss_pred             hhCcCHHHHHH
Confidence            99999998875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.5e-40  Score=268.29  Aligned_cols=214  Identities=17%  Similarity=0.195  Sum_probs=172.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC---CCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-----
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE---QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-----   72 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----   72 (247)
                      +|+.||||++....        ...+..|+.++..++   |+||+++++++...+..++||||+++|+|.++++.     
T Consensus        94 ~~~~vavK~~~~~~--------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~  165 (365)
T 3e7e_A           94 NKQKFVLKVQKPAN--------PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTP  165 (365)
T ss_dssp             CCCCEEEEEESSCC--------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTST
T ss_pred             cCcEEEEEEeCCCC--------hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhccc
Confidence            47899999986431        234667777777776   89999999999999999999999999999999964     


Q ss_pred             -cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC-----------CCCeEEcccccccccC----ccccccC
Q 041080           73 -YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA-----------SGSVKLADFGLAKATT----MNDLKSC  136 (247)
Q Consensus        73 -~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~-----------~~~~~l~df~~~~~~~----~~~~~~~  136 (247)
                       ..+++..++.++.|++.||.|||+.||+|+||||+||+++.           ++.++|+|||++....    .......
T Consensus       166 ~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~  245 (365)
T 3e7e_A          166 EKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK  245 (365)
T ss_dssp             TCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCS
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeee
Confidence             35999999999999999999999999999999999999998           8999999999995432    2233456


Q ss_pred             CCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcC
Q 041080          137 KGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQV  216 (247)
Q Consensus       137 ~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  216 (247)
                      .|++.|+|||.+.+..  ++.++||||||+++|+|++|..||.........   .......  ...++.+.+++..||+.
T Consensus       246 ~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~--~~~~~~~~~~~~~~l~~  318 (365)
T 3e7e_A          246 CETSGFQCVEMLSNKP--WNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---PEGLFRR--LPHLDMWNEFFHVMLNI  318 (365)
T ss_dssp             SCTTSCCCHHHHTTCC--BSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE---ECSCCTT--CSSHHHHHHHHHHHHCC
T ss_pred             cCCCCCCChHHhcCCC--CCccccHHHHHHHHHHHHhCCCccccCCCCcee---echhccc--cCcHHHHHHHHHHHcCC
Confidence            6899999999997654  799999999999999999999998544322111   1111111  13477899999999999


Q ss_pred             CCCCCCChhhhhc
Q 041080          217 NPNDRPTVTELME  229 (247)
Q Consensus       217 ~p~~Rps~~~il~  229 (247)
                      +|.+|++..+.+.
T Consensus       319 ~p~~r~~~~~~l~  331 (365)
T 3e7e_A          319 PDCHHLPSLDLLR  331 (365)
T ss_dssp             CCTTCCCCHHHHH
T ss_pred             CCCCcchHHHHHH
Confidence            9999966544443

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1e-40  Score=275.39  Aligned_cols=226  Identities=19%  Similarity=0.214  Sum_probs=171.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCC-Cceee---------------------eceeeec-----CCc
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ-DNIVQ---------------------YLGTDKD-----ENR   53 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~---------------------~~~~~~~-----~~~   53 (247)
                      +|+.||||++.....  ......+.+.+|+.+++.+.| ++...                     +..++..     ...
T Consensus       102 ~g~~vAvK~~~~~~~--~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (413)
T 3dzo_A          102 TGESFEVHVPYFTER--PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLS  179 (413)
T ss_dssp             TCCEEEEEEECCSCC------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCS
T ss_pred             CCCceEEEEEecCCC--ccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccc
Confidence            588999999874332  233446678899999999977 22211                     1111111     224


Q ss_pred             EEEEEeccccCcHHHHHH--------hcCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccc
Q 041080           54 LYIFLELVTKGSLANLYQ--------KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLA  125 (247)
Q Consensus        54 ~~lv~e~~~~~~L~~~l~--------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~  125 (247)
                      ++++|+.+. ++|.++++        ...+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++
T Consensus       180 ~~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a  258 (413)
T 3dzo_A          180 RFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL  258 (413)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGC
T ss_pred             eEEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccce
Confidence            678888774 59998885        223778889999999999999999999999999999999999999999999998


Q ss_pred             cccCccccccCCCCCCccCCccccc--------CCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCC
Q 041080          126 KATTMNDLKSCKGTPFWMAPEVVNS--------KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPS  197 (247)
Q Consensus       126 ~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  197 (247)
                      ...... .....| +.|+|||.+..        ....++.++||||||+++|+|++|+.||...........+...    
T Consensus       259 ~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~----  332 (413)
T 3dzo_A          259 VRDGAS-AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRS----  332 (413)
T ss_dssp             EETTEE-ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGSS----
T ss_pred             eecCCc-cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHhh----
Confidence            765544 344456 99999999832        1222678999999999999999999999876654433333221    


Q ss_pred             CCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          198 VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       198 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                       ...+|++++++|.+||+.+|.+|||+.++++||||+..
T Consensus       333 -~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          333 -CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             -CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             -cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence             23678999999999999999999999999999999753

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=8.7e-41  Score=268.99  Aligned_cols=223  Identities=17%  Similarity=0.216  Sum_probs=169.9

Q ss_pred             CCceEEEEEEeecCCC---ccchHHHHHHHHHHHHHhhcC--------------------------CCceeeeceeeec-
Q 041080            1 DGFFFAVKEVSLQDQG---AQGKQSILQLEQEISLLSQFE--------------------------QDNIVQYLGTDKD-   50 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~--------------------------h~~i~~~~~~~~~-   50 (247)
                      +|+.||||++......   .......+.+.+|+.+++.++                          ||||+++++++.+ 
T Consensus        42 ~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~  121 (336)
T 2vuw_A           42 DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNST  121 (336)
T ss_dssp             TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHH
T ss_pred             CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhh
Confidence            4789999999876432   122334567889999998886                          5555555555554 


Q ss_pred             ------------CCcEEEEEeccccCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHhh-hCCeeecCCCCCcEEEcCCC--
Q 041080           51 ------------ENRLYIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLH-ERNVVHRDIKCANILVDASG--  115 (247)
Q Consensus        51 ------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~dl~~~ni~~~~~~--  115 (247)
                                  .+..++||||+++|++.+.+.+..+++..++.++.|++.||.||| +.||+|+||||+||+++.++  
T Consensus       122 ~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~  201 (336)
T 2vuw_A          122 KGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLK  201 (336)
T ss_dssp             TCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCS
T ss_pred             ccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCc
Confidence                        789999999999997666665667999999999999999999999 99999999999999999887  


Q ss_pred             ------------------CeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcchhHHHHHHH-HHHHHhCCC
Q 041080          116 ------------------SVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCT-VLEMLTRRP  176 (247)
Q Consensus       116 ------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~l-l~~l~~g~~  176 (247)
                                        .++|+|||++......   ...|++.|+|||.+.+..   +.++||||+|++ .++++.|..
T Consensus       202 ~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---~~~gt~~y~aPE~~~g~~---~~~~Diwsl~~~~~~~~~~g~~  275 (336)
T 2vuw_A          202 KLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---IVVFCDVSMDEDLFTGDG---DYQFDIYRLMKKENNNRWGEYH  275 (336)
T ss_dssp             EEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---EEECCCCTTCSGGGCCCS---SHHHHHHHHHHHHHTTCTTSCC
T ss_pred             ceeeeccCccccccCCCceEEEeeccccEecCCC---cEEEeecccChhhhcCCC---ccceehhhhhCCCCcccccccC
Confidence                              8999999999755432   346899999999997543   779999998777 666778888


Q ss_pred             CCCCChh-hHHHHHhhcC-CC-----CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhh-cCccCC
Q 041080          177 PYSHLEG-VQALFRIGKG-EL-----PSVPSSLSRDARDFILKCLQVNPNDRPTVTELM-EHPFVK  234 (247)
Q Consensus       177 p~~~~~~-~~~~~~~~~~-~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il-~~p~~~  234 (247)
                      ||..... ......+... ..     ...+..+++++++||.+||+.+     |++|++ +||||+
T Consensus       276 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          276 PYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             THHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             CCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            8754211 1111121111 11     1112357889999999999976     999999 999996

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.7e-38  Score=248.82  Aligned_cols=198  Identities=16%  Similarity=0.120  Sum_probs=163.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.||||++.....  ......+.+.+|+..+.+++||||+++++++...+..++||||++|++|.++++. +.....+
T Consensus        55 ~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~  131 (286)
T 3uqc_A           55 LDRQVALTFVDPQGV--LPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-SPSPVGA  131 (286)
T ss_dssp             TTEEEEEEESCTTCC--SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT-CCCHHHH
T ss_pred             CCceEEEEEECcccc--cCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc-CCChHHH
Confidence            478999999976432  2345667889999999999999999999999999999999999999999999965 4566678


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcchh
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTAD  160 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D  160 (247)
                      ..++.|++.||.|||++|++|+||||+||+++.+|.++|++++.                  ++         .++.++|
T Consensus       132 ~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~------------------~~---------~~~~~~D  184 (286)
T 3uqc_A          132 IRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT------------------MP---------DANPQDD  184 (286)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC------------------CT---------TCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc------------------cC---------CCCchhH
Confidence            99999999999999999999999999999999999999985432                  22         2688999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCChhhHHHH---HhhcCCCC---CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          161 IWSLGCTVLEMLTRRPPYSHLEGVQALF---RIGKGELP---SVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       161 i~slG~ll~~l~~g~~p~~~~~~~~~~~---~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      |||||+++|+|++|..||..........   .......+   .....+++++.+++.+||+.||.+| |++++++
T Consensus       185 i~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          185 IRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             HHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence            9999999999999999998765433211   11111111   2235789999999999999999999 9999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-39  Score=283.90  Aligned_cols=216  Identities=22%  Similarity=0.263  Sum_probs=175.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCc-----EEEEEeccccCcHHHHHHhcCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENR-----LYIFLELVTKGSLANLYQKYHL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~   75 (247)
                      +|+.||||++...    ........+.+|+.++++++||||+++++++...+.     .++||||+++++|.+++.. .+
T Consensus       105 ~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~-~l  179 (681)
T 2pzi_A          105 NGRPVVLKGLVHS----GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-KL  179 (681)
T ss_dssp             TTEEEEEEESCSS----CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C-CC
T ss_pred             CCcEEEEEEeCcc----CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC-CC
Confidence            4789999988643    234556678899999999999999999999987665     7999999999999988766 79


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCC
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ++..++.++.|++.||.|||++||+|+||||+||+++.+ .++|+|||++......  ....|++.|+|||.+.+.   .
T Consensus       180 ~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~--~~~~gt~~y~aPE~~~~~---~  253 (681)
T 2pzi_A          180 PVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF--GYLYGTPGFQAPEIVRTG---P  253 (681)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC--SCCCCCTTTSCTTHHHHC---S
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC--CccCCCccccCHHHHcCC---C
Confidence            999999999999999999999999999999999999875 9999999998765433  445689999999998654   4


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCC
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK  234 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~  234 (247)
                      +.++||||||+++++|++|..|+........       .........++.+.++|.+||..+|.+||+..+.+.++|+.
T Consensus       254 ~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          254 TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCceehhhhHHHHHHHHhCCCCCcccccccc-------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            7899999999999999999888754221100       00000113467899999999999999999999988888764

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=5.1e-35  Score=249.38  Aligned_cols=167  Identities=16%  Similarity=0.189  Sum_probs=125.4

Q ss_pred             CceEEEEEEeecCC-----CccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcC-
Q 041080            2 GFFFAVKEVSLQDQ-----GAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYH-   74 (247)
Q Consensus         2 g~~~~lK~~~~~~~-----~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-   74 (247)
                      |+.|++|++.+...     ........+.+.+|+++|+++ .|+||+++++++++++..||||||++|++|.+++.+.+ 
T Consensus       259 g~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~  338 (569)
T 4azs_A          259 GEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEE  338 (569)
T ss_dssp             CSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCC
T ss_pred             cceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCC
Confidence            78899999986532     123344567799999999999 69999999999999999999999999999999998765 


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKN  152 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~  152 (247)
                      +++.   +++.||+.||+|+|++||+||||||+||+++.+|.+||+|||+++......  .....||+.|+|||.+.+. 
T Consensus       339 l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-  414 (569)
T 4azs_A          339 IDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-  414 (569)
T ss_dssp             CCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC----
T ss_pred             CCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCC-
Confidence            5543   588999999999999999999999999999999999999999987554332  2344589999999999654 


Q ss_pred             CCCCcchhHHHHHHHHHHHHhC
Q 041080          153 DGYGLTADIWSLGCTVLEMLTR  174 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g  174 (247)
                        ...++|+|++|++++.+.++
T Consensus       415 --~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          415 --KSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             ----------------CCCCTT
T ss_pred             --CCCcccccccccchhhhccc
Confidence              46689999999988766544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=9.9e-27  Score=197.38  Aligned_cols=168  Identities=19%  Similarity=0.242  Sum_probs=135.7

Q ss_pred             CceEEEEEEeecCCCc---cchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHH
Q 041080            2 GFFFAVKEVSLQDQGA---QGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDS   78 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~   78 (247)
                      |+.+++|.........   ......+.+.+|+.++++++||||+++..++...+..++||||+++++|.++++.      
T Consensus       359 ~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~------  432 (540)
T 3en9_A          359 DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED------  432 (540)
T ss_dssp             SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT------
T ss_pred             CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH------
Confidence            6778999876533221   1222356689999999999999999766666677788999999999999999876      


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc---------ccCCCCCCccCCcccc
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL---------KSCKGTPFWMAPEVVN  149 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~---------~~~~~~~~~~aPE~~~  149 (247)
                       +..++.|++.+|.|||++||+|+||||+||+++.  .++|+|||++........         ....|++.|+|||.+.
T Consensus       433 -~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~  509 (540)
T 3en9_A          433 -NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWE  509 (540)
T ss_dssp             -CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHH
T ss_pred             -HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHH
Confidence             6689999999999999999999999999999988  999999999976654321         2445899999999997


Q ss_pred             cCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 041080          150 SKNDGYGLTADIWSLGCTVLEMLTRRPPY  178 (247)
Q Consensus       150 ~~~~~~~~~~Di~slG~ll~~l~~g~~p~  178 (247)
                      .....|+...|+|+...-..+-+.++.+|
T Consensus       510 ~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          510 RFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             HHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            53334677889999888888877766655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.82  E-value=2.5e-20  Score=145.82  Aligned_cols=126  Identities=16%  Similarity=0.102  Sum_probs=97.4

Q ss_pred             CCceEEEEEEeecCCCcc-----c--------hHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHH
Q 041080            1 DGFFFAVKEVSLQDQGAQ-----G--------KQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLA   67 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~-----~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   67 (247)
                      +|+.||||++........     .        ......+.+|+.++++++  | +++.+++.. +..++||||++|++|.
T Consensus       113 ~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~  188 (282)
T 1zar_A          113 KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELY  188 (282)
T ss_dssp             TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGG
T ss_pred             CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHH
Confidence            488999999965332111     1        135667899999999999  4 666665544 4569999999999998


Q ss_pred             HHHHhcCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcc
Q 041080           68 NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEV  147 (247)
Q Consensus        68 ~~l~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~  147 (247)
                      + +.     ......++.|++.||.+||+.|++|+||||+||+++ ++.++|+|||.+..           +..+.|||.
T Consensus       189 ~-l~-----~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~-----------~~~~~a~e~  250 (282)
T 1zar_A          189 R-VR-----VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE-----------VGEEGWREI  250 (282)
T ss_dssp             G-CC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEE-----------TTSTTHHHH
T ss_pred             H-cc-----hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE-----------CCCCCHHHH
Confidence            7 32     234557999999999999999999999999999999 99999999999853           334677887


Q ss_pred             c
Q 041080          148 V  148 (247)
Q Consensus       148 ~  148 (247)
                      +
T Consensus       251 l  251 (282)
T 1zar_A          251 L  251 (282)
T ss_dssp             H
T ss_pred             H
Confidence            6

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.73  E-value=1.5e-17  Score=128.52  Aligned_cols=119  Identities=21%  Similarity=0.274  Sum_probs=88.1

Q ss_pred             CCce--EEEEEEeecCCCcc-------------------chHHHHHHHHHHHHHhhcCCCce--eeeceeeecCCcEEEE
Q 041080            1 DGFF--FAVKEVSLQDQGAQ-------------------GKQSILQLEQEISLLSQFEQDNI--VQYLGTDKDENRLYIF   57 (247)
Q Consensus         1 ~g~~--~~lK~~~~~~~~~~-------------------~~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~~~~~lv   57 (247)
                      +|+.  ||||++........                   .......+.+|+..+..+.|+++  +.+++.    +..++|
T Consensus        71 ~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lV  146 (258)
T 1zth_A           71 DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTY----MKNVLL  146 (258)
T ss_dssp             TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEE
T ss_pred             CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEE
Confidence            4777  99999865421110                   11223468899999999988754  334332    356899


Q ss_pred             Eecccc-C----cHHHHHHhcCCCHHHHHHHHHHHHHHHHHhh-hCCeeecCCCCCcEEEcCCCCeEEcccccccc
Q 041080           58 LELVTK-G----SLANLYQKYHLSDSQVSSYTRQILNGLVYLH-ERNVVHRDIKCANILVDASGSVKLADFGLAKA  127 (247)
Q Consensus        58 ~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~  127 (247)
                      |||+.+ |    +|.++...  .++..+..++.|++.++.+|| +.|++|+||||+||+++.  .++|+|||++..
T Consensus       147 mE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          147 MEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             EECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred             EEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence            999942 3    67665432  335568899999999999999 999999999999999988  999999999854

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.58  E-value=3.6e-15  Score=120.19  Aligned_cols=121  Identities=15%  Similarity=0.137  Sum_probs=81.0

Q ss_pred             CCceEEEEEEeecCCCcc------------c-----hHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEecccc
Q 041080            1 DGFFFAVKEVSLQDQGAQ------------G-----KQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTK   63 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~------------~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   63 (247)
                      +|+.||||+++.......            .     .........|...|.++.+.++.-..-+.. . ..++||||++|
T Consensus       118 ~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p~~~-~-~~~LVME~i~G  195 (397)
T 4gyi_A          118 KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEPIAQ-S-RHTIVMSLVDA  195 (397)
T ss_dssp             TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCEEEE-E-TTEEEEECCSC
T ss_pred             CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeec-c-CceEEEEecCC
Confidence            589999999864321100            0     001112345667777775444322111111 1 23799999999


Q ss_pred             CcHHHHHHhcCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCC----------eEEccccccccc
Q 041080           64 GSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS----------VKLADFGLAKAT  128 (247)
Q Consensus        64 ~~L~~~l~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~----------~~l~df~~~~~~  128 (247)
                      ++|.++..     ......++.|++.+|.+||+.|++|+||||.||+++.+|.          +.|+||+.+...
T Consensus       196 ~~L~~l~~-----~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          196 LPMRQVSS-----VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEGGGCCC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             ccHhhhcc-----cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            88865422     2235678899999999999999999999999999988763          899999987543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.33  E-value=1.1e-11  Score=95.83  Aligned_cols=115  Identities=13%  Similarity=0.172  Sum_probs=89.1

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      |+.++||+........     ...+.+|+.+++.+. +..++++++++...+..++|||+++|.+|.+...    +....
T Consensus        37 ~~~~vlK~~~~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~----~~~~~  107 (263)
T 3tm0_A           37 NENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE----DEQSP  107 (263)
T ss_dssp             SCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC----TTTCH
T ss_pred             CCcEEEEeCCcccCCC-----HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC----CcccH
Confidence            6789999886432111     124778999999984 6778899999988899999999999999876521    22234


Q ss_pred             HHHHHHHHHHHHHhhh-----------------------------------------------------------CCeee
Q 041080           81 SSYTRQILNGLVYLHE-----------------------------------------------------------RNVVH  101 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~-----------------------------------------------------------~~i~h  101 (247)
                      ..++.++..++..||+                                                           .+++|
T Consensus       108 ~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~H  187 (263)
T 3tm0_A          108 EKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSH  187 (263)
T ss_dssp             HHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEEC
T ss_pred             HHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEEC
Confidence            4678888899999998                                                           45899


Q ss_pred             cCCCCCcEEEcCCCCeEEcccccc
Q 041080          102 RDIKCANILVDASGSVKLADFGLA  125 (247)
Q Consensus       102 ~dl~~~ni~~~~~~~~~l~df~~~  125 (247)
                      +|+++.||++++++.+.|+||+.+
T Consensus       188 gDl~~~Nil~~~~~~~~lIDwe~a  211 (263)
T 3tm0_A          188 GDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             SSCCTTSEEEETTEEEEECCCTTC
T ss_pred             CCCCcCcEEEECCcEEEEEEchhc
Confidence            999999999987555679999865

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.20  E-value=5.5e-11  Score=91.53  Aligned_cols=110  Identities=21%  Similarity=0.216  Sum_probs=80.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCc--eeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDN--IVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~   78 (247)
                      +|+.++||+.....        ...+.+|+..++.+.+.+  +++++++...++..++||||++|.+|.  ..  ..+  
T Consensus        43 ~g~~~vlK~~~~~~--------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~--~~~--  108 (264)
T 1nd4_A           43 GRPVLFVKTDLSGA--------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS--HLA--  108 (264)
T ss_dssp             TSCCEEEEEECSCT--------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS--CCC--
T ss_pred             CCCeEEEEeCCccc--------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC--cCC--
Confidence            36779999875321        124678999998885434  566888888888899999999998884  11  122  


Q ss_pred             HHHHHHHHHHHHHHHhhhCC----------------------------------------------------------ee
Q 041080           79 QVSSYTRQILNGLVYLHERN----------------------------------------------------------VV  100 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~----------------------------------------------------------i~  100 (247)
                       ...++.+++..+..||+..                                                          ++
T Consensus       109 -~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~  187 (264)
T 1nd4_A          109 -PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVT  187 (264)
T ss_dssp             -HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEE
T ss_pred             -HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEE
Confidence             2245666667777777643                                                          99


Q ss_pred             ecCCCCCcEEEcCCCCeEEcccccc
Q 041080          101 HRDIKCANILVDASGSVKLADFGLA  125 (247)
Q Consensus       101 h~dl~~~ni~~~~~~~~~l~df~~~  125 (247)
                      |+|++|.||++++++.+.|+||+.+
T Consensus       188 HgDl~~~Nil~~~~~~~~liD~~~a  212 (264)
T 1nd4_A          188 HGDACLPNIMVENGRFSGFIDCGRL  212 (264)
T ss_dssp             CSSCCGGGEEEETTEEEEECCCTTC
T ss_pred             CCCCCCCcEEEECCcEEEEEcchhc
Confidence            9999999999987655679999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.06  E-value=4.9e-10  Score=90.45  Aligned_cols=121  Identities=15%  Similarity=0.263  Sum_probs=88.0

Q ss_pred             CceEEEEEEe--ecCCCccchHHHHHHHHHHHHHhhcC--CCceeeeceeeecC---CcEEEEEeccccCcHHHHHHhcC
Q 041080            2 GFFFAVKEVS--LQDQGAQGKQSILQLEQEISLLSQFE--QDNIVQYLGTDKDE---NRLYIFLELVTKGSLANLYQKYH   74 (247)
Q Consensus         2 g~~~~lK~~~--~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~   74 (247)
                      +..+++|+..  ....    ......+.+|+.+++.+.  +..+++++.++.+.   +..++||||++|.++.+.. -..
T Consensus        61 ~~~~vlr~~~~p~~~~----~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~-~~~  135 (359)
T 3dxp_A           61 GQTYVMRAKPGPKSKL----LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS-LPG  135 (359)
T ss_dssp             SCEEEEECCCC--------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT-CTT
T ss_pred             CceEEEEeCCCCCCCC----CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc-ccc
Confidence            4567788765  2211    112345778999999996  45678888887766   4589999999997774311 123


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhh----------------------------------------------------------
Q 041080           75 LSDSQVSSYTRQILNGLVYLHE----------------------------------------------------------   96 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~----------------------------------------------------------   96 (247)
                      ++......++.+++.+|..||+                                                          
T Consensus       136 l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  215 (359)
T 3dxp_A          136 MSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADL  215 (359)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSC
T ss_pred             CCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCC
Confidence            6777888899999999999996                                                          


Q ss_pred             CCeeecCCCCCcEEEcCCCC--eEEcccccccc
Q 041080           97 RNVVHRDIKCANILVDASGS--VKLADFGLAKA  127 (247)
Q Consensus        97 ~~i~h~dl~~~ni~~~~~~~--~~l~df~~~~~  127 (247)
                      .+++|+|+++.||+++.++.  +.++||+.+..
T Consensus       216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence            35899999999999997764  58999998753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.00  E-value=7e-10  Score=87.48  Aligned_cols=168  Identities=17%  Similarity=0.151  Sum_probs=104.7

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCc--eeeeceeeecCC---cEEEEEeccccCcHHHHHHhcCCC
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDN--IVQYLGTDKDEN---RLYIFLELVTKGSLANLYQKYHLS   76 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~   76 (247)
                      ..++||+...       ......+.+|...++.+. +..  +++++......+   ..++||++++|.++....- ..++
T Consensus        41 ~~~vlR~~~~-------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~-~~l~  112 (304)
T 3sg8_A           41 RDFIFKFPKH-------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL-NNLP  112 (304)
T ss_dssp             TSEEEEEESS-------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH-HTSC
T ss_pred             CEEEEEecCC-------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc-ccCC
Confidence            4578887532       234567889999998883 433  444555443333   4588999999988865322 2466


Q ss_pred             HHHHHHHHHHHHHHHHHhhh----------------------------------------------------------CC
Q 041080           77 DSQVSSYTRQILNGLVYLHE----------------------------------------------------------RN   98 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~----------------------------------------------------------~~   98 (247)
                      ..+...++.+++..+..||+                                                          ..
T Consensus       113 ~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~  192 (304)
T 3sg8_A          113 KQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPC  192 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCce
Confidence            77777788888888887775                                                          13


Q ss_pred             eeecCCCCCcEEEcC--CCCeEEcccccccccCccccc-cCCCCCCccCCccccc---CCCC---------CCcchhHHH
Q 041080           99 VVHRDIKCANILVDA--SGSVKLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNS---KNDG---------YGLTADIWS  163 (247)
Q Consensus        99 i~h~dl~~~ni~~~~--~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~aPE~~~~---~~~~---------~~~~~Di~s  163 (247)
                      ++|+|+++.||+++.  ++.+.++||+.+........- .......-..|+....   ....         ...-.+.|+
T Consensus       193 ~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~  272 (304)
T 3sg8_A          193 LIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWS  272 (304)
T ss_dssp             EECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHH
T ss_pred             eEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHH
Confidence            799999999999998  455789999887543211100 0000000012222110   0000         011268999


Q ss_pred             HHHHHHHHHhCCCCC
Q 041080          164 LGCTVLEMLTRRPPY  178 (247)
Q Consensus       164 lG~ll~~l~~g~~p~  178 (247)
                      ++.+++.+.+|..+|
T Consensus       273 l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          273 FEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHcCCHHH
Confidence            999999999997664

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.72  E-value=3.3e-07  Score=70.73  Aligned_cols=113  Identities=12%  Similarity=0.095  Sum_probs=80.7

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      |..++||+-..        .....+.+|...|+.+. +-.++++++++.+.+..++|||+++|.++.+.....   ....
T Consensus        50 ~~~~~lk~~~~--------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~---~~~~  118 (272)
T 4gkh_A           50 APELFLKHGKG--------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY---PDSG  118 (272)
T ss_dssp             CCCEEEEEEET--------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC---GGGH
T ss_pred             CeEEEEEECCC--------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC---HHHH
Confidence            45688887642        13445778999999884 445788889888899999999999998887654331   1222


Q ss_pred             HHHHHHHHHHHHHhhhC----------------------------------------------------------Ceeec
Q 041080           81 SSYTRQILNGLVYLHER----------------------------------------------------------NVVHR  102 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~----------------------------------------------------------~i~h~  102 (247)
                      ..+..++...+..||+.                                                          .++|+
T Consensus       119 ~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HG  198 (272)
T 4gkh_A          119 ENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHG  198 (272)
T ss_dssp             HHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECS
T ss_pred             HHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcC
Confidence            33444555555555521                                                          26899


Q ss_pred             CCCCCcEEEcCCCCeEEcccccc
Q 041080          103 DIKCANILVDASGSVKLADFGLA  125 (247)
Q Consensus       103 dl~~~ni~~~~~~~~~l~df~~~  125 (247)
                      |+++.||++++++.+-|+||+.+
T Consensus       199 Dl~~~Nil~~~~~~~~viDwe~a  221 (272)
T 4gkh_A          199 DFSLDNLIFDEGKLIGCIDVGRV  221 (272)
T ss_dssp             CCCTTSEEEETTEEEEECCCTTC
T ss_pred             CCCCCeEEEECCeEEEEEECccc
Confidence            99999999988776779999865

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.62  E-value=7.7e-07  Score=70.07  Aligned_cols=118  Identities=20%  Similarity=0.194  Sum_probs=76.3

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCC---ceeeeceeee-cCCcEEEEEeccccCcHHHHHHhcCCCH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQD---NIVQYLGTDK-DENRLYIFLELVTKGSLANLYQKYHLSD   77 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~   77 (247)
                      |+.++||+..       .......+.+|..+++.+.+.   .+++++.+.. ..+..+++|++++|.++.... -..++.
T Consensus        39 g~~~VlR~~~-------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~-~~~l~~  110 (306)
T 3tdw_A           39 NGDWVFRFPK-------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDG-MAVLPD  110 (306)
T ss_dssp             TTTEEEEEES-------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHH-HTTSCH
T ss_pred             CCEEEEEecC-------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhh-hhhCCH
Confidence            4567888742       123456788999999999642   3566666664 456788999999998776521 111233


Q ss_pred             HHHHHHHHHHHHHHHHhhh------------------------------------------------------------C
Q 041080           78 SQVSSYTRQILNGLVYLHE------------------------------------------------------------R   97 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~------------------------------------------------------------~   97 (247)
                      .....++.++...+..||+                                                            .
T Consensus       111 ~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~  190 (306)
T 3tdw_A          111 DAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTP  190 (306)
T ss_dssp             HHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCC
Confidence            3333333333333333332                                                            2


Q ss_pred             CeeecCCCCCcEEEcC---CCCe-EEcccccccc
Q 041080           98 NVVHRDIKCANILVDA---SGSV-KLADFGLAKA  127 (247)
Q Consensus        98 ~i~h~dl~~~ni~~~~---~~~~-~l~df~~~~~  127 (247)
                      .++|+|+++.||+++.   ++.+ .|+||+.+..
T Consensus       191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence            4699999999999987   4554 7999987643

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.53  E-value=2.7e-06  Score=62.55  Aligned_cols=134  Identities=22%  Similarity=0.156  Sum_probs=91.4

Q ss_pred             CcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHhhh-CCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCC
Q 041080           64 GSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHE-RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTP  140 (247)
Q Consensus        64 ~~L~~~l~~~--~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  140 (247)
                      .||.++++.+  +++++++|.++.|.+.+|..+-. ..-...=+.|..|++..+|++.+.+ ..+.          ....
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------~~~~  101 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------AGEP  101 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc----------cccc
Confidence            4899999876  49999999999999999887732 1111233456899999999988863 1110          1233


Q ss_pred             CccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcC----
Q 041080          141 FWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQV----  216 (247)
Q Consensus       141 ~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~----  216 (247)
                      .+.+||...   ...+.+.=|||||+++|..+-=..|                  +..+..+|+.+.+||..|.+-    
T Consensus       102 ~~~~pe~~~---~~~te~~~IysLG~tLY~ALDygL~------------------e~eE~eLS~~LE~LL~~Mt~~~~d~  160 (229)
T 2yle_A          102 PPVAGKLGY---SQCMETEVIESLGIIIYKALDYGLK------------------ENEERELSPPLEQLIDHMANTVEAD  160 (229)
T ss_dssp             -----CCSS---SSSCHHHHHHHHHHHHHHHHTTTCC------------------TTEEECCCHHHHHHHHHHTTCCC--
T ss_pred             CCCChhhcc---ccchHHHHHHHHHHHHHHHhhcCCC------------------cccchhhCHHHHHHHHHHHhccccc
Confidence            467888763   2257789999999999998742222                  234567899999999999865    


Q ss_pred             ---------------------CCCCCCChhhhhc
Q 041080          217 ---------------------NPNDRPTVTELME  229 (247)
Q Consensus       217 ---------------------~p~~Rps~~~il~  229 (247)
                                           .+..|.+++++++
T Consensus       161 ~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          161 GSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             ------------------CCSCCCCCCSHHHHHH
T ss_pred             ccccccccccccccccccccccccCcCCHHHHHH
Confidence                                 3467888988886

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.17  E-value=3.8e-06  Score=67.45  Aligned_cols=63  Identities=3%  Similarity=0.026  Sum_probs=38.9

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-C--CceeeeceeeecC---CcEEEEEeccccCcH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-Q--DNIVQYLGTDKDE---NRLYIFLELVTKGSL   66 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~---~~~~lv~e~~~~~~L   66 (247)
                      |+.+++|..........  .....+.+|+.+++.+. +  -.+++++.+..+.   +..++|||+++|.++
T Consensus        52 ~~~~vlR~~~~~~~~~~--~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A           52 QQKLVARVAPAAEDVPV--FPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             EEEEEEEECCCGGGCCS--SSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCC
T ss_pred             CceEEEEeCCCCCcccc--CchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCCh
Confidence            56788887653220000  00123567888888774 3  3567777776655   457899999988654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.87  E-value=0.00024  Score=56.40  Aligned_cols=29  Identities=21%  Similarity=0.354  Sum_probs=26.4

Q ss_pred             CCeeecCCCCCcEEEcCCCCeEEcccccc
Q 041080           97 RNVVHRDIKCANILVDASGSVKLADFGLA  125 (247)
Q Consensus        97 ~~i~h~dl~~~ni~~~~~~~~~l~df~~~  125 (247)
                      .+++|+|+++.||+++.++.+.++||+.+
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a  250 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTV  250 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhc
Confidence            57999999999999988888999999865

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.83  E-value=9.5e-05  Score=58.69  Aligned_cols=31  Identities=35%  Similarity=0.389  Sum_probs=26.4

Q ss_pred             CCeeecCCCCCcEEEcCC----CCeEEcccccccc
Q 041080           97 RNVVHRDIKCANILVDAS----GSVKLADFGLAKA  127 (247)
Q Consensus        97 ~~i~h~dl~~~ni~~~~~----~~~~l~df~~~~~  127 (247)
                      ..++|+|+++.||+++.+    +.+.++||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            469999999999999874    6789999987643

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.68  E-value=0.00012  Score=59.59  Aligned_cols=30  Identities=20%  Similarity=0.355  Sum_probs=24.9

Q ss_pred             hCCeeecCCCCCcEEEcCCCCeEEccccccc
Q 041080           96 ERNVVHRDIKCANILVDASGSVKLADFGLAK  126 (247)
Q Consensus        96 ~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~  126 (247)
                      ...++|||+++.||+++.+ .+.++||..+.
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~  255 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAF  255 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence            3579999999999999765 48899997654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.59  E-value=0.00047  Score=54.20  Aligned_cols=58  Identities=16%  Similarity=0.119  Sum_probs=44.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC---CCceeeeceeeecCCcEEEEEeccccCcH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE---QDNIVQYLGTDKDENRLYIFLELVTKGSL   66 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   66 (247)
                      ++..++||+....        ....+..|...|+.|.   ...+++++.+....+..++|||+++|..+
T Consensus        58 ~~~~~vlK~~~~~--------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           58 EVQTVFVKINERS--------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             SSCEEEEEEEEGG--------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             CCCeEEEEeCCcc--------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            3567888887532        2456778988888883   36788888888888899999999998653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.40  E-value=0.00082  Score=52.47  Aligned_cols=28  Identities=25%  Similarity=0.443  Sum_probs=24.0

Q ss_pred             CeeecCCCCCcEEEcCCCCeEEccccccc
Q 041080           98 NVVHRDIKCANILVDASGSVKLADFGLAK  126 (247)
Q Consensus        98 ~i~h~dl~~~ni~~~~~~~~~l~df~~~~  126 (247)
                      .++|+|+.+.||+ ..++.+.++||..+.
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~  201 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSG  201 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence            4899999999999 566788999998764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.35  E-value=0.0015  Score=53.64  Aligned_cols=32  Identities=13%  Similarity=0.323  Sum_probs=27.4

Q ss_pred             hhCCeeecCCCCCcEEEcCCCCeEEcccccccc
Q 041080           95 HERNVVHRDIKCANILVDASGSVKLADFGLAKA  127 (247)
Q Consensus        95 h~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~  127 (247)
                      +...++|||+++.||+++.++ +.++||+.+..
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            456799999999999998776 99999987753

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.33  E-value=0.00056  Score=55.30  Aligned_cols=115  Identities=17%  Similarity=0.151  Sum_probs=68.8

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcHH-----------HH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSLA-----------NL   69 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~-----------~~   69 (247)
                      ++.|+||+....   .   .......+|..+++.+. +.-.+++++.+..    .+|+||++|.+|.           .+
T Consensus        82 ~~~~vlR~~g~~---~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~i  151 (379)
T 3feg_A           82 PREVLLRLYGAI---L---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAI  151 (379)
T ss_dssp             CSEEEEEECC---------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHH
T ss_pred             CCeEEEEECCCc---c---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHH
Confidence            467888886321   1   12334558888888884 3333566666543    2999999986542           11


Q ss_pred             ---HH---hcC------CC--HHHHHHHHHHHHH-------------------HHHHhh----h----CCeeecCCCCCc
Q 041080           70 ---YQ---KYH------LS--DSQVSSYTRQILN-------------------GLVYLH----E----RNVVHRDIKCAN  108 (247)
Q Consensus        70 ---l~---~~~------~~--~~~~~~~~~~l~~-------------------~l~~lh----~----~~i~h~dl~~~n  108 (247)
                         +.   ...      ..  ...+.++..++-.                   .+..|.    .    ..++|+|+.+.|
T Consensus       152 a~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~N  231 (379)
T 3feg_A          152 ATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGN  231 (379)
T ss_dssp             HHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGG
T ss_pred             HHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCe
Confidence               11   111      11  2345555544322                   122222    2    258999999999


Q ss_pred             EEEcCC----CCeEEccccccc
Q 041080          109 ILVDAS----GSVKLADFGLAK  126 (247)
Q Consensus       109 i~~~~~----~~~~l~df~~~~  126 (247)
                      |+++.+    +.+.++||..+.
T Consensus       232 il~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          232 ILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             EEEESCC---CCEEECCCTTCE
T ss_pred             EEEcCCCCccCcEEEEecccCC
Confidence            999876    689999998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.23  E-value=0.0029  Score=49.86  Aligned_cols=28  Identities=25%  Similarity=0.259  Sum_probs=24.1

Q ss_pred             CCeeecCCCCCcEEEcCCCCeEEccccccc
Q 041080           97 RNVVHRDIKCANILVDASGSVKLADFGLAK  126 (247)
Q Consensus        97 ~~i~h~dl~~~ni~~~~~~~~~l~df~~~~  126 (247)
                      ..++|+|+++.||+++ + .+.++||+.+.
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            4589999999999998 4 88999998754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.08  E-value=0.00096  Score=52.51  Aligned_cols=30  Identities=27%  Similarity=0.298  Sum_probs=25.2

Q ss_pred             CCeeecCCCCCcEEEcCCCCeEEccccccc
Q 041080           97 RNVVHRDIKCANILVDASGSVKLADFGLAK  126 (247)
Q Consensus        97 ~~i~h~dl~~~ni~~~~~~~~~l~df~~~~  126 (247)
                      .+++|+|+++.||+++.++.+.++||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            369999999999999877556899998763

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.93  E-value=0.0037  Score=51.40  Aligned_cols=53  Identities=8%  Similarity=-0.004  Sum_probs=32.9

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCce-eeeceeeecCCcEEEEEeccccCc
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNI-VQYLGTDKDENRLYIFLELVTKGS   65 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~   65 (247)
                      ++.++||++...    ..   .+.+..|..+++.+...++ +++++.+..    .+|++|++|.+
T Consensus       105 ~~~~vlRi~~~~----~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~  158 (429)
T 1nw1_A          105 PNKVLLRVYFNP----ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRP  158 (429)
T ss_dssp             CSEEEEEEECSC----CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEE
T ss_pred             CceEEEEEeCCC----Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCcc
Confidence            467899988421    11   1234478888888853333 566665542    28999998744

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.91  E-value=0.004  Score=48.18  Aligned_cols=56  Identities=20%  Similarity=0.102  Sum_probs=35.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCC---CceeeeceeeecCCcEEEEEeccccCc
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ---DNIVQYLGTDKDENRLYIFLELVTKGS   65 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~~~~~lv~e~~~~~~   65 (247)
                      ||+.|+||+.......     ....+..|+..|+.|..   -.+++++++.    ..+++||+..++.
T Consensus        38 DG~~~~vK~~~~~~~~-----~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~   96 (288)
T 3f7w_A           38 DGTPLFVKALPDDAPA-----LDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP   96 (288)
T ss_dssp             TSCEEEEEECCTTCCC-----CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred             CCCEEEEEEeCCCCcc-----hhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence            6899999987543211     12246789998888842   2345555542    3478999987753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=95.39  E-value=0.095  Score=38.44  Aligned_cols=115  Identities=9%  Similarity=0.058  Sum_probs=77.8

Q ss_pred             CCCceeeeceeeecCCcEEEEEecccc-CcHHHHHHhcCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC
Q 041080           37 EQDNIVQYLGTDKDENRLYIFLELVTK-GSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG  115 (247)
Q Consensus        37 ~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~  115 (247)
                      .||+.++. .+..+.+.+.+.++.-+. .++..   -...+....++++.+++....+++  .-+|--++|+|++++.++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~---ik~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~~~  116 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN---IKSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTRDG  116 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG---GGGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECTTS
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH---HHhcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcCCC
Confidence            57888876 555666766666665542 23333   334788899999999988774443  346677999999999999


Q ss_pred             CeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 041080          116 SVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYS  179 (247)
Q Consensus       116 ~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~  179 (247)
                      .+++.-.|+...               ++|.       ..+...=+-.+=+++..++.++..|+
T Consensus       117 ~p~i~~RGik~~---------------l~P~-------~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          117 LPIAKTRGLQNV---------------VDPL-------PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             CEEESCCEETTT---------------BSCC-------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             CEEEEEccCccC---------------CCCC-------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999986665321               1222       13434445567788888998887763

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=94.86  E-value=0.44  Score=35.07  Aligned_cols=114  Identities=9%  Similarity=0.060  Sum_probs=76.8

Q ss_pred             CCCceeeeceeeecCCcEEEEEeccccC-cHHHHHHhcCCCHHHHHHHHHHHHHHHH-HhhhCCeeecCCCCCcEEEcCC
Q 041080           37 EQDNIVQYLGTDKDENRLYIFLELVTKG-SLANLYQKYHLSDSQVSSYTRQILNGLV-YLHERNVVHRDIKCANILVDAS  114 (247)
Q Consensus        37 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~l~~~l~-~lh~~~i~h~dl~~~ni~~~~~  114 (247)
                      .||+. + ...-.+++.+.+.++.-+++ ++..+   ...+....++++.+|+.... ++  ..-+|--++|+|++++.+
T Consensus        48 ~~~~f-~-~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~  120 (219)
T 4ano_A           48 VDPCI-V-RDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA  120 (219)
T ss_dssp             SCSSS-E-EEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred             cCCCC-C-eEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence            57777 3 34446777777777776443 44433   45888999999999988665 33  344677899999999999


Q ss_pred             CCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 041080          115 GSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYS  179 (247)
Q Consensus       115 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~  179 (247)
                      +.+++.-.|+-.               -++|..       .+...=+-.+=+++..++.++..|+
T Consensus       121 ~~p~i~hRGi~~---------------~lpP~e-------~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          121 LEPFFLHVGVKE---------------SLPPDE-------WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             CCEEESCCEETT---------------TBSSCS-------CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             CcEEEEEcCCcc---------------cCCCCC-------CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999998776532               122222       2333344566778888888877653

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=93.78  E-value=0.065  Score=42.44  Aligned_cols=30  Identities=27%  Similarity=0.413  Sum_probs=26.5

Q ss_pred             CCeeecCCCCCcEEEcCCCCeEEccccccc
Q 041080           97 RNVVHRDIKCANILVDASGSVKLADFGLAK  126 (247)
Q Consensus        97 ~~i~h~dl~~~ni~~~~~~~~~l~df~~~~  126 (247)
                      ..++|+|+++.||+++.++.+.++||+.+.
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~  235 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM  235 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence            469999999999999988889999997664

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=92.25  E-value=0.19  Score=40.20  Aligned_cols=28  Identities=25%  Similarity=0.414  Sum_probs=23.4

Q ss_pred             CeeecCCCCCcEEEcCCCCeEEccccccc
Q 041080           98 NVVHRDIKCANILVDASGSVKLADFGLAK  126 (247)
Q Consensus        98 ~i~h~dl~~~ni~~~~~~~~~l~df~~~~  126 (247)
                      +++|+|+++.||+++.++ +.++||..+.
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            589999999999997654 8999998764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=91.80  E-value=0.23  Score=41.14  Aligned_cols=55  Identities=11%  Similarity=-0.013  Sum_probs=33.1

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCce-eeeceeeecCCcEEEEEeccccCcH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNI-VQYLGTDKDENRLYIFLELVTKGSL   66 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L   66 (247)
                      +..++||++......-..      -.+|..+++.|...++ +++++.+. +   ..|+||++|.+|
T Consensus       133 ~~~~vLRi~g~~~~~~id------R~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~~l  188 (458)
T 2qg7_A          133 QAKYLIRLYGPKTDEIIN------REREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGYAL  188 (458)
T ss_dssp             TEEEEEEEECC-CCSCSC------HHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSEEC
T ss_pred             CceEEEEECCCChhhhcC------HHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCccC
Confidence            367889987432111111      1478888888864444 56766663 2   259999987443

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=87.28  E-value=0.35  Score=39.20  Aligned_cols=28  Identities=29%  Similarity=0.400  Sum_probs=24.0

Q ss_pred             eeecCCCCCcEEEc------CCCCeEEccccccc
Q 041080           99 VVHRDIKCANILVD------ASGSVKLADFGLAK  126 (247)
Q Consensus        99 i~h~dl~~~ni~~~------~~~~~~l~df~~~~  126 (247)
                      ++|+|+.+.||++.      .++.+.++||..+.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            68999999999993      45679999998874

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=83.83  E-value=0.55  Score=38.42  Aligned_cols=28  Identities=18%  Similarity=0.490  Sum_probs=25.0

Q ss_pred             CeeecCCCCCcEEEcCCCCeEEccccccc
Q 041080           98 NVVHRDIKCANILVDASGSVKLADFGLAK  126 (247)
Q Consensus        98 ~i~h~dl~~~ni~~~~~~~~~l~df~~~~  126 (247)
                      .++|+|+.+.||+ +.++.+.++||..+.
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~  290 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSA  290 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCC
Confidence            4899999999999 778899999998774

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	247
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-76
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-76
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	8e-76
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-73
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-72
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-69
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-68
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-67
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-67
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-67
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-66
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-66
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-65
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-65
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-62
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-61
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-59
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-59
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-59
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-59
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-59
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-59
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-58
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-58
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-58
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-57
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-56
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-56
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-56
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-56
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-56
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-55
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	8e-55
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-54
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-54
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-53
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-53
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-53
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-53
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-52
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-52
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-52
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-52
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-51
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-51
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-51
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-50
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-50
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-50
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-49
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-48
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-48
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-48
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-47
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-46
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-45
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-45
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-45
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-44
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-40
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-32
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-16

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (590), Expect = 2e-76
 Identities = 87/249 (34%), Positives = 135/249 (54%), Gaps = 14/249 (5%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
                A K +  + +     + +     EI +L+  +  NIV+ L     EN L+I +E 
Sbjct: 36  TSVLAAAKVIDTKSE-----EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90

Query: 61  VTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
              G++  +  +    L++SQ+    +Q L+ L YLH+  ++HRD+K  NIL    G +K
Sbjct: 91  CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIK 150

Query: 119 LADFGLAK--ATTMNDLKSCKGTPFWMAPEVV---NSKNDGYGLTADIWSLGCTVLEMLT 173
           LADFG++     T+    S  GTP+WMAPEVV    SK+  Y   AD+WSLG T++EM  
Sbjct: 151 LADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE 210

Query: 174 RRPPYSHLEGVQALFRIGKGELPSV--PSSLSRDARDFILKCLQVNPNDRPTVTELMEHP 231
             PP+  L  ++ L +I K E P++  PS  S + +DF+ KCL+ N + R T ++L++HP
Sbjct: 211 IEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHP 270

Query: 232 FVKRPLQTP 240
           FV      P
Sbjct: 271 FVTVDSNKP 279

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  231 bits (590), Expect = 3e-76
 Identities = 83/239 (34%), Positives = 127/239 (53%), Gaps = 7/239 (2%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           +    A+K++S    G Q  +    + +E+  L +    N +QY G    E+  ++ +E 
Sbjct: 39  NSEVVAIKKMSYS--GKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96

Query: 61  VTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
               +       K  L + ++++ T   L GL YLH  N++HRD+K  NIL+   G VKL
Sbjct: 97  CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKL 156

Query: 120 ADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTRRPPY 178
            DFG A    M    S  GTP+WMAPEV+ + ++G Y    D+WSLG T +E+  R+PP 
Sbjct: 157 GDFGSAS--IMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Query: 179 SHLEGVQALFRIGKGELPSVPSS-LSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP 236
            ++  + AL+ I + E P++ S   S   R+F+  CLQ  P DRPT   L++H FV R 
Sbjct: 215 FNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (583), Expect = 8e-76
 Identities = 67/235 (28%), Positives = 117/235 (49%), Gaps = 6/235 (2%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
             F  A+K +       +      QL +E+ + S     NI++  G   D  R+Y+ LE 
Sbjct: 30  SKFILALKVLFKAQ--LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87

Query: 61  VTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
              G++    QK     + + ++Y  ++ N L Y H + V+HRDIK  N+L+ ++G +K+
Sbjct: 88  APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKI 147

Query: 120 ADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYS 179
           ADFG +     +   +  GT  ++ PE++  +   +    D+WSLG    E L  +PP+ 
Sbjct: 148 ADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFE 205

Query: 180 HLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                +   RI + E    P  ++  ARD I + L+ NP+ RP + E++EHP++ 
Sbjct: 206 ANTYQETYKRISRVEFT-FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (567), Expect = 4e-73
 Identities = 83/244 (34%), Positives = 129/244 (52%), Gaps = 11/244 (4%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
            G   A+++++LQ Q  +       +  EI ++ + +  NIV YL +    + L++ +E 
Sbjct: 44  TGQEVAIRQMNLQQQPKKE-----LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98

Query: 61  VTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLA 120
           +  GSL ++  +  + + Q+++  R+ L  L +LH   V+HRDIK  NIL+   GSVKL 
Sbjct: 99  LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLT 158

Query: 121 DFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY 178
           DFG     T       +  GTP+WMAPEVV  K   YG   DIWSLG   +EM+   PPY
Sbjct: 159 DFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPY 216

Query: 179 SHLEGVQALFRIGKGELPSV--PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP 236
            +   ++AL+ I     P +  P  LS   RDF+ +CL ++   R +  EL++H F+K  
Sbjct: 217 LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276

Query: 237 LQTP 240
               
Sbjct: 277 KPLS 280

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (559), Expect = 4e-72
 Identities = 75/247 (30%), Positives = 122/247 (49%), Gaps = 19/247 (7%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYL--GTDKDENRLYIFL 58
           DG     KE+         KQ ++    E++LL + +  NIV+Y     D+    LYI +
Sbjct: 28  DGKILVWKELDYGSMTEAEKQMLVS---EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84

Query: 59  ELVTKGSLANLYQKY-----HLSDSQVSSYTRQILNGLVYLHERN-----VVHRDIKCAN 108
           E    G LA++  K      +L +  V     Q+   L   H R+     V+HRD+K AN
Sbjct: 85  EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 144

Query: 109 ILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
           + +D   +VKL DFGLA+    +    K+  GTP++M+PE +N     Y   +DIWSLGC
Sbjct: 145 VFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRM--SYNEKSDIWSLGC 202

Query: 167 TVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTE 226
            + E+    PP++     +   +I +G+   +P   S +  + I + L +    RP+V E
Sbjct: 203 LLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEE 262

Query: 227 LMEHPFV 233
           ++E+P +
Sbjct: 263 ILENPLI 269

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 1e-69
 Identities = 59/245 (24%), Positives = 112/245 (45%), Gaps = 12/245 (4%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
                AVK V ++    +       +++EI +      +N+V++ G  ++ N  Y+FLE 
Sbjct: 29  TEEAVAVKIVDMK----RAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84

Query: 61  VTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
            + G L + +     + +     +  Q++ G+VYLH   + HRDIK  N+L+D   ++K+
Sbjct: 85  CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKI 144

Query: 120 ADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR 175
           +DFGLA     N+    L    GT  ++APE++  + + +    D+WS G  +  ML   
Sbjct: 145 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGE 203

Query: 176 PPYSHLEGVQALFRI--GKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV 233
            P+         +     K    +    +       + K L  NP+ R T+ ++ +  + 
Sbjct: 204 LPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263

Query: 234 KRPLQ 238
            +PL+
Sbjct: 264 NKPLK 268

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 1e-68
 Identities = 70/244 (28%), Positives = 123/244 (50%), Gaps = 16/244 (6%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG----TDKDENRLYI 56
                A  E+  +      +Q   + ++E  +L   +  NIV++      T K +  + +
Sbjct: 33  TTVEVAWCELQDRKLTKSERQ---RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89

Query: 57  FLELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERN--VVHRDIKCANILVDA 113
             EL+T G+L    +++  +    + S+ RQIL GL +LH R   ++HRD+KC NI +  
Sbjct: 90  VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG 149

Query: 114 -SGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEML 172
            +GSVK+ D GLA     +  K+  GTP +MAPE+   K   Y  + D+++ G  +LEM 
Sbjct: 150 PTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEK---YDESVDVYAFGMCMLEMA 206

Query: 173 TRRPPYSHLEGVQALFR-IGKGELP-SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
           T   PYS  +    ++R +  G  P S       + ++ I  C++ N ++R ++ +L+ H
Sbjct: 207 TSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266

Query: 231 PFVK 234
            F +
Sbjct: 267 AFFQ 270

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  210 bits (536), Expect = 1e-67
 Identities = 66/242 (27%), Positives = 122/242 (50%), Gaps = 15/242 (6%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
            G  F  K ++              ++ EIS+++Q     ++      +D+  + + LE 
Sbjct: 53  TGRVFVAKFINTPYP-----LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107

Query: 61  VTKGSLANLYQK--YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA--SGS 116
           ++ G L +      Y +S+++V +Y RQ   GL ++HE ++VH DIK  NI+ +   + S
Sbjct: 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASS 167

Query: 117 VKLADFGLAKATTMNDLKSC-KGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR 175
           VK+ DFGLA     +++      T  + APE+V+ +    G   D+W++G     +L+  
Sbjct: 168 VKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGL 225

Query: 176 PPYSHLEGVQALFRIGKGEL---PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
            P++  + ++ L  + + +        SS+S +A+DFI   LQ  P  R TV + +EHP+
Sbjct: 226 SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 285

Query: 233 VK 234
           +K
Sbjct: 286 LK 287

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  210 bits (535), Expect = 1e-67
 Identities = 68/243 (27%), Positives = 107/243 (44%), Gaps = 15/243 (6%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
            G  FA K V    +          + +EI  +S      +V      +D+N + +  E 
Sbjct: 50  TGNNFAAKFVMTPHE-----SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104

Query: 61  VTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV--DASGS 116
           ++ G L       H  +S+ +   Y RQ+  GL ++HE N VH D+K  NI+     S  
Sbjct: 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE 164

Query: 117 VKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR 175
           +KL DFGL         +K   GT  + APEV   +    G   D+WS+G     +L+  
Sbjct: 165 LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA--EGKPVGYYTDMWSVGVLSYILLSGL 222

Query: 176 PPYSHLEGVQALFRIGKGEL---PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
            P+      + L  +   +     S  S +S D +DFI K L  +PN R T+ + +EHP+
Sbjct: 223 SPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 282

Query: 233 VKR 235
           +  
Sbjct: 283 LTP 285

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (529), Expect = 2e-67
 Identities = 55/238 (23%), Positives = 109/238 (45%), Gaps = 16/238 (6%)

Query: 5   FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKG 64
            AVK +++     Q  Q     + E+ +L +    NI+ ++G      +L I  +     
Sbjct: 33  VAVKMLNVTAPTPQQLQ---AFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGS 88

Query: 65  SLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADF 122
           SL +            ++    RQ   G+ YLH ++++HRD+K  NI +    +VK+ DF
Sbjct: 89  SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDF 148

Query: 123 GLAKATTMND----LKSCKGTPFWMAPEVVNSKNDG-YGLTADIWSLGCTVLEMLTRRPP 177
           GLA   +        +   G+  WMAPEV+  ++   Y   +D+++ G  + E++T + P
Sbjct: 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

Query: 178 YSHLEGVQALFRIGKG-----ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
           YS++     +  +        +L  V S+  +  +  + +CL+   ++RP   +++  
Sbjct: 209 YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 3e-66
 Identities = 72/280 (25%), Positives = 124/280 (44%), Gaps = 51/280 (18%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
            G   A K + L+ + A   Q    + +E+ +L +     IV + G    +  + I +E 
Sbjct: 30  SGLVMARKLIHLEIKPAIRNQ----IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85

Query: 61  VTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERN-VVHRDIKCANILVDASGSVK 118
           +  GSL  + +K   + +  +   +  ++ GL YL E++ ++HRD+K +NILV++ G +K
Sbjct: 86  MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIK 145

Query: 119 LADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY 178
           L DFG++     +   S  GT  +M+PE +      Y + +DIWS+G +++EM   R P 
Sbjct: 146 LCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPI 203

Query: 179 SH------------------------------------------LEGVQALFRIGKGELP 196
                                                       +   + L  I     P
Sbjct: 204 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPP 263

Query: 197 SVPSS-LSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
            +PS   S + +DF+ KCL  NP +R  + +LM H F+KR
Sbjct: 264 KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  204 bits (520), Expect = 3e-66
 Identities = 71/249 (28%), Positives = 120/249 (48%), Gaps = 14/249 (5%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQ----EISLLSQF-EQDNIVQYLGTDKDENRLY 55
               +AVK + +   G+   + + +L +    E+ +L +     NI+Q   T +     +
Sbjct: 27  TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF 86

Query: 56  IFLELVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS 114
           +  +L+ KG L + L +K  LS+ +     R +L  +  LH+ N+VHRD+K  NIL+D  
Sbjct: 87  LVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD 146

Query: 115 GSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVV----NSKNDGYGLTADIWSLGCTVL 169
            ++KL DFG +      + L+   GTP ++APE++    N  + GYG   D+WS G  + 
Sbjct: 147 MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY 206

Query: 170 EMLTRRPPYSHLEGVQALFRIGKGEL---PSVPSSLSRDARDFILKCLQVNPNDRPTVTE 226
            +L   PP+ H + +  L  I  G            S   +D + + L V P  R T  E
Sbjct: 207 TLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 266

Query: 227 LMEHPFVKR 235
            + HPF ++
Sbjct: 267 ALAHPFFQQ 275

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 1e-65
 Identities = 57/246 (23%), Positives = 107/246 (43%), Gaps = 16/246 (6%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
               +  K V ++            +++EIS+L+     NI+    + +    L +  E 
Sbjct: 29  SKKTYMAKFVKVKGTDQV------LVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82

Query: 61  VTKGSLANLYQK--YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS-- 116
           ++   +        + L++ ++ SY  Q+   L +LH  N+ H DI+  NI+     S  
Sbjct: 83  ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSST 142

Query: 117 VKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR 175
           +K+ +FG A+     D  +     P + APEV   ++D      D+WSLG  V  +L+  
Sbjct: 143 IKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH--QHDVVSTATDMWSLGTLVYVLLSGI 200

Query: 176 PPYSHLEGVQALFRIGKGEL---PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
            P+      Q +  I   E          +S +A DF+ + L      R T +E ++HP+
Sbjct: 201 NPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260

Query: 233 VKRPLQ 238
           +K+ ++
Sbjct: 261 LKQKIE 266

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 3e-65
 Identities = 57/240 (23%), Positives = 110/240 (45%), Gaps = 10/240 (4%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
               +A+K +  +      +  +  + +E  ++S+ +    V+   T +D+ +LY  L  
Sbjct: 32  TSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89

Query: 61  VTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
              G L    +K     ++    YT +I++ L YLH + ++HRD+K  NIL++    +++
Sbjct: 90  AKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQI 149

Query: 120 ADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR 175
            DFG AK  +         S  GT  +++PE++  K      ++D+W+LGC + +++   
Sbjct: 150 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGL 207

Query: 176 PPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
           PP+          +I K E    P      ARD + K L ++   R    E+  +  +K 
Sbjct: 208 PPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  196 bits (499), Expect = 1e-62
 Identities = 67/249 (26%), Positives = 119/249 (47%), Gaps = 14/249 (5%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
                A+K ++ +    +GK+    +E EI++L + +  NIV      +    LY+ ++L
Sbjct: 33  TQKLVAIKCIAKKA--LEGKEG--SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88

Query: 61  VTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---DASGS 116
           V+ G L + + +K   ++   S    Q+L+ + YLH+  +VHRD+K  N+L    D    
Sbjct: 89  VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSK 148

Query: 117 VKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR 175
           + ++DFGL+K       L +  GTP ++APEV+  K   Y    D WS+G     +L   
Sbjct: 149 IMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGY 206

Query: 176 PPYSHLEGVQALFRIGKGEL---PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF 232
           PP+      +   +I K E          +S  A+DFI   ++ +P  R T  + ++HP+
Sbjct: 207 PPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 266

Query: 233 VKRPLQTPR 241
           +       +
Sbjct: 267 IAGDTALDK 275

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 3e-61
 Identities = 63/238 (26%), Positives = 112/238 (47%), Gaps = 8/238 (3%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
              FFA+K +               +E+ + L   +E   +     T + +  L+  +E 
Sbjct: 26  TNQFFAIKALKKDVVLMDDDVECTMVEKRV-LSLAWEHPFLTHMFCTFQTKENLFFVMEY 84

Query: 61  VTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
           +  G L   +   +    S+ + Y  +I+ GL +LH + +V+RD+K  NIL+D  G +K+
Sbjct: 85  LNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKI 144

Query: 120 ADFGLAKATTMNDLK--SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPP 177
           ADFG+ K   + D K  +  GTP ++APE++  +   Y  + D WS G  + EML  + P
Sbjct: 145 ADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSP 202

Query: 178 YSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT-ELMEHPFVK 234
           +   +  +    I     P  P  L ++A+D ++K     P  R  V  ++ +HP  +
Sbjct: 203 FHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  190 bits (484), Expect = 1e-59
 Identities = 71/243 (29%), Positives = 117/243 (48%), Gaps = 10/243 (4%)

Query: 1   DGFFFAVKEVSLQD-QGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLE 59
            G  +A+K +  +  +  QG+   L     +SL+S  +   IV         ++L   L+
Sbjct: 28  TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 87

Query: 60  LVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
           L+  G L  +L Q    S++ +  Y  +I+ GL ++H R VV+RD+K ANIL+D  G V+
Sbjct: 88  LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR 147

Query: 119 LADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPY 178
           ++D GLA   +     +  GT  +MAPEV+  K   Y  +AD +SLGC + ++L    P+
Sbjct: 148 ISDLGLACDFSKKKPHASVGTHGYMAPEVL-QKGVAYDSSADWFSLGCMLFKLLRGHSPF 206

Query: 179 SH--LEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV-----TELMEHP 231
                +    + R+       +P S S + R  +   LQ + N R         E+ E P
Sbjct: 207 RQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 266

Query: 232 FVK 234
           F +
Sbjct: 267 FFR 269

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 1e-59
 Identities = 60/242 (24%), Positives = 104/242 (42%), Gaps = 16/242 (6%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
                AVK +  +      K  +L    E +++ Q +   IV+ +G  + E+   + +E+
Sbjct: 33  VVKTVAVKILKNEANDPALKDELLA---EANVMQQLDNPYIVRMIGICEAES-WMLVMEM 88

Query: 61  VTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
              G L   L Q  H+ D  +     Q+  G+ YL E N VHRD+   N+L+      K+
Sbjct: 89  AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKI 148

Query: 120 ADFGLAKA-----TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR 174
           +DFGL+KA              K    W APE +N     +   +D+WS G  + E  + 
Sbjct: 149 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSY 206

Query: 175 -RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL---MEH 230
            + PY  ++G +    + KGE    P+   R+  D +  C   +  +RP    +   + +
Sbjct: 207 GQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

Query: 231 PF 232
            +
Sbjct: 267 YY 268

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 4e-59
 Identities = 49/236 (20%), Positives = 93/236 (39%), Gaps = 14/236 (5%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
             +  A+K +              +  +E  ++     + +VQ  G    +  ++I  E 
Sbjct: 27  GQYDVAIKMIKEGSMSED------EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80

Query: 61  VTKGSLANL--YQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
           +  G L N     ++     Q+    + +   + YL  +  +HRD+   N LV+  G VK
Sbjct: 81  MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVK 140

Query: 119 LADFGLAKATTMNDLKS---CKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR- 174
           ++DFGL++    ++  S    K    W  PEV+      +   +DIW+ G  + E+ +  
Sbjct: 141 VSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLG 198

Query: 175 RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
           + PY      +    I +G     P   S      +  C     ++RPT   L+ +
Sbjct: 199 KMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 4e-59
 Identities = 68/273 (24%), Positives = 113/273 (41%), Gaps = 32/273 (11%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
                A+K++ L  +            +EI LL +    NI+  L     ++ + +  + 
Sbjct: 22  TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81

Query: 61  VTKGSLANLYQ-KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
           +       +      L+ S + +Y    L GL YLH+  ++HRD+K  N+L+D +G +KL
Sbjct: 82  METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKL 141

Query: 120 ADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPP 177
           ADFGLAK+  +          T ++ APE++      YG+  D+W++GC + E+L R P 
Sbjct: 142 ADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR-MYGVGVDMWAVGCILAELLLRVPF 200

Query: 178 YSHLEGVQALFRIGKG---------------------------ELPSVPSSLSRDARDFI 210
                 +  L RI +                             L  + S+   D  D I
Sbjct: 201 LPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLI 260

Query: 211 LKCLQVNPNDRPTVTELMEHPFVK-RPLQTPRC 242
                 NP  R T T+ ++  +   RP  TP C
Sbjct: 261 QGLFLFNPCARITATQALKMKYFSNRPGPTPGC 293

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 8e-59
 Identities = 60/240 (25%), Positives = 106/240 (44%), Gaps = 14/240 (5%)

Query: 1   DGFFFAVKEVSLQDQGAQGK-QSILQLEQEISLLSQFEQD--NIVQYLGTDKDENRLYIF 57
           D    A+K V        G+  +  ++  E+ LL +       +++ L   +  +   + 
Sbjct: 28  DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 87

Query: 58  LELVTKGSLANLY--QKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS- 114
           LE          +  ++  L +    S+  Q+L  + + H   V+HRDIK  NIL+D + 
Sbjct: 88  LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR 147

Query: 115 GSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR 174
           G +KL DFG              GT  +  PE +      +G +A +WSLG  + +M+  
Sbjct: 148 GELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCG 206

Query: 175 RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
             P+ H E       I +G++      +S + +  I  CL + P+DRPT  E+  HP+++
Sbjct: 207 DIPFEHDE------EIIRGQVF-FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 8e-59
 Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 15/235 (6%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTD-KDENRLYIFLE 59
            G   AVK +           +      E S+++Q    N+VQ LG   +++  LYI  E
Sbjct: 29  RGNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81

Query: 60  LVTKGSLANLYQKYH---LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS 116
            + KGSL +  +      L    +  ++  +   + YL   N VHRD+   N+LV     
Sbjct: 82  YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV 141

Query: 117 VKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-R 175
            K++DFGL K  + +   + K    W APE +  K   +   +D+WS G  + E+ +  R
Sbjct: 142 AKVSDFGLTKEAS-STQDTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGR 198

Query: 176 PPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
            PY  +     + R+ KG     P        + +  C  ++   RP+  +L E 
Sbjct: 199 VPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 1e-58
 Identities = 60/245 (24%), Positives = 108/245 (44%), Gaps = 18/245 (7%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
                A+K +    +    K    ++ +E  ++ Q +   IV+ +G  + E  L + +E+
Sbjct: 35  KQIDVAIKVLKQGTE----KADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEM 89

Query: 61  VTKGSLANLY--QKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
              G L      ++  +  S V+    Q+  G+ YL E+N VHRD+   N+L+      K
Sbjct: 90  AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAK 149

Query: 119 LADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
           ++DFGL+KA   +D       + K    W APE +N +   +   +D+WS G T+ E L+
Sbjct: 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALS 207

Query: 174 R-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT---VTELME 229
             + PY  ++G + +  I +G+    P     +    +  C      DRP    V + M 
Sbjct: 208 YGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

Query: 230 HPFVK 234
             +  
Sbjct: 268 ACYYS 272

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  184 bits (468), Expect = 6e-58
 Identities = 60/240 (25%), Positives = 116/240 (48%), Gaps = 12/240 (5%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           +G ++A+K +  +       + +     E  +LS      I++  GT +D  ++++ ++ 
Sbjct: 28  NGRYYAMKVLKKEI--VVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85

Query: 61  VTKGSLANL-YQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
           +  G L +L  +     +     Y  ++   L YLH +++++RD+K  NIL+D +G +K+
Sbjct: 86  IEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKI 145

Query: 120 ADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYS 179
            DFG AK    +   +  GTP ++APEVV++K   Y  + D WS G  + EML    P+ 
Sbjct: 146 TDFGFAKYVP-DVTYTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFY 202

Query: 180 HLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR-----PTVTELMEHPFVK 234
               ++   +I   EL   P   + D +D + + +  + + R         ++  HP+ K
Sbjct: 203 DSNTMKTYEKILNAELR-FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 9e-58
 Identities = 68/244 (27%), Positives = 125/244 (51%), Gaps = 12/244 (4%)

Query: 1   DGFFFAVKEVSLQD-QGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLE 59
            G  +A K +  +  + ++   S   +E+E+S+L + +  N++      +++  + + LE
Sbjct: 34  TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILE 93

Query: 60  LVTKGSLANLY-QKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGS-- 116
           LV  G L +   +K  L++ + + + +QILNG+ YLH   + H D+K  NI++       
Sbjct: 94  LVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 153

Query: 117 --VKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
             +K+ DFGLA      +  K+  GTP ++APE+VN +    GL AD+WS+G     +L+
Sbjct: 154 PRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLS 211

Query: 174 RRPPYSHLEGVQALFRIGKGEL---PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
              P+      + L  +            S+ S  A+DFI + L  +P  R T+ + ++H
Sbjct: 212 GASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271

Query: 231 PFVK 234
           P++K
Sbjct: 272 PWIK 275

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 2e-57
 Identities = 47/236 (19%), Positives = 92/236 (38%), Gaps = 14/236 (5%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           +    A+K +       +         +E  ++ +     +VQ  G   ++  + +  E 
Sbjct: 28  NKDKVAIKTIREGAMSEE------DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81

Query: 61  VTKGSLANLYQK--YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
           +  G L++  +      +   +      +  G+ YL E  V+HRD+   N LV  +  +K
Sbjct: 82  MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIK 141

Query: 119 LADFGLAKATTMNDLK---SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR- 174
           ++DFG+ +    +        K    W +PEV +     Y   +D+WS G  + E+ +  
Sbjct: 142 VSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEG 199

Query: 175 RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
           + PY +    + +  I  G     P   S      +  C +  P DRP  + L+  
Sbjct: 200 KIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 2e-56
 Identities = 63/242 (26%), Positives = 102/242 (42%), Gaps = 19/242 (7%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
                AVK +                  E +L+ Q +   +V+       E  +YI  E 
Sbjct: 36  GHTKVAVKSLKQGSMSPD------AFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEY 88

Query: 61  VTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV 117
           +  GSL +  +      L+ +++     QI  G+ ++ ERN +HRD++ ANILV  + S 
Sbjct: 89  MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSC 148

Query: 118 KLADFGLAK---ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR 174
           K+ADFGLA+          +  K    W APE +N         +D+WS G  + E++T 
Sbjct: 149 KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI--KSDVWSFGILLTEIVTH 206

Query: 175 -RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELM---EH 230
            R PY  +   + +  + +G     P +   +    +  C +  P DRPT   L    E 
Sbjct: 207 GRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266

Query: 231 PF 232
            F
Sbjct: 267 FF 268

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 5e-56
 Identities = 65/242 (26%), Positives = 109/242 (45%), Gaps = 13/242 (5%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
            G ++A+K +  +      K  +     E  +L       +       +  +RL   +E 
Sbjct: 29  TGRYYAMKILRKEV--IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86

Query: 61  VTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
              G L   L ++   ++ +   Y  +I++ L YLH R+VV+RDIK  N+++D  G +K+
Sbjct: 87  ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKI 146

Query: 120 ADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPP 177
            DFGL K    +        GTP ++APEV+      YG   D W LG  + EM+  R P
Sbjct: 147 TDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLP 204

Query: 178 YSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTELMEHPF 232
           + + +  +    I   E+   P +LS +A+  +   L+ +P  R         E+MEH F
Sbjct: 205 FYNQDHERLFELILMEEIR-FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263

Query: 233 VK 234
             
Sbjct: 264 FL 265

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 6e-56
 Identities = 64/239 (26%), Positives = 107/239 (44%), Gaps = 14/239 (5%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
                AVK   L+       +++    +E++ +   +  N+++  G       + +  EL
Sbjct: 35  KTVSVAVKC--LKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTEL 91

Query: 61  VTKGSLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
              GSL +  +K+  H     +S Y  Q+  G+ YL  +  +HRD+   N+L+     VK
Sbjct: 92  APLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVK 151

Query: 119 LADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
           + DFGL +A   ND      +  K    W APE + ++   +   +D W  G T+ EM T
Sbjct: 152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFT 209

Query: 174 R-RPPYSHLEGVQALFRIGK-GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
             + P+  L G Q L +I K GE    P    +D  + +++C    P DRPT   L + 
Sbjct: 210 YGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 6e-56
 Identities = 70/260 (26%), Positives = 121/260 (46%), Gaps = 31/260 (11%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ-DNIVQYLGT----DKDENRLY 55
               FA+K +          Q   +  +E+ L  +  Q  +IV+ +            L 
Sbjct: 36  TQEKFALKML----------QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85

Query: 56  IFLELVTKGSLANLYQKY---HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVD 112
           I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HRD+K  N+L  
Sbjct: 86  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 145

Query: 113 A---SGSVKLADFGLAK-ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           +   +  +KL DFG AK  T+ N L +   TP+++APEV+  +   Y  + D+WSLG  +
Sbjct: 146 SKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIM 203

Query: 169 LEMLTRRPPY------SHLEGVQALFRIGKGELPS-VPSSLSRDARDFILKCLQVNPNDR 221
             +L   PP+      +   G++   R+G+ E P+   S +S + +  I   L+  P  R
Sbjct: 204 YILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQR 263

Query: 222 PTVTELMEHPFVKRPLQTPR 241
            T+TE M HP++ +  + P+
Sbjct: 264 MTITEFMNHPWIMQSTKVPQ 283

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 9e-56
 Identities = 62/245 (25%), Positives = 105/245 (42%), Gaps = 18/245 (7%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
                A+K +       +         QE  ++ +   + +VQ      +E  +YI  E 
Sbjct: 40  GTTRVAIKTLKPGTMSPE------AFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEY 92

Query: 61  VTKGSLANLYQK---YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV 117
           ++KGSL +  +     +L   Q+     QI +G+ Y+   N VHRD++ ANILV  +   
Sbjct: 93  MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 152

Query: 118 KLADFGLAKATTMNDL---KSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR 174
           K+ADFGLA+    N+    +  K    W APE        + + +D+WS G  + E+ T+
Sbjct: 153 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTK 210

Query: 175 -RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME--HP 231
            R PY  +   + L ++ +G     P        D + +C +  P +RPT   L      
Sbjct: 211 GRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270

Query: 232 FVKRP 236
           +    
Sbjct: 271 YFTST 275

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 1e-55
 Identities = 65/236 (27%), Positives = 102/236 (43%), Gaps = 13/236 (5%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
                A+K                +  QE   + QF+  +IV+ +G    EN ++I +EL
Sbjct: 34  PALAVAIKTCKNCTS----DSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMEL 88

Query: 61  VTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
            T G L +  Q     L  + +  Y  Q+   L YL  +  VHRDI   N+LV ++  VK
Sbjct: 89  CTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK 148

Query: 119 LADFGLAKATTMNDLK---SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR- 174
           L DFGL++    +        K    WMAPE +N +   +   +D+W  G  + E+L   
Sbjct: 149 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHG 206

Query: 175 RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
             P+  ++    + RI  GE   +P +        + KC   +P+ RP  TEL   
Sbjct: 207 VKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  176 bits (446), Expect = 8e-55
 Identities = 55/240 (22%), Positives = 98/240 (40%), Gaps = 16/240 (6%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
              F A+K +         ++       E S++ QF+  N++   G       + I  E 
Sbjct: 53  REIFVAIKTLKS----GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEF 108

Query: 61  VTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
           +  GSL +  ++     +  Q+    R I  G+ YL + N VHRD+   NILV+++   K
Sbjct: 109 MENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCK 168

Query: 119 LADFGLAKA-------TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEM 171
           ++DFGL++         T       K    W APE +  +   +   +D+WS G  + E+
Sbjct: 169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR--KFTSASDVWSYGIVMWEV 226

Query: 172 LTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
           ++    PY  +     +  I +      P          +L C Q + N RP   +++  
Sbjct: 227 MSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 2e-54
 Identities = 73/268 (27%), Positives = 110/268 (41%), Gaps = 36/268 (13%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG-----TDKDENRLY 55
            G F A+K V +Q        S ++    +  L  FE  N+V+            E +L 
Sbjct: 32  GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 91

Query: 56  IFLELVTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA 113
           +  E V +     L +     +    +     Q+L GL +LH   VVHRD+K  NILV +
Sbjct: 92  LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS 151

Query: 114 SGSVKLADFGLAKA-TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEML 172
           SG +KLADFGLA+  +    L S   T ++ APEV+      Y    D+WS+GC   EM 
Sbjct: 152 SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMF 209

Query: 173 TRRPPYSHLEGVQALFRIGKG--------------------------ELPSVPSSLSRDA 206
            R+P +     V  L +I                              +    + +    
Sbjct: 210 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG 269

Query: 207 RDFILKCLQVNPNDRPTVTELMEHPFVK 234
           +D +LKCL  NP  R +    + HP+ +
Sbjct: 270 KDLLLKCLTFNPAKRISAYSALSHPYFQ 297

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 5e-54
 Identities = 67/247 (27%), Positives = 113/247 (45%), Gaps = 14/247 (5%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLE 59
            G  +A+K +       Q  ++      E  +L    +   +V      + E +L++ L+
Sbjct: 51  TGKLYAMKVLKKATI-VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILD 109

Query: 60  LVTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
            +  G L   L Q+   ++ +V  Y  +I+  L +LH+  +++RDIK  NIL+D++G V 
Sbjct: 110 YINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 169

Query: 119 LADFGLA---KATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR 175
           L DFGL+    A          GT  +MAP++V   + G+    D WSLG  + E+LT  
Sbjct: 170 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229

Query: 176 PPYSHLEGVQALFRIGKGEL---PSVPSSLSRDARDFILKCLQVNPNDRP-----TVTEL 227
            P++      +   I +  L   P  P  +S  A+D I + L  +P  R         E+
Sbjct: 230 SPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI 289

Query: 228 MEHPFVK 234
            EH F +
Sbjct: 290 KEHLFFQ 296

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  173 bits (438), Expect = 1e-53
 Identities = 56/259 (21%), Positives = 101/259 (38%), Gaps = 36/259 (13%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
                AVK +  +             ++E +L+++F+  NIV+ LG       + +  E 
Sbjct: 42  PFTMVAVKMLKEEAS----ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY 97

Query: 61  VTKGSLANLYQKYH-------------------------LSDSQVSSYTRQILNGLVYLH 95
           +  G L    +                            LS ++     RQ+  G+ YL 
Sbjct: 98  MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS 157

Query: 96  ERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK----SCKGTPFWMAPEVVNSK 151
           ER  VHRD+   N LV  +  VK+ADFGL++     D      +      WM PE +   
Sbjct: 158 ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-- 215

Query: 152 NDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFI 210
            + Y   +D+W+ G  + E+ +    PY  +   + ++ +  G + + P +   +  + +
Sbjct: 216 YNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLM 275

Query: 211 LKCLQVNPNDRPTVTELME 229
             C    P DRP+   +  
Sbjct: 276 RLCWSKLPADRPSFCSIHR 294

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 2e-53
 Identities = 74/266 (27%), Positives = 116/266 (43%), Gaps = 36/266 (13%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
            G   A+K++ L  +      + ++   EISLL +    NIV+ L     EN+LY+  E 
Sbjct: 26  TGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82

Query: 61  VTKGSLANLYQKYH--LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
           + +     +       +    + SY  Q+L GL + H   V+HRD+K  N+L++  G++K
Sbjct: 83  LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIK 142

Query: 119 LADFGLAKA--TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRP 176
           LADFGLA+A    +        T ++ APE++      Y    DIWSLGC   EM+TRR 
Sbjct: 143 LADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRRA 201

Query: 177 PYSHLEGVQALFRIGKG----------------------------ELPSVPSSLSRDARD 208
            +     +  LFRI +                             +   V   L  D R 
Sbjct: 202 LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRS 261

Query: 209 FILKCLQVNPNDRPTVTELMEHPFVK 234
            + + L  +PN R +    + HPF +
Sbjct: 262 LLSQMLHYDPNKRISAKAALAHPFFQ 287

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  171 bits (435), Expect = 2e-53
 Identities = 72/265 (27%), Positives = 118/265 (44%), Gaps = 35/265 (13%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
            G  FA+K++ L+ +      + ++   EIS+L + +  NIV+       + RL +  E 
Sbjct: 25  YGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81

Query: 61  VTKGSLANL-YQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
           + +     L   +  L      S+  Q+LNG+ Y H+R V+HRD+K  N+L++  G +K+
Sbjct: 82  LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKI 141

Query: 120 ADFGLAKATTMNDLKSCK--GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPP 177
           ADFGLA+A  +   K      T ++ AP+V+      Y  T DIWS+GC   EM+   P 
Sbjct: 142 ADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK-KYSTTIDIWSVGCIFAEMVNGTPL 200

Query: 178 YSHLEGVQALFRIGKG----------------------------ELPSVPSSLSRDARDF 209
           +  +     L RI +                                S    L     D 
Sbjct: 201 FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDL 260

Query: 210 ILKCLQVNPNDRPTVTELMEHPFVK 234
           + K L+++PN R T  + +EH + K
Sbjct: 261 LSKMLKLDPNQRITAKQALEHAYFK 285

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 4e-53
 Identities = 52/261 (19%), Positives = 94/261 (36%), Gaps = 37/261 (14%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ-DNIVQYLGTDKDENRLYIFLE 59
                AVK +  +            L  E+ +++Q    +NIV  LG       +Y+  E
Sbjct: 66  VSIQVAVKMLKEKAD----SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 121

Query: 60  LVTKGSLANLYQKYH------------------------LSDSQVSSYTRQILNGLVYLH 95
               G L N  +                           L+   +  +  Q+  G+ +L 
Sbjct: 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 181

Query: 96  ERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSK 151
            ++ VHRD+   N+LV     VK+ DFGLA+    +       + +    WMAPE +   
Sbjct: 182 FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 241

Query: 152 NDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGEL-PSVPSSLSRDARDF 209
              Y + +D+WS G  + E+ +    PY  +      +++ +       P   + +    
Sbjct: 242 --IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYII 299

Query: 210 ILKCLQVNPNDRPTVTELMEH 230
           +  C   +   RP+   L   
Sbjct: 300 MQSCWAFDSRKRPSFPNLTSF 320

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 1e-52
 Identities = 54/250 (21%), Positives = 104/250 (41%), Gaps = 24/250 (9%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ-DNIVQYLGTDKDENRLYIFLE 59
           DG         +++  +  K        E+ +L +     NI+  LG  +    LY+ +E
Sbjct: 34  DGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 91

Query: 60  LVTKGSLANLYQKYH-----------------LSDSQVSSYTRQILNGLVYLHERNVVHR 102
               G+L +  +K                   LS  Q+  +   +  G+ YL ++  +HR
Sbjct: 92  YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR 151

Query: 103 DIKCANILVDASGSVKLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTADI 161
           D+   NILV  +   K+ADFGL++   +   K   +    WMA E +N         +D+
Sbjct: 152 DLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT--NSDV 209

Query: 162 WSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPND 220
           WS G  + E+++    PY  +   +   ++ +G     P +   +  D + +C +  P +
Sbjct: 210 WSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYE 269

Query: 221 RPTVTELMEH 230
           RP+  +++  
Sbjct: 270 RPSFAQILVS 279

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  168 bits (427), Expect = 3e-52
 Identities = 58/247 (23%), Positives = 105/247 (42%), Gaps = 17/247 (6%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN----RLYI 56
                AVK +      A+     L+  +E    +      IV    T + E       YI
Sbjct: 31  LHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88

Query: 57  FLELVTKGSLANLYQKY-HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
            +E V   +L ++      ++  +           L + H+  ++HRD+K ANI++ A+ 
Sbjct: 89  VMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN 148

Query: 116 SVKLADFGLAK-----ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
           +VK+ DFG+A+       ++    +  GT  +++PE    + D     +D++SLGC + E
Sbjct: 149 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA--RGDSVDARSDVYSLGCVLYE 206

Query: 171 MLTRRPPYSHLEGVQALFRIGKGELP---SVPSSLSRDARDFILKCLQVNPNDRPTVTEL 227
           +LT  PP++    V   ++  + +     +    LS D    +LK L  NP +R      
Sbjct: 207 VLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAE 266

Query: 228 MEHPFVK 234
           M    V+
Sbjct: 267 MRADLVR 273

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 4e-52
 Identities = 56/239 (23%), Positives = 99/239 (41%), Gaps = 16/239 (6%)

Query: 2   GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTD-KDENRLYIFLEL 60
               AVK ++           + Q   E  ++  F   N++  LG   + E    + L  
Sbjct: 55  KIHCAVKSLNRITD----IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110

Query: 61  VTKGSLANLY--QKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVK 118
           +  G L N    + ++ +   +  +  Q+  G+ +L  +  VHRD+   N ++D   +VK
Sbjct: 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVK 170

Query: 119 LADFGLAKATTMNDLKS------CKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEML 172
           +ADFGLA+     +  S       K    WMA E + ++       +D+WS G  + E++
Sbjct: 171 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT--KSDVWSFGVLLWELM 228

Query: 173 TR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
           TR  PPY  +        + +G     P        + +LKC       RP+ +EL+  
Sbjct: 229 TRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 4e-52
 Identities = 57/233 (24%), Positives = 107/233 (45%), Gaps = 14/233 (6%)

Query: 5   FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKG 64
            A+KE+          ++  ++  E  +++  +  ++ + LG       + +  +L+  G
Sbjct: 41  VAIKELREATS----PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFG 95

Query: 65  SLANLYQKY--HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADF 122
            L +  +++  ++    + ++  QI  G+ YL +R +VHRD+   N+LV     VK+ DF
Sbjct: 96  CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 155

Query: 123 GLAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPP 177
           GLAK     +     +  K    WMA E +  +   Y   +D+WS G TV E++T    P
Sbjct: 156 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKP 213

Query: 178 YSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH 230
           Y  +   +    + KGE    P   + D    ++KC  ++ + RP   EL+  
Sbjct: 214 YDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 3e-51
 Identities = 55/242 (22%), Positives = 97/242 (40%), Gaps = 16/242 (6%)

Query: 5   FAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKG 64
            A+K +         ++  +    E  ++ QF   NI++  G       + I  E +  G
Sbjct: 39  VAIKTLKAGYT----EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENG 94

Query: 65  SLANLYQK--YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADF 122
           +L    ++     S  Q+    R I  G+ YL   N VHRD+   NILV+++   K++DF
Sbjct: 95  ALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDF 154

Query: 123 GLAK-----ATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RP 176
           GL++               K    W APE ++ +       +D+WS G  + E++T    
Sbjct: 155 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTS--ASDVWSFGIVMWEVMTYGER 212

Query: 177 PYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME--HPFVK 234
           PY  L   + +  I  G     P          +++C Q     RP   +++      ++
Sbjct: 213 PYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272

Query: 235 RP 236
            P
Sbjct: 273 AP 274

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  168 bits (425), Expect = 4e-51
 Identities = 67/240 (27%), Positives = 111/240 (46%), Gaps = 12/240 (5%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
            G  +A+K +  Q       + I     E  +L       +V+   + KD + LY+ +E 
Sbjct: 65  SGNHYAMKILDKQK--VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122

Query: 61  VTKGSLAN-LYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
           V  G + + L +    S+     Y  QI+    YLH  ++++RD+K  N+L+D  G +++
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182

Query: 120 ADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYS 179
            DFG AK        +  GTP  +APE++ SK  GY    D W+LG  + EM    PP+ 
Sbjct: 183 TDFGFAKR-VKGRTWTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFF 239

Query: 180 HLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDR-----PTVTELMEHPFVK 234
             + +Q   +I  G++   PS  S D +D +   LQV+   R       V ++  H +  
Sbjct: 240 ADQPIQIYEKIVSGKVR-FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 8e-51
 Identities = 62/280 (22%), Positives = 108/280 (38%), Gaps = 50/280 (17%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGT--------DKDEN 52
            G   A+K+V ++++      + L+   EI +L   + +N+V  +          ++ + 
Sbjct: 34  TGQKVALKKVLMENEKEGFPITALR---EIKILQLLKHENVVNLIEICRTKASPYNRCKG 90

Query: 53  RLYIFLELVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV 111
            +Y+  +                 + S++    + +LNGL Y+H   ++HRD+K AN+L+
Sbjct: 91  SIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI 150

Query: 112 DASGSVKLADFGLAKA------TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLG 165
              G +KLADFGLA+A      +  N   +   T ++  PE++  +   YG   D+W  G
Sbjct: 151 TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER-DYGPPIDLWGAG 209

Query: 166 CTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPS------------------------- 200
           C + EM TR P          L  I +      P                          
Sbjct: 210 CIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVK 269

Query: 201 ------SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                      A D I K L ++P  R    + + H F  
Sbjct: 270 DRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 1e-50
 Identities = 59/258 (22%), Positives = 104/258 (40%), Gaps = 28/258 (10%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
                A+K V+     A   +  ++   E S++ +F   ++V+ LG         + +EL
Sbjct: 49  PETRVAIKTVNE----AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 104

Query: 61  VTKGSLANLYQKYH-----------LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANI 109
           +T+G L +  +               S S++     +I +G+ YL+    VHRD+   N 
Sbjct: 105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 164

Query: 110 LVDASGSVKLADFGLAKATTMNDLKSC----KGTPFWMAPEVVNSKNDGYGLTADIWSLG 165
           +V    +VK+ DFG+ +     D             WM+PE +      +   +D+WS G
Sbjct: 165 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFG 222

Query: 166 CTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTV 224
             + E+ T    PY  L   Q L  + +G L   P +      + +  C Q NP  RP+ 
Sbjct: 223 VVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 282

Query: 225 TELME------HPFVKRP 236
            E++        P  +  
Sbjct: 283 LEIISSIKEEMEPGFREV 300

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  164 bits (417), Expect = 2e-50
 Identities = 59/236 (25%), Positives = 105/236 (44%), Gaps = 15/236 (6%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
                AVK +       +      +  +E +++ + +  N+VQ LG    E   YI  E 
Sbjct: 41  YSLTVAVKTLKEDTMEVE------EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94

Query: 61  VTKGSLANLYQ---KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSV 117
           +T G+L +  +   +  +S   +     QI + + YL ++N +HRD+   N LV  +  V
Sbjct: 95  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 154

Query: 118 KLADFGLAKATTMNDLKSCKGT---PFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT- 173
           K+ADFGL++  T +   +  G      W APE +      + + +D+W+ G  + E+ T 
Sbjct: 155 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATY 212

Query: 174 RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME 229
              PY  ++  Q    + K      P        + +  C Q NP+DRP+  E+ +
Sbjct: 213 GMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 4e-50
 Identities = 71/285 (24%), Positives = 123/285 (43%), Gaps = 49/285 (17%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG-----TDKDENRLY 55
           +    A+K++S  +     +    +  +EI +L +F  +NI+         T +    +Y
Sbjct: 32  NKVRVAIKKISPFEH----QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87

Query: 56  IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
           +   L+    L  L +  HLS+  +  +  QIL GL Y+H  NV+HRD+K +N+L++ + 
Sbjct: 88  LVTHLM-GADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC 146

Query: 116 SVKLADFGLAKA-----TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLE 170
            +K+ DFGLA+           L     T ++ APE++ +   GY  + DIWS+GC + E
Sbjct: 147 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAE 205

Query: 171 MLTRRPPYSHLEGVQALFRI------------------------------GKGELPSVPS 200
           ML+ RP +     +  L  I                               K     +  
Sbjct: 206 MLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP 265

Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR---PLQTPRC 242
           +    A D + K L  NP+ R  V + + HP++++   P   P  
Sbjct: 266 NADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIA 310

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 5e-49
 Identities = 67/274 (24%), Positives = 103/274 (37%), Gaps = 50/274 (18%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYL------GTDKDENRL 54
            G   A+K+V          Q      +E+ ++ + +  NIV+        G  KDE  L
Sbjct: 44  SGELVAIKKV---------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94

Query: 55  YIFLELVTKGSLANLYQ----KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANIL 110
            + L+ V +            K  L    V  Y  Q+   L Y+H   + HRDIK  N+L
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154

Query: 111 VDASGSV-KLADFGLAKATTMNDLK-SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTV 168
           +D   +V KL DFG AK     +   S   + ++ APE++      Y  + D+WS GC +
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT-DYTSSIDVWSAGCVL 213

Query: 169 LEMLTRRPPYSHLEGVQALFRIGKG-------------------ELPSVPS--------- 200
            E+L  +P +    GV  L  I K                    + P + +         
Sbjct: 214 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 273

Query: 201 SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
               +A     + L+  P  R T  E   H F  
Sbjct: 274 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (404), Expect = 2e-48
 Identities = 61/253 (24%), Positives = 104/253 (41%), Gaps = 29/253 (11%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ-DNIVQYLGTDKDENRLYIFLE 59
                AVK +         ++ +  L  E+ ++    +  NI+  LG    +  LY+ +E
Sbjct: 44  RVTKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 99

Query: 60  LVTKGSLANLYQKY-----------------HLSDSQVSSYTRQILNGLVYLHERNVVHR 102
             +KG+L    Q                    LS   + S   Q+  G+ YL  +  +HR
Sbjct: 100 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 159

Query: 103 DIKCANILVDASGSVKLADFGLAKATTMNDLK----SCKGTPFWMAPEVVNSKNDGYGLT 158
           D+   N+LV     +K+ADFGLA+     D      + +    WMAPE +  +   Y   
Sbjct: 160 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQ 217

Query: 159 ADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVN 217
           +D+WS G  + E+ T    PY  +   +    + +G     PS+ + +    +  C    
Sbjct: 218 SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAV 277

Query: 218 PNDRPTVTELMEH 230
           P+ RPT  +L+E 
Sbjct: 278 PSQRPTFKQLVED 290

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 7e-48
 Identities = 54/255 (21%), Positives = 94/255 (36%), Gaps = 32/255 (12%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ-DNIVQYLGTDKDENRLYIFLE 59
                AVK +               L  E+ +LS      NIV  LG         +  E
Sbjct: 52  AAMTVAVKMLKPSAH----LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107

Query: 60  LVTKGSLANLYQKYH-------------------LSDSQVSSYTRQILNGLVYLHERNVV 100
               G L N  ++                     L    + S++ Q+  G+ +L  +N +
Sbjct: 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI 167

Query: 101 HRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYG 156
           HRD+   NIL+      K+ DFGLA+    +       + +    WMAPE + +    + 
Sbjct: 168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF- 226

Query: 157 LTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGEL-PSVPSSLSRDARDFILKCL 214
             +D+WS G  + E+ +    PY  +      +++ K       P     +  D +  C 
Sbjct: 227 -ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCW 285

Query: 215 QVNPNDRPTVTELME 229
             +P  RPT  ++++
Sbjct: 286 DADPLKRPTFKQIVQ 300

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 9e-48
 Identities = 60/272 (22%), Positives = 101/272 (37%), Gaps = 49/272 (18%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN----RLYI 56
            G   AVK  S +++ +         E EI        +NI+ ++  D  +N    +L++
Sbjct: 25  RGEEVAVKIFSSREERSW------FREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78

Query: 57  FLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHE--------RNVVHRDIKCAN 108
             +    GSL +   +Y ++   +        +GL +LH           + HRD+K  N
Sbjct: 79  VSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 138

Query: 109 ILVDASGSVKLADFGL------AKATTMNDLKSCKGTPFWMAPEV----VNSKNDGYGLT 158
           ILV  +G+  +AD GL      A  T         GT  +MAPEV    +N K+      
Sbjct: 139 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 198

Query: 159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALF----------------RIGKGELPSVPSSL 202
           ADI+++G    E+  R       E  Q  +                   +   P++P+  
Sbjct: 199 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW 258

Query: 203 S-----RDARDFILKCLQVNPNDRPTVTELME 229
                 R     + +C   N   R T   + +
Sbjct: 259 QSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 1e-47
 Identities = 70/265 (26%), Positives = 107/265 (40%), Gaps = 34/265 (12%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
                A+K V L D       S L+   EI LL + +  NIV+       + +L +  E 
Sbjct: 26  THEIVALKRVRLDDDDEGVPSSALR---EICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82

Query: 61  VTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKL 119
             +            L    V S+  Q+L GL + H RNV+HRD+K  N+L++ +G +KL
Sbjct: 83  CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKL 142

Query: 120 ADFGLAKATTM-NDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPP 177
           A+FGLA+A  +     S +    W  P  V      Y  + D+WS GC   E+    RP 
Sbjct: 143 ANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

Query: 178 YSHLEGVQALFRIGKG----------------------------ELPSVPSSLSRDARDF 209
           +   +    L RI +                              L +V   L+   RD 
Sbjct: 203 FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL 262

Query: 210 ILKCLQVNPNDRPTVTELMEHPFVK 234
           +   L+ NP  R +  E ++HP+  
Sbjct: 263 LQNLLKCNPVQRISAEEALQHPYFS 287

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 2e-46
 Identities = 61/269 (22%), Positives = 111/269 (41%), Gaps = 40/269 (14%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
            G   A+K++    Q     +   +  +E+ LL     +N++  L     +  L  F + 
Sbjct: 42  TGAKVAIKKLYRPFQSELFAK---RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98

Query: 61  VT-----KGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
                     L  L +   L + ++     Q+L GL Y+H   ++HRD+K  N+ V+   
Sbjct: 99  YLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC 158

Query: 116 SVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR 175
            +K+ DFGLA+    +++     T ++ APEV+      Y  T DIWS+GC + EM+T +
Sbjct: 159 ELKILDFGLAR-QADSEMTGYVVTRWYRAPEVI-LNWMRYTQTVDIWSVGCIMAEMITGK 216

Query: 176 PPYSHLEGVQALFRIGKG------------------------------ELPSVPSSLSRD 205
             +   + +  L  I K                               +  S+ ++ S  
Sbjct: 217 TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPL 276

Query: 206 ARDFILKCLQVNPNDRPTVTELMEHPFVK 234
           A + + K L ++   R T  E + HP+ +
Sbjct: 277 AVNLLEKMLVLDAEQRVTAGEALAHPYFE 305

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  152 bits (384), Expect = 1e-45
 Identities = 41/262 (15%), Positives = 89/262 (33%), Gaps = 33/262 (12%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG-TDKDENRLYIFLE 59
            G   A+K   ++ +  Q       L  E  +    +    +  +     + +   + +E
Sbjct: 31  AGEEVAIKLECVKTKHPQ-------LHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83

Query: 60  LVTKGSLA-NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILV---DASG 115
           L+         +     S   V     Q+++ + Y+H +N +HRD+K  N L+       
Sbjct: 84  LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN 143

Query: 116 SVKLADFGLAKA---------TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGC 166
            V + DFGLAK              + K+  GT  + +               D+ SLG 
Sbjct: 144 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGY 201

Query: 167 TVLEMLTRRPPYSHLEGVQALFRIGKGE-------LPSVPSSLSRDARDFILKCLQVNPN 219
            ++       P+  L+      +  +         +  +      +   ++  C  +  +
Sbjct: 202 VLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFD 261

Query: 220 DRPT---VTELMEHPFVKRPLQ 238
           D+P    + +L  + F ++   
Sbjct: 262 DKPDYSYLRQLFRNLFHRQGFS 283

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  153 bits (386), Expect = 1e-45
 Identities = 60/276 (21%), Positives = 103/276 (37%), Gaps = 53/276 (19%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ-DNIVQYLGT--DKDENRLYIF 57
           +     VK +              ++++EI +L       NI+       D       + 
Sbjct: 59  NNEKVVVKILK--------PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110

Query: 58  LELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG-S 116
            E V       LYQ   L+D  +  Y  +IL  L Y H   ++HRD+K  N+++D     
Sbjct: 111 FEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK 168

Query: 117 VKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR 175
           ++L D+GLA+        + +  + ++  PE +      Y  + D+WSLGC +  M+ R+
Sbjct: 169 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPE-LLVDYQMYDYSLDMWSLGCMLASMIFRK 227

Query: 176 PPYSH-------------------------------------LEGVQALFRIGKGELPSV 198
            P+ H                                     + G  +  R  +      
Sbjct: 228 EPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSEN 287

Query: 199 PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
              +S +A DF+ K L+ +   R T  E MEHP+  
Sbjct: 288 QHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 5e-45
 Identities = 63/270 (23%), Positives = 112/270 (41%), Gaps = 40/270 (14%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG-----TDKDENRLY 55
            G   AVK++S   Q     +   +  +E+ LL   + +N++  L         +E    
Sbjct: 42  TGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98

Query: 56  IFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG 115
             +  +    L N+ +   L+D  V     QIL GL Y+H  +++HRD+K +N+ V+   
Sbjct: 99  YLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC 158

Query: 116 SVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR 175
            +K+ DFGLA+ T          T ++ APE++ +    Y  T DIWS+GC + E+LT R
Sbjct: 159 ELKILDFGLARHTDDEM-TGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLTGR 216

Query: 176 PPYSHLEGVQALFRIGKG------------------------------ELPSVPSSLSRD 205
             +   + +  L  I +                                  +V    +  
Sbjct: 217 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPL 276

Query: 206 ARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
           A D + K L ++ + R T  + + H +  +
Sbjct: 277 AVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 1e-44
 Identities = 62/254 (24%), Positives = 105/254 (41%), Gaps = 29/254 (11%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG-TDKDENRLYIFLE 59
                AVK   L++     +   L  E +I L+      N+V  LG   K    L + +E
Sbjct: 42  TCRTVAVKM--LKEGATHSEHRALMSELKI-LIHIGHHLNVVNLLGACTKPGGPLMVIVE 98

Query: 60  LVTKGSLANLYQKY-----------------HLSDSQVSSYTRQILNGLVYLHERNVVHR 102
               G+L+   +                    L+   +  Y+ Q+  G+ +L  R  +HR
Sbjct: 99  FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 158

Query: 103 DIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYGLT 158
           D+   NIL+     VK+ DFGLA+    +         +    WMAPE +  +   Y + 
Sbjct: 159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQ 216

Query: 159 ADIWSLGCTVLEMLTR-RPPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILKCLQV 216
           +D+WS G  + E+ +    PY  ++  +   R + +G     P   + +    +L C   
Sbjct: 217 SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 276

Query: 217 NPNDRPTVTELMEH 230
            P+ RPT +EL+EH
Sbjct: 277 EPSQRPTFSELVEH 290

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 2e-41
 Identities = 58/282 (20%), Positives = 116/282 (41%), Gaps = 55/282 (19%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLG------TDKDENRL 54
                A+K++S   Q     +   +  +E+ L+      NI+  L       T ++   +
Sbjct: 41  LDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97

Query: 55  YIFLELVTKGSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS 114
           Y+ +EL+       +  +      ++S    Q+L G+ +LH   ++HRD+K +NI+V + 
Sbjct: 98  YLVMELMDANLCQVIQMEL--DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 155

Query: 115 GSVKLADFGLAKATTMNDLKSCK-GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT 173
            ++K+ DFGLA+    + + +    T ++ APEV+     GY    DIWS+GC + EM+ 
Sbjct: 156 CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGEMVR 213

Query: 174 RRPPYSHLEGVQALFRIGKGELPSVPS--------------------------------- 200
            +  +   + +    ++ +      P                                  
Sbjct: 214 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLF 273

Query: 201 --------SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK 234
                     +  ARD + K L ++P  R +V + ++HP++ 
Sbjct: 274 PADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  138 bits (349), Expect = 2e-40
 Identities = 42/251 (16%), Positives = 84/251 (33%), Gaps = 30/251 (11%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLEL 60
           +    A+K    +    Q +       +   LL+       V Y G +       + ++L
Sbjct: 29  NNQQVAIKFEPRRSDAPQLRDEY----RTYKLLAGCTGIPNVYYFGQE--GLHNVLVIDL 82

Query: 61  VTKGSLANLYQKYH-LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA-----S 114
           +       L       S   V+   +Q+L  +  +HE+++V+RDIK  N L+       +
Sbjct: 83  LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNA 142

Query: 115 GSVKLADFGLAKA---------TTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLG 165
             + + DFG+ K              + K+  GT  +M+      +        D+ +LG
Sbjct: 143 NMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALG 200

Query: 166 CTVLEMLTRR---PPYSHLEGVQALFRIGKGE----LPSVPSSLSRDARDFILKCLQVNP 218
              +  L               Q   RIG+ +    L  + +    +   ++     +  
Sbjct: 201 HVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAF 260

Query: 219 NDRPTVTELME 229
           +  P    L  
Sbjct: 261 DATPDYDYLQG 271

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  118 bits (297), Expect = 2e-32
 Identities = 62/306 (20%), Positives = 115/306 (37%), Gaps = 68/306 (22%)

Query: 1   DGFFFAVKEVSLQDQGAQGKQSILQLEQEIS-----LLSQFEQDNIVQYL--GTDKDENR 53
           +    A+K V       +  +  ++L Q ++            ++I++ L     K  N 
Sbjct: 37  NNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 96

Query: 54  LYIFLELVTKG----SLANLYQKYHLSDSQVSSYTRQILNGLVYLH-ERNVVHRDIKCAN 108
           +++ +     G    +L   Y+   +    V   ++Q+L GL Y+H    ++H DIK  N
Sbjct: 97  VHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 156

Query: 109 ILVDASG------SVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTADIW 162
           +L++          +K+AD G A     +   S   T  + +PEV+      +G  ADIW
Sbjct: 157 VLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI-QTREYRSPEVLLGA--PWGCGADIW 213

Query: 163 SLGCTVLEMLTRRPPY------SHLEGVQALFRIGK--GELPS----------------- 197
           S  C + E++T    +      S+ +    + +I +  GELPS                 
Sbjct: 214 STACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRG 273

Query: 198 ----------------------VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR 235
                                      +++  DF+   LQ++P  R     L+ HP++K 
Sbjct: 274 LLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 333

Query: 236 PLQTPR 241
            L    
Sbjct: 334 TLGMEE 339

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 72.9 bits (178), Expect = 2e-16
 Identities = 27/168 (16%), Positives = 51/168 (30%), Gaps = 16/168 (9%)

Query: 4   FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTK 63
           F  VKE            +I     E   L + +   + +            + +EL+  
Sbjct: 39  FKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY----AWEGNAVLMELIDA 94

Query: 64  GSLANLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFG 123
             L  +  +              IL  +   + R +VH D+   N+LV   G + + DF 
Sbjct: 95  KELYRVRVENPDE------VLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFP 147

Query: 124 LAKATTMNDLKSCKGTPFWMAPEVVNS-KNDGYGLTADIWSLGCTVLE 170
            +        +             + +  +  Y    DI S    +L+
Sbjct: 148 QSVEVGEEGWREI----LERDVRNIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	247
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.84
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.49
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.14
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.64
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.42
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.75
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.67

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-59  Score=361.25  Aligned_cols=231  Identities=29%  Similarity=0.527  Sum_probs=205.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++.+...  ......+.+.+|+.++++++||||+++++++.+++..++||||+++|+|.+++.+. .+++..
T Consensus        30 ~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~  107 (263)
T d2j4za1          30 SKFILALKVLFKAQL--EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR  107 (263)
T ss_dssp             TCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHH
T ss_pred             CCcEEEEEEEchHHc--cChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCCHHH
Confidence            578999999975432  12234567889999999999999999999999999999999999999999998764 599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcch
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTA  159 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~  159 (247)
                      +..++.|++.||+|||++||+||||||+||+++.++.++|+|||++............||+.|+|||.+.+..  ++.++
T Consensus       108 ~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~--~~~~~  185 (263)
T d2j4za1         108 TATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM--HDEKV  185 (263)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCEETTEEGGGCCHHHHTTCC--CCTTH
T ss_pred             HHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCcccccCCCCcccCHHHHcCCC--CCchh
Confidence            9999999999999999999999999999999999999999999999876666666677999999999997654  78999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       160 Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      |||||||++|+|++|+.||...+.......+.... ..++..+|++++++|.+||++||.+|||++|+++||||++.
T Consensus       186 DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         186 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             HHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             hhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence            99999999999999999999888777777766654 35677899999999999999999999999999999999753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-58  Score=358.56  Aligned_cols=235  Identities=25%  Similarity=0.420  Sum_probs=195.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++.....    .+..+.+.+|+.++++++||||+++++++.+++..++||||+++|+|.+++.+. .+++..
T Consensus        29 ~~~~vAiK~i~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~  104 (271)
T d1nvra_          29 TEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD  104 (271)
T ss_dssp             TCCEEEEEEEECC-----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHH
T ss_pred             CCCEEEEEEEehhhc----chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCCCCHHH
Confidence            588999999976432    223456889999999999999999999999999999999999999999988654 599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc----ccccCCCCCCccCCcccccCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++......    ......||+.|+|||.+.+... +
T Consensus       105 ~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-~  183 (271)
T d1nvra_         105 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF-H  183 (271)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSB-C
T ss_pred             HHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCC-C
Confidence            9999999999999999999999999999999999999999999999754322    2345569999999999975442 3


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhh-c-CCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccC
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIG-K-GELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFV  233 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~  233 (247)
                      +.++||||+|+++|+|++|..||............. . .........+|++++++|.+||+.||.+|||++|+++||||
T Consensus       184 ~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf  263 (271)
T d1nvra_         184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY  263 (271)
T ss_dssp             HHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred             CCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence            678999999999999999999997655433322222 2 22223335789999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 041080          234 KRPLQTP  240 (247)
Q Consensus       234 ~~~~~~~  240 (247)
                      +++++.+
T Consensus       264 ~~~l~kg  270 (271)
T d1nvra_         264 NKPLKKG  270 (271)
T ss_dssp             TCCCCCC
T ss_pred             CcCCCCC
Confidence            9987654

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-58  Score=358.50  Aligned_cols=229  Identities=36%  Similarity=0.631  Sum_probs=200.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhcCCCHHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKYHLSDSQV   80 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   80 (247)
                      +|+.||||++.....     ...+.+.+|+.++++++||||+++++++.+++.+++||||++||+|.+++.+.++++..+
T Consensus        44 ~~~~vAvK~~~~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~l~~~~~  118 (293)
T d1yhwa1          44 TGQEVAIRQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI  118 (293)
T ss_dssp             TCCEEEEEEEEGGGC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSCCCHHHH
T ss_pred             CCCEEEEEEEecccC-----hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhccCCCHHHH
Confidence            589999999976432     124568899999999999999999999999999999999999999999999889999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCCcc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      +.++.|++.||.|||++||+||||||+||+++.+|.++|+|||++......  ......|++.|+|||.+.+..  ++.+
T Consensus       119 ~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~  196 (293)
T d1yhwa1         119 AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPK  196 (293)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSC--BCTH
T ss_pred             HHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCC--CCch
Confidence            999999999999999999999999999999999999999999999765432  344556999999999997654  7899


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCC--CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGEL--PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      +||||+||++|+|++|..||...........+.....  ...+..+|++++++|.+||++||.+|||++|+++||||+..
T Consensus       197 ~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             hceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            9999999999999999999988776666555444332  23456789999999999999999999999999999999753

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-57  Score=349.49  Aligned_cols=228  Identities=32%  Similarity=0.569  Sum_probs=192.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec--CCcEEEEEeccccCcHHHHHHh-----c
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD--ENRLYIFLELVTKGSLANLYQK-----Y   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~-----~   73 (247)
                      +|+.||||++.....   .+...+.+.+|+.++++++||||+++++++.+  ++.+++||||+++|+|.+++.+     .
T Consensus        28 ~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~  104 (269)
T d2java1          28 DGKILVWKELDYGSM---TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ  104 (269)
T ss_dssp             TCCEEEEEEECCTTS---CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTC
T ss_pred             CCCEEEEEEEChhhC---CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCC
Confidence            588999999976543   34456778999999999999999999998854  5678999999999999998854     2


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCC-----eeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCc
Q 041080           74 HLSDSQVSSYTRQILNGLVYLHERN-----VVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPE  146 (247)
Q Consensus        74 ~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE  146 (247)
                      .+++..++.++.|++.||.|||+.|     |+||||||+||+++.++.++|+|||++.......  .....|++.|+|||
T Consensus       105 ~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE  184 (269)
T d2java1         105 YLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE  184 (269)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHH
Confidence            4999999999999999999999876     9999999999999999999999999987654332  34466899999999


Q ss_pred             ccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhh
Q 041080          147 VVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTE  226 (247)
Q Consensus       147 ~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  226 (247)
                      .+.+..  ++.++||||||+++|+|++|..||...+..+....+..+..+..+..+|++++++|.+||+.||.+|||++|
T Consensus       185 ~l~~~~--~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~e  262 (269)
T d2java1         185 QMNRMS--YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEE  262 (269)
T ss_dssp             HHTTCC--CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHcCCC--CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHH
Confidence            996544  899999999999999999999999998888888888888877888899999999999999999999999999


Q ss_pred             hhcCccC
Q 041080          227 LMEHPFV  233 (247)
Q Consensus       227 il~~p~~  233 (247)
                      +++|||.
T Consensus       263 ll~hp~i  269 (269)
T d2java1         263 ILENPLI  269 (269)
T ss_dssp             HHTSTTC
T ss_pred             HHhCCcC
Confidence            9999995

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-56  Score=345.52  Aligned_cols=228  Identities=29%  Similarity=0.525  Sum_probs=194.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec----CCcEEEEEeccccCcHHHHHHhc-CC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD----ENRLYIFLELVTKGSLANLYQKY-HL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~-~~   75 (247)
                      +|+.||+|.+....   ......+.+.+|++++++++||||+++++++.+    ...+++||||+++|+|.+++++. .+
T Consensus        33 ~~~~va~K~i~~~~---~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~  109 (270)
T d1t4ha_          33 TTVEVAWCELQDRK---LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM  109 (270)
T ss_dssp             TCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSC
T ss_pred             CCeEEEEEEEchhh---CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccc
Confidence            47899999997653   234556789999999999999999999998764    35689999999999999998765 59


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCC--eeecCCCCCcEEEc-CCCCeEEcccccccccCccccccCCCCCCccCCcccccCC
Q 041080           76 SDSQVSSYTRQILNGLVYLHERN--VVHRDIKCANILVD-ASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKN  152 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~~~ni~~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  152 (247)
                      ++..++.++.|++.||+|||++|  |+||||||+||+++ .++.++|+|||++............||+.|+|||.+.+  
T Consensus       110 ~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~--  187 (270)
T d1t4ha_         110 KIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE--  187 (270)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT--
T ss_pred             cHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCccCCcccCccccCHHHhCC--
Confidence            99999999999999999999998  99999999999997 47899999999998766666667789999999999864  


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCChhhH-HHHHhhcCCC-CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          153 DGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQ-ALFRIGKGEL-PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       153 ~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                       .++.++||||+||++|+|++|+.||....... ....+..+.. +.++...+++++++|.+||++||.+|||++|+++|
T Consensus       188 -~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             -CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence             27899999999999999999999997655443 3344444332 23456789999999999999999999999999999


Q ss_pred             ccCC
Q 041080          231 PFVK  234 (247)
Q Consensus       231 p~~~  234 (247)
                      |||+
T Consensus       267 p~fk  270 (270)
T d1t4ha_         267 AFFQ  270 (270)
T ss_dssp             GGGC
T ss_pred             cccC
Confidence            9996

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-57  Score=351.98  Aligned_cols=231  Identities=36%  Similarity=0.643  Sum_probs=200.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~   78 (247)
                      +|+.||||++....     ....+.+.+|+.++++++||||+++++++.+++..++||||+++|+|.+++.+  ..+++.
T Consensus        36 ~~~~vAvK~i~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~  110 (288)
T d2jfla1          36 TSVLAAAKVIDTKS-----EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTES  110 (288)
T ss_dssp             TCCEEEEEEEECSS-----SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHH
T ss_pred             CCeEEEEEEECcCC-----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHH
Confidence            47899999997542     22345688999999999999999999999999999999999999999998754  349999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccC---CC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSK---ND  153 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~---~~  153 (247)
                      .+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......  ......|++.|+|||.+...   ..
T Consensus       111 ~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~  190 (288)
T d2jfla1         111 QIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR  190 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTS
T ss_pred             HHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCC
Confidence            99999999999999999999999999999999999999999999998654332  23456799999999998532   23


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCC--CCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCc
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPS--VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHP  231 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p  231 (247)
                      .++.++||||+||++|+|++|..||......+....+.....+.  .+..+|++++++|.+||++||.+|||++|+++||
T Consensus       191 ~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp  270 (288)
T d2jfla1         191 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHP  270 (288)
T ss_dssp             STTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred             CCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence            37889999999999999999999999888877777766655433  3467899999999999999999999999999999


Q ss_pred             cCCCC
Q 041080          232 FVKRP  236 (247)
Q Consensus       232 ~~~~~  236 (247)
                      ||+..
T Consensus       271 ~~~~~  275 (288)
T d2jfla1         271 FVTVD  275 (288)
T ss_dssp             GGCCC
T ss_pred             ccCCC
Confidence            99864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=350.79  Aligned_cols=231  Identities=26%  Similarity=0.459  Sum_probs=200.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++.+...  ......+.+.+|+.++++++||||+++++++.+++.+++||||+++|+|.+++... .+++..
T Consensus        32 ~~~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~  109 (288)
T d1uu3a_          32 TSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC  109 (288)
T ss_dssp             TCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHH
T ss_pred             CCCEEEEEEEehHHc--cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHH
Confidence            588999999976432  12233567889999999999999999999999999999999999999999988764 599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc----ccccCCCCCCccCCcccccCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++......    ......||+.|+|||.+.+..  +
T Consensus       110 ~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~  187 (288)
T d1uu3a_         110 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS--A  187 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCC--C
T ss_pred             HHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCC--C
Confidence            9999999999999999999999999999999999999999999999765432    233456999999999997654  7


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhh------hhc
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTE------LME  229 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~------il~  229 (247)
                      +.++||||+||++|+|++|..||...+.......+..... .++..+++++++||.+||+.||.+|||++|      +++
T Consensus       188 ~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~  266 (288)
T d1uu3a_         188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA  266 (288)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHT
T ss_pred             CcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC-CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHc
Confidence            9999999999999999999999998888777777766543 567789999999999999999999999998      578


Q ss_pred             CccCCCC
Q 041080          230 HPFVKRP  236 (247)
Q Consensus       230 ~p~~~~~  236 (247)
                      ||||+.+
T Consensus       267 Hpff~~i  273 (288)
T d1uu3a_         267 HPFFESV  273 (288)
T ss_dssp             SGGGTTC
T ss_pred             CCccCCC
Confidence            9999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.5e-56  Score=351.22  Aligned_cols=233  Identities=34%  Similarity=0.598  Sum_probs=202.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-cCCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-YHLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~   79 (247)
                      +|+.||||++.....  ......+.+.+|+.++++++||||+++++++.+++..++||||+.+|+|..++.. .++++..
T Consensus        39 ~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~  116 (309)
T d1u5ra_          39 NSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE  116 (309)
T ss_dssp             TTEEEEEEEEECCSS--CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHH
T ss_pred             CCcEEEEEEEchhhc--cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHH
Confidence            578999999976542  3345567899999999999999999999999999999999999999999776654 4699999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccC-CCCCCcc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSK-NDGYGLT  158 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~  158 (247)
                      ++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....  .....||+.|+|||.+.+. ...++.+
T Consensus       117 ~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--~~~~~GT~~Y~APE~~~~~~~~~y~~~  194 (309)
T d1u5ra_         117 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGK  194 (309)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--BCCCCSCGGGCCHHHHTTTTSCCBCTH
T ss_pred             HHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--CCccccCccccCHHHHhccCCCCcCch
Confidence            999999999999999999999999999999999999999999999976543  3445699999999998653 3347899


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCC-CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV-PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      +|||||||++|+|++|..||...........+.....+.. +..+|+++++||.+||+.||.+|||++++++||||+...
T Consensus       195 ~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         195 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             hhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence            9999999999999999999988877777666665554443 457899999999999999999999999999999998643

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-55  Score=348.40  Aligned_cols=230  Identities=27%  Similarity=0.462  Sum_probs=184.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++......    ...+.+.+|+.++++++||||+++++++.+++.+++||||++||+|.+++.+. .+++..
T Consensus        33 ~~~~vAvK~i~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~  108 (307)
T d1a06a_          33 TQKLVAIKCIAKKALE----GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERD  108 (307)
T ss_dssp             TCCEEEEEEEEC--------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCCHHH
T ss_pred             CCCEEEEEEEchHHhh----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccCCCHHH
Confidence            4889999999765422    22356789999999999999999999999999999999999999999998765 599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEc---CCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVD---ASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~---~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      +..++.|++.||.|||++||+||||||+||++.   .++.++|+|||++....... .....||+.|+|||.+.+..  +
T Consensus       109 ~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~--~  186 (307)
T d1a06a_         109 ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP--Y  186 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCC--C
T ss_pred             HHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCC--C
Confidence            999999999999999999999999999999995   47889999999997655433 34566999999999997654  8


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCC---CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP---SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      +.++||||+||++|+|++|..||...........+......   ..+..+|++++++|.+||+.||.+|||++|+++|||
T Consensus       187 ~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~  266 (307)
T d1a06a_         187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW  266 (307)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred             CcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence            99999999999999999999999988877777776665432   334678999999999999999999999999999999


Q ss_pred             CCCC
Q 041080          233 VKRP  236 (247)
Q Consensus       233 ~~~~  236 (247)
                      |+..
T Consensus       267 ~~~~  270 (307)
T d1a06a_         267 IAGD  270 (307)
T ss_dssp             TTSS
T ss_pred             hCCC
Confidence            9853

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-56  Score=353.24  Aligned_cols=229  Identities=30%  Similarity=0.522  Sum_probs=192.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||+|++....    .....+.+.+|+.++++++||||+++++++.+++.+++||||+++|+|.+++.+. .+++..
T Consensus        30 ~~~~vAiK~i~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~  105 (322)
T d1s9ja_          30 SGLVMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI  105 (322)
T ss_dssp             TTEEEEEEEEECCC----CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHH
T ss_pred             CCcEEEEEEEChhh----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHH
Confidence            48899999997642    2334567889999999999999999999999999999999999999999998654 599999


Q ss_pred             HHHHHHHHHHHHHHhhh-CCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcc
Q 041080           80 VSSYTRQILNGLVYLHE-RNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~-~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      ++.++.|++.||.|||+ +||+||||||+||+++.+|.++|+|||++............||+.|+|||.+.+..  ++.+
T Consensus       106 ~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~--y~~~  183 (322)
T d1s9ja_         106 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--YSVQ  183 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---CCSSCCCCHHHHHCSC--CCTT
T ss_pred             HHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCccccccCCccccCchHHcCCC--CCcH
Confidence            99999999999999997 59999999999999999999999999999866655566778999999999997655  8999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHH------------------------------------------HHhhcCCCC
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQAL------------------------------------------FRIGKGELP  196 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~------------------------------------------~~~~~~~~~  196 (247)
                      +||||+||++|+|++|+.||...+.....                                          ........+
T Consensus       184 ~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (322)
T d1s9ja_         184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPP  263 (322)
T ss_dssp             HHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCC
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCc
Confidence            99999999999999999999654432211                                          111111122


Q ss_pred             CCC-CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          197 SVP-SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       197 ~~~-~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                      ..+ ..++.+++++|.+||..||.+|||++|+++||||+.
T Consensus       264 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         264 KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             CCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             cCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence            222 246899999999999999999999999999999985

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-55  Score=348.22  Aligned_cols=231  Identities=28%  Similarity=0.466  Sum_probs=203.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++.+....  .....+.+.+|+.++++++||||+++++++++.+.+++||||++||+|.+++.+. .+++..
T Consensus        29 ~~~~~AiK~i~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~  106 (337)
T d1o6la_          29 TGRYYAMKILRKEVII--AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER  106 (337)
T ss_dssp             TCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHH
T ss_pred             CCCEEEEEEEchhhcc--CHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccCCcHHH
Confidence            5899999999764321  1223567889999999999999999999999999999999999999999988765 599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      ++.++.|++.||.|||++||+||||||+||+++.+|.++|+|||++......  ......||+.|+|||.+.+..  ++.
T Consensus       107 ~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~--y~~  184 (337)
T d1o6la_         107 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND--YGR  184 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSC--BCT
T ss_pred             HHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCC--CCh
Confidence            9999999999999999999999999999999999999999999999754432  334566999999999997655  799


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC-----hhhhhcCcc
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT-----VTELMEHPF  232 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~p~  232 (247)
                      ++|+||+||++|+|++|+.||...+.......+.... ..+|..+|+++++||.+||++||.+|++     ++++++|||
T Consensus       185 ~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~  263 (337)
T d1o6la_         185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF  263 (337)
T ss_dssp             THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred             hhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcc
Confidence            9999999999999999999999988888777777665 4678889999999999999999999995     899999999


Q ss_pred             CCCC
Q 041080          233 VKRP  236 (247)
Q Consensus       233 ~~~~  236 (247)
                      |+..
T Consensus       264 f~~i  267 (337)
T d1o6la_         264 FLSI  267 (337)
T ss_dssp             GTTC
T ss_pred             cccC
Confidence            9763

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.4e-55  Score=345.62  Aligned_cols=230  Identities=27%  Similarity=0.486  Sum_probs=202.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++.....  ......+.+.+|+.++++++||||+++++++.+++.+++||||+.||+|..++... .+++..
T Consensus        28 ~g~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~  105 (316)
T d1fota_          28 NGRYYAMKVLKKEIV--VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV  105 (316)
T ss_dssp             TCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHH
T ss_pred             CCCEEEEEEEchHHc--cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccccccccH
Confidence            588999999975432  12233567889999999999999999999999999999999999999999988765 488999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcch
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTA  159 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~  159 (247)
                      ++.++.|++.||+|||++||+||||||+||+++.+|.++|+|||++...... .....|++.|+|||.+.+..  ++.++
T Consensus       106 ~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-~~~~~Gt~~Y~APE~l~~~~--y~~~~  182 (316)
T d1fota_         106 AKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-TYTLCGTPDYIAPEVVSTKP--YNKSI  182 (316)
T ss_dssp             HHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-BCCCCSCTTTCCHHHHTTCC--BCTTH
T ss_pred             HHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-cccccCcccccCHHHHcCCC--CCchh
Confidence            9999999999999999999999999999999999999999999999765533 34567999999999996654  78999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----ChhhhhcCccCC
Q 041080          160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTELMEHPFVK  234 (247)
Q Consensus       160 Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~p~~~  234 (247)
                      ||||+||++|+|++|..||...+.......+..... ..+..+|+++++++.+||.+||.+|+     |++++++||||+
T Consensus       183 DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~  261 (316)
T d1fota_         183 DWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK  261 (316)
T ss_dssp             HHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred             hccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccc
Confidence            999999999999999999999888888777766643 56778999999999999999999996     999999999998


Q ss_pred             CC
Q 041080          235 RP  236 (247)
Q Consensus       235 ~~  236 (247)
                      .+
T Consensus       262 ~i  263 (316)
T d1fota_         262 EV  263 (316)
T ss_dssp             SC
T ss_pred             cC
Confidence            74

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.3e-54  Score=337.35  Aligned_cols=236  Identities=28%  Similarity=0.490  Sum_probs=202.6

Q ss_pred             CCceEEEEEEeecCCCccc----hHHHHHHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-C
Q 041080            1 DGFFFAVKEVSLQDQGAQG----KQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-H   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~----~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~   74 (247)
                      +|+.||||++.........    ....+.+.+|+.++++++ ||||+++++++.+++..++||||+++|+|.++++.. +
T Consensus        27 ~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~  106 (277)
T d1phka_          27 TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT  106 (277)
T ss_dssp             TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS
T ss_pred             CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCC
Confidence            5889999999876544333    233556889999999997 999999999999999999999999999999999654 5


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-ccccCCCCCCccCCcccccC--
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSK--  151 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~--  151 (247)
                      +++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||.+...... ......|++.|.|||.+.+.  
T Consensus       107 l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~  186 (277)
T d1phka_         107 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMN  186 (277)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhcccc
Confidence            999999999999999999999999999999999999999999999999999765533 33456689999999998542  


Q ss_pred             --CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCC---CCCCcCCHHHHHHHHHHhcCCCCCCCChhh
Q 041080          152 --NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP---SVPSSLSRDARDFILKCLQVNPNDRPTVTE  226 (247)
Q Consensus       152 --~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  226 (247)
                        ...++.++||||+|+++|+|++|+.||...+.......+..+...   .....+|+++++++.+||+++|.+|||++|
T Consensus       187 ~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~e  266 (277)
T d1phka_         187 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE  266 (277)
T ss_dssp             TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             ccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence              223688999999999999999999999988877777666655432   223479999999999999999999999999


Q ss_pred             hhcCccCCCC
Q 041080          227 LMEHPFVKRP  236 (247)
Q Consensus       227 il~~p~~~~~  236 (247)
                      +++||||++.
T Consensus       267 il~h~~~~~~  276 (277)
T d1phka_         267 ALAHPFFQQY  276 (277)
T ss_dssp             HTTSGGGCTT
T ss_pred             HHcCHHHHHh
Confidence            9999999874

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-55  Score=342.60  Aligned_cols=234  Identities=29%  Similarity=0.503  Sum_probs=202.8

Q ss_pred             CCceEEEEEEeecCCC-ccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQG-AQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||||++.+.... .......+.+.+|+.++++++||||+++++++.+.+.+++||||+++|+|.+++.+. .+++.
T Consensus        34 ~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~  113 (293)
T d1jksa_          34 TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE  113 (293)
T ss_dssp             TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHH
T ss_pred             CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccccchh
Confidence            5889999999876433 233334678999999999999999999999999999999999999999999998765 59999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC----CeEEcccccccccCcc-ccccCCCCCCccCCcccccCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG----SVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~----~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      .++.++.|++.||+|||+.||+||||||+||+++.++    .++++|||++...... ......+++.|+|||.+.+.. 
T Consensus       114 ~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~-  192 (293)
T d1jksa_         114 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP-  192 (293)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCC-
T ss_pred             HHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCC-
Confidence            9999999999999999999999999999999998776    4999999998765433 344566899999999996544 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCC---CCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPS---VPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                       ++.++||||+|+++|+|++|..||...+..+....+.......   .+..+|++++++|.+||+.||.+|||++|+++|
T Consensus       193 -~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         193 -LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             -BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -CCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             7899999999999999999999999888887777766654322   235789999999999999999999999999999


Q ss_pred             ccCCCC
Q 041080          231 PFVKRP  236 (247)
Q Consensus       231 p~~~~~  236 (247)
                      |||+..
T Consensus       272 p~~~~~  277 (293)
T d1jksa_         272 PWIKPK  277 (293)
T ss_dssp             TTTCC-
T ss_pred             cccCCC
Confidence            999864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.4e-54  Score=347.37  Aligned_cols=230  Identities=30%  Similarity=0.460  Sum_probs=199.4

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~   78 (247)
                      +|+.||||++...     .....+.+.+|+.++++++||||+++++++.+++.+++||||++||+|.+++.+  ..+++.
T Consensus        50 ~g~~vAvK~i~~~-----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~  124 (350)
T d1koaa2          50 TGNNFAAKFVMTP-----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED  124 (350)
T ss_dssp             TTEEEEEEEECCC-----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHH
T ss_pred             CCCEEEEEEEccc-----chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHH
Confidence            5889999999643     234456788999999999999999999999999999999999999999998843  359999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC--CCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA--SGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~--~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .+..++.||+.||.|||++|++||||||+||+++.  ++.++|+|||++....... .....||+.|+|||.+.+..  +
T Consensus       125 ~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~--~  202 (350)
T d1koaa2         125 EAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP--V  202 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCC--B
T ss_pred             HHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCCC--C
Confidence            99999999999999999999999999999999964  5789999999987655433 33466899999999997654  7


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCC---CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP---SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      +.++|||||||++|+|++|..||...+..+....+......   .....+|+++++||.+||..||.+|||++|+++|||
T Consensus       203 ~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~  282 (350)
T d1koaa2         203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW  282 (350)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTT
T ss_pred             ChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence            89999999999999999999999988877777776655432   223568999999999999999999999999999999


Q ss_pred             CCCCC
Q 041080          233 VKRPL  237 (247)
Q Consensus       233 ~~~~~  237 (247)
                      |+...
T Consensus       283 ~~~~~  287 (350)
T d1koaa2         283 LTPGN  287 (350)
T ss_dssp             TSCTT
T ss_pred             cCCCC
Confidence            98753

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.1e-54  Score=348.35  Aligned_cols=229  Identities=29%  Similarity=0.499  Sum_probs=200.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.||||++....     ....+.+.+|+.++++++||||+++++++.+++.+++||||++||+|.+.+.+.  ++++.
T Consensus        53 ~~~~vAiK~i~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~  127 (352)
T d1koba_          53 TGRVFVAKFINTPY-----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEA  127 (352)
T ss_dssp             TCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHH
T ss_pred             CCCEEEEEEECCcc-----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHH
Confidence            58899999997532     334567889999999999999999999999999999999999999998877543  48999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEc--CCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVD--ASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~--~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .++.++.||+.||.|||++||+||||||+||+++  .++.++|+|||++....... .....+++.|+|||.+.+..  +
T Consensus       128 ~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~  205 (352)
T d1koba_         128 EVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP--V  205 (352)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCC--B
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCC--C
Confidence            9999999999999999999999999999999998  56899999999997665443 33456899999999996554  8


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCC---CCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP---SVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      +.++|||||||++|+|++|..||...+.......+......   .....+|+++++||.+||+.||.+|||++|+++|||
T Consensus       206 ~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~  285 (352)
T d1koba_         206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW  285 (352)
T ss_dssp             CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred             CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence            99999999999999999999999998888877776665432   234678999999999999999999999999999999


Q ss_pred             CCCC
Q 041080          233 VKRP  236 (247)
Q Consensus       233 ~~~~  236 (247)
                      |+..
T Consensus       286 ~~~~  289 (352)
T d1koba_         286 LKGD  289 (352)
T ss_dssp             TSSC
T ss_pred             hCCC
Confidence            9864

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=341.33  Aligned_cols=241  Identities=28%  Similarity=0.450  Sum_probs=192.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++.............+.+.+|+.++++++||||+++++++..++..++||||+.++++..+.... .+++..
T Consensus        22 ~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~  101 (299)
T d1ua2a_          22 TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSH  101 (299)
T ss_dssp             CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSH
T ss_pred             CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHH
Confidence            4889999999765543333444567889999999999999999999999999999999999998777666543 499999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      +..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+......  ......+++.|+|||.+..... ++.
T Consensus       102 ~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~  180 (299)
T d1ua2a_         102 IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM-YGV  180 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSC-CCH
T ss_pred             HHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccceecChhhccHHHHccCCC-CCh
Confidence            9999999999999999999999999999999999999999999999755433  2334568999999999864432 789


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC----------------------CCCC-----CCCcCCHHHHHHH
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG----------------------ELPS-----VPSSLSRDARDFI  210 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~----------------------~~~~-----~~~~~~~~~~~li  210 (247)
                      ++||||+||++|+|++|..||......+....+...                      ..+.     .....++++.+||
T Consensus       181 ~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll  260 (299)
T d1ua2a_         181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLI  260 (299)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHH
T ss_pred             hhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHH
Confidence            999999999999999999999887776665443211                      0000     0135688999999


Q ss_pred             HHHhcCCCCCCCChhhhhcCccCCC-CCCCCCC
Q 041080          211 LKCLQVNPNDRPTVTELMEHPFVKR-PLQTPRC  242 (247)
Q Consensus       211 ~~~l~~~p~~Rps~~~il~~p~~~~-~~~~~~~  242 (247)
                      .+||+.||.+|||++|+|+||||+. +...+.|
T Consensus       261 ~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~  293 (299)
T d1ua2a_         261 QGLFLFNPCARITATQALKMKYFSNRPGPTPGC  293 (299)
T ss_dssp             HHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSS
T ss_pred             HHHccCChhhCcCHHHHhCCHhhCCCCCCCCCC
Confidence            9999999999999999999999986 4445555

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.4e-54  Score=345.91  Aligned_cols=235  Identities=29%  Similarity=0.404  Sum_probs=197.0

Q ss_pred             CCceEEEEEEeecCCC-ccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQG-AQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||||++.+.... ...........+++.+++.++||||+++++++.+.+.+++||||++||+|.+++.+. .+++.
T Consensus        28 t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~  107 (364)
T d1omwa3          28 TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA  107 (364)
T ss_dssp             TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHH
T ss_pred             CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHH
Confidence            5899999999764321 122222333345678888889999999999999999999999999999999998665 58999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcc
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLT  158 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  158 (247)
                      .++.++.||+.||.|||++|++||||||+||+++.+|.++|+|||++............||+.|+|||.+.... .++.+
T Consensus       108 ~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~~~~-~~~~~  186 (364)
T d1omwa3         108 DMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGV-AYDSS  186 (364)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHSTTC-CCCTH
T ss_pred             HHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCcccccccccccchhHHhhcCC-CCCcc
Confidence            99999999999999999999999999999999999999999999999877766666778999999999986432 37899


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCChhhHHH--HHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC-----hhhhhcCc
Q 041080          159 ADIWSLGCTVLEMLTRRPPYSHLEGVQAL--FRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT-----VTELMEHP  231 (247)
Q Consensus       159 ~Di~slG~ll~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~p  231 (247)
                      +|||||||++|+|++|..||.........  ...........+..+|++++++|.+||..||.+|||     ++++++||
T Consensus       187 ~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp  266 (364)
T d1omwa3         187 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP  266 (364)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSG
T ss_pred             cchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCc
Confidence            99999999999999999999765543332  223333445667789999999999999999999999     79999999


Q ss_pred             cCCCC
Q 041080          232 FVKRP  236 (247)
Q Consensus       232 ~~~~~  236 (247)
                      ||+..
T Consensus       267 ~f~~i  271 (364)
T d1omwa3         267 FFRSL  271 (364)
T ss_dssp             GGTTC
T ss_pred             cccCC
Confidence            99864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.7e-54  Score=343.30  Aligned_cols=230  Identities=28%  Similarity=0.448  Sum_probs=202.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++.+...  ......+.+.+|+.++++++||||+++++++.+.+..++||||+.+|+|..++.+. .+++..
T Consensus        65 ~g~~~AvK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~  142 (350)
T d1rdqe_          65 SGNHYAMKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH  142 (350)
T ss_dssp             TCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHH
T ss_pred             CCCEEEEEEEchHHc--cCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCCCCHHH
Confidence            589999999975432  12233567889999999999999999999999999999999999999999888664 699999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCCcch
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYGLTA  159 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~  159 (247)
                      ++.++.||+.||.|||++||+||||||+||+++.+|.++|+|||++...... .....|++.|+|||.+.+..  ++.++
T Consensus       143 ~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-~~~~~Gt~~Y~APE~~~~~~--~~~~~  219 (350)
T d1rdqe_         143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-TWTLCGTPEALAPEIILSKG--YNKAV  219 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-BCCCEECGGGCCHHHHTTCC--BCTHH
T ss_pred             HHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-cccccCccccCCHHHHcCCC--CCccc
Confidence            9999999999999999999999999999999999999999999999765533 33456899999999997654  78999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----ChhhhhcCccCC
Q 041080          160 DIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTELMEHPFVK  234 (247)
Q Consensus       160 Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~p~~~  234 (247)
                      |||||||++|+|++|..||...+.......+..... ..+..+++++.++|.+||..||.+|+     |++++++||||+
T Consensus       220 DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~  298 (350)
T d1rdqe_         220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA  298 (350)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred             cccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCcccc
Confidence            999999999999999999998888777777766543 56778999999999999999999994     999999999998


Q ss_pred             CC
Q 041080          235 RP  236 (247)
Q Consensus       235 ~~  236 (247)
                      .+
T Consensus       299 ~~  300 (350)
T d1rdqe_         299 TT  300 (350)
T ss_dssp             TC
T ss_pred             CC
Confidence            64

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-53  Score=335.02  Aligned_cols=231  Identities=27%  Similarity=0.494  Sum_probs=198.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHh-hcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLS-QFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||||++.+....  .....+.+..|..++. .++||||+++++++.+++..++||||+++|+|.++++.. .+++.
T Consensus        26 t~~~vAvK~i~k~~~~--~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~  103 (320)
T d1xjda_          26 TNQFFAIKALKKDVVL--MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS  103 (320)
T ss_dssp             TTEEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHH
T ss_pred             CCCEEEEEEEchhhcc--ChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHH
Confidence            5889999999764321  1223445566666665 689999999999999999999999999999999999765 59999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .++.++.|++.||.|||++|++||||||+||+++.++.++|+|||.+......  ......|++.|+|||.+.+..  ++
T Consensus       104 ~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  181 (320)
T d1xjda_         104 RATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK--YN  181 (320)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC--BC
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCC--CC
Confidence            99999999999999999999999999999999999999999999998754432  233456899999999997654  88


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChh-hhhcCccCCC
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT-ELMEHPFVKR  235 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~il~~p~~~~  235 (247)
                      .++||||+||++|+|++|+.||...+.......+.... +.++..+|+++++||.+||+.||.+|||++ ++++||||+.
T Consensus       182 ~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         182 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence            99999999999999999999999888877777776554 467788999999999999999999999996 8999999986


Q ss_pred             C
Q 041080          236 P  236 (247)
Q Consensus       236 ~  236 (247)
                      .
T Consensus       261 ~  261 (320)
T d1xjda_         261 I  261 (320)
T ss_dssp             C
T ss_pred             C
Confidence            3

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=331.90  Aligned_cols=227  Identities=26%  Similarity=0.451  Sum_probs=193.5

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQV   80 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~   80 (247)
                      ++.||||++....   ......+.+.+|+.++++++||||+++++++..+ ..++||||+++|+|.+++.+. .+++..+
T Consensus        34 ~~~vAvK~~~~~~---~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~l~~~~~  109 (277)
T d1xbba_          34 VKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNI  109 (277)
T ss_dssp             EEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHCTTCCHHHH
T ss_pred             CeEEEEEEEChhh---CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhhccCCCHHHH
Confidence            4679999996542   2234466799999999999999999999998654 678999999999999998775 4999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-----cccCCCCCCccCCcccccCCCCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      +.++.|++.||+|||++||+||||||+||+++.++.++|+|||++.......     .....|++.|+|||.+.+..  +
T Consensus       110 ~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~  187 (277)
T d1xbba_         110 IELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--F  187 (277)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE--E
T ss_pred             HHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCC--C
Confidence            9999999999999999999999999999999999999999999987543222     22345788999999996654  7


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhh---hcCc
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL---MEHP  231 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i---l~~p  231 (247)
                      +.++||||||+++|++++ |..||...+..+....+..+..+..+..+|+++++++.+||+.||.+|||++++   |+++
T Consensus       188 ~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            899999999999999997 899999988888888888877788889999999999999999999999999998   4666


Q ss_pred             cCC
Q 041080          232 FVK  234 (247)
Q Consensus       232 ~~~  234 (247)
                      |++
T Consensus       268 ~~~  270 (277)
T d1xbba_         268 YYD  270 (277)
T ss_dssp             HHH
T ss_pred             Hhh
Confidence            654

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-53  Score=331.14  Aligned_cols=226  Identities=26%  Similarity=0.450  Sum_probs=197.1

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQ   79 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~   79 (247)
                      +..||||++...    ......+.+.+|+.++++++||||+++++++.+ +..++||||+++|+|.+++...  .+++..
T Consensus        36 ~~~vAvK~l~~~----~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~  110 (285)
T d1u59a_          36 QIDVAIKVLKQG----TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSN  110 (285)
T ss_dssp             CEEEEEEEECSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHH
T ss_pred             cEEEEEEEEChh----cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHH
Confidence            457999998643    234556789999999999999999999999865 4689999999999999987543  599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-----cccCCCCCCccCCcccccCCCC
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......     .....+++.|+|||.+.+..  
T Consensus       111 ~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--  188 (285)
T d1u59a_         111 VAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--  188 (285)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE--
T ss_pred             HHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCC--
Confidence            99999999999999999999999999999999999999999999997554332     22344788999999996554  


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhh---hcC
Q 041080          155 YGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTEL---MEH  230 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i---l~~  230 (247)
                      ++.++||||||+++||+++ |..||......+....+..+..+..+..+|+++.+++.+||+.+|.+|||+.++   |++
T Consensus       189 ~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            7999999999999999998 899999888888888888888888889999999999999999999999999988   578


Q ss_pred             ccCC
Q 041080          231 PFVK  234 (247)
Q Consensus       231 p~~~  234 (247)
                      +|+.
T Consensus       269 ~~~~  272 (285)
T d1u59a_         269 CYYS  272 (285)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8874

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-53  Score=335.06  Aligned_cols=229  Identities=24%  Similarity=0.381  Sum_probs=197.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.||||++....      .....+.+|+.+|+.++||||+++++++.+++.+++||||++||+|.+++.+.  .+++.
T Consensus        29 ~~~~~AiK~i~~~~------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~  102 (321)
T d1tkia_          29 SKKTYMAKFVKVKG------TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNER  102 (321)
T ss_dssp             TTEEEEEEEECCCT------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHH
T ss_pred             CCcEEEEEEEcCCc------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHH
Confidence            47899999996532      23346789999999999999999999999999999999999999999999765  48999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC--CCeEEcccccccccCccc-cccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS--GSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~--~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .++.++.||+.||.|||++||+||||||+||+++.+  +.++|+|||.+....... .....+++.|+|||.+.+..  +
T Consensus       103 ~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~--~  180 (321)
T d1tkia_         103 EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV--V  180 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCE--E
T ss_pred             HHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccCCC--C
Confidence            999999999999999999999999999999999854  479999999987654332 33455889999999986554  7


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCC---CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCcc
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSV---PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPF  232 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~  232 (247)
                      +.++||||+||++|+|++|..||......+....+........   ...+|+++++||.+||..||.+|||++|+++|||
T Consensus       181 ~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~  260 (321)
T d1tkia_         181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW  260 (321)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             CchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence            8999999999999999999999999888887777766544221   2468999999999999999999999999999999


Q ss_pred             CCCCC
Q 041080          233 VKRPL  237 (247)
Q Consensus       233 ~~~~~  237 (247)
                      |++..
T Consensus       261 ~~~~~  265 (321)
T d1tkia_         261 LKQKI  265 (321)
T ss_dssp             HHSCG
T ss_pred             hccCc
Confidence            98643

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-53  Score=329.72  Aligned_cols=229  Identities=27%  Similarity=0.425  Sum_probs=191.7

Q ss_pred             CCceEEEEEEeecCCCccc-hHHHHHHHHHHHHHhhcC--CCceeeeceeeecCCcEEEEEecccc-CcHHHHHHh-cCC
Q 041080            1 DGFFFAVKEVSLQDQGAQG-KQSILQLEQEISLLSQFE--QDNIVQYLGTDKDENRLYIFLELVTK-GSLANLYQK-YHL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~-~~~   75 (247)
                      +|+.||||++......... .....++.+|+.++++++  ||||+++++++.+.+..++||||+.+ +++.+++.+ ..+
T Consensus        28 ~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l  107 (273)
T d1xwsa_          28 DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL  107 (273)
T ss_dssp             TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSC
T ss_pred             CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCC
Confidence            5889999999865433211 112234668999999996  89999999999999999999999976 577777755 469


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCC-CCeEEcccccccccCccccccCCCCCCccCCcccccCCCC
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDAS-GSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      ++..++.++.|++.||.|||++||+||||||+||+++.+ +.++|+|||.+............||+.|+|||.+.+... 
T Consensus       108 ~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~-  186 (273)
T d1xwsa_         108 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRY-  186 (273)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCB-
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecccccccccccCCCcCCHHHHcCCCC-
Confidence            999999999999999999999999999999999999854 789999999998766666667789999999999865442 


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCC
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVK  234 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~  234 (247)
                      ++.++||||+||++|+|++|..||...+.      +... ...++..+|++++++|.+||..||.+|||++|+++||||+
T Consensus       187 ~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~  259 (273)
T d1xwsa_         187 HGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ  259 (273)
T ss_dssp             CHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             CCcccccccceeeehhHhhCCCCCCCchH------Hhhc-ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence            46789999999999999999999976431      2222 2356678999999999999999999999999999999999


Q ss_pred             CCC
Q 041080          235 RPL  237 (247)
Q Consensus       235 ~~~  237 (247)
                      ..+
T Consensus       260 ~~~  262 (273)
T d1xwsa_         260 DVL  262 (273)
T ss_dssp             SCC
T ss_pred             CCC
Confidence            864

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=323.22  Aligned_cols=222  Identities=22%  Similarity=0.411  Sum_probs=185.9

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~   78 (247)
                      +|+.||||++.....      ..+.+.+|++++++++||||+++++++.+++..++||||+++|+|.+++...  .+++.
T Consensus        28 ~~~~vAvK~i~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~  101 (263)
T d1sm2a_          28 NKDKVAIKTIREGAM------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE  101 (263)
T ss_dssp             TTEEEEEEECCSSSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHH
T ss_pred             CCCEEEEEEECCCcC------cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHH
Confidence            467899999865322      2346889999999999999999999999999999999999999999988654  48899


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......   .....|+..|+|||.+.+..  +
T Consensus       102 ~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~  179 (263)
T d1sm2a_         102 TLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--Y  179 (263)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTCC--C
T ss_pred             HHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCC--C
Confidence            999999999999999999999999999999999999999999999987554332   22345789999999996554  8


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      +.++||||||+++|+|++ |..|+...........+..+..+..+...++++.+++.+||+.+|.+|||+++++++
T Consensus       180 ~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            999999999999999998 577777777777777777777777788899999999999999999999999999975

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-52  Score=325.61  Aligned_cols=233  Identities=33%  Similarity=0.528  Sum_probs=187.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~   78 (247)
                      +|+.||||++.....   .....+.+.+|++++++++||||+++++++.+++..++||||+.++.+......  .++++.
T Consensus        26 ~~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~  102 (298)
T d1gz8a_          26 TGEVVALKKIRLDTE---TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP  102 (298)
T ss_dssp             TCCEEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHH
T ss_pred             CCCEEEEEEEehhhc---ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchhhhhhhhcccCCCHH
Confidence            588999999965432   233456788999999999999999999999999999999999987544433332  359999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc--ccccCCCCCCccCCcccccCCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      .++.++.|++.||+|||++||+||||||+||+++.++.++|+|||.+......  ......|++.|+|||.+..... ++
T Consensus       103 ~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~-~~  181 (298)
T d1gz8a_         103 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY-YS  181 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSS-CC
T ss_pred             HHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccC-CC
Confidence            99999999999999999999999999999999999999999999998655432  3344568999999999765442 58


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC-----------------CCCC-----------CCCcCCHHHHH
Q 041080          157 LTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG-----------------ELPS-----------VPSSLSRDARD  208 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-----------------~~~~-----------~~~~~~~~~~~  208 (247)
                      .++|+||+|+++|+|++|+.||...+..+....+...                 ....           ....+++++++
T Consensus       182 ~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  261 (298)
T d1gz8a_         182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRS  261 (298)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHH
T ss_pred             ccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHH
Confidence            8999999999999999999999877665554432210                 0000           01256789999


Q ss_pred             HHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          209 FILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       209 li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      |+.+||..||.+|||++|+++||||+...
T Consensus       262 ll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         262 LLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             HHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence            99999999999999999999999999753

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-52  Score=318.48  Aligned_cols=222  Identities=22%  Similarity=0.429  Sum_probs=196.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~   78 (247)
                      +++.||||++.....      ..+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|..++..  ..+++.
T Consensus        27 ~~~~vAvK~l~~~~~------~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~  100 (258)
T d1k2pa_          27 GQYDVAIKMIKEGSM------SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ  100 (258)
T ss_dssp             TTEEEEEEEEESSSS------CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHH
T ss_pred             CCCEEEEEEECcCcC------CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHH
Confidence            467899999976432      234688999999999999999999999999999999999999999988644  358999


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .+++++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......   .....++..|+|||.+.+..  +
T Consensus       101 ~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~  178 (258)
T d1k2pa_         101 QLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK--F  178 (258)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCC--C
T ss_pred             HHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCC--C
Confidence            999999999999999999999999999999999999999999999997544332   22345788899999997654  7


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      +.++||||||+++|+|++ |+.||......+....+..+.....|...++++++++.+||+.+|.+|||++++++|
T Consensus       179 ~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            899999999999999998 899999999888888888877777888999999999999999999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-51  Score=323.85  Aligned_cols=221  Identities=24%  Similarity=0.443  Sum_probs=185.3

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVS   81 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~   81 (247)
                      .||||.+...    ......+.+.+|+.++++++||||+++++++..++..++||||+++|+|.+++...  .+++..+.
T Consensus        56 ~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~  131 (299)
T d1jpaa_          56 FVAIKTLKSG----YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLV  131 (299)
T ss_dssp             EEEEEECCSS----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHH
T ss_pred             EEEEEEECcc----cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHH
Confidence            4788877542    33455678999999999999999999999999999999999999999999988764  48999999


Q ss_pred             HHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc-------ccCCCCCCccCCcccccCCCC
Q 041080           82 SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL-------KSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        82 ~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      .++.|++.||.|||++|++||||||+||+++.++.+||+|||++........       ....+++.|+|||.+.+..  
T Consensus       132 ~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--  209 (299)
T d1jpaa_         132 GMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK--  209 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCC--
T ss_pred             HHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCC--
Confidence            9999999999999999999999999999999999999999999875443221       1234678899999996544  


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          155 YGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      ++.++||||||+++|||++ |..||......+....+..+..+..+..+|+++.+++.+||+.+|.+|||+.++++.
T Consensus       210 ~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         210 FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            8999999999999999998 899999988888888887777777788999999999999999999999999888764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-52  Score=322.56  Aligned_cols=226  Identities=28%  Similarity=0.484  Sum_probs=193.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh---cCCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK---YHLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~   77 (247)
                      +|+.||||++.....      ..+.+.+|+.++++++||||+++++++.+ +..++||||+++|+|.+++..   ..+++
T Consensus        36 ~~~~vAvK~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~  108 (272)
T d1qpca_          36 GHTKVAVKSLKQGSM------SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTI  108 (272)
T ss_dssp             TTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCH
T ss_pred             CCCEEEEEEEccCcC------CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCH
Confidence            367899999964321      23468899999999999999999998755 567899999999999987643   25999


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      ..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......   .....++..|+|||.+.+..  
T Consensus       109 ~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--  186 (272)
T d1qpca_         109 NKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--  186 (272)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCE--
T ss_pred             HHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCC--
Confidence            9999999999999999999999999999999999999999999999997654332   23445788999999986544  


Q ss_pred             CCcchhHHHHHHHHHHHHhC-CCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc--Cc
Q 041080          155 YGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME--HP  231 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--~p  231 (247)
                      ++.++||||||+++|+|++| .+|+...........+..+..+..+..+|+++++++.+||+.+|.+|||++++++  ++
T Consensus       187 ~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence            78999999999999999995 5667777777777777777777788899999999999999999999999999998  78


Q ss_pred             cCCC
Q 041080          232 FVKR  235 (247)
Q Consensus       232 ~~~~  235 (247)
                      ||.+
T Consensus       267 ~fts  270 (272)
T d1qpca_         267 FFTA  270 (272)
T ss_dssp             HHHH
T ss_pred             hhhc
Confidence            8864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7e-52  Score=323.82  Aligned_cols=221  Identities=26%  Similarity=0.445  Sum_probs=190.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~   77 (247)
                      +|+.||||++..+.      ...+.+.+|+.++++++||||+++++++.+++..++||||+++|+|.+++.+.   .+++
T Consensus        41 ~~~~vAvK~i~~~~------~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~  114 (287)
T d1opja_          41 YSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA  114 (287)
T ss_dssp             GTEEEEEEECCTTC------SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCH
T ss_pred             CCeEEEEEEECCcc------chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHH
Confidence            37889999986432      12456889999999999999999999999999999999999999999998764   4899


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc---cCCCCCCccCCcccccCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK---SCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~  154 (247)
                      ..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.........   ...++..|+|||.+.+..  
T Consensus       115 ~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--  192 (287)
T d1opja_         115 VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK--  192 (287)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCC--
T ss_pred             HHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCC--
Confidence            999999999999999999999999999999999999999999999999765443322   233678899999987654  


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCC-CCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPP-YSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      ++.++||||||+++|+|++|..| +...+.......+..+..+..+..+|+++++++.+||+.||.+|||++++++
T Consensus       193 ~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            89999999999999999996555 5555565556666666667788899999999999999999999999999976

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-52  Score=330.62  Aligned_cols=225  Identities=29%  Similarity=0.483  Sum_probs=184.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeec----CCcEEEEEeccccCcHHHHHHhc--
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKD----ENRLYIFLELVTKGSLANLYQKY--   73 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~--   73 (247)
                      +|+.||||++...          ..+.+|+.++.++ +||||+++++++.+    +..+++||||++||+|.+++.+.  
T Consensus        36 ~~~~vAiK~i~~~----------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~  105 (335)
T d2ozaa1          36 TQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD  105 (335)
T ss_dssp             TCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSC
T ss_pred             CCCEEEEEEECCc----------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCC
Confidence            5889999998632          2466899887665 79999999999865    46789999999999999999764  


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC---CCCeEEcccccccccCcc-ccccCCCCCCccCCccc
Q 041080           74 -HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA---SGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVV  148 (247)
Q Consensus        74 -~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~---~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~  148 (247)
                       .+++..++.++.|++.||+|||++||+||||||+||+++.   ++.++|+|||++...... ......|++.|+|||.+
T Consensus       106 ~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~  185 (335)
T d2ozaa1         106 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL  185 (335)
T ss_dssp             CCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCC
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHH
Confidence             4899999999999999999999999999999999999985   457999999998755433 34456699999999999


Q ss_pred             ccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHh----hcCCCCCCC----CcCCHHHHHHHHHHhcCCCCC
Q 041080          149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI----GKGELPSVP----SSLSRDARDFILKCLQVNPND  220 (247)
Q Consensus       149 ~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~  220 (247)
                      .+..  ++.++|||||||++|+|++|+.||...........+    ..... .++    ..+|+++++||.+||+.||.+
T Consensus       186 ~~~~--y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~  262 (335)
T d2ozaa1         186 GPEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPNPEWSEVSEEVKMLIRNLLKTEPTQ  262 (335)
T ss_dssp             CGGG--GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS-SCCTTHHHHSCHHHHHHHHHHSCSSTTT
T ss_pred             cCCC--CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC-CCCCcccccCCHHHHHHHHHHccCChhH
Confidence            7655  889999999999999999999999765544433222    21211 222    358999999999999999999


Q ss_pred             CCChhhhhcCccCCCCCC
Q 041080          221 RPTVTELMEHPFVKRPLQ  238 (247)
Q Consensus       221 Rps~~~il~~p~~~~~~~  238 (247)
                      |||++|+++||||++...
T Consensus       263 R~s~~eil~hp~~~~~~~  280 (335)
T d2ozaa1         263 RMTITEFMNHPWIMQSTK  280 (335)
T ss_dssp             SCCHHHHHHSHHHHTTTS
T ss_pred             CcCHHHHHcCHHhhCCCC
Confidence            999999999999987544

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=320.28  Aligned_cols=224  Identities=25%  Similarity=0.505  Sum_probs=184.1

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHH
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQV   80 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~   80 (247)
                      ..||||++.....   .....+.+.+|+.++++++||||+++++++. .+..++||||+++|+|.+++...  .+++..+
T Consensus        31 ~~vAvK~~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~  106 (276)
T d1uwha_          31 GDVAVKMLNVTAP---TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKL  106 (276)
T ss_dssp             SEEEEEECCCSSC---CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHH
T ss_pred             CEEEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHH
Confidence            4699999976532   2345678999999999999999999999865 45689999999999999999654  4899999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc----ccccCCCCCCccCCcccccCC-CCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DLKSCKGTPFWMAPEVVNSKN-DGY  155 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~-~~~  155 (247)
                      ..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......    ......|++.|+|||.+.+.. ..+
T Consensus       107 ~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~  186 (276)
T d1uwha_         107 IDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY  186 (276)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCC
T ss_pred             HHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCC
Confidence            999999999999999999999999999999999999999999998654432    233456899999999986533 347


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHH-hhcCCC----CCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFR-IGKGEL----PSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      +.++||||||+++|+|++|+.||........... +..+..    ...+..+|+++++++.+||+.+|.+|||+++++++
T Consensus       187 ~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         187 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            8999999999999999999999987665544332 222222    23466789999999999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2e-51  Score=321.91  Aligned_cols=231  Identities=31%  Similarity=0.487  Sum_probs=189.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh-cCCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK-YHLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~   79 (247)
                      +|+.||||++.....   .....+.+.+|+.++++++||||+++++++...+..++++|++.++.+..+... ..+++..
T Consensus        25 ~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~  101 (286)
T d1ob3a_          25 YGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVT  101 (286)
T ss_dssp             TSCEEEEEEECCSSG---GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHH
T ss_pred             CCCEEEEEEEehhhc---ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhh
Confidence            578999999976532   223356788999999999999999999999999999999999988777766654 3599999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      +..++.|++.||+|||+.||+||||||+||+++.++.++++|||.+.......  .....+++.|+|||.+.+.. .++.
T Consensus       102 ~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~  180 (286)
T d1ob3a_         102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK-KYST  180 (286)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCC-SCCT
T ss_pred             hHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCC-CCCc
Confidence            99999999999999999999999999999999999999999999986544332  23445889999999986543 3689


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC----------------------------CCCCCCCcCCHHHHHH
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG----------------------------ELPSVPSSLSRDARDF  209 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~l  209 (247)
                      ++|+||+|+++|+|++|+.||......+....+...                            .........+++++++
T Consensus       181 ~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl  260 (286)
T d1ob3a_         181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDL  260 (286)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHH
T ss_pred             ceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHH
Confidence            999999999999999999999877665554432110                            0012234678999999


Q ss_pred             HHHHhcCCCCCCCChhhhhcCccCCC
Q 041080          210 ILKCLQVNPNDRPTVTELMEHPFVKR  235 (247)
Q Consensus       210 i~~~l~~~p~~Rps~~~il~~p~~~~  235 (247)
                      |++||..||++|||++|+++||||++
T Consensus       261 i~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         261 LSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHccCChhHCcCHHHHhcCcccCc
Confidence            99999999999999999999999985

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-50  Score=318.62  Aligned_cols=230  Identities=32%  Similarity=0.522  Sum_probs=184.5

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc---CCCceeeeceeeec-----CCcEEEEEeccccCcHHHHHHh-
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF---EQDNIVQYLGTDKD-----ENRLYIFLELVTKGSLANLYQK-   72 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~-   72 (247)
                      |+.||||++..........   ..+.+|+.+++.|   +||||+++++++..     ....+++|||+.++++...... 
T Consensus        33 ~~~vAiK~i~~~~~~~~~~---~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~  109 (305)
T d1blxa_          33 GRFVALKRVRVQTGEEGMP---LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP  109 (305)
T ss_dssp             TEEEEEEEEEEEBCTTSCB---CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSC
T ss_pred             CEEEEEEEEehhhccchHH---HHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhcc
Confidence            5679999997754322222   2244666666655   79999999998753     3578999999998766544433 


Q ss_pred             -cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-ccccCCCCCCccCCccccc
Q 041080           73 -YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNS  150 (247)
Q Consensus        73 -~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~  150 (247)
                       ..+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||.+...... ......||+.|+|||.+.+
T Consensus       110 ~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~  189 (305)
T d1blxa_         110 EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ  189 (305)
T ss_dssp             TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcC
Confidence             35899999999999999999999999999999999999999999999999998755433 3445669999999999966


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC--------------------------CCCCCCCcCCH
Q 041080          151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG--------------------------ELPSVPSSLSR  204 (247)
Q Consensus       151 ~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~  204 (247)
                      ..  ++.++||||+||++|+|++|..||...+..+....+...                          ........+++
T Consensus       190 ~~--y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  267 (305)
T d1blxa_         190 SS--YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDE  267 (305)
T ss_dssp             CC--CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCH
T ss_pred             CC--CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCH
Confidence            54  899999999999999999999999887766655443210                          01123456789


Q ss_pred             HHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          205 DARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       205 ~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      .+++||.+||.+||.+|||++|+++||||+..
T Consensus       268 ~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         268 LGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence            99999999999999999999999999999975

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-50  Score=321.90  Aligned_cols=231  Identities=26%  Similarity=0.446  Sum_probs=194.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC------cEEEEEeccccCcHHHHHHhcC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN------RLYIFLELVTKGSLANLYQKYH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~   74 (247)
                      +|+.||||++....   ......+.+.+|+.+|++++||||+++++++...+      .+++||||+ +.+|..+.+..+
T Consensus        42 ~~~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~  117 (346)
T d1cm8a_          42 TGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK  117 (346)
T ss_dssp             TCCEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHCC
T ss_pred             CCCEEEEEEEchhh---cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHhcc
Confidence            58999999997543   34456678899999999999999999999987654      579999999 558999998889


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +++..++.++.|++.||.|||++||+|+||||+||+++.++.++++|||.+...... .....+++.|+|||.+.+.. .
T Consensus       118 l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~-~  195 (346)
T d1cm8a_         118 LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-MTGYVVTRWYRAPEVILNWM-R  195 (346)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-CCSSCSCGGGCCTHHHHTTT-C
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc-cccccccccccCHHHHcCCC-C
Confidence            999999999999999999999999999999999999999999999999999765433 34566899999999986543 2


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc------------------------------CCCCCCCCcCCH
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK------------------------------GELPSVPSSLSR  204 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~  204 (247)
                      ++.++||||+||++|+|++|..||...+..........                              ..........++
T Consensus       196 ~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  275 (346)
T d1cm8a_         196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP  275 (346)
T ss_dssp             CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCH
T ss_pred             CCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCH
Confidence            68899999999999999999999987765544322111                              111223356789


Q ss_pred             HHHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          205 DARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       205 ~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      ++.+||.+||..||.+|||++|+|+||||+...
T Consensus       276 ~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         276 LAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            999999999999999999999999999999754

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=322.80  Aligned_cols=221  Identities=24%  Similarity=0.430  Sum_probs=185.7

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---------
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---------   73 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------   73 (247)
                      .||+|.+....    .......+.+|+.++.++ +||||+++++++.+.+..++||||+++|+|.+++...         
T Consensus        69 ~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~  144 (325)
T d1rjba_          69 QVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI  144 (325)
T ss_dssp             EEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC-----
T ss_pred             EEEEEEecccc----CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhh
Confidence            58899886432    233455688999999998 8999999999999999999999999999999998653         


Q ss_pred             ---------------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcccc----c
Q 041080           74 ---------------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDL----K  134 (247)
Q Consensus        74 ---------------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~  134 (247)
                                     .+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++........    .
T Consensus       145 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~  224 (325)
T d1rjba_         145 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRG  224 (325)
T ss_dssp             ----------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEET
T ss_pred             hhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeec
Confidence                           278899999999999999999999999999999999999999999999999975543332    2


Q ss_pred             cCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHH-hhcCCCCCCCCcCCHHHHHHHHH
Q 041080          135 SCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFR-IGKGELPSVPSSLSRDARDFILK  212 (247)
Q Consensus       135 ~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~  212 (247)
                      ...+++.|+|||.+.+..  ++.++||||||+++|+|++ |..||........... +..+..+..+..+|+++++||.+
T Consensus       225 ~~~gt~~y~aPE~l~~~~--~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~  302 (325)
T d1rjba_         225 NARLPVKWMAPESLFEGI--YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQS  302 (325)
T ss_dssp             TEEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             cccCCCccCChHHHcCCC--CCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence            334688999999986554  8999999999999999997 8999987665554443 34444566778899999999999


Q ss_pred             HhcCCCCCCCChhhhhcC
Q 041080          213 CLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       213 ~l~~~p~~Rps~~~il~~  230 (247)
                      ||+.+|.+|||+++|++|
T Consensus       303 cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         303 CWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HTCSSGGGSCCHHHHHHH
T ss_pred             HcCCChhHCcCHHHHHHH
Confidence            999999999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-50  Score=312.68  Aligned_cols=228  Identities=27%  Similarity=0.452  Sum_probs=189.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHh---cCCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQK---YHLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~   77 (247)
                      +++.||||++.....      ..+.+.+|+.++++++||||+++++++.+ +..++||||+++|+|..++..   ..+++
T Consensus        40 ~~~~vAiK~l~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~  112 (285)
T d1fmka3          40 GTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRL  112 (285)
T ss_dssp             TTEEEEEEECCTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCH
T ss_pred             CCCEEEEEEECcccC------CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchH
Confidence            356899999864432      23568899999999999999999999855 567899999999999888743   35999


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      ..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.......   .....+++.|+|||.+....  
T Consensus       113 ~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--  190 (285)
T d1fmka3         113 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--  190 (285)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCC--
T ss_pred             HHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCC--
Confidence            9999999999999999999999999999999999999999999999987554332   22345789999999996554  


Q ss_pred             CCcchhHHHHHHHHHHHHhC-CCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc--Cc
Q 041080          155 YGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME--HP  231 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--~p  231 (247)
                      ++.++||||||+++|+|++| .+|+......+....+..+.....+..+|+++++++.+||+.+|.+|||++++++  ++
T Consensus       191 ~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  270 (285)
T d1fmka3         191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  270 (285)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence            78999999999999999995 5556666666667777766667788899999999999999999999999999998  89


Q ss_pred             cCCCCC
Q 041080          232 FVKRPL  237 (247)
Q Consensus       232 ~~~~~~  237 (247)
                      ||...-
T Consensus       271 ~~~~~~  276 (285)
T d1fmka3         271 YFTSTE  276 (285)
T ss_dssp             TTSCSC
T ss_pred             hhcCCC
Confidence            998753

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-50  Score=312.29  Aligned_cols=221  Identities=29%  Similarity=0.487  Sum_probs=184.0

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHH
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQV   80 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~   80 (247)
                      ..||||.+...    ......+.+.+|+.++++++||||+++++++. .+..++||||+++|+|.+++...  .+++..+
T Consensus        36 ~~vaik~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~  110 (273)
T d1mp8a_          36 LAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASL  110 (273)
T ss_dssp             EEEEEEECTTT----TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHH
T ss_pred             EEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHH
Confidence            45778877432    34555678999999999999999999999986 46789999999999999987554  4899999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCCCCCCc
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      +.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......   .....+++.|+|||.+.+..  ++.
T Consensus       111 ~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~--~~~  188 (273)
T d1mp8a_         111 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR--FTS  188 (273)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCC--CSH
T ss_pred             HHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCC--CCC
Confidence            9999999999999999999999999999999999999999999987544322   23344788999999997655  889


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          158 TADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      ++||||||+++|+|++ |..||......+....+..+..+..+..+|++++++|.+||+.||.+|||+++++++
T Consensus       189 ~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999997 899999988888888888887778889999999999999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-49  Score=310.12  Aligned_cols=221  Identities=24%  Similarity=0.431  Sum_probs=184.9

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHH
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQV   80 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~   80 (247)
                      ..||||.+...    ........+.+|+.++++++||||+++++++.+.+..++||||+.++++.+.+...  .+++..+
T Consensus        37 ~~vAvK~~~~~----~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~  112 (283)
T d1mqba_          37 VPVAIKTLKAG----YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL  112 (283)
T ss_dssp             EEEEEEEECTT----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHH
T ss_pred             EEEEEEEECcc----cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHH
Confidence            36899998643    23445667899999999999999999999999999999999999999999887654  4899999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-----cccCCCCCCccCCcccccCCCCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ..++.|++.|+.|||+.||+||||||+||+++.++.+||+|||+++......     .....|+..|+|||.+.+..  +
T Consensus       113 ~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~--~  190 (283)
T d1mqba_         113 VGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK--F  190 (283)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCC--C
T ss_pred             HHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCC--C
Confidence            9999999999999999999999999999999999999999999997543322     22344788999999996554  8


Q ss_pred             CcchhHHHHHHHHHHHHhC-CCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          156 GLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +.++||||||+++|+|+++ ..|+...........+..+..+..+..+|+++.+++.+||+.+|.+|||+.++++
T Consensus       191 ~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         191 TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            9999999999999999985 4556666666677777777777788889999999999999999999999999976

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=321.81  Aligned_cols=235  Identities=27%  Similarity=0.416  Sum_probs=194.5

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCC-CceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ-DNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDS   78 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~   78 (247)
                      +|+.||||++........ ....+.+.+|+.++++++| |||+++++++.+....+++|||+.+++|.+++... .+++.
T Consensus        51 ~g~~vAvK~i~~~~~~~~-~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~  129 (322)
T d1vzoa_          51 TGKLYAMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH  129 (322)
T ss_dssp             TTCEEEEEEESEEEEEEE-ESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHH
T ss_pred             CCcEEEEEEEehHHhccc-hHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcccccHH
Confidence            478999999976432211 2234557799999999976 89999999999999999999999999999998765 58899


Q ss_pred             HHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc---cccCCCCCCccCCcccccCCCCC
Q 041080           79 QVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        79 ~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      .+..++.|++.||.|+|+.|++|+||||+||+++.++.++|+|||++.......   .....+++.|++||.+.+....+
T Consensus       130 ~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~  209 (322)
T d1vzoa_         130 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH  209 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---
T ss_pred             HHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCC
Confidence            999999999999999999999999999999999999999999999986543322   23455899999999997666557


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHh---hcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCC-----Chhhh
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI---GKGELPSVPSSLSRDARDFILKCLQVNPNDRP-----TVTEL  227 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~i  227 (247)
                      +.++||||+||++|+|++|..||...........+   .....+..+..+++++.++|.+||.+||.+||     |++|+
T Consensus       210 ~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~ei  289 (322)
T d1vzoa_         210 DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI  289 (322)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHH
T ss_pred             CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHH
Confidence            88999999999999999999999766544433222   22334566778999999999999999999999     48999


Q ss_pred             hcCccCCCC
Q 041080          228 MEHPFVKRP  236 (247)
Q Consensus       228 l~~p~~~~~  236 (247)
                      ++||||+.+
T Consensus       290 l~Hpff~~i  298 (322)
T d1vzoa_         290 KEHLFFQKI  298 (322)
T ss_dssp             HTSGGGTTC
T ss_pred             HcCHhhcCC
Confidence            999999874

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-50  Score=309.39  Aligned_cols=220  Identities=27%  Similarity=0.476  Sum_probs=186.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec-CCcEEEEEeccccCcHHHHHHhc---CCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD-ENRLYIFLELVTKGSLANLYQKY---HLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~---~~~   76 (247)
                      .|+.||||++..+.       ..+.+.+|+.++++++||||+++++++.+ .+.+++||||+++|+|.+++.+.   .++
T Consensus        29 ~~~~vAvK~i~~~~-------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~  101 (262)
T d1byga_          29 RGNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG  101 (262)
T ss_dssp             TTEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCC
T ss_pred             CCeEEEEEEECcHH-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCC
Confidence            37889999996432       23568899999999999999999998854 46789999999999999998654   389


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCCC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGYG  156 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  156 (247)
                      +..++.++.|++.||.|||+.+++|+||||+||+++.++.++++|||.+...... .....++..|+|||.+.+..  ++
T Consensus       102 ~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-~~~~~~~~~y~aPE~l~~~~--~t  178 (262)
T d1byga_         102 GDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-QDTGKLPVKWTAPEALREKK--FS  178 (262)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------------CCTTTSCHHHHHHCC--CC
T ss_pred             HHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC-CccccccccCCChHHHhCCC--CC
Confidence            9999999999999999999999999999999999999999999999998765433 23345788999999997654  89


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          157 LTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       157 ~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      .++||||||+++|+|++ |..||...+..+....+..+..++.+..+++++++++.+||..||.+|||+.+++++
T Consensus       179 ~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            99999999999999998 789999988888888888888888899999999999999999999999999999874

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-49  Score=315.51  Aligned_cols=233  Identities=28%  Similarity=0.475  Sum_probs=188.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC----cEEEEEeccccCcHHHHHHhcCCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN----RLYIFLELVTKGSLANLYQKYHLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~   76 (247)
                      +|+.||||++...    ......+.+.+|+.+|++++||||+++++++....    ..+++++++.+++|.++++..+++
T Consensus        32 ~~~~vAvK~i~~~----~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~~l~  107 (345)
T d1pmea_          32 NKVRVAIKKISPF----EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLS  107 (345)
T ss_dssp             TCSEEEEEEECCT----TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHCCCC
T ss_pred             CCcEEEEEEEehh----cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcCCCC
Confidence            5899999999753    23455677889999999999999999999986543    234444556688999999998999


Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-----cccCCCCCCccCCcccccC
Q 041080           77 DSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSK  151 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~  151 (247)
                      +..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++.......     .....|++.|+|||.+...
T Consensus       108 ~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~  187 (345)
T d1pmea_         108 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS  187 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTB
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcC
Confidence            99999999999999999999999999999999999999999999999986543332     3345588999999998544


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC---------------------------CC---CCCCCc
Q 041080          152 NDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG---------------------------EL---PSVPSS  201 (247)
Q Consensus       152 ~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---------------------------~~---~~~~~~  201 (247)
                      . .++.++|+||+|+++++|++|..||...+..+........                           ..   ......
T Consensus       188 ~-~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (345)
T d1pmea_         188 K-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPN  266 (345)
T ss_dssp             C-SCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTT
T ss_pred             C-CCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCC
Confidence            3 2688999999999999999999999876654443222110                           00   011245


Q ss_pred             CCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCCC
Q 041080          202 LSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQ  238 (247)
Q Consensus       202 ~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~~  238 (247)
                      .++++++|+.+||+.||.+|||++|+|+||||+....
T Consensus       267 ~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         267 ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence            7889999999999999999999999999999996543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.4e-49  Score=309.90  Aligned_cols=230  Identities=25%  Similarity=0.386  Sum_probs=185.3

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC----cEEEEEeccccCcHHHHHHhc-CC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN----RLYIFLELVTKGSLANLYQKY-HL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~-~~   75 (247)
                      +|+.||||++.....  ......+.+.+|+.++++++||||+++++++...+    ..++||||++|++|.+++... .+
T Consensus        31 ~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l  108 (277)
T d1o6ya_          31 LHRDVAVKVLRADLA--RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM  108 (277)
T ss_dssp             TTEEEEEEEECSTTT--TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSC
T ss_pred             CCCEEEEEEEchhhc--cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCC
Confidence            588999999976542  33555678999999999999999999999987643    489999999999999888665 59


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc-----ccccCCCCCCccCCccccc
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-----DLKSCKGTPFWMAPEVVNS  150 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~  150 (247)
                      ++..++.++.|++.||+|||++|++||||||+||+++.++..+++|||.+......     ......|++.|+|||.+.+
T Consensus       109 ~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~  188 (277)
T d1o6ya_         109 TPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG  188 (277)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTT
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcC
Confidence            99999999999999999999999999999999999999999999999987543322     2334558999999999965


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCCCC---CCCCcCCHHHHHHHHHHhcCCCCCCCChhhh
Q 041080          151 KNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGELP---SVPSSLSRDARDFILKCLQVNPNDRPTVTEL  227 (247)
Q Consensus       151 ~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  227 (247)
                      ..  ++.++||||+|+++|+|++|..||...+..+...........   .....+|+++.++|.+||++||.+||+..+.
T Consensus       189 ~~--~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~  266 (277)
T d1o6ya_         189 DS--VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAE  266 (277)
T ss_dssp             CC--CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred             CC--CCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHH
Confidence            44  789999999999999999999999988777666555444321   2346789999999999999999999955555


Q ss_pred             hcCccCC
Q 041080          228 MEHPFVK  234 (247)
Q Consensus       228 l~~p~~~  234 (247)
                      +.++|.+
T Consensus       267 l~~~l~r  273 (277)
T d1o6ya_         267 MRADLVR  273 (277)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            5566654

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=306.29  Aligned_cols=232  Identities=28%  Similarity=0.430  Sum_probs=190.7

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-CCCHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-HLSDSQ   79 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~   79 (247)
                      +|+.||||++....   ......+.+.+|+.+++.++||||+++++++.+....+++++++.++++..++... .+++..
T Consensus        26 ~~~~vAvK~i~~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~  102 (292)
T d1unla_          26 THEIVALKRVRLDD---DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEI  102 (292)
T ss_dssp             TCCEEEEEEEESSC---SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHH
T ss_pred             CCcEEEEEEEehhh---CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccccccccchhH
Confidence            57899999997653   23445678899999999999999999999999999999999999999988887665 589999


Q ss_pred             HHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc--cccCCCCCCccCCcccccCCCCCCc
Q 041080           80 VSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--LKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        80 ~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      ++.++.|++.||+|||++||+|+||||+||+++.++.++|+|||.+.......  .....++..|.|||.+..... ++.
T Consensus       103 ~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~  181 (292)
T d1unla_         103 VKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL-YST  181 (292)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSC-CCT
T ss_pred             HHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCC-CCc
Confidence            99999999999999999999999999999999999999999999997654332  233446788999998865432 688


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCC-hhhHHHHHhhc----------------------------CCCCCCCCcCCHHHHH
Q 041080          158 TADIWSLGCTVLEMLTRRPPYSHL-EGVQALFRIGK----------------------------GELPSVPSSLSRDARD  208 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~g~~p~~~~-~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~  208 (247)
                      ++||||+||++++|++|+.||... +..+....+..                            ..........++.+.+
T Consensus       182 ~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  261 (292)
T d1unla_         182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRD  261 (292)
T ss_dssp             HHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHH
T ss_pred             hhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHH
Confidence            999999999999999999886433 33332222110                            1112233467899999


Q ss_pred             HHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          209 FILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       209 li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ||++||+.||.+|||++|+|+||||++.
T Consensus       262 ll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         262 LLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             HHHHHccCChhHCcCHHHHhcChhhcCC
Confidence            9999999999999999999999999874

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-49  Score=311.52  Aligned_cols=222  Identities=25%  Similarity=0.456  Sum_probs=194.6

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--------   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------   73 (247)
                      |+.||||++...    ......+.+.+|+.++++++||||+++++++...+..+++|||+.+|+|.+++...        
T Consensus        43 ~~~vAvK~i~~~----~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~  118 (301)
T d1lufa_          43 FTMVAVKMLKEE----ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL  118 (301)
T ss_dssp             EEEEEEEECCTT----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC------
T ss_pred             CeEEEEEEEChh----cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccc
Confidence            568999998643    23455678999999999999999999999999999999999999999999988642        


Q ss_pred             -----------------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----
Q 041080           74 -----------------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----  132 (247)
Q Consensus        74 -----------------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----  132 (247)
                                       .+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......    
T Consensus       119 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~  198 (301)
T d1lufa_         119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA  198 (301)
T ss_dssp             ----------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC-
T ss_pred             cccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccc
Confidence                             27888999999999999999999999999999999999999999999999986443322    


Q ss_pred             cccCCCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHH
Q 041080          133 LKSCKGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRR-PPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFIL  211 (247)
Q Consensus       133 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  211 (247)
                      .....+++.|+|||.+.+..  ++.++||||||+++|+|++|. .||......+....+..+..+..+..+|+++.+++.
T Consensus       199 ~~~~~~~~~y~aPE~~~~~~--~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~  276 (301)
T d1lufa_         199 DGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMR  276 (301)
T ss_dssp             ---CCBCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             cCCCCcCcCcCCHHHHccCC--CChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHH
Confidence            22345778899999997655  899999999999999999985 689988888888888888888888999999999999


Q ss_pred             HHhcCCCCCCCChhhhhc
Q 041080          212 KCLQVNPNDRPTVTELME  229 (247)
Q Consensus       212 ~~l~~~p~~Rps~~~il~  229 (247)
                      +||+.+|.+|||+.++++
T Consensus       277 ~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         277 LCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHcCCChhHCcCHHHHHH
Confidence            999999999999999964

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-49  Score=312.76  Aligned_cols=220  Identities=26%  Similarity=0.447  Sum_probs=186.4

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQVS   81 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~   81 (247)
                      .||+|.+...    ......+.+.+|+.++++++||||+++++++.++ ..+++++++.+++|.+.+...  .+++..++
T Consensus        40 ~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~  114 (317)
T d1xkka_          40 PVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLL  114 (317)
T ss_dssp             EEEEEEECC--------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHH
T ss_pred             EEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccccCCCHHHHH
Confidence            4777777532    2233456789999999999999999999999765 567788888899998877654  49999999


Q ss_pred             HHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCCcccccCCCCCCc
Q 041080           82 SYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPEVVNSKNDGYGL  157 (247)
Q Consensus        82 ~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~  157 (247)
                      .++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......    .....|+..|+|||.+.+..  ++.
T Consensus       115 ~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~  192 (317)
T d1xkka_         115 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTH  192 (317)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCC--CCH
T ss_pred             HHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCC--CCh
Confidence            999999999999999999999999999999999999999999987554322    22345789999999997654  899


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC
Q 041080          158 TADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH  230 (247)
Q Consensus       158 ~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  230 (247)
                      ++||||||+++|+|++ |..||...+.......+..+..+..+..+++++.+++.+||..+|.+|||+.++++|
T Consensus       193 ~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         193 QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            9999999999999998 899999888888777777777777888999999999999999999999999999876

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-49  Score=311.24  Aligned_cols=232  Identities=27%  Similarity=0.442  Sum_probs=181.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec--------CCcEEEEEeccccCcHHHHHHh
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD--------ENRLYIFLELVTKGSLANLYQK   72 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~   72 (247)
                      +|+.||||++......   +.....+.+|+.+|++++||||+++++++..        .+..+++|||+.++++......
T Consensus        34 ~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~  110 (318)
T d3blha1          34 TGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV  110 (318)
T ss_dssp             TCCEEEEEEC----CT---TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCT
T ss_pred             CCCEEEEEEEehhhcc---hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhc
Confidence            5889999998765332   2334567799999999999999999998755        3468999999988666544433


Q ss_pred             -cCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCcc------ccccCCCCCCccCC
Q 041080           73 -YHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMN------DLKSCKGTPFWMAP  145 (247)
Q Consensus        73 -~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~------~~~~~~~~~~~~aP  145 (247)
                       ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++++|||++......      ......||+.|+||
T Consensus       111 ~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aP  190 (318)
T d3blha1         111 LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP  190 (318)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCH
T ss_pred             ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhH
Confidence             35899999999999999999999999999999999999999999999999998644322      22334589999999


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcC---CCCCCC-----------------------
Q 041080          146 EVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKG---ELPSVP-----------------------  199 (247)
Q Consensus       146 E~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~-----------------------  199 (247)
                      |.+.+.. .++.++||||+|+++|+|++|+.||...........+...   ..+...                       
T Consensus       191 E~~~~~~-~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (318)
T d3blha1         191 ELLLGER-DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVK  269 (318)
T ss_dssp             HHHTTCS-SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHH
T ss_pred             HHHcCCC-CCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccch
Confidence            9986543 3789999999999999999999999877665554433221   111000                       


Q ss_pred             -----CcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          200 -----SSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       200 -----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                           ...++++.+||.+||+.||++|||++|+++||||+..
T Consensus       270 ~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         270 DRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             HHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             hhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence                 0136778899999999999999999999999999963

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-48  Score=312.09  Aligned_cols=226  Identities=27%  Similarity=0.392  Sum_probs=181.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec------CCcEEEEEeccccCcHHHHHH---
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD------ENRLYIFLELVTKGSLANLYQ---   71 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~---   71 (247)
                      +|+.||||++......         ..+|+.++++++||||+++++++..      ...+++||||++++++..+..   
T Consensus        44 ~~~~vAiK~i~~~~~~---------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~  114 (350)
T d1q5ka_          44 SGELVAIKKVLQDKRF---------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR  114 (350)
T ss_dssp             TCCEEEEEEEECCSSS---------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHH
T ss_pred             CCCEEEEEEECccchH---------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhh
Confidence            4889999999764321         2379999999999999999998743      335799999998754443332   


Q ss_pred             -hcCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC-CeEEcccccccccCcc-ccccCCCCCCccCCccc
Q 041080           72 -KYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG-SVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVV  148 (247)
Q Consensus        72 -~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~-~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~  148 (247)
                       ...+++..++.++.|++.||+|||++||+||||||+||+++.++ .++|+|||++...... ......|+..|+|||.+
T Consensus       115 ~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~  194 (350)
T d1q5ka_         115 AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI  194 (350)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHH
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHh
Confidence             23599999999999999999999999999999999999999775 8999999998755433 34456689999999987


Q ss_pred             ccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc-------------------CCCC---------CCCC
Q 041080          149 NSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK-------------------GELP---------SVPS  200 (247)
Q Consensus       149 ~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-------------------~~~~---------~~~~  200 (247)
                      .+.. .++.++||||+||++|+|++|..||......+....+..                   ...+         ....
T Consensus       195 ~~~~-~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (350)
T d1q5ka_         195 FGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP  273 (350)
T ss_dssp             TTCS-SCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCT
T ss_pred             hccc-CCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhccc
Confidence            6433 379999999999999999999999987776655444321                   0011         1123


Q ss_pred             cCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          201 SLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       201 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ..++++.+||.+||..||.+|||++|+|+||||++.
T Consensus       274 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         274 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            578999999999999999999999999999999875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=307.37  Aligned_cols=222  Identities=27%  Similarity=0.490  Sum_probs=195.2

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-------   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------   73 (247)
                      +..||||++...    ........+.+|...+.++ +||||+++++++.+++..++||||+.+|+|.+++...       
T Consensus        45 ~~~vAvK~~~~~----~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~  120 (299)
T d1fgka_          45 VTKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY  120 (299)
T ss_dssp             EEEEEEECCCTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC----
T ss_pred             ceEEEEEEECcc----cChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCcccc
Confidence            357999998653    2344566788999999888 7999999999999999999999999999999999644       


Q ss_pred             ----------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCC
Q 041080           74 ----------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGT  139 (247)
Q Consensus        74 ----------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~  139 (247)
                                .+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||.+.......    .....++
T Consensus       121 ~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  200 (299)
T d1fgka_         121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP  200 (299)
T ss_dssp             --------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCG
T ss_pred             ccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCC
Confidence                      27999999999999999999999999999999999999999999999999987654433    2334578


Q ss_pred             CCccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCC
Q 041080          140 PFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNP  218 (247)
Q Consensus       140 ~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  218 (247)
                      +.|+|||.+.+..  ++.++||||||+++|+|++ |..||...........+..+..+..+..++++++++|.+||+.+|
T Consensus       201 ~~y~aPE~l~~~~--y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP  278 (299)
T d1fgka_         201 VKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVP  278 (299)
T ss_dssp             GGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSG
T ss_pred             hhhhhhhHhcCCC--CCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCH
Confidence            8899999997654  8999999999999999998 789999888888888887777788889999999999999999999


Q ss_pred             CCCCChhhhhc
Q 041080          219 NDRPTVTELME  229 (247)
Q Consensus       219 ~~Rps~~~il~  229 (247)
                      .+|||+.|+++
T Consensus       279 ~~Rps~~eil~  289 (299)
T d1fgka_         279 SQRPTFKQLVE  289 (299)
T ss_dssp             GGSCCHHHHHH
T ss_pred             hHCcCHHHHHH
Confidence            99999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-49  Score=305.10  Aligned_cols=222  Identities=28%  Similarity=0.491  Sum_probs=183.3

Q ss_pred             ceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCHHHH
Q 041080            3 FFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSDSQV   80 (247)
Q Consensus         3 ~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~   80 (247)
                      ..||||++.....  ...+..+.+.+|+.++++++||||+++++++.+ +..++||||++++++.+.+...  .+++..+
T Consensus        37 ~~vAiK~l~~~~~--~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~  113 (273)
T d1u46a_          37 VSVAVKCLKPDVL--SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTL  113 (273)
T ss_dssp             EEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHH
T ss_pred             EEEEEEEEChhhc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHH
Confidence            3689999876543  234556789999999999999999999999966 4678999999999998876543  4999999


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-----cccCCCCCCccCCcccccCCCCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----LKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      +.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......     .....++..|+|||.+.+..  +
T Consensus       114 ~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~  191 (273)
T d1u46a_         114 SRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT--F  191 (273)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE--E
T ss_pred             HHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCC--C
Confidence            9999999999999999999999999999999999999999999987654332     22334677899999997654  7


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCChhhHHHHHhhcC-CCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          156 GLTADIWSLGCTVLEMLT-RRPPYSHLEGVQALFRIGKG-ELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                      +.++||||||+++|||++ |..||...+..+....+... ..++.+..+|+++++++.+||..||.+|||+++|++
T Consensus       192 ~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         192 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            899999999999999998 89999988888887776544 345667789999999999999999999999999864

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=313.49  Aligned_cols=232  Identities=27%  Similarity=0.406  Sum_probs=187.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecC-----CcEEEEEeccccCcHHHHHHhcCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDE-----NRLYIFLELVTKGSLANLYQKYHL   75 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~   75 (247)
                      +|+.||||++....   ......+.+.+|+.++++++||||+++++++...     ...+++++++.+++|.+++...++
T Consensus        42 ~~~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~~l  118 (348)
T d2gfsa1          42 TGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL  118 (348)
T ss_dssp             TTEEEEEEECSCTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTCCC
T ss_pred             CCCEEEEEEECchh---cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcccccc
Confidence            58899999997643   3445566788999999999999999999998643     334566677778999999988889


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccccCCCCCCccCCcccccCCCCC
Q 041080           76 SDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        76 ~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ++..++.++.|++.||+|||++||+||||||+||+++.++.++++|||.+..... ......|+..|+|||.+.+... +
T Consensus       119 ~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-~~~~~~g~~~y~apE~~~~~~~-~  196 (348)
T d2gfsa1         119 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-EMTGYVATRWYRAPEIMLNWMH-Y  196 (348)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-GGSSSCHHHHTSCHHHHTTCSC-C
T ss_pred             cHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-ccccccccccccCchhhcCCcc-C
Confidence            9999999999999999999999999999999999999999999999999865543 3345568889999998755432 6


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhcCC----------------------CCC--------CCCcCCHH
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGKGE----------------------LPS--------VPSSLSRD  205 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~----------------------~~~--------~~~~~~~~  205 (247)
                      +.++|+||+|+++|+|++|..||...+.......+....                      ...        .....+++
T Consensus       197 ~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  276 (348)
T d2gfsa1         197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPL  276 (348)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHH
T ss_pred             CcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHH
Confidence            889999999999999999999998766554443332110                      001        11357899


Q ss_pred             HHHHHHHHhcCCCCCCCChhhhhcCccCCCCC
Q 041080          206 ARDFILKCLQVNPNDRPTVTELMEHPFVKRPL  237 (247)
Q Consensus       206 ~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~  237 (247)
                      +++||.+||..||.+|||++|+|+||||++..
T Consensus       277 ~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         277 AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence            99999999999999999999999999999753

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-48  Score=306.66  Aligned_cols=221  Identities=25%  Similarity=0.464  Sum_probs=189.1

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc---------
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY---------   73 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------   73 (247)
                      .||||.+....    .....+.+.+|+.+++++ +||||+++++++.+++..++||||+++|+|.+++...         
T Consensus        39 ~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~  114 (309)
T d1fvra_          39 DAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF  114 (309)
T ss_dssp             EEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHH
T ss_pred             EEEEEEECccc----ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhh
Confidence            46777765322    233456789999999999 7999999999999999999999999999999998643         


Q ss_pred             --------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccccc-cCCCCCCccC
Q 041080           74 --------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDLK-SCKGTPFWMA  144 (247)
Q Consensus        74 --------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~a  144 (247)
                              .+++..++.++.|++.||.|+|+.|++||||||+||+++.++.++|+|||++......... ...++..|+|
T Consensus       115 ~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~a  194 (309)
T d1fvra_         115 AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA  194 (309)
T ss_dssp             HHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCC
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEccccccccccccccccceecCCcccc
Confidence                    4899999999999999999999999999999999999999999999999998755443332 3458899999


Q ss_pred             CcccccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCC
Q 041080          145 PEVVNSKNDGYGLTADIWSLGCTVLEMLTRR-PPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPT  223 (247)
Q Consensus       145 PE~~~~~~~~~~~~~Di~slG~ll~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  223 (247)
                      ||.+.+..  ++.++||||||+++|+|++|. .||...+..+....+..+..+..+..++++++++|.+||+.||.+|||
T Consensus       195 PE~l~~~~--~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs  272 (309)
T d1fvra_         195 IESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPS  272 (309)
T ss_dssp             HHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCC
T ss_pred             hHHhccCC--CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcC
Confidence            99997654  789999999999999999965 678888888888888887778888899999999999999999999999


Q ss_pred             hhhhhcC
Q 041080          224 VTELMEH  230 (247)
Q Consensus       224 ~~~il~~  230 (247)
                      +++++++
T Consensus       273 ~~eil~~  279 (309)
T d1fvra_         273 FAQILVS  279 (309)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999975

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-48  Score=306.99  Aligned_cols=228  Identities=25%  Similarity=0.429  Sum_probs=199.0

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--------   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------   73 (247)
                      ++.||||++...    ........+.+|+.++++++||||+++++++..++..++||||+++|+|.+++...        
T Consensus        50 ~~~VAvK~~~~~----~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~  125 (308)
T d1p4oa_          50 ETRVAIKTVNEA----ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP  125 (308)
T ss_dssp             EEEEEEEECCTT----SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCT
T ss_pred             CcEEEEEEECcc----cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhccccccccc
Confidence            467999998642    23455667899999999999999999999999999999999999999999987542        


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCCCCCccCCc
Q 041080           74 ---HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKGTPFWMAPE  146 (247)
Q Consensus        74 ---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~aPE  146 (247)
                         .+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||++.......    .....+++.|+|||
T Consensus       126 ~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe  205 (308)
T d1p4oa_         126 VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE  205 (308)
T ss_dssp             TCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHH
Confidence               26888999999999999999999999999999999999999999999999987544332    22334789999999


Q ss_pred             ccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChh
Q 041080          147 VVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVT  225 (247)
Q Consensus       147 ~~~~~~~~~~~~~Di~slG~ll~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  225 (247)
                      .+.+..  ++.++|+||||+++|+|++| ..||...+.......+..+..+..+..+|+.++++|.+||+.+|.+|||++
T Consensus       206 ~l~~~~--~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~  283 (308)
T d1p4oa_         206 SLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFL  283 (308)
T ss_dssp             HHHHCC--CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHccCC--CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHH
Confidence            997655  78899999999999999997 588988888888888888888888889999999999999999999999999


Q ss_pred             hhhc------CccCCC
Q 041080          226 ELME------HPFVKR  235 (247)
Q Consensus       226 ~il~------~p~~~~  235 (247)
                      ++++      +|+|++
T Consensus       284 ~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         284 EIISSIKEEMEPGFRE  299 (308)
T ss_dssp             HHHHHHGGGSCTTHHH
T ss_pred             HHHHHHHHhcCCCCcC
Confidence            9998      777764

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=7.7e-48  Score=307.05  Aligned_cols=225  Identities=28%  Similarity=0.443  Sum_probs=181.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeec--CCcEEEEEeccccCcHHHHHHhcCCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKD--ENRLYIFLELVTKGSLANLYQKYHLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~   77 (247)
                      +|+.||||++....        .+++.+|+.+|++++ ||||+++++++..  ....++||||+.+++|..+.  ..+++
T Consensus        59 ~~~~vAiK~i~~~~--------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~--~~l~e  128 (328)
T d3bqca1          59 NNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTD  128 (328)
T ss_dssp             TTEEEEEEEECSSC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT--TSCCH
T ss_pred             CCCEEEEEEECHHH--------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh--cCCCH
Confidence            48899999986421        346789999999995 9999999999874  45799999999999998764  35999


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCC-CeEEcccccccccCcc-ccccCCCCCCccCCcccccCCCCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASG-SVKLADFGLAKATTMN-DLKSCKGTPFWMAPEVVNSKNDGY  155 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~-~~~l~df~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~  155 (247)
                      ..++.++.||+.||.|||++||+|+||||+||+++.++ .++|+|||.+...... ......+++.|+|||.+.+... +
T Consensus       129 ~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~  207 (328)
T d3bqca1         129 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM-Y  207 (328)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCC-C
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCC-C
Confidence            99999999999999999999999999999999998765 5899999999765543 3445568999999999865432 6


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCChhhHH-HHHh-------------hcC-----------------------CCCCC
Q 041080          156 GLTADIWSLGCTVLEMLTRRPPYSHLEGVQA-LFRI-------------GKG-----------------------ELPSV  198 (247)
Q Consensus       156 ~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~-~~~~-------------~~~-----------------------~~~~~  198 (247)
                      +.++|+||+|++++++++|..||........ ...+             ...                       .....
T Consensus       208 ~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (328)
T d3bqca1         208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSEN  287 (328)
T ss_dssp             CTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTT
T ss_pred             CcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccc
Confidence            8999999999999999999999865432211 1000             000                       00011


Q ss_pred             CCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          199 PSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       199 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                      ...+++++++||++||..||.+|||++|+|+||||+..
T Consensus       288 ~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v  325 (328)
T d3bqca1         288 QHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  325 (328)
T ss_dssp             GGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            23478999999999999999999999999999999975

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-48  Score=303.80  Aligned_cols=223  Identities=26%  Similarity=0.465  Sum_probs=178.2

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeec-CCcEEEEEeccccCcHHHHHHhc------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKD-ENRLYIFLELVTKGSLANLYQKY------   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~------   73 (247)
                      |+.||||++...    ......+.+.+|...+.++ +|+||+.+++++.. ++..++||||+++|+|.+++...      
T Consensus        43 ~~~vAvK~l~~~----~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~  118 (299)
T d1ywna1          43 CRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP  118 (299)
T ss_dssp             EEEEEEEEC--------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC
T ss_pred             CeEEEEEEEccc----cCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccc
Confidence            568999998643    2344456677888888887 68999999998765 45789999999999999998643      


Q ss_pred             -----------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCCC
Q 041080           74 -----------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCKG  138 (247)
Q Consensus        74 -----------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~~  138 (247)
                                 .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......    .....|
T Consensus       119 ~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~g  198 (299)
T d1ywna1         119 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL  198 (299)
T ss_dssp             -----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCC
T ss_pred             cccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceee
Confidence                       37899999999999999999999999999999999999999999999999986543322    223458


Q ss_pred             CCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCChhhHH-HHHhhcCCCCCCCCcCCHHHHHHHHHHhcC
Q 041080          139 TPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTR-RPPYSHLEGVQA-LFRIGKGELPSVPSSLSRDARDFILKCLQV  216 (247)
Q Consensus       139 ~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g-~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  216 (247)
                      ++.|+|||.+.+..  ++.++||||||+++|+|+++ ..||........ ...+..+..+..+..+++++++++.+||+.
T Consensus       199 t~~y~APE~l~~~~--~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  276 (299)
T d1ywna1         199 PLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG  276 (299)
T ss_dssp             GGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CccccchhHhhcCC--CCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCC
Confidence            89999999997654  89999999999999999986 567876654433 344555666777888999999999999999


Q ss_pred             CCCCCCChhhhhcC
Q 041080          217 NPNDRPTVTELMEH  230 (247)
Q Consensus       217 ~p~~Rps~~~il~~  230 (247)
                      ||.+|||++++++|
T Consensus       277 dP~~Rpt~~eil~~  290 (299)
T d1ywna1         277 EPSQRPTFSELVEH  290 (299)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             ChhHCcCHHHHHHH
Confidence            99999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-47  Score=301.16  Aligned_cols=227  Identities=24%  Similarity=0.407  Sum_probs=188.8

Q ss_pred             eEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec-CCcEEEEEeccccCcHHHHHHhcC--CCHHHH
Q 041080            4 FFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD-ENRLYIFLELVTKGSLANLYQKYH--LSDSQV   80 (247)
Q Consensus         4 ~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~   80 (247)
                      .||||++...    ......+++.+|++++++++||||+++++++.+ ++..++||||+++++|.+++....  .++..+
T Consensus        57 ~vAvK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~  132 (311)
T d1r0pa_          57 HCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL  132 (311)
T ss_dssp             EEEEEEECCC----CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHH
T ss_pred             EEEEEEECcc----cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHH
Confidence            5899998642    345567889999999999999999999998765 568999999999999999887654  778889


Q ss_pred             HHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc------cccCCCCCCccCCcccccCCCC
Q 041080           81 SSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND------LKSCKGTPFWMAPEVVNSKNDG  154 (247)
Q Consensus        81 ~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~aPE~~~~~~~~  154 (247)
                      +.++.|++.||.|+|+.||+||||||+||+++.++.++|+|||++.......      .....|+..|+|||.+....  
T Consensus       133 ~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--  210 (311)
T d1r0pa_         133 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK--  210 (311)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCC--
T ss_pred             HHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCC--
Confidence            9999999999999999999999999999999999999999999997544332      22345788999999986554  


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCC-CChhhHHHHHhhcCCCCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcC---
Q 041080          155 YGLTADIWSLGCTVLEMLTRRPPYS-HLEGVQALFRIGKGELPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEH---  230 (247)
Q Consensus       155 ~~~~~Di~slG~ll~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~---  230 (247)
                      ++.++||||||+++|+|++|..||. ..+..+....+..+..+..+..+++++.+++.+||..||.+|||+.|++++   
T Consensus       211 ~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~  290 (311)
T d1r0pa_         211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA  290 (311)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            7999999999999999999766654 444445566666677777888999999999999999999999999999987   


Q ss_pred             ---ccCCCC
Q 041080          231 ---PFVKRP  236 (247)
Q Consensus       231 ---p~~~~~  236 (247)
                         +|.++.
T Consensus       291 i~~~~~~~~  299 (311)
T d1r0pa_         291 IFSTFIGEH  299 (311)
T ss_dssp             HHHTCCSCC
T ss_pred             HHHhhhhhh
Confidence               666554

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=308.80  Aligned_cols=229  Identities=24%  Similarity=0.396  Sum_probs=178.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeec------CCcEEEEEeccccCcHHHHHHhcC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKD------ENRLYIFLELVTKGSLANLYQKYH   74 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~   74 (247)
                      +|+.||||++....   .......++.+|+.++++++||||+++++++..      ...+|+||||+.++++. .+ ...
T Consensus        41 t~~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~-~~-~~~  115 (355)
T d2b1pa1          41 LDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ-VI-QME  115 (355)
T ss_dssp             TTEEEEEEEEESTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHH-HH-TSC
T ss_pred             CCCEEEEEEEChhh---cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHH-hh-hcC
Confidence            48999999997653   234556778999999999999999999999864      36889999999875554 44 346


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc-cccCCCCCCccCCcccccCCC
Q 041080           75 LSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-LKSCKGTPFWMAPEVVNSKND  153 (247)
Q Consensus        75 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~  153 (247)
                      +++..++.++.|++.||.|||++||+|+||||+||+++.++.++++|||.+....... .....+++.|+|||.+.+.. 
T Consensus       116 ~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~-  194 (355)
T d2b1pa1         116 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-  194 (355)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------------CCTTCCHHHHTTCC-
T ss_pred             CCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccccccccccccccccChhhhcCCC-
Confidence            8999999999999999999999999999999999999999999999999876554433 33455899999999997654 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHhhc----------------------CCCCC--------------
Q 041080          154 GYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRIGK----------------------GELPS--------------  197 (247)
Q Consensus       154 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~----------------------~~~~~--------------  197 (247)
                       ++.++||||+||++++|++|+.||...+.......+..                      .....              
T Consensus       195 -~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (355)
T d2b1pa1         195 -YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLF  273 (355)
T ss_dssp             -CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGS
T ss_pred             -CCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccc
Confidence             78999999999999999999999976655444332210                      00000              


Q ss_pred             -----CCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCC
Q 041080          198 -----VPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRP  236 (247)
Q Consensus       198 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~  236 (247)
                           .....++++.+||++||..||++|||++|+|+||||+..
T Consensus       274 ~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         274 PADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             CCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             cccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence                 001246678999999999999999999999999999874

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-47  Score=299.88  Aligned_cols=222  Identities=25%  Similarity=0.419  Sum_probs=188.6

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhc-CCCceeeeceeeecCCcEEEEEeccccCcHHHHHHhc-------
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQF-EQDNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY-------   73 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------   73 (247)
                      ++.||||++...    ........+.+|+.+++++ +||||+++++++.+++..+++|||+++|+|.+++.+.       
T Consensus        53 ~~~vAvK~i~~~----~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~  128 (311)
T d1t46a_          53 AMTVAVKMLKPS----AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS  128 (311)
T ss_dssp             EEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC---
T ss_pred             CeEEEEEEECcc----cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhcccccccc
Confidence            568999999753    2344566788999999999 6999999999999999999999999999999998653       


Q ss_pred             ------------CCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccCccc----cccCC
Q 041080           74 ------------HLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----LKSCK  137 (247)
Q Consensus        74 ------------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~  137 (247)
                                  .+++..+..++.|++.|++|||++|++||||||+||+++.++.++++|||.+.......    .....
T Consensus       129 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~  208 (311)
T d1t46a_         129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR  208 (311)
T ss_dssp             -----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSE
T ss_pred             ccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecc
Confidence                        38899999999999999999999999999999999999999999999999997654332    22345


Q ss_pred             CCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCChhhHHH-HHhhcCCCCCCCCcCCHHHHHHHHHHhc
Q 041080          138 GTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLT-RRPPYSHLEGVQAL-FRIGKGELPSVPSSLSRDARDFILKCLQ  215 (247)
Q Consensus       138 ~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~  215 (247)
                      +++.|+|||.+.+..  ++.++||||||+++|+|++ |.+|+......... ..+..+..+..+...|+++++||.+||+
T Consensus       209 gt~~y~aPE~~~~~~--~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~  286 (311)
T d1t46a_         209 LPVKWMAPESIFNCV--YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWD  286 (311)
T ss_dssp             ECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             cChHHcCHHHhcCCC--CCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcC
Confidence            788999999997554  7999999999999999998 66667665554444 3344555666778899999999999999


Q ss_pred             CCCCCCCChhhhhc
Q 041080          216 VNPNDRPTVTELME  229 (247)
Q Consensus       216 ~~p~~Rps~~~il~  229 (247)
                      .||.+|||+++|++
T Consensus       287 ~dP~~RPs~~~il~  300 (311)
T d1t46a_         287 ADPLKRPTFKQIVQ  300 (311)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CChhHCcCHHHHHH
Confidence            99999999999985

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-45  Score=285.71  Aligned_cols=223  Identities=25%  Similarity=0.330  Sum_probs=170.6

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCC----cEEEEEeccccCcHHHHHHhcCCC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDEN----RLYIFLELVTKGSLANLYQKYHLS   76 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~   76 (247)
                      +|+.||||++...      .......+.|+..+.+++||||+++++++.+.+    .+++||||+++|+|.+++++.+++
T Consensus        25 ~g~~vAvK~~~~~------~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~l~   98 (303)
T d1vjya_          25 RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT   98 (303)
T ss_dssp             TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCCBC
T ss_pred             CCEEEEEEEECcc------chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcCCCC
Confidence            5789999998532      112223345666777889999999999987543    579999999999999999999999


Q ss_pred             HHHHHHHHHHHHHHHHHhhh--------CCeeecCCCCCcEEEcCCCCeEEcccccccccCccc------cccCCCCCCc
Q 041080           77 DSQVSSYTRQILNGLVYLHE--------RNVVHRDIKCANILVDASGSVKLADFGLAKATTMND------LKSCKGTPFW  142 (247)
Q Consensus        77 ~~~~~~~~~~l~~~l~~lh~--------~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~  142 (247)
                      +..++.++.|++.||+++|+        +||+|+||||+||+++.++.+||+|||++.......      .....|++.|
T Consensus        99 ~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y  178 (303)
T d1vjya_          99 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY  178 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGG
T ss_pred             HHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCc
Confidence            99999999999999999996        599999999999999999999999999986543221      2345689999


Q ss_pred             cCCcccccCCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCh---------------hhHHHHHhhcC-CCCCCCCc-
Q 041080          143 MAPEVVNSKNDG----YGLTADIWSLGCTVLEMLTRRPPYSHLE---------------GVQALFRIGKG-ELPSVPSS-  201 (247)
Q Consensus       143 ~aPE~~~~~~~~----~~~~~Di~slG~ll~~l~~g~~p~~~~~---------------~~~~~~~~~~~-~~~~~~~~-  201 (247)
                      +|||.+.+....    ++.++||||||+++|+|++|..|+....               ........... ..+..+.. 
T Consensus       179 ~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~  258 (303)
T d1vjya_         179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW  258 (303)
T ss_dssp             CCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG
T ss_pred             CChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCccc
Confidence            999998654321    4668999999999999999987653211               11111222221 12233222 


Q ss_pred             ----CCHHHHHHHHHHhcCCCCCCCChhhhhc
Q 041080          202 ----LSRDARDFILKCLQVNPNDRPTVTELME  229 (247)
Q Consensus       202 ----~~~~~~~li~~~l~~~p~~Rps~~~il~  229 (247)
                          .+..+.+++.+||+.||.+|||+.|+++
T Consensus       259 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         259 QSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             GGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             CChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence                3346899999999999999999999976

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.6e-43  Score=274.07  Aligned_cols=226  Identities=19%  Similarity=0.251  Sum_probs=174.0

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCce-eeeceeeecCCcEEEEEeccccCcHHHHHHh--cCCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNI-VQYLGTDKDENRLYIFLELVTKGSLANLYQK--YHLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~   77 (247)
                      +|+.||||++......       +.+..|+.+++.++|+++ +.+.+++.+++..++||||+.+ ++.+.+..  ..+++
T Consensus        31 ~~~~vAvK~~~~~~~~-------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~-~l~~~~~~~~~~~~~  102 (299)
T d1ckia_          31 AGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSL  102 (299)
T ss_dssp             TTEEEEEEEEESCTTS-------CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTTTCCCH
T ss_pred             CCCEEEEEEEchhccC-------HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcCC-chhhhhhhccCCCcH
Confidence            4889999998754321       236789999999987665 5555666788899999999955 66665543  35999


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC---CCCeEEcccccccccCcc---------ccccCCCCCCccCC
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA---SGSVKLADFGLAKATTMN---------DLKSCKGTPFWMAP  145 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~---~~~~~l~df~~~~~~~~~---------~~~~~~~~~~~~aP  145 (247)
                      ..+..++.|++.||+|||++||+||||||+||+++.   +..++++|||++......         ......|++.|+||
T Consensus       103 ~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  182 (299)
T d1ckia_         103 KTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI  182 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCH
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCH
Confidence            999999999999999999999999999999999864   457999999999754322         12345699999999


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHHHHHh-------hcCCCCCCCCcCCHHHHHHHHHHhcCCC
Q 041080          146 EVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQALFRI-------GKGELPSVPSSLSRDARDFILKCLQVNP  218 (247)
Q Consensus       146 E~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~~l~~~p  218 (247)
                      |.+.+..  ++.++||||||+++|+|++|..||............       .....+.....+|+++.+++.+||+.+|
T Consensus       183 E~~~~~~--~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p  260 (299)
T d1ckia_         183 NTHLGIE--QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRF  260 (299)
T ss_dssp             HHHTTBC--CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCT
T ss_pred             HHHhCCC--CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCCh
Confidence            9997655  899999999999999999999999765543332111       1122223446789999999999999999


Q ss_pred             CCCCChhh---hhcCccCCCC
Q 041080          219 NDRPTVTE---LMEHPFVKRP  236 (247)
Q Consensus       219 ~~Rps~~~---il~~p~~~~~  236 (247)
                      .+||++++   +|+++|.+..
T Consensus       261 ~~RP~~~~i~~~l~~~~~~~~  281 (299)
T d1ckia_         261 DDKPDYSYLRQLFRNLFHRQG  281 (299)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHT
T ss_pred             hHCcCHHHHHHHHHHHHHHcC
Confidence            99999874   4678776543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.1e-42  Score=269.31  Aligned_cols=219  Identities=19%  Similarity=0.243  Sum_probs=176.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCC-CceeeeceeeecCCcEEEEEeccccCcHHHHHHhc--CCCH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQ-DNIVQYLGTDKDENRLYIFLELVTKGSLANLYQKY--HLSD   77 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~   77 (247)
                      +|+.||||++......       ..+.+|++.++.+.| +|++.+++++..+...++||||+ +++|.+++...  .++.
T Consensus        29 ~~~~vAvK~~~~~~~~-------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~  100 (293)
T d1csna_          29 NNQQVAIKFEPRRSDA-------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSV  100 (293)
T ss_dssp             TTEEEEEEEEECCTTS-------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCH
T ss_pred             CCCEEEEEEEccccCc-------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhh
Confidence            5789999988654221       236688899999965 89999999999999999999999 56999988664  4899


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcC-----CCCeEEcccccccccCcc---------ccccCCCCCCcc
Q 041080           78 SQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDA-----SGSVKLADFGLAKATTMN---------DLKSCKGTPFWM  143 (247)
Q Consensus        78 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~-----~~~~~l~df~~~~~~~~~---------~~~~~~~~~~~~  143 (247)
                      ..+..++.|++.||++||++||+||||||+||+++.     ++.++|+|||++......         ......||+.|+
T Consensus       101 ~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~  180 (293)
T d1csna_         101 KTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM  180 (293)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhc
Confidence            999999999999999999999999999999999974     568999999999653321         233456999999


Q ss_pred             CCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHH---HHHh----hcCCCCCCCCcCCHHHHHHHHHHhcC
Q 041080          144 APEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQA---LFRI----GKGELPSVPSSLSRDARDFILKCLQV  216 (247)
Q Consensus       144 aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~---~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~  216 (247)
                      |||.+.+..  ++.++|+||||+++|+|++|..||........   ...+    .....+.+...+|+++.+++..|+..
T Consensus       181 aPE~~~~~~--~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~  258 (293)
T d1csna_         181 SINTHLGRE--QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNL  258 (293)
T ss_dssp             CHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHC
T ss_pred             CHHHhcCCC--CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcC
Confidence            999997654  89999999999999999999999975433211   1111    11222334467899999999999999


Q ss_pred             CCCCCCChhhhhc
Q 041080          217 NPNDRPTVTELME  229 (247)
Q Consensus       217 ~p~~Rps~~~il~  229 (247)
                      +|.+||+++.+.+
T Consensus       259 ~~~~rP~y~~l~~  271 (293)
T d1csna_         259 AFDATPDYDYLQG  271 (293)
T ss_dssp             CTTCCCCHHHHHH
T ss_pred             CcccCcCHHHHHH
Confidence            9999999877644

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.8e-40  Score=266.65  Aligned_cols=229  Identities=27%  Similarity=0.409  Sum_probs=168.2

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-----------CCceeeeceeeec--CCcEEEEEeccccCc-H
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-----------QDNIVQYLGTDKD--ENRLYIFLELVTKGS-L   66 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~--~~~~~lv~e~~~~~~-L   66 (247)
                      +|+.||||+++.+      ....+.+.+|+++++.+.           |+||+++++++..  ....++++++...+. .
T Consensus        37 ~g~~vAvKvi~~~------~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~  110 (362)
T d1q8ya_          37 NNTHVAMKIVRGD------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENL  110 (362)
T ss_dssp             TTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEH
T ss_pred             CCCEEEEEEEecc------ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeeccccccc
Confidence            5889999999643      233456678888888775           4789999988754  345666666654433 3


Q ss_pred             HHHHH---hcCCCHHHHHHHHHHHHHHHHHhhh-CCeeecCCCCCcEEEcCCCC------eEEcccccccccCccccccC
Q 041080           67 ANLYQ---KYHLSDSQVSSYTRQILNGLVYLHE-RNVVHRDIKCANILVDASGS------VKLADFGLAKATTMNDLKSC  136 (247)
Q Consensus        67 ~~~l~---~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~~~ni~~~~~~~------~~l~df~~~~~~~~~~~~~~  136 (247)
                      .....   ...+++..++.++.|++.|+.+||+ .||+|+||||+||+++.++.      ++++|||.+..... .....
T Consensus       111 ~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~-~~~~~  189 (362)
T d1q8ya_         111 LALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-HYTNS  189 (362)
T ss_dssp             HHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-CCCSC
T ss_pred             ccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc-ccccc
Confidence            33222   2358899999999999999999997 89999999999999987654      89999999865443 33456


Q ss_pred             CCCCCccCCcccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCChhhHH------HHH---h-h--------c------
Q 041080          137 KGTPFWMAPEVVNSKNDGYGLTADIWSLGCTVLEMLTRRPPYSHLEGVQA------LFR---I-G--------K------  192 (247)
Q Consensus       137 ~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~------~~~---~-~--------~------  192 (247)
                      .|++.|+|||.+....  ++.++|+||+|+++++|++|+.||........      ...   . .        .      
T Consensus       190 ~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  267 (362)
T d1q8ya_         190 IQTREYRSPEVLLGAP--WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRT  267 (362)
T ss_dssp             CSCGGGCCHHHHHTCC--CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHH
T ss_pred             cccccccChhhccccC--CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhccccccc
Confidence            6899999999987554  78999999999999999999999865432110      000   0 0        0      


Q ss_pred             --------CC---------------CCCCCCcCCHHHHHHHHHHhcCCCCCCCChhhhhcCccCCCCCC
Q 041080          193 --------GE---------------LPSVPSSLSRDARDFILKCLQVNPNDRPTVTELMEHPFVKRPLQ  238 (247)
Q Consensus       193 --------~~---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~p~~~~~~~  238 (247)
                              ..               ........++++++||.+||..||.+|||++|+|+||||+....
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~  336 (362)
T d1q8ya_         268 FFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG  336 (362)
T ss_dssp             HBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred             ccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCC
Confidence                    00               00112335678999999999999999999999999999996543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.84  E-value=5e-22  Score=145.12  Aligned_cols=118  Identities=16%  Similarity=0.151  Sum_probs=89.8

Q ss_pred             CCceEEEEEEeecCCC-------------ccchHHHHHHHHHHHHHhhcCCCceeeeceeeecCCcEEEEEeccccCcHH
Q 041080            1 DGFFFAVKEVSLQDQG-------------AQGKQSILQLEQEISLLSQFEQDNIVQYLGTDKDENRLYIFLELVTKGSLA   67 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   67 (247)
                      +|+.||||+++.....             .........+..|...+.++.|.+++..+++.    ..+++|||+++..+.
T Consensus        23 ~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~----~~~lvme~~~~~~~~   98 (191)
T d1zara2          23 KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELY   98 (191)
T ss_dssp             TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE----TTEEEEECCCCEEGG
T ss_pred             CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec----CCEEEEEeecccccc
Confidence            5889999987643211             01122234456788999999999999887653    237999999886553


Q ss_pred             HHHHhcCCCHHHHHHHHHHHHHHHHHhhhCCeeecCCCCCcEEEcCCCCeEEcccccccccC
Q 041080           68 NLYQKYHLSDSQVSSYTRQILNGLVYLHERNVVHRDIKCANILVDASGSVKLADFGLAKATT  129 (247)
Q Consensus        68 ~~l~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~~~ni~~~~~~~~~l~df~~~~~~~  129 (247)
                      +      ++......++.|++.++.+||++|++|+||||+||+++++ .++|+|||.+....
T Consensus        99 ~------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~  153 (191)
T d1zara2          99 R------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVG  153 (191)
T ss_dssp             G------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEETT
T ss_pred             c------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccCC
Confidence            2      4556677899999999999999999999999999999865 58899999986544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.49  E-value=2.6e-07  Score=69.12  Aligned_cols=63  Identities=10%  Similarity=0.123  Sum_probs=44.8

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcHHH
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSLAN   68 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   68 (247)
                      +|+.++||+.......     ....+.+|...+..+. +--+++++++...++..++||++++|.++.+
T Consensus        36 ~~~~~vlk~~~~~~~~-----~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~   99 (263)
T d1j7la_          36 ENENLYLKMTDSRYKG-----TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSE   99 (263)
T ss_dssp             SSCEEEEEEECGGGTT-----STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHH
T ss_pred             CCCeEEEEEcCCCccc-----chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccc
Confidence            3567888887643221     1223567888888774 4446778888888899999999999987754

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.14  E-value=3.5e-06  Score=62.46  Aligned_cols=57  Identities=19%  Similarity=0.103  Sum_probs=40.0

Q ss_pred             CceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcC--CCceeeeceeeecCCcEEEEEeccccCcH
Q 041080            2 GFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFE--QDNIVQYLGTDKDENRLYIFLELVTKGSL   66 (247)
Q Consensus         2 g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   66 (247)
                      |..+++|.......        ..+..|...++.+.  .-.+++++.+..+++..++||++++|.++
T Consensus        35 ~~~~vlK~~~~~~~--------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          35 RPVLFVKTDLSGAL--------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             SCCEEEEEECSCTT--------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             CCEEEEEeCCccCH--------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            55678887654321        13557777777774  23467788888888899999999988655

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.64  E-value=0.00014  Score=57.20  Aligned_cols=28  Identities=21%  Similarity=0.375  Sum_probs=24.0

Q ss_pred             CeeecCCCCCcEEEcCCCCeEEccccccc
Q 041080           98 NVVHRDIKCANILVDASGSVKLADFGLAK  126 (247)
Q Consensus        98 ~i~h~dl~~~ni~~~~~~~~~l~df~~~~  126 (247)
                      .++|||+++.||+++++ .++++||..+.
T Consensus       224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~  251 (392)
T d2pula1         224 TLIHGDLHTGSIFASEH-ETKVIDPEFAF  251 (392)
T ss_dssp             EEECSCCCGGGEEECSS-CEEECCCTTCE
T ss_pred             ceeccCCcCCceeEcCC-ceEEechhhcc
Confidence            58999999999999876 48999997763

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.42  E-value=0.00038  Score=53.17  Aligned_cols=58  Identities=16%  Similarity=0.081  Sum_probs=37.1

Q ss_pred             CCceEEEEEEeecCCCccchHHHHHHHHHHHHHhhcCCCce--eeece-----eeecCCcEEEEEeccccC
Q 041080            1 DGFFFAVKEVSLQDQGAQGKQSILQLEQEISLLSQFEQDNI--VQYLG-----TDKDENRLYIFLELVTKG   64 (247)
Q Consensus         1 ~g~~~~lK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~~-----~~~~~~~~~lv~e~~~~~   64 (247)
                      ||+.|++|+.+...      -+.+.+..|...+..|...++  +..+.     .+...+..+.++++.+|.
T Consensus        45 dg~~~VlK~~rp~~------~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          45 DRRRFVVKFYRPER------WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             TCCCEEEEEECTTT------SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             CCCEEEEEEeCCCC------CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            68899999997532      123456788888888743222  22222     234566789999999874

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.75  E-value=0.0025  Score=49.86  Aligned_cols=38  Identities=13%  Similarity=0.087  Sum_probs=25.9

Q ss_pred             HHHHHHHHHhhcC-CCceeeeceeeecCCcEEEEEeccccCcH
Q 041080           25 QLEQEISLLSQFE-QDNIVQYLGTDKDENRLYIFLELVTKGSL   66 (247)
Q Consensus        25 ~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   66 (247)
                      ...+|..+++.+. +.-.+++++++..    ..|+||++|.++
T Consensus        90 dr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l  128 (395)
T d1nw1a_          90 HLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  128 (395)
T ss_dssp             HHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             HHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence            3457888888885 4334567776643    588999988543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.67  E-value=0.0036  Score=47.23  Aligned_cols=30  Identities=27%  Similarity=0.298  Sum_probs=26.2

Q ss_pred             CCeeecCCCCCcEEEcCCCCeEEccccccc
Q 041080           97 RNVVHRDIKCANILVDASGSVKLADFGLAK  126 (247)
Q Consensus        97 ~~i~h~dl~~~ni~~~~~~~~~l~df~~~~  126 (247)
                      .|++|+|+.++|++++.+...-++||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            479999999999999988777899998763